Each zone had 15 traps divided between the villages with 1–3 sentinel houses per village proportional to village size.,Each zone 15 traps divided villages 1–3 sentinel houses village proportional village size.,G0000000|C1710706|C0450371|C0184047|C0332849|C0562518|G0000000|C0950580|C0442519|C0562518|C0205351|C0562518|C0456389
incapable of carrying out light housework or office work); ii) active liver or kidney disease; iii) prior diagnosis of cancer (excluding non-melanoma skin cancer); iv) diagnosed HIV infection; v) on immunosuppressive therapy; vi) diminished mental capacity; vii) taking ≥50 µg/day of Se supplements in the previous six months (by patient report).,incapable carrying light housework office work); ii) active liver kidney disease; iii) prior diagnosis cancer (excluding non-melanoma skin cancer); iv) diagnosed HIV infection; v) immunosuppressive therapy; vi) diminished mental capacity; vii) ≥50 µg/day Se supplements previous months (by patient report).,C1550518|C0206243|C0023693|C0020053|C0442603|C0043227|G0000000|C0205177|C0023884|C0022646|C0012634|C0439070|C0332152|C0011900|C0006826|C0332196|C1518422|C0444099|C0006826|C0022326|C0011900|C0019682|C0009450|G0000000|C0021081|C0039798|C0205999|C0205216|C0229992|C1516240|C0445385|G0000000|G0000000|C0036919|C0242295|C0205156|C0439231|G0000000|C0030705|C0684224
"The median age of the patients at baseline was 79 years, and approximately half (54%) were female; 67% were non-Hispanic white, 21% were African-American, and 11% were Hispanic/Latino.","The median age patients baseline 79 years, half (54%) female; 67% non-Hispanic white, 21% African-American, 11% Hispanic/Latino.",G0000000|C0549183|C0001779|C0030705|C0168634|C0450371|C0439234|C2825407|C0450371|C0015780|C0450371|C1518424|C0007457|C0450371|C0085756|C0450371|C0086409
"Participants (n = 34) in this qualitative analysis were drawn from a larger, randomized controlled, multiphased, longitudinal, mixed methods trial conducted at the National Institutes of Health (NIH), Clinical Center (CC) to evaluate the efficacy of the Palliative Care Service intervention compared to usual care for patients with advanced malignancies who were enrolled in cancer clinical trials that included undergoing surgical procedures in National Cancer Institute (NCI) Surgery Branch clinical trials.","Participants (n = 34) qualitative analysis drawn larger, randomized controlled, multiphased, longitudinal, mixed methods trial conducted National Institutes Health (NIH), Clinical Center (CC) evaluate efficacy Palliative Care Service intervention compared usual care patients advanced malignancies enrolled cancer clinical trials included undergoing surgical procedures National Cancer Institute (NCI) Surgery Branch clinical trials.",C0679646|G0000000|C0205556|C0002778|C0013113|C0549177|C0034656|C2587213|G0000000|C0205127|C0205430|C0025663|C0008976|C0004927|C3245503|C0021622|C0018684|C0027468|C0205210|C0205099|C3538933|C0220825|C1280519|C0587605|C1947933|C0557854|C0886296|C1707455|C3538928|C1947933|C0030705|C0205179|C0006826|G0000000|C0006826|C0205210|C0008976|C0332257|G0000000|C0543467|C0025664|C3245503|C0006826|C0021622|C1513882|C0038894|C1253959|C0205210|C0008976
The villages randomized to the intervention group received the TSC program and villages in the control group did not receive the TSC until after the study.,The villages randomized intervention received TSC program villages control receive TSC study.,G0000000|C0562518|C0034656|C0886296|C1514756|G0000000|C1709697|C0562518|C0243148|C1514756|G0000000|C0557651
Archival tumor samples and newly obtained core or excisional biopsy samples from nonirradiated sites were permitted.,Archival tumor samples newly core excisional biopsy samples nonirradiated sites permitted.,C0003738|C0027651|C0370003|C0750546|C0444669|C0728940|C0005558|C0370003|G0000000|C0205145|C0329040
Patients between 18 and 85 years and on stable haemodialysis (>3 months on haemodialysis with adequate dialysis efficacy) were included.,Patients 18 85 stable haemodialysis (>3 months haemodialysis adequate dialysis efficacy) included.,C0030705|C0450371|C0450371|C0205360|C0019004|G0000000|C0439231|C0019004|C0205410|C0011945|C1280519|C0332257
pencil case and teddy bear) were provided at each of these visits to minimize attrition.,pencil teddy bear) provided visits minimize attrition.,C0441059|G0000000|C0004897|C1999230|C0545082|G0000000|C0004277
We identified all women aged 75 to 85 years who were residents of greater Vancouver and in whom osteoporosis or osteopenia had been diagnosed at the BC Women’s Hospital and Health Centre (defined as a T-score at the total hip or spine at least 1.0 standard deviations below the young normal sex-matched areal bone mineral density of the Lunar reference database) 11 as potential participants.,We identified women aged 75 85 residents Vancouver osteoporosis osteopenia diagnosed BC Women’s Hospital Health Centre (defined T-score total hip spine 1.0 standard deviations normal sex-matched areal bone mineral density Lunar reference database) 11 potential participants.,G0000000|C0205396|C0043210|C0001779|C0450371|C0450371|C1320928|G0000000|C0029456|C0029453|C0011900|C0006041|G0000000|C0019994|C0018684|C0205099|C1704788|C3854607|C0439175|C0019552|C0037949|G0000000|C1442989|C0012727|C0205307|C0009253|C0017446|C0262950|C0006660|C0178587|C0037125|C1514811|C0242356|C0450371|C3245505|C0679646
"This cohort consists of a carefully characterized population of women with type 1 diabetes, in whom comprehensive data about pregnancy progress and pregnancy outcomes has been collected.","This cohort consists carefully characterized population women type 1 diabetes, comprehensive data pregnancy progress pregnancy outcomes collected.",G0000000|C0599755|C0332529|G0000000|C1880022|C0032659|C0043210|C0332307|G0000000|C0011847|C1880156|C1511726|C0032961|C1272688|C0032961|C1274040|C1516695
Data were obtained from 3608 students in grades 5 through 12 in 10 schools.,Data 3608 students grades 5 12 10 schools.,C1511726|G0000000|C0038492|C0441800|G0000000|C0450371|C0450371|C0036375
"Of the 120 screened participants, 74 met the eligibility criteria and 73 were randomized, 36 to the treated group and 37 to the control group (Figure 1).","Of 120 screened participants, 74 met eligibility criteria 73 randomized, 36 treated 37 control (Figure 1).",G0000000|C1442061|C0220908|C0679646|C0450371|C0268621|C0013893|C0243161|C0450371|C0034656|C0450371|C1522326|C0450371|C0243148|G0000000|G0000000
"Exclusion criteria are current severe exacerbation of bronchiectasis (dyspnoea, hypoxia or hospitalisation), recent (in last 8 weeks) in the entry; CF; liver dysfunction; allergy or sensitivity to penicillin or macrolides; current or recent lower airway infection by a member of the Pseudomonas genus group of Gram-negative bacteria (in the four months prior to study enrolment); has received antibiotics belonging to the macrolide or penicillin class of antibiotics within three weeks immediately prior to study entry; or is currently receiving oncological treatment.","Exclusion criteria current severe exacerbation bronchiectasis (dyspnoea, hypoxia hospitalisation), (in 8 weeks) entry; CF; liver dysfunction; allergy sensitivity penicillin macrolides; current lower airway infection Pseudomonas genus Gram-negative bacteria (in months prior study enrolment); received antibiotics belonging macrolide penicillin class antibiotics weeks prior study entry; receiving oncological treatment.",C0680251|C0243161|C0521116|C0205082|G0000000|C0006267|C0013404|C0242184|C0019993|G0000000|G0000000|C0439230|C1705654|C0009738|C0023884|C0031847|C0002111|C0020517|C0030827|C0003240|C0521116|C0441994|C0178987|C0009450|C0033808|C1708235|C0439208|C0004611|G0000000|C0439231|C0332152|C0557651|C1516879|C1514756|C0003232|G0000000|C0003240|C0030827|C0456387|C0003232|C0439230|C0332152|C0557651|C1705654|C1514756|C0027651|C0039798
"Stroke survivors are eligible to participate if they satisfy the following: (1) primary stroke 6 to 24 months prior to the beginning of the intervention, (2) moderate stroke condition (50 > FMA score > 20) [32,33], (3) ability to understand simple commands (Mini Mental State Examination score > 21), and (4) ability to differentiate sensation on one finger from the other fingers.","Stroke survivors eligible participate satisfy following: (1) primary stroke 6 24 months prior intervention, (2) moderate stroke condition (50 > FMA score > 20) [32,33], (3) ability understand simple commands (Mini Mental State Examination score > 21), (4) ability differentiate sensation finger fingers.",C0038454|C0206194|C1548635|G0000000|G0000000|C0231290|G0000000|C0205225|C0038454|G0000000|C0450371|C0439231|C0332152|C0886296|G0000000|C0205081|C0038454|C0012634|G0000000|G0000000|C0450371|G0000000|C0085732|C0162340|C0205352|C3639196|C0445542|C0229992|C1301808|G0000000|G0000000|G0000000|C0085732|C0205615|C0036658|C0016129|C0016129
Subjects were employees of the Denver Veterans Affairs Medical Center.,Subjects employees Denver Veterans Affairs Medical Center.,C0681850|C0024752|G0000000|C0042610|G0000000|C0199168|C0205099
"We excluded people who were already taking vitamin D supplements and people with conditions that were contraindications to vitamin D supplementation—for example, a history of renal stones, sarcoidosis, or malignancy.","We excluded people vitamin D supplements people conditions contraindications vitamin D supplementation—for example, history renal stones, sarcoidosis, malignancy.",G0000000|C1554077|C0027361|C0042890|C0073187|C0242295|C0027361|C0012634|C0079164|C0042890|C0073187|G0000000|C1707959|C0019664|C0022646|C0006736|C0036202|C0006826
"Case participants were recruited between December 2003 and March 2007 at Atrak Clinic, the only gastrointestinal specialty clinic in the study area.","Case participants recruited December 2003 March 2007 Atrak Clinic, gastrointestinal specialty clinic study area.",C0868928|C0679646|G0000000|C3830550|G0000000|C3829202|G0000000|G0000000|C0002424|C0521362|C0037778|C0002424|C0557651|C0017446
300 smokers attending dental or general health care were randomly assigned to two arms and referred to the local dental clinic for smoking cessation support.,300 smokers attending dental health care randomly assigned arms referred local dental clinic smoking cessation support.,C1442061|C0337664|C1547429|C0011365|C0018684|C1947933|G0000000|C1516050|C0206655|C0205543|C0205276|C0011365|C0002424|C0037369|C1880019|C0183683
Seventy-five female patients with FMS according to the ACR definition between the ages of 18–50 (35.0±8.8) were randomized into three groups.,Seventy-five female patients FMS ACR definition ages 18–50 (35.0±8.8) randomized groups.,C3816957|C0015780|C0030705|G0000000|C1412134|C1550452|C0001779|G0000000|G0000000|C0034656|C0441833
"The patients who had a residual upper extremity deficit from a previous stroke, intolerance to upright position, visual problem, cognitive deficit preventing them from following instructions, and unilateral neglect preventing them from being able to view the mirror were excluded.","The patients residual upper extremity deficit previous stroke, intolerance upright position, visual problem, cognitive deficit preventing instructions, unilateral neglect preventing view mirror excluded.",G0000000|C0030705|C1609982|C1282910|C0015385|C0162429|C0205156|C0038454|C0231199|C0522015|C0733755|C0234621|C0033213|C1516691|C0162429|C0309872|C0302828|C0205092|C0521874|C0309872|C0449911|C0181868|C1554077
The study took place in rural villages located around the town of Ambalavao in the Ambalavao district of Madagascar.,The study rural villages located town Ambalavao Ambalavao district Madagascar.,G0000000|C0557651|C0240919|C0562518|G0000000|C0557750|G0000000|G0000000|G0000000|C0024443
Patients with proved fungal keratitis (smear and culture positive for fungus) with an ulcer area of at least 2 mm2 and not more than 60 mm2 were identified as potential participants for the study.,Patients proved fungal keratitis (smear culture positive fungus) ulcer 2 mm2 60 mm2 identified potential participants study.,C0030705|G0000000|C0016832|C0022568|C0444186|C0010453|C0439178|C0016832|C0041582|G0000000|G0000000|C0450371|G0000000|C0205396|C3245505|C0679646|C0557651
"During baseline, participants had to have headache occurring on ≥15 days/4 weeks, with each day consisting of ≥4 h of continuous headache, and ≥50% of headache days being migraine or probable migraine days (referred to as migraine days).","During baseline, participants headache occurring ≥15 days/4 weeks, day consisting ≥4 continuous headache, ≥50% headache days migraine probable migraine days (referred migraine days).",G0000000|C0168634|C0679646|C0018681|C1709305|G0000000|C0439228|C0439230|C0332173|C0332529|G0000000|C0549178|C0018681|G0000000|C0018681|C0439228|C0149931|C0033204|C0149931|C0439228|C0205543|C0149931|C0439228
"The exclusion criteria were (a) multiple strokes, (b) bilateral impairment, (c) severe sensory deficits in the paretic upper limb, (d) the inability to provide informed consent, and (e) medical conditions that could interfere with treatment (severe cardiovascular disease, severe visual or auditory impairments, and orthopedic contracture).","The exclusion criteria (a) multiple strokes, (b) bilateral impairment, (c) severe sensory deficits paretic upper limb, (d) inability provide informed consent, (e) medical conditions interfere treatment (severe cardiovascular disease, severe visual auditory impairments, orthopedic contracture).",G0000000|C0680251|C0243161|G0000000|C0439064|C0038454|G0000000|C0238767|C0221099|G0000000|C0205082|C0445254|C2987487|G0000000|C1282910|C0015385|C0073187|G0000000|C1999230|C1522154|C1511481|G0000000|C0199168|C0012634|C0521102|C0039798|C0205082|C0007226|C0012634|C0205082|C0234621|C0439825|C0684336|C0029355|C0009917
We conducted a cluster randomised controlled trial in the 40 electoral wards that had Jarman scores at least one standard deviation greater than the national mean.,We conducted cluster randomised controlled trial 40 electoral wards Jarman scores standard deviation national mean.,G0000000|C0004927|C1555715|G0000000|C2587213|C0008976|C0450371|G0000000|C1305702|G0000000|C0449820|C1442989|C0012727|C3245503|C0444504
"All children met diagnostic criteria for Autistic Disorder on the Autism Diagnostic Interview-Revised (ADI-R; Lord, Rutter, & Le Couteur, 1994) and 64 children also met diagnostic criteria for Autistic Disorder on the Autism Diagnostic Observation Schedule-Generic (ADOS-G; Lord et al., 2000).","All children met diagnostic criteria Autistic Disorder Autism Diagnostic Interview-Revised (ADI-R; Lord, Rutter, & Le Couteur, 1994) 64 children met diagnostic criteria Autistic Disorder Autism Diagnostic Observation Schedule-Generic (ADOS-G; Lord al., 2000).",G0000000|C0008059|C0268621|C0011900|C0243161|C0004352|C0012634|C0004352|C0011900|C0021822|C0205090|C1422581|G0000000|G0000000|C0023190|G0000000|G0000000|C0450371|C0008059|C0268621|C0011900|C0243161|C0004352|C0012634|C0004352|C0011900|C0302523|C0086960|C0670018|C1422581|C0202311|G0000000
The selected eye had to show worsening of VA within the past 3 years following either acute optic neuritis (AON) or slowly progressive optic neuropathy (PON).,The selected eye worsening VA 3 acute optic neuritis (AON) slowly progressive optic neuropathy (PON).,G0000000|C1707391|C0015392|C0332271|C1549054|G0000000|C0205178|C0015392|C0027813|G0000000|C0439834|C0205329|C0015392|C0442874|C1418754
Evaluation of the efficacy of nebulized magnesium sulfate (MgSO4) alone and in combination with salbutamol in acute asthma.,Evaluation efficacy nebulized magnesium sulfate (MgSO4) combination salbutamol acute asthma.,C0220825|C1280519|C1549531|C0024467|C0038720|G0000000|C0205195|C0001927|C0205178|C0004096
"Other exclusion criteria were severe pulmonary, cardiovascular, renal, or neurological disease precluding involvement in aerobic exercise and inability to cooperate, but no participants were excluded for these reasons.","Other exclusion criteria severe pulmonary, cardiovascular, renal, neurological disease precluding involvement aerobic exercise inability cooperate, participants excluded reasons.",G0000000|C0680251|C0243161|C0205082|C0024109|C0007226|C0022646|C0205494|C0012634|G0000000|C1314939|C1510824|C0015259|G0000000|G0000000|C0679646|C1554077|C0392360
We aim to recruit 150 COPD patients for whom NIV is indicated.,We aim recruit 150 COPD patients NIV indicated.,G0000000|C1947946|G0000000|C1442061|C0024117|C0030705|C0598902|C1444656
"In order to cover this critical time period effectively, in PANTHERIS treatment was started 9 to 36 hours after stroke onset and continued for 5 days.","In cover critical time period effectively, PANTHERIS treatment started 9 36 hours stroke onset continued 5 days.",G0000000|C0180153|C1511545|C0040223|C0439531|G0000000|G0000000|C0039798|C1272689|G0000000|C0450371|C0439227|C0038454|C0206132|C0549178|G0000000|C0439228
"Design: Healthy, singleton infants aged 6–11 mo (n = 589) were recruited from an urban slum of Cap Haitien and randomly assigned to receive: 1) a control; 2) a 3-mo LNS; or 3) a 6-mo LNS.","Design: Healthy, singleton infants aged 6–11 mo (n = 589) recruited urban slum Cap Haitien randomly assigned receive: 1) control; 2) 3-mo LNS; 3) 6-mo LNS.",C1707689|C3898900|C0481462|C0021270|C0001779|G0000000|C0026544|C0369718|G0000000|C1442061|G0000000|C0442529|C0037345|C0179586|G0000000|G0000000|C1516050|C1514756|G0000000|C0243148|G0000000|C0026544|C0023374|G0000000|C0026544|C0023374
Almost 60% of Australian general practices now employing a practice nurse [18] and practice nurses are increasingly regarded as core members of general practice teams [19].,Almost 60% Australian practices employing practice nurse [18] practice nurses increasingly regarded core practice teams [19].,C3828842|C0450371|C0238711|C0237607|C0557351|C0237607|C0028661|C0450371|C0237607|C0028661|G0000000|G0000000|C0444669|C0237607|C0871489|C0450371
Thirty-four CF patients (26 ± 6.5 years) were included in the study.,Thirty-four CF patients (26 ± 6.5 years) included study.,C3816446|C0009738|C0030705|C0450371|G0000000|G0000000|C0439234|C0332257|C0557651
A punch biopsy specimen taken for culture 8 weeks after the skin graft had broken down was positive.,A punch biopsy specimen culture 8 weeks skin graft broken positive.,G0000000|C0182555|C0005558|C0370003|C0010453|G0000000|C0439230|C0444099|C0181074|C1881704|C0439178
"Patients 13 years or older in whom the CAI was maintained at 5 or less while receiving drugs such as mesalazine, salazosulfapyridine, or steroids, with no change in treatment regimens within 4 wk before study entry, were enrolled in this randomized, double-blind, placebo-controlled study.","Patients 13 CAI maintained 5 receiving drugs mesalazine, salazosulfapyridine, steroids, change treatment regimens 4 wk study entry, enrolled randomized, double-blind, placebo-controlled study.",C0030705|C0450371|C0064494|C1314677|G0000000|C1514756|C0013227|C0127615|C0036078|C0038317|C0392747|C0039798|C2945654|G0000000|C0332174|C0557651|C1705654|G0000000|C0034656|C0013072|C1706408|C0557651
"Other inclusion criteria were as follows: Karnofsky performance status ≥60; life expectancy >8 weeks; estimated ascites volume >1 L by CT scan; at least one symptomatic paracentesis within 5 weeks as well as an objectively verified, clinical need for a second paracentesis and refractory or resistant to chemotherapy or standard chemotherapy was no longer feasible.","Other inclusion criteria follows: Karnofsky performance status ≥60; life expectancy >8 weeks; estimated ascites volume >1 L CT scan; symptomatic paracentesis 5 weeks objectively verified, clinical paracentesis refractory resistant chemotherapy standard chemotherapy feasible.",G0000000|C0007637|C0243161|C0332283|C0206065|C0597198|C0449438|G0000000|C0376558|C0679138|G0000000|C0439230|C0750572|C0003962|C0449468|G0000000|C0439394|C0007673|C0034606|C0231220|C0034115|G0000000|C0439230|G0000000|C1711411|C0205210|C0034115|C0205269|C0332325|C0013216|C1442989|C0013216|G0000000
"Children were excluded if they: (1) were in the lower 10 percentile of U.S. standard weight and height, (2) had a history of esophageal or digestive disease, (3) had congenital craniofacial malformation, or (4) had a history of adenoidectomy, tympanostomy tubes, or tympanic membrane perforations.","Children excluded they: (1) lower 10 percentile U.S. standard weight height, (2) history esophageal digestive disease, (3) congenital craniofacial malformation, (4) history adenoidectomy, tympanostomy tubes, tympanic membrane perforations.",C0008059|C1554077|G0000000|G0000000|C0441994|C0450371|C1264641|C0041703|C1442989|C0005910|C0489786|G0000000|C0019664|C1522619|C0012238|C0012634|G0000000|C0009678|C0596392|C0000768|G0000000|C0019664|C0001425|C0087123|C0175730|C0041445|C0025255|C0549099
"In addition, neuropsychological test data from the baseline assessment battery were reviewed to ensure the absence of dementia or MCI.","In addition, neuropsychological test data baseline assessment battery reviewed ensure absence dementia MCI.",G0000000|C0332287|G0000000|C0022885|C1511726|C0168634|C1261322|C0337088|C0282443|C0218063|C0332197|C0011265|C0560005
Children were excluded from the RCT if they were: (1) unable to take oral medications; (2) had features of severe malaria1; (3) had a known haemoglobinopathy; (4) were enrolled in another project; (5) had already received antimalarial drugs from other sources outside the project team or (6) were prescribed other drugs with potential antimalarial or antianaemic effects such as co-trimoxazole and haematinics.,Children excluded RCT were: (1) unable oral medications; (2) features severe malaria1; (3) haemoglobinopathy; (4) enrolled project; (5) received antimalarial drugs sources project team (6) prescribed drugs potential antimalarial antianaemic effects co-trimoxazole haematinics.,C0008059|C1554077|G0000000|G0000000|G0000000|C1299582|C0442027|C0013227|G0000000|C1521970|C0205082|G0000000|G0000000|C0019045|G0000000|G0000000|C1709701|G0000000|C1514756|C0003374|C0013227|C0449416|C1709701|C0871489|G0000000|C0278329|C0013227|C3245505|C0003374|C0279517|C1280500|C0041044|C0018928
Infants with gestational age (GA) of ≤32 weeks who started enteral feeding within the first 7 days of life were randomized to receive PDHM or PF as a supplement to the OMM insufficient or unavailable.,Infants gestational age (GA) ≤32 weeks started enteral feeding 7 days life randomized receive PDHM PF supplement OMM insufficient unavailable.,C0021270|C0439671|C0001779|C0016993|G0000000|C0439230|C1272689|C1304890|C0204695|G0000000|C0439228|C0376558|C0034656|C1514756|G0000000|C3815179|C0242295|G0000000|C0205412|C0686905
"Inclusion criteria are (1) 2 to 17 years of age, (2) diagnosis of asthma/reactive airways/viral-induced wheeze plus at least one prior acute episode of wheezing treated with inhaled ß2 agonists or oral corticosteroids, (3) persistent moderate to severe airway obstruction after oral steroid and three doses of salbutamol and ipratropium, defined as a PRAM ≥5 [73].","Inclusion criteria (1) 2 17 age, (2) diagnosis asthma/reactive airways/viral-induced wheeze prior acute episode wheezing treated inhaled ß2 agonists oral corticosteroids, (3) persistent moderate severe airway obstruction oral steroid doses salbutamol ipratropium, defined PRAM ≥5 [73].",C0007637|C0243161|G0000000|G0000000|C0450371|C0001779|G0000000|C0011900|C0004096|C0178987|C0043144|C0332152|C0205178|C0332189|C0043144|C1522326|C0004048|G0000000|C0243192|C0442027|C0001617|G0000000|C0205322|C0205081|C0205082|C0178987|C0028778|C0442027|C0038317|C0178602|C0001927|C0027235|C1704788|C0441454|G0000000|C0450371
"Of the 5412 students enrolled in participating schools, 4689 (86.6%) completed the baseline survey.","Of 5412 students enrolled participating schools, 4689 (86.6%) completed baseline survey.",G0000000|G0000000|C0038492|G0000000|C0679823|C0036375|G0000000|C0450371|C0205197|C0168634|C0038951
With a large sample of 500 UHR participants this study will investigate the most effective type and sequence of treatments for improving functioning and reducing the risk of developing psychotic disorder in this clinical population.,With sample 500 UHR participants study investigate effective type sequence treatments improving functioning reducing risk developing psychotic disorder clinical population.,G0000000|C0370003|C1442061|G0000000|C0679646|C0557651|C1292732|C1280519|C0332307|C0004793|C0087111|C1272745|C0205245|C0392756|C0035647|G0000000|C0004936|C0012634|C0205210|C0032659
Patients were to have a Modified Medical Research Council dyspnoea scale score of ≥2 and a history of at least one COPD exacerbation requiring oral corticosteroids or antibacterials within 1–12 months before the first study visit.,Patients Modified Medical Research Council dyspnoea scale score ≥2 history COPD exacerbation requiring oral corticosteroids antibacterials 1–12 months study visit.,C0030705|C0392747|C0199168|C0035168|C1551807|C0013404|C0175659|C0449820|G0000000|C0019664|C0024117|G0000000|G0000000|C0442027|C0001617|C0279516|G0000000|C0439231|C0557651|C0545082
The study will be conducted in eight NHS hospitals (16 wards) which care for those at risk of developing delirium (geriatric medicine or orthopaedic trauma wards).,The study conducted NHS hospitals (16 wards) care risk developing delirium (geriatric medicine orthopaedic trauma wards).,G0000000|C0557651|C0004927|C0796085|C0019994|C0450371|C1305702|C1947933|C0035647|G0000000|C0011206|C1704440|C0013227|C0029355|C0043251|C1305702
The endothelin system is implicated in the pathogenesis of melanoma.,The endothelin system implicated pathogenesis melanoma.,G0000000|C0079284|C0449913|G0000000|C0543483|C0025202
Individuals with a previous history of alcohol or other drug dependence were eligible provided that criteria for dependence had not been met within the last 12 months.,Individuals previous history alcohol drug dependence eligible provided criteria dependence met 12 months.,C0027361|C0205156|C0019664|C0001962|C0013227|C0011546|C1548635|C1999230|C0243161|C0011546|C0268621|C0450371|C0439231
"Patients with glaucoma, cataract, retinal detachment or denaturation, and other ocular diseases affecting vision were excluded.","Patients glaucoma, cataract, retinal detachment denaturation, ocular diseases vision excluded.",C0030705|C0017601|C0086543|C0035298|C0541879|C0301642|C0015392|C0012634|C0042789|C1554077
"Median age at ALL diagnosis was 3.9 years (0.4–18.6), median age at study enrollment was 15.7 years (6.9–28.9), and median time from completion of ALL therapy was 7.4 years (1.9–20.3).","Median age ALL diagnosis 3.9 (0.4–18.6), median age study enrollment 15.7 (6.9–28.9), median time completion ALL therapy 7.4 (1.9–20.3).",C0549183|C0001779|C0444868|C0011900|G0000000|G0000000|C0549183|C0001779|C0557651|C1516879|C0450371|G0000000|C0549183|C0040223|C0205197|C0444868|C0039798|G0000000|G0000000
"Although fewer falls occurred overall in intervention units, this difference was noted only for patients aged 65 years or older, in whom it was found to be significant.","Although fewer falls occurred intervention units, difference patients aged 65 older, significant.",G0000000|C0205388|C0000921|C1709305|C0886296|C0439148|C1705241|C0030705|C0001779|C0450371|C0580836|C0237881
"Eligibility criterions were that the participants had to be healthy, over 65 years of age, and have been relatively sedentary (undertaking no leisure time physical activity or less than 30 minutes of physical activity per day) for at least a year.","Eligibility criterions participants healthy, 65 age, sedentary (undertaking leisure time physical activity 30 minutes physical activity day) year.",C0013893|C0243161|C0679646|C3898900|C0450371|C0001779|C0205254|C0041666|C0086542|C0040223|C0031809|C0205177|C0450371|C0439232|C0031809|C0205177|C0332173|C0439234
"In the intention to treat population of 251 patients—hypericum extract (100 patients), imipramine (105), and placebo (46)—the three treatment groups were comparable for sex, age, height, weight, diagnoses according to the ICD-10, and scores on the initial Hamilton depression and Hamilton anxiety scales (table (table11).","In intention treat population 251 patients—hypericum extract (100 patients), imipramine (105), placebo (46)—the treatment comparable sex, age, height, weight, diagnoses ICD-10, scores initial Hamilton depression Hamilton anxiety scales (table (table11).",G0000000|C0162425|C0087111|C0032659|C1442061|G0000000|C2828366|C1442061|C0030705|C0020934|C1442061|C0032042|G0000000|C0039798|G0000000|C0009253|C0001779|C0489786|C0005910|C0011900|C0021122|C0449820|C0205265|G0000000|C0011570|G0000000|C0003467|C0175659|C0039224|G0000000
"The mean age of the sample was 58.5 (SD, ±15.8) years.","The age sample 58.5 (SD, ±15.8) years.",G0000000|C0001779|C0370003|C0450371|C2699239|G0000000|C0439234
The patients were followed every three months for at least three years or until death.,The patients months death.,G0000000|C0030705|C0439231|C0011065
"Excluded were inmates with history of treatment-limiting reaction to INH or rifamycins, pregnancy or breast-feeding, aspartate aminotransferase (AST) or alanine aminotransferase (ALT) > 3 times the upper limit of normal (ULN), bilirubin > 2 times ULN, platelets < 150 K/mm3, or taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors.","Excluded inmates history treatment-limiting reaction INH rifamycins, pregnancy breast-feeding, aspartate aminotransferase (AST) alanine aminotransferase (ALT) > 3 times upper limit normal (ULN), bilirubin > 2 times ULN, platelets < 150 K/mm3, protease inhibitors nonnucleoside reverse transcriptase inhibitors.",C1554077|G0000000|C0019664|C0039798|C0443286|C0022209|C0035609|C0032961|C0006147|C0085845|C0002594|C3891303|C0001898|C0002594|C1266129|G0000000|G0000000|C0040223|C1282910|C0439801|C0205307|C1519815|C0005437|G0000000|G0000000|C0040223|C1519815|C0005821|G0000000|C1442061|C0597277|C0030946|C0243077|G0000000|C1555029|C0040646|C0243077
"Planned subgroup analyses will be conducted for participants with IPF, dust-related ILD and connective tissue-related ILD.","Planned subgroup analyses conducted participants IPF, dust-related ILD connective tissue-related ILD.",C1301732|C1079230|C0002778|C0004927|C0679646|C0034069|C0013330|C0206062|G0000000|C0040300|C0206062
"At interview we excluded people if they were on long term oral corticosteroids, not taking their prescribed ICS for at least four days a week, or had other chronic active lung disease or lung cancer.","At interview excluded people term oral corticosteroids, prescribed ICS days week, chronic active lung disease lung cancer.",G0000000|C0021822|C1554077|C0027361|C0233324|C0442027|C0001617|C0278329|C0022521|C0439228|C0332174|C0205191|C0205177|C0024109|C0012634|C0024109|C0006826
The usual rate of loss of brain parenchymal tissue reported in the literature for untreated RRMS cohorts is about 1% per annum16.,The usual rate loss brain parenchymal tissue reported literature untreated RRMS cohorts 1% annum16.,G0000000|C3538928|C0871208|C1517945|C0006104|C0933845|C0040300|C0684224|C0023866|C0332155|C1522002|C0599755|G0000000|G0000000
"However, the first respiratory illness in the birth cohort studies was reported between 4.2 and 6 months, and our mean enrolment age was 3.6 months.","However, respiratory illness birth cohort studies reported 4.2 6 months, enrolment age 3.6 months.",G0000000|C0521346|C0221423|C0005615|C0599755|C0947630|C0684224|G0000000|G0000000|C1516879|C0001779|G0000000
402 smokers aged 50 years and older were recruited from the community.,402 smokers aged 50 recruited community.,C1442061|C0337664|C0001779|C0450371|G0000000|C0009462
Their mean age was 9.09±3.12 years (range 3 to 14 years).,Their age 9.09±3.12 (range 3 14 years).,G0000000|C0001779|G0000000|C1514721|G0000000|C0450371|C0439234
"Participants in the trial included 502 black families in rural Georgia; in each family, an adolescent who was 16 years of age at recruitment (51% girls) and the adolescent’s primary caregiver (in most cases the biological mother) provided data.","Participants trial included 502 black families rural Georgia; family, adolescent 16 age recruitment (51% girls) adolescent’s primary caregiver (in biological mother) provided data.",C0679646|C0008976|C0332257|C1442061|C0005680|C0015576|C0240919|C0017452|C0015576|C0205653|C0450371|C0001779|C2949735|C0450371|C0870604|G0000000|C0205225|C0085537|G0000000|C0005532|C0026591|C1999230|C1511726
"When our project began, the largest proportion (41%) of the 1.22 million Vietnamese in the United States lived in California, with 105 000 living in Santa Clara County.11 Many Vietnamese in Santa Clara County were working in high-tech manufacturing plants, restaurants, shops, nail salons, and social service agencies.","When project began, largest proportion (41%) 1.22 Vietnamese United States lived California, 105 000 living Santa Clara County.11 Many Vietnamese Santa Clara County high-tech manufacturing plants, restaurants, shops, nail salons, social service agencies.",G0000000|C1709701|C0439659|C0443228|C1709707|C0450371|C0450371|C0042660|C0166872|C1301808|C1548795|C0006754|C1442061|C1442061|C0376558|G0000000|G0000000|C0079170|G0000000|C0042660|G0000000|G0000000|C0079170|C0205250|C0870840|C0032098|C0035255|C0700383|C0027342|G0000000|C0728831|C0557854|C0237463
"Patients were excluded if they had diarrhoea at least 25% of the time during the previous three months, any history of cathartic colon or laxative abuse, or any other significant bowel disorders.","Patients excluded diarrhoea 25% time previous months, history cathartic colon laxative abuse, bowel disorders.",C0030705|C1554077|C0011991|C0450371|C0040223|C0205156|C0439231|C0019664|C0007422|C0009368|C0282090|C0013146|C0021853|C0012634
"Patients presenting during the hours of screening were invited to participate in the study if they: 1) reported binge drinking,(five or more drinks in two hours for males and four or more for females); and/or high-risk behaviors in conjunction with alcohol use (unplanned or unprotected sex, driving or riding with a drunk driver, injury, fighting, a car crash, or an arrest); and/or an AUDIT score of ≥ 4 for ages 14–17 years, or ≥8 for ages 18–21 years.","Patients hours screening invited participate study they: 1) reported binge drinking,(five drinks hours males females); and/or high-risk behaviors conjunction alcohol (unplanned unprotected sex, driving riding drunk driver, injury, fighting, car crash, arrest); and/or AUDIT score ≥ 4 ages 14–17 years, ≥8 ages 18–21 years.",C0030705|C0439227|C0220908|G0000000|G0000000|C0557651|G0000000|G0000000|C0684224|C0596170|C0001948|C0452428|C0439227|C0086582|C0015780|G0000000|C0332167|C0004927|C2699427|C0001962|G0000000|G0000000|C0009253|C0004379|G0000000|C0001969|C0684312|C3263722|C0424324|C0004381|G0000000|C0237477|G0000000|C1704774|C0449820|G0000000|G0000000|C0001779|G0000000|C0439234|G0000000|C0001779|G0000000|C0439234
A total of 120 elderly participants (65–79 years) were recruited to the Nu-AGE project via the Clinical Research and Trials Unit (CRTU) at the UEA (REC reference 12/EE/0109) and were apparently healthy and free from current or recent (3 months) chronic disease.,A total 120 elderly participants (65–79 years) recruited Nu-AGE project Clinical Research Trials Unit (CRTU) UEA (REC reference 12/EE/0109) healthy free current (3 months) chronic disease.,G0000000|C0439175|C1442061|C0001792|C0679646|G0000000|G0000000|C0025932|C1709701|C0205210|C0035168|C0008976|C0439148|G0000000|G0000000|C1424025|C1514811|C0450371|C3898900|C0332296|C0521116|G0000000|C0205191|C0012634
"To minimise confounding by intercurrent illness and medication changes, the trial was limited to a two-week period and nursing and medical staff were asked not to alter participants’ psychotropic medications if possible.","To minimise confounding intercurrent illness medication changes, trial limited two-week period nursing medical staff alter participants’ psychotropic medications possible.",C0040363|G0000000|G0000000|G0000000|C0221423|C0013227|C0392747|C0008976|C0439801|C0205448|C0439531|C0006147|C0199168|C0851286|C0392747|G0000000|C0033978|C0013227|C0332149
"Exclusion criteria were infantile onset (<1 year); previous episodes of macrohematuria; hepatitis B virus, hepatitis C virus, or HIV infection; positivity for any marker of autoimmunity (antineutrophil antibody, nuclear DNA, antineutrophil cytoplasmic antibody); and low C3 levels.","Exclusion criteria infantile onset (<1 year); previous episodes macrohematuria; hepatitis B virus, hepatitis C virus, HIV infection; positivity marker autoimmunity (antineutrophil antibody, nuclear DNA, antineutrophil cytoplasmic antibody); low C3 levels.",C0680251|C0243161|C0231330|C0206132|G0000000|C0439234|C0205156|C0332189|G0000000|C0019158|G0000000|C0042776|C0019158|G0000000|C0042776|C0019682|C0009450|C0439178|C0005516|C0004364|G0000000|C0003241|C0521447|C0012854|G0000000|C0010834|C0003241|C0205251|G0000000|C0441889
"Interventions for chronic or recurrent low back pain in 579 patients recruited from primary care and comparisons between the trial groups Massage=Six sessions of therapeutic massage, one session per week.","Interventions chronic recurrent low pain 579 patients recruited primary care comparisons trial Massage=Six sessions therapeutic massage, session week.",C0886296|C0205191|C2945760|C0205251|C0030193|C1442061|C0030705|G0000000|C0205225|C1947933|C1707455|C0008976|C0024875|C1883016|C0087111|C0024875|C1883016|C0332174
A total of 40 infected primary mandibular molars were selected in 29 healthy children.,A total 40 infected primary mandibular molars selected 29 healthy children.,G0000000|C0439175|C0450371|C0439663|C0205225|C0024687|C0026367|C1707391|C0450371|C3898900|C0008059
"A total of 212 pregnant women (24 to 36 weeks’ gestation), aged at least 17 years, with LBPGP, will be randomly assigned to the verum auricular acupuncture plus standard obstetric care group (VAAc), to the non-specific auricular acupuncture plus standard obstetric care group (NSAAc), to the non-specific placebo auricular acupuncture plus standard obstetric care group (PAAc), or the standard obstetric care group (SOC).","A total 212 pregnant women (24 36 weeks’ gestation), aged 17 years, LBPGP, randomly assigned verum auricular acupuncture standard obstetric care (VAAc), non-specific auricular acupuncture standard obstetric care (NSAAc), non-specific placebo auricular acupuncture standard obstetric care (PAAc), standard obstetric care (SOC).",G0000000|C0439175|C1442061|C0549206|C0043210|C0450371|C0450371|G0000000|C0032961|C0001779|C0450371|C0439234|G0000000|G0000000|C1516050|G0000000|C1522191|C0001299|C1442989|C0205484|C1947933|G0000000|C0205370|C1522191|C0001299|C1442989|C0205484|C1947933|G0000000|C0205370|C0032042|C1522191|C0001299|C1442989|C0205484|C1947933|G0000000|C1442989|C0205484|C1947933|G0000000
None of the patients was positive for C. difficile as assessed by culture.,None patients positive C. difficile assessed culture.,G0000000|C0030705|C0439178|G0000000|G0000000|C1516048|C0010453
"Inclusion criteria were considered as Systolic pulmonary hypertension > 40mmhg, no drug history of prostanoids, statins, endothelin antagonists and phosphodiesterase, able to doing 6-min walk distance test, obstructive pattern in PFT and functional class 2,3 (NYHA).","Inclusion criteria considered Systolic pulmonary hypertension > 40mmhg, drug history prostanoids, statins, endothelin antagonists phosphodiesterase, 6-min walk distance test, obstructive pattern PFT functional class 2,3 (NYHA).",C0007637|C0243161|C0750591|C0039155|C0024109|C0020538|G0000000|G0000000|C0013227|C0019664|C0033554|C0360714|C0079284|C0243076|C0031640|C0702093|C0080331|C0012751|C0022885|C0549186|C0449774|C0024119|C0205245|C0456387|G0000000|G0000000
"Conclusions: This study suggests that, in severe childhood asthma, there is no significant difference in the effectiveness of a bolus of salbutamol and an aminophylline infusion in the first 2 hours of treatment.","Conclusions: This study suggests that, severe childhood asthma, difference effectiveness bolus salbutamol aminophylline infusion 2 hours treatment.",C1707478|G0000000|C0557651|C1705535|G0000000|C0205082|C0231335|C0004096|C1705241|C1280519|C1511237|C0001927|C0002575|C0574032|G0000000|C0439227|C0039798
"Participants’ demographic characteristics were as follows: Control group (11 women, 81 ± 8.3 years old; two men, 84.5 ± 4.95 years old; MMSE, 4.7 ± 3.9), Passive group (10 women, 81.1 ± 11.0 years old; three men, 78.7 ± 12.1 years old; MMSE, 4.7 ± 4.8), and Interactive group (11 women, 81.2 ± 7.5 years old; two men, 76 ± 7.1 years old; MMSE, 4.6 ± 3.5).","Participants’ demographic characteristics follows: Control (11 women, 81 ± 8.3 old; men, 84.5 ± 4.95 old; MMSE, 4.7 ± 3.9), Passive (10 women, 81.1 ± 11.0 old; men, 78.7 ± 12.1 old; MMSE, 4.7 ± 4.8), Interactive (11 women, 81.2 ± 7.5 old; men, 76 ± 7.1 old; MMSE, 4.6 ± 3.5).",G0000000|C0011298|C1521970|C0332283|C0243148|C0450371|C0043210|C0450371|G0000000|G0000000|C0580836|C0025266|C0450371|G0000000|C0450371|C0580836|C0451306|G0000000|G0000000|G0000000|C3686820|C0450371|C0043210|C0450371|G0000000|C0450371|C0580836|C0025266|C0450371|G0000000|C0450371|C0580836|C0451306|G0000000|G0000000|G0000000|C1704675|C0450371|C0043210|C0450371|G0000000|G0000000|C0580836|C0025266|C0450371|G0000000|G0000000|C0580836|C0451306|G0000000|G0000000|G0000000
We found no systematic reviews of yoga for low back pain.,We systematic reviews yoga low pain.,G0000000|C0220922|C0282443|C0043418|C0205251|C0030193
"Of these, approximately 60% were found to have vitamin D insufficiency (25(OH)D ≤ 50 nmol/L) [27].","Of these, 60% vitamin D insufficiency (25(OH)D ≤ 50 nmol/L) [27].",G0000000|G0000000|C0450371|C0042890|C0073187|C0231179|C0450371|G0000000|C0450371|C0439282|C0450371
"The demographic profiles of the TIV and placebo groups in this cohort were comparable with respect to mean age (35 ± 13 years in both groups), gender (55.3% and 54.2% female in the TIV and placebo groups respectively) and racial distribution (99.8% white Caucasian in both groups).","The demographic profiles TIV placebo cohort comparable respect age (35 ± 13 groups), gender (55.3% 54.2% female TIV placebo respectively) racial distribution (99.8% white Caucasian groups).",G0000000|C0011298|C1979963|C0770694|C0032042|C0599755|G0000000|C0679133|C0001779|C0450371|G0000000|C0450371|C0441833|C0079399|C0450371|C0450371|C0015780|C0770694|C0032042|G0000000|C0034510|C0520511|C0450371|C0007457|C0007457|C0441833
"However, this approach has never been used to prevent relapse in abstinent smokers.","However, approach prevent relapse abstinent smokers.",G0000000|C0449445|C0309872|C0035020|C0457801|C0337664
"Inclusion criteria were: definite diagnosis of RR-MS, age between 18 and 55 years, disease duration of < 1 year, and an Expanded Disability Status Scale (EDSS) score between 1.0 and 3.5.","Inclusion criteria were: definite diagnosis RR-MS, age 18 55 years, disease duration of < 1 year, Expanded Disability Status Scale (EDSS) score 1.0 3.5.",C0007637|C0243161|G0000000|C0439544|C0011900|C0039676|C0001779|C0450371|C0450371|C0439234|C0012634|C0449238|G0000000|C0439234|C0205229|C0231170|C0449438|C0175659|C0451246|C0449820|G0000000|G0000000
Eligibility criteria included age of 18 years or older; smoking 10 or more cigarettes per day in the past week; contemplation or preparation stage of readiness to quit smoking; having a primary care clinician in the Section of General Internal Medicine or Department of Family Medicine; having telephone access; speaking English; and being able and willing to participate in the study protocol and provide informed consent.,Eligibility criteria included age 18 older; smoking 10 cigarettes day week; contemplation preparation stage readiness quit smoking; primary care clinician Section General Internal Medicine Department Family Medicine; telephone access; speaking English; participate study protocol provide informed consent.,C0013893|C0243161|C0332257|C0001779|C0450371|C0580836|C0037369|C0450371|C0677453|C0332173|C0332174|G0000000|C1521827|C0205390|C1318963|C0748223|C0037369|C0205225|C1947933|C0871685|C0152060|C0205246|C0205102|C0013227|C1704729|C0015576|C0013227|C0039457|C0444454|C0234856|C0376245|G0000000|C0557651|C0442711|C1999230|C1522154|C1511481
METHODS—The efficacy and safety of FP 750 µg/day and BDP 1500 µg/day were compared in 30 children with persistent asthma (requiring 1000-2000 µg/day of inhaled corticosteroids) in a 12 week randomised double blind crossover study.,METHODS—The efficacy safety FP 750 µg/day BDP 1500 µg/day compared 30 children persistent asthma (requiring 1000-2000 µg/day inhaled corticosteroids) 12 week randomised double blind crossover study.,G0000000|C1280519|C0036043|C0016704|C1442061|G0000000|C0004906|G0000000|G0000000|C1707455|C0450371|C0008059|C0205322|C0004096|G0000000|G0000000|G0000000|C0004048|C0001617|C0450371|C0332174|G0000000|C0205173|C0150108|C0010366|C0557651
Each patient who enrolled in the study nominated a study partner who could provide collateral information at baseline and proxy information at a follow-up interview that covered the final week of the patient’s life.,Each patient enrolled study nominated study partner provide collateral baseline proxy follow-up interview covered final week patient’s life.,G0000000|C0030705|G0000000|C0557651|G0000000|C0557651|C0682323|C1999230|C1275670|C0168634|C0600420|C0589120|C0021822|C0439844|C0205088|C0332174|G0000000|C0376558
"The sample was recruited who met the inclusion criteria (first birth by cesarean section, using ketoprofen therapy, using spinal anesthesia, awareness compos mentis and never experienced the Benson relaxation yet).","The sample recruited met inclusion criteria (first birth cesarean section, ketoprofen therapy, spinal anesthesia, awareness compos mentis experienced Benson relaxation yet).",G0000000|C0370003|G0000000|C0268621|C0007637|C0243161|C0205435|C0005615|C3841297|C0152060|C0022635|C0039798|C0521329|C0002903|C0004448|C0486616|G0000000|C0237607|G0000000|C0035028|G0000000
"For the second group, serum zinc level was repeatedly measured 1 and 3 months after commencing the treatment.","For group, serum zinc level repeatedly measured 1 3 months commencing treatment.",G0000000|C0441833|C0229671|C0043481|C0441889|C0205341|C0444706|G0000000|G0000000|C0439231|C3274784|C0039798
"Patients with a previous history of hysterectomy, retroperitoneal surgery, abdominal or pelvic radiotherapy, prior chemotherapy, pregnancy, or positive paraaortic nodes on imaging or biopsy proven were excluded.","Patients previous history hysterectomy, retroperitoneal surgery, abdominal pelvic radiotherapy, prior chemotherapy, pregnancy, positive paraaortic nodes imaging biopsy proven excluded.",C0030705|C0205156|C0019664|C0020699|C0035359|C0038894|C0000726|C0030797|C0034619|C0332152|C0013216|C0032961|C0439178|C0442134|C0746922|C0011923|C0005558|C0456369|C1554077
"Childcare organisations in the same wards were approached on the basis of size, the largest first.","Childcare organisations wards approached basis size, largest first.",C0008067|C0029237|C1305702|C0449445|C1527178|C0456389|C0443228|C0205435
The mean age of the patients was 36.90±15.97 years in the study group and 39.94±15.75 years in the control group.,The age patients 36.90±15.97 study 39.94±15.75 control group.,G0000000|C0001779|C0030705|G0000000|C0557651|G0000000|C0243148|C0441833
"A list of the same length, of random, unique, unsorted numbers was generated using randomizer.org.","A list length, random, unique, unsorted generated randomizer.org.",G0000000|C0745732|C1444754|C0034656|C1710548|G0000000|C3146294|C1522486
"5468 men and women (2997 smokers, 2471 ex-smokers) were selected by two stage random sampling and interviewed before the intervention, of whom 3610 were re-interviewed six months later, after the first phase of the campaign.","5468 women (2997 smokers, 2471 ex-smokers) selected stage random sampling interviewed intervention, 3610 re-interviewed months later, phase campaign.",G0000000|C0043210|G0000000|C0337664|G0000000|C0337671|C1707391|C0205390|C0034656|C0441621|C0021822|C0886296|G0000000|C0556581|C0439231|C0205087|C0205390|G0000000
The child is of the appropriate age (< 3 years of age).,The child age (< 3 age).,G0000000|C0008059|C0001779|G0000000|G0000000|C0001779
ICU = intensive care unit; SD = standard deviation.,ICU = intensive care unit; SD = standard deviation.,C0021708|G0000000|C0162425|C1947933|C0439148|C2699239|G0000000|C1442989|C0012727
"For the vitamin D arm, two additional exclusion criteria apply: have current or past abnormal calcium metabolism, e.g.","For vitamin D arm, additional exclusion criteria apply: current abnormal calcium metabolism, e.g.",G0000000|C0042890|C0073187|C0446516|C1524062|C0680251|C0243161|C1632850|C0521116|C0205161|C0006675|C0025519|G0000000
One hundred and fifty patients with COPD and chronic bronchitis for at least 12 months will be recruited into the study and randomized in a 1:1 ratio to receive either roflumilast or placebo.,One fifty patients COPD chronic bronchitis 12 months recruited study randomized 1:1 ratio receive roflumilast placebo.,C0205447|C3816723|C0030705|C0024117|C0205191|C0006277|C0450371|C0439231|G0000000|C0557651|C0034656|G0000000|C0456603|C1514756|C0965618|C0032042
"At the time of the study (2002–2003) there were seven health areas in Helsinki city, divided into 32 health stations, each including at least one maternity health centre (MHC).","At time study (2002–2003) health Helsinki city, divided 32 health stations, including maternity health centre (MHC).",G0000000|C0040223|C0557651|G0000000|C0018684|G0000000|C0008848|C0332849|C0450371|C0018684|C1883167|C0332257|C0681108|C0018684|C0205099|C4049595
"The patient inclusion criteria were as follows: 1) pathologically proven gastric adenocarcinoma, 2) age of 20 to 80 years, 3) a preoperative stage of cT1N0M0, cT1N1M0, and cT2aN0M0 according to American Joint Committee on Cancer/Union for International Cancer Control 6th edition, 4) no history of other cancers, and 5) no history of chemotherapy or radiotherapy.","The patient inclusion criteria follows: 1) pathologically proven gastric adenocarcinoma, 2) age 20 80 years, 3) preoperative stage cT1N0M0, cT1N1M0, cT2aN0M0 American Joint Committee Cancer/Union International Cancer Control 6th edition, 4) history cancers, 5) history chemotherapy radiotherapy.",G0000000|C0030705|C0007637|C0243161|C0332283|G0000000|G0000000|C0456369|C0038351|C0001418|G0000000|C0001779|C0450371|C0450371|C0439234|G0000000|C0445204|C0205390|G0000000|G0000000|G0000000|C0596070|C0022417|C2699414|C0006826|C1512888|C0006826|C0243148|G0000000|C0441792|G0000000|C0019664|C0006826|G0000000|C0019664|C0013216|C0034619
Participants were recruited through public advertisements and 108 cases that had inclusion criteria were selected.,Participants recruited public advertisements 108 inclusion criteria selected.,C0679646|G0000000|G0000000|C0949214|C1442061|C0007637|C0243161|C1707391
All 260 patients were included in the efficacy analyses.,All 260 patients included efficacy analyses.,G0000000|C1442061|C0030705|C0332257|C1280519|C0002778
"Exclusion criteria included: acute severe asthma (defined as an inability to generate an FEV1 value, an FEV1 of less than 30% predicted, or asthma requiring transfer to an intensive care unit on initial assessment); use of ICS within the 8 hours preceding the baseline measurements; receipt of oral or other systemic steroids in the 48 hours before the baseline measurements; β-blocker therapy (including eye drops); any significant disease or concomitant disorder; and known sensitivity to the study medication or lactose.","Exclusion criteria included: acute severe asthma (defined inability generate FEV1 value, FEV1 30% predicted, asthma requiring transfer intensive care unit initial assessment); ICS 8 hours preceding baseline measurements; receipt oral systemic steroids 48 hours baseline measurements; β-blocker therapy (including eye drops); disease concomitant disorder; sensitivity study medication lactose.",C0680251|C0243161|C0332257|C0205178|C0205082|C0004096|C1704788|G0000000|G0000000|G0000000|C1522609|G0000000|C0450371|C0681842|C0004096|G0000000|C0040671|C0162425|C1947933|C0439148|C0205265|C1261322|C0022521|G0000000|C0439227|C0332152|C0168634|C0242485|G0000000|C0442027|C0205373|C0038317|C0450371|C0439227|C0168634|C0242485|G0000000|C0039798|C0332257|C0015392|C0991568|C0012634|C0521115|C0012634|C0020517|C0557651|C0013227|C0022949
Stratification by county also helped control for any potential differences between these geographic areas and their technical assistance staff that might influence implementation.,Stratification county helped control potential differences geographic technical assistance staff influence implementation.,C1514983|C0079170|C1269765|C0243148|C3245505|C1705241|C1517526|C0449851|C0018896|C0851286|C4054723|C1708476
Two participants in the acupressure group and five in the physical therapy group refused to receive the designated intervention.,Two participants acupressure physical therapy refused receive designated intervention.,C0205448|C0679646|C0282614|C0031809|C0039798|C1548564|C1514756|C1524084|C0886296
"Patients were eligible if they met BIS referral criteria (they had a diagnosed appropriately treated cause of breathlessness, were troubled by breathlessness in spite of optimisation of underlying illness, and might benefit from a self-management programme) and excluded (from the trial only) if they had received BIS previously.","Patients eligible met BIS referral criteria (they diagnosed appropriately treated breathlessness, troubled breathlessness spite optimisation underlying illness, benefit self-management programme) excluded (from trial only) received BIS previously.",C0030705|C1548635|C0268621|C0556985|C0034927|C0243161|G0000000|C0011900|G0000000|C1522326|C0013404|G0000000|C0013404|G0000000|C2698650|G0000000|C0221423|C0814225|C0086969|C1709697|C1554077|G0000000|C0008976|C0205171|C1514756|C0556985|G0000000
Nursing home staff of 4 intervention wards and 4 comparison wards will be involved.,Nursing staff 4 intervention wards 4 comparison wards involved.,C0006147|C0851286|G0000000|C0886296|C1305702|G0000000|C1707455|C1305702|C1314939
"The exclusion criteria included the following: (1) patients with bronchial asthma, primary bronchiectasis, diffuse panbronchiolitis (DPB), active tuberculosis, lung cancer, pneumoconiosis, or other lung diseases with restrictive ventilatory impairment and (2) patients with other serious systemic illnesses such as cardiovascular, nervous, or endocrine system illnesses, blood, hepatic, or kidney diseases, and malignant tumors; (3) patients who were not cooperative or were completely unable to communicate; and (4) patients who experienced serious adverse reactions to erythromycin.","The exclusion criteria included following: (1) patients bronchial asthma, primary bronchiectasis, diffuse panbronchiolitis (DPB), active tuberculosis, lung cancer, pneumoconiosis, lung diseases restrictive ventilatory impairment (2) patients systemic illnesses cardiovascular, nervous, endocrine system illnesses, blood, hepatic, kidney diseases, malignant tumors; (3) patients cooperative completely unable communicate; (4) patients experienced adverse reactions erythromycin.",G0000000|C0680251|C0243161|C0332257|C0231290|G0000000|C0030705|C0205039|C0004096|C0205225|C0006267|C0205219|G0000000|C0878555|C0205177|C0041296|C0024109|C0006826|C0032273|C0024109|C0012634|C0443288|G0000000|C0221099|G0000000|C0030705|C0205373|C0221423|C0007226|C0027769|C0014136|C0449913|C0221423|C0005767|C0205054|C0022646|C0012634|C0205282|C0027651|G0000000|C0030705|C0679729|C0205197|C1299582|C0566001|G0000000|C0030705|C0237607|G0000000|C0443286|C0014806
"Rather, a research professional waited in the FMG’s waiting room and, with the permission of medical and nursing staff, recruited patients of enrolled FPs during walk‐in clinic hours.","Rather, professional waited FMG’s waiting and, permission medical nursing staff, recruited patients enrolled FPs walk‐in clinic hours.",G0000000|C0679924|C1610166|G0000000|C1610166|G0000000|C0521104|C0199168|C0006147|C0851286|G0000000|C0030705|G0000000|C1708010|G0000000|C0002424|C0439227
"Women were eligible if they were aged greater than 18 years, at 34-36.5 weeks of gestation with a singleton breech presentation (confirmed by ultrasound), and normal fetal biometry.","Women eligible aged 18 years, 34-36.5 weeks gestation singleton breech presentation (confirmed ultrasound), normal fetal biometry.",C0043210|C1548635|C0001779|C0450371|C0439234|C0450371|C0439230|C0032961|C0481462|C3841404|C0449450|C0521093|C0041618|C0205307|C0015965|C0005544
"Exclusion criteria were high-dose vitamin D supplementation (daily intake >1,000 IU) or change of immunomodulatory therapy within the past 3 months, systemic glucocorticoid therapy or relapse within 30 days, pregnancy, serum creatinine >1.5 mg/dL, hypersensitivity to vitamin D preparations, and history of hyperparathyroidism, tuberculosis, sarcoidosis, or nephrolithiasis.","Exclusion criteria high-dose vitamin D supplementation (daily intake >1,000 IU) change immunomodulatory therapy 3 months, systemic glucocorticoid therapy relapse 30 days, pregnancy, serum creatinine >1.5 mg/dL, hypersensitivity vitamin D preparations, history hyperparathyroidism, tuberculosis, sarcoidosis, nephrolithiasis.",C0680251|C0243161|C0444956|C0042890|C0073187|C0242297|C0332173|C1512806|C1442061|C0049272|C0392747|G0000000|C0039798|G0000000|C0439231|C0205373|C0017710|C0039798|C0035020|C0450371|C0439228|C0032961|C0229671|C0010294|G0000000|C0439269|C0020517|C0042890|C0073187|C1521827|C0019664|C0020502|C0041296|C0036202|C0022650
"SHARP-P was a single-blinded randomized controlled pilot trial of a 4-month physical activity training intervention (PA) and/or cognitive training intervention (CT) in a 2 × 2 factorial design with a health education control condition in 73 community-dwelling persons, aged 70-85 years, who were at risk for cognitive decline but did not have mild cognitive impairment.","SHARP-P single-blinded randomized controlled pilot trial 4-month physical activity training intervention (PA) and/or cognitive training intervention (CT) 2 × 2 factorial design health education control condition 73 community-dwelling persons, aged 70-85 years, risk cognitive decline mild cognitive impairment.",C1444775|C0037179|C0034656|C2587213|C0473169|C0008976|C0332177|C0031809|C0205177|C0040607|C0886296|C0030428|G0000000|C1516691|C0040607|C0886296|C0007673|G0000000|G0000000|G0000000|C2826344|C1707689|C0018684|C0013621|C0243148|C0012634|C0450371|C4045975|C0027361|C0001779|C0450371|C0439234|C0035647|C1516691|G0000000|C2945599|C1516691|C0221099
"But, those who were off-duty during the survey were excluded.","But, off-duty survey excluded.",G0000000|C1518543|C0038951|C1554077
"Hospital, Indore, over a period of 2 years (June 2006 to June 2008) with age group between 10 and 50 years and with first and second degree of burn having burn area less than 50% of TBSA total body surface area) were included in a randomized comparative study.","Hospital, Indore, period 2 (June 2006 June 2008) age 10 50 degree burn burn 50% TBSA total body surface area) included randomized comparative study.",C0019994|G0000000|C0439531|G0000000|C3829443|G0000000|C3829443|G0000000|C0001779|C0450371|C0450371|C0441889|C0006434|C0006434|C0450371|G0000000|C0439175|C0242821|C0205148|C0017446|C0332257|C0034656|G0000000|C0557651
"Their exclusion from the analysis did not modify the reported results, thus they are included in the presented analysis.","Their exclusion analysis modify reported results, included analysis.",G0000000|C0680251|C0002778|C0392747|C0684224|C1274040|C0332257|C0002778
"Other exclusion criteria included a COPD exacerbation within 3 months before the baseline visit; ventilator support for respiratory failure within the past year; lobectomy, pneumonectomy, or lung volume reduction surgery; lung cancer within the past 5 years; nasal continuous positive airway pressure or oxygen use > 2 L/min or for >2 hours per day; initiation of pulmonary rehabilitation within the past 3 months; treatment with chronic or prophylactic antibiotics; inability to use the MF-DPI inhaler; and < 80% adherence in recording diary data between screening and baseline.","Other exclusion criteria included COPD exacerbation 3 months baseline visit; ventilator support respiratory failure year; lobectomy, pneumonectomy, lung volume reduction surgery; lung cancer 5 years; nasal continuous positive airway pressure oxygen > 2 L/min >2 hours day; initiation pulmonary rehabilitation 3 months; treatment chronic prophylactic antibiotics; inability MF-DPI inhaler; < 80% adherence recording diary data screening baseline.",G0000000|C0680251|C0243161|C0332257|C0024117|G0000000|G0000000|C0439231|C0168634|C0545082|C0087153|C0183683|C0521346|C0231174|C0439234|C0023928|C0032284|C0024109|C0449468|C0301630|C0038894|C0024109|C0006826|G0000000|C0439234|C0028429|C0549178|C0439178|C0178987|C0033095|C0030054|G0000000|G0000000|C0439393|G0000000|C0439227|C0332173|C0589507|C0024109|C0034991|G0000000|C0439231|C0039798|C0205191|C0355642|C0003232|G0000000|C0024974|C0021461|G0000000|C0450371|C1510802|G0000000|C0376660|C1511726|C0220908|C0168634
A three-arm cluster randomised controlled trial will be conducted in the Netherlands among fourth-grade secondary school students.,A three-arm cluster randomised controlled trial conducted Netherlands fourth-grade secondary school students.,G0000000|C0205449|C1555715|G0000000|C2587213|C0008976|C0004927|C0027778|C0205438|C0027627|C0036375|C0038492
"Trauma patients admitted to the intensive care unit (ICU) at a university third level hospital between 18 and 75 years (inclusive) with moderate to severe trauma, as defined by an Injury Severity Score (ISS) > 12 points were included in the study.","Trauma patients admitted intensive care unit (ICU) university level hospital 18 75 (inclusive) moderate severe trauma, defined Injury Severity Score (ISS) > 12 included study.",C0043251|C0030705|C0184666|C0162425|C1947933|C0439148|C0021708|C0041740|C0441889|C0019994|C0450371|C0450371|C0332257|C0205081|C0205082|C0043251|C1704788|C3263722|C0439793|C0449820|C1845118|G0000000|C0450371|C0332257|C0557651
"Pregnant women with the following criteria were included; at least one risk factor for gestational diabetes including body mass index (BMI; kg/m2) more than 25, history of macrosome neonate, positive family history for diabetes and gestational diabetes, history of gestational diabetes in previous pregnancies, and glycosuria.","Pregnant women criteria included; risk factor gestational diabetes including body mass (BMI; kg/m2) 25, history macrosome neonate, positive family history diabetes gestational diabetes, history gestational diabetes previous pregnancies, glycosuria.",C0549206|C0043210|C0243161|C0332257|C0035647|C1521761|C0439671|C0011847|C0332257|C0242821|C0577559|G0000000|C0022718|C0450371|C0019664|G0000000|C0021289|C0439178|C0015576|C0019664|C0011847|C0439671|C0011847|C0019664|C0439671|C0011847|C0205156|C0032961|C0017979
The purpose of this study was to compare the effects of a differently designed functional appliance (R-appliance) and the Anterior Inclined Bite Plate (AIBP) in Class II Division I (Cl II Div I) cases.,The purpose study compare effects designed functional appliance (R-appliance) Anterior Inclined Bite Plate (AIBP) Class II Division I (Cl II Div I) cases.,G0000000|C1285529|C0557651|C1707455|C1280500|C1707689|C0205245|C0243112|C0205090|C0205094|G0000000|C0005658|C0005971|C1425525|C0456387|G0000000|C0152060|C0021966|C0596019|G0000000|C0332849|C0021966|C0868928
There were 69 patients in the SPA group and 71 patients in the SL group.,There 69 patients SPA 71 patients SL group.,G0000000|C0450371|C0030705|C1420002|C0450371|C0030705|G0000000|C0441833
"Patients were excluded if any of the following conditions were present: fever, lower respiratory tract infection, cardiac, renal, or hepatic dysfunction, required ventilator care or endotracheal intubation, near-fatal asthma, pregnant or breastfeeding mothers, failed to use PEF meter, or had received oral, inhaled, or parenteral bronchodilators in the past 6 hours, or steroids in the past 12 hours.","Patients excluded conditions present: fever, lower respiratory tract infection, cardiac, renal, hepatic dysfunction, required ventilator care endotracheal intubation, near-fatal asthma, pregnant breastfeeding mothers, failed PEF meter, received oral, inhaled, parenteral bronchodilators 6 hours, steroids 12 hours.",C0030705|C1554077|C0012634|C0150312|C0015967|C0441994|C0521346|C1185740|C0009450|C0018787|C0022646|C0205054|C0031847|C1514873|C0087153|C1947933|C0599554|C0021925|C0475806|C0004096|C0549206|C0006147|C0026591|C0231175|C0030771|C0475209|C1514756|C0442027|C0004048|C0030547|C0006280|G0000000|C0439227|C0038317|C0450371|C0439227
"Inclusion criteria were: age, 18–55 years; relapsing-remitting MS [19]; at least two clinical relapses in the preceding two years; a baseline Expanded Disability Status Scale (EDSS) [20] score from 1.0 to 5.5; effective female contraception and a signed informed consent.","Inclusion criteria were: age, 18–55 years; relapsing-remitting MS [19]; clinical relapses preceding years; baseline Expanded Disability Status Scale (EDSS) [20] score 1.0 5.5; effective female contraception signed informed consent.",C0007637|C0243161|G0000000|C0001779|G0000000|C0439234|C0035020|C0039676|C0450371|C0205210|C0035020|C0332152|C0439234|C0168634|C0205229|C0231170|C0449438|C0175659|C0451246|C0450371|C0449820|G0000000|G0000000|C1280519|C0015780|C0700589|C1519316|C1522154|C1511481
"Subjects were recruited from urology offices at 20 sites in the United States and New Zealand Participants with adequate adherence to the protocol (80% or more pills taken during a 30 day run-in period) were randomized to receive placebo (N = 232), selenium 200 µg/day (N =234), or selenium 400 µg/day (N=233).","Subjects recruited urology offices 20 sites United States New Zealand Participants adequate adherence protocol (80% pills 30 day run-in period) randomized receive placebo (N = 232), selenium 200 µg/day (N =234), selenium 400 µg/day (N=233).",C0681850|G0000000|C0042077|C0442603|C0450371|C0205145|C0166872|C1301808|C0205314|G0000000|C0679646|C0205410|C1510802|C0442711|C0450371|C0994475|C0450371|C0332173|C3274438|C0439531|C0034656|C1514756|C0032042|C0369718|G0000000|C1442061|C0036581|C1442061|G0000000|C0369718|C1442061|C0036581|C1442061|G0000000|C0369718
"Setting Care homes within the NHS South Birmingham primary care trust and the NHS Birmingham East and North primary care trust that had more than five beds and provided for people in the care categories “physical disability” and “older people.” Participants Care home residents with mobility limitations, limitations in activities of daily living (as screened by the Barthel index), and not receiving end of life care were eligible to take part in the study.","Setting Care homes NHS South Birmingham primary care trust NHS Birmingham East North primary care trust beds provided people care categories “physical disability” “older people.” Participants Care residents mobility limitations, limitations activities daily living (as screened Barthel index), receiving life care eligible study.",C0542559|C1947933|C0442519|C0796085|C1710133|G0000000|C0205225|C1947933|C0237935|C0796085|G0000000|C1707877|C1709269|C0205225|C1947933|C0237935|C0004916|C1999230|C0027361|C1947933|C0683312|G0000000|G0000000|G0000000|G0000000|C0679646|C1947933|C1320928|C0425245|C0449295|C0449295|C0441655|C0332173|C0376558|G0000000|C0220908|G0000000|C0918012|C1514756|C0376558|C1947933|C1548635|C0557651
Participants 300 histologically proved cases of oesophageal squamous cell carcinoma and 571 matched neighbourhood controls in the case-control study and 48 582 participants in the cohort study.,Participants 300 histologically proved oesophageal squamous cell carcinoma 571 matched neighbourhood controls case-control study 48 582 participants cohort study.,C0679646|C1442061|C0205462|G0000000|C1522619|C1182670|C0007634|C0007097|C1442061|C0150103|C0027569|C0243148|C0872128|C0557651|C0450371|C1442061|C0679646|C0599755|C0557651
"Children aged <5 years were the sentinel group for incidence of diarrhoea, malaria and acute lower respiratory infections during the study period.","Children aged <5 sentinel incidence diarrhoea, malaria acute lower respiratory infections study period.",C0008059|C0001779|G0000000|C0950580|C0021149|C0011991|C0024530|C0205178|C0441994|C0521346|C3714514|C0557651|C0439531
"Twenty two participants (14 men and 8 women), 33–64 years old, mean age 45.8 (SD 8.3) years with a BMI of 27.9 (SD 3.6) kg/m2 completed the study and were included in the final analysis.","Twenty participants (14 8 women), 33–64 old, age 45.8 (SD 8.3) BMI 27.9 (SD 3.6) kg/m2 completed study included final analysis.",C0724000|C0679646|C0450371|G0000000|C0043210|G0000000|C0580836|C0001779|C0450371|G0000000|G0000000|G0000000|C0450371|G0000000|G0000000|C0022718|C0205197|C0557651|C0332257|C0205088|C0002778
"Baseline Characteristics by Energy-adjusted Quintile of selenium intake in the Shanghai Women’s Health Study (SWHS; 1997–2000) and the Shanghai Men’s Health Study (SMHS; 2002–2006) The median and cut points for the quintile of Se intake in the SWHS were 15.86 (7.19–19.04), 21.16 (19.05–23.15), 25.18 (23.16–27.31), 30.02 (27.32–33.35) and 42.22 (33.36–124.64) μg/4184KJ (1000kcal) per d and in the SMHS were 16.46 (7.43–19.36), 21.33 (19.37–23.20), 25.09 (23.21–27.11), 29.72 (27.12–32.91), 41.70 (32.92–165.38) μg/4184KJ (1000kcal) per d. During an average follow-up of 13.90 years in the SWHS and 8.37 years in the SMHS, we documented 9966 deaths from all causes (4217 men and 5749 women), including 3154 deaths from CVD (1402 men and 1752 women) and 4352 deaths from cancer (1798 men and 2554 women).","Baseline Characteristics Energy-adjusted Quintile selenium intake Shanghai Women’s Health Study (SWHS; 1997–2000) Shanghai Men’s Health Study (SMHS; 2002–2006) The median cut quintile Se intake SWHS 15.86 (7.19–19.04), 21.16 (19.05–23.15), 25.18 (23.16–27.31), 30.02 (27.32–33.35) 42.22 (33.36–124.64) μg/4184KJ (1000kcal) SMHS 16.46 (7.43–19.36), 21.33 (19.37–23.20), 25.09 (23.21–27.11), 29.72 (27.12–32.91), 41.70 (32.92–165.38) μg/4184KJ (1000kcal) d. During average follow-up 13.90 SWHS 8.37 SMHS, documented 9966 deaths (4217 5749 women), including 3154 deaths CVD (1402 1752 women) 4352 deaths cancer (1798 2554 women).",C0168634|C1521970|C0424589|C1508496|C0036581|C1512806|G0000000|G0000000|C0018684|C0557651|G0000000|G0000000|G0000000|G0000000|C0018684|C0557651|C1824631|G0000000|G0000000|C0549183|C0000925|C1508496|C0036919|C1512806|G0000000|C0450371|G0000000|C0450371|G0000000|C0450371|G0000000|C0450371|G0000000|C0450371|G0000000|G0000000|G0000000|C1824631|C0450371|G0000000|C0450371|G0000000|C0450371|G0000000|C0450371|G0000000|C0450371|G0000000|G0000000|G0000000|C0073187|G0000000|C1510992|C0589120|C0450371|G0000000|C0450371|C1824631|C1301725|G0000000|C0011065|G0000000|G0000000|C0043210|C0332257|G0000000|C0011065|C0007222|G0000000|G0000000|C0043210|G0000000|C0011065|C0006826|G0000000|G0000000|C0043210
SFP 10–14 UK will be implemented in seven geographical areas of Wales by local agencies that are independent of the research team (e.g.,SFP 10–14 UK implemented geographical Wales local agencies independent team (e.g.,C0075029|G0000000|C0041700|G0000000|C0017447|C0043015|C0205276|C0237463|C0085862|C0871489|G0000000
"In the present study, VAP was defined as early when it occurred between 1 and 8 days after initiation of mechanical ventilation.","In study, VAP defined occurred 1 8 days initiation mechanical ventilation.",G0000000|C0557651|G0000000|C1704788|C1709305|G0000000|G0000000|C0439228|C0589507|C0443254|C0035203
"Volunteers were eligible for the study if: (1) they were between ages 18–65; (2) they met ICHD-II diagnostic criteria for migraine, with or without aura; (3) their migraines had been present for at least one year; (4) they experienced at least 48 continuous hours of freedom from headache or migraine per month; (5) their age of onset of migraine was less than 50 years; (6) they were able to provide informed consent; (7) they had a migraine at least twice a month; (8) they had daily Internet access with email; and (9) they completed the Daily Headache Record for a minimum of 5 out of 14 days during a “run-in” period.","Volunteers eligible study if: (1) ages 18–65; (2) met ICHD-II diagnostic criteria migraine, aura; (3) migraines year; (4) experienced 48 continuous hours freedom headache migraine month; (5) age onset migraine 50 years; (6) provide informed consent; (7) migraine month; (8) daily Internet access email; (9) completed Daily Headache Record minimum 5 14 days “run-in” period.",C0042960|C1548635|C0557651|G0000000|G0000000|C0001779|G0000000|G0000000|C0268621|G0000000|C0011900|C0243161|C0149931|C0236018|G0000000|C0149931|C0439234|G0000000|C0237607|C0450371|C0549178|C0439227|C0016694|C0018681|C0149931|C0332177|G0000000|C0001779|C0206132|C0149931|C0450371|C0439234|G0000000|C1999230|C1522154|C1511481|G0000000|C0149931|C0332177|G0000000|C0332173|C0282111|C0444454|C0013849|G0000000|C0205197|C0332173|C0018681|C0034869|C1524031|G0000000|C0450371|C0439228|G0000000|C0439531
This is in contrast to the Western population in which gastric carcinoma is usually diagnosed at an advanced stage [13].,This contrast Western population gastric carcinoma diagnosed advanced stage [13].,G0000000|C0009924|C1705493|C0032659|C0038351|C0007097|C0011900|C0205179|C0205390|C0450371
"Eligible pregnant women were identified through antenatal consultations (women attending their third antenatal visit), and were included until the desired sample size was reached in each health center.","Eligible pregnant women identified antenatal consultations (women attending antenatal visit), included desired sample size reached health center.",C1548635|C0549206|C0043210|C0205396|C2828394|C0009818|C0043210|C1547429|C2828394|C0545082|C0332257|C0871633|C0370003|C0456389|C2584321|C0018684|C0205099
Mother–newborn dyads intending to breastfeed were recruited from a maternity ward.,Mother–newborn dyads intending breastfeed recruited maternity ward.,G0000000|C0870454|G0000000|C0006147|G0000000|C0681108|C1305702
Twenty-five nursing homes serviced by two long-term care pharmacies.,Twenty-five nursing homes serviced long-term care pharmacies.,C3715062|C0006147|C0442519|C0557854|C0443252|C1947933|C0031322
A median of four cycles of study treatment was given in both arms.,A median cycles study treatment arms.,G0000000|C0549183|C1511572|C0557651|C0039798|C0206655
"Patients with histologically proven transitional-cell carcinoma of the urinary tract (including renal pelvis, ureters, urinary bladder), unresected lymph node(s) (N+), distant metastases (M1, stage IV) or unresectable primary bladder cancer (T3-4), and with measurable disease as defined by the Response Evaluation Criteria in Solid Tumors (RECIST)23 were included in this trial.","Patients histologically proven transitional-cell carcinoma urinary tract (including renal pelvis, ureters, urinary bladder), unresected lymph node(s) (N+), distant metastases (M1, stage IV) unresectable primary bladder cancer (T3-4), measurable disease defined Response Evaluation Criteria Solid Tumors (RECIST)23 included trial.",C0030705|C0205462|C0456369|C0225340|C0007097|C0042027|C1185740|C0332257|C0022646|C0030797|C0041951|C0042027|C0005682|C2986425|C0024202|C0746922|C0369718|C0443203|C0027627|C0025885|C0205390|C0022326|C1519810|C0205225|C0005682|C0006826|C0041403|C1513040|C0012634|C1704788|C0871261|C0220825|C0243161|C0205208|C0027651|C1709926|C0332257|C0008976
This variability was also seen in the melatonin groups.,This variability melatonin groups.,G0000000|C2827666|C0025219|C0441833
Participants (N=54) were randomised to 960 mL decaffeinated green or placebo tea daily for 6 months.,Participants (N=54) randomised 960 mL decaffeinated green placebo tea daily 6 months.,C0679646|C0369718|G0000000|C1442061|C0439526|G0000000|C0332583|C0032042|C0039400|C0332173|G0000000|C0439231
"Men age > 18 years with prostate adenocarcinoma were eligible if they met the following criteria: a clinical classification of T1b to T2c (according to American Joint Committee on Cancer staging system, 6th edition),11 a Gleason score of 2 to 6, and a prostate-specific antigen (PSA) < 10.","Men age > 18 prostate adenocarcinoma eligible met criteria: clinical classification T1b T2c (according American Joint Committee Cancer staging system, 6th edition),11 Gleason score 2 6, prostate-specific antigen (PSA) < 10.",C0025266|C0001779|G0000000|C0450371|C0033572|C0001418|C1548635|C0268621|C0243161|C0205210|C0008902|G0000000|G0000000|C0680240|C0596070|C0022417|C2699414|C0006826|C0332305|C0449913|G0000000|C0441792|G0000000|C0449820|G0000000|G0000000|C0033572|C0003320|C3810537|G0000000|C0450371
Additional eligibility criteria included 5) body mass index (BMI) ≤ 50 kg/m2; 6) no plans for surgery during the study; 7) no history of bilateral lymph node removal; 8) no weight lifting in the previous year; and 9) stable body weight and not attempting to lose weight.,Additional eligibility criteria included 5) body mass (BMI) ≤ 50 kg/m2; 6) plans surgery study; 7) history bilateral lymph node removal; 8) weight lifting previous year; 9) stable body weight attempting lose weight.,C1524062|C0013893|C0243161|C0332257|G0000000|C0242821|C0577559|G0000000|G0000000|C0450371|C0022718|G0000000|C0270724|C0038894|C0557651|G0000000|C0019664|C0238767|C0024202|C0746922|C0015252|G0000000|C0005910|C0206244|C0205156|C0439234|G0000000|C0205360|C0242821|C0005910|C1516084|G0000000|C0005910
"Overview of project strategies The project was implemented in the local government areas of Liverpool and Fairfield, with a third adjoining local government area (Bankstown) as the comparison area.","Overview project strategies The project implemented local government Liverpool Fairfield, adjoining local government (Bankstown) comparison area.",C0814812|C1709701|C0679199|G0000000|C1709701|G0000000|C0205276|C0018104|G0000000|G0000000|G0000000|C0205276|C0018104|G0000000|C1707455|C0017446
"Patients with slide-confirmed malaria (due to P. falciparum, P. vivax, or both) and fever or a history of fever during the preceding 48 h who presented to the outpatient clinic were eligible for enrollment.","Patients slide-confirmed malaria (due P. falciparum, P. vivax, both) fever history fever preceding 48 outpatient clinic eligible enrollment.",C0030705|C0444330|C0024530|C0678226|C0369773|G0000000|C0369773|G0000000|G0000000|C0015967|C0019664|C0015967|C0332152|C0450371|C0029921|C0002424|C1548635|C1516879
"Exclusion criteria for study patients included: American Society of Anesthesiologists (ASA) class 4; age ≥70 yr; emergency procedure; status post pneumonectomy; diagnosed COPD, emphysema, asthma, pulmonary hypertension, sleep apnea or any other respiratory disease; oxygen-therapy during last month; tobacco use in the last 5 yr; severe obesity (body mass index [BMI] ≥35 kg/m2); immunosupression within 3 months prior to the procedure; diagnosed infection; or shock.","Exclusion criteria study patients included: American Society Anesthesiologists (ASA) class 4; age ≥70 yr; emergency procedure; status post pneumonectomy; diagnosed COPD, emphysema, asthma, pulmonary hypertension, sleep apnea respiratory disease; oxygen-therapy month; tobacco 5 yr; severe obesity (body mass [BMI] ≥35 kg/m2); immunosupression 3 months prior procedure; diagnosed infection; shock.",C0680251|C0243161|C0557651|C0030705|C0332257|C0596070|C0037455|C0334910|C0004057|C0456387|G0000000|C0001779|G0000000|C0439234|C0013956|C0184661|C0449438|C0687676|C0032284|C0011900|C0024117|C0013990|C0004096|C0024109|C0020538|C0037313|C0003578|C0521346|C0012634|C0184633|C0332177|C0040329|G0000000|C0439234|C0205082|C0028754|C0242821|C0577559|G0000000|G0000000|C0022718|G0000000|G0000000|C0439231|C0332152|C0184661|C0011900|C0009450|C0036974
No comparisons of different doses of docetaxel-capecitabine in patients with advanced gastric cancer have been performed.,No comparisons doses docetaxel-capecitabine patients advanced gastric cancer performed.,G0000000|C1707455|C0178602|C0246415|C0030705|C0205179|C0038351|C0006826|C0884358
"We prospectively examined whether use of ibuprofen or other NSAIDs is associated with lower PD risk among 136,197 participants in the Nurses' Health Study (NHS) and the Health Professionals Follow-up Study (HPFS) free of PD at baseline (1998 for NHS and 2000 for HPFS).","We prospectively examined ibuprofen NSAIDs lower PD risk 136,197 participants Nurses' Health Study (NHS) Health Professionals Follow-up Study (HPFS) free PD baseline (1998 NHS 2000 HPFS).",G0000000|G0000000|C0332128|C0020740|C0003211|C0441994|G0000000|C0035647|C1442061|C0679646|C0028661|C0018684|C0557651|C0796085|C0018684|C0679924|C0589120|C0557651|C0439530|C0332296|G0000000|C0168634|G0000000|C0796085|G0000000|C0439530
Figure 2a: Breast milk DHA levels in Group A mothers (who entered the trial in the last trimester of pregnancy).,Figure 2a: Breast milk DHA levels Group A mothers (who entered trial trimester pregnancy).,G0000000|C1420849|C0006141|C0026131|C0142831|C0441889|C0441833|G0000000|C0026591|G0000000|C1521975|C0008976|C0032982|C0032961
"Potential participants were excluded if they were unable to follow instructions, had a prestroke modified Rankin score of ≥2, were medically unstable or had uncontrolled hypertension according to the treating physician, were experiencing a severe illness with a life expectancy <3 months, experienced unstable angina, or had recent myocardial infarction (within 3 months), had a history of seizures or epilepsy (except for febrile seizures of childhood), were participating in another clinical trial involving an investigational drug or physical therapy, or had any condition that might put the patient at risk (ie, known shoulder subluxation or fracture) at study entry.","Potential participants excluded unable follow instructions, prestroke modified Rankin score ≥2, medically unstable uncontrolled hypertension treating physician, experiencing severe illness life expectancy <3 months, experienced unstable angina, myocardial infarction (within 3 months), history seizures epilepsy (except febrile seizures childhood), participating clinical trial involving investigational drug physical therapy, condition patient risk (ie, shoulder subluxation fracture) study entry.",C3245505|C0679646|C1554077|C1299582|C0332283|C0302828|G0000000|C0392747|G0000000|C0449820|G0000000|G0000000|C0443343|C0205318|C0020538|C1522326|C0031831|C0237607|C0205082|C0221423|C0376558|C0679138|G0000000|C0439231|C0237607|C0443343|C0002962|C0027061|C0021308|G0000000|G0000000|C0439231|C0019664|C0036572|C0014544|G0000000|C0015967|C0036572|C0231335|C0679823|C0205210|C0008976|C1314939|C1517586|C0013227|C0031809|C0039798|C0012634|C0030705|C0035647|G0000000|C0037004|C0332768|C0016658|C0557651|C1705654
"Women who had singleton pregnancies between 7 and 14 weeks with NVP, and who had not responded to conservative management of lifestyle and dietary modifications, were randomized to receive either Diclectin® or a similar appearing placebo.8 Women were excluded if they had previously received other antiemetics or had other medical conditions during the current pregnancy.","Women singleton pregnancies 7 14 weeks NVP, responded conservative management lifestyle dietary modifications, randomized receive Diclectin® appearing placebo.8 Women excluded received antiemetics medical conditions current pregnancy.",C0043210|C0481462|C0032961|G0000000|C0450371|C0439230|C0132326|G0000000|G0000000|C0001554|C0023676|C0012155|C0392747|C0034656|C1514756|G0000000|C0700364|C0032042|C0043210|C1554077|C1514756|C0003297|C0199168|C0012634|C0521116|C0032961
"School inclusion criteria included enrollment of greater than 80% African American and less than 10% Latino or Hispanic students; grades kindergarten through 8 (or through 6 if students were tracked to 1 middle school); enrollment greater than 500; not on probation or slated for reorganization; not a special designated school (ie, magnet, academic center); and moderate mobility (<50% annual turnover, meaning approximately <25% transferred in and <25% transferred out).","School inclusion criteria included enrollment 80% African American 10% Latino Hispanic students; grades kindergarten 8 (or 6 students tracked 1 middle school); enrollment 500; probation slated reorganization; special designated school (ie, magnet, academic center); moderate mobility (<50% annual turnover, meaning <25% transferred <25% transferred out).",C0036375|C0007637|C0243161|C0332257|C1516879|C0450371|C0027567|C0596070|C0450371|C0086528|C0086409|C0038492|C0441800|C0681406|G0000000|G0000000|G0000000|C0038492|C0040594|G0000000|C0444598|C0036375|C1516879|C1442061|C0687758|C0303752|C0680829|C0205555|C1524084|C0036375|G0000000|C0024483|C1510747|C0205099|C0205081|C0425245|C0450371|C0332181|C0031227|C0876919|C0450371|C0348011|C0450371|C0348011|C0439787
"176 nulliparous women with low-risk pregnancies, attending hospital-based antenatal clinics.","176 nulliparous women low-risk pregnancies, attending hospital-based antenatal clinics.",C1442061|C0425979|C0043210|C3272281|C0032961|C1547429|C0019994|C2828394|C0442592
"For patients with liver metastases, those with AST, ALT, and ALP values that were 5-fold less than the reference values at the study center were eligible.","For patients liver metastases, AST, ALT, ALP values 5-fold reference values study center eligible.",G0000000|C0030705|C0023884|C0027627|C3891303|C1266129|C3812647|C0042295|C0332462|C1514811|C0042295|C0557651|C0205099|C1548635
Randomised clinical trial on 40 bilateral carious primary molars in 20 participant children (aged 5-10 years) was carried out by same operator using Ca3SiO5(group-1) and CH (group-2) as vital pulpotomy agents.,Randomised clinical trial 40 bilateral carious primary molars 20 participant children (aged 5-10 years) carried operator Ca3SiO5(group-1) CH (group-2) vital pulpotomy agents.,G0000000|C0205210|C0008976|C0450371|C0238767|G0000000|C0205225|C0026367|C0450371|C0679646|C0008059|C0001779|C0450371|C0439234|C0206243|C1705273|C0441857|C0008115|C0441857|C0442732|C0034104|C0450442
After giving informed consent liver transplant recipients are randomized to two parallel groups treated for eight days (day of surgery and the following seven days) using glycine solution or placebo.,After informed consent liver transplant recipients randomized parallel treated days (day surgery days) glycine solution placebo.,G0000000|C1522154|C1511481|C0023884|C0040732|C1709854|C0034656|C2348042|C1522326|C0439228|C0332173|C0038894|C0439228|C0017890|C0037633|C0032042
"Between June 2000 and July 2001, research nurses recruited similar numbers of men and women from each of three age groups: 60–64, 65–69 and 70–74 years.","Between June 2000 July 2001, nurses recruited women age groups: 60–64, 65–69 70–74 years.",G0000000|C3829443|G0000000|C3829447|G0000000|C0028661|G0000000|C0043210|C0001779|C0441833|G0000000|G0000000|G0000000|C0439234
"Exclusion criteria were inability to receive oral intake, major malabsorption, severe renal insufficiency (creatinine clearance < 30 mL/min), and participation in another trial.","Exclusion criteria inability receive oral intake, major malabsorption, severe renal insufficiency (creatinine clearance < 30 mL/min), participation trial.",C0680251|C0243161|G0000000|C1514756|C0442027|C1512806|C0205082|C0024523|C0205082|C0022646|C0231179|C0010294|C0449297|G0000000|C0450371|C0439445|C0679823|C0008976
Children >7 to <12 years with HIV infection could enroll if their baseline CD4% was ≥15.,Children >7 <12 HIV infection enroll baseline CD4% ≥15.,C0008059|G0000000|C0450371|C0019682|C0009450|G0000000|C0168634|C0285590|G0000000
"Patients were recruited from Clatterbridge Centre for Oncology, a regional cancer facility treating solid tumours and lymphomas serving a population of 2 million people in Merseyside, UK.","Patients recruited Clatterbridge Centre Oncology, regional cancer facility treating solid tumours lymphomas serving population 2 people Merseyside, UK.",C0030705|G0000000|G0000000|C0205099|C0027651|C0205147|C0006826|C1547538|C1522326|C0205208|C0027651|C0024299|C1519269|C0032659|G0000000|C0027361|C0454865|C0041700
"The participants in this double-blind, randomized, placebo-controlled, multi-center clinical trial were male and female adult out-patients with an episode of mild or moderate major depressive episode (single or recurrent episode, DSM-IV criteria).","The participants double-blind, randomized, placebo-controlled, multi-center clinical trial male female adult out-patients episode mild moderate major depressive episode (single recurrent episode, DSM-IV criteria).",G0000000|C0679646|C0013072|C0034656|C1706408|C0439743|C0205210|C0008976|C0086582|C0015780|C0001675|C0029921|C0332189|C2945599|C0205081|C0205082|G0000000|C0332189|C0037179|C2945760|C0332189|C0220952|C0243161
"Inclusion criteria were patients who are willing to participate in the study and signed informed consent, normal body mass index (BMI) that BMI was calculated by measuring height and weight, gestational age (GA) between 14 and 16 weeks that was based on the evaluation of the gynecologist (last menstrual period, or sonography or clinical examination), the absence of a history of Type 2 diabetes and gestational diabetes, and no family history of diabetes in first-degree relatives.","Inclusion criteria patients participate study signed informed consent, normal body mass (BMI) BMI calculated measuring height weight, gestational age (GA) 14 16 weeks based evaluation gynecologist (last menstrual period, sonography clinical examination), absence history Type 2 diabetes gestational diabetes, family history diabetes first-degree relatives.",C0007637|C0243161|C0030705|G0000000|C0557651|C1519316|C1522154|C1511481|C0205307|C0242821|C0577559|G0000000|G0000000|C0444686|C0444706|C0489786|C0005910|C0439671|C0001779|C0016993|C0450371|C0450371|C0439230|C1527178|C0220825|C0237419|C1517741|C0025344|C0439531|C0041618|C0205210|G0000000|C0332197|C0019664|C0332307|G0000000|C0011847|C0439671|C0011847|C0015576|C0019664|C0011847|C0444502|C0080103
Women who had a urinary tract infection caused by Escherichia coli (⩾105 colony forming units/ml in clean voided midstream urine) and were not taking antimicrobial prophylaxis were invited to participate.,Women urinary tract infection caused Escherichia coli (⩾105 colony forming units/ml clean voided midstream urine) antimicrobial prophylaxis invited participate.,C0043210|C0042027|C1185740|C0009450|C0015127|C0014833|G0000000|G0000000|C0439158|C0205431|C2945590|C1947930|C0042034|G0000000|C0042036|C1136254|C0033107|G0000000|G0000000
"Study participants will be 1350 students who smoke tobacco daily/occasionally, from vocational schools in Switzerland.","Study participants 1350 students smoke tobacco daily/occasionally, vocational schools Switzerland.",C0557651|C0679646|G0000000|C0038492|C0037366|C0040329|C0332173|C0087164|C0036375|C0039021
"Outcomes were measured in individual residents, but the nursing homes served as the unit of allocation, intervention, and analysis.","Outcomes measured individual residents, nursing homes served unit allocation, intervention, analysis.",C1274040|C0444706|C0027361|C1320928|C0006147|C0442519|G0000000|C0439148|C1706778|C0886296|C0002778
"Ultimately, the implementation of SDM in the care for advanced cancer patients may enhance the quality of medical decision making, and hence the quality of patients’ (end of) life.","Ultimately, implementation SDM care advanced cancer patients enhance quality medical decision making, quality patients’ (end of) life.",G0000000|C1708476|C0643808|C1947933|C0205179|C0006826|C0030705|C2349975|C0332306|C0199168|C0679006|C1881534|C0332306|G0000000|C0444930|G0000000|C0376558
"Exclusion criteria were (a) evidence of severe psychopathology symptoms of psychosis on interview or endorsement of active suicidal ideation with intent within the past 6 months (two potential participants were excluded on this basis); and (b) a score of 21 or greater on the Telephone Interview of Cognitive Status (Brandt, Spencer, & Folstein, 1988), indicative of severe cognitive deficits that could potentially interfere with the focused attention required for hypnosis (no potential participants were excluded for this reason).","Exclusion criteria (a) evidence severe psychopathology symptoms psychosis interview endorsement active suicidal ideation intent 6 months (two potential participants excluded basis); (b) score 21 Telephone Interview Cognitive Status (Brandt, Spencer, & Folstein, 1988), indicative severe cognitive deficits interfere focused attention required hypnosis (no potential participants excluded reason).",C0680251|C0243161|G0000000|C3887511|C0205082|C0033927|C0683368|C0033975|C0021822|G0000000|C0205177|C0438696|C0392348|C0162425|G0000000|C0439231|C0205448|C3245505|C0679646|C1554077|C1527178|G0000000|C0449820|C0450371|C0039457|C0021822|C1516691|C0449438|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|C0205082|C1516691|C2987487|C0521102|C0205234|C0004268|C1514873|C0020587|G0000000|C3245505|C0679646|C1554077|C0392360
"Excluded were patients with antibiotic use within the previous 14 days, psychiatric disorders or other inability to give written informed consent, not being available for follow-up, severe immunosuppression, heart failure, cystic fibrosis, active tuberculosis, pregnancy and chest radiography–confirmed pneumonia.","Excluded patients antibiotic previous 14 days, psychiatric disorders inability written informed consent, follow-up, severe immunosuppression, heart failure, cystic fibrosis, active tuberculosis, pregnancy chest radiography–confirmed pneumonia.",C1554077|C0030705|C0003232|C0205156|C0450371|C0439228|C0205487|C0012634|G0000000|C0043266|C1522154|C1511481|C0589120|C0205082|C0021079|C0018787|C0231174|C0205207|C0016059|C0205177|C0041296|C0032961|C0817096|G0000000|C0032285
"Exclusion criteria were known HIV infection, allergy to albendazole, severe anemia, and any other underlying severe physical condition.","Exclusion criteria HIV infection, allergy albendazole, severe anemia, underlying severe physical condition.",C0680251|C0243161|C0019682|C0009450|C0002111|C0001911|C0205082|C0002871|G0000000|C0205082|C0031809|C0012634
"of nursing, who meet the inclusion criteria and exclusively work in emergency or acute, chronic, or specialized men and women wards of psychiatry in the two hospitals.","nursing, meet inclusion criteria exclusively emergency acute, chronic, specialized women wards psychiatry hospitals.",C0006147|C1550543|C0007637|C0243161|G0000000|C0013956|C0205178|C0205191|C0205555|C0043210|C1305702|C0033873|C0019994
"To increase sample generalizability, we had only two exclusion criteria: having an autoimmune rheumatic disease or the inability to read and write English.","To increase sample generalizability, exclusion criteria: autoimmune rheumatic disease inability read write English.",C0040363|C0442805|C0370003|G0000000|C0680251|C0243161|C0443146|G0000000|C0012634|G0000000|C0034754|C0043266|C0376245
The exclusion criteria were: interval headaches not distinguishable from migraine; medication-overuse headache; regular exercise (once or more per week during the 12 weeks prior to the study); earlier regular practice of relaxation; pregnancy; breastfeeding; use of daily migraine prophylaxis in the 12 weeks prior to the study; inability to understand Swedish; use of antipsychotic or antidepressive medication in the 12 weeks prior to the study; drug or alcohol abuse; and topiramate intolerance.,The exclusion criteria were: interval headaches distinguishable migraine; medication-overuse headache; regular exercise (once week 12 weeks prior study); earlier regular practice relaxation; pregnancy; breastfeeding; daily migraine prophylaxis 12 weeks prior study; inability understand Swedish; antipsychotic antidepressive medication 12 weeks prior study; drug alcohol abuse; topiramate intolerance.,G0000000|C0680251|C0243161|G0000000|C1272706|C0018681|G0000000|C0149931|C3266697|C0018681|C0205272|C0015259|C0585347|C0332174|C0450371|C0439230|C0332152|C0557651|C1279919|C0205272|C0237607|C0035028|C0032961|C0006147|C0332173|C0149931|C0033107|C0450371|C0439230|C0332152|C0557651|G0000000|C0162340|C1710263|C0040615|C0003289|C0013227|C0450371|C0439230|C0332152|C0557651|C0013227|C0001962|C0013146|C0076829|C0231199
"On average, 46 students in each school completed the pretest.","On average, 46 students school completed pretest.",G0000000|C1510992|C0450371|C0038492|C0036375|C0205197|C0033101
"We excluded patients who had received any investigational drugs 30 days prior to the enrollment, such as progesterone, estrogen and investigational compound, patients with severe anoxic intracerebral damage or brain death, and patients whose clinical condition was unstable (partial pressure of oxygen < 60 mmHg or a systolic blood pressure < 90 mmHg, or both).","We excluded patients received investigational drugs 30 days prior enrollment, progesterone, estrogen investigational compound, patients severe anoxic intracerebral damage brain death, patients clinical condition unstable (partial pressure oxygen < 60 mmHg systolic blood pressure < 90 mmHg, both).",G0000000|C1554077|C0030705|C1514756|C1517586|C0013227|C0450371|C0439228|C0332152|C1516879|C0033308|C0014939|C1517586|C0205198|C0030705|C0205082|C0003130|C0442111|C0010957|C0006104|C0011065|C0030705|C0205210|C0012634|C0443343|C0728938|C0033095|C0030054|G0000000|C0450371|C0439475|C0039155|C0005767|C0033095|G0000000|C0450371|C0439475|G0000000
"Families who had consented to be enrolled were visited at home for a baseline enrolment interview in the week the child turned 6 months of age, across all five groups.","Families consented enrolled visited baseline enrolment interview week child 6 months age, groups.",C0015576|C2711213|G0000000|C0545082|C0168634|C1516879|C0021822|C0332174|C0008059|G0000000|C0439231|C0001779|C0441833
The study was approved by the University of Colorado Institutional Review Board and by the Denver Veterans Affairs Research Committee as safe and appropriate for human subjects.,The study approved University Colorado Institutional Review Board Denver Veterans Affairs Research Committee safe human subjects.,G0000000|C0557651|C0205540|C0041740|C0009399|C0018704|C0282443|C0972401|G0000000|C0042610|G0000000|C0035168|C2699414|G0000000|C0086418|C0681850
"Consort Flow Diagram Inclusion criteria for child participants was: (1) chronological age between 7–14 years; (2) a confirmed diagnosis of an ASD, determined by one of three expert clinical psychologists (JR, SH, ABS) based upon review of a recent (within one year or newly administered) Autism Diagnostic Observation Schedule (ADOS; Lord et al., 1999) and the Social Communication Questionnaire (SCQ; Berument, et al., 1999); (3) speaking in full, complex sentences (required for completion of Module III of the ADOS), and as reflected in recent standardized cognitive assessment1, and (4) clinically significant symptoms of anxiety, defined as a score above the clinical significance cutoff on separation (SEP) social (SOC) and/or generalized anxiety (GAD) subscales of the Screen for Child Anxiety and Related Emotional Disorders—parent version (SCARED; Birmaher et al., 1999).","Consort Flow Diagram Inclusion criteria child participants was: (1) chronological age 7–14 years; (2) confirmed diagnosis ASD, determined expert clinical psychologists (JR, SH, ABS) based review (within newly administered) Autism Diagnostic Observation Schedule (ADOS; Lord al., 1999) Social Communication Questionnaire (SCQ; Berument, al., 1999); (3) speaking full, complex sentences (required completion Module III ADOS), reflected standardized cognitive assessment1, (4) clinically symptoms anxiety, defined score clinical significance cutoff separation (SEP) social (SOC) and/or generalized anxiety (GAD) subscales Screen Child Anxiety Related Emotional Disorders—parent version (SCARED; Birmaher al., 1999).",G0000000|C0806140|C0681494|C0007637|C0243161|C0008059|C0679646|G0000000|G0000000|C0008717|C0001779|G0000000|C0439234|G0000000|C0521093|C0011900|C0003516|G0000000|G0000000|C0205210|C0033908|C1708595|C0038108|G0000000|C1527178|C0282443|G0000000|C0750546|C1521801|C0004352|C0011900|C0302523|C0086960|C0670018|C1422581|C0202311|G0000000|C0728831|C0009452|C0034394|C0451482|G0000000|C0202311|G0000000|G0000000|C0234856|C0443225|C0439855|C0876929|C1514873|C0205197|C1709061|C0439070|C0670018|C0558058|G0000000|C1516691|G0000000|G0000000|G0000000|C0683368|C0003467|C1704788|C0449820|C0205210|C0237881|C1442160|C0036679|C1418664|C0728831|G0000000|G0000000|C0205246|C0003467|C0270549|G0000000|C0220908|C0008059|C0003467|C0439849|C0013987|G0000000|C0333052|C0015726|G0000000|C0202311|G0000000
"Students reported having a diagnosis of asthma by a medical provider, as well as experiencing symptoms of moderate persistent or severe persistent asthma as defined by NHLBI guidelines (32) and taking asthma medication prescribed by a medical provider in the last 12 months.","Students reported diagnosis asthma medical provider, experiencing symptoms moderate persistent severe persistent asthma defined NHLBI guidelines (32) asthma medication prescribed medical provider 12 months.",C0038492|C0684224|C0011900|C0004096|C0199168|C1138603|C0237607|C0683368|C0205081|C0205322|C0205082|C0205322|C0004096|C1704788|C1955970|C0162791|C0450371|C0004096|C0013227|C0278329|C0199168|C1138603|C0450371|C0439231
"Following discussions with local board certified psychiatrists, a consensus diagnosis is established using DSM IV criteria.","Following discussions local board certified psychiatrists, consensus diagnosis established DSM IV criteria.",C0231290|C0557061|C0205276|C0972401|C0007836|C0033872|C0376298|C0011900|C0443211|G0000000|C0022326|C0243161
"Patients with COPD were eligible for the studies if they had post-bronchodilator forced expiratory volume in 1 second (FEV1) greater than or equal to 30% and less than 80% of predicted normal and post-bronchodilator FEV1/forced vital capacity (FVC) less than 70% (Global initiative for chronic Obstructive Lung Disease 2–3).3,13 Patients were at least 40 years of age and current or former smokers with a smoking history of more than 10 pack-years.","Patients COPD eligible studies post-bronchodilator forced expiratory volume 1 (FEV1) equal 30% 80% predicted normal post-bronchodilator FEV1/forced vital capacity (FVC) 70% (Global initiative chronic Obstructive Lung Disease 2–3).3,13 Patients 40 age current smokers smoking history 10 pack-years.",C0030705|C0024117|C1548635|C0947630|C2599594|C0441722|C0231800|C0449468|G0000000|G0000000|C0205163|C0450371|C0450371|C0681842|C0205307|C2599594|C0441722|C0442732|C1516240|C3714541|C0450371|C0205246|C0424093|C0205191|C0549186|C0024109|C0012634|G0000000|C0030705|C0450371|C0001779|C0521116|C0337664|C0037369|C0019664|C0450371|C1277691
"Abstinence rates of the three intervention arms through 30-month assessment, bolder line indicates the duration of the Traditional Self-Help (1 mailing), Standard Repeated Mailings (8 mailings over 12 months), and Intensive Repeated Mailings (19 mailings over 18 months) conditions.","Abstinence rates intervention arms 30-month assessment, bolder duration Traditional Self-Help (1 mailing), Standard Repeated Mailings (8 mailings 12 months), Intensive Repeated Mailings (19 mailings 18 months) conditions.",C3843422|C0871208|C0886296|C0206655|C0450371|C1261322|G0000000|C0449238|C0443324|C0597431|G0000000|C0024492|C1442989|C0205341|C0024492|G0000000|C0024492|C0450371|C0439231|C0162425|C0205341|C0024492|C0450371|C0024492|C0450371|C0439231|C0012634
"aldosterone producing tumor), or estimation by clinic physicians that the individual was within 6 months of requiring dialysis or of dying from other causes.","aldosterone producing tumor), estimation clinic physicians individual 6 months requiring dialysis dying causes.",C0002006|G0000000|C0027651|C0680844|C0002424|C0031831|C0027361|G0000000|C0439231|G0000000|C0011945|C0184532|C0015127
"Finally, semistructured interviews will be conducted to gain insight into patients’ perceptions of NIV.","Finally, semistructured interviews conducted gain insight patients’ perceptions NIV.",G0000000|G0000000|C0021822|C0004927|C1517378|C0233820|G0000000|C0030971|C0598902
"Major eligibility criteria included age 8 to <12 years and refractive error meeting all the following, obtained by cycloplegic autorefraction: spherical equivalent −0.75 to −2.50 D in both eyes, astigmatism ≤1.50 D in both eyes, and spherical equivalent anisometropia ≤1.00 D. Other major eligibility criteria included near esophoria ≥2 PD, by prism and alternate cover test (PACT) at 33 cm, and high accommodative lag, as assessed by noncycloplegic autorefraction.","Major eligibility criteria included age 8 <12 refractive error meeting following, cycloplegic autorefraction: spherical equivalent −0.75 −2.50 D eyes, astigmatism ≤1.50 D eyes, spherical equivalent anisometropia ≤1.00 D. Other major eligibility criteria included esophoria ≥2 PD, prism alternate cover test (PACT) 33 cm, accommodative lag, assessed noncycloplegic autorefraction.",C0205082|C0013893|C0243161|C0332257|C0001779|G0000000|C0450371|C0429585|C0743559|C0556656|C0231290|C0010586|G0000000|C0332501|C0205163|G0000000|G0000000|C0073187|C0015392|C0004106|G0000000|C0073187|C0015392|C0332501|C0205163|C0003081|G0000000|C0073187|G0000000|C0205082|C0013893|C0243161|C0332257|C0152216|G0000000|G0000000|C0814195|C0332270|C0180153|C0022885|G0000000|C0450371|G0000000|C0000936|C1416797|C1516048|G0000000|G0000000
Fathers whose partners also had epilepsy (n=4) were excluded.,Fathers partners epilepsy (n=4) excluded.,C0015671|C0682323|C0014544|C0369718|C1554077
"Neonates with major congenital anomalies, hemolytic disease, using phenobarbital or herbal medications (such as Alhagi pseudoalhagi, Fumaria parviflora, Zizyphus jujube, Purgative manna and Cichorium Intybus), elevated direct bilirubin (direct bilirubin more than 20% of total serum bilirubin), symptoms of infection and postnatal age less than 48 hours and more than two weeks at the start of phototherapy were excluded.","Neonates major congenital anomalies, hemolytic disease, phenobarbital herbal medications (such Alhagi pseudoalhagi, Fumaria parviflora, Zizyphus jujube, Purgative manna Cichorium Intybus), elevated direct bilirubin (direct bilirubin 20% total serum bilirubin), symptoms infection postnatal age 48 hours weeks start phototherapy excluded.",C0021289|C0205082|C0009678|C0000769|C0312853|C0012634|C0031412|C3146288|C0013227|G0000000|C1013017|G0000000|C1135827|G0000000|C1029148|C1123049|C0007422|C0043572|C0331374|G0000000|C0205250|C0439851|C0005437|C0439851|C0005437|C0450371|C0439175|C0229671|C0005437|C0683368|C0009450|C0443281|C0001779|C0450371|C0439227|C0439230|C0439659|C0031765|C1554077
"Overall, 26 patients were taking levodopa, 21 were taking agonists, 8 were taking COMT inhibitors and 7 were taking MAO inhibitors.","Overall, 26 patients levodopa, 21 agonists, 8 COMT inhibitors 7 MAO inhibitors.",C0282416|C0450371|C0030705|C0023570|C0450371|C0243192|G0000000|G0000000|C0243077|G0000000|C2658720|C0243077
We previously demonstrated that the AS04-HPV-16/18 vaccine administered as a 2-dose schedule (either 6 months or 12 months apart) to girls aged 9–14 years elicited an immune response that was noninferior to the one elicited by 3 doses in women aged 15–25 years up to 6 months after the first dose.,We demonstrated AS04-HPV-16/18 vaccine administered 2-dose schedule (either 6 months 12 months apart) girls aged 9–14 elicited immune response noninferior elicited 3 doses women aged 15–25 6 months dose.,G0000000|G0000000|C0021344|C0042210|C1521801|C0178602|C0086960|C3844638|G0000000|C0439231|C0450371|C0439231|G0000000|C0870604|C0001779|G0000000|C0449265|C0439662|C0871261|G0000000|C0449265|G0000000|C0178602|C0043210|C0001779|G0000000|G0000000|C0439231|C0178602
"The 2011 Ethiopian Demographic and Health Survey (EDHS) revealed that 13% of the Ethiopian children had diarrhea in the 2 weeks preceding the survey [12, 13].","The 2011 Ethiopian Demographic Health Survey (EDHS) revealed 13% Ethiopian children diarrhea 2 weeks preceding survey [12, 13].",G0000000|G0000000|C0239304|C0011298|C0018684|C0038951|C1415081|C0443289|C0450371|C0239304|C0008059|C0011991|G0000000|C0439230|C0332152|C0038951|C0450371|C0450371
The physical exercise component was either a mixed aerobic and resistance (AR) training program or its control condition composed of stretching and toning (ST) exercises.,The physical exercise component mixed aerobic resistance (AR) training program control condition composed stretching toning (ST) exercises.,G0000000|C0031809|C0015259|C0449432|C0205430|C1510824|C0237834|C2986463|C0040607|C1709697|C0243148|C0012634|G0000000|C0600080|G0000000|C0036056|C0015259
Rescue albuterol use at baseline was similar in the UMEC/VI 62.5/25 μg (3.4 puffs/day) and PBO (3.8 puffs/day) groups.,Rescue albuterol baseline UMEC/VI 62.5/25 μg (3.4 puffs/day) PBO (3.8 puffs/day) groups.,G0000000|C0001927|C0168634|C0205999|C0450371|G0000000|G0000000|C1533107|C0031962|G0000000|C1533107|C0441833
Twelve adult patients meeting the Berlin definition of acute respiratory distress syndrome with a PaO2/FiO2 ratio of < 200 were randomized to receive allogeneic adipose-derived MSCs or placebo in a 1:1 fashion.,Twelve adult patients meeting Berlin definition acute respiratory distress syndrome PaO2/FiO2 ratio of < 200 randomized receive allogeneic adipose-derived MSCs placebo 1:1 fashion.,C0205458|C0001675|C0030705|C0556656|C0005125|C1550452|C0205178|C0521346|C0231303|C0039082|C1427155|C0456603|G0000000|C0034656|C1514756|C1515895|C0028754|C2248778|C0032042|G0000000|G0000000
"MA, MS, DD, and AC: enrolled patients from the neurology department of Henri Mondor Hospital.","MA, MS, DD, AC: enrolled patients neurology department Henri Mondor Hospital.",C0024443|C0039676|C3538867|C0003354|G0000000|C0030705|C0027855|C1704729|G0000000|G0000000|C0019994
"About 80 patients with CLBP (females 37) registered for a week long treatment at SVYASA Holistic Health Centre in Bengaluru, India.","About 80 patients CLBP (females 37) registered week treatment SVYASA Holistic Health Centre Bengaluru, India.",G0000000|C0450371|C0030705|G0000000|C0015780|C0450371|C1514821|C0332174|C0039798|G0000000|C1552235|C0018684|C0205099|G0000000|C0021201
"Of the 216 participants, 108 were randomized to the Girls OnGuard intervention group and 108 were randomized to the health promotion comparison condition (Fig.","Of 216 participants, 108 randomized Girls OnGuard intervention 108 randomized health promotion comparison condition (Fig.",G0000000|C1442061|C0679646|C1442061|C0034656|C0870604|G0000000|C0886296|C1442061|C0034656|C0018684|C0033414|C1707455|C0012634|C0349966
Eligible patients were required to have tumors with a distinct ring-like pattern of contrast enhancement with thick irregular walls on MRI and a core area of reduced signal suggestive for tumor necrosis.,Eligible patients required tumors distinct ring-like pattern contrast enhancement thick irregular walls MRI core reduced signal suggestive tumor necrosis.,C1548635|C0030705|C1514873|C0027651|G0000000|C0521164|C0449774|C0009924|C1627358|C1280412|C0205271|C0677535|C0024485|C0444669|C0392756|C1710082|C0332299|C0027651|C0027540
Adolescents aged 11–14 years in Gulu municipality voluntarily attended a registration day for the GMKL in September 2010 (boys: n = 495; girls: n = 167).,Adolescents aged 11–14 Gulu municipality voluntarily attended registration day GMKL September 2010 (boys: n = 495; girls: n = 167).,C0205653|C0001779|G0000000|G0000000|C0600182|G0000000|C1456498|C1514821|C0332173|G0000000|C3828193|G0000000|C0870221|G0000000|C0870604|G0000000
"The exclusion criteria of participating were: occurrence of stressful event (e.g bereavement), using drugs which might interact with NSAIDs, using oral contraceptive pills and lack of compliance.","The exclusion criteria participating were: occurrence stressful event (e.g bereavement), drugs interact NSAIDs, oral contraceptive pills lack compliance.",G0000000|C0680251|C0243161|C0679823|G0000000|C0243132|C0231297|C0441471|G0000000|C0005119|C0013227|G0000000|C0003211|C0442027|C0009871|C0994475|C0332268|C0009563
"Patients aged between 4 and 25 years old with a confirmed diagnosis of dystonic cerebral palsy, Gross Motor Functioning Classification System level IV or V, with lesions in the cerebral white matter, basal ganglia or central cortex and who are eligible for intrathecal baclofen treatment will be included.","Patients aged 4 25 confirmed diagnosis dystonic cerebral palsy, Gross Motor Functioning Classification System level IV V, lesions cerebral white matter, basal ganglia central cortex eligible intrathecal baclofen treatment included.",C0030705|C0001779|G0000000|C0450371|C0521093|C0011900|G0000000|G0000000|C0522224|C0439806|C1513492|C0205245|C0008902|C0449913|C0441889|C0022326|G0000000|C0221198|G0000000|C0007457|G0000000|C0205112|C0017067|C0205099|C0007776|C1548635|C1370196|C0004609|C0039798|C0332257
"During the study period, 7,439 patients attending the malaria clinic and presenting with fever were examined for the presence of the malaria parasite, 1,695 of whom were positive (148 P. falciparum, 1,544 P. vivax, and 3 mixed infections with both P. falciparum and P. vivax).","During study period, 7,439 patients attending malaria clinic fever examined presence malaria parasite, 1,695 positive (148 P. falciparum, 1,544 P. vivax, 3 mixed infections P. falciparum P. vivax).",G0000000|C0557651|C0439531|C1442061|C0030705|C1547429|C0024530|C0002424|C0015967|C0332128|C0150312|C0024530|C0030498|C1442061|C0439178|C1442061|C0369773|G0000000|C1442061|C0369773|G0000000|G0000000|C0205430|C3714514|C0369773|G0000000|C0369773|G0000000
"Additional exclusion criteria included a body mass index <18 or >30 kg/m2, use of tobacco products within the previous 12 months, and regular consumption of medications or over-the-counter therapies that might affect inflammation such as: green or black tea (≥8 oz./day), green or black tea supplements, cherry juice (≥8 oz./day), vitamin E (≥400 IU/day), vitamin C (≥1,000 mg/day), aspirin, corticosteroids, anabolic steroids, or NSAIDs.","Additional exclusion criteria included body mass <18 >30 kg/m2, tobacco products previous 12 months, regular consumption medications over-the-counter therapies affect inflammation as: green black tea (≥8 oz./day), green black tea supplements, cherry juice (≥8 oz./day), vitamin E (≥400 IU/day), vitamin C (≥1,000 mg/day), aspirin, corticosteroids, anabolic steroids, NSAIDs.",C1524062|C0680251|C0243161|C0332257|C0242821|C0577559|C0450371|C0450371|C0022718|C0040329|C1514468|C0205156|C0450371|C0439231|C0205272|C0009830|C0013227|C0013231|C0087111|C0001721|C0021368|G0000000|C0332583|C0005680|C0039400|G0000000|C0560718|C0332583|C0005680|C0039400|C0242295|C0330657|C1268568|G0000000|C0560718|C0042890|G0000000|G0000000|C0439465|C0042890|G0000000|G0000000|C0439422|C0004057|C0001617|C0002744|C0038317|C0003211
"Per school, all the students in the fourth grade are invited to participate.","Per school, students fourth grade invited participate.",G0000000|C0036375|C0038492|C0205438|C0441800|G0000000|G0000000
The primary outcome was complete clearance of all plantar warts at 12 weeks after randomisation.,The primary outcome complete clearance plantar warts 12 weeks randomisation.,G0000000|C0205225|C1274040|C0205197|C0449297|C0230463|C1367460|C0450371|C0439230|C0034656
"Patients with multiple brain lesions, unstable medical or neurologic conditions, a metallic foreign body within the brain, a pacemaker or artificial cochlear implant, and those with severe depression, a history of seizure, or unable to perform the protocol-related behavioral task were excluded.","Patients multiple brain lesions, unstable medical neurologic conditions, metallic foreign body brain, pacemaker artificial cochlear implant, severe depression, history seizure, unable perform protocol-related behavioral task excluded.",C0030705|C0439064|C0006104|C0221198|C0443343|C0199168|C0205494|C0012634|C2986473|C0376327|C0242821|C0006104|C0030163|C2004457|C0009195|C0021102|C0205082|C0011570|C0019664|C0036572|C1299582|C0884358|C0442711|C0004927|C3540678|C1554077
229 subjects were randomized to receive five intramuscular injections of the nicotine vaccine and 112 to receive placebo at monthly intervals.,229 subjects randomized receive intramuscular injections nicotine vaccine 112 receive placebo monthly intervals.,C1442061|C0681850|C0034656|C1514756|C0021492|C0021485|C0028040|C0042210|C1442061|C1514756|C0032042|C0332177|C1272706
"However, these co-infections were not associated with increased mortality in the present cohort.","However, co-infections increased mortality cohort.",G0000000|C0275524|C0205217|C0026565|C0599755
"Consent for the house modifications will be obtained from individual homeowners during door-to-door visits, following the randomization of villages to trial arms.","Consent house modifications individual homeowners door-to-door visits, randomization villages trial arms.",C1511481|C0442519|C0392747|C0027361|C0578827|C0557698|C0545082|C0034656|C0562518|C0008976|C0206655
"At a mean of 3.3 +/- 2.0 days after hip fracture surgery, 73.7% of participants were mobilising with unrestricted weight bearing.","At 3.3 +/- 2.0 days hip fracture surgery, 73.7% participants mobilising unrestricted weight bearing.",G0000000|G0000000|G0000000|G0000000|C0439228|C0019552|C0016658|C0038894|C0450371|C0679646|C0185112|C3858706|C0005910|C1704689
The inclusion criteria were: (i) age over 18 years; (ii) chronic neuropathic pain at or below SCI level for at least 6 months following trauma or disease of the spinal cord; (iii) a pain intensity of at least 4 out of 10 in the numerical rating scale (NRS) at both screening (scored during the previous 24 h) and randomization; and (iv) stable pharmacological treatment for at least 2 weeks prior to the study and throughout the trial.,The inclusion criteria were: (i) age 18 years; (ii) chronic neuropathic pain SCI level 6 months trauma disease spinal cord; (iii) pain intensity 4 10 numerical rating scale (NRS) screening (scored previous 24 h) randomization; (iv) stable pharmacological treatment 2 weeks prior study trial.,G0000000|C0007637|C0243161|G0000000|C0021966|C0001779|C0450371|C0439234|G0000000|C0205191|C0442874|C0030193|C3642273|C0441889|G0000000|C0439231|C0043251|C0012634|C0521329|C1550235|C0439070|C0030193|C0522510|G0000000|C0450371|C0237753|C0871208|C0175659|C2240043|C0220908|C0449820|C0205156|G0000000|C0034656|C0022326|C0205360|C0031330|C0039798|G0000000|C0439230|C0332152|C0557651|C0008976
"The inclusion criteria were slide-confirmed infection with asexual stages of P. vivax, written informed consent by the patient or attending parent/guardian, and a negative urine pregnancy test in women of childbearing age.","The inclusion criteria slide-confirmed infection asexual stages P. vivax, written informed consent patient attending parent/guardian, negative urine pregnancy test women childbearing age.",G0000000|C0007637|C0243161|C0444330|C0009450|C0599655|C1306673|C0369773|G0000000|C0043266|C1522154|C1511481|C0030705|C1547429|C0030551|C0205160|C0042036|C0032961|C0022885|C0043210|G0000000|C0001779
"A total of 212 parturients participated in the study, 105 in the intervention group and 107 in the control group (Figure (Figure1).1).","A total 212 parturients participated study, 105 intervention 107 control (Figure (Figure1).1).",G0000000|C0439175|C1442061|G0000000|G0000000|C0557651|C1442061|C0886296|C1442061|C0243148|G0000000|G0000000
A total of 155 adult patients were approached to participate in this study over a 7 month period (6/08–12/08).,A total 155 adult patients approached participate study 7 month period (6/08–12/08).,G0000000|C0439175|C1442061|C0001675|C0030705|C0449445|G0000000|C0557651|G0000000|C0332177|C0439531|G0000000
Forty-six SCD subjects (7–21 years) were enrolled during steady state i.e.,Forty-six SCD subjects (7–21 years) enrolled steady i.e.,C3816449|G0000000|C0681850|G0000000|C0439234|G0000000|C0205361|C0683454
"All samples were to be obtained, if possible, before antimicrobial/influenza antiviral therapy was started.","All samples obtained, possible, antimicrobial/influenza antiviral therapy started.",G0000000|C0370003|C1301820|C0332149|C1136254|C0003451|C0039798|C1272689
"Exclusion criteria: - Pregnancy; - Patients under 18 or older than 65 years; - GCS under 3 or more than 8; - Patients with chronic disease such as diabetes mellitus, ischemic heart disease, renal failure, acute pulmonary edema, history of massive myocardial infarction, and heart failure; - Patients with a baseline blood pressure of less than 90/60; - Patients with successful cardiopulmonary resuscitation (CPR); - Death or loss to follow-up; - Patients in the control group in which oxygen therapy was inevitable was also excluded from this study.","Exclusion criteria: - Pregnancy; - Patients 18 65 years; - GCS 3 8; - Patients chronic disease diabetes mellitus, ischemic heart disease, renal failure, acute pulmonary edema, history massive myocardial infarction, heart failure; - Patients baseline blood pressure 90/60; - Patients successful cardiopulmonary resuscitation (CPR); - Death loss follow-up; - Patients control oxygen therapy inevitable excluded study.",C0680251|C0243161|G0000000|C0032961|G0000000|C0030705|C0450371|C0450371|C0439234|G0000000|G0000000|G0000000|G0000000|G0000000|C0030705|C0205191|C0012634|C0011847|G0000000|C0475224|C0018787|C0012634|C0022646|C0231174|C0205178|C0024109|C0013604|C0019664|C0522501|C0027061|C0021308|C0018787|C0231174|G0000000|C0030705|C0168634|C0005767|C0033095|C0450371|G0000000|C0030705|C0597535|C0553534|C0035273|C0007203|G0000000|C0011065|C1517945|C0589120|G0000000|C0030705|C0243148|C0030054|C0039798|G0000000|C1554077|C0557651
"During the period of 2014–2016, 60 patients [28 females/32 males, age 54 (45–60) years] scheduled for major pancreatoduodenal surgery (mostly, extended pancreatic resection of pancreatic cancer or chronic calcific pancreatitis) with expected duration of the intervention exceeding 2 h were included into a prospective randomized study.","During period 2014–2016, 60 patients [28 females/32 males, age 54 (45–60) years] scheduled major pancreatoduodenal surgery (mostly, extended pancreatic resection pancreatic cancer chronic calcific pancreatitis) expected duration intervention exceeding 2 h included prospective randomized study.",G0000000|C0439531|G0000000|C0450371|C0030705|C0450371|C0015780|C0086582|C0001779|C0450371|G0000000|C0439234|C0086960|C0205082|G0000000|C0038894|C0205393|C0231448|C0030274|C0015252|C0030274|C0006826|C0205191|C0175895|C0030305|C1517001|C0449238|C0886296|G0000000|G0000000|C0332257|C0023981|C0034656|C0557651
"The inclusion criteria were age 6–16 years, children and parents agreed to wear randomly assigned CLs, spherical refractive error from −0.75 D to −3.50 D with astigmatism <1.0 D, vision correctable to at least 20/20 in both eyes with spherical lenses, normal ocular findings, and willing to wear the lens type assigned to them and to adhere to the protocol schedule.","The inclusion criteria age 6–16 years, children parents agreed wear randomly assigned CLs, spherical refractive error −0.75 D −3.50 D astigmatism <1.0 D, vision correctable 20/20 eyes spherical lenses, normal ocular findings, wear lens type assigned adhere protocol schedule.",G0000000|C0007637|C0243161|C0001779|G0000000|C0439234|C0008059|C0030551|C3641827|G0000000|G0000000|C1516050|C3890598|C0332501|C0429585|C0743559|G0000000|C0073187|G0000000|C0073187|C0004106|G0000000|C0073187|C0042789|G0000000|C0450371|C0015392|C0332501|C0023317|C0205307|C0015392|C2607943|G0000000|C0023317|C0332307|C1516050|C3714578|C0442711|C0086960
"Male and female patients ≥ 40 years of age with a clinical diagnosis of COPD (post-bronchodilator FEV1 < 80% of predicted normal, and post-bronchodilator FEV1/forced vital capacity [FVC] < 70%) and current COPD symptoms were eligible for inclusion.","Male female patients ≥ 40 age clinical diagnosis COPD (post-bronchodilator FEV1 < 80% predicted normal, post-bronchodilator FEV1/forced vital capacity [FVC] < 70%) current COPD symptoms eligible inclusion.",C0086582|C0015780|C0030705|G0000000|C0450371|C0001779|C0205210|C0011900|C0024117|C2599594|G0000000|G0000000|C0450371|C0681842|C0205307|C2599594|C0441722|C0442732|C1516240|C3714541|G0000000|C0450371|C0521116|C0024117|C0683368|C1548635|C0007637
Sixty pediatric patients of both genders who were presented for strabismus surgery and satisfied the inclusion criteria were enrolled for the present study.,Sixty pediatric patients genders strabismus surgery satisfied inclusion criteria enrolled study.,C3816724|C0030755|C0030705|C0079399|C0038379|C0038894|C0242428|C0007637|C0243161|G0000000|C0557651
"To be included in the study participants must meet the following criteria: (i) aged 18 years or older; (ii) a diagnosis of idiopathic PD using the UK Brain Bank criteria; (iii) able to walk 100 m independently with or without gait aids; (iv) rated stage I-IV on Hoehn and Yahr disability scale [26]; and (v) report reduced step length or slowed gait speed, confirmed by clinical examination.","To included study participants meet criteria: (i) aged 18 older; (ii) diagnosis idiopathic PD UK Brain Bank criteria; (iii) walk 100 independently gait aids; (iv) rated stage I-IV Hoehn Yahr disability scale [26]; (v) report reduced step length slowed gait speed, confirmed clinical examination.",C0040363|C0332257|C0557651|C0679646|C1550543|C0243161|C0021966|C0001779|C0450371|C0580836|G0000000|C0011900|C0332240|G0000000|C0041700|C0006104|C0442598|C0243161|C0439070|C0080331|C1442061|G0000000|C0016928|C0001175|C0022326|C0871208|C0205390|C0021966|G0000000|G0000000|C0231170|C0175659|C0450371|G0000000|C0684224|C0392756|C1261552|C1444754|C0439834|C0016928|C0678536|C0521093|C0205210|G0000000
"We therefore investigated the effect of DHA intake during the second half of pregnancy on infant illness symptoms in the context of a large randomized controlled trial in Mexico.27 We recruited study participants at the Mexican Institute of Social Security (Instituto Mexicano del Seguro Social [IMSS]) General Hospital I, Cuernavaca, Mexico, and 3 small health clinics within the IMSS system in Cuernavaca during routine prenatal care visits between February 2005 and February 2007.","We investigated DHA intake half pregnancy infant illness symptoms context randomized controlled trial Mexico.27 We recruited study participants Mexican Institute Social Security (Instituto Mexicano del Seguro Social [IMSS]) General Hospital I, Cuernavaca, Mexico, 3 health clinics IMSS system Cuernavaca routine prenatal care visits February 2005 February 2007.",G0000000|C1292732|C0142831|C1512806|C2825407|C0032961|C0021270|C0221423|C0683368|C0449255|C0034656|C2587213|C0008976|C0025885|G0000000|G0000000|C0557651|C0679646|C0240339|C0021622|C0728831|C1519222|G0000000|C1553368|C0008628|G0000000|C0728831|G0000000|C0205246|C0019994|C0021966|G0000000|C0025885|G0000000|C0018684|C0442592|G0000000|C0449913|G0000000|C0205547|C0678804|C1947933|C0545082|C3830166|G0000000|C3830166|G0000000
Type and duration of exercises are among other differences which should be mentioned (30).,Type duration exercises differences mentioned (30).,C0332307|C0449238|C0015259|C1705241|G0000000|C0450371
Participants included 479 students attending two public high schools in northeast Florida during fall 2008.,Participants included 479 students attending public schools northeast Florida fall 2008.,C0679646|C0332257|C1442061|C0038492|C1547429|G0000000|C0036375|C1709272|C0016253|C0085639|G0000000
Randomized patients were managed in an intensive care or acute stroke unit for 24 hours following treatment using standard guidelines for post-thrombolytic stroke treatment.,Randomized patients managed intensive care acute stroke unit 24 hours treatment standard guidelines post-thrombolytic stroke treatment.,C0034656|C0030705|C1273870|C0162425|C1947933|C0205178|C0038454|C0439148|C0450371|C0439227|C0039798|C1442989|C0162791|C0687676|C0038454|C0039798
Only cases less than 30 years of age and were living in the Kaohsiung metropolitan area at the time of diagnosis were eligible.,Only 30 age living Kaohsiung metropolitan time diagnosis eligible.,C0205171|C0450371|C0001779|C0376558|G0000000|C0599587|C0040223|C0011900|C1548635
The mean age of the 37 randomized study participants was 49.5 years (range = 19–70 years).,The age 37 randomized study participants 49.5 (range = 19–70 years).,G0000000|C0001779|C0450371|C0034656|C0557651|C0679646|C0450371|C1514721|G0000000|G0000000|C0439234
"We evaluated the role of tea and coffee and substances added (sugar/honey, creamers, and milk) on endometrial cancer risk in a population-based case–control study in six counties in New Jersey, including 417 cases and 395 controls.","We evaluated role tea coffee substances (sugar/honey, creamers, milk) endometrial cancer risk population-based case–control study counties New Jersey, including 417 395 controls.",G0000000|C0220825|C0035820|C0039400|C0009237|C0439861|C0007004|G0000000|C0026131|C0227843|C0006826|C0035647|C0032659|G0000000|C0557651|C0079170|C0205314|C0454673|C0332257|C1442061|C1442061|C0243148
"The inclusion criteria was aged over 18 years old, completed primary and adjuvant treatments for colorectal and breast cancer (stage I, II, III) (within 36months after curative surgery), able to read and speak Korean.","The inclusion criteria aged 18 old, completed primary adjuvant treatments colorectal breast cancer (stage I, II, III) (within 36months curative surgery), read speak Korean.",G0000000|C0007637|C0243161|C0001779|C0450371|C0580836|C0205197|C0205225|C0001551|C0087111|C0555952|C0006141|C0006826|C0205390|C0021966|G0000000|C0439070|G0000000|G0000000|C1880198|C0038894|C0034754|C0234856|C1556095
The mean age was 66 years (SD = 8.9) in the clarithromycin group versus 64 years (SD = 9.3) in the placebo group.,The age 66 (SD = 8.9) clarithromycin versus 64 (SD = 9.3) placebo group.,G0000000|C0001779|C0450371|G0000000|G0000000|G0000000|C0055856|G0000000|C0450371|G0000000|G0000000|G0000000|C0032042|C0441833
"This randomized, comparative two way cross-over study comprised 60 single female students at Faculty of Medicine, Ain Shams University, Egypt, aged 19–28 years with moderate (n = 46) or severe (n = 14) primary dysmenorrhea.","This randomized, comparative cross-over study comprised 60 single female students Faculty Medicine, Ain Shams University, Egypt, aged 19–28 moderate (n = 46) severe (n = 14) primary dysmenorrhea.",G0000000|C0034656|G0000000|C0010366|C0557651|C2700400|C0450371|C0037179|C0015780|C0038492|C0015535|C0013227|C0347129|C0073980|C0041740|C0013715|C0001779|G0000000|C0205081|G0000000|C0205082|G0000000|C0205225|C0013390
Eligible participants were (i) Hong Kong residents aged 18 or older; (ii) daily smokers who smoked at least one cigarette per day in the past 6 months; (iii) exhaled carbon monoxide (CO) of 4 ppm or above; (iv) able to communicate in Cantonese and read Chinese and (v) had a mobile phone to receive SMS.,Eligible participants (i) Hong Kong residents aged 18 older; (ii) daily smokers smoked cigarette day 6 months; (iii) exhaled carbon monoxide (CO) 4 ppm above; (iv) communicate Cantonese read Chinese (v) mobile phone receive SMS.,C1548635|C0679646|C0021966|G0000000|G0000000|C1320928|C0001779|C0450371|C0580836|G0000000|C0332173|C0337664|C0037366|C0677453|C0332173|G0000000|C0439231|C0439070|C0231800|C0007009|G0000000|C3245499|G0000000|C0439187|C1282910|C0022326|C0566001|G0000000|C0034754|C0008120|G0000000|C0231435|C1515258|C1514756|G0000000
"Of the 9,959 total telephone screening invitation calls attempted, 2,638 individuals completed a telephone screening call that resulted in 1,296 screening appointments scheduled.","Of 9,959 total telephone screening invitation calls attempted, 2,638 individuals completed telephone screening call 1,296 screening appointments scheduled.",G0000000|C1442061|C0439175|C0039457|C0220908|C2826348|C0679006|C1516084|C1442061|C0027361|C0205197|C0039457|C0220908|C0679006|C1442061|C0220908|C0003629|C0086960
The study was open to individuals aged 14 to 21 years who met DSM-IV criteria for opioid dependence with physiologic features18 and who sought outpatient treatment.,The study individuals aged 14 21 met DSM-IV criteria opioid dependence physiologic features18 sought outpatient treatment.,G0000000|C0557651|C0027361|C0001779|C0450371|C0450371|C0268621|C0220952|C0243161|C0242402|C0011546|C0205463|G0000000|G0000000|C0029921|C0039798
To compare the effects of true and sham acupuncture in relieving symptoms of IBS.,To compare effects true sham acupuncture relieving symptoms IBS.,C0040363|C1707455|C1280500|C0205238|C0068899|C0001299|C0332303|C0683368|C0022104
"From March 2008 until July 2010, patients aged 75 years or older with a primary hip fracture and who were scheduled for surgery and admitted to the Medical Center Alkmaar (MCA, Alkmaar, The Netherlands) or to the Red Cross Hospital Beverwijk (RKZ, Beverwijk, The Netherlands) were included in the study.","From March 2008 July 2010, patients aged 75 primary hip fracture scheduled surgery admitted Medical Center Alkmaar (MCA, Alkmaar, The Netherlands) Red Cross Hospital Beverwijk (RKZ, Beverwijk, The Netherlands) included study.",G0000000|C3829202|G0000000|C3829447|G0000000|C0030705|C0001779|C0450371|C0205225|C0019552|C0016658|C0086960|C0038894|C0184666|C0199168|C0205099|G0000000|C0149566|G0000000|G0000000|C0027778|C0332575|C2828360|C0019994|G0000000|G0000000|G0000000|G0000000|C0027778|C0332257|C0557651
A sample of 125 consecutive married female patients with FMS was recruited from 10 outpatient rheumatological clinics.,A sample 125 consecutive married female patients FMS recruited 10 outpatient rheumatological clinics.,G0000000|C0370003|C1442061|C1707491|C0024841|C0015780|C0030705|G0000000|G0000000|C0450371|C0029921|C0035452|C0442592
(4) Subjects were selected based on specific criteria that may also limit generalizability (insomnia did not predate LBP onset by more than 1 mo; subjects reported usual nightly TST less than 6.5 h and/ or usual SOL more than 30 min for the month prior to screening; ISI greater than14).,(4) Subjects selected based specific criteria limit generalizability (insomnia predate LBP onset 1 mo; subjects reported usual nightly TST 6.5 and/ usual SOL 30 min month prior screening; ISI than14).,G0000000|C0681850|C1707391|C1527178|C0205369|C0243161|C0439801|G0000000|C0917801|C0699540|C1505993|C0206132|G0000000|C0026544|C0681850|C0684224|C3538928|G0000000|C1421210|G0000000|G0000000|C3538928|G0000000|C0450371|C0702093|C0332177|C0332152|C0220908|G0000000|G0000000
Nausea and vomiting of pregnancy are amongst the most common complaints that effects on both the physical and mental conditions of the pregnant women.,Nausea vomiting pregnancy common complaints effects physical mental conditions pregnant women.,C0027497|C0042963|C0032961|C0205214|C0277786|C1280500|C0031809|C0229992|C0012634|C0549206|C0043210
"Pericardial effusions, lung disease, or pericardial involvement were treated with 10.5 Gy.","Pericardial effusions, lung disease, pericardial involvement treated 10.5 Gy.",C0031050|C0013687|C0024109|C0012634|C0031050|C1314939|C1522326|C0450371|C0018408
"[30] Sixty pregnant women were screened for the current study; of them, 46 met the inclusion criteria.","[30] Sixty pregnant women screened current study; them, 46 met inclusion criteria.",C0450371|C3816724|C0549206|C0043210|C0220908|C0521116|C0557651|G0000000|C0450371|C0268621|C0007637|C0243161
Inclusion criteria were: (1) mothers with healthy children aged 6 to 35 mos; and (2) mothers who were primary caregivers (>8 hrs per day) and had at least one active caries lesion within a yr. Exclusion criteria included: (1) children who had oral or systemic diseases; and (2) mothers or children who in the previous 3 mos had taken antibiotics or other medication that would affect oral flora.,Inclusion criteria were: (1) mothers healthy children aged 6 35 mos; (2) mothers primary caregivers (>8 hrs day) active caries lesion yr. Exclusion criteria included: (1) children oral systemic diseases; (2) mothers children previous 3 mos antibiotics medication affect oral flora.,C0007637|C0243161|G0000000|G0000000|C0026591|C3898900|C0008059|C0001779|G0000000|C0450371|C3813178|G0000000|C0026591|C0205225|C0085537|G0000000|G0000000|C0332173|C0205177|C0011334|C0221198|C0439234|C0680251|C0243161|C0332257|G0000000|C0008059|C0442027|C0205373|C0012634|G0000000|C0026591|C0008059|C0205156|G0000000|C3813178|C0003232|C0013227|C0001721|C0442027|G0000000
"Eligibility criteria included at least 7 hot flashes per day, and at least one missed menstrual cycle or spontaneous or medically-induced menopause.","Eligibility criteria included 7 hot flashes day, missed menstrual cycle spontaneous medically-induced menopause.",C0013893|C0243161|C0332257|G0000000|C0444519|C0085635|C0332173|C1705492|C0025344|C1511572|C0205359|C0205263|C0025320
Randomisation will also be stratified by rurality and dementia-specificity following evidence that these variables may be associated with quality of care for residents with advanced dementia [18].,Randomisation stratified rurality dementia-specificity evidence variables quality care residents advanced dementia [18].,C0034656|C0205363|C0240919|C0011265|C3887511|C0439828|C0332306|C1947933|C1320928|C0205179|C0011265|C0450371
Initiatives that could optimize rehabilitation for stroke patients are important.,Initiatives optimize rehabilitation stroke patients important.,C0424093|G0000000|C0034991|C0038454|C0030705|C3898777
"Seasonal allergic conjunctivitis (SAC), or hay fever conjunctivitis, is a hypersensitivity reaction to specific airborne allergens, mainly pollens.","Seasonal allergic conjunctivitis (SAC), hay fever conjunctivitis, hypersensitivity reaction specific airborne allergens, pollens.",C0439601|C0700624|C0009763|C1325744|C1440666|C0015967|C0009763|C0020517|C0443286|C0205369|C3242389|C0002092|C0032385
"In 2007, participants who had reached 10 years of age were replaced by infants 6–18 months of age and those who left the study were replaced by additional children from the same village.","In 2007, participants reached 10 age replaced infants 6–18 months age left study replaced additional children village.",G0000000|G0000000|C0679646|C2584321|C0450371|C0001779|C0559956|C0021270|G0000000|C0439231|C0001779|C0205091|C0557651|C0559956|C1524062|C0008059|C0562518
"Randomised, controlled, double‐masked, double‐dummy, non‐inferiority explanatory study including 670 children from Guinea Conakry and Pakistan if: 1–10 years old; active trachoma (TF+TI0 or TF+TI+ on simplified World Health Organisation (WHO) scale).","Randomised, controlled, double‐masked, double‐dummy, non‐inferiority explanatory study including 670 children Guinea Conakry Pakistan if: 1–10 years old; active trachoma (TF+TI0 TF+TI+ simplified World Health Organisation (WHO) scale).",G0000000|C2587213|G0000000|G0000000|G0000000|C0681841|C0557651|C0332257|C1442061|C0008059|C0018381|G0000000|C0030211|G0000000|G0000000|C0580836|C0205177|C0040592|C4048299|C4048299|G0000000|C2700280|C0018684|C0029237|G0000000|C0175659
"For inclusion, patients had to have a forced expiratory volume in 1 s (FEV1) ≥ 50% and ≤ 90% of predicted normal (prebronchodilator), reversibility of ≥ 12% FEV1 after inhalation of terbutaline 1 mg (Bricanyl® Turbuhaler®, AstraZeneca) and a history of daily ICS use (stable dose of 500–1600 mu g/day within 30 days prior to enrolment) for ≥ 3 months.","For inclusion, patients forced expiratory volume 1 (FEV1) ≥ 50% ≤ 90% predicted normal (prebronchodilator), reversibility ≥ 12% FEV1 inhalation terbutaline 1 (Bricanyl® Turbuhaler®, AstraZeneca) history daily ICS (stable dose 500–1600 mu g/day 30 days prior enrolment) ≥ 3 months.",G0000000|C0007637|C0030705|C0441722|C0231800|C0449468|G0000000|G0000000|G0000000|C0450371|G0000000|C0450371|C0681842|C0205307|C2599602|C0449261|G0000000|C0450371|G0000000|C0004048|C0039542|G0000000|G0000000|G0000000|G0000000|C0019664|C0332173|C0022521|C0205360|C0178602|G0000000|C0028971|C0439417|C0450371|C0439228|C0332152|C1516879|G0000000|G0000000|C0439231
Recruitment ran from 31 August 2010 to 7 March 2011.,Recruitment 31 August 2010 7 March 2011.,C2949735|C0450371|C3831448|G0000000|G0000000|C3829202|G0000000
"Furthermore, patients who had cardiac, respiratory, gastrointestinal, renal, or hematological disorders and neurological, or psychiatric disorders too severe to allow participation in balneotherapy or exercise program were excluded.","Furthermore, patients cardiac, respiratory, gastrointestinal, renal, hematological disorders neurological, psychiatric disorders severe participation balneotherapy exercise program excluded.",G0000000|C0030705|C0018787|C0521346|C0521362|C0022646|C0018943|C0012634|C0205494|C0205487|C0012634|C0205082|C0679823|C0085867|C0015259|C1709697|C1554077
Seventy-two stage II to III colorectal cancer survivors were randomly assigned to either a home-based exercise (n = 38) or usual care (n = 34) group for 6 weeks.,Seventy-two stage II III colorectal cancer survivors randomly assigned home-based exercise (n = 38) usual care (n = 34) 6 weeks.,C3816957|C0205390|G0000000|C0439070|C0555952|C0006826|C0206194|G0000000|C1516050|C0442519|C0015259|C0369718|G0000000|C0450371|C3538928|C1947933|C0369718|G0000000|C0450371|G0000000|C0439230
"Fifty-three elderly male patients undergoing HD were recruited from the Department of Nephrology and Internal Medicine, Fattouma Bourguiba Hospital, Monastir, Tunisia.","Fifty-three elderly male patients undergoing HD recruited Department Nephrology Internal Medicine, Fattouma Bourguiba Hospital, Monastir, Tunisia.",C3816723|C0001792|C0086582|C0030705|G0000000|G0000000|G0000000|C1704729|C0027712|C0205102|C0013227|G0000000|G0000000|C0019994|G0000000|C0041388
"The ATP was designed for delivery in public schools, with a model that links universal, selected, and indicated family interventions in a way that titrates intervention intensity to the needs and motivation of the family (13).","The ATP designed delivery public schools, model links universal, selected, family interventions titrates intervention intensity motivation family (13).",G0000000|G0000000|C1707689|C0011209|G0000000|C0036375|C3161035|C1517892|C0173021|C1707391|C0015576|C0886296|C1883350|C0886296|C0522510|C0026605|C0015576|C0450371
"A total of 198 adult brain tumor survivors ≥ 6 months after partial- or whole-brain irradiation were randomly assigned to receive a single daily dose (5 mg for 6 weeks, 10 mg for 18 weeks) of donepezil or placebo.","A total 198 adult brain tumor survivors ≥ 6 months partial- whole-brain irradiation randomly assigned receive single daily dose (5 6 weeks, 10 18 weeks) donepezil placebo.",G0000000|C0439175|C1442061|C0001675|C0006104|C0027651|C0206194|G0000000|G0000000|C0439231|C0728938|C1269537|C1282930|G0000000|C1516050|C1514756|C0037179|C0332173|C0178602|G0000000|G0000000|C0439230|C0450371|C0450371|C0439230|C0527316|C0032042
"All patients provided written, informed consent.","All patients provided written, informed consent.",G0000000|C0030705|C1999230|C0043266|C1522154|C1511481
"In Cambodia, various supplements and supplementary or therapeutic foods, including Sprinkles micronutrient powders, CSB++, BP100 and Plumpy'Nut, have been used or trialled.","In Cambodia, supplements supplementary therapeutic foods, including Sprinkles micronutrient powders, CSB++, BP100 Plumpy'Nut, trialled.",G0000000|C0006797|C0242295|G0000000|C0087111|C0016452|C0332257|C1720266|C0040577|C0032861|C1707866|G0000000|C0028723|G0000000
"Participants will be 710 pregnant women who attend one of five hospitals during the recruitment period and are English speaking, 18 years and over, have a singleton pregnancy, have a gestation of 18 weeks or under and agree to participate (signed consent forms and verbal consent provided at first coaching call).","Participants 710 pregnant women attend hospitals recruitment period English speaking, 18 over, singleton pregnancy, gestation 18 weeks agree participate (signed consent forms verbal consent provided coaching call).",C0679646|C1442061|C0549206|C0043210|C1999232|C0019994|C2949735|C0439531|C0376245|C0234856|C0450371|C0205136|C0481462|C0032961|C0032961|C0450371|C0439230|C3641827|G0000000|C1519316|C1511481|C0348078|C0439824|C1511481|C1999230|C0557773|C0679006
Operators with <6 years experience were classified as “registrars” and the operators with >6 years of experience were classified as “consultants.” The right FV was catheterized as the first choice.,Operators <6 experience classified “registrars” operators >6 experience classified “consultants.” The FV catheterized choice.,C1705273|G0000000|C0237607|C0008902|G0000000|C1705273|G0000000|C0237607|C0008902|G0000000|G0000000|G0000000|C0007430|C0008300
doses of C + P demonstrated clinically relevant benefits in patients with recurrent malignant ascites due to carcinomas of different origin.,doses C + P demonstrated clinically relevant benefits patients recurrent malignant ascites carcinomas origin.,C0178602|G0000000|G0000000|C0369773|G0000000|G0000000|C2347946|C0814225|C0030705|C2945760|C0205282|C0003962|C0007097|C0079946
"The study sites included 7 out of the total 16 unions (approximately 65 villages) of Mirsarai sub‐district in the south‐eastern part of Bangladesh that houses one of the icddr,b.","The study sites included 7 total 16 unions (approximately 65 villages) Mirsarai sub‐district south‐eastern Bangladesh houses icddr,b.",G0000000|C0557651|C0205145|C0332257|G0000000|C0439175|C0450371|C2825217|C0332232|C0450371|C0562518|G0000000|G0000000|G0000000|C0004732|C0442519|G0000000
"Exclusion criteria included (1) high-risk pregnancy, (2) lipid metabolism/absorption disorders, (3) regular intake of fish oil or DHA supplements, or (4) chronic use of certain medications.","Exclusion criteria included (1) high-risk pregnancy, (2) lipid metabolism/absorption disorders, (3) regular intake fish oil DHA supplements, (4) chronic medications.",C0680251|C0243161|C0332257|G0000000|C0332167|C0032961|G0000000|C0023779|C0025519|C0012634|G0000000|C0205272|C1512806|C0016163|C0028908|C0142831|C0242295|G0000000|C0205191|C0013227
A total of 67% reported using a male condom during vaginal intercourse at least once during the prior 3 months.,A total 67% reported male condom vaginal intercourse prior 3 months.,G0000000|C0439175|C0450371|C0684224|C0086582|C0009653|C0042232|C0009253|C0332152|G0000000|C0439231
"Paget's disease); pre-existing bone abnormality; cancer in the past 10 years likely to metastasize to bone; renal insufficiency (creatinine <30 mls/min); renal stones in past 10 years; hypercalcemia (primary hyperparathyroidism; granulomatous diseases); hypocalcemia; stroke within the last 3 months; or had taken hormone replacement therapy, calcitonin, bisphosphonates, raloxifen, or parathyroid hormone during the previous 24 months.","Paget's disease); pre-existing bone abnormality; cancer 10 metastasize bone; renal insufficiency (creatinine <30 mls/min); renal stones 10 years; hypercalcemia (primary hyperparathyroidism; granulomatous diseases); hypocalcemia; stroke 3 months; hormone replacement therapy, calcitonin, bisphosphonates, raloxifen, parathyroid hormone previous 24 months.",G0000000|C0012634|C2347662|C0262950|C1704258|C0006826|C0450371|C0027627|C0262950|C0022646|C0231179|C0010294|C0450371|C0796070|C0022646|C0006736|C0450371|C0439234|C0020437|C0205225|C0020502|C0439667|C0012634|C0020598|C0038454|G0000000|C0439231|C0019932|C0035139|C0039798|C0006668|C0012544|G0000000|C0030518|C0019932|C0205156|C0450371|C0439231
"The groups were similar in sex (11 male and 9 female in each group), age (62 ± 17 vs 62 ± 17 years), delay between onset of bleeding and endoscopy, systolic blood pressure, and heart rate.","The sex (11 male 9 female group), age (62 ± 17 62 ± 17 years), delay onset bleeding endoscopy, systolic blood pressure, heart rate.",G0000000|C0009253|C0450371|C0086582|G0000000|C0015780|C0441833|C0001779|C0450371|G0000000|C0450371|C0450371|G0000000|C0450371|C0439234|C0205421|C0206132|C0019080|C0014245|C0039155|C0005767|C0033095|C0018787|C0871208
"Veterans with a diagnosis of possible or probable AD10 of mild to moderate severity, defined as a Mini-Mental State Examination (MMSE) total score between 12 and 26 inclusive,11 who were currently taking an AChEI were recruited from 14 VA medical centers between August 2007 and March 2012.","Veterans diagnosis probable AD10 mild moderate severity, defined Mini-Mental State Examination (MMSE) total score 12 26 inclusive,11 AChEI recruited 14 VA medical centers August 2007 March 2012.",C0042610|C0011900|C0033204|G0000000|C2945599|C0205081|C0439793|C1704788|C0445542|C1301808|G0000000|C0451306|C0439175|C0449820|C0450371|C0450371|C0332257|G0000000|G0000000|C0450371|C1549054|C0199168|C0205099|C3831448|G0000000|C3829202|G0000000
Eligible patients are informed about the project by a doctor or nurse in the outpatient clinic.,Eligible patients informed project doctor nurse outpatient clinic.,C1548635|C0030705|C1522154|C1709701|C0031831|C0028661|C0029921|C0002424
"The exclusion criteria were: other conditions that may affect motor function, impaired cognitive functioning (Mini Mental Status Examination score less than 24).","The exclusion criteria were: conditions affect motor function, impaired cognitive functioning (Mini Mental Status Examination score 24).",G0000000|C0680251|C0243161|G0000000|C0012634|C0001721|C1513492|C0031843|C0221099|C1516691|C0205245|C0445542|C0229992|C0449438|G0000000|C0449820|C0450371
Results General practitioners in the C reactive protein test group prescribed antibiotics to 31% of patients compared with 53% in the no test group (P=0.02).,Results General practitioners C reactive protein test prescribed antibiotics 31% patients compared 53% test (P=0.02).,C1274040|C0205246|C1709627|G0000000|C0205332|C0033684|C0022885|C0278329|C0003232|C0450371|C0030705|C1707455|C0450371|C0022885|C0369773
METHODS—Seventy five infants less than 30 weeks of gestation and ventilated from birth for lung disease were randomly assigned to receive erythromycin intravenously for 7 days or to no treatment.,METHODS—Seventy infants 30 weeks gestation ventilated birth lung disease randomly assigned receive erythromycin intravenously 7 days treatment.,G0000000|C0021270|C0450371|C0439230|C0032961|C0231923|C0005615|C0024109|C0012634|G0000000|C1516050|C1514756|C0014806|G0000000|G0000000|C0439228|C0039798
"Adults with TBI who are within 8 h of injury, with any intracranial bleeding on CT scan, or, if no scan is available, who have a Glasgow Coma Score (GCS) of 12 or less, and no significant extracranial bleeding (that is, not in need of immediate blood transfusion) are eligible, if the responsible clinician is substantially uncertain as to the appropriateness of TXA for them.","Adults TBI 8 injury, intracranial bleeding CT scan, or, scan available, Glasgow Coma Score (GCS) 12 less, extracranial bleeding (that is, blood transfusion) eligible, responsible clinician uncertain appropriateness TXA them.",C0001675|C0876926|G0000000|C3263722|C0524466|C0019080|C0007673|C0034606|G0000000|C0034606|C0470187|G0000000|C0009421|C0449820|G0000000|C0450371|C0439092|C0580586|C0019080|G0000000|G0000000|C0005767|C0005841|C1548635|C1273518|C0871685|C0087130|C0814634|G0000000|G0000000
Patients diagnosed with colorectal cancer were identified in out-patient clinics.,Patients diagnosed colorectal cancer identified out-patient clinics.,C0030705|C0011900|C0555952|C0006826|C0205396|C0029921|C0442592
315 children aged between 6 months and 10 years presenting with acute otitis media.,315 children aged 6 months 10 acute otitis media.,C1442061|C0008059|C0001779|G0000000|C0439231|C0450371|C0205178|C0029877|C0009458
Their average age at menopause was 51.0 years (0.5).,Their average age menopause 51.0 (0.5).,G0000000|C1510992|C0001779|C0025320|C0450371|G0000000
"The remaining residents had diagnoses of Vascular, Frontal Lobe, Lewy Body and Mixed Type Dementia, while 18 % of participants had an Unspecified dementia diagnosis.","The remaining residents diagnoses Vascular, Frontal Lobe, Lewy Body Mixed Type Dementia, 18 % participants Unspecified dementia diagnosis.",G0000000|C1527428|C1320928|C0011900|C0005847|C0205123|C0796494|G0000000|C0242821|C0205430|C0332307|C0011265|C0450371|G0000000|C0679646|C0205370|C0011265|C0011900
This study includes three of the most deprived electoral wards in Stoke-on-Trent.,This study includes deprived electoral wards Stoke-on-Trent.,G0000000|C0557651|C0332257|G0000000|G0000000|C1305702|C1720176
"Eligible participants were both male and female between the ages of 6–17, required to have confirmed Crohn’s disease by endoscopic or radiographic methods for a minimum of 6 months, and have moderate to severe clinical disease activity with a PCDAI of > 30 20.","Eligible participants male female ages 6–17, required confirmed Crohn’s disease endoscopic radiographic methods minimum 6 months, moderate severe clinical disease activity PCDAI > 30 20.",C1548635|C0679646|C0086582|C0015780|C0001779|G0000000|C1514873|C0521093|G0000000|C0012634|C0014245|C0444708|C0025663|C1524031|G0000000|C0439231|C0205081|C0205082|C0205210|C0012634|C0205177|G0000000|G0000000|C0450371|C0450371
Adult patients with ulcerative colitis in clinical remission for at least one month and who required corticosteroids to go into remission previously were recruited from the Digestive Disease Center of the University of Illinois at Chicago (UIC) and in the Gastroenterology Clinic of the University of Chicago (U of C).,Adult patients ulcerative colitis clinical remission month required corticosteroids remission recruited Digestive Disease Center University Illinois Chicago (UIC) Gastroenterology Clinic University Chicago (U C).,C0001675|C0030705|C0041582|C0009319|C0205210|C0544452|C0332177|C1514873|C0001617|C0544452|G0000000|C0012238|C0012634|C0205099|C0041740|C0020898|C0008044|G0000000|C0017163|C0002424|C0041740|C0008044|G0000000|G0000000
The full and phone versions of the baseline survey identified 2402 individuals who reported being current cigarette smokers.,The phone versions baseline survey identified 2402 individuals reported current cigarette smokers.,G0000000|C1515258|C0333052|C0168634|C0038951|C0205396|G0000000|C0027361|C0684224|C0521116|C0677453|C0337664
"We analyzed data from 5435 participants of the Rotterdam Study, a prospective population-based cohort study among subjects aged 55 years and older.","We analyzed data 5435 participants Rotterdam Study, prospective population-based cohort study subjects aged 55 older.",G0000000|C0936012|C1511726|G0000000|C0679646|G0000000|C0557651|C0023981|C0032659|C0599755|C0557651|C0681850|C0001779|C0450371|C0580836
This vaccination could prevent episodes of pneumococcal pneumonia frequently labelled as “pneumonia of unknown aetiology”.,This vaccination prevent episodes pneumococcal pneumonia frequently labelled “pneumonia unknown aetiology”.,G0000000|C0042196|C0309872|C0332189|C0038410|C0032285|C0332183|C0181496|G0000000|C0439673|G0000000
"Subjects with major depressive disorder (MDD) were recruited by advertisements and referrals to our MGH Depression Clinical and Research Program, beginning in January 2003 and ending in June 2006.","Subjects major depressive disorder (MDD) recruited advertisements referrals MGH Depression Clinical Research Program, January 2003 June 2006.",C0681850|C0205082|G0000000|C0012634|C1269683|G0000000|C0949214|C0034927|G0000000|C0011570|C0205210|C0035168|C1709697|C3829466|G0000000|C3829443|G0000000
Exclusion criteria were as follows: a severe cognitive impairment (K-MMSE ≤10) or aphasia; previous stroke history; not independent ‘sit to stand’ activity (Berg Balance Scale score <18)8); acute systemic illness or infection; a significant orthopedic condition or pain that limited participation in exercise; and visual impairment or vestibular system deficit that caused balance impairment.,Exclusion criteria follows: severe cognitive impairment (K-MMSE ≤10) aphasia; previous stroke history; independent ‘sit stand’ activity (Berg Balance Scale score <18)8); acute systemic illness infection; orthopedic condition pain limited participation exercise; visual impairment vestibular system deficit caused balance impairment.,C0680251|C0243161|C0332283|C0205082|C1516691|C0221099|C0597277|G0000000|C0003537|C0205156|C0038454|C0019664|C0085862|G0000000|G0000000|C0205177|G0000000|C0014653|C0175659|C0449820|C0450371|C0205178|C0205373|C0221423|C0009450|C0029355|C0012634|C0030193|C0439801|C0679823|C0015259|C0234621|C0221099|C0042606|C0449913|C0162429|C0015127|C0014653|C0221099
"Children with a history of active airway disease, sleep apnoea, developmental delay, psychological, neurological disorder, cardiovascular abnormality or requirement of post-operative ventilation were excluded from the study.","Children history active airway disease, sleep apnoea, developmental delay, psychological, neurological disorder, cardiovascular abnormality requirement post-operative ventilation excluded study.",C0008059|C0019664|C0205177|C0178987|C0012634|C0037313|C0003578|C0458003|C0205421|C0205486|C0205494|C0012634|C0007226|C1704258|C1514873|C0032790|C0035203|C1554077|C0557651
"Six months after the intervention, we conducted a cross-sectional cohort study in 30 villages (15 intervention and 15 control) that included 600 households, and 929 children <5 years of age.","Six months intervention, conducted cross-sectional cohort study 30 villages (15 intervention 15 control) included 600 households, 929 children <5 age.",C0205452|C0439231|C0886296|C0004927|C0552389|C0599755|C0557651|C0450371|C0562518|C0450371|C0886296|C0450371|C0243148|C0332257|C1442061|C0020052|C1442061|C0008059|G0000000|C0001779
"All end points were analyzed, both for the total FAS population (N=65) and for the subpopulation of patients suffering from comorbid insomnia (PSQI ≥6 at baseline [N=13]).","All analyzed, total FAS population (N=65) subpopulation patients suffering comorbid insomnia (PSQI ≥6 baseline [N=13]).",G0000000|C0936012|C0439175|G0000000|C0032659|C0369718|C1257890|C0030705|C0683278|C0009488|C0917801|C3697468|G0000000|C0168634|C0369718
"The analysis was performed for preterm children born at or before 32 weeks gestational age, who are at high risk of developing severe RSV disease requiring hospitalisation.","The analysis performed preterm children born 32 weeks gestational age, risk developing severe RSV disease requiring hospitalisation.",G0000000|C0002778|C0884358|C0151526|C0008059|C0005615|C0450371|C0439230|C0439671|C0001779|C0035647|G0000000|C0205082|G0000000|C0012634|G0000000|C0019993
"Eligibility criteria included receipt of the BCG vaccine by 30 days of age; no history of tuberculosis in the infant, known exposure to a microbiologically confirmed case of tuberculosis, or active antituberculosis treatment in the mother at the time of the infant's birth; and no evidence of failure to thrive, recurrent pneumonia, chronic diarrhea, or immunosuppressive conditions other than HIV infection.","Eligibility criteria included receipt BCG vaccine 30 days age; history tuberculosis infant, exposure microbiologically confirmed tuberculosis, active antituberculosis treatment mother time infant's birth; evidence failure thrive, recurrent pneumonia, chronic diarrhea, immunosuppressive conditions HIV infection.",C0013893|C0243161|C0332257|G0000000|G0000000|C0042210|C0450371|C0439228|C0001779|C0019664|C0041296|C0021270|C0274281|G0000000|C0521093|C0041296|C0205177|C0003448|C0039798|C0026591|C0040223|C0021270|C0005615|C3887511|C0231174|C2938208|C2945760|C0032285|C0205191|C0011991|C0021081|C0012634|C0019682|C0009450
"Adult patients (age ≥ 18), male or female, who undergo day dialysis (haemodialysis (HD), Peritoneal Dialysis (PD), at home, a hospital or a dialysis centre); Experiencing (severe) fatigue (score CIS-fatigue scale ≥ 35); Being able to walk/move for at least 10 min with or without a supporting device such as a walking stick; Having a sufficient understanding of the Dutch language in order to participate in counselling, (group) interviews and fill out the questionnaires adequately.","Adult patients (age ≥ 18), male female, undergo day dialysis (haemodialysis (HD), Peritoneal Dialysis (PD), home, hospital dialysis centre); Experiencing (severe) fatigue (score CIS-fatigue scale ≥ 35); Being walk/move 10 min supporting device walking stick; Having sufficient understanding Dutch language participate counselling, (group) interviews fill questionnaires adequately.",C0001675|C0030705|G0000000|C0086582|C0015780|G0000000|C0332173|C0011945|C0019004|G0000000|C0031153|C0011945|G0000000|C0442519|C0019994|C0011945|C0205099|C0237607|C0205082|C0015672|C0449820|C1504308|G0000000|G0000000|C0080331|C0450371|C0702093|C0183683|C0025080|C0080331|C1706582|G0000000|C0205410|C0162340|C0013331|C0023008|G0000000|C0010210|C0441833|C0021822|C1708059|C0034394|G0000000
"Persons in the preintentional stage will receive text messages addressing (1) risks of smoking, (2) monetary costs of smoking, (3) social norms of smoking, (4) outcome expectancies, and (5) motivation to reduce the number of cigarettes smoked per day (daily smokers) or week (occasional smokers).","Persons preintentional stage receive text messages addressing (1) risks smoking, (2) monetary costs smoking, (3) social norms smoking, (4) outcome expectancies, (5) motivation reduce cigarettes smoked day (daily smokers) week (occasional smokers).",C0027361|G0000000|C0205390|C1514756|C1527021|C0470166|C0376649|G0000000|C0035647|C0037369|G0000000|C0870909|C0010186|C0037369|G0000000|C0728831|C0205307|C0037369|G0000000|C1274040|C0679138|G0000000|C0026605|G0000000|C0677453|C0037366|C0332173|C0332173|C0337664|C0332174|C0521114|C0337664
"The mean age of the patients was 51 ± 12.2 years (range, 20-72 years).","The age patients 51 ± 12.2 (range, 20-72 years).",G0000000|C0001779|C0030705|C0450371|G0000000|C0450371|C1514721|C0450371|C0439234
Most of these patients had non-significant coronary artery disease.,Most patients non-significant coronary artery disease.,C0205393|C0030705|C1518422|C0018787|C0003842|C0012634
"Second, we used a far less conservative approach in children aged 2–11 months, of one or more doses of IPTi as reported by the mother and written on the health card.","Second, conservative approach children aged 2–11 months, doses IPTi reported mother written health card.",C0205436|G0000000|C0449445|C0008059|C0001779|G0000000|C0439231|C0178602|G0000000|C0684224|C0026591|C0043266|C0018684|C3275277
Patients with one to three brain metastases of solid tumors (small-cell lung cancer excluded) with stable systemic disease or asymptomatic primary tumors and WHO performance status (PS) of 0 to 2 were treated with complete surgery or radiosurgery and randomly assigned to adjuvant WBRT (30 Gy in 10 fractions) or observation (OBS).,Patients brain metastases solid tumors (small-cell lung cancer excluded) stable systemic disease asymptomatic primary tumors WHO performance status (PS) 0 2 treated complete surgery radiosurgery randomly assigned adjuvant WBRT (30 Gy 10 fractions) observation (OBS).,C0030705|C0006104|C0027627|C0205208|C0027651|C0700321|C0024109|C0006826|C1554077|C0205360|C0205373|C0012634|C0231221|C0205225|C0027651|G0000000|C0597198|C0449438|C0242397|G0000000|G0000000|C1522326|C0205197|C0038894|C0085203|G0000000|C1516050|C0001551|C1520143|C0450371|C0018408|C0450371|C1264633|C0302523|C2986870
"Overall, 917 (20.6%) unvaccinated adolescents were enrolled, and 334 were randomized to no intervention, 281 were randomized to the website educational program only, and 302 were randomized to the website educational program plus the face to face lesson.","Overall, 917 (20.6%) unvaccinated adolescents enrolled, 334 randomized intervention, 281 randomized website educational program only, 302 randomized website educational program lesson.",C0282416|C1442061|C0450371|G0000000|C0205653|G0000000|C1442061|C0034656|C0886296|C1442061|C0034656|C2349146|C0587721|C1709697|C0205171|C1442061|C0034656|C2349146|C0587721|C1709697|G0000000
"In view of the original hypothesis, an additional inclusion criterion was positive serology for C. pneumoniae (IgG antibody titre ≥1:64).","In view original hypothesis, additional inclusion criterion positive serology C. pneumoniae (IgG antibody titre ≥1:64).",G0000000|C0449911|C0205313|C1512571|C1524062|C0007637|C0243161|C0439178|C0036745|G0000000|C0032285|G0000000|C0003241|C0475208|G0000000
Breast cancer patients undergoing daily adjuvant radiation therapy for 6 weeks.,Breast cancer patients undergoing daily adjuvant radiation therapy 6 weeks.,C0006141|C0006826|C0030705|G0000000|C0332173|C0001551|C0034519|C0039798|G0000000|C0439230
"The procedure is repeated every 2 hours for 48 consecutive hours during the Initial Treatment Period, which begins within the infant’s first 96 hours of life.","The procedure repeated 2 hours 48 consecutive hours Initial Treatment Period, infant’s 96 hours life.",G0000000|C0184661|C0205341|G0000000|C0439227|C0450371|C1707491|C0439227|C0205265|C0039798|C0439531|G0000000|C0450371|C0439227|C0376558
"All patients had evaluations at baseline, 6 months, 12 months, and 14 months (i.e., allowing a 2-month washout phase of exenatide).","All patients evaluations baseline, 6 months, 12 months, 14 months (i.e., allowing 2-month washout phase exenatide).",G0000000|C0030705|C0220825|C0168634|G0000000|C0439231|C0450371|C0439231|C0450371|C0439231|C0683454|C0683607|C0332177|C1710661|C0205390|C0167117
Five were not seen at 18 months: 2 in the TAU group and 3 in the TAU+FT group.,Five 18 months: 2 TAU 3 TAU+FT group.,C0205451|C0450371|C0439231|G0000000|C1720655|G0000000|C1720655|C0441833
Patients were eligible for enrollment if they had PD meeting Queen Square Brain bank criteria at Hoehn and Yahr stage 2 to 2.5 in the “on-medication” state; they had at least 5 years duration of symptoms; they were between 45 and 70 years of age; they were on l-dopa treatment with wearing-off phenomenon; they were on stable PD medication regimes; they had “off-medication” MDS-UPDRS part 3 scores greater than 15 points; and they had at least 33% improvement in response to l-dopa.,Patients eligible enrollment PD meeting Queen Square Brain bank criteria Hoehn Yahr stage 2 2.5 “on-medication” state; 5 duration symptoms; 45 70 age; l-dopa treatment wearing-off phenomenon; stable PD medication regimes; “off-medication” MDS-UPDRS 3 scores 15 points; 33% improvement response l-dopa.,C0030705|C1548635|C1516879|G0000000|C0556656|G0000000|C0205120|C0006104|C0442598|C0243161|G0000000|G0000000|C0205390|G0000000|G0000000|G0000000|C1301808|G0000000|C0449238|C0683368|C0450371|C0450371|C0001779|C0023570|C0039798|G0000000|C1882365|C0205360|G0000000|C0013227|G0000000|G0000000|C3639714|G0000000|C0449820|C0450371|C1552961|C0450371|C2986411|C0871261|C0023570
"Of 82 patients screened for M. ulcerans disease, 39 were excluded; of the 39, 17 did not meet clinical and or epidemiological criteria of M. ulcerans disease, 18 had large category III ulcers, 1 was pregnant, and 3 were below the age criteria for inclusion.","Of 82 patients screened M. ulcerans disease, 39 excluded; 39, 17 meet clinical epidemiological criteria M. ulcerans disease, 18 category III ulcers, 1 pregnant, 3 age criteria inclusion.",G0000000|C0450371|C0030705|C0220908|C0369637|G0000000|C0012634|C0450371|C1554077|C0450371|C0450371|C1550543|C0205210|C0014507|C0243161|C0369637|G0000000|C0012634|C0450371|C0683312|C0439070|C0041582|G0000000|C0549206|G0000000|C0001779|C0243161|C0007637
The HEWs in the intervention kebeles advised people with productive cough of 2 weeks or more duration to attend the health posts.,The HEWs intervention kebeles advised people productive cough 2 weeks duration attend health posts.,G0000000|G0000000|C0886296|G0000000|G0000000|C0027361|C0033268|C0010200|G0000000|C0439230|C0449238|C1999232|C0018684|C0687676
"In all models, poorer survival was associated with older age, higher injury severity score and lower revised trauma score (i.e., more severe).","In models, poorer survival age, injury severity score lower revised trauma score (i.e., severe).",G0000000|C3161035|C0032854|C0038952|C0001779|C3263722|C0439793|C0449820|C0441994|C1527075|C0043251|C0449820|C0683454|C0205082
All patients with suspected AE-IPF admitted to the respiratory department were assessed for eligibility from January 2009 to December 2011.,All patients suspected AE-IPF admitted respiratory department assessed eligibility January 2009 December 2011.,G0000000|C0030705|C0332147|C3887670|C0184666|C0521346|C1704729|C1516048|C0013893|C3829466|G0000000|C3830550|G0000000
"Participants who were unable to communicate in English, lacked capacity to provide informed consent, or were in receipt of palliative care were excluded.","Participants unable communicate English, lacked capacity provide informed consent, receipt palliative care excluded.",C0679646|C1299582|C0566001|C0376245|C0332268|C1516240|C1999230|C1522154|C1511481|G0000000|C0587605|C1947933|C1554077
"[14], it was considered appropriate to update the results of a prior cost-effectiveness analysis [15] comparing palivizumab versus absence of prophylaxis in the prevention of RSV infections in preterm infants of different gestational ages (less than 33 weeks, and 33 to 35 weeks) with or without complications (BPD).","[14], considered update prior cost-effectiveness analysis [15] comparing palivizumab versus absence prophylaxis prevention RSV infections preterm infants gestational ages (less 33 weeks, 33 35 weeks) complications (BPD).",C0450371|C0750591|C1519814|C0332152|C0010181|C0002778|C0450371|C1707455|C0672596|G0000000|C0332197|C0033107|C0199176|G0000000|C3714514|C0151526|C0021270|C0439671|C0001779|C0439092|C0450371|C0439230|C0450371|C0450371|C0439230|C0009566|G0000000
"Patients with a one-week visual analog scale (VAS) pain recall score ≥40 mm to ≤90 mm at screening were entered into the open-label, run-in period of this study and continued receiving duloxetine 60 mg/day for an additional 2 weeks in order to confirm that they were not having an adequate response to duloxetine under study conditions.","Patients one-week visual analog scale (VAS) pain recall score ≥40 mm ≤90 mm screening entered open-label, run-in period study continued receiving duloxetine 60 mg/day additional 2 weeks confirm adequate response duloxetine study conditions.",C0030705|C4082116|C0234621|C0243071|C0175659|C0042815|C0030193|C0034770|C0449820|G0000000|G0000000|G0000000|G0000000|C0220908|C1521975|C1709323|C3274438|C0439531|C0557651|C0549178|C1514756|C0245561|C0450371|C0439422|C1524062|G0000000|C0439230|C0521093|C0205410|C0871261|C0245561|C0557651|C0012634
"Between January 1987 and March 1993, 145 consecutive previously untreated patients with stage I MM were randomized between treatment with MPH-P (administered for 4 days every 6 weeks) just after diagnosis and treatment only at disease progression.","Between January 1987 March 1993, 145 consecutive untreated patients stage I MM randomized treatment MPH-P (administered 4 days 6 weeks) diagnosis treatment disease progression.",G0000000|C3829466|G0000000|C3829202|G0000000|C1442061|C1707491|C0332155|C0030705|C0205390|C0021966|G0000000|C0034656|C0039798|C1513008|C1521801|G0000000|C0439228|G0000000|C0439230|C0011900|C0039798|C0012634|C0242656
"Exclusion criteria were: 1) chronic medical conditions or regular use of medications that are associated with fatigue (e.g., untreated hypothyroidism, diabetes, autoimmune disease, anemia (defined as hematocrit < 24), chronic fatigue syndrome); 2) evidence that fatigue was primarily driven by a medical or psychiatric disorder other than cancer (e.g., current major depression, insomnia, sleep apnea); 3) evidence that fatigue was primarily driven by other non-cancer related factors (e.g., shift work, recent change in activity or schedule); 4) physical problems or conditions that could make yoga unsafe (e.g., serious neck injuries, unstable joints); and 5) body mass index greater than 31 kg/m2.","Exclusion criteria were: 1) chronic medical conditions regular medications fatigue (e.g., untreated hypothyroidism, diabetes, autoimmune disease, anemia (defined hematocrit < 24), chronic fatigue syndrome); 2) evidence fatigue driven medical psychiatric disorder cancer (e.g., current major depression, insomnia, sleep apnea); 3) evidence fatigue driven non-cancer factors (e.g., shift work, change activity schedule); 4) physical conditions yoga unsafe (e.g., neck injuries, unstable joints); 5) body mass 31 kg/m2.",C0680251|C0243161|G0000000|G0000000|C0205191|C0199168|C0012634|C0205272|C0013227|C0015672|G0000000|C0332155|C0020676|C0011847|C0443146|C0012634|C0002871|C1704788|C0018935|G0000000|C0450371|C0205191|C0015672|C0039082|G0000000|C3887511|C0015672|C0013126|C0199168|C0205487|C0012634|C0006826|G0000000|C0521116|C0205082|C0011570|C0917801|C0037313|C0003578|G0000000|C3887511|C0015672|C0013126|C1518422|C1521761|G0000000|C0333051|C0043227|C0392747|C0205177|C0086960|G0000000|C0031809|C0012634|C0043418|G0000000|G0000000|C0027530|C1510467|C0443343|C0022417|G0000000|C0242821|C0577559|C0450371|C0022718
"Frequency of side effects recorded by physicians aBetween group 1–2 and group 3 bBetween group 1 and group 2–3 cBetween group 1 and group 3 On the basis of data presented in Table 3, the severity scale of all the side effects recorded by physicians, were found to be mild in intermittent groups.","Frequency effects recorded physicians aBetween 1–2 3 bBetween 1 2–3 cBetween 1 3 On basis data Table 3, severity scale effects recorded physicians, mild intermittent groups.",C0376249|C1280500|C0034869|C0031831|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|C1527178|C1511726|C0039224|G0000000|C0439793|C0175659|C1280500|C0034869|C0031831|C2945599|C0205267|C0441833
"Patients aged between 20 and 85 years, undergoing hepatectomy, were considered eligible for enrolment in this study.","Patients aged 20 85 years, undergoing hepatectomy, considered eligible enrolment study.",C0030705|C0001779|C0450371|C0450371|C0439234|G0000000|C0019144|C0750591|C1548635|C1516879|C0557651
"GEM, gemcitabine; GEM FDR, gemcitabine fixed-dose rate.","GEM, gemcitabine; GEM FDR, gemcitabine fixed-dose rate.",G0000000|C0045093|G0000000|C1517194|C0045093|C0443218|C0871208
This service evaluation demonstrated outcomes from a nurse led primary care setting that are as good as or better than in the traditional hospital setting.,This service evaluation demonstrated outcomes nurse led primary care setting traditional hospital setting.,G0000000|C0557854|C0220825|G0000000|C1274040|C0028661|C1708698|C0205225|C1947933|C0542559|C0443324|C0019994|C0542559
"Patients receiving standardized abdomen and pelvic irradiation 5000 cGy (1000 cGy weekly) for prostate, uterus, cervix, bladder, rectum and colon, willing and able to provide written informed consent for study participation were included.","Patients receiving standardized abdomen pelvic irradiation 5000 cGy (1000 cGy weekly) prostate, uterus, cervix, bladder, rectum colon, provide written informed consent study participation included.",C0030705|C1514756|G0000000|C0000726|C0030797|C1282930|G0000000|C0556645|G0000000|C0556645|C0332174|C0033572|C0042149|C0007874|C0005682|C0034896|C0009368|C1999230|C0043266|C1522154|C1511481|C0557651|C0679823|C0332257
"Thus, a total of 323 mothers and 333 children were included in the analyses.","Thus, total 323 mothers 333 children included analyses.",G0000000|C0439175|C1442061|C0026591|C1442061|C0008059|C0332257|C0002778
Five fractions per week were planned.,Five fractions week planned.,C0205451|C1264633|C0332174|C1301732
"Exclusion criteria were major surgery or chronic disease in the last 3 months, such as aortic or lower extremity arterial surgery, myocardial infarction, active cancer, uncontrolled hypertension, or other contraindications to treadmill testing.","Exclusion criteria major surgery chronic disease 3 months, aortic lower extremity arterial surgery, myocardial infarction, active cancer, uncontrolled hypertension, contraindications treadmill testing.",C0680251|C0243161|C0205082|C0038894|C0205191|C0012634|G0000000|C0439231|C0003483|C0441994|C0015385|C0003842|C0038894|C0027061|C0021308|C0205177|C0006826|C0205318|C0020538|C0079164|C0184069|C0039593
"2 public hospitals in Sydney, Australia.","2 public hospitals Sydney, Australia.",G0000000|G0000000|C0019994|G0000000|C0004340
Any caregivers or children who become ill during the trial will be excluded and referred for treatment.,Any caregivers children ill trial excluded referred treatment.,G0000000|C0085537|C0008059|C0231218|C0008976|C1554077|C0205543|C0039798
"Sixty women (one Native American, two African American and 57 Caucasian), with a mean ± SEM age of 35.9 ± 0.8 years and BMI of 31.0 ± 0.6 kg/m2 began the intervention.","Sixty women (one Native American, African American 57 Caucasian), ± SEM age 35.9 ± 0.8 BMI 31.0 ± 0.6 kg/m2 intervention.",C3816724|C0043210|C0205447|C0302891|C0596070|C0027567|C0596070|C0450371|C0007457|G0000000|G0000000|C0001779|C0450371|G0000000|G0000000|G0000000|C0450371|G0000000|G0000000|C0022718|C0886296
"Persons who met all other study requirements, but who were not receiving hospice or palliative care, could also qualify, provided they had been diagnosed with AIDS or stage IV cancer.","Persons met study requirements, receiving hospice palliative care, qualify, provided diagnosed AIDS stage IV cancer.",C0027361|C0268621|C0557651|C1514873|C1514756|C0019947|C0587605|C1947933|G0000000|C1999230|C0011900|C0001175|C0205390|C0022326|C0006826
"Of all the patients with gynecological malignancy treated at our institute, medical records of patients who presented with MBO due to disease progression or recurrence between 2005 and 2010 were reviewed.","Of patients gynecological malignancy treated institute, medical records patients MBO disease progression recurrence 2005 2010 reviewed.",G0000000|C0030705|C0018417|C0006826|C1522326|C0021622|C0199168|C0034869|C0030705|C0683736|C0012634|C0242656|C0034897|G0000000|G0000000|C0282443
The authors did not find a dose‐response effect of exercise; more exercise was not associated with greater improvement in joint symptoms.,The authors dose‐response exercise; exercise improvement joint symptoms.,G0000000|C3812881|G0000000|C0015259|C0015259|C2986411|C0022417|C0683368
The women with ≥ 2 weight measurements were comparable between the multivitamins and the placebo groups with respect to baseline characteristics.,The women with ≥ 2 weight measurements comparable multivitamins placebo respect baseline characteristics.,G0000000|C0043210|G0000000|C0005910|C0242485|G0000000|C0301532|C0032042|C0679133|C0168634|C1521970
Subjects with a clinical history of asthma or any other clinically significant medical illness other than COPD were excluded.,Subjects clinical history asthma clinically medical illness COPD excluded.,C0681850|C0205210|C0019664|C0004096|G0000000|C0199168|C0221423|C0024117|C1554077
Fifty-two patients with bilateral carpal tunnel syndrome had one hand randomized to undergo endoscopic release and the other to undergo mini-incision release.,Fifty-two patients bilateral carpal tunnel syndrome hand randomized undergo endoscopic release undergo mini-incision release.,C3816723|C0030705|C0238767|C0007285|C0337138|C0039082|C0018563|C0034656|G0000000|C0014245|C0030685|G0000000|C0445542|C0030685
"Children known to have chronic illness, including HIV, cardiac disease, congenital abnormalities, cerebral palsy, or cancer, or those who had participated in a treatment program for SAM within the past 12 wk were not eligible for the study.","Children chronic illness, including HIV, cardiac disease, congenital abnormalities, cerebral palsy, cancer, participated treatment program SAM 12 wk eligible study.",C0008059|C0205191|C0221423|C0332257|C0019682|C0018787|C0012634|C0009678|C0000768|G0000000|C0522224|C0006826|G0000000|C0039798|C1709697|C0036002|C0450371|C0332174|C1548635|C0557651
"Methods: Double-blind, controlled study in 53 neonates (<34 weeks’ gestation) randomized to receive at least 7 days of PN containing either an emulsion of MCTs and soybean, olive, and fish oils or a soybean oil emulsion.","Methods: Double-blind, controlled study 53 neonates (<34 weeks’ gestation) randomized receive 7 days PN emulsion MCTs soybean, olive, fish oils soybean oil emulsion.",C0025663|C0013072|C2587213|C0557651|C0450371|C0021289|C0450371|G0000000|C0032961|C0034656|C1514756|G0000000|C0439228|C0219433|C0014020|C0724624|C0037733|C0228539|C0016163|C0028908|C0037733|C0028908|C0014020
Women attending antenatal clinic were eligible to participate in the study from 24 to 34 weeks' gestation.,Women attending antenatal clinic eligible participate study 24 34 weeks' gestation.,C0043210|C1547429|C2828394|C0002424|C1548635|G0000000|C0557651|C0450371|G0000000|C0032961
Female patients of childbearing age were required to utilize an effective birth control method for the duration of the study.,Female patients childbearing age required utilize effective birth control method duration study.,C0015780|C0030705|G0000000|C0001779|C1514873|G0000000|C1280519|C0005615|C0243148|C0025663|C0449238|C0557651
The study population consisted of all people (vaccinated and unvaccinated) registered in Stockholm county on 1 October 2009 and who had lived in the region since 1 January 1998 (to enable characterisation of cohorts from data tracked in the healthcare database before the pandemic period).,The study population consisted people (vaccinated unvaccinated) registered Stockholm county 1 October 2009 lived region 1 January 1998 (to enable characterisation cohorts data tracked healthcare database pandemic period).,G0000000|C0557651|C0032659|C0332529|C0027361|C1116171|G0000000|C1514821|G0000000|C0079170|G0000000|C3828732|G0000000|C1548795|C0017446|G0000000|C3829466|G0000000|G0000000|C0562342|C1880022|C0599755|C1511726|C0040594|C0086388|C0242356|C1615608|C0439531
The exclusion criteria in the study are: 1) treatment with antibiotics within two weeks just before the recruitment; 2) bacterial infection in other parts of body than the respiratory system; 3) chest X-ray confirmed pneumonia; 4) suffering from other chronic respiratory diseases; 5) suffering from severe organ dysfunction.,The exclusion criteria study are: 1) treatment antibiotics weeks recruitment; 2) bacterial infection body respiratory system; 3) chest X-ray confirmed pneumonia; 4) suffering chronic respiratory diseases; 5) suffering severe organ dysfunction.,G0000000|C0680251|C0243161|C0557651|G0000000|G0000000|C0039798|C0003232|C0439230|C2949735|G0000000|C0521009|C0009450|C0242821|C0521346|C0449913|G0000000|C0817096|C0034571|C0521093|C0032285|G0000000|C0683278|C0205191|C0521346|C0012634|G0000000|C0683278|C0205082|C0178784|C0031847
"Between January 2001 and June 2004, 130 patients from seven teaching hospitals underwent curative R0 surgery for colon or rectal cancer.","Between January 2001 June 2004, 130 patients teaching hospitals underwent curative R0 surgery colon rectal cancer.",G0000000|C3829466|G0000000|C3829443|G0000000|C1442061|C0030705|C0039401|C0019994|G0000000|C1880198|C1425688|C0038894|C0009368|C0205052|C0006826
"Baseline clinical characteristics of patients with, or at risk of, serious extracranial bleeding and traumatic brain injury who were allocated to tranexamic acid or placebo.","Baseline clinical characteristics patients with, risk of, extracranial bleeding traumatic brain injury allocated tranexamic acid placebo.",C0168634|C0205210|C1521970|C0030705|G0000000|C0035647|G0000000|C0580586|C0019080|C0332663|C0006104|C3263722|G0000000|G0000000|C0001128|C0032042
"In addition, patients were instructed to spend 2 hours a day in outdoor daylight.","In addition, patients instructed spend 2 hours day outdoor daylight.",G0000000|C0332287|C0030705|G0000000|C0680968|G0000000|C0439227|C0332173|G0000000|G0000000
"At 56 days, there were no raised PIVKA II values in the oral group, although three infants in the IM group had raised values.","At 56 days, raised PIVKA II values oral group, infants IM raised values.",G0000000|C0450371|C0439228|C0442818|C0950246|G0000000|C0042295|C0442027|C0441833|C0021270|C3539078|C0442818|C0042295
"Those eligible for enrollment included healthy HIV-seronegative girls and young women 10–25 years old at first vaccination, who had a negative urine pregnancy test and ≤6 lifetime sexual partners.","Those eligible enrollment included healthy HIV-seronegative girls women 10–25 vaccination, negative urine pregnancy test ≤6 lifetime sexual partners.",G0000000|C1548635|C1516879|C0332257|C3898900|C0019682|C0870604|C0043210|G0000000|C0042196|C0205160|C0042036|C0032961|C0022885|G0000000|C4071830|C0036864|C0682323
Participants 349 participants aged 18-55 with chronic low back pain of at least one year's duration who were considered candidates for spinal fusion.,Participants 349 participants aged 18-55 chronic low pain year's duration considered candidates spinal fusion.,C0679646|C1442061|C0679646|C0001779|C0450371|C0205191|C0205251|C0030193|C0439234|C0449238|C0750591|G0000000|C0521329|C0332466
"In prospective studies, about 60 to 80% of patients with multiple organ failure (MOF) with or without sepsis or systemic inflammatory response syndrome (SIRS) presented with CIPNM [5-7].","In prospective studies, 60 80% patients multiple organ failure (MOF) sepsis systemic inflammatory response syndrome (SIRS) CIPNM [5-7].",G0000000|C0023981|C0947630|C0450371|C0450371|C0030705|C0439064|C0178784|C0231174|G0000000|C0036690|C0205373|C0333348|C0871261|C0039082|C0242966|G0000000|G0000000
Eligible participants had to be at least 18 years old and have histologically proven oral leukoplakia and/or erythroplakia capable of being measured bi-dimensionally (to enable estimates of lesion area).,Eligible participants 18 histologically proven oral leukoplakia and/or erythroplakia capable measured bi-dimensionally (to enable estimates lesion area).,C1548635|C0679646|C0450371|C0205462|C0456369|C0442027|C0023531|G0000000|C0014818|C2698977|C0444706|G0000000|G0000000|C0562342|C0750572|C0221198|C0017446
"The current study was designed and implemented to investigate the effect of vitamin D during the first and second trimesters of pregnancy in reducing the risk of gestational diabetes mellitus (GDM) in women who are at high risk [history of GDM, birth macrosomia, family history, and high body mass index (BMI)].","The current study designed implemented investigate vitamin D trimesters pregnancy reducing risk gestational diabetes mellitus (GDM) women risk [history GDM, birth macrosomia, family history, body mass (BMI)].",G0000000|C0521116|C0557651|C1707689|G0000000|C1292732|C0042890|C0073187|C0032982|C0032961|C0392756|C0035647|C0439671|C0011847|G0000000|C0085207|C0043210|C0035647|C0019664|C0085207|C0005615|C0158915|C0015576|C0019664|C0242821|C0577559|G0000000
Centers that had participated in NAPSACC during the past 6 months were excluded.,Centers participated NAPSACC 6 months excluded.,C0205099|G0000000|G0000000|G0000000|C0439231|C1554077
Patients with significant neurologic disease other than suspected incipient AD or with current major depression were excluded from the study.,Patients neurologic disease suspected incipient AD current major depression excluded study.,C0030705|C0205494|C0012634|C0332147|C0205256|G0000000|C0521116|C0205082|C0011570|C1554077|C0557651
"Of the combined samples, 3927 were smokers at baseline, 4630 were at risk for diet and 6324 for sun exposure.","Of combined samples, 3927 smokers baseline, 4630 risk diet 6324 sun exposure.",G0000000|C0205195|C0370003|G0000000|C0337664|C0168634|G0000000|C0035647|C0012155|G0000000|C0038817|C0274281
veteran home and long term care facility and adopted the principle of equal allocation to encode the two categories respectively.,veteran term care facility principle equal allocation encode categories respectively.,C0042610|C0233324|C1947933|C1547538|G0000000|C0205163|C1706778|C2700640|C0683312|G0000000
The participants were ages 13 to 18 years during the study period.,The participants ages 13 18 study period.,G0000000|C0679646|C0001779|C0450371|C0450371|C0557651|C0439531
"YO28252 was conducted in more than 30 sites across Australia, Korea, Singapore, Taiwan, Thailand, and the U.S.","YO28252 conducted 30 sites Australia, Korea, Singapore, Taiwan, Thailand, U.S.",G0000000|C0004927|C0450371|C0205145|C0004340|C0022771|C0037173|C0039260|C0039725|C0041703
Correct genotyping was verified in 10% of the samples.,Correct genotyping verified 10% samples.,C2349182|C1285573|C1711411|C0450371|C0370003
Assays of antiepileptic drugs were done on 105 in the intervention and 86 in the nonintervention group who provided blood samples.,Assays antiepileptic drugs 105 intervention 86 nonintervention provided blood samples.,C0005507|C0003299|C0013227|C1442061|C0886296|C0450371|G0000000|C1999230|C0005767|C0370003
"The supplements (in the form of capsules) were of the same shape, colour and taste.","The supplements (in form capsules) shape, colour taste.",G0000000|C0242295|G0000000|C0348078|C0006935|C0332479|C0009393|C0039336
"Of the 49 patients recruited, 45 underwent colorectal resection.","Of 49 patients recruited, 45 underwent colorectal resection.",G0000000|C0450371|C0030705|G0000000|C0450371|G0000000|C0555952|C0015252
The demographics of the comparison schools were similar.,The demographics comparison schools similar.,G0000000|C0011298|C1707455|C0036375|C2348205
"Our analysis focuses on the 744 and 2382 participants randomised to a sodium intervention or control in TOHP I and TOHP II, respectively.","Our analysis focuses 744 2382 participants randomised sodium intervention control TOHP I TOHP II, respectively.",G0000000|C0002778|C0205234|C1442061|G0000000|C0679646|G0000000|C0037473|C0886296|C0243148|G0000000|C0021966|G0000000|G0000000|G0000000
"Histologically proven invasive unilateral breast carcinoma, stage I or II (T1-3N0 or T1-2N1 M0, American Joint Committee on Cancer (AJCC)/TNM 6th edition).","Histologically proven invasive unilateral breast carcinoma, stage I II (T1-3N0 T1-2N1 M0, American Joint Committee Cancer (AJCC)/TNM 6th edition).",C0205462|C0456369|C0205281|C0205092|C0006141|C0007097|C0205390|C0021966|G0000000|C0041403|C0041403|C0025885|C0596070|C0022417|C2699414|C0006826|C0441915|G0000000|C0441792
"Therefore, we examined the effect of different training protocols on quality of life, vitality and depression of older adults living in long-term care facilities.","Therefore, examined training protocols quality life, vitality depression adults living long-term care facilities.",G0000000|C0332128|C0040607|C0442711|C0332306|C0376558|C0424589|C0011570|C0001675|C0376558|C0443252|C1947933|C1547538
We attempted to enroll as respondents all eligible caregivers in the 72 study villages; no changes to eligibility criteria were made after trial commencement.,We attempted enroll respondents eligible caregivers 72 study villages; eligibility criteria trial commencement.,G0000000|C1516084|G0000000|C0282122|C1548635|C0085537|C0450371|C0557651|C0562518|C0013893|C0243161|C0008976|G0000000
"The mean age of participants was 83.6 (SD 4.8) years, and ages ranged from 75 to 96 years.","The age participants 83.6 (SD 4.8) years, ages ranged 75 96 years.",G0000000|C0001779|C0679646|C0450371|G0000000|G0000000|C0439234|C0001779|C1514721|C0450371|C0450371|C0439234
"It is worth remarking that PPT participants were, by nature of the study exclusion criteria, ‘healthy’ with atypically low alcohol intake (7.4 g/day in the intervention group; 8.0 g/day in the control group) low prevalence of smoking (13.4%: intervention group; 13.2%: control group) and only borderline overweight in terms of BMI (27.6 kg/m2 in the intervention group; 27.5 kg/m2 in the control group).","It worth remarking PPT participants were, nature study exclusion criteria, ‘healthy’ atypically low alcohol intake (7.4 g/day intervention group; 8.0 g/day control group) low prevalence smoking (13.4%: intervention group; 13.2%: control group) borderline overweight terms BMI (27.6 kg/m2 intervention group; 27.5 kg/m2 control group).",G0000000|G0000000|C0282411|G0000000|C0679646|G0000000|C0349590|C0557651|C0680251|C0243161|G0000000|G0000000|C0205251|C0001962|C1512806|G0000000|C0439417|C0886296|C0441833|G0000000|C0439417|C0243148|C0441833|C0205251|C0033105|C0037369|C0450371|C0886296|C0441833|C0450371|C0243148|C0441833|C0205189|C0497406|C0233324|G0000000|C0450371|C0022718|C0886296|C0441833|C0450371|C0022718|C0243148|C0441833
Only patients for whom the index breast cancer was the first cancer diagnosed were included.,Only patients breast cancer cancer diagnosed included.,C0205171|C0030705|C0006141|C0006826|C0006826|C0011900|C0332257
The primary objective of the RCT was to assess the safety and efficacy of weekly IFA supplementation in young women of child-bearing age living in a highly malarious area of Africa.,The primary objective RCT assess safety efficacy weekly IFA supplementation women child-bearing age living highly malarious Africa.,G0000000|C0205225|C0018017|G0000000|C1516048|C0036043|C1280519|C0332174|C0281643|C0242297|C0043210|C0008059|C0001779|C0376558|C0205250|G0000000|C0001737
who have only been treated with short-acting β-agonists on an as-needed basis in the 6 months prior to study enrollment and who have symptomatic shortness of breath.,treated short-acting β-agonists as-needed basis 6 months prior study enrollment symptomatic shortness breath.,C1522326|C1282927|G0000000|C1879745|C1527178|G0000000|C0439231|C0332152|C0557651|C1516879|C0231220|C1282927|C0225386
These are not available and too costly for use in developing countries such as Iran.,These costly developing countries Iran.,G0000000|G0000000|G0000000|C0454664|C0022065
Mean age of the participants in the active arm (46.8 ± 8.3 years) was comparable to the control arm (50.2 ± 5.7 years).,Mean age participants active arm (46.8 ± 8.3 years) comparable control arm (50.2 ± 5.7 years).,C0444504|C0001779|C0679646|C0205177|C0446516|G0000000|C0439234|G0000000|C0243148|C0446516|G0000000|C0439234
The demographics of the 76 caregivers of the 104 children and adolescents who needed HBV vaccine are shown in Table 2; the profile of the 37 caregivers in the HBV video group was similar to that of the 39 caregivers in the Smoking video group.,The demographics 76 caregivers 104 children adolescents HBV vaccine Table 2; profile 37 caregivers HBV video 39 caregivers Smoking video group.,G0000000|C0011298|C0450371|C0085537|C1442061|C0008059|C0205653|G0000000|C0042210|C0039224|G0000000|C1979963|C0450371|C0085537|G0000000|C0042655|C0450371|C0085537|C0037369|C0042655|C0441833
"Twenty-one patients (ΔF508 homo/heterozygous, FEV1 > 40% pred.)","Twenty-one patients (ΔF508 homo/heterozygous, FEV1 > 40% pred.)",C3715213|C0030705|G0000000|C1300203|G0000000|G0000000|C0450371|C0032952
This is reflected in the comparison of the costs of the two arms of the study.,This reflected comparison costs arms study.,G0000000|C0558058|C1707455|C0010186|C0206655|C0557651
"Subjects with known sensitivity to any of the test ingredients, renal impairment, minors and non-English speakers/readers were excluded from participation.","Subjects sensitivity test ingredients, renal impairment, minors non-English speakers/readers excluded participation.",C0681850|C0020517|C0022885|C1550600|C0022646|C0221099|C0026193|C1518422|C1707716|C1554077|C0679823
"Additionally, lung function was assessed as an objective measure to support the subjective patient-reported outcomes, and to provide additional evidence for the use of UMEC/VI 62.5/25 μg for the maintenance treatment of COPD.","Additionally, lung function assessed objective measure support subjective patient-reported outcomes, provide additional evidence UMEC/VI 62.5/25 μg maintenance treatment COPD.",G0000000|C0024109|C0031843|C1516048|C0018017|C0079809|C0183683|C0439655|C0747307|C1274040|C1999230|C1524062|C3887511|C0205999|C0450371|G0000000|C0024501|C0039798|C0024117
"After confirmation, patients’ primary care providers are contacted to confirm the study team can contact their patients and to explain the study.","After confirmation, patients’ primary care providers contacted confirm study team contact patients explain study.",G0000000|C0521091|G0000000|C0205225|C1947933|C1138603|C0332158|C0521093|C0557651|C0871489|C0332158|C0030705|G0000000|C0557651
"The age range was 56–98 years, with 84 years as the mean age.","The age range 56–98 years, 84 age.",G0000000|C0001779|C1514721|G0000000|C0439234|C0450371|C0001779
"The aim of this prospective, randomized, controlled trial was to investigate the impact of yoga on newly diagnosed patients with early breast cancer in the immediate postoperative phase.","The aim prospective, randomized, controlled trial investigate impact yoga newly diagnosed patients breast cancer postoperative phase.",G0000000|C1947946|C0023981|C0034656|C2587213|C0008976|C1292732|C1825598|C0043418|C0750546|C0011900|C0030705|C0006141|C0006826|C0032790|C0205390
"Of those eligible, reasons for not enrolling were lack of time or unwillingness to make the commitment to study procedures.","Of eligible, reasons enrolling lack time unwillingness commitment study procedures.",G0000000|C1548635|C0392360|G0000000|C0332268|C0040223|C0558080|C0870312|C0557651|C0025664
"Students (n = 1,566) completed a questionnaire prior to curriculum implementation and follow-up questionnaires toward the end of 5th and 6th grade.","Students (n = 1,566) completed questionnaire prior curriculum implementation follow-up questionnaires 5th 6th grade.",C0038492|C0369718|G0000000|C1442061|C0205197|C0034394|C0332152|C0010478|C1708476|C0589120|C0034394|G0000000|G0000000|C0441800
"Methods: To help define the role of humidified CPAP in mild OSA, a randomised crossover study was undertaken of patients with an apnoea hypopnoea index (AHI) of 5–30/hour.","Methods: To define role humidified CPAP mild OSA, randomised crossover study undertaken patients apnoea hypopnoea (AHI) 5–30/hour.",C0025663|C0040363|G0000000|C0035820|G0000000|C0199451|C2945599|C0520679|G0000000|C0010366|C0557651|G0000000|C0030705|C0003578|C0235546|G0000000|G0000000
18 primary care clinics provided data one year before and one year after implementing the EHR modifications.,18 primary care clinics provided data implementing EHR modifications.,C0450371|C0205225|C1947933|C0442592|C1999230|C1511726|G0000000|G0000000|C0392747
Male or female patients aged 6–18 years old suffering from acute bronchitis with symptoms starting ≤48 h prior to inclusion in the study and with a total score of bronchitis-specific symptoms (BSS) ≥5 points at screening were included in the study.,Male female patients aged 6–18 suffering acute bronchitis symptoms starting ≤48 prior inclusion study total score bronchitis-specific symptoms (BSS) ≥5 screening included study.,C0086582|C0015780|C0030705|C0001779|G0000000|C0683278|C0205178|C0006277|C0683368|C0439659|G0000000|C0332152|C0007637|C0557651|C0439175|C0449820|C0006277|C0683368|G0000000|G0000000|C0220908|C0332257|C0557651
There were only three households who took advantage of this enrollment option.,There households advantage enrollment option.,G0000000|C0020052|G0000000|C1516879|C1518601
Stroke onset is considered to have occurred at the time the patient was last known to be well.,Stroke onset considered occurred time patient well.,C0038454|C0206132|C0750591|C1709305|C0040223|C0030705|C0205170
"On submission of this information, computer randomization allocated participants to an intervention or control group, using stratified minimization for age (25 years and under, over 25 years), ethnicity (Maori, non-Maori), and level of nicotine dependence (time to first cigarette 30 minutes or less, more than 30 minutes).","On submission information, computer randomization allocated participants intervention control group, stratified minimization age (25 under, 25 years), ethnicity (Maori, non-Maori), level nicotine dependence (time cigarette 30 minutes less, 30 minutes).",G0000000|C1515022|C1533716|C0009622|C0034656|G0000000|C0679646|C0886296|C0243148|C0441833|C0205363|G0000000|C0001779|C0450371|G0000000|C0450371|C0439234|C0015031|C0024770|C1518422|C0441889|C0028040|C0011546|C0040223|C0677453|C0450371|C0439232|C0439092|C0450371|C0439232
Patients who experienced progression before 7 months were included in the 7-month PSA > 4 ng/mL group.,Patients experienced progression 7 months included 7-month PSA > 4 ng/mL group.,C0030705|C0237607|C0242656|G0000000|C0439231|C0332257|C0332177|C3810537|G0000000|G0000000|C0439275|C0441833
Clinical cure was observed in 49 of 54 (91%) patients in the group A and in 47 of 51 (92%) patients in the group B (p = 0.68).,Clinical cure observed 49 54 (91%) patients A 47 51 (92%) patients B (p = 0.68).,C0205210|C1880198|C1441672|C0450371|C0450371|C0450371|C0030705|G0000000|C0450371|C0450371|C0450371|C0030705|G0000000|C0369773|G0000000|C0450371
"Setting 12 specialist nursing homes for people with dementia in London, Newcastle, and Oxford.","Setting 12 specialist nursing homes people dementia London, Newcastle, Oxford.",C0542559|C0450371|C0087009|C0006147|C0442519|C0027361|C0011265|C0023973|G0000000|G0000000
Footnote: All children in the deferred arm started ART because of protocol-defined CD4 criteria.,Footnote: All children deferred arm started ART protocol-defined CD4 criteria.,C2825232|G0000000|C0008059|C0205421|C0446516|C1272689|C0003826|C0442711|C0285590|C0243161
"Inclusion criteria were the following: residence in trial communes, age >16 y, confirmed pregnancy at <16 wk gestation, and registration with the commune health station.","Inclusion criteria following: residence trial communes, age >16 y, confirmed pregnancy <16 wk gestation, registration commune health station.",C0007637|C0243161|C0231290|C0237096|C0008976|C0598781|C0001779|C0450371|G0000000|C0521093|C0032961|C0450371|C0332174|C0032961|C1514821|C0598781|C0018684|C1883167
"One patient (2.2%) in the placebo group, 3 (7.0%) in the escitalopram group, and 2 (4.9%) in the PST group were receiving benzodiazepines.","One patient (2.2%) placebo group, 3 (7.0%) escitalopram group, 2 (4.9%) PST receiving benzodiazepines.",C0205447|C0030705|G0000000|C0032042|C0441833|G0000000|G0000000|C1099456|C0441833|G0000000|G0000000|C1152487|C1514756|C0005064
"Of these, 169 were randomly allocated to the intervention group and 149 to the control group.","Of these, 169 randomly allocated intervention 149 control group.",G0000000|G0000000|C1442061|G0000000|G0000000|C0886296|C1442061|C0243148|C0441833
"We enrolled primarily African-American women <29 weeks gestation, with no previous live births, and with at least 2 sociodemographic risk characteristics (unmarried, <12 years of education, unemployed).","We enrolled African-American women <29 weeks gestation, previous live births, 2 sociodemographic risk characteristics (unmarried, <12 education, unemployed).",G0000000|G0000000|C0085756|C0043210|C0450371|C0439230|C0032961|C0205156|C1548795|C0005615|G0000000|G0000000|C0035647|C1521970|C0037179|C0450371|C0013621|C0041674
"Subjects were also excluded if they did not obtain neurologist verification of their RRMS diagnosis, did not complete a baseline Automated Self-Administered 24-hour dietary recall application (ASA-24), or a 2-week Food Diary before randomization.","Subjects excluded neurologist verification RRMS diagnosis, complete baseline Automated Self-Administered 24-hour dietary recall application (ASA-24), 2-week Food Diary randomization.",C0681850|C1554077|C0237426|C0237944|C1522002|C0011900|C0205197|C0168634|C0205554|C1519231|C0450371|C0012155|C0034770|C0185125|C0004057|C0332174|C0016452|C0376660|C0034656
"• Persistent, stable pain for a minimum of three months.","• Persistent, stable pain minimum months.",G0000000|C0205322|C0205360|C0030193|C1524031|C0439231
Study staff screened consecutive patients who presented to the oncology clinics and notified clinicians via e-mail when patients were eligible to participate.,Study staff screened consecutive patients oncology clinics notified clinicians e-mail patients eligible participate.,C0557651|C0851286|C0220908|C1707491|C0030705|C0027651|C0442592|C0422202|C0871685|C0013849|C0030705|C1548635|G0000000
"Children of both sexes, between 4 and 12 years of age, with average weight of 26.76 kg, suffering from medically resistant epilepsy,[13] regardless of the type of seizure (partial or generalized) were randomly divided into 2 groups: 1) the intervention or fish oil-supplemented group and 2) the control or placebo assigned group.","Children sexes, 4 12 age, average weight 26.76 kg, suffering medically resistant epilepsy,[13] type seizure (partial generalized) randomly divided 2 groups: 1) intervention fish oil-supplemented 2) control placebo assigned group.",C0008059|C0009253|G0000000|C0450371|C0001779|C1510992|C0005910|C0450371|C0022718|C0683278|G0000000|C0332325|C0014544|C0332307|C0036572|C0728938|C0205246|G0000000|C0332849|G0000000|C0441833|G0000000|C0886296|C0016163|C0028908|G0000000|C0243148|C0032042|C1516050|C0441833
"A computer-generated random-number sequence was used to assign the patients to either the TENS group (n = 26; mean age ± SD, 35.5 ± 9.0 years) or to the control group (n = 26; mean age ± SD, 33.6 ± 8.5 years).","A computer-generated random-number sequence assign patients TENS (n = 26; age ± SD, 35.5 ± 9.0 years) control (n = 26; age ± SD, 33.6 ± 8.5 years).",G0000000|C0009622|C0034656|C0004793|C1516050|C0030705|C0014518|C0369718|G0000000|C0450371|C0001779|G0000000|C2699239|C0450371|G0000000|G0000000|C0243148|C0369718|G0000000|C0450371|C0001779|G0000000|C2699239|C0450371|G0000000|G0000000
"Among all patients visiting the collaborating physicians, those aged 14–75 years and who were taking benzodiazepines at least five times a week for over a year, were asked for their consent.","Among patients visiting collaborating physicians, aged 14–75 benzodiazepines times week year, consent.",G0000000|C0030705|C0545082|G0000000|C0031831|C0001779|G0000000|C0005064|C0040223|C0332174|C0439234|C1511481
All analyses were carried out using Microsoft Excel and STATA 9.15 A total of 579 participants were randomised across the eight groups.,All analyses carried Microsoft Excel STATA 9.15 A total 579 participants randomised groups.,G0000000|C0002778|C0206243|G0000000|C2740529|G0000000|C0450371|G0000000|C0439175|C1442061|C0679646|G0000000|C0441833
"Patients with a confounding disease, including other significant respiratory conditions, were excluded, as were those who had a disease that might put them at risk because of study participation.","Patients confounding disease, including respiratory conditions, excluded, disease risk study participation.",C0030705|G0000000|C0012634|C0332257|C0521346|C0012634|C1554077|C0012634|C0035647|C0557651|C0679823
"Patients with congestive heart failure are limited by exertional dyspnoea, which persists even after resolution of pulmonary oedema.","Patients congestive heart failure limited exertional dyspnoea, persists resolution pulmonary oedema.",C0030705|C0742742|C0018787|C0231174|C0439801|C0239313|C0013404|G0000000|C1514893|C0024109|C0013604
"Other inclusion criteria included Karnofsky performance status (KPS) ≥ 60, life expectancy ≥ 12 weeks, adequate bone marrow function (WBC ≥ 3,000/µL, ANC ≥ 1,500/mm3, platelet count ≥ 100,000/mm3, and hemoglobin ≥ 10 gm/dL), adequate liver function [SGOT, SGPT ≤ 2.5 times upper limit of normal (ULN); bilirubin ≤ 1.5 times ULN], and adequate renal function (creatinine < 1.5 mg/dL, and/or serum creatinine ≤ 1.5 × ULN, and/or creatinine clearance >30 mL/minute, calculated by Cockcroft-Gault formula).","Other inclusion criteria included Karnofsky performance status (KPS) ≥ 60, life expectancy ≥ 12 weeks, adequate bone marrow function (WBC ≥ 3,000/µL, ANC ≥ 1,500/mm3, platelet count ≥ 100,000/mm3, hemoglobin ≥ 10 gm/dL), adequate liver function [SGOT, SGPT ≤ 2.5 times upper limit normal (ULN); bilirubin ≤ 1.5 times ULN], adequate renal function (creatinine < 1.5 mg/dL, and/or serum creatinine ≤ 1.5 × ULN, and/or creatinine clearance >30 mL/minute, calculated Cockcroft-Gault formula).",G0000000|C0007637|C0243161|C0332257|C0206065|C0597198|C0449438|C0206065|G0000000|C0450371|C0376558|C0679138|G0000000|C0450371|C0439230|C0205410|C0262950|C0086590|C0031843|C0023516|G0000000|G0000000|C0948762|G0000000|C1442061|C0005821|C0750480|G0000000|C1442061|C0019046|G0000000|C0450371|C0017480|C0205410|C0023884|C0031843|G0000000|G0000000|G0000000|G0000000|C0040223|C1282910|C0439801|C0205307|C1519815|C0005437|G0000000|G0000000|C0040223|C1519815|C0205410|C0022646|C0031843|C0010294|G0000000|G0000000|C0439269|G0000000|C0229671|C0010294|G0000000|G0000000|G0000000|C1519815|G0000000|C0010294|C0449297|C0450371|C0439526|C0444686|G0000000|C0489829
"In the case-control study, a total of 70 children with medically resistant epilepsy underwent assessment of the frequency and severity of the epileptic attacks at baseline, after one month, two months and three months from the beginning of the study; 35 children received fish oil and the other 35 children received placebo.","In case-control study, total 70 children medically resistant epilepsy underwent assessment frequency severity epileptic attacks baseline, month, months months study; 35 children received fish oil 35 children received placebo.",G0000000|C0872128|C0557651|C0439175|C0450371|C0008059|G0000000|C0332325|C0014544|G0000000|C1261322|C0376249|C0439793|C0014544|C1261512|C0168634|C0332177|C0439231|C0439231|C0557651|C0450371|C0008059|C1514756|C0016163|C0028908|C0450371|C0008059|C1514756|C0032042
"The California survey was a telephone interview and probed non-response with the follow question, “Of all the cigarette advertisements you have seen, which attracts your attention the most?”, a procedure that could have increased positive responses compared with ours.","The California survey telephone interview probed non-response follow question, “Of cigarette advertisements seen, attracts attention most?”, procedure increased positive responses compared ours.",G0000000|C0006754|C0038951|C0039457|C0021822|C0182400|C1518422|C0332283|C1522634|G0000000|C0677453|C0949214|C0205397|G0000000|C0004268|G0000000|C0184661|C0205217|C0439178|C0871261|C1707455|G0000000
"Patients with no prior treatment for advanced/metastatic disease, Eastern Cooperative Oncology Group (ECOG) performance status 0–2, adequate organ function, and measurable or nonmeasurable but evaluable disease were included in the study.","Patients prior treatment advanced/metastatic disease, Eastern Cooperative Oncology Group (ECOG) performance status 0–2, adequate organ function, measurable nonmeasurable evaluable disease included study.",C0030705|C0332152|C0039798|C0205179|C0012634|C1707877|C0679729|C0027651|C0441833|C0430797|C0597198|C0449438|G0000000|C0205410|C0178784|C0031843|C1513040|C1518373|C1516986|C0012634|C0332257|C0557651
We excluded patients who underwent bilateral mastectomies for metachronous bilateral breast cancer (contralateral breast cancer within 6 months of diagnosis of the primary breast cancer) and patients with contralateral invasive or ductal carcinoma in situ incidentally discovered at the time of CPM.,We excluded patients underwent bilateral mastectomies metachronous bilateral breast cancer (contralateral breast cancer 6 months diagnosis primary breast cancer) patients contralateral invasive ductal carcinoma situ incidentally discovered time CPM.,G0000000|C1554077|C0030705|G0000000|C0238767|C0024881|G0000000|C0238767|C0006141|C0006826|C0441988|C0006141|C0006826|G0000000|C0439231|C0011900|C0205225|C0006141|C0006826|C0030705|C0441988|C0205281|C1512083|C0007097|G0000000|G0000000|C1880355|C0040223|G0000000
"Before enrolling in this actual study, patients received 3–4 mg kg−1 tramadol, plus nonsteroidal anti-inflammatory drugs; however, they still complained of pain VAS ⩾4 cm.","Before enrolling actual study, patients received 3–4 mg kg−1 tramadol, nonsteroidal anti-inflammatory drugs; however, complained pain VAS ⩾4 cm.",C0332152|G0000000|C0237400|C0557651|C0030705|C1514756|G0000000|C0040610|G0000000|C0003209|C0013227|G0000000|G0000000|C0030193|C0042815|G0000000
A patient would also be excluded from participation in this trial if the attending physician insisted on the need for transfusion of FFP and/or platelets.,A patient excluded participation trial attending physician insisted transfusion FFP and/or platelets.,G0000000|C0030705|C1554077|C0679823|C0008976|C1547429|C0031831|G0000000|C0005841|C0016709|G0000000|C0005821
"Subjects were excluded if they 1) had excessive spasticity in upper and lower limbs as measured by the Ashworth scale [51] over 4; 2) had pain exceeding 4 on a visual analog pain scale [52, 53]; 3) had total paralysis or muscular contractures of upper or lower extremity; 4) had a history of psychiatric disorder or cardiac problems; 5) had metallic implants near electrical stimulation site or cardiac defibrillators implants; 6) were pregnant or breast feeding; and 7) they were unwilling to participate or comply with the protocol.","Subjects excluded 1) excessive spasticity upper lower limbs measured Ashworth scale [51] 4; 2) pain exceeding 4 visual analog pain scale [52, 53]; 3) total paralysis muscular contractures upper lower extremity; 4) history psychiatric disorder cardiac problems; 5) metallic implants electrical stimulation site cardiac defibrillators implants; 6) pregnant breast feeding; 7) unwilling participate comply protocol.",C0681850|C1554077|G0000000|C0442802|C0026838|C1282910|C0441994|C0015385|C0444706|G0000000|C0175659|C0450371|G0000000|G0000000|C0030193|G0000000|G0000000|C0234621|C0243071|C0030193|C0175659|C0450371|C0450371|G0000000|C0439175|C0522224|C0026845|C0009917|C1282910|C0441994|C0015385|G0000000|C0019664|C0205487|C0012634|C0018787|C1546466|G0000000|C2986473|C0021102|C0013790|C1292856|C0205145|C0018787|C0180307|C0021102|G0000000|C0549206|C0006141|C0204695|G0000000|C0558080|G0000000|C0725694|C0442711
Primary outcome was antibiotic use after the index consultation.,Primary outcome antibiotic consultation.,C0205225|C1274040|C0003232|C0009818
"An additional 30 volunteers in the active group were challenged with virus 1 h after application, and the final group of 32 volunteers was challenged 3 h after application.","An additional 30 volunteers active challenged virus 1 application, final 32 volunteers challenged 3 application.",G0000000|C1524062|C0450371|C0042960|C0205177|C0798503|C0042776|G0000000|C0185125|C0205088|C0450371|C0042960|C0798503|G0000000|C0185125
"Women were excluded for miscarriage after trimester 1 (n = 2), intrauterine fetal death (n = 1), duplex pregnancy (n = 1), sudden infant death syndrome (n = 1), abortion (n = 1), and delivery before pregnancy week 34 (n = 1).","Women excluded miscarriage trimester 1 (n = 2), intrauterine fetal death (n = 1), duplex pregnancy (n = 1), sudden infant death syndrome (n = 1), abortion (n = 1), delivery pregnancy week 34 (n = 1).",C0043210|C1554077|C0000786|C0032982|G0000000|G0000000|C0694756|C0015965|C0011065|G0000000|C0444916|C0032961|G0000000|C1276802|C0021270|C0011065|C0039082|G0000000|C0156543|G0000000|C0011209|C0032961|C0332174|C0450371|G0000000
"#: smoking pack years defined as (number of cigarettes smoked per day/20)×number of years smoked.",#: smoking pack defined (number cigarettes smoked day/20)×number smoked.,G0000000|C0037369|C1968515|C1704788|C0237753|C0677453|C0037366|G0000000|C0037366
The following exclusion criteria were identified: (e) bilateral impairment; (f) severe sensory deficits in the paretic upper limb; (g) cognitive impairment or behavioral dysfunction that would influence the ability to comprehend or perform the experiment; (h) refusal or inability to provide informed consent; (i) other current severe medical problems.,The exclusion criteria identified: (e) bilateral impairment; (f) severe sensory deficits paretic upper limb; (g) cognitive impairment behavioral dysfunction influence ability comprehend perform experiment; (h) refusal inability provide informed consent; (i) current severe medical problems.,G0000000|C0680251|C0243161|C0205396|G0000000|C0238767|C0221099|C0016327|C0205082|C0445254|C2987487|G0000000|C1282910|C0015385|C0439267|C1516691|C0221099|C0004927|C0031847|C4054723|C0085732|G0000000|C0884358|C0681814|C0033727|G0000000|G0000000|C1999230|C1522154|C1511481|C0021966|C0521116|C0205082|C0199168|C1546466
Five hundred and forty (540) women with a BMI > 25.0 kg/m2 will be recruited over 2 years and receive either probiotics or placebo capsules from 16 weeks gestation until delivery.,Five forty (540) women BMI > 25.0 kg/m2 recruited 2 receive probiotics placebo capsules 16 weeks gestation delivery.,C0205451|C3816449|C1442061|C0043210|G0000000|G0000000|C0450371|C0022718|G0000000|G0000000|C1514756|C0525033|C0032042|C0006935|C0450371|C0439230|C0032961|C0011209
"The mean number of chemotherapy cycles was (VG vs VC, respectively) 2.6 vs 2.7, while patients ⩾75 years received 2.3 vs 2.7 cycles.","The chemotherapy cycles (VG VC, respectively) 2.6 2.7, patients ⩾75 received 2.3 2.7 cycles.",G0000000|C0013216|C1511572|C0205999|G0000000|G0000000|G0000000|G0000000|C0030705|G0000000|C1514756|G0000000|G0000000|C1511572
"The proportions of patients who experienced ≥50% reduction from baseline in frequencies of headache days, migraine days, moderate/severe headache days, headache episodes, migraine episodes, and total cumulative hours of headache on headache days were also determined.","The proportions patients experienced ≥50% reduction baseline frequencies headache days, migraine days, moderate/severe headache days, headache episodes, migraine episodes, total cumulative hours headache headache days determined.",G0000000|C1709707|C0030705|C0237607|G0000000|C0301630|C0168634|C0439603|C0018681|C0439228|C0149931|C0439228|C0205081|C0018681|C0439228|C0018681|C0332189|C0149931|C0332189|C0439175|C1511559|C0439227|C0018681|C0018681|C0439228|G0000000
"However, a potential subject was not excluded if all of these qualities were not met.","However, potential subject excluded qualities met.",G0000000|C3245505|C0681850|C1554077|C0332306|C0268621
"The SIRT group consisted of eight men and four women, the TACE group comprised ten men and two women.","The SIRT consisted women, TACE comprised ten women.",G0000000|C1831994|C0332529|C0043210|C0723595|C2700400|C0014518|C0043210
"Babies born between 32+ 0 and 35+ 6 weeks’ gestation, whose mothers intend to breastfeed, who are admitted to the neonatal nursery and require insertion of an intravenous line for clinical reasons.","Babies born 32+ 0 35+ 6 weeks’ gestation, mothers intend breastfeed, admitted neonatal nursery require insertion intravenous clinical reasons.",C0021270|C0005615|G0000000|G0000000|G0000000|C0032961|C0026591|G0000000|C0006147|C0184666|C1552240|C0028659|G0000000|C0021107|C0348016|C0205210|C0392360
"Patients who were classified as acute or subacute, within 6 months from their stroke, and who showed no damage to their temporal lobe on magnetic resonance imaging, were selected.","Patients classified acute subacute, 6 months stroke, damage temporal lobe magnetic resonance imaging, selected.",C0030705|C0008902|C0205178|C0205365|G0000000|C0439231|C0038454|C0010957|C0442043|C0796494|C0024488|C0231881|C0011923|C1707391
"The screening GM was positive in 82 patients, with 44 receiving fluconazole and 38 receiving voriconazole.","The screening GM positive 82 patients, 44 receiving fluconazole 38 receiving voriconazole.",G0000000|C0220908|C0017480|C0439178|C0450371|C0030705|C0450371|C1514756|C0016277|C0450371|C1514756|C0393080
"Of these, 359 patients (187 pregabalin, 172 gabapentin) completed the treatment phase.","Of these, 359 patients (187 pregabalin, 172 gabapentin) completed treatment phase.",G0000000|G0000000|C1442061|C0030705|C1442061|C0657912|C1442061|C0060926|C0205197|C0039798|C0205390
"Eligible students were enrolled in grades pre-kindergarten through eighth (ages 4 –14) at Louisa May Alcott Elementary School or Walsh Math and Science Academy in Chicago, Illinois.","Eligible students enrolled grades pre-kindergarten eighth (ages 4 –14) Louisa May Alcott Elementary School Walsh Math Science Academy Chicago, Illinois.",C1548635|C0038492|G0000000|C0441800|C0332152|C0205442|C0001779|G0000000|G0000000|G0000000|G0000000|G0000000|C0013879|C0036375|G0000000|C0024934|C0036397|C0000876|C0008044|C0020898
This study has been approved by the institutional review boards of the University of Michigan Health System and the St. Joseph Mercy Health System.,This study approved institutional review boards University Michigan Health System St. Joseph Mercy Health System.,G0000000|C0557651|C0205540|C0018704|C0282443|C0972401|C0041740|C0025939|C0018684|C0449913|C0036056|G0000000|G0000000|C0018684|C0449913
"The selection criteria were as follows: a diagnosis of hemiplegia due to stroke, stroke of at least 6 months in duration, a score on the Mini-Mental State Examination not lower than 24 points, understood the procedure and purpose of the study, and volunteered to participate in the study.","The selection criteria follows: diagnosis hemiplegia stroke, stroke 6 months duration, score Mini-Mental State Examination lower 24 points, understood procedure purpose study, volunteered participate study.",G0000000|C0036576|C0243161|C0332283|C0011900|C0018991|C0038454|C0038454|G0000000|C0439231|C0449238|C0449820|C0445542|C1301808|G0000000|C0441994|C0450371|C1552961|C0162340|C0184661|C1285529|C0557651|C0042960|G0000000|C0557651
"Eligibility criteria were: (a) PD, according to the UK Brain Bank Criteria[19]; (b) age between 40 and 75 years; (c) sedentary lifestyle defined as: < 3 times a week vigorous-intensity physical activity for < 60 minutes; or < 3 times a week moderate-intensity physical activity for < 150 minutes);[20] (d) Hoehn and Yahr ≤ 3.","Eligibility criteria were: (a) PD, UK Brain Bank Criteria[19]; (b) age 40 75 years; (c) sedentary lifestyle defined as: < 3 times week vigorous-intensity physical activity < 60 minutes; < 3 times week moderate-intensity physical activity < 150 minutes);[20] (d) Hoehn Yahr ≤ 3.",C0013893|C0243161|G0000000|G0000000|G0000000|C0041700|C0006104|C0442598|C0243161|G0000000|C0001779|C0450371|C0450371|C0439234|G0000000|C0205254|C0023676|C1704788|G0000000|G0000000|G0000000|C0040223|C0332174|C0522510|C0031809|C0205177|G0000000|C0450371|C0439232|G0000000|G0000000|C0040223|C0332174|C0205081|C0031809|C0205177|G0000000|C1442061|C0439232|C0073187|G0000000|G0000000|G0000000|G0000000
Grade 3 or 4 toxicities and study compliance were similar in the 2 arms.,Grade 3 4 toxicities study compliance 2 arms.,C0441800|G0000000|G0000000|C0600688|C0557651|C0009563|G0000000|C0206655
Other APL households are also encouraged to build latrines.,Other APL households encouraged build latrines.,G0000000|G0000000|C0020052|G0000000|C1707059|C0023124
"These patients were invited to participate and those with conditions significantly limiting their ability to undertake the stretching exercises were excluded; for example, severe osteoarthritis; leg pain that might be confused with cramp, such as severe peripheral vascular disease; inability to reliably report on symptoms, such as dementia; and patients who described being previously taught leg exercises aimed at preventing cramp.","These patients invited participate conditions limiting ability undertake stretching exercises excluded; example, severe osteoarthritis; leg pain confused cramp, severe peripheral vascular disease; inability reliably report symptoms, dementia; patients taught leg exercises aimed preventing cramp.",G0000000|C0030705|G0000000|G0000000|C0012634|C0439801|C0085732|G0000000|C0600080|C0015259|C1554077|C1707959|C0205082|C0029408|C0023216|C0030193|C0009676|C0026821|C0205082|C0205100|C0005847|C0012634|G0000000|G0000000|C0684224|C0683368|C0011265|C0030705|C0348054|C0023216|C0015259|C1947946|C0309872|C0026821
"Children were eligible for inclusion in the study if they had not received steroids, had mild to moderate croup as defined by clinical symptoms and the modified Taussig croup score (table 11),), and were older than 3 months.","Children eligible inclusion study received steroids, mild moderate croup defined clinical symptoms modified Taussig croup score (table 11),), 3 months.",C0008059|C1548635|C0007637|C0557651|C1514756|C0038317|C2945599|C0205081|C0010380|C1704788|C0205210|C0683368|C0392747|G0000000|C0010380|C0449820|C0039224|C0450371|G0000000
"Our objective in this study was to examine the associations between CPM and DFS and OS in a large cohort of patients with early-stage breast cancer, applying the propensity score method to reduce the impact of selection bias.13 The prospective Breast Cancer Management System (BCMS) database of The University of Texas MD Anderson Cancer Center was searched to identify women with clinical stage I-III primary unilateral invasive breast cancer who underwent a mastectomy at MD Anderson between June 1997 and August 2009.","Our objective study examine associations CPM DFS OS cohort patients early-stage breast cancer, applying propensity score method reduce impact selection bias.13 The prospective Breast Cancer Management System (BCMS) database The University Texas MD Anderson Cancer Center searched identify women clinical stage I-III primary unilateral invasive breast cancer underwent mastectomy MD Anderson June 1997 August 2009.",G0000000|C0018017|C0557651|G0000000|C0004083|G0000000|G0000000|C0229090|C0599755|C0030705|C2363430|C0006141|C0006826|C1632850|G0000000|C0449820|C0025663|G0000000|C1825598|C0036576|C0242568|G0000000|C0023981|C0006141|C0006826|C0001554|C0449913|C1333221|C0242356|G0000000|C0041740|C0039711|G0000000|G0000000|C0006826|C0205099|C1706202|G0000000|C0043210|C0205210|C0205390|C0021966|C0205225|C0205092|C0205281|C0006141|C0006826|G0000000|C0024881|G0000000|G0000000|C3829443|G0000000|C3831448|G0000000
"We identified 1,931 patients with a first time diagnosis for PD between 2001 and 2006 as reported in the Danish national hospital/outpatient database and density matched them by birth year and sex to 9,651 controls from the population register.","We identified 1,931 patients time diagnosis PD 2001 2006 reported Danish national hospital/outpatient database density matched birth sex 9,651 controls population register.",G0000000|C0205396|C1442061|C0030705|C0040223|C0011900|G0000000|G0000000|G0000000|C0684224|G0000000|C3245503|C0019994|C0242356|C0178587|C0150103|C0005615|C0009253|C1442061|C0243148|C0032659|G0000000
The median age of the study population was 66 ± 12 years.,The median age study population 66 ± 12 years.,G0000000|C0549183|C0001779|C0557651|C0032659|C0450371|G0000000|C0450371|C0439234
"PARTICIPANTS—21 individuals with phenylketonuria (ages 6 to 28 years, mean 11.3).","PARTICIPANTS—21 individuals phenylketonuria (ages 6 28 years, 11.3).",G0000000|C0027361|C0031485|C0001779|G0000000|C0450371|C0439234|C0450371
"Inclusion criteria are as follows: women ≥ 35 years of age presenting with at least a 5-year diagnosis of FM and TMD, optimized drug treatment, cognitive independence to respond to inquiries, functionally independent regarding daily physical activity, availability and ability to fully comply with the training process and phototherapy, and no contraindication to the research procedures.","Inclusion criteria follows: women ≥ 35 age 5-year diagnosis FM TMD, optimized drug treatment, cognitive independence respond inquiries, functionally independent daily physical activity, availability ability comply training process phototherapy, contraindication procedures.",C0007637|C0243161|C0332283|G0000000|C0001779|C0439234|C0011900|C3540627|C3538714|G0000000|C0013227|C0039798|C1516691|C0085862|G0000000|C0035168|G0000000|C0085862|C0332173|C0031809|C0205177|C0470187|C0085732|C0725694|C0040607|C1184743|C0031765|C0522473|C0025664
Note: Intervention included point of care C-reactive protein testing or training in enhanced communication skills.,Note: Intervention included care C-reactive protein testing training enhanced communication skills.,C1316572|C0886296|C0332257|C1947933|C0205332|C0033684|C0039593|C0040607|C2349975|C0009452|C0678856
A total of 232 patients from eight centers were randomized to receive either ALC (n = 117) or MC (n = 115).,A total 232 patients centers randomized receive ALC (n = 117) MC (n = 115).,G0000000|C0439175|C1442061|C0030705|C0205099|C0034656|C1514756|C1424945|C0369718|G0000000|C1442061|C0024403|C0369718|G0000000|C1442061
"For ABVE-PC, the doxorubicin dose density was 20 mg/m2 per week and 0.93 mg/m2 per week for vincristine.","For ABVE-PC, doxorubicin dose density 20 mg/m2 week 0.93 mg/m2 week vincristine.",G0000000|C1879497|C0013089|C0178602|C0178587|C0450371|C0026410|C0332174|C0450371|C0026410|C0332174|C0042679
"Students in the intervention schools were eligible if they were in the age group with the highest AR (aged 9–14 years), had a history of two MMR vaccine doses, had not previously received a third MMR vaccine dose, and had no history of mumps.","Students intervention schools eligible age AR (aged 9–14 years), history MMR vaccine doses, received MMR vaccine dose, history mumps.",C0038492|C0886296|C0036375|C1548635|C0001779|C2986463|C0001779|G0000000|C0439234|C0019664|C3538741|C0042210|C0178602|C1514756|C3538741|C0042210|C0178602|C0019664|C0026780
This study documents the benefits of treating OA of the knee with BNHS for OA patients who were either unresponsive to or presented with adverse events from previous NSAID therapy.,This study documents benefits treating OA knee BNHS OA patients unresponsive adverse events previous NSAID therapy.,G0000000|C0557651|C1301746|C0814225|C1522326|C0029408|C0022742|C1859093|C0029408|C0030705|C0205269|G0000000|C0441471|C0205156|C0003211|C0039798
"Exclusion criteria: medical history of ocular surgery, trauma or refractive laser vision correction procedure <3 months earlier; corneal/conjunctival infection; Sjögren's syndrome; contact lens use during study and <1 week earlier; ocular allergic symptoms; known allergy to eye drop constituents; current or planned pregnancy or nursing during study.","Exclusion criteria: medical history ocular surgery, trauma refractive laser vision correction procedure <3 months earlier; corneal/conjunctival infection; Sjögren's syndrome; contact lens study <1 week earlier; ocular allergic symptoms; allergy eye drop constituents; current planned pregnancy nursing study.",C0680251|C0243161|C0199168|C0019664|C0015392|C0038894|C0043251|C0429585|C0023089|C0042789|C1705565|C0184661|G0000000|C0439231|C1279919|C0010031|C0009450|G0000000|C0039082|C0332158|C0023317|C0557651|G0000000|C0332174|C1279919|C0015392|C0700624|C0683368|C0002111|C0015392|C1321095|C0729650|C0521116|C1301732|C0032961|C0006147|C0557651
HIV prevention among young people in southern Africa is a public health priority.,HIV prevention people southern Africa public health priority.,C0019682|C0199176|C0027361|C1710133|C0001737|G0000000|C0018684|C0549179
"The criteria for selecting the subjects were as follows: more than 6 months since the onset of non-traumatic and unilateral stroke, a score of more than 24 in the Korean version of the Mini Mental State Examination, a score of less than 2.26 in the Vividness of Movement Imagery Questions, the ability to stand independently for more than three minutes, the ability to walk farther than 10 m, and no orthopedic diseases that would have affected standing balance.","The criteria selecting subjects follows: 6 months onset non-traumatic unilateral stroke, score 24 Korean version Mini Mental State Examination, score 2.26 Vividness Movement Imagery Questions, ability stand independently minutes, ability walk farther 10 m, orthopedic diseases standing balance.",G0000000|C0243161|C1707391|C0681850|C0332283|G0000000|C0439231|C0206132|C1518422|C0205092|C0038454|C0449820|C0450371|C1556095|C0333052|C0445542|C0229992|C1301808|G0000000|C0449820|C0450371|C1268943|C0026649|C0150627|C1522634|C0085732|C0596013|G0000000|C0439232|C0085732|C0080331|C0205108|C0450371|C0369637|C0029355|C0012634|C0231472|C0014653
"Thus, 936 patients (69.4%) who met the inclusion criteria and successfully completed the study were included in the efficacy analysis.","Thus, 936 patients (69.4%) met inclusion criteria completed study included efficacy analysis.",G0000000|C1442061|C0030705|C0450371|C0268621|C0007637|C0243161|C0205197|C0557651|C0332257|C1280519|C0002778
"The relevant CDS treatment databases were searched and any children in the ""unregistered group"" found to be under treatment with the CDS in Lothian or Fife were excluded from further analysis.","The relevant CDS treatment databases searched children ""unregistered group"" treatment CDS Lothian Fife excluded analysis.",G0000000|C2347946|C0079141|C0039798|C0242356|C1706202|C0008059|G0000000|C0441833|C0039798|C0079141|C0454912|C0454909|C1554077|C0002778
"Patients were excluded who were pregnant or breastfeeding, had an ileostomy, colostomy, or ileoanal anastomosis, short bowel syndrome, or abnormal liver enzymes.","Patients excluded pregnant breastfeeding, ileostomy, colostomy, ileoanal anastomosis, short bowel syndrome, abnormal liver enzymes.",C0030705|C1554077|C0549206|C0006147|C0020883|C0009410|G0000000|C0332853|C1282927|C0021853|C0039082|C0205161|C0023884|C0014442
"In addition, written assent (or verbal assent in the presence of a literate witness for illiterates) from children 12 to 17 years as per local practice.","In addition, written assent (or verbal assent presence literate witness illiterates) children 12 17 local practice.",G0000000|C0332287|C0043266|C1879749|G0000000|C0439824|C1879749|C0150312|C0023864|C0682356|C0020899|C0008059|C0450371|C0450371|C0205276|C0237607
"Eligible patients were 18 to 65 years of age with a diagnosis of schizophrenia, as determined on the basis of the Structured Clinical Interview of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition.","Eligible patients 18 65 age diagnosis schizophrenia, determined basis Structured Clinical Interview Diagnostic Statistical Manual Mental Disorders, Fourth Edition.",C1548635|C0030705|C0450371|C0450371|C0001779|C0011900|C0036341|G0000000|C1527178|C0678594|C0205210|C0021822|C0011900|C0038215|C0024763|C0229992|C0012634|C0205438|C0441792
"Of 6350 children enrolled in the study, 588 eventually met the eligibility criteria for the clinical trial; of these, 429 children (73 percent) underwent randomization after their parents or guardians gave consent.","Of 6350 children enrolled study, 588 eventually met eligibility criteria clinical trial; these, 429 children (73 percent) underwent randomization parents guardians consent.",G0000000|G0000000|C0008059|G0000000|C0557651|C1442061|G0000000|C0268621|C0013893|C0243161|C0205210|C0008976|G0000000|C1442061|C0008059|C0450371|C0439165|G0000000|C0034656|C0030551|C1274041|C1511481
"The samples were female students of Tabriz University and Tabriz University of Medical Science, who suffered from primary dysmenorrhea.","The samples female students Tabriz University Tabriz University Medical Science, suffered primary dysmenorrhea.",G0000000|C0370003|C0015780|C0038492|G0000000|C0041740|G0000000|C0041740|C0199168|C0036397|C0683278|C0205225|C0013390
"Exclusion criteria were delirium prior to inclusion, Parkinson disease, dementia, alcohol abuse, an acute neurological condition, history of a psychiatric disease and use of antipsychotic agents, history of clinically relevant ventricular arrhythmia in the last 12 months, QTc time of at least 500 milliseconds, pregnant or breastfeeding, expected death within 2 days, known allergy or intolerance to haloperidol, and inability to give or have no one able to give informed consent.","Exclusion criteria delirium prior inclusion, Parkinson disease, dementia, alcohol abuse, acute neurological condition, history psychiatric disease antipsychotic agents, history clinically relevant ventricular arrhythmia 12 months, QTc time 500 milliseconds, pregnant breastfeeding, expected death 2 days, allergy intolerance haloperidol, inability informed consent.",C0680251|C0243161|C0011206|C0332152|C0007637|C1021144|C0012634|C0011265|C0001962|C0013146|C0205178|C0205494|C0012634|C0019664|C0205487|C0012634|C0040615|C0450442|C0019664|G0000000|C2347946|C0018827|C0003811|C0450371|C0439231|G0000000|C0040223|C1442061|C0439223|C0549206|C0006147|C1517001|C0011065|G0000000|C0439228|C0002111|C0231199|C0018546|G0000000|C1522154|C1511481
"In contrast to other studies, our study was performed on patients with sepsis, severe sepsis, and septic shock using moderate-dose prednisolone with or without vasopressor support.","In contrast studies, study performed patients sepsis, severe sepsis, septic shock moderate-dose prednisolone vasopressor support.",G0000000|C0009924|C0947630|C0557651|C0884358|C0030705|C0036690|C0205082|C0036690|C0333534|C0036974|C0205081|C0032950|C0042397|C0183683
"Since the role of haloperidol as a strategy to prevent delirium in critically ill adults remained unclear, we sought to test the hypothesis that the administration of IV haloperidol to mechanically ventilated, critically ill adults, patients with subsyndromal delirium would prevent conversion to delirium.","Since role haloperidol strategy prevent delirium critically ill adults remained unclear, sought test hypothesis administration IV haloperidol mechanically ventilated, critically ill adults, patients subsyndromal delirium prevent conversion delirium.",C1711239|C0035820|C0018546|C0679199|C0309872|C0011206|G0000000|C0231218|C0001675|G0000000|G0000000|G0000000|C0022885|C1512571|C0001554|C0022326|C0018546|G0000000|C0231923|G0000000|C0231218|C0001675|C0030705|G0000000|C0011206|C0309872|C0439836|C0011206
"Also, children with a previously diagnosed intellectual disability (IQ < 70) were excluded from participation.","Also, children diagnosed intellectual disability (IQ < 70) excluded participation.",G0000000|C0008059|C0011900|G0000000|C0231170|G0000000|C1554077|C0679823
The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-244X/5/1/prepub,The pre-publication history paper accessed here: http://www.biomedcentral.com/1471-244X/5/1/prepub,G0000000|C0332152|C0019664|C0030351|C0444454|G0000000|C1555015
Services already identified through local health service data as comprehensively implementing healthy eating and physical activity policies and practices were also excluded.,Services identified local health service data comprehensively implementing healthy eating physical activity policies practices excluded.,C0557854|C0205396|C0205276|C0018684|C0557854|C1511726|G0000000|G0000000|C3898900|C0013470|C0031809|C0205177|C0242456|C0237607|C1554077
"The following inclusion criteria were applied: patients aged over 18 years, aided by a family member or paid caregiver for treatment application; risk of impaired skin integrity according to the Braden Scale ≤16, identified by a nurse, and nutritional status of ≤10 according to the Mini Nutritional Assessment (MNA).","The inclusion criteria applied: patients aged 18 years, aided family paid caregiver treatment application; risk impaired skin integrity Braden Scale ≤16, identified nurse, nutritional status ≤10 Mini Nutritional Assessment (MNA).",G0000000|C0007637|C0243161|C4048755|C0030705|C0001779|C0450371|C0439234|C0449435|C0015576|C0871051|C0085537|C0039798|C0185125|C0035647|C0221099|C0444099|C0205266|G0000000|C0175659|G0000000|C0205396|C0028661|C1521739|C0449438|G0000000|C0445542|C1521739|C1261322|G0000000
Our inclusion criteria were: CDR mild and moderate dementia.,Our inclusion criteria were: CDR mild moderate dementia.,G0000000|C0007637|C0243161|G0000000|G0000000|C2945599|C0205081|C0011265
"Participants will be included if they meet the following criteria: Aged 18 or over; Diagnosis of stroke(s); Onset of stroke at least four months prior to randomisation; Diagnosis of aphasia, subsequent to stroke, as confirmed by a trained speech and language therapist; Ability to retrieve 10 to 90% of words on the Comprehensive Aphasia Test Naming Objects subtest (score of 5 to 43 out of 48); Ability to perform a simple matching task in StepByStep with at least 50% accuracy (to confirm sufficient vision and cognitive ability) and Ability to repeat at least 50% of words in a simple word repetition task in the StepByStep© program.","Participants included meet criteria: Aged 18 over; Diagnosis stroke(s); Onset stroke months prior randomisation; Diagnosis aphasia, subsequent stroke, confirmed trained speech language therapist; Ability retrieve 10 90% Comprehensive Aphasia Test Naming Objects subtest (score 5 43 48); Ability perform simple matching task StepByStep 50% accuracy (to confirm sufficient vision cognitive ability) Ability repeat 50% simple word repetition task StepByStep© program.",C0679646|C0332257|C1550543|C0243161|C0001779|C0450371|C0205136|C0011900|C0038454|C0206132|C0038454|C0439231|C0332152|C0034656|C0011900|C0003537|C0332282|C0038454|C0521093|C0336809|C0037817|C0023008|C0871525|C0085732|G0000000|C0450371|C0450371|C1880156|C0003537|C0022885|C0233735|C0347997|G0000000|C0449820|G0000000|C0450371|C0450371|C0085732|C0884358|C0205352|C0150103|C3540678|G0000000|C0450371|C0443131|G0000000|C0521093|C0205410|C0042789|C1516691|C0085732|C0085732|C0205341|C0450371|C0205352|C1705313|C0205341|C3540678|G0000000|C1709697
Participating physicians will be randomly assigned to either the experimental group or the control group (Fig.,Participating physicians randomly assigned experimental control (Fig.,C0679823|C0031831|G0000000|C1516050|C1517586|C0243148|C0349966
Physicians will be randomly assigned to 30-h CST program (experimental group) or to a waiting list (control group).,Physicians randomly assigned 30-h CST program (experimental group) waiting list (control group).,C0031831|G0000000|C1516050|C0450371|C3539520|C1709697|C1517586|C0441833|C1610166|C0745732|C0243148|C0441833
A total of 301 subjects were randomized.,A total 301 subjects randomized.,G0000000|C0439175|C1442061|C0681850|C0034656
"This randomized clinical trial was conducted at Alzahra and Shahid Beheshti Hospital in Isfahan, Iran, from January, 2013 to January, 2014 on 210 pregnant women referred to gynecology clinics.","This randomized clinical trial conducted Alzahra Shahid Beheshti Hospital Isfahan, Iran, January, 2013 January, 2014 210 pregnant women referred gynecology clinics.",G0000000|C0034656|C0205210|C0008976|C0004927|G0000000|G0000000|G0000000|C0019994|G0000000|C0022065|C3829466|G0000000|C3829466|G0000000|C1442061|C0549206|C0043210|C0205543|C0018417|C0442592
"[25] In our study, the cohort sample were patients with stage II and III breast cancer receiving adjuvant therapy and our results support benefits of yoga in modulating distressful symptoms related to adjuvant radiotherapy.","[25] In study, cohort sample patients stage II III breast cancer receiving adjuvant therapy support benefits yoga modulating distressful symptoms adjuvant radiotherapy.",C0450371|G0000000|C0557651|C0599755|C0370003|C0030705|C0205390|G0000000|C0439070|C0006141|C0006826|C1514756|C0001551|C0039798|C0183683|C0814225|C0043418|C0443264|C0231304|C0683368|C0001551|C0034619
"After a 1-month run-in period, participants with good adherence (≥90%) were monitored.","After 1-month run-in period, participants adherence (≥90%) monitored.",G0000000|C0332177|C3274438|C0439531|C0679646|C1510802|G0000000|C0030695
No statistically significant differences in objective sleep measures were seen between baseline and treatment periods for the any of the 3 groups.,No statistically differences objective sleep measures baseline treatment periods 3 groups.,G0000000|C0038215|C1705241|C0018017|C0037313|C0079809|C0168634|C0039798|C0439531|G0000000|C0441833
"A sample of seventh, eighth, and ninth grade girls (N = 236) from 42 states and 4 Canadian provinces were randomly assigned to an intervention or control group.","A sample seventh, eighth, ninth grade girls (N = 236) 42 4 Canadian provinces randomly assigned intervention control group.",G0000000|C0370003|C0205441|C0205442|C0205443|C0441800|C0870604|C0369718|G0000000|C1442061|C0450371|G0000000|C0238884|C1514578|G0000000|C1516050|C0886296|C0243148|C0441833
The problem of anaemia in patients undergoing major surgery is being increasingly recognised [4].,The anaemia patients undergoing major surgery increasingly recognised [4].,G0000000|C0002871|C0030705|G0000000|C0205082|C0038894|G0000000|G0000000|G0000000
"Participants with any other associated skin disease, which could alter the picture of scabies; known/suspected immunocompromised individuals, having scabies with atypical presentations like crusted scabies or scabies incognito; participants who had taken any antiscabetic treatment in the preceding week; and noncompliant participants were excluded.","Participants skin disease, alter picture scabies; known/suspected immunocompromised individuals, scabies atypical presentations crusted scabies scabies incognito; participants antiscabetic treatment preceding week; noncompliant participants excluded.",C0679646|C0444099|C0012634|C0392747|C0441468|C0036262|C0205309|C0085393|C0027361|C0036262|C0205182|C0449450|C0392749|C0036262|C0036262|G0000000|C0679646|G0000000|C0039798|C0332152|C0332174|C0457432|C0679646|C1554077
"Acupuncture has been widely used as a treatment for stroke in China for more than 3,000 years.","Acupuncture treatment stroke China 3,000 years.",C0001299|C0039798|C0038454|C0008115|C1442061|C0439234
Her institution received reimbursement from Novartis for the conduct of the study and analysis of the physical activity data.,Her institution received reimbursement Novartis conduct study analysis physical activity data.,G0000000|C0018704|C1514756|G0000000|G0000000|C0004927|C0557651|C0002778|C0031809|C0205177|C1511726
"Exclusion criteria were: The need to take antibiotics for the presence of signs and/or symptoms of infection; Use of non-steroidal anti-inflammatory drugs during the 30 days prior to the beginning of the study; Use of steroid medications during the 30 days prior to the beginning of the study; Dental care in progress; Current gingivitis and periodontitis; Systemic diseases such as: chronic liver disease, chronic renal failure, gastro-esophageal reflux; Alcoholism and/or drug addiction.","Exclusion criteria were: The antibiotics presence signs and/or symptoms infection; Use non-steroidal anti-inflammatory drugs 30 days prior study; Use steroid medications 30 days prior study; Dental care progress; Current gingivitis periodontitis; Systemic diseases as: chronic liver disease, chronic renal failure, gastro-esophageal reflux; Alcoholism and/or drug addiction.",C0680251|C0243161|G0000000|G0000000|C0003232|C0150312|C0220912|G0000000|C0683368|C0009450|C0042153|C1518422|C0003209|C0013227|C0450371|C0439228|C0332152|C0557651|C0042153|C0038317|C0013227|C0450371|C0439228|C0332152|C0557651|C0011365|C1947933|C1272688|C0521116|C0017574|C0031099|C0205373|C0012634|G0000000|C0205191|C0023884|C0012634|C0205191|C0022646|C0231174|C0744316|C0017168|C0001973|G0000000|C0013227|C0085281
"We enrolled 66 refractory adult epileptic cases, aged from 18 to 57 years, who referred to the Adult Neurology Clinic of Kashani Hospital from February 2010 to December 2012.","We enrolled 66 refractory adult epileptic cases, aged 18 57 years, referred Adult Neurology Clinic Kashani Hospital February 2010 December 2012.",G0000000|G0000000|C0450371|C0205269|C0001675|C0014544|C0868928|C0001779|C0450371|C0450371|C0439234|C0205543|C0001675|C0027855|C0002424|G0000000|C0019994|C3830166|G0000000|C3830550|G0000000
"Exclusion criteria were history of asthma, allergic rhinitis or atopy; a recent lower respiratory tract infection or any exacerbation (within the previous six weeks); a recent history of myocardial infarction (within the previous six months) or cardiac arrhythmia requiring drug therapy; and oral corticosteroid use at unstable doses during the six weeks before entering the study or at a stable dose exceeding the equivalent of 10 mg prednisone daily.","Exclusion criteria history asthma, allergic rhinitis atopy; lower respiratory tract infection exacerbation (within previous weeks); history myocardial infarction (within previous months) cardiac arrhythmia requiring drug therapy; oral corticosteroid unstable doses weeks entering study stable dose exceeding equivalent 10 prednisone daily.",C0680251|C0243161|C0019664|C0004096|C0700624|C0035455|C0392707|C0441994|C0521346|C1185740|C0009450|G0000000|G0000000|C0205156|C0439230|C0019664|C0027061|C0021308|G0000000|C0205156|C0439231|C0018787|C0003811|G0000000|C0013227|C0039798|C0442027|C0001617|C0443343|C0178602|C0439230|C1522196|C0557651|C0205360|C0178602|G0000000|C0205163|C0450371|C0032952|C0332173
"These features are important because they increase the scope of EHR-guided patient care beyond an individual healthcare system, allowing for efficient delivery and integration of care both within and outside a healthcare system.","These features increase scope EHR-guided patient care individual healthcare system, allowing efficient delivery integration care healthcare system.",G0000000|C1521970|C0442805|C1710028|C0181090|C0030705|C1947933|C0027361|C0086388|C0449913|C0683607|C0442799|C0011209|C1158478|C1947933|C0086388|C0449913
"The exclusion criteria were as follows: estimated glomerular filtration rate (GFR) <60 mL/min/1.73 m2 of body surface area; active or chronic infection; live-attenuated vaccination within 1 month leading up to the study; underlying cardiovascular or pulmonary disease; uncontrolled hypertension; neutropenia or thrombocytopenia; pregnancy or potential pregnancy; patients with known genetic causes such as NPHS1, NPHS2, WT1, or LAMB2; and previous use of RTX.","The exclusion criteria follows: estimated glomerular filtration rate (GFR) <60 mL/min/1.73 m2 body surface area; active chronic infection; live-attenuated vaccination 1 month leading study; underlying cardiovascular pulmonary disease; uncontrolled hypertension; neutropenia thrombocytopenia; pregnancy potential pregnancy; patients genetic NPHS1, NPHS2, WT1, LAMB2; previous RTX.",G0000000|C0680251|C0243161|C0332283|C0750572|C0022663|C0016107|C0871208|C0017654|G0000000|C0242821|C0205148|C0017446|C0205177|C0205191|C0009450|C1548795|C0042196|G0000000|C0332177|C0332152|C0557651|G0000000|C0007226|C0024109|C0012634|C0205318|C0020538|C0023530|C0040034|C0032961|C3245505|C0032961|C0030705|C0017296|G0000000|G0000000|C1825263|G0000000|C0205156|C0073081
"PDN was confirmed by 1) the patient’s medical history, 2) a diabetic neuropathy symptom (DNS) score of >1 point (7), 3) a diabetic neuropathy examination (DNE) score of >3 points (8), 4) a modified neuropathy symptom score (NSS) (9,10), and 5) increased thresholds on the vibration perception test and monofilament test.","PDN confirmed 1) patient’s medical history, 2) diabetic neuropathy symptom (DNS) score >1 (7), 3) diabetic neuropathy examination (DNE) score >3 (8), 4) modified neuropathy symptom score (NSS) (9,10), 5) increased thresholds vibration perception test monofilament test.",G0000000|C0521093|G0000000|G0000000|C0199168|C0019664|G0000000|C0241863|C0442874|C1457887|C2314896|C0449820|G0000000|G0000000|G0000000|C0241863|C0442874|G0000000|G0000000|C0449820|G0000000|G0000000|G0000000|C0392747|C0442874|C1457887|C0449820|G0000000|C0450371|G0000000|C0205217|C0449864|C0455941|C0030971|C0022885|G0000000|C0022885
"This study found, one year after the intervention, a reduction of several adverse psychosocial factors in the experimental group whereas no such reduction was found in the control group.","This study found, intervention, reduction adverse psychosocial factors experimental reduction control group.",G0000000|C0557651|C0150312|C0886296|C0301630|G0000000|C0542298|C1521761|C1517586|C0301630|C0243148|C0441833
"Eligibility criteria included child age of 6 to 12 years; physician-diagnosed asthma, symptom frequency, and/or controller medication use signifying persistent asthma6; a smoker in the home who smoked more than 5 cigarettes per day and resided in the home at least 4 days per week; and residence in the Baltimore metropolitan area.","Eligibility criteria included child age 6 12 years; physician-diagnosed asthma, symptom frequency, and/or controller medication signifying persistent asthma6; smoker smoked 5 cigarettes day resided 4 days week; residence Baltimore metropolitan area.",C0013893|C0243161|C0332257|C0008059|C0001779|G0000000|C0450371|C0439234|C0031831|C0004096|C1457887|C0376249|G0000000|C0180112|C0013227|G0000000|C0205322|G0000000|C0337664|C0037366|G0000000|C0677453|C0332173|C2982691|G0000000|C0439228|C0332174|C0237096|C0004716|C0599587|C0017446
Two reminders will be sent in case questionnaires are not received within 1 week after the required date.,Two reminders questionnaires received 1 week required date.,C0205448|C1709896|C0034394|C1514756|G0000000|C0332174|C1514873|C0011008
"Patients were included in the study if they could communicate in English, Spanish, Haitian Creole, or Cape Verdean Creole; were alert and oriented to person, time, and place; and could give autonomous informed consent (or assent if they were below the age of 18).","Patients included study communicate English, Spanish, Haitian Creole, Cape Verdean Creole; alert oriented person, time, place; autonomous informed consent (or assent age 18).",C0030705|C0332257|C0557651|C0566001|C0376245|C0086409|C0239806|G0000000|C0453952|G0000000|G0000000|C0239110|C1704322|C0027361|C0040223|C0442504|G0000000|C1522154|C1511481|G0000000|C1879749|C0001779|C0450371
"Over 12 months, all children between the ages of six months and five years who presented with febrile seizures (tonic, clonic, or tonic-clonic) lasting for at least 10 minutes were eligible for inclusion in our study.","Over 12 months, children ages months febrile seizures (tonic, clonic, tonic-clonic) lasting 10 minutes eligible inclusion study.",C0205136|C0450371|C0439231|C0008059|C0001779|C0439231|C0015967|C0036572|C3543842|G0000000|C3543842|C1517741|C0450371|C0439232|C1548635|C0007637|C0557651
"On the other hand, the exclusion criteria of the study were having allergic reaction or digestive disease to the medicines.","On hand, exclusion criteria study allergic reaction digestive disease medicines.",G0000000|C0018563|C0680251|C0243161|C0557651|C0700624|C0443286|C0012238|C0012634|C0013227
Patients with any respiratory infection or COPD exacerbation in the 4 weeks prior to the screening Visit (Visit 1) or during the run-in period are not permitted to participate.,Patients respiratory infection COPD exacerbation 4 weeks prior screening Visit (Visit 1) run-in period permitted participate.,C0030705|C0521346|C0009450|C0024117|G0000000|G0000000|C0439230|C0332152|C0220908|C0545082|C0545082|G0000000|C3274438|C0439531|C0329040|G0000000
Both trials included a heterogeneous sample of post-treatment cancer survivors enrolled based on the presence of clinically significant fatigue and randomized to either a mindfulness-based intervention for CRF or a wait-list control group.,Both trials included heterogeneous sample post-treatment cancer survivors enrolled based presence clinically fatigue randomized mindfulness-based intervention CRF wait-list control group.,G0000000|C0008976|C0332257|C0019409|C0370003|C2709088|C0006826|C0206194|G0000000|C1527178|C0150312|G0000000|C0015672|C0034656|C0086045|C0886296|G0000000|C0043010|C0243148|C0441833
"Inclusion criteria included the infant having been born at term with birth weight > 2500 g; healthy appearance with no apparent congenital anomalies; current immunization status; family social situation such that they were able to comply with study requirements; willingness to provide informed consent and agree to weekly visits for MNP distribution and data collection, as well as stool, urine and blood collections; hemoglobin concentration ≥ 10 g/dL; infant still breastfeeding at enrollment and intended to continue during the three months of the study period; and negative blood slide for malaria parasites.","Inclusion criteria included infant born term birth weight > 2500 g; healthy appearance apparent congenital anomalies; current immunization status; family social situation comply study requirements; willingness provide informed consent agree weekly visits MNP distribution data collection, stool, urine blood collections; hemoglobin concentration ≥ 10 g/dL; infant breastfeeding enrollment intended continue months study period; negative blood slide malaria parasites.",C0007637|C0243161|C0332257|C0021270|C0005615|C0233324|C0005615|C0005910|G0000000|G0000000|C0439267|C3898900|C0233426|C0750489|C0009678|C0000769|C0521116|C0020971|C0449438|C0015576|C0728831|G0000000|C0725694|C0557651|C1514873|C0600109|C1999230|C1522154|C1511481|C3641827|C0332174|C0545082|C0282245|C0520511|C1511726|C1516698|C0015733|C0042036|C0005767|C0600644|C0019046|C0004268|G0000000|C0450371|C0439267|C0021270|C0006147|C1516879|C1283828|C0549178|C0439231|C0557651|C0439531|C0205160|C0005767|C0444330|C0024530|C0030498
Initially only patients with recurrence of lung cancer after first line therapy could be included in the study.,Initially patients recurrence lung cancer therapy included study.,C0205265|C0030705|C0034897|C0024109|C0006826|C0039798|C0332257|C0557651
"Besides the place of residence, the inclusion criteria are: - Dutch-speaking patients, aged 18 years or older, with a progressive oncological disease, - a score of ≤ 60 on the Karnofsky Performance Scale (assessed by the GP), - a life expectancy of ≤ 3 months.","Besides residence, inclusion criteria are: - Dutch-speaking patients, aged 18 older, progressive oncological disease, - score ≤ 60 Karnofsky Performance Scale (assessed GP), - life expectancy ≤ 3 months.",G0000000|C0237096|C0007637|C0243161|G0000000|G0000000|C0013331|C0030705|C0001779|C0450371|C0580836|C0205329|C0027651|C0012634|G0000000|C0449820|G0000000|C0450371|C0206065|C0597198|C0175659|C1516048|C3811116|G0000000|C0376558|C0679138|G0000000|G0000000|C0439231
"bleeding, hydrocephalus), severe renal failure, metabolic disorders, initial serum sodium >150 mmol/l and initial serum osmolarity >320 mosm/kg.","bleeding, hydrocephalus), severe renal failure, metabolic disorders, initial serum sodium >150 mmol/l initial serum osmolarity >320 mosm/kg.",C0019080|C0020255|C0205082|C0022646|C0231174|C0311400|C0012634|C0205265|C0229671|C0037473|C1442061|C1532563|C0205265|C0229671|C0029387|C1442061|C0439353
"Among those with IGT, the 90-min postprandial glucose was 114 ± 3 mg/dl (6.3 ± 0.2 mmol/l) in the insulin group, 122 ± 4 mg/dl (6.8 ± 0.2 mmol/l) in the placebo group, and 131 ± 9 mg/dl (7.3 ± 0.5 mmol/l) in the repaglinide group (P = 0.20, insulin vs. placebo; P = 0.81, repaglinide vs. placebo; and P = 0.03, insulin vs. repaglinide).","Among IGT, 90-min postprandial glucose 114 ± 3 mg/dl (6.3 ± 0.2 mmol/l) insulin group, 122 ± 4 mg/dl (6.8 ± 0.2 mmol/l) placebo group, 131 ± 9 mg/dl (7.3 ± 0.5 mmol/l) repaglinide (P = 0.20, insulin vs. placebo; P = 0.81, repaglinide vs. placebo; P = 0.03, insulin vs. repaglinide).",G0000000|G0000000|C0450371|C0376674|C0017725|C1442061|G0000000|G0000000|C0439269|G0000000|G0000000|G0000000|C1532563|C0021641|C0441833|C1442061|G0000000|G0000000|C0439269|G0000000|G0000000|G0000000|C1532563|C0032042|C0441833|C1442061|G0000000|G0000000|C0439269|G0000000|G0000000|G0000000|C1532563|C0246689|C0369773|G0000000|C0450371|C0021641|G0000000|C0032042|C0369773|G0000000|C0450371|C0246689|G0000000|C0032042|C0369773|G0000000|C0450371|C0021641|G0000000|C0246689
"Patients were excluded if they were: aged <16 year, malnourished (weight loss ≥10% of body weight within the last 6 months), had undergone previous wide-field radical radiotherapy, or were pregnant, diabetic or immuno-suppressed.","Patients excluded were: aged <16 year, malnourished (weight loss ≥10% body weight 6 months), undergone previous wide-field radical radiotherapy, pregnant, diabetic immuno-suppressed.",C0030705|C1554077|G0000000|C0001779|C0450371|C0439234|C0162429|C0005910|C1517945|G0000000|C0242821|C0005910|G0000000|C0439231|G0000000|C0205156|C0332464|C0302912|C0034619|C0549206|C0241863|C1260953
"To identify live births whether before or after the histological sample had been obtained, we linked women by their NHS number and date of birth to hospital episode statistics of inpatient obstetric records between April 1998 and April 2010 for the whole of England.","To identify live births histological sample obtained, linked women NHS birth hospital episode statistics inpatient obstetric records April 1998 April 2010 England.",C0040363|G0000000|C1548795|C0005615|C0205462|C0370003|C1301820|C1517892|C0043210|C0796085|C0005615|C0019994|C0332189|C0038215|C0021562|C0205484|C0034869|C3715024|G0000000|C3715024|G0000000|C0014282
MAIN OUTCOME MEASURES: Attendance for breast screening in relation to ethnic group in women who had not taken up their original invitation.,MAIN OUTCOME MEASURES: Attendance breast screening relation ethnic women original invitation.,C0205225|C1274040|C0079809|C2827364|C0006141|C0220908|C0080103|C0015031|C0043210|C0205313|C2826348
"We included stroke patients aged 25–85 years admitted to the stroke unit with an initial Functional Independence Measure of up to 100, who gave informed consent.","We included stroke patients aged 25–85 years admitted stroke unit initial Functional Independence Measure 100, informed consent.",G0000000|C0332257|C0038454|C0030705|C0001779|G0000000|C0184666|C0038454|C0439148|C0205265|C0205245|C0085862|C0079809|C1442061|C1522154|C1511481
Those aged 18–75 years with excessive daytime sleepiness (Epworth Sleepiness Score >9) and proven OSA on a one night respiratory polysomnography sleep study were considered eligible.,Those aged 18–75 years excessive daytime sleepiness (Epworth Sleepiness Score >9) proven OSA night respiratory polysomnography sleep study considered eligible.,G0000000|C0001779|G0000000|C0442802|C0332169|C0013144|G0000000|C0013144|C0449820|G0000000|C0456369|C0520679|C0240526|C0521346|C0162701|C0037313|C0557651|C0750591|C1548635
"Results: 227 subjects participated, including 102 men and 124 women.","Results: 227 subjects participated, including 102 124 women.",C1274040|C1442061|C0681850|G0000000|C0332257|C1442061|C1442061|C0043210
"We conducted the study on patients with mild-to-moderate active UC on the basis of two inclusion criteria: 1) outpatients who were 16–64 years of age at the time of informed consent, and 2) patients who had mild-to-moderate active UC defined by UC-DAI of 3–8 and a bloody stool score of 1 or greater.","We conducted study patients mild-to-moderate active UC basis inclusion criteria: 1) outpatients 16–64 age time informed consent, 2) patients mild-to-moderate active UC defined UC-DAI 3–8 bloody stool score 1 greater.",G0000000|C0004927|C0557651|C0030705|C1299392|C0205177|G0000000|C1527178|C0007637|C0243161|G0000000|C0029921|G0000000|C0001779|C0040223|C1522154|C1511481|G0000000|C0030705|C1299392|C0205177|G0000000|C1704788|C0683432|G0000000|C0333275|C0015733|C0449820|G0000000|C1704243
Aim—To evaluate the effects of low dose fentanyl infusion analgesia on behavioural and neuroendocrine stress response and short term outcome in premature infants ventilated for hyaline membrane disease.,Aim—To evaluate effects low dose fentanyl infusion analgesia behavioural neuroendocrine stress response short term outcome premature infants ventilated hyaline membrane disease.,G0000000|C0220825|C1280500|C0205251|C0178602|C0015846|C0574032|C0002766|C0004927|C0027912|C0038435|C0871261|C1282927|C0233324|C1274040|C0151526|C0021270|C0231923|C0020191|C0025255|C0012634
"We hypothesize that the in-home HB intervention relative to usual nutrition education will be associated with: • An increase in maternal responsiveness • An increase in healthy maternal feeding style • An increase in healthy age-appropriate infant feeding practices • Healthy, age-appropriate infant growth patterns of weight and length • Mothers' satisfaction with the HB intervention • Feasibility in a community-based setting in the United States The design of this study is a randomized, experimental, short-term, longitudinal controlled trial (RCT) with a convenience sample of economically and educationally disadvantaged mothers of infants living in Colorado and Michigan.","We hypothesize in-home HB intervention relative usual nutrition education with: • An increase maternal responsiveness • An increase healthy maternal feeding style • An increase healthy age-appropriate infant feeding practices • Healthy, age-appropriate infant growth patterns weight length • Mothers' satisfaction HB intervention • Feasibility community-based setting United States The design study randomized, experimental, short-term, longitudinal controlled trial (RCT) convenience sample economically educationally disadvantaged mothers infants living Colorado Michigan.",G0000000|G0000000|C0150312|C0019046|C0886296|C0080103|C3538928|C0028707|C0013621|G0000000|G0000000|G0000000|C0442805|C2347083|C0205342|G0000000|G0000000|C0442805|C3898900|C2347083|C0204695|C0489654|G0000000|G0000000|C0442805|C3898900|C0001779|C0021270|C0204695|C0237607|G0000000|C3898900|C0001779|C0021270|C0018270|C0449774|C0005910|C1444754|G0000000|C0026591|C0242428|C0019046|C0886296|G0000000|G0000000|C0009462|C0542559|C0166872|C1301808|G0000000|C1707689|C0557651|C0034656|C1517586|C0443303|C0205127|C2587213|C0008976|G0000000|C3831015|C0370003|C0013556|G0000000|C0012613|C0026591|C0021270|C0376558|C0009399|C0025939
"Total protein intake was further broken down to sources including formula, meat, dairy, and vegetable proteins.","Total protein intake broken sources including formula, meat, dairy, vegetable proteins.",C0439175|C0033684|C1512806|C1881704|C0449416|C0332257|C0489829|C0025017|C3687582|C0042440|C0033684
The impact of the policy on non-SSB options were highly variable across venues with almost no substitution observed for Concord and ICE Sheffield (comprising lower socioeconomic status and younger attendees respectively) but much higher in Ponds Forge in the city centre and Hillsborough suggesting that the response to the policy and impact on revenues are likely to be highly dependent on the population demographics (see Tables I-P in S1 File).,The impact policy non-SSB options highly variable venues substitution observed Concord ICE Sheffield (comprising lower socioeconomic status attendees respectively) Ponds Forge city centre Hillsborough suggesting response policy impact revenues highly dependent population demographics (see Tables I-P S1 File).,G0000000|C1825598|C0242456|C1518422|C1518601|C0205250|C0439828|G0000000|C1555721|C1441672|C0680240|C0020746|G0000000|C2700400|C0441994|C0748878|C0449438|G0000000|G0000000|C0337048|G0000000|C0008848|C0205099|G0000000|C1705535|C0871261|C0242456|C1825598|C0681042|C0205250|C0851827|C0032659|C0011298|C0042789|C0039224|C0021966|C1519428|C0016094
"Individuals manifesting any of the following were excluded from the study: pain from traumatic injury or structural or regional rheumatic disease, rheumatoid arthritis, inflammatory arthritis, autoimmune disease, unstable medical or psychiatric illness, active suicidal ideation, a history of psychosis, current psychoactive substance dependence, or a medication regimen that had not been stable for at least 2 months prior to baseline.","Individuals manifesting excluded study: pain traumatic injury structural regional rheumatic disease, rheumatoid arthritis, inflammatory arthritis, autoimmune disease, unstable medical psychiatric illness, active suicidal ideation, history psychosis, current psychoactive substance dependence, medication regimen stable 2 months prior baseline.",C0027361|C0205319|C1554077|C0557651|C0030193|C0332663|C3263722|C0678594|C0205147|G0000000|C0012634|G0000000|C0003864|C0333348|C0003864|C0443146|C0012634|C0443343|C0199168|C0205487|C0221423|C0205177|C0438696|C0392348|C0019664|C0033975|C0521116|G0000000|C0439861|C0011546|C0013227|C0040808|C0205360|G0000000|C0439231|C0332152|C0168634
"); contraindication to participation in a regular physical activity program; metastatic or recurrent disease; unable to ambulate; engaged in ≥ 60 weekly minutes of vigorous physical activity or ≥ 150 weekly minutes of moderate plus vigorous activity during the past month (based on self-report); anticipated undergoing elective surgery during the intervention which would interfere with participation (e.g., breast reconstructive surgery); did not live or work within 50 miles of the study site.","); contraindication participation regular physical activity program; metastatic recurrent disease; unable ambulate; engaged ≥ 60 weekly minutes vigorous physical activity ≥ 150 weekly minutes moderate vigorous activity month (based self-report); anticipated undergoing elective surgery intervention interfere participation (e.g., breast reconstructive surgery); live 50 miles study site.",G0000000|C0522473|C0679823|C0205272|C0031809|C0205177|C1709697|C0036525|C2945760|C0012634|C1299582|C4036205|C0425152|G0000000|C0450371|C0332174|C0439232|G0000000|C0031809|C0205177|G0000000|C1442061|C0332174|C0439232|C0205081|G0000000|C0205177|C0332177|C1527178|C0681906|C3840775|G0000000|C0206058|C0038894|C0886296|C0521102|C0679823|G0000000|C0006141|C0020912|C0038894|C1548795|C0450371|C0331865|C0557651|C0205145
Patients 18–72 years of age with suspected or newly diagnosed untreated malignant gliomas and eligible for surgery were randomized to either the ALA or the white light (WL) control group.,Patients 18–72 age suspected newly diagnosed untreated malignant gliomas eligible surgery randomized ALA white light (WL) control group.,C0030705|G0000000|C0001779|C0332147|C0750546|C0011900|C0332155|C0205282|C0017638|C1548635|C0038894|C0034656|C0523459|C0007457|C0023693|G0000000|C0243148|C0441833
The optimal duration of firstline chemotherapy in advanced esophagogastric cancer is unknown.,The optimal duration firstline chemotherapy advanced esophagogastric cancer unknown.,G0000000|C2698651|C0449238|G0000000|C0013216|C0205179|C0475468|C0006826|C0439673
Our hypothesis was that differential trauma exposures for war‐affected youth in refugee and host communities would have discernable impacts on programme responsiveness.,Our hypothesis differential trauma exposures war‐affected youth refugee host communities discernable impacts programme responsiveness.,G0000000|C1512571|C0443199|C0043251|C0274281|G0000000|C0001578|C0034961|C1167395|C0009462|C0205396|C1825598|C1709697|C0205342
"The basic eligibility requirements were a negative test for HIV infection, gestational age between 12 and 27 weeks according to the date of the last menstrual period, 18 years of age or older and an intention to deliver and stay in Dar es Salaam for at least 1 year after delivery.","The basic eligibility requirements negative test HIV infection, gestational age 12 27 weeks menstrual period, 18 years age intention deliver stay Dar es Salaam 1 year delivery.",G0000000|C1527178|C0013893|C1514873|C0205160|C0022885|C0019682|C0009450|C0439671|C0001779|C0450371|G0000000|C0025344|C0439531|G0000000|C0001779|C0162425|C0308779|G0000000|C0022595|C0013754|G0000000|G0000000|C0011209
The safety profile of dacarbazine is well established in the treatment of metastatic melanoma.,The safety profile dacarbazine established treatment metastatic melanoma.,G0000000|C0036043|C1979963|C0010927|C0443211|C0039798|C0036525|C0025202
Subjects received DRCFI or placebo in three treatment cycles of 28 days on/28 days off.,Subjects received DRCFI placebo treatment cycles 28 days on/28 days off.,C0681850|C1514756|G0000000|C0032042|C0039798|C1511572|G0000000|G0000000|G0000000
"In all, 3037 women were recruited to the study, and 2928 were randomised.","In all, 3037 women recruited study, 2928 randomised.",G0000000|G0000000|G0000000|C0043210|G0000000|C0557651|G0000000|G0000000
A total of 71 patients who initially received chemotherapy for ROC followed by DC-based immunotherapy were included in our study.,A total 71 patients initially received chemotherapy ROC DC-based immunotherapy included study.,G0000000|C0439175|C0450371|C0030705|C0205265|C1514756|C0013216|C0683187|C1527178|C0021083|C0332257|C0557651
"Patients with any of the following conditions were excluded from the study: severe hypertension, type 1 diabetes mellitus, familial hypercholesterolemia, fasting TG ≥ 400 mg / dL, myocardial infarction or cerebrovascular disorder within 3 months prior to the start of the study, serious cardiac insufficiency (NYHA grade III or IV), revascularization scheduled during the study period, active hepatic disease (ALT or AST > 100 IU / L, or total bilirubin > 2.5 mg / dL), renal dysfunction (serum creatinine ≥ 2.0 mg / dL or creatinine clearance < 30 ml / min / 1.73 m2), serum CK > 1000 IU / L, pregnancy or possibly pregnancy, hypothyroidism, hereditary muscular disease (e.g., muscular dystrophy) or family history of the disease, past history of drug-induced muscular disorder, drug abuse, and alcohol addiction.","Patients conditions excluded study: severe hypertension, type 1 diabetes mellitus, familial hypercholesterolemia, fasting TG ≥ 400 / dL, myocardial infarction cerebrovascular disorder 3 months prior start study, cardiac insufficiency (NYHA grade III IV), revascularization scheduled study period, active hepatic disease (ALT AST > 100 IU / L, total bilirubin > 2.5 / dL), renal dysfunction (serum creatinine ≥ 2.0 / dL creatinine clearance < 30 / min / 1.73 m2), serum CK > 1000 IU / L, pregnancy pregnancy, hypothyroidism, hereditary muscular disease (e.g., muscular dystrophy) family history disease, history drug-induced muscular disorder, drug abuse, alcohol addiction.",C0030705|C0012634|C1554077|C0557651|C0205082|C0020538|C0332307|G0000000|C0011847|G0000000|C0015576|C0020443|C0015663|C0337445|G0000000|C1442061|G0000000|C3642216|C0027061|C0021308|C1880018|C0012634|G0000000|C0439231|C0332152|C0439659|C0557651|C0018787|C0231179|G0000000|C0441800|C0439070|C0022326|C0581603|C0086960|C0557651|C0439531|C0205177|C0205054|C0012634|C1266129|C3891303|G0000000|C1442061|C0049272|G0000000|C0439394|C0439175|C0005437|G0000000|G0000000|G0000000|C3642216|C0022646|C0031847|C0229671|C0010294|G0000000|G0000000|G0000000|C3642216|C0010294|C0449297|G0000000|C0450371|G0000000|C0702093|G0000000|C0450371|C0025885|C0229671|C0009212|G0000000|G0000000|C0049272|G0000000|C0439394|C0032961|C0032961|C0020676|C0439660|C0026845|C0012634|G0000000|C0026845|C0333606|C0015576|C0019664|C0012634|C0019664|C0458082|C0026845|C0012634|C0013227|C0013146|C0001962|C0085281
"Data were collected from 10 right-handed sub-acute patients (3–9 months since stroke) who were participating in an ongoing national clinical trial examining the effects of CIT on UE motor performance and quality of life.8 Study design, including detailed inclusion and exclusion criteria, has been reported previously.8 Briefly, all patients had only 1 stroke, at least 20 degrees active wrist extension, 10 degrees active finger extension, minimum passive range of motion of 90 degrees for shoulder flexion and abduction, score of at least 24 on the Mini Mental State Exam, and they were not receiving any other therapy at the time of the study (for more details, see previous publication8).","Data collected 10 right-handed sub-acute patients (3–9 months stroke) participating ongoing national clinical trial examining effects CIT UE motor performance quality life.8 Study design, including detailed inclusion exclusion criteria, reported previously.8 Briefly, patients 1 stroke, 20 degrees active wrist extension, 10 degrees active finger extension, minimum passive range motion 90 degrees shoulder flexion abduction, score 24 Mini Mental State Exam, receiving therapy time study (for details, previous publication8).",C1511726|C1516695|C0450371|C0230370|C0542339|C0030705|G0000000|C0439231|C0038454|C0679823|C0549178|C3245503|C0205210|C0008976|C0332128|C1280500|C0523573|G0000000|C1513492|C0597198|C0332306|C0376558|C0557651|C1707689|C0332257|C1522508|C0007637|C0680251|C0243161|C0684224|G0000000|G0000000|C0030705|G0000000|C0038454|C0450371|C0449286|C0205177|C0043262|C0231448|C0450371|C0449286|C0205177|C0016129|C0231448|C1524031|C3686820|C1514721|C0026597|C0450371|C0449286|C0037004|C0231452|C0086505|C0449820|C0450371|C0445542|C0229992|C1301808|C0582103|C1514756|C0039798|C0040223|C0557651|G0000000|C1522508|C0205156|G0000000
"Methods: This randomised, double blind (DB), placebo controlled, flexible dose study with an open label extension (OLE) assessed efficacy, QoL, and safety of sildenafil citrate in men with MS and ED.","Methods: This randomised, double blind (DB), placebo controlled, flexible dose study label extension (OLE) assessed efficacy, QoL, safety sildenafil citrate MS ED.",C0025663|G0000000|G0000000|C0205173|C0150108|C1418892|C0032042|C2587213|C0443220|C0178602|C0557651|C0181496|C0231448|G0000000|C1516048|C1280519|C0518214|C0036043|C0529793|C0008857|C0039676|C3538926
A CA-125 progression without any evidence of RECIST or symptomatic progression was observed in 28% of patients (Table 1).,A CA-125 progression evidence RECIST symptomatic progression observed 28% patients (Table 1).,G0000000|C3887642|C0242656|C3887511|C1709926|C0231220|C0242656|C1441672|C0450371|C0030705|C0039224|G0000000
"The children used an ambulatory cough meter, kept cough diaries, and performed the capsaicin cough sensitivity, hypertonic saline bronchoprovocation, and skin prick tests.","The children ambulatory cough meter, cough diaries, performed capsaicin cough sensitivity, hypertonic saline bronchoprovocation, skin prick tests.",G0000000|C0008059|C0439841|C0010200|C0475209|C0010200|C0376660|C0884358|C0006931|C0010200|C0020517|G0000000|C0036082|G0000000|C0444099|C0033119|C0022885
"Through multi-stage random sampling, subjects who had delivered a baby were randomly selected; in the intervention group, women who consumed fortified flour for less than 12 months were excluded (x = 46).","Through multi-stage random sampling, subjects delivered baby randomly selected; intervention group, women consumed fortified flour 12 months excluded (x = 46).",G0000000|C0439064|C0034656|C0441621|C0681850|C1705822|C0021270|G0000000|C1707391|C0886296|C0441833|C0043210|G0000000|G0000000|C0016260|C0450371|C0439231|C1554077|G0000000|G0000000|C0450371
Participants needed to be opioid naive (not formerly treated with long term opioids) adults with dyspnoea at rest in spite of receiving optimal treatment of reversible factors.,Participants opioid naive (not treated term opioids) adults dyspnoea rest spite receiving optimal treatment reversible factors.,C0679646|C0242402|G0000000|C1518422|C1522326|C0233324|C0242402|C0001675|C0013404|C0035253|G0000000|C1514756|C2698651|C0039798|C0205343|C1521761
"Despite clear need, brief web-based interventions for marijuana using college students have not been evaluated in the literature.","Despite need, web-based interventions marijuana college students evaluated literature.",G0000000|C0027552|C0282111|C0886296|C0024808|C0557806|C0038492|C0220825|C0023866
"The children were followed up once a week for six months, and morbidity information was collected.","The children week months, morbidity collected.",G0000000|C0008059|C0332174|C0439231|C0026538|C1516695
"After delivery, mother–infant pairs underwent randomization if they met secondary eligibility criteria: a birth weight of a least 2000 g, no infant or maternal condition that would preclude the use of a study drug, the mother’s acceptance of a 7-day maternal and infant perinatal antiretroviral regimen, and enrollment within 36 hours after delivery.","After delivery, mother–infant pairs underwent randomization met secondary eligibility criteria: birth weight 2000 g, infant maternal condition preclude study drug, mother’s acceptance 7-day maternal infant perinatal antiretroviral regimen, enrollment 36 hours delivery.",G0000000|C0011209|G0000000|C1709450|G0000000|C0034656|C0268621|C0027627|C0013893|C0243161|C0005615|C0005910|G0000000|C0439267|C0021270|C2347083|C0012634|G0000000|C0557651|C0013227|G0000000|G0000000|C0332173|C2347083|C0021270|C0178795|G0000000|C0040808|C1516879|C0450371|C0439227|C0011209
METHODS: A prospective randomised control study of an asthma home management training programme was performed in children aged two years or over admitted with acute asthma.,METHODS: A prospective randomised control study asthma management training programme performed children aged admitted acute asthma.,C0025663|G0000000|C0023981|G0000000|C0243148|C0557651|C0004096|C0001554|C0040607|C1709697|C0884358|C0008059|C0001779|C0184666|C0205178|C0004096
those from 6/50 EAs) of 18–22 year olds living in trial communities as originally defined were eligible for inclusion in the final survey.,6/50 EAs) 18–22 olds living trial communities originally defined eligible inclusion final survey.,C0450371|G0000000|G0000000|C0580836|C0376558|C0008976|C0009462|G0000000|C1704788|C1548635|C0007637|C0205088|C0038951
"A total of 3,274 uncircumcised men, aged 18–24 y, were randomized to a control or an intervention group with follow-up visits at months 3, 12, and 21.","A total 3,274 uncircumcised men, aged 18–24 y, randomized control intervention follow-up visits months 3, 12, 21.",G0000000|C0439175|C1442061|C0282021|C0025266|C0001779|G0000000|G0000000|C0034656|C0243148|C0886296|C0589120|C0545082|C0439231|G0000000|C0450371|C0450371
All 29 (100%) potential participants were confirmed as being eligible and were subsequently randomised.,All 29 (100%) potential participants confirmed eligible subsequently randomised.,G0000000|C0450371|C1442061|C3245505|C0679646|C0521093|C1548635|G0000000|G0000000
CONCLUSION: Imipramine may be effective in the treatment of IBS patients and is associated with improved QoL.,CONCLUSION: Imipramine effective treatment IBS patients improved QoL.,C1707478|C0020934|C1280519|C0039798|C0022104|C0030705|C0184511|C0518214
"At screening, they were required to have a post-bronchodilator forced expiratory volume in 1 s (FEV1) ≥30% and <80% predicted normal and post-bronchodilator FEV1/forced vital capacity (FVC) ratio <0.70.","At screening, required post-bronchodilator forced expiratory volume 1 (FEV1) ≥30% <80% predicted normal post-bronchodilator FEV1/forced vital capacity (FVC) ratio <0.70.",G0000000|C0220908|C1514873|C2599594|C0441722|C0231800|C0449468|G0000000|G0000000|G0000000|C0450371|C0681842|C0205307|C2599594|C0441722|C0442732|C1516240|C3714541|C0456603|C0450371
"Significant differences existed in the Standardized Swallowing Assessment, Dysphagia Outcome Severity Scale, Modified Barthel Index, and Swallowing-Related Quality of Life scores of each group after the treatment (P < 0.01).","Significant differences existed Standardized Swallowing Assessment, Dysphagia Outcome Severity Scale, Modified Barthel Index, Swallowing-Related Quality Life scores treatment (P < 0.01).",C0237881|C1705241|C2987476|G0000000|C0011167|C1261322|C0011168|C1274040|C0439793|C0175659|C0392747|G0000000|C0918012|C0011167|C0332306|C0376558|C0449820|C0039798|C0369773|G0000000|C0450371
"Patients were excluded if they had an insufficient diagnostic workup, received AC treatment within the last three months, were receiving concomitant medication with effects on the gut, such as 5‐HT3 antagonists or spasmolytics, or were pregnant.","Patients excluded insufficient diagnostic workup, received AC treatment months, receiving concomitant medication effects gut, 5‐HT3 antagonists spasmolytics, pregnant.",C0030705|C1554077|C0205412|C0011900|C0750430|C1514756|C0003354|C0039798|C0439231|C1514756|C0521115|C0013227|C1280500|C0017189|G0000000|C0243076|C0037766|C0549206
"Participants were stratified according to PSA level (< 4 ng/mL v 4 to 10 ng/mL), Gleason score (2 to 4 v 5 to 6), and radiation modality (three-dimensional conformal RT [3D-CRT] v intensity-modulated RT [IMRT]).","Participants stratified PSA level (< 4 ng/mL 4 10 ng/mL), Gleason score (2 4 5 6), radiation modality (three-dimensional conformal RT [3D-CRT] intensity-modulated RT [IMRT]).",C0679646|C0205363|C3810537|C0441889|G0000000|G0000000|C0439275|G0000000|C0450371|C0439275|G0000000|C0449820|G0000000|G0000000|G0000000|G0000000|C0034519|C0695347|C0450363|C0026377|C0230425|C0043316|C0522510|C0230425|C1512814
All adult residents (defined for this purpose as those ≥18 y of age) of part of section B were eligible for inclusion; there were no exclusion criteria.,All adult residents (defined purpose ≥18 age) B eligible inclusion; exclusion criteria.,G0000000|C0001675|C1320928|C1704788|C1285529|G0000000|C0001779|G0000000|C1548635|C0007637|C0680251|C0243161
"Out of 660 eligible children contacted, we received consent for 633 children (316 in intervention, 317 in control) to participate in the study (figure)(figure) and collected data on 190 324 child days of follow-up.","Out 660 eligible children contacted, received consent 633 children (316 intervention, 317 control) participate study (figure)(figure) collected data 190 324 child days follow-up.",C0439787|C1442061|C1548635|C0008059|C0332158|C1514756|C1511481|C1442061|C0008059|C1442061|C0886296|C1442061|C0243148|G0000000|C0557651|G0000000|C1516695|C1511726|G0000000|C0008059|C0439228|C0589120
There is extensive research evidence available of pharmacological pain relief during labour; however this evidence is not readily available to pregnant women.,There extensive evidence pharmacological pain relief labour; evidence pregnant women.,G0000000|C0205231|C3887511|C0031330|C0030193|C0564405|C0022864|C3887511|C0549206|C0043210
"In the intervention group, Benson relaxation technique was performed (respondents in the Cibabat hospital); whereas, those who were not given the intervention Benson relaxation considered as control group (respondents in the Sartika Asih hospital).","In intervention group, Benson relaxation technique performed (respondents Cibabat hospital); whereas, intervention Benson relaxation considered control (respondents Sartika Asih hospital).",G0000000|C0886296|C0441833|G0000000|C0035028|C0449851|C0884358|C0282122|G0000000|C0019994|G0000000|C0886296|G0000000|C0035028|C0750591|C0243148|C0282122|G0000000|G0000000|C0019994
However there was an effect of treatment over time for both the overweight and normal weight groups.,However treatment time overweight normal weight groups.,G0000000|C0039798|C0040223|C0497406|C0205307|C0005910|C0441833
Patients will be eligible for the trial if they have been admitted to a participating ward and are aged 65 years or over.,Patients eligible trial admitted participating ward aged 65 over.,C0030705|C1548635|C0008976|C0184666|C0679823|C1305702|C0001779|C0450371|C0205136
"The third dose intervention was implemented in the highest AR schools in the most affected age group (students aged 9–14 years), but occurred after the outbreak peaked (Figure 3a); 186 (37%) of the 505 outbreak cases occurred after the intervention.","The dose intervention implemented AR schools age (students aged 9–14 years), occurred outbreak peaked (Figure 3a); 186 (37%) 505 outbreak occurred intervention.",G0000000|C0178602|C0886296|G0000000|C2986463|C0036375|C0001779|C0038492|C0001779|G0000000|C0439234|C1709305|C0012652|C0444505|G0000000|C1420849|C1442061|C0450371|C1442061|C0012652|C1709305|C0886296
"Furthermore, positive effects upon pulmonary exacerbation outcomes were seen for the first time in a double-blind RCT of inhaled antibiotics in this patient group, although this was statistically significant only per protocol and may have been influenced by baseline age imbalance in this modest-sized phase II study.","Furthermore, positive effects pulmonary exacerbation outcomes time double-blind RCT inhaled antibiotics patient group, statistically protocol influenced baseline age imbalance modest-sized phase II study.",G0000000|C0439178|C1280500|C0024109|G0000000|C1274040|C0040223|C0013072|G0000000|C0004048|C0003232|C0030705|C0441833|C0038215|C0442711|G0000000|C0168634|C0001779|C1397014|C4054480|C0205390|G0000000|C0557651
"The study was carried out from July 2009 to June 2010 at the Kyung Hee University Hospital at Gangdong, Korea.","The study carried July 2009 June 2010 Kyung Hee University Hospital Gangdong, Korea.",G0000000|C0557651|C0206243|C3829447|G0000000|C3829443|G0000000|G0000000|G0000000|C0041740|C0019994|G0000000|C0022771
Study inclusion criteria were: self-report smoking (even a puff in the past 7 days) at a prenatal visit; self-report an estimated gestational age of ≤20 weeks; reside within the county in which the study clinic is located; plan to remain in the geographical area for 6 months following delivery; and speaks English.,Study inclusion criteria were: self-report smoking (even puff 7 days) prenatal visit; self-report estimated gestational age ≤20 weeks; reside county study clinic located; plan remain geographical 6 months delivery; speaks English.,C0557651|C0007637|C0243161|G0000000|C0681906|C0037369|G0000000|C1533107|G0000000|C0439228|C0678804|C0545082|C0681906|C0750572|C0439671|C0001779|G0000000|C0439230|C2982691|C0079170|C0557651|C0002424|G0000000|C0270724|G0000000|C0017447|G0000000|C0439231|C0011209|C0234856|C0376245
To evaluate the effectiveness of quetiapine and haloperidol in patients of delirium referred to psychiatry consultation liaison services.,To evaluate effectiveness quetiapine haloperidol patients delirium referred psychiatry consultation liaison services.,C0040363|C0220825|C1280519|C0123091|C0018546|C0030705|C0011206|C0205543|C0033873|C0009818|C0683597|C0557854
"Women were recruited if they were aged over 18 years, were having a singleton pregnancy, were of a gestation less than 17 weeks based on last menstrual period and had 25(OH)D between 25 and 100nmol/l and serum calcium<2.75mmol/l.","Women recruited aged 18 years, singleton pregnancy, gestation 17 weeks based menstrual period 25(OH)D 25 100nmol/l serum calcium<2.75mmol/l.",C0043210|G0000000|C0001779|C0450371|C0439234|C0481462|C0032961|C0032961|C0450371|C0439230|C1527178|C0025344|C0439531|C0450371|C0450371|C0439394|C0229671|C0006675
Children were eligible if they had a history of cough or difficulty breathing within 5 days prior to treatment and clinical signs of LAO (defined as an expiratory wheeze on auscultation or hyperinflation of the chest).,Children eligible history cough difficulty breathing 5 days prior treatment clinical signs LAO (defined expiratory wheeze auscultation hyperinflation chest).,C0008059|C1548635|C0019664|C0010200|C1299586|C0004048|G0000000|C0332152|C0039798|C0205210|C0220912|C0023034|C1704788|C0231800|C0043144|C0004339|C0020449|C0817096
"The breakdown of number of infants for each health center (included in the final analysis) was as follows: Center 1: 63 (31 M, 32 F); Center 2: 49 (18 M, 31 F); Center 3: 57 (31 M, 26 F); and Center 4: 53 (28 M, 25 F).","The breakdown infants health center (included final analysis) follows: Center 1: 63 (31 M, 32 F); Center 2: 49 (18 M, 31 F); Center 3: 57 (31 M, 26 F); Center 4: 53 (28 M, 25 F).",G0000000|C0443161|C0021270|C0018684|C0205099|C0332257|C0205088|C0002778|C0332283|C0205099|G0000000|C0450371|C0450371|C0369637|C0450371|C0016327|C0205099|G0000000|C0450371|C0450371|C0369637|C0450371|C0016327|C0205099|G0000000|C0450371|C0450371|C0369637|C0450371|C0016327|C0205099|G0000000|C0450371|C0450371|C0369637|C0450371|C0016327
For the main trial approximately 1700 young women (median age 16 years) were enrolled prior to their first pregnancy between April and August 2011 in 24 study villages [24].,For main trial 1700 women (median age 16 years) enrolled prior pregnancy April August 2011 24 study villages [24].,G0000000|C0205225|C0008976|G0000000|C0043210|C0549183|C0001779|C0450371|C0439234|G0000000|C0332152|C0032961|C3715024|C3831448|G0000000|C0450371|C0557651|C0562518|C0450371
"A baseline household census estimated that the area comprised ∼119,000 households in 197 villages with a total of 600,000 inhabitants who are predominantly dependent on rain-fed agriculture.","A baseline household census estimated comprised ∼119,000 households 197 villages total 600,000 inhabitants dependent rain-fed agriculture.",G0000000|C0168634|C0020052|C0007663|C0750572|C2700400|G0000000|C0020052|C1442061|C0562518|C0439175|C1442061|G0000000|C0851827|C0034640|C0001829
"Patients with severe brain injury, intubated patients, those with open fractures or ipsilateral limb fracture and those with injury precluding operative fixation within 7 days of admission were excluded from the study.","Patients severe brain injury, intubated patients, fractures ipsilateral limb fracture injury precluding operative fixation 7 days admission excluded study.",C0030705|C0205082|C0006104|C3263722|G0000000|C0030705|C0016658|C0441989|C0015385|C0016658|C3263722|G0000000|C1882154|C0185023|G0000000|C0439228|C0184666|C1554077|C0557651
"We defined insulin resistance with the HOMA of insulin resistance (HOMA-IR) score (calculated as [fasting insulin, μU/mL × fasting glucose, mmol/L]/22.5) (8).","We defined insulin resistance HOMA insulin resistance (HOMA-IR) score (calculated [fasting insulin, μU/mL × fasting glucose, mmol/L]/22.5) (8).",G0000000|C1704788|C0021641|C0237834|G0000000|C0021641|C0237834|C0022065|C0449820|C0444686|C0015663|C0021641|G0000000|G0000000|C0015663|C0017725|C1532563|G0000000
"Participants will be excluded if they have a Mini-Mental State Examination score of < 24, or suffer from unstable cardiovascular disease, or suffer from other uncontrolled chronic conditions that would interfere with the safety and conduct of the training and testing protocol or interpretation of the results.","Participants excluded Mini-Mental State Examination score < 24, suffer unstable cardiovascular disease, suffer uncontrolled chronic conditions interfere safety conduct training testing protocol interpretation results.",C0679646|C1554077|C0445542|C1301808|G0000000|C0449820|G0000000|C0450371|C0683278|C0443343|C0007226|C0012634|C0683278|C0205318|C0205191|C0012634|C0521102|C0036043|C0004927|C0040607|C0039593|C0442711|C0459471|C1274040
"Inclusion criteria were patients aged 25–80 years, scheduled for elective cataract surgery with intraocular lens implantation using phacoemulsification under topical anesthesia for the first time according to the American Society of Anesthesiologists (ASA) physical status classification[15] I–III (the ASA classification method is a system to assess the risk associated with anesthesia in patients undergoing surgery and is divided into six categories).","Inclusion criteria patients aged 25–80 years, scheduled elective cataract surgery intraocular lens implantation phacoemulsification topical anesthesia time American Society Anesthesiologists (ASA) physical status classification[15] I–III (the ASA classification method system assess risk anesthesia patients undergoing surgery divided categories).",C0007637|C0243161|C0030705|C0001779|G0000000|C0439234|C0086960|C0206058|C0086543|C0038894|C3282905|C0023317|C0021107|C0282545|C0332237|C0002903|C0040223|C0596070|C0037455|C0334910|C0004057|C0031809|C0449438|C0008902|G0000000|G0000000|C0004057|C0008902|C0025663|C0449913|C1516048|C0035647|C0002903|C0030705|G0000000|C0038894|C0332849|C0683312
The maximum decrease of MMSE score was also negligible.,The maximum decrease MMSE score negligible.,G0000000|C0806909|C0392756|C0451306|C0449820|C0332269
"The study included adult patients with type 2 diabetes and high-average or high peritoneal transport, prevalent on PD, with no previous exposure to icodextrin (30 in the ICO group: 18 women, 58.9 ± 7.9 years of age; 29 in the GLU group: 13 women, 60.5 ± 9.3 years of age).","The study included adult patients type 2 diabetes high-average peritoneal transport, prevalent PD, previous exposure icodextrin (30 ICO group: 18 women, 58.9 ± 7.9 age; 29 GLU group: 13 women, 60.5 ± 9.3 age).",G0000000|C0557651|C0332257|C0001675|C0030705|C0332307|G0000000|C0011847|C0205250|C0031153|C0005528|C0033105|G0000000|C0205156|C0274281|C0538727|C0450371|G0000000|C0441833|C0450371|C0043210|C0450371|G0000000|G0000000|C0001779|C0450371|C0061472|C0441833|C0450371|C0043210|C0450371|G0000000|G0000000|C0001779
"METHODS—In a randomised controlled trial in 17 Scottish local council areas, with immediate and nine month follow up, 182 children and their foster families were randomly allocated to either standard services alone or standard services plus extra training for foster carers on communication and attachment.","METHODS—In randomised controlled trial 17 Scottish local council areas, month follow up, 182 children foster families randomly allocated standard services standard services extra training foster carers communication attachment.",G0000000|G0000000|C2587213|C0008976|C0450371|C0240966|C0205276|C1551807|C0205146|C0332177|C0332283|G0000000|C1442061|C0008059|C0242298|C0015576|G0000000|G0000000|C1442989|C0557854|C1442989|C0557854|G0000000|C0040607|C0242298|C0085537|C0009452|C0185023
Neuromuscular electrical stimulation (NMES) may serve as a treatment alternative to traditional pulmonary rehabilitation.,Neuromuscular electrical stimulation (NMES) serve treatment alternative traditional pulmonary rehabilitation.,C1979768|C0013790|C1292856|C2985393|G0000000|C0039798|C1523987|C0443324|C0024109|C0034991
"Eligible patients had high-risk neuroblastoma, defined strictly by the COG2 and confirmed by means of review of clinical, pathological, and biologic features by the COG Neuroblastoma Biology Study Committee and local institutions, before study enrollment.","Eligible patients high-risk neuroblastoma, defined strictly COG2 confirmed review clinical, pathological, biologic features COG Neuroblastoma Biology Study Committee local institutions, study enrollment.",C1548635|C0030705|C0332167|C0027819|C1704788|G0000000|G0000000|C0521093|C0282443|C0205210|C0030664|C0005515|C1521970|G0000000|C0027819|C0005532|C0557651|C2699414|C0205276|C1272753|C0557651|C1516879
"0–24 h wmFEV1 and trough FEV1 by GOLD subgroup (ITT population) Descriptive analyses of change from baseline in 0–24 h wmFEV1 on Day 84 and in trough FEV1 on Day 85 by GOLD subgroup FEV 1 forced expiratory volume in 1 s, FP/SAL fluticasone propionate/salmeterol, GOLD Global Initiative for Chronic Obstructive Lung Disease™, ITT intent-to-treat, SD standard deviation, UMEC umeclidinium, VI vilanterol, wm weighted mean aFEV1 ≥ 50 % to <80 % predicted; bAll but three patients fulfilled the exclusion criterion regarding no exacerbations in the past year—no further details of exacerbation history were collected; cFEV1 ≥ 30 % to <50 % predicted For peak FEV1 over 0–6 h post-dose, statistically significantly greater improvements in LS mean change from baseline were seen with UMEC/VI versus FP/SAL on Days 1 (p = 0.003) and 84 (p < 0.001) (Table 2).","0–24 wmFEV1 trough FEV1 GOLD subgroup (ITT population) Descriptive analyses change baseline 0–24 wmFEV1 Day 84 trough FEV1 Day 85 GOLD subgroup FEV 1 forced expiratory volume 1 s, FP/SAL fluticasone propionate/salmeterol, GOLD Global Initiative Chronic Obstructive Lung Disease™, ITT intent-to-treat, SD standard deviation, UMEC umeclidinium, VI vilanterol, wm weighted aFEV1 ≥ 50 % <80 % predicted; bAll patients fulfilled exclusion criterion exacerbations year—no details exacerbation history collected; cFEV1 ≥ 30 % <50 % predicted For peak FEV1 0–6 post-dose, statistically improvements LS change baseline UMEC/VI versus FP/SAL Days 1 (p = 0.003) 84 (p < 0.001) (Table 2).",G0000000|G0000000|C0444506|G0000000|C0018026|C1079230|G0000000|C0032659|C0678257|C0002778|C0392747|C0168634|G0000000|G0000000|C0332173|C0450371|C0444506|G0000000|C0332173|C0450371|C0018026|C1079230|C3714541|G0000000|C0441722|C0231800|C0449468|G0000000|C0565930|C0016704|C0082607|C0033474|C0018026|C0205246|C0424093|C0205191|C0549186|C0024109|G0000000|G0000000|C0162425|C2699239|C1442989|C0012727|G0000000|C3661274|C0205999|C2935023|G0000000|C0005910|G0000000|G0000000|C0450371|G0000000|C0681842|C1706910|C0030705|C1550543|C0680251|C0243161|G0000000|G0000000|C1522508|G0000000|C0019664|C1516695|G0000000|G0000000|C0450371|G0000000|C0681842|G0000000|C0444505|G0000000|G0000000|C0439568|C0038215|C2986411|C0023668|C0392747|C0168634|C0205999|G0000000|C0016704|C0439228|G0000000|G0000000|C0450371|G0000000|C0039224|G0000000
"For example, 23% to 39% of households in the selected tracts experienced poverty compared with national rates of 15%.38 Communities were located in the southeastern region of the United States, with 1 or 2 census tracts targeted in each community, 5 targeted for the study, and approximately 45 to 90 miles separating each community.","For example, 23% 39% households selected tracts experienced poverty compared national rates 15%.38 Communities located southeastern region United States, 1 2 census tracts targeted community, 5 targeted study, 45 90 miles separating community.",G0000000|C1707959|C0450371|C0450371|C0020052|C1707391|C1185740|C0237607|C0032854|C1707455|C3245503|C0871208|C0450371|C0009462|G0000000|C1711190|C0017446|C0166872|C1301808|G0000000|G0000000|C0007663|C1185740|C1521840|C0009462|G0000000|C1521840|C0557651|C0450371|C0450371|C0331865|C0443299|C0009462
The current study is one of the first to examine a web-based preventive intervention for incoming college students who have recently reported using or trying marijuana.,The current study examine web-based preventive intervention incoming college students reported marijuana.,G0000000|C0521116|C0557651|G0000000|C0282111|C0445202|C0886296|G0000000|C0557806|C0038492|C0684224|C0024808
"Candidates for this study were patients with histologic proof of cancer in the pelvis (without distant metastases) who were scheduled to receive a continuous course of radiation therapy, either as definitive treatment or in an adjuvant setting.","Candidates study patients histologic proof cancer pelvis (without distant metastases) scheduled receive continuous radiation therapy, definitive treatment adjuvant setting.",G0000000|C0557651|C0030705|C0205462|C0556981|C0006826|C0030797|G0000000|C0443203|C0027627|C0086960|C1514756|C0549178|C0034519|C0039798|C0443196|C0039798|C0001551|C0542559
"Exclusion criteria were an inability to fill out study documentation, being previously included in the study, immunocompromised status (HIV patients, immunosuppressive treatment), and ongoing treatment with oral corticosteroids.","Exclusion criteria inability fill study documentation, included study, immunocompromised status (HIV patients, immunosuppressive treatment), ongoing treatment oral corticosteroids.",C0680251|C0243161|G0000000|C1708059|C0557651|C0175636|C0332257|C0557651|C0085393|C0449438|C0019682|C0030705|C0021081|C0039798|C0549178|C0039798|C0442027|C0001617
"The exclusion criteria will be: acute liver failure, an indication for a peripherally inserted central venous catheter, current use of orally administered (e.g., inhibitors of factor Xa, thrombin and vitamin K-dependent factors) or parenterally administered anticoagulants (e.g., nonfractionated heparin or low-molecular-weight heparin) in full therapeutic dosage, von Willebrand disease and enrollment in another clinical trial with blood transfusion as intervention.","The exclusion criteria be: acute liver failure, indication peripherally inserted central venous catheter, current orally administered (e.g., inhibitors factor Xa, thrombin vitamin K-dependent factors) parenterally administered anticoagulants (e.g., nonfractionated heparin low-molecular-weight heparin) therapeutic dosage, von Willebrand disease enrollment clinical trial blood transfusion intervention.",G0000000|C0680251|C0243161|G0000000|C0205178|C0023884|C0231174|C0392360|G0000000|C0441587|C0205099|C0042449|C0085590|C0521116|C0442027|C1521801|G0000000|C0243077|C1521761|C1420849|C0040018|C0042890|C0597277|C1521761|G0000000|C1521801|C0003280|G0000000|G0000000|C0019134|C0041667|C0019134|C0087111|C0178602|G0000000|G0000000|C0012634|C1516879|C0205210|C0008976|C0005767|C0005841|C0886296
"Exclusion criteria included use of medications affecting glucose or lipid metabolism, frequent (>4 times/wk) use of anti-inflammatory medications, pregnancy or lactation, smoking, high alcohol intake (>14 drinks/wk), and diagnosed CVD, diabetes, or inflammatory disease.","Exclusion criteria included medications glucose lipid metabolism, frequent (>4 times/wk) anti-inflammatory medications, pregnancy lactation, smoking, alcohol intake (>14 drinks/wk), diagnosed CVD, diabetes, inflammatory disease.",C0680251|C0243161|C0332257|C0013227|C0017725|C0023779|C0025519|C0332183|G0000000|C0040223|C0003209|C0013227|C0032961|C0006147|C0037369|C0001962|C1512806|C0450371|C0452428|C0011900|C0007222|C0011847|C0333348|C0012634
"METHOD: Twenty-two GPs in Avon recruited 154 patients, aged 16-60 years, presenting to their GP with a sore throat, and for whom the GP would normally prescribe an antibiotic.","METHOD: Twenty-two GPs Avon recruited 154 patients, aged 16-60 years, GP sore throat, GP prescribe antibiotic.",C0025663|C0724000|C0272302|C0454839|G0000000|C1442061|C0030705|C0001779|C0450371|C0439234|C3811116|C0234233|C0031354|C3811116|G0000000|C0003232
We have shown that there are lasting benefits to an exercise intervention delivered during treatment to breast cancer survivors.,We lasting benefits exercise intervention delivered treatment breast cancer survivors.,G0000000|C1517741|C0814225|C0015259|C0886296|C1705822|C0039798|C0006141|C0006826|C0206194
The GET FIT trial will provide important new knowledge about preventing falls using accessible and implementable exercise interventions for women following chemotherapy for cancer.,The GET FIT trial provide knowledge preventing falls accessible implementable exercise interventions women chemotherapy cancer.,G0000000|G0000000|C0036572|C0008976|C1999230|C0376554|C0309872|C0000921|C0814423|G0000000|C0015259|C0886296|C0043210|C0013216|C0006826
Children aged 12 years and older need to sign informed consent in addition to their parents.,Children aged 12 sign informed consent addition parents.,C0008059|C0001779|C0450371|C0311392|C1522154|C1511481|C0332287|C0030551
"The inclusion criteria were as follows: (1) infarction or hemorrhage as the primary diagnosis; (2) hemiplegia with unilateral lesions; (3) subacute status, meaning that the stroke occurred more than 1 month before the study began but within the previous 6 months; (4) the ability to lift a cup and open a door using the impaired extremity, with a rating of stage >3 on the Brunnstrom scale (to permit upper extremity motion analysis); (5) K-MMSE scores of >24 (to be able to understand and follow instructions during the MP study); and (6) adequate degree of imagination for MP (i.e., patients who score low on the VMIQ are effectively able to use motor imagery for movement of the upper extremity) [17,18].","The inclusion criteria follows: (1) infarction hemorrhage primary diagnosis; (2) hemiplegia unilateral lesions; (3) subacute status, meaning stroke occurred 1 month study previous 6 months; (4) ability lift cup door impaired extremity, rating stage >3 Brunnstrom scale (to permit upper extremity motion analysis); (5) K-MMSE scores >24 (to understand follow instructions MP study); (6) adequate degree imagination MP (i.e., patients score low VMIQ effectively motor imagery movement upper extremity) [17,18].",G0000000|C0007637|C0243161|C0332283|G0000000|C0021308|C0019080|C0205225|C0011900|G0000000|C0018991|C0205092|C0221198|G0000000|C0205365|C0449438|C0876919|C0038454|C1709305|G0000000|C0332177|C0557651|C0205156|G0000000|C0439231|G0000000|C0085732|C0181620|C1533124|C0557698|C0221099|C0015385|C0871208|C0205390|G0000000|G0000000|C0175659|G0000000|C0023636|C1282910|C0015385|C0026597|C0002778|G0000000|C0597277|C0449820|C0450371|G0000000|C0162340|C0332283|C0302828|C0024944|C0557651|G0000000|C0205410|C0441889|C0020913|C0024944|C0683454|C0030705|C0449820|C0205251|G0000000|G0000000|C1513492|C0150627|C0026649|C1282910|C0015385|C0450371
"The inclusion criteria for the mothers included singleton pregnancy, gestational age of 38–42 weeks, age range of 18–40 years old, and elective cesarean section surgery under spinal anesthesia.","The inclusion criteria mothers included singleton pregnancy, gestational age 38–42 weeks, age range 18–40 old, elective cesarean surgery spinal anesthesia.",G0000000|C0007637|C0243161|C0026591|C0332257|C0481462|C0032961|C0439671|C0001779|G0000000|C0439230|C0001779|C1514721|G0000000|C0580836|C0206058|C3841297|C0038894|C0521329|C0002903
Migraine patients with 2–6 attacks per month were recruited.,Migraine patients 2–6 attacks month recruited.,C0149931|C0030705|G0000000|C1261512|C0332177|G0000000
Most patients underwent a laparotomy before the study and had measurable residual or metastatic disease.,Most patients underwent laparotomy study measurable residual metastatic disease.,C0205393|C0030705|G0000000|C0023038|C0557651|C1513040|C1609982|C0036525|C0012634
"The study population will be composed of pregnant women (24 to 36 weeks’ gestation), aged 17 years or more, referred by their family physicians from the 21 primary care centres participating in the study, belonging to the Andalusian Public Health System and located in the provinces of Seville and Málaga, diagnosed with pregnancy-related LBPGP and who have not previously received auricular acupuncture.","The study population composed pregnant women (24 36 weeks’ gestation), aged 17 more, referred family physicians 21 primary care centres participating study, belonging Andalusian Public Health System located provinces Seville Málaga, diagnosed pregnancy-related LBPGP received auricular acupuncture.",G0000000|C0557651|C0032659|G0000000|C0549206|C0043210|C0450371|C0450371|G0000000|C0032961|C0001779|C0450371|C0205172|C0205543|C0015576|C0031831|C0450371|C0205225|C1947933|C0205099|C0679823|C0557651|G0000000|C1553359|G0000000|C0018684|C0449913|G0000000|C1514578|G0000000|G0000000|C0011900|C0747919|G0000000|C1514756|C1522191|C0001299
"Eligibility required a diagnosis of primary IgA nephropathy proven on kidney biopsy, an eGFR between 20 and 120 mL/min/1.73 m2 (calculated using the Chronic Kidney Disease Epidemiology Collaboration creatinine equation), and urinary protein excretion greater than 1 g/d.","Eligibility required diagnosis primary IgA nephropathy proven kidney biopsy, eGFR 20 120 mL/min/1.73 m2 (calculated Chronic Kidney Disease Epidemiology Collaboration creatinine equation), urinary protein excretion 1 g/d.",C0013893|C1514873|C0011900|C0205225|C2825347|C0022658|C0456369|C0022646|C0005558|C1739039|C0450371|C1442061|C0439445|C0025885|C0444686|C0205191|C0022646|C0012634|C0014507|C0282116|C0010294|C0552449|C0042027|C0033684|C0221102|G0000000|C0439417
"Inclusion criteria for the study were birth weight between 401 and 1500 g, < 1 week of age, and parental informed consent.","Inclusion criteria study birth weight 401 1500 g, < 1 week age, parental informed consent.",C0007637|C0243161|C0557651|C0005615|C0005910|C1442061|G0000000|C0439267|G0000000|G0000000|C0332174|C0001779|C0030551|C1522154|C1511481
Study participants were identified through hospital records at the transplant outpatient clinic and recruitment commenced in February 2014 and ended in October 2014.,Study participants identified hospital records transplant outpatient clinic recruitment commenced February 2014 October 2014.,C0557651|C0679646|C0205396|C0019994|C0034869|C0040732|C0029921|C0002424|C2949735|C3274784|C3830166|G0000000|C3828732|G0000000
"Patients are excluded if they have a significant disease other than COPD, a history of asthma, clinically relevant abnormal baseline haematology, blood chemistry or urinalysis, or conditions excluding them from exercise.","Patients excluded disease COPD, history asthma, clinically relevant abnormal baseline haematology, blood chemistry urinalysis, conditions excluding exercise.",C0030705|C1554077|C0012634|C0024117|C0019664|C0004096|G0000000|C2347946|C0205161|C0168634|C0018943|C0005767|C0007996|C0042014|C0012634|C0332196|C0015259
"Children aged 6 months to ≤ 12 years with a bodyweight > 5 kg and microscopically confirmed P. falciparum malaria were randomly assigned in a 1:1 ratio to orally receive pyronaridine–artesunate or artemether–lumefantrine, dosed according to bodyweight, for 3 days.","Children aged 6 months to ≤ 12 bodyweight > 5 microscopically confirmed P. falciparum malaria randomly assigned 1:1 ratio orally receive pyronaridine–artesunate artemether–lumefantrine, dosed bodyweight, 3 days.",C0008059|C0001779|G0000000|C0439231|G0000000|G0000000|G0000000|C0521093|C0369773|G0000000|C0024530|G0000000|C1516050|G0000000|C0456603|C0442027|C1514756|G0000000|G0000000|C0178602|C0005910|G0000000|C0439228
"Thus, 14 Tango, 17 Waltz/Foxtrot, and 17 Control participants successfully completed the study.","Thus, 14 Tango, 17 Waltz/Foxtrot, 17 Control participants completed study.",G0000000|C0450371|C1332116|C0450371|G0000000|C0450371|C0243148|C0679646|C0205197|C0557651
Population studies have shown that a large majority of COPD patients have mild-to-moderate disease [4].,Population studies majority COPD patients mild-to-moderate disease [4].,C0032659|C0947630|C0680220|C0024117|C0030705|C1299392|C0012634|G0000000
"Data, inclusive of sociodemographics, sexual behaviors, knowledge, attitudes, and beliefs about HPV and vaccination were collected via ACASI from 216 African American adolescent females (ages 14–18 years) seeking services in family planning and STI public health clinics in metropolitan Atlanta.","Data, inclusive sociodemographics, sexual behaviors, knowledge, attitudes, beliefs HPV vaccination collected ACASI 216 African American adolescent females (ages 14–18 years) seeking services family planning STI public health clinics metropolitan Atlanta.",C1511726|C0332257|G0000000|C0036864|C0004927|C0376554|C0004271|C0004951|C0021344|C0042196|C1516695|G0000000|C1442061|C0027567|C0596070|C0205653|C0015780|C0001779|G0000000|C0439234|G0000000|C0557854|C0015576|C0032074|C0036916|G0000000|C0018684|C0442592|C0599587|C2993063
"One hundred children with mild to moderate AD (2-9 years old) were randomly allocated to the probiotics (Lactobacilluss casei, Lactobacillus rhamnosus, Lactobacillus plantarum, and Bifidobacterium lactis) or placebo groups.","One children mild moderate AD (2-9 old) randomly allocated probiotics (Lactobacilluss casei, Lactobacillus rhamnosus, Lactobacillus plantarum, Bifidobacterium lactis) placebo groups.",C0205447|C0008059|C2945599|C0205081|G0000000|G0000000|C0580836|G0000000|G0000000|C0525033|G0000000|G0000000|C0022938|G0000000|C0022938|G0000000|C0005380|C3844603|C0032042|C0441833
Background: Non-invasive ventilation is an established treatment for chronic respiratory failure due to chest wall deformity.,Background: Non-invasive ventilation established treatment chronic respiratory failure chest wall deformity.,C1706907|C0205303|C0035203|C0443211|C0039798|C0205191|C0521346|C0231174|C0817096|C0677535|C0000768
DESIGN OF STUDY: Open randomised controlled trial of delayed versus immediate prescribing of antibiotics.,DESIGN OF STUDY: Open randomised controlled trial delayed versus prescribing antibiotics.,C1707689|G0000000|C0557651|C0175566|G0000000|C2587213|C0008976|C0205421|G0000000|C0278329|C0003232
Twenty‐four patients completed the study.,Twenty‐four patients completed study.,G0000000|C0030705|C0205197|C0557651
"People with febrile seizures, neonatal seizures, single seizures not fulfilling the current operational definition for epilepsy, and acute symptomatic seizures associated with head injury, stroke, and toxic, metabolic, and acute infective conditions were excluded.27 The randomization‐cluster (as distinct from the screening‐cluster) unit was fixed at 10 subjects with confirmed active epilepsy derived from a screening‐cluster (Figure 2).","People febrile seizures, neonatal seizures, single seizures fulfilling current operational definition epilepsy, acute symptomatic seizures head injury, stroke, toxic, metabolic, acute infective conditions excluded.27 The randomization‐cluster (as distinct screening‐cluster) unit fixed 10 subjects confirmed active epilepsy derived screening‐cluster (Figure 2).",C0027361|C0015967|C0036572|C1552240|C0036572|C0037179|C0036572|C1550543|C0521116|C0038895|C1550452|C0014544|C0205178|C0231220|C0036572|C0018670|C3263722|C0038454|C0600688|C0311400|C0205178|G0000000|C0012634|C1554077|G0000000|G0000000|G0000000|G0000000|G0000000|C0439148|C0443218|C0450371|C0681850|C0521093|C0205177|C0014544|C1441547|G0000000|G0000000|G0000000
"Exclusion criteria included (1) total plegia (0/5) at paretic ankle; (2) fixed or painful contractures or other LE pain syndrome that could impede participation; (3) dementia, based on clinical diagnosis; (4) orthopedic, arthritic, or inflammatory condition limiting ankle movement; (5) known or suspected current or recent (< 3 months) signs or symptoms of deep venous thrombosis or pulmonary thrombo-embolism; (6) vision impairment to preclude visual tracking needed for training; and (7) severe receptive or global aphasia confounding testing and training.","Exclusion criteria included (1) total plegia (0/5) paretic ankle; (2) fixed painful contractures LE pain syndrome impede participation; (3) dementia, based clinical diagnosis; (4) orthopedic, arthritic, inflammatory condition limiting ankle movement; (5) suspected current (< 3 months) signs symptoms deep venous thrombosis pulmonary thrombo-embolism; (6) vision impairment preclude visual tracking training; (7) severe receptive global aphasia confounding testing training.",C0680251|C0243161|C0332257|G0000000|C0439175|C0522224|G0000000|G0000000|C0003086|G0000000|C0443218|C0030193|C0009917|C0023190|C0030193|C0039082|G0000000|C0679823|G0000000|C0011265|C1527178|C0205210|C0011900|G0000000|C0029355|G0000000|C0333348|C0012634|C0439801|C0003086|C0026649|G0000000|C0332147|C0521116|G0000000|G0000000|C0439231|C0220912|C0683368|C0205125|C0042449|C0040053|C0024109|C0013922|G0000000|C0042789|C0221099|G0000000|C0234621|C0546881|C0040607|G0000000|C0205082|C0544683|C0205246|C0003537|G0000000|C0039593|C0040607
This study investigated the acceptability of a text message-based intervention for prevention of excessive weight gain in infants from Hawai‘i and Puerto Rico WIC clinics.,This study investigated acceptability text message-based intervention prevention excessive weight gain infants Hawai‘i Puerto Rico WIC clinics.,G0000000|C0557651|C1292732|C0814633|C1527021|C0470166|C0886296|C0199176|C0442802|C0005910|C1517378|C0021270|G0000000|G0000000|G0000000|G0000000|C0442592
The expected survival improvement was 15% in stage I patients and 25% in stage II or III patients.,The expected survival improvement 15% stage I patients 25% stage II III patients.,G0000000|C1517001|C0038952|C2986411|C0450371|C0205390|C0021966|C0030705|C0450371|C0205390|G0000000|C0439070|C0030705
"The median time since cancer diagnosis was 12.1 years (interquartile range, 7.8–17.5 years).","The median time cancer diagnosis 12.1 (interquartile range, 7.8–17.5 years).",G0000000|C0549183|C0040223|C0006826|C0011900|C0450371|G0000000|C1514721|G0000000|C0439234
This open label phase II feasibility investigation used intensified chemotherapy and simultaneous enoxaparin treatment in patients with first line chemotherapy.,This label phase II feasibility investigation intensified chemotherapy simultaneous enoxaparin treatment patients chemotherapy.,G0000000|C0181496|C0205390|G0000000|G0000000|C0220825|G0000000|C0013216|C0205420|C0206460|C0039798|C0030705|C0013216
An information letter will be given to participants.,An letter participants.,G0000000|C1096774|C0679646
"Of them, 68 patients did not meet inclusion criteria (a previous history of drug therapy with potential antirickettsial activity in 9 patients, a temperature of lower than 37.5°C in 27 patients, severe complications associated with scrub typhus in 9 patients [4 cases of shock requiring vasopressor therapy for more than 1 h, 3 cases of stuporous or comatose-level consciousness, and 2 cases of respiratory failure requiring mechanical ventilation], 1 case of vomiting in which oral intake was impossible, and refusal of participation in 22 patients).","Of them, 68 patients meet inclusion criteria (a previous history drug therapy potential antirickettsial activity 9 patients, temperature lower 37.5°C 27 patients, severe complications scrub typhus 9 patients [4 shock requiring vasopressor therapy 1 h, 3 stuporous comatose-level consciousness, 2 respiratory failure requiring mechanical ventilation], 1 vomiting oral intake impossible, refusal participation 22 patients).",G0000000|G0000000|C0450371|C0030705|C1550543|C0007637|C0243161|G0000000|C0205156|C0019664|C0013227|C0039798|C3245505|G0000000|C0205177|G0000000|C0030705|C0005903|C0441994|G0000000|C0450371|C0030705|C0205082|C0009566|G0000000|C0041471|G0000000|C0030705|G0000000|C0036974|G0000000|C0042397|C0039798|G0000000|C0033727|G0000000|C0023380|C0009421|C0009791|G0000000|C0521346|C0231174|G0000000|C0443254|C0035203|G0000000|C0042963|C0442027|C1512806|G0000000|G0000000|C0679823|C0450371|C0030705
"We will screen 400 first-time stroke (ischaemic and haemorrhagic) or Transient Ischaemic Attack (TIA) patients, and expect a 75% response rate (300).","We screen 400 first-time stroke (ischaemic haemorrhagic) Transient Ischaemic Attack (TIA) patients, expect 75% response rate (300).",G0000000|C0220908|C1442061|C0205435|C0038454|C0475224|C0333275|C0040704|C0475224|C0277793|C0007787|C0030705|G0000000|C0450371|C0871261|C0871208|C1442061
"Specifically, how do the results relate to normal children?","Specifically, relate normal children?",G0000000|C0163712|C0205307|C0008059
"Patients were recruited in the asthma clinic, hospital wards, and emergency department of the Sainte-Justine University Health Centre, Montreal, QC, Canada, during the winter months, November 2013 to February 2014.","Patients recruited asthma clinic, hospital wards, emergency department Sainte-Justine University Health Centre, Montreal, QC, Canada, winter months, November 2013 February 2014.",C0030705|G0000000|C0004096|C0002424|C0019994|C1305702|C0013956|C1704729|G0000000|C0041740|C0018684|C0205099|G0000000|C0034378|C0006823|C0241737|C0439231|C3828767|G0000000|C3830166|G0000000
"The training inclusion criteria required that participants be actively performing aerobic exercise and partaking in resistance training at least twice per week, for a minimum of 3 months.","The training inclusion criteria required participants actively performing aerobic exercise partaking resistance training week, minimum 3 months.",G0000000|C0040607|C0007637|C0243161|C1514873|C0679646|G0000000|C0884358|C1510824|C0015259|G0000000|C0237834|C0040607|C0332174|C1524031|G0000000|C0439231
"In one hospital, the 30 controls were given another traditional Chinese drug; whereas a Western medicine (chondroprotection drug/Viartril-s) was used as the control in the other hospital.","In hospital, 30 controls traditional Chinese drug; Western medicine (chondroprotection drug/Viartril-s) control hospital.",G0000000|C0019994|C0450371|C0243148|C0443324|C0008120|C0013227|C1705493|C0013227|G0000000|C0013227|C0243148|C0019994
"Outcome measures included agitation, quality of life and medication.","Outcome measures included agitation, quality life medication.",C1274040|C0079809|C0332257|C0085631|C0332306|C0376558|C0013227
"For children discharged as cured, the average weight gain was 3.5 g kg−1 day−1 for children in the WPC‐RUTF group and 3.4 g kg−1 day−1 for those in the P‐RUTF group.","For children discharged cured, average weight gain 3.5 g kg−1 day−1 children WPC‐RUTF 3.4 g kg−1 day−1 P‐RUTF group.",G0000000|C0008059|C0030685|C1880198|C1510992|C0005910|C1517378|G0000000|C0008059|G0000000|G0000000|G0000000|C0441833
"Women were eligible if they were HIV-infected, pregnant between 12 and 27 gestational weeks at enrollment, resided in Dar es Salaam, and intended to stay in the city until delivery and for 1 y thereafter.","Women eligible HIV-infected, pregnant 12 27 gestational weeks enrollment, resided Dar es Salaam, intended stay city delivery 1 thereafter.",C0043210|C1548635|C0019682|C0549206|C0450371|C0450371|C0439671|C0439230|C1516879|C2982691|C0022595|C0013754|G0000000|C1283828|G0000000|C0008848|C0011209|G0000000|G0000000
"After a year of duty in malarious Papua, Indonesia, Indonesian soldiers with vivax malaria were randomized to radical cure with DHA-PP or QN and PQ or treatment with artesunate (AS) without PQ and followed for 12 months in an area free from risk of reinfection at their base in Java, Indonesia.","After duty malarious Papua, Indonesia, Indonesian soldiers vivax malaria randomized radical cure DHA-PP QN PQ treatment artesunate (AS) PQ 12 months free risk reinfection base Java, Indonesia.",G0000000|G0000000|G0000000|G0000000|C0021247|C0021248|C0524647|G0000000|C0024530|C0034656|C0302912|C1880198|C0142831|C1442116|C2987314|C0039798|C0052432|G0000000|C2987314|C0450371|C0439231|C0332296|C0035647|C0205339|C0002055|C0205803|C0021247
"Inclusion criteria were pulse oximetry > 90 percent with a fraction of inspired oxygen ≤50 percent, positive end-expiratory pressure level ≤ 8 cm of water, no need for epinephrine or norepinephrine at a rate >1 mg per hour, body temperature between 36 °C and 39 °C, and a stable neurological status with little or no sedation.","Inclusion criteria pulse oximetry > 90 percent fraction inspired oxygen ≤50 percent, positive end-expiratory pressure level ≤ 8 cm water, epinephrine norepinephrine rate >1 hour, body temperature 36 °C 39 °C, stable neurological status sedation.",C0007637|C0243161|C0232117|C0523807|G0000000|C0450371|C0439165|C1264633|C0004048|C0030054|G0000000|C0439165|C0439178|C0442700|C0033095|C0441889|G0000000|G0000000|G0000000|C0043047|C0014563|C0028351|C0871208|G0000000|C0439227|C0242821|C0005903|C0450371|G0000000|C0450371|G0000000|C0205360|C0205494|C0449438|C0235195
The findings confirmed the beneficial effects of add-on yogasana intervention in schizophrenia.,The findings confirmed beneficial effects add-on yogasana intervention schizophrenia.,G0000000|C2607943|C0521093|G0000000|C1280500|C1883712|G0000000|C0886296|C0036341
"Of the 1,449 children eligible for asthma education who were still enrolled in school at the time of the classes, 1,217 (83%) attended at least one Kickin’Asthma© session (Table 3).","Of 1,449 children eligible asthma education enrolled school time classes, 1,217 (83%) attended Kickin’Asthma© session (Table 3).",G0000000|C1442061|C0008059|C1548635|C0004096|C0013621|G0000000|C0036375|C0040223|C0456387|C1442061|C0450371|C1456498|G0000000|C1883016|C0039224|G0000000
Table 1 shows baseline characteristics of the total study sample and of the intervention and control group.,Table 1 baseline characteristics total study sample intervention control group.,C0039224|G0000000|C0168634|C1521970|C0439175|C0557651|C0370003|C0886296|C0243148|C0441833
"Nutritional composition of daily intake of pregnancy supplements in the Early Nutrition and Immune Development trial1 At enrollment (“booking”) and at 20 and 30 wk of gestation, women attended the Medical Research Council (MRC) Keneba clinic for a detailed antenatal assessment.","Nutritional composition daily intake pregnancy supplements Early Nutrition Immune Development trial1 At enrollment (“booking”) 20 30 wk gestation, women attended Medical Research Council (MRC) Keneba clinic detailed antenatal assessment.",C1521739|C0486616|C0332173|C1512806|C0032961|C0242295|C1279919|C0028707|C0439662|C0243107|G0000000|G0000000|C1516879|G0000000|C0450371|C0450371|C0332174|C0032961|C0043210|C1456498|C0199168|C0035168|C1551807|C1540289|G0000000|C0002424|C1522508|C2828394|C1261322
"Among them, the inclusion criteria for the study were: 1) well-defined, unifocal intracranial seizure onset preceding objective clinical change on video; 2) seizure onset characterized by discrete HFOs (≥70 Hz activity, ≥400 ms duration).","Among them, inclusion criteria study were: 1) well-defined, unifocal intracranial seizure onset preceding objective clinical change video; 2) seizure onset characterized discrete HFOs (≥70 Hz activity, ≥400 ms duration).",G0000000|G0000000|C0007637|C0243161|C0557651|G0000000|G0000000|C0442825|C0443337|C0524466|C0036572|C0206132|C0332152|C0018017|C0205210|C0392747|C0042655|G0000000|C0036572|C0206132|C1880022|C0443299|G0000000|G0000000|C0439482|C0205177|G0000000|C0039676|C0449238
"This study was performed to identify the appropriate dose of EPs 7630 and to demonstrate its efficacy, safety and tolerability in the treatment of patients aged 6–18 years suffering from acute bronchitis.","This study performed identify dose EPs 7630 demonstrate efficacy, safety tolerability treatment patients aged 6–18 suffering acute bronchitis.",G0000000|C0557651|C0884358|G0000000|C0178602|G0000000|G0000000|G0000000|C1280519|C0036043|C3274448|C0039798|C0030705|C0001779|G0000000|C0683278|C0205178|C0006277
"diabetes, hypertension, cardiac disease, HIV/hepatitis, renal disease, haematology disorder (i.e.","diabetes, hypertension, cardiac disease, HIV/hepatitis, renal disease, haematology disorder (i.e.",C0011847|C0020538|C0018787|C0012634|C0019682|C0022646|C0012634|C0018943|C0012634|C0683454
"Other criteria for inclusion were that the child was not severely anaemic (haemoglobin <70 g L−1), underweight [weight‐for‐age z‐score (WAZ) <−3], stunted [length‐for‐age z‐score (HAZ) <−3] or wasted [weight‐for‐length z‐score (WHZ) <−3] at baseline, as well as the mother's willingness to remain in the study area for at least 1 year from the start of the MNP supplementation.","Other criteria inclusion child severely anaemic (haemoglobin <70 g L−1), underweight [weight‐for‐age z‐score (WAZ) <−3], stunted [length‐for‐age z‐score (HAZ) <−3] wasted [weight‐for‐length z‐score (WHZ) <−3] baseline, mother's willingness remain study 1 start MNP supplementation.",G0000000|C0243161|C0007637|C0008059|C0205082|C0857322|C0019046|G0000000|C0041667|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|C0235394|G0000000|G0000000|G0000000|G0000000|C0168634|C0026591|C0600109|G0000000|C0557651|G0000000|C0439659|C0282245|C0242297
"In 2005, 25 % of the admitted patients in hospitals were 70 years old or older, for totaling 400,000 people [3].","In 2005, 25 % admitted patients hospitals 70 older, totaling 400,000 people [3].",G0000000|G0000000|C0450371|G0000000|C0184666|C0030705|C0019994|C0450371|C0580836|C0439175|C1442061|C0027361|G0000000
Both parents and the youth had to be willing to answer questions about their experiences inside and outside of the family.,Both parents youth answer questions experiences inside family.,G0000000|C0030551|C0001578|C1706817|C1522634|C0596545|G0000000|C0015576
Trial Protocol eTable 1.,Trial Protocol eTable 1.,C0008976|C0442711|G0000000|G0000000
The ethnicity of the sample was as follows: African American (16%); Latino/Hispanic (18%); White (36%); American Indian (3%); Asian (8%); and biracial/mixed ethnicity (19%).,The ethnicity sample follows: African American (16%); Latino/Hispanic (18%); White (36%); American Indian (3%); Asian (8%); biracial/mixed ethnicity (19%).,G0000000|C0015031|C0370003|C0332283|C0027567|C0596070|C0450371|C0086528|C0450371|C0007457|C0450371|C0596070|C1524069|G0000000|C0078988|G0000000|C0205430|C0015031|C0450371
The patients fulfilling the inclusion exclusion criteria and consenting to participate in the study were enrolled in the study.,The patients fulfilling inclusion exclusion criteria consenting participate study enrolled study.,G0000000|C0030705|C1550543|C0007637|C0680251|C0243161|C1511481|G0000000|C0557651|G0000000|C0557651
"For this experimental study, participants were recruited from 6 institutions that specialize in the care of dementia patients in Taiwan.","For experimental study, participants recruited 6 institutions specialize care dementia patients Taiwan.",G0000000|C1517586|C0557651|C0679646|G0000000|G0000000|C1272753|C0205555|C1947933|C0011265|C0030705|C0039260
This 12-month randomized clinical trial of 89 perimenopausal and postmenopausal women with moderate to severe hot flashes found that neither black cohosh nor red clover had a significant effect on reduction of vasomotor symptoms as compared with placebo.,This 12-month randomized clinical trial 89 perimenopausal postmenopausal women moderate severe hot flashes black cohosh red clover reduction vasomotor symptoms compared placebo.,G0000000|C0450371|C0034656|C0205210|C0008976|C0450371|C0849668|C0232970|C0043210|C0205081|C0205082|C0444519|C0085635|C0005680|G0000000|C0332575|C0950074|C0301630|C1519957|C0683368|C1707455|C0032042
Eligible patients were at least 18 years of age and diagnosed within 48 hours with a PaO2/FiO2 ratio of < 200.,Eligible patients 18 age diagnosed 48 hours PaO2/FiO2 ratio of < 200.,C1548635|C0030705|C0450371|C0001779|C0011900|C0450371|C0439227|C1427155|C0456603|G0000000
"Patients in this study were heavily pretreated, with 9 of 25 having 3 or more prior chemotherapy regimens.","Patients study heavily pretreated, 9 25 3 prior chemotherapy regimens.",C0030705|C0557651|G0000000|G0000000|G0000000|C0450371|G0000000|C0332152|C0013216|C2945654
"Out of these participants, 29 % (7412) were children under the age of 5 years but DP peaked in older children between the age of five and ten.","Out participants, 29 % (7412) children age 5 DP peaked children age ten.",C0439787|C0679646|C0450371|G0000000|G0000000|C0008059|C0001779|G0000000|C1531217|C0444505|C0008059|C0001779|C0014518
"Patients with any of the following were excluded: (1) impaired renal function (serum creatinine >1.2 mg/dl confirmed once over a period of 2 weeks), (2) intake of immunosuppressive medications other than oral prednisolone in the preceding 6 months, or (3) steroid threshold exceeding 1 mg/kg on alternate days for maintaining remission and one or more features of steroid toxicity (body mass index, >95th percentile for age [13], cataract, or stage 2 hypertension [14]).","Patients excluded: (1) impaired renal function (serum creatinine >1.2 mg/dl confirmed period 2 weeks), (2) intake immunosuppressive medications oral prednisolone preceding 6 months, (3) steroid threshold exceeding 1 mg/kg alternate days maintaining remission features steroid toxicity (body mass index, >95th percentile age [13], cataract, stage 2 hypertension [14]).",C0030705|C1554077|G0000000|C0221099|C0022646|C0031843|C0229671|C0010294|G0000000|C0439269|C0521093|C0439531|G0000000|C0439230|G0000000|C1512806|C0021081|C0013227|C0442027|C0032950|C0332152|G0000000|C0439231|G0000000|C0038317|C0449864|G0000000|G0000000|C0439272|C0332270|C0439228|C0024501|C0544452|C1521970|C0038317|C0040539|C0242821|C0577559|C0918012|G0000000|C1264641|C0001779|C0450371|C0086543|C0205390|G0000000|C0020538|C0450371
"The inclusion criteria consisted of (a) meeting ACR (American College of Rheumatology) criteria of FMS [1], (b) pain for a period of at least 6 months, (c) married, (d) willingness of the spouse to participate, and (e) ability to complete the questionnaires and understand the treatment components.","The inclusion criteria consisted (a) meeting ACR (American College Rheumatology) criteria FMS [1], (b) pain period 6 months, (c) married, (d) willingness spouse participate, (e) ability complete questionnaires understand treatment components.",G0000000|C0007637|C0243161|C0332529|G0000000|C0556656|C1412134|C0596070|C0557806|C0035452|C0243161|G0000000|G0000000|G0000000|C0030193|C0439531|G0000000|C0439231|G0000000|C0024841|C0073187|C0600109|C0162409|G0000000|G0000000|C0085732|C0205197|C0034394|C0162340|C0039798|C0449432
"The inclusion criteria included parasitemia of 1,000 to 100,000 parasites/μl blood, absence of severe disease, no antimalarial treatment during the preceding 4 weeks, and no history of hepatic or kidney diseases.","The inclusion criteria included parasitemia 1,000 100,000 parasites/μl blood, absence severe disease, antimalarial treatment preceding 4 weeks, history hepatic kidney diseases.",G0000000|C0007637|C0243161|C0332257|C0242723|C1442061|C1442061|G0000000|C0005767|C0332197|C0205082|C0012634|C0003374|C0039798|C0332152|G0000000|C0439230|C0019664|C0205054|C0022646|C0012634
"In the individual-deposit group, this sum included a $150 deposit that would be refunded to participants who quit smoking.","In individual-deposit group, sum included $150 deposit refunded participants quit smoking.",G0000000|C0027361|C0441833|C1515051|C0332257|C1442061|C0333562|G0000000|C0679646|C0748223|C0037369
"Children and mothers will be systematically assessed at T1 (pre-intervention, child age 3 to 6 months), at the end of the 9-month intervention (T2, postintervention) and 6 months postintervention (T3, follow-up).","Children mothers systematically assessed T1 (pre-intervention, child age 3 6 months), 9-month intervention (T2, postintervention) 6 months postintervention (T3, follow-up).",C0008059|C0026591|G0000000|C1516048|C0041403|C2347663|C0008059|C0001779|G0000000|G0000000|C0439231|C0332177|C0886296|C0041403|G0000000|G0000000|C0439231|G0000000|C0041403|C0589120
60 general practices in north east England.,60 practices north east England.,C0450371|C0237607|C1709269|C1707877|C0014282
"During a median follow-up of 7.1 years, 184 participants developed pancreatic adenocarcinoma.","During median follow-up 7.1 years, 184 participants developed pancreatic adenocarcinoma.",G0000000|C0549183|C0589120|G0000000|C0439234|C1442061|C0679646|G0000000|C0030274|C0001418
The pre-1997 group were patients operated from January 1986 to December 1997 (n = 192).,The pre-1997 patients operated January 1986 December 1997 (n = 192).,G0000000|C0332152|C0030705|C3242339|C3829466|G0000000|C3830550|G0000000|C0369718|G0000000|C1442061
A total of 170 eligible participants will be randomly allocated into intervention group (the Baduanjin exercise group) and control group (general physical activity group) in a 1:1 ratio.,A total 170 eligible participants randomly allocated intervention (the Baduanjin exercise group) control (general physical activity group) 1:1 ratio.,G0000000|C0439175|C1442061|C1548635|C0679646|G0000000|G0000000|C0886296|G0000000|G0000000|C0015259|C0441833|C0243148|C0205246|C0031809|C0205177|C0441833|G0000000|C0456603
"Therefore, the statistical analysis included 28 patients, who completed the pulmonary rehabilitation programme.","Therefore, statistical analysis included 28 patients, completed pulmonary rehabilitation programme.",G0000000|C0038215|C0002778|C0332257|C0450371|C0030705|C0205197|C0024109|C0034991|C1709697
"Participants were excluded if they (1) had any active symptomatic illness (ie, cancer, heart failure, ischemic heart disease with known coronary artery or valvular heart disease, psychiatric illness, or neuromuscular disease); (2) participated in a pulmonary rehabilitation program in the last 12 months; or (3) were currently participating in > 2 days of supervised maintenance exercise.","Participants excluded (1) active symptomatic illness (ie, cancer, heart failure, ischemic heart disease coronary artery valvular heart disease, psychiatric illness, neuromuscular disease); (2) participated pulmonary rehabilitation program 12 months; (3) participating > 2 days supervised maintenance exercise.",C0679646|C1554077|G0000000|C0205177|C0231220|C0221423|G0000000|C0006826|C0018787|C0231174|C0475224|C0018787|C0012634|C0018787|C0003842|C0184252|C0018787|C0012634|C0205487|C0221423|C1979768|C0012634|G0000000|G0000000|C0024109|C0034991|C1709697|C0450371|C0439231|G0000000|C0679823|G0000000|G0000000|C0439228|G0000000|C0024501|C0015259
"All at-risk patients aged 70 years or over presenting to the emergency department (ED), admitted for general medicine or surgical specialties will be screened for predefined in- and exclusion criteria as described in the section ‘Study population and recruitment’.","All at-risk patients aged 70 emergency department (ED), admitted medicine surgical specialties screened predefined in- exclusion criteria ‘Study population recruitment’.",G0000000|C1444641|C0030705|C0001779|C0450371|C0013956|C1704729|C3538926|C0184666|C0013227|C0543467|C0037778|C0220908|G0000000|G0000000|C0680251|C0243161|G0000000|C0032659|G0000000
Eligible participants had to be a resident of the village; be able to walk at least 50 m; agree to undergo physical and cognitive testing; plan to stay in the village for the next 12 mo; and obtain medical clearance to participate in the study.,Eligible participants resident village; walk 50 m; agree undergo physical cognitive testing; plan stay village 12 mo; medical clearance participate study.,C1548635|C0679646|C1320928|C0562518|C0080331|C0450371|C0369637|C3641827|G0000000|C0031809|C1516691|C0039593|C0270724|G0000000|C0562518|C0450371|C0026544|C0199168|C0449297|G0000000|C0557651
Eligible men were 50 years or older (African Americans) or 55 years or older (all others) with a PSA ≤4.0 ng/mL and a digital rectal examination not suspicious for prostate cancer.,Eligible 50 (African Americans) 55 (all others) PSA ≤4.0 ng/mL digital rectal examination suspicious prostate cancer.,C1548635|C0450371|C0027567|C0596070|C0450371|G0000000|C1955473|C3810537|G0000000|C0439275|C0442015|C0205052|G0000000|C0750493|C0033572|C0006826
"The PMP22 mRNA levels were obtained at baseline and at 2 years in a subset of 69 subjects, 55 in the AA group and 14 in the placebo group.","The PMP22 mRNA levels baseline 2 subset 69 subjects, 55 AA 14 placebo group.",G0000000|G0000000|C0035696|C0441889|C0168634|G0000000|C1515021|C0450371|C0681850|C0450371|C0282379|C0450371|C0032042|C0441833
"The study was conducted in the rural north-western study site that our research group established in 1999, located in 18 Unions of the Gaibandha and one Union of the Rangpur district, under the ‘JiVitA Project’ of the Johns Hopkins University in Bangladesh non-governmental organization.","The study conducted rural north-western study site established 1999, located 18 Unions Gaibandha Union Rangpur district, ‘JiVitA Project’ Johns Hopkins University Bangladesh non-governmental organization.",G0000000|C0557651|C0004927|C0240919|C1709269|C0557651|C0205145|C0443211|G0000000|G0000000|C0450371|C2825217|G0000000|C2825217|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|C0041740|C0004732|C1518422|C0029237
Conclusion Glucosamine was no better than placebo in reducing pain from osteoarthritis of the knee in this group of patients.,Conclusion Glucosamine placebo reducing pain osteoarthritis knee patients.,C1707478|C0017718|C0032042|C0392756|C0030193|C0029408|C0022742|C0030705
"Exclusion criteria included having a history of serious or adverse experiences in the last six months, being treated with antidepressant medications, hospitalization due to acute disease, and unwillingness to continue to participate in the study.","Exclusion criteria included history adverse experiences months, treated antidepressant medications, hospitalization acute disease, unwillingness continue participate study.",C0680251|C0243161|C0332257|C0019664|G0000000|C0596545|C0439231|C1522326|C0003289|C0013227|C0019993|C0205178|C0012634|C0558080|C0549178|G0000000|C0557651
"We excluded children with allergy to cows' milk, lactose intolerance, severe food allergy, and other severe chronic diseases.","We excluded children allergy cows' milk, lactose intolerance, severe food allergy, severe chronic diseases.",G0000000|C1554077|C0008059|C0002111|C3539595|C0026131|C0022949|C0231199|C0205082|C0016452|C0002111|C0205082|C0205191|C0012634
"Patients who received DHA supplementation were slightly older than patients in the placebo group (mean, 16.1 vs 14.9 years, respectively) and had marginally higher RBC DHA levels (Table 1).","Patients received DHA supplementation patients placebo (mean, 16.1 14.9 years, respectively) marginally RBC DHA levels (Table 1).",C0030705|C1514756|C0142831|C0242297|C0030705|C0032042|C0444504|C0450371|C0450371|C0439234|G0000000|G0000000|C0014792|C0142831|C0441889|C0039224|G0000000
"All 41 eligible subjects had an APC gene mutation, as did their parents with familial adenomatous polyposis.","All 41 eligible subjects APC gene mutation, parents familial adenomatous polyposis.",G0000000|C0450371|C1548635|C0681850|C0032580|C0017337|C0026882|C0030551|C0015576|C0001430|C0334108
"Exclusion criteria (Table 1) included prior CPAP treatment, shift work, unstable depression or psychosis, history of medical non-adherence, moderate to severe chronic obstructive pulmonary disease, uncontrolled hypertension, uncontrolled restless legs syndrome, known or suspected narcolepsy, use of daytime supplemental oxygen, severe congestive heart failure, use of nightly narcotics, known hypoventilation, a neuromuscular disorder, and a reported sleep duration < 4 h night.","Exclusion criteria (Table 1) included prior CPAP treatment, shift work, unstable depression psychosis, history medical non-adherence, moderate severe chronic obstructive pulmonary disease, uncontrolled hypertension, uncontrolled restless legs syndrome, suspected narcolepsy, daytime supplemental oxygen, severe congestive heart failure, nightly narcotics, hypoventilation, neuromuscular disorder, reported sleep duration < 4 night.",C0680251|C0243161|C0039224|G0000000|C0332257|C0332152|C0199451|C0039798|C0333051|C0043227|C0443343|C0011570|C0033975|C0019664|C0199168|C1518422|C0205081|C0205082|C0205191|C0549186|C0024109|C0012634|C0205318|C0020538|C0205318|C0085631|C1140621|C0039082|C0332147|C0027404|C0332169|C2348609|C0030054|C0205082|C0742742|C0018787|C0231174|G0000000|C0027415|C3203358|C1979768|C0012634|C0684224|C0037313|C0449238|G0000000|G0000000|C0240526
"Inclusion criteria consisted of: being single, having a menstrual cycle that lasts from 21 to 35 days with 2 to 6 days of flow and average blood loss of 20 to 60 ml [20], with moderate to severe primary dysmenorrha.","Inclusion criteria consisted of: single, menstrual cycle lasts 21 35 days 2 6 days flow average blood loss 20 60 ml [20], moderate severe primary dysmenorrha.",C0007637|C0243161|C0332529|G0000000|C0037179|C0025344|C1511572|C1517741|C0450371|G0000000|G0000000|G0000000|C0806140|C1510992|C0005767|C1517945|C0450371|G0000000|C0450371|C0205081|C0205082|C0205225|G0000000
"In OSA patients, unfavorable gravitational effects in supine sleep lead to an increased propensity for and frequency of upper airway collapse,7,8 higher airway opening pressures,9 and more prolonged and severe respiratory events with greater oxygen desaturation.10 Positional OSA, traditionally defined as supine AHI ≥ twice that of non-supine postures, has a prevalence of 50% to 60%.7,11,12 According to a more recent and stringent definition requiring a supine AHI ≥ twice that of non-supine AHI and normalization of AHI in non-supine postures,13 positional OSA patients who meet these criteria should remain within normal limits by using effective positional therapy alone to simply avoid supine sleep.","In OSA patients, unfavorable gravitational effects supine sleep lead increased propensity frequency upper airway collapse,7,8 airway pressures,9 prolonged severe respiratory events oxygen desaturation.10 Positional OSA, traditionally defined supine AHI ≥ non-supine postures, prevalence 50% 60%.7,11,12 According stringent definition requiring supine AHI ≥ non-supine AHI normalization AHI non-supine postures,13 positional OSA patients meet criteria remain normal limits effective positional therapy simply avoid supine sleep.",G0000000|C0520679|C0030705|C3640815|C0018216|C1280500|C0038846|C0037313|C0023175|C0205217|G0000000|C0376249|C1282910|C0178987|C0036974|C0178987|C0033095|C0439590|C0205082|C0521346|C0441471|C0030054|C0746961|C0240795|C0520679|G0000000|C1704788|C0038846|G0000000|G0000000|C1518422|C1262869|C0033105|C0450371|C0450371|C0680240|G0000000|C1550452|G0000000|C0038846|G0000000|G0000000|C1518422|G0000000|C1882115|G0000000|C1518422|C1262869|C0240795|C0520679|C0030705|C1550543|C0243161|G0000000|C0205307|C0439801|C1280519|C0240795|C0039798|G0000000|G0000000|C0038846|C0037313
"Women are visited at home weekly for supplement administration and morbidity assessment and seen at MRC Keneba at 20 and 30 weeks gestation for a detailed antenatal examination, including ultrasound.","Women visited weekly supplement administration morbidity assessment MRC Keneba 20 30 weeks gestation detailed antenatal examination, including ultrasound.",C0043210|C0545082|C0332174|C0242295|C0001554|C0026538|C1261322|C1540289|G0000000|C0450371|C0450371|C0439230|C0032961|C1522508|C2828394|G0000000|C0332257|C0041618
"Major symptoms associated with narcolepsy include somnolence, cataplexy, hypnagogic hallucinations, and sleep paralysis.","Major symptoms narcolepsy somnolence, cataplexy, hypnagogic hallucinations, sleep paralysis.",C0205082|C0683368|C0027404|C0013144|C0007384|G0000000|C0018524|C0037313|C0522224
"With primary care provider approval, veterans are mailed letters describing the study and providing contact information for study staff if they are interested in participating.","With primary care provider approval, veterans mailed letters describing study providing contact study staff participating.",G0000000|C0205225|C1947933|C1138603|C0205540|C0042610|C0024492|C0282413|G0000000|C0557651|C1999230|C0332158|C0557651|C0851286|C0679823
"Patients with past history of irradiation, diarrhea before the beginning of pelvic irradiation were ineligible for the study.","Patients history irradiation, diarrhea pelvic irradiation ineligible study.",C0030705|C0019664|C1282930|C0011991|C0030797|C1282930|C1512714|C0557651
An additional eligibility criterion enforced early on in the study was the requirement for enrollment in the COG biology study (ANBL00B1).,An additional eligibility criterion enforced study requirement enrollment COG biology study (ANBL00B1).,G0000000|C1524062|C0013893|C0243161|G0000000|C0557651|C1514873|C1516879|G0000000|C0005532|C0557651|G0000000
"Of the 279 eligible patients, 240 consented and were enrolled in the study.","Of 279 eligible patients, 240 consented enrolled study.",G0000000|C1442061|C1548635|C0030705|C1442061|C2711213|G0000000|C0557651
"Exclusion criteria were: Recurrent brain tumor, multiple brain tumor localizations, earlier skull radiotherapy, earlier chemotherapy for glioblastoma, chronic kidney disease or other renal function disorder, and a known MR-contrast allergy.","Exclusion criteria were: Recurrent brain tumor, multiple brain tumor localizations, earlier skull radiotherapy, earlier chemotherapy glioblastoma, chronic kidney disease renal function disorder, MR-contrast allergy.",C0680251|C0243161|G0000000|C2945760|C0006104|C0027651|C0439064|C0006104|C0027651|C0475264|C1279919|C0037303|C0034619|C1279919|C0013216|C0017636|C0205191|C0022646|C0012634|C0022646|C0031843|C0012634|C1417249|C0002111
"Of 231 participants, 111 (48.1%) smokers were randomly assigned to the usual care group, while the rest (120 smokers) of them allocated to the intervention group.","Of 231 participants, 111 (48.1%) smokers randomly assigned usual care group, rest (120 smokers) allocated intervention group.",G0000000|C1442061|C0679646|C1442061|C0450371|C0337664|G0000000|C1516050|C3538928|C1947933|C0441833|C0035253|C1442061|C0337664|G0000000|C0886296|C0441833
"Eleven young children 1 to 6 years old and with CF were randomly assigned to immunization groups A1 (n = 4), B1 (n = 5), and C (n = 2).","Eleven children 1 6 CF randomly assigned immunization A1 (n = 4), B1 (n = 5), C (n = 2).",C0205457|C0008059|G0000000|G0000000|C0009738|G0000000|C1516050|C0020971|C0336669|C0369718|G0000000|G0000000|C0005558|C0369718|G0000000|G0000000|G0000000|C0369718|G0000000|G0000000
"During the 12-week treatment period, patients were randomized to receive placebo or pitavastatin 1, 2, or 4 mg, administered orally once daily in the morning.","During 12-week treatment period, patients randomized receive placebo pitavastatin 1, 2, 4 mg, administered orally daily morning.",G0000000|C0450371|C0039798|C0439531|C0030705|C0034656|C1514756|C0032042|C1101838|G0000000|G0000000|G0000000|C0026410|C1521801|C0442027|C0332173|C0332170
"Among the total 151 patients admitted with suspicion of 2009 influenza A (H1N1) infection, 77 cases (33 females and 44 males) were confirmed.","Among total 151 patients admitted suspicion 2009 influenza A (H1N1) infection, 77 (33 females 44 males) confirmed.",G0000000|C0439175|C1442061|C0030705|C0184666|C0242114|G0000000|C0021400|G0000000|G0000000|C0009450|C0450371|C0450371|C0015780|C0450371|C0086582|C0521093
"Results: In the nursing home, 101 patients (Phase 1) and 110 patients (Phase 2) were included.","Results: In nursing home, 101 patients (Phase 1) 110 patients (Phase 2) included.",C1274040|G0000000|C0006147|C0442519|C1442061|C0030705|C0205390|G0000000|C1442061|C0030705|C0205390|G0000000|C0332257
124 patients 21 years of age or older were recruited and randomized to receive conventional care or conventional care and an intervention.,124 patients 21 age recruited randomized receive conventional care conventional care intervention.,C1442061|C0030705|C0450371|C0001779|G0000000|C0034656|C1514756|C0439858|C1947933|C0439858|C1947933|C0886296
Colistin administered through the I-neb increases time to exacerbation compared with placebo in adherent patients with bronchiectasis and chronic P. aeruginosa infection.,Colistin administered I-neb increases time exacerbation compared placebo adherent patients bronchiectasis chronic P. aeruginosa infection.,C0009316|C1521801|C0021966|C0205217|C0040223|G0000000|C1707455|C0032042|C0334154|C0030705|C0006267|C0205191|C0369773|G0000000|C0009450
"Weight gain will be calculated as the difference between the booking-in weight and the last recorded weight from 36 weeks gestation to birth, as recorded in the pregnancy care records.","Weight gain calculated difference booking-in weight recorded weight 36 weeks gestation birth, recorded pregnancy care records.",C0005910|C1517378|C0444686|C1705241|C0006002|C0005910|C0034869|C0005910|C0450371|C0439230|C0032961|C0005615|C0034869|C0032961|C1947933|C0034869
"Inclusion criteria: 1) 65-80 years old; 2) bilateral or unilateral stenosis; 3) carotid stenosis ≤70% without clinical symptoms; 4) carotid stenosis >50% with clinical symptoms.4 Exclusion criteria: 1) patients who were suffering from intracranial hemorrhage or whose intracranial hemorrhage occurred in recent three months, or those suffering from fresh lesions of cerebral infarction; 2) patients with blood pressures that were not maintained ideally; 3) patients who were prone to hemorrhage; 4) patients with complete occlusion of carotid artery; 5) stenosis was located in distal site, which was touchable by intervention or surgery; 6) patients with intracranial aneurysm which could not be treated simultaneously or in advance; 7) patients with surgical contraindications; (8) patients with malignant tumors and other malignant diseases.","Inclusion criteria: 1) 65-80 old; 2) bilateral unilateral stenosis; 3) carotid stenosis ≤70% clinical symptoms; 4) carotid stenosis >50% clinical symptoms.4 Exclusion criteria: 1) patients suffering intracranial hemorrhage intracranial hemorrhage occurred months, suffering fresh lesions cerebral infarction; 2) patients blood pressures maintained ideally; 3) patients prone hemorrhage; 4) patients complete occlusion carotid artery; 5) stenosis located distal site, touchable intervention surgery; 6) patients intracranial aneurysm treated simultaneously advance; 7) patients surgical contraindications; (8) patients malignant tumors malignant diseases.",C0007637|C0243161|G0000000|C0450371|C0580836|G0000000|C0238767|C0205092|C0678234|G0000000|C0741968|C0678234|G0000000|C0205210|C0683368|G0000000|C0741968|C0678234|C0450371|C0205210|C0683368|C0680251|C0243161|G0000000|C0030705|C0683278|C0524466|C0019080|C0524466|C0019080|C1709305|C0439231|C0683278|C0443224|C0221198|G0000000|C0021308|G0000000|C0030705|C0005767|C0033095|C1314677|G0000000|G0000000|C0030705|C0033422|C0019080|G0000000|C0030705|C0205197|C0011382|C0741968|C0003842|G0000000|C0678234|G0000000|C0205108|C0205145|G0000000|C0886296|C0038894|G0000000|C0030705|C0524466|C0002940|C1522326|C0521115|C0725066|G0000000|C0030705|C0543467|C0079164|G0000000|C0030705|C0205282|C0027651|C0205282|C0012634
METHODS—Patients were recruited to this prospective multicentre randomised study if they had a newly diagnosed malignant bile duct stricture below the hilum of the liver suitable for stenting with a 10 Fr stent.,METHODS—Patients recruited prospective multicentre randomised study newly diagnosed malignant bile duct stricture hilum liver suitable stenting 10 Fr stent.,G0000000|G0000000|C0023981|C0439743|G0000000|C0557651|C0750546|C0011900|C0205282|C0005388|C0687028|C1261287|C0929176|C0023884|C3900053|C0038257|C0450371|C2348513|C0038257
"The Sequential Organ Failure Assessment (SOFA) [17], Acute Physiology and Chronic Health Evaluation (APACHE) II [18] and Simplified Acute Physiology (SAPS) III [19] severity scores were calculated for all patients on the day of admission.","The Sequential Organ Failure Assessment (SOFA) [17], Acute Physiology Chronic Health Evaluation (APACHE) II [18] Simplified Acute Physiology (SAPS) III [19] severity scores calculated patients day admission.",G0000000|C1548958|C0178784|C0231174|C1261322|G0000000|C0450371|C0205178|C0031842|C0205191|C0018684|C0220825|C0243030|G0000000|C0450371|G0000000|C0205178|C0031842|C1705598|C0439070|C0450371|C0439793|C0449820|C0444686|C0030705|C0332173|C0184666
This study of a school-based asthma management education and medical intervention program did not show any differences between the intervention and control groups on morbidity outcomes.,This study school-based asthma management education medical intervention program differences intervention control morbidity outcomes.,G0000000|C0557651|C0036375|C0004096|C0001554|C0013621|C0199168|C0886296|C1709697|C1705241|C0886296|C0243148|C0026538|C1274040
This was a double-blind study in which neither patients nor investigators knew which treatment patients were receiving.,This double-blind study patients investigators treatment patients receiving.,G0000000|C0013072|C0557651|C0030705|C0035173|C0039798|C0030705|C1514756
"Subjects 5.0-18.9 years of age with a diagnosis of hemoglobin SS, hemoglobin S-β0 thalassemia, or hemoglobin S-OArab and prior documented stroke were eligible for participation and randomization in a 1:1 fashion to either treatment arm if they had received at least 18 months of chronic transfusions after the index stroke and had documented iron overload, defined by LIC > 5 mg/g dry weight liver on baseline liver biopsy.","Subjects 5.0-18.9 age diagnosis hemoglobin SS, hemoglobin S-β0 thalassemia, hemoglobin S-OArab prior documented stroke eligible participation randomization 1:1 fashion treatment arm received 18 months chronic transfusions stroke documented iron overload, defined LIC > 5 mg/g dry weight liver baseline liver biopsy.",C0681850|C0450371|C0001779|C0011900|C0019046|C2699257|C0019046|G0000000|C0039730|C0019046|G0000000|C0332152|C1301725|C0038454|C1548635|C0679823|C0034656|G0000000|G0000000|C0039798|C0446516|C1514756|C0450371|C0439231|C0205191|C0005841|C0038454|C1301725|C0302583|G0000000|C1704788|G0000000|G0000000|G0000000|C1300563|C0011682|C0005910|C0023884|C0168634|C0023884|C0005558
Hospitalisation of patients in the PEI group was significantly shorter than that in the PAI or RFTA group (table 2 ▶).,Hospitalisation patients PEI shorter PAI RFTA (table 2 ▶).,C0019993|C0030705|C0814202|C1282927|C1620101|G0000000|C0039224|G0000000|G0000000
"The GLOW6 study enrolled men and women ≥40 years of age, with moderate-to-severe stable COPD (GOLD stage II or III according to the 2010 GOLD guidelines),28 who were current or ex-smokers with a smoking history of at least 10 pack-years, and had a post-bronchodilator forced expiratory volume in 1 second (FEV1) ≥30% and <80% of the predicted normal and postbronchodilator FEV1/forced vital capacity (FVC) ratio of <0.70 at screening (GOLD stage II or III).28 Postbronchodilator refers to 1 hour after sequential inhalation of 84 μg ipratropium bromide (or equivalent dose) and 400 μg salbutamol (or equivalent dose).","The GLOW6 study enrolled women ≥40 age, moderate-to-severe stable COPD (GOLD stage II III 2010 GOLD guidelines),28 current ex-smokers smoking history 10 pack-years, post-bronchodilator forced expiratory volume 1 (FEV1) ≥30% <80% predicted normal postbronchodilator FEV1/forced vital capacity (FVC) ratio <0.70 screening (GOLD stage II III).28 Postbronchodilator refers 1 hour sequential inhalation 84 μg ipratropium bromide (or equivalent dose) 400 μg salbutamol (or equivalent dose).",G0000000|G0000000|C0557651|G0000000|C0043210|G0000000|C0001779|C0205081|C0205360|C0024117|C0018026|C0205390|G0000000|C0439070|G0000000|C0018026|C0162791|C0521116|C0337671|C0037369|C0019664|C0450371|C1277691|C2599594|C0441722|C0231800|C0449468|G0000000|G0000000|G0000000|C0450371|C0681842|C0205307|C2599594|C0441722|C0442732|C1516240|C3714541|C0456603|C0450371|C0220908|C0018026|C0205390|G0000000|C0439070|C2599594|C0205543|G0000000|C0439227|C1548958|C0004048|C0450371|G0000000|C0027235|C0006222|G0000000|C0205163|C0178602|C1442061|G0000000|C0001927|G0000000|C0205163|C0178602
The study participants will be adult critically ill patients admitted to the ICU at any of the three study sites.,The study participants adult critically ill patients admitted ICU study sites.,G0000000|C0557651|C0679646|C0001675|G0000000|C0231218|C0030705|C0184666|C0021708|C0557651|C0205145
"The inclusion criteria of participating in this study were: age between 18 and 24, being single, BMI = 19-25, getting pain intensity score of 5-8 in visual analogue scale, filling written consent, no history of abdominopelvic surgery, not being prohibited from taking herbs and non-steroidal anti-inflammatory drugs (e.g.","The inclusion criteria participating study were: age 18 24, single, BMI = 19-25, pain intensity score 5-8 visual analogue scale, filling written consent, history abdominopelvic surgery, prohibited herbs non-steroidal anti-inflammatory drugs (e.g.",G0000000|C0007637|C0243161|C0679823|C0557651|G0000000|C0001779|C0450371|C0450371|C0037179|G0000000|G0000000|C0450371|C0030193|C0522510|C0449820|G0000000|C0234621|C0243071|C0175659|G0000000|C0043266|C1511481|C0019664|G0000000|C0038894|C0138547|C0019240|C1518422|C0003209|C0013227|G0000000
"The study was conducted in three Aboriginal communities located 70 Km from Darwin, in tropical northern Australia.","The study conducted Aboriginal communities located 70 Km Darwin, tropical northern Australia.",G0000000|C0557651|C0004927|C0935542|C0009462|G0000000|C0450371|G0000000|G0000000|G0000000|C1709269|C0004340
The walking group did not differ significantly from the flexibility and relaxation group and the Nordic walking group.,The walking flexibility relaxation Nordic walking group.,G0000000|C0080331|C0242808|C0035028|C0331873|C0080331|C0441833
Objective To assess the effect of brief interventions during the “watchful waiting” period for hypertension.,Objective To assess interventions “watchful waiting” period hypertension.,C0018017|C0040363|C1516048|C0886296|G0000000|G0000000|C0439531|C0020538
"During the study period, 540 population controls and 540 hospital controls were selected from Shenyang residents and from outpatients at the same hospital to separately match cases in a 1:1 ratio.","During study period, 540 population controls 540 hospital controls selected Shenyang residents outpatients hospital separately match 1:1 ratio.",G0000000|C0557651|C0439531|C1442061|C0032659|C0243148|C1442061|C0019994|C0243148|C1707391|G0000000|C1320928|C0029921|C0019994|G0000000|C0150103|G0000000|C0456603
"Incident patients at 2 centers in Canada and 1 in Hong Kong were randomized (by minimization) in an open-label parallel group trial to receive Gambrosol Trio or standard PD solution (Dianeal; Baxter Healthcare, Mississauga, Canada) for 2 years.","Incident patients 2 centers Canada 1 Hong Kong randomized (by minimization) open-label parallel trial receive Gambrosol Trio standard PD solution (Dianeal; Baxter Healthcare, Mississauga, Canada) 2 years.",C1551358|C0030705|G0000000|C0205099|C0006823|G0000000|G0000000|G0000000|C0034656|G0000000|G0000000|C1709323|C2348042|C0008976|C1514756|G0000000|C1336674|C1442989|G0000000|C0037633|G0000000|G0000000|C0086388|G0000000|C0006823|G0000000|C0439234
"Diabetes,…), dermatologic disorders (any kinds of lesions, inflammation or eczema within the field of heat and cold therapy), gestational hypertension, polyhydramnios or oligohydramnios, decreased fetal movements, intrauterine growth retardation, fetal death, and history of infertility were not enrolled.","Diabetes,…), dermatologic disorders (any kinds lesions, inflammation eczema field heat cold therapy), gestational hypertension, polyhydramnios oligohydramnios, decreased fetal movements, intrauterine growth retardation, fetal death, history infertility enrolled.",G0000000|C0205489|C0012634|G0000000|C0332307|C0221198|C0021368|C0013595|C0440042|C0018837|C0009264|C0039798|C0439671|C0020538|C0020224|C0079924|C0205216|C0015965|C0026649|C0694756|C0018270|C0521111|C0015965|C0011065|C0019664|C0021359|G0000000
"Women were excluded if they were pregnant or intended to become pregnant during the next 6 months, were currently breastfeeding, had an untreated abnormal pap smear, or had major medical morbidity or severe anemia with hemoglobin <8.0 mg/dL, elevated liver enzymes more than 1.5 times the upper limit of normal, or active substance abuse.","Women excluded pregnant intended pregnant 6 months, breastfeeding, untreated abnormal pap smear, major medical morbidity severe anemia hemoglobin <8.0 mg/dL, elevated liver enzymes 1.5 times upper limit normal, active substance abuse.",C0043210|C1554077|C0549206|C1283828|C0549206|G0000000|C0439231|C0006147|C0332155|C0205161|C1740167|C0444186|C0205082|C0199168|C0026538|C0205082|C0002871|C0019046|G0000000|C0439269|C0205250|C0023884|C0014442|G0000000|C0040223|C1282910|C0439801|C0205307|C0205177|C0439861|C0013146
Median time to progression for patients on study was 2.5 months (breast cancer) and 2.0 months (ovarian cancer).,Median time progression patients study 2.5 months (breast cancer) 2.0 months (ovarian cancer).,C0549183|C0040223|C0242656|C0030705|C0557651|G0000000|C0439231|C0006141|C0006826|G0000000|C0439231|C0205065|C0006826
There were no significant differences in the baseline EDSS between the two groups.,There differences baseline EDSS groups.,G0000000|C1705241|C0168634|C0451246|C0441833
"Glutamine dipeptide-supplemented parenteral nutrition did not alter infection rates following pancreatic necrosis surgery but significantly decreased infections in SICU patients after cardiac, vascular, and colonic surgery.","Glutamine dipeptide-supplemented parenteral nutrition alter infection rates pancreatic necrosis surgery decreased infections SICU patients cardiac, vascular, colonic surgery.",C0017797|C0012512|C0030547|C0028707|C0392747|C0009450|C0871208|C0030274|C0027540|C0038894|C0205216|C3714514|G0000000|C0030705|C0018787|C0005847|C0009368|C0038894
International funds may be needed for long-term follow up and conduct of nested case–control analyses.,International funds long-term follow conduct nested case–control analyses.,C1512888|C0016820|C0443252|C0332283|C0004927|G0000000|G0000000|C0002778
A random sample of 100 children aged 0 to 60 per community were taken from a door-to-door census and were assessed for active trachoma according to the WHO simplified grading system.,A random sample 100 children aged 0 60 community door-to-door census assessed active trachoma WHO simplified grading system.,G0000000|C0034656|C0370003|C1442061|C0008059|C0001779|G0000000|C0450371|C0009462|C0557698|C0007663|C1516048|C0205177|C0040592|G0000000|G0000000|C0441800|C0449913
"Areas were mapped so that a predominantly vulnerable population (20 DMCs, intervention area, population ~2 million) received the ICF intervention whereas the remainder (11 DMCs, non-intervention area, population ~1.1 million) did not.","Areas mapped vulnerable population (20 DMCs, intervention area, population ~2 million) received ICF intervention remainder (11 DMCs, non-intervention area, population ~1.1 million) not.",C0205146|C3858752|G0000000|C0032659|C0450371|G0000000|C0886296|C0017446|C0032659|G0000000|C1881839|C1514756|G0000000|C0886296|G0000000|C0450371|G0000000|C1518422|C0017446|C0032659|G0000000|C1881839|C1518422
"Therefore, the use of a similar exercise training regimen for people with dust-related pleural and interstitial respiratory diseases, as has been previously used in COPD [17], resulted in improvements in exercise capacity that exceeded the MID established for people with COPD or other ILD.","Therefore, exercise training regimen people dust-related pleural interstitial respiratory diseases, COPD [17], improvements exercise capacity exceeded MID established people COPD ILD.",G0000000|C0015259|C0040607|C0040808|C0027361|C0013330|C0032225|C0596790|C0521346|C0012634|C0024117|C0450371|C2986411|C0015259|C1516240|G0000000|C0444598|C0443211|C0027361|C0024117|C0206062
"In addition, they had to achieve a score higher than 24 in the Short Orientation Memory Concentration (SOMC) assessment.","In addition, achieve score 24 Short Orientation Memory Concentration (SOMC) assessment.",G0000000|C0332287|G0000000|C0449820|C0450371|C1282927|C0029266|C0025260|C0004268|G0000000|C1261322
In fact between 10-20% of C. difficile cases are observed in the elderly patients [26].,In 10-20% C. difficile observed elderly patients [26].,G0000000|C0450371|G0000000|G0000000|C1441672|C0001792|C0030705|C0450371
Remission was defined as patients with a UC-DAI of 2 or less and a bloody stool score of 0 at the final assessment.,Remission defined patients UC-DAI 2 bloody stool score 0 final assessment.,C0544452|C1704788|C0030705|C0683432|G0000000|C0333275|C0015733|C0449820|G0000000|C0205088|C1261322
"*Children had less than one rescue oral corticosteroid course in the past 6 months, or less than two in the previous 12 months.","*Children rescue oral corticosteroid 6 months, previous 12 months.",C0008059|G0000000|C0442027|C0001617|G0000000|C0439231|C0205156|C0450371|C0439231
"Subjects without OSA (AHI ≤5 events/h of sleep), or with severe oxygen desaturation (nadir overnight SaO2 <70 %), were excluded from further participation.","Subjects OSA (AHI ≤5 events/h sleep), severe oxygen desaturation (nadir overnight SaO2 <70 %), excluded participation.",C0681850|C0520679|G0000000|G0000000|C0441471|C0037313|C0205082|C0030054|C0746961|C1708760|C0439583|G0000000|C0450371|G0000000|C1554077|C0679823
"A total of 68 schools met eligibility criteria, of which 18 agreed to participate, and the 7 best-matched pairs (the N that funding would support) were selected for participation; the following variables were used in the matching process: ethnicity, percentage of students who met or exceeded criteria for passing the ISAT, attendance rate, truancy rate, percentage of students who received free lunch, percentage of students who enrolled in or left school during the academic year, number of students per grade, percentage of parents reported to demonstrate school involvement, percentage of teachers employed by the school who met minimal teaching standards, and crime rate for the neighborhood in which the school was located.15–18 A series of t-tests revealed that the 7 pairs of schools did not significantly differ from the remainder of the 68 schools eligible for the study, and the PA and control schools were not significantly different from each other on any of the matching variables.15, 17 Throughout the 6 years of the study, 100% of schools were retained.","A total 68 schools met eligibility criteria, 18 agreed participate, 7 best-matched pairs (the N funding support) selected participation; variables matching process: ethnicity, percentage students met exceeded criteria passing ISAT, attendance rate, truancy rate, percentage students received free lunch, percentage students enrolled left school academic year, students grade, percentage parents reported demonstrate school involvement, percentage teachers employed school met minimal teaching standards, crime rate neighborhood school located.15–18 A series t-tests revealed 7 pairs schools remainder 68 schools eligible study, PA control schools matching variables.15, 17 Throughout 6 study, 100% schools retained.",G0000000|C0439175|C0450371|C0036375|C0268621|C0013893|C0243161|C0450371|C3641827|G0000000|G0000000|C1522427|C1709450|G0000000|C0369718|C0243098|C0183683|C1707391|C0679823|C0439828|C0150103|C1184743|C0015031|C0439165|C0038492|C0268621|G0000000|C0243161|G0000000|G0000000|C2827364|C0871208|C0424357|C0871208|C0439165|C0038492|C1514756|C0332296|C2697949|C0439165|C0038492|G0000000|C0205091|C0036375|C1510747|C0439234|C0038492|C0441800|C0439165|C0030551|C0684224|G0000000|C0036375|C1314939|C0439165|C0221457|C0014003|C0036375|C0268621|C0547040|C0039401|C0038137|C0010325|C0871208|C0027569|C0036375|G0000000|G0000000|C0205549|C0871472|C0443289|G0000000|C1709450|C0036375|G0000000|C0450371|C0036375|C1548635|C0557651|C0030428|C0243148|C0036375|C0150103|C0439828|C0450371|G0000000|G0000000|C0557651|C1442061|C0036375|C0333118
"To test the difference in outcomes after 2 years of treatment between the intervention group and the placebo group, analysis of covariance (ANCOVA) was performed.","To test difference outcomes 2 treatment intervention placebo group, analysis covariance (ANCOVA) performed.",C0040363|C0022885|C1705241|C1274040|G0000000|C0039798|C0886296|C0032042|C0441833|C0002778|G0000000|C0814908|C0884358
A sample of ninety (90) consenting pregnant women will be recruited to participate.,A sample (90) consenting pregnant women recruited participate.,G0000000|C0370003|C0450371|C1511481|C0549206|C0043210|G0000000|G0000000
We randomly assigned 70 renal transplant recipients (CMV-seropositive recipient or donor) to 3-month prophylaxis with valacyclovir (n=34) or pre-emptive valganciclovir for significant CMV viremia detected at predefined assessments through month 12 (n=36).,We randomly assigned 70 renal transplant recipients (CMV-seropositive recipient donor) 3-month prophylaxis valacyclovir (n=34) pre-emptive valganciclovir CMV viremia detected predefined assessments month 12 (n=36).,G0000000|G0000000|C1516050|C0450371|C0022646|C0040732|C1709854|C0521143|C1709854|C0013018|C0332177|C0033107|C0249458|C0369718|C0332152|C0909381|G0000000|C0042749|C0442726|G0000000|C1261322|C0332177|C0450371|C0369718
"The trial will be conducted in Rupganj, a rural subdistrict/upazila of Narayanganj district about 50 km from Dhaka, in Bangladesh.","The trial conducted Rupganj, rural subdistrict/upazila Narayanganj district 50 km Dhaka, Bangladesh.",G0000000|C0008976|C0004927|G0000000|C0240919|G0000000|G0000000|G0000000|G0000000|G0000000|C0004732
"Mother–child interaction, maternal psychological health attitudes and behaviour, infant functioning and development, and risk of neglect or abuse.","Mother–child interaction, maternal psychological health attitudes behaviour, infant functioning development, risk neglect abuse.",G0000000|C1704675|C2347083|C0205486|C0018684|C0004271|C0004927|C0021270|C0205245|C0243107|C0035647|C0521874|C0013146
"Patients eligible for this study were aged 18 years or older, had a Karnofsky performance score of 70 or higher (a score of ≥70 ensures independence in activities of daily living), and had newly diagnosed and histologically confirmed supratentorial glioblastoma (World Health Organization [WHO] grade IV astrocytoma).","Patients eligible study aged 18 older, Karnofsky performance score 70 (a score ≥70 ensures independence activities daily living), newly diagnosed histologically confirmed supratentorial glioblastoma (World Health Organization [WHO] grade IV astrocytoma).",C0030705|C1548635|C0557651|C0001779|C0450371|C0580836|C0206065|C0597198|C0449820|C0450371|G0000000|C0449820|G0000000|C0218063|C0085862|C0441655|C0332173|C0376558|C0750546|C0011900|C0205462|C0521093|C0441938|C0017636|C2700280|C0018684|C0029237|G0000000|C0441800|C0022326|C0004114
"For each one, write down something you can do instead, e.g., if you’re angry, try deep breathing.”; and “Stay away from people/places that make you think of smoking.","For one, write instead, e.g., you’re angry, deep breathing.”; “Stay people/places smoking.",G0000000|C0205447|C0043266|G0000000|G0000000|G0000000|C0002957|C0205125|G0000000|G0000000|C0027361|C0037369
": a post-bronchodilator FEV1 of less than 80% predicted, an FEV1/FVC ratio of less than 70% and a pre to post-bronchodilator change in FEV1of less than 15%.",": post-bronchodilator FEV1 80% predicted, FEV1/FVC ratio 70% pre post-bronchodilator change FEV1of 15%.",G0000000|C2599594|G0000000|C0450371|C0681842|C3714541|C0456603|C0450371|C0332152|C2599594|C0392747|G0000000|C0450371
"The study was conducted at three project sites (cities in the south, southeast, and northeast United States) and families were recruited from ASD specialty clinics, early intervention programs, pediatric and neurology practices, and the online Interactive Autism Network.","The study conducted project sites (cities south, southeast, northeast United States) families recruited ASD specialty clinics, intervention programs, pediatric neurology practices, online Interactive Autism Network.",G0000000|C0557651|C0004927|C1709701|C0205145|C0008848|C1710133|C1711190|C1709272|C0166872|C1301808|C0015576|G0000000|C0003516|C0037778|C0442592|C0886296|C0376691|C0030755|C0027855|C0237607|G0000000|C1704675|C0004352|C0150775
"Exclusion criteria included concomitant illness with reasonable likelihood of limiting survival to less than one year, current substance abuse, known, suspected or planned pregnancy in next year, other concomitant menopause treatment, participating in acupuncture treatment or formal psychological stress management program within the last year, participating in another treatment for VMS, unless willing to stop it 4 weeks in advance of participation, HIV infection, chronic or active hepatitis or other blood-borne illness.","Exclusion criteria included concomitant illness reasonable likelihood limiting survival year, current substance abuse, known, suspected planned pregnancy year, concomitant menopause treatment, participating acupuncture treatment formal psychological stress management program year, participating treatment VMS, 4 weeks advance participation, HIV infection, chronic active hepatitis blood-borne illness.",C0680251|C0243161|C0332257|C0521115|C0221423|G0000000|C0033204|C0439801|C0038952|C0439234|C0521116|C0439861|C0013146|C0205309|C0332147|C1301732|C0032961|C0439234|C0521115|C0025320|C0039798|C0679823|C0001299|C0039798|C0348078|C0205486|C0038435|C0001554|C1709697|C0439234|C0679823|C0039798|G0000000|G0000000|C0439230|C0725066|C0679823|C0019682|C0009450|C0205191|C0205177|C0019158|C0005767|C0221423
Patients’ baseline characteristics Note: Data are presented as mean ± standard deviation.,Patients’ baseline characteristics Note: Data ± standard deviation.,G0000000|C0168634|C1521970|C1316572|C1511726|G0000000|C1442989|C0012727
"All adult cancer patients who were candidates for HPN according to the European guidelines 7, 8 were consecutively enrolled when meeting all the following criteria: proven and prolonged failure to meet nutrition requirements by the oral or enteral route, with impending risk of death due to malnutrition; life expectancy >2 months; Karnofsky performance status (KPS) >50; control of pain; absence of severe organ dysfunctions; written informed consent confirming that the patient accepted this modality of nutrition support; approval by the physician responsible for HPN, the oncologist and the general practitioner; presence of environmental conditions compatible with HPN; availability of an in‐home caregiver; and availability of a specifically trained nursing team dedicated to the patient home care, as provided by the Public Health Service.","All adult cancer patients candidates HPN European guidelines 7, 8 consecutively enrolled meeting criteria: proven prolonged failure meet nutrition requirements oral enteral route, impending risk death malnutrition; life expectancy >2 months; Karnofsky performance status (KPS) >50; control pain; absence severe organ dysfunctions; written informed consent confirming patient accepted modality nutrition support; approval physician responsible HPN, oncologist practitioner; presence environmental conditions compatible HPN; availability in‐home caregiver; availability trained nursing team dedicated patient care, provided Public Health Service.",G0000000|C0001675|C0006826|C0030705|G0000000|C1415700|C0239307|C0162791|G0000000|G0000000|G0000000|G0000000|C0556656|C0243161|C0456369|C0439590|C0231174|C1550543|C0028707|C1514873|C0442027|C1304890|C0013153|C0332190|C0035647|C0011065|C0162429|C0376558|C0679138|G0000000|C0439231|C0206065|C0597198|C0449438|C0206065|C0450371|C0243148|C0030193|C0332197|C0205082|C0178784|C0031847|C0043266|C1522154|C1511481|C0521093|C0030705|C1272684|C0695347|C0028707|C0183683|C0205540|C0031831|C1273518|C1415700|C0259990|C1709627|C0150312|C0014406|C0012634|C0332290|C1415700|C0470187|G0000000|C0085537|C0470187|C0336809|C0006147|C0871489|C0011129|C0030705|C1947933|C1999230|G0000000|C0018684|C0557854
"To reduce the burden on coaches, some participants might choose to complete activities in community centers.","To reduce burden coaches, participants choose complete activities community centers.",C0040363|G0000000|C2828008|C0876909|C0679646|C1707391|C0205197|C0441655|C0009462|C0205099
"Potential participants with a cognitive impairment (< 24 MMSE) or with long/unpredictable ""off"" periods making stable testing difficult will also be excluded.","Potential participants cognitive impairment (< 24 MMSE) long/unpredictable ""off"" periods stable testing difficult excluded.",C3245505|C0679646|C1516691|C0221099|G0000000|C0450371|C0451306|C0205166|G0000000|C0439531|C0205360|C0039593|C0332218|C1554077
Values at screening phase refer to the mean number of nocturnal leg cramps per week during the 2 weeks of screening; error bars represent standard errors.,Values screening phase refer nocturnal leg cramps week 2 weeks screening; error bars represent standard errors.,C0042295|C0220908|C0205390|C0205543|C0240526|C0023216|C0026821|C0332174|G0000000|C0439230|C0220908|C0743559|C0687760|C1882932|C1442989|C0743559
"The aim, therefore, of this trial was to examine the feasibility of undertaking an RCT smoking cessation intervention, delivered by trained dental hygienists, in a cohort of periodontal patients attending an outpatient dental hospital department.","The aim, therefore, trial examine feasibility undertaking RCT smoking cessation intervention, delivered trained dental hygienists, cohort periodontal patients attending outpatient dental hospital department.",G0000000|C1947946|G0000000|C0008976|G0000000|G0000000|C0041666|G0000000|C0037369|C1880019|C0886296|C1705822|C0336809|C0011365|C0011369|C0599755|C2960678|C0030705|C1547429|C0029921|C0011365|C0019994|C1704729
"Only patients with DM and no documented CVD as defined above need ≥1 additional risk factor as listed, and they will be counted under CV Risk Stratum 2.","Only patients DM documented CVD defined ≥1 additional risk factor listed, counted CV Risk Stratum 2.",C0205171|C0030705|C3250443|C1301725|C0007222|C1704788|G0000000|C1524062|C0035647|C1521761|C0745732|C0750480|C3538987|C0035647|G0000000|G0000000
Acute respiratory illness (ARI) is the most common cause of acute presentations and hospitalisations of young Indigenous children in Australia and New Zealand (NZ).,Acute respiratory illness (ARI) common acute presentations hospitalisations Indigenous children Australia New Zealand (NZ).,C0205178|C0521346|C0221423|C1412533|C0205214|C0205178|C0449450|C0019993|C1512704|C0008059|C0004340|C0205314|G0000000|C0027978
Figure 1.,Figure 1.,G0000000|G0000000
Participants 166 extremely preterm infants born before 28 weeks of gestation: 86 were randomised to cerebral NIRS monitoring and 80 to blinded NIRS monitoring.,Participants 166 extremely preterm infants born 28 weeks gestation: 86 randomised cerebral NIRS monitoring 80 blinded NIRS monitoring.,C0679646|C1442061|C0205403|C0151526|C0021270|C0005615|C0450371|C0439230|C0032961|C0450371|G0000000|G0000000|C1826446|C0150369|C0450371|C0150108|C1826446|C0150369
All women except one were Caucasian.,All women Caucasian.,G0000000|C0043210|C0007457
"It targeted the enrollment of 80 community-dwelling persons, aged 70-85 years, who were at risk for cognitive decline but who did not have mild cognitive impairment [17] as defined by the inclusion/exclusion criteria related to cognition (Table (Table1).1).","It targeted enrollment 80 community-dwelling persons, aged 70-85 years, risk cognitive decline mild cognitive impairment [17] defined inclusion/exclusion criteria cognition (Table (Table1).1).",G0000000|C1521840|C1516879|C0450371|C4045975|C0027361|C0001779|C0450371|C0439234|C0035647|C1516691|G0000000|C2945599|C1516691|C0221099|C0450371|C1704788|C0680252|C0243161|C0009240|C0039224|G0000000
"Patients had stable disease within the last four weeks before enrolment, and FEV1 > 40% pred.","Patients stable disease weeks enrolment, FEV1 > 40% pred.",C0030705|C0205360|C0012634|C0439230|C1516879|G0000000|G0000000|C0450371|C0032952
The Peter James Centre is a metropolitan hospital for rehabilitation and the care of elderly patients with three subacute wards (98 beds).,The Peter James Centre metropolitan hospital rehabilitation care elderly patients subacute wards (98 beds).,G0000000|G0000000|G0000000|C0205099|C0599587|C0019994|C0034991|C1947933|C0001792|C0030705|C0205365|C1305702|C0450371|C0004916
"3) Patients with a known history of hypersensitivity to any part of the drugs or products used in this study including calcium alginate, polyurethane foam, or silver derivatives.","3) Patients history hypersensitivity drugs products study including calcium alginate, polyurethane foam, silver derivatives.",G0000000|C0030705|C0019664|C0020517|C0013227|C1514468|C0557651|C0332257|C0006675|C0102137|C0032616|C0280592|C0037125|C0243072
"All potential participants were first screened by a telephone interview based on the following inclusion criteria: (1) a single stroke >1 year onset, (2) age ≥50 years, (3) ability to walk >10 meters independently (with or without walking aids), and (4) living at home.","All potential participants screened telephone interview based inclusion criteria: (1) single stroke >1 onset, (2) age ≥50 years, (3) ability walk >10 meters independently (with walking aids), (4) living home.",G0000000|C3245505|C0679646|C0220908|C0039457|C0021822|C1527178|C0007637|C0243161|G0000000|C0037179|C0038454|G0000000|C0206132|G0000000|C0001779|G0000000|C0439234|G0000000|C0085732|C0080331|C0450371|C0441074|G0000000|G0000000|C0080331|C0001175|G0000000|C0376558|C0442519
Their mean (± SD) age at onset of OCD was 9.5 ± 3.2 (range 3 to 17) years.,Their (± SD) age onset OCD 9.5 ± 3.2 (range 3 17) years.,G0000000|G0000000|C2699239|C0001779|C0206132|C0028768|G0000000|G0000000|G0000000|C1514721|G0000000|C0450371|C0439234
"Enrolled in the study were 148 individuals, 29 females (20%) and 119 males, with an average age of 39.4 years (median =39.0).","Enrolled study 148 individuals, 29 females (20%) 119 males, average age 39.4 (median =39.0).",G0000000|C0557651|C1442061|C0027361|C0450371|C0015780|C0450371|C1442061|C0086582|C1510992|C0001779|C0450371|C0549183|C0450371
"Patients eligible for the RCT were ≥18 years of age with advanced illness (defined as a terminal illness [e.g., incurable cancer or other end-stage disease]), had a life expectancy of ≥1 month and OIC (<3 bowel movements in the last week and no bowel movement in 24 hours or no bowel movement in 48 hours), and were receiving stable doses of laxatives and opioids.","Patients eligible RCT ≥18 age advanced illness (defined terminal illness [e.g., incurable cancer end-stage disease]), life expectancy ≥1 month OIC (<3 bowel movements week bowel movement 24 hours bowel movement 48 hours), receiving stable doses laxatives opioids.",C0030705|C1548635|G0000000|G0000000|C0001779|C0205179|C0221423|C1704788|C0205088|C0221423|G0000000|G0000000|C0006826|C0205088|C0012634|C0376558|C0679138|G0000000|C0332177|C0268358|G0000000|C0021853|C0026649|C0332174|C0021853|C0026649|C0450371|C0439227|C0021853|C0026649|C0450371|C0439227|C1514756|C0205360|C0178602|C0282090|C0242402
"Managers of the TB program also perceived this as a problem, not for the reasons of equity cited by patients and nurses, but because they feared that it would act as a perverse incentive: ‘If you target for example the TB patients, then people see that TB patients have better or get things for just being TB patients.","Managers TB program perceived problem, reasons equity cited patients nurses, feared perverse incentive: ‘If target TB patients, people TB patients TB patients.",C0335141|G0000000|C1709697|C0030971|C0033213|C0392360|G0000000|G0000000|C0030705|C0028661|C0015726|G0000000|C0021147|G0000000|C1521840|G0000000|C0030705|C0027361|G0000000|C0030705|G0000000|C0030705
"The inclusion criteria were; 1) able to walk more than 10 meters without or with assisting devices such as orthotics, a walker, or a cane; 2) no symptoms with any lower motor neuron lesion and orthopedic diseases; 3) a score higher than 24 points on the MMSE; and 4) able to read the words on a monitor 60 cm away at eye level.","The inclusion criteria were; 1) walk 10 meters assisting devices orthotics, walker, cane; 2) symptoms lower motor neuron lesion orthopedic diseases; 3) score 24 MMSE; 4) read monitor 60 cm eye level.",G0000000|C0007637|C0243161|G0000000|G0000000|C0080331|C0450371|C0441074|C0557034|C0025080|C0813253|C0043016|C0006856|G0000000|C0683368|C0441994|C1513492|C0027882|C0221198|C0029355|C0012634|G0000000|C0449820|C0450371|C0451306|G0000000|C0034754|C0030695|G0000000|C0015392|C0441889
The Costa Rica Vaccine Trial (CVT)9 is a study in Costa Rica sponsored by the National Cancer Institute (NCI).,The Costa Rica Vaccine Trial (CVT)9 study Costa Rica sponsored National Cancer Institute (NCI).,G0000000|C0035561|G0000000|C0042210|C0008976|C0240912|C0557651|C0035561|G0000000|C1711305|C3245503|C0006826|C0021622|C1513882
"Even among subjects who stopped wearing GP lenses after the run-in period was completed, everyone reported that his or her contact lenses were “always comfortable” or “usually comfortable.” This crossover analysis was based upon a small sample, so it is difficult to make strong conclusions.","Even subjects stopped wearing GP lenses run-in period completed, reported contact lenses “always comfortable” “usually comfortable.” This crossover analysis based sample, difficult strong conclusions.",G0000000|C0681850|C1272691|G0000000|C3811116|C0023317|C3274438|C0439531|C0205197|C0684224|C0332158|C0023317|G0000000|G0000000|G0000000|G0000000|G0000000|C0010366|C0002778|C1527178|C0370003|C0332218|C0442821|C1707478
"Patients were randomly assigned to receive 3 times a week either 250 mg of azithromycin (n = 243) or placebo (n = 237) for 2 years, starting at the time of the conditioning regimen.","Patients randomly assigned receive 3 times week 250 azithromycin (n = 243) placebo (n = 237) 2 years, starting time conditioning regimen.",C0030705|G0000000|C1516050|C1514756|G0000000|C0040223|C0332174|C1442061|C0052796|G0000000|C0032042|G0000000|G0000000|C0439234|C0439659|C0040223|C0009647|C0040808
"Backache, interscapular and radicular pain were most frequently present in the acute phase.","Backache, interscapular radicular pain frequently acute phase.",C0004604|G0000000|C0040452|C0030193|C0332183|C0205178|C0205390
Eligible patients were those already taking insulin and receiving endocrinologist-directed care through a diabetes centre and whose most recent HbA1c level was 0.085 or higher.,Eligible patients insulin receiving endocrinologist-directed care diabetes centre HbA1c level 0.085 higher.,C1548635|C0030705|C0021641|C1514756|C0259863|C1947933|C0011847|C0205099|G0000000|C0441889|C1442061|C0205250
Exclusion criteria included any significant general health problem or orthopedic problem that would keep them from fully participating in the intervention protocol and/or the inability to attend at least 80% of the training sessions.,Exclusion criteria included health orthopedic participating intervention protocol and/or inability attend 80% training sessions.,C0680251|C0243161|C0332257|C0018684|C0029355|C0679823|C0886296|C0442711|G0000000|G0000000|C1999232|C0450371|C0040607|C1883016
Surgical candidates from 13 centers in 11 U.S. states who had at least 12 weeks of symptoms and image-confirmed degenerative spondylolisthesis were offered enrollment in a randomized cohort or an observational cohort.,Surgical candidates 13 centers 11 U.S. 12 weeks symptoms image-confirmed degenerative spondylolisthesis offered enrollment randomized cohort observational cohort.,C0543467|G0000000|C0450371|C0205099|C0450371|C0041703|C0450371|C0439230|C0683368|C1704254|C0011164|C0038016|C1444648|C1516879|C0034656|C0599755|C1518527|C0599755
"Between 1992 and 2003 there were 79 patients (median age 62, range 19–91) who had laparotomy for small bowel obstruction due to recurrent cancer.","Between 1992 2003 79 patients (median age 62, range 19–91) laparotomy bowel obstruction recurrent cancer.",G0000000|G0000000|G0000000|C0450371|C0030705|C0549183|C0001779|C0450371|C1514721|G0000000|C0023038|C0021853|C0028778|C2945760|C0006826
"The total cumulative doses of previously used ICS must not have exceeded 36 mg, 12 mg of nasal corticosteroids or oral doses equivalent to 200 mg prednisolone.","The total cumulative doses ICS exceeded 36 mg, 12 nasal corticosteroids oral doses equivalent 200 prednisolone.",G0000000|C0439175|C1511559|C0178602|C0022521|G0000000|C0450371|C0026410|C0450371|C0028429|C0001617|C0442027|C0178602|C0205163|C1442061|C0032950
"Infants were excluded if they were already below the 5th percentile in WHO growth charts on weight-for-age at baseline, had a history of two or more hospital admissions at the time of enrollment (each hospital stay >7 days), had serious congenital anomalies (cleft palate, congenital heart disease, neural tube defect), other chronic conditions impairing feeding (e.g.","Infants excluded 5th percentile WHO growth charts weight-for-age baseline, history hospital admissions time enrollment (each hospital stay >7 days), congenital anomalies (cleft palate, congenital heart disease, neural tube defect), chronic conditions impairing feeding (e.g.",C0021270|C1554077|G0000000|C1264641|G0000000|C0018270|C0684240|C0005910|C0168634|C0019664|C0019994|C0184666|C0040223|C1516879|G0000000|C0019994|G0000000|G0000000|C0439228|C0009678|C0000769|C0205242|C0700374|C0009678|C0018787|C0012634|C3714606|C0175730|C1457869|C0205191|C0012634|C0221099|C0204695|G0000000
"The sample was 66% Female, 62% non-Hispanic Caucasian, 33% married, 57% with an annual household income below $20,000, average age 47.5 (SD=12.0) and average cigarettes per day at baseline of 20.5 (SD=11.8).","The sample 66% Female, 62% non-Hispanic Caucasian, 33% married, 57% annual household income $20,000, average age 47.5 (SD=12.0) average cigarettes day baseline 20.5 (SD=11.8).",G0000000|C0370003|C0450371|C0015780|C0450371|C1518424|C0007457|C0450371|C0024841|C0450371|C0332181|C0020052|C0021162|C0450371|C1510992|C0001779|C0450371|C0450371|C1510992|C0677453|C0332173|C0168634|C0450371|C0450371
"Exclusion Criteria consisted of abnormalities of vitamin D related hormonal system other than low dietary intake or decreased sun exposure (such as: intestinal malabsorption, chirosis, nephrotic syndrome, hyperthyroidism, creatinine clearance of less than 40 ml/min, rickets, hypoparathyroidism, hypercalcemia at baseline, known malignancy, Granulomatous disorders and lymphomas).","Exclusion Criteria consisted abnormalities vitamin D hormonal system low dietary intake decreased sun exposure (such as: intestinal malabsorption, chirosis, nephrotic syndrome, hyperthyroidism, creatinine clearance 40 ml/min, rickets, hypoparathyroidism, hypercalcemia baseline, malignancy, Granulomatous disorders lymphomas).",C0680251|C0243161|C0332529|C0000768|C0042890|C0073187|C0458083|C0449913|C0205251|C0012155|C1512806|C0205216|C0038817|C0274281|G0000000|G0000000|C0021853|C0024523|G0000000|G0000000|C0039082|C0020550|C0010294|C0449297|C0450371|C0439445|C0035579|C0020626|C0020437|C0168634|C0006826|C0439667|C0012634|C0024299
Exclusion criteria included patients: receiving concomitant chemotherapy and radiation; on adjuvant phase III studies; with hematopoietic malignancies; with primary brain tumors; not fluent in English; less than 18 years of age or lacking a willing caregiver.,Exclusion criteria included patients: receiving concomitant chemotherapy radiation; adjuvant phase III studies; hematopoietic malignancies; primary brain tumors; fluent English; 18 age lacking caregiver.,C0680251|C0243161|C0332257|C0030705|C1514756|C0521115|C0013216|C0034519|C0001551|C0205390|C0439070|C0947630|C0018957|C0006826|C0205225|C0006104|C0027651|C0870569|C0376245|C0450371|C0001779|C0332268|C0085537
"Potentially eligible women > 34 weeks gestation will be identified during their attendance at the antenatal clinic, antenatal classes, or midwifery group practice, or while an in-patient on the antenatal ward.","Potentially eligible women > 34 weeks gestation identified attendance antenatal clinic, antenatal classes, midwifery practice, in-patient antenatal ward.",G0000000|C1548635|C0043210|G0000000|C0450371|C0439230|C0032961|C0205396|C2827364|C2828394|C0002424|C2828394|C0456387|C0026082|C0237607|C0150312|C2828394|C1305702
"Fellows are first, second, or third-year fellows in Pediatric Critical Care, Cardiology, Hematology/Oncology, or Neonatal-Perinatal Medicine.","Fellows first, second, third-year fellows Pediatric Critical Care, Cardiology, Hematology/Oncology, Neonatal-Perinatal Medicine.",G0000000|C0205435|C0205436|C0205437|G0000000|C0030755|C1511545|C1947933|C0007189|C1441600|C1552240|C0013227
"Questionnaires were administered to obtain the subjects' characteristics, including smoking habits and green tea consumption from 170 primary lung cancer cases and 340 healthy controls.","Questionnaires administered subjects' characteristics, including smoking habits green tea consumption 170 primary lung cancer 340 healthy controls.",C0034394|C1521801|C0681850|C1521970|C0332257|C0037369|C0018464|C0332583|C0039400|C0009830|C1442061|C0205225|C0024109|C0006826|C1442061|C3898900|C0243148
"Eligibility criteria included a Karnofsky performance status of ≥70, stable systemic disease in the 3 months prior to study entry, serum creatinine ≤3 mg/dL, creatinine clearance ≥30 mL/min, total bilirubin ≤2.5 mg/dL, blood urea nitrogen (BUN) <20 mg/dL, Mini Mental State Exam (MMSE) score >18, negative serum pregnancy test, no memantine allergy, no current alcohol or drug abuse, no chronic use of benzodiazepines, and no severe active comorbidity.13 Patients could have received prior therapy for brain metastasis, including radiosurgery and surgical resection (but no prior cranial external beam radiotherapy).","Eligibility criteria included Karnofsky performance status ≥70, stable systemic disease 3 months prior study entry, serum creatinine ≤3 mg/dL, creatinine clearance ≥30 mL/min, total bilirubin ≤2.5 mg/dL, blood urea nitrogen (BUN) <20 mg/dL, Mini Mental State Exam (MMSE) score >18, negative serum pregnancy test, memantine allergy, current alcohol drug abuse, chronic benzodiazepines, severe active comorbidity.13 Patients received prior therapy brain metastasis, including radiosurgery surgical resection (but prior cranial external beam radiotherapy).",C0013893|C0243161|C0332257|C0206065|C0597198|C0449438|G0000000|C0205360|C0205373|C0012634|G0000000|C0439231|C0332152|C0557651|C1705654|C0229671|C0010294|G0000000|C0439269|C0010294|C0449297|G0000000|C0439445|C0439175|C0005437|G0000000|C0439269|C0005767|C0041942|C0028158|G0000000|C0450371|C0439269|C0445542|C0229992|C1301808|C0582103|C0451306|C0449820|C0450371|C0205160|C0229671|C0032961|C0022885|C0025242|C0002111|C0521116|C0001962|C0013227|C0013146|C0205191|C0005064|C0205082|C0205177|C0009488|C0030705|C1514756|C0332152|C0039798|C0006104|C0027627|C0332257|C0085203|C0543467|C0015252|G0000000|C0332152|C0037303|C0205101|C0338248|C0034619
CRF is a distressing and prolonged symptom associated with prostate cancer treatment.,CRF distressing prolonged symptom prostate cancer treatment.,G0000000|C0231303|C0439590|C1457887|C0033572|C0006826|C0039798
"A total of 3,125 children who met the eligibility criteria were enrolled, including 1,017 in the intervention arm and 2,108 in the control arm (Figure 1).","A total 3,125 children met eligibility criteria enrolled, including 1,017 intervention arm 2,108 control arm (Figure 1).",G0000000|C0439175|C1442061|C0008059|C0268621|C0013893|C0243161|G0000000|C0332257|C1442061|C0886296|C0446516|C1442061|C0243148|C0446516|G0000000|G0000000
Patients with HPV-positive OPSCC tend to be young (mean age 54 years) and fit at presentation [2].,Patients HPV-positive OPSCC tend (mean age 54 years) fit presentation [2].,C0030705|C0021344|G0000000|G0000000|C0444504|C0001779|C0450371|C0439234|C0036572|C0449450|G0000000
Participants were able-bodied adolescents aged 11–14 years.,Participants able-bodied adolescents aged 11–14 years.,C0679646|C0085732|C0205653|C0001779|G0000000|C0439234
"We excluded patients with symptoms and signs suggestive of median nerve denervation with axonal loss, including thenar muscular atrophy or weakness, or persistent numbness.28 We also excluded patients with secondary carpal tunnel syndrome owing to coexisting polyneuropathy, inflammatory arthropathy, pregnancy, diabetes mellitus, hypothyroidism, malignancy, rheumatoid arthritis, alcoholism, infections, space-occupying lesions (tumours, hypertrophic synovial tissue, fracture callus and osteophytes) and familial neuropathy.29 Patients who had previous carpal tunnel release surgery, who were taking oral steroids or warfarin, who had received treatment with local steroid injections or acupuncture for carpal tunnel syndrome, or patients with other serious diseases requiring inpatient care were also considered ineligible.","We excluded patients symptoms signs suggestive median nerve denervation axonal loss, including thenar muscular atrophy weakness, persistent numbness.28 We excluded patients secondary carpal tunnel syndrome coexisting polyneuropathy, inflammatory arthropathy, pregnancy, diabetes mellitus, hypothyroidism, malignancy, rheumatoid arthritis, alcoholism, infections, space-occupying lesions (tumours, hypertrophic synovial tissue, fracture callus osteophytes) familial neuropathy.29 Patients previous carpal tunnel release surgery, oral steroids warfarin, received treatment local steroid injections acupuncture carpal tunnel syndrome, patients diseases requiring inpatient care considered ineligible.",G0000000|C1554077|C0030705|C0683368|C0220912|C0332299|C0549183|C0027740|C0011307|C0004461|C1517945|C0332257|C0230374|C0026845|C0333641|C3714552|C0205322|C0020580|G0000000|C1554077|C0030705|C0027627|C0007285|C0337138|C0039082|G0000000|C0152025|C0333348|C0022408|C0032961|C0011847|G0000000|C0020676|C0006826|G0000000|C0003864|C0001973|C3714514|C1883067|C0221198|C0027651|C0020564|C1550315|C0040300|C0016658|C0006767|C0015302|C0015576|C0442874|C0030705|C0205156|C0007285|C0337138|C0030685|C0038894|C0442027|C0038317|C0043031|C1514756|C0039798|C0205276|C0038317|C0021485|C0001299|C0007285|C0337138|C0039082|C0030705|C0012634|G0000000|C0021562|C1947933|C0750591|C1512714
"Patients aged <40 years, with a restart of menstrual bleeding within 6 months after the completion of cytostatic treatment, or with premenopausal hormone levels received goserelin 3.6 mg subcutaneously every 4 weeks for 2 years.","Patients aged <40 years, restart menstrual bleeding 6 months completion cytostatic treatment, premenopausal hormone levels received goserelin 3.6 mg subcutaneously 4 weeks 2 years.",C0030705|C0001779|C0450371|C0439234|C1514902|C0025344|C0019080|G0000000|C0439231|C0205197|C0010858|C0039798|C0279752|C0019932|C0441889|C1514756|C0120107|G0000000|G0000000|G0000000|C0439230|G0000000|C0439234
"Participants will be excluded if they: • have clinically evident brainstem signs • have severe cognitive and/or language deficits which preclude them from following instructions in training sessions • have unstable cardiac status which would preclude participation in a rehabilitation program, or • have any pre-morbid history of orthopaedic conditions of the lower limbs which would preclude them from relearning to walk.","Participants excluded they: • clinically evident brainstem signs • severe cognitive and/or language deficits preclude instructions training sessions • unstable cardiac status preclude participation rehabilitation program, • pre-morbid history orthopaedic conditions lower limbs preclude relearning walk.",C0679646|C1554077|G0000000|G0000000|G0000000|C3887511|C0006121|C0220912|G0000000|C0205082|C1516691|G0000000|C0023008|C2987487|G0000000|C0302828|C0040607|C1883016|G0000000|C0443343|C0018787|C0449438|G0000000|C0679823|C0034991|C1709697|G0000000|C0332152|C0019664|C0029355|C0012634|C0441994|C0015385|G0000000|C0679065|C0080331
"• Serious medical comorbidities or other contraindications to radiotherapy, chemotherapy or surgery • Prior history of head and neck cancer within 5 years • Prior head and neck radiation at any time • Metastatic disease • Inability to attend full course of radiotherapy or follow-up visits • Prior invasive malignant disease unless disease-free for at least 5 years or more, with the exception of non-melanoma skin cancer • Unable or unwilling to complete QoL questionnaires • Pregnant or lactating women The following evaluations are required: • History and physical examination by a radiation oncologist and head and neck surgeon within 8 weeks prior to randomization, including laryngopharyngoscopy.","• Serious medical comorbidities contraindications radiotherapy, chemotherapy surgery • Prior history head neck cancer 5 years • Prior head neck radiation time • Metastatic disease • Inability attend radiotherapy follow-up visits • Prior invasive malignant disease disease-free 5 years more, exception non-melanoma skin cancer • Unable unwilling complete QoL questionnaires • Pregnant lactating women The evaluations required: • History physical examination radiation oncologist head neck surgeon 8 weeks prior randomization, including laryngopharyngoscopy.",G0000000|C0199168|C0009488|C0079164|C0034619|C0013216|C0038894|G0000000|C0019664|C0018670|C0027530|C0006826|G0000000|G0000000|C0018670|C0027530|C0034519|C0040223|G0000000|C0012634|G0000000|C1999232|C0034619|C0589120|C0545082|G0000000|C0205281|C0205282|C0012634|C0012634|G0000000|C0205172|C1554961|C1518422|C0444099|C0006826|G0000000|C0558080|C0205197|C0518214|C0034394|G0000000|C2828358|C0043210|G0000000|C0220825|C1514873|G0000000|C0031809|G0000000|C0034519|C0259990|C0018670|C0027530|C0582175|G0000000|C0332152|C0034656|C0332257|G0000000
Informed consent was taken from all parents.,Informed consent parents.,C1522154|C1511481|C0030551
"not solitary confinement), language proficiency in English, post-sentencing status, and a release date that would allow adequate time for study participation.","solitary confinement), language proficiency English, post-sentencing status, release adequate time study participation.",C0205171|G0000000|C0023008|G0000000|C0376245|C0687676|C0449438|C0030685|C0205410|C0040223|C0557651|C0679823
"Briefly, 63 257 Chinese women and men aged 45–74 years belonging to the Hokkien or Cantonese dialect group in Singapore were enrolled in the study between April 1993 and December 1998.","Briefly, 63 257 Chinese women aged 45–74 belonging Hokkien Cantonese dialect Singapore enrolled study April 1993 December 1998.",G0000000|G0000000|C0008120|C0043210|C0001779|G0000000|G0000000|G0000000|G0000000|C0870413|C0037173|G0000000|C0557651|C3715024|G0000000|C3830550|G0000000
Twenty people with PD (Hoehn and Yahr stages I through III) were recruited and randomly assigned to either a balance-based exergaming group (N = 10) or a balance training group (N = 10) for an 8-week balance training period.,Twenty people PD (Hoehn Yahr stages I III) recruited randomly assigned balance-based exergaming (N = 10) balance training (N = 10) 8-week balance training period.,C0724000|C0027361|G0000000|G0000000|G0000000|C1306673|C0021966|C0439070|G0000000|G0000000|C1516050|C0014653|G0000000|G0000000|C0014653|C0040607|G0000000|C0332174|C0014653|C0040607|C0439531
"From a total of 43 children accessed for eligibility during 2014, 27 children (nine girls and 18 boys) with a mean age 4.9 years old (standard deviation “SD” 0.8) met the inclusion criteria and received the interventions.","From total 43 children accessed eligibility 2014, 27 children (nine girls 18 boys) age 4.9 (standard deviation “SD” 0.8) met inclusion criteria received interventions.",G0000000|C0439175|C0450371|C0008059|C0444454|C0013893|G0000000|C0450371|C0008059|C0205455|C0870604|C0450371|C0870221|C0001779|G0000000|C1442989|C0012727|G0000000|G0000000|C0268621|C0007637|C0243161|C1514756|C0886296
"In seven cases, neither measure of validation was available, and we classified participants as smokers.","In cases, measure validation available, classified participants smokers.",G0000000|C0868928|C0079809|C1519941|C0470187|C0008902|C0679646|C0337664
Patients with AECOPD leading to hypoxemia and respiratory acidosis with pH < 7.35 and PaCO2 > 45 mm of Hg admitted to the intensive care unit (ICU) were eligible for inclusion (n=62).,Patients AECOPD leading hypoxemia respiratory acidosis pH < 7.35 PaCO2 > 45 mm Hg admitted intensive care unit (ICU) eligible inclusion (n=62).,C0030705|G0000000|C0332152|C0700292|C0521346|C0001122|C0450407|G0000000|C0450371|G0000000|G0000000|C0450371|G0000000|C0025424|C0184666|C0162425|C1947933|C0439148|C0021708|C1548635|C0007637|C0369718
The present study was conducted to determine the effect of hollyhock combined with warm and cold compresses on improving breast engorgement in lactating women.,The study conducted determine hollyhock combined warm cold compresses improving breast engorgement lactating women.,G0000000|C0557651|C0004927|G0000000|G0000000|C0205195|C0184348|C0009264|C0180053|C1272745|C0006141|C0020452|C2828358|C0043210
"All subjects were unrelated ethnic Han Chinese and residents in 5 townships of Chuzhou District, which were located at the north side of the General Irrigation Canal, Huaian City, Jiangsu Province, China.","All subjects unrelated ethnic Han Chinese residents 5 townships Chuzhou District, located north General Irrigation Canal, Huaian City, Jiangsu Province, China.",G0000000|C0681850|C0445356|C0015031|C1551910|C0008120|C1320928|G0000000|C1552925|G0000000|G0000000|G0000000|C1709269|C0205246|C0022100|C0086881|G0000000|C0008848|G0000000|C1514578|C0008115
"As per the initial dataset, the cumulative dose of sc or iv bortezomib to the first onset of any grade, grade 2 or higher, and grade 3 or higher PN is shown in Figure 2.","As initial dataset, cumulative dose sc iv bortezomib onset grade, grade 2 higher, grade 3 PN Figure 2.",G0000000|C0205265|C0150098|C1511559|C0178602|C0282380|C0022326|C1176309|C0206132|C0441800|C0441800|G0000000|C0205250|C0441800|G0000000|C0219433|G0000000|G0000000
All patients had not taken oral tetracycline drugs (including doxycycline and minocycline) or oral corticosteroids for at least 3 months and had discontinued all topical medications for at least 1 month prior to study enrollment.,All patients oral tetracycline drugs (including doxycycline minocycline) oral corticosteroids 3 months discontinued topical medications 1 month prior study enrollment.,G0000000|C0030705|C0442027|C0039644|C0013227|C0332257|C0013090|C0026187|C0442027|C0001617|G0000000|C0439231|C1444662|C0332237|C0013227|G0000000|C0332177|C0332152|C0557651|C1516879
Infants with life-threatening abnormalities and those for whom we were unable to administer trial PN within 24 h of birth were ineligible.,Infants life-threatening abnormalities unable administer trial PN 24 birth ineligible.,C0021270|C1517874|C0000768|C1299582|C1621583|C0008976|C0219433|C0450371|C0005615|C1512714
"The median of PI in the right middle cerebral artery was significantly lower in the cerebrolysin group compared with the placebo group on days 30, 60, and 90 (P<0.05).","The median PI middle cerebral artery lower cerebrolysin compared placebo days 30, 60, 90 (P<0.05).",G0000000|C0549183|C0429863|C0444598|G0000000|C0003842|C0441994|C0055108|C1707455|C0032042|C0439228|C0450371|C0450371|C0450371|C0369773
"In asthma and other diseases, vitamin D insufficiency is associated with adverse outcomes.","In asthma diseases, vitamin D insufficiency adverse outcomes.",G0000000|C0004096|C0012634|C0042890|C0073187|C0231179|G0000000|C1274040
"The Dutch guideline for managing acute cough, including diagnostic and therapeutic advice for lower respiratory tract infection, is distributed to all general practitioners in the Netherlands and informs usual care.41 Fig 1 Trial profile.","The Dutch guideline managing acute cough, including diagnostic therapeutic advice lower respiratory tract infection, distributed practitioners Netherlands informs usual care.41 Fig 1 Trial profile.",G0000000|C0013331|C0162791|C1273870|C0205178|C0010200|C0332257|C0011900|C0087111|C0150600|C0441994|C0521346|C1185740|C0009450|C1704711|C1709627|C0027778|C0537670|C3538928|C1947933|C0349966|G0000000|C1979963
The primary aim is to evaluate the effectiveness of the intervention package to reduce psychological distress for women receiving radiotherapy with curative intent for GC.,The primary aim evaluate effectiveness intervention package reduce psychological distress women receiving radiotherapy curative intent GC.,G0000000|C0205225|C1947946|C0220825|C1280519|C0886296|C0013194|G0000000|C0205486|C0231303|C0043210|C1514756|C0034619|C1880198|C0162425|C3537453
Adults with CF providing written informed consent were randomised to a crossover trial of HTS before ACT or HTS during ACT on consecutive days.,Adults CF providing written informed consent randomised crossover trial HTS ACT HTS ACT consecutive days.,C0001675|C0009738|C1999230|C0043266|C1522154|C1511481|G0000000|C0010366|C0008976|C0036085|C0079613|C0036085|C0079613|C1707491|C0439228
Inclusion criteria were apnoea–hypopnoea index (AHI) ⩾5–40 and Epworth Sleepiness Scale (ESS)19 >9 for those with AHI 5–20.,Inclusion criteria apnoea–hypopnoea (AHI) ⩾5–40 Epworth Sleepiness Scale (ESS)19 >9 AHI 5–20.,C0007637|C0243161|G0000000|G0000000|G0000000|G0000000|C0013144|C0175659|C0206630|G0000000|G0000000|G0000000
Participants Children aged between 6 months and 6 years with axillary temperatures of at least 37.8°C and up to 41.0°C.,Participants Children aged 6 months 6 axillary temperatures 37.8°C 41.0°C.,C0679646|C0008059|C0001779|G0000000|C0439231|G0000000|C0004454|C0039476|G0000000|G0000000
The objective of this study is to explore the effects of acupuncture and auricular acupressure in relieving menopausal hot flashes of bilaterally ovariectomized Chinese women.,The objective study explore effects acupuncture auricular acupressure relieving menopausal hot flashes bilaterally ovariectomized Chinese women.,G0000000|C0018017|C0557651|G0000000|C1280500|C0001299|C1522191|C0282614|C0332303|C0025320|C0444519|C0085635|G0000000|G0000000|C0008120|C0043210
"Of the 4360 AREDS participants alive at the time of the implementation of the ancillary study, 3070 (70%) gave consent and completed the AREDS Cognitive Function Battery.","Of 4360 AREDS participants alive time implementation ancillary study, 3070 (70%) consent completed AREDS Cognitive Function Battery.",G0000000|G0000000|G0000000|C0679646|C0376558|C0040223|C1708476|C1549485|C0557651|G0000000|C0450371|C1511481|C0205197|G0000000|C1516691|C0031843|C0337088
Mobility rates also differ according to the characteristics of students.,Mobility rates characteristics students.,C0425245|C0871208|C1521970|C0038492
Methylprednisolone seems to have no positive effect on the development and reduction of pain during the acute phase of GBS.,Methylprednisolone positive development reduction pain acute phase GBS.,C0025815|C0439178|C0243107|C0301630|C0030193|C0205178|C0205390|C0018378
"In a double-masked randomized controlled trial (RCT) conducted in 4 primary schools, 1010 children from classes 1–4 (age 6–9 years) were randomly allocated to receive either micronutrient fortified yoghurt (FY, n = 501) or non-fortified yoghurt (NFY, n = 509).","In double-masked randomized controlled trial (RCT) conducted 4 primary schools, 1010 children classes 1–4 (age 6–9 years) randomly allocated receive micronutrient fortified yoghurt (FY, n = 501) non-fortified yoghurt (NFY, n = 509).",G0000000|C0013072|C0034656|C2587213|C0008976|G0000000|C0004927|G0000000|C0205225|C0036375|G0000000|C0008059|C0456387|G0000000|C0001779|G0000000|C0439234|G0000000|G0000000|C1514756|C0040577|G0000000|C0043419|C0013278|G0000000|C1518422|C0043419|G0000000|G0000000
"Exclusion criteria were specific low back pain, advice by general practitioner not to perform physically straining activities, pregnancy, pelvic girdle pain, legal involvement related to either low back pain or related to work disability.","Exclusion criteria specific low pain, advice practitioner perform physically straining activities, pregnancy, pelvic girdle pain, legal involvement low pain disability.",C0680251|C0243161|C0205369|C0205251|C0030193|C0150600|C1709627|C0884358|G0000000|C0442694|C0441655|C0032961|C0030797|C0453903|C0030193|C1301860|C1314939|C0205251|C0030193|C0231170
"Although an experienced operator was arbitrarily defined as one having more than 6 years of experience, this may not truly reflect the experience of the operator.","Although experienced operator arbitrarily defined 6 experience, reflect experience operator.",G0000000|C0237607|C1705273|G0000000|C1704788|G0000000|C0237607|C0558058|C0237607|C1705273
I have recently had opportunities to get involved in physical activity.,I opportunities involved physical activity.,C0021966|G0000000|C1314939|C0031809|C0205177
Relative adrenal insufficiency was very common in patients with cirrhosis presenting with septic shock.,Relative adrenal insufficiency common patients cirrhosis septic shock.,C0080103|G0000000|C0231179|C0205214|C0030705|C0023890|C0333534|C0036974
Age and underlying disease were comparable.,Age underlying disease comparable.,C0001779|G0000000|C0012634|G0000000
"This prospective, randomized, double blind trial investigating the supplementation of preterm infants with a probiotic was done from May 2012 to April 2013, with 112 subjects randomized into two groups.","This prospective, randomized, double blind trial investigating supplementation preterm infants probiotic May 2012 April 2013, 112 subjects randomized groups.",G0000000|C0023981|C0034656|C0205173|C0150108|C0008976|C1292732|C0242297|C0151526|C0021270|C0525033|G0000000|G0000000|C3715024|G0000000|C1442061|C0681850|C0034656|C0441833
Three care homes which had shortlisted 30 potential participants subsequently withdrew from the research.,Three care homes shortlisted 30 potential participants subsequently withdrew research.,C0205449|C1947933|C0442519|G0000000|C0450371|C3245505|C0679646|G0000000|C2349954|C0035168
Participants Residents of the 12 nursing homes; numbers varied during the study period.,Participants Residents 12 nursing homes; varied study period.,C0679646|C1320928|C0450371|C0006147|C0442519|G0000000|C0557651|C0439531
"Spirometry was performed in accordance with American Thoracic Society/European Respiratory Society standards.19,20 Measures of FEV1 and FVC were compared with reference values from the Third National Health and Nutrition Examination Survey (NHANES III).21 Patients with pulmonary disease other than COPD, including asthma, clinically significant bronchiectasis, interstitial lung disease, pleural disease, and previous history of thoracic surgery, such as lung resection or lung volume reduction surgery, were excluded.","Spirometry performed American Thoracic Society/European Respiratory Society standards.19,20 Measures FEV1 FVC compared reference values Third National Health Nutrition Examination Survey (NHANES III).21 Patients pulmonary disease COPD, including asthma, clinically bronchiectasis, interstitial lung disease, pleural disease, previous history thoracic surgery, lung resection lung volume reduction surgery, excluded.",C0037981|C0884358|C0596070|G0000000|C0037455|C0521346|C0037455|C0038137|C0079809|G0000000|C3714541|C1707455|C1514811|C0042295|C0205437|C3245503|C0018684|C0028707|G0000000|C0038951|C0376344|C0439070|C0030705|C0024109|C0012634|C0024117|C0332257|C0004096|G0000000|C0006267|C0596790|C0024109|C0012634|C0032225|C0012634|C0205156|C0019664|G0000000|C0038894|C0024109|C0015252|C0024109|C0449468|C0301630|C0038894|C1554077
The trial was a randomised controlled pilot study undertaken at Cambridge University Hospitals NHS Foundation Trust (CUHFT) on five adult medical wards from a range of medical specialities where patients did not routinely receive MR from a pharmacist within 24 hours of admission.,The trial randomised controlled pilot study undertaken Cambridge University Hospitals NHS Foundation Trust (CUHFT) adult medical wards range medical specialities patients routinely receive MR pharmacist 24 hours admission.,G0000000|C0008976|G0000000|C2587213|C0473169|C0557651|G0000000|G0000000|C0041740|C0019994|C0796085|C0016617|C0237935|G0000000|C0001675|C0199168|C1305702|C1514721|C0199168|C0205555|C0030705|G0000000|C1514756|C1417249|C0031323|G0000000|C0184666
"Inclusion criteria for study participation include the following: age ≥ 18, unilateral ischemic or hemorrhagic stroke within six months confirmed with neuroimaging, persistent hemiparesis with UE voluntary activity as indicated by a score of 11–55 on the Fugl-Meyer Assessment, limited access to an organized stroke rehabilitation program, preserved cognitive function as indicated by a score of ≤3on the Short Portable Mental Status Questionnaire, and no UE injury or condition that limited function of the more affected side before the stroke.","Inclusion criteria study participation following: age ≥ 18, unilateral ischemic hemorrhagic stroke months confirmed neuroimaging, persistent hemiparesis UE voluntary activity score 11–55 Fugl-Meyer Assessment, limited access organized stroke rehabilitation program, preserved cognitive function score ≤3on Short Portable Mental Status Questionnaire, UE injury condition limited function stroke.",C0007637|C0243161|C0557651|C0679823|C0231290|C0001779|G0000000|C0450371|C0205092|C0475224|C0333275|C0038454|C0439231|C0521093|C0679575|C0205322|C0018989|G0000000|C0439656|C0205177|C0449820|G0000000|G0000000|C1261322|C0439801|C0444454|C1300196|C0038454|C0034991|C1709697|C0033085|C1516691|C0031843|C0449820|G0000000|C1282927|G0000000|C0229992|C0449438|C0034394|G0000000|C3263722|C0012634|C0439801|C0031843|C0038454
Written informed consent for chemotherapy was obtained from all patients.,Written informed consent chemotherapy patients.,C0043266|C1522154|C1511481|C0013216|C0030705
We chose to use a single point to avoid confusing our pregnant women who were to self- treat.,We chose single avoid confusing pregnant women self- treat.,G0000000|C1707391|C0037179|G0000000|G0000000|C0549206|C0043210|C0036588|C0087111
"Inclusion criteria: Aged 20-70 years, smoking more than 10 cigarettes daily.","Inclusion criteria: Aged 20-70 years, smoking 10 cigarettes daily.",C0007637|C0243161|C0001779|C0450371|C0439234|C0037369|C0450371|C0677453|C0332173
"Our eligiblity criteria were; people living at home and under the care of a case manager or community matron; the housebound (identified through Read code searching of general practitioner (GP) registers of National Institute for Health Research (NIHR) ‘Research Ready’ GP practices); attending a day centre or respite care; residence in assisted living sites; at discharge from intermediate care hospitals; and following attendance at elderly medicine outpatient clinics in Bradford, UK.","Our eligiblity criteria were; people living care manager community matron; housebound (identified Read code searching practitioner (GP) registers National Institute Health Research (NIHR) ‘Research Ready’ GP practices); attending day centre respite care; residence assisted living sites; discharge intermediate care hospitals; attendance elderly medicine outpatient clinics Bradford, UK.",G0000000|G0000000|C0243161|G0000000|C0027361|C0376558|C1947933|C0335141|C0009462|G0000000|C0242798|C0205396|C0034754|C0009219|C1552603|C1709627|C3811116|C0600375|C3245503|C0021622|C0018684|C0035168|G0000000|G0000000|G0000000|C3811116|C0237607|C1547429|C0332173|C0205099|G0000000|C1947933|C0237096|C1269765|C0376558|C0205145|C0012621|C0205103|C1947933|C0019994|C2827364|C0001792|C0013227|C0029921|C0442592|G0000000|C0041700
"First, we included infants with a birth weight up to 2500g; they included only infants <1500g.","First, included infants birth weight 2500g; included infants <1500g.",C0205435|C0332257|C0021270|C0005615|C0005910|G0000000|C0332257|C0021270|G0000000
Patients aged 20–70 years were eligible for the study if they fulfilled the Rome II criteria for IBS.1 Organic or metabolic disease had to be adequately excluded by routine biochemistry and colonoscopy in the past five years.,Patients aged 20–70 years eligible study fulfilled Rome II criteria IBS.1 Organic metabolic disease adequately excluded routine biochemistry colonoscopy years.,C0030705|C0001779|G0000000|C1548635|C0557651|C1550543|C0035831|G0000000|C0243161|C0022104|C0747055|C0311400|C0012634|G0000000|C1554077|C0205547|C0005477|C0009378|C0439234
Children aged 0–14 years who were diagnosed and registered with TB in the intervention and control districts were included in the study.,Children aged 0–14 diagnosed registered TB intervention control districts included study.,C0008059|C0001779|G0000000|C0011900|C1514821|G0000000|C0886296|C0243148|G0000000|C0332257|C0557651
We identified 416 subjects who had both first and second molars present in at least 1 quadrant at baseline and had at least 1 follow-up examination.,We identified 416 subjects molars 1 quadrant baseline 1 follow-up examination.,G0000000|C0205396|C1442061|C0681850|C0026367|G0000000|C1631280|C0168634|G0000000|C0589120|G0000000
"Subjects and parents were also masked, and they were told not to discuss their contact lens wear, vision, or care with the masked examiner.","Subjects parents masked, told contact lens wear, vision, care masked examiner.",C0681850|C0030551|C0150108|G0000000|C0332158|C0023317|G0000000|C0042789|C1947933|C0150108|G0000000
"There were 68 patients admitted with influenza A H1N1 infection, and their median age was 23 years.","There 68 patients admitted influenza A H1N1 infection, median age 23 years.",G0000000|C0450371|C0030705|C0184666|C0021400|G0000000|G0000000|C0009450|C0549183|C0001779|C0450371|C0439234
"We enrolled children between the ages of 12 and 53 months who met all the following criteria: during the previous year, they had at least four episodes of wheezing (or three episodes of wheezing and controller use for ≥3 months), positive values on the modified API,7 and at least one exacerbation requiring the use of systemic glucocorticoids, urgent or emergency care, or hospitalization, and during a 2-week run-in period, they had fewer than 3 days per week of albuterol use and fewer than 2 nights with awakening.","We enrolled children ages 12 53 months met criteria: previous year, episodes wheezing (or episodes wheezing controller ≥3 months), positive values modified API,7 exacerbation requiring systemic glucocorticoids, urgent emergency care, hospitalization, 2-week run-in period, fewer 3 days week albuterol fewer 2 nights awakening.",G0000000|G0000000|C0008059|C0001779|C0450371|C0450371|C0439231|C0268621|C0243161|C0205156|C0439234|C0332189|C0043144|G0000000|C0332189|C0043144|C0180112|G0000000|C0439231|C0439178|C0042295|C0392747|G0000000|G0000000|G0000000|C0205373|C0017710|C0439609|C0013956|C1947933|C0019993|C0332174|C3274438|C0439531|C0205388|G0000000|C0439228|C0332174|C0001927|C0205388|G0000000|C0240526|C1720052
"However, these 19 patients were also considered at high immunological risk, because 12 were recipients of a third graft and seven were recipients of a second graft after rejection of their previous graft within the first 2 years.","However, 19 patients considered immunological risk, 12 recipients graft recipients graft rejection previous graft 2 years.",G0000000|C0450371|C0030705|C0750591|C0205470|C0035647|C0450371|C1709854|C0181074|C1709854|C0181074|C0035015|C0205156|C0181074|G0000000|C0439234
The average years of education for mothers was 15 years for both groups.,The average education mothers 15 groups.,G0000000|C1510992|C0013621|C0026591|C0450371|C0441833
A total of 50 teeth were treated and followed up clinically and radiographically for 18 months.,A total 50 teeth treated clinically radiographically 18 months.,G0000000|C0439175|C0450371|C0040426|C1522326|G0000000|G0000000|C0450371|C0439231
Pilot study conducted at an academic medical center breast clinic.,Pilot study conducted academic medical center breast clinic.,C0473169|C0557651|C0004927|C1510747|C0199168|C0205099|C0006141|C0002424
Childcare services were randomly allocated to either the intervention or control condition by a blinded research assistant using a random number function in Microsoft Excel in a 1:1 ratio.,Childcare services randomly allocated intervention control condition blinded assistant random function Microsoft Excel 1:1 ratio.,C0008067|C0557854|G0000000|G0000000|C0886296|C0243148|C0012634|C0150108|C0011327|C0034656|C0031843|G0000000|C2740529|G0000000|C0456603
"After the use of usual medications had ceased for 7 days, the visual analog scale (VAS) score that assessed pain during the most painful knee movement had to be more than 40, and Lequesne's functional index 21 had to be over 7 points.","After usual medications ceased 7 days, visual analog scale (VAS) score assessed pain painful knee movement 40, Lequesne's functional 21 7 points.",G0000000|C3538928|C0013227|C1272693|G0000000|C0439228|C0234621|C0243071|C0175659|C0042815|C0449820|C1516048|C0030193|C0030193|C0022742|C0026649|C0450371|G0000000|C0205245|C0450371|G0000000|C1552961
A participant will be considered eligible for inclusion in this study only if all of the following criteria apply: Age 12–25 years (inclusive) at entry.,A participant considered eligible inclusion study criteria apply: Age 12–25 (inclusive) entry.,G0000000|C0679646|C0750591|C1548635|C0007637|C0557651|C0243161|C1632850|C0001779|G0000000|C0332257|C1705654
"The design is a two-group, prospective (RCT) trial to examine whether Therapeutic Interactive Voice Response (TIVR) is an effective relapse prevention intervention for patients with chronic musculoskeletal pain.","The design two-group, prospective (RCT) trial examine Therapeutic Interactive Voice Response (TIVR) effective relapse prevention intervention patients chronic musculoskeletal pain.",G0000000|C1707689|C0205448|C0023981|G0000000|C0008976|G0000000|C0087111|C1704675|C0042939|C0871261|G0000000|C1280519|C0035020|C0199176|C0886296|C0030705|C0205191|C0497254|C0030193
"The inclusion criteria were: women with breast cancer stages I-III, aged 15-55 years and for whom two years had passed from the completion of their breast cancer related treatment (except for hormone therapy), and their performance status were 0-4.","The inclusion criteria were: women breast cancer stages I-III, aged 15-55 passed completion breast cancer treatment (except hormone therapy), performance status 0-4.",G0000000|C0007637|C0243161|G0000000|C0043210|C0006141|C0006826|C1306673|C0021966|C0001779|C0450371|C2828386|C0205197|C0006141|C0006826|C0039798|G0000000|C0019932|C0039798|C0597198|C0449438|G0000000
Our study was performed in a relatively small group of patients with severe sepsis.,Our study performed patients severe sepsis.,G0000000|C0557651|C0884358|C0030705|C0205082|C0036690
The effectiveness and efficacy of Iyengar yoga for chronic low back pain (CLBP) were assessed with intention-to-treat and per-protocol analysis.,The effectiveness efficacy Iyengar yoga chronic low pain (CLBP) assessed intention-to-treat per-protocol analysis.,G0000000|C1280519|C1280519|G0000000|C0043418|C0205191|C0205251|C0030193|G0000000|C1516048|C0162425|C1698058|C0002778
"Sixty individuals [32 in dark chocolate group (DCG) and 28 in white chocolate group (WCG)] with Type 2 diabetes on stable medication were enrolled in a randomized, placebo-controlled double-blind study.","Sixty individuals [32 dark chocolate (DCG) 28 white chocolate (WCG)] Type 2 diabetes stable medication enrolled randomized, placebo-controlled double-blind study.",C3816724|C0027361|C0450371|C0332582|C0006622|G0000000|C0450371|C0007457|C0006622|G0000000|C0332307|G0000000|C0011847|C0205360|C0013227|G0000000|C0034656|C1706408|C0013072|C0557651
"Exclusion criteria were as follows: infants with CSS <4, oxygen saturation (SaO2) <80% in room air, chronic cardiopulmonary or neurological disease, premature birth, birth weight <2500 g, history of recurrent wheezing episodes, proven immune deficiency, age <1 month or >2 years, proven or suspected acute bacterial infection, previous treatment with bronchodilators or corticosteroids, the presence of symptoms >7 days, consolidation or atelectasis on a chest roentgenogram.","Exclusion criteria follows: infants CSS <4, oxygen saturation (SaO2) <80% air, chronic cardiopulmonary neurological disease, premature birth, birth weight <2500 g, history recurrent wheezing episodes, proven immune deficiency, age <1 month >2 years, proven suspected acute bacterial infection, previous treatment bronchodilators corticosteroids, presence symptoms >7 days, consolidation atelectasis chest roentgenogram.",C0680251|C0243161|C0332283|C0021270|C0265338|G0000000|C0030054|C0522534|G0000000|C0450371|C0001861|C0205191|C0553534|C0205494|C0012634|C0151526|C0005615|C0005615|C0005910|G0000000|C0439267|C0019664|C2945760|C0043144|C0332189|C0456369|C0439662|C0011155|C0001779|G0000000|C0332177|G0000000|C0439234|C0456369|C0332147|C0205178|C0521009|C0009450|C0205156|C0039798|C0006280|C0001617|C0150312|C0683368|G0000000|C0439228|C0702116|C0004144|C0817096|C1306645
"Participants were children aged 2-59 months with complaints of cough, rapid respiration, or difficulty in breathing.","Participants children aged 2-59 months complaints cough, rapid respiration, difficulty breathing.",C0679646|C0008059|C0001779|C0450371|C0439231|C0277786|C0010200|C0456962|C0035203|C1299586|C0004048
Risk of falls for each patient was assessed blindly.,Risk falls patient assessed blindly.,C0035647|C0000921|C0030705|C1516048|G0000000
The mean gestational age was 27± 2.3 weeks and the mean birth weight was 924± 238 g for both groups combined.,The gestational age 27± 2.3 weeks birth weight 924± 238 combined.,G0000000|C0439671|C0001779|G0000000|G0000000|C0439230|C0005615|C0005910|G0000000|C1442061|C0205195
The provision of behavioural incentives to households in rural Madagascar significantly increased the use of ITNs after one month compared to households that did not receive incentives.,The provision behavioural incentives households rural Madagascar increased ITNs month compared households receive incentives.,G0000000|C1549071|C0004927|C0021147|C0020052|C0240919|C0024443|C0205217|G0000000|C0332177|C1707455|C0020052|C1514756|C0021147
"In both groups, the median EDSS remained 1.5 from baseline to 8 years.","In groups, median EDSS remained 1.5 baseline 8 years.",G0000000|C0441833|C0549183|C0451246|G0000000|G0000000|C0168634|G0000000
"Approximately, one-third of patients have seizures after tumor resection [6–8], and in the case of supratentorial craniotomy, 20%–50% of patients have ≥1 seizure [9, 10].","Approximately, one-third patients seizures tumor resection [6–8], supratentorial craniotomy, 20%–50% patients ≥1 seizure [9, 10].",C0332232|C0205447|C0030705|C0036572|C0027651|C0015252|G0000000|C0441938|C0010280|G0000000|C0030705|G0000000|C0036572|G0000000|C0450371
"At a median age of 19.3 years (interquartile range, 15.6–24.5 years), 28.1% of all survivors had at least one renal adverse effect or elevated BP.","At median age 19.3 (interquartile range, 15.6–24.5 years), 28.1% survivors renal adverse elevated BP.",G0000000|C0549183|C0001779|C0450371|G0000000|C1514721|G0000000|C0439234|C0450371|C0206194|C0022646|G0000000|C0205250|C0037623
Methods: A total of 88 stroke patients with dysphagia (within 2 weeks of acute stroke) were enrolled and classified into the experimental and control groups (n=44).,Methods: A total 88 stroke patients dysphagia (within 2 weeks acute stroke) enrolled classified experimental control (n=44).,C0025663|G0000000|C0439175|C0450371|C0038454|C0030705|C0011168|G0000000|G0000000|C0439230|C0205178|C0038454|G0000000|C0008902|C1517586|C0243148|C0369718
"Reliability of the scale was done on 20 breast cancer patients each undergoing radiation therapy in Shirdi Sai Baba Cancer Hospital and Research Center, Kasturba Hospital, Manipal, and it was found to be 0.82.","Reliability scale 20 breast cancer patients undergoing radiation therapy Shirdi Sai Baba Cancer Hospital Research Center, Kasturba Hospital, Manipal, 0.82.",C2347947|C0175659|C0450371|C0006141|C0006826|C0030705|G0000000|C0034519|C0039798|G0000000|G0000000|G0000000|C0006826|C0019994|C0035168|C0205099|G0000000|C0019994|G0000000|C0450371
"Children with a congenital disability, psychological disorder, chronic illness, hereditary disease, or a visual or hearing impairment were excluded if the disorder will likely disable the child from performing the behavioral tasks or participating in the intervention.","Children congenital disability, psychological disorder, chronic illness, hereditary disease, visual hearing impairment excluded disorder disable child performing behavioral tasks participating intervention.",C0008059|C0009678|C0231170|C0205486|C0012634|C0205191|C0221423|C0439660|C0012634|C0234621|C0018767|C0221099|C1554077|C0012634|G0000000|C0008059|C0884358|C0004927|C3540678|C0679823|C0886296
"A total of 82 patients were screened for participation in the study; 64 were excluded for various reasons, including not meeting inclusion criteria: cardiac, respiratory, joint/musculoskeletal comorbidities (n = 24), diagnosed with another cancer or leukemia (n = 12), missed recruitment window (n = 10), a hospital stay less than 3 weeks (n = 5), exercise physiologist not available for testing (n = 3), unable to speak or understand English (n = 2), VO2peak testing equipment unavailable (n = 2), bleeding, thrombosis, hemodynamically unstable, uncontrolled pain (n = 2), prior malignancy (n = 2), unable to provide informed consent (n = 1), or patient discharged to hospice (n = 1; Figure 1).","A total 82 patients screened participation study; 64 excluded reasons, including meeting inclusion criteria: cardiac, respiratory, joint/musculoskeletal comorbidities (n = 24), diagnosed cancer leukemia (n = 12), missed recruitment window (n = 10), hospital stay 3 weeks (n = 5), exercise physiologist testing (n = 3), unable speak understand English (n = 2), VO2peak testing equipment unavailable (n = 2), bleeding, thrombosis, hemodynamically unstable, uncontrolled pain (n = 2), prior malignancy (n = 2), unable provide informed consent (n = 1), patient discharged hospice (n = 1; Figure 1).",G0000000|C0439175|C0450371|C0030705|C0220908|C0679823|C0557651|C0450371|C1554077|C0392360|C0332257|C0556656|C0007637|C0243161|C0018787|C0521346|C0022417|C0009488|C0369718|G0000000|C0450371|C0011900|C0006826|C0023418|C0369718|G0000000|C0450371|C1705492|C2949735|C0557702|C0369718|G0000000|C0450371|C0019994|G0000000|G0000000|C0439230|C0369718|G0000000|G0000000|C0015259|C0260141|C0039593|C0369718|G0000000|G0000000|C1299582|C0234856|C0162340|C0376245|C0369718|G0000000|G0000000|G0000000|C0039593|C0014672|C0686905|C0369718|G0000000|G0000000|C0019080|C0040053|G0000000|C0443343|C0205318|C0030193|C0369718|G0000000|G0000000|C0332152|C0006826|C0369718|G0000000|G0000000|C1299582|C1999230|C1522154|C1511481|C0369718|G0000000|G0000000|C0030705|C0030685|C0019947|C0369718|G0000000|G0000000|G0000000|G0000000
Exclusion criteria were as follows: severe cardiovascular disease; degenerative neurological or psychiatric diseases; and severe visual or auditory impairments.,Exclusion criteria follows: severe cardiovascular disease; degenerative neurological psychiatric diseases; severe visual auditory impairments.,C0680251|C0243161|C0332283|C0205082|C0007226|C0012634|C0011164|C0205494|C0205487|C0012634|C0205082|C0234621|C0439825|C0684336
The primary end-point was trough forced expiratory volume in 1 s (FEV1) at week 26 for QVA149 versus its monocomponents.,The primary end-point trough forced expiratory volume 1 (FEV1) week 26 QVA149 versus monocomponents.,G0000000|C0205225|C2349179|C0444506|C0441722|C0231800|C0449468|G0000000|G0000000|C0332174|C0450371|G0000000|G0000000|G0000000
"Patients were excluded if they had an underlying malignancy, systemic lupus erythematosus, or chronic valvular or congenital heart disease.","Patients excluded underlying malignancy, systemic lupus erythematosus, chronic valvular congenital heart disease.",C0030705|C1554077|G0000000|C0006826|C0205373|C0024131|G0000000|C0205191|C0184252|C0009678|C0018787|C0012634
"Patients who met the criteria of the European-American consensus conference (bilateral pulmonary infiltrates on frontal chest x-ray, PaO2/FiO2 ratio ≤300 mmHg, and a pulmonary capillary wedge pressure ≤18 mmHg or no clinical evidence of left atrial hypertension) [25], had an EVLWI ≥8 mL/kg predicted body weight (PBW), had a negative pregnancy test (for females of child-bearing potential), and presented with stable hemodynamics for at least 8 h were included.","Patients met criteria European-American consensus conference (bilateral pulmonary infiltrates frontal chest x-ray, PaO2/FiO2 ratio ≤300 mmHg, pulmonary capillary wedge pressure ≤18 mmHg clinical evidence left atrial hypertension) [25], EVLWI ≥8 mL/kg predicted body weight (PBW), negative pregnancy test (for females child-bearing potential), stable hemodynamics 8 included.",C0030705|C0268621|C0243161|C0683983|C0376298|C0086047|C0238767|C0024109|C0332448|C0205123|C0817096|C0034571|C1427155|C0456603|G0000000|C0439475|C0024109|C0006901|C0439639|C0033095|G0000000|C0439475|C0205210|C3887511|C0205091|C0018792|C0020538|C0450371|G0000000|G0000000|C1300574|C0681842|C0242821|C0005910|G0000000|C0205160|C0032961|C0022885|G0000000|C0015780|C0008059|C3245505|C0205360|C0019010|G0000000|C0332257
"This secondary analysis used data from an open, randomized controlled trial (registered under number 2004-36001-0004, Cochrane Renal Group CRG040600073) published previously (24,25) in which the main objective was to compare the effects of icodextrin-based PD solutions (ICO group) with those of glucose-based PD solutions (GLU group) on metabolic and extracellular fluid volume control in patients with type 2 diabetes on continuous ambulatory PD with high or high-average peritoneal transport.","This secondary analysis data open, randomized controlled trial (registered 2004-36001-0004, Cochrane Renal Group CRG040600073) published (24,25) main objective compare effects icodextrin-based PD solutions (ICO group) glucose-based PD solutions (GLU group) metabolic extracellular fluid volume control patients type 2 diabetes continuous ambulatory PD high-average peritoneal transport.",G0000000|C0027627|C0002778|C1511726|C0175566|C0034656|C2587213|C0008976|C1514821|G0000000|G0000000|C0022646|C0441833|G0000000|C0034037|C0450371|C0205225|C0018017|C1707455|C1280500|C0538727|G0000000|C0037633|G0000000|C0441833|C0017725|G0000000|C0037633|C0061472|C0441833|C0311400|C0521119|C0005889|C0449468|C0243148|C0030705|C0332307|G0000000|C0011847|C0549178|C0439841|G0000000|C0205250|C0031153|C0005528
There was only 1 symptomatic hypoglycemic patient in the loose control group (4%) and 0 in the tight control group.,There 1 symptomatic hypoglycemic patient loose control (4%) 0 tight control group.,G0000000|G0000000|C0231220|C0020616|C0030705|C0205407|C0243148|G0000000|G0000000|C0439816|C0243148|C0441833
"Exclusion criteria included AGE that did not require IVT per clinicians’ judgment, chronic health conditions such as renal failure affecting the ability to tolerate fluids or those that result in electrolyte abnormalities, or the use of prohibited medications (eg, antacids/anti-diarrhea or systemic corticosteroids within 24 or 72 h prior to presentation, respectively).","Exclusion criteria included AGE require IVT clinicians’ judgment, chronic health conditions renal failure ability tolerate fluids result electrolyte abnormalities, prohibited medications (eg, antacids/anti-diarrhea systemic corticosteroids 24 72 prior presentation, respectively).",C0680251|C0243161|C0332257|C0001779|G0000000|G0000000|G0000000|C0022423|C0205191|C0018684|C0012634|C0022646|C0231174|C0085732|G0000000|C0302908|C1274040|C0013832|C0000768|C0138547|C0013227|C0013715|C0003138|C0205373|C0001617|C0450371|C0450371|C0332152|C0449450|G0000000
"Pregnant or lactating women and children aged <1 year or who weighed <5 kg were excluded, as were patients with WHO-specified danger signs or signs of severity [17], patients with a parasite load >4%, or patients with concomitant disease that required hospital admission.","Pregnant lactating women children aged <1 weighed <5 excluded, patients WHO-specified danger signs signs severity [17], patients parasite load >4%, patients concomitant disease required hospital admission.",C0549206|C2828358|C0043210|C0008059|C0001779|G0000000|G0000000|G0000000|C1554077|C0030705|C0205369|G0000000|C0220912|C0220912|C0439793|C0450371|C0030705|C0030498|C1550025|G0000000|C0030705|C0521115|C0012634|C1514873|C0019994|C0184666
The mean patient age was 72.65 ± 12.10 years (range 40-90 years).,The patient age 72.65 ± 12.10 (range 40-90 years).,G0000000|C0030705|C0001779|C0450371|G0000000|C0450371|C1514721|C0450371|C0439234
"The action observation group (5 males, 3 females) watched a video of the task, the action practice group (5 males, 4 females) performed the action, the combined action observation-action practice group (5 males, 4 females) watched the video of the task and practiced the action, and the control group (4 males, 3 females) did not perform either action observation or action practice.","The action observation (5 males, 3 females) watched video task, action practice (5 males, 4 females) performed action, combined action observation-action practice (5 males, 4 females) watched video task practiced action, control (4 males, 3 females) perform action observation action practice.",G0000000|C0441472|C0302523|G0000000|C0086582|G0000000|C0015780|G0000000|C0042655|C3540678|C0441472|C0237607|G0000000|C0086582|G0000000|C0015780|C0884358|C0441472|C0205195|C0441472|C1292786|C0237607|G0000000|C0086582|G0000000|C0015780|G0000000|C0042655|C3540678|C0237607|C0441472|C0243148|G0000000|C0086582|G0000000|C0015780|C0884358|C0441472|C0302523|C0441472|C0237607
No infants in either group developed NEC.,No infants developed NEC.,G0000000|C0021270|G0000000|C0206695
"Inclusion criteria were age 60 years or older, no severe cognitive impairment (Short Portable Mental Questionnaire15 [see below] score, ≥3), ambulatory before fracture, and body mass index 28 kg/m2 or lower.","Inclusion criteria age 60 older, severe cognitive impairment (Short Portable Mental Questionnaire15 [see below] score, ≥3), ambulatory fracture, body mass 28 kg/m2 lower.",C0007637|C0243161|C0001779|C0450371|C0580836|C0205082|C1516691|C0221099|C1282927|G0000000|C0229992|G0000000|C0042789|G0000000|C0449820|G0000000|C0439841|C0016658|C0242821|C0577559|C0450371|C0022718|C0441994
"Furthermore, the degree of shoulder pain, as measured by the CMSA pain inventory scale, did not worsen for either group over the course of treatment.","Furthermore, degree shoulder pain, measured CMSA pain inventory scale, worsen treatment.",G0000000|C0441889|C0037004|C0030193|C0444706|G0000000|C0030193|C0021941|C0175659|C0332271|C0039798
Total of 61 community-dwelling older adults with chronic stroke.,Total 61 community-dwelling adults chronic stroke.,C0439175|C0450371|C4045975|C0001675|C0205191|C0038454
The inclusion criteria were: (1) age 25–65 years; (2) DSM-IV diagnosis of MDD [17]; (3) 17-item Hamilton Rating Scale for Depression (HAMD-17) score ≥18 [18]; and (4) Clinical Global Impression-Severity (CGI-S) score ≥4 [19].,The inclusion criteria were: (1) age 25–65 years; (2) DSM-IV diagnosis MDD [17]; (3) 17-item Hamilton Rating Scale Depression (HAMD-17) score ≥18 [18]; (4) Clinical Global Impression-Severity (CGI-S) score ≥4 [19].,G0000000|C0007637|C0243161|G0000000|G0000000|C0001779|G0000000|C0439234|G0000000|C0220952|C0011900|C1269683|C0450371|G0000000|C0450371|G0000000|C0871208|C0175659|C0011570|C0450371|C0449820|G0000000|C0450371|G0000000|C0205210|C0205246|C0596764|C3639708|C0449820|G0000000|C0450371
"We also applied the following exclusion criteria: Subjects with severe aphasia, severe shoulder pain affecting therapy or any comorbid condition that could limit upper extremity function.","We applied exclusion criteria: Subjects severe aphasia, severe shoulder pain therapy comorbid condition limit upper extremity function.",G0000000|C4048755|C0680251|C0243161|C0681850|C0205082|C0003537|C0205082|C0037004|C0030193|C0039798|C0009488|C0012634|C0439801|C1282910|C0015385|C0031843
"Our two primary outcomes were primary cesarean rates among nulliparous women carrying term, singleton pregnancies in the vertex position and VBAC rates among women with a history of prior cesarean.","Our primary outcomes primary cesarean rates nulliparous women carrying term, singleton pregnancies vertex position VBAC rates women history prior cesarean.",G0000000|C0205225|C1274040|C0205225|C3841297|C0871208|C0425979|C0043210|C0206243|C0233324|C0481462|C0032961|C0230003|C0733755|C0080301|C0871208|C0043210|C0019664|C0332152|C3841297
Patients with NIHSS score <2 were included if modified Rankin Scale (mRS) [10] score was ≥2.,Patients NIHSS score <2 included modified Rankin Scale (mRS) [10] score ≥2.,C0030705|C3476804|C0449820|G0000000|C0332257|C0392747|G0000000|C0175659|C1522706|C0450371|C0449820|G0000000
Patients requiring supplemental oxygen at rest or during exercise to prevent desaturation (<85%) were also excluded.,Patients requiring supplemental oxygen rest exercise prevent desaturation (<85%) excluded.,C0030705|G0000000|C2348609|C0030054|C0035253|C0015259|C0309872|C0746961|C0450371|C1554077
"The study was conducted from October 26th to November 30th 2012 at 3 large teaching hospitals in Bogota, Colombia.","The study conducted October 26th November 30th 2012 3 teaching hospitals Bogota, Colombia.",G0000000|C0557651|C0004927|C3828732|G0000000|C3828767|G0000000|G0000000|G0000000|C0039401|C0019994|G0000000|C3245499
"The exclusion criteria were pulmonary disease other than COPD; treatment with antibiotics, exacerbation or an investigational drug in the four weeks before randomisation; pregnancy (serum pregnancy test) or breast feeding; history of hypersensitivity to macrolides, tetracyclines, beta-lactams or sulfamethoxazole:trimethoprim; serious cardiovascular, hepatic, renal or other systemic diseases; known long QT syndrome or corrected QT interval (QTc) >450 ms, sick sinus syndrome, bradycardia (<50 beats per minute) or severe hypokalaemia; epilepsy; treatment with medicine known to have important interaction with macrolides or tetracyclines; impaired hepatic function (aspartate aminotransferase or alanine aminotransferase ≥ 2 times of the upper limit of normal (ULN), alkaline phosphatase ≥ 1.25 times the ULN, bilirubin >2 times the ULN and albumin <30 g/L); or unlikely to comply.","The exclusion criteria pulmonary disease COPD; treatment antibiotics, exacerbation investigational drug weeks randomisation; pregnancy (serum pregnancy test) breast feeding; history hypersensitivity macrolides, tetracyclines, beta-lactams sulfamethoxazole:trimethoprim; cardiovascular, hepatic, renal systemic diseases; QT syndrome corrected QT interval (QTc) >450 ms, sick sinus syndrome, bradycardia (<50 beats minute) severe hypokalaemia; epilepsy; treatment medicine interaction macrolides tetracyclines; impaired hepatic function (aspartate aminotransferase alanine aminotransferase ≥ 2 times upper limit normal (ULN), alkaline phosphatase ≥ 1.25 times ULN, bilirubin >2 times ULN albumin <30 g/L); comply.",G0000000|C0680251|C0243161|C0024109|C0012634|C0024117|C0039798|C0003232|G0000000|C1517586|C0013227|C0439230|C0034656|C0032961|C0229671|C0032961|C0022885|C0006141|C0204695|C0019664|C0020517|C0003240|C0039651|C0282215|C0041044|C0007226|C0205054|C0022646|C0205373|C0012634|C1552934|C0039082|C0205202|C1552934|C1272706|G0000000|C1442061|C0039676|C0221423|C0016169|C0039082|C0428977|C0450371|G0000000|C0439232|C0205082|C0020621|C0014544|C0039798|C0013227|C1704675|C0003240|C0039651|C0221099|C0205054|C0031843|C0085845|C0002594|C0001898|G0000000|C0040223|C1282910|C0439801|C0205307|C1519815|C1979842|G0000000|C0040223|C1519815|C0005437|G0000000|C0040223|C1519815|C0001924|C0450371|C0439294|C0725694
Participants will be 220 pregnant women.,Participants 220 pregnant women.,C0679646|C1442061|C0549206|C0043210
"Entry criteria included age ≥ 18 years, plasma HIV-1 RNA ≥ 5,000 copies/mL, CD4+ lymphocytes ≥ 300/μL with no documented count ≤ 250/μL, no antiretroviral therapy for ≥ 12 weeks, no history of acquired immunodeficiency syndrome-defining illness and only R5 HIV-1 detectable.","Entry criteria included age ≥ 18 years, plasma HIV-1 RNA ≥ 5,000 copies/mL, CD4+ lymphocytes ≥ 300/μL documented count ≤ 250/μL, antiretroviral therapy ≥ 12 weeks, history acquired immunodeficiency syndrome-defining illness R5 HIV-1 detectable.",C1705654|C0243161|C0332257|C0001779|G0000000|C0450371|C0439234|C0032105|C0019682|C0035668|G0000000|C1442061|C1531853|C0285590|C0024264|G0000000|G0000000|C1301725|C0750480|G0000000|G0000000|G0000000|C0039798|G0000000|C0450371|C0439230|C0019664|C0439661|C0021051|C0039082|C0221423|C1425688|C0019682|C3830527
Physical activity was measured using the short version of the International Physical Activity Questionnaire (IPAQ-SV) [[29]].,Physical activity measured short version International Physical Activity Questionnaire (IPAQ-SV) [[29]].,C0031809|C0205177|C0444706|C1282927|C0333052|C1512888|C0031809|C0205177|C0034394|C0013754|C0450371
"Although the caregivers worked an average of 41.5 hours per week (SD = 20.36), 63.8% of the families lived below federal poverty standards and another 18% lived within 150% of the poverty threshold; they can be described as working poor.11 Schools in 6 counties provided lists of 10th-grade students from which participants were selected randomly.","Although caregivers average 41.5 hours week (SD = 20.36), 63.8% families lived federal poverty standards 18% lived 150% poverty threshold; poor.11 Schools 6 counties provided lists 10th-grade students participants selected randomly.",G0000000|C0085537|C1510992|C0450371|C0439227|C0332174|G0000000|G0000000|C0450371|C0450371|C0015576|C1548795|G0000000|C0032854|C0038137|C0450371|C1548795|C1442061|C0032854|C0449864|C0032854|C0036375|G0000000|C0079170|C1999230|C0745732|C0441800|C0038492|C0679646|C1707391|G0000000
Exclusion criteria were: polytrauma patients; patients suffering from osteogenesis imperfecta or other bone diseases; pre-existent fractures or deformity of the injured forearm (congenital or acquired); concurrent participation in another study.,Exclusion criteria were: polytrauma patients; patients suffering osteogenesis imperfecta bone diseases; pre-existent fractures deformity injured forearm (congenital acquired); concurrent participation study.,C0680251|C0243161|G0000000|C0026771|C0030705|C0030705|C0683278|C0029433|G0000000|C0262950|C0012634|C0332152|C0016658|C0000768|C0332664|C0016536|C0009678|C0439661|C0205420|C0679823|C0557651
"Exclusion criteria included pregnant or lactating women; women of child bearing age or planning for conception in near future; participants with abnormal liver and kidney functions, known thyroid disease, cardiac disorders, nervous system disorders, and psychiatric illnesses; and participants with history of diabetes mellitus, hypertension, or chronic infectious diseases.","Exclusion criteria included pregnant lactating women; women child bearing age planning conception future; participants abnormal liver kidney functions, thyroid disease, cardiac disorders, nervous system disorders, psychiatric illnesses; participants history diabetes mellitus, hypertension, chronic infectious diseases.",C0680251|C0243161|C0332257|C0549206|C2828358|C0043210|C0043210|C0008059|C1704689|C0001779|C0032074|C0009637|C0016884|C0679646|C0205161|C0023884|C0022646|C0542341|C0040132|C0012634|C0018787|C0012634|C0027769|C0449913|C0012634|C0205487|C0221423|C0679646|C0019664|C0011847|G0000000|C0020538|C0205191|C0009450|C0012634
"[14], who reported 31 cases of central grade 1 CS of long bones with long-term follow-up (mean 157 months, minimum 66 months), treated with curettage in 15 cases and resection in 16 cases.","[14], reported 31 central grade 1 CS bones long-term follow-up (mean 157 months, minimum 66 months), treated curettage 15 resection 16 cases.",C0450371|C0684224|C0450371|C0205099|C0441800|G0000000|C0010182|C0262950|C0443252|C0589120|C0444504|C1442061|C0439231|C1524031|C0450371|C0439231|C1522326|C0010468|C0450371|C0015252|C0450371|C0868928
Tobacco smoke exposure (TSE) is a serious threat to child health.,Tobacco smoke exposure (TSE) threat child health.,C0040329|C0037366|C0274281|G0000000|C0749385|C0008059|C0018684
Daily chart reviews of all new stroke admissions are being performed by a site-designated-research-nurse (who is not the treating clinician) to identify potential first mild stroke patients.,Daily chart reviews stroke admissions performed site-designated-research-nurse (who treating clinician) identify potential mild stroke patients.,C0332173|C0007963|C0282443|C0038454|C0184666|C0884358|C0205145|G0000000|C1522326|C0871685|G0000000|C3245505|C2945599|C0038454|C0030705
"Exclusion criteria were moderate or severe wasting, presence of oedema, congenital malformations, history of peanut allergy or any severe allergic reaction, severe illness warranting hospitalization, concurrent participation in another clinical trial or any symptoms of food intolerance within 30 min after the ingestion of a 6‐g test dose of Nutributter (given to all potential participants to exclude the possibility of peanut allergy).","Exclusion criteria moderate severe wasting, presence oedema, congenital malformations, history peanut allergy severe allergic reaction, severe illness warranting hospitalization, concurrent participation clinical trial symptoms food intolerance 30 min ingestion 6‐g test dose Nutributter (given potential participants exclude possibility peanut allergy).",C0680251|C0243161|C0205081|C0205082|C0006625|C0150312|C0013604|C0009678|C0000768|C0019664|C0030736|C0002111|C0205082|C0700624|C0443286|C0205082|C0221423|G0000000|C0019993|C0205420|C0679823|C0205210|C0008976|C0683368|C0016452|C0231199|G0000000|C0232478|G0000000|C0022885|C0178602|G0000000|C1442162|C3245505|C0679646|C0332196|C0332149|C0030736|C0002111
A total of 371 NPC cases and 321 unaffected controls were included in the analyses.,A total 371 NPC 321 unaffected controls included analyses.,G0000000|C0439175|C1442061|G0000000|C1442061|C2986417|C0243148|C0332257|C0002778
"Entry criteria included children 1 to 14 years old, physician-diagnosed asthma needing a rescue inhaler in the last year, with a history of asthma exacerbations associated with apparent respiratory viral infections.","Entry criteria included children 1 14 old, physician-diagnosed asthma rescue inhaler year, history asthma exacerbations apparent respiratory viral infections.",C1705654|C0243161|C0332257|C0008059|G0000000|C0450371|C0580836|C0031831|C0004096|G0000000|C0021461|C0439234|C0019664|C0004096|G0000000|C0750489|C0521346|C0521026|C3714514
Male and female literacy rates are 79.6% and 48.6% respectively.,Male female literacy rates 79.6% 48.6% respectively.,C0086582|C0015780|C0023864|C0871208|C0450371|C0450371|G0000000
Two samples of two different subjects were lost during processing; therefore 20 patients (13 females) with a median age of 10 years (range 5–16) were left for the final analysis.,Two samples subjects lost processing; 20 patients (13 females) median age 10 (range 5–16) left final analysis.,C0205448|C0370003|C0681850|C0745777|C1709694|C0450371|C0030705|C0450371|C0015780|C0549183|C0001779|C0450371|C1514721|G0000000|C0205091|C0205088|C0002778
Inclusion criteria were either a pre-gravid BMI ≥ 30 kg/m2 or gestational diabetes (GDM) and a singleton pregnancy.,Inclusion criteria pre-gravid BMI ≥ 30 kg/m2 gestational diabetes (GDM) singleton pregnancy.,C0007637|C0243161|C0332152|G0000000|G0000000|C0450371|C0022718|C0439671|C0011847|C0085207|C0481462|C0032961
A pilot randomised controlled trial recruited patients with new reduced upper limb function within 14 days of acute stroke from three stroke units.,A pilot randomised controlled trial recruited patients reduced upper limb function 14 days acute stroke stroke units.,G0000000|C0473169|G0000000|C2587213|C0008976|G0000000|C0030705|C0392756|C1282910|C0015385|C0031843|C0450371|C0439228|C0205178|C0038454|C0038454|C0439148
"Co-morbidities related to obesity (hypertension, diabetes, CVD, arthritis and metabolic syndrome) were common in these patients [11].","Co-morbidities obesity (hypertension, diabetes, CVD, arthritis metabolic syndrome) common patients [11].",C0009488|C0028754|C0020538|C0011847|C0007222|C0003864|C0311400|C0039082|C0205214|C0030705|C0450371
Women less than 16 weeks’ gestation with a singleton pregnancy were eligible for participation in the study.,Women 16 weeks’ gestation singleton pregnancy eligible participation study.,C0043210|C0450371|G0000000|C0032961|C0481462|C0032961|C1548635|C0679823|C0557651
Inclusion criteria were women aged 18–45 years (inclusive) diagnosed with GDM with singleton pregnancies and a gestational age ≤35 weeks.,Inclusion criteria women aged 18–45 (inclusive) diagnosed GDM singleton pregnancies gestational age ≤35 weeks.,C0007637|C0243161|C0043210|C0001779|G0000000|C0332257|C0011900|C0085207|C0481462|C0032961|C0439671|C0001779|G0000000|C0439230
"thyroid dysfunction), psychiatric or psychosomatic diseases, and any other diseases which could interfere with compliance according to the study protocol.","thyroid dysfunction), psychiatric psychosomatic diseases, diseases interfere compliance study protocol.",C0040132|C0031847|C0205487|C1537048|C0012634|C0012634|C0521102|C0009563|C0557651|C0442711
"Follow-up continued until December 2002, when all babies had left hospital.","Follow-up continued December 2002, babies left hospital.",C0589120|C0549178|C3830550|G0000000|C0021270|C0205091|C0019994
Results: 519 subjects were randomised to treatment.,Results: 519 subjects randomised treatment.,C1274040|C1442061|C0681850|G0000000|C0039798
"[22] In the current study, during dental treatment in midazolam-ketamine group 3, 8, 5, 2 and in midazolam-fentanyl group 4, 7, 6, 3 individuals got Frankl score of -2, -1, +1, and +2, respectively; most children got -1 and the two groups had no significant difference in this regard.","[22] In current study, dental treatment midazolam-ketamine 3, 8, 5, 2 midazolam-fentanyl 4, 7, 6, 3 individuals Frankl score -2, -1, +1, +2, respectively; children -1 difference regard.",C0450371|G0000000|C0521116|C0557651|C0011365|C0039798|C0026056|G0000000|G0000000|G0000000|G0000000|C0026056|G0000000|G0000000|G0000000|G0000000|C0027361|G0000000|C0449820|G0000000|G0000000|G0000000|G0000000|G0000000|C0008059|G0000000|C1705241|G0000000
"Asthmatics aged ≥18 years, with a forced expiratory volume in the first second (FEV1) ≥40 and <80% of predicted normal value and with a documented positive reversibility test, defined as change in FEV1 ≥ 12% and ≥200 mL over baseline within 30 min after administration of 400 μg of salbutamol, were enrolled.","Asthmatics aged ≥18 years, forced expiratory volume (FEV1) ≥40 <80% predicted normal documented positive reversibility test, defined change FEV1 ≥ 12% ≥200 mL baseline 30 min administration 400 μg salbutamol, enrolled.",C0004096|C0001779|G0000000|C0439234|C0441722|C0231800|C0449468|G0000000|G0000000|C0450371|C0681842|C0205307|C1301725|C0439178|C0449261|C0022885|C1704788|C0392747|G0000000|G0000000|C0439526|C0168634|C0450371|C0702093|C0001554|C1442061|G0000000|C0001927|G0000000
"clinical severity score  Bronchiolitis was clinically defined as per the AAP consensus guidelines [4, 27] as the first episode of acute wheezing in children less than two years of age, starting as a viral upper respiratory infection (coryza, cough or fever).","clinical severity score Bronchiolitis clinically defined AAP consensus guidelines [4, 27] episode acute wheezing children age, starting viral upper respiratory infection (coryza, cough fever).",C0205210|C0439793|C0449820|C0006271|G0000000|C1704788|C0054943|C0376298|C0162791|G0000000|C0450371|C0332189|C0205178|C0043144|C0008059|C0001779|C0439659|C0521026|C1282910|C0521346|C0009450|C0009443|C0010200|C0015967
"Patients with intraparenchymal, supratentorial brain tumors either proven by biopsy to be a brain metastasis or a glioma, or with compelling CT or MRI evidence of metastasis or glioma were selected for this study.","Patients intraparenchymal, supratentorial brain tumors proven biopsy brain metastasis glioma, compelling CT MRI evidence metastasis glioma selected study.",C0030705|C3898701|C0441938|C0006104|C0027651|C0456369|C0005558|C0006104|C0027627|C0017638|G0000000|C0007673|C0024485|C3887511|C0027627|C0017638|C1707391|C0557651
Clinically stable adults with a CD4 count > 100 and on antiretroviral treatment for at least four weeks at the district hospital were assigned to either nurse led primary care based antiretroviral treatment care or usual hospital care.,Clinically stable adults CD4 count > 100 antiretroviral treatment weeks district hospital assigned nurse led primary care based antiretroviral treatment care usual hospital care.,G0000000|C0205360|C0001675|C0285590|C0750480|G0000000|C1442061|G0000000|C0039798|C0439230|G0000000|C0019994|C1516050|C0028661|C1708698|C0205225|C1947933|C1527178|G0000000|C0039798|C1947933|C3538928|C0019994|C1947933
Participants Adults aged 30-54 years with prehypertension.,Participants Adults aged 30-54 prehypertension.,C0679646|C0001675|C0001779|C0450371|C1696708
"Methods: Twenty infants (mean age 163.5 days, range 34–319 days) exclusively bottle fed, with symptoms clinically suggestive of GOR, underwent 24 hour studies of intra-oesophageal 6 channel impedance and dual channel pH monitoring, during which six random administrations (3+3) of Gaviscon Infant (625 mg in 225 ml milk) or placebo (mannitol and Solvito N, 625 mg in 225 ml milk) were given in a double blind fashion.","Methods: Twenty infants (mean age 163.5 days, range 34–319 days) exclusively bottle fed, symptoms clinically suggestive GOR, underwent 24 hour studies intra-oesophageal 6 channel impedance dual channel pH monitoring, random administrations (3+3) Gaviscon Infant (625 225 milk) placebo (mannitol Solvito N, 625 225 milk) double blind fashion.",C0025663|C0724000|C0021270|C0444504|C0001779|C1442061|C0439228|C1514721|G0000000|C0439228|G0000000|C0179376|C0342895|C0683368|G0000000|C0332299|C1826799|G0000000|C0450371|C0439227|C0947630|C0524446|G0000000|C0439799|C0162537|C1554184|C0439799|C0450407|C0150369|C0034656|C0001554|G0000000|C0061146|C0021270|C1442061|C1442061|C0026131|C0032042|C0024730|G0000000|C0369718|C1442061|C1442061|C0026131|C0205173|C0150108|G0000000
Exceptions were made for the use of hormonal contraception in women younger than 35 years of age that was discontinued before randomization and for hormonal treatment for up to 2 months for the purposes of in vitro fertilization and cryopreservation of embryos or oocytes before randomization.,Exceptions hormonal contraception women 35 age discontinued randomization hormonal treatment 2 months purposes vitro fertilization cryopreservation embryos oocytes randomization.,C1554961|C0458083|C0700589|C0043210|C0450371|C0001779|C1444662|C0034656|C0458083|C0039798|G0000000|C0439231|C1285529|C1533691|C0015914|C0010405|C0013935|C0029045|C0034656
"Orlistat) or diet/exercise regime designed for weight loss; use of corticosteroids, anti-depressants, or anti-epileptic, lipid-lowering, and diabetes medications; previous bariatric or other intestinal surgery; pregnancy or lactation; use of bulk laxatives or probiotic/prebiotic supplements; chronic use of antacids; use of antibiotics within the preceding 3 months of enrollment; clinically significant cardiovascular or respiratory disease; liver disease; alcohol or drug dependence; body weight >350 lb; active malignancy; and chronic infections.","Orlistat) diet/exercise regime designed weight loss; corticosteroids, anti-depressants, anti-epileptic, lipid-lowering, diabetes medications; previous bariatric intestinal surgery; pregnancy lactation; bulk laxatives probiotic/prebiotic supplements; chronic antacids; antibiotics preceding 3 months enrollment; clinically cardiovascular respiratory disease; liver disease; alcohol drug dependence; body weight >350 lb; active malignancy; chronic infections.",C0076275|C0012155|G0000000|C1707689|C0005910|C1517945|C0001617|G0000000|C0003299|C0023779|C0011847|C0013227|C0205156|G0000000|C0021853|C0038894|C0032961|C0006147|C0012173|C0282090|C0525033|C0242295|C0205191|C0003138|C0003232|C0332152|G0000000|C0439231|C1516879|G0000000|C0007226|C0521346|C0012634|C0023884|C0012634|C0001962|C0013227|C0011546|C0242821|C0005910|C1442061|G0000000|C0205177|C0006826|C0205191|C3714514
"Patients (age ≥18 years) with symptomatic relapsed or refractory MM after 1-3 prior therapies who had measurable disease, adequate hematologic, renal and hepatic function, no prior bortezomib treatment, and no grade 2 or higher peripheral neuropathy (PN) were randomized to receive up to eight 21-day cycles of sc or iv bortezomib 1.3 mg/m2 on Days 1, 4, 8 and 11.","Patients (age ≥18 years) symptomatic relapsed refractory MM 1-3 prior therapies measurable disease, adequate hematologic, renal hepatic function, prior bortezomib treatment, grade 2 peripheral neuropathy (PN) randomized receive 21-day cycles sc iv bortezomib 1.3 mg/m2 Days 1, 4, 8 11.",C0030705|C0001779|G0000000|C0439234|C0231220|C0205336|C0205269|G0000000|G0000000|C0332152|C0087111|C1513040|C0012634|C0205410|C0018943|C0022646|C0205054|C0031843|C0332152|C1176309|C0039798|C0441800|G0000000|C0205100|C0442874|C0219433|C0034656|C1514756|C0450371|C1511572|C0282380|C0022326|C1176309|G0000000|C0026410|C0439228|G0000000|G0000000|G0000000|C0450371
"Patients were eligible for inclusion if they were adults with a confirmed angiographic diagnosis of ischemic heart disease, defined as stenosis of more than 50% of at least 1 coronary artery, that could be treated by elective revascularization (bypass surgery and/or angioplasty) with the option of ongoing medical therapy.","Patients eligible inclusion adults confirmed angiographic diagnosis ischemic heart disease, defined stenosis 50% 1 coronary artery, treated elective revascularization (bypass surgery and/or angioplasty) option ongoing medical therapy.",C0030705|C1548635|C0007637|C0001675|C0521093|C0002978|C0011900|C0475224|C0018787|C0012634|C1704788|C0678234|C0450371|G0000000|C0018787|C0003842|C1522326|C0206058|C0581603|C0741847|C0038894|G0000000|C0162577|C1518601|C0549178|C0199168|C0039798
"Initial inclusion criteria were: 1) patients were alive with a functional kidney at one-year post-transplantation, 2) patients with high-speed internet access, usually digital subscriber line or fiber optic cable, 3) patients without ongoing CMV or BKV infection, 4) men or non-pregnant women, 5) patients without mental disorders and 6) patients with a written informed consent.","Initial inclusion criteria were: 1) patients alive functional kidney one-year post-transplantation, 2) patients high-speed internet access, digital subscriber fiber optic cable, 3) patients ongoing CMV BKV infection, 4) non-pregnant women, 5) patients mental disorders 6) patients written informed consent.",C0205265|C0007637|C0243161|G0000000|G0000000|C0030705|C0376558|C0205245|C0022646|C4082117|C0687676|G0000000|C0030705|C0205250|C0282111|C0444454|C0442015|C3242716|C0012173|C0015392|C0492124|G0000000|C0030705|C0549178|G0000000|C0005670|C0009450|G0000000|C1518422|C0043210|G0000000|C0030705|C0229992|C0012634|G0000000|C0030705|C0043266|C1522154|C1511481
One additional subject moved before follow-up data could be obtained but did complete the intervention portion in the control group.,One additional subject moved follow-up data complete intervention portion control group.,C0205447|C1524062|C0681850|C1269909|C0589120|C1511726|C0205197|C0886296|C0449719|C0243148|C0441833
Patients who are considered by the RN in discussion with their centre leader to be unable to do one or more of the trial therapies or to complete all trial measures (travel expenses will be offered for therapy and research assessments).,Patients considered RN discussion centre leader unable trial therapies complete trial measures (travel expenses offered therapy assessments).,C0030705|C0750591|C2827110|C0557061|C0205099|G0000000|C1299582|C0008976|C0087111|C0205197|C0008976|C0079809|C0040802|C0680864|C1444648|C0039798|C1261322
"For inclusion, both the patient and caregiver had to be able to read and speak English and have access to a telephone.","For inclusion, patient caregiver read speak English access telephone.",G0000000|C0007637|C0030705|C0085537|C0034754|C0234856|C0376245|C0444454|C0039457
PCR analysis for the molecular form of Anopheles gambiae s.s. identified the collections either as a mix of approximately 80% of the S and 19% of the M form at Ijesa (PN 2.0 village) or as pure collections of the S form at Ilara (UTC village) and Irolu (PN 3.0 village) respectively.,PCR analysis molecular form Anopheles gambiae s.s. identified collections mix 80% S 19% M form Ijesa (PN 2.0 village) pure collections S form Ilara (UTC village) Irolu (PN 3.0 village) respectively.,C0032520|C0002778|C1521991|C0348078|C0003117|G0000000|C0565930|C0205396|C0600644|C0205430|C0450371|C0565930|C0450371|C0369637|C0348078|G0000000|C0219433|G0000000|C0562518|C2247561|C0600644|C0565930|C0348078|G0000000|G0000000|C0562518|G0000000|C0219433|G0000000|C0562518|G0000000
"Using a 2-by-2 factorial design, we randomly assigned 1400 adults with definite or probable tuberculous pericarditis to either prednisolone or placebo for 6 weeks and to either M. indicus pranii or placebo, administered in five injections over the course of 3 months.","Using 2-by-2 factorial design, randomly assigned 1400 adults definite probable tuberculous pericarditis prednisolone placebo 6 weeks M. indicus pranii placebo, administered injections 3 months.",C1524063|G0000000|C2826344|C1707689|G0000000|C1516050|G0000000|C0001675|C0439544|C0033204|C0041296|C0031046|C0032950|C0032042|G0000000|C0439230|C0369637|G0000000|G0000000|C0032042|C1521801|C0021485|G0000000|C0439231
"Patients on no treatment, maintenance treatment with a 5-aminosalicylic preparation or low dose Azathioprine (1 mg/kg) were eligible for inclusion in the trial, but those on steroids (prednisolone > 4 mg/day) and biologics were excluded from the study.","Patients treatment, maintenance treatment 5-aminosalicylic preparation low dose Azathioprine (1 mg/kg) eligible inclusion trial, steroids (prednisolone > 4 mg/day) biologics excluded study.",C0030705|C0039798|C0024501|C0039798|G0000000|C1521827|C0205251|C0178602|C0004482|G0000000|C0439272|C1548635|C0007637|C0008976|C0038317|C0032950|G0000000|C0439422|C0005515|C1554077|C0557651
"Other exclusion criteria included known hypersensitivity to anticholinergics or any component of the Respimat® inhalation solution; drugs contraindicated with anticholinergics; prior use of Spiriva® HandiHaler®; regular use of daytime oxygen therapy, oral β-adrenergics, or long-acting β-adrenergics; or significant alcohol or drug abuse.","Other exclusion criteria included hypersensitivity anticholinergics component Respimat® inhalation solution; drugs contraindicated anticholinergics; prior Spiriva® HandiHaler®; regular daytime oxygen therapy, oral β-adrenergics, long-acting β-adrenergics; alcohol drug abuse.",G0000000|C0680251|C0243161|C0332257|C0020517|C0242896|C0449432|G0000000|C0004048|C0037633|C0013227|C1444657|C0242896|C0332152|G0000000|G0000000|C0205272|C0332169|C0030054|C0039798|C0442027|G0000000|C0205166|G0000000|C0001962|C0013227|C0013146
"In August 2009 to July 2010, 540 incident cases with a primary diagnosis of leukemia, or breast cancer, or colorectal cancer were identified from histopathology and haematology records at the First Hospital of China Medical University, a public teaching hospital with 2,249 beds, around 32,000 inpatients annually and 3,000 outpatients daily.","In August 2009 July 2010, 540 incident primary diagnosis leukemia, breast cancer, colorectal cancer identified histopathology haematology records First Hospital China Medical University, public teaching hospital 2,249 beds, 32,000 inpatients annually 3,000 outpatients daily.",G0000000|C3831448|G0000000|C3829447|G0000000|C1442061|C1551358|C0205225|C0011900|C0023418|C0006141|C0006826|C0555952|C0006826|C0205396|C0243140|C0018943|C0034869|C0205435|C0019994|C0008115|C0199168|C0041740|G0000000|C0039401|C0019994|C1442061|C0004916|C0450371|C0021562|C0332181|C1442061|C0029921|C0332173
"Smokers are about 1.5 more days per year absent from work than non-smokers [5, 6].","Smokers 1.5 days absent non-smokers [5, 6].",C0337664|G0000000|C0439228|C0332197|C0337672|G0000000|G0000000
"Sixty nine children between the ages of 2 months and 5 years admitted to hospital with acute lower respiratory tract infection and an oxygen saturation (SaO2) < 90% were compared with 67 children matched for age and diagnosis from the same referral hospital with an SaO2 of 90% or above (control group 1), and 44unreferred children admitted to a secondary care hospital with acute lower respiratory infection (control group 2).","Sixty children ages 2 months 5 admitted hospital acute lower respiratory tract infection oxygen saturation (SaO2) < 90% compared 67 children matched age diagnosis referral hospital SaO2 90% (control 1), 44unreferred children admitted secondary care hospital acute lower respiratory infection (control 2).",C3816724|C0008059|C0001779|G0000000|C0439231|G0000000|C0184666|C0019994|C0205178|C0441994|C0521346|C1185740|C0009450|C0030054|C0522534|G0000000|G0000000|C0450371|C1707455|C0450371|C0008059|C0150103|C0001779|C0011900|C0034927|C0019994|G0000000|C0450371|C0243148|G0000000|G0000000|C0008059|C0184666|C0027627|C1947933|C0019994|C0205178|C0441994|C0521346|C0009450|C0243148|G0000000
The participants will make 4 visits to the clinic.,The participants 4 visits clinic.,G0000000|C0679646|G0000000|C0545082|C0002424
"Exclusion criteria included previous receipt of H5N1 vaccine; receipt of seasonal influenza vaccine within 14 days (inactivated vaccine) or 30 days (live vaccine); receipt of any vaccine not foreseen by the protocol up to 42 days from baseline; receipt of any investigational or nonregistered product from 30 days before to 42 days after study vaccination; any significant acute or chronic uncontrolled illness; temperature of ≥38°C (≥100.4°F) at baseline assessment; cancer diagnosis within previous 3 years; immunosuppressive or immunodeficient conditions; receipt of glucocorticoids within 1 month of the start of and throughout the study; receipt of cytotoxic, immunosuppressive drugs within 6 months of the start of and throughout the study; receipt of immunoglobulins within 3 months of the start of and throughout the study; and history of allergy to influenza vaccine.","Exclusion criteria included previous receipt H5N1 vaccine; receipt seasonal influenza vaccine 14 days (inactivated vaccine) 30 days (live vaccine); receipt vaccine foreseen protocol 42 days baseline; receipt investigational nonregistered product 30 days 42 days study vaccination; acute chronic uncontrolled illness; temperature ≥38°C (≥100.4°F) baseline assessment; cancer diagnosis previous 3 years; immunosuppressive immunodeficient conditions; receipt glucocorticoids 1 month start study; receipt cytotoxic, immunosuppressive drugs 6 months start study; receipt immunoglobulins 3 months start study; history allergy influenza vaccine.",C0680251|C0243161|C0332257|C0205156|G0000000|G0000000|C0042210|G0000000|C0439601|C0021400|C0042210|C0450371|C0439228|G0000000|C0042210|C0450371|C0439228|C1548795|C0042210|G0000000|C0042210|G0000000|C0442711|C0450371|C0439228|C0168634|G0000000|C1517586|G0000000|C1514468|C0450371|C0439228|C0450371|C0439228|C0557651|C0042196|C0205178|C0205191|C0205318|C0221423|C0005903|G0000000|G0000000|C0168634|C1261322|C0006826|C0011900|C0205156|G0000000|C0439234|C0021081|C0021051|C0012634|G0000000|C0017710|G0000000|C0332177|C0439659|C0557651|G0000000|C0677881|C0021081|C0013227|G0000000|C0439231|C0439659|C0557651|G0000000|C0021027|G0000000|C0439231|C0439659|C0557651|C0019664|C0002111|C0021400|C0042210
Capsules will be taken once daily from enrolment prior to 16 weeks gestation until birth (Figure (Figure1).1).,Capsules daily enrolment prior 16 weeks gestation birth (Figure (Figure1).1).,C0006935|C0332173|C1516879|C0332152|C0450371|C0439230|C0032961|C0005615|G0000000|G0000000
"Individuals (i) gave informed consent; (ii) had a diagnosis of a first single, unilateral stroke; (iii) were between the ages of 16-90; (iv) were 2-8 weeks post stroke; (v) had arm motor impairment between stages 1-4 as measured by the CMSA; and (vi) were able to follow simple instructions.","Individuals (i) informed consent; (ii) diagnosis single, unilateral stroke; (iii) ages 16-90; (iv) 2-8 weeks post stroke; (v) arm motor impairment stages 1-4 measured CMSA; (vi) follow simple instructions.",C0027361|C0021966|C1522154|C1511481|G0000000|C0011900|C0037179|C0205092|C0038454|C0439070|C0001779|C0450371|C0022326|G0000000|C0439230|C0687676|C0038454|G0000000|C0446516|C1513492|C0221099|C1306673|G0000000|C0444706|G0000000|C0205999|C0332283|C0205352|C0302828
"Exclusion criteria included (i) Patients with CHC with other co-morbid states such as autoimmune disease, alcoholic liver disease, HBV or HIVco-infection, renal impairment (serum creatinine >1.5 × ULN), hepatic decompensation; (ii) biochemical abnormalities such as elevated creatine kinase (CK), Alanine aminotransferase (ALT) > 3 × ULN, low total serum cholesterol (<80 mg/dL); (iii) evidence for primary (familial hypercholesterolaemia, combined hyperlipidaemia) or secondary dyslipidaemias (including hypothyroidism, diabetes mellitus, obesity, renal impairment, nephrotic syndrome, or drugs such as thiazide diuretics, retinoids and corticosteroids) and (iv) known hypersensitivity and/or myopathy (CK > 10 × ULN with muscle symptoms) to previous lipid-lowering therapy.","Exclusion criteria included (i) Patients CHC co-morbid autoimmune disease, alcoholic liver disease, HBV HIVco-infection, renal impairment (serum creatinine >1.5 × ULN), hepatic decompensation; (ii) biochemical abnormalities elevated creatine kinase (CK), Alanine aminotransferase (ALT) > 3 × ULN, low total serum cholesterol (<80 mg/dL); (iii) evidence primary (familial hypercholesterolaemia, combined hyperlipidaemia) secondary dyslipidaemias (including hypothyroidism, diabetes mellitus, obesity, renal impairment, nephrotic syndrome, drugs thiazide diuretics, retinoids corticosteroids) (iv) hypersensitivity and/or myopathy (CK > 10 × ULN muscle symptoms) previous lipid-lowering therapy.",C0680251|C0243161|C0332257|C0021966|C0030705|C1413512|C0009488|C0443146|C0012634|C0687725|C0023884|C0012634|G0000000|C0009450|C0022646|C0221099|C0229671|C0010294|G0000000|G0000000|C1519815|C0205054|C0231187|G0000000|C0205474|C0000768|C0205250|C0010286|C0031727|C0009212|C0001898|C0002594|C1266129|G0000000|G0000000|G0000000|C1519815|C0205251|C0439175|C0229671|C0008377|C0450371|C0439269|C0439070|C3887511|C0205225|C0015576|C0020443|C0205195|C0020473|C0027627|C0242339|C0332257|C0020676|C0011847|G0000000|C0028754|C0022646|C0221099|G0000000|C0039082|C0013227|C0541746|C0012798|C0035339|C0001617|C0022326|C0020517|G0000000|C0026848|C0009212|G0000000|C0450371|G0000000|C1519815|C0026845|C0683368|C0205156|C0023779|C0039798
Fifty patients were enrolled.,Fifty patients enrolled.,C3816723|C0030705|G0000000
"In the United Kingdom study, a single flexible sigmoidoscopic screening for participants 55 to 64 years of age was performed.","In United Kingdom study, single flexible sigmoidoscopic screening participants 55 64 age performed.",G0000000|C0166872|C1708611|C0557651|C0037179|C0443220|C0037075|C0220908|C0679646|C0450371|C0450371|C0001779|C0884358
"Ten, 17, and 15 patients in the RFTA, PEI, and PAI groups, respectively, died during follow up.","Ten, 17, 15 patients RFTA, PEI, PAI groups, respectively, died follow up.",C0014518|C0450371|C0450371|C0030705|G0000000|C0814202|C1620101|C0441833|G0000000|C0011065|C0332283|G0000000
"Methods: This study included 120 primary molars in 58 children 5–9 years of age who underwent an identical conventional pulpotomy technique; the molars were allocated to FC, FS, and DL groups.","Methods: This study included 120 primary molars 58 children 5–9 age underwent identical conventional pulpotomy technique; molars allocated FC, FS, DL groups.",C0025663|G0000000|C0557651|C0332257|C1442061|C0205225|C0026367|C0450371|C0008059|G0000000|C0001779|G0000000|C0205280|C0439858|C0034104|C0449851|C0026367|G0000000|C2983605|C1517317|C3642216|C0441833
"Seventeen had one of three types of neuropathic pain: 12 of these had SCI pain, defined as a neuropathic diffuse pain below the level of injury in areas without normal sensation and not affected by position; 4 had transition zone pain, defined as bilateral allodynia at the level of injury; and 1 had radicular pain, defined as pain at any dermatomal level, usually unilateral, usually radiating, related to activity, affected by position, and not worse with light touch.","Seventeen types neuropathic pain: 12 SCI pain, defined neuropathic diffuse pain level injury normal sensation position; 4 transition zone pain, defined bilateral allodynia level injury; 1 radicular pain, defined pain dermatomal level, unilateral, radiating, activity, position, worse light touch.",C0450331|C0332307|C0442874|C0030193|C0450371|C3642273|C0030193|C1704788|C0442874|C0205219|C0030193|C0441889|C3263722|C0205307|C0036658|C0733755|G0000000|C0599156|C1710706|C0030193|C1704788|C0238767|C0458247|C0441889|C3263722|G0000000|C0040452|C0030193|C1704788|C0030193|C0180383|C0441889|C0205092|C0332301|C0205177|C0733755|C0332271|C0023693|C0152054
"Children aged between two and 15 years, with irritative cough for at least 24hours, which led to the need for medical consultation, participated in the study.","Children aged 15 years, irritative cough 24hours, led medical consultation, participated study.",C0008059|C0001779|C0450371|C0439234|C0441723|C0010200|G0000000|C1708698|C0199168|C0009818|G0000000|C0557651
"The CRASH-2 trial has shown reliably that early administration of tranexamic acid in trauma patients with, or at risk of, significant bleeding reduces the risk of all cause mortality.","The CRASH-2 trial reliably administration tranexamic acid trauma patients with, risk of, bleeding reduces risk mortality.",G0000000|G0000000|C0008976|G0000000|C0001554|G0000000|C0001128|C0043251|C0030705|G0000000|C0035647|G0000000|C0019080|G0000000|C0035647|C0026565
"American Society of Anesthesiologists Physical Status 1 children 3–9 years of age, with no mental or physical deficiency, presenting early childhood caries and negative behavior were included in the study.","American Society Anesthesiologists Physical Status 1 children 3–9 age, mental physical deficiency, childhood caries negative behavior included study.",C0596070|C0037455|C0334910|C0031809|C0449438|G0000000|C0008059|G0000000|C0001779|C0229992|C0031809|C0011155|C0231335|C0011334|C0205160|C0004927|C0332257|C0557651
"The explanation-of-treatment variable was the subject’s answer (yes or no) at 4 weeks to the question, “Did your provider explain your low back pain treatment plan (for example, did he or she tell you how often you should schedule visits)?” We used administrative data to calculate number of low back pain office visits, number of patients who received radiological studies, and copayment amounts during the 4-week period as well as to identify the primary provider.","The explanation-of-treatment variable subject’s answer (yes no) 4 weeks question, “Did provider explain low pain treatment plan (for example, schedule visits)?” We administrative data calculate low pain office visits, patients received radiological studies, copayment amounts 4-week period identify primary provider.",G0000000|C0681841|C0439828|G0000000|C1706817|C1549445|G0000000|G0000000|C0439230|C1522634|G0000000|C1138603|G0000000|C0205251|C0030193|C0039798|C0270724|G0000000|C1707959|C0086960|G0000000|G0000000|C1292785|C1511726|C1441506|C0205251|C0030193|C0442603|C0545082|C0030705|C1514756|C0034599|C0947630|C0680272|C1265611|C0332174|C0439531|G0000000|C0205225|C1138603
"Our study on 30 cases of generalized vitiligo showed no significant improvement in pigmentation in the lesions on topical tetracycline side, compared to placebo sides.","Our study 30 generalized vitiligo improvement pigmentation lesions topical tetracycline side, compared placebo sides.",G0000000|C0557651|C0450371|C0205246|C0042900|C2986411|C0031911|C0221198|C0332237|C0039644|C0441987|C1707455|C0032042|C0441987
"Management of pulmonary nontuberculous mycobacterial (PNTM) disease is limited by lengthy multidrug regimens, drug toxicity and/or intolerance, and poor drug efficacy.","Management pulmonary nontuberculous mycobacterial (PNTM) disease limited lengthy multidrug regimens, drug toxicity and/or intolerance, poor drug efficacy.",C0001554|C0024109|G0000000|C0521015|G0000000|C0012634|C0439801|C1444754|G0000000|C2945654|C0013227|C0040539|G0000000|C0231199|C0032854|C0013227|C1280519
Children in the trial ranged in age from 4 to 12 years with a mean age of 7.64 years.,Children trial ranged age 4 12 age 7.64 years.,C0008059|C0008976|C1514721|C0001779|G0000000|C0450371|C0001779|C0450371|C0439234
Those reporting cough for ⩾3 weeks were asked to provide a sputum specimen.,Those reporting cough ⩾3 weeks provide sputum specimen.,G0000000|C0700287|C0010200|G0000000|C0439230|C1999230|C0038056|C0370003
We have selected children aged 6 months to 13 years for two reasons.,We selected children aged 6 months 13 reasons.,G0000000|C1707391|C0008059|C0001779|G0000000|C0439231|C0450371|C0392360
"Inclusion criteria for children were: born in 2012, attended the included kindergartens in Vest-Agder and Aust-Agder, were in kindergarten departments for toddlers, and had a parent that understood Norwegian.","Inclusion criteria children were: born 2012, attended included kindergartens Vest-Agder Aust-Agder, kindergarten departments toddlers, parent understood Norwegian.",C0007637|C0243161|C0008059|G0000000|C0005615|G0000000|C1456498|C0332257|C0681406|C0453884|G0000000|C0681406|C1704729|C0682053|C0030551|C0162340|C0337812
We used all relevant records from the provincial population-based registry of patients with angiographically-proven coronary artery disease identified as needing bypass surgery on a non-emergency basis.,We relevant records provincial population-based registry patients angiographically-proven coronary artery disease identified bypass surgery non-emergency basis.,G0000000|C2347946|C0034869|G0000000|C0032659|C0034975|C0030705|C0456369|C0018787|C0003842|C0012634|C0205396|C0741847|C0038894|C1518422|C1527178
512/15 s. Written informed consent is obtained by all patients prior to inclusion into the trial.,512/15 s. Written informed consent patients prior inclusion trial.,C1442061|C0565930|C0043266|C1522154|C1511481|C0030705|C0332152|C0007637|C0008976
"Children with a severe physical disability (eg, blindness, deafness) or learning disability (eg, dyslexia) were also excluded on the basis of the child’s medical file and a standardized interview administered by phone to parents.","Children severe physical disability (eg, blindness, deafness) learning disability (eg, dyslexia) excluded basis child’s medical file standardized interview administered phone parents.",C0008059|C0205082|C0031809|C0231170|C0013715|C0456909|C0011053|C0013621|C0231170|C0013715|C0476254|C1554077|C1527178|G0000000|C0199168|C0016094|G0000000|C0021822|C1521801|C1515258|C0030551
"Results: The mean patient age was 72.65 ± 12.10 years, and the duration of BMS was 5.43 ± 3.23 years on average.","Results: The patient age 72.65 ± 12.10 years, duration BMS 5.43 ± 3.23 average.",C1274040|G0000000|C0030705|C0001779|C0450371|G0000000|C0450371|C0439234|C0449238|G0000000|C0450371|G0000000|C0450371|C1510992
"Exclusion criteria were a serum creatinine level >150 µmol/L, the presence of cancer in the past 5 years (excluding non-melanoma skin cancer), use of high doses of B-vitamins (intramuscular injections of vitamin B12 and/or folic acid intake >300 µg/day) or permanent use of a wheel chair.","Exclusion criteria serum creatinine level >150 µmol/L, presence cancer 5 (excluding non-melanoma skin cancer), doses B-vitamins (intramuscular injections vitamin B12 and/or folic acid intake >300 µg/day) permanent wheel chair.",C0680251|C0243161|C0229671|C0010294|C0441889|C1442061|G0000000|C0150312|C0006826|G0000000|C0332196|C1518422|C0444099|C0006826|C0178602|C0042849|C0021492|C0021485|C0042890|G0000000|G0000000|G0000000|C0001128|C1512806|C1442061|G0000000|C0205355|C1710669|C0179847
"¶: number of patients contributing to the mixed model for repeated measurements for adjusted mean trough FEV1 Study 1237.5: tiotropium+olodaterol 5/5 μg n=521, tiotropium+olodaterol 2.5/5 μg n=518, tiotropium 5 μg n=520, tiotropium 2.5 μg n=519, olodaterol 5 μg n=519; Study 1237.6: tiotropium+olodaterol 5/5 μg n=497, tiotropium+olodaterol 2.5/5 μg n=500, tiotropium 5 μg n=498, tiotropium 2.5 μg n=499, olodaterol 5 μg n=503.","¶: patients contributing mixed model repeated measurements adjusted trough FEV1 Study 1237.5: tiotropium+olodaterol 5/5 μg n=521, tiotropium+olodaterol 2.5/5 μg n=518, tiotropium 5 μg n=520, tiotropium 2.5 μg n=519, olodaterol 5 μg n=519; Study 1237.6: tiotropium+olodaterol 5/5 μg n=497, tiotropium+olodaterol 2.5/5 μg n=500, tiotropium 5 μg n=498, tiotropium 2.5 μg n=499, olodaterol 5 μg n=503.",G0000000|C0030705|C1880177|C0205430|C3161035|C0205341|C0242485|C0456081|C0444506|G0000000|C0557651|G0000000|C0213771|G0000000|C0369718|C0213771|G0000000|C0369718|C0213771|G0000000|C0369718|C0213771|G0000000|C0369718|C2934193|G0000000|C0369718|C0557651|G0000000|C0213771|G0000000|C0369718|C0213771|G0000000|C0369718|C0213771|G0000000|C0369718|C0213771|G0000000|C0369718|C2934193|G0000000|C0369718
"Exclusion criteria included patients with paralysis of other cranial nerves, passing more than 3 days of symptoms onset, patients with less than 2 years of age and older than 18 years, presence of secondary causes of the 7th nerve palsy, suspicion of meningitis, vasculopathy, Ramsey Hunt syndrome, peptic ulcer, anti-herpetic treatment within the last 2 weeks, and sensitivity to acyclovir.","Exclusion criteria included patients paralysis cranial nerves, passing 3 days symptoms onset, patients 2 age 18 years, presence secondary 7th nerve palsy, suspicion meningitis, vasculopathy, Ramsey Hunt syndrome, peptic ulcer, anti-herpetic treatment 2 weeks, sensitivity acyclovir.",C0680251|C0243161|C0332257|C0030705|C0522224|C0037303|C0027740|G0000000|G0000000|C0439228|C0683368|C0206132|C0030705|G0000000|C0001779|C0450371|C0439234|C0150312|C0027627|G0000000|C0027740|C0522224|C0242114|C0025289|C0042373|G0000000|G0000000|C0039082|C0443277|C0041582|C0019340|C0039798|G0000000|C0439230|C0020517|C0001367
All stroke patients with thalamic and parietal lobe lesions within 48 hours of stroke onset who had upper limb weakness and provided informed consent were included.,All stroke patients thalamic parietal lobe lesions 48 hours stroke onset upper limb weakness provided informed consent included.,G0000000|C0038454|C0030705|C0039729|C0442030|C0796494|C0221198|C0450371|C0439227|C0038454|C0206132|C1282910|C0015385|C3714552|C1999230|C1522154|C1511481|C0332257
"The exclusion criteria used in this study were children with (1) severe AD (SCORAD score >40), (2) exposure to commercial probiotic products during the previous 4 weeks, (3) acute gastrointestinal infections, (4) chronic underlying disease or baseline factors predisposing to the infection (e.g., neurologic disease, metabolic disease, chronic respiratory disease, congenital anomaly of the heart, gastrointestinal system, or lung), (5) known or suspected immunodeficiency, (6) prematurity, and (7) receiving antibiotic, systemic corticosteroid, immunosuppressive, or Chinese herbal therapies within 4 weeks prior to enrollment.","The exclusion criteria study children (1) severe AD (SCORAD score >40), (2) exposure commercial probiotic products previous 4 weeks, (3) acute gastrointestinal infections, (4) chronic underlying disease baseline factors predisposing infection (e.g., neurologic disease, metabolic disease, chronic respiratory disease, congenital anomaly heart, gastrointestinal system, lung), (5) suspected immunodeficiency, (6) prematurity, (7) receiving antibiotic, systemic corticosteroid, immunosuppressive, Chinese herbal therapies 4 weeks prior enrollment.",G0000000|C0680251|C0243161|C0557651|C0008059|G0000000|C0205082|G0000000|G0000000|C0449820|C0450371|G0000000|C0274281|C0680536|C0525033|C1514468|C0205156|G0000000|C0439230|G0000000|C0205178|C0521362|C3714514|G0000000|C0205191|G0000000|C0012634|C0168634|C1521761|C0231203|C0009450|G0000000|C0205494|C0012634|C0311400|C0012634|C0205191|C0521346|C0012634|C0009678|C0332447|C0018787|C0521362|C0449913|C0024109|G0000000|C0332147|C0021051|G0000000|C0021294|G0000000|C1514756|C0003232|C0205373|C0001617|C0021081|C0008120|C3146288|C0087111|G0000000|C0439230|C0332152|C1516879
"Study participants were drawn from the community with assistance from the local Ohio Epilepsy Association, MetroHealth System, a regional safety-net healthcare provider, the Lois Stoke VA, and University Hospitals of Cleveland Neurological Institute, a tertiary care center.","Study participants drawn community assistance local Ohio Epilepsy Association, MetroHealth System, regional safety-net healthcare provider, Lois Stoke VA, University Hospitals Cleveland Neurological Institute, tertiary care center.",C0557651|C0679646|C0013113|C0009462|C0018896|C0205276|C0028905|C0014544|C0004083|G0000000|C0449913|C0205147|C0036043|C0086388|C1138603|G0000000|G0000000|C1549054|C0041740|C0019994|C0454845|C0205494|C0021622|C0205372|C1947933|C0205099
After 4 weeks patients whose asthma was well controlled (n=505) were re-randomised to receive budesonide 400 µg daily and either eformoterol 9 µg or placebo twice daily for a further 6 months.,After 4 weeks patients asthma controlled (n=505) re-randomised receive budesonide 400 µg daily eformoterol 9 µg placebo daily 6 months.,G0000000|G0000000|C0439230|C0030705|C0004096|C2587213|C0369718|C0556581|C1514756|C0054201|C1442061|G0000000|C0332173|C0060657|G0000000|G0000000|C0032042|C0332173|G0000000|C0439231
"HPV PCR, cytology and anoscopy variables of the screening population LSIL low squamous intra-epithelial lesion, HSIL high squamous intra-epithelial lesion, ASC-US atypical squamous cells undetermined significance, HPV human papillomavirus, HR-HPV high-risk HPV, LR-HPV low-risk HPV Of the 162 patients, 129 (79.6%) were finally included in the trial; 30 (18.5%) were excluded for not fulfilling the selection criteria and 3 (1.8%) for withdrawal of consent; 66 (51.2%) were vaccinated while 63 (48.8%) received placebo; 128 (99.2%) received 3 doses of the vaccine (or placebo) and completed the first 6 months of follow-up.","HPV PCR, cytology anoscopy variables screening population LSIL low squamous intra-epithelial lesion, HSIL squamous intra-epithelial lesion, ASC-US atypical squamous cells undetermined significance, HPV human papillomavirus, HR-HPV high-risk HPV, LR-HPV low-risk HPV Of 162 patients, 129 (79.6%) finally included trial; 30 (18.5%) excluded fulfilling selection criteria 3 (1.8%) withdrawal consent; 66 (51.2%) vaccinated 63 (48.8%) received placebo; 128 (99.2%) received 3 doses vaccine (or placebo) completed 6 months follow-up.",C0021344|C0032520|C0010818|C0193158|C0439828|C0220908|C0032659|C1302773|C0205251|C1182670|C1512942|C0221198|C0333875|C1182670|C1512942|C0221198|C0521184|C0205182|C1182670|C0007634|C0205258|C0237881|C0021344|C0086418|C0030358|C0021344|C0332167|C0021344|C0023617|C3272281|C0021344|G0000000|C1442061|C0030705|C1442061|C0450371|G0000000|C0332257|C0008976|C0450371|C0450371|C1554077|C1550543|C0036576|C0243161|G0000000|G0000000|C2349954|C1511481|C0450371|C0450371|C1116171|C0450371|C0450371|C1514756|C0032042|C1442061|C0450371|C1514756|G0000000|C0178602|C0042210|G0000000|C0032042|C0205197|G0000000|C0439231|C0589120
"In our clinical practice, more women than men presented with complaints of symptoms of allergic conjunctivitis.","In clinical practice, women complaints symptoms allergic conjunctivitis.",G0000000|C0205210|C0237607|C0043210|C0277786|C0683368|C0700624|C0009763
"These analyses conservatively underestimated the smoking cessation effects of the HS intervention since the level of attrition in the experimental group was 3.9% higher than in the control group (13.14% vs. 9.24%, p <.01).","These analyses conservatively underestimated smoking cessation effects HS intervention level attrition experimental 3.9% control (13.14% vs. 9.24%, <.01).",G0000000|C0002778|G0000000|G0000000|C0037369|C1880019|C1280500|G0000000|C0886296|C0441889|C0004277|C1517586|G0000000|C0243148|C0450371|G0000000|C0450371|C0450371
"The children were between six years 11 months of age and 11 years 11 months of age, with a Diagnostic and Statistical Manual of Mental Disorders, Fourth edition (DSM-IV) diagnosis of ADHD based on the results of the parent and teacher Conners’ questionnaires and a clinical evaluation.","The children 11 months age 11 11 months age, Diagnostic Statistical Manual Mental Disorders, Fourth edition (DSM-IV) diagnosis ADHD based parent teacher Conners’ questionnaires clinical evaluation.",G0000000|C0008059|C0450371|C0439231|C0001779|C0450371|C0450371|C0439231|C0001779|C0011900|C0038215|C0024763|C0229992|C0012634|C0205438|C0441792|C0220952|C0011900|C1263846|C1527178|C0030551|C0221457|G0000000|C0034394|C0205210|C0220825
"Results: Of 60 patients recruited, 30 were randomised to receive HaH care.","Results: Of 60 patients recruited, 30 randomised receive HaH care.",C1274040|G0000000|C0450371|C0030705|G0000000|C0450371|G0000000|C1514756|G0000000|C1947933
"The sample consisted of 90 subjects, of both genders, aged at least 65 years old and with probable AD, according to Diagnostic Statistical Manual 4th Edition (DSM IV) criteria and clinical dementia rating (CDR) of 1, 2 or 3.","The sample consisted 90 subjects, genders, aged 65 probable AD, Diagnostic Statistical Manual 4th Edition (DSM IV) criteria clinical dementia rating (CDR) 1, 2 3.",G0000000|C0370003|C0332529|C0450371|C0681850|C0079399|C0001779|C0450371|C0033204|G0000000|C0011900|C0038215|C0024763|G0000000|C0441792|G0000000|C0022326|C0243161|C0205210|C0011265|C0871208|G0000000|G0000000|G0000000|G0000000
"Non-ART women may have been exposed to ART later during their follow-up period, but without a following pregnancy, thus misclassified as unexposed.","Non-ART women exposed ART follow-up period, pregnancy, misclassified unexposed.",C1518422|C0043210|C0332157|C0003826|C0589120|C0439531|C0032961|G0000000|G0000000
"In 23 families, both parents took part in the VIPI intervention; in most families, the mothers chose to participate in the study.","In 23 families, parents VIPI intervention; families, mothers chose participate study.",G0000000|C0450371|C0015576|C0030551|G0000000|C0886296|C0015576|C0026591|C1707391|G0000000|C0557651
"These pregnant women had mild to moderate nausea, with or without vomiting and six to 16 weeks gestation, singleton pregnancy, without signs of threatened abortion and any other disease with nausea and vomiting as a symptom, and without any antiemetic drug use in the past 24 hours.","These pregnant women mild moderate nausea, vomiting 16 weeks gestation, singleton pregnancy, signs threatened abortion disease nausea vomiting symptom, antiemetic drug 24 hours.",G0000000|C0549206|C0043210|C2945599|C0205081|C0027497|C0042963|C0450371|C0439230|C0032961|C0481462|C0032961|C0220912|G0000000|C0156543|C0012634|C0027497|C0042963|C1457887|C0003297|C0013227|C0450371|C0439227
"Patients were randomised in a ratio of 2:1 for “hospital at home” or hospital admission, using blinded sealed envelopes.","Patients randomised ratio 2:1 “hospital home” hospital admission, blinded sealed envelopes.",C0030705|G0000000|C0456603|G0000000|G0000000|G0000000|C0019994|C0184666|C0150108|C0036492|C1622204
"Families were eligible to participate provided that (a) at least one parent was born in a Spanish-speaking country in the Americas, (b) the adolescent was attending one of the three participating middle schools, (c) the adolescent would advance to the eighth grade in the next school year, (d) neither the adolescent nor the primary parent had ever been hospitalized for psychiatric reasons, (e) the family was not planning to move out of the Miami area during the 1st year of participation or out of the South Florida area during the 3 years of the study, (f) the adolescent was living with an adult primary caregiver who was willing to participate in the study, and (g) a primary caregiver was available on weekday evenings to attend weekly meetings.","Families eligible participate provided (a) parent born Spanish-speaking country Americas, (b) adolescent attending participating middle schools, (c) adolescent advance eighth grade school year, (d) adolescent primary parent hospitalized psychiatric reasons, (e) family planning move Miami 1st participation South Florida 3 study, (f) adolescent living adult primary caregiver participate study, (g) primary caregiver weekday evenings attend weekly meetings.",C0015576|C1548635|G0000000|C1999230|G0000000|C0030551|C0005615|C0086409|C0454664|C0002454|G0000000|C0205653|C1547429|C0679823|C0444598|C0036375|G0000000|C0205653|C0725066|C0205442|C0441800|C0036375|C0439234|C0073187|C0205653|C0205225|C0030551|C0701159|C0205487|C0392360|G0000000|C0015576|C0032074|C0560560|C1551421|G0000000|C0679823|C1710133|C0016253|G0000000|C0557651|C0016327|C0205653|C0376558|C0001675|C0205225|C0085537|G0000000|C0557651|C0439267|C0205225|C0085537|C0680189|C0587117|C1999232|C0332174|C0556656
Intensity of ultrasound treatment was below sensitivity threshold.,Intensity ultrasound treatment sensitivity threshold.,C0522510|C0041618|C0039798|C0020517|C0449864
"The design will allow for testing of the main effect of CBT, the main effect of physical exercise, and the additive or interactive effects of CBT and exercise on menopausal symptoms, the primary outcome measure.","The design testing main CBT, main physical exercise, additive interactive effects CBT exercise menopausal symptoms, primary outcome measure.",G0000000|C1707689|C0039593|C0205225|C0009244|C0205225|C0031809|C0015259|C0442796|C1704675|C1280500|C0009244|C0015259|C0025320|C0683368|C0205225|C1274040|C0079809
A prospective double-blinded randomized placebo-controlled multicenter study with two parallel groups in a total of 130 liver transplant recipients was designed to assess the effect of multiple intravenous doses of glycine after transplantation.,A prospective double-blinded randomized placebo-controlled multicenter study parallel total 130 liver transplant recipients designed assess multiple intravenous doses glycine transplantation.,G0000000|C0023981|C0205173|C0034656|C1706408|C0439743|C0557651|C2348042|C0439175|C1442061|C0023884|C0040732|C1709854|C1707689|C1516048|C0439064|C0348016|C0178602|C0017890|C0040732
60 Patients diagnosed with BMS were included in the study: 55 women (91.7%) and only 5 men (8.3%) with a median age of 62.13 years (range 36-86).,60 Patients diagnosed BMS included study: 55 women (91.7%) 5 (8.3%) median age 62.13 (range 36-86).,C0450371|C0030705|C0011900|G0000000|C0332257|C0557651|C0450371|C0043210|C0450371|G0000000|G0000000|C0549183|C0001779|C0450371|C1514721|C0450371
The participant's GP will also be asked to consent to their patient's involvement in the study.,The participant's GP consent patient's involvement study.,G0000000|C0679646|C3811116|C1511481|C0030705|C1314939|C0557651
"Inclusion criteria specified a primary DSM-IV diagnosis of ADHD-I (confirmed by the KSADS-PL; see below), Full Scale IQ > 80 (confirmed with the Wechsler Intelligence Scale for Children, version IV [WISC-IV, Wechsler, 2003]), living with at least one parent for the past year, child age between 7–11 years (and grades 2–5), attending school full time in a regular classroom, ability to participate in our groups on the days scheduled, school proximity within 45 minutes of study site to allow for the clinician to conduct school meetings, and teacher consent to participate in a school-based treatment.","Inclusion criteria primary DSM-IV diagnosis ADHD-I (confirmed KSADS-PL; below), Full Scale IQ > 80 (confirmed Wechsler Intelligence Scale Children, version IV [WISC-IV, Wechsler, 2003]), living parent year, child age 7–11 (and grades 2–5), attending school time regular classroom, ability participate days scheduled, school proximity 45 minutes study site clinician conduct school meetings, teacher consent participate school-based treatment.",C0007637|C0243161|C0205225|C0220952|C0011900|C1263846|C0521093|C3897966|G0000000|C0443225|C0175659|G0000000|G0000000|C0450371|C0521093|G0000000|C0021704|C0175659|C0008059|C0333052|C0022326|C0204457|G0000000|G0000000|C0376558|C0030551|C0439234|C0008059|C0001779|G0000000|G0000000|C0441800|G0000000|C1547429|C0036375|C0040223|C0205272|C0870287|C0085732|G0000000|C0439228|C0086960|C0036375|C1514583|C0450371|C0439232|C0557651|C0205145|C0871685|C0004927|C0036375|C0556656|C0221457|C1511481|G0000000|C0036375|C0039798
"After 3 months of treatment, the two groups reported fishy taste.","After 3 months treatment, reported fishy taste.",G0000000|G0000000|C0439231|C0039798|C0684224|C0016163|C0039336
"[10] The exclusion criteria were: evidences of disease recurrence, treatment with anticoagulants, signs of cardiac diseases, and the patients who underwent arrhythmia or MI, having dementia or other psychotic conditions, women who had regular exercise two to three sessions per week in the past 6 months.","[10] The exclusion criteria were: evidences disease recurrence, treatment anticoagulants, signs cardiac diseases, patients underwent arrhythmia MI, dementia psychotic conditions, women regular exercise sessions week 6 months.",C0450371|G0000000|C0680251|C0243161|G0000000|C3887511|C0012634|C0034897|C0039798|C0003280|C0220912|C0018787|C0012634|C0030705|G0000000|C0003811|C3810814|C0011265|C0004936|C0012634|C0043210|C0205272|C0015259|C1883016|C0332174|G0000000|C0439231
"Mean change at follow-up in NPI scores, by item, for the three patients groups of Phase 1 and Phase 2.","Mean change follow-up NPI scores, item, patients Phase 1 Phase 2.",C0444504|C0392747|C0589120|C1412208|C0449820|C1551338|C0030705|C0205390|G0000000|C0205390|G0000000
Sixty one children older than 3 years admitted to a large teaching hospital and a district general hospital with acute asthma completed the study.,Sixty children 3 admitted teaching hospital district hospital acute asthma completed study.,C3816724|C0008059|G0000000|C0184666|C0039401|C0019994|G0000000|C0019994|C0205178|C0004096|C0205197|C0557651
The infants were singleton and exclusively breastfed and had the gestational age of 37–42 weeks and no disease or disorder.,The infants singleton exclusively breastfed gestational age 37–42 weeks disease disorder.,G0000000|C0021270|C0481462|G0000000|C0006147|C0439671|C0001779|G0000000|C0012634|C0012634
All patients had either acute severe or life threatening asthma.,All patients acute severe life threatening asthma.,G0000000|C0030705|C0205178|C0205082|C0376558|G0000000|C0004096
This action supports the continuation of breastfeeding in infants of smoking mothers.,This action supports continuation breastfeeding infants smoking mothers.,G0000000|C0441472|C0183683|G0000000|C0006147|C0021270|C0037369|C0026591
Four hundred forty-six women recruited from 2 urgent care clinics in San Francisco in 2005.,Four forty-six women recruited 2 urgent care clinics San Francisco 2005.,C0205450|C3816449|C0043210|G0000000|G0000000|C0439609|C1947933|C0442592|C1826357|G0000000|G0000000
Those women with a pregnancy greater than 16 weeks of gestation as calculated by last menstrual period were not eligible to participate.,Those women pregnancy 16 weeks gestation calculated menstrual period eligible participate.,G0000000|C0043210|C0032961|C0450371|C0439230|C0032961|C0444686|C0025344|C0439531|C1548635|G0000000
Patients with CR were randomized to PUVA maintenance for 9 months (14 total exposures) or no maintenance.,Patients CR randomized PUVA maintenance 9 months (14 total exposures) maintenance.,C0030705|C0201975|C0034656|C0853073|C0024501|G0000000|C0439231|C0450371|C0439175|C0274281|C0024501
"Women were recruited and randomized regardless of past sexual behavior, HPV status, or cytology.","Women recruited randomized sexual behavior, HPV status, cytology.",C0043210|G0000000|C0034656|C0036864|C0004927|C0021344|C0449438|C0010818
"The latter was defined as at least a 20% diurnal variation in repeatable peak expiratory flow (PEF) measurements, or at least a 15% increase in PEF at least three times within 2 weeks of home recording, or at least a 15% increase in forced expiratory volume in 1 second (FEV1) 15 min after inhalation of a β2-agonist, or at least a 15% decline in FEV1 in an outdoor exercise test in the clinic.15 According to the symptoms and lung-function tests, the majority of children could be categorised as having mild persistent asthma.16 Children with acute asthma, an FEV1<50%17 and with treatment during the preceding 2 months with ICS, cromones, leukotriene modifiers or long-acting β2-agonists were excluded.","The defined 20% diurnal variation repeatable peak expiratory flow (PEF) measurements, 15% increase PEF times 2 weeks recording, 15% increase forced expiratory volume 1 (FEV1) 15 min inhalation β2-agonist, 15% decline FEV1 outdoor exercise test clinic.15 According symptoms lung-function tests, majority children categorised mild persistent asthma.16 Children acute asthma, FEV1<50%17 treatment preceding 2 months ICS, cromones, leukotriene modifiers long-acting β2-agonists excluded.",G0000000|C1704788|C0450371|C0332169|C0205419|G0000000|C0444505|C0231800|C0806140|C0030771|C0242485|C0450371|C0442805|C0030771|C0040223|G0000000|C0439230|G0000000|C0450371|C0442805|C0441722|C0231800|C0449468|G0000000|G0000000|C0450371|C0702093|C0004048|G0000000|C0450371|G0000000|G0000000|G0000000|C0015259|C0022885|C0002424|C0680240|C0683368|C0035245|C0022885|C0680220|C0008059|G0000000|C2945599|C0205322|C0004096|C0008059|C0205178|C0004096|C0450371|C0039798|C0332152|G0000000|C0439231|C0022521|G0000000|C0023545|C0205349|C0205166|G0000000|C1554077
We compared a group in which both the caregivers and the children were counseled/educated and a group in which neither caregivers nor children received the intervention.,We compared caregivers children counseled/educated caregivers children received intervention.,G0000000|C1707455|C0085537|C0008059|C0341618|C0085537|C0008059|C1514756|C0886296
"Inclusion criteria were ability to cope with the study protocol, body mass index 30-42, age 18-60 years, previously diagnosed asthma with a spontaneous diurnal variation or a bronchodilator response of 15% or more, and being a non-smoker or having stopped smoking for two years or more before age 50.","Inclusion criteria ability cope study protocol, body mass 30-42, age 18-60 years, diagnosed asthma spontaneous diurnal variation bronchodilator response 15% more, non-smoker stopped smoking age 50.",C0007637|C0243161|C0085732|C0009967|C0557651|C0442711|C0242821|C0577559|C0450371|C0001779|C0450371|C0439234|C0011900|C0004096|C0205359|C0332169|C0205419|C0006280|C0871261|C0450371|C0205172|C0337672|C1272691|C0037369|C0001779|C0450371
None of the participants had been traveling to areas where ETEC is endemic for 6 months prior to the study.,None participants traveling ETEC endemic 6 months prior study.,G0000000|C0679646|C0040802|C0580797|G0000000|G0000000|C0439231|C0332152|C0557651
"Infants were excluded if they had congenital airway anomalies, congenital heart disease, neuromuscular disease, feeding intolerance, or gastric or esophageal pathology.","Infants excluded congenital airway anomalies, congenital heart disease, neuromuscular disease, feeding intolerance, gastric esophageal pathology.",C0021270|C1554077|C0009678|C0178987|C0000769|C0009678|C0018787|C0012634|C1979768|C0012634|C0204695|C0231199|C0038351|C1522619|C0030664
"Exclusion criteria were: vertebral fracture, spinal inflammatory disease, spinal infections or malignancy, current nerve root pathology, spondylolysis or spondylolisthesis, lumbar spondylodesis, medical co-morbidity making intensive exercising impossible (e.g.","Exclusion criteria were: vertebral fracture, spinal inflammatory disease, spinal infections malignancy, current nerve root pathology, spondylolysis spondylolisthesis, lumbar spondylodesis, medical co-morbidity intensive exercising impossible (e.g.",C0680251|C0243161|G0000000|C0549207|C0016658|C0521329|C0333348|C0012634|C0521329|C3714514|C0006826|C0521116|C0027740|C0040452|C0030664|C0038018|C0038016|C0024090|C0936239|C0199168|C0009488|C0162425|C0015259|G0000000|G0000000
"Most of them were on rotating shifts (73.3%), and most were in the age range of 25-30 (55.4%).","Most rotating shifts (73.3%), age range 25-30 (55.4%).",C0205393|C0231458|C0333051|C0450371|C0001779|C1514721|C0450371|C0450371
"Eighty-three were found to have an average axial growth rate of 0.075–0.39 mm per 6 months, and were enrolled in the study.","Eighty-three average axial growth rate 0.075–0.39 mm 6 months, enrolled study.",C3816958|C1510992|C0205131|C0018270|C0871208|G0000000|G0000000|G0000000|C0439231|G0000000|C0557651
To compare the systemic cytokine response in patients after laparoscopic-assisted resection with those after open resection of rectosigmoid carcinoma.,To compare systemic cytokine response patients laparoscopic-assisted resection resection rectosigmoid carcinoma.,C0040363|C1707455|C0205373|C0079189|C0871261|C0030705|C0031150|C0015252|C0015252|C0521377|C0007097
"The trial included 60 patients with 1 to 3 brain metastases treated at the Radiotherapy Department, National Cancer Institute.","The trial included 60 patients 1 3 brain metastases treated Radiotherapy Department, National Cancer Institute.",G0000000|C0008976|C0332257|C0450371|C0030705|G0000000|G0000000|C0006104|C0027627|C1522326|C0034619|C1704729|C3245503|C0006826|C0021622
"In order to confirm that they had a retrospective history of 2–8 migraine attacks/month, the participants underwent a prospective baseline period of at least 1 month, during which time they kept a migraine diary.","In confirm retrospective history 2–8 migraine attacks/month, participants underwent prospective baseline period 1 month, time migraine diary.",G0000000|C0521093|C0035363|C0019664|G0000000|C0149931|C1261512|C0679646|G0000000|C0023981|C0168634|C0439531|G0000000|C0332177|C0040223|C0149931|C0376660
"Randomized controlled trial was conducted in adolescent girls visiting ‘Urban Health and Training Centre’ during the study period June, 2011 to October, 2012.","Randomized controlled trial conducted adolescent girls visiting ‘Urban Health Training Centre’ study period June, 2011 October, 2012.",C0034656|C2587213|C0008976|C0004927|C0205653|C0870604|C0545082|G0000000|C0018684|C0040607|G0000000|C0557651|C0439531|C3829443|G0000000|C3828732|G0000000
A total of 88 consenting in-patients with psychosis were randomized into yoga therapy group (n=44) and physical exercise group (n=44).,A total 88 consenting in-patients psychosis randomized yoga therapy (n=44) physical exercise (n=44).,G0000000|C0439175|C0450371|C1511481|C0150312|C0033975|C0034656|C0043418|C0039798|C0369718|C0031809|C0015259|C0369718
Most people with stroke develop trunk asymmetry due to paralysis.,Most people stroke develop trunk asymmetry paralysis.,C0205393|C0027361|C0038454|G0000000|C0225442|C0332514|C0522224
"Consequently, it cannot be isolated, whether conceptually or functionally, from other cognitive functions.","Consequently, isolated, conceptually functionally, cognitive functions.",G0000000|C0205409|G0000000|G0000000|C1516691|C0542341
"A total of 232 patients were randomized (ALC n = 117, MC n = 115), 88% of which completed the trial.","A total 232 patients randomized (ALC = 117, MC = 115), 88% completed trial.",G0000000|C0439175|C1442061|C0030705|C0034656|C1424945|G0000000|C1442061|C0024403|G0000000|C1442061|C0450371|C0205197|C0008976
"This trial enrolled 256 paired surrogate decision-makers and residents in 24 nursing home sites, and 99% completed participation through the 3-month study period.","This trial enrolled 256 paired surrogate decision-makers residents 24 nursing sites, 99% completed participation 3-month study period.",G0000000|C0008976|G0000000|C1442061|C1709450|C4053457|C0679006|C1320928|C0450371|C0006147|C0205145|C0450371|C0205197|C0679823|C0332177|C0557651|C0439531
"If eligible and willing to participate, family members became participants in the field experiment that tested the efficacy of the intervention by randomly assigning families to a 9-session intervention or a 2-h control group workshop.","If eligible participate, family participants field experiment tested efficacy intervention randomly assigning families 9-session intervention 2-h control workshop.",G0000000|C1548635|G0000000|C0015576|C0679646|C0440042|C0681814|C0392366|C1280519|C0886296|G0000000|C1516050|C0015576|C1883016|C0886296|C0033727|C0243148|C0242262
"The study site is in Chikhwawa District, an area of high malaria transmission in the Lower Shire River Valley region of southern Malawi [67].","The study site Chikhwawa District, malaria transmission Lower Shire River Valley region southern Malawi [67].",G0000000|C0557651|C0205145|G0000000|G0000000|C0024530|C0040722|C0441994|G0000000|C0337050|C0563004|C0017446|C1710133|C0024548|C0450371
Subjects were infants aged <12 months who were hospitalized for laboratory-confirmed influenza between October 2000 and April 2009 (prior to the arrival of the 2009 pandemic influenza in this region).,Subjects infants aged <12 months hospitalized laboratory-confirmed influenza October 2000 April 2009 (prior arrival 2009 pandemic influenza region).,C0681850|C0021270|C0001779|C0450371|C0439231|C0701159|C0022877|C0021400|C3828732|G0000000|C3715024|G0000000|C0332152|C1555577|G0000000|C1615608|C0021400|C0017446
"Particularly noteworthy is the revised Project ALERT’s impact on baseline cigarette experimenters and smokers, as well as the highest-risk early drinkers.","Particularly noteworthy revised Project ALERT’s impact baseline cigarette experimenters smokers, highest-risk drinkers.",G0000000|G0000000|C1527075|C1709701|G0000000|C1825598|C0168634|C0677453|G0000000|C0337664|C0332167|G0000000
"Data were gathered from 418 students, of whom 44% were male.","Data gathered 418 students, 44% male.",C1511726|G0000000|C1442061|C0038492|C0450371|C0086582
"Seven patients did not complete the study: five IVIg subjects suffered side effects, including headache, nausea, and abdominal pain, and two control subjects did not complete the trial for personal reasons.","Seven patients complete study: IVIg subjects suffered effects, including headache, nausea, abdominal pain, control subjects complete trial personal reasons.",C0205453|C0030705|C0205197|C0557651|C0085297|C0681850|C0683278|C1280500|C0332257|C0018681|C0027497|C0000726|C0030193|C0243148|C0681850|C0205197|C0008976|C1519021|C0392360
"Inclusion criteria included: (1) women ages 18 to 70 years with history of ductal carcinoma in situ (DCIS) or Stage I-IIIA breast cancer who were not currently receiving or planning to receive chemotherapy or radiation therapy, (2) ≥8 weeks post-surgical procedure; (3) English speaking; (4) medical clearance for participation provided by physician; and (5) participating, on average, in ≤30 min of vigorous physical activity or 60 min of moderate activity per week during the past 6 months.","Inclusion criteria included: (1) women ages 18 70 history ductal carcinoma situ (DCIS) Stage I-IIIA breast cancer receiving planning receive chemotherapy radiation therapy, (2) ≥8 weeks post-surgical procedure; (3) English speaking; (4) medical clearance participation provided physician; (5) participating, average, ≤30 min vigorous physical activity 60 min moderate activity week 6 months.",C0007637|C0243161|C0332257|G0000000|C0043210|C0001779|C0450371|C0450371|C0019664|C1512083|C0007097|G0000000|C0007124|C0205390|C0021966|C0006141|C0006826|C1514756|C0032074|C1514756|C0013216|C0034519|C0039798|G0000000|G0000000|C0439230|C0687676|C0184661|G0000000|C0376245|C0234856|G0000000|C0199168|C0449297|C0679823|C1999230|C0031831|G0000000|C0679823|C1510992|G0000000|C0702093|G0000000|C0031809|C0205177|C0450371|C0702093|C0205081|C0205177|C0332174|G0000000|C0439231
"Study groups comprised:  Control group (CG): Mothers and infants in this group received only the routine ICDS 1 services, which were operating across all study groups.","Study comprised: Control (CG): Mothers infants received routine ICDS 1 services, operating study groups.",C0557651|C2700400|C0243148|C0043444|C0026591|C0021270|C1514756|C0205547|C0162589|G0000000|C0557854|C3242339|C0557651|C0441833
This randomized double-blind placebo-controlled clinical trial was performed among 42 pregnant women aged 18–40 years who were at week 25 of gestation.,This randomized double-blind placebo-controlled clinical trial performed 42 pregnant women aged 18–40 week 25 gestation.,G0000000|C0034656|C0013072|C1706408|C0205210|C0008976|C0884358|C0450371|C0549206|C0043210|C0001779|G0000000|C0332174|C0450371|C0032961
"Further inclusion criteria were a KPS >60, no signs for renal or hepatic insufficiency, and no history of other malignant tumors.","Further inclusion criteria KPS >60, signs renal hepatic insufficiency, history malignant tumors.",C1517331|C0007637|C0243161|C0206065|C0450371|C0220912|C0022646|C0205054|C0231179|C0019664|C0205282|C0027651
"13 subjects completed the study (mean (SD) age 33 (12) years, forced expiratory volume in 1second % (FEV1%) predicted 51% (22), LCI (no.","13 subjects completed study (mean (SD) age 33 (12) years, forced expiratory volume 1second % (FEV1%) predicted 51% (22), LCI (no.",C0450371|C0681850|C0205197|C0557651|C0444504|G0000000|C0001779|C0450371|C0450371|C0439234|C0441722|C0231800|C0449468|G0000000|G0000000|G0000000|C0681842|C0450371|C0450371|C0231990|G0000000
Patients with stable brain metastasis (BM) were allowed.,Patients stable brain metastasis (BM) allowed.,C0030705|C0205360|C0006104|C0027627|C0006416|C0683607
Groups consist of six to ten young cannabis users and one or two trainers.,Groups consist ten cannabis users trainers.,C0441833|C0332529|C0014518|C0024808|C1706077|C0453962
Thirty patients were recruited and 29 successfully randomised.,Thirty patients recruited 29 randomised.,C3816446|C0030705|G0000000|C0450371|G0000000
"An unanswered question remains the optimal management of asymptomatic or minimally symptomatic NSCLC patients not suitable for radical treatment, in whom one of the options is watchful waiting.","An unanswered question remains optimal management asymptomatic minimally symptomatic NSCLC patients suitable radical treatment, options watchful waiting.",G0000000|G0000000|C1522634|G0000000|C2698651|C0001554|C0231221|G0000000|C0231220|C0007131|C0030705|C3900053|C0302912|C0039798|C1518601|C0699864|C1610166
"Of the original 244 entrants, 34 were excluded from this analysis.","Of original 244 entrants, 34 excluded analysis.",G0000000|C0205313|C1442061|G0000000|C0450371|C1554077|C0002778
"This was a 6-week randomized, double-blind, placebo-controlled, multi-center, clinical phase III trial comparing the efficacy of St. John's wort extract WS® 5570 600 mg/day (in one dose) and 1200 mg/day (in two 600 mg doses) with placebo in patients suffering from a mild or moderate major depressive episode according to DSM-IV [21].","This 6-week randomized, double-blind, placebo-controlled, multi-center, clinical phase III trial comparing efficacy St. John's wort extract WS® 5570 600 mg/day (in dose) 1200 mg/day (in 600 doses) placebo patients suffering mild moderate major depressive episode DSM-IV [21].",G0000000|C0332174|C0034656|C0013072|C1706408|C0439743|C0205210|C0205390|C0439070|C0008976|C1707455|C1280519|C0036056|G0000000|G0000000|C2828366|G0000000|G0000000|C1442061|C0439422|G0000000|C0178602|G0000000|C0439422|G0000000|C1442061|C0178602|C0032042|C0030705|C0683278|C2945599|C0205081|C0205082|G0000000|C0332189|C0220952|C0450371
"To detect a true difference in the change in 6MWD between groups using the upper limit of the MID of 34m [30] with SD 43m, a total of 54 subjects, 27 in each group, would be required.","To detect true difference change 6MWD upper limit MID 34m [30] SD 43m, total 54 subjects, 27 group, required.",C0040363|C0442726|C0205238|C1705241|C0392747|G0000000|C1282910|C0439801|C0444598|G0000000|C0450371|C2699239|G0000000|C0439175|C0450371|C0681850|C0450371|C0441833|C1514873
A SARS case was defined using the criteria for probable SARS cases provided by the Health Ministry of China [12].,A SARS defined criteria probable SARS provided Health Ministry China [12].,G0000000|C1175175|C1704788|C0243161|C0033204|C1175175|C1999230|C0018684|G0000000|C0008115|C0450371
"Patients were excluded if they had serious cardiac disease, serious renal disease, hypotension (systolic blood pressure, ≤ 80 mmHg), a history of shock during extracorporeal circulation, serious infections such as sepsis or pneumonia, or a serum hemoglobin concentration of less than 10 g/dL.","Patients excluded cardiac disease, renal disease, hypotension (systolic blood pressure, ≤ 80 mmHg), history shock extracorporeal circulation, infections sepsis pneumonia, serum hemoglobin concentration 10 g/dL.",C0030705|C1554077|C0018787|C0012634|C0022646|C0012634|C0020649|C0039155|C0005767|C0033095|G0000000|C0450371|C0439475|C0019664|C0036974|C0442087|C0005775|C3714514|C0036690|C0032285|C0229671|C0019046|C0004268|C0450371|C0439267
Twenty nine healthy children of age 4-7 years (mean age 5.6 years) from both the sexes were selected from patients who were referred to the department.,Twenty healthy children age 4-7 (mean age 5.6 years) sexes selected patients referred department.,C0724000|C3898900|C0008059|C0001779|G0000000|C0444504|C0001779|G0000000|C0439234|C0009253|C1707391|C0030705|C0205543|C1704729
"The second and third sessions will be conducted when infants are aged 9 and 12 months, respectively.","The sessions conducted infants aged 9 12 months, respectively.",G0000000|C1883016|C0004927|C0021270|C0001779|G0000000|C0450371|C0439231|G0000000
Patients who are aged between 1 and 18 years old at the time of onset of idiopathic nephrotic syndrome and are aged 2 years or above at the time of registration are eligible if they fall into the complicated FRNS/SDNS category.,Patients aged 1 18 time onset idiopathic nephrotic syndrome aged 2 time registration eligible fall complicated FRNS/SDNS category.,C0030705|C0001779|G0000000|C0450371|C0040223|C0206132|C0332240|G0000000|C0039082|C0001779|G0000000|C0040223|C1514821|C1548635|C0085639|C0231242|C0220730|C0683312
"However, none of these studies have attempted to target therapy to patients based on elevated nasal resistance as we propose to do.","However, studies attempted target therapy patients based elevated nasal resistance propose do.",G0000000|C0947630|C1516084|C1521840|C0039798|C0030705|C1527178|C0205250|C0028429|C0237834|G0000000|G0000000
Females (N = 30) who received a biopsy-proven breast cancer diagnosis without metastatic disease.,Females (N = 30) received biopsy-proven breast cancer diagnosis metastatic disease.,C0015780|C0369718|G0000000|C0450371|C1514756|C0005558|C0006141|C0006826|C0011900|C0036525|C0012634
"Children 6 to 15 years of age were recruited from February 2002 to January 2006 from a 297-bed regional tertiary care center that serves about 950,000 children in Central California.","Children 6 15 age recruited February 2002 January 2006 297-bed regional tertiary care center serves 950,000 children Central California.",C0008059|G0000000|C0450371|C0001779|G0000000|C3830166|G0000000|C3829466|G0000000|C1442061|C0205147|C0205372|C1947933|C0205099|G0000000|C1442061|C0008059|C0205099|C0006754
This effect is related to a higher baseline risk of contralateral breast cancer.,This baseline risk contralateral breast cancer.,G0000000|C0168634|C0035647|C0441988|C0006141|C0006826
PPROM was diagnosed via the Fern test and sonography.,PPROM diagnosed Fern test sonography.,C0729264|C0011900|C0331729|C0022885|C0041618
Patients were excluded from the study for the following reasons: if the mean score for abdominal pain/discomfort was ≤1.0 on a four point scale during the baseline period; if they were considered to be suffering from IBS with diarrhoea; if they had a history of organic disease of the gastrointestinal tract; severe laxative dependence; regular use of medications that could affect gastrointestinal motility and/or perception; use of other investigational drugs; and the presence of any disease likely to compromise the patient’s ability to complete the study or that would significantly affect bowel motility.,Patients excluded study reasons: score abdominal pain/discomfort ≤1.0 scale baseline period; considered suffering IBS diarrhoea; history organic disease gastrointestinal tract; severe laxative dependence; regular medications affect gastrointestinal motility and/or perception; investigational drugs; presence disease compromise patient’s ability complete study affect bowel motility.,C0030705|C1554077|C0557651|C0392360|C0449820|C0000726|C0030193|G0000000|C0175659|C0168634|C0439531|C0750591|C0683278|C0022104|C0011991|C0019664|C0747055|C0012634|C0521362|C1185740|C0205082|C0282090|C0011546|C0205272|C0013227|C0001721|C0521362|C0007608|G0000000|C0030971|C1517586|C0013227|C0150312|C0012634|C2945640|G0000000|C0085732|C0205197|C0557651|C0001721|C0021853|C0007608
The majority of patients with multiple prior chemotherapy regimens and advanced metastatic disease had progressive disease at first restaging.,The majority patients multiple prior chemotherapy regimens advanced metastatic disease progressive disease restaging.,G0000000|C0680220|C0030705|C0439064|C0332152|C0013216|C2945654|C0205179|C0036525|C0012634|C0205329|C0012634|G0000000
Patients with any of the following conditions were excluded from the study; Experiencing new stressful events during the time of study based on the Holmes-Rahe list of stressful life events Any change in dialysis schedule Starting any other psychiatric treatment during the study A known history of previous psychiatric disorder Having a new stressor during previous six months except for those related to kidney disease Failure to attend in all educational sessions Eligible patients (n = 60) were selected randomly from dialysis center of Imam Khomeini Hospital in Sari.,Patients conditions excluded study; Experiencing stressful events time study based Holmes-Rahe list stressful life events Any change dialysis schedule Starting psychiatric treatment study A history previous psychiatric disorder Having stressor previous months kidney disease Failure attend educational sessions Eligible patients (n = 60) selected randomly dialysis center Imam Khomeini Hospital Sari.,C0030705|C0012634|C1554077|C0557651|C0237607|C0231297|C0441471|C0040223|C0557651|C1527178|G0000000|C0745732|C0231297|C0376558|C0441471|G0000000|C0392747|C0011945|C0086960|C0439659|C0205487|C0039798|C0557651|G0000000|C0019664|C0205156|C0205487|C0012634|G0000000|C0597530|C0205156|C0439231|C0022646|C0012634|C0231174|C1999232|C0587721|C1883016|C1548635|C0030705|C0369718|G0000000|C0450371|C1707391|G0000000|C0011945|C0205099|C0521321|G0000000|C0019994|C0443055
"Study participants are members of the VITAL cohort study of 77,719 men and women ages 50 to 76 years living in a 13-county area of western Washington State.","Study participants VITAL cohort study 77,719 women ages 50 76 living 13-county western Washington State.",C0557651|C0679646|C0442732|C0599755|C0557651|C0450371|C0043210|C0001779|C0450371|C0450371|C0376558|C0450371|C1705493|C0043038|C1301808
Initial exclusion criteria included postmenopausal age due to differing physiological characteristics8 and previous abdominal and pelvic surgeries because of scar tissue and postsurgical adhesions.,Initial exclusion criteria included postmenopausal age differing physiological characteristics8 previous abdominal pelvic surgeries scar tissue postsurgical adhesions.,C0205265|C0680251|C0243161|C0332257|C0232970|C0001779|G0000000|C0205463|G0000000|C0205156|C0000726|C0030797|C0543467|C0241158|C0040300|G0000000|C0001511
Fever clearance was faster in children given paracetamol plus ibuprofen than in those given paracetamol but was similar for those given ibuprofen.,Fever clearance faster children paracetamol ibuprofen paracetamol ibuprofen.,C0015967|C0449297|C0015663|C0008059|C0000970|C0020740|C0000970|C0020740
The aim of this study is to assess the efficacy and safety of thromboprophylaxis with LMWH in children treated for primary ALL in the DCOG ALL-11 or subsequent study.,The aim study assess efficacy safety thromboprophylaxis LMWH children treated primary ALL DCOG ALL-11 subsequent study.,G0000000|C1947946|C0557651|C1516048|C1280519|C0036043|G0000000|C0019139|C0008059|C1522326|C0205225|C0444868|G0000000|C0444868|C0332282|C0557651
"For this trail, 22 Gots (11 intervention and 11 control villages) were included.","For trail, 22 Gots (11 intervention 11 control villages) included.",G0000000|C1143949|C0450371|G0000000|C0450371|C0886296|C0450371|C0243148|C0562518|C0332257
"Renal function was acceptable in these young children, with four children having a glomerular filtration rate of less than 60 ml per minute per 1.73 m2 at the end of treatment or follow-up.26,37 The initiation of sodium thiosulfate after a 6-hour delay from the completion of cisplatin administration caused no tumor protection and did not adversely affect disease outcome.","Renal function acceptable children, children glomerular filtration rate 60 minute 1.73 m2 treatment follow-up.26,37 The initiation sodium thiosulfate 6-hour delay completion cisplatin administration caused tumor protection adversely affect disease outcome.",C0022646|C0031843|C1879533|C0008059|C0008059|C0022663|C0016107|C0871208|C0450371|C0439232|C0450371|C0025885|C0039798|C0589120|G0000000|C0589507|C0037473|C0039950|C0439227|C0205421|C0205197|C0008838|C0001554|C0015127|C0027651|C1545588|G0000000|C0001721|C0012634|C1274040
There were significantly more total hospital days used and post-protocol FBT sessions in the WR group.,There total hospital days post-protocol FBT sessions WR group.,G0000000|C0439175|C0019994|C0439228|C0687676|G0000000|C1883016|C1420193|C0441833
"None of the enrolled children had been treated with any antibiotics, probiotics or other drugs and food at least two weeks prior to the start of this study.","None enrolled children treated antibiotics, probiotics drugs food weeks prior start study.",G0000000|G0000000|C0008059|C1522326|C0003232|C0525033|C0013227|C0016452|C0439230|C0332152|C0439659|C0557651
A total of 13 patients were in the insomnia comorbid subpopulation (seven in the PRM and six in the placebo cohorts).,A total 13 patients insomnia comorbid subpopulation (seven PRM placebo cohorts).,G0000000|C0439175|C0450371|C0030705|C0917801|C0009488|C1257890|C0205453|C1704520|C0032042|C0599755
"Linear regression analyses with baseline demographic data (including age, gender, body mass index [BMI], previous AHI, prescribed level CPAP, and days elapsed from initial diagnosis) as independent variables and therapy daily use as dependent variables were also performed to study whether baseline characteristics were predictive of ultimate compliance.","Linear regression analyses baseline demographic data (including age, gender, body mass [BMI], previous AHI, prescribed level CPAP, days elapsed initial diagnosis) independent variables therapy daily dependent variables performed study baseline characteristics predictive ultimate compliance.",C0205132|C0684320|C0002778|C0168634|C0011298|C1511726|C0332257|C0001779|C0079399|C0242821|C0577559|G0000000|C0205156|G0000000|C0278329|C0441889|C0199451|C0439228|C1707889|C0205265|C0011900|C0085862|C0439828|C0039798|C0332173|C0851827|C0439828|C0884358|C0557651|C0168634|C1521970|C0681890|G0000000|C0009563
"Exclusion criteria were: 1) breast cancer recurrence, metastasis, or another cancer diagnosis (excluding non-melanoma skin cancer); 2) active, uncontrolled medical illness that could impact inflammation; and 3) unable to commit to intervention schedule.","Exclusion criteria were: 1) breast cancer recurrence, metastasis, cancer diagnosis (excluding non-melanoma skin cancer); 2) active, uncontrolled medical illness impact inflammation; 3) unable commit intervention schedule.",C0680251|C0243161|G0000000|G0000000|C0006141|C0006826|C0034897|C0027627|C0006826|C0011900|C0332196|C1518422|C0444099|C0006826|G0000000|C0205177|C0205318|C0199168|C0221423|C1825598|C0021368|G0000000|C1299582|C1171947|C0886296|C0086960
The sample was 99% white.,The sample 99% white.,G0000000|C0370003|C0450371|C0007457
There is a need for accessible and effective interventions for the treatment of sexual dysfunctions in breast cancer survivors.,There accessible effective interventions treatment sexual dysfunctions breast cancer survivors.,G0000000|C0814423|C1280519|C0886296|C0039798|C0036864|C0031847|C0006141|C0006826|C0206194
Pregnant women make labour analgesia decisions in a milieu of choice and anecdote that is on the whole devoid of evidence[19].,Pregnant women labour analgesia decisions milieu choice anecdote devoid evidence[19].,C0549206|C0043210|C0022864|C0002766|C0679006|G0000000|C0008300|C0002867|G0000000|C3887511
All GDM women were followed up for metabolic and obstetric purposes until delivery.,All GDM women metabolic obstetric purposes delivery.,G0000000|C0085207|C0043210|C0311400|C0205484|C1285529|C0011209
A total of 48 patients (40 females and 8 males) were recruited and randomly assigned into 2 groups; i) control group and ii) TXA group.,A total 48 patients (40 females 8 males) recruited randomly assigned 2 groups; i) control ii) TXA group.,G0000000|C0439175|C0450371|C0030705|C0450371|C0015780|G0000000|C0086582|G0000000|G0000000|C1516050|G0000000|C0441833|C0021966|C0243148|G0000000|G0000000|C0441833
"In this paper, we describe the measures of intervention exposure used in the cluster randomised trial of the Well London programme, a public health intervention using community engagement and community-based projects to increase physical activity, healthy eating and mental health and well-being in 20 of the most deprived neighbourhoods in London.10 No earmarked resources to support the development of these measures and associated data collection were provided to either the research team or to those delivering the interventions on the ground.","In paper, measures intervention exposure cluster randomised trial Well London programme, public health intervention community engagement community-based projects increase physical activity, healthy eating mental health well-being 20 deprived neighbourhoods London.10 No earmarked resources support development measures data collection provided team delivering interventions ground.",G0000000|C0030351|C0079809|C0886296|C0274281|C1555715|G0000000|C0008976|C0205170|C0023973|C1709697|G0000000|C0018684|C0886296|C0009462|C0425152|C0009462|C1709701|C0442805|C0031809|C0205177|C3898900|C0013470|C0229992|C0018684|C0018684|C0450371|G0000000|G0000000|C0023973|G0000000|G0000000|C0035201|C0183683|C0243107|C0079809|C1511726|C1516698|C1999230|C0871489|C0308779|C0886296|G0000000
"Exclusion criteria consisted of contraindications to MRI, history of diabetes mellitus, cardiovascular, respiratory, or neurological illnesses, rheumatoid arthritis, wrist fracture with direct trauma to median nerve, current usage of prescriptive opioid medication, thenar atrophy, previous acupuncture treatment (manual, EA, and TENS) for CTS, nerve entrapment other than median nerve, cervical radiculopathy or myelopathy, generalized peripheral neuropathy, blood dyscrasia or coagulopathy or current use of anticoagulation therapy.","Exclusion criteria consisted contraindications MRI, history diabetes mellitus, cardiovascular, respiratory, neurological illnesses, rheumatoid arthritis, wrist fracture direct trauma median nerve, current usage prescriptive opioid medication, thenar atrophy, previous acupuncture treatment (manual, EA, TENS) CTS, nerve entrapment median nerve, cervical radiculopathy myelopathy, generalized peripheral neuropathy, blood dyscrasia coagulopathy current anticoagulation therapy.",C0680251|C0243161|C0332529|C0079164|C0024485|C0019664|C0011847|G0000000|C0007226|C0521346|C0205494|C0221423|G0000000|C0003864|C0043262|C0016658|C0439851|C0043251|C0549183|C0027740|C0521116|C0457083|G0000000|C0242402|C0013227|C0230374|C0333641|C0205156|C0001299|C0039798|C0024763|C0014963|C0014518|C0007286|C0027740|C1285497|C0549183|C0027740|C0027530|C0700594|C0005956|C0205246|C0205100|C0442874|C0005767|C0334044|C0005779|C0521116|C0003281|C0039798
"Criteria of inclusion were refractoriness to standard topical treatment (corticosteroid ointments, UVA, UVB, PUVA, tar).","Criteria inclusion refractoriness standard topical treatment (corticosteroid ointments, UVA, UVB, PUVA, tar).",C0243161|C0007637|C0205269|C1442989|C0332237|C0039798|C0001617|C0028912|G0000000|C0454530|C0853073|C0039315
"Stroke causes 6 million deaths each year among 17 million affected people, with the greatest burden experienced in populations of low- and middle-income countries [1].","Stroke 6 deaths 17 people, burden experienced populations low- middle-income countries [1].",C0038454|G0000000|C0011065|C0450371|C0027361|C2828008|C0237607|C0032659|C0205251|C0444598|C0454664|G0000000
"FSM is located in the poorest communal section of the city, Petite Anse, with a population of >80,000 people.","FSM located poorest communal city, Petite Anse, population >80,000 people.",C0282244|G0000000|C0032854|C0598781|C0008848|G0000000|G0000000|C0032659|C0450371|C0027361
"Adult outpatients with anaemia (Hb ⩽11 g dl−1) associated with multiple myeloma, non-Hodgkin's lymphoma or chronic lymphocytic leukaemia and any solid tumour treated with myelosuppressive chemotherapy, with at least three cycles remaining, were eligible for study inclusion.","Adult outpatients anaemia (Hb ⩽11 g dl−1) multiple myeloma, non-Hodgkin's lymphoma chronic lymphocytic leukaemia solid tumour treated myelosuppressive chemotherapy, cycles remaining, eligible study inclusion.",C0001675|C0029921|C0002871|C0019046|G0000000|C0439064|C0026764|C0024305|C0024299|C0205191|C0024264|C0023418|C0205208|C0027651|C1522326|G0000000|C0013216|C1511572|C1527428|C1548635|C0557651|C0007637
"Of these, 1,949 (13%) had cough for two or more weeks, with or without other symptoms and 1,290 (66%) provided sputum samples.","Of these, 1,949 (13%) cough weeks, symptoms 1,290 (66%) provided sputum samples.",G0000000|G0000000|C1442061|C0450371|C0010200|C0439230|C0683368|C1442061|C0450371|C1999230|C0038056|C0370003
The scale used in this study was a 13 items Norwegian version (range 0–34) [9].,The scale study 13 items Norwegian version (range 0–34) [9].,G0000000|C0175659|C0557651|C0450371|C1551338|C0337812|C0333052|C1514721|G0000000|G0000000
"Inclusion criteria were age 18–40 years (inclusive), singleton pregnancy, no previous GDM, nonsmoker, diagnosis of GDM and seen for the first dietary visit between 28 and 32 weeks of gestation, and ability to follow the protocol requirements.","Inclusion criteria age 18–40 (inclusive), singleton pregnancy, previous GDM, nonsmoker, diagnosis GDM dietary visit 28 32 weeks gestation, ability follow protocol requirements.",C0007637|C0243161|C0001779|G0000000|C0332257|C0481462|C0032961|C0205156|C0085207|C0337672|C0011900|C0085207|C0012155|C0545082|C0450371|C0450371|C0439230|C0032961|C0085732|C0332283|C0442711|C1514873
A total of 820 patients with at least 1 PrU-II will be recruited from primary health care and home care centers.,A total 820 patients 1 PrU-II recruited primary health care care centers.,G0000000|C0439175|C1442061|C0030705|G0000000|G0000000|G0000000|C0205225|C0018684|C1947933|C1947933|C0205099
"Eligible participants were healthy men and women 18 to 46 years of age, recruited at four study sites (two university sites and two community sites) in Michigan, who had not yet received an influenza vaccine for the 2004–2005 season.","Eligible participants healthy women 18 46 age, recruited study sites (two university sites community sites) Michigan, received influenza vaccine 2004–2005 season.",C1548635|C0679646|C3898900|C0043210|C0450371|C0450371|C0001779|G0000000|C0557651|C0205145|C0205448|C0041740|C0205145|C0009462|C0205145|C0025939|C1514756|C0021400|C0042210|G0000000|C0036497
"Those with a clinical relapse within two months prior to enrollment, prior use of immunomodulatory or immunosuppressive drugs, women who were pregnant, lactating, or of childbearing age who did not consent to approved contraceptive use during the study, those with abnormal blood tests performed during the screening studies, and patients with other major medical illnesses (e.g.","Those clinical relapse months prior enrollment, prior immunomodulatory immunosuppressive drugs, women pregnant, lactating, childbearing age consent approved contraceptive study, abnormal blood tests performed screening studies, patients major medical illnesses (e.g.",G0000000|C0205210|C0035020|C0439231|C0332152|C1516879|C0332152|G0000000|C0021081|C0013227|C0043210|C0549206|C2828358|G0000000|C0001779|C1511481|C0205540|C0009871|C0557651|C0205161|C0005767|C0022885|C0884358|C0220908|C0947630|C0030705|C0205082|C0199168|C0221423|G0000000
Women will be excluded from participating in the study if they are currently taking an omega-3 fatty acid supplement; taking antidepressant or other psychiatric medications; using therapeutic or prophylactic anticoagulation medication; or consuming more than 2 fish meals per week.,Women excluded participating study omega-3 fatty acid supplement; antidepressant psychiatric medications; therapeutic prophylactic anticoagulation medication; consuming 2 fish meals week.,C0043210|C1554077|C0679823|C0557651|C1719844|G0000000|C0001128|C0242295|C0003289|C0205487|C0013227|C0087111|C0355642|C0003281|C0013227|G0000000|G0000000|C0016163|C1998602|C0332174
A total of 100 women (25% of eligible women) then were randomly assigned into the LEAN Study.,A total 100 women (25% eligible women) randomly assigned LEAN Study.,G0000000|C0439175|C1442061|C0043210|C0450371|C1548635|C0043210|G0000000|C1516050|G0000000|C0557651
"Excluded from the study were individuals with short bowel syndrome, diverticulitis, or any other major diagnosis that affects the GI tract; special dietary restrictions; mental, emotional, cognitive, or other disorders that might interfere with the ability to independently follow detailed dietary instructions over time; cancer; pregnancy; unstable or uncontrolled kidney or cardiovascular disease; decompensated liver disease; penetrating CD; clinically significant stricturing CD; and a pHBI score >9.","Excluded study individuals short bowel syndrome, diverticulitis, major diagnosis GI tract; special dietary restrictions; mental, emotional, cognitive, disorders interfere ability independently follow detailed dietary instructions time; cancer; pregnancy; unstable uncontrolled kidney cardiovascular disease; decompensated liver disease; penetrating CD; clinically stricturing CD; pHBI score >9.",C1554077|C0557651|C0027361|C1282927|C0021853|C0039082|C0012813|C0205082|C0011900|C1708130|C1185740|C0205555|C0012155|C0443288|C0229992|C0013987|C1516691|C0012634|C0521102|C0085732|G0000000|C0332283|C1522508|C0012155|C0302828|C0040223|C0006826|C0032961|C0443343|C0205318|C0022646|C0007226|C0012634|C0205434|C0023884|C0012634|C0205321|C0007928|G0000000|C1261287|C0007928|G0000000|C0449820|G0000000
"‡ Quintile cutpoints for toenail selenium (μg/g) are 0.758, 0.832, 0.901, and 1.003.","‡ Quintile cutpoints toenail selenium (μg/g) 0.758, 0.832, 0.901, 1.003.",G0000000|C1508496|G0000000|C0222007|C0036581|G0000000|C1442061|C1442061|C1442061|C1442061
"By age group, the percentage increase was significant in those aged 0–4 years but was not significant in those aged 5–14 years.","By age group, percentage increase aged 0–4 aged 5–14 years.",G0000000|C0001779|C0441833|C0439165|C0442805|C0001779|G0000000|C0001779|G0000000|C0439234
"Patients ≥6 months to <11 years of age were eligible for enrollment if they presented to the ED with moderate-to-severe dehydration due to AGE, defined as ≥3 episodes of diarrhea or nonbilious vomiting within the previous 24 h and a Gorelick dehydration score ≥4 [20].","Patients ≥6 months <11 age eligible enrollment ED moderate-to-severe dehydration AGE, defined ≥3 episodes diarrhea nonbilious vomiting previous 24 Gorelick dehydration score ≥4 [20].",C0030705|G0000000|C0439231|C0450371|C0001779|C1548635|C1516879|C3538926|C0205081|C0011175|C0001779|C1704788|G0000000|C0332189|C0011991|G0000000|C0042963|C0205156|C0450371|G0000000|C0011175|C0449820|G0000000|C0450371
"The trial involved men and women from Australia and the United States who were 70 years of age or older (or ≥65 years of age among blacks and Hispanics in the United States) (Tables S1 and S2 in the Supplementary Appendix, available with the full text of this article at NEJM.org).","The trial involved women Australia United States 70 age (or ≥65 age blacks Hispanics United States) (Tables S1 S2 Supplementary Appendix, text article NEJM.org).",G0000000|C0008976|C1314939|C0043210|C0004340|C0166872|C1301808|C0450371|C0001779|G0000000|G0000000|C0001779|C0005680|C0086409|C0166872|C1301808|C0039224|C1519428|C1519428|G0000000|C0003617|C1527021|C1706852|C1522486
Bladder cancer cases were enrolled from the University of Texas MD Anderson Cancer Center and Baylor College of Medicine.,Bladder cancer enrolled University Texas MD Anderson Cancer Center Baylor College Medicine.,C0005682|C0006826|G0000000|C0041740|C0039711|G0000000|G0000000|C0006826|C0205099|G0000000|C0557806|C0013227
"The exclusion criteria were (i) known or suspected chronic or congenital disease, (ii) pregnancy and (iii) reported severe anaemia.","The exclusion criteria (i) suspected chronic congenital disease, (ii) pregnancy (iii) reported severe anaemia.",G0000000|C0680251|C0243161|C0021966|C0332147|C0205191|C0009678|C0012634|G0000000|C0032961|C0439070|C0684224|C0205082|C0002871
"Overall, the results for height SDS and LBM for the subgroup of subjects who were Tanner stage 1 at Month 12 were similar to those obtained for all subjects.","Overall, height SDS LBM subgroup subjects Tanner stage 1 Month 12 subjects.",C0282416|C0489786|C3813719|C0424678|C1079230|C0681850|C0335730|C0205390|G0000000|C0332177|C0450371|C0681850
a) Males and females Age 18 to 69 years b) Physician diagnosis of asthma and prescribed at least one rescue medication.,a) Males females Age 18 69 b) Physician diagnosis asthma prescribed rescue medication.,G0000000|C0086582|C0015780|C0001779|C0450371|C0450371|G0000000|C0031831|C0011900|C0004096|C0278329|G0000000|C0013227
To evaluate the effectiveness of a telephone option as part of a routine structured asthma review service.,To evaluate effectiveness telephone option routine structured asthma review service.,C0040363|C0220825|C1280519|C0039457|C1518601|C0205547|C0678594|C0004096|C0282443|C0557854
"The average age of subjects was 63 years, with an average post-bronchodilator FEV1 of 67% predicted, average FEV1/FVC ratio of 0.65, a mean of 35 pack-years smoking, and 63% were male.","The average age subjects 63 years, average post-bronchodilator FEV1 67% predicted, average FEV1/FVC ratio 0.65, 35 pack-years smoking, 63% male.",G0000000|C1510992|C0001779|C0681850|C0450371|C0439234|C1510992|C2599594|G0000000|C0450371|C0681842|C1510992|C3714541|C0456603|C0450371|C0450371|C1277691|C0037369|C0450371|C0086582
Pregnant and breastfeeding women were excluded.,Pregnant breastfeeding women excluded.,C0549206|C0006147|C0043210|C1554077
"Moreover, patients who were in a physical therapy program within the last year were also excluded.","Moreover, patients physical therapy program excluded.",G0000000|C0030705|C0031809|C0039798|C1709697|C1554077
"A cluster-randomized field experiment in 52 predominantly Hispanic elementary schools in San Antonio, TX, and Phoenix, AZ, tested whether student mobility in early elementary school was reduced through Families and Schools Together (FAST), an intervention that builds social capital among families, children, and schools.","A cluster-randomized field experiment 52 Hispanic elementary schools San Antonio, TX, Phoenix, AZ, tested student mobility elementary school reduced Families Schools Together (FAST), intervention builds social capital families, children, schools.",G0000000|C1555715|C0440042|C0681814|C0450371|C0086409|C0013879|C0036375|C1826357|G0000000|C0041403|C0331993|G0000000|C0392366|C0038492|C0425245|C0013879|C0036375|C0392756|C0015576|C0036375|C1883357|C0015663|C0886296|C1707059|C0728831|C0006909|C0015576|C0008059|C0036375
Participants were 312 new mothers who had given birth between September 2002 and November 2003.,Participants 312 mothers birth September 2002 November 2003.,C0679646|C1442061|C0026591|C0005615|C3828193|G0000000|C3828767|G0000000
In cases of multiple births only one of the infants could be included due to technical reasons.,In multiple births infants included technical reasons.,G0000000|C0439064|C0005615|C0021270|C0332257|C0449851|C0392360
"Flow of practices through trial We randomly selected 292 of the 323 general practices in Norway with the WinMed electronic medical record system, and we sent a letter inviting them to participate.","Flow practices trial We randomly selected 292 323 practices Norway WinMed electronic medical record system, letter inviting participate.",C0806140|C0237607|C0008976|G0000000|G0000000|C1707391|C1442061|C1442061|C0237607|C0028423|G0000000|C0013850|C0199168|C0034869|C0449913|C1096774|G0000000|G0000000
The effects of adding eformoterol to corticosteroids on asthma control and exacerbations in patients with mild to moderate asthma were studied.,The effects adding eformoterol corticosteroids asthma control exacerbations patients mild moderate asthma studied.,G0000000|C1280500|C1883712|C0060657|C0001617|C0004096|C0243148|G0000000|C0030705|C2945599|C0205081|C0004096|C0557651
Both groups had comparable baseline clinical and demographic characteristics (table 1).,Both comparable baseline clinical demographic characteristics (table 1).,G0000000|G0000000|C0168634|C0205210|C0011298|C1521970|C0039224|G0000000
"We extend special thanks to the cancer survivors, yoga instructors, and research staff in the University of Rochester Community Clinical Oncology Program (CCOP) Research Base and at each of the National Cancer Institute (NCI) CCOP affiliates who recruited and followed participants in this study.","We extend special cancer survivors, yoga instructors, staff University Rochester Community Clinical Oncology Program (CCOP) Research Base National Cancer Institute (NCI) CCOP affiliates recruited participants study.",G0000000|C0231448|C0205555|C0006826|C0206194|C0043418|C0556993|C0851286|C0041740|G0000000|C0009462|C0205210|C0027651|C1709697|C1516732|C0035168|C0002055|C3245503|C0006826|C0021622|C1513882|C1516732|C1510825|G0000000|C0679646|C0557651
"Additional major eligibility criteria included no strabismus, best corrected distance visual acuity at least 20/20, and no current or prior use of PALs, bifocals, or contact lenses in either eye (prior or current use of SVLs was permitted).","Additional major eligibility criteria included strabismus, corrected distance visual acuity 20/20, current prior PALs, bifocals, contact lenses eye (prior current SVLs permitted).",C1524062|C0205082|C0013893|C0243161|C0332257|C0038379|C0205202|C0012751|C0234621|C0750509|C0450371|C0521116|C0332152|C0030360|C1275647|C0332158|C0023317|C0015392|C0332152|C0521116|G0000000|C0329040
"CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio; Q, quintiles; SMHS, Shanghai Men's Health Study; SWHS, Shanghai Women's Health Study.","CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio; Q, quintiles; SMHS, Shanghai Men's Health Study; SWHS, Shanghai Women's Health Study.",C0008107|C0237529|C1272706|C0007222|C0007226|C0012634|G0000000|C0598697|C0456603|G0000000|C1508496|C1824631|G0000000|C0025266|C0018684|C0557651|G0000000|G0000000|C0043210|C0018684|C0557651
Youth and families were recruited in sixth grade across two cohorts.,Youth families recruited sixth grade cohorts.,C0001578|C0015576|G0000000|C0205440|C0441800|C0599755
Women were eligible to participate in the study if they were not pregnant and if they had not undergone hysterectomy.,Women eligible participate study pregnant undergone hysterectomy.,C0043210|C1548635|G0000000|C0557651|C0549206|G0000000|C0020699
At weaning the infants were randomised to one of the formula groups.,At weaning infants randomised formula groups.,G0000000|C0043084|C0021270|G0000000|C0489829|C0441833
"Key exclusion criteria were: life-threatening asthma; chronic sinus disease; respiratory diseases such as emphysema; use of immunosuppressants, β-adrenergic blocking agents, or anticoagulants; and history in the previous year of three or more hospitalizations for asthma, three or more lower respiratory tract infections, and four or more pulses of OCS use for asthma.","Key exclusion criteria were: life-threatening asthma; chronic sinus disease; respiratory diseases emphysema; immunosuppressants, β-adrenergic blocking agents, anticoagulants; history previous hospitalizations asthma, lower respiratory tract infections, pulses OCS asthma.",G0000000|C0680251|C0243161|G0000000|C1517874|C0004096|C0205191|C0016169|C0012634|C0521346|C0012634|C0013990|C0021081|G0000000|C0233660|C0450442|C0003280|C0019664|C0205156|C0019993|C0004096|C0441994|C0521346|C1185740|C3714514|C0034107|G0000000|C0004096
"Participants included healthy, singleton infants aged 8 weeks (± 7 days) at the time of enrollment and excluded infants who: (1) had been previously vaccinated against poliovirus, (2) had a low birth weight (ie, <2500 g), (3) resided in a household with someone who had received OPV within the previous 6 months or was scheduled to receive OPV in the following 6 months, (4) had a confirmed or suspected immunosuppressive or immunodeficiency condition, (5) had a family history of immunodeficiency, (6) had a major congenital defect or serious chronic illness, (7) had a known allergy to any component of the vaccines, (8) had an uncontrolled blood disorder contraindicating intramuscular injections, (9) was or would be administered immunoglobulins and/or blood products since birth or during the study period, or (10) was deemed unfit for inclusion in the study based on investigator discretion.","Participants included healthy, singleton infants aged 8 weeks (± 7 days) time enrollment excluded infants who: (1) vaccinated poliovirus, (2) low birth weight (ie, <2500 g), (3) resided household received OPV previous 6 months scheduled receive OPV 6 months, (4) confirmed suspected immunosuppressive immunodeficiency condition, (5) family history immunodeficiency, (6) major congenital defect chronic illness, (7) allergy component vaccines, (8) uncontrolled blood disorder contraindicating intramuscular injections, (9) administered immunoglobulins and/or blood products birth study period, (10) deemed unfit inclusion study based investigator discretion.",C0679646|C0332257|C3898900|C0481462|C0021270|C0001779|G0000000|C0439230|G0000000|G0000000|C0439228|C0040223|C1516879|C1554077|C0021270|G0000000|G0000000|C1116171|C0206435|G0000000|C0205251|C0005615|C0005910|G0000000|G0000000|C0439267|G0000000|C2982691|C0020052|C1514756|C0032375|C0205156|G0000000|C0439231|C0086960|C1514756|C0032375|G0000000|C0439231|G0000000|C0521093|C0332147|C0021081|C0021051|C0012634|G0000000|C0015576|C0019664|C0021051|G0000000|C0205082|C0009678|C1457869|C0205191|C0221423|G0000000|C0002111|C0449432|C0042210|G0000000|C0205318|C0005767|C0012634|G0000000|C0021492|C0021485|G0000000|C1521801|C0021027|G0000000|C0005767|C1514468|C0005615|C0557651|C0439531|C0450371|G0000000|G0000000|C0007637|C0557651|C1527178|C0035173|G0000000
"Excluded were patients with severe skin disease other than AD (e.g., psoriasis); secondary infections; major systemic diseases; women who were pregnant and subjects unable to comply with study and follow-up procedures.","Excluded patients severe skin disease AD (e.g., psoriasis); secondary infections; major systemic diseases; women pregnant subjects unable comply study follow-up procedures.",C1554077|C0030705|C0205082|C0444099|C0012634|G0000000|G0000000|C0033860|C0027627|C3714514|C0205082|C0205373|C0012634|C0043210|C0549206|C0681850|C1299582|C0725694|C0557651|C0589120|C0025664
"The exclusion criteria were: (1) insufficient language skills to understand the study procedures, (2) cognitive impairment (Mini-Cog: 1–2 recalled words and abnormal clock drawing test) [12], and (3) medical conditions precluding participation in a regular exercise program (i.e., uncontrolled hypertension, severe neurological disorder, acute cancer, psychiatric disorder, acute infection).","The exclusion criteria were: (1) insufficient language skills understand study procedures, (2) cognitive impairment (Mini-Cog: 1–2 recalled abnormal clock drawing test) [12], (3) medical conditions precluding participation regular exercise program (i.e., uncontrolled hypertension, severe neurological disorder, acute cancer, psychiatric disorder, acute infection).",G0000000|C0680251|C0243161|G0000000|G0000000|C0205412|C0023008|C0678856|C0162340|C0557651|C0025664|G0000000|C1516691|C0221099|C3496552|G0000000|C0034770|C0205161|C1413503|C0013113|C0022885|C0450371|G0000000|C0199168|C0012634|G0000000|C0679823|C0205272|C0015259|C1709697|C0683454|C0205318|C0020538|C0205082|C0205494|C0012634|C0205178|C0006826|C0205487|C0012634|C0205178|C0009450
"Mother’s ethnicity was 88% Caucasian, non-Hispanic; 8% Hispanic; 2% African American; 1% Asian/Pacific Islander; and 1% other.","Mother’s ethnicity 88% Caucasian, non-Hispanic; 8% Hispanic; 2% African American; 1% Asian/Pacific Islander; 1% other.",G0000000|C0015031|C0450371|C0007457|C1518424|G0000000|C0086409|G0000000|C0027567|C0596070|G0000000|C0078988|G0000000|G0000000|G0000000
The eGFR remained stable over the follow-up period.,The eGFR remained stable follow-up period.,G0000000|C1739039|G0000000|C0205360|C0589120|C0439531
"The exclusion criteria were neurological disease, anatomical abnormalities, or urinary tract infection (UTI).","The exclusion criteria neurological disease, anatomical abnormalities, urinary tract infection (UTI).",G0000000|C0680251|C0243161|C0205494|C0012634|C0220784|C0000768|C0042027|C1185740|C0009450|C0042029
We excluded families if they had participated in the Lead Safe Babies program or received services from the Childhood Lead Poisoning Prevention Program of the Philadelphia Department of Public Health for other children in the family.,We excluded families participated Lead Safe Babies program received services Childhood Lead Poisoning Prevention Program Philadelphia Department Public Health children family.,G0000000|C1554077|C0015576|G0000000|C0023175|G0000000|C0021270|C1709697|C1514756|C0557854|C0231335|C0023175|C0032343|C0199176|C1709697|C0031525|C1704729|G0000000|C0018684|C0008059|C0015576
"However, patients with stage I MM randomized to have treatment delayed and who actually progressed and were treated had shorter survival than those with stable disease and no treatment.","However, patients stage I MM randomized treatment delayed progressed treated shorter survival stable disease treatment.",G0000000|C0030705|C0205390|C0021966|G0000000|C0034656|C0039798|C0205421|C1272688|C1522326|C1282927|C0038952|C0205360|C0012634|C0039798
"However, this community based intervention with limited funding had very limited reach into the community and did not increase population cycling levels.","However, community based intervention limited funding limited reach community increase population cycling levels.",G0000000|C0009462|C1527178|C0886296|C0439801|C0243098|C0439801|C2584321|C0009462|C0442805|C0032659|C1511572|C0441889
Women were excluded if they had a serious infection or reported previous use of antiretroviral drugs during this or previous pregnancies.,Women excluded infection reported previous antiretroviral drugs previous pregnancies.,C0043210|C1554077|C0009450|C0684224|C0205156|G0000000|C0013227|C0205156|C0032961
Demodex was found in 80 of 104 men (77%) and 201 of 231 women (87%).,Demodex 80 104 (77%) 201 231 women (87%).,C0323683|C0450371|C1442061|C0450371|C1442061|C1442061|C0043210|C0450371
"Baseline characteristics of general practitioners (n=89) participating in the study in 2000 Patients' characteristics in 2000 and 2001 in the intervention and control groups At baseline, mean antibiotic prescription rates for registered encounters for respiratory tract symptoms did not differ significantly between the two groups (27% v 29%, 95% confidence interval -9.1 to 5.0).","Baseline characteristics practitioners (n=89) participating study 2000 Patients' characteristics 2000 2001 intervention control At baseline, antibiotic prescription rates registered encounters respiratory tract symptoms (27% 29%, 95% confidence interval -9.1 5.0).",C0168634|C1521970|C1709627|C0369718|C0679823|C0557651|G0000000|C0030705|C1521970|G0000000|G0000000|C0886296|C0243148|G0000000|C0168634|C0003232|C0033080|C0871208|C1514821|C0545082|C0521346|C1185740|C0683368|C0450371|C0450371|C0450371|C0237529|C1272706|G0000000|G0000000
Fifty patients (25 in each group) were randomly allocated to receive either mannitol or HS.,Fifty patients (25 group) randomly allocated receive mannitol HS.,C3816723|C0030705|C0450371|C0441833|G0000000|G0000000|C1514756|C0024730|G0000000
Nausea and vomiting in pregnancy is a common complaint of nearly 50-80% of pregnant women.,Nausea vomiting pregnancy common complaint 50-80% pregnant women.,C0027497|C0042963|C0032961|C0205214|C0277786|C0450371|C0549206|C0043210
"To clarify whether memantine monotherapy is more efficacious than placebo for patients with AD, we have performed a meta-analysis of memantine monotherapy for AD including 9 studies with a total of 2433 patients.","To clarify memantine monotherapy efficacious placebo patients AD, performed meta-analysis memantine monotherapy AD including 9 studies total 2433 patients.",C0040363|C2986669|C0025242|G0000000|C1280519|C0032042|C0030705|G0000000|C0884358|C0282458|C0025242|G0000000|G0000000|C0332257|G0000000|C0947630|C0439175|G0000000|C0030705
"Children with Influenza-like Illness (ILI) <12 y of age admitted to SGH and among those who were PCR confirmed H1N1 infected: August 2009–January 2010 Among the 92 H1N1-confirmed cases, 43 (47%) were males and the median age was 2.5 y (IQR 1.3–6), with 16 (17%) cases less than 1 y of age.","Children Influenza-like Illness (ILI) <12 age admitted SGH PCR confirmed H1N1 infected: August 2009–January 2010 Among 92 H1N1-confirmed cases, 43 (47%) males median age 2.5 (IQR 1.3–6), 16 (17%) 1 age.",C0008059|C0021400|C0221423|G0000000|C0450371|C0001779|C0184666|G0000000|C0032520|C0521093|G0000000|C0439663|C3831448|G0000000|G0000000|G0000000|C0450371|C0521093|C0868928|C0450371|C0450371|C0086582|C0549183|C0001779|G0000000|G0000000|G0000000|C0450371|C0450371|G0000000|C0001779
"Baseline characteristics of women according to treatment group assignment1 The proportions of women with at least 1 sample < 2 wk from delivery and at 3, 6, 9, 12, and >12 mo were 49, 70, 45, 30, 18, and 31%, respectively.","Baseline characteristics women treatment assignment1 The proportions women 1 sample < 2 wk delivery 3, 6, 9, 12, >12 mo 49, 70, 45, 30, 18, 31%, respectively.",C0168634|C1521970|C0043210|C0039798|G0000000|G0000000|C1709707|C0043210|G0000000|C0370003|G0000000|G0000000|C0332174|C0011209|G0000000|G0000000|G0000000|C0450371|C0450371|C0026544|C0450371|C0450371|C0450371|C0450371|C0450371|C0450371|G0000000
The study involved students from the school systems of 14 communities in Alaska.,The study involved students school systems 14 communities Alaska.,G0000000|C0557651|C1314939|C0038492|C0036375|C0449913|C0450371|C0009462|C0001905
"Moreover, the mean age of the 159 children randomised was virtually identical to that of the 278 who were ineligible.","Moreover, age 159 children randomised virtually identical 278 ineligible.",G0000000|C0001779|C1442061|C0008059|G0000000|G0000000|C0205280|C1442061|C1512714
A complication after restorative rectal surgery with a straight anastomosis is low- anterior resection syndrome with a postoperatively deteriorated anorectal function.,A complication restorative rectal surgery straight anastomosis low- anterior resection syndrome postoperatively deteriorated anorectal function.,G0000000|C0009566|G0000000|C0205052|C0038894|C0445291|C0332853|C0205251|C0205094|C0015252|C0039082|G0000000|C1457868|C0178825|C0031843
"Exclusion criteria were: 1) A history of confirmed or suspected heart disease; 2) The presence of other concomitant illness; 3) Patients treated by herbal medicine, vitamins and enzymes; 4) Arrhythmia in ECG; 5) Inappropriate view in echocardiography.","Exclusion criteria were: 1) A history confirmed suspected heart disease; 2) The presence concomitant illness; 3) Patients treated herbal medicine, vitamins enzymes; 4) Arrhythmia ECG; 5) Inappropriate view echocardiography.",C0680251|C0243161|G0000000|G0000000|G0000000|C0019664|C0521093|C0332147|C0018787|C0012634|G0000000|G0000000|C0150312|C0521115|C0221423|G0000000|C0030705|C1522326|C3146288|C0013227|C0042890|C0014442|G0000000|C0003811|C1623258|G0000000|C1548788|C0449911|C0013516
"Patients older than 35 years who had experienced stroke (ischemic or hemorrhagic that documented by computed tomography or magnetic resonance imaging) with onset of at least 3 months ago, were evaluated by Modified Ashworth Scale (MAS) for their upper limb spasticity.","Patients 35 experienced stroke (ischemic hemorrhagic documented computed tomography magnetic resonance imaging) onset 3 months ago, evaluated Modified Ashworth Scale (MAS) upper limb spasticity.",C0030705|C0450371|C0237607|C0038454|C0475224|C0333275|C1301725|C1441526|C0040395|C0024488|C0231881|C0011923|C0206132|G0000000|C0439231|G0000000|C0220825|C0392747|G0000000|C0175659|C1096155|C1282910|C0015385|C0026838
"Overall, 44 health visitors from 36 practices took part in the study.","Overall, 44 health visitors 36 practices study.",C0282416|C0450371|C0018684|G0000000|C0450371|C0237607|C0557651
Study personnel then screen individual medical records to confirm eligibility.,Study personnel screen individual medical records confirm eligibility.,C0557651|C0024752|C0220908|C0027361|C0199168|C0034869|C0521093|C0013893
Both the Onco-Move and OnTrack program start in the week of the first cycle of chemotherapy and continue until three weeks after the last cycle of chemotherapy.,Both Onco-Move OnTrack program start week cycle chemotherapy continue weeks cycle chemotherapy.,G0000000|C0560560|G0000000|C1709697|C0439659|C0332174|C1511572|C0013216|C0549178|C0439230|C1511572|C0013216
"Exclusion criteria were: known psychosis and personality disorders; receiving psychological therapy; participating in PR, or having had PR within the previous six months; cognitive impairment; dementia; and verbal and/or written communication problems.","Exclusion criteria were: psychosis personality disorders; receiving psychological therapy; participating PR, PR previous months; cognitive impairment; dementia; verbal and/or written communication problems.",C0680251|C0243161|G0000000|C0033975|C0003944|C0012634|C1514756|C0205486|C0039798|C0679823|C0279759|C0279759|C0205156|C0439231|C1516691|C0221099|C0011265|C0439824|G0000000|C0043266|C0009452|C1546466
This is a randomised controlled trial (RCT) in patients with a past history of stroke or TIA.,This randomised controlled trial (RCT) patients history stroke TIA.,G0000000|G0000000|C2587213|C0008976|G0000000|C0030705|C0019664|C0038454|C0007787
"First, the number of patients with known EGFR mutation status (79/296, 26.7%) is insufficient for subgroup analyses according to EGFR mutation.","First, patients EGFR mutation status (79/296, 26.7%) insufficient subgroup analyses EGFR mutation.",C0205435|C0030705|C1739039|C0026882|C0449438|C0450371|C0450371|C0205412|C1079230|C0002778|C1739039|C0026882
"We excluded patients with neurocognitive or psychiatric conditions (as defined by the clinical trial investigators), pregnant or lactating women, patients with hepatic impairment or renal insufficiency, and patients with a life expectancy of less than six months (e.g., those with metastatic malignancies).","We excluded patients neurocognitive psychiatric conditions (as defined clinical trial investigators), pregnant lactating women, patients hepatic impairment renal insufficiency, patients life expectancy months (e.g., metastatic malignancies).",G0000000|C1554077|C0030705|C0518895|C0205487|C0012634|G0000000|C1704788|C0205210|C0008976|C0035173|C0549206|C2828358|C0043210|C0030705|C0205054|C0221099|C0022646|C0231179|C0030705|C0376558|C0679138|C0439231|G0000000|C0036525|C0006826
"The inclusion criteria were (a) unilateral paresis as a result of first ischemic or hemorrhagic stroke confirmed by computed tomography or MRI that occurred less than 3 months before enrollment, (b) the ability to understand and follow simple instructions, and (c) the ability to perform some active movements in the shoulder and/or elbow joints in the sitting position, allowing for trunk compensation if needed.","The inclusion criteria (a) unilateral paresis result ischemic hemorrhagic stroke confirmed computed tomography MRI occurred 3 months enrollment, (b) ability understand follow simple instructions, (c) ability perform active movements shoulder and/or elbow joints sitting position, allowing trunk compensation needed.",G0000000|C0007637|C0243161|G0000000|C0205092|C0030552|C1274040|C0475224|C0333275|C0038454|C0521093|C1441526|C0040395|C0024485|C1709305|G0000000|C0439231|C1516879|G0000000|C0085732|C0162340|C0332283|C0205352|C0302828|G0000000|C0085732|C0884358|C0205177|C0026649|C0037004|G0000000|C0013769|C0022417|C0277814|C0733755|C0683607|C0225442|C0152057|C0027552
"Children aged 4 to 60 months with AGE, defined as the passage of three or more loose or watery stools per day for >1 day but <5 days, were eligible for inclusion.","Children aged 4 60 months AGE, defined passage loose watery stools day >1 day <5 days, eligible inclusion.",C0008059|C0001779|G0000000|C0450371|C0439231|C0001779|C1704788|C0439799|C0205407|C0443350|C0015733|C0332173|G0000000|C0332173|G0000000|C0439228|C1548635|C0007637
The primary objective of this study is to evaluate the effectiveness of providing structured information about the results of spirometry testing to increase the rate of prolonged abstinence from smoking at 12 months after an anti-smoking intervention in primary care patients who smoke but do not have a known respiratory disease.,The primary objective study evaluate effectiveness providing structured spirometry testing increase rate prolonged abstinence smoking 12 months anti-smoking intervention primary care patients smoke respiratory disease.,G0000000|C0205225|C0018017|C0557651|C0220825|C1280519|C1999230|C0678594|C0037981|C0039593|C0442805|C0871208|C0439590|C3843422|C0037369|C0450371|C0439231|C0037369|C0886296|C0205225|C1947933|C0030705|C0037366|C0521346|C0012634
"Inclusion criteria were age ≥ 18 years, diagnosis of T2D and moderately impaired kidney function (CKD stage 3, as defined by eGFRMDRD ≥ 30 and < 60 mL/min/1.73 m2), plus the following at screening: naïve to the use of oral antihyperglycemic agents or on monotherapy or combination therapy with no more than two antihyperglycemic medications; HbA1c 6.5–10%; FPG ≤ 13.3 mmol/L; urinary albumin/creatinine ratio (UACR) ≤ 3000 μg/mg; body mass index from 25.0 kg/m2 (Asian patients: from 23.0 kg/m2) to 35.0 kg/m2.","Inclusion criteria age ≥ 18 years, diagnosis T2D moderately impaired kidney function (CKD stage 3, defined eGFRMDRD ≥ 30 and < 60 mL/min/1.73 m2), screening: naïve oral antihyperglycemic agents monotherapy combination therapy antihyperglycemic medications; HbA1c 6.5–10%; FPG ≤ 13.3 mmol/L; urinary albumin/creatinine ratio (UACR) ≤ 3000 μg/mg; body mass 25.0 kg/m2 (Asian patients: 23.0 kg/m2) 35.0 kg/m2.",C0007637|C0243161|G0000000|C0439234|C0011900|G0000000|C0205081|C0221099|C0022646|C0031843|C1561643|C0205390|G0000000|C1704788|G0000000|G0000000|C0439445|C0025885|C0220908|G0000000|C0442027|C0020616|C0450442|G0000000|C0205195|C0039798|C0020616|C0013227|G0000000|G0000000|G0000000|C1532563|C0042027|C0486293|C0456603|G0000000|G0000000|C0242821|C0577559|C0450371|C0022718|C0078988|C0030705|C0450371|C0022718|C0450371|C0022718
All patients in this study had initially received chemotherapy for ROC.,All patients study initially received chemotherapy ROC.,G0000000|C0030705|C0557651|C0205265|C1514756|C0013216|C0683187
The children enrolled at both surveys were between 8 and 13 years of age (mean = 9.4) and 44.6% were boys (P< 0.05).,The children enrolled surveys 8 13 age (mean = 9.4) 44.6% boys (P< 0.05).,G0000000|C0008059|G0000000|C0038951|G0000000|C0450371|C0001779|C0444504|G0000000|G0000000|C0450371|C0870221|C0369773|C0450371
"We describe the prevalence of antibodies to EBOV in oral fluid samples (OFSs) from individuals who returned to the UK or Ireland after responding to the West African EVD epidemic, as well as potential exposures to EBOV and experience of illness in West Africa or within 1 mo of return.","We prevalence antibodies EBOV oral fluid samples (OFSs) individuals returned UK Ireland responding West African EVD epidemic, potential exposures EBOV experience illness West Africa 1 mo return.",G0000000|C0033105|C0003241|C0949892|C0442027|C0005889|C0370003|G0000000|C0027361|C0332156|C0041700|C0022067|G0000000|C1705493|C0027567|G0000000|C0014499|C3245505|C0274281|C0949892|C0237607|C0221423|C1705493|C0001737|G0000000|C0026544|C0332156
There were no cases of neurodevelopmental disorder in the children of women with untreated epilepsy.,There neurodevelopmental disorder children women untreated epilepsy.,G0000000|C0599855|C0012634|C0008059|C0043210|C0332155|C0014544
"The children were selected from among 25 schools in Odense, Denmark.","The children selected 25 schools Odense, Denmark.",G0000000|C0008059|C1707391|C0450371|C0036375|G0000000|C0011318
"Given that these CLAMP subjects had experienced both types of lenses because of the run-in period, this indicates a preference for the soft contact lenses.","Given CLAMP subjects experienced types lenses run-in period, preference soft contact lenses.",C1442162|C0175721|C0681850|C0237607|C0332307|C0023317|C3274438|C0439531|C0558295|C0205358|C0332158|C0023317
This paper identifies factors and characteristics of women that affect bednet use among their children less than five years of age in Ghana.,This paper identifies factors characteristics women affect bednet children age Ghana.,G0000000|C0030351|G0000000|C1521761|C1521970|C0043210|C0001721|G0000000|C0008059|C0001779|C0017516
The psychological depth of nurses' utterances was rated as well.,The psychological depth nurses' utterances rated well.,G0000000|C0205486|C0205125|C0028661|G0000000|C0871208|C0205170
Two electrodes were placed on the region with pain.,Two electrodes region pain.,C0205448|C0013812|C0017446|C0030193
ORR was compared between the two groups using Chi-square tests.,ORR compared Chi-square tests.,G0000000|C1707455|C1552646|C0022885
"Other exclusion criteria were the presence of an unstable medical condition, hepatic or renal disease, malignancy, serum thyrotropin level ≥5 μIU/ml, abnormal breast examination or mammogram, history of endometrial hyperplasia or endometrial cancer, rapidly growing uterine leiomyomata, undiagnosed abnormal uterine bleeding, abnormal gynecological examination precluding use of black cohosh, or known sensitivity to black cohosh.","Other exclusion criteria presence unstable medical condition, hepatic renal disease, malignancy, serum thyrotropin level ≥5 μIU/ml, abnormal breast examination mammogram, history endometrial hyperplasia endometrial cancer, rapidly growing uterine leiomyomata, undiagnosed abnormal uterine bleeding, abnormal gynecological examination precluding black cohosh, sensitivity black cohosh.",G0000000|C0680251|C0243161|C0150312|C0443343|C0199168|C0012634|C0205054|C0022646|C0012634|C0006826|C0229671|C0040160|C0441889|G0000000|G0000000|C0205161|C0006141|G0000000|C0024671|C0019664|C0227843|C0020507|C0227843|C0006826|C0456962|G0000000|C0042149|C0023267|C1408353|C0205161|C0042149|C0019080|C0205161|C0018417|G0000000|G0000000|C0005680|G0000000|C0020517|C0005680|G0000000
His institution received reimbursement from Novartis for the conduct of the study and analysis of the physical activity data.,His institution received reimbursement Novartis conduct study analysis physical activity data.,G0000000|C0018704|C1514756|G0000000|G0000000|C0004927|C0557651|C0002778|C0031809|C0205177|C1511726
"In this mono-centric, randomized, non-inferiority trial, infants were eligible if they had GA of ≤32 weeks, started enteral feeding within the first 7 days of life, and if OMM was unavailable or insufficient to satisfy the planned enteral intakes.","In mono-centric, randomized, non-inferiority trial, infants eligible GA ≤32 weeks, started enteral feeding 7 days life, OMM unavailable insufficient satisfy planned enteral intakes.",G0000000|C1551432|C0034656|C1518422|C0008976|C0021270|C1548635|C0016993|G0000000|C0439230|C1272689|C1304890|C0204695|G0000000|C0439228|C0376558|G0000000|C0686905|C0205412|G0000000|C1301732|C1304890|C1512806
540 smokers admitted to hospital after myocardial infarction or for cardiac bypass surgery who expressed interest in stopping smoking.,540 smokers admitted hospital myocardial infarction cardiac bypass surgery expressed stopping smoking.,C1442061|C0337664|C0184666|C0019994|C0027061|C0021308|C0018787|C0741847|C0038894|G0000000|C0723457|C0037369
"Participants will include males and females, over 17 years of age, who are within 90 days of diagnosis of first probable or definite TIA (symptom resolution in less than 24 hours) or ischemic or hemorrhagic NDS (National Institutes of Health Stroke Scale less than 6) [63] for which medical attention was sought.","Participants males females, 17 age, 90 days diagnosis probable definite TIA (symptom resolution 24 hours) ischemic hemorrhagic NDS (National Institutes Health Stroke Scale 6) [63] medical attention sought.",C0679646|C0086582|C0015780|C0450371|C0001779|C0450371|C0439228|C0011900|C0033204|C0439544|C0007787|C1457887|C1514893|C0450371|C0439227|C0475224|C0333275|C0057753|C3245503|C0021622|C0018684|C0038454|C0175659|G0000000|C0450371|C0199168|C0004268|G0000000
"Exclusion criteria were evidence of stroke, head injury, major psychiatric problem or mental retardation on chart review, which was conducted by a gerontological nurse practitioner.","Exclusion criteria evidence stroke, head injury, major psychiatric mental retardation chart review, conducted gerontological nurse practitioner.",C0680251|C0243161|C3887511|C0038454|C0018670|C3263722|C0205082|C0205487|C0229992|C0521111|C0007963|C0282443|C0004927|C0017469|C0028661|C1709627
"At the time of this change in inclusion criteria, only 31 patients were enrolled.","At time change inclusion criteria, 31 patients enrolled.",G0000000|C0040223|C0392747|C0007637|C0243161|C0450371|C0030705|G0000000
The participants were patients referred to the Medical Centre Alkmaar with signs and symptoms of the carpal tunnel syndrome of more than 3 months’ duration confirmed by electrophysiological tests.,The participants patients referred Medical Centre Alkmaar signs symptoms carpal tunnel syndrome 3 months’ duration confirmed electrophysiological tests.,G0000000|C0679646|C0030705|C0205543|C0199168|C0205099|G0000000|C0220912|C0683368|C0007285|C0337138|C0039082|G0000000|G0000000|C0449238|C0521093|C0013865|C0022885
"We describe our study protocol for a randomized control trial with an anticipated sample of 100 low-income African- American and Caucasian adolescent, first–time mothers of infants.","We study protocol randomized control trial anticipated sample 100 low-income African- American Caucasian adolescent, first–time mothers infants.",G0000000|C0557651|C0442711|C0034656|C0243148|C0008976|C3840775|C0370003|C1442061|C0032854|C0027567|C0596070|C0007457|C0205653|G0000000|C0026591|C0021270
"We recruited Bangladeshi adults (aged over 20 years) with diabetes, arthritis, respiratory or cardiovascular disease, by writing to people listed on disease registers of 10 general practices serving large Bangladeshi populations in Tower Hamlets.","We recruited Bangladeshi adults (aged 20 years) diabetes, arthritis, respiratory cardiovascular disease, writing people listed disease registers 10 practices serving Bangladeshi populations Tower Hamlets.",G0000000|G0000000|C0422784|C0001675|C0001779|C0450371|C0439234|C0011847|C0003864|C0521346|C0007226|C0012634|C0043266|C0027361|C0745732|C0012634|C0600375|C0450371|C0237607|C1519269|C0422784|C0032659|C1710443|C0562520
"Subjects were recruited from the general neurology and subspecialty epilepsy clinics at Columbia University and Washington University, as well as through announcements in local periodicals.","Subjects recruited neurology subspecialty epilepsy clinics Columbia University Washington University, announcements local periodicals.",C0681850|G0000000|C0027855|G0000000|C0014544|C0442592|C1551442|C0041740|C0043038|C0041740|G0000000|C0205276|C0031082
Inclusion criteria were assignment to the jail’s general population (i.e.,Inclusion criteria assignment jail’s population (i.e.,C0007637|C0243161|C1516050|G0000000|C0032659|C0683454
Diagnosis of chronic HCV infection was based on positive HCV RNA levels with liver biopsy (within 1 year of initiation of study) with or without elevated liver enzymes.,Diagnosis chronic HCV infection based positive HCV RNA levels liver biopsy (within 1 initiation study) elevated liver enzymes.,C0011900|C0205191|C0220847|C0009450|C1527178|C0439178|C0220847|C0035668|C0441889|C0023884|C0005558|G0000000|G0000000|C0589507|C0557651|C0205250|C0023884|C0014442
"Twenty-eight free-living, young (18–20 years old) male soccer players consumed daily 105 g of FCMC (168 mg of flavanols) or CBC (<5 mg of flavanols), as part of their normal diet.","Twenty-eight free-living, (18–20 old) male soccer players consumed daily 105 FCMC (168 flavanols) CBC (<5 flavanols), normal diet.",C0724000|C0332296|G0000000|C0580836|C0086582|C0037393|G0000000|G0000000|C0332173|C1442061|G0000000|C1442061|C2348678|C0009555|G0000000|C2348678|C0205307|C0012155
Median age was 59 years; a majority were male (88%) and white (96%) with an ECOG performance status of either 0 (48%) or 1 (49%).,Median age 59 years; majority male (88%) white (96%) ECOG performance status 0 (48%) 1 (49%).,C0549183|C0001779|C0450371|C0439234|C0680220|C0086582|C0450371|C0007457|C0450371|C0430797|C0597198|C0449438|G0000000|C0450371|G0000000|C0450371
"Exclusion criteria include a diagnosis of asthma as defined by the American Thoracic Society/European Respiratory Society guidelines, clinically significant bronchiectasis, known sensitivity to roflumilast, the use of other methylxanthines (specifically theophylline) within 1 month of screening, changes to maintenance COPD therapy within 1 month of screening, and other factors as listed in the online supplement.","Exclusion criteria diagnosis asthma defined American Thoracic Society/European Respiratory Society guidelines, clinically bronchiectasis, sensitivity roflumilast, methylxanthines (specifically theophylline) 1 month screening, maintenance COPD therapy 1 month screening, factors listed online supplement.",C0680251|C0243161|C0011900|C0004096|C1704788|C0596070|G0000000|C0037455|C0521346|C0037455|C0162791|G0000000|C0006267|C0020517|C0965618|C0066447|G0000000|C0039771|G0000000|C0332177|C0220908|C0024501|C0024117|C0039798|G0000000|C0332177|C0220908|C1521761|C0745732|G0000000|C0242295
Call up of participants should be through the Ministry of Health to ensure that appropriate people attend for training.,Call participants Ministry Health ensure people attend training.,C0679006|C0679646|G0000000|C0018684|C0218063|C0027361|C1999232|C0040607
The controls were women aged over 20 years old without a history of breast cancer who underwent breast cancer screening at Mizushima Kyodo Hospital and Okayama Saiseikai Hospital in Okayama and at Kagawa Prefectural Cancer Detection Center in Kagawa.,The controls women aged 20 history breast cancer underwent breast cancer screening Mizushima Kyodo Hospital Okayama Saiseikai Hospital Okayama Kagawa Prefectural Cancer Detection Center Kagawa.,G0000000|C0243148|C0043210|C0001779|C0450371|C0019664|C0006141|C0006826|G0000000|C0006141|C0006826|C0220908|G0000000|G0000000|C0019994|G0000000|G0000000|C0019994|G0000000|G0000000|C1709636|C0006826|C1511790|C0205099|G0000000
"gambiae s.s. collected indoor during 12-months post intervention at Ilara, Irolu and Ijesa.","gambiae s.s. collected indoor 12-months post intervention Ilara, Irolu Ijesa.",G0000000|C0565930|C1516695|G0000000|C0450371|C0687676|C0886296|G0000000|G0000000|G0000000
"Pregnancy or cancer, having advanced osteoarthritis, joint malformation, spinal disorders, or trauma within the last three months, inflammatory rheumatic disorders, history of smoking, having had modifications related to fibromyalgia medications within the last three months or alcohol intake were also among exclusion criteria.","Pregnancy cancer, advanced osteoarthritis, joint malformation, spinal disorders, trauma months, inflammatory rheumatic disorders, history smoking, modifications fibromyalgia medications months alcohol intake exclusion criteria.",C0032961|C0006826|C0205179|C0029408|C0022417|C0000768|C0521329|C0012634|C0043251|C0439231|C0333348|G0000000|C0012634|C0019664|C0037369|C0392747|C0016053|C0013227|C0439231|C0001962|C1512806|C0680251|C0243161
The median age was 64 years in each arm and 78% arm IG and 86% arm G patients had stage IV disease.,The median age 64 arm 78% arm IG 86% arm G patients stage IV disease.,G0000000|C0549183|C0001779|C0450371|C0446516|C0450371|C0446516|C0021027|C0450371|C0446516|C0439267|C0030705|C0205390|C0022326|C0012634
"Individuals will be included if they are between 18 and 70, have a confirmed asthma diagnosis, and their asthma is classified as not well controlled by their physician.","Individuals included 18 70, confirmed asthma diagnosis, asthma classified controlled physician.",C0027361|C0332257|C0450371|C0450371|C0521093|C0004096|C0011900|C0004096|C0008902|C2587213|C0031831
"Children were included if they were on stable medication for another psychiatric disorder (e.g., Ritalin for attention deficit/hyperactive disorder).","Children included stable medication psychiatric disorder (e.g., Ritalin attention deficit/hyperactive disorder).",C0008059|C0332257|C0205360|C0013227|C0205487|C0012634|G0000000|C0728759|C0004268|C0162429|C0012634
"Following a census, 130 households per village with at least one member aged <5 years were randomly selected.","Following census, 130 households village aged <5 randomly selected.",C0231290|C0007663|C1442061|C0020052|C0562518|C0001779|G0000000|G0000000|C1707391
"However, information leaflets with regard to ETS exposure are not yet given routinely to parents of children aged 1 to 4 years who are exposed to ETS.","However, leaflets regard ETS exposure routinely parents children aged 1 4 exposed ETS.",G0000000|C1708664|G0000000|G0000000|C0274281|G0000000|C0030551|C0008059|C0001779|G0000000|G0000000|C0332157|G0000000
[1] This may be the reason why US did not have an additional benefit for relieving chronic lower back pain.,[1] This reason US additional benefit relieving chronic lower pain.,G0000000|G0000000|C0392360|G0000000|C1524062|C0814225|C0332303|C0205191|C0441994|C0030193
"Participants Infants born in 1990-2005 identified with severe congenital heart defects (tetralogy of Fallot, endocardial cushion defects, univentricular hearts, truncus arteriosus, or transposition complexes) in Quebec administrative databases.","Participants Infants born 1990-2005 identified severe congenital heart defects (tetralogy Fallot, endocardial cushion defects, univentricular hearts, truncus arteriosus, transposition complexes) Quebec administrative databases.",C0679646|C0021270|C0005615|G0000000|C0205396|C0205082|C0009678|C0018787|C0243067|G0000000|G0000000|C0014124|C0180249|C0243067|G0000000|C0018787|C0460005|G0000000|C0040674|C1704241|C0034390|C1292785|C0242356
"We also excluded those who intended to change medications that might affect mood, those who intended to seek professional treatment for anxiety or depression during the study period, and those who were unwilling to make the required time commitment.","We excluded intended change medications affect mood, intended seek professional treatment anxiety depression study period, unwilling required time commitment.",G0000000|C1554077|C1283828|C0392747|C0013227|C0001721|C0026516|C1283828|G0000000|C0679924|C0039798|C0003467|C0011570|C0557651|C0439531|C0558080|C1514873|C0040223|C0870312
"Keywords: glutamine supplementation; parenteral nutrition The structure of the trial showing the numbers of patients screened, randomised, dying, and surviving.","Keywords: glutamine supplementation; parenteral nutrition The structure trial patients screened, randomised, dying, surviving.",C1708608|C0017797|C0242297|C0030547|C0028707|G0000000|C0678594|C0008976|C0030705|C0220908|G0000000|C0184532|C0310255
"Methods: After three consecutive weekly visits, 86 patients were randomised to receive either fluticasone 500 µg twice daily (n = 43, 23F, mean (SD) age 57.7 (14.4) years) or matched placebo (n = 43, 34F, 59.2 (14.2) years) and reviewed regularly for 52 weeks in a double blind fashion.","Methods: After consecutive weekly visits, 86 patients randomised receive fluticasone 500 µg daily (n = 43, 23F, (SD) age 57.7 (14.4) years) matched placebo (n = 43, 34F, 59.2 (14.2) years) reviewed regularly 52 weeks double blind fashion.",C0025663|G0000000|C1707491|C0332174|C0545082|C0450371|C0030705|G0000000|C1514756|C0082607|C1442061|G0000000|C0332173|C0369718|G0000000|C0450371|G0000000|G0000000|C0001779|C0450371|C0450371|C0439234|C0150103|C0032042|C0369718|G0000000|C0450371|G0000000|C0450371|C0450371|C0439234|C0282443|G0000000|C0450371|C0439230|C0205173|C0150108|G0000000
"progressive neurological condition, severe arthritis, unstable heart condition) impacting on their ability to participate in the study, or visual problems such that they weren’t able to adequately see the games when displayed on the television screen.","progressive neurological condition, severe arthritis, unstable heart condition) impacting ability participate study, visual weren’t adequately games displayed television screen.",C0205329|C0205494|C0012634|C0205082|C0003864|C0443343|C0018787|C0012634|C1825598|C0085732|G0000000|C0557651|C0234621|G0000000|G0000000|C0150593|C0870432|C0039461|C0220908
"The Education group included significantly more household members of Latino descent (98.1%) than the other two groups (94.2% for the Hand Sanitizer group and 96.4% for the Hand Sanitizer and Face Mask group) (p<0.005), as well as members who had not completed high school (54.6% vs. 44.7% in the Hand Sanitizer group and 39.8% in the Hand Sanitizer and Face Mask group (p<0.005).","The Education included household Latino descent (98.1%) (94.2% Hand Sanitizer 96.4% Hand Sanitizer Face Mask group) (p<0.005), completed school (54.6% vs. 44.7% Hand Sanitizer 39.8% Hand Sanitizer Face Mask (p<0.005).",G0000000|C0013621|C0332257|C0020052|C0086528|C0205386|C0450371|C0450371|C0018563|C0183086|C0450371|C0018563|C0183086|C0015450|C0024861|C0441833|C0369773|C0205197|C0036375|C0450371|G0000000|C0450371|C0018563|C0183086|C0450371|C0018563|C0183086|C0015450|C0024861|C0369773
We plan to recruit Group Health members who have made visits to their primary care physician for low back pain and whose pain has persisted for at least three months.,We plan recruit Group Health visits primary care physician low pain pain persisted months.,G0000000|C0270724|G0000000|C0441833|C0018684|C0545082|C0205225|C1947933|C0031831|C0205251|C0030193|C0030193|G0000000|C0439231
(A) Survival with WHO performance score ≤ 2 and (B) overall survival after observation or adjuvant whole-brain radiotherapy (WBRT).,(A) Survival WHO performance score ≤ 2 (B) survival observation adjuvant whole-brain radiotherapy (WBRT).,G0000000|C0038952|G0000000|C0597198|C0449820|G0000000|G0000000|G0000000|C0038952|C0302523|C0001551|C1269537|C0034619|C1520143
Participants were 445 parents of male and female adolescents (ages 11 to 15 y who had not previously received the HPV vaccine) recruited from the Teen Health Center (THC).,Participants 445 parents male female adolescents (ages 11 15 received HPV vaccine) recruited Teen Health Center (THC).,C0679646|C1442061|C0030551|C0086582|C0015780|C0205653|C0001779|C0450371|C0450371|C1514756|C0021344|C0042210|G0000000|C0205653|C0018684|C0205099|C0039663
"To be eligible, participants must be less than 20 weeks gestation at the time of recruitment, have asthma which has been previously diagnosed by a doctor and is not currently in remission (remission defined as no asthma symptoms and no use of asthma medications in previous year), aged 18–45 years, expected to give birth to a singleton and be able to speak English.","To eligible, participants 20 weeks gestation time recruitment, asthma diagnosed doctor remission (remission defined asthma symptoms asthma medications previous year), aged 18–45 years, expected birth singleton speak English.",C0040363|C1548635|C0679646|C0450371|C0439230|C0032961|C0040223|C2949735|C0004096|C0011900|C0031831|C0544452|C0544452|C1704788|C0004096|C0683368|C0004096|C0013227|C0205156|C0439234|C0001779|G0000000|C0439234|C1517001|C0005615|C0481462|C0234856|C0376245
"In addition, the stroke patients must be capable of standing and walking without manual assistance for extended period of time assessed by FAC ≥ 4 and Berg Balance Scale, BBS ≥ 40.","In addition, stroke patients capable standing walking manual assistance extended period time assessed FAC ≥ 4 Berg Balance Scale, BBS ≥ 40.",G0000000|C0332287|C0038454|C0030705|C2698977|C0231472|C0080331|C0024763|C0018896|C0231448|C0439531|C0040223|C1516048|G0000000|G0000000|C0014653|C0175659|G0000000
"From March, 2006 through December, 2008, 112 patients were randomized into the trial at 10 hospitals in 8 clinical centers (see Appendix).","From March, 2006 December, 2008, 112 patients randomized trial 10 hospitals 8 clinical centers (see Appendix).",G0000000|C3829202|G0000000|C3830550|G0000000|C1442061|C0030705|C0034656|C0008976|C0450371|C0019994|G0000000|C0205210|C0205099|C0042789|C0003617
"Patients who are under the age of 18 years or who have not had asthma symptoms (wheeze, chest tightness and/or use of their reliever asthma medication) in the last year will be excluded.","Patients age 18 asthma symptoms (wheeze, chest tightness and/or reliever asthma medication) excluded.",C0030705|C0001779|C0450371|C0004096|C0683368|C0043144|C0817096|C0439816|G0000000|G0000000|C0004096|C0013227|C1554077
All patients were current or previous cigarette smokers with a smoking history of ≥10 pack-years.,All patients current previous cigarette smokers smoking history ≥10 pack-years.,G0000000|C0030705|C0521116|C0205156|C0677453|C0337664|C0037369|C0019664|G0000000|C1277691
"At the baseline visit, 56 (51.9%) of azithromycin participants and 43 (39.8%) of placebo participants had Pa-positive cultures.","At baseline visit, 56 (51.9%) azithromycin participants 43 (39.8%) placebo participants Pa-positive cultures.",G0000000|C0168634|C0545082|C0450371|C0450371|C0052796|C0679646|C0450371|C0450371|C0032042|C0679646|C0030428|C0010453
"There is no generally accepted quantitative definition of sleep disturbance or insomnia in the AD population, although one has recently been proposed by a group of AD sleep investigators.48 For the purpose of this study, sleep disturbance was defined as averaging less than 7 hours of total time immobile (ie, 0 activity counts) between 8:00 PM and 8:00 AM during the screening period of at least 1 week plus 2 or more episodes per week of nighttime behaviors as reported by the caregiver on the Sleep Disorders Inventory (SDI), a scale developed specifically for this protocol.","There accepted quantitative definition sleep disturbance insomnia AD population, proposed AD sleep investigators.48 For purpose study, sleep disturbance defined averaging 7 hours total time immobile (ie, 0 activity counts) 8:00 PM 8:00 AM screening period 1 week 2 episodes week nighttime behaviors reported caregiver Sleep Disorders Inventory (SDI), scale developed protocol.",G0000000|C1272684|C0392762|C1550452|C0037313|C2699787|C0917801|G0000000|C0032659|C1553874|G0000000|C0037313|C0035173|G0000000|C1285529|C0557651|C0037313|C2699787|C1704788|C1510992|G0000000|C0439227|C0439175|C0040223|C0231441|G0000000|G0000000|C0205177|C0439157|C0450371|C0030266|C0450371|G0000000|C0220908|C0439531|G0000000|C0332174|G0000000|C0332189|C0332174|C0240526|C0004927|C0684224|C0085537|C0037313|C0012634|C0021941|C0683833|C0175659|G0000000|C0442711
Males and females with a histologically verified diagnosis of a primary squamous cell carcinoma of the oral cavity or the oropharynx are eligible.,Males females histologically verified diagnosis primary squamous cell carcinoma oral cavity oropharynx eligible.,C0086582|C0015780|C0205462|C1711411|C0011900|C0205225|C1182670|C0007634|C0007097|C0442027|C0011334|C0521367|C1548635
"[22, 23] Among cancer patients, high levels of perceived vulnerability are associated with greater motivation to quit[24] and smoking cessation.","[22, 23] Among cancer patients, levels perceived vulnerability motivation quit[24] smoking cessation.",C0450371|C0450371|G0000000|C0006826|C0030705|C0441889|C0030971|G0000000|C0026605|C0748223|C0037369|C1880019
"Eligible patients submitted tissue to confirm histologic diagnosis (EOC or primary peritoneal carcinoma [PPC]) and International Federation of Gynecology and Obstetrics stage (III or IV), with either optimal (≤ 1 cm) or suboptimal residual disease.","Eligible patients submitted tissue confirm histologic diagnosis (EOC primary peritoneal carcinoma [PPC]) International Federation Gynecology Obstetrics stage (III IV), optimal (≤ 1 cm) suboptimal residual disease.",C1548635|C0030705|C1515023|C0040300|C0521093|C0205462|C0011900|G0000000|C0205225|C0031153|C0007097|C1514428|C1512888|G0000000|C0018417|C0028773|C0205390|C0439070|C0022326|C2698651|G0000000|G0000000|G0000000|C2984009|C1609982|C0012634
See Table 2 for detailed information.,See Table 2 detailed information.,C0042789|C0039224|G0000000|C1522508|C1533716
"Patients who underwent extensive surgery (defined as complete excision of the entire lesion including margins of non-necrotic tissue, with either direct closure or the use of a SSG or a vascularised skin and tissue flap for reconstruction or to cover the defect) were excluded from the formal analysis.","Patients underwent extensive surgery (defined complete excision entire lesion including margins non-necrotic tissue, direct closure SSG vascularised skin tissue flap reconstruction cover defect) excluded formal analysis.",C0030705|G0000000|C0205231|C0038894|C1704788|C0205197|C0015252|C0439751|C0221198|C0332257|C0205284|C1518422|C0040300|C0439851|C0185003|C0003383|C0042382|C0444099|C0040300|C0038925|C0020912|C0180153|C1457869|C1554077|C0348078|C0002778
"Two public sector ambulatory HIV clinics in central Mozambique (Beira Central Hospital and Chimoio Provincial Hospital), the region that has consistently had the highest adult HIV prevalence in Mozambique, were the setting for this study.","Two public sector ambulatory HIV clinics central Mozambique (Beira Central Hospital Chimoio Provincial Hospital), region consistently adult HIV prevalence Mozambique, setting study.",C0205448|G0000000|C1708237|C0439841|C0019682|C0442592|C0205099|C0026655|C3346612|C0205099|C0019994|G0000000|G0000000|C0019994|C0017446|G0000000|C0001675|C0019682|C0033105|C0026655|C0542559|C0557651
Patients will be equally randomized to either roflumilast treatment or placebo in a 1:1 ratio by means of a computerized central randomization system IVRS/IWRS.,Patients equally randomized roflumilast treatment placebo 1:1 ratio computerized central randomization system IVRS/IWRS.,C0030705|G0000000|C0034656|C0965618|C0039798|C0032042|G0000000|C0456603|G0000000|C0205099|C0034656|C0449913|C3890944
"In the loose control group, the median time in range was 90%; for the tight control group, the median time in range was 44%.","In loose control group, median time range 90%; tight control group, median time range 44%.",G0000000|C0205407|C0243148|C0441833|C0549183|C0040223|C1514721|C0450371|C0439816|C0243148|C0441833|C0549183|C0040223|C1514721|C0450371
Objectives To assess the effectiveness of a multiple intervention aimed at reducing antibiotic prescription rates for symptoms of the respiratory tract in primary care.,Objectives To assess effectiveness multiple intervention aimed reducing antibiotic prescription rates symptoms respiratory tract primary care.,C0018017|C0040363|C1516048|C1280519|C0439064|C0886296|C1947946|C0392756|C0003232|C0033080|C0871208|C0683368|C0521346|C1185740|C0205225|C1947933
"To allow for practices dropping out, 15 practices were sought for each group, a total of 60 practices.","To practices dropping out, 15 practices sought group, total 60 practices.",C0040363|C0237607|C1705648|C0439787|C0450371|C0237607|G0000000|C0441833|C0439175|C0450371|C0237607
"Exclusion criteria were: (a) pre-existing clinical conditions such as diabetes, hypertension, autoimmune diseases, asthma, allergies, renal or hepatic diseases, viral, bacterial or protozoan infection, anemia (hemoglobin, Hb < 10 g/L); (b) twin pregnancies; (c) pregnancy disease and preterm deliveries; (d) smoking more than 10 cigarettes per day; (e) use of other probiotics during the study protocol.","Exclusion criteria were: (a) pre-existing clinical conditions diabetes, hypertension, autoimmune diseases, asthma, allergies, renal hepatic diseases, viral, bacterial protozoan infection, anemia (hemoglobin, Hb < 10 g/L); (b) twin pregnancies; (c) pregnancy disease preterm deliveries; (d) smoking 10 cigarettes day; (e) probiotics study protocol.",C0680251|C0243161|G0000000|G0000000|C2347662|C0205210|C0012634|C0011847|C0020538|C0443146|C0012634|C0004096|C0020517|C0022646|C0205054|C0012634|C0521026|C0521009|C0033739|C0009450|C0002871|C0019046|C0019046|G0000000|C0450371|C0439294|G0000000|C0041427|C0032961|G0000000|C0032961|C0012634|C0151526|C0011209|C0073187|C0037369|C0450371|C0677453|C0332173|G0000000|C0525033|C0557651|C0442711
"At screening, subjects had to demonstrate a visual analog scale (VAS) score between 40 and 70 mm during the most painful knee movement, and Lequesne's Functional Index (LFI) score greater than 7 points after 7-day withdrawal of usual medication.","At screening, subjects demonstrate visual analog scale (VAS) score 40 70 mm painful knee movement, Lequesne's Functional Index (LFI) score 7 7-day withdrawal usual medication.",G0000000|C0220908|C0681850|G0000000|C0234621|C0243071|C0175659|C0042815|C0449820|C0450371|C0450371|G0000000|C0030193|C0022742|C0026649|G0000000|C0205245|C0918012|G0000000|C0449820|G0000000|C0332173|C2349954|C3538928|C0013227
"Women were excluded if they were under 18 years of age, unable to speak Finnish, had multiple pregnancy, gestational or type 1 or 2 diabetes, physical restriction preventing PA, substance abuse, treatment or clinical history of any psychiatric or other illness.","Women excluded 18 years age, unable speak Finnish, multiple pregnancy, gestational type 1 2 diabetes, physical restriction preventing PA, substance abuse, treatment clinical history psychiatric illness.",C0043210|C1554077|G0000000|C0001779|C1299582|C0234856|C1711254|C0439064|C0032961|C0439671|C0332307|G0000000|G0000000|C0011847|C0031809|C0443288|C0309872|C0030428|C0439861|C0013146|C0039798|C0205210|C0019664|C0205487|C0221423
"A randomised controlled trial tested our hypothesis in Lasbela, one of the poorest districts of Balochistan province in Pakistan.","A randomised controlled trial tested hypothesis Lasbela, poorest districts Balochistan province Pakistan.",G0000000|G0000000|C2587213|C0008976|C0392366|C1512571|G0000000|C0032854|G0000000|G0000000|C1514578|C0030211
The prevalence of stroke is increasing [1].,The prevalence stroke increasing [1].,G0000000|C0033105|C0038454|C0442808|G0000000
"Though residing in 42 states and 4 Canadian provinces, girls were recruited from a single youth-oriented website.","Though residing 42 4 Canadian provinces, girls recruited single youth-oriented website.",G0000000|C2982691|C0450371|G0000000|C0238884|C1514578|C0870604|G0000000|C0037179|C0001578|C2349146
The Health Professionals Follow-Up Study (HPFS) and the Nurses' Health Study (NHS) cohorts provided data for our analyses of toenail selenium concentrations and bladder cancer risk.,The Health Professionals Follow-Up Study (HPFS) Nurses' Health Study (NHS) cohorts provided data analyses toenail selenium concentrations bladder cancer risk.,G0000000|C0018684|C0679924|C0589120|C0557651|C0439530|C0028661|C0018684|C0557651|C0796085|C0599755|C1999230|C1511726|C0002778|C0222007|C0036581|C0086045|C0005682|C0006826|C0035647
"Eligibility requirements stipulated that couples were age 18 and above, living together, and expecting a first child at recruitment.","Eligibility requirements stipulated couples age 18 above, living together, expecting child recruitment.",C0013893|C1514873|G0000000|C0010222|C0001779|C0450371|C1282910|C0376558|C1883357|G0000000|C0008059|C2949735
"(ver 1.0, may 2004; Saghaei) The inclusion criteria for the patients were: confirmed cutaneous leishmaniasis with direct smear, no history of systemic or topical therapy for cutaneous leishmaniasis, absence of the malnutrition or severe predisposing disease such as cardiac, renal or hepatic disease and other contraindication for glucantime.","(ver 1.0, 2004; Saghaei) The inclusion criteria patients were: confirmed cutaneous leishmaniasis direct smear, history systemic topical therapy cutaneous leishmaniasis, absence malnutrition severe predisposing disease cardiac, renal hepatic disease contraindication glucantime.",C0302357|G0000000|G0000000|G0000000|G0000000|C0007637|C0243161|C0030705|G0000000|C0521093|C0221912|C0023281|C0439851|C0444186|C0019664|C0205373|C0332237|C0039798|C0221912|C0023281|C0332197|C0162429|C0205082|C0231203|C0012634|C0018787|C0022646|C0205054|C0012634|C0522473|C0061366
Patients who had taken SPS in the 7 days before their initial visit were eligible if their serum potassium level measured for their regular follow-up was from 4.5 to 5.5 mEq/L (multiply by 1 to convert to millimoles per liter) inclusively and from 5.0 to 5.9 mEq/L inclusively after a 7-day washout period (day of randomization).,Patients SPS 7 days initial visit eligible serum potassium level measured regular follow-up 4.5 5.5 mEq/L (multiply 1 convert millimoles liter) inclusively 5.0 5.9 mEq/L inclusively 7-day washout period (day randomization).,C0030705|C3813609|G0000000|C0439228|C0205265|C0545082|C1548635|C0229671|C0032821|C0441889|C0444706|C0205272|C0589120|G0000000|G0000000|C0439375|C1719797|G0000000|G0000000|C0439190|C0475211|G0000000|G0000000|G0000000|C0439375|G0000000|C0332173|C1710661|C0439531|C0332173|C0034656
"We excluded children who had signs of severe pneumonia or disease (cyanosis, convulsions, inability to drink, difficult to wake, severe malnutrition, stridor), other conditions requiring antibiotic treatment, clinically recognised congenital heart disease, chronic systemic disorders, a history of repeated wheezing or asthma, been hospitalised in the previous two weeks, taken antibiotics in the previous two days, measles within the previous month, or a history of penicillin allergy and those already enrolled in the study.","We excluded children signs severe pneumonia disease (cyanosis, convulsions, inability drink, difficult wake, severe malnutrition, stridor), conditions requiring antibiotic treatment, clinically recognised congenital heart disease, chronic systemic disorders, history repeated wheezing asthma, hospitalised previous weeks, antibiotics previous days, measles previous month, history penicillin allergy enrolled study.",G0000000|C1554077|C0008059|C0220912|C0205082|C0032285|C0012634|C0010520|C0036572|G0000000|C0452428|C0332218|C0442696|C0205082|C0162429|C0038450|C0012634|G0000000|C0003232|C0039798|G0000000|G0000000|C0009678|C0018787|C0012634|C0205191|C0205373|C0012634|C0019664|C0205341|C0043144|C0004096|G0000000|C0205156|C0439230|C0003232|C0205156|C0439228|C0025007|C0205156|C0332177|C0019664|C0030827|C0002111|G0000000|C0557651
"The intervention is discontinued at the participant’s request or if interventions are no longer possible due to the separation of the mother and child (>3 months) or any other serious harm (severe illnesses of either mother or child, death of participants) preventing study participation.","The intervention discontinued participant’s request interventions separation mother child (>3 months) harm (severe illnesses mother child, death participants) preventing study participation.",G0000000|C0886296|C1444662|G0000000|C1272683|C0886296|C0036679|C0026591|C0008059|G0000000|C0439231|G0000000|C0205082|C0221423|C0026591|C0008059|C0011065|C0679646|C0309872|C0557651|C0679823
"Among American Indian centers, 3 were in each BMI group.","Among American Indian centers, 3 BMI group.",G0000000|C0596070|C1524069|C0205099|G0000000|G0000000|C0441833
The same eligibility criteria (women of reproductive age with a child less than six years of age) were used in the selection of clients and non-clients.,The eligibility criteria (women reproductive age child age) selection clients non-clients.,G0000000|C0013893|C0243161|C0043210|C0035150|C0001779|C0008059|C0001779|C0036576|C0008942|C1518422
Participants were pre-screened over the telephone.,Participants pre-screened telephone.,C0679646|C0332152|C0039457
"A total of 152 women were randomly assigned to one of the two diets, 76 in each group.","A total 152 women randomly assigned diets, 76 group.",G0000000|C0439175|C1442061|C0043210|G0000000|C1516050|C0012155|C0450371|C0441833
These children were receiving continuing chemotherapy for acute lymphoblastic leukaemia or were within six months of completing chemotherapy.,These children receiving continuing chemotherapy acute lymphoblastic leukaemia months completing chemotherapy.,G0000000|C0008059|C1514756|C0549178|C0013216|C0205178|C0229613|C0023418|C0439231|C0205197|C0013216
"Toddlers in Norway spend much of their time in kindergarten [17]; food and feeding practices in kindergartens influence children’s diet and eating habits, which in turn affects public health [18].","Toddlers Norway spend time kindergarten [17]; food feeding practices kindergartens influence children’s diet eating habits, public health [18].",C0682053|C0028423|C0680968|C0040223|C0681406|C0450371|C0016452|C0204695|C0237607|C0681406|C4054723|G0000000|C0012155|C0013470|C0018464|G0000000|C0018684|C0450371
"Active trachoma affecting mostly children, patients to be recruited were children.1,3,5,11 They could be enrolled if aged 1–10 years with trachomatous inflammation: TF+TI0 (trachomatous inflammation − follicular) or TF+TI+ (trachomatous inflammation − follicular and intense) on the simplified WHO grading system.21 The exclusion criteria were as follows: trichiasis or corneal opacity; fibrosis with palpebral deformation; ocular abnormality; ocular infection; organic amblyopia; hypersensitivity to the investigational product; immunosuppressive conditions; systemic steroids, or ophthalmic systemic antibiotics, or topical treatments, or systemic non‐steroidal anti‐inflammatory drugs prior to the study.","Active trachoma children, patients recruited children.1,3,5,11 They enrolled aged 1–10 years trachomatous inflammation: TF+TI0 (trachomatous inflammation − follicular) TF+TI+ (trachomatous inflammation − follicular intense) simplified WHO grading system.21 The exclusion criteria follows: trichiasis corneal opacity; fibrosis palpebral deformation; ocular abnormality; ocular infection; organic amblyopia; hypersensitivity investigational product; immunosuppressive conditions; systemic steroids, ophthalmic systemic antibiotics, topical treatments, systemic non‐steroidal anti‐inflammatory drugs prior study.",C0205177|C0040592|C0008059|C0030705|G0000000|C0008059|G0000000|G0000000|C0001779|G0000000|C0040592|C0021368|C4048299|C0040592|C0021368|G0000000|C0439682|C4048299|C0040592|C0021368|G0000000|C0439682|C0522510|G0000000|G0000000|C0441800|C0449913|G0000000|C0680251|C0243161|C0332283|C0221259|C0010031|C0029053|C0016059|C0015426|C0333067|C0015392|C1704258|C0015392|C0009450|C0747055|C0002418|C0020517|C1517586|C1514468|C0021081|C0012634|C0205373|C0038317|C0015392|C0205373|C0003232|C0332237|C0087111|C0205373|G0000000|G0000000|C0013227|C0332152|C0557651
"In each instance, both twins were randomised to the same group.","In instance, twins randomised group.",G0000000|C1550608|C0041427|G0000000|C0441833
Outcomes were self‐reported joint symptoms and psychosocial measures.,Outcomes self‐reported joint symptoms psychosocial measures.,C1274040|G0000000|C0022417|C0683368|C0542298|C0079809
"Adolescents were included in the study if they met any of the following substance use screening criteria: (1) in the year before incarceration they (1a) used marijuana or drank regularly (at least monthly) or (1b) drank heavily (five or more standard drinks for boys, four or more standard drinks for girls) at least once, (2) they used marijuana or drank in the 4 weeks before the offense for which they were incarcerated, or (3) they used marijuana or drank in the 4 weeks before they were incarcerated.","Adolescents included study met substance screening criteria: (1) incarceration (1a) marijuana drank regularly (at monthly) (1b) drank heavily (five standard drinks boys, standard drinks girls) once, (2) marijuana drank 4 weeks offense incarcerated, (3) marijuana drank 4 weeks incarcerated.",C0205653|C0332257|C0557651|C0268621|C0439861|C0220908|C0243161|G0000000|C0205255|C1420849|C0024808|C0452428|G0000000|G0000000|C0332177|C1420850|C0452428|G0000000|C0205451|C1442989|C0452428|C0870221|C1442989|C0452428|C0870604|G0000000|G0000000|C0024808|C0452428|G0000000|C0439230|G0000000|C0392751|G0000000|C0024808|C0452428|G0000000|C0439230|C0392751
Fifty-six female FMS patients who were admitted to the FMS Out-patient Clinic of the Physical Medicine and Rehabilitation Department of our institution were invited to participate in the study.,Fifty-six female FMS patients admitted FMS Out-patient Clinic Physical Medicine Rehabilitation Department institution invited participate study.,C3816723|C0015780|G0000000|C0030705|C0184666|G0000000|C0029921|C0002424|C0031809|C0013227|C0034991|C1704729|C0018704|G0000000|G0000000|C0557651
Median age was 61 years (35-75 years) in TP group and 63 years (32-75 years) in CF group.,Median age 61 (35-75 years) TP 63 (32-75 years) CF group.,C0549183|C0001779|C0450371|C0450371|C0439234|C0036183|C0450371|C0450371|C0439234|C0009738|C0441833
"Patients considered for inclusion were 18 to 65 years of age, able to understand and read Spanish, fulfilled the criteria for FM according to the American College of Rheumatology [18], had undergone no psychological treatment during the preceding two years, were receiving no pharmacological treatment at that time or were willing to discontinue it for two weeks before the start of the study, and had signed an informed consent statement.","Patients considered inclusion 18 65 age, understand read Spanish, fulfilled criteria FM American College Rheumatology [18], undergone psychological treatment preceding years, receiving pharmacological treatment time discontinue weeks start study, signed informed consent statement.",C0030705|C0750591|C0007637|C0450371|C0450371|C0001779|C0162340|C0034754|C0086409|C1550543|C0243161|C3540627|C0596070|C0557806|C0035452|C0450371|G0000000|C0205486|C0039798|C0332152|C0439234|C1514756|C0031330|C0039798|C0040223|C1444662|C0439230|C0439659|C0557651|C1519316|C1522154|C1511481|C1710187
"Enrollment occurred between July of 2005 and October of 2008, and included (89 randomized) individuals between the ages of 18 and 65 who were HIV-seropositive, prescribed antiretroviral therapy for HIV, endorsed a history of injection drug use, were currently enrolled in opioid treatment for at least one month, and met criteria for a diagnosis of current or subsyndromal depressive mood disorder (72 major depressive disorder; 1 dysthymia; 16 bipolar disorder, most recent episode depressed).","Enrollment occurred July 2005 October 2008, included (89 randomized) individuals ages 18 65 HIV-seropositive, prescribed antiretroviral therapy HIV, endorsed history injection drug use, enrolled opioid treatment month, met criteria diagnosis current subsyndromal depressive mood disorder (72 major depressive disorder; 1 dysthymia; 16 bipolar disorder, episode depressed).",C1516879|C1709305|C3829447|G0000000|C3828732|G0000000|C0332257|C0450371|C0034656|C0027361|C0001779|C0450371|C0450371|C0019699|C0278329|G0000000|C0039798|C0019682|G0000000|C0019664|C0021485|C0013227|C0042153|G0000000|C0242402|C0039798|C0332177|C0268621|C0243161|C0011900|C0521116|G0000000|G0000000|C0026516|C0012634|C0450371|C0205082|G0000000|C0012634|G0000000|C0013415|C0450371|C0443156|C0012634|C0332189|C0344315
"All patients were required to have asthma, as defined by the American Thoracic Society criteria (including symptoms of wheeze, episodic cough, and dyspnea) [12], with a pre-bronchodilator forced expiratory volume in 1 second (FEV1; measured on arrival in the acute setting) ≥30% and ≤55% of predicted normal.","All patients required asthma, defined American Thoracic Society criteria (including symptoms wheeze, episodic cough, dyspnea) [12], pre-bronchodilator forced expiratory volume 1 (FEV1; measured arrival acute setting) ≥30% ≤55% predicted normal.",G0000000|C0030705|C1514873|C0004096|C1704788|C0596070|G0000000|C0037455|C0243161|C0332257|C0683368|C0043144|C1455761|C0010200|C0013404|C0450371|C2599602|C0441722|C0231800|C0449468|G0000000|G0000000|C0444706|C1555577|C0205178|C0542559|G0000000|G0000000|C0681842|C0205307
"The trial was carried out in maternity health centers (MHC) in Helsinki, Finland.","The trial carried maternity health centers (MHC) Helsinki, Finland.",G0000000|C0008976|C0206243|C0681108|C0018684|C0205099|C4049595|G0000000|C0016132
"Demographics included ages from 17 to 35 years, time since injury from 6 months to 17 years, lesion level between C5 to C7, time playing rugby from 3 months to 16 years, and rugby classification from .5 to 3.5.40 Eleven subjects had complete lesions, 11 had incomplete lesions, 1 had spastic cerebral palsy, and 1 had congenital upper and lower limb deformities.","Demographics included ages 17 35 years, time injury 6 months 17 years, lesion level C5 C7, time playing rugby 3 months 16 years, rugby classification .5 3.5.40 Eleven subjects complete lesions, 11 incomplete lesions, 1 spastic cerebral palsy, 1 congenital upper lower limb deformities.",C0011298|C0332257|C0001779|C0450371|C0450371|C0439234|C0040223|C3263722|G0000000|C0439231|C0450371|C0439234|C0221198|C0441889|G0000000|G0000000|C0040223|C0032214|C0035945|G0000000|C0439231|C0450371|C0439234|C0035945|C0008902|G0000000|C0450371|C0205457|C0681850|C0205197|C0221198|C0450371|C0205257|C0221198|G0000000|C0026838|G0000000|C0522224|G0000000|C0009678|C1282910|C0441994|C0015385|C0000768
"Key inclusion criteria are: patient’s written informed consent; 60 years or older at time of informed consent; patients with primary or secondary AML according to WHO who are not expected to benefit from standard remission-induction chemotherapy; <30.000 leukocytes/μl and performance status ECOG 0, 1, 2.","Key inclusion criteria are: patient’s written informed consent; 60 time informed consent; patients primary secondary AML WHO expected benefit standard remission-induction chemotherapy; <30.000 leukocytes/μl performance status ECOG 0, 1, 2.",G0000000|C0007637|C0243161|G0000000|G0000000|C0043266|C1522154|C1511481|C0450371|C0040223|C1522154|C1511481|C0030705|C0205225|C0027627|C0023467|G0000000|C1517001|C0814225|C1442989|C0035052|C0013216|C0450371|G0000000|C0597198|C0449438|C0430797|G0000000|G0000000|G0000000
REDUCE‐IT enrolled men or women age ≥45 years with established cardiovascular disease or age ≥50 years with diabetes mellitus and 1 additional risk factor.,REDUCE‐IT enrolled women age ≥45 years established cardiovascular disease age ≥50 years diabetes mellitus 1 additional risk factor.,G0000000|G0000000|C0043210|C0001779|G0000000|C0443211|C0007226|C0012634|C0001779|G0000000|C0011847|G0000000|G0000000|C1524062|C0035647|C1521761
"All concomitant medications were allowed throughout the study, including immune modulators and immunosuppressive drugs provided they were introduced at least 3 months before inclusion (⩾1 month for fampridine).","All concomitant medications allowed study, including immune modulators immunosuppressive drugs provided introduced 3 months inclusion (⩾1 month fampridine).",G0000000|C0521115|C0013227|C0683607|C0557651|C0332257|C0439662|C1709060|C0021081|C0013227|C1999230|C1292748|G0000000|C0007637|G0000000|C0000477
Breast cancer characteristics were obtained from the Danish Breast Cancer Group—clinical database.25 Cohabitation status and age were obtained from the Civil Registration System.26 The required sample size was calculated based on a 7‐point difference in the change from T1 to T2 between the randomised groups on the IES Total measure.,Breast cancer characteristics Danish Breast Cancer Group—clinical database.25 Cohabitation status age Civil Registration System.26 The required sample size calculated based 7‐point difference change T1 T2 randomised IES Total measure.,C0006141|C0006826|C1521970|G0000000|C0006141|C0006826|G0000000|C0242356|C0221179|C0449438|C0001779|G0000000|C1514821|C0449913|G0000000|C1514873|C0370003|C0456389|C0444686|C1527178|G0000000|C1705241|C0392747|C0041403|C0041403|G0000000|G0000000|C0439175|C0079809
"Inclusion criteria were parental informed consent and permanent residence in the study area; exclusion criteria were conditions requiring hospital admission, signs of hepatic or renal dysfunction, and reported allergy to sulfa-containing drugs.","Inclusion criteria parental informed consent permanent residence study area; exclusion criteria conditions requiring hospital admission, signs hepatic renal dysfunction, reported allergy sulfa-containing drugs.",C0007637|C0243161|C0030551|C1522154|C1511481|C0205355|C0237096|C0557651|C0017446|C0680251|C0243161|C0012634|G0000000|C0019994|C0184666|C0220912|C0205054|C0022646|C0031847|C0684224|C0002111|C0749139|C0013227
Average time since diagnosis was 2 years and mean BMI was 42.3 kg/m2 [11].,Average time diagnosis 2 BMI 42.3 kg/m2 [11].,C1510992|C0040223|C0011900|G0000000|G0000000|C0450371|C0022718|C0450371
"The mean age in Group 1 was 25.07 ± 6 years and in Group 2, it was 23.05 ± 5.7 years.","The age Group 1 25.07 ± 6 Group 2, 23.05 ± 5.7 years.",G0000000|C0001779|C0441833|G0000000|C0450371|G0000000|G0000000|C0441833|G0000000|C0450371|G0000000|G0000000|C0439234
All counselling was carried out by three dental hygienists who had been educated and trained in smoking cessation support methods in general and especially for the specific programmes used in this study.,All counselling carried dental hygienists educated trained smoking cessation support methods specific programmes study.,G0000000|C0010210|C0206243|C0011365|C0011369|C0039401|C0336809|C0037369|C1880019|C0183683|C0025663|C0205369|G0000000|C0557651
"2686 people (2037 men and 649 women) aged 65-85 years living in the general community, recruited from the British doctors register and a general practice register in Suffolk.","2686 people (2037 649 women) aged 65-85 living community, recruited British doctors register practice register Suffolk.",G0000000|C0027361|G0000000|C1442061|C0043210|C0001779|C0450371|C0376558|C0009462|G0000000|C0596227|C0031831|G0000000|C0237607|G0000000|C0324140
Melatonin (up to 3 mg) at bedtime was permitted to treat insomnia.,Melatonin (up 3 mg) bedtime permitted treat insomnia.,C0025219|G0000000|G0000000|C0026410|C0521112|C0329040|C0087111|C0917801
"Subjects were excluded if they had asthma or respiratory disorders other than COPD; recent (≤12 months) lung resection; clinically significant abnormal chest X-ray, laboratory, Holter, or electrocardiogram (ECG) finding at screening; recent (≤12 weeks) hospitalization for COPD; recent (≤6 weeks) acute worsening of COPD requiring treatment with corticosteroids or antibiotics or lower respiratory tract infection requiring antibiotics; noncompliance, COPD exacerbation, or lower respiratory tract infection during the run-in period; cancer not in complete remission for ≥5 years; long-term or nocturnal oxygen therapy (>12 h/day); or other diseases or contraindications that would put the subject at risk.","Subjects excluded asthma respiratory disorders COPD; (≤12 months) lung resection; clinically abnormal chest X-ray, laboratory, Holter, electrocardiogram (ECG) finding screening; (≤12 weeks) hospitalization COPD; (≤6 weeks) acute worsening COPD requiring treatment corticosteroids antibiotics lower respiratory tract infection requiring antibiotics; noncompliance, COPD exacerbation, lower respiratory tract infection run-in period; cancer complete remission ≥5 years; long-term nocturnal oxygen therapy (>12 h/day); diseases contraindications subject risk.",C0681850|C1554077|C0004096|C0521346|C0012634|C0024117|G0000000|C0439231|C0024109|C0015252|G0000000|C0205161|C0817096|C0034571|C0022877|G0000000|C0013798|C1623258|C0037088|C0220908|G0000000|C0439230|C0019993|C0024117|G0000000|C0439230|C0205178|C0332271|C0024117|G0000000|C0039798|C0001617|C0003232|C0441994|C0521346|C1185740|C0009450|G0000000|C0003232|C0376405|C0024117|G0000000|C0441994|C0521346|C1185740|C0009450|C3274438|C0439531|C0006826|C0205197|C0544452|G0000000|C0439234|C0443252|C0240526|C0030054|C0039798|C0450371|C0033727|C0012634|C0079164|C0681850|C0035647
"Although there is no universally accepted HCC staging system, many have adopted the Barcelona Clinic Liver Cancer (BCLC) staging classification, which links the stage of the disease to a specific treatment strategy [4,5].","Although universally accepted HCC staging system, Barcelona Clinic Liver Cancer (BCLC) staging classification, links stage disease specific treatment strategy [4,5].",G0000000|G0000000|C1272684|C2239176|C0332305|C0449913|G0000000|C0002424|C0023884|C0006826|G0000000|C0332305|C0008902|C1517892|C0205390|C0012634|C0205369|C0039798|C0679199|G0000000
For unilateral children the unaffected foot is free and for bilateral children a pair of FAS was needed at night.,For unilateral children unaffected foot free bilateral children pair FAS night.,G0000000|C0205092|C0008059|C2986417|C0016504|C0332296|C0238767|C0008059|C1709450|G0000000|C0240526
"thalassaemia, thrombophilia), thyroid disorder, psychiatric disease requiring therapy with antidepressant or antipsychotic, epilepsy).","thalassaemia, thrombophilia), thyroid disorder, psychiatric disease requiring therapy antidepressant antipsychotic, epilepsy).",C0039730|C0398623|C0040132|C0012634|C0205487|C0012634|G0000000|C0039798|C0003289|C0040615|C0014544
"Therefore, given that patients are eligible for inclusion in the CRASH-3 trial if they have sustained a traumatic brain injury and have either intracranial bleeding on a CT scan or a GCS of 12 or less, they will, by default, be physically or mentally incapable of giving consent.","Therefore, patients eligible inclusion CRASH-3 trial sustained traumatic brain injury intracranial bleeding CT scan GCS 12 less, will, default, physically mentally incapable consent.",G0000000|C0030705|C1548635|C0007637|G0000000|C0008976|C0443318|C0332663|C0006104|C3263722|C0524466|C0019080|C0007673|C0034606|G0000000|C0450371|C0439092|G0000000|C2828024|G0000000|G0000000|C1550518|C1511481
"The neonatal care units in maternity hospitals in Auckland, New Zealand.","The neonatal care units maternity hospitals Auckland, New Zealand.",G0000000|C1552240|C1947933|C0439148|C0681108|C0019994|G0000000|C0205314|G0000000
"Patients planned for bedside PDT with mild coagulation disorders (prothrombin time, PT, 14.7–20.0 seconds, and/or platelet counts 40–100×109/L) and/or active treatment with acetylsalicylic acid at any dose were eligible.","Patients planned bedside PDT mild coagulation disorders (prothrombin time, PT, 14.7–20.0 seconds, and/or platelet counts 40–100×109/L) and/or active treatment acetylsalicylic acid dose eligible.",C0030705|C1301732|G0000000|C0031740|C2945599|C0005778|C0012634|C0033706|C0040223|C0699718|G0000000|C0457385|G0000000|C0005821|C0439157|G0000000|G0000000|C0205177|C0039798|G0000000|C0001128|C0178602|C1548635
"Detailed descriptions of the rationale, design, conduct, and initial results of SELECT have been previously published.6,7 The study enrolled healthy men at average risk of prostate cancer based on a baseline PSA of ≤ 4 ng/mL and normal digital rectal exam (DRE) commencing at age 50 for African Americans or age 55 for all others.","Detailed descriptions rationale, design, conduct, initial SELECT published.6,7 The study enrolled healthy average risk prostate cancer based baseline PSA ≤ 4 ng/mL normal digital rectal exam (DRE) commencing age 50 African Americans age 55 others.",C1522508|C0678257|C0392360|C1707689|C0004927|C0205265|C1707391|C0034037|G0000000|C0557651|G0000000|C3898900|C1510992|C0035647|C0033572|C0006826|C1527178|C0168634|C3810537|G0000000|G0000000|C0439275|C0205307|C0442015|C0205052|C0582103|C1384593|C3274784|C0001779|C0450371|C0027567|C0596070|C0001779|C0450371|C1955473
At least 3 months of highly active antiretroviral therapy (HAART) was required for subjects with a CD4% <25.,At 3 months highly active antiretroviral therapy (HAART) required subjects CD4% <25.,G0000000|G0000000|C0439231|C0205250|C0205177|G0000000|C0039798|C0887947|C1514873|C0681850|C0285590|C0450371
Previous research incorporating yoga (YG) into radiotherapy (XRT) for women with breast cancer finds improved quality of life (QOL).,Previous incorporating yoga (YG) radiotherapy (XRT) women breast cancer improved quality life (QOL).,C0205156|G0000000|C0043418|C1883582|C0034619|G0000000|C0043210|C0006141|C0006826|C0184511|C0332306|C0376558|C0518214
"Still, we see observe a doubling of the consumption of rice from PDS in the KBK districts for the BPL households.","Still, observe doubling consumption rice PDS KBK districts BPL households.",G0000000|C1441672|C0205173|C0009830|C0035567|G0000000|G0000000|G0000000|G0000000|C0020052
Participants were from the Women's Healthy Eating and Living (WHEL) Study randomized trial of a dietary intervention on breast cancer recurrence/survival [58]: 3088 women (≤ 4 years post-completion of initial treatment for Stage I (≥ 1 cm)–IIIA disease).,Participants Women's Healthy Eating Living (WHEL) Study randomized trial dietary intervention breast cancer recurrence/survival [58]: 3088 women (≤ 4 post-completion initial treatment Stage I (≥ 1 cm)–IIIA disease).,C0679646|C0043210|C3898900|C0013470|C0376558|G0000000|C0557651|C0034656|C0008976|C0012155|C0886296|C0006141|C0006826|C0034897|C0450371|G0000000|C0043210|G0000000|G0000000|C0687676|C0205265|C0039798|C0205390|C0021966|G0000000|G0000000|G0000000|C0012634
"Inclusion criteria were: age 30–60 years, Expanded Disability Status Score (EDSS) between 1.5 ≥ x ≤ 6.5 (Kurtzke, 1983), Mini Mental State Examination score ≥24 (Folstein et al., 1975), ability to maintain standing position without aids for at least 1 min and ability to walk independently for at least 15 m, absence of concomitant neurological or orthopedic conditions that may interfere with ambulation.","Inclusion criteria were: age 30–60 years, Expanded Disability Status Score (EDSS) 1.5 ≥ ≤ 6.5 (Kurtzke, 1983), Mini Mental State Examination score ≥24 (Folstein al., 1975), ability maintain standing position aids 1 min ability walk independently 15 m, absence concomitant neurological orthopedic conditions interfere ambulation.",C0007637|C0243161|G0000000|C0001779|G0000000|C0439234|C0205229|C0231170|C0449438|C0449820|C0451246|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|C0445542|C0229992|C1301808|G0000000|C0449820|G0000000|G0000000|C0202311|G0000000|C0085732|C0024501|C0231472|C0733755|C0001175|G0000000|C0702093|C0085732|C0080331|G0000000|C0450371|C0369637|C0332197|C0521115|C0205494|C0029355|C0012634|C0521102|C0080331
"To assess the contributions of both microbial larvicides and ITNs in decreasing malaria transmission and infection in an integrated vector management programme we used the incidence of new Plasmodium infections in children as the primary outcome, and anopheline larval and adult abundance as secondary outcomes.","To assess contributions microbial larvicides ITNs decreasing malaria transmission infection integrated vector management programme incidence Plasmodium infections children primary outcome, anopheline larval adult abundance secondary outcomes.",C0040363|C1516048|C1880177|C0599840|G0000000|G0000000|C0442797|C0024530|C0040722|C0009450|G0000000|C0086022|C0001554|C1709697|C0021149|C0032148|C3714514|C0008059|C0205225|C1274040|G0000000|C0023047|C0001675|C2346714|C0027627|C1274040
The enrolment of patients with clinically manifest atherosclerotic cardiovascular disease was specified to comprise at least 50% of the entire study cohort.,The enrolment patients clinically manifest atherosclerotic cardiovascular disease comprise 50% entire study cohort.,G0000000|C1516879|C0030705|G0000000|C0205319|C0333482|C0007226|C0012634|C2700400|C0450371|C0439751|C0557651|C0599755
"Briefly, the cohort consists of 27,959 men and 35,298 women recruited between April 1993 and December 1998, who were permanent residents or citizens of Singapore aged 45–74 years and resided in government-built housing estates (86 % of the Singapore population resided in such facilities) at the time of enrollment.","Briefly, cohort consists 27,959 35,298 women recruited April 1993 December 1998, permanent residents citizens Singapore aged 45–74 resided government-built housing estates (86 % Singapore population resided facilities) time enrollment.",G0000000|C0599755|C0332529|C0450371|C0450371|C0043210|G0000000|C3715024|G0000000|C3830550|G0000000|C0205355|C1320928|C0682134|C0037173|C0001779|G0000000|C2982691|C0018104|C0020056|G0000000|C0450371|G0000000|C0037173|C0032659|C2982691|C1547538|C0040223|C1516879
Gemcitabine-based chemotherapy appears to be a worthwhile treatment option for pretreated patients with metastatic breast cancer.,Gemcitabine-based chemotherapy appears worthwhile treatment option pretreated patients metastatic breast cancer.,C0045093|C0013216|C0700364|G0000000|C0039798|C1518601|G0000000|C0030705|C0036525|C0006141|C0006826
"CombiRx Design & Trial Assessments Participants were between the ages of 18–60, with an Expanded Disability Status Scale (EDSS) score 0–5.5, diagnosis of RRMS by Poser or McDonald criteria, with at least 2 exacerbations in the prior three years where one exacerbation could be an MRI change meeting the 2001 McDonald MRI criteria for dissemination in time (Tables 1 & 2)7.","CombiRx Design & Trial Assessments Participants ages 18–60, Expanded Disability Status Scale (EDSS) score 0–5.5, diagnosis RRMS Poser McDonald criteria, 2 exacerbations prior exacerbation MRI change meeting 2001 McDonald MRI criteria dissemination time (Tables 1 & 2)7.",G0000000|C1707689|G0000000|C0008976|C1261322|C0679646|C0001779|G0000000|C0205229|C0231170|C0449438|C0175659|C0451246|C0449820|G0000000|C0011900|C1522002|G0000000|G0000000|C0243161|G0000000|G0000000|C0332152|G0000000|C0024485|C0392747|C0556656|G0000000|G0000000|C0024485|C0243161|C0205221|C0040223|C0039224|G0000000|G0000000|G0000000
Hypovitaminosis D is particularly common among older people with a proximal femoral (hip) fracture.,Hypovitaminosis D common people proximal femoral (hip) fracture.,C0376286|C0073187|C0205214|C0027361|C0205107|C0015811|C0019552|C0016658
"Inclusion and exclusion criteria for participation in the trial MCI = Mild Cognitive Impairment, RCT = Randomized Controlled Trial, 10 WLT = 10 Word Learning Test, TICS = Telephone Interview for Cognitive Status, MMSE = Mini Mental State Examination, GARS = Groningen Activity Restriction Scale, GDS = Geriatric Depression Scale After the baseline interview, subjects were randomly assigned to the interventions using the statistical computer program SPSS.","Inclusion exclusion criteria participation trial MCI = Mild Cognitive Impairment, RCT = Randomized Controlled Trial, 10 WLT = 10 Word Learning Test, TICS = Telephone Interview Cognitive Status, MMSE = Mini Mental State Examination, GARS = Groningen Activity Restriction Scale, GDS = Geriatric Depression Scale After baseline interview, subjects randomly assigned interventions statistical computer program SPSS.",C0007637|C0680251|C0243161|C0679823|C0008976|C0560005|G0000000|C2945599|C1516691|C0221099|G0000000|G0000000|C0034656|C2587213|C0008976|C0450371|G0000000|G0000000|C0450371|C1705313|C0013621|C0022885|C0040188|G0000000|C0039457|C0021822|C1516691|C0449438|C0451306|G0000000|C0445542|C0229992|C1301808|G0000000|C0327763|G0000000|G0000000|C0205177|C0443288|C0175659|C0451184|G0000000|C1704440|C0011570|C0175659|G0000000|C0168634|C0021822|C0681850|G0000000|C1516050|C0886296|C0038215|C0009622|C1709697|C3813609
"The trial will include 816 otherwise healthy children who are 2 to 17 years old, having had at least one previous wheezing episode, have received systemic corticosteroids, and have a Pediatric Respiratory Assessment Measure (PRAM) ≥ 5 points after three salbutamol and ipratropium treatments for a current acute asthma exacerbation.","The trial 816 healthy children 2 17 old, previous wheezing episode, received systemic corticosteroids, Pediatric Respiratory Assessment Measure (PRAM) ≥ 5 salbutamol ipratropium treatments current acute asthma exacerbation.",G0000000|C0008976|C1442061|C3898900|C0008059|G0000000|C0450371|C0580836|C0205156|C0043144|C0332189|C1514756|C0205373|C0001617|C0030755|C0521346|C1261322|C0079809|G0000000|C0001927|C0027235|C0087111|C0521116|C0205178|C0004096|G0000000
"Further, patients with a serious concurrent condition were also excluded.","Further, patients concurrent condition excluded.",C1517331|C0030705|C0205420|C0012634|C1554077
"More than 30,000 patients in two regions of Germany, who visit their general practitioner or pediatrician for respiratory tract infections will be included.","More 30,000 patients regions Germany, visit practitioner pediatrician respiratory tract infections included.",C0205172|C0450371|C0030705|C0017446|C0017480|C0545082|C1709627|C0237433|C0521346|C1185740|C3714514|C0332257
"No significant differences were found between the subjects in terms of average age, age at marriage, marriage duration, age at first pregnancy, number of pregnancies, cesarean delivery, natural labor, abortion, or curettage in the two treatment groups according to the results of the t-test and Mann-Whitney U test (Table 1).","No differences subjects terms average age, age marriage, marriage duration, age pregnancy, pregnancies, cesarean delivery, natural labor, abortion, curettage treatment t-test Mann-Whitney U test (Table 1).",G0000000|C1705241|C0681850|C0233324|C1510992|C0001779|C0001779|C0024841|C0024841|C0449238|C0001779|C0032961|C0032961|C3841297|C0011209|C0205296|C0022864|C0156543|C0010468|C0039798|C0871472|G0000000|G0000000|C0022885|C0039224|G0000000
"Main exclusion criteria were chronic diseases, history of reactions to vaccines, and history of hepatitis A or vaccination against it.","Main exclusion criteria chronic diseases, history reactions vaccines, history hepatitis A vaccination it.",C0205225|C0680251|C0243161|C0205191|C0012634|C0019664|C0443286|C0042210|C0019664|C0019158|G0000000|C0042196|G0000000
"In this study, a clear history of asthma, allergic rhinitis or atopic eczema was an exclusion criterion, while reversibility to bronchodilators was not.","In study, history asthma, allergic rhinitis atopic eczema exclusion criterion, reversibility bronchodilators not.",G0000000|C0557651|C0019664|C0004096|C0700624|C0035455|C0392707|C0013595|C0680251|C0243161|C0449261|C0006280|C1518422
"The stroke onset must be between two to seven days beforehand, with a National Institutes of Health Stroke Scale (NIHSS) score of between 4 and 24.","The stroke onset days beforehand, National Institutes Health Stroke Scale (NIHSS) score 4 24.",G0000000|C0038454|C0206132|C0439228|G0000000|C3245503|C0021622|C0018684|C0038454|C0175659|C3476804|C0449820|G0000000|C0450371
"Criteria for exclusion included antibiotic treatment over the last 48 h, hospitalization, or catheterization within the previous 2 weeks, kidney stones, diabetes, pregnancy or cranberry allergy, and a negative urine culture result.","Criteria exclusion included antibiotic treatment 48 h, hospitalization, catheterization previous 2 weeks, kidney stones, diabetes, pregnancy cranberry allergy, negative urine culture result.",C0243161|C0680251|C0332257|C0003232|C0039798|C0450371|C0033727|C0019993|C0007430|C0205156|G0000000|C0439230|C0022646|C0006736|C0011847|C0032961|C0453273|C0002111|C0205160|C0042036|C0010453|C1274040
"Prior to this lead-in study, patients had received up to 15 months of treatment with milnacipran 100 mg/day or 200 mg/day during double-blind studies [20,21,23-27], resulting in up to 4.5 years of milnacipran exposure prior to entering into the current discontinuation study.","Prior lead-in study, patients received 15 months treatment milnacipran 100 mg/day 200 mg/day double-blind studies [20,21,23-27], 4.5 milnacipran exposure prior entering current discontinuation study.",C0332152|C0023175|C0557651|C0030705|C1514756|C0450371|C0439231|C0039798|C1533126|C1442061|C0439422|C1442061|C0439422|C0013072|C0947630|C0450371|G0000000|C1533126|C0274281|C0332152|C1522196|C0521116|C0457454|C0557651
The participating nursing homes send the questionnaire with the EOLD-instruments to the family caregiver of a nursing home resident who died with dementia.,The participating nursing homes send questionnaire EOLD-instruments family caregiver nursing resident died dementia.,G0000000|C0679823|C0006147|C0442519|C1519246|C0034394|C0348000|C0015576|C0085537|C0006147|C1320928|C0011065|C0011265
"Any woman knowing of an impending, permanent move out of her community was excluded.","Any woman knowing impending, permanent move community excluded.",G0000000|C0043210|G0000000|C0332190|C0205355|C0560560|C0009462|C1554077
"These criteria include a history of widespread musculoskeletal pain on the right and left sides of the body as well as above and below the waist, with a minimum duration of 3 months, and tenderness on pressure at 11 or more of 18 specific sites (tender points), with moderate or more severe tenderness reported on digital palpation.16 We excluded persons who had participated in tai chi training within the past 6 months; those with serious medical conditions that might limit their participation; those with other diagnosed medical conditions known to contribute to fibromyalgia symptoms, such as thyroid disease, inflammatory arthritis, systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, myositis, vasculitis, or Sjögren’s syndrome; women who had a positive pregnancy test or who were planning to become pregnant during the study period; and persons who were unable to pass the Mini–Mental State Examination (i.e., those with a score less than or equal to 24 [out of 30] points).17 Participants were allowed to continue routine medications and maintain usual visits with their primary care physicians or rheumatologists throughout the study.","These criteria history widespread musculoskeletal pain left body waist, minimum duration 3 months, tenderness pressure 11 18 specific sites (tender points), moderate severe tenderness reported digital palpation.16 We excluded persons participated tai chi training 6 months; medical conditions limit participation; diagnosed medical conditions contribute fibromyalgia symptoms, thyroid disease, inflammatory arthritis, systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, myositis, vasculitis, Sjögren’s syndrome; women positive pregnancy test planning pregnant study period; persons unable pass Mini–Mental State Examination (i.e., score equal 24 [out 30] points).17 Participants allowed continue routine medications maintain usual visits primary care physicians rheumatologists study.",G0000000|C0243161|C0019664|C0205219|C0497254|C0030193|C0205091|C0242821|C0230097|C1524031|C0449238|G0000000|C0439231|C0234233|C0033095|C0450371|C0450371|C0205369|C0205145|C0234234|C1552961|C0205081|C0205082|C0234233|C0684224|C0442015|C0030247|G0000000|C1554077|C0027361|G0000000|G0000000|C1720589|C0040607|G0000000|C0439231|C0199168|C0012634|C0439801|C0679823|C0011900|C0199168|C0012634|C1880177|C0016053|C0683368|C0040132|C0012634|C0333348|C0003864|C0205373|C0024131|G0000000|C0205373|C0036429|G0000000|C0003864|C0027121|C0042384|G0000000|C0039082|C0043210|C0439178|C0032961|C0022885|C0032074|C0549206|C0557651|C0439531|C0027361|C1299582|C2828386|G0000000|C1301808|G0000000|C0683454|C0449820|C0205163|C0450371|C0439787|C0450371|C1552961|C0679646|C0683607|C0549178|C0205547|C0013227|C0024501|C3538928|C0545082|C0205225|C1947933|C0031831|C0334889|C0557651
Kaplan-Meier survival curves for IVIg and PLEX treatment in patients with myasthenia gravis.,Kaplan-Meier survival curves IVIg PLEX treatment patients myasthenia gravis.,G0000000|C0038952|C0205134|C0085297|G0000000|C0039798|C0030705|C0947912|C0205082
"Patients with metastatic breast, ovarian, or colorectal cancer whose tumors expressed HER-2 were eligible.","Patients metastatic breast, ovarian, colorectal cancer tumors expressed HER-2 eligible.",C0030705|C0036525|C0006141|C0205065|C0555952|C0006826|C0027651|G0000000|G0000000|C1548635
Main outcome measures: All cause mortality for 520 subjects in arms 1 and 2 and for 104 subjects who were randomised into these arms from arm 3.,Main outcome measures: All mortality 520 subjects arms 1 2 104 subjects randomised arms arm 3.,C0205225|C1274040|C0079809|G0000000|C0026565|C1442061|C0681850|C0206655|G0000000|G0000000|C1442061|C0681850|G0000000|C0206655|C0446516|G0000000
"Here, we propose the Exercise During and After Neoadjuvant Rectal Cancer Treatment (EXERT) trial which, to our knowledge, is the first phase II trial designed to examine the preliminary efficacy of exercise training in rectal cancer patients during and after NACRT.","Here, propose Exercise During After Neoadjuvant Rectal Cancer Treatment (EXERT) trial which, knowledge, phase II trial designed examine preliminary efficacy exercise training rectal cancer patients NACRT.",G0000000|G0000000|C0015259|G0000000|G0000000|C0600558|C0205052|C0006826|C0039798|C0015264|C0008976|G0000000|C0376554|C0205390|G0000000|C0008976|C1707689|G0000000|C0439611|C1280519|C0015259|C0040607|C0205052|C0006826|C0030705|G0000000
"BE WELL is a two-arm randomized controlled clinical trial (RCT) in which obese patients ages 18-70 years with suboptimally controlled, persistent asthma (n = 324) will be equally randomized to the WL or UC arm.","BE WELL two-arm randomized controlled clinical trial (RCT) obese patients ages 18-70 suboptimally controlled, persistent asthma (n = 324) equally randomized WL UC arm.",G0000000|C0205170|C0205448|C0034656|C2587213|C0205210|C0008976|G0000000|C0028754|C0030705|C0001779|C0450371|G0000000|C2587213|C0205322|C0004096|C0369718|G0000000|C1442061|G0000000|C0034656|G0000000|G0000000|C0446516
"Exclusion criteria were segmental Winquist types III and IV comminuted fractures, previously diagnosed neuromuscular disease (e.g., cerebral palsy), metabolic bone disorders (e.g., osteomalacia), or pathological fractures.","Exclusion criteria segmental Winquist types III IV comminuted fractures, diagnosed neuromuscular disease (e.g., cerebral palsy), metabolic bone disorders (e.g., osteomalacia), pathological fractures.",C0680251|C0243161|C0205122|G0000000|C0332307|C0439070|C0022326|C0476171|C0016658|C0011900|C1979768|C0012634|G0000000|G0000000|C0522224|C0311400|C0262950|C0012634|G0000000|C0029442|C0030664|C0016658
"Children in three cohorts - 32 HIV-infected children, 154 HIV-uninfected children born to HIV-infected mothers, and 187 uninfected children born to HIV-uninfected mothers - were separately randomly assigned to receive daily vitamin A (VA) [n = 124], vitamin A plus zinc (VAZ) [n = 123], or multiple micronutrients that included vitamin A and zinc (MM) [n = 126].","Children cohorts - 32 HIV-infected children, 154 HIV-uninfected children born HIV-infected mothers, 187 uninfected children born HIV-uninfected mothers - separately randomly assigned receive daily vitamin A (VA) [n = 124], vitamin A zinc (VAZ) [n = 123], multiple micronutrients included vitamin A zinc (MM) [n = 126].",C0008059|C0599755|G0000000|C0450371|C0019682|C0008059|C1442061|C0019682|C0008059|C0005615|C0019682|C0026591|C1442061|G0000000|C0008059|C0005615|C0019682|C0026591|G0000000|G0000000|G0000000|C1516050|C1514756|C0332173|C0042890|G0000000|C1549054|C0369718|G0000000|C1442061|C0042890|G0000000|C0043481|G0000000|C0369718|G0000000|C1442061|C0439064|C0282575|C0332257|C0042890|G0000000|C0043481|G0000000|C0369718|G0000000|C1442061
"Baseline (n = 76) and 6-month follow-up data (n = 70) from patients with CF (age ≥12 years, FEV1 ≥35%) were analysed.","Baseline (n = 76) 6-month follow-up data (n = 70) patients CF (age ≥12 years, FEV1 ≥35%) analysed.",C0168634|G0000000|C0332177|C0589120|C1511726|G0000000|C0030705|C0009738|C0001779|G0000000|C0439234|G0000000|G0000000
We followed a randomized single-blind study on sixty referred children to EEG Unit of Shahid Sadoughi Hospital from January 2010 to February 2011.,We randomized single-blind study sixty referred children EEG Unit Shahid Sadoughi Hospital January 2010 February 2011.,G0000000|C0034656|C0242570|C0557651|C3816724|C0205543|C0008059|C0013819|C0439148|G0000000|G0000000|C0019994|C3829466|G0000000|C3830166|G0000000
This is a teaching hospital and the main regional referral centre for high-risk pregnancies in Yunnan province.,This teaching hospital main regional referral centre high-risk pregnancies Yunnan province.,G0000000|C0039401|C0019994|C0205225|C0205147|C0034927|C0205099|C0332167|C0032961|G0000000|C1514578
"Candidates whose screening was successful by telephone received a clinical screening to exclude those with a high probability of lumbar radiculopathy, a specific cause of low back pain and a relative contraindication to OMT.","Candidates screening successful telephone received clinical screening exclude probability lumbar radiculopathy, specific low pain relative contraindication OMT.",G0000000|C0220908|C0597535|C0039457|C1514756|C0205210|C0220908|C0332196|C0033204|C0024090|C0700594|C0205369|C0205251|C0030193|C0080103|C0522473|G0000000
"In this study, we aimed to evaluate the effects of walking training performed with the i-Walker robotic device on walking performances of patients in the subacute phase following mild/moderate stroke.","In study, aimed evaluate effects walking training performed i-Walker robotic device walking performances patients subacute phase mild/moderate stroke.",G0000000|C0557651|C1947946|C0220825|C1280500|C0080331|C0040607|C0884358|C0021966|C0035785|C0025080|C0080331|C0597198|C0030705|C0205365|C0205390|C1299392|C0038454
"Study inclusion required that participants were between the ages of 18–65, met DSM-IV criteria for a current cannabis dependence diagnosis, and were smoking at least 5 cannabis joints per week.","Study inclusion required participants ages 18–65, met DSM-IV criteria current cannabis dependence diagnosis, smoking 5 cannabis joints week.",C0557651|C0007637|C1514873|C0679646|C0001779|G0000000|C0268621|C0220952|C0243161|C0521116|C0024808|C0011546|C0011900|C0037369|G0000000|C0024808|C0022417|C0332174
Loco-regional recurrence was observed in 15 out of the 70 randomized patients (three in the AHF and 12 in the CF groups).,Loco-regional recurrence observed 15 70 randomized patients (three AHF 12 CF groups).,C0205147|C0034897|C1441672|C0450371|C0450371|C0034656|C0030705|C0205449|C0015506|C0450371|C0009738|C0441833
Children aged below 6 years were excluded as they receive vitamin A supplementation every 6 months on national immunisation or vitamin A days.,Children aged 6 excluded receive vitamin A supplementation 6 months national immunisation vitamin A days.,C0008059|C0001779|G0000000|C1554077|C1514756|C0042890|G0000000|C0242297|G0000000|C0439231|C3245503|C0020971|C0042890|G0000000|C0439228
The selected eye was the eye with the worst VA at baseline and with evidence of worsening during the past 3 years.,The selected eye eye worst VA baseline evidence worsening 3 years.,G0000000|C1707391|C0015392|C0015392|C1522166|C1549054|C0168634|C3887511|C0332271|G0000000|C0439234
Pain felt by participants was recorded.,Pain participants recorded.,C0030193|C0679646|C0034869
For the principal analysis of primary outcomes we used an unpaired t-test of vaccination rates children aged 12-23 months in intervention clusters compared with control clusters.,For principal analysis primary outcomes unpaired t-test vaccination rates children aged 12-23 months intervention clusters compared control clusters.,G0000000|C0205225|C0002778|C0205225|C1274040|C2700112|C0871472|C0042196|C0871208|C0008059|C0001779|C0450371|C0439231|C0886296|C1555715|C1707455|C0243148|C1555715
"The dyskinetic form of cerebral palsy, including the dystonic form, is in most patients caused by lesions in the basal ganglia.","The dyskinetic form cerebral palsy, including dystonic form, patients caused lesions basal ganglia.",G0000000|C0439842|C0348078|G0000000|C0522224|C0332257|G0000000|C0348078|C0030705|C0015127|C0221198|C0205112|C0017067
"To fill this gap, a pragmatic intervention has been designed to improve supportive care for FC of patients with lung cancer.","To fill gap, pragmatic intervention designed improve supportive care FC patients lung cancer.",C0040363|C1708059|C3887622|C0871858|C0886296|C1707689|G0000000|C1521721|C1947933|C2983605|C0030705|C0024109|C0006826
"The study population consisted of 250 healthy, pregnant women, who were recruited from eight gynecological practices by their staff between February 2010 and August 2011 in Munich, Germany.","The study population consisted 250 healthy, pregnant women, recruited gynecological practices staff February 2010 August 2011 Munich, Germany.",G0000000|C0557651|C0032659|C0332529|C1442061|C3898900|C0549206|C0043210|G0000000|C0018417|C0237607|C0851286|C3830166|G0000000|C3831448|G0000000|G0000000|C0017480
"Criteria of exclusion were pregnancy, uncontrolled hypertension, previous malignancy, infectious disease, liver/kidney disease, or active treatment with ECP or immunosuppressants within 4 weeks prior to start of trial.","Criteria exclusion pregnancy, uncontrolled hypertension, previous malignancy, infectious disease, liver/kidney disease, active treatment ECP immunosuppressants 4 weeks prior start trial.",C0243161|C0680251|C0032961|C0205318|C0020538|C0205156|C0006826|C0009450|C0012634|C0545792|C0012634|C0205177|C0039798|C3889675|C0021081|G0000000|C0332152|C0439659|C0008976
"The design is a 2-arm, parallel group cross-over, randomized clinical trial (RCT) that examines the efficacy of this adjunctive youth early intervention program (called “YES”) for improving social, vocational, mental and physical health functioning in a trans-diagnostic sample of 120 young persons aged 14–25 years who are currently receiving a range of “usual treatments” for clinically diagnosed anxiety, affective and/or psychotic disorders.","The design 2-arm, parallel cross-over, randomized clinical trial (RCT) examines efficacy adjunctive youth intervention program (called “YES”) improving social, vocational, mental physical health functioning trans-diagnostic sample 120 persons aged 14–25 receiving range “usual treatments” clinically diagnosed anxiety, affective and/or psychotic disorders.",G0000000|C1707689|C0446516|C2348042|C0010366|C0034656|C0205210|C0008976|G0000000|G0000000|C1280519|C2825951|C0001578|C0886296|C1709697|C0679006|G0000000|C1272745|C0728831|C0087164|C0229992|C0031809|C0018684|C0205245|C2826298|C0370003|C1442061|C0027361|C0001779|G0000000|C1514756|C1514721|G0000000|G0000000|G0000000|C0011900|C0003467|G0000000|G0000000|C0004936|C0012634
Other criteria were postoperative Karnofsky performance status (KPS) ≥ 60 and adequate marrow and other organ function.,Other criteria postoperative Karnofsky performance status (KPS) ≥ 60 adequate marrow organ function.,G0000000|C0243161|C0032790|C0206065|C0597198|C0449438|C0206065|G0000000|C0450371|C0205410|C0086590|C0178784|C0031843
Early stage endometrial cancer survivors were randomized to intervention (n = 23) or usual care (n = 22) groups.,Early stage endometrial cancer survivors randomized intervention (n = 23) usual care (n = 22) groups.,C1279919|C0205390|C0227843|C0006826|C0206194|C0034656|C0886296|C0369718|G0000000|C0450371|C3538928|C1947933|C0369718|G0000000|C0450371|C0441833
"Exclusion criteria included emergent, nonscheduled surgery, cardiogenic shock (preoperative ino-tropic or intra-aortic balloon support), preexisting pulmonary disease (significant obstructive or restrictive lung disease), active infection (treated with antibiotics), and the need for single lung ventilation during the procedure.","Exclusion criteria included emergent, nonscheduled surgery, cardiogenic shock (preoperative ino-tropic intra-aortic balloon support), preexisting pulmonary disease (significant obstructive restrictive lung disease), active infection (treated antibiotics), single lung ventilation procedure.",C0680251|C0243161|C0332257|C0750573|G0000000|C0038894|C1749797|C0036974|C0445204|G0000000|C0347985|C0336867|C0183683|C2347662|C0024109|C0012634|C0237881|C0549186|C0443288|C0024109|C0012634|C0205177|C0009450|C1522326|C0003232|C0037179|C0024109|C0035203|C0184661
Transition from acute herpes zoster to PHN occurs when the pain in the affected area persists months after crusting of the skin lesions.,Transition acute herpes zoster PHN occurs pain persists months crusting skin lesions.,C0599156|C0205178|C0019340|C0019360|C0032768|C1709305|C0030193|G0000000|C0439231|C0205204|C0444099|C0221198
"Patients were consecutively enrolled from patients referred to the urology and pediatric clinics at Salman Bin Abdul-Aziz University Hospital, Al-Kharj; Royal Commission Hospital, Jubail; and King Khalid Hospitals, AL-Kharj and Tabouk, Kingdom of Saudi Arabia, for treatment of enuresis.","Patients consecutively enrolled patients referred urology pediatric clinics Salman Bin Abdul-Aziz University Hospital, Al-Kharj; Royal Commission Hospital, Jubail; King Khalid Hospitals, AL-Kharj Tabouk, Kingdom Saudi Arabia, treatment enuresis.",C0030705|G0000000|G0000000|C0030705|C0205543|C0042077|C0030755|C0442592|G0000000|C1879840|G0000000|C0041740|C0019994|C0202311|G0000000|G0000000|C0019994|G0000000|G0000000|G0000000|C0019994|C0202311|G0000000|C1708611|G0000000|C0003671|C0039798|C0014394
Median age at inclusion was 5.4 (range 0.49-24.8) years.,Median age inclusion 5.4 (range 0.49-24.8) years.,C0549183|C0001779|C0007637|G0000000|C1514721|C0450371|C0439234
"Patients listed for or having undergone surgical repair of fractured neck of femur, who are aged 70 years or over and are admitted directly to the study centre through the emergency department will be included.","Patients listed undergone surgical repair fractured neck femur, aged 70 admitted directly study centre emergency department included.",C0030705|C0745732|G0000000|C0543467|C0043240|C0016658|C0027530|C0015811|C0001779|C0450371|C0184666|C1947931|C0557651|C0205099|C0013956|C1704729|C0332257
The number of smear-positive cases detected increased by 8.8% relative to the pre-intervention period (July–December 2012) in intervention communities as compared to an 8.6% decrease in communities without the ICF intervention.,The smear-positive detected increased 8.8% relative pre-intervention period (July–December 2012) intervention communities compared 8.6% decrease communities ICF intervention.,G0000000|C0444186|C0442726|C0205217|G0000000|C0080103|C2347663|C0439531|G0000000|G0000000|C0886296|C0009462|C1707455|G0000000|C0392756|C0009462|G0000000|C0886296
"Among the 475 patients undergoing a PAP titration night, 360 were further excluded (280 were living outside Istanbul, 15 were unable to come to follow-up, and 65 were not interested in the study).","Among 475 patients undergoing PAP titration night, 360 excluded (280 living Istanbul, 15 unable follow-up, 65 study).",G0000000|C1442061|C0030705|G0000000|C1740167|C0162621|C0240526|C1442061|C1554077|C1442061|C0376558|G0000000|C0450371|C1299582|C0589120|C0450371|C0557651
"Experimental hut trials were conducted in Malanville (Benin), Pitoa (Cameroon) and Vallée du Kou (Burkina Faso), where An.","Experimental hut trials conducted Malanville (Benin), Pitoa (Cameroon) Vallée du Kou (Burkina Faso), An.",C1517586|G0000000|C0008976|C0004927|G0000000|C0005005|G0000000|C0006802|G0000000|C0011535|C1077817|G0000000|G0000000|G0000000
The 200 stage 0 to IIIa breast cancer survivors ranged in age from 27 to 76 years (Table 1).,The 200 stage 0 IIIa breast cancer survivors ranged age 27 76 (Table 1).,G0000000|C1442061|C0205390|G0000000|G0000000|C0006141|C0006826|C0206194|C1514721|C0001779|C0450371|C0450371|C0039224|G0000000
Fifty patients were needed in each treatment group.,Fifty patients treatment group.,C3816723|C0030705|C0039798|C0441833
Mindfulness‐based stress reduction for menopausal symptoms after risk‐reducing salpingo‐oophorectomy (PURSUE study): a randomised controlled trial.,Mindfulness‐based stress reduction menopausal symptoms risk‐reducing salpingo‐oophorectomy (PURSUE study): randomised controlled trial.,G0000000|C0038435|C0301630|C0025320|C0683368|G0000000|G0000000|G0000000|C0557651|G0000000|C2587213|C0008976
"During the study period, the eMM will not be available in the intensive care units (ICUs), theatres or outpatients.","During study period, eMM intensive care units (ICUs), theatres outpatients.",G0000000|C0557651|C0439531|G0000000|C0162425|C1947933|C0439148|C0021708|C0475307|C0029921
"Only women with confirmed endometrial hyperplasia fulfilling the inclusion criteria were eligible, after having signed the informed consent during the second consultation.","Only women confirmed endometrial hyperplasia fulfilling inclusion criteria eligible, signed informed consent consultation.",C0205171|C0043210|C0521093|C0227843|C0020507|C1550543|C0007637|C0243161|C1548635|C1519316|C1522154|C1511481|C0009818
"Among alcohol dependent smokers who received concurrent alcohol and smoking cessation treatment, increased cigarette craving was a significant antecedent to both tobacco and alcohol relapse (11).","Among alcohol dependent smokers received concurrent alcohol smoking cessation treatment, increased cigarette craving antecedent tobacco alcohol relapse (11).",G0000000|C0001962|C0851827|C0337664|C1514756|C0205420|C0001962|C0037369|C1880019|C0039798|C0205217|C0677453|C0870371|G0000000|C0040329|C0001962|C0035020|C0450371
Randomization is blocked and stratified within primary care provider to increase the comparability of treatment groups and to ensure equal allocation by provider.,Randomization blocked stratified primary care provider increase comparability treatment ensure equal allocation provider.,C0034656|C0028778|C0205363|C0205225|C1947933|C1138603|C0442805|G0000000|C0039798|C0218063|C0205163|C1706778|C1138603
"Women were ineligible if they engaged in over 5 hours of vigorous physical activity per week, if they had a prior history of any other cancer (except basal or squamous cell skin cancer), or if they suffered from major medical conditions such as anemia, diabetes, multiple sclerosis, chronic obstructive pulmonary disease, symptomatic ischemic heart disease, uncontrolled hypertension, or liver or kidney failure.","Women ineligible engaged 5 hours vigorous physical activity week, prior history cancer (except basal squamous cell skin cancer), suffered major medical conditions anemia, diabetes, multiple sclerosis, chronic obstructive pulmonary disease, symptomatic ischemic heart disease, uncontrolled hypertension, liver kidney failure.",C0043210|C1512714|C0425152|G0000000|C0439227|G0000000|C0031809|C0205177|C0332174|C0332152|C0019664|C0006826|G0000000|C0205112|C1182670|C0007634|C0444099|C0006826|C0683278|C0205082|C0199168|C0012634|C0002871|C0011847|C0439064|C0036429|C0205191|C0549186|C0024109|C0012634|C0231220|C0475224|C0018787|C0012634|C0205318|C0020538|C0023884|C0022646|C0231174
"The inclusion criteria included: age 13 to18 years, being single, suffering from dysmenorrhea, having regular menstrual cycles, having no other health problems (according to their medical history), and low dietary fish intake (not more than once per week).The girls were randomly assigned to 1 of 4 schedules.","The inclusion criteria included: age 13 to18 years, single, suffering dysmenorrhea, regular menstrual cycles, health (according medical history), low dietary fish intake (not week).The girls randomly assigned 1 4 schedules.",G0000000|C0007637|C0243161|C0332257|C0001779|C0450371|G0000000|C0439234|C0037179|C0683278|C0013390|C0205272|C0025344|C1511572|C0018684|C0680240|C0199168|C0019664|C0205251|C0012155|C0016163|C1512806|C1518422|C0332174|C0870604|G0000000|C1516050|G0000000|G0000000|C0086960
"Participants 156 children aged 4-15 who had a sore throat for less than seven days and at least two of the four Centor criteria (history of fever, absence of cough, swollen tender anterior cervical lymph nodes, and tonsillar exudate).","Participants 156 children aged 4-15 sore throat days Centor criteria (history fever, absence cough, swollen tender anterior cervical lymph nodes, tonsillar exudate).",C0679646|C1442061|C0008059|C0001779|C0450371|C0234233|C0031354|C0439228|G0000000|C0243161|C0019664|C0015967|C0332197|C0010200|C0038999|C0234234|C0205094|C0027530|C0024202|C0746922|C0040421|C0015388
"Eligibility criteria included a clinical diagnosis of Parkinson's disease, with a disease severity rating of stage 1 to 4 on the Hoehn and Yahr scale (which ranges from 1 to 5, with higher scores indicating more severe disease)4; an age of 40 to 85 years; at least one score of 2 or more for at least one limb for the tremor, rigidity, postural stability, or bradykinesia items in the motor section of the Unified Parkinson's Disease Rating Scale (UPDRS) III)18; stable medication use; ability to stand unaided and walk with or without an assistive device; medical clearance for participation; and willingness to be assigned to any of the three interventions.","Eligibility criteria included clinical diagnosis Parkinson's disease, disease severity rating stage 1 4 Hoehn Yahr scale (which ranges 1 5, scores indicating severe disease)4; age 40 85 years; score 2 limb tremor, rigidity, postural stability, bradykinesia items motor Unified Parkinson's Disease Rating Scale (UPDRS) III)18; stable medication use; ability stand unaided walk assistive device; medical clearance participation; willingness assigned interventions.",C0013893|C0243161|C0332257|C0205210|C0011900|C1021144|C0012634|C0012634|C0439793|C0871208|C0205390|G0000000|G0000000|G0000000|G0000000|C0175659|G0000000|C1514721|G0000000|G0000000|C0449820|G0000000|C0205082|C0012634|C0001779|C0450371|C0450371|C0439234|C0449820|G0000000|C0015385|C0040822|C0026837|C0205278|C0205360|C0233565|C1551338|C1513492|C1548174|C1021144|C0012634|C0871208|C0175659|C3639721|C0439070|C0205360|C0013227|C0042153|C0085732|C0596013|C0439846|C0080331|G0000000|C0025080|C0199168|C0449297|C0679823|C0600109|C1516050|C0886296
"Other eligibility criteria include stage I to III disease, age greater than 18 years and adequate understanding of English.","Other eligibility criteria stage I III disease, age 18 adequate understanding English.",G0000000|C0013893|C0243161|C0205390|C0021966|C0439070|C0012634|C0001779|C0450371|C0205410|C0162340|C0376245
"Eligible participants are defined as those with fasting blood glucose < 126 mg/dL, TSH < 6.0 mlU/L, creatinine clearance < 30 ml/min (calculated using Cockcroft equation) [7], and serum vitamin B12 120-700 pmol/L.","Eligible participants defined fasting blood glucose < 126 mg/dL, TSH < 6.0 mlU/L, creatinine clearance < 30 ml/min (calculated Cockcroft equation) [7], serum vitamin B12 120-700 pmol/L.",C1548635|C0679646|C1704788|C0015663|C0005767|C0017725|G0000000|C1442061|C0439269|G0000000|G0000000|G0000000|C0439394|C0010294|C0449297|G0000000|C0450371|C0439445|C0444686|G0000000|C0552449|G0000000|C0229671|C0042890|G0000000|C1442061|C0439284
"Of 1861 patients with ALL, the following were excluded: 21 patients with acute leukemia of ambiguous lineage, 54 with ALL predisposition syndromes (eg, Down syndrome or ataxia telangiectasia), and 1 not treated according to the ALL2008 protocol.","Of 1861 patients ALL, excluded: 21 patients acute leukemia ambiguous lineage, 54 ALL predisposition syndromes (eg, Down syndrome ataxia telangiectasia), 1 treated ALL2008 protocol.",G0000000|G0000000|C0030705|G0000000|C1554077|C0450371|C0030705|C0205178|C0023418|C1549102|C1881379|C0450371|C0444868|C0012655|C0039082|C0013715|G0000000|C0039082|C0004134|C0039446|G0000000|C1522326|G0000000|C0442711
"Similarly, the mean CC2 regular word reading scores for groups 1 and 2 in McArthur et al.","Similarly, CC2 regular word reading scores 1 2 McArthur al.",G0000000|C0055717|C0205272|C1705313|C0034754|C0449820|G0000000|G0000000|G0000000|C0202311
"Both cohorts included infants who were preterm (≤32 weeks gestational age) and were less than 6 months old at start of RSV season, in line with Spanish recommendations for the use of palivizumab [7].","Both cohorts included infants preterm (≤32 weeks gestational age) 6 months start RSV season, Spanish recommendations palivizumab [7].",G0000000|C0599755|C0332257|C0021270|C0151526|G0000000|C0439230|C0439671|C0001779|G0000000|C0439231|C0439659|G0000000|C0036497|C0086409|C0034866|C0672596|G0000000
"The study was a non-blinded prospective randomized controlled trial carried out between May 2007 and January 2008 in patients who were scheduled for radical resection of the oral cavity, pharynx or larynx and who were expected to require artificial feeding by the enteral route postoperatively.","The study non-blinded prospective randomized controlled trial carried May 2007 January 2008 patients scheduled radical resection oral cavity, pharynx larynx expected require artificial feeding enteral route postoperatively.",G0000000|C0557651|C1518422|C0023981|C0034656|C2587213|C0008976|C0206243|G0000000|G0000000|C3829466|G0000000|C0030705|C0086960|C0302912|C0015252|C0442027|C0011334|C0031354|C0023078|C1517001|G0000000|C2004457|C0204695|C1304890|C0013153|G0000000
"Inclusion criteria for the trial were: 1) parent of a child between the ages of 10 and 17 years with chronic pain, 2) child’s pain of a duration ≥ 3 months and interfering with daily functioning, 3) child received evaluation for chronic pain from one of the two pain clinics, and 4) parents were English-speaking.","Inclusion criteria trial were: 1) parent child ages 10 17 chronic pain, 2) child’s pain duration ≥ 3 months interfering daily functioning, 3) child received evaluation chronic pain pain clinics, 4) parents English-speaking.",C0007637|C0243161|C0008976|G0000000|G0000000|C0030551|C0008059|C0001779|C0450371|C0450371|C0205191|C0030193|G0000000|G0000000|C0030193|C0449238|G0000000|G0000000|C0439231|C0521102|C0332173|C0205245|G0000000|C0008059|C1514756|C0220825|C0205191|C0030193|C0030193|C0442592|G0000000|C0030551|C0376245
"Despite the training sessions the protocol physiotherapists received, we found that in 18% of the patients the protocol was not adequately followed.","Despite training sessions protocol physiotherapists received, 18% patients protocol adequately followed.",G0000000|C0040607|C1883016|C0442711|C2362565|C1514756|C0450371|C0030705|C0442711|G0000000|C0332283
The full sample included 998 youth recruited in two cohorts from three urban public middle schools.,The sample included 998 youth recruited cohorts urban public middle schools.,G0000000|C0370003|C0332257|C1442061|C0001578|G0000000|C0599755|C0442529|G0000000|C0444598|C0036375
"Patients were to have had symptoms for at least 3 mo and to have failed to respond to standard therapies including: increased dietary fiber, reduction of lactose-containing foods, antispasmodics, simple laxatives (in those with predominant constipation), and opioids (in those with predominant diarrhea).","Patients symptoms 3 mo failed respond standard therapies including: increased dietary fiber, reduction lactose-containing foods, antispasmodics, simple laxatives (in predominant constipation), opioids (in predominant diarrhea).",C0030705|C0683368|G0000000|C0026544|C0231175|G0000000|C1442989|C0087111|C0332257|C0205217|C0012155|C0012173|C0301630|C0022949|C0016452|C0037766|C0205352|C0282090|G0000000|C1542147|C0009806|C0242402|G0000000|C1542147|C0011991
Baseline CO reading of at least 10 ppm.,Baseline CO reading 10 ppm.,C0168634|C3245499|C0034754|G0000000
Participants 128 employed patients aged 25-60 years with clinically diagnosed and electrophysiologically confirmed idiopathic carpal tunnel syndrome.,Participants 128 employed patients aged 25-60 clinically diagnosed electrophysiologically confirmed idiopathic carpal tunnel syndrome.,C0679646|C1442061|C0014003|C0030705|C0001779|C0450371|G0000000|C0011900|G0000000|C0521093|C0332240|C0007285|C0337138|C0039082
"The figurefigure shows the flow of participants through the trial, and table 11 summarises their baseline characteristics.","The figurefigure flow participants trial, table 11 summarises baseline characteristics.",G0000000|G0000000|C0806140|C0679646|C0008976|C0039224|C0450371|G0000000|C0168634|C1521970
turnovers) 14 (4)).,turnovers) 14 (4)).,C0031227|C0450371|G0000000
All control group participants were included in this analysis.,All control participants included analysis.,G0000000|C0243148|C0679646|C0332257|C0002778
"Tiotropium also improved health related quality of life, dyspnoea, and lung function in patients with COPD.","Tiotropium improved health quality life, dyspnoea, lung function patients COPD.",C0213771|C0184511|C0018684|C0332306|C0376558|C0013404|C0024109|C0031843|C0030705|C0024117
Nine hundred thirty-six randomized patients completed the protocol and had an adequate outcome assessment.,Nine thirty-six randomized patients completed protocol adequate outcome assessment.,C0205455|C3816446|C0034656|C0030705|C0205197|C0442711|C0205410|C1274040|C1261322
"However, in this study we only used a VAS approach for pain and not function and so we limited the possible responder entry criteria to pain metrics.","However, study VAS approach pain function limited responder entry criteria pain metrics.",G0000000|C0557651|C0042815|C0449445|C0030193|C0031843|C0439801|G0000000|C1705654|C0243161|C0030193|C0699680
Potential participants with genital ulcerations were temporarily excluded until successful treatment.,Potential participants genital ulcerations temporarily excluded successful treatment.,C3245505|C0679646|C0559522|C0041582|G0000000|C1554077|C0597535|C0039798
"The children in the IG were an average age of 3 years, 4 months (SD: 2.6; range: 6 months–6 years, 2 months), and WG were an average age of 1 year, 4 months (SD: 1.10; range: 9 months–3 years, 2 months).","The children IG average age 3 years, 4 months (SD: 2.6; range: 6 months–6 years, 2 months), WG average age 1 year, 4 months (SD: 1.10; range: 9 months–3 years, 2 months).",G0000000|C0008059|C0021027|C1510992|C0001779|G0000000|C0439234|G0000000|C0439231|G0000000|G0000000|C1514721|G0000000|G0000000|C0439234|G0000000|C0439231|C3495801|C1510992|C0001779|G0000000|C0439234|G0000000|C0439231|G0000000|C0450371|C1514721|G0000000|G0000000|C0439234|G0000000|C0439231
Inclusion criteria were infants born more than 12 weeks before term (gestational age <27 weeks and six days) with a decision to provide full life support and the possibility to start cerebral NIRS monitoring within three hours after birth.,Inclusion criteria infants born 12 weeks term (gestational age <27 weeks days) decision provide life support possibility start cerebral NIRS monitoring hours birth.,C0007637|C0243161|C0021270|C0005615|C0450371|C0439230|C0233324|C0439671|C0001779|C0450371|C0439230|C0439228|C0679006|C1999230|C0376558|C0183683|C0332149|C0439659|G0000000|C1826446|C0150369|C0439227|C0005615
About 64% of migraine patients are migraine without aura (MwoA) subtype2.,About 64% migraine patients migraine aura (MwoA) subtype2.,G0000000|C0450371|C0149931|C0030705|C0149931|C0236018|G0000000|G0000000
"There were 60 respondents from NSC, 77 from TTSH A&E, and 185 from TTSH ICU, which is the largest among the 3 departments.","There 60 respondents NSC, 77 TTSH A&E, 185 TTSH ICU, largest 3 departments.",G0000000|C0450371|C0282122|G0000000|C0450371|G0000000|G0000000|C1442061|G0000000|C0021708|C0443228|G0000000|C1704729
This was an open label study and no concealment of treatment allocation was followed.,This label study concealment treatment allocation followed.,G0000000|C0181496|C0557651|G0000000|C0039798|C1706778|C0332283
"Each of them was given a set of envelopes, half of which enclosed a paper marked ‘C’ for the control group, and the other half ‘I’ for the intervention group.","Each set envelopes, half enclosed paper marked ‘C’ control group, half ‘I’ intervention group.",G0000000|C0036849|C1622204|C2825407|C0205380|C0030351|C0522501|G0000000|C0243148|C0441833|C2825407|G0000000|C0886296|C0441833
"Creighton University's institutional review board approved the study protocol, including written, informed surrogate consent, before enrolling any patients.","Creighton University's institutional review board approved study protocol, including written, informed surrogate consent, enrolling patients.",G0000000|C0041740|C0018704|C0282443|C0972401|C0205540|C0557651|C0442711|C0332257|C0043266|C1522154|C4053457|C1511481|G0000000|C0030705
"Briefly, male and female outpatients aged between 20 and 75 years who met the ACR 1990 criteria for fibromyalgia [2] and had a Brief Pain Inventory (BPI) average pain score ≥4 [26, 27] at visits 1 and 2 were included.","Briefly, male female outpatients aged 20 75 met ACR 1990 criteria fibromyalgia [2] Brief Pain Inventory (BPI) average pain score ≥4 [26, 27] visits 1 2 included.",G0000000|C0086582|C0015780|C0029921|C0001779|C0450371|C0450371|C0268621|C1412134|G0000000|C0243161|C0016053|G0000000|C1282927|C0030193|C0021941|C1443145|C1510992|C0030193|C0449820|G0000000|C0450371|C0450371|C0545082|G0000000|G0000000|C0332257
"Individuals were excluded if they (a) were living in an assisted- or extended-care facility, (b) were receiving outpatient HD on a temporary basis following a peritoneal dialysis complication or an episode of transplant rejection, (c) reported having no intent to comply with dietary or fluid restrictions, or (d) were receiving home HD.","Individuals excluded (a) living assisted- extended-care facility, (b) receiving outpatient HD temporary basis peritoneal dialysis complication episode transplant rejection, (c) reported intent comply dietary fluid restrictions, (d) receiving HD.",C0027361|C1554077|G0000000|C0376558|C1269765|C0023977|C1547538|G0000000|C1514756|C0029921|G0000000|C0205374|C1527178|C0031153|C0011945|C0009566|C0332189|C0040732|C0035015|G0000000|C0684224|C0162425|C0725694|C0012155|C0005889|C0443288|C0073187|C1514756|G0000000
Patients were randomized after the end of radiochemotherapy at a ratio of 2:1 to receive standard maintenance temozolomide chemotherapy (150-200 mg/m2/d for 5 days every 28 days for 6 cycles) with or without the addition of TTFields.,Patients randomized radiochemotherapy ratio 2:1 receive standard maintenance temozolomide chemotherapy (150-200 mg/m2/d 5 days 28 days 6 cycles) addition TTFields.,C0030705|C0034656|C0436307|C0456603|G0000000|C1514756|C1442989|C0024501|C0076080|C0013216|C1442061|C0439422|G0000000|C0439228|C0450371|C0439228|G0000000|C1511572|C0332287|G0000000
Levodopa preparations had to be administered at least three times daily.,Levodopa preparations administered times daily.,C0023570|C1521827|C1521801|C0040223|C0332173
"Exclusion criteria included severe maternal hypertension, history of peptic ulceration, severe fetal rhesus sensitisation, and evidence of intrauterine infection.","Exclusion criteria included severe maternal hypertension, history peptic ulceration, severe fetal rhesus sensitisation, evidence intrauterine infection.",C0680251|C0243161|C0332257|C0205082|C2347083|C0020538|C0019664|C0443277|C0041582|C0205082|C0015965|C0024400|C1325847|C3887511|C0694756|C0009450
Cases reporting a previous cardiovascular event were eligible.,Cases reporting previous cardiovascular event eligible.,C0868928|C0700287|C0205156|C0007226|C0441471|C1548635
Patients were allowed to start hormonal therapy up to 120 days before random assignment.,Patients allowed start hormonal therapy 120 days random assignment.,C0030705|C0683607|C0439659|C0458083|C0039798|C1442061|C0439228|C0034656|C1516050
Patients Patients with incontinence of any cause of grade I or higher who were at least 18 years old were considered potential trial participants.,Patients Patients incontinence grade I 18 considered potential trial participants.,C0030705|C0030705|C0021167|C0441800|C0021966|C0450371|C0750591|C3245505|C0008976|C0679646
"All patients were at least 50 years old and met the criteria for AD, as described in the Diagnostic and Statistical Manual of Mental Disorders, 4th edition,15 and in accordance with criteria for “probable” AD of the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS‐ADRDA).16 Inclusion criteria also specified that patients were community dwelling with entry scores of 10–26 on the Mini‐Mental State Examination (MMSE).17 Recruitment was by referral to the research centre, advertising or from those known to the investigators at the participating research centre.","All patients 50 years met criteria AD, Diagnostic Statistical Manual Mental Disorders, 4th edition,15 criteria “probable” AD National Institute Neurological Communicative Disorders Stroke Alzheimer's Disease Related Disorders Association (NINCDS‐ADRDA).16 Inclusion criteria patients community dwelling entry scores 10–26 Mini‐Mental State Examination (MMSE).17 Recruitment referral centre, advertising investigators participating centre.",G0000000|C0030705|G0000000|C0268621|C0243161|G0000000|C0011900|C0038215|C0024763|C0229992|C0012634|G0000000|C0441792|C0243161|G0000000|G0000000|C3245503|C0021622|C0205494|C0009452|C0012634|C0038454|G0000000|C0012634|C0439849|C0012634|C0004083|G0000000|C0007637|C0243161|C0030705|C0009462|C0442519|C1705654|C0449820|G0000000|G0000000|C1301808|G0000000|C0451306|C2949735|C0034927|C0205099|C0001690|C0035173|C0679823|C0205099
"Exclusion criteria were age <18 years or >80 years; urine volume <400 ml/d; urinary tract obstruction due to neoplasm; neurogenic bladder; pregnancy; and previous renal replacement therapies including PD, HD, and renal transplantation.","Exclusion criteria age <18 >80 years; urine volume <400 ml/d; urinary tract obstruction neoplasm; neurogenic bladder; pregnancy; previous renal replacement therapies including PD, HD, renal transplantation.",C0680251|C0243161|C0001779|C0450371|C0450371|C0439234|C0042036|C0449468|C1442061|C0439446|C0042027|C1185740|C0028778|C0027651|C0814002|C0005682|C0032961|C0205156|C0022646|C0035139|C0087111|C0332257|G0000000|G0000000|C0022646|C0040732
Two hundred and seventy participants were randomly allocated to an intervention (n = 134) or a standard care (n = 136) arm.,Two seventy participants randomly allocated intervention (n = 134) standard care (n = 136) arm.,C0205448|C3816957|C0679646|G0000000|G0000000|C0886296|G0000000|C1442989|C1947933|G0000000|C0446516
Subjects were not to have received previous vaccination with a HPV vaccine.,Subjects received previous vaccination HPV vaccine.,C0681850|C1514756|C0205156|C0042196|C0021344|C0042210
Intake of decaffeinated green tea for 6 months was associated with a slight reduction in body weight and improved HDL and glucose homeostasis in overweight breast cancer survivors.,Intake decaffeinated green tea 6 months slight reduction body weight improved HDL glucose homeostasis overweight breast cancer survivors.,C1512806|G0000000|C0332583|C0039400|G0000000|C0439231|C2937276|C0301630|C0242821|C0005910|C0184511|C3715113|C0017725|C0019868|C0497406|C0006141|C0006826|C0206194
"Patients were excluded if they had a known hypersensitivity to the study drugs; had intercurrent illness or were pregnant, lactating, or severely anemic (hematocrit, <20%); or had received mefloquine treatment in the previous 60 days or DP in the previous 3 months.","Patients excluded hypersensitivity study drugs; intercurrent illness pregnant, lactating, severely anemic (hematocrit, <20%); received mefloquine treatment previous 60 days DP previous 3 months.",C0030705|C1554077|C0020517|C0557651|C0013227|G0000000|C0221423|C0549206|C2828358|C0205082|C0857322|C0018935|C0450371|C1514756|C0025153|C0039798|C0205156|C0450371|C0439228|C1531217|C0205156|G0000000|C0439231
"Exclusion criteria were requirement of a noncorticosteroid agent to attain disease remission; prior ACTH use; cyclophosphamide or rituximab treatment within 4 months of screening; lactation, pregnancy, or refusal of birth control in patients with child-bearing potential; planned treatment with live or live-attenuated vaccines once enrolled in the study; participation in another therapeutic trial concurrently or 30 days before study randomization; active serious infection; malignancy within the last 2 years; BP >95th percentile for age/height while receiving maximal doses of three or more medications; diagnosis of diabetes mellitus or fasting glucose >200 mg/dl; organ transplantation; eGFR≤70 ml/min per 1.73 m2 via the modified bedside Schwartz equation (20); contraindications to repository corticotropin injection per product labeling; biopsy demonstrating a diagnosis other than minimal change, FSGS or a variant; or inability to consent/assent.","Exclusion criteria requirement noncorticosteroid agent attain disease remission; prior ACTH use; cyclophosphamide rituximab treatment 4 months screening; lactation, pregnancy, refusal birth control patients child-bearing potential; planned treatment live live-attenuated vaccines enrolled study; participation therapeutic trial concurrently 30 days study randomization; active infection; malignancy 2 years; BP >95th percentile age/height receiving maximal doses medications; diagnosis diabetes mellitus fasting glucose >200 mg/dl; organ transplantation; eGFR≤70 ml/min 1.73 m2 modified bedside Schwartz equation (20); contraindications repository corticotropin injection product labeling; biopsy demonstrating diagnosis minimal change, FSGS variant; inability consent/assent.",C0680251|C0243161|C1514873|G0000000|C0450442|G0000000|C0012634|C0544452|C0332152|C3539087|C0042153|C0010583|C0393022|C0039798|G0000000|C0439231|C0220908|C0006147|C0032961|G0000000|C0005615|C0243148|C0030705|C0008059|C3245505|C1301732|C0039798|C1548795|C1548795|C0042210|G0000000|C0557651|C0679823|C0087111|C0008976|G0000000|C0450371|C0439228|C0557651|C0034656|C0205177|C0009450|C0006826|G0000000|C0439234|C0037623|G0000000|C1264641|C0001779|C1514756|C0205289|C0178602|C0013227|C0011900|C0011847|G0000000|C0015663|C0017725|C1442061|C0439269|C0178784|C0040732|G0000000|C0439445|C0450371|C0025885|C0392747|G0000000|G0000000|C0552449|C0450371|C0079164|C3830485|C0001655|C0021485|C1514468|C0033263|C0005558|G0000000|C0011900|C0547040|C0392747|C0017668|C0205419|G0000000|C1511481
"Large for gestational age infants have an increased risk of obesity, cardiovascular and metabolic complications during life.","Large gestational age infants increased risk obesity, cardiovascular metabolic complications life.",C0549177|C0439671|C0001779|C0021270|C0205217|C0035647|C0028754|C0007226|C0311400|C0009566|C0376558
Bezafibrate 400 mg daily (783 men) or placebo (785 men).,Bezafibrate 400 daily (783 men) placebo (785 men).,C0005330|C1442061|C0332173|C1442061|C0025266|C0032042|C1442061|C0025266
"Patients between 1 and 19 years of age with primary ALL, who are treated within the Dutch Childhood Oncology Group (DCOG) ALL-11 or 12 study will be randomized to thromboprophylaxis with LMWH once daily, (dose of 85 IU/kg (intervention arm A)), or to no thromboprophylaxis (arm B, standard of care) during asparaginase courses of ALL treatment.","Patients 1 19 age primary ALL, treated Dutch Childhood Oncology Group (DCOG) ALL-11 12 study randomized thromboprophylaxis LMWH daily, (dose 85 IU/kg (intervention arm A)), thromboprophylaxis (arm B, standard care) asparaginase courses ALL treatment.",C0030705|G0000000|C0450371|C0001779|C0205225|G0000000|C1522326|C0013331|C0231335|C0027651|C0441833|G0000000|C0444868|C0450371|C0557651|C0034656|G0000000|C0019139|C0332173|C0178602|C0450371|C0439463|C0886296|C0446516|G0000000|G0000000|C0446516|G0000000|C1442989|C1947933|C0003993|C0750729|C0444868|C0039798
"Exclusion criteria were non-compliance due to cognitive impairment, medical history of stroke, nervous system disease, or musculoskeletal disease, and medical history of injury to an upper extremity or upper chest area or surgery.","Exclusion criteria non-compliance cognitive impairment, medical history stroke, nervous system disease, musculoskeletal disease, medical history injury upper extremity upper chest surgery.",C0680251|C0243161|C0376405|C1516691|C0221099|C0199168|C0019664|C0038454|C0027769|C0449913|C0012634|C0497254|C0012634|C0199168|C0019664|C3263722|C1282910|C0015385|C1282910|C0817096|C0038894
"severe spinal issues such kyphosis, osteoporosis, or compression fractures that inhibit their ability to stand for more than a few minutes at a time); or otherwise not a candidate for gait and balance training (e.g.","severe spinal issues kyphosis, osteoporosis, compression fractures inhibit ability stand minutes time); candidate gait balance training (e.g.",C0205082|C0521329|C0033213|C0022821|C0029456|C0332459|C0016658|C0018790|C0085732|C0596013|C0439232|C0040223|G0000000|C0016928|C0014653|C0040607|G0000000
"Eligibility criteria included the following: age ≥ 18 years; 6 to 36 months from complete resection of histologically proven stage IA (pT1N0) or stage IB (pT2N0) NSCLC (carcinoid tumors were excluded); pathologic stage N0 confirmed by sampling at least one mediastinal lymph node at resection; chest x-ray or computed tomography scan ≤ 8 weeks before registration without sign of new or recurrent lung cancer; no concurrent cancers or any other prior cancer history within the past 5 years, except localized nonmelanoma skin cancer; no synchronous lesions (lung + nonlung) or metastasis, even if resectable; no history of greater than one lung cancer primary tumor at any time; normal hepatic function (total bilirubin and AST or ALT ≤ institutional upper limit of normal); laboratory values (including CBC) obtained within 8 weeks before registration; and Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.","Eligibility criteria included following: age ≥ 18 years; 6 36 months complete resection histologically proven stage IA (pT1N0) stage IB (pT2N0) NSCLC (carcinoid tumors excluded); pathologic stage N0 confirmed sampling mediastinal lymph node resection; chest x-ray computed tomography scan ≤ 8 weeks registration sign recurrent lung cancer; concurrent cancers prior cancer history 5 years, localized nonmelanoma skin cancer; synchronous lesions (lung + nonlung) metastasis, resectable; history lung cancer primary tumor time; normal hepatic function (total bilirubin AST ALT ≤ institutional upper limit normal); laboratory values (including CBC) 8 weeks registration; Eastern Cooperative Oncology Group (ECOG) performance status 0 1.",C0013893|C0243161|C0332257|C0231290|C0001779|G0000000|C0450371|C0439234|G0000000|C0450371|C0439231|C0205197|C0015252|C0205462|C0456369|C0205390|C0694634|G0000000|C0205390|C2744579|G0000000|C0007131|C0007095|C0027651|C1554077|C1521733|C0205390|C0445085|C0521093|C0441621|C0025066|C0024202|C0746922|C0015252|C0817096|C0034571|C1441526|C0040395|C0034606|G0000000|G0000000|C0439230|C1514821|C0311392|C2945760|C0024109|C0006826|C0205420|C0006826|C0332152|C0006826|C0019664|G0000000|C0439234|C0392752|G0000000|C0444099|C0006826|C0439580|C0221198|C0024109|G0000000|G0000000|C0027627|C1514888|C0019664|C0024109|C0006826|C0205225|C0027651|C0040223|C0205307|C0205054|C0031843|C0439175|C0005437|C3891303|C1266129|G0000000|C0018704|C1282910|C0439801|C0205307|C0022877|C0042295|C0332257|C0009555|G0000000|C0439230|C1514821|C1707877|C0679729|C0027651|C0441833|C0430797|C0597198|C0449438|G0000000|G0000000
"Clinical inclusion criteria required a diagnosis of moderate to severe chronic blepharitis and simple obstructive MGD (Figure 2), with onset and greater than 3 months duration of ocular symptoms consistent with blepharitis, dry eye, and meibomian gland disease.","Clinical inclusion criteria required diagnosis moderate severe chronic blepharitis simple obstructive MGD (Figure 2), onset 3 months duration ocular symptoms consistent blepharitis, dry eye, meibomian gland disease.",C0205210|C0007637|C0243161|C1514873|C0011900|C0205081|C0205082|C0205191|C0005741|C0205352|C0549186|G0000000|G0000000|G0000000|C0206132|G0000000|C0439231|C0449238|C0015392|C0683368|C0332290|C0005741|C0011682|C0015392|G0000000|C1285092|C0012634
"Association of dietary selenium intake with total and cause-specific mortality in the Shanghai Women’s Health Study (SWHS; 1997–2000) and the Shanghai Men’s Health Study (SMHS; 2002–2006) HR, hazard ratio.","Association dietary selenium intake total cause-specific mortality Shanghai Women’s Health Study (SWHS; 1997–2000) Shanghai Men’s Health Study (SMHS; 2002–2006) HR, hazard ratio.",C0004083|C0012155|C0036581|C1512806|C0439175|C0015127|C0026565|G0000000|G0000000|C0018684|C0557651|G0000000|G0000000|G0000000|G0000000|C0018684|C0557651|C1824631|G0000000|G0000000|C0598697|C0456603
"Exclusion criteria were (1) an estimated total Intelligent Quotient (IQ) lower than 80 (determined by vocabulary and block design subtests of the Wechsler Intelligence Scale for Children III [WISC-III] [36,48,49], (2) substance abuse problems (eg, drugs, alcohol), (3) conduct disorder, (4) autism spectrum disorder (both previously diagnosed by health care professionals), (5) comorbid acute psychiatric disorder (eg, depression, mania; confirmed by the K-SADS [44,45]), and (6) participation in a previous pilot study with a prototype of Plan-It Commander.","Exclusion criteria (1) estimated total Intelligent Quotient (IQ) lower 80 (determined vocabulary block design subtests Wechsler Intelligence Scale Children III [WISC-III] [36,48,49], (2) substance abuse (eg, drugs, alcohol), (3) conduct disorder, (4) autism spectrum disorder (both diagnosed health care professionals), (5) comorbid acute psychiatric disorder (eg, depression, mania; confirmed K-SADS [44,45]), (6) participation previous pilot study prototype Plan-It Commander.",C0680251|C0243161|G0000000|C0750572|C0439175|C0021704|C2347741|G0000000|C0441994|C0450371|C0680730|C0042926|C0028778|C1707689|G0000000|G0000000|C0021704|C0175659|C0008059|C0439070|C0204457|C0450371|G0000000|C0439861|C0013146|C0013715|C0013227|C0001962|G0000000|C0004927|C0012634|G0000000|C0004352|C1883073|C0012634|G0000000|C0011900|C0018684|C1947933|C0679924|G0000000|C0009488|C0205178|C0205487|C0012634|C0013715|C0011570|C0338831|C0521093|C0597277|C0450371|G0000000|C0679823|C0205156|C0473169|C0557651|G0000000|C0270724|G0000000
"Participants were 83 adolescents (15 males, 68 females) between the ages of 11–17 years (M = 14.5, SD = 1.7) and one of their parents/guardians.","Participants 83 adolescents (15 males, 68 females) ages 11–17 (M = 14.5, SD = 1.7) parents/guardians.",C0679646|C0450371|C0205653|C0450371|C0086582|C0450371|C0015780|C0001779|G0000000|C0369637|G0000000|C0450371|C2699239|G0000000|G0000000|C0030551
These rates of exposure are particularly troubling as ETS represents a serious health threat for children on treatment for cancer due to their disease and treatment-related vulnerabilities [10].,These rates exposure troubling ETS represents health threat children treatment cancer disease treatment-related vulnerabilities [10].,G0000000|C0871208|C0274281|G0000000|G0000000|C1882932|C0018684|C0749385|C0008059|C0039798|C0006826|C0012634|C0039798|G0000000|C0450371
A previous history of exacerbations was not required.,A previous history exacerbations required.,G0000000|C0205156|C0019664|G0000000|C1514873
"within the first eight weeks after diagnosis), patients will be referred to the PC physician.","weeks diagnosis), patients referred PC physician.",C0439230|C0011900|C0030705|C0205543|C0031995|C0031831
"Exclusion criteria included: 1) age <18 years and >75 years; 2) no written informed consent available; 3) known hypersensitivity to steroids; 4) steroid treatment in the previous 48 h; 5) need for steroid treatment for any reason (asthma, chronic obstructive pulmonary disease (COPD), and so on); 6) uncontrolled diabetes mellitus; 7) active peptic ulcer; 8) active mycobacterial or fungal infection; 9) reported severe immunosuppression; 10) hospital admission during the previous eight days; 11) empyema; 12) extrapulmonary septic manifestations; 13) presence of shock; 14) pre-mortem status; 15) aspiration pneumonia; and 16) need for mechanical ventilation (MV) prior to inclusion in the study.","Exclusion criteria included: 1) age <18 >75 years; 2) written informed consent available; 3) hypersensitivity steroids; 4) steroid treatment previous 48 h; 5) steroid treatment reason (asthma, chronic obstructive pulmonary disease (COPD), on); 6) uncontrolled diabetes mellitus; 7) active peptic ulcer; 8) active mycobacterial fungal infection; 9) reported severe immunosuppression; 10) hospital admission previous days; 11) empyema; 12) extrapulmonary septic manifestations; 13) presence shock; 14) pre-mortem status; 15) aspiration pneumonia; 16) mechanical ventilation (MV) prior inclusion study.",C0680251|C0243161|C0332257|G0000000|C0001779|C0450371|C0450371|C0439234|G0000000|C0043266|C1522154|C1511481|C0470187|G0000000|C0020517|C0038317|G0000000|C0038317|C0039798|C0205156|C0450371|C0033727|G0000000|C0038317|C0039798|C0392360|C0004096|C0205191|C0549186|C0024109|C0012634|C0024117|G0000000|G0000000|C0205318|C0011847|G0000000|G0000000|C0205177|C0443277|C0041582|G0000000|C0205177|C0521015|C0016832|C0009450|G0000000|C0684224|C0205082|C0021079|C0450371|C0019994|C0184666|C0205156|C0439228|C0450371|C0014009|C0450371|G0000000|C0333534|C0205319|C0450371|C0150312|C0036974|C0450371|C0332152|C0449438|C0450371|C0220787|C0032285|C0450371|C0443254|C0035203|C0428679|C0332152|C0007637|C0557651
"In this randomized, blinded, double-dummy, parallel-group study ({""type"":""clinical-trial"",""attrs"":{""text"":""NCT01899742"",""term_id"":""NCT01899742""}}NCT01899742), patients (N=494) who were prescribed TIO for ≥3 months at screening (forced expiratory volume in 1 s [FEV1]: 50%–70% of predicted; modified Medical Research Council [mMRC] score ≥1) and completed a 4-week run-in with TIO were randomized to UMEC/VI 62.5/25 µg or TIO 18 µg for 12 weeks.","In randomized, blinded, double-dummy, parallel-group study ({""type"":""clinical-trial"",""attrs"":{""text"":""NCT01899742"",""term_id"":""NCT01899742""}}NCT01899742), patients (N=494) prescribed TIO ≥3 months screening (forced expiratory volume 1 [FEV1]: 50%–70% predicted; modified Medical Research Council [mMRC] score ≥1) completed 4-week run-in TIO randomized UMEC/VI 62.5/25 µg TIO 18 µg 12 weeks.",G0000000|C0034656|C0150108|C0205173|C2348042|C0557651|C0332307|C0030705|C0369718|C0278329|G0000000|G0000000|C0439231|C0220908|C0441722|C0231800|C0449468|G0000000|G0000000|G0000000|C0681842|C0392747|C0199168|C0035168|C1551807|C3826977|C0449820|G0000000|C0205197|C0332174|C3274438|G0000000|C0034656|C0205999|C0450371|G0000000|G0000000|C0450371|G0000000|C0450371|C0439230
Nineteen patients were excluded from analysis due to abnormal baseline audiometry.,Nineteen patients excluded analysis abnormal baseline audiometry.,C0450337|C0030705|C1554077|C0002778|C0205161|C0168634|C0004286
"Forty-two overweight, nonsmoking, healthy adult women who reported intense cravings for carbohydrates at least 2 days per week completed this 8-week randomized, double-blind, placebo-controlled study.","Forty-two overweight, nonsmoking, healthy adult women reported intense cravings carbohydrates 2 days week completed 8-week randomized, double-blind, placebo-controlled study.",C3816449|C0497406|G0000000|C3898900|C0001675|C0043210|C0684224|C0522510|C0870371|C0007004|G0000000|C0439228|C0332174|C0205197|C0332174|C0034656|C0013072|C1706408|C0557651
New patients were given the next available appointment and were permanently assigned to both their primary care physician and half-day practice session.,New patients appointment permanently assigned primary care physician half-day practice session.,C0205314|C0030705|C0003629|G0000000|C1516050|C0205225|C1947933|C0031831|C2825407|C0237607|C1883016
"Five sites participated during the period from 2003 to 2008: the Children’s National Medical Center in Washington, DC; the Johns Hopkins Medical Institutions in Baltimore, Maryland; the University of Pittsburgh in Pennsylvania; the University of Texas Medical Branch in Galveston and the University of Texas Southwestern in Dallas; and Washington University in St Louis, Missouri.","Five sites participated period 2003 2008: Children’s National Medical Center Washington, DC; Johns Hopkins Medical Institutions Baltimore, Maryland; University Pittsburgh Pennsylvania; University Texas Medical Branch Galveston University Texas Southwestern Dallas; Washington University St Louis, Missouri.",C0205451|C0205145|G0000000|C0439531|G0000000|G0000000|G0000000|C3245503|C0199168|C0205099|C0043038|G0000000|G0000000|G0000000|C0199168|C1272753|C0004716|C0024858|C0041740|G0000000|C0030853|C0041740|C0039711|C0199168|C1253959|G0000000|C0041740|C0039711|C1710136|G0000000|C0043038|C0041740|C0036056|G0000000|C0026222
"Patients on chemotherapy, renal and/or liver failure, immunocompromised state and those with bronchial asthma were excluded.","Patients chemotherapy, renal and/or liver failure, immunocompromised bronchial asthma excluded.",C0030705|C0013216|C0022646|G0000000|C0023884|C0231174|C0085393|C0205039|C0004096|C1554077
Twenty three were randomised to receive LGG and 22 to receive placebo.,Twenty randomised receive LGG 22 receive placebo.,C0724000|G0000000|C1514756|C1629836|C0450371|C1514756|C0032042
"Those otherwise meeting the inclusion criteria were excluded for any of the following reasons: 1) use of systemic or topical oral steroids within three months, 2) currently pregnant or lactating, 3) presence of head-and-neck cancer (including in-situ disease), or history of such within two years, 4) retinoid or beta-carotene therapy for any reason within two years, or beta-carotene capsules of any size within six months (patients were allowed up to 2 multi-vitamins per day), 5) participation in another randomized clinical trial within six months.","Those meeting inclusion criteria excluded reasons: 1) systemic topical oral steroids months, 2) pregnant lactating, 3) presence head-and-neck cancer (including in-situ disease), history years, 4) retinoid beta-carotene therapy reason years, beta-carotene capsules size months (patients allowed 2 multi-vitamins day), 5) participation randomized clinical trial months.",G0000000|C0556656|C0007637|C0243161|C1554077|C0392360|G0000000|C0205373|C0332237|C0442027|C0038317|C0439231|G0000000|C0549206|C2828358|G0000000|C0150312|C0018670|C0006826|C0332257|C0444498|C0012634|C0019664|C0439234|G0000000|C0035339|C0053396|C0039798|C0392360|C0439234|C0053396|C0006935|C0456389|C0439231|C0030705|C0683607|G0000000|C0301532|C0332173|G0000000|C0679823|C0034656|C0205210|C0008976|C0439231
We included consecutive patients having a microbiological diagnosis of MDR-TB presenting for consultation to a tertiary care private hospital in Mumbai from May 2006 to 2010.,We included consecutive patients microbiological diagnosis MDR-TB consultation tertiary care private hospital Mumbai May 2006 2010.,G0000000|C0332257|C1707491|C0030705|C0025953|C0011900|G0000000|C0009818|C0205372|C1947933|C0033175|C0019994|G0000000|G0000000|G0000000|G0000000
The median age of the 453 children enrolled in the CAE trial was 7 years 5 months (range 2 years 7 months to 12 years 11 months) (Table 3).,The median age 453 children enrolled CAE trial 7 5 months (range 2 7 months 12 11 months) (Table 3).,G0000000|C0549183|C0001779|C1442061|C0008059|G0000000|G0000000|C0008976|G0000000|G0000000|C0439231|C1514721|G0000000|G0000000|C0439231|C0450371|C0450371|C0439231|C0039224|G0000000
"All participants in both studies were diagnosed with Stage 0–IIIA breast cancer, were nonsmokers, had no previous cancer diagnoses, and were free of other serious health problems.","All participants studies diagnosed Stage 0–IIIA breast cancer, nonsmokers, previous cancer diagnoses, free health problems.",G0000000|C0679646|C0947630|C0011900|C0205390|G0000000|C0006141|C0006826|C0337672|C0205156|C0006826|C0011900|C0332296|C0018684|C1546466
"Exclusion criteria included salt-wasting CKD, pregnant or breastfeeding, current prescription of medications providing >20 mmol sodium per day, life expectancy <6 months, current involvement in another intervention study, or insufficient mental or physical capacity to adhere to the study protocol.","Exclusion criteria included salt-wasting CKD, pregnant breastfeeding, current prescription medications providing >20 mmol sodium day, life expectancy <6 months, current involvement intervention study, insufficient mental physical capacity adhere study protocol.",C0680251|C0243161|C0332257|C1846347|C1561643|C0549206|C0006147|C0521116|C0033080|C0013227|C1999230|C0450371|C0439190|C0037473|C0332173|C0376558|C0679138|G0000000|C0439231|C0521116|C1314939|C0886296|C0557651|C0205412|C0229992|C0031809|C1516240|C3714578|C0557651|C0442711
"Within an ongoing randomized trial of antioxidant vitamins, 5,442 female US health professionals 42 years of age or older, with either a history of CVD or three or more coronary risk factors were randomized to a combination pill containing folic acid, vitamin B6, and vitamin B12 or a matching placebo and were followed for 7.3 years from April, 1998 until July, 2006.","Within ongoing randomized trial antioxidant vitamins, 5,442 female US health professionals 42 age older, history CVD coronary risk factors randomized combination pill folic acid, vitamin B6, vitamin B12 matching placebo 7.3 April, 1998 July, 2006.",G0000000|C0549178|C0034656|C0008976|C0003402|C0042890|C1442061|C0015780|G0000000|C0018684|C0679924|C0450371|C0001779|C0580836|C0019664|C0007222|C0018787|C0035647|C1521761|C0034656|C0205195|C0009905|G0000000|C0001128|C0042890|C0005558|C0042890|G0000000|C0150103|C0032042|G0000000|C3715024|G0000000|C3829447|G0000000
"Subjects were excluded from the study if: they were using topical cyclosporine 0.05%, topical corticosteroids, nonsteroidal anti-inflammatory drugs, glaucoma medications, or oral omega-3 fatty acids within 3 weeks of screening and anytime during their participation in the study.","Subjects excluded study if: topical cyclosporine 0.05%, topical corticosteroids, nonsteroidal anti-inflammatory drugs, glaucoma medications, oral omega-3 fatty acids 3 weeks screening anytime participation study.",C0681850|C1554077|C0557651|G0000000|C0332237|C0010592|C0450371|C0332237|C0001617|G0000000|C0003209|C0013227|C0017601|C0013227|C0442027|C1719844|G0000000|C0001128|G0000000|C0439230|C0220908|G0000000|C0679823|C0557651
A total of 184 participants will be randomly assigned to two different groups.,A total 184 participants randomly assigned groups.,G0000000|C0439175|C1442061|C0679646|G0000000|C1516050|C0441833
"No prior chemotherapy, radiotherapy, or anti-EGFR therapy was permitted.","No prior chemotherapy, radiotherapy, anti-EGFR therapy permitted.",G0000000|C0332152|C0013216|C0034619|C4055105|C0039798|C0329040
"Also, prior cancer diagnosis (yes/no), and current cancer treatment (yes/no) were assessed.","Also, prior cancer diagnosis (yes/no), current cancer treatment (yes/no) assessed.",G0000000|C0332152|C0006826|C0011900|C1512698|C0521116|C0006826|C0039798|C1512698|C1516048
"We recruited male and female patients, 18 to 65 years of age, with a diagnosis of a mild or moderate, single or recurrent, major depressive episode as defined by the DSM-IV [22] (diagnostic codes for general practitioners: single episode 296.21, recurrent episode 296.31; for psychiatrists: single episode 296.21 or 296.22, recurrent episode 296.31 and 296.32).","We recruited male female patients, 18 65 age, diagnosis mild moderate, single recurrent, major depressive episode defined DSM-IV [22] (diagnostic codes practitioners: single episode 296.21, recurrent episode 296.31; psychiatrists: single episode 296.21 296.22, recurrent episode 296.31 296.32).",G0000000|G0000000|C0086582|C0015780|C0030705|C0450371|C0450371|C0001779|C0011900|C2945599|C0205081|C0037179|C2945760|C0205082|G0000000|C0332189|C1704788|C0220952|C0450371|C0011900|C0919279|C1709627|C0037179|C0332189|C1442061|C2945760|C0332189|C1442061|C0033872|C0037179|C0332189|C1442061|C1442061|C2945760|C0332189|C1442061|C1442061
"The age of the 208 included patients did not differ from that of the 380 excluded ones who stayed for longer than 48 hours (mean [± standard deviation] age: 57 ± 16 years versus 54 ± 19 years), but their length of stay was longer (mean 21 ± 19 days versus 13 ± 18 days; P < 0.000001) and their severity of illness or injury was greater (SAPS II score: 44 ± 17 versus 37 ± 18; P < 0.0001).","The age 208 included patients 380 excluded stayed 48 hours (mean [± standard deviation] age: 57 ± 16 versus 54 ± 19 years), length stay (mean 21 ± 19 days versus 13 ± 18 days; P < 0.000001) severity illness injury (SAPS II score: 44 ± 17 versus 37 ± 18; P < 0.0001).",G0000000|C0001779|C1442061|C0332257|C0030705|C1442061|C1554077|G0000000|C0450371|C0439227|C0444504|G0000000|C1442989|C0012727|C0001779|C0450371|G0000000|C0450371|G0000000|C0450371|G0000000|C0450371|C0439234|C1444754|G0000000|C0444504|C0450371|G0000000|C0450371|C0439228|G0000000|C0450371|G0000000|C0450371|C0439228|C0369773|G0000000|G0000000|C0439793|C0221423|C3263722|C1705598|G0000000|C0449820|C0450371|G0000000|C0450371|G0000000|C0450371|G0000000|C0450371|C0369773|G0000000|G0000000
"therapy, at least for low-risk patients with febrile cancer and neutropenia (6).","therapy, low-risk patients febrile cancer neutropenia (6).",C0039798|C3272281|C0030705|C0015967|C0006826|C0023530|G0000000
"This was a randomized, controlled clinical trial that was performed in 2009-2010 in St-Alzahra hospital, Isfahan University of Medical Sciences, Isfahan, Iran (Registration No. severe diarrhoea, severe anaemia, high fever); and (iv) had received anthelminthic treatment in the previous month.","This randomized, controlled clinical trial performed 2009-2010 St-Alzahra hospital, Isfahan University Medical Sciences, Isfahan, Iran (Registration No. severe diarrhoea, severe anaemia, fever); (iv) received anthelminthic treatment previous month.",G0000000|C0034656|C2587213|C0205210|C0008976|C0884358|G0000000|C0036056|C0019994|G0000000|C0041740|C0199168|C0036397|G0000000|C0022065|C1514821|G0000000|C0205082|C0011991|C0205082|C0002871|C0015967|C0022326|C1514756|C0003158|C0039798|C0205156|C0332177
"Third, the participants in our study were restricted to an age range of 4–6 years old, whilst other trials included older children ranging from 3–10 [9], 6–14 [10], and 6–15 [12] years old.","Third, participants study restricted age range 4–6 old, whilst trials included children ranging 3–10 [9], 6–14 [10], 6–15 [12] old.",C0205437|C0679646|C0557651|C0443288|C0001779|C1514721|G0000000|C0580836|G0000000|C0008976|C0332257|C0008059|C1514721|G0000000|G0000000|G0000000|C0450371|G0000000|C0450371|C0580836
"Eleven patients (61.1%) had metastatic breast cancer, 3 (16.7%) had metastatic colorectal cancer, and 4 (22.2%) had metastatic ovarian cancer.","Eleven patients (61.1%) metastatic breast cancer, 3 (16.7%) metastatic colorectal cancer, 4 (22.2%) metastatic ovarian cancer.",C0205457|C0030705|C0450371|C0036525|C0006141|C0006826|G0000000|C0450371|C0036525|C0555952|C0006826|G0000000|C0450371|C0036525|C0205065|C0006826
Lack of social or emotional reciprocity?,Lack social emotional reciprocity?,C0332268|C0728831|C0013987|C0871226
"Subjects: 1444 students in the intervention and 1118 students in the control group, all in the first grade, average age 13 years.","Subjects: 1444 students intervention 1118 students control group, grade, average age 13 years.",C0681850|G0000000|C0038492|C0886296|G0000000|C0038492|C0243148|C0441833|C0441800|C1510992|C0001779|C0450371|C0439234
"Exclusion criteria were dermographism (because of the difficulty in interpreting skin prick test results), children who did not use a duvet, those already using allergy control bedding, and cat or dog ownership.","Exclusion criteria dermographism (because difficulty interpreting skin prick test results), children duvet, allergy control bedding, cat dog ownership.",C0680251|C0243161|C0343065|G0000000|C1299586|C1285553|C0444099|C0033119|C0022885|C1274040|C0008059|G0000000|C0002111|C0243148|C0004914|C0007450|C0012984|C0029981
The EPC services provided in this study are aimed at patients with advanced metastatic cancer that is unresponsive to curative treatments (ICD 10 C 1–80 plus ICD 10 C 78–79).,The EPC services provided study aimed patients advanced metastatic cancer unresponsive curative treatments (ICD 10 C 1–80 ICD 10 C 78–79).,G0000000|C0169014|C0557854|C1999230|C0557651|C1947946|C0030705|C0205179|C0036525|C0006826|C0205269|C1880198|C0087111|C0021122|C0450371|G0000000|G0000000|C0021122|C0450371|G0000000|G0000000
Inclusions: community dwelling women aged ≥45 years with at least two antibiotic-treated UTIs or episodes of cystitis in the previous 12 months confirmed by their general practitioner (GP) but not necessarily confirmed by microbiological culture.,Inclusions: community dwelling women aged ≥45 antibiotic-treated UTIs episodes cystitis previous 12 months confirmed practitioner (GP) confirmed microbiological culture.,C0007637|C0009462|C0442519|C0043210|C0001779|G0000000|C0003232|C0042029|C0332189|C0010692|C0205156|C0450371|C0439231|C0521093|C1709627|C3811116|C0521093|C0025953|C0010453
Model describing possible mechanisms underlying the effectiveness of yoga for chronic low back pain.,Model describing mechanisms underlying effectiveness yoga chronic low pain.,C3161035|G0000000|C0441712|G0000000|C1280519|C0043418|C0205191|C0205251|C0030193
"The cohort mainly consists of African Americans, Native Hawaiians, Japanese Americans, Latinos, and whites aged 45-75 years at baseline, 96,896 of whom are male.","The cohort consists African Americans, Native Hawaiians, Japanese Americans, Latinos, whites aged 45-75 baseline, 96,896 male.",G0000000|C0599755|C0332529|C0027567|C0596070|C0302891|C0337920|C1556094|C0596070|C0086528|C0007457|C0001779|C0450371|C0168634|C0450371|C0086582
"In a study of seven general practices in South Birmingham in 2002, 63% of patients with a previous stroke or TIA had BP above the 140 mmHg target, and 80% above the 130 mmHg target [11].","In study practices South Birmingham 2002, 63% patients previous stroke TIA BP 140 mmHg target, 80% 130 mmHg target [11].",G0000000|C0557651|C0237607|C1710133|G0000000|G0000000|C0450371|C0030705|C0205156|C0038454|C0007787|C0037623|C1442061|C0439475|C1521840|C0450371|C1442061|C0439475|C1521840|C0450371
"This study confirms that monotherapy with meropenem is as effective as the combination of ceftazidime plus amikacin for the empiric treatment of fever in persistently granulocytopenic cancer patients, and both regimens were well tolerated.","This study confirms monotherapy meropenem effective combination ceftazidime amikacin empiric treatment fever persistently granulocytopenic cancer patients, regimens tolerated.",G0000000|C0557651|C0521093|G0000000|C0066005|C1280519|C0205195|C0007559|C0002499|C1880496|C0039798|C0015967|C0750508|C0001824|C0006826|C0030705|C2945654|G0000000
In Step 1 we hypothesize that 50% of participants (n = 500) will respond to the open label SPS intervention.,In Step 1 hypothesize 50% participants (n = 500) respond label SPS intervention.,G0000000|C1261552|G0000000|G0000000|C0450371|C0679646|C0369718|G0000000|C1442061|G0000000|C0181496|C3813609|C0886296
"Although there was no group difference in current treatment, more survivors who had a prior cancer diagnosis were in the SLM group.","Although difference current treatment, survivors prior cancer diagnosis SLM group.",G0000000|C1705241|C0521116|C0039798|C0206194|C0332152|C0006826|C0011900|C0072980|C0441833
"Age was ≥18 years with performance status (PS) 0–2 (ECOG) and adequate bone marrow, renal and liver function.","Age ≥18 years performance status (PS) 0–2 (ECOG) adequate bone marrow, renal liver function.",C0001779|G0000000|C0597198|C0449438|C0242397|G0000000|C0430797|C0205410|C0262950|C0086590|C0022646|C0023884|C0031843
Sixty-six survivors of triple-negative breast cancer with BMI >25 were invited to participate.,Sixty-six survivors triple-negative breast cancer BMI >25 invited participate.,C3816724|C0206194|C0205174|C0006141|C0006826|G0000000|C0450371|G0000000|G0000000
"All included in this trial met the following criteria: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision diagnosis of insomnia because of a general medical condition (LBP)13; insomnia did not predate LBP onset by more than 1 mo; based on a sleep history taken by the study psychiatrist, the subject had a usual nightly TST less than 6.5 h and/or usual sleep onset latency (SOL) more than 30 min for the month prior to screening; Insomnia Severity Index (ISI) greater than14 (at least moderate insomnia); were 21–64 y of age; visual analog scale (VAS) pain greater than 40; Patient Global Impression (PGI) Pain greater than 2 (at least moderate severity); more back pain than leg pain; no signs of spinal nerve root compression; normal motor strength on physical exam; LBP duration longer than 3 mo; pain inferior to T12 and superior to the gluteal fold.","All included trial met criteria: Diagnostic Statistical Manual Mental Disorders, Fourth Edition, Text Revision diagnosis insomnia medical condition (LBP)13; insomnia predate LBP onset 1 mo; based sleep history study psychiatrist, subject usual nightly TST 6.5 and/or usual sleep onset latency (SOL) 30 min month prior screening; Insomnia Severity Index (ISI) than14 (at moderate insomnia); 21–64 age; visual analog scale (VAS) pain 40; Patient Global Impression (PGI) Pain 2 (at moderate severity); pain leg pain; signs spinal nerve root compression; normal motor strength physical exam; LBP duration 3 mo; pain inferior T12 superior gluteal fold.",G0000000|C0332257|C0008976|C0268621|C0243161|C0011900|C0038215|C0024763|C0229992|C0012634|C0205438|C0441792|C1527021|C0439617|C0011900|C0917801|C0199168|C0012634|C1505993|C0917801|C0699540|C1505993|C0206132|G0000000|C0026544|C1527178|C0037313|C0019664|C0557651|C0033872|C0681850|C3538928|G0000000|C1421210|G0000000|G0000000|C3538928|C0037313|C0206132|C0205275|G0000000|C0450371|C0702093|C0332177|C0332152|C0220908|C0917801|C0439793|C0918012|G0000000|G0000000|G0000000|C0205081|C0917801|G0000000|C0001779|C0234621|C0243071|C0175659|C0042815|C0030193|C0450371|C0030705|C0205246|C0596764|C0523816|C0030193|G0000000|G0000000|C0205081|C0439793|C0030193|C0023216|C0030193|C0220912|C0521329|C0027740|C0040452|C0332459|C0205307|C1513492|C0237897|C0031809|C0582103|C1505993|C0449238|G0000000|C0026544|C0030193|C0542339|G0000000|C1282910|C1550262|C0332462
"In this exploratory study we found that adding high dose vitamin D3 supplementation during pregnancy to routine care of women with MS had significant effect on the serum 25(OH)D levels, EDSS, and number of relapse events during pregnancy and within 6 months after delivery.","In exploratory study adding dose vitamin D3 supplementation pregnancy routine care women MS serum 25(OH)D levels, EDSS, relapse events pregnancy 6 months delivery.",G0000000|G0000000|C0557651|C1883712|C0178602|C0042890|C3538936|C0242297|C0032961|C0205547|C1947933|C0043210|C0039676|C0229671|C0450371|C0441889|C0451246|C0035020|C0441471|C0032961|G0000000|C0439231|C0011209
Women were eligible to participate if they were (i) diagnosed with stages I–III breast cancer; (ii) at least 18 years old; (iii) proficient in English; (iv) had received chemotherapy 6–60 months prior to recruitment; (v) reporting subjectively assessed cognitive impairment since the initiation of chemotherapy (four items of the FACT-Cog [61]; see measures); (vi) living within 2 hours driving distance of the institution in order to participate in the meditation sessions; and (vii) receiving hormone therapy at the time of recruitment.,Women eligible participate (i) diagnosed stages I–III breast cancer; (ii) 18 old; (iii) proficient English; (iv) received chemotherapy 6–60 months prior recruitment; (v) reporting subjectively assessed cognitive impairment initiation chemotherapy (four items FACT-Cog [61]; measures); (vi) living 2 hours driving distance institution participate meditation sessions; (vii) receiving hormone therapy time recruitment.,C0043210|C1548635|G0000000|C0021966|C0011900|C1306673|G0000000|C0006141|C0006826|G0000000|C0450371|C0580836|C0439070|G0000000|C0376245|C0022326|C1514756|C0013216|G0000000|C0439231|C0332152|C2949735|G0000000|C0700287|G0000000|C1516048|C1516691|C0221099|C0589507|C0013216|C0205450|C1551338|C3641649|C0450371|C0079809|C0205999|C0376558|G0000000|C0439227|C0004379|C0012751|C0018704|G0000000|C0150277|C1883016|C0445385|C1514756|C0019932|C0039798|C0040223|C2949735
"The final sample is stratified in the following way: pregnant women, women with children 0–5 months of age, and women with children 6–11 months of age.","The final sample stratified way: pregnant women, women children 0–5 months age, women children 6–11 months age.",G0000000|C0205088|C0370003|C0205363|G0000000|C0549206|C0043210|C0043210|C0008059|G0000000|C0439231|C0001779|C0043210|C0008059|G0000000|C0439231|C0001779
"The trial was a prospective, open-label, single center investigation in patients with advanced pancreatic cancer who were treated with first-line chemotherapy in an outpatient setting.","The trial prospective, open-label, single center investigation patients advanced pancreatic cancer treated first-line chemotherapy outpatient setting.",G0000000|C0008976|C0023981|C1709323|C0037179|C0205099|C0220825|C0030705|C0205179|C0030274|C0006826|C1522326|C0205435|C0013216|C0029921|C0542559
"In the nephrology setting, Patients with chronic kidney disease (CKD) may remain asymptomatic at the early stages of the disease, leading to suboptimal care [2–4].","In nephrology setting, Patients chronic kidney disease (CKD) remain asymptomatic stages disease, leading suboptimal care [2–4].",G0000000|C0027712|C0542559|C0030705|C0205191|C0022646|C0012634|C1561643|G0000000|C0231221|C1306673|C0012634|C0332152|C2984009|C1947933|G0000000
"There are anticipated to be n = 25 communities in each arm (n = 1250 pregnant women, n = 1250 children 0–6 months old, and n = 1250 children 6–18 months old).","There anticipated n = 25 communities arm (n = 1250 pregnant women, n = 1250 children 0–6 months old, n = 1250 children 6–18 months old).",G0000000|C3840775|G0000000|C0009462|C0446516|G0000000|C0549206|C0043210|G0000000|C0008059|G0000000|C0439231|C0580836|G0000000|C0008059|G0000000|C0439231|C0580836
†Children had less than four parent-reported upper respiratory tract infections (URTIs) in the past 12 months.,†Children parent-reported upper respiratory tract infections (URTIs) 12 months.,G0000000|C4054215|C1282910|C0521346|C1185740|C3714514|G0000000|C0450371|C0439231
Long term renal function was assessed in the 36 surviving patients with a median age at follow-up of 6.7 years (range: 1.3-14.6 years) with median follow-up at the time of renal function assessment of 3.7years (range: 0.03-13.4 years) (Table 3).,Long term renal function assessed 36 surviving patients median age follow-up 6.7 (range: 1.3-14.6 years) median follow-up time renal function assessment 3.7years (range: 0.03-13.4 years) (Table 3).,C0205166|C0233324|C0022646|C0031843|C1516048|C0450371|C0310255|C0030705|C0549183|C0001779|C0589120|G0000000|C1514721|C0450371|C0439234|C0549183|C0589120|C0040223|C0022646|C0031843|C1261322|G0000000|C1514721|C0450371|C0439234|C0039224|G0000000
"The results of this analysis, in conjunction with analyses of mean pain scores at various time points (that is, pre-milnacipran exposure, study randomization and end of study), may provide some important insights about pain responses in patients who had received up to 4.5 years of prior milnacipran treatment.","The analysis, conjunction analyses pain scores time (that is, pre-milnacipran exposure, study randomization study), provide insights pain responses patients received 4.5 prior milnacipran treatment.",G0000000|C0002778|C2699427|C0002778|C0030193|C0449820|C0040223|G0000000|G0000000|C0332152|C0274281|C0557651|C0034656|C0557651|C1999230|C0233820|C0030193|C0871261|C0030705|C1514756|G0000000|C0332152|C1533126|C0039798
"Schools were cluster-randomized to receive class-based delivery, in which vaccine was offered to all girls enrolled in school class 6 in 2010, or age-based delivery, in which vaccine was offered to all girls born in 1998.","Schools cluster-randomized receive class-based delivery, vaccine offered girls enrolled school class 6 2010, age-based delivery, vaccine offered girls born 1998.",C0036375|C1555715|C1514756|C0456387|C0011209|C0042210|C1444648|C0870604|G0000000|C0036375|C0456387|G0000000|G0000000|C0001779|C0011209|C0042210|C1444648|C0870604|C0005615|G0000000
"They were also invited to participate in an examination of cerebrospinal fluid, which, however, was not a criterion of inclusion.","They invited participate examination cerebrospinal fluid, which, however, criterion inclusion.",G0000000|G0000000|G0000000|G0000000|G0000000|C0005889|G0000000|G0000000|C0243161|C0007637
Participants in the study were recruited by distributing letters to parents of children in 4 classrooms of the childcare facility that included children aged 3–5 y; these classrooms had a total of ∼75 children present at snack time.,Participants study recruited distributing letters parents children 4 classrooms childcare facility included children aged 3–5 y; classrooms total ∼75 children snack time.,C0679646|C0557651|G0000000|C0520511|C0282413|C0030551|C0008059|G0000000|C0870287|C0008067|C1547538|C0332257|C0008059|C0001779|G0000000|G0000000|C0870287|C0439175|G0000000|C0008059|C0453863|C0040223
Patients were grouped according to stage as follows.,Patients stage follows.,C0030705|C0205390|C0332283
The singing group (n=13 mean(SD) FEV1 44.4(14.4)% predicted) and film group (n=11 FEV1 63.5(25.5)%predicted) did not differ significantly at baseline.,The singing (n=13 mean(SD) FEV1 44.4(14.4)% predicted) film (n=11 FEV1 63.5(25.5)%predicted) baseline.,G0000000|C0234857|C0369718|C0444504|G0000000|C0450371|C0681842|C0086296|C0369718|G0000000|C0450371|C0168634
The program was adapted for use specifically for breast cancer survivors.,The program adapted breast cancer survivors.,G0000000|C1709697|C2937289|C0006141|C0006826|C0206194
A telephone-based screening interview was used to assess the eligibility of each candidate.,A telephone-based screening interview assess eligibility candidate.,G0000000|C0039457|C0220908|C0021822|C1516048|C0013893|G0000000
"Participants were randomly assigned to 1 of 3 groups: (1) supervised flexibility/balance/function exercise (FBF), (2) supervised aerobic exercise (AE), and (3) home exercise (control).","Participants randomly assigned 1 3 groups: (1) supervised flexibility/balance/function exercise (FBF), (2) supervised aerobic exercise (AE), (3) exercise (control).",C0679646|G0000000|C1516050|G0000000|G0000000|C0441833|G0000000|G0000000|C0242808|C0015259|G0000000|G0000000|G0000000|C1510824|C0015259|C3887670|G0000000|C0015259|C0243148
"Once patients were deemed eligible, they were randomly assigned to one of two treatment conditions: switching to treatment with clozapine or staying on their current antipsychotic medication.","Once patients deemed eligible, randomly assigned treatment conditions: switching treatment clozapine staying current antipsychotic medication.",C0585347|C0030705|G0000000|C1548635|G0000000|C1516050|C0039798|C0012634|C1707719|C0039798|C0009079|G0000000|C0521116|C0040615|C0013227
"To compare the efficacy and safety of scheduled low-dose, haloperidol vs. placebo for the prevention of delirium [Intensive Care Delirium Screening Checklist (ICDSC) ≥ 4)] administered to critically ill adults with subsyndromal delirium (ICDSC = 1-3).","To compare efficacy safety scheduled low-dose, haloperidol vs. placebo prevention delirium [Intensive Care Delirium Screening Checklist (ICDSC) ≥ 4)] administered critically ill adults subsyndromal delirium (ICDSC = 1-3).",C0040363|C1707455|C1280519|C0036043|C0086960|C0445550|C0018546|G0000000|C0032042|C0199176|C0011206|C0162425|C1947933|C0011206|C0220908|C1707357|G0000000|G0000000|G0000000|C1521801|G0000000|C0231218|C0001675|G0000000|C0011206|G0000000|G0000000|G0000000
This suggests that temporary reduction is probably real (no compensatory smoking) but not appropriate in the long term for highly dependent smokers [19].,This suggests temporary reduction real (no compensatory smoking) term highly dependent smokers [19].,G0000000|C1705535|C0205374|C0301630|C0237400|G0000000|C0231186|C0037369|C0233324|C0205250|C0851827|C0337664|C0450371
"From August 2004 to October 2008, a total of 241 lung cancer patients (International Classification of Diseases, 9th revision; ICD code 162) were recruited from Changhwa Christian Hospital (Changhwa County, Taiwan).","From August 2004 October 2008, total 241 lung cancer patients (International Classification Diseases, 9th revision; ICD code 162) recruited Changhwa Christian Hospital (Changhwa County, Taiwan).",G0000000|C3831448|G0000000|C3828732|G0000000|C0439175|C1442061|C0024109|C0006826|C0030705|C1512888|C0008902|C0012634|G0000000|C0439617|C0021122|C0009219|C1442061|G0000000|G0000000|C0008532|C0019994|G0000000|C0079170|C0039260
Patients with stage III and stage IV disease were randomized to receive six cycles of either C5V or CC with or without amifostine.,Patients stage III stage IV disease randomized receive cycles C5V CC amifostine.,C0030705|C0205390|C0439070|C0205390|C0022326|C0012634|C0034656|C1514756|C1511572|G0000000|C3538933|C0015020
Physician participants will be randomly assigned in groups (n = 3/group) to a 30-h CST program (experimental group) or to a waiting list (control group).,Physician participants randomly assigned (n = 3/group) 30-h CST program (experimental group) waiting list (control group).,C0031831|C0679646|G0000000|C1516050|C0369718|G0000000|C0441833|C0450371|C3539520|C1709697|C1517586|C0441833|C1610166|C0745732|C0243148|C0441833
"Sixty-three post-treatment stage 0–III borderline overweight and obese (body mass index ≥ 24 kg/m2) breast cancer survivors were randomly assigned to a 6-month, facility- and home-based viniyoga intervention (n = 32) or a waitlist control group (n = 31).","Sixty-three post-treatment stage 0–III borderline overweight obese (body mass ≥ 24 kg/m2) breast cancer survivors randomly assigned 6-month, facility- home-based viniyoga intervention (n = 32) waitlist control (n = 31).",C3816724|C2709088|C0205390|G0000000|C0205189|C0497406|C0028754|C0242821|C0577559|G0000000|C0450371|C0022718|C0006141|C0006826|C0206194|G0000000|C1516050|C0332177|C1547538|C0442519|G0000000|C0886296|C0369718|G0000000|C0450371|C0043010|C0243148|C0369718|G0000000|C0450371
"Inclusion criteria were age between 3-12 year, administering insulin by mothers by use of syringe or insulin pen, as well as observed behavioral distress in children, or what their mothers’ stated as children’s distress while injecting insulin, willing to participate in the study, no morbidity of specific mental and physical disorders, and home availability of computer.","Inclusion criteria age 3-12 year, administering insulin mothers syringe insulin pen, observed behavioral distress children, mothers’ stated children’s distress injecting insulin, participate study, morbidity specific mental physical disorders, availability computer.",C0007637|C0243161|C0001779|C0450371|C0439234|C1533734|C0021641|C0026591|C0039142|C0021641|C3273588|C1441672|C0004927|C0231303|C0008059|G0000000|C1301808|G0000000|C0231303|C1720154|C0021641|G0000000|C0557651|C0026538|C0205369|C0229992|C0031809|C0012634|C0470187|C0009622
"Exclusion criteria included a strong indication, or contraindication, for corticosteroid therapy, based on the judgement of the treating physician (patients were included if the patient and physician had clinical equipoise regarding the use of the treatment), or the use of systemic immunosuppressive therapy in the previous year.","Exclusion criteria included strong indication, contraindication, corticosteroid therapy, based judgement treating physician (patients included patient physician clinical equipoise treatment), systemic immunosuppressive therapy previous year.",C0680251|C0243161|C0332257|C0442821|C0392360|C0522473|C0001617|C0039798|C1527178|C0022423|C1522326|C0031831|C0030705|C0332257|C0030705|C0031831|C0205210|C0702057|C0039798|C0205373|C0021081|C0039798|C0205156|C0439234
This study only used male participants in order to control for any physiological variables between genders.,This study male participants control physiological variables genders.,G0000000|C0557651|C0086582|C0679646|C0243148|C0205463|C0439828|C0079399
Surgeons approached patients who were candidates for spinal fusion.,Surgeons approached patients candidates spinal fusion.,C0582175|C0449445|C0030705|G0000000|C0521329|C0332466
"There were 4 smokers in the flexibility and relaxation group and 5 smokers in the walking and Nordic walking group, respectively.","There 4 smokers flexibility relaxation 5 smokers walking Nordic walking group, respectively.",G0000000|G0000000|C0337664|C0242808|C0035028|G0000000|C0337664|C0080331|C0331873|C0080331|C0441833|G0000000
"Inclusion criteria specified non-pregnant women and age 40-80 years, with primary osteoarthritis of at least one knee.","Inclusion criteria non-pregnant women age 40-80 years, primary osteoarthritis knee.",C0007637|C0243161|C1518422|C0043210|C0001779|C0450371|C0439234|C0205225|C0029408|C0022742
"Subjects who could sit independently for at least 30 minutes, who had a Korean Mini Mental State Examination (MMSE-K) score of > 21 points, who had not participated in any balance training program during the previous six months, who had no orthopedic problems, such as a fracture, deformity, or severe osteoarthritis, and who were not taking any drugs for balance maintenance were included.","Subjects sit independently 30 minutes, Korean Mini Mental State Examination (MMSE-K) score > 21 points, participated balance training program previous months, orthopedic problems, fracture, deformity, severe osteoarthritis, drugs balance maintenance included.",C0681850|C0277814|G0000000|C0450371|C0439232|C1556095|C0445542|C0229992|C1301808|G0000000|C0451306|C0449820|G0000000|C0450371|C1552961|G0000000|C0014653|C0040607|C1709697|C0205156|C0439231|C0029355|C1546466|C0016658|C0000768|C0205082|C0029408|C0013227|C0014653|C0024501|C0332257
Study population: Smokers (n = 3024) aged 14 to 75 years consulting for any reason to PCC and who provided written informed consent to participate in the trial.,Study population: Smokers (n = 3024) aged 14 75 consulting reason PCC provided written informed consent participate trial.,C0557651|C0032659|C0337664|C0369718|G0000000|G0000000|C0001779|C0450371|C0450371|C0009818|C0392360|C0031511|C1999230|C0043266|C1522154|C1511481|G0000000|C0008976
"In a randomised trial in patients under the age of 70 years, PACEBOM was shown to be as efficacious as CHOP (Linch et al, 2000).","In randomised trial patients age 70 years, PACEBOM efficacious CHOP (Linch al, 2000).",G0000000|G0000000|C0008976|C0030705|C0001779|C0450371|C0439234|G0000000|C1280519|C2945739|G0000000|C0202311|G0000000
"In this blind clinical trial, 67 primiparous women with natural pregnancy at 34–36 weeks of gestational age and with no indication of cesarean section were selected from the health care centers in Mashhad.","In blind clinical trial, 67 primiparous women natural pregnancy 34–36 weeks gestational age indication cesarean selected health care centers Mashhad.",G0000000|C0150108|C0205210|C0008976|C0450371|C0033150|C0043210|C0205296|C0032961|G0000000|C0439230|C0439671|C0001779|C0392360|C3841297|C1707391|C0018684|C1947933|C0205099|G0000000
Non cephalic presentation in childbirth involves various risks to both the mother and the foetus.,Non cephalic presentation childbirth involves risks mother foetus.,C1518422|C0205096|C0449450|C0005615|G0000000|C0035647|C0026591|C0015965
"appropriate candidates for combination ICS/long-acting β2-adrenoceptor agonist [LABA] therapy): age ≥40 years, diagnosis of symptomatic COPD for >2 years, ≥10 pack-year smoking history, prebronchodilator forced expiratory volume in 1 second (FEV1) of ≤50% of predicted normal and prebronchodilator FEV1/forced vital capacity (FVC) of <70%.","candidates combination ICS/long-acting β2-adrenoceptor agonist [LABA] therapy): age ≥40 years, diagnosis symptomatic COPD >2 years, ≥10 pack-year smoking history, prebronchodilator forced expiratory volume 1 (FEV1) ≤50% predicted normal prebronchodilator FEV1/forced vital capacity (FVC) <70%.",G0000000|C0205195|C0022521|G0000000|C2987634|G0000000|C0039798|C0001779|G0000000|C0439234|C0011900|C0231220|C0024117|G0000000|C0439234|G0000000|C1277691|C0037369|C0019664|C2599602|C0441722|C0231800|C0449468|G0000000|G0000000|G0000000|C0681842|C0205307|C2599602|C0441722|C0442732|C1516240|C3714541|C0450371
"One hundred children (2 to 9 years of age) with mild-to-moderate AD were recruited from the Pediatric Allergy and Respiratory Center of Soonchunhyang University Hospital, a tertiary medical center located in Seoul, Korea.","One children (2 9 age) mild-to-moderate AD recruited Pediatric Allergy Respiratory Center Soonchunhyang University Hospital, tertiary medical center located Seoul, Korea.",C0205447|C0008059|G0000000|G0000000|C0001779|C1299392|G0000000|G0000000|C0030755|C0002111|C0521346|C0205099|G0000000|C0041740|C0019994|C0205372|C0199168|C0205099|G0000000|C3850150|C0022771
"They were also excluded if any physical damage, making the subjects unable to continue their participation, was made or if they used new medical treatments (new drugs effective on pain, physical therapy or other methods).","They excluded physical damage, subjects unable continue participation, medical treatments (new drugs effective pain, physical therapy methods).",G0000000|C1554077|C0031809|C0010957|C0681850|C1299582|C0549178|C0679823|C0199168|C0087111|C0205314|C0013227|C1280519|C0030193|C0031809|C0039798|C0025663
"Patients with photosensitivity, eye disorders, history of mood swings, mania, pregnancy, lactation, positive serology for syphilis, and age less than five years were excluded from the study.","Patients photosensitivity, eye disorders, history mood swings, mania, pregnancy, lactation, positive serology syphilis, age excluded study.",C0030705|C0349506|C0015392|C0012634|C0019664|C0026516|G0000000|C0338831|C0032961|C0006147|C0439178|C0036745|C0039128|C0001779|C1554077|C0557651
Those who reported current yoga practice or prior yoga practice exceeding three months were also excluded.,Those reported current yoga practice prior yoga practice exceeding months excluded.,G0000000|C0684224|C0521116|C0043418|C0237607|C0332152|C0043418|C0237607|G0000000|C0439231|C1554077
"A total of 274 male and female patients, aged 18 to 65 years, were enrolled in the 2 studies (134 in Study 1 and 140 in Study 2; Figure 1).","A total 274 male female patients, aged 18 65 years, enrolled 2 studies (134 Study 1 140 Study 2; Figure 1).",G0000000|C0439175|C1442061|C0086582|C0015780|C0030705|C0001779|C0450371|C0450371|C0439234|G0000000|G0000000|C0947630|C1442061|C0557651|G0000000|C1442061|C0557651|G0000000|G0000000|G0000000
"A total of 49.5% of companions were already present when the parturient was admitted to hospital, while 50.5% were located and invited to participate by telephone.","A total 49.5% companions parturient admitted hospital, 50.5% located invited participate telephone.",G0000000|C0439175|C0450371|C0335343|G0000000|C0184666|C0019994|C0450371|G0000000|G0000000|G0000000|C0039457
"Consistent with the demographics in the Rochester (NY) City School District, PCGs were mostly African American, single mothers who were at least 30 years old.","Consistent demographics Rochester (NY) City School District, PCGs African American, single mothers 30 old.",C0332290|C0011298|G0000000|C0027976|C0008848|C0036375|G0000000|C1623167|C0027567|C0596070|C0037179|C0026591|C0450371|C0580836
"Eighty two patients were randomly assigned in 18 CF centres, 40 to receive azithromycin and 42 placebo.","Eighty patients randomly assigned 18 CF centres, 40 receive azithromycin 42 placebo.",C3816958|C0030705|G0000000|C1516050|C0450371|C0009738|C0205099|C0450371|C1514756|C0052796|C0450371|C0032042
"Eligible patients had an expected length of stay in the ICU of more than 24 hours, were Dutch- or English-speaking and scored a minimum Glasgow Coma Scale of 10.","Eligible patients expected length stay ICU 24 hours, Dutch- English-speaking scored minimum Glasgow Coma Scale 10.",C1548635|C0030705|C1517001|C1444754|G0000000|C0021708|C0450371|C0439227|C0013331|C0376245|C0449820|C1524031|G0000000|C0009421|C0175659|C0450371
In late or slow-adopter communities like rural areas of Phu-Cuong (i.e.,In late slow-adopter communities rural Phu-Cuong (i.e.,G0000000|C0205087|C0439834|C0009462|C0240919|G0000000|C0683454
"Routine criteria for OTP admission included children aged between 6 and 59 months with a weight-for-height Z (WHZ) score of < −3 and/or a mid-upper-arm-circumference (MUAC) of < 115 mm, and/or the presence of mild or moderate bilateral edema.","Routine criteria OTP admission included children aged 6 59 months weight-for-height Z (WHZ) score < −3 and/or mid-upper-arm-circumference (MUAC) < 115 mm, and/or presence mild moderate bilateral edema.",C0205547|C0243161|C1418198|C0184666|C0332257|C0008059|C0001779|G0000000|C0450371|C0439231|C0005910|G0000000|G0000000|C0449820|G0000000|G0000000|G0000000|C0562351|G0000000|G0000000|C1442061|G0000000|G0000000|C0150312|C2945599|C0205081|C0238767|C0013604
Participants were patients with FM referred for a one week SMP at Lillehammer Hospital for Rheumatic Diseases.,Participants patients FM referred week SMP Lillehammer Hospital Rheumatic Diseases.,C0679646|C0030705|C3540627|C0205543|C0332174|C1428758|G0000000|C0019994|G0000000|C0012634
Twenty-six percent of the participants withdrew from FBT (n = 20) and 25% (n = 20) withdrew from SyFT.,Twenty-six percent participants withdrew FBT (n = 20) 25% (n = 20) withdrew SyFT.,C0724000|C0439165|C0679646|C2349954|G0000000|C0369718|G0000000|C0450371|C0450371|C0369718|G0000000|C0450371|C2349954|G0000000
"The present longitudinal study was carried out on 45 primary molars in 37 children (age group 4–7 years) at Sudha Rustagi Dental College, Faridabad over a period of 9 months.","The longitudinal study carried 45 primary molars 37 children (age 4–7 years) Sudha Rustagi Dental College, Faridabad period 9 months.",G0000000|C0205127|C0557651|C0206243|C0450371|C0205225|C0026367|C0450371|C0008059|C0001779|G0000000|C0439234|G0000000|G0000000|C0011365|C0557806|G0000000|C0439531|G0000000|C0439231
Oral and written consent was obtained from the selected mothers and guardians before administering the questionnaires.,Oral written consent selected mothers guardians administering questionnaires.,C0442027|C0043266|C1511481|C1707391|C0026591|C1274041|C1533734|C0034394
"and AHI while on APAP, but prior to randomization to the study intervention (ramelteon or placebo).","AHI APAP, prior randomization study intervention (ramelteon placebo).",G0000000|C0000970|C0332152|C0034656|C0557651|C0886296|C1565316|C0032042
"The following patients were excluded: the patients with depression who were unable to cooperate in the treatment; the patients who cannot perform the active task training due to the presence of musculoskeletal problems, such as the spasticity of Modified Ashworth Scale (MAS) II or higher; and the patients who have complex regional pain syndrome or secondary adhesive capsulitis.","The patients excluded: patients depression unable cooperate treatment; patients perform active task training presence musculoskeletal problems, spasticity Modified Ashworth Scale (MAS) II higher; patients complex regional pain syndrome secondary adhesive capsulitis.",G0000000|C0030705|C1554077|C0030705|C0011570|C1299582|G0000000|C0039798|C0030705|C0884358|C0205177|C3540678|C0040607|C0150312|C0497254|C1546466|C0026838|C0392747|G0000000|C0175659|C1096155|G0000000|C0205250|C0030705|C0439855|C0205147|C0030193|C0039082|C0027627|C0001516|C0263907
Eight patients with bilateral primary congenital glaucoma were enrolled in the study.,Eight patients bilateral primary congenital glaucoma enrolled study.,C0205454|C0030705|C0238767|C0205225|C0009678|C0017601|G0000000|C0557651
Randomization will be performed during surgery after finding the internal opening.,Randomization performed surgery finding internal opening.,C0034656|C0884358|C0038894|C0037088|C0205102|C0175566
"Exclusion criteria were a history of either invasive vulvar, vaginal, anal or cervical cancer, but not a history of CIN.","Exclusion criteria history invasive vulvar, vaginal, anal cervical cancer, history CIN.",C0680251|C0243161|C0019664|C0205281|C0042993|C0042232|C0003461|C0027530|C0006826|C0019664|G0000000
"If two or more villages are immediately adjacent to each other, we only selected one so as to minimize the likelihood of spillover.","If villages adjacent other, selected minimize likelihood spillover.",G0000000|C0562518|C0205117|G0000000|C1707391|G0000000|C0033204|G0000000
"In the UK, there are currently around 550,000 breast cancer survivors [2].","In UK, 550,000 breast cancer survivors [2].",G0000000|C0041700|C1442061|C0006141|C0006826|C0206194|G0000000
"In accordance with the Oxford and CDC criteria [1,2], patients whose fatigue is explained by any active medical condition are excluded, as are patients with schizophrenia, bipolar disorder, dementia, eating disorders or substance abuse.","In Oxford CDC criteria [1,2], patients fatigue explained active medical condition excluded, patients schizophrenia, bipolar disorder, dementia, eating disorders substance abuse.",G0000000|G0000000|C0007670|C0243161|G0000000|C0030705|C0015672|G0000000|C0205177|C0199168|C0012634|C1554077|C0030705|C0036341|C0443156|C0012634|C0011265|C0013470|C0012634|C0439861|C0013146
"Study exclusion criteria were: uncontrolled hypertension, on-state freezing or exercise limitations from other disorders, and Mini-Mental State Examination45 score of less than 24.","Study exclusion criteria were: uncontrolled hypertension, on-state freezing exercise limitations disorders, Mini-Mental State Examination45 score 24.",C0557651|C0680251|C0243161|G0000000|C0205318|C0020538|C1720176|C0016701|C0015259|C0449295|C0012634|C0445542|C1301808|G0000000|C0449820|C0450371
"Patients with neglect, pusher syndrome, visual deficits, and history of multiple stroke, or comorbidities that influenced lower extremity usage were excluded.","Patients neglect, pusher syndrome, visual deficits, history multiple stroke, comorbidities influenced lower extremity usage excluded.",C0030705|C0521874|C1709778|C0039082|C0234621|C2987487|C0019664|C0439064|C0038454|C0009488|G0000000|C0441994|C0015385|C0457083|C1554077
"Patients 6 to 14 years of age, having wetting episodes at least twice per week over 3 consecutive months, and whose parents agreed to allocation of treatment were eligible for enrollment.","Patients 6 14 age, wetting episodes week 3 consecutive months, parents agreed allocation treatment eligible enrollment.",C0030705|G0000000|C0450371|C0001779|C0162598|C0332189|C0332174|G0000000|C1707491|C0439231|C0030551|C3641827|C1706778|C0039798|C1548635|C1516879
"• Stable medication for the past 1 month and anticipated over a period of 6 months • Psychiatric co-morbidity (e.g., major depressive disorder as determined by DSM IV criteria) • Clinical diagnosis of dementia or other severe cognitive impairment (Mini Mental State Exam score <24) • History of stroke, traumatic brain injury or other neurological disorders (other than PD and MCI, for those groups) • Acute lower back or lower extremity pain, peripheral neuropathy, rheumatic and orthopaedic diseases • Unstable medical condition including cardio-vascular instability in the past 6 months • Unable to comply with the training or currently participating in another interfering therapy or a fall clinics programInterfering therapy  Inclusion • Diagnosis of idiopathic PD, as defined by the UK Brain Bank criteria • Hoehn and Yahr stage II-III • Taking anti-Parkinsonian medication • Stable medication for past 1 month and anticipated over next 6 months or stable Deep Brain Stimulation for at least one month and expected following 6 months Exclusion • Severe freezing of gait (defined as having >15 on the new FOG questionnaire) [53]  Inclusion • Score 0.5 on the Clinical Dementia Rating Scale (CDR) • Free from any neurological disorders that may have caused the cognitive impairment The primary outcome measure is fall incidence rates during the 6 month post-training follow-up period.","• Stable medication 1 month anticipated period 6 months • Psychiatric co-morbidity (e.g., major depressive disorder determined DSM IV criteria) • Clinical diagnosis dementia severe cognitive impairment (Mini Mental State Exam score <24) • History stroke, traumatic brain injury neurological disorders (other PD MCI, groups) • Acute lower lower extremity pain, peripheral neuropathy, rheumatic orthopaedic diseases • Unstable medical condition including cardio-vascular instability 6 months • Unable comply training participating interfering therapy fall clinics programInterfering therapy Inclusion • Diagnosis idiopathic PD, defined UK Brain Bank criteria • Hoehn Yahr stage II-III • Taking anti-Parkinsonian medication • Stable medication 1 month anticipated 6 months stable Deep Brain Stimulation month expected 6 months Exclusion • Severe freezing gait (defined >15 FOG questionnaire) [53] Inclusion • Score 0.5 Clinical Dementia Rating Scale (CDR) • Free neurological disorders caused cognitive impairment The primary outcome measure fall incidence rates 6 month post-training follow-up period.",G0000000|C0205360|C0013227|G0000000|C0332177|C3840775|C0439531|G0000000|C0439231|G0000000|C0205487|C0009488|G0000000|C0205082|G0000000|C0012634|G0000000|G0000000|C0022326|C0243161|G0000000|C0205210|C0011900|C0011265|C0205082|C1516691|C0221099|C0445542|C0229992|C1301808|C0582103|C0449820|C0450371|G0000000|C0019664|C0038454|C0332663|C0006104|C3263722|C0205494|C0012634|G0000000|G0000000|C0560005|C0441833|G0000000|C0205178|C0441994|C0441994|C0015385|C0030193|C0205100|C0442874|G0000000|C0029355|C0012634|G0000000|C0443343|C0199168|C0012634|C0332257|C0018787|C1444783|G0000000|C0439231|G0000000|C1299582|C0725694|C0040607|C0679823|C0521102|C0039798|C0085639|C0442592|G0000000|C0039798|C0007637|G0000000|C0011900|C0332240|G0000000|C1704788|C0041700|C0006104|C0442598|C0243161|G0000000|G0000000|G0000000|C0205390|C0439070|G0000000|G0000000|G0000000|C0013227|G0000000|C0205360|C0013227|G0000000|C0332177|C3840775|G0000000|C0439231|C0205360|C0205125|C0006104|C1292856|C0332177|C1517001|G0000000|C0439231|C0680251|G0000000|C0205082|C0016701|C0016928|C1704788|C0450371|C0450030|C0034394|C0450371|C0007637|G0000000|C0449820|G0000000|C0205210|C0011265|C0871208|C0175659|G0000000|G0000000|C0332296|C0205494|C0012634|C0015127|C1516691|C0221099|G0000000|C0205225|C1274040|C0079809|C0085639|C0021149|C0871208|G0000000|C0332177|C1709607|C0589120|C0439531
A total of 68 patients with type 2 diabetes (range: 40–79 years) suffering from mild or moderate NPDR were enrolled.,A total 68 patients type 2 diabetes (range: 40–79 years) suffering mild moderate NPDR enrolled.,G0000000|C0439175|C0450371|C0030705|C0332307|G0000000|C0011847|C1514721|G0000000|C0439234|C0683278|C2945599|C0205081|G0000000|G0000000
"This 26 week, randomised, double blind, placebo controlled, parallel group study was conducted at 37 centres in Australia, Canada, Ireland, Italy, South Africa and the UK.","This 26 week, randomised, double blind, placebo controlled, parallel study conducted 37 centres Australia, Canada, Ireland, Italy, South Africa UK.",G0000000|G0000000|G0000000|C0205173|C0150108|C0032042|C2587213|C2348042|C0557651|C0004927|C0450371|C0205099|C0004340|C0006823|C0022067|C0022277|C1710133|C0001737|C0041700
Patients were randomly assigned to duloxetine 40 or 60 mg or placebo groups in a 1:1:2 ratio by stochastic minimization allocation taking into account the following four factors: (i) weekly mean of 24‐h average pain score at baseline < or ≥6; (ii) duration of diabetic neuropathy < or ≥2 years; (iii) type 1 or type 2 diabetes mellitus; and (iv) each study center.,Patients randomly assigned duloxetine 40 60 mg placebo 1:1:2 ratio stochastic minimization allocation account factors: (i) weekly 24‐h average pain score baseline < ≥6; (ii) duration diabetic neuropathy < ≥2 years; (iii) type 1 type 2 diabetes mellitus; (iv) study center.,C0030705|G0000000|C1516050|C0245561|C0450371|G0000000|C0032042|G0000000|C0456603|G0000000|G0000000|C1706778|C2741673|C1521761|C0021966|C0332174|G0000000|C1510992|C0030193|C0449820|C0168634|G0000000|G0000000|G0000000|C0449238|C0241863|C0442874|G0000000|G0000000|C0439070|G0000000|G0000000|C0011847|G0000000|C0022326|C0557651|C0205099
"Use of alternative entry screening approaches and intervals between official confirmation of first imported pandemic influenza A (H1N1) case and official confirmation of first untraceable local case for 26 nations with more than 100 confirmed cases by July 6, 2009.","Use alternative entry screening approaches intervals official confirmation imported pandemic influenza A (H1N1) official confirmation untraceable local 26 nations 100 confirmed July 6, 2009.",C0042153|C1523987|C1705654|C0220908|C0449445|C1272706|C2347387|C0521091|C0699788|C1615608|C0021400|G0000000|G0000000|C2347387|C0521091|G0000000|C0205276|C0450371|C1555720|C1442061|C0521093|C3829447|G0000000|G0000000
"Patients were eligible for inclusion if they were 18–55 years of age with clinically definite MS according to McDonald criteria and an EDSS score of 0–6.5.15,16 Patients could continue with their MS disease-modifying medication while in the trial, the monitoring of which was performed by authors Dr. Burton and Dr. O'Connor.","Patients eligible inclusion 18–55 age clinically definite MS McDonald criteria EDSS score 0–6.5.15,16 Patients continue MS disease-modifying medication trial, monitoring performed authors Dr. Burton Dr. O'Connor.",C0030705|C1548635|C0007637|G0000000|C0001779|G0000000|C0439544|C0039676|G0000000|C0243161|C0451246|C0449820|G0000000|C0030705|C0549178|C0039676|C0012634|C0013227|C0008976|C0150369|C0884358|C3812881|C0013014|G0000000|C0013014|C0483204
Participants are read a list of 12 words and asked to recall as many as possible after 1 trial.,Participants read list 12 recall 1 trial.,C0679646|C0034754|C0745732|C0450371|C0034770|G0000000|C0008976
"The participants were, on average, 26.5 ± 4.8 y of age and at 21.8 ± 3.4 gestational weeks at randomization.","The participants were, average, 26.5 ± 4.8 age 21.8 ± 3.4 gestational weeks randomization.",G0000000|C0679646|G0000000|C1510992|C0450371|G0000000|G0000000|C0001779|C0450371|G0000000|G0000000|C0439671|C0439230|C0034656
Patients 18 years of age or older who had histologically confirmed metastatic melanoma with either BRAF V600E or BRAF V600K mutations were eligible for inclusion.,Patients 18 age histologically confirmed metastatic melanoma BRAF V600E BRAF V600K mutations eligible inclusion.,C0030705|C0450371|C0001779|C0205462|C0521093|C0036525|C0025202|C0104940|G0000000|C0104940|G0000000|C0026882|C1548635|C0007637
We hypothesised that dexmedetomidine would be more effective than haloperidol in the treatment of ICU-associated delirious agitation in mechanically ventilated patients.,We hypothesised dexmedetomidine effective haloperidol treatment ICU-associated delirious agitation mechanically ventilated patients.,G0000000|G0000000|C0113293|C1280519|C0018546|C0039798|C0021708|C0011206|C0085631|G0000000|C0231923|C0030705
"Of the two clinics selected, one was a primary care clinic (viz., a family medicine clinic with seven physicians) while the other was a specialty clinic (viz., pulmonary medicine with six physicians).","Of clinics selected, primary care clinic (viz., family medicine clinic physicians) specialty clinic (viz., pulmonary medicine physicians).",G0000000|C0442592|C1707391|C0205225|C1947933|C0002424|G0000000|C0015576|C0013227|C0002424|C0031831|C0037778|C0002424|G0000000|C0024109|C0013227|C0031831
"STRONG participants include 60 community-dwelling elderly people aged 90 years or over recruited from a geriatric nursing home (Los Nogales-Pacífico, Madrid, Spain).","STRONG participants 60 community-dwelling elderly people aged 90 recruited geriatric nursing (Los Nogales-Pacífico, Madrid, Spain).",C0442821|C0679646|C0450371|C4045975|C0001792|C0027361|C0001779|C0450371|G0000000|C1704440|C0006147|G0000000|G0000000|G0000000|C0037747
"M.Y., T.M., H.M. have full access to the data.","M.Y., T.M., H.M. access data.",C3846401|C2603360|C2348952|C0444454|C1511726
To compare the efficacy and tolerability of Hypericum perforatum (St John's wort extract) with imipramine in patients with mild to moderate depression.,To compare efficacy tolerability Hypericum perforatum (St John's wort extract) imipramine patients mild moderate depression.,C0040363|C1707455|C1280519|C3274448|C1256259|G0000000|C0036056|G0000000|G0000000|C2828366|C0020934|C0030705|C2945599|C0205081|C0011570
"Exclusion criteria are as follows: trauma occurrence within the past 4 weeks; non-resident of Australia; less than 18 years of age; currently receiving treatment for trauma/PTSD; frequent suicidal ideation (indicated by a score of 3 to item 9 of the Patient Health Questionnaire 9-item version (PHQ9)); regularly using illicit drugs or regularly consuming more than three standard drinks per day; psychotic disorder or taking atypical antipsychotics or benzodiazepines; if taking medication for anxiety or depression, has been taking the same dose for less than 1 month or intending to change the dose during the course of the program; currently highly dissociative (indicated by score ≥40 on the Dissociative Experiences Scale as per Spence et al.","Exclusion criteria follows: trauma occurrence 4 weeks; non-resident Australia; 18 age; receiving treatment trauma/PTSD; frequent suicidal ideation (indicated score 3 item 9 Patient Health Questionnaire 9-item version (PHQ9)); regularly illicit drugs regularly consuming standard drinks day; psychotic disorder atypical antipsychotics benzodiazepines; medication anxiety depression, dose 1 month intending change dose program; highly dissociative (indicated score ≥40 Dissociative Experiences Scale Spence al.",C0680251|C0243161|C0332283|C0043251|C0243132|G0000000|C0439230|C1518422|C0004340|C0450371|C0001779|C1514756|C0039798|C0043251|C0332183|C0438696|C0392348|C1444656|C0449820|G0000000|C1551338|G0000000|C0030705|C0018684|C0034394|C1551338|C0333052|G0000000|G0000000|C0332266|C0013227|G0000000|G0000000|C1442989|C0452428|C0332173|C0004936|C0012634|C0205182|C0040615|C0005064|C0013227|C0003467|C0011570|C0178602|G0000000|C0332177|G0000000|C0392747|C0178602|C1709697|C0205250|C0086168|C1444656|C0449820|G0000000|C0086168|C0596545|C0175659|G0000000|C0202311
The mean age of the children participated in this study was observed to be 6.5 ± 1.2 years with 33 boys and 15 girls in both the groups.,The age children participated study observed 6.5 ± 1.2 33 boys 15 girls groups.,G0000000|C0001779|C0008059|G0000000|C0557651|C1441672|G0000000|G0000000|G0000000|C0450371|C0870221|C0450371|C0870604|C0441833
Families were eligible for inclusion if they met the following criteria: nonsmoking mothers and their newborns were currently exposed to SHS in the home; fathers currently smoked cigarettes in the home; the parents both owned a mobile phone that could receive text messages; and the family was able to provide informed consent.,Families eligible inclusion met criteria: nonsmoking mothers newborns exposed SHS home; fathers smoked cigarettes home; parents owned mobile phone receive text messages; family provide informed consent.,C0015576|C1548635|C0007637|C0268621|C0243161|G0000000|C0026591|C0021289|C0332157|G0000000|C0442519|C0015671|C0037366|C0677453|C0442519|C0030551|G0000000|C0231435|C1515258|C1514756|C1527021|C0470166|C0015576|C1999230|C1522154|C1511481
"Participants were 148 individuals (119 men, 29 women), diagnosed with HIV disease; 112 (76%) completing the study groups.","Participants 148 individuals (119 men, 29 women), diagnosed HIV disease; 112 (76%) completing study groups.",C0679646|C1442061|C0027361|C1442061|C0025266|C0450371|C0043210|C0011900|C0019682|C0012634|C1442061|C0450371|C0205197|C0557651|C0441833
"The cases were women with a newly diagnosed, histologically confirmed epithelial endometrial cancer, identified through the New Jersey State Cancer Registry between July 1, 2001 and June 30, 2005.","The women newly diagnosed, histologically confirmed epithelial endometrial cancer, identified New Jersey State Cancer Registry July 1, 2001 June 30, 2005.",G0000000|C0043210|C0750546|C0011900|C0205462|C0521093|C0221908|C0227843|C0006826|C0205396|C0205314|C0454673|C1301808|C0006826|C0034975|C3829447|G0000000|G0000000|C3829443|C0450371|G0000000
185 children age 8-17 years with a diagnosis of Crohn's (CD) or Ulcerative Colitis (UC) and their parents were randomized to one of two 3-session conditions: 1.),185 children age 8-17 diagnosis Crohn's (CD) Ulcerative Colitis (UC) parents randomized 3-session conditions: 1.),C1442061|C0008059|C0001779|C0450371|C0011900|C0010346|C0007928|C0041582|C0009319|G0000000|C0030551|C0034656|C1883016|C0012634|G0000000
"As only patients with moderate thalamic hemorrhage will be enrolled in this trial, it is unlikely that our study will include many, if any, subjects with hand paresis only.","As patients moderate thalamic hemorrhage enrolled trial, study many, any, subjects hand paresis only.",G0000000|C0030705|C0205081|C0039729|C0019080|G0000000|C0008976|C0557651|G0000000|G0000000|C0681850|C0018563|C0030552|C0205171
"Patients with characteristics indicative of a high risk for bacterial infection (ie, ICU requirement, active chemotherapy or radiation, immunosuppression, definitive infiltrate on chest radiograph, enrollment systolic blood pressure of <90 mm Hg, and ≥15% band forms in peripheral blood) were excluded.","Patients characteristics indicative risk bacterial infection (ie, ICU requirement, active chemotherapy radiation, immunosuppression, definitive infiltrate chest radiograph, enrollment systolic blood pressure <90 mm Hg, ≥15% band forms peripheral blood) excluded.",C0030705|C1521970|G0000000|C0035647|C0521009|C0009450|G0000000|C0021708|C1514873|C0205177|C0013216|C0034519|C0021079|C0443196|C0332448|C0817096|C1306645|C1516879|C0039155|C0005767|C0033095|C0450371|G0000000|C0025424|G0000000|C0175723|C0348078|C0205100|C0005767|C1554077
"All patients diagnosed with pulmonary drug-sensitive TB, and attending intervention clinics within the period 1 July 2009 to 31 March 2010 were recruited into the trial and started receiving the voucher immediately, irrespective of their stage of treatment.","All patients diagnosed pulmonary drug-sensitive TB, attending intervention clinics period 1 July 2009 31 March 2010 recruited trial started receiving voucher immediately, irrespective stage treatment.",G0000000|C0030705|C0011900|C0024109|C0013227|G0000000|C1547429|C0886296|C0442592|C0439531|G0000000|C3829447|G0000000|C0450371|C3829202|G0000000|G0000000|C0008976|C1272689|C1514756|C0872304|C0205548|G0000000|C0205390|C0039798
"METHODS—In a randomised, double blind, controlled trial in 168 patients clinically accepted for parenteral nutrition, standard feeds were compared with feeds in which 3.8 g of the total nitrogen was replaced with the equivalent 20 g glutamine.","METHODS—In randomised, double blind, controlled trial 168 patients clinically accepted parenteral nutrition, standard feeds compared feeds 3.8 total nitrogen replaced equivalent 20 glutamine.",G0000000|G0000000|C0205173|C0150108|C2587213|C0008976|C1442061|C0030705|G0000000|C1272684|C0030547|C0028707|C1442989|C1510670|C1707455|C1510670|G0000000|C0439175|C0028158|C0559956|C0205163|C0450371|C0017797
"The study participants were a cohort of 432 infants residing in Lungwena, Malindi and Mangochi from rural Malawi who participated in the iLiNS Project DYAD-Malawi nutrient supplementation trial, part of the iLiNS Project [20].","The study participants cohort 432 infants residing Lungwena, Malindi Mangochi rural Malawi participated iLiNS Project DYAD-Malawi nutrient supplementation trial, iLiNS Project [20].",G0000000|C0557651|C0679646|C0599755|C1442061|C0021270|C2982691|G0000000|G0000000|G0000000|C0240919|C0024548|G0000000|G0000000|C1709701|C0870454|C0678695|C0242297|C0008976|G0000000|C1709701|C0450371
Treatment was commenced with the onset of menstruation or when pain is felt to be impending (up to two days before the expected start of menstruation) and stopped when there was mild or no pain (VAS score 3 or less) 6–8 hours from the last test tablet or after 5 days treatment duration.,Treatment commenced onset menstruation pain impending (up days expected start menstruation) stopped mild pain (VAS score 3 less) 6–8 hours test tablet 5 days treatment duration.,C0039798|C3274784|C0206132|C0025344|C0030193|C0332190|G0000000|C0439228|C1517001|C0439659|C0025344|C1272691|C2945599|C0030193|C0042815|C0449820|G0000000|C0439092|G0000000|C0439227|C0022885|C0039225|G0000000|C0439228|C0039798|C0449238
"Study eligibility required SELECT enrollment at a participating site and absence of: dementia, active neurologic and/or neuropsychiatric conditions that affect cognition, as well as history of serious head injury (>30-minute loss of consciousness within the last five years prior to enrollment) and substance abuse.","Study eligibility required SELECT enrollment participating site absence of: dementia, active neurologic and/or neuropsychiatric conditions affect cognition, history head injury (>30-minute loss consciousness prior enrollment) substance abuse.",C0557651|C0013893|C1514873|C1707391|C1516879|C0679823|C0205145|C0332197|G0000000|C0011265|C0205177|C0205494|G0000000|G0000000|C0012634|C0001721|C0009240|C0019664|C0018670|C3263722|C0450371|C1517945|C0009791|C0332152|C1516879|C0439861|C0013146
"In this randomized, parallel-group, placebo-controlled trial, participants were randomly assigned in a 1:1 ratio to receive simvastatin orally at a dose of 40 mg or an identical-appearing placebo once daily.","In randomized, parallel-group, placebo-controlled trial, participants randomly assigned 1:1 ratio receive simvastatin orally dose 40 identical-appearing placebo daily.",G0000000|C0034656|C2348042|C1706408|C0008976|C0679646|G0000000|C1516050|G0000000|C0456603|C1514756|C0074554|C0442027|C0178602|C0450371|C0205280|C0032042|C0332173
The results demonstrate that paracentesis plus catumaxomab had superior efficacy compared to paracentesis alone for the treatment of malignant ascites in patients with epithelial cancer.,The demonstrate paracentesis catumaxomab superior efficacy compared paracentesis treatment malignant ascites patients epithelial cancer.,G0000000|G0000000|C0034115|C1831854|C1282910|C1280519|C1707455|C0034115|C0039798|C0205282|C0003962|C0030705|C0221908|C0006826
"Participants were at least 40 years of age, could stand at least 30 minutes, and walk independently for three or more meters with or without an assistive device.","Participants 40 age, stand 30 minutes, walk independently meters assistive device.",C0679646|C0450371|C0001779|C0596013|C0450371|C0439232|C0080331|G0000000|C0441074|G0000000|C0025080
"Fifth, although baseline assessments of HPV vaccination status among those aged 11 to 12 years was identical between arms, baseline vaccination status among those aged 11 to 17 years was slightly lower among intervention practices than control practices, which could have influenced the degree to which the intervention increased vaccination rates.","Fifth, baseline assessments HPV vaccination status aged 11 12 identical arms, baseline vaccination status aged 11 17 lower intervention practices control practices, influenced degree intervention increased vaccination rates.",C0205439|C0168634|C1261322|C0021344|C0042196|C0449438|C0001779|C0450371|C0450371|C0205280|C0206655|C0168634|C0042196|C0449438|C0001779|C0450371|C0450371|C0441994|C0886296|C0237607|C0243148|C0237607|G0000000|C0441889|C0886296|C0205217|C0042196|C0871208
"PAH was idiopathic, heritable, or associated with connective tissue disease (CTD; restricted in some countries to scleroderma), or surgical repair (≥5 years previously) of septal defect (United States only).","PAH idiopathic, heritable, connective tissue disease (CTD; restricted countries scleroderma), surgical repair (≥5 previously) septal defect (United States only).",C3203102|C0332240|C0439660|G0000000|C0040300|C0012634|C1335071|C0443288|C0454664|C0011644|C0543467|C0043240|G0000000|G0000000|C0442004|C1457869|G0000000|C1301808|C0205171
"We approached all family physicians, including physician teachers and residents, who provided care in the walk-in clinics of the 12 family practice teaching units.","We approached family physicians, including physician teachers residents, provided care walk-in clinics 12 family practice teaching units.",G0000000|C0449445|C0015576|C0031831|C0332257|C0031831|C0221457|C1320928|C1999230|C1947933|C3846681|C0442592|C0450371|C0015576|C0237607|C0039401|C0439148
"In February through April 2004 and again in 2006, the City of Boston and the Harvard Youth Violence Prevention Center conducted the Boston Youth Survey among students in grades 9 through 12 in Boston's public high schools.","In February April 2004 2006, City Boston Harvard Youth Violence Prevention Center conducted Boston Youth Survey students grades 9 12 Boston's public schools.",G0000000|C3830166|C3715024|G0000000|G0000000|C0008848|C0006037|G0000000|C0001578|C0042693|C0199176|C0205099|C0004927|C0006037|C0001578|C0038951|C0038492|C0441800|G0000000|C0450371|C0006037|G0000000|C0036375
"Study flow chart Older people were included if they met the following eligibility criteria: (1) aged 65 years and older, (2) living in the community, (3) able to walk 20 m without a walking aid, (4) able to watch television TV with or without their glasses from 3 m distance, and (5) have enough space for system use (3.5 m2).","Study flow chart Older people included met eligibility criteria: (1) aged 65 older, (2) living community, (3) walk 20 walking aid, (4) watch television TV glasses 3 distance, (5) space system (3.5 m2).",C0557651|C0806140|C0007963|C0580836|C0027361|C0332257|C0268621|C0013893|C0243161|G0000000|C0001779|C0450371|C0580836|G0000000|C0376558|C0009462|G0000000|C0080331|C0450371|C0080331|C0449435|G0000000|C0699864|C0039461|C0040210|C0015421|G0000000|C0012751|G0000000|C1883067|C0449913|G0000000|C0025885
"The inability to detect any additional value of robot-assisted reaching may have been due to this pilot study's limited sample size, the specific diagnoses of the participants, or the inclusion of only individuals with chronic stroke.","The inability detect additional robot-assisted reaching pilot study's limited sample size, specific diagnoses participants, inclusion individuals chronic stroke.",G0000000|G0000000|C0442726|C1524062|C3844190|C2584321|C0473169|C0557651|C0439801|C0370003|C0456389|C0205369|C0011900|C0679646|C0007637|C0027361|C0205191|C0038454
This study was conducted to obtain preliminary evidence of clinical response in metastatic breast and ovarian cancer patients.,This study conducted preliminary evidence clinical response metastatic breast ovarian cancer patients.,G0000000|C0557651|C0004927|C0439611|C3887511|C0205210|C0871261|C0036525|C0006141|C0205065|C0006826|C0030705
"The EPP is informed by philosophies of social inclusion and patient empowerment,18 and access is not based on medical definitions, but on self‐defined long‐term conditions.","The EPP informed philosophies social inclusion patient empowerment,18 access based medical definitions, self‐defined long‐term conditions.",G0000000|C0162568|C1522154|C0031534|C0728831|C0007637|C0030705|C0679959|C0444454|C1527178|C0199168|C1550452|G0000000|G0000000|C0012634
"Exclusion criteria included: BMI < 18.5 kg/m2 or ≥ 35.0 kg/m2, multiple gestation (e.g., twins), having had eating disorders or gastric bypass surgery in the past, having had three or more consecutive miscarriages, or the presence of pre-pregnancy medical conditions that could influence weight loss or gain.","Exclusion criteria included: BMI < 18.5 kg/m2 ≥ 35.0 kg/m2, multiple gestation (e.g., twins), eating disorders gastric bypass surgery past, consecutive miscarriages, presence pre-pregnancy medical conditions influence weight loss gain.",C0680251|C0243161|C0332257|G0000000|G0000000|C0450371|C0022718|G0000000|C0450371|C0022718|C0439064|C0032961|G0000000|C0041427|C0013470|C0012634|C0038351|C0741847|C0038894|C1444637|C1707491|C0000786|C0150312|C2709093|C0199168|C0012634|C4054723|C0005910|C1517945|C1517378
"The study population comprises family caregivers (i.e., the main contact person) of nursing home residents with dementia who died on a psychogeriatric ward.","The study population comprises family caregivers (i.e., main contact person) nursing residents dementia died psychogeriatric ward.",G0000000|C0557651|C0032659|C2700400|C0015576|C0085537|C0683454|C0205225|C0332158|C0027361|C0006147|C1320928|C0011265|C0011065|C0017467|C1305702
"Methods—Colonoscopic surveillance in all patients with UC who had died from colorectal cancer after 1975 was compared with that in controls matched for age, sex, extent, and duration of the disease.","Methods—Colonoscopic surveillance patients UC died colorectal cancer 1975 compared controls matched age, sex, extent, duration disease.",G0000000|C0220920|C0030705|G0000000|C0011065|C0555952|C0006826|G0000000|C1707455|C0243148|C0150103|C0001779|C0009253|C0439792|C0449238|C0012634
TRUST: Trial to Re-evaluate Ultrasound in the Treatment of Tibial Fractures; CAC: Central Adjudication Committee.,TRUST: Trial Re-evaluate Ultrasound Treatment Tibial Fractures; CAC: Central Adjudication Committee.,C0237935|C0008976|C0556581|C0041618|C0039798|C0040184|C0016658|G0000000|C0205099|C0680730|C2699414
"During the PROACTIVE Feasibility Study, patients with sickle cell disease age two years or older admitted for pain without acute chest syndrome were enrolled for possible randomization to preventive blood transfusion or standard care.","During PROACTIVE Feasibility Study, patients sickle cell disease age admitted pain acute chest syndrome enrolled randomization preventive blood transfusion standard care.",G0000000|G0000000|G0000000|C0557651|C0030705|G0000000|C0007634|C0012634|C0001779|C0184666|C0030193|C0205178|C0817096|C0039082|G0000000|C0034656|C0445202|C0005767|C0005841|C1442989|C1947933
The diagnosis of epilepsy was questionable in 16/300 (5%) women.,The diagnosis epilepsy questionable 16/300 (5%) women.,G0000000|C0011900|C0014544|C0332241|C0450371|G0000000|C0043210
"The nephrology care schedule for patients in populations 1 and 2 abides by the French recommendations [10, 15, 17], likewise for transplanted patients (population 3) in the control group.","The nephrology care schedule patients populations 1 2 abides French recommendations [10, 15, 17], likewise transplanted patients (population 3) control group.",G0000000|C0027712|C1947933|C0086960|C0030705|C0032659|G0000000|G0000000|G0000000|C0376246|C0034866|C0450371|C0450371|C0450371|G0000000|C0040732|C0030705|C0032659|G0000000|C0243148|C0441833
"Furthermore, assuming that 7–9 eligible children (6–15 years) would be available from each bari and using a statistics book generated random number table, a total of 44 baris were randomly selected from the total listed baris for distribution of the flour.","Furthermore, assuming 7–9 eligible children (6–15 years) bari statistics book generated random table, total 44 baris randomly selected total listed baris distribution flour.",G0000000|G0000000|G0000000|C1548635|C0008059|G0000000|C0439234|G0000000|C0038215|C0006002|C3146294|C0034656|C0039224|C0439175|C0450371|C1890660|G0000000|C1707391|C0439175|C0745732|C1890660|C0520511|C0016260
"After informed written consent, patients eligible for inclusion (>18 yrs with IDA, ferritin <300 mcg/L, transferrin saturation <25%, Hb <12.0 g/dL for women, Hb <13.0 g/dL for men) were randomized between 4 and 21 days before surgery into 2 groups.","After informed written consent, patients eligible inclusion (>18 yrs IDA, ferritin <300 mcg/L, transferrin saturation <25%, Hb <12.0 g/dL women, Hb <13.0 g/dL men) randomized 4 21 days surgery 2 groups.",G0000000|C1522154|C0043266|C1511481|C0030705|C1548635|C0007637|C0450371|G0000000|C0020789|C0015879|G0000000|C0040679|C0522534|C0450371|C0019046|G0000000|C0043210|C0019046|G0000000|C0025266|C0034656|G0000000|C0450371|C0439228|C0038894|G0000000|C0441833
A total of 330 patients from 20 medical centers were randomized to receive either IGF-1 or placebo.,A total 330 patients 20 medical centers randomized receive IGF-1 placebo.,G0000000|C0439175|C1442061|C0030705|C0450371|C0199168|C0205099|C0034656|C1514756|C0037657|C0032042
"The argument for early treatment in these patients is that enhanced local control may prolong survival and improve quality of life by delaying development of thoracic symptoms (Falk et al, 2002).","The argument treatment patients enhanced local control prolong survival improve quality life delaying development thoracic symptoms (Falk al, 2002).",G0000000|C0680226|C0039798|C0030705|C2349975|C0205276|C0243148|G0000000|C0038952|G0000000|C0332306|C0376558|C0205421|C0243107|G0000000|C0683368|G0000000|C0202311|G0000000
"In this study (study code SD-039-0735), outpatients aged ≥ 12 years with a diagnosis of asthma [as defined by the American Thoracic Society (15)] for ≥ 6 months and using ICS for ≥ 3 months [≥ 500 μg/day of budesonide or fluticasone (or ≥ 1000 μg/day of another ICS) for ≥ 1 month] were eligible for enrolment.","In study (study code SD-039-0735), outpatients aged ≥ 12 diagnosis asthma [as defined American Thoracic Society (15)] ≥ 6 months ICS ≥ 3 months [≥ 500 μg/day budesonide fluticasone (or ≥ 1000 μg/day ICS) ≥ 1 month] eligible enrolment.",G0000000|C0557651|C0557651|C0009219|C2699239|C0029921|C0001779|G0000000|C0450371|C0011900|C0004096|G0000000|C1704788|C0596070|G0000000|C0037455|C0450371|G0000000|G0000000|C0439231|C0022521|G0000000|G0000000|C0439231|G0000000|C1442061|G0000000|C0054201|C0082607|G0000000|G0000000|G0000000|G0000000|C0022521|G0000000|G0000000|C0332177|C1548635|C1516879
Ginger is more effective than acupressure to relieve mild to moderate nausea and vomiting in symptomatic pregnant women in less than 16 weeks of gestational age.,Ginger effective acupressure relieve mild moderate nausea vomiting symptomatic pregnant women 16 weeks gestational age.,C0162751|C1280519|C0282614|C1301676|C2945599|C0205081|C0027497|C0042963|C0231220|C0549206|C0043210|C0450371|C0439230|C0439671|C0001779
Subjects were randomly assigned in two groups.,Subjects randomly assigned groups.,C0681850|G0000000|C1516050|C0441833
Male and female patients with COPD [21] aged ≥40 years were eligible for enrollment if they had recent (≤14 days) history of exacerbation requiring: a) hospitalization for ≤10 days; b) emergency room observation of duration ≥24 hours during which OCS/OCS + antibiotics treatment was administered; or c) physician’s office or emergency room visit of <24 hours duration with OCS/OCS + antibiotics treatment plus 6-month history of exacerbation-related hospitalization.,Male female patients COPD [21] aged ≥40 eligible enrollment (≤14 days) history exacerbation requiring: a) hospitalization ≤10 days; b) emergency observation duration ≥24 hours OCS/OCS + antibiotics treatment administered; c) physician’s office emergency visit <24 hours duration OCS/OCS + antibiotics treatment 6-month history exacerbation-related hospitalization.,C0086582|C0015780|C0030705|C0024117|C0450371|C0001779|G0000000|C1548635|C1516879|G0000000|C0439228|C0019664|G0000000|G0000000|G0000000|C0019993|G0000000|C0439228|G0000000|C0013956|C0302523|C0449238|G0000000|C0439227|G0000000|C0039798|C1521801|G0000000|G0000000|C0442603|C0013956|C0545082|C0450371|C0439227|C0449238|G0000000|C0039798|C0332177|C0019664|C0439849|C0019993
Patients with no lung function data or who did not fulfil spirometric criteria for chronic obstructive pulmonary disease were excluded from the subgroup analyses.,Patients lung function data fulfil spirometric criteria chronic obstructive pulmonary disease excluded subgroup analyses.,C0030705|C0024109|C0031843|C1511726|C1550543|C0037981|C0243161|C0205191|C0549186|C0024109|C0012634|C1554077|C1079230|C0002778
Just over 7% of patients fell at least once: 6.1% in acute wards and 10.7% in rehabilitation wards.,Just 7% patients fell once: 6.1% acute wards 10.7% rehabilitation wards.,G0000000|G0000000|C0030705|C0085639|G0000000|G0000000|C0205178|C1305702|C0450371|C0034991|C1305702
"LBP and NP, either alone or in conjunction, affect over 30% of the population 70 years of age and older on a monthly basis [5].","LBP NP, conjunction, affect 30% population 70 age monthly basis [5].",C1505993|C0065827|C2699427|C0001721|C0450371|C0032659|C0450371|C0001779|C0332177|C1527178|G0000000
BIDMC provides cancer care to patients 18 years of age or older.,BIDMC cancer care patients 18 age older.,G0000000|C0006826|C1947933|C0030705|C0450371|C0001779|C0580836
"Seven (6.4%) subjects in the Diclectin® group and 12 (12.9%) in the placebo group withdrew their consent before receiving study medication, leaving 133 women in the Diclectin®-treated group and 128 in the placebo group for inclusion in the intent-to-treat effectiveness analysis.","Seven (6.4%) subjects Diclectin® 12 (12.9%) placebo withdrew consent receiving study medication, leaving 133 women Diclectin®-treated 128 placebo inclusion intent-to-treat effectiveness analysis.",C0205453|G0000000|C0681850|G0000000|C0450371|C0450371|C0032042|C2349954|C1511481|C1514756|C0557651|C0013227|G0000000|C1442061|C0043210|G0000000|C1442061|C0032042|C0007637|C0162425|C1280519|C0002778
Patients were also excluded if they: had any asthma exacerbation or any respiratory tract infection within 4 weeks prior to enrolment and/or during the screening period; were participating in another trial; had narrow-angle glaucoma and/or micturition disorder because of prostatic hyperplasia; and had failed to complete ≥80% of their electronic diary during the run-in period.,Patients excluded they: asthma exacerbation respiratory tract infection 4 weeks prior enrolment and/or screening period; participating trial; narrow-angle glaucoma and/or micturition disorder prostatic hyperplasia; failed complete ≥80% electronic diary run-in period.,C0030705|C1554077|G0000000|C0004096|G0000000|C0521346|C1185740|C0009450|G0000000|C0439230|C0332152|C1516879|G0000000|C0220908|C0439531|C0679823|C0008976|C0205168|C0017601|G0000000|C0042034|C0012634|C0033572|C0020507|C0231175|C0205197|G0000000|C0013850|C0376660|C3274438|C0439531
"Of the 120 enrolled participants, 113 completed their final visit and data collection.","Of 120 enrolled participants, 113 completed final visit data collection.",G0000000|C1442061|G0000000|C0679646|C1442061|C0205197|C0205088|C0545082|C1511726|C1516698
"The study population included equal numbers of males and females, was predominantly Caucasian and of non-Jewish descent, and ranged in age from 16 to 63 years (mean 32 years).","The study population included equal males females, Caucasian non-Jewish descent, ranged age 16 63 (mean 32 years).",G0000000|C0557651|C0032659|C0332257|C0205163|C0086582|C0015780|C0007457|C1518422|C0205386|C1514721|C0001779|C0450371|C0450371|C0444504|C0450371|C0439234
"After baseline monitoring, three valleys were selected for Group 1, the larval control intervention (LCI), and another three for Group 2, the non-LCI group.","After baseline monitoring, valleys selected Group 1, larval control intervention (LCI), Group 2, non-LCI group.",G0000000|C0168634|C0150369|C0563004|C1707391|C0441833|G0000000|C0023047|C0243148|C0886296|C0231990|C0441833|G0000000|C1518422|C0441833
Participants 391 women and men aged ≥75 with visual acuity of 6/24 or worse who were living in the community; 92% (361 of 391) completed one year of follow-up.,Participants 391 women aged ≥75 visual acuity 6/24 worse living community; 92% (361 391) completed follow-up.,C0679646|C1442061|C0043210|C0001779|G0000000|C0234621|C0750509|C0450371|C0332271|C0376558|C0009462|C0450371|C1442061|C1442061|C0205197|C0589120
"Key exclusion criteria included a history of HER2-positive tumors, previous chemotherapy for locally advanced or metastatic gastric carcinoma, a significant history of cardiac disease, peripheral neuropathy, and/or active (significant or uncontrolled) gastrointestinal bleeding.","Key exclusion criteria included history HER2-positive tumors, previous chemotherapy locally advanced metastatic gastric carcinoma, history cardiac disease, peripheral neuropathy, and/or active (significant uncontrolled) gastrointestinal bleeding.",G0000000|C0680251|C0243161|C0332257|C0019664|C0439178|C0027651|C0205156|C0013216|C1517927|C0205179|C0036525|C0038351|C0007097|C0019664|C0018787|C0012634|C0205100|C0442874|G0000000|C0205177|C0237881|C0205318|C0521362|C0019080
"Adults ≥21 years of age with symptoms compatible with LRTI (ie, admission diagnosis of pneumonia, acute exacerbations of chronic obstructive pulmonary disease [COPD], bronchitis, asthma, influenza, viral syndrome, respiratory failure, and congestive heart failure [CHF]) were identified by reviewing the daily admission census.","Adults ≥21 age symptoms compatible LRTI (ie, admission diagnosis pneumonia, acute exacerbations chronic obstructive pulmonary disease [COPD], bronchitis, asthma, influenza, viral syndrome, respiratory failure, congestive heart failure [CHF]) identified reviewing daily admission census.",C0001675|G0000000|C0001779|C0683368|C0332290|C0149725|G0000000|C0184666|C0011900|C0032285|C0205178|G0000000|C0205191|C0549186|C0024109|C0012634|C0024117|C0006277|C0004096|C0021400|C0521026|C0039082|C0521346|C0231174|C0742742|C0018787|C0231174|C0018802|C0205396|C0282443|C0332173|C0184666|C0007663
"Exclusions included impaired cognition (Callahan score ≤ 4),18 active axis I psychiatric (schizophrenia, bipolar disorder) or substance use disorder, uncorrectable hearing disorder, or unreliable telephone service.","Exclusions included impaired cognition (Callahan score ≤ 4),18 active axis I psychiatric (schizophrenia, bipolar disorder) substance disorder, uncorrectable hearing disorder, unreliable telephone service.",C0680251|C0332257|C0221099|C0009240|G0000000|C0449820|G0000000|C0450371|C0205177|C0004457|C0021966|C0205487|C0036341|C0443156|C0012634|C0439861|C0012634|G0000000|C0018767|C0012634|C0749770|C0039457|C0557854
"Direct costs included in the study were drug costs, hospitalization costs, monitoring costs, and physician visit costs.","Direct costs included study drug costs, hospitalization costs, monitoring costs, physician visit costs.",C0439851|C0010186|C0332257|C0557651|C0013227|C0010186|C0019993|C0010186|C0150369|C0010186|C0031831|C0545082|C0010186
"The tobacco order template was used for 7,278 (41.5%) of the 17,530 admissions in the postimplementation period.","The tobacco template 7,278 (41.5%) 17,530 admissions postimplementation period.",G0000000|C0040329|C0728990|C1442061|C0450371|C0450371|C0184666|G0000000|C0439531
"Exclusion criteria included preexisting type 1 or type 2 diabetes, hypertension, parathyroid disease, uncontrolled thyroid disease, and use of vitamin D supplements beyond a prenatal vitamin in the last 6 months.","Exclusion criteria included preexisting type 1 type 2 diabetes, hypertension, parathyroid disease, uncontrolled thyroid disease, vitamin D supplements prenatal vitamin 6 months.",C0680251|C0243161|C0332257|C2347662|C0332307|G0000000|C0332307|G0000000|C0011847|C0020538|C0030518|C0012634|C0205318|C0040132|C0012634|C0042890|C0073187|C0242295|C0678804|C0042890|G0000000|C0439231
"We would like to thank the data collection team at the University of Zambia Masters in Public Health Programme, as well as the population of the Luangwa District for participating in the survey.","We data collection team University Zambia Masters Public Health Programme, population Luangwa District participating survey.",G0000000|C1511726|C1516698|C0871489|C0041740|C0043445|C0444649|G0000000|C0018684|C1709697|C0032659|G0000000|G0000000|C0679823|C0038951
"Patients were excluded from the study if they had a prior history of skin cancer, as noted in the medical record or self-reported, or a history of dermatologic disease treated with ultraviolet light, e.g., psoriasis, atopic dermatitis, or under the care of a dermatologist within the last 5 years.","Patients excluded study prior history skin cancer, medical record self-reported, history dermatologic disease treated ultraviolet light, e.g., psoriasis, atopic dermatitis, care dermatologist 5 years.",C0030705|C1554077|C0557651|C0332152|C0019664|C0444099|C0006826|C0199168|C0034869|C0681906|C0019664|C0205489|C0012634|C1522326|C1532472|C0023693|G0000000|C0033860|C0392707|C0011603|C1947933|C0259831|G0000000|C0439234
The median FEV1 % predicted value at baseline ranged from 72.0 to 75.0 (Table (Table1).1).,The median FEV1 % predicted baseline ranged 72.0 75.0 (Table (Table1).1).,G0000000|C0549183|G0000000|G0000000|C0681842|C0168634|C1514721|C0450371|C0450371|C0039224|G0000000
"Patients were included in the study if their peripheral-blood smears had asexual forms of Plasmodium falciparum and had at least one of the following severe complications: cerebral malaria (Glasgow Coma Score was less than 11), renal acute failure (oliguria and serum creatinine > 250 μmol/L), jaundice (total serum bilirubin > 50 μmol/L) with a parasite count of more than 100,000/μL or with serum creatinine > 250 μmol/L, hypoglycaemia (blood glucose < 2.2 mmol/L), anaemia (haematocrit < 20%) with a parasite count of more than 100,000/μL, hyperparasitaemia (parasite count > 500,000/μL), hyperlactataemia (plasma lactate > 4 mmol/L), metabolic acidosis (standard base excess > - 5 mmol/L, base deficit < 10 mmol/L) and shock (systolic blood pressure < 80 mmHg with cool extremities).","Patients included study peripheral-blood smears asexual forms Plasmodium falciparum severe complications: cerebral malaria (Glasgow Coma Score 11), renal acute failure (oliguria serum creatinine > 250 μmol/L), jaundice (total serum bilirubin > 50 μmol/L) parasite count 100,000/μL serum creatinine > 250 μmol/L, hypoglycaemia (blood glucose < 2.2 mmol/L), anaemia (haematocrit < 20%) parasite count 100,000/μL, hyperparasitaemia (parasite count > 500,000/μL), hyperlactataemia (plasma lactate > 4 mmol/L), metabolic acidosis (standard base excess > - 5 mmol/L, base deficit < 10 mmol/L) shock (systolic blood pressure < 80 mmHg cool extremities).",C0030705|C0332257|C0557651|C0229664|C0444186|C0599655|C0348078|C0032148|G0000000|C0205082|C0009566|G0000000|C0024530|G0000000|C0009421|C0449820|C0450371|C0022646|C0205178|C0231174|C0028961|C0229671|C0010294|G0000000|C1442061|G0000000|C0022346|C0439175|C0229671|C0005437|G0000000|C0450371|G0000000|C0030498|C0750480|G0000000|C0229671|C0010294|G0000000|C1442061|G0000000|C0020615|C0005767|C0017725|G0000000|G0000000|C1532563|C0002871|C0018935|G0000000|C0450371|C0030498|C0750480|G0000000|G0000000|C0030498|C0750480|G0000000|G0000000|C0795692|C0032105|C0022924|G0000000|G0000000|C1532563|C0311400|C0001122|C1442989|C0002055|C1979886|G0000000|G0000000|G0000000|C1532563|C0002055|C0162429|G0000000|C0450371|C1532563|C0036974|C0039155|C0005767|C0033095|G0000000|C0450371|C0439475|C1548792|C0015385
Exclusion criteria were patients with other types of primary and secondary pediatric glaucomas and previous ocular surgery except incisional glaucoma surgery (trabeculotomy or trabeculectomy).,Exclusion criteria patients types primary secondary pediatric glaucomas previous ocular surgery incisional glaucoma surgery (trabeculotomy trabeculectomy).,C0680251|C0243161|C0030705|C0332307|C0205225|C0027627|C0030755|C0017601|C0205156|C0015392|C0038894|C0184898|C0017601|C0038894|C0040576|C0040574
Cross-sectional study of 4524 northern New England adolescents aged 10–14 in 1999 with longitudinal follow-up of 2603 baseline never-smokers.,Cross-sectional study 4524 northern New England adolescents aged 10–14 1999 longitudinal follow-up 2603 baseline never-smokers.,C0552389|C0557651|G0000000|C1709269|C0205314|C0014282|C0205653|C0001779|G0000000|G0000000|C0205127|C0589120|G0000000|C0168634|C0425293
"Exclusion criteria included: living in residential aged care, severe dementia, terminal illness, not able to communicate in English or unstable medical condition such that participation in a physical activity programme was unsafe (as judged by their general practitioner (GP)).","Exclusion criteria included: living residential aged care, severe dementia, terminal illness, communicate English unstable medical condition participation physical activity programme unsafe (as judged practitioner (GP)).",C0680251|C0243161|C0332257|C0376558|C0237096|C0001779|C1947933|C0205082|C0011265|C0205088|C0221423|C0566001|C0376245|C0443343|C0199168|C0012634|C0679823|C0031809|C0205177|C1709697|G0000000|G0000000|C0221191|C1709627|C3811116
It is suggested prednisolone should be added to standard short course chemotherapy to treat HIV related effusive tuberculous pericarditis.,It suggested prednisolone standard short chemotherapy treat HIV effusive tuberculous pericarditis.,G0000000|C1705535|C0032950|C1442989|C1282927|C0013216|C0087111|C0019682|C0013687|C0041296|C0031046
"Sixteen patients (13 women, 3 men, mean age 48.9 ± 10.0 years, age range 38–67 years) completed the study (Figure (Figure44 illustrates the flowchart of all participants).","Sixteen patients (13 women, 3 men, age 48.9 ± 10.0 years, age range 38–67 years) completed study (Figure (Figure44 illustrates flowchart participants).",C3715157|C0030705|C0450371|C0043210|G0000000|C0025266|C0001779|C0450371|G0000000|C0450371|C0439234|C0001779|C1514721|G0000000|C0439234|C0205197|C0557651|G0000000|G0000000|G0000000|C0016262|C0679646
"The mean (SD) age was 42.8 (14.7) years (range, 14–69 years), and 58% were female.","The (SD) age 42.8 (14.7) (range, 14–69 years), 58% female.",G0000000|G0000000|C0001779|C0450371|C0450371|C1514721|G0000000|C0439234|C0450371|C0015780
"We will conduct a three-group, single-blind, parallel design, randomized controlled trial in women, aged 50–75 years old, who have completed chemotherapy for cancer comparing 1) tai chi 2) strength training and 3) a placebo control group of seated stretching exercise.","We conduct three-group, single-blind, parallel design, randomized controlled trial women, aged 50–75 old, completed chemotherapy cancer comparing 1) tai chi 2) strength training 3) placebo control seated stretching exercise.",G0000000|C0004927|C0205449|C0242570|C2348042|C1707689|C0034656|C2587213|C0008976|C0043210|C0001779|G0000000|C0580836|C0205197|C0013216|C0006826|C1707455|G0000000|G0000000|C1720589|G0000000|C0237897|C0040607|G0000000|C0032042|C0243148|C0277814|C0600080|C0015259
"Inclusion criteria were an established diagnosis of CF, the ability to perform lung function tests, normal lung function defined as a FEV1 > 80% predicted, and absence of acute respiratory tract infections prior to bronchoscopy for at least 6 weeks.","Inclusion criteria established diagnosis CF, ability perform lung function tests, normal lung function defined FEV1 > 80% predicted, absence acute respiratory tract infections prior bronchoscopy 6 weeks.",C0007637|C0243161|C0443211|C0011900|C0009738|C0085732|C0884358|C0024109|C0031843|C0022885|C0205307|C0024109|C0031843|C1704788|G0000000|G0000000|C0450371|C0681842|C0332197|C0205178|C0521346|C1185740|C3714514|C0332152|C0006290|G0000000|C0439230
571 healthy children aged 1-6 years: 282 (mean (SD) age 4.6 (1.5) years) in the intervention group and 289 (mean (SD) age 4.4 (1.5) years) in the control group.,571 healthy children aged 1-6 years: 282 (mean (SD) age 4.6 (1.5) years) intervention 289 (mean (SD) age 4.4 (1.5) years) control group.,C1442061|C3898900|C0008059|C0001779|G0000000|C0439234|C1442061|C0444504|G0000000|C0001779|G0000000|G0000000|C0439234|C0886296|C1442061|C0444504|G0000000|C0001779|G0000000|G0000000|C0439234|C0243148|C0441833
"Households consisted of just over five members on average, and the mean age of the head was 37 years.","Households consisted average, age head 37 years.",C0020052|C0332529|C1510992|C0001779|C0018670|C0450371|C0439234
"Of 1,118 women initially enrolled, 834 women comprised the study cohort: 230 (28%) in luteal phase; 363 (44%) in follicular phase; and 241 grouped as other.","Of 1,118 women initially enrolled, 834 women comprised study cohort: 230 (28%) luteal phase; 363 (44%) follicular phase; 241 other.",G0000000|C1442061|C0043210|C0205265|G0000000|C1442061|C0043210|C2700400|C0557651|C0599755|C1442061|C0450371|G0000000|C0205390|C1442061|C0450371|C0439682|C0205390|C1442061|G0000000
"Patients were excluded if they had previously received rituximab, were receiving other immunosuppressive therapy, or had ever received >6 months of prednisone or other systemic corticosteroid therapy in the past.","Patients excluded received rituximab, receiving immunosuppressive therapy, received >6 months prednisone systemic corticosteroid therapy past.",C0030705|C1554077|C1514756|C0393022|C1514756|C0021081|C0039798|C1514756|G0000000|C0439231|C0032952|C0205373|C0001617|C0039798|C1444637
Representative histopathologic and neuroradiologic findings in patients with cavernous angiomas and arteriovenous malformations.,Representative histopathologic neuroradiologic findings patients cavernous angiomas arteriovenous malformations.,C1882932|C0677043|C2985415|C2607943|C0030705|C0205201|C0018916|C0450109|C0000768
"Pregnant women, aged 18-40 years, were eligible if they had gestational age <14 weeks based on last menstrual period or obstetrical estimation, singleton pregnancy, and had planned to receive ongoing prenatal and delivery in the Masjed-Soleiman.","Pregnant women, aged 18-40 years, eligible gestational age <14 weeks based menstrual period obstetrical estimation, singleton pregnancy, planned receive ongoing prenatal delivery Masjed-Soleiman.",C0549206|C0043210|C0001779|C0450371|C0439234|C1548635|C0439671|C0001779|C0450371|C0439230|C1527178|C0025344|C0439531|C0028773|C0680844|C0481462|C0032961|C1301732|C1514756|C0549178|C0678804|C0011209|G0000000
METHODS—Eight children with mild or moderate asthma participated in swimming training every day for six weeks.,METHODS—Eight children mild moderate asthma participated swimming training day weeks.,G0000000|C0008059|C2945599|C0205081|C0004096|G0000000|C0039003|C0040607|C0332173|C0439230
The mean (SD) age of subjects was 42.28 (8.02) years in the test group and 39.48 (5.73) years in the control group.,The (SD) age subjects 42.28 (8.02) test 39.48 (5.73) control group.,G0000000|G0000000|C0001779|C0681850|C0450371|C0450371|C0022885|C0450371|C0450371|C0243148|C0441833
About 18% had endosonographically diagnosed sphincter damage; the location and extent were similar.,About 18% endosonographically diagnosed sphincter damage; location extent similar.,G0000000|C0450371|G0000000|C0011900|C1409894|C0010957|C0450429|C0439792|C2348205
Study participants will be recruited from all child/community health clinics in metropolitan Perth (fluoridated; 0.8 mg/L fluoride) and Bunbury/Busselton (non-fluoridated; < 0.2 mg/L fluoride).,Study participants recruited child/community health clinics metropolitan Perth (fluoridated; 0.8 mg/L fluoride) Bunbury/Busselton (non-fluoridated; < 0.2 mg/L fluoride).,C0557651|C0679646|G0000000|C0008059|C0018684|C0442592|C0599587|G0000000|G0000000|G0000000|C0439268|C0016327|G0000000|C1518422|G0000000|G0000000|C0439268|C0016327
"Also, the ethnic make-up of the experimental group and the control group was not equally dispersed.","Also, ethnic make-up experimental control equally dispersed.",G0000000|C0015031|C1881534|C1517586|C0243148|G0000000|C0332624
The iron-zinc and iron-only supplements were precoded and supplied by Nutricaps pharmaceutical company in the United States of America (USA).,The iron-zinc iron-only supplements precoded supplied Nutricaps pharmaceutical company United States America (USA).,G0000000|C0302583|C0302583|C0242295|G0000000|C1999230|G0000000|C0031336|C0683757|C0166872|C1301808|C0002454|C0041703
AIM—To investigate the colonisation with Bifidobacterium breve of the bowels of very low birthweight (VLBW) infants.,AIM—To investigate colonisation Bifidobacterium breve bowels low birthweight (VLBW) infants.,G0000000|C1292732|G0000000|C0005380|G0000000|C0021853|C0205251|C0005612|C0282666|C0021270
"The intervention resulted in improved asthma control: patients receiving the intervention were 2.7 times more likely to improve from “severe” to “not severe” than control patients (OR 2.68, 95% CI 1.64 to 4.37; p<0.001).","The intervention improved asthma control: patients receiving intervention 2.7 times improve “severe” “not severe” control patients (OR 2.68, 95% CI 1.64 4.37; p<0.001).",G0000000|C0886296|C0184511|C0004096|C0243148|C0030705|C1514756|C0886296|G0000000|C0040223|G0000000|G0000000|G0000000|G0000000|C0243148|C0030705|G0000000|C0450371|C0450371|C0008107|C0450371|C0450371|C0369773
"When screening parents for participation, antisocial risk behavior in adolescent was defined as the presence of at least one of the following, as indicated by single-item descriptions: delinquent behavior; bullying; repeated conflicts regarding family rules; any use of alcohol, tobacco, and/or drugs; or excessive computer use.","When screening parents participation, antisocial risk behavior adolescent defined presence following, single-item descriptions: delinquent behavior; bullying; repeated conflicts family rules; alcohol, tobacco, and/or drugs; excessive computer use.",G0000000|C0220908|C0030551|C0679823|C0233523|C0035647|C0004927|C0205653|C1704788|C0150312|C0231290|C0037179|C0678257|C0522175|C0004927|C0424318|C0205341|C0009671|C0015576|C0870077|C0001962|C0040329|G0000000|C0013227|C0442802|C0009622|C0042153
Other exclusion criteria included: clinically relevant abnormal baseline laboratory parameters or a history of asthma; myocardial infarction within 1 year of screening; unstable or life-threatening cardiac arrhythmia; known active tuberculosis; clinically evident bronchiectasis; cystic fibrosis or life-threatening pulmonary obstruction; hospitalised for heart failure within the past year; diagnosed thyrotoxicosis or paroxysmal tachycardia; previous thoracotomy with pulmonary resection; regular use of daytime oxygen if patients were unable to abstain during clinic visits; or currently enrolled in a pulmonary rehabilitation programme (or completed in the 6 weeks before screening).,Other exclusion criteria included: clinically relevant abnormal baseline laboratory parameters history asthma; myocardial infarction 1 year screening; unstable life-threatening cardiac arrhythmia; active tuberculosis; clinically evident bronchiectasis; cystic fibrosis life-threatening pulmonary obstruction; hospitalised heart failure year; diagnosed thyrotoxicosis paroxysmal tachycardia; previous thoracotomy pulmonary resection; regular daytime oxygen patients unable abstain clinic visits; enrolled pulmonary rehabilitation programme (or completed 6 weeks screening).,G0000000|C0680251|C0243161|C0332257|G0000000|C2347946|C0205161|C0168634|C0022877|C0449381|C0019664|C0004096|C0027061|C0021308|G0000000|C0220908|C0443343|C1517874|C0018787|C0003811|C0205177|C0041296|G0000000|C3887511|C0006267|C0205207|C0016059|C1517874|C0024109|C0028778|G0000000|C0018787|C0231174|C0439234|C0011900|C0040156|C0205311|C0039231|C0205156|C0039991|C0024109|C0015252|C0205272|C0332169|C0030054|C0030705|C1299582|G0000000|C0002424|C0545082|G0000000|C0024109|C0034991|C1709697|G0000000|C0205197|G0000000|C0220908
"During the visit, neighbourhood contacts were pre-screened for TB symptoms (cough, fever, weight loss, and/or night sweats of more than two weeks) on the spot by trained community volunteers and health workers.","During visit, neighbourhood contacts pre-screened TB symptoms (cough, fever, weight loss, and/or night sweats weeks) spot trained community volunteers health workers.",G0000000|C0545082|C0027569|C4036459|C0332152|G0000000|C0683368|C0010200|C0015967|C0005910|C1517945|G0000000|C0240526|C0038984|C0439230|C0329155|C0336809|C0009462|C0042960|C0018684|C0024752
"In addition, those subjects infected with HIV (human immunodeficiency virus) and those who were otherwise immunocompromised were not eligible for enrolment.","In addition, subjects infected HIV (human immunodeficiency virus) immunocompromised eligible enrolment.",G0000000|C0332287|C0681850|C0439663|C0019682|C0086418|C0021051|C0042776|C0085393|C1548635|C1516879
"The use of ultrasound for subclavian venous cannulation has been controversial for anatomical reasons [11,12].","The ultrasound subclavian venous cannulation controversial anatomical reasons [11,12].",G0000000|C0041618|C0589488|C0042449|C0917707|C0680243|C0220784|C0392360|C0450371
"For the nutrition education programme, caregivers with a child aged 5–18 months were recruited on the basis of their interest in participating; priority was given to caregiver–child pairs from households already participating in a farmer field or farmer business school.","For nutrition education programme, caregivers child aged 5–18 months recruited basis participating; priority caregiver–child pairs households participating farmer field farmer business school.",G0000000|C0028707|C0013621|C1709697|C0085537|C0008059|C0001779|G0000000|C0439231|G0000000|C1527178|C0679823|C0549179|G0000000|C1709450|C0020052|C0679823|C0221460|C0440042|C0221460|C0085936|C0036375
"The stratification included age (≤4 years and >4 years) and global rating scale scores[24] (≤5 and >5), a measure of involved hand severity created for the parent study of cerebral palsy outcomes.","The stratification included age (≤4 >4 years) global rating scale scores[24] (≤5 >5), measure involved hand severity created parent study cerebral palsy outcomes.",G0000000|C1514983|C0332257|C0001779|G0000000|G0000000|C0439234|C0205246|C0871208|C0175659|C0449820|G0000000|G0000000|C0079809|C1314939|C0018563|C0439793|C1706214|C0030551|C0557651|G0000000|C0522224|C1274040
Premenopausal and perimenopausal women were required to agree to employ adequate birth-control methods and have a negative pregnancy test.,Premenopausal perimenopausal women required agree employ adequate birth-control methods negative pregnancy test.,C0279752|C0849668|C0043210|C1514873|C3641827|C0457083|C0205410|C0700589|C0025663|C0205160|C0032961|C0022885
A total of 800 very preterm infants of ≤32 weeks of gestational age were admitted to the NICU during the observation period (Fig (Fig1).1).,A total 800 preterm infants ≤32 weeks gestational age admitted NICU observation period (Fig (Fig1).1).,G0000000|C0439175|C1442061|C0151526|C0021270|G0000000|C0439230|C0439671|C0001779|C0184666|C0021709|C0302523|C0439531|C0349966|G0000000
"In total, 140 420 residents participated in this study, with 61 595 participants in Cohort I aged 40–59 years identified in the areas supervised by six PHCs and 78 825 participants in Cohort II aged 40–69 years identified in the areas supervised by five PHCs.","In total, 140 420 residents participated study, 61 595 participants Cohort I aged 40–59 identified supervised PHCs 78 825 participants Cohort II aged 40–69 identified supervised PHCs.",G0000000|C0439175|C1442061|C1442061|C1320928|G0000000|C0557651|C0450371|C1442061|C0679646|C0599755|C0021966|C0001779|G0000000|C0205396|G0000000|C1420160|C0450371|C1442061|C0679646|C0599755|G0000000|C0001779|G0000000|C0205396|G0000000|C1420160
Twenty subjects with a clinical diagnosis of SB completed this study.,Twenty subjects clinical diagnosis SB completed study.,C0724000|C0681850|C0205210|C0011900|C0038111|C0205197|C0557651
"Women self administered daily a vaginal suppository of 1% BC (53) or matched placebo (54) from 36 weeks of pregnancy, plus a single dose during labour.","Women administered daily vaginal suppository 1% BC (53) matched placebo (54) 36 weeks pregnancy, single dose labour.",C0043210|C1521801|C0332173|C0042232|C0031246|G0000000|C0006041|C0450371|C0150103|C0032042|C0450371|C0450371|C0439230|C0032961|C0037179|C0178602|C0022864
"The mean age of the trial cohort was 55 (SD 10) years; 56% (165/294) of patients were male, and 31% (80/258) had higher education (beyond A level).","The age trial cohort 55 (SD 10) years; 56% (165/294) patients male, 31% (80/258) education (beyond A level).",G0000000|C0001779|C0008976|C0599755|C0450371|G0000000|C0450371|C0439234|C0450371|C1442061|C0030705|C0086582|C0450371|C0450371|C0013621|G0000000|G0000000|C0441889
"The inclusion criteria included the pregnant women since 20 weeks of pregnancy who had a natural vaginal delivery without any problem (such as preeclampsia, placenta previa, premature labor symptoms, multiparity and high risk of PROM [premature rupture of membrane] pregnancy) and also lack of abnormal stresses in the past year due to unfortunate events of the life such as death of spouse, divorce, separation and antagonize with her husband, imprisonment, death of one of the close family members according to the 5-item modified scale of Holmes and Rahe.","The inclusion criteria included pregnant women 20 weeks pregnancy natural vaginal delivery (such preeclampsia, placenta previa, premature labor symptoms, multiparity risk PROM [premature rupture membrane] pregnancy) lack abnormal stresses unfortunate events life death spouse, divorce, separation antagonize husband, imprisonment, death close family 5-item modified scale Holmes Rahe.",G0000000|C0007637|C0243161|C0332257|C0549206|C0043210|C0450371|C0439230|C0032961|C0205296|C0042232|C0011209|G0000000|C0032914|C0032043|G0000000|C0151526|C0022864|C0683368|C0026751|C0035647|C0015944|C0151526|C1881712|C0025255|C0032961|C0332268|C0205161|C0038435|G0000000|C0441471|C0376558|C0011065|C0162409|C0012828|C0036679|G0000000|C0242664|C0205255|C0011065|C0587267|C0015576|C1551338|C0392747|C0175659|G0000000|G0000000
"Participants Adults aged 18 to 70 presenting symptoms associated with respiratory tract infection of less than one week’s duration, with cough as the predominant symptom, the presence of discoloured sputum, and at least one other symptom of lower respiratory tract infection (dyspnoea, wheezing, chest discomfort, or chest pain).","Participants Adults aged 18 70 symptoms respiratory tract infection week’s duration, cough predominant symptom, presence discoloured sputum, symptom lower respiratory tract infection (dyspnoea, wheezing, chest discomfort, chest pain).",C0679646|C0001675|C0001779|C0450371|C0450371|C0683368|C0521346|C1185740|C0009450|G0000000|C0449238|C0010200|C1542147|C1457887|C0150312|C0332572|C0038056|C1457887|C0441994|C0521346|C1185740|C0009450|C0013404|C0043144|C0817096|C0231218|C0817096|C0030193
"A researcher screened volunteers using the following study criteria derived from previous mCIT research: (1) history of no more than one stroke; (2) ability to actively extend at least 10° at the metacarpophalangeal joints of each digit and actively extend 20° at the wrist; (3) stroke experienced > 6 months before study participation; (4) a score ≥ 24 on the Korean version of Mini Mental Status Examination, and (5) affected arm nonuse, defined as a score < 2.5 for the amount of use scale of the Motor Activity Log.","A researcher screened volunteers study criteria derived previous mCIT research: (1) history stroke; (2) ability actively extend 10° metacarpophalangeal joints digit actively extend 20° wrist; (3) stroke experienced > 6 months study participation; (4) score ≥ 24 Korean version Mini Mental Status Examination, (5) arm nonuse, defined score < 2.5 amount scale Motor Activity Log.",G0000000|C0035173|C0220908|C0042960|C0557651|C0243161|C1441547|C0205156|G0000000|C0035168|G0000000|C0019664|C0038454|G0000000|C0085732|G0000000|C0231448|G0000000|G0000000|C0022417|C0582802|G0000000|C0231448|G0000000|C0043262|G0000000|C0038454|C0237607|G0000000|G0000000|C0439231|C0557651|C0679823|G0000000|C0449820|G0000000|C0450371|C1556095|C0333052|C0445542|C0229992|C0449438|G0000000|G0000000|C0446516|G0000000|C1704788|C0449820|G0000000|G0000000|C1265611|C0175659|C1513492|C0205177|C1708728
"Age itself was not found to be a significant prognostic factor (<75 years: 6.9 months, ⩾75 years: 6.2 months, P=0.066).","Age prognostic factor (<75 years: 6.9 months, ⩾75 years: 6.2 months, P=0.066).",C0001779|C0220901|C1521761|C0450371|C0439234|G0000000|C0439231|G0000000|C0439234|G0000000|C0439231|C0369773
"Four hundred ninety consecutive patients attending the outpatient clinics of the Cancer X-Ray Unit of the University of Messina, Italy, from May 1999 to December 2005, who had received adjuvant postoperative radiation therapy after surgery for sigmoid, rectal, or cervical cancers were randomly assigned to either treatment with VSL#3 (VSL Pharmaceuticals, Fort Lauderdale, MD), one sachet t.i.d., or a VSL#3-identical appearing placebo starting from the first day of radiation therapy until the end of the scheduled cycles of radiation therapy.","Four consecutive patients attending outpatient clinics Cancer X-Ray Unit University Messina, Italy, May 1999 December 2005, received adjuvant postoperative radiation therapy surgery sigmoid, rectal, cervical cancers randomly assigned treatment VSL#3 (VSL Pharmaceuticals, Fort Lauderdale, MD), sachet t.i.d., VSL#3-identical appearing placebo starting day radiation therapy scheduled cycles radiation therapy.",C0205450|C1707491|C0030705|C1547429|C0029921|C0442592|C0006826|C0034571|C0439148|C0041740|G0000000|C0022277|G0000000|G0000000|C3830550|G0000000|C1514756|C0001551|C0032790|C0034519|C0039798|C0038894|C0227391|C0205052|C0027530|C0006826|G0000000|C1516050|C0039798|G0000000|G0000000|C1135440|G0000000|G0000000|G0000000|C1319685|C2603360|C0205280|C0700364|C0032042|C0439659|C0332173|C0034519|C0039798|C0086960|C1511572|C0034519|C0039798
"Between June 2000 and October 2006, 127 patients underwent elective pancreaticoduodenectomy for benign or malignant pathologies of pancreas or periampullary region at Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.","Between June 2000 October 2006, 127 patients underwent elective pancreaticoduodenectomy benign malignant pathologies pancreas periampullary region Department Surgery, The University Hong Kong, Queen Mary Hospital, Hong Kong, China.",G0000000|C3829443|G0000000|C3828732|G0000000|C1442061|C0030705|G0000000|C0206058|C0085162|C0205183|C0205282|C0030664|C0030274|G0000000|C0017446|C1704729|C0038894|G0000000|C0041740|G0000000|G0000000|G0000000|G0000000|C0019994|G0000000|G0000000|C0008115
"Among the 199 contacts, 133 were eligible and 113 enrolled (85 percent recruitment rate) and were randomized into the control group (57 participants) or intervention group (56 participants).","Among 199 contacts, 133 eligible 113 enrolled (85 percent recruitment rate) randomized control (57 participants) intervention (56 participants).",G0000000|C1442061|C4036459|C1442061|C1548635|C1442061|G0000000|C0450371|C0439165|C2949735|C0871208|C0034656|C0243148|C0450371|C0679646|C0886296|C0450371|C0679646
"1568 men, mean age 68.2 years (range 35 to 92) at recruitment.","1568 men, age 68.2 (range 35 92) recruitment.",G0000000|C0025266|C0001779|C0450371|C1514721|C0450371|C0450371|C2949735
"In four additional newborns, the heart rate remained < 60 bpm after 30 s of ventilation with the LM and they were resuscitated using ETI.","In additional newborns, heart rate remained < 60 bpm 30 ventilation LM resuscitated ETI.",G0000000|C1524062|C0021289|C0018787|C0871208|G0000000|G0000000|C0450371|C0035203|C1261082|C2587207|G0000000
"Participants underwent a baseline assessment, which included a standard endoscopic protocol for collecting esophageal mucosal biopsies as well as a personal interview performed by the study team at their first visit on or after February 1, 1995.","Participants underwent baseline assessment, included standard endoscopic protocol collecting esophageal mucosal biopsies personal interview performed study team visit February 1, 1995.",C0679646|G0000000|C0168634|C1261322|C0332257|C1442989|C0014245|C0442711|C1516698|C1522619|C0026724|C0005558|C1519021|C0021822|C0884358|C0557651|C0871489|C0545082|C3830166|G0000000|G0000000
"Exclusion criteria were severe contractures that would preclude passive ROM in lower limb assessed by Modified Ashworth Scale, MAS ≥ 3.","Exclusion criteria severe contractures preclude passive ROM lower limb assessed Modified Ashworth Scale, MAS ≥ 3.",C0680251|C0243161|C0205082|C0009917|G0000000|C3686820|C4048784|C0441994|C0015385|C1516048|C0392747|G0000000|C0175659|G0000000
Therefore the total number of eligible pregnancies between 2000 and 2004 was 528 (243 WWE and 285 controls).,Therefore total eligible pregnancies 2000 2004 528 (243 WWE 285 controls).,G0000000|C0439175|C1548635|C0032961|G0000000|G0000000|C1442061|C1442061|G0000000|C1442061|C0243148
The actual number of screening appointments conducted totaled 949 with 391 individuals screening pre-eligible and 312 individuals recruited into the study.,The actual screening appointments conducted totaled 949 391 individuals screening pre-eligible 312 individuals recruited study.,G0000000|C0237400|C0220908|C0003629|C0004927|C0439175|C1442061|C1442061|C0027361|C0220908|C0332152|C1442061|C0027361|G0000000|C0557651
"Only those who had Helicobacter pylori (H pylori) infection and a histological diagnosis of severe chronic atrophic gastritis (CAG), intestinal metaplasia (IM) or dysplasia (DYS) were enrolled in the intervention trial.","Only Helicobacter pylori (H pylori) infection histological diagnosis severe chronic atrophic gastritis (CAG), intestinal metaplasia (IM) dysplasia (DYS) enrolled intervention trial.",C0205171|C0085508|C0034196|C0033727|C0034196|C0009450|C0205462|C0011900|C0205082|C0205191|C0151514|C0017152|G0000000|C0021853|C0025568|C3539078|C0334044|C0013364|G0000000|C0886296|C0008976
"At baseline, the 5th grade students (n = 1,566) attended 1 of 23 public middle schools (81 homerooms) in Phoenix, Arizona.","At baseline, 5th grade students (n = 1,566) attended 1 23 public middle schools (81 homerooms) Phoenix, Arizona.",G0000000|C0168634|G0000000|C0441800|C0038492|C0369718|G0000000|C1442061|C1456498|G0000000|C0450371|G0000000|C0444598|C0036375|C0450371|G0000000|C0331993|C0003787
"In this study, patients at least 18 years old with clinically active collagenous colitis were included.","In study, patients 18 clinically active collagenous colitis included.",G0000000|C0557651|C0030705|C0450371|G0000000|C0205177|C0439689|C0009319|C0332257
"Inclusion criteria were adults aged 18 years or older, a fever higher than 37.5°C, the concurrent presence of eschar or a maculopapular skin rash, and the clear presence of more than two symptoms such as headache, malaise, myalgia, coughing, nausea, and abdominal discomfort.","Inclusion criteria adults aged 18 older, fever 37.5°C, concurrent presence eschar maculopapular skin rash, presence symptoms headache, malaise, myalgia, coughing, nausea, abdominal discomfort.",C0007637|C0243161|C0001675|C0001779|C0450371|C0580836|C0015967|G0000000|C0205420|C0150312|C0521172|C0443253|C0444099|C0015230|C0150312|C0683368|C0018681|C0231218|C0231528|C0010200|C0027497|C0000726|C0231218
Two different intervention methods were applied to parents of the exposed children.,Two intervention methods applied parents exposed children.,C0205448|C0886296|C0025663|C4048755|C0030551|C0332157|C0008059
"In line with recommended guidelines [61], participants will be asked to exercise for 30 minutes five times a week at moderate intensity (defined as walking at a brisk pace).","In recommended guidelines [61], participants exercise 30 minutes times week moderate intensity (defined walking brisk pace).",G0000000|C0034866|C0162791|C0450371|C0679646|C0015259|C0450371|C0439232|C0040223|C0332174|C0205081|C0522510|C1704788|C0080331|C0443162|C0287990
Gastrointestinal function of preterm children with a gestational age less than 34 weeks is immaturely developed.,Gastrointestinal function preterm children gestational age 34 weeks immaturely developed.,C0521362|C0031843|C0151526|C0008059|C0439671|C0001779|C0450371|C0439230|G0000000|G0000000
"Two subjects (5.6%) in the treated group permanently discontinued study drug, as compared with four (10.8%) in the control group.","Two subjects (5.6%) treated permanently discontinued study drug, compared (10.8%) control group.",C0205448|C0681850|G0000000|C1522326|G0000000|C1444662|C0557651|C0013227|C1707455|C0450371|C0243148|C0441833
A participant was considered a control if he was free of self reported Parkinson’s disease at the time of the diagnosis of the case (index date) and remained free of the disease for five years from the index date (to avoid the possibility of subclinical disease).,A participant considered control free reported Parkinson’s disease time diagnosis (index date) remained free disease (to avoid possibility subclinical disease).,G0000000|C0679646|C0750591|C0243148|C0332296|C0684224|G0000000|C0012634|C0040223|C0011900|C0918012|C0011008|G0000000|C0332296|C0012634|G0000000|G0000000|C0332149|C0205211|C0012634
"GDM diagnosis will be based on the following criteria: 2 h, 75 g OGTT: fasting venous plasma glucose level, 5.5 mmol·L−1 or higher or 75-g oral glucose tolerance test [OGTT] 2-hour venous plasma glucose level, 8.0 mmol·L−1 or higher [20].","GDM diagnosis based criteria: 2 h, 75 g OGTT: fasting venous plasma glucose level, 5.5 mmol·L−1 75-g oral glucose tolerance test [OGTT] 2-hour venous plasma glucose level, 8.0 mmol·L−1 [20].",C0085207|C0011900|C1527178|C0243161|G0000000|G0000000|C0029161|C0015663|C0042449|C0032105|C0017725|C0441889|G0000000|C0450371|C0442027|C0017725|C0013220|C0022885|C0029161|C0439227|C0042449|C0032105|C0017725|C0441889|G0000000|C0450371
"There was no evidence that when they presented for ART, men were at more advanced WHO HIV stage or had significantly lower CD4 count than women.","There evidence ART, advanced WHO HIV stage lower CD4 count women.",G0000000|C3887511|C0003826|C0205179|G0000000|C0019682|C0205390|C0441994|C0285590|C0750480|C0043210
We will recruit 384 adults who meet inclusion criteria for a first mild stroke across six Canadian sites.,We recruit 384 adults meet inclusion criteria mild stroke Canadian sites.,G0000000|G0000000|C1442061|C0001675|C1550543|C0007637|C0243161|C2945599|C0038454|C0238884|C0205145
"Patients must have had three or fewer total prior systemic therapies, including cytokines and cytotoxic chemotherapy drugs, and had progression on or after the last therapy received and within 6 months before study enrollment.","Patients fewer total prior systemic therapies, including cytokines cytotoxic chemotherapy drugs, progression therapy received 6 months study enrollment.",C0030705|C0205388|C0439175|C0332152|C0205373|C0087111|C0332257|C0079189|C0677881|C0013216|C0013227|C0242656|C0039798|C1514756|G0000000|C0439231|C0557651|C1516879
We would like to thank all the mothers and children who participated in this research for their time and cooperation.,We mothers children participated time cooperation.,G0000000|C0026591|C0008059|G0000000|C0040223|C0392337
"Pregnant women at less than 16 week gestation from outpatient clinics at “Shahid Beheshti” hospital were eligible if they did not have any sign of vitamin D deficiency, did not using aspirin and had no diagnosis of chronic hypertension, gestational diabetes, renal disease or systemic lupus erythematus.","Pregnant women 16 week gestation outpatient clinics “Shahid Beheshti” hospital eligible sign vitamin D deficiency, aspirin diagnosis chronic hypertension, gestational diabetes, renal disease systemic lupus erythematus.",C0549206|C0043210|C0450371|C0332174|C0032961|C0029921|C0442592|G0000000|G0000000|C0019994|C1548635|C0311392|C0042890|C0073187|C0011155|C0004057|C0011900|C0205191|C0020538|C0439671|C0011847|C0022646|C0012634|C0205373|C0024131|G0000000
Patients with CR were randomly assigned to receive either PUVA maintenance therapy for 9 months (arm A) or no maintenance (arm B) (Figure 1).,Patients CR randomly assigned receive PUVA maintenance therapy 9 months (arm A) maintenance (arm B) (Figure 1).,C0030705|C0201975|G0000000|C1516050|C1514756|C0853073|C0024501|C0039798|G0000000|C0439231|C0446516|G0000000|C0024501|C0446516|G0000000|G0000000|G0000000
"Inclusion criteria are (1) female, (2) with a history of stage 0, I, II, or III BC, (3) within 2 years from the date of BC diagnosis, (4) currently under at least one adjuvant therapy.","Inclusion criteria (1) female, (2) history stage 0, I, II, III BC, (3) 2 BC diagnosis, (4) adjuvant therapy.",C0007637|C0243161|G0000000|C0015780|G0000000|C0019664|C0205390|G0000000|C0021966|G0000000|C0439070|C0006041|G0000000|G0000000|C0006041|C0011900|G0000000|C0001551|C0039798
"Initially, 102 women were enrolled in the study according to the following specifications: 18–40 years of age; married; in a monogamous relationship; not pregnant or lactating; not menstruating at the time of referral; receiving clotrimazole; absence of condition improvement; not using any vaginal medication, antibiotics, immunosuppressive drugs, or exogenous hormones, including oral contraceptives, during the 2 weeks before study initiation; abstaining from intercourse or vaginal douche in the previous 24 h; absence of other trichomonal vaginal infections or bacterial vaginosis; absence of known systemic disease such as diabetes or other autoimmune disease; showing positive potassium hydroxide (KOH) samples in culture.","Initially, 102 women enrolled study specifications: 18–40 age; married; monogamous relationship; pregnant lactating; menstruating time referral; receiving clotrimazole; absence condition improvement; vaginal medication, antibiotics, immunosuppressive drugs, exogenous hormones, including oral contraceptives, 2 weeks study initiation; abstaining intercourse vaginal douche previous 24 h; absence trichomonal vaginal infections bacterial vaginosis; absence systemic disease diabetes autoimmune disease; positive potassium hydroxide (KOH) samples culture.",C0205265|C1442061|C0043210|G0000000|C0557651|C2348235|G0000000|C0001779|C0024841|C0558125|C0439849|C0549206|C2828358|G0000000|C0040223|C0034927|C1514756|C0009074|C0332197|C0012634|C2986411|C0042232|C0013227|C0003232|C0021081|C0013227|C0205101|C0019932|C0332257|C0442027|C0009871|G0000000|C0439230|C0557651|C0589507|G0000000|C0009253|C0042232|C0150554|C0205156|G0000000|C0332197|C0040919|C0042232|C3714514|C0521009|C0042251|C0332197|C0205373|C0012634|C0011847|C0443146|C0012634|C0439178|C0032821|C0220853|C0071767|C0370003|C0010453
"The present work involved 60 patients with 1 to 3 brain metastases, each with a maximum diameter of no more than 4 cm on contrast-enhanced MRI scans, derived from a histologically confirmed systemic cancer.","The involved 60 patients 1 3 brain metastases, maximum diameter 4 cm contrast-enhanced MRI scans, derived histologically confirmed systemic cancer.",G0000000|C1314939|C0450371|C0030705|G0000000|G0000000|C0006104|C0027627|C0806909|C1301886|G0000000|G0000000|C0009924|C0024485|C0034606|C1441547|C0205462|C0521093|C0205373|C0006826
"In all cases, serial venous blood samples were obtained at entry, before initial treatment, and on days 1, 2, 3, 5 and 7 after inclusion.","In cases, serial venous blood samples entry, initial treatment, days 1, 2, 3, 5 7 inclusion.",G0000000|C0868928|C0031082|C0042449|C0005767|C0370003|C1705654|C0205265|C0039798|C0439228|G0000000|G0000000|G0000000|G0000000|G0000000|C0007637
"We retrospectively searched the records of two tertiary cancer centers located in Seoul, Korea (Asan Medical Center and Samsung Medical Center) and identified all consecutive patients with stage IB2 or IIA2 cervical cancer who underwent RH followed by tailored adjuvant therapy, or primary chemoradiation therapy.","We retrospectively searched records tertiary cancer centers located Seoul, Korea (Asan Medical Center Samsung Medical Center) identified consecutive patients stage IB2 IIA2 cervical cancer underwent RH tailored adjuvant therapy, primary chemoradiation therapy.",G0000000|G0000000|C1706202|C0034869|C0205372|C0006826|C0205099|G0000000|C3850150|C0022771|G0000000|C0199168|C0205099|G0000000|C0199168|C0205099|C0205396|C1707491|C0030705|C0205390|G0000000|G0000000|C0027530|C0006826|G0000000|C0035493|C0402883|C0001551|C0039798|C0205225|C0436307|C0039798
Objective: To study the safety and efficacy of the cholinesterase inhibitor donepezil in patients with Parkinson's disease (PD) and cognitive impairment.,Objective: To study safety efficacy cholinesterase inhibitor donepezil patients Parkinson's disease (PD) cognitive impairment.,C0018017|C0040363|C0557651|C0036043|C1280519|C0008429|C1999216|C0527316|C0030705|C1021144|C0012634|G0000000|C1516691|C0221099
"Additional criteria were no nodal or distant metastatic disease, Zubrod performance status < 2, and no prior bilateral orchiectomy, chemotherapy, RT, cryosurgery, or definitive surgery for prostate cancer.","Additional criteria nodal distant metastatic disease, Zubrod performance status < 2, prior bilateral orchiectomy, chemotherapy, RT, cryosurgery, definitive surgery prostate cancer.",C1524062|C0243161|C0443268|C0443203|C0036525|C0012634|C3714786|C0597198|C0449438|G0000000|G0000000|C0332152|C0238767|C0029189|C0013216|C0230425|C0010408|C0443196|C0038894|C0033572|C0006826
"Exclusion criteria included HER2-positive disease, previous chemotherapy for locally advanced or metastatic disease, or therapy targeting the MET pathway.","Exclusion criteria included HER2-positive disease, previous chemotherapy locally advanced metastatic disease, therapy targeting MET pathway.",C0680251|C0243161|C0332257|C0439178|C0012634|C0205156|C0013216|C1517927|C0205179|C0036525|C0012634|C0039798|C1521840|C0268621|C1704259
"We used a multi-centre randomised controlled trial to test the hypothesis that a day hospital-based falls prevention programme would reduce the rate of falls over 12 months in community-dwelling older people, identified through a screening programme as being at high risk of falls.","We multi-centre randomised controlled trial test hypothesis day hospital-based falls prevention programme reduce rate falls 12 months community-dwelling people, identified screening programme risk falls.",G0000000|C0439743|G0000000|C2587213|C0008976|C0022885|C1512571|C0332173|C0019994|C0000921|C0199176|C1709697|G0000000|C0871208|C0000921|C0450371|C0439231|C4045975|C0027361|C0205396|C0220908|C1709697|C0035647|C0000921
"Exclusion criteria were: receiving palliative treatment; receiving ≤ 10 fractions of radiotherapy treatment; unable to read and speak Dutch and unable to complete questionnaires (e.g., too sick).","Exclusion criteria were: receiving palliative treatment; receiving ≤ 10 fractions radiotherapy treatment; unable read speak Dutch unable complete questionnaires (e.g., sick).",C0680251|C0243161|G0000000|C1514756|C0587605|C0039798|C1514756|G0000000|C0450371|C1264633|C0034619|C0039798|C1299582|C0034754|C0234856|C0013331|C1299582|C0205197|C0034394|G0000000|C0221423
A total of 48 participants were analyzed for the primary endpoint on an intent-to-treat basis.,A total 48 participants analyzed primary endpoint intent-to-treat basis.,G0000000|C0439175|C0450371|C0679646|C0936012|C0205225|C2349179|C0162425|C1527178
"Of the 261 participants enrolled in the study, the majority of patients were male (73%).","Of 261 participants enrolled study, majority patients male (73%).",G0000000|C1442061|C0679646|G0000000|C0557651|C0680220|C0030705|C0086582|C0450371
"In the current study, the rate of cognitive decline over time slowed by 4 months after WBRT in both arms, but more so in the memantine arm.","In current study, rate cognitive decline time slowed 4 months WBRT arms, memantine arm.",G0000000|C0521116|C0557651|C0871208|C1516691|G0000000|C0040223|C0439834|G0000000|C0439231|C1520143|C0206655|C0025242|C0446516
"Patients with any of the following conditions were excluded from the study: (a) residing >70 miles from the research site or unavailable to attend the intervention at one of the scheduled times, (b) currently engaged in intensive yoga practice (practice >3 days/week), (c) actively contemplating suicide (none were excluded on this basis), (d) currently undergoing disability application, determination or litigation, (e) scheduled for elective surgery during the study period, (f) physically disabled in a manner that precluded meaningful participation in the intervention (e.g., quadriplegic paralysis), (g) unwilling to forgo changing their voluntary pharmacologic and/or non-pharmacologic treatments for the length of their participation in the study, or (h) do not speak English.","Patients conditions excluded study: (a) residing >70 miles site unavailable attend intervention scheduled times, (b) engaged intensive yoga practice (practice >3 days/week), (c) actively contemplating suicide (none excluded basis), (d) undergoing disability application, determination litigation, (e) scheduled elective surgery study period, (f) physically disabled manner precluded meaningful participation intervention (e.g., quadriplegic paralysis), (g) unwilling forgo changing voluntary pharmacologic and/or non-pharmacologic treatments length participation study, (h) speak English.",C0030705|C0012634|C1554077|C0557651|G0000000|C2982691|C0450371|C0331865|C0205145|C0686905|C1999232|C0886296|C0086960|C0040223|G0000000|C0425152|C0162425|C0043418|C0237607|C0237607|G0000000|C0677547|G0000000|G0000000|G0000000|C0038661|G0000000|C1554077|C1527178|C0073187|G0000000|C0231170|C0185125|C1148554|C0079706|G0000000|C0086960|C0206058|C0038894|C0557651|C0439531|C0016327|G0000000|C0018576|G0000000|G0000000|C0876919|C0679823|C0886296|G0000000|G0000000|C0522224|C0439267|C0558080|G0000000|C0392747|C0439656|C0031330|G0000000|C1518422|C0087111|C1444754|C0679823|C0557651|C0033727|C0234856|C0376245
"At 6 months, FCRS was 6.9 per cent (SD 5.0) in the intervention group and 7.4 per cent (SD 5.0) in the control group (p=0.17).","At 6 months, FCRS 6.9 cent (SD 5.0) intervention 7.4 cent (SD 5.0) control (p=0.17).",G0000000|G0000000|C0034805|G0000000|C0562018|G0000000|G0000000|C0886296|G0000000|C0562018|G0000000|G0000000|C0243148|C0369773
"Families were eligible to participate if (1) the child was 6 years or younger when entering the study, (2) the child had previously been diagnosed with Autism Spectrum Disorder, (3) the child showed limited or no use of spoken language (generally fewer than 25 words and no phrases based on parent report), (4) the child’s mother was fluent in English and willing/available to participate in all assessment and treatment sessions, and (5) the family lived within a reasonable travel distance from the research lab (generally less than 90 minutes).","Families eligible participate (1) child 6 entering study, (2) child diagnosed Autism Spectrum Disorder, (3) child limited spoken language (generally fewer 25 phrases based parent report), (4) child’s mother fluent English willing/available participate assessment treatment sessions, (5) family lived reasonable travel distance lab (generally 90 minutes).",C0015576|C1548635|G0000000|G0000000|C0008059|G0000000|C1522196|C0557651|G0000000|C0008059|C0011900|C0004352|C1883073|C0012634|G0000000|C0008059|C0439801|C0234856|C0023008|G0000000|C0205388|C0450371|C0600665|C1527178|C0030551|C0684224|G0000000|G0000000|C0026591|C0870569|C0376245|C0600109|G0000000|C1261322|C0039798|C1883016|G0000000|C0015576|C1548795|G0000000|C0040802|C0012751|C0022877|G0000000|C0450371|C0439232
The mean age of patients was 6.9 ± 0.7 (5 boys with the mean age of 6.6 ± 0.2 years and 16 girls with the age range of 7 ± 0.6 years).,The age patients 6.9 ± 0.7 (5 boys age 6.6 ± 0.2 16 girls age range 7 ± 0.6 years).,G0000000|C0001779|C0030705|G0000000|G0000000|G0000000|G0000000|C0870221|C0001779|G0000000|G0000000|G0000000|C0450371|C0870604|C0001779|C1514721|G0000000|G0000000|G0000000|C0439234
There were three measurement periods: prior to randomization (Time 1) and at 5 and 9 months post enrollment (Times 2 and 3).,There measurement periods: prior randomization (Time 1) 5 9 months post enrollment (Times 2 3).,G0000000|C0242485|C0439531|C0332152|C0034656|C0040223|G0000000|G0000000|G0000000|C0439231|C0687676|C1516879|C0040223|G0000000|G0000000
The study will include male and female young adults: Who are aged between 15 and 30 years; Who have a confirmed diagnosis of spastic hemiplegia or diplegia-type CP; Who are able to walk independently; Who are Gross Motor Function Classification System (GMFCS)69 level I or II; Who have a maximum passive ankle dorsiflexion range of motion of <5° (knee fully extended).,The study male female adults: Who aged 15 30 years; Who confirmed diagnosis spastic hemiplegia diplegia-type CP; Who walk independently; Who Gross Motor Function Classification System (GMFCS)69 level I II; Who maximum passive ankle dorsiflexion range motion <5° (knee extended).,G0000000|C0557651|C0086582|C0015780|C0001675|G0000000|C0001779|C0450371|G0000000|G0000000|C0521093|C0011900|C0026838|C0018991|C0221165|C4050020|G0000000|C0080331|G0000000|G0000000|C0439806|C1513492|C0031843|C0008902|C0449913|C0450371|C0441889|C0021966|G0000000|G0000000|C0806909|C3686820|C0003086|G0000000|C1514721|C0026597|G0000000|C0022742|C0231448
As soon as the diagnostic process has been concluded and treatment has started (i.e.,As diagnostic process concluded treatment started (i.e.,G0000000|C0011900|C1184743|C0917903|C0039798|C1272689|C0683454
"Between 2000 and 2004, 628 pregnant women were recruited from antenatal clinics in the North West of England.","Between 2000 2004, 628 pregnant women recruited antenatal clinics North West England.",G0000000|G0000000|G0000000|C1442061|C0549206|C0043210|G0000000|C2828394|C0442592|C1709269|C1705493|C0014282
METHODS—The adverse effects of B breve were examined in 66 VLBW infants (preliminary study).,METHODS—The adverse effects B breve examined 66 VLBW infants (preliminary study).,G0000000|G0000000|C1280500|G0000000|G0000000|C0332128|C0450371|C0282666|C0021270|C0439611|C0557651
"An active case finding component, in which HEWs conducted house-to-house visits to identify individuals with chronic cough, informed symptomatic individuals how to produce sputum and preparation of smears of two sputum specimens for smear microscopy.","An active finding component, HEWs conducted house-to-house visits identify individuals chronic cough, informed symptomatic individuals produce sputum preparation smears sputum specimens smear microscopy.",G0000000|C0205177|C0037088|C0449432|G0000000|C0004927|C0442519|C0545082|G0000000|C0027361|C0205191|C0010200|C1522154|C0231220|C0027361|G0000000|C0038056|C1521827|C0444186|C0038056|C0370003|C0444186|C0026018
The eligible cases were permanent residents of urban Shenyang aged 18 to 85 years.,The eligible permanent residents urban Shenyang aged 18 85 years.,G0000000|C1548635|C0205355|C1320928|C0442529|G0000000|C0001779|C0450371|C0450371|C0439234
A total of 199 patients underwent colorectal surgery and were randomly assigned to early feeding (n = 99) or a regular diet (n = 100).,A total 199 patients underwent colorectal surgery randomly assigned feeding (n = 99) regular diet (n = 100).,G0000000|C0439175|C1442061|C0030705|G0000000|C0555952|C0038894|G0000000|C1516050|C0204695|G0000000|C0205272|C0012155|G0000000
"After participants completed the baseline survey, they were randomly assigned to the intervention or control group.","After participants completed baseline survey, randomly assigned intervention control group.",G0000000|C0679646|C0205197|C0168634|C0038951|G0000000|C1516050|C0886296|C0243148|C0441833
"The diversity in age, disease, and inpatient or outpatient status was included to represent the diverse patient population in this clinical setting and to permit an evaluation of the feasibility of implementing massage in the clinical setting while also maximizing the external validity of the study.","The diversity age, disease, inpatient outpatient status included represent diverse patient population clinical setting permit evaluation feasibility implementing massage clinical setting maximizing external validity study.",G0000000|C1880371|C0001779|C0012634|C0021562|C0029921|C0449438|C0332257|C1882932|C1880371|C0030705|C0032659|C0205210|C0542559|C0023636|C0220825|G0000000|G0000000|C0024875|C0205210|C0542559|G0000000|C0205101|C2349101|C0557651
"Clusters were randomized as soon as they were assembled according to a computer‐generated, simple randomization scheme to either home‐based care or usual clinic‐based care.","Clusters randomized assembled computer‐generated, simple randomization scheme home‐based care usual clinic‐based care.",C1555715|C0034656|C1706853|G0000000|C0205352|C0034656|C1519193|G0000000|C1947933|C3538928|G0000000|C1947933
Total intended platinum dose for stage I (non-pure fetal) and stage II patients was 400 mg/m2 (12 mg/kg for patients < 1 year of age) of cisplatin.,Total intended platinum dose stage I (non-pure fetal) stage II patients 400 mg/m2 (12 mg/kg patients < 1 age) cisplatin.,C0439175|C1283828|C0032207|C0178602|C0205390|C0021966|C1518422|C0015965|C0205390|G0000000|C0030705|C1442061|C0026410|C0450371|C0439272|C0030705|G0000000|G0000000|C0001779|C0008838
Participants who were medically unstable were eligible for entry to the study when they became medically stable for outpatient treatment.,Participants medically unstable eligible entry study medically stable outpatient treatment.,C0679646|G0000000|C0443343|C1548635|C1705654|C0557651|G0000000|C0205360|C0029921|C0039798
"Intracranial Progression and Salvage Therapy Abbreviation: WBRT, whole-brain radiotherapy.","Intracranial Progression Salvage Therapy Abbreviation: WBRT, whole-brain radiotherapy.",C0524466|C0242656|C0085405|C0039798|C0000723|C1520143|C1269537|C0034619
Control participants received payments only for delivering a breath CO sample.,Control participants received payments delivering breath CO sample.,C0243148|C0679646|C1514756|C0680264|C0308779|C0225386|C3245499|C0370003
Patients who have bilateral carpal tunnel syndrome would be ideal candidates to investigate regarding which technique is better from the patient’s perspective.,Patients bilateral carpal tunnel syndrome ideal candidates investigate technique patient’s perspective.,C0030705|C0238767|C0007285|C0337138|C0039082|C1512612|G0000000|C1292732|C0449851|G0000000|G0000000
The ability of sorafenib to significantly inhibit the MAP kinase pathway in melanoma remains unproven.,The ability sorafenib inhibit MAP kinase pathway melanoma remains unproven.,G0000000|C0085732|C1516119|C0018790|C0024779|C0031727|C1704259|C0025202|G0000000|C0456370
"RESULTS—Children in the intervention group were significantly less likely to be readmitted to hospital in the next six months than those in the control group (12 of 80 v 30 of 80 patients), and significantly less likely to attend the A&E department (6 of 80v 31 of 80).","RESULTS—Children intervention readmitted hospital months control (12 80 30 80 patients), attend A&E department (6 80v 31 80).",G0000000|C0886296|G0000000|C0019994|C0439231|C0243148|C0450371|C0450371|C0450371|C0450371|C0030705|C1999232|G0000000|C1704729|G0000000|G0000000|C0450371|C0450371
"This was a 12-week, multinational, randomised, double-blind, double-dummy study involving patients aged ≥ 12 years with asthma.","This 12-week, multinational, randomised, double-blind, double-dummy study involving patients aged ≥ 12 asthma.",G0000000|C0450371|G0000000|G0000000|C0013072|C0205173|C0557651|C1314939|C0030705|C0001779|G0000000|C0450371|C0004096
"Exclusion criteria were as follows: Chronic diseases including renal, rheumatologic, hepatic, thyroid; pregnant women who had had diabetes before pregnancy; gestational diabetes at the time of admission; history of consuming vitamin D and drugs that interfere with glucose metabolism.","Exclusion criteria follows: Chronic diseases including renal, rheumatologic, hepatic, thyroid; pregnant women diabetes pregnancy; gestational diabetes time admission; history consuming vitamin D drugs interfere glucose metabolism.",C0680251|C0243161|C0332283|C0205191|C0012634|C0332257|C0022646|C0035452|C0205054|C0040132|C0549206|C0043210|C0011847|C0032961|C0439671|C0011847|C0040223|C0184666|C0019664|G0000000|C0042890|C0073187|C0013227|C0521102|C0017725|C0025519
"Eligibility was extended in 2005 to include asymptomatic patients, for whom the criteria were stenosis of 60% or more on angiography, 70% or more on ultrasonography, or 80% or more on computed tomographic angiography or magnetic resonance angiography if the stenosis on ultrasonography was 50 to 69%.","Eligibility extended 2005 asymptomatic patients, criteria stenosis 60% angiography, 70% ultrasonography, 80% computed tomographic angiography magnetic resonance angiography stenosis ultrasonography 50 69%.",C0013893|C0231448|G0000000|C0231221|C0030705|C0243161|C0678234|C0450371|C0002978|C0450371|C0041618|C0450371|C1441526|C0040395|C0002978|C0024488|C0231881|C0002978|C0678234|C0041618|C0450371|C0450371
Seventy-two women were enrolled at 25–29 weeks gestation (mean 26.6 weeks) and randomized to either placebo (corn/soy oil) or DHA (800 mg/day) supplementation (purchased from DSM Nutritional Products) for the remainder of their pregnancy.,Seventy-two women enrolled 25–29 weeks gestation (mean 26.6 weeks) randomized placebo (corn/soy oil) DHA (800 mg/day) supplementation (purchased DSM Nutritional Products) remainder pregnancy.,C3816957|C0043210|G0000000|G0000000|C0439230|C0032961|C0444504|C0450371|C0439230|C0034656|C0032042|C0010028|C0028908|C0142831|C1442061|C0439422|C0242297|C0870238|G0000000|C1521739|C1514468|G0000000|C0032961
"The following entry criteria were used: (a) Probable Alzheimer’s disease based on National Institute of Neurologic and Communicative Disorders and Stroke-Alzheimer’s Disease and Related Disorders Association (NINCDS/ADRDA) criteria (McKhann et al., 1984); (b) Mini-Mental State Exam Score (MMSE) (Folstein et al., 1975) > = 10; (c) community-residing (not in assisted living); (d) stable medical history and general health; (e) ambulatory (f)A caregiver who spent at least 10 h per week with the participant.","The entry criteria used: (a) Probable Alzheimer’s disease based National Institute Neurologic Communicative Disorders Stroke-Alzheimer’s Disease Related Disorders Association (NINCDS/ADRDA) criteria (McKhann al., 1984); (b) Mini-Mental State Exam Score (MMSE) (Folstein al., 1975) > = 10; (c) community-residing (not assisted living); (d) stable medical history health; (e) ambulatory (f)A caregiver spent 10 week participant.",G0000000|C1705654|C0243161|C1273517|G0000000|C0033204|G0000000|C0012634|C1527178|C3245503|C0021622|C0205494|C0009452|C0012634|G0000000|C0012634|C0439849|C0012634|C0004083|G0000000|C0243161|G0000000|C0202311|G0000000|G0000000|C0445542|C1301808|C0582103|C0449820|C0451306|G0000000|C0202311|G0000000|G0000000|G0000000|C0450371|G0000000|C0009462|C1518422|C1269765|C0376558|C0073187|C0205360|C0199168|C0019664|C0018684|G0000000|C0439841|C0016327|C0085537|C0680968|C0450371|C0332174|C0679646
"This controlled-clinical trial was conducted on formula-fed children, aged 1 to 24 months, referring with acute non-bloody diarrhea (≤2 weeks).","This controlled-clinical trial conducted formula-fed children, aged 1 24 months, referring acute non-bloody diarrhea (≤2 weeks).",G0000000|C2587213|C0008976|C0004927|C0489829|C0008059|C0001779|G0000000|C0450371|C0439231|C0205543|C0205178|C1518422|C0011991|G0000000|C0439230
"In particular, the colonization of preterm infants by bifidobacteria is delayed.","In particular, colonization preterm infants bifidobacteria delayed.",G0000000|G0000000|G0000000|C0151526|C0021270|C0005380|C0205421
"Subjects were recruited from large urban asthma clinics, community clinics, and schools.","Subjects recruited urban asthma clinics, community clinics, schools.",C0681850|G0000000|C0442529|C0004096|C0442592|C0009462|C0442592|C0036375
"gambiae s.s, M form, and 5% An.","gambiae s.s, M form, 5% An.",G0000000|C0565930|C0369637|C0348078|G0000000|G0000000
"Results Most patients with tuberculosis were poor, malnourished men living close to the clinics; 265/270 (98%) contributed to the analysis.","Results Most patients tuberculosis poor, malnourished living close clinics; 265/270 (98%) contributed analysis.",C1274040|C0205393|C0030705|C0041296|C0032854|C0162429|C0376558|C0587267|C0442592|C1442061|C0450371|C1880177|C0002778
Asthma knowledge was significantly increased in parents and the youngest children (grades 1–2) but not in the older children (grades 3–5).,Asthma knowledge increased parents children (grades 1–2) children (grades 3–5).,C0004096|C0376554|C0205217|C0030551|C0008059|C0441800|G0000000|C0008059|C0441800|G0000000
"A single oral dose of azithromycin was given at 20 mg/kg body weight, up to 1 g. Pregnant women and infants under the age of 6 months were instead offered tetracycline eye ointment for daily use for up to 6 weeks.","A single oral dose azithromycin 20 mg/kg body weight, 1 g. Pregnant women infants age 6 months offered tetracycline eye ointment daily 6 weeks.",G0000000|C0037179|C0442027|C0178602|C0052796|C0450371|C0439272|C0242821|C0005910|G0000000|C0439267|C0549206|C0043210|C0021270|C0001779|G0000000|C0439231|C1444648|C0039644|C0015392|C0028912|C0332173|G0000000|C0439230
Demographic characteristics of the patients can be found in Table 1; they were similar in the massage group (Touch) and control groups (No Touch and Usual Care).,Demographic characteristics patients Table 1; massage (Touch) control (No Touch Usual Care).,C0011298|C1521970|C0030705|C0039224|G0000000|C0024875|C0152054|C0243148|G0000000|C0152054|C3538928|C1947933
A total of 292 children were enrolled and 257 completed the 12-month study (87.7% retention).,A total 292 children enrolled 257 completed 12-month study (87.7% retention).,G0000000|C0439175|C1442061|C0008059|G0000000|C1442061|C0205197|C0450371|C0557651|C0450371|C0035280
"Briefly, this prospective cohort study was started in 1994 and included 26 481 men aged 40–79 years living in 14 municipalities of Miyagi Prefecture (95% response rate) (Anzai et al, 2005).","Briefly, prospective cohort study started 1994 included 26 481 aged 40–79 living 14 municipalities Miyagi Prefecture (95% response rate) (Anzai al, 2005).",G0000000|C0023981|C0599755|C0557651|C1272689|G0000000|C0332257|G0000000|C0001779|G0000000|C0376558|C0450371|C0600182|G0000000|C1709636|C0450371|C0871261|C0871208|G0000000|C0202311|G0000000
"Inclusion criteria were: Age at enrolment: 8–13 years Spherical equivalent refractions (SERs): −1.00 to −5.00 Dioptres (D) Astigmatism: 1.00 D or less Anisometropia: 1.25 D or less Spectacle corrected monocular visual acuity (VA): 0.0 logMAR or better Contact lens corrected monocular VA: 0.1 logMAR or better Free of ocular and systemic abnormalities might affect visual functions or refractive development No prior use of PALs, bifocal contact lenses No contraindication for contact lens wear Willingness to wear contact lenses regularly Parents’ understanding and acceptance of random allocation of grouping  We sought 90% power to detect 0.50 D difference (with 0.7 D of SD)6 in myopia progression between two groups with a significance α level of 0.01 (two-tailed); the minimum subject number required in each group was 59.","Inclusion criteria were: Age enrolment: 8–13 years Spherical equivalent refractions (SERs): −1.00 −5.00 Dioptres (D) Astigmatism: 1.00 D Anisometropia: 1.25 D Spectacle corrected monocular visual acuity (VA): 0.0 logMAR Contact lens corrected monocular VA: 0.1 logMAR Free ocular systemic abnormalities affect visual functions refractive development No prior PALs, bifocal contact lenses No contraindication contact lens wear Willingness wear contact lenses regularly Parents’ understanding acceptance random allocation We sought 90% power detect 0.50 D difference (with 0.7 D SD)6 myopia progression significance α level 0.01 (two-tailed); minimum subject required 59.",C0007637|C0243161|G0000000|C0001779|C1516879|G0000000|C0332501|C0205163|C0429585|C1419818|G0000000|G0000000|C0439484|C0073187|C0004106|G0000000|C0003081|G0000000|C0015421|C0205202|G0000000|C0234621|C0750509|C1549054|G0000000|G0000000|C0332158|C0023317|C0205202|G0000000|C1549054|G0000000|G0000000|C0332296|C0015392|C0205373|C0000768|C0001721|C0234621|C0542341|C0429585|C0243107|G0000000|C0332152|C0030360|C1275647|C0332158|C0023317|G0000000|C0522473|C0332158|C0023317|G0000000|C0600109|G0000000|C0332158|C0023317|G0000000|G0000000|C0162340|G0000000|C0034656|C1706778|G0000000|G0000000|C0450371|C0032863|C0442726|G0000000|C1705241|G0000000|G0000000|C2699239|C0027092|C0242656|C0237881|G0000000|C0441889|C0450371|C0205448|C1524031|C0681850|C1514873|C0450371
C1 = first sleep cycle; C2 = second sleep cycle; C3 = third sleep cycle; C4 = fourth sleep cycle; RMMA/SB = rhythmic masticatory muscle activity/sleep bruxism.,C1 = sleep cycle; C2 = sleep cycle; C3 = sleep cycle; C4 = fourth sleep cycle; RMMA/SB = rhythmic masticatory muscle activity/sleep bruxism.,G0000000|G0000000|C0037313|C1511572|G0000000|G0000000|C0037313|C1511572|G0000000|G0000000|C0037313|C1511572|G0000000|G0000000|C0205438|C0037313|C1511572|C0038111|G0000000|C0031084|G0000000|C0026845|C0037322|C0006325
Subjects with CMT1A between the ages of 13 and 70 years were eligible for the study.,Subjects CMT1A ages 13 70 eligible study.,C0681850|G0000000|C0001779|C0450371|C0450371|C1548635|C0557651
"The University of Rochester Cancer Center (URCC) Community Clinical Oncology Program (CCOP) Research Base conducted a nationwide, multicenter, randomized controlled trial (RCT) examining the efficacy of yoga compared with standard care for improving global sleep quality in post-treatment cancer survivors.","The University Rochester Cancer Center (URCC) Community Clinical Oncology Program (CCOP) Research Base conducted nationwide, multicenter, randomized controlled trial (RCT) examining efficacy yoga compared standard care improving global sleep quality post-treatment cancer survivors.",G0000000|C0041740|G0000000|C0006826|C0205099|C1425565|C0009462|C0205210|C0027651|C1709697|C1516732|C0035168|C0002055|C0004927|G0000000|C0439743|C0034656|C2587213|C0008976|G0000000|C0332128|C1280519|C0043418|C1707455|C1442989|C1947933|C1272745|C0205246|C0037313|C0332306|C2709088|C0006826|C0206194
"All of the subjects were included in this study if they were 1) between 21 and 75 years; 2) had hemiparesis due to a cerebral vascular accident (CVA) stroke (confirmed by a physician); 3) were at least 6-months post-stroke and medically stable; 4) had the ability to sit for 60 min and to stand, assisted or unassisted, for 30–40 min; 5) had a score less than eight in the Geriatric Depression Scale [49] indicating mild depression and a likelihood of completing the 24 sessions required; 6) were no be more than moderately cognitively impaired as defined by a Mini-mental Test [41] score greater than 20--they were able to give consent and understand instructions; 7) had residual movement in shoulder flexion/adduction and active elbow flexion/extension and/or residual movement in leg flexion/extension and hip adduction as defined by a Brunnstrom Test Score [39] ranging from 2 to 5; and 8) had a muscle strength scores on the Manual Muscle Test [50] between >1 and <3 in both extremities.","All subjects included study 1) 21 75 years; 2) hemiparesis cerebral vascular accident (CVA) stroke (confirmed physician); 3) 6-months post-stroke medically stable; 4) ability sit 60 min stand, assisted unassisted, 30–40 min; 5) score Geriatric Depression Scale [49] indicating mild depression likelihood completing 24 sessions required; 6) moderately cognitively impaired defined Mini-mental Test [41] score 20--they consent understand instructions; 7) residual movement shoulder flexion/adduction active elbow flexion/extension and/or residual movement leg flexion/extension hip adduction defined Brunnstrom Test Score [39] ranging 2 5; 8) muscle strength scores Manual Muscle Test [50] >1 <3 extremities.",G0000000|C0681850|C0332257|C0557651|G0000000|C0450371|C0450371|C0439234|G0000000|C0018989|G0000000|C0005847|C0000924|C0038454|C0038454|C0521093|C0031831|G0000000|C0439231|C0687676|G0000000|C0205360|G0000000|C0085732|C0277814|C0450371|C0702093|C0596013|C1269765|G0000000|G0000000|C0702093|G0000000|C0449820|C1704440|C0011570|C0175659|C0450371|G0000000|C2945599|C0011570|C0033204|C0205197|C0450371|C1883016|C1514873|G0000000|C0205081|G0000000|C0221099|C1704788|C0445542|C0022885|C0450371|C0449820|C0450371|C1511481|C0162340|C0302828|G0000000|C1609982|C0026649|C0037004|C0231452|C0205177|C0013769|C0444509|G0000000|C1609982|C0026649|C0023216|C0444509|C0019552|C0231457|C1704788|G0000000|C0022885|C0449820|C0450371|C1514721|G0000000|G0000000|G0000000|C0026845|C0237897|C0449820|C0024763|C0026845|C0022885|C0450371|G0000000|G0000000|C0015385
"Withdrawals were due to death unrelated to the study (one patient), uncontrollable nausea and vomiting (one patient), and unstable pain control requiring spinal drugs (two patients).","Withdrawals death unrelated study (one patient), uncontrollable nausea vomiting (one patient), unstable pain control requiring spinal drugs (two patients).",C2349954|C0011065|C0445356|C0557651|C0205447|C0030705|G0000000|C0027497|C0042963|C0205447|C0030705|C0443343|C0030193|C0243148|G0000000|C0521329|C0013227|C0205448|C0030705
"In Bangladesh, approximately 40 percent of children (6–15 years aged) have anemia with 6.9 percent of them having iron deficiency [9].","In Bangladesh, 40 percent children (6–15 aged) anemia 6.9 percent iron deficiency [9].",G0000000|C0004732|C0450371|C0439165|C0008059|G0000000|C0001779|C0002871|G0000000|C0439165|C0302583|C0011155|G0000000
Weekly assessment analyses based on the results of the mixed-effect model repeated measure (MMRM) analysis with weekly pain score defined as the mean of the last seven daily diary pain ratings.,Weekly assessment analyses based mixed-effect model repeated measure (MMRM) analysis weekly pain score defined daily diary pain ratings.,C0332174|C1261322|C0002778|C1527178|C0205430|C3161035|C0205341|C0079809|G0000000|C0002778|C0332174|C0030193|C0449820|C1704788|C0332173|C0376660|C0030193|C0871208
Ten doses were administered over 56 weeks.,Ten doses administered 56 weeks.,C0014518|C0178602|C1521801|C0450371|C0439230
"Criteria for exclusion: Patients not speaking or reading Swedish, other severe somatic or psychiatric disease, ongoing or planned physical therapy, including exercise, and an inability to accept times for planned exercise sessions.","Criteria exclusion: Patients speaking reading Swedish, severe somatic psychiatric disease, ongoing planned physical therapy, including exercise, inability accept times planned exercise sessions.",C0243161|C0680251|C0030705|C0234856|C0034754|C1710263|C0205082|C1257909|C0205487|C0012634|C0549178|C1301732|C0031809|C0039798|C0332257|C0015259|G0000000|C1272684|C0040223|C1301732|C0015259|C1883016
"The early feeding group included 52 males and 47 females, with a mean age of 62±12.33 years, whereas the regular feeding group consisted of 61 males and 39 females, with a mean age of 61±15.82 years.","The feeding included 52 males 47 females, age 62±12.33 years, regular feeding consisted 61 males 39 females, age 61±15.82 years.",G0000000|C0204695|C0332257|C0450371|C0086582|C0450371|C0015780|C0001779|G0000000|C0439234|C0205272|C0204695|C0332529|C0450371|C0086582|C0450371|C0015780|C0001779|G0000000|C0439234
"Criteria for ineligibility included allergy to octreotide, inflammatory bowel disease, renal failure, grade 3 or higher diarrhea before study entry, Eastern Cooperative Oncology Group performance status of 3 or 4, planned concurrent radiation therapy and cytotoxic chemotherapy (other than with fluorouracil or cisplatin), planned brachytherapy before completion of external radiation therapy, lack of a functional rectum, and fecal incontinence.","Criteria ineligibility included allergy octreotide, inflammatory bowel disease, renal failure, grade 3 diarrhea study entry, Eastern Cooperative Oncology Group performance status 3 4, planned concurrent radiation therapy cytotoxic chemotherapy (other fluorouracil cisplatin), planned brachytherapy completion external radiation therapy, lack functional rectum, fecal incontinence.",C0243161|C1512714|C0332257|C0002111|C0028833|C0333348|C0021853|C0012634|C0022646|C0231174|C0441800|G0000000|C0011991|C0557651|C1705654|C1707877|C0679729|C0027651|C0441833|C0597198|C0449438|G0000000|G0000000|C1301732|C0205420|C0034519|C0039798|C0677881|C0013216|G0000000|C0016360|C0008838|C1301732|C0006098|C0205197|C0205101|C0034519|C0039798|C0332268|C0205245|C0034896|C0015733|C0021167
Setting 41 low level dependency residential care homes in New Zealand.,Setting 41 low level dependency residential care homes New Zealand.,C0542559|C0450371|C0205251|C0441889|C0011546|C0237096|C1947933|C0442519|C0205314|G0000000
The Institutional Review Board of the Kyung Hee University Hospital at Gangdong approved the study protocol.,The Institutional Review Board Kyung Hee University Hospital Gangdong approved study protocol.,G0000000|C0018704|C0282443|C0972401|G0000000|G0000000|C0041740|C0019994|G0000000|C0205540|C0557651|C0442711
"Our primary hypothesis was that ginkgo would improve cognitive function in people with MS. We tested this hypothesis, providing Class I evidence by comparing the 2 groups on their performance at exit adjusted for baseline performance on the 4 neuropsychological tests (Stroop Test, California Verbal Learning Test II [CVLT-II; long-delay free-recall score], Controlled Oral Word Association Test [COWAT], and the 2-second version of the Paced Auditory Serial Addition Task [PASAT]).","Our primary hypothesis ginkgo improve cognitive function people MS. We tested hypothesis, providing Class I evidence comparing 2 performance exit adjusted baseline performance 4 neuropsychological tests (Stroop Test, California Verbal Learning Test II [CVLT-II; long-delay free-recall score], Controlled Oral Word Association Test [COWAT], 2-second version Paced Auditory Serial Addition Task [PASAT]).",G0000000|C0205225|C1512571|C0330205|G0000000|C1516691|C0031843|C0027361|C0039676|G0000000|C0392366|C1512571|C1999230|C0456387|C0021966|C3887511|C1707455|G0000000|C0597198|C0337094|C0456081|C0168634|C0597198|G0000000|G0000000|C0022885|G0000000|C0022885|C0006754|C0439824|C0013621|C0022885|G0000000|C3899729|C0205166|C0332296|C0449820|C2587213|C0442027|C1705313|C0004083|C0022885|C3827022|C0205436|C0333052|C0287990|C0439825|C0031082|C0332287|C3540678|C3898036
All households in each cluster/Gots were included in the study.,All households cluster/Gots included study.,G0000000|C0020052|C1555715|C0332257|C0557651
The proportion of four patients per intervention group was equally divided into cardiology and gastroenterology procedures.,The proportion patients intervention equally divided cardiology gastroenterology procedures.,G0000000|C1709707|C0030705|C0886296|G0000000|C0332849|C0007189|C0017163|C0025664
"Inclusion criteria were nulliparous women, age between 18 to 35 years, gestational age between 37 to 41 weeks, single fetus, cephalic presentation, and beginning of the active phase of labor (dilatation of 3 to 4 cm).","Inclusion criteria nulliparous women, age 18 35 years, gestational age 37 41 weeks, single fetus, cephalic presentation, active phase labor (dilatation 3 4 cm).",C0007637|C0243161|C0425979|C0043210|C0001779|C0450371|C0450371|C0439234|C0439671|C0001779|C0450371|C0450371|C0439230|C0037179|C0015965|C0205096|C0449450|C0205177|C0205390|C0022864|C0012359|G0000000|G0000000|G0000000
The target population was pregnant women at or before 16 weeks of gestation who had nausea with or without vomiting and required treatment.,The target population pregnant women 16 weeks gestation nausea vomiting required treatment.,G0000000|C1521840|C0032659|C0549206|C0043210|C0450371|C0439230|C0032961|C0027497|C0042963|C1514873|C0039798
Daily adherence to supplement consumption was made by the investigators being present at every session.,Daily adherence supplement consumption investigators session.,C0332173|C1510802|C0242295|C0009830|C0035173|C1883016
"History of axis I psychiatric diagnosis (substance use disorder, psychotic disorder, or bipolar disorder), and use of psychotropic medications were also exclusions for this study.","History axis I psychiatric diagnosis (substance disorder, psychotic disorder, bipolar disorder), psychotropic medications exclusions study.",C0019664|C0004457|C0021966|C0205487|C0011900|C0439861|C0012634|C0004936|C0012634|C0443156|C0012634|C0033978|C0013227|C0680251|C0557651
"A research team member screened volunteers using the following inclusion criteria, derived from previous MP research: (1) 10° of active flexion in the affected wrist, as well as 2 digits in the more affected hand; (2) stroke experienced > 12 months prior to study enrollment; (3) a score ≥ 70 on the Modified Mini Mental Status Examination (MMSE);18 (4) age > 18 < 75; (5) only have experienced one stroke; (6) discharged from all forms of physical rehabilitation.","A team screened volunteers inclusion criteria, derived previous MP research: (1) 10° active flexion wrist, 2 digits hand; (2) stroke experienced > 12 months prior study enrollment; (3) score ≥ 70 Modified Mini Mental Status Examination (MMSE);18 (4) age > 18 < 75; (5) experienced stroke; (6) discharged forms physical rehabilitation.",G0000000|C0871489|C0220908|C0042960|C0007637|C0243161|C1441547|C0205156|C0024944|C0035168|G0000000|G0000000|C0205177|C0231452|C0043262|G0000000|C0582802|C0018563|G0000000|C0038454|C0237607|G0000000|C0450371|C0439231|C0332152|C0557651|C1516879|G0000000|C0449820|G0000000|C0450371|C0392747|C0445542|C0229992|C0449438|G0000000|C0451306|G0000000|C0001779|G0000000|C0450371|G0000000|C0450371|G0000000|C0237607|C0038454|G0000000|C0030685|C0348078|C0031809|C0034991
Lack of obvious barriers and medical diagnosis for vaginal delivery during sampling such as detectable medical causes.,Lack obvious barriers medical diagnosis vaginal delivery sampling detectable medical causes.,C0332268|G0000000|C1706912|C0199168|C0011900|C0042232|C0011209|C0441621|C3830527|C0199168|C0015127
"Bortezomib, a protease inhibitor, is an active agent in newly diagnosed as well as relapsed and refractory multiple myeloma.","Bortezomib, protease inhibitor, active agent newly diagnosed relapsed refractory multiple myeloma.",C1176309|C0030946|C1999216|C0205177|C0450442|C0750546|C0011900|C0205336|C0205269|C0439064|C0026764
"gambiae s.s. during the 12 months post intervention in the three villages was similar to baseline (100% at Ilara, 96% at Irolu and 99% at Ijesa).","gambiae s.s. 12 months post intervention villages baseline (100% Ilara, 96% Irolu 99% Ijesa).",G0000000|C0565930|C0450371|C0439231|C0687676|C0886296|C0562518|C0168634|C1442061|G0000000|C0450371|G0000000|C0450371|G0000000
"A convenience sample was recruited of 242 children 2-14 years of age with asthma who, when a parent/guardian was screened, were identified as living in households with at least one current smoker and where smoking had occurred at home, either indoors or outdoors, at least once in the previous month.","A convenience sample recruited 242 children 2-14 age asthma who, parent/guardian screened, identified living households current smoker smoking occurred home, indoors outdoors, previous month.",G0000000|C3831015|C0370003|G0000000|C1442061|C0008059|C0450371|C0001779|C0004096|G0000000|C0030551|C0220908|C0205396|C0376558|C0020052|C0521116|C0337664|C0037369|C1709305|C0442519|G0000000|C1709359|C0205156|C0332177
"In conclusion, our placebo-controlled, double-blind and randomised study found no evidence of a survival benefit or lasting tumor response in patients with locally advanced or metastasised HCC treated with thymostimulin.","In conclusion, placebo-controlled, double-blind randomised study evidence survival benefit lasting tumor response patients locally advanced metastasised HCC treated thymostimulin.",G0000000|C1707478|C1706408|C0013072|G0000000|C0557651|C3887511|C0038952|C0814225|C1517741|C0027651|C0871261|C0030705|C1517927|C0205179|G0000000|C2239176|C1522326|C0076625
Participating HCPs are the physicians and nurses working at the respective clinics.,Participating HCPs physicians nurses respective clinics.,C0679823|G0000000|C0031831|C0028661|G0000000|C0442592
"Exclusion criteria were an inability to take oral medications, pregnancy, hypersensitivity to the trial drugs, previous drug therapy with potential antirickettsial activity (e.g., rifampin, chloramphenicol, macrolides, fluoroquinolones, or tetracyclines) within 48 h prior to admission, severe scrub typhus (shock requiring vasopressor therapy for more than 1 h, a stuporous or comatose level of consciousness, respiratory failure requiring mechanical ventilation, or renal failure requiring immediate dialysis) (10, 14).","Exclusion criteria inability oral medications, pregnancy, hypersensitivity trial drugs, previous drug therapy potential antirickettsial activity (e.g., rifampin, chloramphenicol, macrolides, fluoroquinolones, tetracyclines) 48 prior admission, severe scrub typhus (shock requiring vasopressor therapy 1 h, stuporous comatose level consciousness, respiratory failure requiring mechanical ventilation, renal failure requiring dialysis) (10, 14).",C0680251|C0243161|G0000000|C0442027|C0013227|C0032961|C0020517|C0008976|C0013227|C0205156|C0013227|C0039798|C3245505|G0000000|C0205177|G0000000|C0035608|C0008168|C0003240|C0949665|C0039651|C0450371|C0332152|C0184666|C0205082|G0000000|C0041471|C0036974|G0000000|C0042397|C0039798|G0000000|C0033727|C0023380|C0009421|C0441889|C0009791|C0521346|C0231174|G0000000|C0443254|C0035203|C0022646|C0231174|G0000000|C0011945|C0450371|C0450371
SFP 10–14 is open to families from a loosely defined and fairly large geographical area.,SFP 10–14 families loosely defined fairly geographical area.,C0075029|G0000000|C0015576|G0000000|C1704788|G0000000|C0017447|C0017446
"The study included 60 administrative villages (clustered) in nine domains in Xichou County, Yunnan Province, China, a rural community with a 30% rate of stunting.","The study included 60 administrative villages (clustered) domains Xichou County, Yunnan Province, China, rural community 30% rate stunting.",G0000000|C0557651|C0332257|C0450371|C1292785|C0562518|C1555715|C1880389|G0000000|C0079170|G0000000|C1514578|C0008115|C0240919|C0009462|C0450371|C0871208|C0018273
This randomized study showed the clinical benefit of a vaccine in the treatment of patients with measurable metastatic melanoma.,This randomized study clinical benefit vaccine treatment patients measurable metastatic melanoma.,G0000000|C0034656|C0557651|C0205210|C0814225|C0042210|C0039798|C0030705|C1513040|C0036525|C0025202
"Among the 44 selected baris, 22 baris were randomly assigned to the intervention group and 22 baris to the control group (control).","Among 44 selected baris, 22 baris randomly assigned intervention 22 baris control (control).",G0000000|C0450371|C1707391|C1890660|C0450371|C1890660|G0000000|C1516050|C0886296|C0450371|C1890660|C0243148|C0243148
"For the final survey, we selected six enumeration areas (EAs) (Census Bureau geographical areas ≈100 households) in each trial community.","For final survey, selected enumeration (EAs) (Census Bureau geographical ≈100 households) trial community.",G0000000|C0205088|C0038951|C1707391|C1707927|G0000000|C0007663|G0000000|C0017447|G0000000|C0020052|C0008976|C0009462
We were able to lower the PIP and FiO2 in a subset of these infants during NIV-NAVA compared with nasal intermittent mandatory ventilation (NIMV).,We lower PIP FiO2 subset infants NIV-NAVA compared nasal intermittent mandatory ventilation (NIMV).,G0000000|C0441994|C0279391|G0000000|C1515021|C0021270|C0598902|C1707455|C0028429|C0205267|C1514873|C0035203|G0000000
People with dementia and their family carers were the participants.,People dementia family carers participants.,C0027361|C0011265|C0015576|C0085537|C0679646
Survey C = 10 mo after first intervention spray and 6 mo after second intervention spray.,Survey C = 10 mo intervention spray 6 mo intervention spray.,C0038951|G0000000|C0026544|C0886296|C1704413|G0000000|C0026544|C0886296|C1704413
"They were included when the expected length of stay in the ICU was more than 24 hours, when speaking Dutch or English and scoring a minimum Glasgow Coma Scale of 10.","They included expected length stay ICU 24 hours, speaking Dutch English scoring minimum Glasgow Coma Scale 10.",G0000000|C0332257|C1517001|C1444754|G0000000|C0021708|C0450371|C0439227|C0234856|C0013331|C0376245|C0449820|C1524031|G0000000|C0009421|C0175659|C0450371
The 10 family practice clinics were paired by the investigators based on the following characteristics: (1) patient volume; (2) smoking prevalence; (3) average age; and (4) gender distribution.,The 10 family practice clinics paired investigators based characteristics: (1) patient volume; (2) smoking prevalence; (3) average age; (4) gender distribution.,G0000000|C0450371|C0015576|C0237607|C0442592|C1709450|C0035173|C1527178|C1521970|G0000000|C0030705|C0449468|G0000000|C0037369|C0033105|G0000000|C1510992|C0001779|G0000000|C0079399|C0520511
"We will describe our study protocol for a multisite randomized control trial being conducted in Colorado and Michigan with an anticipated sample of 372 economically and educationally disadvantaged African American, Hispanic, and Caucasian mothers with infants.","We study protocol multisite randomized control trial conducted Colorado Michigan anticipated sample 372 economically educationally disadvantaged African American, Hispanic, Caucasian mothers infants.",G0000000|C0557651|C0442711|G0000000|C0034656|C0243148|C0008976|C0004927|C0009399|C0025939|C3840775|C0370003|C1442061|C0013556|G0000000|C0012613|C0027567|C0596070|C0086409|C0007457|C0026591|C0021270
"Of the remaining 75 patients, 31 patients, with an average age of 40.3 years (range 20–45), were in the HRT group.","Of remaining 75 patients, 31 patients, average age 40.3 (range 20–45), HRT group.",G0000000|C1527428|C0450371|C0030705|C0450371|C0030705|C1510992|C0001779|C0450371|C1514721|G0000000|C0282402|C0441833
"We enrolled 4065 healthy boys and men 16 to 26 years of age, from 18 countries in a randomized, placebo-controlled, double-blind trial.","We enrolled 4065 healthy boys 16 26 age, 18 countries randomized, placebo-controlled, double-blind trial.",G0000000|G0000000|G0000000|C3898900|C0870221|C0450371|C0450371|C0001779|C0450371|C0454664|C0034656|C1706408|C0013072|C0008976
"Of the 129 randomised patients, 127 were treated (Figure 1).","Of 129 randomised patients, 127 treated (Figure 1).",G0000000|C1442061|G0000000|C0030705|C1442061|C1522326|G0000000|G0000000
"Dialysis during the night (since it is assumed that patients on day dialysis experience more severe fatigue compared to patients on night dialysis); Participation in other studies or treatments aimed at reducing fatigue; Treatment by a psychologist or psychiatrist (for severe psychiatric problems such as depression, psychosis, personality disorders or schizophrenia); Alcohol or drug addiction.","Dialysis night (since assumed patients day dialysis experience severe fatigue compared patients night dialysis); Participation studies treatments aimed reducing fatigue; Treatment psychologist psychiatrist (for severe psychiatric depression, psychosis, personality disorders schizophrenia); Alcohol drug addiction.",C0011945|C0240526|C1711239|C3242379|C0030705|C0332173|C0011945|C0237607|C0205082|C0015672|C1707455|C0030705|C0240526|C0011945|C0679823|C0947630|C0087111|C1947946|C0392756|C0015672|C0039798|C0033908|C0033872|G0000000|C0205082|C0205487|C0011570|C0033975|C0003944|C0012634|C0036341|C0001962|C0013227|C0085281
"Before supplementation (~10 wks) and at 32 weeks gestation, the technicians collected 7 mL of maternal venous blood.","Before supplementation (~10 wks) 32 weeks gestation, technicians collected 7 mL maternal venous blood.",C0332152|C0242297|C0450371|G0000000|C0450371|C0439230|C0032961|C1556020|C1516695|G0000000|C0439526|C2347083|C0042449|C0005767
"In the industrialized countries of the northern hemisphere, between one in eight and one in ten women will be diagnosed with breast cancer in their lifetime 2, 3.","In industrialized countries northern hemisphere, ten women diagnosed breast cancer lifetime 2, 3.",G0000000|G0000000|C0454664|C1709269|C0205139|C0014518|C0043210|C0011900|C0006141|C0006826|C4071830|G0000000
The effectiveness of an individualised unsupervised home based exercise programme was examined in adults with cystic fibrosis over a 1 year period.,The effectiveness individualised unsupervised based exercise programme examined adults cystic fibrosis 1 period.,G0000000|C1280519|G0000000|G0000000|C1527178|C0015259|C1709697|C0332128|C0001675|C0205207|C0016059|G0000000|C0439531
"Patients who had the following problems were excluded: 1) Patients with severe cognitive impairment or aphasia who could not understand the instructions given by therapists, 2) patients who had so severely damaged sitting balance that they could not sit down on a chair with a back and armrests, 3) patients with problems in cervical movement due to orthopedic impairment, and 4) patients who could not recognize objects on a computer screen due to severely damaged eyesight.","Patients excluded: 1) Patients severe cognitive impairment aphasia understand instructions therapists, 2) patients severely damaged sitting balance sit chair armrests, 3) patients cervical movement orthopedic impairment, 4) patients recognize objects computer screen severely damaged eyesight.",C0030705|C1554077|G0000000|C0030705|C0205082|C1516691|C0221099|C0003537|C0162340|C0302828|C0871525|G0000000|C0030705|C0205082|C0010957|C0277814|C0014653|C0277814|C0179847|G0000000|G0000000|C0030705|C0027530|C0026649|C0029355|C0221099|G0000000|C0030705|G0000000|C0347997|C0009622|C0220908|C0205082|C0010957|G0000000
"Inclusion criteria were nonmonosymptomatic enuresis, absence of prior treatment for UI, age between five and ten years old, and signed Inform Consent.","Inclusion criteria nonmonosymptomatic enuresis, absence prior treatment UI, age ten old, signed Inform Consent.",C0007637|C0243161|G0000000|C0014394|C0332197|C0332152|C0039798|C1421312|C0001779|C0014518|C0580836|C1519316|C0537670|C1511481
"To be eligible for the study, participants must be community-dwelling stroke survivors aged 40 years and above and be able to walk 10 m independently with or without a mobility aid.","To eligible study, participants community-dwelling stroke survivors aged 40 walk 10 independently mobility aid.",C0040363|C1548635|C0557651|C0679646|C4045975|C0038454|C0206194|C0001779|C0450371|C0080331|C0450371|G0000000|C0425245|C0449435
"This clinical trial was conducted in newborns with a GA of 29 to 34 weeks, who required resuscitation at the birth time.","This clinical trial conducted newborns GA 29 34 weeks, required resuscitation birth time.",G0000000|C0205210|C0008976|C0004927|C0021289|C0016993|C0450371|C0450371|C0439230|C1514873|C0035273|C0005615|C0040223
The anxiolytic effects of CBD present in nabiximols may also ameliorate cravings and anxiety associated with dependent cannabis use and withdrawal.,The anxiolytic effects CBD nabiximols ameliorate cravings anxiety dependent cannabis withdrawal.,G0000000|C0040616|C1280500|C0006863|C2347556|G0000000|C0870371|C0003467|C0851827|C0024808|C2349954
"The exclusion criteria were weight >120 kg; femoral length <35 cm or femoral length >47 cm; history of low extremity fracture after stroke, instability or subluxation of the hip joint, or pressure ulcers on the hips or lower extremities; and any underlying disease preventing execution of RAGT.","The exclusion criteria weight >120 kg; femoral length <35 cm femoral length >47 cm; history low extremity fracture stroke, instability subluxation hip joint, pressure ulcers hips lower extremities; underlying disease preventing execution RAGT.",G0000000|C0680251|C0243161|C0005910|G0000000|C0015811|C1444754|G0000000|C0015811|C1444754|G0000000|C0019664|C0205251|C0015385|C0016658|C0038454|C1444783|C0332768|C0019552|C0022417|C0033095|C0041582|C0019552|C0441994|C0015385|G0000000|C0012634|C0309872|C1278561|G0000000
"All patients admitted to the inpatient hospital rehabilitation unit with the primary diagnosis of acute cerebrovascular accident (inclusive of cerebral infarction, intracranial haemorrhage, and subarachnoid haemorrhage) will be eligible to participate in this study provided informed written consent is obtained.","All patients admitted inpatient hospital rehabilitation unit primary diagnosis acute cerebrovascular accident (inclusive cerebral infarction, intracranial haemorrhage, subarachnoid haemorrhage) eligible participate study provided informed written consent obtained.",G0000000|C0030705|C0184666|C0021562|C0019994|C0034991|C0439148|C0205225|C0011900|C0205178|C1880018|C0000924|C0332257|G0000000|C0021308|C0524466|C0019080|C1515008|C0019080|C1548635|G0000000|C0557651|C1999230|C1522154|C0043266|C1511481|C1301820
"Childhood vaccination rates are low in Lasbela, one of the poorest districts in Pakistan's Balochistan province.","Childhood vaccination rates low Lasbela, poorest districts Pakistan's Balochistan province.",C0231335|C0042196|C0871208|C0205251|G0000000|C0032854|G0000000|C0030211|G0000000|C1514578
Central systolic BP was reduced by 13 [95% CI 2 – 24] mm Hg from 143 ± 20 mm Hg at the high sodium period to 130 ± 21 mm Hg at the low sodium period (p = 0.03) while central diastolic BP was not significantly reduced (mean change 4 [95% CI −2.2 – 10] mm Hg; from 84 ± 80 mm Hg at the high sodium period to 80 ± 14 mm Hg at the low sodium period; p = 0.20).,Central systolic BP reduced 13 [95% CI 2 – 24] mm Hg 143 ± 20 mm Hg sodium period 130 ± 21 mm Hg low sodium period (p = 0.03) central diastolic BP reduced (mean change 4 [95% CI −2.2 – 10] mm Hg; 84 ± 80 mm Hg sodium period 80 ± 14 mm Hg low sodium period; p = 0.20).,C0205099|C0039155|C0037623|C0392756|C0450371|C0450371|C0008107|G0000000|G0000000|C0450371|G0000000|C0025424|G0000000|G0000000|C0025424|C0037473|C0439531|G0000000|C0450371|G0000000|C0025424|C0205251|C0037473|C0439531|G0000000|C0205099|C0012000|C0037623|C0392756|C0444504|C0392747|G0000000|C0450371|C0008107|G0000000|G0000000|C0450371|G0000000|C0025424|G0000000|G0000000|C0025424|C0037473|C0439531|G0000000|G0000000|C0025424|C0205251|C0037473|C0439531|G0000000
During the 12-month study patients with active asthma were offered a review service according to the allocation of the group with which they were registered.,During 12-month study patients active asthma offered review service allocation registered.,G0000000|C0450371|C0557651|C0030705|C0205177|C0004096|C1444648|C0282443|C0557854|C1706778|C1514821
"Subjects were selected on the basis of a chart diagnosis of dementia, six or more errors out of 10 items on the Short Portable Mental Status Questionnaire, and the ability to stand with the assistance of two people.","Subjects selected basis chart diagnosis dementia, errors 10 items Short Portable Mental Status Questionnaire, ability stand assistance people.",C0681850|C1707391|C1527178|C0007963|C0011900|C0011265|C0743559|C0450371|C1551338|C1282927|G0000000|C0229992|C0449438|C0034394|C0085732|C0596013|C0018896|C0027361
"Of the 53 patients (81 feet) selected for the study, eight patients were lost to follow-up and hence were excluded from the study, leaving 45 patients with 67 feet (36 in the Ponseti group and 31 in the Kite group).","Of 53 patients (81 feet) selected study, patients lost follow-up excluded study, leaving 45 patients 67 feet (36 Ponseti 31 Kite group).",G0000000|C0450371|C0030705|C0450371|C0016504|C1707391|C0557651|C0030705|C0745777|C0589120|C1554077|C0557651|G0000000|C0450371|C0030705|C0450371|C0016504|C0450371|G0000000|C0450371|C0336865|C0441833
Response to treatment was considered if 25% or more repigmentation of the total affected body surface area was achieved.,Response treatment considered 25% repigmentation total body surface achieved.,C0871261|C0039798|C0750591|C0450371|G0000000|C0439175|C0242821|C0205148|G0000000
"Additional exclusion criteria were a serum level of creatinine, bilirubin, alanine aminotransferase, or aspartate aminotransferase that was greater than two times the upper limit of the normal range, as well as a forced vital capacity, forced expiratory volume in 1 second, or diffusing capacity of the lung for carbon monoxide that was less than 50% of the predicted value.","Additional exclusion criteria serum level creatinine, bilirubin, alanine aminotransferase, aspartate aminotransferase times upper limit normal range, forced vital capacity, forced expiratory volume 1 second, diffusing capacity lung carbon monoxide 50% predicted value.",C1524062|C0680251|C0243161|C0229671|C0441889|C0010294|C0005437|C0001898|C0002594|C0085845|C0002594|C0040223|C1282910|C0439801|C0205307|C1514721|C0441722|C0442732|C1516240|C0441722|C0231800|C0449468|G0000000|C0205436|C0012222|C1516240|C0024109|C0007009|G0000000|C0450371|C0681842|C1522609
"Participants had chronic, moderate hand impairment resulting from a single stroke incurred at least 6 months prior.","Participants chronic, moderate hand impairment single stroke incurred 6 months prior.",C0679646|C0205191|C0205081|C0018563|C0221099|C0037179|C0038454|G0000000|G0000000|C0439231|C0332152
"Other anxiety disorders were most prevalent (n = 30, 75%).","Other anxiety disorders prevalent (n = 30, 75%).",G0000000|C0003467|C0012634|C0033105|C0369718|G0000000|C0450371|C0450371
"Of these 44 subjects, 23 (52%) were randomized to receive extended IVR calls from weeks 13 to 52 and 21 (48%) were in the control group.","Of 44 subjects, 23 (52%) randomized receive extended IVR calls weeks 13 52 21 (48%) control group.",G0000000|C0450371|C0681850|C0450371|C0450371|C0034656|C1514756|C0231448|C3890944|C0679006|C0439230|C0450371|C0450371|C0450371|C0450371|C0243148|C0441833
Patients who were receiving any sort of treatment such as psychological or physical therapy for FMS in the last 3 months and the patients who were in need of medication for anxiety or depression during the study were also excluded.,Patients receiving sort treatment psychological physical therapy FMS 3 months patients medication anxiety depression study excluded.,C0030705|C1514756|C0237886|C0039798|C0205486|C0031809|C0039798|G0000000|G0000000|C0439231|C0030705|C0013227|C0003467|C0011570|C0557651|C1554077
"Of the 152 850 individuals recruited, 76 466 were randomised by household to the intervention group and 76 384 to the control group; 547 (0.4%) could not be traced by ONS or had emigrated and were therefore excluded from the mortality analysis.","Of 152 850 individuals recruited, 76 466 randomised household intervention 76 384 control group; 547 (0.4%) traced ONS emigrated excluded mortality analysis.",G0000000|C1442061|C1442061|C0027361|G0000000|C0450371|C1442061|G0000000|C0020052|C0886296|C0450371|C1442061|C0243148|C0441833|C1442061|G0000000|C0442822|C1518579|G0000000|C1554077|C0026565|C0002778
Patients were excluded if they had a concomitant diagnosis of another malignancy that was not a GCT or an endometrial carcinoma.,Patients excluded concomitant diagnosis malignancy GCT endometrial carcinoma.,C0030705|C1554077|C0521115|C0011900|C0006826|C3538813|C0227843|C0007097
"Women were excluded if they had any condition preventing physical activity, such as cervical incompetence, placenta praevia, or persistent bleeding.","Women excluded condition preventing physical activity, cervical incompetence, placenta praevia, persistent bleeding.",C0043210|C1554077|C0012634|C0309872|C0031809|C0205177|C0027530|C0231189|C0032043|G0000000|C0205322|C0019080
"Exclusion criteria were: (1) history of CNS disease; (2) history of CNS radiation, intrathecal therapy or CNS-involved surgery; (3) neuro-behavioral risk factors such as traumatic brain injury, history of neurological disorder, learning disability or substance addiction; (4) current psychiatric disorder.","Exclusion criteria were: (1) history CNS disease; (2) history CNS radiation, intrathecal therapy CNS-involved surgery; (3) neuro-behavioral risk factors traumatic brain injury, history neurological disorder, learning disability substance addiction; (4) current psychiatric disorder.",C0680251|C0243161|G0000000|G0000000|C0019664|C3714787|C0012634|G0000000|C0019664|C3714787|C0034519|C1370196|C0039798|C3714787|C0038894|G0000000|C2986478|C0035647|C1521761|C0332663|C0006104|C3263722|C0019664|C0205494|C0012634|C0013621|C0231170|C0439861|C0085281|G0000000|C0521116|C0205487|C0012634
"The SDI items include difficulty falling asleep, getting up during the night (other than for toileting), nighttime wandering, awakening the caregiver, awakening and thinking it is daytime, awakening too early, and excessive daytime sleeping.","The SDI items difficulty falling asleep, night (other toileting), nighttime wandering, awakening caregiver, awakening thinking daytime, awakening early, excessive daytime sleeping.",G0000000|C0683833|C1551338|C1299586|C0000921|C0424522|C0240526|G0000000|C0150810|C0240526|C0233569|C1720052|C0085537|C1720052|C0039869|C0332169|C1720052|C1279919|C0442802|C0332169|C0037313
A sample of 76 children was recruited from six clinics and seven schools in a large urban area.,A sample 76 children recruited clinics schools urban area.,G0000000|C0370003|C0450371|C0008059|G0000000|C0442592|C0036375|C0442529|C0017446
OBJECTIVE: To compare the impact of mass treatment with oral azithromycin and topical tetracycline on the prevalence of active trachoma.,OBJECTIVE: To compare impact mass treatment oral azithromycin topical tetracycline prevalence active trachoma.,C0018017|C0040363|C1707455|C1825598|C0577559|C0039798|C0442027|C0052796|C0332237|C0039644|C0033105|C0205177|C0040592
"The exclusion criteria were unstable seizures, any treatment for spasticity or surgical procedures in the 6 months before the study, any change in medication expected during the study period, of any other disease that would have interfered with physical activity.","The exclusion criteria unstable seizures, treatment spasticity surgical procedures 6 months study, change medication expected study period, disease interfered physical activity.",G0000000|C0680251|C0243161|C0443343|C0036572|C0039798|C0026838|C0543467|C0025664|G0000000|C0439231|C0557651|C0392747|C0013227|C1517001|C0557651|C0439531|C0012634|C0521102|C0031809|C0205177
Patients taking cardioactive drug or potentially hemolytic drugs or drugs that may interact with study drugs were not included in the study.,Patients cardioactive drug hemolytic drugs drugs interact study drugs included study.,C0030705|G0000000|C0013227|C0312853|C0013227|C0013227|G0000000|C0557651|C0013227|C0332257|C0557651
Families were not recruited based on weight status.,Families recruited based weight status.,C0015576|G0000000|C1527178|C0005910|C0449438
"Patients were eligible if they 1) reported smoking on 1 or more days in the past 30 days, 2) volunteered to participate, and 3) provided written assent and consent (a parent or guardian had to be present).","Patients eligible 1) reported smoking 1 days 30 days, 2) volunteered participate, 3) provided written assent consent (a parent guardian present).",C0030705|C1548635|G0000000|C0684224|C0037369|G0000000|C0439228|C0450371|C0439228|G0000000|C0042960|G0000000|G0000000|C1999230|C0043266|C1879749|C1511481|G0000000|C0030551|C0023226|C0150312
"The remaining 108 patients were assigned randomly to ROLL patients whose non-palpable breast lesions were localized by ROLL and followed by surgical resection (ROLL group, n  =  56) or WGL patients whose non-palpable breast lesions were localized with a wire hook and followed by surgical resection (WGL group, n =  52).","The remaining 108 patients assigned randomly ROLL patients non-palpable breast lesions localized ROLL surgical resection (ROLL group,  =  56) WGL patients non-palpable breast lesions localized wire hook surgical resection (WGL group, n =  52).",G0000000|C1527428|C1442061|C0030705|C1516050|G0000000|G0000000|C0030705|C1518422|C0006141|C0221198|C0392752|G0000000|C0543467|C0015252|G0000000|C0441833|G0000000|C0450371|G0000000|C0030705|C1518422|C0006141|C0221198|C0392752|C0005978|C0181209|C0543467|C0015252|G0000000|C0441833|G0000000|C0450371
"Patients ages 18-70 years who are obese and have suboptimally controlled, persistent asthma will be eligible to participate.","Patients ages 18-70 obese suboptimally controlled, persistent asthma eligible participate.",C0030705|C0001779|C0450371|C0028754|G0000000|C2587213|C0205322|C0004096|C1548635|G0000000
"Study participants were community-dwelling men and women of at least 50 years of age, with a clinical diagnosis of probable AD using Diagnostic and Statistical Manual of Mental Disorders-Text Revision (DSM-IV-TR) [14] and National Institute of Neurological and Communicative Disorders and Stroke–Alzheimer’s Disease and Related Disorders Association (NINCDS–ADRDA) [15] criteria, a Mini-Mental State Examination (MMSE) score [16] in the 3–14 range at screening and baseline, and results of a magnetic resonance imaging (MRI) or computed tomography (CT) scan (within the past 12 months) consistent with this diagnosis.","Study participants community-dwelling women 50 age, clinical diagnosis probable AD Diagnostic Statistical Manual Mental Disorders-Text Revision (DSM-IV-TR) [14] National Institute Neurological Communicative Disorders Stroke–Alzheimer’s Disease Related Disorders Association (NINCDS–ADRDA) [15] criteria, Mini-Mental State Examination (MMSE) score [16] 3–14 range screening baseline, magnetic resonance imaging (MRI) computed tomography (CT) scan (within 12 months) consistent diagnosis.",C0557651|C0679646|C4045975|C0043210|C0450371|C0001779|C0205210|C0011900|C0033204|G0000000|C0011900|C0038215|C0024763|C0229992|C0012634|C0439617|C0220952|C0450371|C3245503|C0021622|C0205494|C0009452|C0012634|G0000000|C0012634|C0439849|C0012634|C0004083|G0000000|C0450371|C0243161|C0445542|C1301808|G0000000|C0451306|C0449820|C0450371|G0000000|C1514721|C0220908|C0168634|C0024488|C0231881|C0011923|C0024485|C1441526|C0040395|C0007673|C0034606|G0000000|C0450371|C0439231|C0332290|C0011900
Postoperative adjuvant chemotherapy was administered to 4 (10.9%) group A patients and 5 (8.9%) group B patients.,Postoperative adjuvant chemotherapy administered 4 (10.9%) A patients 5 (8.9%) B patients.,C0032790|C0001551|C0013216|C1521801|G0000000|C0450371|G0000000|C0030705|G0000000|G0000000|G0000000|C0030705
This methodology was successfully employed during the original InFANT Program intervention when children were aged approximately 19 months.,This methodology employed original InFANT Program intervention children aged 19 months.,G0000000|C0969625|C0014003|C0205313|C0021270|C1709697|C0886296|C0008059|C0001779|C0450371|C0439231
Thalamic hemorrhage (TH) is a neurological insult with a high rate of morbidity and mortality.,Thalamic hemorrhage (TH) neurological insult rate morbidity mortality.,C0039729|C0019080|C0039725|C0205494|G0000000|C0871208|C0026538|C0026565
"As well as impairing balance, stroke alters gait.","As impairing balance, stroke alters gait.",G0000000|C0221099|C0014653|C0038454|C0392747|C0016928
"Group 2 had almost an eleven-fold higher risk of developing EA than did Group 1, and the incidence of EA in Group 4 was sixty-nine-fold higher than that of Group 1.","Group 2 eleven-fold risk developing EA Group 1, incidence EA Group 4 sixty-nine-fold Group 1.",C0441833|G0000000|C0205457|C0035647|G0000000|C0014963|C0441833|G0000000|C0021149|C0014963|C0441833|G0000000|C0450388|C0441833|G0000000
Pregnant or lactating women or women of child-bearing potential not using medically accepted means of birth control were also excluded from the study.,Pregnant lactating women women child-bearing potential medically accepted birth control excluded study.,C0549206|C2828358|C0043210|C0043210|C0008059|C3245505|G0000000|C1272684|C0005615|C0243148|C1554077|C0557651
"Twenty-four male WR athletes (22 with tetraplegia, 1 with a spastic cerebral palsy, and 1 with congenital upper and lower limb deformities) were matched by lesion level, completeness of injury, and rugby classification prior to being randomly assigned to 1 of 3 groups: (1) CPTR (n=8), (2) CFR (n=8), or (3) controls (CON, n=8).","Twenty-four male WR athletes (22 tetraplegia, 1 spastic cerebral palsy, 1 congenital upper lower limb deformities) matched lesion level, completeness injury, rugby classification prior randomly assigned 1 3 groups: (1) CPTR (n=8), (2) CFR (n=8), (3) controls (CON, n=8).",C3715070|C0086582|C1420193|C0238703|C0450371|C0034372|G0000000|C0026838|G0000000|C0522224|G0000000|C0009678|C1282910|C0441994|C0015385|C0000768|C0150103|C0221198|C0441889|C0439812|C3263722|C0035945|C0008902|C0332152|G0000000|C1516050|G0000000|G0000000|C0441833|G0000000|C0010621|C0369718|G0000000|G0000000|C0369718|G0000000|C0243148|G0000000|C0369718
"The inclusion criteria for this study were: (a) having an SCI for at least 6 months; (b) reporting chronic daily pain that was bothersome; (c) being 18 years old or older; (d) being able to speak, read, and write English; and (e) expressing an interest in participating in a clinical trial comparing two treatments for chronic pain.","The inclusion criteria study were: (a) SCI 6 months; (b) reporting chronic daily pain bothersome; (c) 18 older; (d) speak, read, write English; (e) expressing participating clinical trial comparing treatments chronic pain.",G0000000|C0007637|C0243161|C0557651|G0000000|G0000000|C3642273|G0000000|C0439231|G0000000|C0700287|C0205191|C0332173|C0030193|G0000000|G0000000|C0450371|C0580836|C0073187|C0234856|C0034754|C0043266|C0376245|G0000000|G0000000|C0679823|C0205210|C0008976|C1707455|C0087111|C0205191|C0030193
Seropositive women were asked to participate in the trial.,Seropositive women participate trial.,C0521143|C0043210|G0000000|C0008976
"Patients were required to meet the following criteria for inclusion in the study: (1) First episode of unilateral stroke with hemiparesis (onset ≤ 2 weeks), (2) able to understand and follow simple verbal instructions, (3) Brunnstrom recovery stage 2 and above, (4) no severe cognitive disorders that would interfere with the study's purpose (Mini-Mental State Examination score > 23), (5) stable medical condition to allow participation in the study, (6) ambulatory before stroke.","Patients required meet criteria inclusion study: (1) First episode unilateral stroke hemiparesis (onset ≤ 2 weeks), (2) understand follow simple verbal instructions, (3) Brunnstrom recovery stage 2 above, (4) severe cognitive disorders interfere study's purpose (Mini-Mental State Examination score > 23), (5) stable medical condition participation study, (6) ambulatory stroke.",C0030705|C1514873|C1550543|C0243161|C0007637|C0557651|G0000000|C0205435|C0332189|C0205092|C0038454|C0018989|C0206132|G0000000|G0000000|C0439230|G0000000|C0162340|C0332283|C0205352|C0439824|C0302828|G0000000|G0000000|C0237820|C0205390|G0000000|C1282910|G0000000|C0205082|C1516691|C0012634|C0521102|C0557651|C1285529|C0445542|C1301808|G0000000|C0449820|G0000000|C0450371|G0000000|C0205360|C0199168|C0012634|C0679823|C0557651|G0000000|C0439841|C0038454
"The trial was conducted in Sydney, Australia in two obstetric hospitals between September 2004 and April 2006, in accordance with the published protocol [16].","The trial conducted Sydney, Australia obstetric hospitals September 2004 April 2006, published protocol [16].",G0000000|C0008976|C0004927|G0000000|C0004340|C0205484|C0019994|C3828193|G0000000|C3715024|G0000000|C0034037|C0442711|C0450371
All nursing staff (i.e.,All nursing staff (i.e.,G0000000|C0006147|C0851286|C0683454
Patients had to be stable (hemodynamic: 70 <mean arterial pressure (MAP) <130 mm Hg; 90 <systolic blood pressure (SBP) <180 mm Hg and headache <6 in the visual analogue scale [VAS]) at the intensive or intermediate care unit (ICU or IMCU) before randomization.,Patients stable (hemodynamic: 70 <mean arterial pressure (MAP) <130 mm Hg; 90 <systolic blood pressure (SBP) <180 mm Hg headache <6 visual analogue scale [VAS]) intensive intermediate care unit (ICU IMCU) randomization.,C0030705|C0205360|C0019010|C0450371|C0444504|C0003842|C0033095|C0024779|C1442061|G0000000|C0025424|C0450371|C0039155|C0005767|C0033095|G0000000|C1442061|G0000000|C0025424|C0018681|G0000000|C0234621|C0243071|C0175659|C0042815|C0162425|C0205103|C1947933|C0439148|C0021708|G0000000|C0034656
"Exclusion criteria were participation in another study, renal impairment by causes other than diabetes, elevated liver enzymes, hyper- or hypothyroidism, blood pressure >160/90 mmHg, neoplasm, severe general diseases, drug abuse, pregnancy, lactation, active menses, hypersensitivity to benfotiamine, use of vitamin B–containing supplements, changes in concomitant medication during the previous 3 months, and use of nonsteroidal anti-inflammatory drugs >3 times per week.","Exclusion criteria participation study, renal impairment diabetes, elevated liver enzymes, hyper- hypothyroidism, blood pressure >160/90 mmHg, neoplasm, severe diseases, drug abuse, pregnancy, lactation, active menses, hypersensitivity benfotiamine, vitamin B–containing supplements, concomitant medication previous 3 months, nonsteroidal anti-inflammatory drugs >3 times week.",C0680251|C0243161|C0679823|C0557651|C0022646|C0221099|C0011847|C0205250|C0023884|C0014442|C0424295|C0020676|C0005767|C0033095|C1442061|C0439475|C0027651|C0205082|C0012634|C0013227|C0013146|C0032961|C0006147|C0205177|C0025344|C0020517|C0053116|C0042890|G0000000|C0242295|C0521115|C0013227|C0205156|G0000000|C0439231|G0000000|C0003209|C0013227|G0000000|C0040223|C0332174
"Immediately after adjudication, adolescents were identified as potential candidates for the study if they were between the ages of 14 and 19 years (inclusive) and were sentenced to the facility for 4–12 months (inclusive).","Immediately adjudication, adolescents identified potential candidates study ages 14 19 (inclusive) sentenced facility 4–12 months (inclusive).",C0205548|C0680730|C0205653|C0205396|C3245505|G0000000|C0557651|C0001779|C0450371|C0450371|C0332257|C0876929|C1547538|G0000000|C0439231|C0332257
We excluded patients with lesions breaching the bone cortex and/or associated with a soft tissue mass because such lesions were treated by wide excision.,We excluded patients lesions breaching bone cortex and/or soft tissue mass lesions treated wide excision.,G0000000|C1554077|C0030705|C0221198|G0000000|C0262950|C0007776|G0000000|C0205358|C0040300|C0577559|C0221198|C1522326|C0332464|C0015252
Couples had to be willing to spend 6 weeks engaged in an in-home educational program if they were randomly assigned to the intervention condition and not to be planning to move out of the study area during the intervention period.,Couples spend 6 weeks engaged in-home educational program randomly assigned intervention condition planning move study intervention period.,C0010222|C0680968|G0000000|C0439230|C0425152|C0150312|C0587721|C1709697|G0000000|C1516050|C0886296|C0012634|C0032074|C0560560|C0557651|C0886296|C0439531
"A randomized controlled trial (n = 746) evaluated the effectiveness of Familias Unidas among Hispanic eighth graders (age range = 12–16 years), relative to prevention as usual, within a public school system.","A randomized controlled trial (n = 746) evaluated effectiveness Familias Unidas Hispanic eighth graders (age range = 12–16 years), relative prevention usual, public school system.",G0000000|C0034656|C2587213|C0008976|G0000000|C0220825|C1280519|G0000000|G0000000|C0086409|C0205442|G0000000|C0001779|G0000000|C0439234|C0080103|C0199176|C3538928|G0000000|C0036375|C0449913
We obtained written consent from all parents and from those children who were old enough to complete the form.,We written consent parents children complete form.,G0000000|C0043266|C1511481|C0030551|C0008059|C0205197|C0348078
"Other exclusion criteria were neurosurgical procedure (n = 10), second stroke (n = 10), or fixed contracture (n = 1).","Other exclusion criteria neurosurgical procedure (n = 10), stroke (n = 10), fixed contracture (n = 1).",G0000000|C0680251|C0243161|G0000000|C0184661|C0369718|G0000000|C0450371|C0038454|C0369718|G0000000|C0450371|C0443218|C0009917|C0369718|G0000000|G0000000
Patients with stages 0 to III breast cancer were recruited before starting XRT and were randomly assigned to YG (n = 53) or stretching (ST; n = 56) three times a week for 6 weeks during XRT or waitlist (WL; n = 54) control.,Patients stages 0 III breast cancer recruited starting XRT randomly assigned YG (n = 53) stretching (ST; = 56) times week 6 weeks XRT waitlist (WL; = 54) control.,C0030705|C1306673|G0000000|C0439070|C0006141|C0006826|G0000000|C0439659|G0000000|G0000000|C1516050|C1883582|C0369718|G0000000|C0450371|C0600080|C0036056|G0000000|C0450371|C0040223|C0332174|G0000000|C0439230|G0000000|C0043010|G0000000|G0000000|C0450371|C0243148
"Smokers received 12 smoking cessation behavioral counseling sessions and were randomized to 8, 24, or 52 weeks of nicotine patch treatment.","Smokers received 12 smoking cessation behavioral counseling sessions randomized 8, 24, 52 weeks nicotine patch treatment.",C0337664|C1514756|C0450371|C0037369|C1880019|C0004927|C0010210|C1883016|C0034656|G0000000|C0450371|C0450371|C0439230|C0028040|C0332461|C0039798
"The study enrolled a random sample of 5,209 children <5 years old from 3,039 households that had at least one child <24 months at the beginning of the study.","The study enrolled random sample 5,209 children <5 3,039 households child <24 months study.",G0000000|C0557651|G0000000|C0034656|C0370003|C1442061|C0008059|G0000000|C1442061|C0020052|C0008059|C0450371|C0439231|C0557651
Forty-two clinical sites enrolled 200 male and female research participants with PD within 5 years of diagnosis and not yet requiring symptomatic therapy.,Forty-two clinical sites enrolled 200 male female participants PD 5 diagnosis requiring symptomatic therapy.,C3816449|C0205210|C0205145|G0000000|C1442061|C0086582|C0015780|C0679646|G0000000|G0000000|C0011900|G0000000|C0231220|C0039798
"One hundred and forty consecutive critically ill patients with an APACHE II score ≥ 13 were randomly assigned after stratification to the EMS group (n = 68) (age:61 ± 19 years) (APACHE II:18 ± 4, SOFA:9 ± 3) or to the control group (n = 72) (age:58 ± 18 years) (APACHE II:18 ± 5, SOFA:9 ± 3).","One forty consecutive critically ill patients APACHE II score ≥ 13 randomly assigned stratification EMS (n = 68) (age:61 ± 19 years) (APACHE II:18 ± 4, SOFA:9 ± 3) control (n = 72) (age:58 ± 18 years) (APACHE II:18 ± 5, SOFA:9 ± 3).",C0205447|C3816449|C1707491|G0000000|C0231218|C0030705|C0243030|G0000000|C0449820|G0000000|C0450371|G0000000|C1516050|C1514983|G0000000|C0369718|G0000000|C0450371|C0001779|G0000000|C0450371|C0439234|C0243030|C0450371|G0000000|G0000000|G0000000|G0000000|G0000000|C0243148|C0369718|G0000000|C0450371|C0001779|G0000000|C0450371|C0439234|C0243030|C0450371|G0000000|G0000000|G0000000|G0000000|G0000000
"Participants were recruited via oncologist referrals, community-based advertising, public service announcements, website, and direct mailings to women who had expressed an interest in Fred Hutchinson Cancer Research Center (FHCRC) studies.","Participants recruited oncologist referrals, community-based advertising, public service announcements, website, direct mailings women expressed Fred Hutchinson Cancer Research Center (FHCRC) studies.",C0679646|G0000000|C0259990|C0034927|C0009462|C0001690|G0000000|C0557854|G0000000|C2349146|C0439851|C0024492|C0043210|G0000000|G0000000|G0000000|C0006826|C0035168|C0205099|G0000000|C0947630
"Assuming a 20% dropout rate at week 26, a proposed sample size of 2138 randomised patients (475 in each of the QVA149, indacaterol, glycopyrronium and tiotropium groups and 238 in the placebo group) was determined.","Assuming 20% dropout rate week 26, proposed sample size 2138 randomised patients (475 QVA149, indacaterol, glycopyrronium tiotropium 238 placebo group) determined.",G0000000|C0450371|C0013135|C0871208|C0332174|C0450371|C1553874|C0370003|C0456389|G0000000|G0000000|C0030705|C1442061|G0000000|C1722260|C0017970|C0213771|C1442061|C0032042|C0441833|G0000000
The trial compared the usual level of cessation support provided by primary care nurses with that recommended by the NHS stop smoking service as best practice (fig 11).).,The trial compared usual level cessation support provided primary care nurses recommended NHS smoking service practice (fig 11).).,G0000000|C0008976|C1707455|C3538928|C0441889|C1880019|C0183683|C1999230|C0205225|C1947933|C0028661|C0034866|C0796085|C0037369|C0557854|C0237607|C0349966|C0450371
"Exclusion criteria were donor-specific anti-HLA antibodies, prior allogeneic or autologous transplantation, human immunodeficiency virus infection, pregnancy or breast-feeding, cardiac insufficiency or coronary artery disease requiring treatment, active infection, or concomitant enrollment in a phase 1 study.","Exclusion criteria donor-specific anti-HLA antibodies, prior allogeneic autologous transplantation, human immunodeficiency virus infection, pregnancy breast-feeding, cardiac insufficiency coronary artery disease requiring treatment, active infection, concomitant enrollment phase 1 study.",C0680251|C0243161|C0013018|C4049595|C0003241|C0332152|C1515895|C0439859|C0040732|C0086418|C0021051|C0042776|C0009450|C0032961|C0006147|C0018787|C0231179|C0018787|C0003842|C0012634|G0000000|C0039798|C0205177|C0009450|C0521115|C1516879|C0205390|G0000000|C0557651
"Men and women with type 1 or type 2 diabetes mellitus were eligible to participate if they were aged between 18 and 70 years, had been diagnosed with DPN according to electrodiagnostic criteria from San Antonio Conference15, and had abnormal nerve conduction velocity (NCV) and/or amplitude found in at least one nerve of the extremities.","Men women type 1 type 2 diabetes mellitus eligible participate aged 18 70 years, diagnosed DPN electrodiagnostic criteria San Antonio Conference15, abnormal nerve conduction velocity (NCV) and/or amplitude nerve extremities.",C0025266|C0043210|C0332307|G0000000|C0332307|G0000000|C0011847|G0000000|C1548635|G0000000|C0001779|C0450371|C0450371|C0439234|C0011900|C0027270|G0000000|C0243161|C1826357|G0000000|G0000000|C0205161|C0027740|C0232217|C0439830|C2982003|G0000000|C2346753|C0027740|C0015385
"Two of these errors occurred in the SMS group and were recorded by a single participant (age >65 years of age, grade 6 or less education, and no prior internet use) as a malfunction with device output; the error in the PDA group occurred as an inaccurate output response to the reportedly queried medication (participant was >65 years of age and a high school graduate with no prior internet use).","Two errors occurred SMS recorded single participant (age >65 age, grade 6 education, prior internet use) malfunction device output; error PDA occurred inaccurate output response reportedly queried medication (participant >65 age school graduate prior internet use).",C0205448|C0743559|C1709305|G0000000|C0034869|C0037179|C0679646|C0001779|C0450371|C0001779|C0441800|G0000000|C0013621|C0332152|C0282111|C0042153|C0231174|C0025080|C1709366|C0743559|C0013274|C1709305|C0443236|C1709366|C0871261|G0000000|C1522634|C0013227|C0679646|C0450371|C0001779|C0036375|C0588053|C0332152|C0282111|C0042153
"Exclusion criteria were selected to exclude patient subsets previously described as being at risk for iatrogenic probiotic infection: pregnancy; immunosuppression; prosthetic cardiac valve or vascular graft; cardiac trauma; history of rheumatic fever, endocarditis, or congenital cardiac abnormality; gastroesophageal or intestinal injury or foregut surgery during the current admission; oropharyngeal mucosal injury; and placement of a tracheostomy.","Exclusion criteria selected exclude patient subsets risk iatrogenic probiotic infection: pregnancy; immunosuppression; prosthetic cardiac valve vascular graft; cardiac trauma; history rheumatic fever, endocarditis, congenital cardiac abnormality; gastroesophageal intestinal injury foregut surgery current admission; oropharyngeal mucosal injury; placement tracheostomy.",C0680251|C0243161|C1707391|C0332196|C0030705|C1515021|C0035647|C0439669|C0525033|C0009450|C0032961|C0021079|G0000000|C0018787|C0184252|C0005847|C0181074|C0018787|C0043251|C0019664|G0000000|C0015967|C0014118|C0009678|C0018787|C1704258|C0744316|C0021853|C3263722|C0231051|C0038894|C0521116|C0184666|C0521367|C0026724|C3263722|C0441587|C0040590
"Meanwhile, the following will used as the exclusion criteria: craniofacial abnormalities; undergoing active treatment of sleep apnea; active malignancy; active alcohol and/or drug abuse; and dementia or treatment-refractory psychiatric diseases leading to an inability to provide informed consent.","Meanwhile, exclusion criteria: craniofacial abnormalities; undergoing active treatment sleep apnea; active malignancy; active alcohol and/or drug abuse; dementia treatment-refractory psychiatric diseases leading inability provide informed consent.",G0000000|C0680251|C0243161|C0596392|C0000768|G0000000|C0205177|C0039798|C0037313|C0003578|C0205177|C0006826|C0205177|C0001962|G0000000|C0013227|C0013146|C0011265|C0039798|C0205487|C0012634|C0332152|G0000000|C1999230|C1522154|C1511481
"placebo or bosentan, until their study participation was completed.","placebo bosentan, study participation completed.",C0032042|C0252643|C0557651|C0679823|C0205197
*Years of pancreatic surgery.,*Years pancreatic surgery.,C0439234|C0030274|C0038894
"The following patients completed the study: 35 patients (87.5%) from the active group (mean age, 63.7 ± 11.9 years; mean forced expiratory volume in one second (FEV1), 41.9 ± 2.6% of the predicted value); and 36 patients (88%) from the control group (mean age, 65.9 ± 10.3 years; mean FEV1, 43.33 ± 3.6% of the predicted value).","The patients completed study: 35 patients (87.5%) active (mean age, 63.7 ± 11.9 years; forced expiratory volume (FEV1), 41.9 ± 2.6% predicted value); 36 patients (88%) control (mean age, 65.9 ± 10.3 years; FEV1, 43.33 ± 3.6% predicted value).",G0000000|C0030705|C0205197|C0557651|C0450371|C0030705|C0450371|C0205177|C0444504|C0001779|C0450371|G0000000|C0450371|C0439234|C0441722|C0231800|C0449468|G0000000|C0450371|G0000000|G0000000|C0681842|C1522609|C0450371|C0030705|C0450371|C0243148|C0444504|C0001779|C0450371|G0000000|C0450371|C0439234|G0000000|C0450371|G0000000|G0000000|C0681842|C1522609
"Patients were diagnosed with vivax malaria at Kasturba Hospital, Manipal and Dr. Pai Hospital, Udupi, tertiary and secondary care hospitals, respectively, in Udupi district of Karnataka State, India.","Patients diagnosed vivax malaria Kasturba Hospital, Manipal Dr. Pai Hospital, Udupi, tertiary secondary care hospitals, respectively, Udupi district Karnataka State, India.",C0030705|C0011900|G0000000|C0024530|G0000000|C0019994|G0000000|C0013014|C1620101|C0019994|G0000000|C0205372|C0027627|C1947933|C0019994|G0000000|G0000000|G0000000|G0000000|C1301808|C0021201
"Exclusion criteria included a diagnosis of progressive MS,19 MS relapse within 50 days before randomization, clinically significant infectious illness within 30 days of randomization, abnormal laboratory results (or history thereof) indicative of any major organ system disease precluding administration of natalizumab or GA, history of severe allergic or anaphylactic reactions, known drug hypersensitivity, or history of malignancy (excluding nonmetastatic basal cell carcinoma).","Exclusion criteria included diagnosis progressive MS,19 MS relapse 50 days randomization, clinically infectious illness 30 days randomization, abnormal laboratory (or history thereof) indicative major organ system disease precluding administration natalizumab GA, history severe allergic anaphylactic reactions, drug hypersensitivity, history malignancy (excluding nonmetastatic basal cell carcinoma).",C0680251|C0243161|C0332257|C0011900|C0205329|C0039676|C0039676|C0035020|C0450371|C0439228|C0034656|G0000000|C0009450|C0221423|C0450371|C0439228|C0034656|C0205161|C0022877|G0000000|C0019664|G0000000|G0000000|C0205082|C0178784|C0449913|C0012634|G0000000|C0001554|C1172734|C0016993|C0019664|C0205082|C0700624|C0002792|C0443286|C0013227|C0020517|C0019664|C0006826|C0332196|C1518409|C0205112|C0007634|C0007097
IVIg has comparable efficacy to PLEX in the treatment of patients with moderate to severe MG.,IVIg comparable efficacy PLEX treatment patients moderate severe MG.,C0085297|G0000000|C1280519|G0000000|C0039798|C0030705|C0205081|C0205082|C0026410
"Patients were excluded from the study if they were of childbearing potential (unless they were practicing acceptable birth control methods); had a current diagnosis of asthma; had alpha-1 antitrypsin deficiency, an active lung infection (such as tuberculosis), lung cancer, or another clinically significant disease/abnormality; had an abnormal or significant electrocardiogram finding; had a history of allergy or hypersensitivity to any anticholinergic, muscarinic receptor antagonist, β2-agonist, lactose/milk protein, or magnesium stearate; had been hospitalized for COPD or pneumonia within 12 weeks prior to visit 1; had undergone lung volume reduction surgery within 12 months prior to visit 1; were receiving long-term oxygen therapy; had received any of the prohibited medications listed in Table S1 in the Electronic Supplementary Material; or were in the acute phase of a pulmonary rehabilitation program.","Patients excluded study childbearing potential (unless practicing acceptable birth control methods); current diagnosis asthma; alpha-1 antitrypsin deficiency, active lung infection (such tuberculosis), lung cancer, clinically disease/abnormality; abnormal electrocardiogram finding; history allergy hypersensitivity anticholinergic, muscarinic receptor antagonist, β2-agonist, lactose/milk protein, magnesium stearate; hospitalized COPD pneumonia 12 weeks prior visit 1; undergone lung volume reduction surgery 12 months prior visit 1; receiving long-term oxygen therapy; received prohibited medications listed Table S1 Electronic Supplementary Material; acute phase pulmonary rehabilitation program.",C0030705|C1554077|C0557651|G0000000|C3245505|G0000000|C0237607|C1879533|C0005615|C0243148|C0025663|C0521116|C0011900|C0004096|C0439095|C0072348|C0011155|C0205177|C0024109|C0009450|G0000000|C0041296|C0024109|C0006826|G0000000|C0012634|C0205161|C0013798|C0037088|C0019664|C0002111|C0020517|C0242896|C0026815|C0597357|C0231491|G0000000|C0022949|C0033684|C0024467|C0038228|C0701159|C0024117|C0032285|C0450371|C0439230|C0332152|C0545082|G0000000|G0000000|C0024109|C0449468|C0301630|C0038894|C0450371|C0439231|C0332152|C0545082|G0000000|C1514756|C0443252|C0030054|C0039798|C1514756|C0138547|C0013227|C0745732|C0039224|C1519428|C0013850|G0000000|C0520510|C0205178|C0205390|C0024109|C0034991|C1709697
"Heterogeneity of treatment effects in subgroups defined by the following factors was considered: prior treatment (radiosurgery v surgery), initial WHO PS (0 v 1 v 2), number of brain metastases (single v multiple), localization of the primary tumor (lung v other), and macroscopic tumor outside the brain (absent v present); however, no heterogeneity and no treatment effect for the primary end point in any subset was observed.","Heterogeneity treatment effects subgroups defined factors considered: prior treatment (radiosurgery surgery), initial WHO PS (0 1 2), brain metastases (single multiple), localization primary tumor (lung other), macroscopic tumor brain (absent present); however, heterogeneity treatment primary subset observed.",C0019409|C0039798|C1280500|C1079230|C1704788|C1521761|C0750591|C0332152|C0039798|C0085203|C0038894|C0205265|G0000000|C0242397|G0000000|G0000000|G0000000|C0006104|C0027627|C0037179|C0439064|C0475264|C0205225|C0027651|C0024109|G0000000|C0439806|C0027651|C0006104|C0332197|C0150312|G0000000|C0019409|C0039798|C0205225|C1515021|C1441672
"Children and parents in the Internet treatment group reported moderate to high ratings of treatment acceptability (child report M= 3.55, SD = .80, parent report M= 3.82, SD = .50).","Children parents Internet treatment reported moderate ratings treatment acceptability (child report M= 3.55, SD = .80, parent report M= 3.82, SD = .50).",C0008059|C0030551|C0282111|C0039798|C0684224|C0205081|C0871208|C0039798|C0814633|C0008059|C0684224|C0369637|C0450371|C2699239|G0000000|C0450371|C0030551|C0684224|C0369637|C0450371|C2699239|G0000000|C0450371
"Briefly, included participants were aged 18 years or older, presenting to a primary care clinician (general practitioner or practice nurse) with acute symptoms (onset within the last 7 days) of sore throat and odynophagia (pain on swallowing) that the clinician judged to be caused by an infection but that did not need immediate antibiotics, and who had the capacity and willingness to give consent and complete the trial paperwork.","Briefly, included participants aged 18 older, primary care clinician (general practitioner practice nurse) acute symptoms (onset 7 days) sore throat odynophagia (pain swallowing) clinician judged caused infection antibiotics, capacity willingness consent complete trial paperwork.",G0000000|C0332257|C0679646|C0001779|C0450371|C0580836|C0205225|C1947933|C0871685|C0205246|C1709627|C0237607|C0028661|C0205178|C0683368|C0206132|G0000000|C0439228|C0234233|C0031354|C0221150|C0030193|C0011167|C0871685|C0221191|C0015127|C0009450|C0003232|C1516240|C0600109|C1511481|C0205197|C0008976|C2986711
"According to the Pew Internet and American Life Project, SMS text messaging is increasingly common among middle age and older adults, with 72% (72/100) of mobile phone owners aged 50-64 and 34% (34/100) of those aged 65+ years reporting using their mobile phone to send or receive SMS text messages [40].","According Pew Internet American Life Project, SMS text messaging increasingly common middle age adults, 72% (72/100) mobile phone owners aged 50-64 34% (34/100) aged 65+ reporting mobile phone send receive SMS text messages [40].",C0680240|G0000000|C0282111|C0596070|C0376558|C1709701|G0000000|C1527021|C0470166|G0000000|C0205214|C0444598|C0001779|C0001675|C0450371|C0450371|C0231435|C1515258|C1704784|C0001779|C0450371|C0450371|C0450371|C0001779|C0450371|C0700287|C0231435|C1515258|C1519246|C1514756|G0000000|C1527021|C0470166|C0450371
Eight consecutive patients with newly diagnosed bilateral primary congenital glaucoma were enrolled in the study between June 2003 and December 2004.,Eight consecutive patients newly diagnosed bilateral primary congenital glaucoma enrolled study June 2003 December 2004.,C0205454|C1707491|C0030705|C0750546|C0011900|C0238767|C0205225|C0009678|C0017601|G0000000|C0557651|C3829443|G0000000|C3830550|G0000000
Usual care practice will be monitored yearly with a questionnaire administered to nurses most involved with the usual care of women with GC receiving radiotherapy at each site.,Usual care practice monitored yearly questionnaire administered nurses involved usual care women GC receiving radiotherapy site.,C3538928|C1947933|C0237607|C0030695|C0332181|C0034394|C1521801|C0028661|C1314939|C3538928|C1947933|C0043210|C3537453|C1514756|C0034619|C0205145
"In contrast, 4 (15%) of the 27 volunteers who used 3.5% salicylic acid and none of the 27 volunteers who used the 1% salicylic acid formulated with 3.5% pyroglutamic acid had positive hand cultures, indicating that these preparations provided effective residual antiviral activity (≥2-log reduction) on the hands.","In contrast, 4 (15%) 27 volunteers 3.5% salicylic acid 27 volunteers 1% salicylic acid formulated 3.5% pyroglutamic acid positive hand cultures, indicating preparations provided effective residual antiviral activity (≥2-log reduction) hands.",G0000000|C0009924|G0000000|C0450371|C0450371|C0042960|G0000000|C0036079|C0001128|C0450371|C0042960|G0000000|C0036079|C0001128|G0000000|G0000000|G0000000|C0001128|C0439178|C0018563|C0010453|G0000000|C1521827|C1999230|C1280519|C1609982|C0003451|C0205177|G0000000|C0301630|C0018563
"Male and female patients were included if they were aged 18–75 years old, and met the diagnostic criteria for delirium as defined by the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision (DSM-IV-TR).25 Since the Confusion Assessment Method (CAM) is a measure with high sensitivity (91%–97%) and specificity (85%–94%) for the detection of delirium, it was used to confirm the diagnosis.26–28 Exclusion criteria were substance-induced delirium (eg, alcohol-withdrawal delirium), known allergy or intolerance to quetiapine or haloperidol, pregnancy or breast feeding, being on an antipsychotic medication, and renal or hepatic failure.","Male female patients included aged 18–75 old, met diagnostic criteria delirium defined Diagnostic Statistical Manual Mental Disorders, 4th edition, text revision (DSM-IV-TR).25 Since Confusion Assessment Method (CAM) measure sensitivity (91%–97%) specificity (85%–94%) detection delirium, confirm diagnosis.26–28 Exclusion criteria substance-induced delirium (eg, alcohol-withdrawal delirium), allergy intolerance quetiapine haloperidol, pregnancy breast feeding, antipsychotic medication, renal hepatic failure.",C0086582|C0015780|C0030705|C0332257|C0001779|G0000000|C0580836|C0268621|C0011900|C0243161|C0011206|C1704788|C0011900|C0038215|C0024763|C0229992|C0012634|G0000000|C0441792|C1527021|C0439617|C0220952|C1711239|C0009676|C1261322|C0025663|C0597815|C0079809|C0020517|G0000000|C0037791|G0000000|C1511790|C0011206|C0521093|G0000000|C0680251|C0243161|C0439861|C0011206|C0013715|C0236663|C0011206|C0002111|C0231199|C0123091|C0018546|C0032961|C0006141|C0204695|C0040615|C0013227|C0022646|C0205054|C0231174
Young people with first episode psychosis referred to Early Intervention Services will be recruited over a two-year period from 1 March 2004.,Young people episode psychosis referred Early Intervention Services recruited two-year period 1 March 2004.,C0332239|C0027361|C0332189|C0033975|C0205543|C1279919|C0886296|C0557854|G0000000|C0205448|C0439531|G0000000|C3829202|G0000000
In this study patients with migraine with or without aura according to the IHS criteria (25) were enrolled.,In study patients migraine aura IHS criteria (25) enrolled.,G0000000|C0557651|C0030705|C0149931|C0236018|G0000000|C0243161|C0450371|G0000000
"The mean weight was 21.74 kg (range, 12–30 kg).","The weight 21.74 (range, 12–30 kg).",G0000000|C0005910|C0450371|C1514721|G0000000|C0022718
All pregnant women and women with age-eligible children living in the catchment area of a project site are eligible to participate in the standard growth monitoring and nutritional education that occurs in a group setting in a community center in all sites.,All pregnant women women age-eligible children living catchment project site eligible participate standard growth monitoring nutritional education occurs setting community center sites.,G0000000|C0549206|C0043210|C0043210|C0001779|C0008059|C0376558|G0000000|C1709701|C0205145|C1548635|G0000000|C1442989|C0018270|C0150369|C1521739|C0013621|C1709305|C0542559|C0009462|C0205099|C0205145
Eligible patients were adults (aged over 18 years) admitted with a diagnosis of heart failure and prescribed five or more medicines (from any class) at discharge.,Eligible patients adults (aged 18 years) admitted diagnosis heart failure prescribed medicines (from class) discharge.,C1548635|C0030705|C0001675|C0001779|C0450371|C0439234|C0184666|C0011900|C0018787|C0231174|C0278329|C0013227|G0000000|C0456387|C0012621
"Other major exclusion criteria included: ASCVD, low-density lipoprotein cholesterol (LDL-C) >4.9 mmol/L, liver transaminases three times the upper limit of normal, renal insufficiency, fibrates, or dietary supplements (excluding a multivitamin with <100 μg chromium).","Other major exclusion criteria included: ASCVD, low-density lipoprotein cholesterol (LDL-C) >4.9 mmol/L, liver transaminases times upper limit normal, renal insufficiency, fibrates, dietary supplements (excluding multivitamin <100 μg chromium).",G0000000|C0205082|C0680251|C0243161|C0332257|C3665365|C0205251|C0023820|C0008377|G0000000|G0000000|C0023884|C0002594|C0040223|C1282910|C0439801|C0205307|C0022646|C0231179|C1449704|C0012155|C0242295|C0332196|C0301532|C1442061|G0000000|C0008574
"We report on a randomized controlled trial conducted between 1996 and 2001 to evaluate a minimal contact behavioral counseling intervention to decrease household SHS exposure among children with asthma from low-income, predominantly ethnic minority families.","We report randomized controlled trial conducted 1996 2001 evaluate minimal contact behavioral counseling intervention decrease household SHS exposure children asthma low-income, ethnic minority families.",G0000000|C0684224|C0034656|C2587213|C0008976|C0004927|G0000000|G0000000|C0220825|C0547040|C0332158|C0004927|C0010210|C0886296|C0392756|C0020052|G0000000|C0274281|C0008059|C0004096|C0032854|C0015031|C0026192|C0015576
"Proportion of children received ≥4 food groups every day in past 7 days Proportion of children received animal source food every day in past 7 days In this study of community‐based WASH and nutrition promotion interventions, we found that children from households that received the nutrition interventions were more likely to meet MDD and MAD criteria compared with the control arm over 2 years of follow‐up.","Proportion children received ≥4 food day 7 days Proportion children received animal source food day 7 days In study community‐based WASH nutrition promotion interventions, children households received nutrition interventions meet MDD MAD criteria compared control arm 2 follow‐up.",C1709707|C0008059|C1514756|G0000000|C0016452|C0332173|G0000000|C0439228|C1709707|C0008059|C1514756|C0003062|C0449416|C0016452|C0332173|G0000000|C0439228|G0000000|C0557651|G0000000|C0441648|C0028707|C0033414|C0886296|C0008059|C0020052|C1514756|C0028707|C0886296|C1550543|C1269683|C0002957|C0243161|C1707455|C0243148|C0446516|G0000000|G0000000
Women unable or unwilling to give informed consent; <15+0 weeks or >18+6 weeks’ gestation; essential hypertension requiring treatment either pre-pregnancy or in index pregnancy; pre-existing renal disease; systemic lupus erythematosus; antiphospholipid syndrome; sickle cell disease; thalassemia; coeliac disease; thyroid disease; current psychosis; multiple pregnancy; currently prescribed metformin.,Women unable unwilling informed consent; <15+0 weeks >18+6 weeks’ gestation; essential hypertension requiring treatment pre-pregnancy pregnancy; pre-existing renal disease; systemic lupus erythematosus; antiphospholipid syndrome; sickle cell disease; thalassemia; coeliac disease; thyroid disease; current psychosis; multiple pregnancy; prescribed metformin.,C0043210|C1299582|C0558080|C1522154|C1511481|C0450371|C0439230|C0450371|G0000000|C0032961|C0205224|C0020538|G0000000|C0039798|C2709093|C0032961|C2347662|C0022646|C0012634|C0205373|C0024131|G0000000|G0000000|C0039082|G0000000|C0007634|C0012634|C0039730|G0000000|C0012634|C0040132|C0012634|C0521116|C0033975|C0439064|C0032961|C0278329|C0025598
The target population was Veterans with a diagnosis of possible or probable Alzheimer's disease7of mild-to-moderate severity defined as a Mini-Mental State Examination (MMSE) total score between 12 and 26 inclusive.8 Figure 1 displays an overall schematic of the study design.,The target population Veterans diagnosis probable Alzheimer's disease7of mild-to-moderate severity defined Mini-Mental State Examination (MMSE) total score 12 26 inclusive.8 Figure 1 displays schematic study design.,G0000000|C1521840|C0032659|C0042610|C0011900|C0033204|G0000000|G0000000|C1299392|C0439793|C1704788|C0445542|C1301808|G0000000|C0451306|C0439175|C0449820|C0450371|C0450371|C0332257|G0000000|G0000000|C0870432|G0000000|C0557651|C1707689
Average Anopheles densities in different areas and different months in 2010 (A) and 2011 (B).,Average Anopheles densities months 2010 (A) 2011 (B).,C1510992|C0003117|C0178587|C0439231|G0000000|G0000000|G0000000|G0000000
"Women testing positive for HIV-1 infection in prenatal care units in Abidjan, Côte d'Ivoire, and Bobo-Dioulasso, Burkina Faso, from November 1996 to April 1997 were eligible, with their informed consent.","Women testing positive HIV-1 infection prenatal care units Abidjan, Côte d'Ivoire, Bobo-Dioulasso, Burkina Faso, November 1996 April 1997 eligible, informed consent.",C0043210|C0039593|C0439178|C0019682|C0009450|C0678804|C1947933|C0439148|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|C3828767|G0000000|C3715024|G0000000|C1548635|C1522154|C1511481
Families with children (0–13 years of age) having an asthma predisposition who experience PS exposure at home are randomized into an intervention group receiving an intervention or a control group receiving care as usual.,Families children (0–13 age) asthma predisposition experience PS exposure randomized intervention receiving intervention control receiving care usual.,C0015576|C0008059|G0000000|C0001779|C0004096|C0012655|C0237607|C0242397|C0274281|C0034656|C0886296|C1514756|C0886296|C0243148|C1514756|C1947933|C3538928
Recruited patients were asked to identify who gave them the most help and support at home (family member or friend); these informal carers were also invited to participate.,Recruited patients identify support (family friend); informal carers invited participate.,G0000000|C0030705|G0000000|C0183683|C0015576|C0079382|G0000000|C0085537|G0000000|G0000000
"The 200 infants in the developmental substudy did not differ from the overall sample in birth weight, gestational age, or socioeconomic status.","The 200 infants developmental substudy sample birth weight, gestational age, socioeconomic status.",G0000000|C1442061|C0021270|C0458003|G0000000|C0370003|C0005615|C0005910|C0439671|C0001779|C0748878|C0449438
Nursing homes systematically invite the family after death of a resident with dementia to provide feedback using the End-of-Life in Dementia (EOLD) – instruments.,Nursing homes systematically invite family death resident dementia provide feedback End-of-Life Dementia (EOLD) – instruments.,C0006147|C0442519|G0000000|G0000000|C0015576|C0011065|C1320928|C0011265|C1999230|C0015744|C0444930|C0011265|G0000000|G0000000|C0348000
We report updated and new death rates in subjects in arms 1 and 2 and in those who were randomised from arm 3 (bromocriptine) to arms 1 or 2.,We report updated death rates subjects arms 1 2 randomised arm 3 (bromocriptine) arms 1 2.,G0000000|C0684224|C1519814|C0011065|C0871208|C0681850|C0206655|G0000000|G0000000|G0000000|C0446516|G0000000|C0006230|C0206655|G0000000|G0000000
The patients were 2 months to 15 years old and came to our emergency department suffering from an acute seizure episode.,The patients 2 months 15 emergency department suffering acute seizure episode.,G0000000|C0030705|G0000000|C0439231|C0450371|C0013956|C1704729|C0683278|C0205178|C0036572|C0332189
Bleedings were compared between treatment regimens.,Bleedings compared treatment regimens.,C0019080|C1707455|C0039798|C2945654
"The asthma severity/control status of most of the patients (79%) was “severe”, with a higher proportion of patients with severe asthma in the intervention group than in the control group (88% vs 71%; p<0.001, table 33).","The asthma severity/control status patients (79%) “severe”, proportion patients severe asthma intervention control (88% 71%; p<0.001, table 33).",G0000000|C0004096|C0439793|C0449438|C0030705|C0450371|G0000000|C1709707|C0030705|C0205082|C0004096|C0886296|C0243148|C0450371|C0450371|C0369773|C0039224|C0450371
Subjects were recruited from the local community through advertisements in local media.,Subjects recruited local community advertisements local media.,C0681850|G0000000|C0205276|C0009462|C0949214|C0205276|C0009458
"The groups differed at baseline in terms of age, gender and MS subtype (Table 1).","The differed baseline terms age, gender MS subtype (Table 1).",G0000000|G0000000|C0168634|C0233324|C0001779|C0079399|C0039676|C0449560|C0039224|G0000000
"The inclusion criteria were: 1) first ever stroke, 2) 18–85 years old 3) clinically diagnosed with a central paresis of the arm-hand (strength: MRC grade 2–4 at entry into study), 4) post-stroke time ≥12 months, 5) normal cognitive level (Mini Mental State Examination (MMSE) score ≥26 [24]), 6) able to read and understand the Dutch language, 7) unable to fully perform, but motivated to train on, at least two of the following skills: ‘drinking from a cup’, ‘eating with knife and fork’, ‘taking money from a purse’ and ‘using a tray’.","The inclusion criteria were: 1) stroke, 2) 18–85 3) clinically diagnosed central paresis arm-hand (strength: MRC grade 2–4 entry study), 4) post-stroke time ≥12 months, 5) normal cognitive level (Mini Mental State Examination (MMSE) score ≥26 [24]), 6) read understand Dutch language, 7) unable perform, motivated train on, skills: ‘drinking cup’, ‘eating knife fork’, ‘taking money purse’ ‘using tray’.",G0000000|C0007637|C0243161|G0000000|G0000000|C0038454|G0000000|G0000000|G0000000|G0000000|C0011900|C0205099|C0030552|C0446516|C0237897|C1540289|C0441800|G0000000|C1705654|C0557651|G0000000|C0687676|C0040223|G0000000|C0439231|G0000000|C0205307|C1516691|C0441889|C0445542|C0229992|C1301808|G0000000|C0451306|C0449820|G0000000|C0450371|G0000000|C0034754|C0162340|C0013331|C0023008|G0000000|C1299582|C0884358|G0000000|C0336809|G0000000|C0678856|G0000000|G0000000|G0000000|C0181467|G0000000|G0000000|C0870909|G0000000|G0000000|G0000000
"Gynecological malignancy may develop into bowel obstruction at primary presentation, but obstruction occurs more frequently with recurrence and disease progression as the consequence of resistance to and failure of anticancer therapy.","Gynecological malignancy develop bowel obstruction primary presentation, obstruction occurs frequently recurrence disease progression consequence resistance failure anticancer therapy.",C0018417|C0006826|G0000000|C0021853|C0028778|C0205225|C0449450|C0028778|C1709305|C0332183|C0034897|C0012634|C0242656|C0686907|C0237834|C0231174|G0000000|C0039798
"Exclusion criteria: inability to speak or read French, and/or understand the interview questions, any metabolic pathology interfering with eating or digestion (e.g., diabetes), or psychotic disorder.","Exclusion criteria: inability speak read French, and/or understand interview questions, metabolic pathology interfering eating digestion (e.g., diabetes), psychotic disorder.",C0680251|C0243161|G0000000|C0234856|C0034754|C0376246|G0000000|C0162340|C0021822|C1522634|C0311400|C0030664|C0521102|C0013470|C0012238|G0000000|C0011847|C0004936|C0012634
"Furthermore, we only tested patients with severe dementia.","Furthermore, tested patients severe dementia.",G0000000|C0392366|C0030705|C0205082|C0011265
"Women were also excluded if they had a body mass index greater than 40 kg/m2; had a history of breast, endometrial, or cervical cancer; had a positive pregnancy test; or had a history of undiagnosed abnormal vaginal bleeding, thromboembolic disease, cardiovascular disease, liver or kidney disease, diabetes mellitus, or other major illnesses.","Women excluded body mass 40 kg/m2; history breast, endometrial, cervical cancer; positive pregnancy test; history undiagnosed abnormal vaginal bleeding, thromboembolic disease, cardiovascular disease, liver kidney disease, diabetes mellitus, major illnesses.",C0043210|C1554077|C0242821|C0577559|C0450371|C0022718|C0019664|C0006141|C0227843|C0027530|C0006826|C0439178|C0032961|C0022885|C0019664|C1408353|C0205161|C0042232|C0019080|C0333214|C0012634|C0007226|C0012634|C0023884|C0022646|C0012634|C0011847|G0000000|C0205082|C0221423
"Within each group, participants will be selected on the basis of: age (tertiles); socio-economic status (using IMD scores); number of different classes of medications; and whether they have had a stroke or a TIA.","Within group, participants selected basis of: age (tertiles); socio-economic status (using IMD scores); classes medications; stroke TIA.",G0000000|C0441833|C0679646|C1707391|C1527178|G0000000|C0001779|G0000000|C0013556|C0449438|C1524063|G0000000|C0449820|C0456387|C0013227|C0038454|C0007787
"At baseline, participants chose a minimum of 2 out of 4 skills to train: ‘drinking from a cup’, ‘eating with knife and fork’, ‘taking money from a purse’ or ‘using a tray’.","At baseline, participants chose minimum 2 4 skills train: ‘drinking cup’, ‘eating knife fork’, ‘taking money purse’ ‘using tray’.",G0000000|C0168634|C0679646|C1707391|C1524031|G0000000|G0000000|C0678856|C0336809|G0000000|G0000000|G0000000|C0181467|G0000000|G0000000|C0870909|G0000000|G0000000|G0000000
"The proportion of children with low pZC increased from 9 to 18 months (p < 0.0001), but did not differ among the intervention groups or between the cohorts at 18 months (Table 2).","The proportion children low pZC increased 9 18 months (p < 0.0001), intervention cohorts 18 months (Table 2).",G0000000|C1709707|C0008059|C0205251|G0000000|C0205217|G0000000|C0450371|C0439231|G0000000|C0886296|C0599755|C0450371|C0439231|C0039224|G0000000
The inclusion criteria were the age of ≥ 18 years and refractory epilepsy (two or more seizures attacks every month in spite of treatment with at least two appropriate antiepileptic drugs).,The inclusion criteria age ≥ 18 refractory epilepsy (two seizures attacks month spite treatment antiepileptic drugs).,G0000000|C0007637|C0243161|C0001779|G0000000|C0450371|C0205269|C0014544|C0205448|C0036572|C1261512|C0332177|G0000000|C0039798|C0003299|C0013227
We previously reported that prompt as compared with delayed insertion of tympanostomy tubes in children with persistent effusion who were younger than three years of age did not result in improved developmental outcomes at three or four years of age.,We reported prompt compared delayed insertion tympanostomy tubes children persistent effusion age result improved developmental outcomes age.,G0000000|C0684224|C0871157|C1707455|C0205421|C0021107|C0087123|C0175730|C0008059|C0205322|C0013687|C0001779|C1274040|C0184511|C0458003|C1274040|C0001779
A total of 4384 adolescents age 11–15 years at baseline and re-surveyed 1 year later; ever smoking prevalence was 38% at time 1.,A total 4384 adolescents age 11–15 baseline re-surveyed 1 later; smoking prevalence 38% time 1.,G0000000|C0439175|G0000000|C0205653|C0001779|G0000000|C0168634|C0556581|G0000000|C0205087|C0037369|C0033105|C0450371|C0040223|G0000000
"A total of 5892 patients, or 84.7% of all adults who initiated ART, met the inclusion criteria for the study and were considered in analysis.","A total 5892 patients, 84.7% adults initiated ART, met inclusion criteria study considered analysis.",G0000000|C0439175|G0000000|C0030705|C0450371|C0001675|C1548602|C0003826|C0268621|C0007637|C0243161|C0557651|C0750591|C0002778
"Only the serologically confirmed cases of dengue IgM ELISA were included, when their platelet counts dropped below 50000/cumm during the acute stage of the illness.","Only serologically confirmed dengue IgM ELISA included, platelet counts dropped 50000/cumm acute stage illness.",C0205171|G0000000|C0521093|C0011311|G0000000|C0014441|C0332257|C0005821|C0439157|C1705648|G0000000|C0205178|C0205390|C0221423
"Children/parent dyads attending the child health clinics from these locations will be invited to participate, and the randomisation procedure will be based on individual randomisation stratified on the basis of residential location of Perth or Bunbury/Busselton.","Children/parent dyads attending child health clinics locations invited participate, randomisation procedure based individual randomisation stratified basis residential location Perth Bunbury/Busselton.",C0260096|C0870454|C1547429|C0008059|C0018684|C0442592|C0450429|G0000000|G0000000|C0034656|C0184661|C1527178|C0027361|C0034656|C0205363|C1527178|C0237096|C0450429|G0000000|G0000000
Primary study outcomes for the cross-sectional study design in Mali and Burkina Faso are: the prevalence of AM defined by a WLZ < -2 or a MUAC < 125 mm (only in children older than 6 months) or the presence of bilateral pitting edema; AM screening coverage defined as the number of children screened in the month preceding the survey (as reported by the caregiver) over the total number of eligible study children; AM treatment compliance defined as the number of AM children under appropriate treatment at the time of the survey over the total number of AM cases identified in the study sample.,Primary study outcomes cross-sectional study design Mali Burkina Faso are: prevalence AM defined WLZ < -2 MUAC < 125 mm (only children 6 months) presence bilateral pitting edema; AM screening coverage defined children screened month preceding survey (as reported caregiver) total eligible study children; AM treatment compliance defined AM children treatment time survey total AM identified study sample.,C0205225|C0557651|C1274040|C0552389|C0557651|C1707689|C0024581|G0000000|G0000000|G0000000|C0033105|G0000000|C1704788|G0000000|G0000000|G0000000|C0205171|C0008059|G0000000|C0439231|C0150312|C0238767|C0205323|C0013604|G0000000|C0220908|C1551362|C1704788|C0008059|C0220908|C0332177|C0332152|C0038951|G0000000|C0684224|C0085537|C0439175|C1548635|C0557651|C0008059|G0000000|C0039798|C0009563|C1704788|G0000000|C0008059|C0039798|C0040223|C0038951|C0439175|G0000000|C0205396|C0557651|C0370003
TABLE 2.,TABLE 2.,C0039224|G0000000
We considered for inclusion all children presenting to these clinics from primary care from December 1995 to March 1998.,We considered inclusion children clinics primary care December 1995 March 1998.,G0000000|C0750591|C0007637|C0008059|C0442592|C0205225|C1947933|C3830550|G0000000|C3829202|G0000000
"CONSORT flow diagram of the RCT Among the participants, 39.4% were female and the mean age of the participants was 39.3 ± 12.1.","CONSORT flow diagram RCT Among participants, 39.4% female age participants 39.3 ± 12.1.",G0000000|C0806140|C0681494|G0000000|G0000000|C0679646|C0450371|C0015780|C0001779|C0679646|G0000000
Exclusion criteria were: (1) BMI below 25 kg/m2; (2) habitual consumption of >30 g whole grain per d (i.e.,Exclusion criteria were: (1) BMI 25 kg/m2; (2) habitual consumption >30 grain (i.e.,C0680251|C0243161|G0000000|G0000000|G0000000|C0450371|C0022718|G0000000|C0205353|C0009830|C0450371|C0007757|C0683454
"For the as-treated analysis, the times are from the beginning of treatment (i.e., the time of surgery for the surgical group and the time of enrollment for the non operative group).","For as-treated analysis, times treatment (i.e., time surgery surgical time enrollment operative group).",G0000000|C0004340|C0002778|C0040223|C0039798|C0683454|C0040223|C0038894|C0543467|C0040223|C1516879|C1882154|C0441833
"The exclusion criteria were (1) musculoskeletal disease, (2) neglect, and (3) mental illness.","The exclusion criteria (1) musculoskeletal disease, (2) neglect, (3) mental illness.",G0000000|C0680251|C0243161|G0000000|C0497254|C0012634|G0000000|C0521874|G0000000|C0229992|C0221423
Subjects could not be blinded to their treatment assignments.,Subjects blinded treatment assignments.,C0681850|C0150108|C0039798|C1516050
"To be included in the study, patients had to fulfil the following criteria: 18 years of age or older; critically ill with an anticipated need for mechanical ventilation of at least 24 hours; not moribund; not suffering from pneumonia at admission; no fractures in the facial skeleton or the base of the skull; no oral ulcers; not immune deficient; not a carrier of HIV or viral hepatitis.","To included study, patients fulfil criteria: 18 age older; critically ill anticipated mechanical ventilation 24 hours; moribund; suffering pneumonia admission; fractures facial skeleton base skull; oral ulcers; immune deficient; carrier HIV viral hepatitis.",C0040363|C0332257|C0557651|C0030705|C1550543|C0243161|C0450371|C0001779|C0580836|G0000000|C0231218|C3840775|C0443254|C0035203|C0450371|C0439227|C0424547|C0683278|C0032285|C0184666|C0016658|C0015450|C0037253|C0002055|C0037303|C0442027|C0041582|C0439662|C0011155|C0007294|C0019682|C0521026|C0019158
"We did not find statistical differences for “age” and “time since stroke” between both groups (age: mean Group 1 = 63 years, mean Group 2 = 66 years, p = 0.371; time since stroke: mean Group 1 = 62 months, mean Group 2 = 102 months, p = 0.331).","We statistical differences “age” “time stroke” (age: Group 1 = 63 years, Group 2 = 66 years, = 0.371; time stroke: Group 1 = 62 months, Group 2 = 102 months, = 0.331).",G0000000|C0038215|C1705241|G0000000|G0000000|G0000000|C0001779|C0441833|G0000000|G0000000|C0450371|C0439234|C0441833|G0000000|G0000000|C0450371|C0439234|G0000000|C1442061|C0040223|C0038454|C0441833|G0000000|G0000000|C0450371|C0439231|C0441833|G0000000|G0000000|C1442061|C0439231|G0000000|C1442061
"The average age was 20.4 years (SD 2.6), with 49% aged 14−19 years.","The average age 20.4 (SD 2.6), 49% aged 14−19 years.",G0000000|C1510992|C0001779|C0450371|G0000000|G0000000|C0450371|C0001779|G0000000|C0439234
"This reflects standard primary care, where giving written information is common practice.","This reflects standard primary care, written common practice.",G0000000|C0558058|C1442989|C0205225|C1947933|C0043266|C0205214|C0237607
"To determine whether eliglustat, a novel oral substrate-reduction therapy, safely reverses clinical manifestations in previously untreated adults with Gaucher disease type 1.","To determine eliglustat, oral substrate-reduction therapy, safely reverses clinical manifestations untreated adults Gaucher disease type 1.",C0040363|G0000000|C3272698|C0442027|C1710236|C0039798|G0000000|C1555029|C0205210|C0205319|C0332155|C0001675|G0000000|C0012634|C0332307|G0000000
Inclusion criteria were a post bronchodilator FEV1/FVC <70% and FEV1<80% [14] and persistent neutrophilic bronchitis defined as sputum neutrophil proportion of more than 61% or more than 162×104/mL sputum neutrophils demonstrated on two occasions (at least one being the screening visit).,Inclusion criteria post bronchodilator FEV1/FVC <70% FEV1<80% [14] persistent neutrophilic bronchitis defined sputum neutrophil proportion 61% 162×104/mL sputum neutrophils demonstrated occasions (at screening visit).,C0007637|C0243161|C0687676|C0006280|C3714541|C0450371|C0450371|C0450371|C0205322|C0746885|C0006277|C1704788|C0038056|C0027950|C1709707|C0450371|G0000000|C0038056|C0027950|G0000000|C0521114|G0000000|C0220908|C0545082
"The patient, parent or legal guardian had to be able to read, understand and write French.","The patient, parent legal guardian read, understand write French.",G0000000|C0030705|C0030551|C1301860|C0023226|C0034754|C0162340|C0043266|C0376246
"Setting 68 general practices with about 480 000 patients in Wales, United Kingdom.","Setting 68 practices 480 000 patients Wales, United Kingdom.",C0542559|C0450371|C0237607|G0000000|C0030705|C0043015|C0166872|C1708611
This study started patient recruitment in 1999 and is currently ongoing.,This study started patient recruitment 1999 ongoing.,G0000000|C0557651|C1272689|C0030705|C2949735|G0000000|C0549178
"The first definition of clinical influenza was fever ≥38°C or at least two of the following symptoms: headache, coryza, sore throat, aches or pains in muscles or joints, cough, or fatigue.","The definition clinical influenza fever ≥38°C symptoms: headache, coryza, sore throat, aches pains muscles joints, cough, fatigue.",G0000000|C1550452|C0205210|C0021400|C0015967|G0000000|C0683368|C0018681|C0009443|C0234233|C0031354|C0234238|C0030193|C0026845|C0022417|C0010200|C0015672
The diagnosis of pneumonia was confirmed by bronchoalveolar lavage (BAL) culture of ≥104 colony-forming units/ml for at least one bacterial species.,The diagnosis pneumonia confirmed bronchoalveolar lavage (BAL) culture ≥104 colony-forming units/ml bacterial species.,G0000000|C0011900|C0032285|C0521093|G0000000|C0022100|C0428249|C0010453|G0000000|C0439158|C2945590|C0521009|C1705920
The results on confirmed EDSS progression show that most patients fared quite well on any of the treatments with low rates of progression over a three year period.,The confirmed EDSS progression patients fared treatments low rates progression period.,G0000000|C0521093|C0451246|C0242656|C0030705|G0000000|C0087111|C0205251|C0871208|C0242656|C0439531
All patients had a forced expiratory volume in 1 s of 50–90% predicted normal and were inadequately controlled on inhaled corticosteroids (500–1600 mu g/day) alone.,All patients forced expiratory volume 1 50–90% predicted normal inadequately controlled inhaled corticosteroids (500–1600 mu g/day) alone.,G0000000|C0030705|C0441722|C0231800|C0449468|G0000000|G0000000|C0681842|C0205307|G0000000|C2587213|C0004048|C0001617|G0000000|C0028971|C0439417|C0205171
"Administration, evaluation and case reports of all patients were in accordance with the test program, Naïve patients in accordance with TNM staging of International Union Against Cancer (UICC), confirmed to be with NSCLC by pathology or cytology, at stages of IIIB and IV, inoperable due to medical reasons or rejecting surgery; or the patients accepting 4 to 8 cycles of first-line chemotherapy and achieving complete remission, partial response and stability.","Administration, evaluation reports patients test program, Naïve patients TNM staging International Union Against Cancer (UICC), confirmed NSCLC pathology cytology, stages IIIB IV, inoperable medical reasons rejecting surgery; patients accepting 4 8 cycles first-line chemotherapy achieving complete remission, partial response stability.",C0001554|C0220825|C0684224|C0030705|C0022885|C1709697|G0000000|C0030705|C0039694|C0332305|C1512888|C2825217|G0000000|C0006826|C0441914|C0521093|C0007131|C0030664|C0010818|C1306673|G0000000|C0022326|C0205187|C0199168|C0392360|C1548437|C0038894|C0030705|C1272684|G0000000|G0000000|C1511572|C0205435|C0013216|G0000000|C0205197|C0544452|C0728938|C0871261|C0205360
when infants are aged 12 months).,infants aged 12 months).,C0021270|C0001779|C0450371|C0439231
"In a recent Cochrane review of published trials of PSST in children with chronic medical conditions [15], treatment was also associated with improved parent mental health and behavior with similar small effect sizes; however there were no treatment effects observed on child outcomes.","In Cochrane review published trials PSST children chronic medical conditions [15], treatment improved parent mental health behavior sizes; treatment effects observed child outcomes.",G0000000|G0000000|C0282443|C0034037|C0008976|C1417650|C0008059|C0205191|C0199168|C0012634|C0450371|C0039798|C0184511|C0030551|C0229992|C0018684|C0004927|C0456389|C0039798|C1280500|C1441672|C0008059|C1274040
"for adolescent and young adult cannabis users is nearly entirely missing, is the juvenile penal system [20].","adolescent adult cannabis users missing, juvenile penal system [20].",C0205653|C0001675|C0024808|C1706077|C1551393|C3146221|G0000000|C0449913|C0450371
"Exclusion criteria were severe concomitant diseases, which limit physical performances, and a second neurological disease.","Exclusion criteria severe concomitant diseases, limit physical performances, neurological disease.",C0680251|C0243161|C0205082|C0521115|C0012634|C0439801|C0031809|C0597198|C0205494|C0012634
"Considering the extra toxicity and complexity, this concurrent BCT regimen cannot be recommended for patients with metastatic melanoma.","Considering extra toxicity complexity, concurrent BCT regimen recommended patients metastatic melanoma.",C0750591|G0000000|C0040539|C0439855|C0205420|C0917927|C0040808|C0034866|C0030705|C0036525|C0025202
"Exclusion criteria were IgAN secondary to other diseases; previous adverse reaction to telmisartan, clopidogrel, or leflunomide; diabetes mellitus; pregnancy or unreliable contraception; and use of corticosteroids or other immunosuppressive agents (including leflunomide) in the preceding 3 months.","Exclusion criteria IgAN secondary diseases; previous adverse reaction telmisartan, clopidogrel, leflunomide; diabetes mellitus; pregnancy unreliable contraception; corticosteroids immunosuppressive agents (including leflunomide) preceding 3 months.",C0680251|C0243161|C3160719|C0027627|C0012634|C0205156|G0000000|C0443286|C0248719|C0070166|C0063041|C0011847|G0000000|C0032961|C0749770|C0700589|C0001617|C0021081|C0450442|C0332257|C0063041|C0332152|G0000000|C0439231
"To reduce the risks of corticosteroid-related adverse effects, children with FRNS or SDNS (FRNS/SDNS) may require other agents.","To reduce risks corticosteroid-related adverse effects, children FRNS SDNS (FRNS/SDNS) require agents.",C0040363|G0000000|C0035647|C0001617|G0000000|C1280500|C0008059|C0220730|C0038642|C0220730|G0000000|C0450442
Participants were recruited nationally from community and clinical settings serving persons with TBI and referrals from clinicians.,Participants recruited nationally community clinical settings serving persons TBI referrals clinicians.,C0679646|G0000000|G0000000|C0009462|C0205210|C0542559|C1519269|C0027361|C0876926|C0034927|C0871685
"Bortezomib is active for newly diagnosed and relapsed multiple myeloma, and has synergistic activity with melphalan.","Bortezomib active newly diagnosed relapsed multiple myeloma, synergistic activity melphalan.",C1176309|C0205177|C0750546|C0011900|C0205336|C0439064|C0026764|C2986495|C0205177|C0025241
"First, the three groups did not demonstrate any significant differences in terms of age, even though the study was conducted on children, ranging in age from 2 to 14 years, and was not restricted to preschool children particularly vulnerable to EA.","First, demonstrate differences terms age, study conducted children, ranging age 2 14 years, restricted preschool children vulnerable EA.",C0205435|G0000000|C1705241|C0233324|C0001779|C0557651|C0004927|C0008059|C1514721|C0001779|G0000000|C0450371|C0439234|C0443288|C0424930|C0008059|G0000000|C0014963
"With this background, the National Surgical Adjuvant Breast and Bowel Project (NSABP) led a national randomized intergroup clinical trial to test the value of capecitabine and oxaliplatin as components of preoperative (neoadjuvant) combined-modality therapy in patients with clinical stage II and III rectal cancer.","With background, National Surgical Adjuvant Breast Bowel Project (NSABP) led national randomized intergroup clinical trial test capecitabine oxaliplatin components preoperative (neoadjuvant) combined-modality therapy patients clinical stage II III rectal cancer.",G0000000|C1706907|C3245503|C0543467|C0001551|C0006141|C0021853|C1709701|C1513905|C1708698|C3245503|C0034656|G0000000|C0205210|C0008976|C0022885|C0671970|C0069717|C0449432|C0445204|C0600558|C0205195|C0039798|C0030705|C0205210|C0205390|G0000000|C0439070|C0205052|C0006826
Patients were assigned to the surveillance group when they had undergone one or more surveillance colonoscopies before a diagnosis of CRC.,Patients assigned surveillance undergone surveillance colonoscopies diagnosis CRC.,C0030705|C1516050|C0220920|G0000000|C0220920|C0009378|C0011900|C0009402
Median duration of IBS was similar in both groups.,Median duration IBS groups.,C0549183|C0449238|C0022104|C0441833
"The medical cases included in this study comprised inpatients/outpatients with a pathologically confirmed diagnosis of ovarian cancer who were registered at the Department of Gynecological Oncology of the Cancer Hospital of Guangxi Medical University, China, between August 1999 and June 2003.","The medical included study comprised inpatients/outpatients pathologically confirmed diagnosis ovarian cancer registered Department Gynecological Oncology Cancer Hospital Guangxi Medical University, China, August 1999 June 2003.",G0000000|C0199168|C0332257|C0557651|C2700400|C0021562|G0000000|C0521093|C0011900|C0205065|C0006826|C1514821|C1704729|C0018417|C0027651|C0006826|C0019994|G0000000|C0199168|C0041740|C0008115|C3831448|G0000000|C3829443|G0000000
"Within each of the 4 categories of median BMI and site ethnicity, centers were randomly assigned to intervention and comparison groups.","Within 4 categories median BMI site ethnicity, centers randomly assigned intervention comparison groups.",G0000000|G0000000|C0683312|C0549183|G0000000|C0205145|C0015031|C0205099|G0000000|C1516050|C0886296|C1707455|C0441833
A total of 245 patients were treated.,A total 245 patients treated.,G0000000|C0439175|C1442061|C0030705|C1522326
Conscious patients presenting within 12 h of acute stroke with limb weakness are eligible.,Conscious patients 12 acute stroke limb weakness eligible.,C0234421|C0030705|C0450371|C0205178|C0038454|C0015385|C3714552|C1548635
"This study seeks to extend earlier Australian school drug education research by developing and measuring the effectiveness of a comprehensive, evidence-based, harm reduction focused school drug education program for junior secondary students aged 13 to 15 years.","This study seeks extend earlier Australian school drug education developing measuring effectiveness comprehensive, evidence-based, harm reduction focused school drug education program junior secondary students aged 13 15 years.",G0000000|C0557651|G0000000|C0231448|C1279919|C0238711|C0036375|C0013227|C0013621|G0000000|C0444706|C1280519|C1880156|C3887511|G0000000|C0301630|C0205234|C0036375|C0013227|C0013621|C1709697|C1708595|C0027627|C0038492|C0001779|C0450371|C0450371|C0439234
The first was restricted to failures occuring in months 2–11.,The restricted failures occuring months 2–11.,G0000000|C0443288|C0231174|C1709305|C0439231|G0000000
"All of the patients fulfilled the inclusion criteria, which were age of 19–75 years, the use of antihypertensive medication or a diagnosis of hypertension, Modification of Diet in Renal Disease study eGFR≥30 ml/min per 1.73 m2, random urine albumin-to-creatinine ratio ≥30 mg/g creatinine more than two times with a ≥1-week interval in the last 6 months, and an ability and willingness to provide written informed consent.","All patients fulfilled inclusion criteria, age 19–75 years, antihypertensive medication diagnosis hypertension, Modification Diet Renal Disease study eGFR≥30 ml/min 1.73 m2, random urine albumin-to-creatinine ratio ≥30 mg/g creatinine times ≥1-week interval 6 months, ability willingness provide written informed consent.",G0000000|C0030705|C1550543|C0007637|C0243161|C0001779|G0000000|C0439234|C0003364|C0013227|C0011900|C0020538|C0392747|C0012155|C0022646|C0012634|C0557651|G0000000|C0439445|C0450371|C0025885|C0034656|C0042036|C0486293|C0456603|G0000000|C1300563|C0010294|C0040223|G0000000|C1272706|G0000000|C0439231|C0085732|C0600109|C1999230|C0043266|C1522154|C1511481
"Exclusion criteria were allergy to macrolide antibiotics, long term treatment (>3 months) with macrolides during the 12 month period before study entry, liver disease with liver function tests more than twice the laboratory upper limit, history of portal hypertension, kidney disease with serum creatinine >150 μmol/l and/or creatinine clearance <50 ml/min, introduction of recombinant human dornase alfa (rhDNase) and/or inhaled tobramycin and/or inhaled steroids in the 3 months before study entry.","Exclusion criteria allergy macrolide antibiotics, term treatment (>3 months) macrolides 12 month period study entry, liver disease liver function tests laboratory upper limit, history portal hypertension, kidney disease serum creatinine >150 μmol/l and/or creatinine clearance <50 ml/min, introduction recombinant human dornase alfa (rhDNase) and/or inhaled tobramycin and/or inhaled steroids 3 months study entry.",C0680251|C0243161|C0002111|C0003240|C0003232|C0233324|C0039798|G0000000|C0003240|G0000000|C0439531|C0557651|C1705654|C0023884|C0012634|C0023884|C0031843|C0022885|C0022877|C1282910|C0439801|C0019664|C0205054|C0020538|C0022646|C0012634|C0229671|C0010294|G0000000|G0000000|C0010294|C0449297|G0000000|C1293116|C1514798|C0086418|G0000000|C0439095|C1135662|G0000000|C0004048|C0040341|G0000000|C0004048|C0038317|G0000000|C0557651|C1705654
Twenty-six of 41 (63%) patients had been seizure-free since surgery (Table 1).,Twenty-six 41 (63%) patients seizure-free surgery (Table 1).,C0724000|C0450371|C0450371|C0030705|C1299590|C0038894|C0039224|G0000000
"Patients were eligible if treated on the ALL-BFM 2000 or AIEOP-BFM ALL 2009 protocol,28–30 if they had a CVC inserted by day 8 of induction and if the CVC remained in place until at least day 33.","Patients eligible treated ALL-BFM 2000 AIEOP-BFM ALL 2009 protocol,28–30 CVC inserted day 8 induction CVC remained day 33.",C0030705|C1548635|C1522326|C0444868|G0000000|G0000000|C0444868|G0000000|G0000000|G0000000|C0441587|C0332173|G0000000|C0205263|G0000000|G0000000|C0332173|C0450371
"Thus, we consider this study as a continuation to the previous one, seeking an effective intervention aimed at all health professionals within a primary care team.","Thus, study continuation previous one, seeking effective intervention aimed health professionals primary care team.",G0000000|C0557651|G0000000|C0205156|C0205447|G0000000|C1280519|C0886296|C1947946|C0018684|C0679924|C0205225|C1947933|C0871489
"This was a double-blind, randomized, controlled study of alanyl-glutamine dipeptide-supplemented parenteral nutrition in SICU patients requiring parenteral nutrition and SICU care after surgery for pancreatic necrosis, cardiac, vascular, or colonic surgery.","This double-blind, randomized, controlled study alanyl-glutamine dipeptide-supplemented parenteral nutrition SICU patients requiring parenteral nutrition SICU care surgery pancreatic necrosis, cardiac, vascular, colonic surgery.",G0000000|C0013072|C0034656|C2587213|C0557651|C0051080|C0012512|C0030547|C0028707|G0000000|C0030705|G0000000|C0030547|C0028707|G0000000|C1947933|C0038894|C0030274|C0027540|C0018787|C0005847|C0009368|C0038894
"When patients complained of pain (VAS ≥4/10), despite the 80–90 mg daily oral morphine, they were submitted to the epidural test drugs and all patients were blind to the treatments.","When patients complained pain (VAS ≥4/10), 80–90 mg daily oral morphine, submitted epidural test drugs patients blind treatments.",G0000000|C0030705|G0000000|C0030193|C0042815|G0000000|G0000000|C0332173|C0442027|C0026549|C1515023|C0228134|C0022885|C0013227|C0030705|C0150108|C0087111
"In addition, women were excluded if they reported current or recent (within the past 3 months) use of the following medications: oral or systemic corticosteroids, hormones (estrogen, progestin, oral contraceptives), herbal or botanical supplements with possible hormonal or EGCG effects, or if they reported use of GnRH analogues or Depo-Provera within the past 6 months.","In addition, women excluded reported current (within 3 months) medications: oral systemic corticosteroids, hormones (estrogen, progestin, oral contraceptives), herbal botanical supplements hormonal EGCG effects, reported GnRH analogues Depo-Provera 6 months.",G0000000|C0332287|C0043210|C1554077|C0684224|C0521116|G0000000|G0000000|C0439231|C0013227|C0442027|C0205373|C0001617|C0019932|C0014939|C0033306|C0442027|C0009871|C3146288|C1456557|C0242295|C0458083|C0059438|C1280500|C0684224|C0023610|C0243071|C0699700|G0000000|C0439231
"In a subgroup analysis, no benefit for adjuvant chemotherapy was seen in the stage IB patients.","In subgroup analysis, benefit adjuvant chemotherapy stage IB patients.",G0000000|C1079230|C0002778|C0814225|C0001551|C0013216|C0205390|C2744579|C0030705
Forty adult female breast cancer survivors who received adjuvant chemotherapy for stage I and II breast cancer were recruited for the study through letters asking for volunteers mailed to survivors from the Comprehensive Breast Program at Dartmouth-Hitchcock Medical Center.,Forty adult female breast cancer survivors received adjuvant chemotherapy stage I II breast cancer recruited study letters volunteers mailed survivors Comprehensive Breast Program Dartmouth-Hitchcock Medical Center.,C3816449|C0001675|C0015780|C0006141|C0006826|C0206194|C1514756|C0001551|C0013216|C0205390|C0021966|G0000000|C0006141|C0006826|G0000000|C0557651|C0282413|C0042960|C0024492|C0206194|C1880156|C0006141|C1709697|G0000000|C0199168|C0205099
Objective To assess the effectiveness of penicillin for three days and treatment for seven days compared with placebo in resolving symptoms in children with sore throat.,Objective To assess effectiveness penicillin days treatment days compared placebo resolving symptoms children sore throat.,C0018017|C0040363|C1516048|C1280519|C0030827|C0439228|C0039798|C0439228|C1707455|C0032042|C3714811|C0683368|C0008059|C0234233|C0031354
"We estimated that at least one group of 15 children per school would meet inclusion criteria after screening, and therefore decided to sample 12 schools per study condition.","We estimated 15 children school meet inclusion criteria screening, decided sample 12 schools study condition.",G0000000|C0750572|C0450371|C0008059|C0036375|C1550543|C0007637|C0243161|C0220908|G0000000|C0370003|C0450371|C0036375|C0557651|C0012634
"Some units were open to the influx of potentially infectious convalescents (hereafter referred to as “open units,” and some were closed to such an influx (hereafter referred to as “closed units”).","Some units influx infectious convalescents (hereafter referred “open units,” closed influx (hereafter referred “closed units”).",G0000000|C0439148|G0000000|C0009450|C0740326|G0000000|C0205543|G0000000|G0000000|C0587267|G0000000|G0000000|C0205543|G0000000|G0000000
"Excluded were patients younger than 16 years, those whose injury had occurred more than 8 hours before the call to emergency medical services and those who were pronounced dead at the scene.","Excluded patients 16 years, injury occurred 8 hours call emergency medical services pronounced dead scene.",C1554077|C0030705|C0450371|C0439234|C3263722|C1709305|G0000000|C0439227|C0679006|C0013956|C0199168|C0557854|G0000000|C0011065|G0000000
Anaemia is common in patients undergoing major surgery.,Anaemia common patients undergoing major surgery.,C0002871|C0205214|C0030705|G0000000|C0205082|C0038894
"Potential participants were excluded by their general practitioner if they lived in a care home were in receipt of end of life care or by researchers if they were already attending a falls prevention programme were unwilling or unable to attend a falls prevention programme were unable to provide informed consent or assent had interventions  Eligible participants in both arms received a falls prevention information leaflet (‘Avoiding slips, trips and broken hips’ [7]).","Potential participants excluded practitioner lived care receipt life care researchers attending falls prevention programme unwilling unable attend falls prevention programme unable provide informed consent assent interventions Eligible participants arms received falls prevention leaflet (‘Avoiding slips, trips broken hips’ [7]).",C3245505|C0679646|C1554077|C1709627|C1548795|C1947933|G0000000|C0376558|C1947933|C0035173|C1547429|C0000921|C0199176|C1709697|C0558080|C1299582|C1999232|C0000921|C0199176|C1709697|C1299582|C1999230|C1522154|C1511481|C1879749|C0886296|C1548635|C0679646|C0206655|C1514756|C0000921|C0199176|C1708664|G0000000|C0337209|C0221188|C1881704|G0000000|G0000000
"All consenting women presenting for urinalysis at the University of Michigan Health Service laboratory with symptoms of UTI between August 2005 and October 2007 were eligible for enrollment in the study if they were 18–40 years of age, had ≥3 urinary symptoms (painful and frequent urination, and report of either urgency, hematuria, or supra-pubic pressure), and would be in Ann Arbor for the next 6 months.","All consenting women urinalysis University Michigan Health Service laboratory symptoms UTI August 2005 October 2007 eligible enrollment study 18–40 age, ≥3 urinary symptoms (painful frequent urination, report urgency, hematuria, supra-pubic pressure), Ann Arbor 6 months.",G0000000|C1511481|C0043210|C0042014|C0041740|C0025939|C0018684|C0557854|C0022877|C0683368|C0042029|C3831448|G0000000|C3828732|G0000000|C1548635|C1516879|C0557651|G0000000|C0001779|G0000000|C0042027|C0683368|C0030193|C0332183|C0042034|C0684224|C0439609|C0018965|C1282910|C0033095|G0000000|G0000000|G0000000|C0439231
Women in case group participated in delivery preparation classes since 20 weeks of pregnancy for 8 sessions.,Women participated delivery preparation classes 20 weeks pregnancy 8 sessions.,C0043210|G0000000|C0011209|C1521827|C0456387|C0450371|C0439230|C0032961|G0000000|C1883016
"Median age was 58 years (GemVin), 60 years (gemcitabine plus cisplatin, GemCis) and 60 years (GemCap), respectively.","Median age 58 (GemVin), 60 (gemcitabine cisplatin, GemCis) 60 (GemCap), respectively.",C0549183|C0001779|C0450371|G0000000|C0450371|C0045093|C0008838|G0000000|C0450371|G0000000|G0000000
"Patients were excluded if they were taking another supplement; had progressive forms of MS; had history of severe depression; had history of acute liver or renal dysfunction; had history of tobacco, drug, or alcohol abuse; had intolerance, contraindication, or allergy to fish oil; and had customary antioxidant intake.","Patients excluded supplement; progressive forms MS; history severe depression; history acute liver renal dysfunction; history tobacco, drug, alcohol abuse; intolerance, contraindication, allergy fish oil; customary antioxidant intake.",C0030705|C1554077|C0242295|C0205329|C0348078|C0039676|C0019664|C0205082|C0011570|C0019664|C0205178|C0023884|C0022646|C0031847|C0019664|C0040329|C0013227|C0001962|C0013146|C0231199|C0522473|C0002111|C0016163|C0028908|C3242380|C0003402|C1512806
* Rates of adverse events were similar in the randomized groups and were generally higher among women in the observational group (Table 3).,* Rates adverse events randomized women observational (Table 3).,G0000000|C0871208|G0000000|C0441471|C0034656|C0043210|C1518527|C0039224|G0000000
A question regarding history of PD was first asked in 1988 in men and 1994 in women and then updated biennially and ascertainment in these cohorts has been previously described6.,A question history PD 1988 1994 women updated biennially ascertainment cohorts described6.,G0000000|C1522634|C0019664|G0000000|G0000000|G0000000|C0043210|C1519814|G0000000|G0000000|C0599755|G0000000
"Patients were excluded if (i) they had a history of psychiatric disease or symptoms, including depressive disorders; (ii) adverse interactions between modafinil and other prescribed medications were expected (eg, decreased effectiveness of oral contraceptives, levonorgestrel-releasing intrauterine systems and antidepressants, fluctuations in the effectiveness of antiepileptic drugs acting on similar enzymes); (iii) they were unable to communicate in Dutch.","Patients excluded (i) history psychiatric disease symptoms, including depressive disorders; (ii) adverse interactions modafinil prescribed medications expected (eg, decreased effectiveness oral contraceptives, levonorgestrel-releasing intrauterine systems antidepressants, fluctuations effectiveness antiepileptic drugs acting enzymes); (iii) unable communicate Dutch.",C0030705|C1554077|C0021966|C0019664|C0205487|C0012634|C0683368|C0332257|G0000000|C0012634|G0000000|G0000000|C1704675|C0066677|C0278329|C0013227|C1517001|C0013715|C0205216|C1280519|C0442027|C0009871|C0023566|C0694756|C0449913|C0003289|C0231239|C1280519|C0003299|C0013227|G0000000|C0014442|C0439070|C1299582|C0566001|C0013331
"Children with SCD between the ages of 6 and 12, from primarily English-speaking families, receiving follow-up care at one of two comprehensive sickle cell clinics in children’s hospitals in a northeastern city were included.","Children SCD ages 6 12, English-speaking families, receiving follow-up care comprehensive sickle cell clinics children’s hospitals northeastern city included.",C0008059|G0000000|C0001779|G0000000|C0450371|C0376245|C0015576|C1514756|C0589120|C1947933|C1880156|G0000000|C0007634|C0442592|G0000000|C0019994|C1709272|C0008848|C0332257
Adolescents were eligible if they were African American or Latino and enrolled in grade 6 or 7.,Adolescents eligible African American Latino enrolled grade 6 7.,C0205653|C1548635|C0027567|C0596070|C0086528|G0000000|C0441800|G0000000|G0000000
"Study subjects were enrolled 4 weeks prior to receiving the first intervention, and were subsequently excluded from analysis if diagnosed with clinical malaria or they died or out-migrated from the study area within that 4-week period.","Study subjects enrolled 4 weeks prior receiving intervention, subsequently excluded analysis diagnosed clinical malaria died out-migrated study 4-week period.",C0557651|C0681850|G0000000|G0000000|C0439230|C0332152|C1514756|C0886296|G0000000|C1554077|C0002778|C0011900|C0205210|C0024530|C0011065|C0439787|C0557651|C0332174|C0439531
The objective of this study was to investigate the efficacy and tolerability of sumatriptan 50 mg vs. placebo in migraine patents with infrequent migraine attacks when medication is taken during the mild phase of an attack.,The objective study investigate efficacy tolerability sumatriptan 50 vs. placebo migraine patents infrequent migraine attacks medication mild phase attack.,G0000000|C0018017|C0557651|C1292732|C1280519|C3274448|C0075632|C0450371|G0000000|C0032042|C0149931|C0030650|C0521114|C0149931|C1261512|C0013227|C2945599|C0205390|C0277793
"3,236 students participated in at least one survey, with 48% males, 52% females and a mean age at baseline of 12.4 years (SD=0.6); 75% were European-American, 11.5% African-American, and 13.5% of other racial backgrounds.","3,236 students participated survey, 48% males, 52% females age baseline 12.4 (SD=0.6); 75% European-American, 11.5% African-American, 13.5% racial backgrounds.",C1442061|C0038492|G0000000|C0038951|C0450371|C0086582|C0450371|C0015780|C0001779|C0168634|C0450371|G0000000|C0450371|C0683983|C0450371|C0085756|C0450371|C0034510|C1706907
Acquisition costs of pulmonary drugs from the NHS perspective were based on public prices and calculated as the ex-factory prices multiplied by a mark-up of 1.596 to convert these prices to public prices [27].,Acquisition costs pulmonary drugs NHS perspective based public prices calculated ex-factory prices multiplied mark-up 1.596 convert prices public prices [27].,C1706701|C0010186|C0024109|C0013227|C0796085|G0000000|C1527178|G0000000|C0080045|C0444686|C1704625|C0080045|C1719797|C1552817|C1442061|G0000000|C0080045|G0000000|C0080045|C0450371
Acupuncture is used widely in the prevention and treatment of migraine.,Acupuncture prevention treatment migraine.,C0001299|C0199176|C0039798|C0149931
A prospective randomised clinical study of 91 VLBW infants was also completed and these infants were followed up for three years.,A prospective randomised clinical study 91 VLBW infants completed infants years.,G0000000|C0023981|G0000000|C0205210|C0557651|C0450371|C0282666|C0021270|C0205197|C0021270|C0439234
"gambiae s.s [25,26].","gambiae s.s [25,26].",G0000000|C0565930|C0450371
"The inclusion criterion was: children aged 3–60 months requiring admission for severe acute gastroenteritis, as evidenced by a Vesikari score of >11 (figures 1 and and2)2) with written parental consent.12 13 The Vesikari clinical severity scoring system parameters and scores.","The inclusion criterion was: children aged 3–60 months requiring admission severe acute gastroenteritis, evidenced Vesikari score >11 (figures 1 and2)2) written parental consent.12 13 The Vesikari clinical severity scoring system parameters scores.",G0000000|C0007637|C0243161|G0000000|C0008059|C0001779|G0000000|G0000000|C0184666|C0205082|C0205178|C0017160|C3887511|G0000000|C0449820|C0450371|G0000000|G0000000|G0000000|C0043266|C0030551|C1511481|C0450371|G0000000|G0000000|C0205210|C0439793|C0449820|C0449913|C0449381|C0449820
"Excluded were individuals with (1) current use of selective serotonin reuptake inhibitor (e.g., fluoxetine), venlafaxine, duloxetine or mirtazapine; (2) past or current use of milnacipran; (3) current use of tricyclics ≥100 mg per day; (4) uncontrolled hypertension; (5) active suicidal ideation; (6) planned elective surgery during the study period; (7) ongoing unresolved disability claims; (8) inflammatory rheumatic conditions (e.g., rheumatoid arthritis); (9) active psychosis; (10) pregnancy; and (11) previous CBT for pain-related issues.","Excluded individuals (1) current selective serotonin reuptake inhibitor (e.g., fluoxetine), venlafaxine, duloxetine mirtazapine; (2) current milnacipran; (3) current tricyclics ≥100 day; (4) uncontrolled hypertension; (5) active suicidal ideation; (6) planned elective surgery study period; (7) ongoing unresolved disability claims; (8) inflammatory rheumatic conditions (e.g., rheumatoid arthritis); (9) active psychosis; (10) pregnancy; (11) previous CBT pain-related issues.",C1554077|C0027361|G0000000|C0521116|C0036576|C0036751|C0599702|C1999216|G0000000|C0016365|C0078569|C0245561|C0049506|G0000000|C0521116|C1533126|G0000000|C0521116|C0003290|G0000000|C0332173|G0000000|C0205318|C0020538|G0000000|C0205177|C0438696|C0392348|G0000000|C1301732|C0206058|C0038894|C0557651|C0439531|G0000000|C0549178|C0443342|C0231170|G0000000|G0000000|C0333348|G0000000|C0012634|G0000000|G0000000|C0003864|G0000000|C0205177|C0033975|C0450371|C0032961|C0450371|C0205156|C0009244|C0030193|C0033213
"Nineteen patients (nine men and 10 women) with mean (SEM) age of 45 (3) years, FEV1 of 90 (4) % predicted and FEF25–75 of 66 (5) % predicted completed the study per protocol.","Nineteen patients (nine 10 women) (SEM) age 45 (3) years, FEV1 90 (4) % predicted FEF25–75 66 (5) % predicted completed study protocol.",C0450337|C0030705|C0205455|C0450371|C0043210|G0000000|C0001779|C0450371|G0000000|C0439234|G0000000|C0450371|G0000000|G0000000|C0681842|G0000000|C0450371|G0000000|G0000000|C0681842|C0205197|C0557651|C0442711
"Participants were eligible for the study if they had documented HIV infection, had a CD4 cell count greater than 350/μL and they were ART-naive; other requirements were a body mass index (BMI) greater than 18 for women and 18.5 for men (calculated as weight in kilograms divided by height in meters squared), age of 18 years or older, no current AIDS-defining conditions or history of AIDS-defining conditions, and no history of endocrine or psychiatric disorders.","Participants eligible study documented HIV infection, CD4 cell count 350/μL ART-naive; requirements body mass (BMI) 18 women 18.5 (calculated weight kilograms divided height meters squared), age 18 older, current AIDS-defining conditions history AIDS-defining conditions, history endocrine psychiatric disorders.",C0679646|C1548635|C0557651|C1301725|C0019682|C0009450|C0285590|C0007634|C0750480|G0000000|C0003826|C1514873|C0242821|C0577559|G0000000|C0450371|C0043210|C0450371|C0444686|C0005910|C0439209|C0332849|C0489786|C0441074|C0205120|C0001779|C0450371|C0580836|C0521116|C0001175|C0012634|C0019664|C0001175|C0012634|C0019664|C0014136|C0205487|C0012634
"The Posttraumatic Stress Diagnostic Scale (PDS) was used to identify if patients reported the minimum number of symptoms required by DSM-IV for each of the symptom clusters (at least 1 intrusion, 3 avoidance, and 2 hyperarousal symptoms).","The Posttraumatic Stress Diagnostic Scale (PDS) identify patients reported minimum symptoms required DSM-IV symptom clusters (at 1 intrusion, 3 avoidance, 2 hyperarousal symptoms).",G0000000|G0000000|C0038435|C0011900|C0175659|G0000000|G0000000|C0030705|C0684224|C1524031|C0683368|C1514873|C0220952|C1457887|C1555715|G0000000|G0000000|C2825978|G0000000|C0870186|G0000000|G0000000|C0683368
"Male or female, aged 40–75 years Inpatients with UUI after stroke, according to the diagnosis criteria of the American Stroke Association and the ICS 4th to 48th week after stroke onset Normal consciousness, communication ability and recognition Written informed consent.","Male female, aged 40–75 years Inpatients UUI stroke, diagnosis criteria American Stroke Association ICS 4th 48th week stroke onset Normal consciousness, communication ability recognition Written informed consent.",C0086582|C0015780|C0001779|G0000000|C0021562|G0000000|C0038454|C0011900|C0243161|C0596070|C0038454|C0004083|C0022521|G0000000|G0000000|C0332174|C0038454|C0206132|C0205307|C0009791|C0009452|C0085732|C0524637|C0043266|C1522154|C1511481
"The number of newborns with a gestational age ≥ 34 weeks or birth weight ≥ 2.0 kg was 22,546, which included 7891 born by cesarean section and 14,655 born by vaginal delivery.","The newborns gestational age ≥ 34 weeks birth weight ≥ 2.0 22,546, included 7891 born cesarean 14,655 born vaginal delivery.",G0000000|C0021289|C0439671|G0000000|C0439230|C0005615|G0000000|C0450371|C0332257|G0000000|C0005615|C3841297|C0450371|C0005615|C0042232|C0011209
"There was no significant difference between the two groups regarding mothers’ BMI and age, and weight, height and head circumference of infants at the beginning of the study (Table 1).","There difference mothers’ BMI age, weight, height head circumference infants study (Table 1).",G0000000|C1705241|G0000000|G0000000|C0001779|C0005910|C0489786|C0018670|C0332520|C0021270|C0557651|C0039224|G0000000
"The following randomized, blinded, prospective clinical study was conducted to investigate the potential benefits of using the Step radially expanding needle compared to conventional trocars and to confirm the findings of the previous studies.2,3,6 The Step devices are FDA-approved and are commercially available.","The randomized, blinded, prospective clinical study conducted investigate potential benefits Step radially expanding needle compared conventional trocars confirm findings previous studies.2,3,6 The Step devices FDA-approved commercially available.",G0000000|C0034656|C0150108|C0023981|C0205210|C0557651|C0004927|C1292732|C3245505|C0814225|C1261552|G0000000|C0205229|C0027551|C1707455|C0439858|C0041158|C0521093|C2607943|C0205156|C0947630|G0000000|C1261552|C0025080|C0041714|G0000000|C0470187
Use of current medication was permitted during the testing sessions in order to obtain accurate baseline information on how the child interacted in usual circumstances.,Use current medication permitted testing sessions accurate baseline child interacted usual circumstances.,C0042153|C0521116|C0013227|C0329040|C0039593|C1883016|C0443131|C0168634|C0008059|G0000000|C3538928|G0000000
It is feasible to improve the liver disease–associated deficiency of AA or DHA with modest intakes of AA and DHA.,It feasible improve liver disease–associated deficiency AA DHA modest intakes AA DHA.,G0000000|G0000000|G0000000|C0023884|G0000000|C0011155|C0282379|C0142831|C4054480|C1512806|C0282379|C0142831
"Following approval by our Institutional Review Board, participants were recruited through notices in local newspapers and Web sites, fliers in physician offices, community sites, and support groups.","Following approval Institutional Review Board, participants recruited notices local newspapers Web sites, fliers physician offices, community sites, support groups.",C0231290|C0205540|C0018704|C0282443|C0972401|C0679646|G0000000|G0000000|C0205276|C0027989|C0282111|C0205145|C0328806|C0031831|C0442603|C0009462|C0205145|C0183683|C0441833
Inclusion criteria: adults (aged 18 years or older) admitted to the intensive care unit with cirrhosis and an indication for central venous line insertion.,Inclusion criteria: adults (aged 18 older) admitted intensive care unit cirrhosis indication central venous insertion.,C0007637|C0243161|C0001675|C0001779|C0450371|C0580836|C0184666|C0162425|C1947933|C0439148|C0023890|C0392360|C0205099|C0042449|C0021107
"Women aged 18–25 years from Jiangsu province were randomized (1:1) to receive HPV vaccine (n = 3,026) or Al(OH)3 control (n = 3,025) at months 0, 1 and 6.","Women aged 18–25 Jiangsu province randomized (1:1) receive HPV vaccine (n = 3,026) Al(OH)3 control (n = 3,025) months 0, 1 6.",C0043210|C0001779|G0000000|G0000000|C1514578|C0034656|G0000000|C1514756|C0021344|C0042210|G0000000|C0202311|C0243148|G0000000|C0439231|G0000000|G0000000|G0000000
"One hundred fifty-seven subjects were randomly assigned to treatment groups, but because of technical difficulties, actigraph data from only 151 subjects were available for inclusion in the intent-to-treat analysis.","One fifty-seven subjects randomly assigned treatment groups, technical difficulties, actigraph data 151 subjects inclusion intent-to-treat analysis.",C0205447|C3816723|C0681850|G0000000|C1516050|C0039798|C0441833|C0449851|C1299586|C1139952|C1511726|C1442061|C0681850|C0007637|C0162425|C0002778
Results 744 participants in TOHP I and 2382 in TOHP II were randomised to a sodium reduction intervention or control.,Results 744 participants TOHP I 2382 TOHP II randomised sodium reduction intervention control.,C1274040|C1442061|C0679646|G0000000|C0021966|G0000000|G0000000|G0000000|G0000000|C0037473|C0301630|C0886296|C0243148
Women who undergo radiotherapy for gynaecological cancer (GC) can experience distressing side effects which impact on psychosocial functioning and intimate relationships.,Women undergo radiotherapy gynaecological cancer (GC) experience distressing effects impact psychosocial functioning intimate relationships.,C0043210|G0000000|C0034619|C0018417|C0006826|C3537453|C0237607|C0231303|C1280500|C1825598|C0542298|C0205245|C0699756|C0439849
The physicians who participated in this study (a trial of aspirin for prevention of cardiovascular disease and cancer) were particularly motivated to report NSAID use accurately.,The physicians participated study (a trial aspirin prevention cardiovascular disease cancer) motivated report NSAID accurately.,G0000000|C0031831|G0000000|C0557651|G0000000|C0008976|C0004057|C0199176|C0007226|C0012634|C0006826|G0000000|C0684224|C0003211|G0000000
"The range of scores for each question is from one to five points and for the total score is between 3 and 15; the score ≤ 6 indicates mild nausea, 7-12 moderate nausea and vomiting, and ≥ 13 indicates the severe type (13).","The range scores question total score 3 15; score ≤ 6 mild nausea, 7-12 moderate nausea vomiting, ≥ 13 severe type (13).",G0000000|C1514721|C0449820|C1522634|C0439175|C0449820|G0000000|C0450371|C0449820|G0000000|G0000000|C2945599|C0027497|C0450371|C0205081|C0027497|C0042963|G0000000|C0450371|C0205082|C0332307|C0450371
Fever of unknown origin occurred in 51% of the cooked group and 36% of the raw group.,Fever unknown origin occurred 51% cooked 36% raw group.,C0015967|C0439673|C0079946|C1709305|C0450371|C0335326|C0450371|C0001884|C0441833
Contralateral prophylactic mastectomy was associated with improved breast cancer–specific survival.,Contralateral prophylactic mastectomy improved breast cancer–specific survival.,C0441988|C0355642|C0024881|C0184511|C0006141|G0000000|C0038952
"Participants will be eligible if they are: age 18–65 years; smoke at least 5 cigarettes per day; less than 3 months abstinence in the past year; own an iPhone (https://www.apple.com/iphone/) or Android (https://www.android.com/intl/en_us/); and are motivated to quit, as indicated by a score of at least 9 of 10 on the Contemplation Ladder [28], and at least 4 of 5 on one item of the Action subscale of the Readiness to Change Questionnaire [29].","Participants eligible are: age 18–65 years; smoke 5 cigarettes day; 3 months abstinence year; iPhone (https://www.apple.com/iphone/) Android (https://www.android.com/intl/en_us/); motivated quit, score 9 10 Contemplation Ladder [28], 4 5 item Action subscale Readiness Change Questionnaire [29].",C0679646|C1548635|G0000000|C0001779|G0000000|C0439234|C0037366|G0000000|C0677453|C0332173|G0000000|C0439231|C3843422|C0439234|G0000000|C1555015|C0336541|C1555015|G0000000|C0748223|C0449820|G0000000|C0450371|G0000000|C0336762|C0450371|G0000000|G0000000|C1551338|C0441472|G0000000|C1318963|C0392747|C0034394|C0450371
"Sixteen consecutive patients with stable CHF (15 men, mean (SEM) age 61 (2.2), range 38–75 years, mean left ventricular ejection fraction 35.3%, range 16–45%) undergoing cardiopulmonary exercise testing were recruited.","Sixteen consecutive patients stable CHF (15 men, (SEM) age 61 (2.2), range 38–75 years, left ventricular ejection fraction 35.3%, range 16–45%) undergoing cardiopulmonary exercise testing recruited.",C3715157|C1707491|C0030705|C0205360|C0018802|C0450371|C0025266|G0000000|C0001779|C0450371|G0000000|C1514721|G0000000|C0439234|C0205091|C0018827|C0302131|C1264633|C0450371|C1514721|G0000000|G0000000|C0553534|C0015259|C0039593|G0000000
"Specific inclusion criteria were: 1) one-time stroke in the LH; 2) > 6-months post-stroke onset; 3) < 85-years of age; 4) pre-morbidly right-handed; 5) native English speaker; and 6) been a participant in a previous study that included functional magnetic resonance imaging (fMRI) examination,4 which was used to guide the location of cortical stimulation in the present study.","Specific inclusion criteria were: 1) one-time stroke LH; 2) > 6-months post-stroke onset; 3) < 85-years age; 4) pre-morbidly right-handed; 5) native English speaker; 6) participant previous study included functional magnetic resonance imaging (fMRI) examination,4 guide location cortical stimulation study.",C0205369|C0007637|C0243161|G0000000|G0000000|C3241998|C0038454|C0023879|G0000000|G0000000|C0439231|C0687676|C0206132|G0000000|G0000000|C0450371|C0001779|G0000000|C0332152|C0230370|G0000000|C0302891|C0376245|C1707716|G0000000|C0679646|C0205156|C0557651|C0332257|C0205245|C0024488|C0231881|C0011923|C0376335|G0000000|C0181090|C0450429|C0001613|C1292856|C0557651
"Stool consistency was evaluated through a score system, as previously described,15 and faeces were graded as 1 (normal), 2 (loose), 3 (semiliquid), and 4 (liquid).","Stool consistency evaluated score system, described,15 faeces graded 1 (normal), 2 (loose), 3 (semiliquid), 4 (liquid).",C0015733|C0332529|C0220825|C0449820|C0449913|C1552738|C0015733|C0441800|G0000000|C0205307|G0000000|C0205407|G0000000|G0000000|G0000000|C0301571
"The inclusion criteria for the primary caregivers include: (1) being defined as primary caregivers by patients during inpatient rehabilitation, including family members, friends, employed nursing aides, and foreign caregivers; (2) willing to participate in supervising and guiding the patients’ VR training; and (3) capable of communicating in Mandarin Chinese or Taiwanese.","The inclusion criteria primary caregivers include: (1) defined primary caregivers patients inpatient rehabilitation, including family members, friends, employed nursing aides, foreign caregivers; (2) participate supervising guiding patients’ VR training; (3) capable communicating Mandarin Chinese Taiwanese.",G0000000|C0007637|C0243161|C0205225|C0085537|C0332257|G0000000|C1704788|C0205225|C0085537|C0030705|C0021562|C0034991|C0332257|C0015576|C0680022|C0079382|C0014003|C0006147|C1907758|C0376327|C0085537|G0000000|G0000000|G0000000|C0181090|G0000000|C3476815|C0040607|G0000000|C2698977|C0205196|G0000000|C0008120|C1556096
"Study sites were located at 4 inner-city hospitals in New York City, NY, Baton Rouge, La, Chicago, Ill, and Miami, Fla. We selected the sites from an existing research network of EDs,8 based on the size of the uninsured pediatric population and the absence of significant SCHIP outreach efforts.","Study sites located 4 inner-city hospitals New York City, NY, Baton Rouge, La, Chicago, Ill, Miami, Fla. We selected sites existing network EDs,8 based size uninsured pediatric population absence SCHIP outreach efforts.",C0557651|C0205145|G0000000|G0000000|C0557849|C0019994|C0205314|G0000000|C0008848|C0027976|G0000000|G0000000|C0023031|C0008044|C0231218|C1551421|G0000000|G0000000|C1707391|C0205145|C2987476|C0150775|G0000000|C1527178|C0456389|C0087134|C0030755|C0032659|C0332197|G0000000|C0683805|C0015264
"Predictor variables included gender, age, months on ART, ARV regimen, body mass index (BMI), haemoglobin and CD4 count at down-referral eligibility(Appendix 1).","Predictor variables included gender, age, months ART, ARV regimen, body mass (BMI), haemoglobin CD4 count down-referral eligibility(Appendix 1).",C2698872|C0439828|C0332257|C0079399|C0001779|C0439231|C0003826|G0000000|C0040808|C0242821|C0577559|G0000000|C0019046|C0285590|C0750480|C0034927|C0013893|G0000000
"Conclusion: Adding high dose vitamin D3 supplementation during pregnancy to routine care of women with MS had significant effect on the serum 25(OH)D levels, EDSS and number of relapse events during pregnancy and within 6 months after delivery.","Conclusion: Adding dose vitamin D3 supplementation pregnancy routine care women MS serum 25(OH)D levels, EDSS relapse events pregnancy 6 months delivery.",C1707478|C1883712|C0178602|C0042890|C3538936|C0242297|C0032961|C0205547|C1947933|C0043210|C0039676|C0229671|C0450371|C0441889|C0451246|C0035020|C0441471|C0032961|G0000000|C0439231|C0011209
"In a prospective one-blinded clinical trial, 86 patients were selected who referred to Al-Zahra Hospital Dermatology Clinic and Isfahan Skin Research Center within the second 6 months of 2010 (project no.","In prospective one-blinded clinical trial, 86 patients selected referred Al-Zahra Hospital Dermatology Clinic Isfahan Skin Research Center 6 months 2010 (project no.",G0000000|C0023981|C0205447|C0205210|C0008976|C0450371|C0030705|C1707391|C0205543|C0202311|C0019994|C0011627|C0002424|G0000000|C0444099|C0035168|C0205099|G0000000|C0439231|G0000000|C1709701|G0000000
"If household smokers were reported to be in the home, then parents would be further questioned as to whether the patient experienced ETS exposure in the home or car setting.","If household smokers reported home, parents questioned patient experienced ETS exposure car setting.",G0000000|C0020052|C0337664|C0684224|C0442519|C0030551|C1522634|C0030705|C0237607|G0000000|C0274281|C0004381|C0542559
Patients following alternative/complementary diets or taking high dose antioxidant supplements.,Patients alternative/complementary diets dose antioxidant supplements.,C0030705|C1523987|C0012155|C0178602|C0003402|C0242295
Sixty adult patients who required subclavian venous catheterization for neurosurgery were enrolled in this prospective randomized controlled study.,Sixty adult patients required subclavian venous catheterization neurosurgery enrolled prospective randomized controlled study.,C3816724|C0001675|C0030705|C1514873|C0589488|C0042449|C0007430|C0027926|G0000000|C0023981|C0034656|C2587213|C0557651
Our purpose is to describe the design and methods of the MAGIC (Medication Adherence Given Individual SystemCHANGE™) trial We report the design of a randomized controlled trial with an attention-control group to test an innovative 6-month SystemCHANGE™ intervention designed to enhance immunosuppressive medication adherence in adult non-adherent kidney transplant recipients from two transplant centers.,Our purpose design methods MAGIC (Medication Adherence Given Individual SystemCHANGE™) trial We report design randomized controlled trial attention-control test innovative 6-month SystemCHANGE™ intervention designed enhance immunosuppressive medication adherence adult non-adherent kidney transplant recipients transplant centers.,G0000000|C1285529|C1707689|C0025663|C0024460|C0013227|C1510802|C1442162|C0027361|G0000000|C0008976|G0000000|C0684224|C1707689|C0034656|C2587213|C0008976|C0004268|C0022885|C0683243|C0332177|G0000000|C0886296|C1707689|C2349975|C0021081|C0013227|C1510802|C0001675|C1518422|C0022646|C0040732|C1709854|C0040732|C0205099
"Of the original 367 children who met the criteria, 17 were absent at the time of enrolment, and 14 were excluded because they had infections with fever on the day of enrolment.","Of original 367 children met criteria, 17 absent time enrolment, 14 excluded infections fever day enrolment.",G0000000|C0205313|C1442061|C0008059|C0268621|C0243161|C0450371|C0332197|C0040223|C1516879|C0450371|C1554077|C3714514|C0015967|C0332173|C1516879
"Inclusion criteria in the study included alertness, verbal, subjective, visual and hearing ability, absence of pain and physiological needs (thirst, need for excretion) before injection.","Inclusion criteria study included alertness, verbal, subjective, visual hearing ability, absence pain physiological (thirst, excretion) injection.",C0007637|C0243161|C0557651|C0332257|C1443086|C0439824|C0439655|C0234621|C0018767|C0085732|C0332197|C0030193|C0205463|C0039971|C0221102|C0021485
METHODS: Ten patients (seven men) of mean (SE) age 22 (4) years and mean forced expiratory volume in one second (FEV1) 52.0 (6.7)% predicted completed the study.,METHODS: Ten patients (seven men) (SE) age 22 (4) forced expiratory volume (FEV1) 52.0 (6.7)% predicted completed study.,C0025663|C0014518|C0030705|C0205453|C0025266|C0036919|C0001779|C0450371|G0000000|C0441722|C0231800|C0449468|G0000000|C0450371|G0000000|C0681842|C0205197|C0557651
Six patients in the moxifloxacin group and six in the comparator group underwent laparoscopy.,Six patients moxifloxacin comparator underwent laparoscopy.,C0205452|C0030705|C0536495|C1707454|G0000000|C0031150
One patient in the cerebrolysin group and two patients in the placebo group died before day 30 (4.3% versus 8.7%).,One patient cerebrolysin patients placebo died day 30 (4.3% versus 8.7%).,C0205447|C0030705|C0055108|C0030705|C0032042|C0011065|C0332173|C0450371|G0000000|G0000000|G0000000
"In an initial, randomized controlled study on elderly subjects with increased dementia risk (mild cognitive impairment according to 2004 Petersen criteria), we showed that high-dose B-vitamin treatment (folic acid 0.8 mg, vitamin B6 20 mg, vitamin B12 0.5 mg) slowed shrinkage of the whole brain volume over 2 y.","In initial, randomized controlled study elderly subjects increased dementia risk (mild cognitive impairment 2004 Petersen criteria), high-dose B-vitamin treatment (folic acid 0.8 mg, vitamin B6 20 mg, vitamin B12 0.5 mg) slowed shrinkage brain volume 2 y.",G0000000|C0205265|C0034656|C2587213|C0557651|C0001792|C0681850|C0205217|C0011265|C0035647|C2945599|C1516691|C0221099|G0000000|G0000000|C0243161|C0444956|C1704763|C0039798|G0000000|C0001128|G0000000|C0026410|C0042890|C0005558|C0450371|C0026410|C0042890|G0000000|G0000000|C0026410|C0439834|C0332513|C0006104|C0449468|G0000000|G0000000
Secondary endpoints are change in FEV1% predicted and change in BMI-Z-score.,Secondary endpoints change FEV1% predicted change BMI-Z-score.,C0027627|C2349179|C0392747|G0000000|C0681842|C0392747|C0871421
Children whose family’s non-model for health extension programme were more likely to develop diarrhoea when compared to children whose families were model for health extension programme.,Children family’s non-model health extension programme develop diarrhoea compared children families model health extension programme.,C0008059|G0000000|C1518422|C0018684|C0231448|C1709697|G0000000|C0011991|C1707455|C0008059|C0015576|C3161035|C0018684|C0231448|C1709697
All participants had a diagnosis of idiopathic PD (Hoehn and Yahr (H&Y) stages of I-III) using diagnostic criteria for clinically defined “definite PD” 22 and demonstrated clear benefit from levodopa.,All participants diagnosis idiopathic PD (Hoehn Yahr (H&Y) stages I-III) diagnostic criteria clinically defined “definite PD” 22 demonstrated benefit levodopa.,G0000000|C0679646|C0011900|C0332240|G0000000|G0000000|G0000000|C0033727|C1306673|C0021966|C0011900|C0243161|G0000000|C1704788|G0000000|G0000000|C0450371|G0000000|C0814225|C0023570
"Follow-up started at the examination in 1970-74 at age 50 and the censoring date for the present study was December 31, 2003, with a mean of 26.5 years of observation for the full cohort of 2045 men (54243 person years) and a mean of 31.1 years of observation for the genotyped 1005 men (31290 person years).","Follow-up started examination 1970-74 age 50 censoring study December 31, 2003, 26.5 observation cohort 2045 (54243 person years) 31.1 observation genotyped 1005 (31290 person years).",C0589120|C1272689|G0000000|C0450371|C0001779|C0450371|C3889990|C0557651|C3830550|C0450371|G0000000|C0450371|C0302523|C0599755|G0000000|G0000000|C0027361|C0439234|C0450371|C0302523|C0017431|G0000000|G0000000|C0027361|C0439234
200 patients were randomised to either intervention or control.,200 patients randomised intervention control.,C1442061|C0030705|G0000000|C0886296|C0243148
Controls were selected among patients admitted for acute conditions to the Emergency Department of the same hospital as cases.,Controls selected patients admitted acute conditions Emergency Department hospital cases.,C0243148|C1707391|C0030705|C0184666|C0205178|C0012634|C0013956|C1704729|C0019994|C0868928
"In addition, 100 females between the ages of 9–12 y were randomized in a 4:1 ratio to receive either qHPV vaccine (n = 80) or placebo (n = 20).","In addition, 100 females ages 9–12 randomized 4:1 ratio receive qHPV vaccine (n = 80) placebo (n = 20).",G0000000|C0332287|C1442061|C0015780|C0001779|G0000000|C0034656|G0000000|C0456603|C1514756|G0000000|C0042210|C0369718|G0000000|C0450371|C0032042|C0369718|G0000000|C0450371
We were not able to demonstrate a statistically significant effect of LF on the rate of first late-onset sepsis episodes in infants with a birth weight < 2500g.,We demonstrate statistically LF rate late-onset sepsis episodes infants birth weight < 2500g.,G0000000|G0000000|C0038215|C1416933|C0871208|C4025592|C0036690|C0332189|C0021270|C0005615|C0005910|G0000000|G0000000
"Children aged 2–10 years, who were referred by their primary care pediatricians or by pediatric otolaryngologists and who underwent overnight sleep studies for suspected OSA, were identified.","Children aged 2–10 years, referred primary care pediatricians pediatric otolaryngologists underwent overnight sleep studies suspected OSA, identified.",C0008059|C0001779|G0000000|C0439234|C0205543|C0205225|C1947933|C0237433|C0030755|C0260087|G0000000|C0439583|C0037313|C0947630|C0332147|C0520679|C0205396
The original ROLO trial had appropriate ethics approval from the National Maternity Hospital Ireland.,The original ROLO trial ethics approval National Maternity Hospital Ireland.,G0000000|C0205313|G0000000|C0008976|C0015000|C0205540|C3245503|C0681108|C0019994|C0022067
"Women had to be physically able to exercise (ie, not be in a wheelchair or use a cane), agree to be randomly assigned, and give informed consent to participate in all study activities.","Women physically exercise (ie, wheelchair cane), agree randomly assigned, informed consent participate study activities.",C0043210|G0000000|C0015259|G0000000|C0043143|C0006856|C3641827|G0000000|C1516050|C1522154|C1511481|G0000000|C0557651|C0441655
The Tango group improved while those within Waltz/Foxtrot did not change and the Control group worsened.,The Tango improved Waltz/Foxtrot change Control worsened.,G0000000|C1332116|C0184511|G0000000|C0392747|C0243148|C1457868
"Exclusion criteria for the study were: a) Gestational age >18 weeks; b) Presence of chronic medical conditions: (i) hypertension on medications, (ii) diabetes mellitus, (iii) parathyroid disease, (iv) uncontrolled thyroid disease, v) kidney stones, and (vi) sarcoidosis; c) Intake of vitamin D supplements containing > 2,000 IU/day of vitamin D3; d) Multiple gestation pregnancy; e) Pregnancy achieved by assisted reproduction techniques (e.g.","Exclusion criteria study were: a) Gestational age >18 weeks; b) Presence chronic medical conditions: (i) hypertension medications, (ii) diabetes mellitus, (iii) parathyroid disease, (iv) uncontrolled thyroid disease, v) kidney stones, (vi) sarcoidosis; c) Intake vitamin D supplements > 2,000 IU/day vitamin D3; d) Multiple gestation pregnancy; e) Pregnancy achieved assisted reproduction techniques (e.g.",C0680251|C0243161|C0557651|G0000000|G0000000|C0439671|C0001779|C0450371|C0439230|G0000000|C0150312|C0205191|C0199168|C0012634|C0021966|C0020538|C0013227|G0000000|C0011847|G0000000|C0439070|C0030518|C0012634|C0022326|C0205318|C0040132|C0012634|G0000000|C0022646|C0006736|C0205999|C0036202|G0000000|C1512806|C0042890|C0073187|C0242295|G0000000|C1442061|C0439465|C0042890|C3538936|C0073187|C0439064|C0032961|C0032961|G0000000|C0032961|G0000000|C1269765|C0035150|C0025664|G0000000
"Relapse was defined as a mean of ≥3 stools/day, including a mean of ≥1 watery stool/day, during the week prior to the study visit.","Relapse defined ≥3 stools/day, including ≥1 watery stool/day, week prior study visit.",C0035020|C1704788|G0000000|C0015733|C0332257|G0000000|C0443350|C0015733|C0332174|C0332152|C0557651|C0545082
Differences between the two study groups are given as mean (SD or 95% CI).,Differences study (SD 95% CI).,C1705241|C0557651|G0000000|C0450371|C0008107
Inclusion criteria were: (1) diagnosis of stage I or II breast cancer; (2) at least 18 months post-treatment currently disease free (not excluding individuals on hormonal therapies such as selective estrogen receptor modulators or aromatase inhibitors); (3) treatment involved standard dose adjuvant chemotherapy; (4) complaint of memory and attention problems following chemotherapy; (5) able to speak and read English; (6) at least 18 years of age at diagnosis and able to provide informed written consent.,Inclusion criteria were: (1) diagnosis stage I II breast cancer; (2) 18 months post-treatment disease free (not excluding individuals hormonal therapies selective estrogen receptor modulators aromatase inhibitors); (3) treatment involved standard dose adjuvant chemotherapy; (4) complaint memory attention chemotherapy; (5) speak read English; (6) 18 age diagnosis provide informed written consent.,C0007637|C0243161|G0000000|G0000000|C0011900|C0205390|C0021966|G0000000|C0006141|C0006826|G0000000|C0450371|C0439231|C2709088|C0012634|C0332296|C1518422|C0332196|C0027361|C0458083|C0087111|C0036576|C0014939|C0597357|C1709060|C0003805|C0243077|G0000000|C0039798|C1314939|C1442989|C0178602|C0001551|C0013216|G0000000|C0277786|C0025260|C0004268|C0013216|G0000000|C0234856|C0034754|C0376245|G0000000|C0450371|C0001779|C0011900|C1999230|C1522154|C0043266|C1511481
Neonates and infants (<3 months age) with baseline direct bilirubin of <1.0mg/dL and a gastrointestinal disease requiring surgical intervention who were expected to be PN-dependent for ≥21days were eligible.,Neonates infants (<3 months age) baseline direct bilirubin <1.0mg/dL gastrointestinal disease requiring surgical intervention expected PN-dependent ≥21days eligible.,C0021289|C0021270|G0000000|C0439231|C0001779|C0168634|C0439851|C0005437|C3642216|C0521362|C0012634|G0000000|C0543467|C0886296|C1517001|C0219433|G0000000|C1548635
Comparison of baseline characteristics among the treatment groups revealed no significant differences (P>0.05).,Comparison baseline characteristics treatment revealed differences (P>0.05).,C1707455|C0168634|C1521970|C0039798|C0443289|C1705241|C0369773
"A population based case-control study was conducted in 107 ESCC newly diagnosed cases and 107 residency- age-, and sex-matched controls in 5 townships of Huaian.","A population based case-control study conducted 107 ESCC newly diagnosed 107 residency- age-, sex-matched controls 5 townships Huaian.",G0000000|C0032659|C1527178|C0872128|C0557651|C0004927|C1442061|C0279626|C0750546|C0011900|C1442061|C0035182|C0001779|C0009253|C0243148|G0000000|C1552925|G0000000
"The study was randomized, double-blinded, of 1-year duration consisting of two arms: (1) a placebo-controlled crossover study consisting of 6 months placebo then 6 months of inosine, and (2) inosine treatment for 12 months following baseline assessment.","The study randomized, double-blinded, 1-year duration consisting arms: (1) placebo-controlled crossover study consisting 6 months placebo 6 months inosine, (2) inosine treatment 12 months baseline assessment.",G0000000|C0557651|C0034656|C0205173|C0439234|C0449238|C0332529|C0206655|G0000000|C1706408|C0010366|C0557651|C0332529|G0000000|C0439231|C0032042|G0000000|C0439231|C0021528|G0000000|C0021528|C0039798|C0450371|C0439231|C0168634|C1261322
"684 participants (daily smokers of cigarettes, 18 years old or over) recruited passively from app stores in the USA, Australia, UK and Singapore, and randomised to one of two sub-apps.","684 participants (daily smokers cigarettes, 18 over) recruited passively app stores USA, Australia, UK Singapore, randomised sub-apps.",C1442061|C0679646|C0332173|C0337664|C0677453|C0450371|C0205136|G0000000|G0000000|G0000000|C1698986|C0041703|C0004340|C0041700|C0037173|G0000000|C0542339
Inclusion criteria were: 1) extensive radiological consolidations (completely affecting at least two lobes); and 2) respiratory failure (pO2/FiO2 <300).,Inclusion criteria were: 1) extensive radiological consolidations (completely lobes); 2) respiratory failure (pO2/FiO2 <300).,C0007637|C0243161|G0000000|G0000000|C0205231|C0034599|C0702116|C0205197|C0796494|G0000000|C0521346|C0231174|C1418945|C1442061
"The inclusion criteria were: GA of 29-34 weeks and the need for resuscitation (HR < 100 or cyanosis) at the birth and the exclusion criteria of the study were: Major congenital anomalies, the need for chest compressions during resuscitation, endotracheal intubation and no need for resuscitation at the birth time.","The inclusion criteria were: GA 29-34 weeks resuscitation (HR < 100 cyanosis) birth exclusion criteria study were: Major congenital anomalies, chest compressions resuscitation, endotracheal intubation resuscitation birth time.",G0000000|C0007637|C0243161|G0000000|C0016993|C0450371|C0439230|C0035273|G0000000|G0000000|C1442061|C0010520|C0005615|C0680251|C0243161|C0557651|G0000000|C0205082|C0009678|C0000769|C0817096|C0332459|C0035273|C0599554|C0021925|C0035273|C0005615|C0040223
"AE-IPF was defined according to the criteria established by the Idiopathic Pulmonary Fibrosis Clinical Research Network8: (1) previous or concurrent diagnosis of idiopathic pulmonary fibrosis; (2) unexplained worsening or development of dyspnea within 30 days; (3) high-resolution computed tomography with new bilateral ground-glass; (4) abnormality and/or consolidation superimposed on a background reticular or honeycomb pattern consistent with usual interstitial pneumonia pattern; (5) no evidence of pulmonary infection by endotracheal aspirate or bronchoalveolar lavage; (6) exclusion of left heart failure, pulmonary embolism and identifiable cause of acute lung injury.","AE-IPF defined criteria established Idiopathic Pulmonary Fibrosis Clinical Research Network8: (1) previous concurrent diagnosis idiopathic pulmonary fibrosis; (2) unexplained worsening development dyspnea 30 days; (3) high-resolution computed tomography bilateral ground-glass; (4) abnormality and/or consolidation superimposed background reticular honeycomb pattern consistent usual interstitial pneumonia pattern; (5) evidence pulmonary infection endotracheal aspirate bronchoalveolar lavage; (6) exclusion left heart failure, pulmonary embolism identifiable acute lung injury.",C3887670|C1704788|C0243161|C0443211|C0332240|C0024109|C0016059|C0205210|C0035168|G0000000|G0000000|C0205156|C0205420|C0011900|C0332240|C0024109|C0016059|G0000000|G0000000|C0332271|C0243107|C0013404|C0450371|C0439228|G0000000|C1719039|C1441526|C0040395|C0238767|C0185051|G0000000|C1704258|G0000000|C0702116|G0000000|C1706907|C0439739|C0332468|C0449774|C0332290|C3538928|C0596790|C0032285|C0449774|G0000000|C3887511|C0024109|C0009450|C0599554|C0370199|G0000000|C0022100|G0000000|C0680251|C0205091|C0018787|C0231174|C0024109|C0013922|C0205396|C0205178|C0024109|C3263722
"Participants included adult (age ≥ 18 years) primary or metastatic brain tumor survivors who had completed a course of fractionated PBI or WBI of at least 30 Gy ≥ 6 months before enrollment, had no imaging evidence of disease progression within 3 months before enrollment, had a life expectancy > 6 months, had an Eastern Cooperative Oncology Group score ≥ 2, were not using cognition-enhancing medications or undergoing or planning to undergo therapies except hormonal treatments or herceptin for the next 6 months, and were not pregnant.","Participants included adult (age ≥ 18 years) primary metastatic brain tumor survivors completed fractionated PBI WBI 30 Gy ≥ 6 months enrollment, imaging evidence disease progression 3 months enrollment, life expectancy > 6 months, Eastern Cooperative Oncology Group score ≥ 2, cognition-enhancing medications undergoing planning undergo therapies hormonal treatments herceptin 6 months, pregnant.",C0679646|C0332257|C0001675|C0001779|G0000000|C0450371|C0439234|C0205225|C0036525|C0006104|C0027651|C0206194|C0205197|C1979893|C1424926|G0000000|C0450371|C0018408|G0000000|G0000000|C0439231|C1516879|C0011923|C3887511|C0012634|C0242656|G0000000|C0439231|C1516879|C0376558|C0679138|G0000000|G0000000|C0439231|C1707877|C0679729|C0027651|C0441833|C0449820|G0000000|G0000000|C0009240|C0013227|G0000000|C0032074|G0000000|C0087111|C0458083|C0087111|C0338204|G0000000|C0439231|C0549206
"Individuals eligible for the study were: pregnant, age 18 or older, ≤30 weeks of gestation, nicotine dependent or smoked 10 or more cigarettes daily, and capable of providing informed consent.","Individuals eligible study were: pregnant, age 18 older, ≤30 weeks gestation, nicotine dependent smoked 10 cigarettes daily, capable providing informed consent.",C0027361|C1548635|C0557651|G0000000|C0549206|C0001779|C0450371|C0580836|G0000000|C0439230|C0032961|C0028040|C0851827|C0037366|C0450371|C0677453|C0332173|C2698977|C1999230|C1522154|C1511481
"This study was conducted as a double-blind randomized controlled clinical trial on 126 participants, 18–35-year-old pregnant women with a minimum of two leg cramps per week who were referred to health-care centers in Tabriz-Iran in 2013.","This study conducted double-blind randomized controlled clinical trial 126 participants, 18–35-year-old pregnant women minimum leg cramps week referred health-care centers Tabriz-Iran 2013.",G0000000|C0557651|C0004927|C0013072|C0034656|C2587213|C0205210|C0008976|C1442061|C0679646|G0000000|C0549206|C0043210|C1524031|C0023216|C0026821|C0332174|C0205543|C0086388|C0205099|C0022065|G0000000
"This study was conducted in the health district of Houndé, located 250 km west of Ouagadougou, Burkina Faso’s capital city.","This study conducted health district Houndé, located 250 west Ouagadougou, Burkina Faso’s capital city.",G0000000|C0557651|C0004927|C0018684|G0000000|G0000000|G0000000|C1442061|C1705493|G0000000|G0000000|G0000000|C0006909|C0008848
Methods: Subjects were randomised to undertake three sessions per week of upper and lower body exercise based on individualised preferences (n = 30) or to a control group (n = 18).,Methods: Subjects randomised undertake sessions week upper lower body exercise based individualised preferences (n = 30) control (n = 18).,C0025663|C0681850|G0000000|G0000000|C1883016|C0332174|C1282910|C0441994|C0242821|C0015259|C1527178|G0000000|C0558295|C0369718|G0000000|C0450371|C0243148|C0369718|G0000000|C0450371
"We used a parent questionnaire to determine if children had any known problems with their hearing, vision, neurology, or psychology, as well as establish if the children used English as their primary language at both school and home.","We parent questionnaire determine children hearing, vision, neurology, psychology, establish children English primary language school home.",G0000000|C0030551|C0034394|G0000000|C0008059|C0018767|C0042789|C0027855|C0033909|C0443211|C0008059|C0376245|C0205225|C0023008|C0036375|C0442519
"Participation also necessitated living in one of the five participating municipalities (see “Procedure”), and the adolescent had to live at least part-time with the participating parent or caregiver.","Participation necessitated living participating municipalities (see “Procedure”), adolescent live part-time participating parent caregiver.",C0679823|G0000000|C0376558|C0679823|C0600182|C0042789|G0000000|C0205653|C1548795|C0682294|C0679823|C0030551|C0085537
"Materials and methods: In a randomized clinical trial, 30 primary molars indicated for pulpotomy in children aged 4 to 10 years were treated using either a FS (10 teeth), ES technique (10 teeth) and laser (10 teeth).","Materials methods: In randomized clinical trial, 30 primary molars pulpotomy children aged 4 10 treated FS (10 teeth), ES technique (10 teeth) laser (10 teeth).",C0520510|C0025663|G0000000|C0034656|C0205210|C0008976|C0450371|C0205225|C0026367|C0034104|C0008059|C0001779|G0000000|C0450371|C1522326|C1517317|C0450371|C0040426|C0013754|C0449851|C0450371|C0040426|C0023089|C0450371|C0040426
"We excluded patients with a K-MMSE score of less than 10, patients presenting with severe cognitive impairment or aphasia and not being able to understand instructions, patients with poor sitting balance such that they could not sit on a chair with back and armrests, patients with limited range of motion of the neck due to orthopedic problems, and patients with loss of visual acuity such that they could not perceive content on a computer screen.","We excluded patients K-MMSE score 10, patients severe cognitive impairment aphasia understand instructions, patients poor sitting balance sit chair armrests, patients limited range motion neck orthopedic problems, patients loss visual acuity perceive content computer screen.",G0000000|C1554077|C0030705|C0597277|C0449820|C0450371|C0030705|C0205082|C1516691|C0221099|C0003537|C0162340|C0302828|C0030705|C0032854|C0277814|C0014653|C0277814|C0179847|G0000000|C0030705|C0439801|C1514721|C0026597|C0027530|C0029355|C1546466|C0030705|C1517945|C0234621|C0750509|G0000000|C0423896|C0009622|C0220908
All patients had histologically proven squamous cell carcinoma of the esophagus.,All patients histologically proven squamous cell carcinoma esophagus.,G0000000|C0030705|C0205462|C0456369|C1182670|C0007634|C0007097|C0014876
"According to these criteria, only 9 patients were included over the period.","According criteria, 9 patients included period.",C0680240|C0243161|G0000000|C0030705|C0332257|C0439531
The statistician used random size blocks for group balance while accommodating camp sizes of 4 to 8 participants.,The statistician random size blocks balance accommodating camp sizes 4 8 participants.,G0000000|C0334957|C0034656|C0456389|C0028778|C0014653|G0000000|C0050063|C0456389|G0000000|G0000000|C0679646
"The mean age of cohort children was similar in the two study arms in each year, but rose gradually from 5.2 y in the first study year to 6.25 y in the third year (Table 1).","The age cohort children study arms year, rose gradually 5.2 study 6.25 (Table 1).",G0000000|C0001779|C0599755|C0008059|C0557651|C0206655|C0439234|C0035853|G0000000|G0000000|C0557651|C0450371|C0039224|G0000000
"Patients with postoperative wounds, burns, and skin grafts donor sites, wound size >5 cm in maximum diameter, known allergy to honey, povidone iodine, and Tegaderm.","Patients postoperative wounds, burns, skin grafts donor sites, wound size >5 cm maximum diameter, allergy honey, povidone iodine, Tegaderm.",C0030705|C0032790|C0021501|C0006434|C0444099|C0332835|C0013018|C0205145|C0043250|C0456389|G0000000|G0000000|C0806909|C1301886|C0002111|C0019906|C0032856|C0021966|G0000000
αv integrins are involved in angiogenesis and melanoma tumourigenesis.,αv integrins involved angiogenesis melanoma tumourigenesis.,G0000000|C0021701|C1314939|C0302600|C0025202|C0007621
"All of the fractures fulfilled the criteria of being in the distal third of the radius, of being either a greenstick or torus fracture, and of being angulated <10° without a clinical deformity.","All fractures fulfilled criteria distal radius, greenstick torus fracture, angulated <10° clinical deformity.",G0000000|C0016658|C1550543|C0243161|C0205108|C0034627|C0332716|C0332567|C0016658|C0333179|G0000000|C0205210|C0000768
We included adult patients with CT- or MRI-confirmed ischemic stroke within 48 h of symptom onset who were admitted from March to November 2012 to the acute vascular unit or general emergency unit of a large urban emergency department (ED) at the Hospital de Clínicas de Porto Alegre.,We included adult patients CT- MRI-confirmed ischemic stroke 48 symptom onset admitted March November 2012 acute vascular unit emergency unit urban emergency department (ED) Hospital de Clínicas de Porto Alegre.,G0000000|C0332257|C0001675|C0030705|C0007673|C0024485|C0475224|C0038454|C0450371|C1457887|C0206132|C0184666|C3829202|C3828767|G0000000|C0205178|C0005847|C0439148|C0013956|C0439148|C0442529|C0013956|C1704729|C3538926|C0019994|C0011198|G0000000|C0011198|G0000000|G0000000
"Key criteria were age ≥18 to ≤80 years, a diagnosis of epilepsy with POSs (equivalent to the 2010 ILAE classification10 of focal seizures) that had been inadequately controlled with ≥2 to <5 prior AEDs, and receiving 1 or 2 standard AEDs (other than pregabalin or gabapentin) with a minimum of 4 POSs (regardless of secondary generalization) during the 6-week baseline phase with no 28-day POS-free period.","Key criteria age ≥18 ≤80 years, diagnosis epilepsy POSs (equivalent 2010 ILAE classification10 focal seizures) inadequately controlled ≥2 <5 prior AEDs, receiving 1 2 standard AEDs (other pregabalin gabapentin) minimum 4 POSs (regardless secondary generalization) 6-week baseline phase 28-day POS-free period.",G0000000|C0243161|C0001779|G0000000|G0000000|C0439234|C0011900|C0014544|C1262869|C0205163|G0000000|G0000000|G0000000|C0205234|C0036572|G0000000|C2587213|G0000000|G0000000|C0332152|C0180309|C1514756|G0000000|G0000000|C1442989|C0180309|G0000000|C0657912|C0060926|C1524031|G0000000|C1262869|C3641650|C0027627|C0017324|C0332174|C0168634|C0205390|C0450371|C1262869|C0439531
"Women were excluded if they had a history of cancer (excluding nonmelanoma skin cancer) within the past ten years, any serious non-CVD illness, or were currently using warfarin or other anticoagulants.","Women excluded history cancer (excluding nonmelanoma skin cancer) ten years, non-CVD illness, warfarin anticoagulants.",C0043210|C1554077|C0019664|C0006826|C0332196|G0000000|C0444099|C0006826|C0014518|C0439234|C1518422|C0221423|C0043031|C0003280
"Overall, 100 patients with confirmed cutaneous leishmaniasis were evaluated.","Overall, 100 patients confirmed cutaneous leishmaniasis evaluated.",C0282416|C1442061|C0030705|C0521093|C0221912|C0023281|C0220825
"The study inclusion criteria for the mothers who were in the 1st to 15th days after delivery consisted of having breast engorgement with a minimum intensity score of 2 based on the checklist (with a maximum score of 19), a sublingual temperature below 38°C, having had engorgement symptoms during the first 15 days after delivery, no use of medications for stopping breastfeeding, no use of topical herbal therapies, not having developed breast abscess or mastitis, no prohibition on lactation, no history of any allergies to hollyhock or other plants, and nursing every 2 to 3 hours.","The study inclusion criteria mothers 1st 15th days delivery consisted breast engorgement minimum intensity score 2 based checklist (with maximum score 19), sublingual temperature 38°C, engorgement symptoms 15 days delivery, medications stopping breastfeeding, topical herbal therapies, developed breast abscess mastitis, prohibition lactation, history allergies hollyhock plants, nursing 2 3 hours.",G0000000|C0557651|C0007637|C0243161|C0026591|G0000000|G0000000|C0439228|C0011209|C0332529|C0006141|C0020452|C1524031|C0522510|C0449820|G0000000|C1527178|C1707357|G0000000|C0806909|C0449820|C0450371|C0001565|C0005903|G0000000|C0020452|C0683368|C0450371|C0439228|C0011209|C0013227|C0723457|C0006147|C0332237|C3146288|C0087111|G0000000|C0006141|C0000833|C0024894|C0683610|C0006147|C0019664|C0020517|G0000000|C0032098|C0006147|G0000000|G0000000|C0439227
Massage is an ancient method that women had received relaxation through it for thousands of years but in modern labour rooms no accurate evaluation has been conducted [7].,Massage ancient method women received relaxation thousands modern labour accurate evaluation conducted [7].,C0024875|G0000000|C0025663|C0043210|C1514756|C0035028|C1883310|G0000000|C0022864|C0443131|C0220825|C0004927|G0000000
Secondary arm lymphoedema continues to affect at least 20% of women after treatment for breast cancer requiring lifelong professional treatment and self-management.,Secondary arm lymphoedema continues affect 20% women treatment breast cancer requiring lifelong professional treatment self-management.,C0027627|C0446516|C0024236|C0549178|C0001721|C0450371|C0043210|C0039798|C0006141|C0006826|G0000000|G0000000|C0679924|C0039798|C0086969
"METHODS—A randomised, controlled, prospective study of 100 preterm infants, weighing less than 1750 g at birth and requiring ventilatory support and parenteral nutrition, was performed.","METHODS—A randomised, controlled, prospective study 100 preterm infants, weighing 1750 birth requiring ventilatory support parenteral nutrition, performed.",G0000000|G0000000|C2587213|C0023981|C0557651|C1442061|C0151526|C0021270|C1305866|G0000000|C0005615|G0000000|G0000000|C0183683|C0030547|C0028707|C0884358
"The inclusion criteria were satisfaction of the American College of Rheumatology (ACR 1990 and 2010) criteria, which include experiencing widespread pain for more than 3 months and pain with 4 kg/cm2 of pressure on 11 or more of 18 TPs (in every case, the diagnosis of FM had been established by the patient's rheumatologist); age of 18 to 60 years; a score of >5 on the visual analog scale (VAS), in the last three months; tenderness of at least 2 of the 4 tender points on the back; and baseline condition of sedentary lifestyle with no or irregular physical activity.","The inclusion criteria satisfaction American College Rheumatology (ACR 1990 2010) criteria, experiencing widespread pain 3 months pain 4 kg/cm2 pressure 11 18 TPs (in case, diagnosis FM established patient's rheumatologist); age 18 60 years; score >5 visual analog scale (VAS), months; tenderness 2 4 tender back; baseline condition sedentary lifestyle irregular physical activity.",G0000000|C0007637|C0243161|C0242428|C0596070|C0557806|C0035452|C1412134|G0000000|G0000000|C0243161|C0237607|C0205219|C0030193|G0000000|C0439231|C0030193|G0000000|C0033095|C0450371|C0450371|G0000000|G0000000|C0868928|C0011900|C3540627|C0443211|C0030705|C0334889|C0001779|C0450371|C0450371|C0439234|C0449820|G0000000|C0234621|C0243071|C0175659|C0042815|C0439231|C0234233|G0000000|G0000000|C0234234|C0004600|C0168634|C0012634|C0205254|C0023676|C0205271|C0031809|C0205177
"UC was diagnosed in accordance with the diagnostic criteria proposed by the Survey Research Group of Intractable Inflammatory Intestinal Disorders/Specified Diseases, Japanese Ministry of Health, Labour and Welfare.","UC diagnosed diagnostic criteria proposed Survey Research Group Intractable Inflammatory Intestinal Disorders/Specified Diseases, Japanese Ministry Health, Labour Welfare.",G0000000|C0011900|C0011900|C0243161|C1553874|C0038951|C0035168|C0441833|C0205269|C0333348|C0021853|C0012634|C0012634|C1556094|G0000000|C0018684|C0022864|C0037440
"In the medical literature to date, there are only a few studies on confirmation of self-reported exposure status of 9–11 year-old school children.","In medical literature date, studies confirmation self-reported exposure status 9–11 year-old school children.",G0000000|C0199168|C0023866|C0011008|C0947630|C0521091|C0681906|C0274281|C0449438|G0000000|C0439234|C0036375|C0008059
"Patients were matched for age (18–30 years, 31–40 years, 41–55 years), disease duration (0–9 years, 10–19 years, ≥20 years), EDSS (≤2.5, 3.0–5.5, 6.0–6.5), and disease-modifying drug (interferon, glatiramer acetate, none).","Patients matched age (18–30 years, 31–40 years, 41–55 years), disease duration (0–9 years, 10–19 years, ≥20 years), EDSS (≤2.5, 3.0–5.5, 6.0–6.5), disease-modifying drug (interferon, glatiramer acetate, none).",C0030705|C0150103|C0001779|G0000000|C0439234|G0000000|C0439234|G0000000|C0439234|C0012634|C0449238|G0000000|C0439234|G0000000|C0439234|G0000000|C0439234|C0451246|G0000000|G0000000|G0000000|C0012634|C0013227|C0021747|C0717787|C0000975|G0000000
The severe cases were suggested to visit the government health facility.,The severe suggested visit government health facility.,G0000000|C0205082|C1705535|C0545082|C0018104|C0018684|C1547538
The natural history of ovarian cancer poses a unique challenge to anaemia management.,The natural history ovarian cancer poses unique challenge anaemia management.,G0000000|C0205296|C0019664|C0205065|C0006826|G0000000|C1710548|C0798503|C0002871|C0001554
The groups were heterogeneous in terms of gender and the majority of the members were fixed until the end of the sessions.,The heterogeneous terms gender majority fixed sessions.,G0000000|C0019409|C0233324|C0079399|C0680220|C0443218|C1883016
"Participants had to be 16 years of age or over, be current daily smokers, be ready to quit, and have a video message-capable phone.","Participants 16 age over, current daily smokers, ready quit, video message-capable phone.",C0679646|C0450371|C0001779|C0205136|C0521116|C0332173|C0337664|C1318963|C0748223|C0042655|C0470166|C1515258
"Exclusion criteria were treatment with medically prescribed marijuana; active suicidal ideation; meeting DSM-IV criteria for current abuse or dependence on substances other than cannabis or nicotine; significant medical or psychiatric disorders, including current depressive and anxiety disorders; treatment with an investigational drug during the previous month or ongoing treatment with medications that could affect study outcomes, eg, other psychoactive medications; and being mandated to treatment by a legal authority.","Exclusion criteria treatment medically prescribed marijuana; active suicidal ideation; meeting DSM-IV criteria current abuse dependence substances cannabis nicotine; medical psychiatric disorders, including current depressive anxiety disorders; treatment investigational drug previous month ongoing treatment medications affect study outcomes, eg, psychoactive medications; mandated treatment legal authority.",C0680251|C0243161|C0039798|G0000000|C0278329|C0024808|C0205177|C0438696|C0392348|C0556656|C0220952|C0243161|C0521116|C0013146|C0011546|C0439861|C0024808|C0028040|C0199168|C0205487|C0012634|C0332257|C0521116|G0000000|C0003467|C0012634|C0039798|C1517586|C0013227|C0205156|C0332177|C0549178|C0039798|C0013227|C0001721|C0557651|C1274040|C0013715|G0000000|C0013227|G0000000|C0039798|C1301860|C0599437
"In a 1:1:1 ratio, 60 inpatients with post-stroke cognitive dysfunction will be randomly allocated into either the acupuncture group, the computer-assisted cognitive training group, or the ACoTrain group in addition to their individual rehabilitation programme.","In 1:1:1 ratio, 60 inpatients post-stroke cognitive dysfunction randomly allocated acupuncture group, computer-assisted cognitive training group, ACoTrain addition individual rehabilitation programme.",G0000000|G0000000|C0456603|C0450371|C0021562|C0687676|C1516691|C0031847|G0000000|G0000000|C0001299|C0441833|C2362103|C1516691|C0040607|C0441833|G0000000|C0332287|C0027361|C0034991|C1709697
"Women with a singleton pregnancy, BMI ≥ 30 kg/m2, between 120 and 176 weeks of gestation and able to provide informed written consent.","Women singleton pregnancy, BMI ≥ 30 kg/m2, 120 176 weeks gestation provide informed written consent.",C0043210|C0481462|C0032961|G0000000|C0022718|C1442061|C1442061|C0439230|C0032961|C1999230|C1522154|C0043266|C1511481
Diarrhea among under five children significantly reduced among families who fully implemented basic health packages.,Diarrhea children reduced families implemented basic health packages.,C0011991|C0008059|C0392756|C0015576|G0000000|C1527178|C0018684|C0013194
"Major exclusion criteria included previous EGFR-TKIs therapy, pregnancy, breast-feeding or unable to take oral medications.","Major exclusion criteria included previous EGFR-TKIs therapy, pregnancy, breast-feeding unable oral medications.",C0205082|C0680251|C0243161|C0332257|C0205156|C1739039|C0039798|C0032961|C0006147|C1299582|C0442027|C0013227
"Patients were excluded if they had other respiratory conditions that are not included in the COPD definition (bronchiectasis, asthma or cystic fibrosis) or cognitive impairment problems registered in their clinical record (dementia, Alzheimer’s, Parkinson’s or cognitive decline).","Patients excluded respiratory conditions included COPD definition (bronchiectasis, asthma cystic fibrosis) cognitive impairment registered clinical record (dementia, Alzheimer’s, Parkinson’s cognitive decline).",C0030705|C1554077|C0521346|C0012634|C0332257|C0024117|C1550452|C0006267|C0004096|C0205207|C0016059|C1516691|C0221099|C1514821|C0205210|C0034869|C0011265|G0000000|G0000000|C1516691|G0000000
"Exclusion criteria at screening included the use of inhaled corticosteroids (ICS) or maintenance COPD medications other than TIO in the 3 months prior to screening (including other LAMAs, LABAs, LAMA/LABA combinations, ICS/LABA combinations, phosphodiesterase-4 inhibitors, theophyllines, and oral β2-agonists), a current diagnosis of asthma, respiratory diseases other than COPD considered clinically significant by the study investigator, and more than one moderate-to-severe COPD exacerbation in the past 12 months (defined as worsening symptoms of COPD requiring treatment with oral/systemic corticosteroids, antibiotics, or in-patient hospitalization).","Exclusion criteria screening included inhaled corticosteroids (ICS) maintenance COPD medications TIO 3 months prior screening (including LAMAs, LABAs, LAMA/LABA combinations, ICS/LABA combinations, phosphodiesterase-4 inhibitors, theophyllines, oral β2-agonists), current diagnosis asthma, respiratory diseases COPD considered clinically study investigator, moderate-to-severe COPD exacerbation 12 months (defined worsening symptoms COPD requiring treatment oral/systemic corticosteroids, antibiotics, in-patient hospitalization).",C0680251|C0243161|C0220908|C0332257|C0004048|C0001617|C0022521|C0024501|C0024117|C0013227|G0000000|G0000000|C0439231|C0332152|C0220908|C0332257|C0999593|G0000000|C0999593|C0453882|C0022521|C0453882|C0031640|C0243077|C0039771|C0442027|G0000000|C0521116|C0011900|C0004096|C0521346|C0012634|C0024117|C0750591|G0000000|C0557651|C0035173|C0205081|C0024117|G0000000|C0450371|C0439231|C1704788|C0332271|C0683368|C0024117|G0000000|C0039798|C0442027|C0001617|C0003232|C0150312|C0019993
Extremely premature infants are eligible for the study if they meet the following inclusion criteria: birth weight < 1250 g; mother plans to pump and provide milk for at least 2 months; absence of severe congenital anomalies; NICU admission ≤ 24 hours of life; ability to begin protocol within 96 hours of life.,Extremely premature infants eligible study meet inclusion criteria: birth weight < 1250 g; mother plans pump provide milk 2 months; absence severe congenital anomalies; NICU admission ≤ 24 hours life; ability protocol 96 hours life.,C0205403|C0151526|C0021270|C1548635|C0557651|C1550543|C0007637|C0243161|C0005615|C0005910|G0000000|G0000000|C0439267|C0026591|C0270724|C0182537|C1999230|C0026131|G0000000|C0439231|C0332197|C0205082|C0009678|C0000769|C0021709|G0000000|C0439227|C0376558|C0085732|C0442711|C0450371|C0439227|C0376558
"Exclusion criteria included recent changes to medications, type I diabetes (T1D), use of steroids or immunomodulatory medication, or antibiotic use either currently or within the previous 2 months.","Exclusion criteria included medications, type I diabetes (T1D), steroids immunomodulatory medication, antibiotic previous 2 months.",C0680251|C0243161|C0332257|C0013227|C0332307|C0021966|C0011847|G0000000|C0038317|G0000000|C0013227|C0003232|C0205156|G0000000
"Patients of either sex with type 2 diabetes, aged between 18 and 75 years, who were on stable glucose-lowering medications during the preceding month and who had PDN for at least 1 month were considered for the study.","Patients sex type 2 diabetes, aged 18 75 years, stable glucose-lowering medications preceding month PDN 1 month considered study.",C0030705|C0009253|C0332307|G0000000|C0011847|C0001779|C0450371|C0450371|C0439234|C0205360|C0017725|C0013227|C0332152|C0332177|G0000000|G0000000|C0332177|C0750591|C0557651
"METHODS—Fifty four patients with active CD (Crohn's disease activity index (CDAI) >200, serum C reactive protein (CRP) 10 mg/l) were randomised to a high or low LCT feed for three weeks.","METHODS—Fifty patients active CD (Crohn's disease activity (CDAI) >200, serum C reactive protein (CRP) 10 mg/l) randomised low LCT feed weeks.",G0000000|C0030705|C0205177|C0007928|C0010346|C0012634|C0205177|C0683448|C1442061|C0229671|G0000000|C0205332|C0033684|C3890735|C0450371|C0439268|G0000000|C0205251|C1416808|C0204695|C0439230
108 ethnically diverse mothers who exposed their children (aged <4 years) to tobacco smoke in the home.,108 ethnically diverse mothers exposed children (aged <4 years) tobacco smoke home.,C1442061|G0000000|C1880371|C0026591|C0332157|C0008059|C0001779|G0000000|C0439234|C0040329|C0037366|C0442519
"Patients will be excluded in case of previous incontinence surgery, in case of pelvic organ prolapse more than 1 centimeter beyond the hymen and/or in case of residual bladder volume of more than 150 milliliter on ultrasound or catheterisation.","Patients excluded previous incontinence surgery, pelvic organ prolapse 1 centimeter hymen and/or residual bladder volume 150 milliliter ultrasound catheterisation.",C0030705|C1554077|C0205156|C0021167|C0038894|C0030797|C0178784|C0033377|G0000000|C0475210|C0020412|G0000000|C1609982|C0005682|C0449468|C1442061|C0439242|C0041618|C0007430
"Women were eligible for inclusion if they had stage one unilateral secondary lymphoedema of the arm, as defined by the International Society of Lymphology [3] confirmed by a professional lymphoedema therapist, and had completed treatment for breast cancer (surgery, radiotherapy and chemotherapy) at least six months previously, were over 18 and had sufficient English literacy to provide informed consent.","Women eligible inclusion stage unilateral secondary lymphoedema arm, defined International Society Lymphology [3] confirmed professional lymphoedema therapist, completed treatment breast cancer (surgery, radiotherapy chemotherapy) months previously, 18 sufficient English literacy provide informed consent.",C0043210|C1548635|C0007637|C0205390|C0205092|C0027627|C0024236|C0446516|C1704788|C1512888|C0037455|G0000000|G0000000|C0521093|C0679924|C0024236|C0871525|C0205197|C0039798|C0006141|C0006826|C0038894|C0034619|C0013216|C0439231|G0000000|C0450371|C0205410|C0376245|C0023864|C1999230|C1522154|C1511481
"However, in the field of brain injury rehabilitation, only one article has been published [14].","However, field brain injury rehabilitation, article published [14].",G0000000|C0440042|C0006104|C3263722|C0034991|C1706852|C0034037|C0450371
"The mean BMI of the 1st graders was 16.0 ± 2.3 kg/m2 with 12.0% being over 85 percentile of BMI curve, whereas the mean BMI of the 4th graders was 18.1 ± 3.0 kg/m2 with 17.3% having the corresponding figure.","The BMI 1st graders 16.0 ± 2.3 kg/m2 12.0% 85 percentile BMI curve, BMI 4th graders 18.1 ± 3.0 kg/m2 17.3% figure.",G0000000|G0000000|G0000000|G0000000|C0450371|G0000000|G0000000|C0022718|C0450371|C0450371|C1264641|G0000000|C0205134|G0000000|G0000000|G0000000|C0450371|G0000000|G0000000|C0022718|C0450371|G0000000
PHQ-9 data were available for 614 patients at 3 months and 572 patients at 12 months.,PHQ-9 data 614 patients 3 months 572 patients 12 months.,C1879301|C1511726|C1442061|C0030705|G0000000|C0439231|C1442061|C0030705|C0450371|C0439231
Eligible patients were contacted by research nurses at the first follow‐up appointment for patients receiving hormonal therapy or at the last treatment for patients undergoing chemotherapy.,Eligible patients contacted nurses follow‐up appointment patients receiving hormonal therapy treatment patients undergoing chemotherapy.,C1548635|C0030705|C0332158|C0028661|G0000000|C0003629|C0030705|C1514756|C0458083|C0039798|C0039798|C0030705|G0000000|C0013216
"A randomized, controlled clinical trial is proposed, enrolling current smokers with no previous history of respiratory disease in the Primary Care Centres of the province of Tarragona (Spain).","A randomized, controlled clinical trial proposed, enrolling current smokers previous history respiratory disease Primary Care Centres province Tarragona (Spain).",G0000000|C0034656|C2587213|C0205210|C0008976|C1553874|G0000000|C0521116|C0337664|C0205156|C0019664|C0521346|C0012634|C0205225|C1947933|C0205099|C1514578|G0000000|C0037747
"We conducted an investigator-initiated, single-center, double-blind, randomized, parallel-groups, placebo-controlled trial between December 2010 and December 2014 in the medical intensive care unit of Siriraj Hospital, Bangkok, Thailand.","We conducted investigator-initiated, single-center, double-blind, randomized, parallel-groups, placebo-controlled trial December 2010 December 2014 medical intensive care unit Siriraj Hospital, Bangkok, Thailand.",G0000000|C0004927|C0035173|C0037179|C0013072|C0034656|C2348042|C1706408|C0008976|C3830550|G0000000|C3830550|G0000000|C0199168|C0162425|C1947933|C0439148|G0000000|C0019994|G0000000|C0039725
"Exclusion criteria were use of a bronchodilator within the preceding 4 h, known underlying cardiac or chronic pulmonary disease (other than asthma), presence of stridor or daily treatment with oral corticosteroids for >2 days prior.","Exclusion criteria bronchodilator preceding 4 h, underlying cardiac chronic pulmonary disease (other asthma), presence stridor daily treatment oral corticosteroids >2 days prior.",C0680251|C0243161|C0006280|C0332152|G0000000|G0000000|C0018787|C0205191|C0024109|C0012634|G0000000|C0004096|C0150312|C0038450|C0332173|C0039798|C0442027|C0001617|G0000000|C0332152
The teeth were randomized into two groups for pulpotomy with the ABS (n = 35) and the FS (n = 35) agents.,The teeth randomized pulpotomy ABS (n = 35) FS (n = 35) agents.,G0000000|C0040426|C0034656|C0034104|G0000000|C0369718|G0000000|C0450371|C1517317|C0369718|G0000000|C0450371|C0450442
"Eligible subjects were consecutive, consenting adult patients (>18 years) of either sex clinically diagnosed as PR at the dermatology outpatient department of a teaching hospital in eastern India.","Eligible subjects consecutive, consenting adult patients (>18 years) sex clinically diagnosed PR dermatology outpatient department teaching hospital eastern India.",C1548635|C0681850|C1707491|C1511481|C0001675|C0030705|C0450371|C0439234|C0009253|G0000000|C0011900|C0279759|C0011627|C0029921|C1704729|C0039401|C0019994|C1707877|C0021201
"Associated features include the pathological manifestations of rapid-eye-movement (REM) sleep: cataplexy, sleep paralysis, hypnagogic hallucinations, and abnormal sleep-onset REM periods and disturbed nocturnal sleep.","Associated features pathological manifestations rapid-eye-movement (REM) sleep: cataplexy, sleep paralysis, hypnagogic hallucinations, abnormal sleep-onset REM periods disturbed nocturnal sleep.",C0332281|C1521970|C0030664|C0205319|C0034673|G0000000|C0037313|C0007384|C0037313|C0522224|G0000000|C0018524|C0205161|C0871908|G0000000|C0439531|G0000000|C0240526|C0037313
"Diarrhea was also significantly associated with lower mean plasma levels of zinc (0.59 ±0.11 vs. 0.68±0.21, p<0.001), and remained significant after controlling for ART, levels of hsCRP, CD4+ cell count, and viral load (p=0.006).","Diarrhea lower plasma levels zinc (0.59 ±0.11 vs. 0.68±0.21, p<0.001), remained controlling ART, levels hsCRP, CD4+ cell count, viral load (p=0.006).",C0011991|C0441994|C0032105|C0441889|C0043481|C0450371|G0000000|G0000000|G0000000|C0369773|G0000000|C2239193|C0003826|C0441889|G0000000|C0285590|C0007634|C0750480|C0521026|C1550025|C0369773
"The experimental intervention36 included (1) a 2-session in-office physician training (1.75 hours) using a brief video, feedback from standardized patients portraying roles of patients with advanced cancer who also critiqued up to 2 audio recorded study patient visits, and (2) a single 1-hour patient and caregiver coaching session incorporating a question prompt list to help patients bring their most important concerns to their oncologist’s attention at an upcoming office visit, plus up to 3 follow-up phone calls (Table 1; eTable 2 in Supplement 3).","The experimental intervention36 included (1) 2-session in-office physician training (1.75 hours) video, feedback standardized patients portraying roles patients advanced cancer critiqued 2 audio recorded study patient visits, (2) single 1-hour patient caregiver coaching session incorporating question prompt list patients bring concerns oncologist’s attention upcoming office visit, 3 follow-up phone calls (Table 1; eTable 2 Supplement 3).",G0000000|C1517586|G0000000|C0332257|G0000000|C1883016|C0150312|C0031831|C0040607|C0450371|C0439227|C0042655|C0015744|G0000000|C0030705|G0000000|C0035820|C0030705|C0205179|C0006826|C0010341|G0000000|C3273156|C0034869|C0557651|C0030705|C0545082|G0000000|C0037179|C0439227|C0030705|C0085537|C0557773|C1883016|G0000000|C1522634|C0871157|C0745732|C0030705|G0000000|C2699424|G0000000|C0004268|G0000000|C0442603|C0545082|G0000000|C0589120|C1515258|C0679006|C0039224|G0000000|G0000000|G0000000|C0242295|G0000000
"Participants were fully informed about the purpose, procedures, and measurements of the study.","Participants informed purpose, procedures, measurements study.",C0679646|C1522154|C1285529|C0025664|C0242485|C0557651
"At baseline, the median CD4% was 11.9% (IQR: 6.6–18.3%), and the majority (75.2%) were severely immunosuppressed (CD4% below 25% for children younger than 1, or below 20% for children 1 to 2 years, or below 15% for children 3–15 years [12]); the median viral load was 5.2 (IQR 4.5–5.9) log copies/ml; and the median WAZ was−2.3 (IQR: −3.6––1.3) with 34.7% of children severely under-weight-for-age.","At baseline, median CD4% 11.9% (IQR: 6.6–18.3%), majority (75.2%) severely immunosuppressed (CD4% 25% children 1, 20% children 1 2 years, 15% children 3–15 [12]); median viral load 5.2 (IQR 4.5–5.9) log copies/ml; median WAZ was−2.3 (IQR: −3.6––1.3) 34.7% children severely under-weight-for-age.",G0000000|C0168634|C0549183|C0285590|C0450371|G0000000|G0000000|C0680220|C0450371|C0205082|C0085393|C0285590|C0450371|C0008059|G0000000|C0450371|C0008059|G0000000|G0000000|C0439234|C0450371|C0008059|G0000000|C0450371|C0549183|C0521026|C1550025|G0000000|G0000000|G0000000|C1708728|C1531853|C0549183|G0000000|G0000000|G0000000|G0000000|C0450371|C0008059|C0205082|C0542339
A total of 11 adult smokers with PTSD were enrolled.,A total 11 adult smokers PTSD enrolled.,G0000000|C0439175|C0450371|C0001675|C0337664|C0038436|G0000000
Younger than 18 years at the time of onset of idiopathic NS.,Younger 18 years time onset idiopathic NS.,C0332239|G0000000|C0040223|C0206132|C0332240|C0038944
Other inclusion criteria comprised evidence of muscle weakness by clinical or functional assessment and the ability to provide a reproducible unilateral quantitative muscle testing (QMT) biceps score within 15% of the first assessment.,Other inclusion criteria comprised evidence muscle weakness clinical functional assessment ability provide reproducible unilateral quantitative muscle testing (QMT) biceps score 15% assessment.,G0000000|C0007637|C0243161|C2700400|C3887511|C0026845|C3714552|C0205210|C0205245|C1261322|C0085732|C1999230|C1514863|C0205092|C0392762|C0026845|C0039593|C4053513|C0559499|C0449820|C0450371|C1261322
Cancer-related-fatigue (CRF) is common in advanced cancer.,Cancer-related-fatigue (CRF) common advanced cancer.,C1332836|G0000000|C0205214|C0205179|C0006826
The patients were randomly assigned to receive standard care or to have regular telephone contact with a diabetes nurse educator for advice about adjustment of insulin therapy.,The patients randomly assigned receive standard care regular telephone contact diabetes nurse educator advice adjustment insulin therapy.,G0000000|C0030705|G0000000|C1516050|C1514756|C1442989|C1947933|C0205272|C0039457|C0332158|C0011847|C0028661|C0221457|C0150600|C0376209|C0021641|C0039798
"Subjects were at least 18 years old, spoke English or Spanish and had at least 1 of the following diagnoses: hypertension, hyperlipidemia, heart failure, coronary artery disease, myocardial infarction, transient ischemic attack, stroke, diabetes, asthma, chronic obstructive pulmonary disease or require anticoagulation.","Subjects 18 old, spoke English Spanish 1 diagnoses: hypertension, hyperlipidemia, heart failure, coronary artery disease, myocardial infarction, transient ischemic attack, stroke, diabetes, asthma, chronic obstructive pulmonary disease require anticoagulation.",C0681850|C0450371|C0580836|G0000000|C0376245|C0086409|G0000000|C0011900|C0020538|C0020473|C0018787|C0231174|C0018787|C0003842|C0012634|C0027061|C0021308|C0040704|C0475224|C0277793|C0038454|C0011847|C0004096|C0205191|C0549186|C0024109|C0012634|G0000000|C0003281
One hundred and eighty-six adults who met eligibility criteria and whose chief complaint included sore throat.,One eighty-six adults met eligibility criteria chief complaint included sore throat.,C0205447|C3816958|C0001675|C0268621|C0013893|C0243161|G0000000|C0277786|C0332257|C0234233|C0031354
"This double-blind, randomized, noninferiority trial compared the efficacy of intramuscular midazolam with that of intravenous lorazepam for children and adults in status epilepticus treated by paramedics.","This double-blind, randomized, noninferiority trial compared efficacy intramuscular midazolam intravenous lorazepam children adults status epilepticus treated paramedics.",G0000000|C0013072|C0034656|G0000000|C0008976|C1707455|C1280519|C0021492|C0026056|C0348016|C0024002|C0008059|C0001675|C0449438|G0000000|C1522326|C0030450
"In addition, those with a baseline International Normalized Ratio (INR) >1.5 (>2 if ≤1 week of age) or triglyceride level >400mg/dL and those with a hemolytic disorder, liver disease or shock requiring vasopressor support, extracorporeal membrane oxygenation and/or nitric oxide treatment were excluded.","In addition, baseline International Normalized Ratio (INR) >1.5 (>2 ≤1 week age) triglyceride level >400mg/dL hemolytic disorder, liver disease shock requiring vasopressor support, extracorporeal membrane oxygenation and/or nitric oxide treatment excluded.",G0000000|C0332287|C0168634|C1512888|C1882115|C0456603|C0525032|G0000000|G0000000|G0000000|C0332174|C0001779|C0041004|C0441889|C3642216|C0312853|C0012634|C0023884|C0012634|C0036974|G0000000|C0042397|C0183683|C0442087|C0025255|C0231940|G0000000|G0000000|C0030015|C0039798|C1554077
"All children visiting the selected EPI centers for DTP1 were eligible to participate in the study, provided that the mother had been living in the area for last six months or more.","All children visiting selected EPI centers DTP1 eligible participate study, provided mother living months more.",G0000000|C0008059|C0545082|C1707391|G0000000|C0205099|G0000000|C1548635|G0000000|C0557651|C1999230|C0026591|C0376558|C0439231|C0205172
Participants will be consented and enrolled by the research assistant on the first visit.,Participants consented enrolled assistant visit.,C0679646|C2711213|G0000000|C0011327|C0545082
"Exclusion criteria included diarrhea lasting <1 or >5 days, a recent history of diarrhea indicated either by parents/guardian or hospital case notes, underlying chronic gastrointestinal disease, undernutrition (weight/height ratio below the 5th percentile), systemic infection, and immune defects or immunosuppressive treatment.","Exclusion criteria included diarrhea lasting <1 >5 days, history diarrhea parents/guardian hospital notes, underlying chronic gastrointestinal disease, undernutrition (weight/height ratio 5th percentile), systemic infection, immune defects immunosuppressive treatment.",C0680251|C0243161|C0332257|C0011991|C1517741|G0000000|G0000000|C0439228|C0019664|C0011991|C0030551|C0019994|C1317574|G0000000|C0205191|C0521362|C0012634|C0162429|C0424638|C0456603|G0000000|C1264641|C0205373|C0009450|C0439662|C0243067|C0021081|C0039798
"The number of subjects in each category of respiratory disorders was as follows: upper respiratory tract infection (n = 22, 24.7%); wheezing illness (n = 9, 10.1%); pneumonia with wheezing (n = 30, 33.7%); and pneumonia without wheezing (n = 28, 31.5%).","The subjects category respiratory disorders follows: upper respiratory tract infection (n = 22, 24.7%); wheezing illness (n = 9, 10.1%); pneumonia wheezing (n = 30, 33.7%); pneumonia wheezing (n = 28, 31.5%).",G0000000|C0681850|C0683312|C0521346|C0012634|C0332283|C1282910|C0521346|C1185740|C0009450|G0000000|C0450371|C0043144|C0221423|G0000000|C0450371|C0032285|C0043144|G0000000|C0450371|C0032285|C0043144|G0000000|C0450371
Male and female students in their first year of high school (year 8 in participating states).,Male female students school (year 8 participating states).,C0086582|C0015780|C0038492|C0036375|C0439234|G0000000|C0679823|C1301808
"Patients taking insulin within 12 weeks of the screening visit, patients with type 1 diabetes, history of ketoacidosis, acute renal disease, history of renal transplant, liver disease, a recent (within 3 months) cardiovascular event, hepatic transaminase levels two or more times the upper limit of normal, thyroid stimulating hormone outside the reference range, or triglycerides >600 mg/dL were excluded from participation.","Patients insulin 12 weeks screening visit, patients type 1 diabetes, history ketoacidosis, acute renal disease, history renal transplant, liver disease, (within 3 months) cardiovascular event, hepatic transaminase levels times upper limit normal, thyroid stimulating hormone reference range, triglycerides >600 mg/dL excluded participation.",C0030705|C0021641|C0450371|C0439230|C0220908|C0545082|C0030705|C0332307|G0000000|C0011847|C0019664|C0022638|C0205178|C0022646|C0012634|C0019664|C0022646|C0040732|C0023884|C0012634|G0000000|G0000000|C0439231|C0007226|C0441471|C0205054|C0002594|C0441889|C0040223|C1282910|C0439801|C0205307|C0040132|C1948023|C0019932|C1514811|C1514721|C0041004|C1442061|C0439269|C1554077|C0679823
"Stroop Test.51 This test of selective attention and response inhibition has 3 trials lasting 45 seconds each: (1) color naming, (2) color reading, and (3) color-word interference, also known as the Stroop effect.","Stroop Test.51 This test selective attention response inhibition 3 trials lasting 45 each: (1) color naming, (2) color reading, (3) color-word interference, Stroop effect.",G0000000|C0022885|G0000000|C0022885|C0036576|C0004268|C0871261|C0021467|G0000000|C0008976|C1517741|C0450371|G0000000|G0000000|C0009393|C0233735|G0000000|C0009393|C0034754|G0000000|C0009393|C0521102|G0000000|C1280500
"Participants will be excluded if they have a Mini-Mental State Examination score [20] of < 20, have insufficient communication skills to participate in assessment and intervention, have a medical condition which precludes exercise (eg.","Participants excluded Mini-Mental State Examination score [20] < 20, insufficient communication skills participate assessment intervention, medical condition precludes exercise (eg.",C0679646|C1554077|C0445542|C1301808|G0000000|C0449820|C0450371|G0000000|C0450371|C0205412|C0009452|C0678856|G0000000|C1261322|C0886296|C0199168|C0012634|G0000000|C0015259|C0013715
Inclusion criteria were planned pancreatoduodenectomy at one of the participating academic centers and age more than 18 years.,Inclusion criteria planned pancreatoduodenectomy participating academic centers age 18 years.,C0007637|C0243161|C1301732|C0085162|C0679823|C1510747|C0205099|C0001779|C0450371|C0439234
The primary outcome was self-reported use of emergency contraception.,The primary outcome self-reported emergency contraception.,G0000000|C0205225|C1274040|C0681906|C0013956|C0700589
The OUSD School Board passed an asthma policy that requires that the District to maintain an unspecified system for identifying students with current asthma and to designate a nurse to be responsible for asthma-related activities.,The OUSD School Board passed asthma policy requires District maintain unspecified system identifying students current asthma designate nurse responsible asthma-related activities.,G0000000|G0000000|C0036375|C0972401|C2828386|C0004096|C0242456|G0000000|G0000000|C0024501|C0205370|C0449913|G0000000|C0038492|C0521116|C0004096|G0000000|C0028661|C1273518|C0004096|C0441655
"We used advertisements in CHS clinics, the local media, and pharmacies to invite individuals suffering from NLC to participate in the trial.","We advertisements CHS clinics, local media, pharmacies invite individuals suffering NLC participate trial.",G0000000|C0949214|G0000000|C0442592|C0205276|C0009458|C0031322|G0000000|C0027361|C0683278|G0000000|G0000000|C0008976
"All consecutive patients (18 years or older) who had been admitted to an ED, taking at least one medication or had been prescribed a minimum of one prescription medication before admission, who had been assessed as triage I and II on admission and who had been hospitalised for at least 24 hours were eligible for inclusion.","All consecutive patients (18 older) admitted ED, medication prescribed minimum prescription medication admission, assessed triage I II admission hospitalised 24 hours eligible inclusion.",G0000000|C1707491|C0030705|C0450371|C0580836|C0184666|C3538926|C0013227|C0278329|C1524031|C0033080|C0013227|C0184666|C1516048|C0040861|C0021966|G0000000|C0184666|G0000000|C0450371|C0439227|C1548635|C0007637
"After diagnosis, roughly 40 % of patients continue to experience at least two seizures per year [2] and the consequences for this group include elevated risks of injury, depression, and premature death [1].","After diagnosis, roughly 40 % patients continue experience seizures [2] consequences elevated risks injury, depression, premature death [1].",G0000000|C0011900|G0000000|C0450371|G0000000|C0030705|C0549178|C0237607|C0036572|G0000000|C0686907|C0205250|C0035647|C3263722|C0011570|C0151526|C0011065|G0000000
The children had never previously received medical treatment for ADHD.,The children received medical treatment ADHD.,G0000000|C0008059|C1514756|C0199168|C0039798|C1263846
Sixty-four perinatally HIV-infected children and adolescents who were aged 6 to 16 years underwent screening.,Sixty-four perinatally HIV-infected children adolescents aged 6 16 underwent screening.,C3816724|G0000000|C0019682|C0008059|C0205653|C0001779|G0000000|C0450371|G0000000|C0220908
Eligible participants had residual upper extremity spastic hemiparesis following a single cortical or subcortical ischemic stroke.,Eligible participants residual upper extremity spastic hemiparesis single cortical subcortical ischemic stroke.,C1548635|C0679646|C1609982|C1282910|C0015385|C0026838|C0018989|C0037179|C0001613|C0815275|C0475224|C0038454
"Patients with a history of COPD for at least 12 months, associated with chronic productive cough for at least three months, in each of the two years prior to baseline visit will be recruited into the study.","Patients history COPD 12 months, chronic productive cough months, prior baseline visit recruited study.",C0030705|C0019664|C0024117|C0450371|C0439231|C0205191|C0033268|C0010200|C0439231|C0332152|C0168634|C0545082|G0000000|C0557651
"Twenty-four patients with stroke, who were hospitalized at the K Hospital in Seoul, were selected based on the following selection criteria: (1) stroke of >6 months duration; (2) a score of >24 points on the Korean version of the Mini-Mental State Examination; (3) ability to walk a distance of 10 m with or without an auxiliary device17); (4) no history of orthopedic conditions involving the lower limbs; (5) ability to follow instructions and perform the exercise programs; and (6) no visual or hearing impairment18).","Twenty-four patients stroke, hospitalized K Hospital Seoul, selected based selection criteria: (1) stroke >6 months duration; (2) score >24 Korean version Mini-Mental State Examination; (3) ability walk distance 10 m auxiliary device17); (4) history orthopedic conditions involving lower limbs; (5) ability follow instructions perform exercise programs; (6) visual hearing impairment18).",C3715070|C0030705|C0038454|C0701159|C0597277|C0019994|C3850150|C1707391|C1527178|C0036576|C0243161|G0000000|C0038454|G0000000|C0439231|C0449238|G0000000|C0449820|C0450371|C1556095|C0333052|C0445542|C1301808|G0000000|G0000000|C0085732|C0080331|C0012751|G0000000|G0000000|G0000000|G0000000|C0019664|C0029355|C0012634|C1314939|C0441994|C0015385|G0000000|C0085732|C0332283|C0302828|C0884358|C0015259|C0376691|G0000000|C0234621|C0018767|G0000000
"For this pilot study, twenty pregnant immigrant women with GDM followed up at the Metabolic Disease and Diabetology Unit of Padova University between January and June 2008 were enrolled.","For pilot study, twenty pregnant immigrant women GDM Metabolic Disease Diabetology Unit Padova University January June 2008 enrolled.",G0000000|C0473169|C0557651|C0724000|C0549206|C0282163|C0043210|C0085207|C0311400|C0012634|C1441552|C0439148|G0000000|C0041740|C3829466|C3829443|G0000000|G0000000
Persons were eligible for study inclusion if they were not taking antihypertensive medication and had a mean systolic BP (SBP) of 130 to 159 or diastolic BP (DBP) of 85 to 99 mm Hg based on 4 screening visits.,Persons eligible study inclusion antihypertensive medication systolic BP (SBP) 130 159 diastolic BP (DBP) 85 99 mm Hg based 4 screening visits.,C0027361|C1548635|C0557651|C0007637|C0003364|C0013227|C0039155|C0037623|G0000000|C1442061|C1442061|C0012000|C0037623|C0536221|C0450371|C0450371|G0000000|C0025424|C1527178|G0000000|C0220908|C0545082
"Our hospital, one of the leading national tertiary centres in China and the best referral centre in Yunnan province, had the lowest rates of caesareans of all types and of primary caesareans – 40.3% and 35.4%, respectively – among all tertiary referral centres in China.","Our hospital, leading national tertiary centres China referral centre Yunnan province, lowest rates caesareans types primary caesareans – 40.3% 35.4%, – tertiary referral centres China.",G0000000|C0019994|C0332152|C3245503|C0205372|C0205099|C0008115|C0034927|C0205099|G0000000|C1514578|C1708760|C0871208|G0000000|C0332307|C0205225|G0000000|G0000000|C0450371|C0450371|G0000000|C0205372|C0034927|C0205099|C0008115
"A total of 45 subjects, age ≥18 years, with chronic wounds of duration ≥6 weeks were enrolled after informed written consent.","A total 45 subjects, age ≥18 years, chronic wounds duration ≥6 weeks enrolled informed written consent.",G0000000|C0439175|C0450371|C0681850|C0001779|G0000000|C0439234|C0205191|C0021501|C0449238|G0000000|C0439230|G0000000|C1522154|C0043266|C1511481
Social smile is usually absent in a child with Autism?,Social smile absent child Autism?,C0728831|C0037363|C0332197|C0008059|C0004352
"Exclusion criteria were pregnant and lactating women, advanced disease of vital organs, history of sensitivity to acyclovir or cetirizine, and suspicion of mimicking diseases (fungal infection, psoriasis, or eczema).","Exclusion criteria pregnant lactating women, advanced disease vital organs, history sensitivity acyclovir cetirizine, suspicion mimicking diseases (fungal infection, psoriasis, eczema).",C0680251|C0243161|C0549206|C2828358|C0043210|C0205179|C0012634|C0442732|C0178784|C0019664|C0020517|C0001367|C0055147|C0242114|G0000000|C0012634|C0016832|C0009450|C0033860|C0013595
"Individuals who reported acute distress due to sexual revictimization in the past month, impaired mental status, or extreme distress evidenced by suicidal intention or severe depressive symptomatology (≥30 on the Beck Depression Inventory; Beck & Steer, 1993) were excluded and referred to services as appropriate.","Individuals reported acute distress sexual revictimization month, impaired mental status, extreme distress evidenced suicidal intention severe depressive symptomatology (≥30 Beck Depression Inventory; Beck & Steer, 1993) excluded referred services appropriate.",C0027361|C0684224|C0205178|C0231303|C0036864|G0000000|C0332177|C0221099|C0229992|C0449438|C0205403|C0231303|C3887511|C0438696|C0162425|C0205082|G0000000|G0000000|G0000000|G0000000|C0011570|C0021941|G0000000|G0000000|C0553654|G0000000|C1554077|C0205543|C0557854|C1548787
"Inclusion criteria were 18-25 years of age, living in a dormitory, nonsmoker, no systemic disease, not taking OCP and other hormonal and herbal drugs prior to and during menstrual cycle, a regular menstruation condition, and suffering from moderate to severe primary dysmenorrhea.","Inclusion criteria 18-25 age, living dormitory, nonsmoker, systemic disease, OCP hormonal herbal drugs prior menstrual cycle, regular menstruation condition, suffering moderate severe primary dysmenorrhea.",C0007637|C0243161|C0450371|C0001779|C0376558|C0870443|C0337672|C0205373|C0012634|C1282359|C0458083|C3146288|C0013227|C0332152|C0025344|C1511572|C0205272|C0025344|C0012634|C0683278|C0205081|C0205082|C0205225|C0013390
"Patients >25 years requiring surgeries around the hip joint who underwent surgery within 2 weeks of sustaining trauma, and were operated under spinal anesthesia were enrolled.","Patients >25 requiring surgeries hip joint underwent surgery 2 weeks sustaining trauma, operated spinal anesthesia enrolled.",C0030705|C0450371|G0000000|C0543467|C0019552|C0022417|G0000000|C0038894|G0000000|C0439230|C0443318|C0043251|C3242339|C0521329|C0002903|G0000000
"All subjects met the following inclusion criteria: adults between the ages of 18 and 65 with a diagnosis of MS greater than 1 year, no history of exacerbation within 6 months prior to study, no regular participation in an aerobic exercise program within 6 months prior to the study, the ability to walk independently 100 meters with or without resting (may use intermittent or constant unilateral assistance such as a cane, crutch, or a brace), and an Expanded Disability Status Score28 (EDSS) ≤ 6.0.","All subjects met inclusion criteria: adults ages 18 65 diagnosis MS 1 year, history exacerbation 6 months prior study, regular participation aerobic exercise program 6 months prior study, ability walk independently 100 meters resting (may intermittent constant unilateral assistance cane, crutch, brace), Expanded Disability Status Score28 (EDSS) ≤ 6.0.",G0000000|C0681850|C0268621|C0007637|C0243161|C0001675|C0001779|C0450371|C0450371|C0011900|C0039676|G0000000|C0439234|C0019664|G0000000|G0000000|C0439231|C0332152|C0557651|C0205272|C0679823|C1510824|C0015259|C1709697|G0000000|C0439231|C0332152|C0557651|C0085732|C0080331|G0000000|C1442061|C0441074|C0035253|G0000000|C0205267|C1547014|C0205092|C0018896|C0006856|C0010397|C0006086|C0205229|C0231170|C0449438|G0000000|C0451246|G0000000|G0000000
"Schools were excluded from participation if they: (1) were non-community schools (eg, charter schools and magnet schools)’ (2) already had PA or a similar intervention; (3) had an enrollments below 50 or above 140 students per grade; (4) had annual student mobility rates over 40%; (5) had more than 50% of students who passed the Illinois State Achievement Test (ISAT); and (6) had fewer than 50% of students who received free lunch.","Schools excluded participation they: (1) non-community schools (eg, charter schools magnet schools)’ (2) PA intervention; (3) enrollments 50 140 students grade; (4) annual student mobility rates 40%; (5) 50% students passed Illinois State Achievement Test (ISAT); (6) fewer 50% students received free lunch.",C0036375|C1554077|C0679823|G0000000|G0000000|C1518422|C0036375|C0013715|G0000000|C0036375|C0024483|G0000000|G0000000|C0030428|C0886296|G0000000|C1516879|C0450371|C1442061|C0038492|C0441800|G0000000|C0332181|C0038492|C0425245|C0871208|C0450371|G0000000|C0450371|C0038492|C2828386|C0020898|C1301808|C0001072|C0022885|G0000000|G0000000|C0205388|C0450371|C0038492|C1514756|C0332296|C2697949
"Eligible participants include all patients aged 35 to 70 years who smoke, who consult their primary care team during regular office hours for any reason during the inclusion period, and who meet all inclusion criteria and none of the exclusion criteria, as follows: Inclusion criteria: active cigarette smoker with a cumulative habit of more than 10 packs/year.","Eligible participants patients aged 35 70 smoke, consult primary care team regular office hours reason inclusion period, meet inclusion criteria exclusion criteria, follows: Inclusion criteria: active cigarette smoker cumulative habit 10 packs/year.",C1548635|C0679646|C0030705|C0001779|C0450371|C0450371|C0037366|C0009818|C0205225|C1947933|C0871489|C0205272|C0442603|C0439227|C0392360|C0007637|C0439531|C1550543|C0007637|C0243161|C0680251|C0243161|C0332283|C0007637|C0243161|C0205177|C0677453|C0337664|C1511559|C0018464|C0450371|C1277691
"In the present study, vitamin D supplement was administered to pregnant women with history of preeclampsia in previous pregnancies.","In study, vitamin D supplement administered pregnant women history preeclampsia previous pregnancies.",G0000000|C0557651|C0042890|C0073187|C0242295|C1521801|C0549206|C0043210|C0019664|C0032914|C0205156|C0032961
A total 78 patients with MDR TB were included.,A total 78 patients MDR TB included.,G0000000|C0439175|C0450371|C0030705|G0000000|G0000000|C0332257
rheumatoid arthritis).,rheumatoid arthritis).,G0000000|C0003864
"In all, 655 patients were enrolled and randomly assigned.","In all, 655 patients enrolled randomly assigned.",G0000000|G0000000|C1442061|C0030705|G0000000|G0000000|C1516050
"In March-April 2012, we recruited Hopi mothers or female guardians with daughters aged 9–12 years for a cluster-randomized intervention study on the Hopi Reservation.","In March-April 2012, recruited Hopi mothers female guardians daughters aged 9–12 cluster-randomized intervention study Hopi Reservation.",G0000000|C3829202|G0000000|G0000000|C0574606|C0026591|C0015780|C1274041|C0011011|C0001779|G0000000|C1555715|C0886296|C0557651|C0574606|C1514889
"Catumaxomab showed a clear clinical benefit in patients with malignant ascites secondary to epithelial cancers, especially gastric cancer, with an acceptable safety profile.","Catumaxomab clinical benefit patients malignant ascites secondary epithelial cancers, gastric cancer, acceptable safety profile.",C1831854|C0205210|C0814225|C0030705|C0205282|C0003962|C0027627|C0221908|C0006826|C0038351|C0006826|C1879533|C0036043|C1979963
"These 20 clinics included four community health centers, nine hospital-based clinics, and seven off-site practices.","These 20 clinics included community health centers, hospital-based clinics, off-site practices.",G0000000|C0450371|C0442592|C0332257|C0009462|C0018684|C0205099|C0019994|C0442592|C3828730|C0237607
The aim of this study was to investigate the effects of intramuscular BoNT-A injection on orofacial motor events during sleep in patients with clinical diagnosis of SB.,The aim study investigate effects intramuscular BoNT-A injection orofacial motor events sleep patients clinical diagnosis SB.,G0000000|C1947946|C0557651|C1292732|C1280500|C0021492|G0000000|C0021485|C2827582|C1513492|C0441471|C0037313|C0030705|C0205210|C0011900|C0038111
"BACKGROUND: Although oral appliances are effective in some patients with obstructive sleep apnoea (OSA), they are not universally effective.","BACKGROUND: Although oral appliances effective patients obstructive sleep apnoea (OSA), universally effective.",C1706907|G0000000|C0442027|C0243112|C1280519|C0030705|C0549186|C0037313|C0003578|C0520679|G0000000|C1280519
Chronic Obstructive Pulmonary Disease (COPD) is recognized as a major public health problem with an increasing morbidity and mortality.,Chronic Obstructive Pulmonary Disease (COPD) recognized major public health increasing morbidity mortality.,C0205191|C0549186|C0024109|C0012634|C0024117|G0000000|C0205082|G0000000|C0018684|C0442808|C0026538|C0026565
"Given this, recruitment of 128 services into the trial at baseline would be sufficient to provide follow-up data from approximately 102 childcare services (51 per group) and enable the detection of an absolute difference between groups in the proportion of services implementing all policies and practices of 27 with 80 % power and an alpha value of 0.05.","Given this, recruitment 128 services trial baseline sufficient provide follow-up data 102 childcare services (51 group) enable detection absolute difference proportion services implementing policies practices 27 80 % power alpha 0.05.",C1442162|G0000000|C2949735|C1442061|C0557854|C0008976|C0168634|C0205410|C1999230|C0589120|C1511726|C1442061|C0008067|C0557854|C0450371|C0441833|C0562342|C1511790|C0205344|C1705241|C1709707|C0557854|G0000000|C0242456|C0237607|C0450371|C0450371|G0000000|C0032863|C0439095|C0450371
gambiae s.s. or An.,gambiae s.s. An.,G0000000|C0565930|G0000000
Most patients had metastatic disease and more than 50 % of patients in each arm have undergone gastrectomy (primary tumor resection) as part of curative or palliative treatment.,Most patients metastatic disease 50 % patients arm undergone gastrectomy (primary tumor resection) curative palliative treatment.,C0205393|C0030705|C0036525|C0012634|C0450371|G0000000|C0030705|C0446516|G0000000|C0017118|C0205225|C0027651|C0015252|C1880198|C0587605|C0039798
"A M. ulcerans case was defined by a lesion clinically suggestive of M. ulcerans plus any of (1) a culture of M. ulcerans from the lesion, (2) a positive polymerase chain reaction (PCR) test from a swab or biopsy of the lesion, or (3) histopathology of an excised lesion showing a necrotic granulomatous lesion with the presence of acid-fast bacilli (AFB) consistent with acute M. ulcerans infection.","A M. ulcerans defined lesion clinically suggestive M. ulcerans (1) culture M. ulcerans lesion, (2) positive polymerase chain reaction (PCR) test swab biopsy lesion, (3) histopathology excised lesion necrotic granulomatous lesion presence acid-fast bacilli (AFB) consistent acute M. ulcerans infection.",G0000000|C0369637|G0000000|C1704788|C0221198|G0000000|C0332299|C0369637|G0000000|G0000000|C0010453|C0369637|G0000000|C0221198|G0000000|C0439178|C1335439|C0337112|C0443286|C0032520|C0022885|C0183753|C0005558|C0221198|G0000000|C0243140|G0000000|C0221198|C0027540|C0439667|C0221198|C0150312|C1318720|C0004587|C0483226|C0332290|C0205178|C0369637|G0000000|C0009450
One hundred and thirteen children completed the study and are included in this analysis (see Figure 1).,One thirteen children completed study included analysis (see Figure 1).,C0205447|C3715149|C0008059|C0205197|C0557651|C0332257|C0002778|C0042789|G0000000|G0000000
"The prevalence of MetS at enrollment was 46.5%, with 40.7% taking medication for cholesterol, diabetes, or blood pressure among ALL participants.","The prevalence MetS enrollment 46.5%, 40.7% medication cholesterol, diabetes, blood pressure ALL participants.",G0000000|C0033105|C0812270|C1516879|C0450371|C0450371|C0013227|C0008377|C0011847|C0005767|C0033095|C0444868|C0679646
Eligible participants will also have a history of falls or be identified as being at risk of falls on assessment.,Eligible participants history falls identified risk falls assessment.,C1548635|C0679646|C0019664|C0000921|C0205396|C0035647|C0000921|C1261322
"Exclusion criteria were known sarcoidosis, osteomalacia, renal dysfunction or tuberculosis.","Exclusion criteria sarcoidosis, osteomalacia, renal dysfunction tuberculosis.",C0680251|C0243161|C0036202|C0029442|C0022646|C0031847|C0041296
Eighty-eight stage II and III breast cancer outpatients were randomly assigned to receive yoga (n = 44) or brief supportive therapy (n = 44) prior to their radiotherapy treatment.,Eighty-eight stage II III breast cancer outpatients randomly assigned receive yoga (n = 44) supportive therapy (n = 44) prior radiotherapy treatment.,C3816958|C0205390|G0000000|C0439070|C0006141|C0006826|C0029921|G0000000|C1516050|C1514756|C0043418|C0369718|G0000000|C0450371|C1521721|C0039798|C0369718|G0000000|C0450371|C0332152|C0034619|C0039798
"Pregnant women were enrolled at a maternal health clinic in inner-city Dhaka, Bangladesh (23°N) in February 2010 if they were: Aged 18 to <35 years; at 27 to <31 completed weeks of gestation based on the reported first day of the last menstrual period; held permanent residence in Dhaka at a fixed address; and, planned to stay in Dhaka for at least four months.","Pregnant women enrolled maternal health clinic inner-city Dhaka, Bangladesh (23°N) February 2010 were: Aged 18 <35 years; 27 <31 completed weeks gestation based reported day menstrual period; held permanent residence Dhaka fixed address; and, planned stay Dhaka months.",C0549206|C0043210|G0000000|C2347083|C0018684|C0002424|C0557849|G0000000|C0004732|G0000000|C3830166|G0000000|G0000000|C0001779|C0450371|C0450371|C0439234|C0450371|C0450371|C0205197|C0439230|C0032961|C1527178|C0684224|C0332173|C0025344|C0439531|C0675390|C0205355|C0237096|G0000000|C0443218|C0376649|G0000000|C1301732|G0000000|G0000000|C0439231
Patients requiring prednisolone at a dose of >1 mg/kg on alternate days to maintain remission but without the above features of steroid toxicity were treated with the combination of levamisole (2 mg/kg on alternate days) and alternate-day prednisolone as above.,Patients requiring prednisolone dose >1 mg/kg alternate days maintain remission features steroid toxicity treated combination levamisole (2 mg/kg alternate days) alternate-day prednisolone above.,C0030705|G0000000|C0032950|C0178602|G0000000|C0439272|C0332270|C0439228|C0024501|C0544452|C1521970|C0038317|C0040539|C1522326|C0205195|C0023556|G0000000|C0439272|C0332270|C0439228|C0558287|C0032950|C1282910
"Patients with PAH (idiopathic [IPAH] or associated with connective tissue disease [APAH-CTD]) taking bosentan (62.5 or 125 mg twice daily at a stable dose for ≥3 months) were randomized (1:1) to sildenafil (20 mg, 3 times daily; n = 50) or placebo (n = 53).","Patients PAH (idiopathic [IPAH] connective tissue disease [APAH-CTD]) bosentan (62.5 125 daily stable dose ≥3 months) randomized (1:1) sildenafil (20 mg, 3 times daily; = 50) placebo (n = 53).",C0030705|C3203102|C0332240|C0152171|G0000000|C0040300|C0012634|C0245778|C0252643|C0450371|C1442061|C0332173|C0205360|C0178602|G0000000|C0439231|C0034656|G0000000|C0529793|C0450371|C0026410|G0000000|C0040223|C0332173|G0000000|C0450371|C0032042|C0369718|G0000000|C0450371
"Apneas and hypopneas were scored from polysomnography records using the Chicago criteria.27 A cutoff of 15/h using these criteria corresponds to approximately 5/h using more recent AASM “recommended” criteria.28,29 Exclusion criteria were existing treatment(s) for OSA; mobility-limiting problems inhibiting lateral sleep; and a cardiac pacemaker (given unknown potential for device interference).","Apneas hypopneas scored polysomnography records Chicago criteria.27 A cutoff 15/h criteria corresponds 5/h AASM “recommended” criteria.28,29 Exclusion criteria existing treatment(s) OSA; mobility-limiting inhibiting lateral sleep; cardiac pacemaker (given unknown potential device interference).",C0003578|C0235546|C0449820|C0162701|C0034869|C0008044|C0243161|G0000000|C1442160|C0450371|C0243161|G0000000|C0033727|G0000000|G0000000|C0243161|C0680251|C0243161|C2987476|C0039798|C0520679|C0425245|C3463820|C0205093|C0037313|C0018787|C0030163|C1442162|C0439673|C3245505|C0025080|C0521102
Patients were irradiated with a dose of 50 Gy during 5 weeks with a dose per fraction of 2 Gy.,Patients irradiated dose 50 Gy 5 weeks dose fraction 2 Gy.,C0030705|C1522449|C0178602|C0450371|C0018408|G0000000|C0439230|C0178602|C1264633|G0000000|C0018408
"HIV-infected subjects, naïve to ART without evidence of resistance to the antiretrovirals in the regimen and with HIV-1 RNA>1000 copies/ml, were eligible if they met the following criteria: screening 25(OH)D level ≥ 10 and <75 ng/mL (≥25 and <188 nmol/L), CrCl ≥60 ml/min by Cockcroft-Gault, and serum calcium <10.5 mg/dl.","HIV-infected subjects, naïve ART evidence resistance antiretrovirals regimen HIV-1 RNA>1000 copies/ml, eligible met criteria: screening 25(OH)D level ≥ 10 <75 ng/mL (≥25 <188 nmol/L), CrCl ≥60 ml/min Cockcroft-Gault, serum calcium <10.5 mg/dl.",C0019682|C0681850|G0000000|C0003826|C3887511|C0237834|G0000000|C0040808|C0019682|C0035668|C1531853|C1548635|C0268621|C0243161|C0220908|C0450371|C0441889|G0000000|C0450371|C0450371|C0439275|G0000000|C1442061|C0439282|C1846718|G0000000|C0439445|G0000000|C0229671|C0006675|C0450371|C0439269
"From July 5th, 2005, to June 22nd, 2007, 51 patients with 14 open and 37 closed tibial fractures were treated with reamed intramedullary nailing.","From July 5th, 2005, June 22nd, 2007, 51 patients 14 37 closed tibial fractures treated reamed intramedullary nailing.",G0000000|C3829447|G0000000|G0000000|C3829443|G0000000|G0000000|C0450371|C0030705|C0450371|C0450371|C0587267|C0040184|C0016658|C1522326|G0000000|C1512957|C0021885
The exclusion criteria were (1) significant encephalopathy that would make it difficult to participate; (2) hospitalized patients; (3) active gastrointestinal bleeding; (4) inability to sign an informed consent; (5) diabetes; and (6) receiving glucocorticoid therapy.,The exclusion criteria (1) encephalopathy difficult participate; (2) hospitalized patients; (3) active gastrointestinal bleeding; (4) inability sign informed consent; (5) diabetes; (6) receiving glucocorticoid therapy.,G0000000|C0680251|C0243161|G0000000|C0006111|C0332218|G0000000|G0000000|C0701159|C0030705|G0000000|C0205177|C0521362|C0019080|G0000000|G0000000|C0311392|C1522154|C1511481|G0000000|C0011847|G0000000|C1514756|C0017710|C0039798
"Among baseline daily smokers, increased self-efficacy to resist smoking in stressful situations statistically mediated 56.9% of the intervention’s effect (p < .001).","Among baseline daily smokers, increased self-efficacy resist smoking stressful situations statistically mediated 56.9% intervention’s (p < .001).",G0000000|C0168634|C0332173|C0337664|C0205217|C0600564|G0000000|C0037369|C0231297|G0000000|C0038215|C0086597|C0450371|G0000000|C0369773|G0000000|C1442061
"In contrast, disease progression was reported for 2 of 3 breast cancer patients and only 2 out of 6 ovarian cancer patients.","In contrast, disease progression reported 2 3 breast cancer patients 2 6 ovarian cancer patients.",G0000000|C0009924|C0012634|C0242656|C0684224|G0000000|G0000000|C0006141|C0006826|C0030705|G0000000|G0000000|C0205065|C0006826|C0030705
"The 129 unmarried girls, aged 15–19, who completed the pre-intervention survey met the following study inclusion criteria: sexually active with a male partner in the past 3 months, not pregnant and no births within the past 3 months, and able to participate in an English-language intervention.","The 129 unmarried girls, aged 15–19, completed pre-intervention survey met study inclusion criteria: sexually active male partner 3 months, pregnant births 3 months, participate English-language intervention.",G0000000|C1442061|C0037179|C0870604|C0001779|G0000000|C0205197|C2347663|C0038951|C0268621|C0557651|C0007637|C0243161|C0036864|C0205177|C0086582|C0682323|G0000000|C0439231|C0549206|C0005615|G0000000|C0439231|G0000000|C0376245|C0886296
Chronic lung disease (CLD) was defined as oxygen dependency at 36 weeks of gestation.,Chronic lung disease (CLD) defined oxygen dependency 36 weeks gestation.,C0205191|C0024109|C0012634|G0000000|C1704788|C0030054|C0011546|C0450371|C0439230|C0032961
Results The median age of the patients with measles was 5.4 (range 0.49-24.8) years.,Results The median age patients measles 5.4 (range 0.49-24.8) years.,C1274040|G0000000|C0549183|C0001779|C0030705|C0025007|G0000000|C1514721|C0450371|C0439234
The study will recruit 230 community-dwelling participants diagnosed with Alzheimer's disease.,The study recruit 230 community-dwelling participants diagnosed Alzheimer's disease.,G0000000|C0557651|G0000000|C1442061|C4045975|C0679646|C0011900|G0000000|C0012634
"Eligible participants were breast cancer survivors with a BMI ≥ 25.0 kg/m2, diagnosed in the 5 years before enrollment with stage 0 to 3 breast cancer, who had completed chemotherapy and/or radiation therapy at least 3 months before enrollment.","Eligible participants breast cancer survivors BMI ≥ 25.0 kg/m2, diagnosed 5 enrollment stage 0 3 breast cancer, completed chemotherapy and/or radiation therapy 3 months enrollment.",C1548635|C0679646|C0006141|C0006826|C0206194|G0000000|G0000000|C0450371|C0022718|C0011900|G0000000|C1516879|C0205390|G0000000|G0000000|C0006141|C0006826|C0205197|C0013216|G0000000|C0034519|C0039798|G0000000|C0439231|C1516879
"Among all hospitalized patients, subjects who presented with respiratory disorders were eligible as study subjects and classified into four groups based on their respiratory disorders: upper respiratory tract infection, wheezing illness, pneumonia with wheezing, and pneumonia without wheezing (Figure 1).","Among hospitalized patients, subjects respiratory disorders eligible study subjects classified based respiratory disorders: upper respiratory tract infection, wheezing illness, pneumonia wheezing, pneumonia wheezing (Figure 1).",G0000000|C0701159|C0030705|C0681850|C0521346|C0012634|C1548635|C0557651|C0681850|C0008902|C1527178|C0521346|C0012634|C1282910|C0521346|C1185740|C0009450|C0043144|C0221423|C0032285|C0043144|C0032285|C0043144|G0000000|G0000000
"We show that an intervention that identifies and modifies three sources of potential triggers of problem behaviors has immediate positive effects on the most problematic behavior identified by caregivers, and caregiver upset with and confidence managing that behavior.","We intervention identifies modifies sources potential triggers behaviors positive effects problematic behavior identified caregivers, caregiver upset confidence managing behavior.",G0000000|C0886296|G0000000|C0392747|C0449416|C3245505|C0032930|C0004927|C0439178|C1280500|G0000000|C0004927|C0205396|C0085537|C0085537|C3887804|C0237529|C1273870|C0004927
47 children aged six months to five years with prolonged febrile seizure (at least 10 minutes) during a 12 month period.,47 children aged months prolonged febrile seizure (at 10 minutes) 12 month period.,C0450371|C0008059|C0001779|C0439231|C0439590|C0015967|C0036572|G0000000|C0450371|C0439232|C0450371|C0332177|C0439531
Patients with idiopathic PD at Hoehn and Yahr stages 1–3 were enrolled in the study.,Patients idiopathic PD Hoehn Yahr stages 1–3 enrolled study.,C0030705|C0332240|G0000000|G0000000|G0000000|C1306673|G0000000|G0000000|C0557651
"Comorbid conditions, work disability, and low back pain co-treatments were self-reported by patients, but were not verified through medical or employment records.","Comorbid conditions, disability, low pain co-treatments self-reported patients, verified medical employment records.",C0009488|C0012634|C0231170|C0205251|C0030193|C0814472|C0681906|C0030705|C1711411|C0199168|C0014003|C0034869
"Although chemotherapy has been shown to increase survival for women with ovarian cancer, most eventually relapse and die (Harries and Gore, 2002b).","Although chemotherapy increase survival women ovarian cancer, eventually relapse die (Harries Gore, 2002b).",G0000000|C0013216|C0442805|C0038952|C0043210|C0205065|C0006826|G0000000|C0035020|C0011065|G0000000|G0000000|G0000000
We report results from a randomised double blind trial of four monthly supplementation with oral vitamin D3 on fractures and mortality in 2686 men and women aged 65-85 years living in the community.,We report randomised double blind trial monthly supplementation oral vitamin D3 fractures mortality 2686 women aged 65-85 living community.,G0000000|C0684224|G0000000|C0205173|C0150108|C0008976|C0332177|C0242297|C0442027|C0042890|C3538936|C0016658|C0026565|G0000000|C0043210|C0001779|C0450371|C0376558|C0009462
"Historically, metastatic melanoma has been considered relatively refractory to systemic therapy.","Historically, metastatic melanoma considered refractory systemic therapy.",G0000000|C0036525|C0025202|C0750591|C0205269|C0205373|C0039798
EDSS is Expanded Disability Status Scale; MS is multiple sclerosis; POS-S-MS is Palliative Care Outcome Scale-Symptoms-Multiple Sclerosis.,EDSS Expanded Disability Status Scale; MS multiple sclerosis; POS-S-MS Palliative Care Outcome Scale-Symptoms-Multiple Sclerosis.,C0451246|C0205229|C0231170|C0449438|C0175659|C0039676|C0439064|C0036429|C1262869|C0587605|C1947933|C1274040|C0175659|C0036429
"For our study we examined data from 4 API communities served by REACH: 2 Vietnamese communities (1 in Los Angeles County and Orange County, California, and 1 in Santa Clara County, California) that targeted breast and cervical cancer; a Cambodian community in Lowell, Massachusetts, that targeted cardiovascular disease; and an API community in King County, Washington, that targeted diabetes.","For study examined data 4 API communities served REACH: 2 Vietnamese communities (1 Los Angeles County Orange County, California, 1 Santa Clara County, California) targeted breast cervical cancer; Cambodian community Lowell, Massachusetts, targeted cardiovascular disease; API community King County, Washington, targeted diabetes.",G0000000|C0557651|C0332128|C1511726|G0000000|G0000000|C0009462|G0000000|C2584321|G0000000|C0042660|C0009462|G0000000|G0000000|G0000000|C0079170|C0440277|C0079170|C0006754|G0000000|G0000000|G0000000|C0079170|C0006754|C1521840|C0006141|C0027530|C0006826|C1553323|C0009462|G0000000|C0024874|C1521840|C0007226|C0012634|G0000000|C0009462|G0000000|C0079170|C0043038|C1521840|C0011847
"At diagnosis, a glomerular filtration rate of less than 75% of the lower limit of the normal range for age (<60 ml per minute per 1.73 m2 in children >2 years of age) was an exclusion criterion.","At diagnosis, glomerular filtration rate 75% lower limit normal range age (<60 minute 1.73 m2 children >2 age) exclusion criterion.",G0000000|C0011900|C0022663|C0016107|C0871208|C0450371|C0441994|C0439801|C0205307|C1514721|C0001779|C0450371|C0439232|C0450371|C0025885|C0008059|G0000000|C0001779|C0680251|C0243161
Cumulative CRC incidence at the end of the follow up period was similar in the intervention group and the control group (1.51 v 1.53 per 1000 person years; p=0.76) (table 1 ▶).,Cumulative CRC incidence follow period intervention control (1.51 1.53 1000 person years; p=0.76) (table 1 ▶).,C1511559|C0009402|C0021149|C0332283|C0439531|C0886296|C0243148|C0450371|C0450371|G0000000|C0027361|C0439234|C0369773|C0039224|G0000000|G0000000
"Patients were scheduled for intravenous sedation if they met the following criteria during the initial examination appointment: extremely apprehensive or uncooperative and unlikely to tolerate treatment in the dental clinic with or without nitrous oxide conscious sedation, healthy (ASA I), severe caries that involved 2 or more quadrants of the mouth, likely to require 2 or more oral conscious sedation visits, and parental consent to have children receive intravenous sedation.","Patients scheduled intravenous sedation met criteria initial examination appointment: extremely apprehensive uncooperative tolerate treatment dental clinic nitrous oxide conscious sedation, healthy (ASA I), severe caries involved 2 quadrants mouth, require 2 oral conscious sedation visits, parental consent children receive intravenous sedation.",C0030705|C0086960|C0348016|C0235195|C0268621|C0243161|C0205265|G0000000|C0003629|C0205403|C0233485|C0424350|G0000000|C0039798|C0011365|C0002424|C0028158|C0030015|C0234421|C0235195|C3898900|C0004057|C0021966|C0205082|C0011334|C1314939|G0000000|C1631280|C0226896|G0000000|G0000000|C0442027|C0234421|C0235195|C0545082|C0030551|C1511481|C0008059|C1514756|C0348016|C0235195
"At 6 months, atorvastatin treatment in patients with SPAH, as compared with placebo, had no statistically significant influence on the pulmonary hypertension.","At 6 months, atorvastatin treatment patients SPAH, compared placebo, statistically influence pulmonary hypertension.",G0000000|G0000000|C0439231|C0286651|C0039798|C0030705|G0000000|C1707455|C0032042|C0038215|C4054723|C0024109|C0020538
Controls were selected from children who did not present with acute diarrhoea for at least 14 days before the date of interview.,Controls selected children acute diarrhoea 14 days interview.,C0243148|C1707391|C0008059|C0205178|C0011991|C0450371|C0439228|C0021822
"Finally, subjects were required to have a Fine mortality risk class of I, I, or III (i.e., a risk score of ≤90) (10).","Finally, subjects required Fine mortality risk class I, I, III (i.e., risk score ≤90) (10).",G0000000|C0681850|C1514873|C0205232|C0026565|C0035647|C0456387|C0021966|C0021966|C0439070|C0683454|C0035647|C0449820|G0000000|C0450371
"Exclusion criteria included the use of a long-acting β2-agonist, leukotriene antagonist, or oral corticosteroids in the previous 4 weeks, other significant medical problems, smoking history more than 20 pack years, pregnancy, or inadequate contraception in women of childbearing age.","Exclusion criteria included long-acting β2-agonist, leukotriene antagonist, oral corticosteroids previous 4 weeks, medical problems, smoking history 20 pack years, pregnancy, inadequate contraception women childbearing age.",C0680251|C0243161|C0332257|C0205166|G0000000|C0023545|C0231491|C0442027|C0001617|C0205156|G0000000|C0439230|C0199168|C1546466|C0037369|C0019664|C0450371|C1968515|C0439234|C0032961|C0205412|C0700589|C0043210|G0000000|C0001779
"Participants were randomly assigned to partnered or non-partnered tango and attended 1-hour classes twice per week, completing 20 lessons within 10 weeks.","Participants randomly assigned partnered non-partnered tango attended 1-hour classes week, completing 20 lessons 10 weeks.",C0679646|G0000000|C1516050|C0682323|C1518422|C1332116|C1456498|C0439227|C0456387|C0332174|C0205197|C0450371|G0000000|C0450371|C0439230
The intervention may have made some parents less inclined to stop smoking.,The intervention parents inclined smoking.,G0000000|C0886296|C0030551|G0000000|C0037369
All cases histologically confirmed or diagnosed by operation from January 1993 to July 1995 were collected from cancer registry and a quick-reporting system from hospitals.,All histologically confirmed diagnosed operation January 1993 July 1995 collected cancer registry quick-reporting system hospitals.,G0000000|C0205462|C0521093|C0011900|C0543467|C3829466|G0000000|C3829447|G0000000|C1516695|C0006826|C0034975|C0456962|C0449913|C0019994
The cause of acute fever was determined for 151 patients (51%): 69 patients (23.3%) had leptospirosis; 57 patients (19.3%) had scrub typhus; 14 patients (4.7%) had murine typhus; and 11 patients (3.7%) had evidence of both leptospirosis and a rickettsial infection.,The acute fever determined 151 patients (51%): 69 patients (23.3%) leptospirosis; 57 patients (19.3%) scrub typhus; 14 patients (4.7%) murine typhus; 11 patients (3.7%) evidence leptospirosis rickettsial infection.,G0000000|C0205178|C0015967|G0000000|C1442061|C0030705|C0450371|C0450371|C0030705|C0450371|C0023364|C0450371|C0030705|C0450371|G0000000|C0041471|C0450371|C0030705|G0000000|C0026809|C0041471|C0450371|C0030705|G0000000|C3887511|C0023364|C0220906|C0009450
"The details of the methods that we used in this study have been described previously.17 Briefly, women were recruited at antenatal clinics in Lilongwe, Malawi, where HIV testing is conducted.18 Primary eligibility criteria included an age of at least 14 years, a gestation of 30 weeks or less, a CD4+ lymphocyte count of at least 250 cells per cubic millimeter (≥200 cells per cubic millimeter before July 24, 2006), a hemoglobin level of at least 7 g per deciliter, an alanine aminotransferase level of no more than 2.5 times the upper limit of the normal range, and no serious complications of pregnancy.","The details methods study previously.17 Briefly, women recruited antenatal clinics Lilongwe, Malawi, HIV testing conducted.18 Primary eligibility criteria included age 14 years, gestation 30 weeks less, CD4+ lymphocyte count 250 cells cubic millimeter (≥200 cells cubic millimeter July 24, 2006), hemoglobin level 7 deciliter, alanine aminotransferase level 2.5 times upper limit normal range, complications pregnancy.",G0000000|C1522508|C0025663|C0557651|C0450371|G0000000|C0043210|G0000000|C2828394|C0442592|G0000000|C0024548|C0019682|C0039593|C0004927|C0205225|C0013893|C0243161|C0332257|C0001779|C0450371|C0439234|C0032961|C0450371|C0439230|C0439092|C0285590|C0024264|C0750480|C1442061|C0007634|C1880194|C0439200|G0000000|C0007634|C1880194|C0439200|C3829447|C0450371|G0000000|C0019046|C0441889|G0000000|C0439241|C0001898|C0002594|C0441889|G0000000|C0040223|C1282910|C0439801|C0205307|C1514721|C0009566|C0032961
"General practitioner (GP)-diagnosed patients with chronic bronchitis and COPD from 44 general practices participated in the study, when postbronchodilator forced expiratory volume in one second (FEV1) was between 40%–90% predicted, and FEV1/forced vital capacity (FVC) was below 88% (males) or 89% (females) according to former European Respiratory Society (ERS) criteria.13 A clear history of asthma, allergic rhinitis, or atopic eczema was an exclusion criterion, while reversibility to bronchodilators was not.","General practitioner (GP)-diagnosed patients chronic bronchitis COPD 44 practices participated study, postbronchodilator forced expiratory volume (FEV1) 40%–90% predicted, FEV1/forced vital capacity (FVC) 88% (males) 89% (females) European Respiratory Society (ERS) criteria.13 A history asthma, allergic rhinitis, atopic eczema exclusion criterion, reversibility bronchodilators not.",C0205246|C1709627|C3811116|C0030705|C0205191|C0006277|C0024117|C0450371|C0237607|G0000000|C0557651|C2599594|C0441722|C0231800|C0449468|G0000000|G0000000|C0681842|C0441722|C0442732|C1516240|C3714541|C0450371|C0086582|C0450371|C0015780|C0239307|C0521346|C0037455|C1704489|C0243161|G0000000|C0019664|C0004096|C0700624|C0035455|C0392707|C0013595|C0680251|C0243161|C0449261|C0006280|C1518422
"Restrictions on concurrent medications included the following: steroids greater than 10 mg daily, anti-TNFα agents, and diphenoxylate hydrochloride and atropine sulfate (Lomotil©) were not permitted and patients had to be off biologics for a minimum of 8 weeks prior to screening.","Restrictions concurrent medications included following: steroids 10 daily, anti-TNFα agents, diphenoxylate hydrochloride atropine sulfate (Lomotil©) permitted patients biologics minimum 8 weeks prior screening.",C0443288|C0205420|C0013227|C0332257|C0231290|C0038317|C0450371|C0332173|G0000000|C0450442|C0012525|C1512523|C0004259|C0038720|G0000000|C0329040|C0030705|C0005515|C1524031|G0000000|C0439230|C0332152|C0220908
159 eligible pregnant women with symptoms of mild to moderate nausea and/or vomiting before 16 weeks gestational age participated in a 7-day clinical trial.,159 eligible pregnant women symptoms mild moderate nausea and/or vomiting 16 weeks gestational age participated 7-day clinical trial.,C1442061|C1548635|C0549206|C0043210|C0683368|C2945599|C0205081|C0027497|G0000000|C0042963|C0450371|C0439230|C0439671|C0001779|G0000000|C0332173|C0205210|C0008976
"Spontaneous resolution of PHN, which is primarily observed during the first 6 months, may have confounded the results.","Spontaneous resolution PHN, observed 6 months, confounded results.",C0205359|C1514893|C0032768|C1441672|G0000000|C0439231|G0000000|C1274040
Objective: To examine whether an athletic trainer-directed ST intervention could decrease initiation and promote cessation of ST use among male collegiate baseball athletes.,Objective: To examine athletic trainer-directed ST intervention decrease initiation promote cessation ST male collegiate baseball athletes.,C0018017|C0040363|G0000000|C1510656|C0453962|C0036056|C0886296|C0392756|C0589507|C0033414|C1880019|C0036056|C0086582|C0557806|C0004795|C0238703
"To be included in the study it was not necessary to be proved a carrier of the family mutation; however, we also excluded affected women who were known to be non-carriers.","To included study proved carrier family mutation; however, excluded women non-carriers.",C0040363|C0332257|C0557651|G0000000|C0007294|C0015576|C0026882|G0000000|C1554077|C0043210|C1518422
"Children with severe illness requiring hospitalisation, allergy to milk and haemoglobin <6 g/dL, and who were unable to consume the test feed were considered to have complicated SAM and were taken to health facilities for hospital management.","Children severe illness requiring hospitalisation, allergy milk haemoglobin <6 g/dL, unable consume test feed considered complicated SAM health facilities hospital management.",C0008059|C0205082|C0221423|G0000000|C0019993|C0002111|C0026131|C0019046|G0000000|C1299582|G0000000|C0022885|C0204695|C0750591|C0231242|C0036002|C0018684|C1547538|C0019994|C0001554
"Participants with a diagnosis of migraine without aura will be recruited at three centers (enrollment areas of Chengdu, Hunan and Chongqing) taking part in the study.","Participants diagnosis migraine aura recruited centers (enrollment Chengdu, Hunan Chongqing) study.",C0679646|C0011900|C0149931|C0236018|G0000000|C0205099|C1516879|G0000000|G0000000|G0000000|C0557651
Infants will be recruited when aged 6 months and followed up until they attain 15 months.,Infants recruited aged 6 months attain 15 months.,C0021270|G0000000|C0001779|G0000000|C0439231|G0000000|C0450371|C0439231
"Also not permissible was medication such as oral EcN within 4 weeks prior to the study, rectal treatment with steroids or aminosalicylates within 2 weeks before the study, immunosuppressants within 90 days before inclusion, and antibiotics or sulphonamides during the study course.","Also permissible medication oral EcN 4 weeks prior study, rectal treatment steroids aminosalicylates 2 weeks study, immunosuppressants 90 days inclusion, antibiotics sulphonamides study course.",G0000000|G0000000|C0013227|C0442027|C0760481|G0000000|C0439230|C0332152|C0557651|C0205052|C0039798|C0038317|C0368663|G0000000|C0439230|C0557651|C0021081|C0450371|C0439228|C0007637|C0003232|C0038760|C0557651|C0750729
"The participants were 30 children with cancer or blood disease, ages 6 months to 17 years.","The participants 30 children cancer blood disease, ages 6 months 17 years.",G0000000|C0679646|C0450371|C0008059|C0006826|C0005767|C0012634|C0001779|G0000000|C0439231|C0450371|C0439234
"Inclusion criteria: • Have a documented diagnosis of epilepsy (all epilepsy syndromes and seizures types permitted) • Are currently being prescribed AEDs • Are aged ≥16 years (no upper age limit) • Are able to provide informed consent, participate in the workshops and complete the questionnaires in English • Have had at least 2 seizures in previous 12 months (as reported by patient) Exclusion criteria: • Have actual/suspected psychogenic non-epileptic seizures only • Have acute symptomatic seizures related to acute neurological illness or substance misuse • Have a severe psychiatric disorder (e.g., psychosis) or terminal medical condition • Are enrolled in other epilepsy-related non-pharmacological treatment studies Patients attending neurology outpatient clinics within the preceding 12 months will be identified by Local Investigators (neurologists) from electronic medical records at the participating NHS Trusts.","Inclusion criteria: • Have documented diagnosis epilepsy (all epilepsy syndromes seizures types permitted) • Are prescribed AEDs • Are aged ≥16 (no upper age limit) • Are provide informed consent, participate workshops complete questionnaires English • Have 2 seizures previous 12 months (as reported patient) Exclusion criteria: • Have actual/suspected psychogenic non-epileptic seizures • Have acute symptomatic seizures acute neurological illness substance misuse • Have severe psychiatric disorder (e.g., psychosis) terminal medical condition • Are enrolled epilepsy-related non-pharmacological treatment studies Patients attending neurology outpatient clinics preceding 12 months identified Local Investigators (neurologists) electronic medical records participating NHS Trusts.",C0007637|C0243161|G0000000|G0000000|C1301725|C0011900|C0014544|G0000000|C0014544|C0039082|C0036572|C0332307|C0329040|G0000000|G0000000|C0278329|C0180309|G0000000|G0000000|C0001779|G0000000|G0000000|C1282910|C0001779|C0439801|G0000000|G0000000|C1999230|C1522154|C1511481|G0000000|C0242262|C0205197|C0034394|C0376245|G0000000|G0000000|G0000000|C0036572|C0205156|C0450371|C0439231|G0000000|C0684224|C0030705|C0680251|C0243161|G0000000|G0000000|C0237400|C0458006|C1518422|C0036572|G0000000|G0000000|C0205178|C0231220|C0036572|C0205178|C0205494|C0221423|C0439861|C0549649|G0000000|G0000000|C0205082|C0205487|C0012634|G0000000|C0033975|C0205088|C0199168|C0012634|G0000000|G0000000|G0000000|C0014544|C1518422|C0039798|C0947630|C0030705|C1547429|C0027855|C0029921|C0442592|C0332152|C0450371|C0439231|C0205396|C0205276|C0035173|C0237426|C0013850|C0199168|C0034869|C0679823|C0796085|C0237935
"Eligible were preterm neonates of both sexes, born ≤34 weeks of gestation, and weighing ≥750 g and ≤1,800 g from adult mothers (aged ≥18 years).","Eligible preterm neonates sexes, born ≤34 weeks gestation, weighing ≥750 ≤1,800 adult mothers (aged ≥18 years).",C1548635|C0151526|C0021289|C0009253|C0005615|G0000000|C0439230|C0032961|C1305866|G0000000|G0000000|C0001675|C0026591|C0001779|G0000000|C0439234
Two hundred forty ambulatory patients with ischemic heart disease amenable to elective revascularization and ongoing medical therapy.,Two forty ambulatory patients ischemic heart disease amenable elective revascularization ongoing medical therapy.,C0205448|C3816449|C0439841|C0030705|C0475224|C0018787|C0012634|C3900053|C0206058|C0581603|C0549178|C0199168|C0039798
The pre-specified number of patients was not achieved.,The pre-specified patients achieved.,G0000000|C2826245|C0030705|G0000000
found a fracture rate of 25.9% in 3 years of follow-up for men on ADT3.,fracture rate 25.9% 3 follow-up ADT3.,C0016658|C0871208|C0450371|G0000000|C0589120|G0000000
Data will also be collected on IPTp coverage (for women aged 15–49 years) and treatment-seeking behaviour for fever and ACT use (for children aged 6–59 months and women aged 15–49 years).,Data collected IPTp coverage (for women aged 15–49 years) treatment-seeking behaviour fever ACT (for children aged 6–59 months women aged 15–49 years).,C1511726|C1516695|G0000000|C1551362|G0000000|C0043210|C0001779|G0000000|C0439234|C0039798|C0004927|C0015967|C0079613|G0000000|C0008059|C0001779|G0000000|C0439231|C0043210|C0001779|G0000000|C0439234
"Exclusion criteria were complicated or severe malaria, non-P. falciparum or mixed Plasmodium infection, a history of hepatic and/or renal impairment, any clinically significant illness other than malaria, anaemia with a haemoglobin (Hb) concentration < 6 g/dL, severe malnutrition, treatment with anti-malarial therapy in the previous 2 weeks, known hypersensitivity to artemisinins, previous participation in this study, current participation in other anti-malarial drug intervention studies or not being available for follow-up.","Exclusion criteria complicated severe malaria, non-P. falciparum mixed Plasmodium infection, history hepatic and/or renal impairment, clinically illness malaria, anaemia haemoglobin (Hb) concentration < 6 g/dL, severe malnutrition, treatment anti-malarial therapy previous 2 weeks, hypersensitivity artemisinins, previous participation study, current participation anti-malarial drug intervention studies follow-up.",C0680251|C0243161|C0231242|C0205082|C0024530|C1518422|G0000000|C0205430|C0032148|C0009450|C0019664|C0205054|G0000000|C0022646|C0221099|G0000000|C0221423|C0024530|C0002871|C0019046|C0019046|G0000000|C0439267|C0205082|C0162429|C0039798|C0003374|C0039798|C0205156|G0000000|C0439230|C0020517|C1136174|C0205156|C0679823|C0557651|C0521116|C0679823|C0003374|C0013227|C0886296|C0947630|C0589120
"The inclusion criteria were: pregnant women with a single fetus, age 16 to 40 years and gestational age 18 to 24 weeks.","The inclusion criteria were: pregnant women single fetus, age 16 40 gestational age 18 24 weeks.",G0000000|C0007637|C0243161|G0000000|C0549206|C0043210|C0037179|C0015965|C0001779|C0450371|C0450371|C0439671|C0001779|C0450371|C0450371|C0439230
"All patients aged 70 years and older who are at risk for delirium and are admitted to cardiology, internal medicine, geriatrics, orthopedics and surgery at two participating community hospitals will be included.","All patients aged 70 risk delirium admitted cardiology, internal medicine, geriatrics, orthopedics surgery participating community hospitals included.",G0000000|C0030705|C0001779|C0450371|C0035647|C0011206|C0184666|C0007189|C0205102|C0013227|C0017469|C0029355|C0038894|C0679823|C0009462|C0019994|C0332257
Exclusion criteria were: elevated ICP due to space-occupying lesions with indication for neurosurgical intervention (e.g.,Exclusion criteria were: elevated ICP space-occupying lesions indication neurosurgical intervention (e.g.,C0680251|C0243161|G0000000|C0205250|C1881201|C1883067|C0221198|C0392360|G0000000|C0886296|G0000000
"Patients with the following were excluded: relapse within 60 days, steroid use within 30 days, chemotherapy within 12 months, pregnancy/inadequate contraception, vitamin D intake >4,000 IU/day, serum 25(OH)D level >150 nmol/L, lymphoma, granulomatous disease, cardiac arrhythmia, kidney dysfunction, or disordered calcium metabolism.","Patients excluded: relapse 60 days, steroid 30 days, chemotherapy 12 months, pregnancy/inadequate contraception, vitamin D intake >4,000 IU/day, serum 25(OH)D level >150 nmol/L, lymphoma, granulomatous disease, cardiac arrhythmia, kidney dysfunction, disordered calcium metabolism.",C0030705|C1554077|C0035020|C0450371|C0439228|C0038317|C0450371|C0439228|C0013216|C0450371|C0439231|C0032961|C0700589|C0042890|C0073187|C1512806|C1442061|C0439465|C0229671|C0450371|C0441889|C1442061|C0439282|C0024299|C0439667|C0012634|C0018787|C0003811|C0022646|C0031847|C0012634|C0006675|C0025519
Rates were calculated for the overall academic year (October to May) and for influenza season (October to December) [23].,Rates calculated academic (October May) influenza season (October December) [23].,C0871208|C0444686|C1510747|C3828732|G0000000|C0021400|C0036497|C3828732|C3830550|C0450371
"Among the 107 patients recruited for the study, 32 were excluded because: 9 were postmenopausal, 10 were over 50 years, refused to participate in the study, one had a cardiovascular problem, one had Cushing syndrome, and one was under 18 years.","Among 107 patients recruited study, 32 excluded because: 9 postmenopausal, 10 50 years, refused participate study, cardiovascular problem, Cushing syndrome, 18 years.",G0000000|C1442061|C0030705|G0000000|C0557651|C0450371|C1554077|G0000000|G0000000|C0232970|C0450371|G0000000|C1548564|G0000000|C0557651|C0007226|C0033213|G0000000|C0039082|G0000000
Study subjects included consecutive ART-naive adult patients initiating ART at the study clinics between July 2004 and October 2007.,Study subjects included consecutive ART-naive adult patients initiating ART study clinics July 2004 October 2007.,C0557651|C0681850|C0332257|C1707491|C0003826|C0001675|C0030705|C1548602|C0003826|C0557651|C0442592|C3829447|G0000000|C3828732|G0000000
We aim to be as inclusive as possible and recruit all patients who had their first ischaemic or haemorrhagic stroke or TIA 3 months earlier and were discharged from the ward or clinic on any secondary preventative medication and are living at home.,We aim inclusive recruit patients ischaemic haemorrhagic stroke TIA 3 months earlier discharged ward clinic secondary preventative medication living home.,G0000000|C1947946|C0332257|G0000000|C0030705|C0475224|C0333275|C0038454|C0007787|G0000000|C0439231|C1279919|C0030685|C1305702|C0002424|C0027627|G0000000|C0013227|C0376558|C0442519
Twenty-five patients with CEA- or MUC-1-expressing metastatic cancers who had progressive disease following standard chemotherapy were enrolled in a pilot trial approved by the National Cancer Institute (NCI) Institutional Review Board and conducted at the NCI.,Twenty-five patients CEA- MUC-1-expressing metastatic cancers progressive disease standard chemotherapy enrolled pilot trial approved National Cancer Institute (NCI) Institutional Review Board conducted NCI.,C3715062|C0030705|C3463961|G0000000|C0036525|C0006826|C0205329|C0012634|C1442989|C0013216|G0000000|C0473169|C0008976|C0205540|C3245503|C0006826|C0021622|C1513882|C0018704|C0282443|C0972401|C0004927|C1513882
One hundred and seven patients were enrolled in the trial including 62 males and 45 females (p >0.9).,One patients enrolled trial including 62 males 45 females (p >0.9).,C0205447|C0030705|G0000000|C0008976|C0332257|C0450371|C0086582|C0450371|C0015780|C0369773|G0000000
"Subjects with a history of any undiagnosed fever/infection of more than 3 days duration within 1 month prior to vaccination and any established or clinically suspected immunosuppressive or immune compromised disorder/state (congenital or acquired- drug induced, neoplastic, tuberculosis etc.)","Subjects history undiagnosed fever/infection 3 days duration 1 month prior vaccination established clinically suspected immunosuppressive immune compromised disorder/state (congenital acquired- drug induced, neoplastic, tuberculosis etc.)",C0681850|C0019664|C1408353|C0015967|G0000000|C0439228|C0449238|G0000000|C0332177|C0332152|C0042196|C0443211|G0000000|C0332147|C0021081|C0439662|C2945640|C0012634|C0009678|C0439661|C0013227|C0205263|C1709160|C0041296|C1548556
"Other eligibility criteria included: no prior chemotherapy for metastatic disease (patients might have received 5FU-based adjuvant treatment more than 6 months before the development of metastatic disease); evaluable or measurable disease according to the criteria of Miller (Miller et al, 1981); creatinine <150 μm l−1 or creatinine clearance >1 ml s−1; bilirubin <25 μm l−1, aspartate aminotransferase (AST) <2 × upper limit of normal (ULN), alanine transferase (ALT) <3 × ULN; granulocytes >1.5 × 109 l−1, platelets >100 × 109 l−1; no central nervous system metastases; no history of prior invasive malignant disease; and no uncontrolled medical condition that would be aggravated by treatment.","Other eligibility criteria included: prior chemotherapy metastatic disease (patients received 5FU-based adjuvant treatment 6 months development metastatic disease); evaluable measurable disease criteria Miller (Miller al, 1981); creatinine <150 μm l−1 creatinine clearance >1 ml s−1; bilirubin <25 μm l−1, aspartate aminotransferase (AST) <2 × upper limit normal (ULN), alanine transferase (ALT) <3 × ULN; granulocytes >1.5 × 109 l−1, platelets >100 × 109 l−1; central nervous system metastases; history prior invasive malignant disease; uncontrolled medical condition aggravated treatment.",G0000000|C0013893|C0243161|C0332257|C0332152|C0013216|C0036525|C0012634|C0030705|C1514756|C1527178|C0001551|C0039798|G0000000|C0439231|C0243107|C0036525|C0012634|C1516986|C1513040|C0012634|C0243161|C0402830|C0402830|C0202311|G0000000|C0010294|G0000000|C0010294|C0449297|G0000000|C0005437|G0000000|C0085845|C0002594|C3891303|G0000000|G0000000|C1282910|C0439801|C0205307|C1519815|C0001898|C0040676|C1266129|G0000000|G0000000|C1519815|C0018183|G0000000|G0000000|G0000000|C0005821|C1442061|G0000000|G0000000|C0205099|C0027769|C0449913|C0027627|C0019664|C0332152|C0205281|C0205282|C0012634|C0205318|C0199168|C0012634|C0436331|C0039798
"Eligible caregivers had to be the parent or legal guardian of a child aged 6 months to 6 years, who reported one or more smokers living in the home, and who spoke English.","Eligible caregivers parent legal guardian child aged 6 months 6 years, reported smokers living home, spoke English.",C1548635|C0085537|C0030551|C1301860|C0023226|C0008059|C0001779|G0000000|C0439231|G0000000|C0439234|C0684224|C0337664|C0376558|C0442519|G0000000|C0376245
"Patients with lacunar infarction, cerebral hemorrhagic infarction, epilepsy or epileptic seizures, history of neurological diseases, myocardial infarction, renal and hepatic abnormalities, metabolic diseases and contraindications to antiplatelet treatments were excluded.","Patients lacunar infarction, cerebral hemorrhagic infarction, epilepsy epileptic seizures, history neurological diseases, myocardial infarction, renal hepatic abnormalities, metabolic diseases contraindications antiplatelet treatments excluded.",C0030705|C0241970|C0021308|G0000000|C0333275|C0021308|C0014544|C0014544|C0036572|C0019664|C0205494|C0012634|C0027061|C0021308|C0022646|C0205054|C0000768|C0311400|C0012634|C0079164|G0000000|C0087111|C1554077
A larger proportion of patients in the doripenem arm than the imipenem-cilastatin arm had pneumonia due to P. aeruginosa (21.5% versus 11.4%) and Acinetobacter spp.,A larger proportion patients doripenem arm imipenem-cilastatin arm pneumonia P. aeruginosa (21.5% versus 11.4%) Acinetobacter spp.,G0000000|C0549177|C1709707|C0030705|C0389169|C0446516|C0071972|C0446516|C0032285|C0369773|G0000000|C0450371|G0000000|C0450371|C0001138|C1424276
"Consecutive patients with newly diagnosed (<3 months) prostate, gastrointestinal (GI=colorectal or gastric) or breast cancer were included.","Consecutive patients newly diagnosed (<3 months) prostate, gastrointestinal (GI=colorectal gastric) breast cancer included.",C1707491|C0030705|C0750546|C0011900|G0000000|C0439231|C0033572|C0521362|C1708130|C0038351|C0006141|C0006826|C0332257
"We tested the moderation effects of smoking status, number of smokers in the home, and whether there were any children younger than 18 or younger than 5 years of age in the home using the χ2 and Wilcoxon–Mann–Whitney tests.","We tested moderation effects smoking status, smokers home, children 18 5 age χ2 Wilcoxon–Mann–Whitney tests.",G0000000|C0392366|C1881878|C1280500|C0037369|C0449438|C0337664|C0442519|C0008059|C0450371|G0000000|C0001779|G0000000|G0000000|C0022885
"The children from 2 mo to 12 years of age presenting with acute watery diarrhoea of mild to moderate severity, fulfilling the inclusion criteria were included in this trial.","The children 2 mo 12 age acute watery diarrhoea mild moderate severity, fulfilling inclusion criteria included trial.",G0000000|C0008059|G0000000|C0026544|C0450371|C0001779|C0205178|C0443350|C0011991|C2945599|C0205081|C0439793|C1550543|C0007637|C0243161|C0332257|C0008976
"Men and women with moderate-to-severe COPD (as defined in the 2008 GOLD guidelines) [9] were eligible for enrolment if they were ≥ 40 years of age, had a smoking history of ≥ 10 pack-years, post-bronchodilator forced expiratory volume in 1 second (FEV1) of < 80% and ≥ 30% of predicted normal value and post-bronchodilator FEV1/forced vital capacity (FVC) ratio of < 0.70.","Men women moderate-to-severe COPD (as defined 2008 GOLD guidelines) [9] eligible enrolment ≥ 40 age, smoking history ≥ 10 pack-years, post-bronchodilator forced expiratory volume 1 (FEV1) < 80% ≥ 30% predicted normal post-bronchodilator FEV1/forced vital capacity (FVC) ratio < 0.70.",C0025266|C0043210|C0205081|C0024117|G0000000|C1704788|G0000000|C0018026|C0162791|G0000000|C1548635|C1516879|G0000000|C0450371|C0001779|C0037369|C0019664|G0000000|C0450371|C1277691|C2599594|C0441722|C0231800|C0449468|G0000000|G0000000|G0000000|C0450371|G0000000|C0450371|C0681842|C0205307|C2599594|C0441722|C0442732|C1516240|C3714541|C0456603|G0000000|C0450371
"Patients eligible for the present study had to have a confirmed diagnosis of CF substantiated either by the identification of two mutations known to cause CF (5) or by the sweat iontophoresis test (positive for CF if sweat Cl− concentrations greater than 60 mmol/L in at least two samples of 100 mg sweat [6]), be clinically stable at the time of enrolment and have at least two positive cultures for P aeruginosa within the past six months.","Patients eligible study confirmed diagnosis CF substantiated identification mutations CF (5) sweat iontophoresis test (positive CF sweat Cl− concentrations 60 mmol/L samples 100 sweat [6]), clinically stable time enrolment positive cultures P aeruginosa months.",C0030705|C1548635|C0557651|C0521093|C0011900|C0009738|G0000000|C0020792|C0026882|C0009738|G0000000|C0038984|C0022024|C0022885|C0439178|C0009738|C0038984|G0000000|C0086045|C0450371|C1532563|C0370003|C1442061|C0038984|G0000000|G0000000|C0205360|C0040223|C1516879|C0439178|C0010453|C0369773|G0000000|C0439231
"The mean patient age was 5.13 years (range, 2–9 years).","The patient age 5.13 (range, 2–9 years).",G0000000|C0030705|C0001779|C0450371|C1514721|G0000000|C0439234
The rate of breast-feeding intention among mothers of infants in the neonatal intensive care unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt exceeded 95% during the period of study.,The rate breast-feeding intention mothers infants neonatal intensive care unit Monroe Carell Jr. Children’s Hospital Vanderbilt exceeded 95% period study.,G0000000|C0871208|C0006147|C0162425|C0026591|C0021270|C1552240|C0162425|C1947933|C0439148|G0000000|G0000000|C1708595|G0000000|C0019994|G0000000|G0000000|C0450371|C0439531|C0557651
EEG recording usually needs induced sedation and sleep in children who uncooperative with the device setup and EEG recording.,EEG recording induced sedation sleep children uncooperative device setup EEG recording.,C0013819|G0000000|C0205263|C0235195|C0037313|C0008059|C0424350|C0025080|C1521827|C0013819|G0000000
Patients who had undergone an intestinal lengthening procedure were not eligible.,Patients undergone intestinal lengthening procedure eligible.,C0030705|G0000000|C0021853|C0441592|C0184661|C1548635
Participants will be excluded from the study if they meet any of the following criteria: They have another pre-morbid speech and language disorder caused by a neurological deficit other than stroke (a formal diagnosis can be reported by the participant or relatives and confirmed by the recruiting speech and language therapist).,Participants excluded study meet criteria: They pre-morbid speech language disorder caused neurological deficit stroke (a formal diagnosis reported participant relatives confirmed recruiting speech language therapist).,C0679646|C1554077|C0557651|C1550543|C0243161|G0000000|C0332152|C0037817|C0023008|C0012634|C0015127|C0205494|C0162429|C0038454|G0000000|C0348078|C0011900|C0684224|C0679646|C0080103|C0521093|G0000000|C0037817|C0023008|C0871525
"Patients were eligible for inclusion in the trial if they were 18 years of age or older, had a pericardial effusion confirmed by echocardiography, had evidence of definite or probable tuberculous pericarditis (as defined in Tables S2 and S3 in the Supplementary Appendix), and had begun to receive antituberculosis treatment less than 1 week before enrollment.","Patients eligible inclusion trial 18 age older, pericardial effusion confirmed echocardiography, evidence definite probable tuberculous pericarditis (as defined Tables S2 S3 Supplementary Appendix), begun receive antituberculosis treatment 1 week enrollment.",C0030705|C1548635|C0007637|C0008976|C0450371|C0001779|C0580836|C0031050|C0013687|C0521093|C0013516|C3887511|C0439544|C0033204|C0041296|C0031046|G0000000|C1704788|C0039224|C1519428|C1519428|G0000000|C0003617|C0439659|C1514756|C0003448|C0039798|G0000000|C0332174|C1516879
"A total of 81 patients (age: 64.3 ±10.1, range: 31–80) with carcinomas of cervix (n=11) or corpus uteri (n=70) with a significant whole blood Se deficiency after curative surgical treatment were randomized as described earlier [15].","A total 81 patients (age: 64.3 ±10.1, range: 31–80) carcinomas cervix (n=11) corpus uteri (n=70) blood Se deficiency curative surgical treatment randomized earlier [15].",G0000000|C0439175|C0450371|C0030705|C0001779|C0450371|G0000000|C1514721|G0000000|C0007097|C0007874|C0369718|C0227813|C0042149|C0369718|C0005767|C0036919|C0011155|C1880198|C0543467|C0039798|C0034656|C1279919|C0450371
"Patients with the history of pelvic or organic disorders, any known gastrointestinal or urogenital or hematological or other systems disorders, irregularity of menstrual cycles, taking any drug, and previous sensitivity to NSAIDs or Dill and or mild dysmenorrheal were not included.","Patients history pelvic organic disorders, gastrointestinal urogenital hematological systems disorders, irregularity menstrual cycles, drug, previous sensitivity NSAIDs Dill mild dysmenorrheal included.",C0030705|C0019664|C0030797|C0747055|C0012634|C0521362|C0042066|C0018943|C0449913|C0012634|C0205271|C0025344|C1511572|C0013227|C0205156|C0020517|C0003211|C1256256|C2945599|C0013390|C0332257
The authors wish to acknowledge the High Performance Sports Research Funds received from the Australian Institute of Sport and the Australian Sports Commission.,The authors acknowledge High Performance Sports Research Funds received Australian Institute Sport Australian Sports Commission.,G0000000|C3812881|G0000000|C0205250|C0597198|C0038039|C0035168|C0016820|C1514756|C0238711|C0021622|C0038039|C0238711|C0038039|G0000000
"The exclusion criteria were people with BMI ≥ 30 kg/m2, people who have asthma, women who are pregnant or breastfeeding, people with a chronic disease such as cancer, heart disease, or diabetes, and people with food allergies or food aversions.","The exclusion criteria people BMI ≥ 30 kg/m2, people asthma, women pregnant breastfeeding, people chronic disease cancer, heart disease, diabetes, people food allergies food aversions.",G0000000|C0680251|C0243161|C0027361|G0000000|C0027361|C0004096|C0043210|C0549206|C0006147|C0027361|C0205191|C0012634|C0006826|C0018787|C0012634|C0011847|C0027361|C0016452|C0020517|C0016452|C0233496
"All patients randomly allocated to arms 1 and 2, including those randomised from arm 3.","All patients randomly allocated arms 1 2, including randomised arm 3.",G0000000|C0030705|G0000000|G0000000|C0206655|G0000000|G0000000|C0332257|G0000000|C0446516|G0000000
Enrolled patients who were discharged from the hospital were eligible to participate again if they were readmitted to a participating ICU.,Enrolled patients discharged hospital eligible participate readmitted participating ICU.,G0000000|C0030705|C0030685|C0019994|C1548635|G0000000|G0000000|C0679823|C0021708
Linezolid belongs to the group 5 drugs (unclear clinical efficacy) and is not currently recommended by the WHO in the starter regimen of MDR TB [1].,Linezolid belongs 5 drugs (unclear clinical efficacy) recommended WHO starter regimen MDR TB [1].,C0663241|G0000000|G0000000|C0013227|G0000000|C0205210|C1280519|C0034866|G0000000|G0000000|C0040808|G0000000|G0000000|G0000000
Age 2–16 years.,Age 2–16 years.,C0001779|G0000000
"Parents in the SLCBT condition reported fewer health care visits and missed school days for Crohn's disease or ulcerative colitis at 6 and 12 months post-treatment, but the treatment difference was statistically significant (p < .05) only at 6 months post-treatment for the number of missed school days (Table 5).","Parents SLCBT condition reported fewer health care visits missed school days Crohn's disease ulcerative colitis 6 12 months post-treatment, treatment difference statistically (p < .05) 6 months post-treatment missed school days (Table 5).",C0030551|G0000000|C0012634|C0684224|C0205388|C0018684|C1947933|C0545082|C1705492|C0036375|C0439228|C0010346|C0012634|C0041582|C0009319|G0000000|C0450371|C0439231|C2709088|C0039798|C1705241|C0038215|C0369773|G0000000|C0450371|G0000000|C0439231|C2709088|C1705492|C0036375|C0439228|C0039224|G0000000
"The exclusion criteria were the presence of concomitant autoimmune diseases, psychiatric disorders (as a diagnosis of major depression), or other causes of chronic pain; other diseases that prevented physical loading; severe scoliosis or kyphoscoliosis; surgery of the spine; vertebral fractures; sciatic pain; tumors; and enrollment in another type of physical therapy program.","The exclusion criteria presence concomitant autoimmune diseases, psychiatric disorders (as diagnosis major depression), chronic pain; diseases prevented physical loading; severe scoliosis kyphoscoliosis; surgery spine; vertebral fractures; sciatic pain; tumors; enrollment type physical therapy program.",G0000000|C0680251|C0243161|C0150312|C0521115|C0443146|C0012634|C0205487|C0012634|G0000000|C0011900|C0205082|C0011570|C0205191|C0030193|C0012634|C0309872|C0031809|C1708715|C0205082|C0036439|C0345392|C0038894|C0037949|C0549207|C0016658|G0000000|C0030193|C0027651|C1516879|C0332307|C0031809|C0039798|C1709697
Eligible patients had to have a history of primary breast cancer without evidence of detectable disease and 14 or more weekly hot flashes for at least 1 month.,Eligible patients history primary breast cancer evidence detectable disease 14 weekly hot flashes 1 month.,C1548635|C0030705|C0019664|C0205225|C0006141|C0006826|C3887511|C3830527|C0012634|C0450371|C0332174|C0444519|C0085635|G0000000|C0332177
"The subjects included in the study will be pregnant women, aged at least 18 years, whose foetus is in a non cephalic position (diagnosed by physical examination and by echography), with a gestational age of 33–35 weeks (estimated by echography), normal foetal biometry, who have signed their informed consent and who have not previously received moxibustion treatment to correct the position of their unborn baby.","The subjects included study pregnant women, aged 18 years, foetus cephalic position (diagnosed physical examination echography), gestational age 33–35 weeks (estimated echography), normal foetal biometry, signed informed consent received moxibustion treatment correct position unborn baby.",G0000000|C0681850|C0332257|C0557651|C0549206|C0043210|C0001779|C0450371|C0439234|C0015965|C0205096|C0733755|C0011900|C0031809|G0000000|C0041618|C0439671|C0001779|G0000000|C0439230|C0750572|C0041618|C0205307|C0015965|C0005544|C1519316|C1522154|C1511481|C1514756|C0026652|C0039798|C2349182|C0733755|C0678804|C0021270
Patients who did not experience progression and did not have PSA assessments during months 4 to 7 were excluded from the analysis.,Patients experience progression PSA assessments months 4 7 excluded analysis.,C0030705|C0237607|C0242656|C3810537|C1261322|C0439231|G0000000|G0000000|C1554077|C0002778
"Exclusion criteria were current participation in any other behavioral or pharmacologic study or instructor-led exercise program, a Mini–Mental State examination19 score lower than 24 (indicating some degree of cognitive impairment), debilitating conditions or vision impairment that would impede full participation in the study, and unavailability during the study period.","Exclusion criteria current participation behavioral pharmacologic study instructor-led exercise program, Mini–Mental State examination19 score lower 24 (indicating degree cognitive impairment), debilitating conditions vision impairment impede participation study, unavailability study period.",C0680251|C0243161|C0521116|C0679823|C0004927|C0031330|C0557651|C0221457|C0015259|C1709697|G0000000|C1301808|G0000000|C0449820|C0441994|C0450371|G0000000|C0441889|C1516691|C0221099|G0000000|C0012634|C0042789|C0221099|G0000000|C0679823|C0557651|C0686905|C0557651|C0439531
"On average, more children were found to be anemic in the control group (93%) than in the intervention group (88%).","On average, children anemic control (93%) intervention (88%).",G0000000|C1510992|C0008059|C0857322|C0243148|C0450371|C0886296|C0450371
"To assess whether a CM intervention can be successfully added to standard stop smoking services treatment, in patients undergoing outpatient treatment for opioid addiction.","To assess CM intervention standard smoking services treatment, patients undergoing outpatient treatment opioid addiction.",C0040363|C1516048|G0000000|C0886296|C1442989|C0037369|C0557854|C0039798|C0030705|G0000000|C0029921|C0039798|C0242402|C0085281
"BEST is a 2×2 full factorial double-blind randomized controlled trial of 7,000 adults having manifest arsenical skin lesions evaluating the efficacy of 6-year supplementation with alpha-tocopherol (100 mg daily) and L-selenomethionine (200 μg daily) for the prevention of non-melanoma skin cancer.","BEST 2×2 factorial double-blind randomized controlled trial 7,000 adults manifest arsenical skin lesions evaluating efficacy 6-year supplementation alpha-tocopherol (100 daily) L-selenomethionine (200 μg daily) prevention non-melanoma skin cancer.",C1522427|G0000000|C2826344|C0013072|C0034656|C2587213|C0008976|C1442061|C0001675|C0205319|C0003819|C0444099|C0221198|C0220825|C1280519|C0439234|C0242297|C0969677|C1442061|C0332173|C1517683|C1442061|G0000000|C0332173|C0199176|C1518422|C0444099|C0006826
"Management of CRF is critical for improving quality of life during and after treatment for prostate cancer [4, 5, 82].","Management CRF critical improving quality life treatment prostate cancer [4, 5, 82].",C0001554|G0000000|C1511545|C1272745|C0332306|C0376558|C0039798|C0033572|C0006826|G0000000|G0000000|C0450371
"In addition, those patients with a significant disease other than COPD that would put the patient at risk because of participation in the study, or patients with a disease that may have influenced the results of the study, were not enrolled.","In addition, patients disease COPD patient risk participation study, patients disease influenced study, enrolled.",G0000000|C0332287|C0030705|C0012634|C0024117|C0030705|C0035647|C0679823|C0557651|C0030705|C0012634|G0000000|C0557651|G0000000
Sixty-eight subjects were randomized at 24 sites; 32 to the control group and 36 to the rhGH group.,Sixty-eight subjects randomized 24 sites; 32 control 36 rhGH group.,C3816724|C0681850|C0034656|C0450371|C0205145|C0450371|C0243148|C0450371|C0169964|C0441833
Any customer aged 18 – 64 with any food or beverage purchased was eligible; older consumers were excluded as they are most likely to be on a special diet.,Any customer aged 18 – 64 food beverage purchased eligible; consumers excluded special diet.,G0000000|C2981734|C0001779|C0450371|G0000000|C0450371|C0016452|C0005329|C0870238|C1548635|C1707496|C1554077|C0205555|C0012155
"Exclusion criteria are patients in a prior regular and structured physical activity program; missing more than three times from treatment; presence of psychiatric disorders, missing teeth, and/or use of dentures; a history of trauma to the face; currently undergoing orthodontic intervention; and any contraindication to exercise or phototherapy.","Exclusion criteria patients prior regular structured physical activity program; missing times treatment; presence psychiatric disorders, missing teeth, and/or dentures; history trauma face; undergoing orthodontic intervention; contraindication exercise phototherapy.",C0680251|C0243161|C0030705|C0332152|C0205272|C0678594|C0031809|C0205177|C1709697|C1551393|C0040223|C0039798|C0150312|C0205487|C0012634|C1551393|C0040426|G0000000|C0011394|C0019664|C0043251|C0015450|G0000000|C0332276|C0886296|C0522473|C0015259|C0031765
"Chronic low back pain (LBP) is among the most prevalent of all health complaints.1 Approximately 25% of the US population report experiencing at least 1 day of low back pain in the prior 3 mo and 7.6% report severe back pain in the past year.2,3 LBP is also associated with substantial health care and productivity costs, reduced quality of life and function, and is commonly associated with insomnia.1–4 A recent study reported that 78% of patients with chronic LBP experience insomnia and, of these, in 64% of cases the insomnia was caused by the LBP.4 Although the long-standing view has been that this insomnia is a symptom of the pain, a growing body of literature suggests that insomnia might have important independent effects on the clinical course of pain syndromes.5 Although pain may disrupt sleep, it appears that problems with sleep increase pain.","Chronic low pain (LBP) prevalent health complaints.1 Approximately 25% US population report experiencing 1 day low pain prior 3 mo 7.6% report severe pain year.2,3 LBP substantial health care productivity costs, reduced quality life function, commonly insomnia.1–4 A study reported 78% patients chronic LBP experience insomnia and, these, 64% insomnia caused LBP.4 Although long-standing view insomnia symptom pain, growing body literature suggests insomnia independent effects clinical pain syndromes.5 Although pain disrupt sleep, appears sleep increase pain.",C0205191|C0205251|C0030193|C1505993|C0033105|C0018684|C0277786|C0332232|C0450371|G0000000|C0032659|C0684224|C0237607|G0000000|C0332173|C0205251|C0030193|C0332152|G0000000|C0026544|G0000000|C0684224|C0205082|C0030193|C0439234|C1505993|G0000000|C0018684|C1947933|C0033269|C0010186|C0392756|C0332306|C0376558|C0031843|G0000000|G0000000|G0000000|C0557651|C0684224|C0450371|C0030705|C0205191|C1505993|C0237607|C0917801|G0000000|G0000000|C0450371|C0917801|C0015127|C1505993|G0000000|C0205166|C0449911|C0917801|C1457887|C0030193|G0000000|C0242821|C0023866|C1705535|C0917801|C0085862|C1280500|C0205210|C0030193|C0206064|G0000000|C0030193|C0332454|C0037313|C0700364|C0037313|C0442805|C0030193
All patients with CR were randomized to either PUVA maintenance or no maintenance.,All patients CR randomized PUVA maintenance maintenance.,G0000000|C0030705|C0201975|C0034656|C0853073|C0024501|C0024501
"Among these, follow-up observations of WASH in the home were available for 8,592 (91.2%) cases and 12,390 (94.4%) controls.","Among these, follow-up observations WASH 8,592 (91.2%) 12,390 (94.4%) controls.",G0000000|G0000000|C0589120|C0302523|C0441648|C1442061|C0450371|C0450371|C0450371|C0243148
"Plasma vitamin A concentrations in the supplemented group were significantly higher at 24 hours of age but did not differ significantly at birth, 12 hours of age, 7 days, or 28days of life.","Plasma vitamin A concentrations supplemented 24 hours age birth, 12 hours age, 7 days, 28days life.",C0032105|C0042890|G0000000|C0086045|C0242295|C0450371|C0439227|C0001779|C0005615|C0450371|C0439227|C0001779|G0000000|C0439228|G0000000|C0376558
"Exclusion criteria were inability to walk without assistance prior to the acute ICU illness (use of cane or walkers were not exclusions), cognitive impairment prior to acute ICU illness described by surrogate, as nonverbal, acute stroke, body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) greater than 50, neuromuscular disease impairing weaning from mechanical ventilation, acute hip fracture, unstable cervical spine or pathologic fracture, mechanically ventilate d more than 80 hours or current hospitalization (including transferring hospital) more than 7 days, orders for do not intubate on admission, considered to be moribund by the primary attending, or enrolled in another research study.","Exclusion criteria inability walk assistance prior acute ICU illness (use cane walkers exclusions), cognitive impairment prior acute ICU illness surrogate, nonverbal, acute stroke, body mass (BMI; calculated weight kilograms divided height meters squared) 50, neuromuscular disease impairing weaning mechanical ventilation, acute hip fracture, unstable cervical spine pathologic fracture, mechanically ventilate 80 hours current hospitalization (including transferring hospital) 7 days, intubate admission, considered moribund primary attending, enrolled study.",C0680251|C0243161|G0000000|C0080331|C0018896|C0332152|C0205178|C0021708|C0221423|C0042153|C0006856|C0043016|C0680251|C1516691|C0221099|C0332152|C0205178|C0021708|C0221423|C4053457|C0746940|C0205178|C0038454|C0242821|C0577559|G0000000|C0444686|C0005910|C0439209|C0332849|C0489786|C0441074|C0205120|C0450371|C1979768|C0012634|C0221099|C0043084|C0443254|C0035203|C0205178|C0019552|C0016658|C0443343|C0027530|C0037949|C1521733|C0016658|G0000000|C0042491|C0450371|C0439227|C0521116|C0019993|C0332257|C1540850|C0019994|G0000000|C0439228|G0000000|C0184666|C0750591|C0424547|C0205225|C1547429|G0000000|C0557651
"The SAFIRE project was a randomised controlled trial involving a multifaceted intervention conducted in residential care facilities in metropolitan Adelaide, South Australia.","The SAFIRE project randomised controlled trial involving multifaceted intervention conducted residential care facilities metropolitan Adelaide, South Australia.",G0000000|G0000000|C1709701|G0000000|C2587213|C0008976|C1314939|C0205291|C0886296|C0004927|C0237096|C1947933|C1547538|C0599587|G0000000|C1710133|C0004340
"Nevertheless, the safety and feasibly of HIIT during NACRT in rectal cancer patients has yet to be established and is a key objective of our study.","Nevertheless, safety feasibly HIIT NACRT rectal cancer patients established key objective study.",G0000000|C0036043|G0000000|G0000000|G0000000|C0205052|C0006826|C0030705|C0443211|G0000000|C0018017|C0557651
"Patients were excluded if they had tuberculosis, leprosy, or clinical and/or laboratory evidence of significant renal or hepatic impairment or auditory problems and if they were already receiving treatment with antibiotics or herbal preparations.","Patients excluded tuberculosis, leprosy, clinical and/or laboratory evidence renal hepatic impairment auditory receiving treatment antibiotics herbal preparations.",C0030705|C1554077|C0041296|C0023343|C0205210|G0000000|C0022877|C3887511|C0022646|C0205054|C0221099|C0439825|C1514756|C0039798|C0003232|C3146288|C1521827
"The 61 participants (see Table 1) ranged in age from 24 to 60 years (mean ± SD, 47.95 ± 8.76 years) and the majority were White (n=54, 89%), married (n=40, 66%) and not employed full-time (n=48, 79%).","The 61 participants (see Table 1) ranged age 24 60 (mean ± SD, 47.95 ± 8.76 years) majority White (n=54, 89%), married (n=40, 66%) employed full-time (n=48, 79%).",G0000000|C0450371|C0679646|C0042789|C0039224|G0000000|C1514721|C0001779|C0450371|C0450371|C0444504|G0000000|C2699239|C0450371|G0000000|C0450371|C0439234|C0680220|C0007457|C0369718|C0450371|C0024841|C0369718|C0450371|C0014003|C0682295|C0369718|C0450371
"The other main criteria for selection of subjects included glycated hemoglobin (HbA1c) ≤9.4% at screening, fluctuation of HbA1c≤1.0% at 42–70 days before screening, and the weekly mean of the 24‐h average pain score rated by the 11‐point (0–10) Numerical Rating Scale27 collected from patient diaries over 7 days before initiation of the study drug administration being ≥4, that is, indicative of moderate or severe pain.","The main criteria selection subjects included glycated hemoglobin (HbA1c) ≤9.4% screening, fluctuation HbA1c≤1.0% 42–70 days screening, weekly 24‐h average pain score rated 11‐point (0–10) Numerical Rating Scale27 collected patient diaries 7 days initiation study drug administration ≥4, is, indicative moderate severe pain.",G0000000|C0205225|C0243161|C0036576|C0681850|C0332257|C3666909|C0019046|G0000000|G0000000|C0220908|C0231239|G0000000|G0000000|C0220908|C0332174|G0000000|C1510992|C0030193|C0449820|C0871208|G0000000|G0000000|C0237753|C0871208|G0000000|C1516695|C0030705|C0376660|G0000000|C0589507|C0557651|C0013227|C0001554|G0000000|G0000000|G0000000|C0205081|C0205082|C0030193
"Exclusion criteria were recent use of opioids, confusion, obtundation, adverse reactions to opioids, and history of substance misuse.","Exclusion criteria opioids, confusion, obtundation, adverse reactions opioids, history substance misuse.",C0680251|C0243161|C0242402|C0009676|C0085628|G0000000|C0443286|C0242402|C0019664|C0439861|C0549649
infusion on day 1) or pemetrexed–platinum alone.,infusion day 1) pemetrexed–platinum alone.,C0574032|C0332173|G0000000|G0000000|C0205171
Most participants had stage IIIB disease.,Most participants stage IIIB disease.,C0205393|C0679646|C0205390|G0000000|C0012634
"CRS-207 was evaluated in a dose-escalation study in subjects with mesothelioma, lung, pancreatic or ovarian cancers.","CRS-207 evaluated dose-escalation study subjects mesothelioma, lung, pancreatic ovarian cancers.",C0010278|C0220825|C2983683|C0557651|C0681850|C0025500|C0024109|C0030274|C0205065|C0006826
The study population comprised patients undergoing primary cervicotomy for thyroid or parathyroid surgery at a single district general hospital.,The study population comprised patients undergoing primary cervicotomy thyroid parathyroid surgery single district hospital.,G0000000|C0557651|C0032659|C2700400|C0030705|G0000000|C0205225|G0000000|C0040132|C0030518|C0038894|C0037179|G0000000|C0019994
"The authors thank Dr. Bastiaan Maes, the study participants, the staff from the Rotterdam Study, and the participating pharmacists and general practitioners.","The authors Dr. Bastiaan Maes, study participants, staff Rotterdam Study, participating pharmacists practitioners.",G0000000|C3812881|C0013014|G0000000|C0286540|C0557651|C0679646|C0851286|G0000000|C0557651|C0679823|C0031323|C1709627
"Twenty stroke survivors (eight female; mean age, 67 ± 6.8 yrs; mean time since stroke, 3.8 ± 3.3 yrs; 10 left-cerebral vascular accident) were recruited for this study; one failed to complete it because of intercurrent health problems unrelated to the study.","Twenty stroke survivors (eight female; age, 67 ± 6.8 yrs; time stroke, 3.8 ± 3.3 yrs; 10 left-cerebral vascular accident) recruited study; failed complete intercurrent health unrelated study.",C0724000|C0038454|C0206194|C0205454|C0015780|C0001779|C0450371|G0000000|G0000000|G0000000|C0040223|C0038454|G0000000|G0000000|G0000000|G0000000|C0450371|C0205091|C0005847|C0000924|G0000000|C0557651|C0231175|C0205197|G0000000|C0018684|C0445356|C0557651
Patients with uveal melanoma were also excluded.,Patients uveal melanoma excluded.,C0030705|C0042160|C0025202|C1554077
The primary molars (70) were selected from 35 children (18 boys and 17 girls) aged 4 to 6 years who had no medical condition that would contraindicate pulp therapy.,The primary molars (70) selected 35 children (18 boys 17 girls) aged 4 6 medical condition contraindicate pulp therapy.,G0000000|C0205225|C0026367|C0450371|C1707391|C0450371|C0008059|C0450371|C0870221|C0450371|C0870604|C0001779|G0000000|G0000000|C0199168|C0012634|G0000000|C0011399|C0039798
A large number of stroke patients are using inpatient services because they are not safe and independent in their mobility.,A stroke patients inpatient services safe independent mobility.,G0000000|C0038454|C0030705|C0021562|C0557854|G0000000|C0085862|C0425245
Setting Population based screening in two areas in Norway—city of Oslo and Telemark county (urban and mixed urban and rural populations).,Setting Population based screening Norway—city Oslo Telemark county (urban mixed urban rural populations).,C0542559|C0032659|C1527178|C0220908|G0000000|G0000000|G0000000|C0079170|C0442529|C0205430|C0442529|C0240919|C0032659
The recruited women resided in 4 adjacent villages or communities of Xiangshui County in Jiangsu Province.,The recruited women resided 4 adjacent villages communities Xiangshui County Jiangsu Province.,G0000000|G0000000|C0043210|C2982691|G0000000|C0205117|C0562518|C0009462|G0000000|C0079170|G0000000|C1514578
"Eligibility for this study included: being a university student (full- or part-time), smoking 5 or more cigarettes a day, having an email address for personal use, having a cell phone for personal use with an unlimited text messaging plan, having an interest in quitting in the next month, and not being pregnant.","Eligibility study included: university student (full- part-time), smoking 5 cigarettes day, email address personal use, cell phone personal unlimited text messaging plan, quitting month, pregnant.",C0013893|C0557651|C0332257|C0041740|C0038492|C0443225|C0682294|C0037369|G0000000|C0677453|C0332173|C0013849|C0376649|C1519021|C0042153|C0007634|C1515258|C1519021|C1549481|C1527021|C0470166|C0270724|C0748223|C0332177|C0549206
"The final study population consisted of 24 patients, 12 in each group of patients (mean age in SIRT group 71.8 ± 7.2 years, range, 58–82 years; mean age in TACE group 70.5 years, range 59–87 years).","The final study population consisted 24 patients, 12 patients (mean age SIRT 71.8 ± 7.2 years, range, 58–82 years; age TACE 70.5 years, range 59–87 years).",G0000000|C0205088|C0557651|C0032659|C0332529|C0450371|C0030705|C0450371|C0030705|C0444504|C0001779|C1831994|C0450371|G0000000|G0000000|C0439234|C1514721|G0000000|C0439234|C0001779|C0723595|C0450371|C0439234|C1514721|G0000000|C0439234
"Subjects were excluded if they had: (1) unstable medical conditions; (2) suicidal attempts or aggressive behavior; (3) a history of manic, hypomanic, or mixed episode; (4) a family history of bipolar or psychotic disorders; (5) a history of substance abuse within the previous 12 months; (6) investigational drug treatment in the previous 6 months; (7) current psychotropic treatment exceed one week; or (8) needle phobia.","Subjects excluded had: (1) unstable medical conditions; (2) suicidal attempts aggressive behavior; (3) history manic, hypomanic, mixed episode; (4) family history bipolar psychotic disorders; (5) history substance abuse previous 12 months; (6) investigational drug treatment previous 6 months; (7) current psychotropic treatment exceed week; (8) needle phobia.",C0681850|C1554077|G0000000|G0000000|C0443343|C0199168|C0012634|G0000000|C0438696|C1516084|C0001807|C0004927|G0000000|C0019664|C0338831|C0241934|C0205430|C0332189|G0000000|C0015576|C0019664|C0443156|C0004936|C0012634|G0000000|C0019664|C0439861|C0013146|C0205156|C0450371|C0439231|G0000000|C1517586|C0013227|C0039798|C0205156|G0000000|C0439231|G0000000|C0521116|C0033978|C0039798|G0000000|C0332174|G0000000|C0027551|C0349231
"HIV-positive MSM patients of ≥18 years of age who, at the time of study inclusion were not infected simultaneously by the four genotypes of HPV that the quadrivalent vaccine addresses.","HIV-positive MSM patients ≥18 age who, time study inclusion infected simultaneously genotypes HPV quadrivalent vaccine addresses.",C0019699|C0058231|C0030705|G0000000|C0001779|G0000000|C0040223|C0557651|C0007637|C0439663|C0521115|C0017431|C0021344|G0000000|C0042210|C0376649
Sixty-eight subjects were randomized (control n = 32; rhGH n = 36).,Sixty-eight subjects randomized (control = 32; rhGH = 36).,C3816724|C0681850|C0034656|C0243148|G0000000|C0450371|C0169964|G0000000|C0450371
"The change in ODI was a mean 1.3 points for the calcitonin group and 0.6 points for the placebo group (P = 0.51), the mean change in visual analogue score for leg pain was 10 mm in the calcitonin group and 0 mm in the placebo group (P = 0.51).","The change ODI 1.3 calcitonin 0.6 placebo (P = 0.51), change visual analogue score leg pain 10 mm calcitonin 0 mm placebo (P = 0.51).",G0000000|C0392747|G0000000|G0000000|C0006668|G0000000|C0032042|C0369773|G0000000|C0450371|C0392747|C0234621|C0243071|C0449820|C0023216|C0030193|C0450371|G0000000|C0006668|G0000000|G0000000|C0032042|C0369773|G0000000|C0450371
The two largest diagnostic groups with ABI are traumatic brain injury (TBI) [1] and stroke [2].,The largest diagnostic ABI traumatic brain injury (TBI) [1] stroke [2].,G0000000|C0443228|C0011900|C1328319|C0332663|C0006104|C3263722|C0876926|G0000000|C0038454|G0000000
The study targets stroke patients who are unable to walk independently on admission to rehabilitation.,The study targets stroke patients unable walk independently admission rehabilitation.,G0000000|C0557651|C1521840|C0038454|C0030705|C1299582|C0080331|G0000000|C0184666|C0034991
"At the time of randomization, patients were stratified by the type of neurotoxic chemotherapy they were to receive (taxane vs. cisplatin vs. carboplatin vs. oxaliplatin vs. combination), by age (≤50 vs. >50 years) and by gender.","At time randomization, patients stratified type neurotoxic chemotherapy receive (taxane vs. cisplatin vs. carboplatin vs. oxaliplatin vs. combination), age (≤50 vs. >50 years) gender.",G0000000|C0040223|C0034656|C0030705|C0205363|C0332307|C0235032|C0013216|C1514756|C0215136|G0000000|C0008838|G0000000|C0079083|G0000000|C0069717|G0000000|C0205195|C0001779|G0000000|G0000000|C0450371|C0439234|C0079399
"The inclusion criteria includes (i) women aged 15–49 years-old, (ii) possession of VGD programme card and (iii) provision of written consent agreement with their household head to participate in the study.","The inclusion criteria includes (i) women aged 15–49 years-old, (ii) possession VGD programme card (iii) provision written consent agreement household head participate study.",G0000000|C0007637|C0243161|C0332257|C0021966|C0043210|C0001779|G0000000|C0439234|G0000000|C0871103|G0000000|C1709697|C3275277|C0439070|C1549071|C0043266|C1511481|C0680240|C0020052|C0018670|G0000000|C0557651
The treatment focused on several core modules: (a) a Functional Analysis of Cannabis Use (b) Coping with Cannabis Cravings and Urges (c) Managing Thoughts about smoking Cannabis (d) Cannabis Refusal Skills (e) Seemingly Irrelevant Decisions related to cannabis use and (f) Planning for Emergencies.,The treatment focused core modules: (a) Functional Analysis Cannabis Use (b) Coping Cannabis Cravings Urges (c) Managing Thoughts smoking Cannabis (d) Cannabis Refusal Skills (e) Seemingly Irrelevant Decisions cannabis (f) Planning Emergencies.,G0000000|C0039798|C0205234|C0444669|C1709061|G0000000|C0205245|C0002778|C0024808|C0042153|G0000000|C0009967|C0024808|C0870371|G0000000|G0000000|C1273870|C0039869|C0037369|C0024808|C0073187|C0024808|G0000000|C0678856|G0000000|G0000000|G0000000|C0679006|C0024808|C0016327|C0032074|C0013956
"Depending on the admission criteria, being cured was defined as either achieving a MUAC of 125 mm or a WHZ score of ≥ −2 taking length at admission, with no presence of bilateral edema in the previous 14 days.","Depending admission criteria, cured defined achieving MUAC 125 mm WHZ score ≥ −2 length admission, presence bilateral edema previous 14 days.",C0725813|C0184666|C0243161|C1880198|C1704788|G0000000|G0000000|C1442061|G0000000|G0000000|C0449820|G0000000|G0000000|C1444754|C0184666|C0150312|C0238767|C0013604|C0205156|C0450371|C0439228
"Partners of eligible smokers had to be at least 18 years of age, nonsmokers (or not used tobacco in the previous one year), willing to participate in the study, and have an expired carbon monoxide (CO) level at baseline < 10 parts per million.","Partners eligible smokers 18 age, nonsmokers (or tobacco previous year), participate study, expired carbon monoxide (CO) level baseline < 10 million.",C0682323|C1548635|C0337664|C0450371|C0001779|C0337672|G0000000|C0040329|C0205156|C0439234|G0000000|C0557651|C0011065|C0007009|G0000000|C3245499|C0441889|C0168634|G0000000|C0450371|C1881839
"We hypothesized that the community-based participatory research–designed intervention would significantly improve breast cancer screening knowledge, improve attitudes, and promote screening behaviors among Hmong women in the intervention group compared with women in the control group.19 The baseline data and methodology of the Life is Precious program are described elsewhere.11,20 The Hmong are a preliterate population that has endured centuries of persecution in China and Southeast Asia.","We hypothesized community-based participatory research–designed intervention improve breast cancer screening knowledge, improve attitudes, promote screening behaviors Hmong women intervention compared women control group.19 The baseline data methodology Life Precious program elsewhere.11,20 The Hmong preliterate population endured centuries persecution China Southeast Asia.",G0000000|G0000000|C0009462|G0000000|G0000000|C0886296|G0000000|C0006141|C0006826|C0220908|C0376554|G0000000|C0004271|C0033414|C0220908|C0004927|C1553324|C0043210|C0886296|C1707455|C0043210|C0243148|C0441833|G0000000|C0168634|C1511726|C0969625|C0376558|G0000000|C1709697|C0450371|G0000000|C1553324|G0000000|C0032659|G0000000|C0719214|C0871062|C0008115|C1711190|C0003980
"Children suffering from pneumonia, capillary bronchitis and other diseases or who had been treated with antibiotics or hormones during the experimental process were excluded from this study.","Children suffering pneumonia, capillary bronchitis diseases treated antibiotics hormones experimental process excluded study.",C0008059|C0683278|C0032285|C0006901|C0006277|C0012634|C1522326|C0003232|C0019932|C1517586|C1184743|C1554077|C0557651
"After randomization, 26 participants were enrolled in each of the usual care and contingency management interventions while 24 were enrolled in each of the lung age and lung age combined with contingency management interventions.","After randomization, 26 participants enrolled usual care contingency management interventions 24 enrolled lung age lung age combined contingency management interventions.",G0000000|C0034656|C0450371|C0679646|G0000000|C3538928|C1947933|C1701901|C0001554|C0886296|C0450371|G0000000|C0024109|C0001779|C0024109|C0001779|C0205195|C1701901|C0001554|C0886296
At least one of the child’s biological parents had to be of Mexican descent and at least one guardian living in the home had to be of Mexican descent and willing to participate with the 7th grader.,At child’s biological parents Mexican descent guardian living Mexican descent participate 7th grader.,G0000000|G0000000|C0005532|C0030551|C0240339|C0205386|C0023226|C0376558|C0240339|C0205386|G0000000|G0000000|G0000000
Participants 626 men and women aged 38 to 99 years (average 80 years) were recruited from consecutive admissions to subacute hospital wards.,Participants 626 women aged 38 99 (average 80 years) recruited consecutive admissions subacute hospital wards.,C0679646|C1442061|C0043210|C0001779|C0450371|C0450371|C1510992|C0450371|C0439234|G0000000|C1707491|C0184666|C0205365|C0019994|C1305702
Participants were identified through a number of care homes around North Wales.,Participants identified care homes North Wales.,C0679646|C0205396|C1947933|C0442519|C1709269|C0043015
"In this phase I/II study, 14 high-risk disease-free ovarian (OC) and breast cancer (BC) patients after completion of standard therapies were vaccinated with MUC1, ErbB2 and carcinoembryonic antigen (CEA) HLA-A2+-restricted peptides and Montanide.","In phase I/II study, 14 high-risk disease-free ovarian (OC) breast cancer (BC) patients completion standard therapies vaccinated MUC1, ErbB2 carcinoembryonic antigen (CEA) HLA-A2+-restricted peptides Montanide.",G0000000|C0205390|C0021966|C0557651|C0450371|C0332167|C0012634|C0205065|C1412791|C0006141|C0006826|C0006041|C0030705|C0205197|C1442989|C0087111|C1116171|G0000000|G0000000|C1440204|C0003320|C3463961|C4049595|C0030956|G0000000
SUBJECTS: 472 children aged 6 to 59 months with clinical diagnosis of pneumonia.,SUBJECTS: 472 children aged 6 59 months clinical diagnosis pneumonia.,C0681850|C1442061|C0008059|C0001779|G0000000|C0450371|C0439231|C0205210|C0011900|C0032285
We conducted a retrospective cohort study of all deliveries that were attended at The First Affiliated Hospital of Kunming Medical University from January 2005 to December 2011.,We conducted retrospective cohort study deliveries attended The First Affiliated Hospital Kunming Medical University January 2005 December 2011.,G0000000|C0004927|C0035363|C0599755|C0557651|C0011209|C1456498|G0000000|C0205435|C1510825|C0019994|C0445517|C0199168|C0041740|C3829466|G0000000|C3830550|G0000000
"Participants were required to (1) be a healthy female without any chronic disease, (2) be a carbohydrate craver, determined by self-reported carbohydrate cravings on 2 or more days of the week, (3) be >18 years of age and <50 years of age, (4) have a body mass index (BMI) between 25 and 39.9 kg/m2, and (5) be a nonsmoker.","Participants required (1) healthy female chronic disease, (2) carbohydrate craver, determined self-reported carbohydrate cravings 2 days week, (3) >18 age <50 age, (4) body mass (BMI) 25 39.9 kg/m2, (5) nonsmoker.",C0679646|C1514873|G0000000|C3898900|C0015780|C0205191|C0012634|G0000000|C0007004|C0872137|G0000000|C0681906|C0007004|C0870371|G0000000|C0439228|C0332174|G0000000|C0450371|C0001779|C0450371|C0001779|G0000000|C0242821|C0577559|G0000000|C0450371|C0450371|C0022718|G0000000|C0337672
"72 students were randomly assigned to two groups using the list of students studying in the second and third year in 2010-2011 and based on the odd and even numbers.first group (n=38) trained stress management training program (8 two hours sessions, twice a week).","72 students randomly assigned list students studying 2010-2011 based odd numbers.first (n=38) trained stress management training program (8 hours sessions, week).",C0450371|C0038492|G0000000|C1516050|C0745732|C0038492|C0557651|G0000000|C1527178|C1415068|C0237753|C0369718|C0336809|C0038435|C0001554|C0040607|C1709697|G0000000|C0439227|C1883016|C0332174
"As an example, participants are considered at medical risk if they have any underlying medical conditions (e.g., hypertension, thyroid disease) or if they have multiple gestations.","As example, participants considered medical risk underlying medical conditions (e.g., hypertension, thyroid disease) multiple gestations.",G0000000|C1707959|C0679646|C0750591|C0199168|C0035647|G0000000|C0199168|C0012634|G0000000|C0020538|C0040132|C0012634|C0439064|C0032961
"There were 5 AN purging subtype in the TAU+FT group and 3 in the TAU group (no group effect, p = .71).","There 5 AN purging subtype TAU+FT 3 TAU (no effect, p = .71).",G0000000|G0000000|G0000000|C0855227|C0449560|C1720655|G0000000|C1720655|G0000000|C1280500|G0000000
Questionnaires were administered by the study staff.,Questionnaires administered study staff.,C0034394|C1521801|C0557651|C0851286
"Our study followed students who were in first or second grade at baseline (the 2001–2002 academic year) and who stayed in the study schools through fifth grade (the 2005–2006 academic year for the first-grade cohort, and the 2004–2005 academic year for the second-grade cohort).","Our study students grade baseline (the 2001–2002 academic year) stayed study schools grade (the 2005–2006 academic first-grade cohort, 2004–2005 academic second-grade cohort).",G0000000|C0557651|C0038492|C0441800|C0168634|G0000000|G0000000|C1510747|C0439234|G0000000|C0557651|C0036375|C0441800|G0000000|G0000000|C1510747|C0205435|C0599755|G0000000|C1510747|C0205436|C0599755
Patients with any competing dietary issues (i.e.,Patients competing dietary issues (i.e.,C0030705|G0000000|C0012155|C0033213|C0683454
Patients who met eligibility criteria were randomly assigned to voriconazole or fluconazole before transplantation.,Patients met eligibility criteria randomly assigned voriconazole fluconazole transplantation.,C0030705|C0268621|C0013893|C0243161|G0000000|C1516050|C0393080|C0016277|C0040732
Participants were current smokers or those who had recently stopped smoking.,Participants current smokers stopped smoking.,C0679646|C0521116|C0337664|C1272691|C0037369
The interventions will be tested on vocational school students due to the high smoking prevalence in this population (approximately 42% of the Swiss sample were daily or occasional tobacco smokers) [11].,The interventions tested vocational school students smoking prevalence population (approximately 42% Swiss sample daily occasional tobacco smokers) [11].,G0000000|C0886296|C0392366|C0087164|C0036375|C0038492|C0037369|C0033105|C0032659|C0332232|C0450371|C0241315|C0370003|C0332173|C0521114|C0040329|C0337664|C0450371
Mothers received PCP prophylaxis if indicated.,Mothers received PCP prophylaxis indicated.,C0026591|C1514756|C1535939|C0033107|C1444656
A study was therefore undertaken to investigate whether CPAP improves symptoms and daytime function in patients with mild SAHS.,A study undertaken investigate CPAP improves symptoms daytime function patients mild SAHS.,G0000000|C0557651|G0000000|C1292732|C0199451|C0184511|C0683368|C0332169|C0031843|C0030705|C2945599|C0520679
"To further explore the use of CES in persons with SCI, we conducted a double-blind, sham-controlled, pilot study in 2002–2003 in which 38 veterans with SCI with neuropathic or musculoskeletal pain were randomly assigned to either CES (n = 18) or sham CES (n = 20).19 They were trained to self-administer the CES treatment at home and to complete pain ratings on a 0–10 scale immediately before and after each treatment session.","To explore CES persons SCI, conducted double-blind, sham-controlled, pilot study 2002–2003 38 veterans SCI neuropathic musculoskeletal pain randomly assigned CES (n = 18) sham CES (n = 20).19 They trained self-administer CES treatment complete pain ratings 0–10 scale treatment session.",C0040363|G0000000|C0265493|C0027361|C3642273|C0004927|C0013072|C0068899|C0473169|C0557651|G0000000|C0450371|C0042610|C3642273|C0442874|C0497254|C0030193|G0000000|C1516050|C0265493|C0369718|G0000000|C0450371|C0068899|C0265493|C0369718|G0000000|C0450371|G0000000|C0336809|C0036588|C0265493|C0039798|C0205197|C0030193|C0871208|G0000000|C0175659|C0039798|C1883016
"The following inclusion criteria were applied: (i) a history of stroke 1–6 months prior to participation in the project; (ii) Action Research Arm Test (ARAT) score of between 3 and 51 (maximum score 57; Lyle, 1981) indicating a persistent motor weakness with the preserved ability to make some movement with the affected arm; (iii) no alcohol dependency or evidence of substance abuse; (iv) no severe cognitive impairment (Mental Status Questionnaire score of 7 or more; Kahn et al., 1981); and (v) no severe aphasia [based on clinical notes and verified at baseline assessment using 10 representative items of the language comprehension Token Test (De Renzi and Faglioni, 1978; items 1.1–2; 2.1–2; 4.1–2; 6.1–2; 6.4–5, passing 8/10 trials or more)].","The inclusion criteria applied: (i) history stroke 1–6 months prior participation project; (ii) Action Research Arm Test (ARAT) score 3 51 (maximum score 57; Lyle, 1981) indicating persistent motor weakness preserved ability movement arm; (iii) alcohol dependency evidence substance abuse; (iv) severe cognitive impairment (Mental Status Questionnaire score 7 more; Kahn al., 1981); (v) severe aphasia [based clinical notes verified baseline assessment 10 representative items language comprehension Token Test (De Renzi Faglioni, 1978; items 1.1–2; 2.1–2; 4.1–2; 6.1–2; 6.4–5, passing 8/10 trials more)].",G0000000|C0007637|C0243161|C4048755|C0021966|C0019664|C0038454|G0000000|C0439231|C0332152|C0679823|C1709701|G0000000|C0441472|C0035168|C0446516|C0022885|C1152215|C0449820|G0000000|C0450371|C0806909|C0449820|C0450371|G0000000|G0000000|G0000000|C0205322|C1513492|C3714552|C0033085|C0085732|C0026649|C0446516|C0439070|C0001962|C0011546|C3887511|C0439861|C0013146|C0022326|C0205082|C1516691|C0221099|C0229992|C0449438|C0034394|C0449820|G0000000|C0205172|G0000000|C0202311|G0000000|G0000000|C0205082|C0003537|C1527178|C0205210|C1317574|C1711411|C0168634|C1261322|C0450371|C1882932|C1551338|C0023008|C0162340|C1883682|C0022885|C0011198|G0000000|G0000000|G0000000|C1551338|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|C0450371|C0008976|C0205172
"Participants were also excluded after randomization, if they repeatedly vomited their first dose of study medications.","Participants excluded randomization, repeatedly vomited dose study medications.",C0679646|C1554077|C0034656|C0205341|C0042963|C0178602|C0557651|C0013227
"Exclusion criteria were having pain in the Duration of the menstruation period or before the onset of menstrual bleeding, use of oral hormonal contraception during treatment, having urinary tract infection in the study period, simultaneous participation in another clinical trial or participation in another clinical trial prior to study entry that might have an impact on the study objectives at the discretion of the investigator.","Exclusion criteria pain Duration menstruation period onset menstrual bleeding, oral hormonal contraception treatment, urinary tract infection study period, simultaneous participation clinical trial participation clinical trial prior study entry impact study objectives discretion investigator.",C0680251|C0243161|C0030193|C0449238|C0025344|C0439531|C0206132|C0025344|C0019080|C0442027|C0458083|C0700589|C0039798|C0042027|C1185740|C0009450|C0557651|C0439531|C0205420|C0679823|C0205210|C0008976|C0679823|C0205210|C0008976|C0332152|C0557651|C1705654|C1825598|C0557651|C0018017|G0000000|C0035173
This series of questions approximates that used to obtain national estimates of the prevalence of smoking.20 Respondents who reported that they had smoked 100 cigarettes in their lifetimes and were current cigarette smokers composed the cigarette smoking cohort that is the subject of this report.,This series questions approximates national estimates prevalence smoking.20 Respondents reported smoked 100 cigarettes lifetimes current cigarette smokers composed cigarette smoking cohort subject report.,G0000000|C0205549|C1522634|C0332232|C3245503|C0750572|C0033105|C0037369|C0282122|C0684224|C0037366|C1442061|C0677453|C4071830|C0521116|C0677453|C0337664|G0000000|C0677453|C0037369|C0599755|C0681850|C0684224
"To determine the malaria incidence based on active case detection, a cohort of 1548, 774 children per arm, will be followed by monthly household visits.","To determine malaria incidence based active detection, cohort 1548, 774 children arm, monthly household visits.",C0040363|G0000000|C0024530|C0021149|C1527178|C0205177|C1511790|C0599755|G0000000|C1442061|C0008059|C0446516|C0332177|C0020052|C0545082
This study is conducted in the Netherlands among fourth-grade secondary school students (aged 15–16 years).,This study conducted Netherlands fourth-grade secondary school students (aged 15–16 years).,G0000000|C0557651|C0004927|C0027778|C0205438|C0027627|C0036375|C0038492|C0001779|G0000000|C0439234
"Inclusion criteria were: (1) age 3–12 years, (2) diagnosis of spastic diplegia: defined as spastic motor impairment with more involvement of lower limbs than upper, fair to good trunk and head control, and little or no bulbar involvement, (3) community or indoor ambulation status,12–14 (4) cooperative and tolerant to testing procedures during clinic screening, (5) No fixed musculoskeletal deformities greater than 15 degrees (ie, normal knee extension range of motion = 0 degrees, ankle dorsiflexion = + 15 degrees, (6) stable social environment, (7) ongoing physical therapy (PT) of a minimum of one 60-minute session per week, and (8) pharmacological treatment (baclofen) for spasticity was not a basis for exclusion.","Inclusion criteria were: (1) age 3–12 years, (2) diagnosis spastic diplegia: defined spastic motor impairment involvement lower limbs upper, fair trunk head control, bulbar involvement, (3) community indoor ambulation status,12–14 (4) cooperative tolerant testing procedures clinic screening, (5) No fixed musculoskeletal deformities 15 degrees (ie, normal knee extension range motion = 0 degrees, ankle dorsiflexion = + 15 degrees, (6) stable social environment, (7) ongoing physical therapy (PT) minimum 60-minute session week, (8) pharmacological treatment (baclofen) spasticity basis exclusion.",C0007637|C0243161|G0000000|G0000000|C0001779|G0000000|C0439234|G0000000|C0011900|C0026838|C0221165|C1704788|C0026838|C1513492|C0221099|C1314939|C0441994|C0015385|C1282910|C2911689|C0225442|C0018670|C0243148|C1947952|C1314939|G0000000|C0009462|G0000000|C0080331|G0000000|G0000000|C0679729|C0231198|C0039593|C0025664|C0002424|C0220908|G0000000|G0000000|C0443218|C0497254|C0000768|C0450371|C0449286|G0000000|C0205307|C0022742|C0231448|C1514721|C0026597|G0000000|G0000000|C0449286|C0003086|G0000000|G0000000|G0000000|C0450371|C0449286|G0000000|C0205360|C0728831|C0014406|G0000000|C0549178|C0031809|C0039798|C0699718|C1524031|C0450371|C1883016|C0332174|G0000000|C0031330|C0039798|C0004609|C0026838|C1527178|C0680251
Design and Measurements: The research was a controlled randomized study conducted with 113 adults who were recruited from the community and who expressed a concern about memory loss in a family member.,Design Measurements: The controlled randomized study conducted 113 adults recruited community expressed concern memory loss family member.,C1707689|C0242485|G0000000|C2587213|C0034656|C0557651|C0004927|C1442061|C0001675|G0000000|C0009462|G0000000|C2699424|C0025260|C1517945|C0015576|C0680022
We identified 291 incident PD cases during 6 years of follow-up.,We identified 291 incident PD 6 follow-up.,G0000000|C0205396|C1442061|C1551358|G0000000|G0000000|C0589120
"A cluster randomized trial of 12 villages in Maradi, Niger.","A cluster randomized trial 12 villages Maradi, Niger.",G0000000|C1555715|C0034656|C0008976|C0450371|C0562518|G0000000|C0028074
All patients having elective spinal surgery were included in our study from February 2006 to November 2006.,All patients elective spinal surgery included study February 2006 November 2006.,G0000000|C0030705|C0206058|C0521329|C0038894|C0332257|C0557651|C3830166|G0000000|C3828767|G0000000
"We, ourselves, funded this study.","We, ourselves, funded study.",G0000000|G0000000|C0016820|C0557651
Epilepsy neurosurgery is a treatment option for children with refractory epilepsy.,Epilepsy neurosurgery treatment option children refractory epilepsy.,C0014544|C0027926|C0039798|C1518601|C0008059|C0205269|C0014544
"In the community, 20% of women aged 80 to 85 are anaemic, with anaemia of chronic disease being the most common cause.","In community, 20% women aged 80 85 anaemic, anaemia chronic disease common cause.",G0000000|C0009462|C0450371|C0043210|C0001779|C0450371|C0450371|C0857322|C0002871|C0205191|C0012634|C0205214|C0015127
These may include visual spatial planning tasks (e.g.,These visual spatial planning tasks (e.g.,G0000000|C0234621|C1428114|C0032074|C3540678|G0000000
"Severe refractory atopic dermatitis (AD) is a chronic, debilitating condition that is associated with elevated serum immunoglobulin E (IgE) levels.","Severe refractory atopic dermatitis (AD) chronic, debilitating condition elevated serum immunoglobulin E (IgE) levels.",C0205082|C0205269|C0392707|C0011603|G0000000|C0205191|G0000000|C0012634|C0205250|C0229671|C0021027|G0000000|G0000000|C0441889
"Exclusion criteria included pregnant or nursing women, men or women of childbearing potential unwilling to use adequate contraception, inability to complete a magnetic resonance imaging scan with contrast, prior resection of cerebral metastasis, chemotherapy within 7 days of preregistration or planned chemotherapy during the radiotherapy, prior cranial radiotherapy, leptomeningeal metastases, lesion located within 5 mm of the optic chiasm or within the brainstem, or metastases from primary germ cell tumor, small cell carcinoma, or lymphoma.","Exclusion criteria included pregnant nursing women, women childbearing potential unwilling adequate contraception, inability complete magnetic resonance imaging scan contrast, prior resection cerebral metastasis, chemotherapy 7 days preregistration planned chemotherapy radiotherapy, prior cranial radiotherapy, leptomeningeal metastases, lesion located 5 mm optic chiasm brainstem, metastases primary germ cell tumor, cell carcinoma, lymphoma.",C0680251|C0243161|C0332257|C0549206|C0006147|C0043210|C0043210|G0000000|C3245505|C0558080|C0205410|C0700589|G0000000|C0205197|C0024488|C0231881|C0011923|C0034606|C0009924|C0332152|C0015252|G0000000|C0027627|C0013216|G0000000|C0439228|C1882499|C1301732|C0013216|C0034619|C0332152|C0037303|C0034619|C0228126|C0027627|C0221198|G0000000|G0000000|G0000000|C0015392|C0504074|C0006121|C0027627|C0205225|C1517528|C0007634|C0027651|C0007634|C0007097|C0024299
4) Vaginal delivery and in need of anaesthesiological assistance and either: a) estimated blood loss exceeding 500 ml and intended manual removal of placenta; or b) estimated blood loss exceeding 1000 ml and intended manual exploration of the uterus due to continuous bleeding after the birth of placenta.,4) Vaginal delivery anaesthesiological assistance either: a) estimated blood loss exceeding 500 ml intended manual removal placenta; b) estimated blood loss exceeding 1000 ml intended manual exploration uterus continuous bleeding birth placenta.,G0000000|C0042232|C0011209|C0002930|C0018896|C3844638|G0000000|C0750572|C0005767|C1517945|G0000000|G0000000|C1283828|C0024763|C0015252|C0032043|G0000000|C0750572|C0005767|C1517945|G0000000|G0000000|C1283828|C0024763|C1280903|C0042149|C0549178|C0019080|C0005615|C0032043
Forty patients with chronic stroke will be included.,Forty patients chronic stroke included.,C3816449|C0030705|C0205191|C0038454|C0332257
"Exclusion criteria included pregnancy, lactation, long-term antibiotic therapy, immune compromised, cancer and other conditions that would affect the ability to provide informed consent or comply with the protocol.","Exclusion criteria included pregnancy, lactation, long-term antibiotic therapy, immune compromised, cancer conditions affect ability provide informed consent comply protocol.",C0680251|C0243161|C0332257|C0032961|C0006147|C0443252|C0003232|C0039798|C0439662|C2945640|C0006826|C0012634|C0001721|C0085732|C1999230|C1522154|C1511481|C0725694|C0442711
INTERVENTIONS—All patients received standard short course antituberculous chemotherapy and were randomly assigned to receive prednisolone or placebo for six weeks.,INTERVENTIONS—All patients received standard short antituberculous chemotherapy randomly assigned receive prednisolone placebo weeks.,G0000000|C0030705|C1514756|C1442989|C1282927|G0000000|C0013216|G0000000|C1516050|C1514756|C0032950|C0032042|C0439230
The ADEBAR study was a randomised phase III trial for women with primary invasive breast cancer and ⩾4 metastatic axillary lymph nodes (n=1364).,The ADEBAR study randomised phase III trial women primary invasive breast cancer ⩾4 metastatic axillary lymph nodes (n=1364).,G0000000|G0000000|C0557651|G0000000|C0205390|C0439070|C0008976|C0043210|C0205225|C0205281|C0006141|C0006826|G0000000|C0036525|C0004454|C0024202|C0746922|C0369718
"To accomplish multiple repetitions, stroke survivors may require augmented duration of practice.","To accomplish multiple repetitions, stroke survivors require augmented duration practice.",C0040363|G0000000|C0439064|C0205341|C0038454|C0206194|G0000000|C0205217|C0449238|C0237607
"At the time of this study, the system was being used by 255 primary care physicians practicing at 20 outpatient clinics for the care of all patients in their panels.","At time study, system 255 primary care physicians practicing 20 outpatient clinics care patients panels.",G0000000|C0040223|C0557651|C0449913|C1442061|C0205225|C1947933|C0031831|C0237607|C0450371|C0029921|C0442592|C1947933|C0030705|C0441833
"The mean age of persons in the study was 40.7 years (SD = 11.3), with a mean duration of pain of 76.9 months (SD = 97.4).","The age persons study 40.7 (SD = 11.3), duration pain 76.9 months (SD = 97.4).",G0000000|C0001779|C0027361|C0557651|C0450371|G0000000|G0000000|C0450371|C0449238|C0030193|C0450371|C0439231|G0000000|G0000000|C0450371
"During the 52-week treatment period, patients were randomized to receive either pitavastatin 1 mg once daily or pitavastatin 2 mg once daily, administered orally before breakfast.","During 52-week treatment period, patients randomized receive pitavastatin 1 daily pitavastatin 2 daily, administered orally breakfast.",G0000000|C0450371|C0039798|C0439531|C0030705|C0034656|C1514756|C1101838|G0000000|C0332173|C1101838|G0000000|C0332173|C1521801|C0442027|C2698559
TABLE 3.,TABLE 3.,C0039224|G0000000
Women who were either postmenopausal for ≥12 months or peri-menopausal (with amenorrhea lasting 2 to 11 months in the proceeding year) were included.,Women postmenopausal ≥12 months peri-menopausal (with amenorrhea lasting 2 11 months proceeding year) included.,C0043210|C0232970|G0000000|C0439231|C0849668|G0000000|C0002453|C1517741|G0000000|C0450371|C0439231|G0000000|C0439234|C0332257
Children lost to follow-up did not differ from those still in care by any of the baseline characteristics or timing of ART initiation.,Children lost follow-up care baseline characteristics timing ART initiation.,C0008059|C0745777|C0589120|C1947933|C0168634|C1521970|C0449243|C0003826|C0589507
Patients: Preterm infants < 33 weeks gestation and < 1700 g birth weight meeting specific criteria indicating a high possibility of requiring blood transfusion.,Patients: Preterm infants < 33 weeks gestation < 1700 birth weight meeting specific criteria indicating possibility requiring blood transfusion.,C0030705|C0151526|C0021270|G0000000|C0450371|C0439230|C0032961|G0000000|G0000000|C0005615|C0005910|C0556656|C0205369|C0243161|G0000000|C0332149|G0000000|C0005767|C0005841
"Current infective illness (ie, respiratory infection, diarrhoea) with fever; however, children may be rescreened again after recovery if otherwise eligible.","Current infective illness (ie, respiratory infection, diarrhoea) fever; however, children rescreened recovery eligible.",C0521116|G0000000|C0221423|G0000000|C0521346|C0009450|C0011991|C0015967|G0000000|C0008059|G0000000|C0237820|C1548635
"For the current analysis, we excluded subjects with prior diagnosed of cancer (n=947), stroke (n=1894), heart disease (n=8919), chronic obstructive pulmonary disease (n=27525), asthma (n=1043), tuberculosis (n=4145), peptic ulcer (n=8728), diabetes (n=733), hypertension (n=6400), kidney disease (n=1730), cirrhosis (n=271), chronic hepatitis (n=2169).","For current analysis, excluded subjects prior diagnosed cancer (n=947), stroke (n=1894), heart disease (n=8919), chronic obstructive pulmonary disease (n=27525), asthma (n=1043), tuberculosis (n=4145), peptic ulcer (n=8728), diabetes (n=733), hypertension (n=6400), kidney disease (n=1730), cirrhosis (n=271), chronic hepatitis (n=2169).",G0000000|C0521116|C0002778|C1554077|C0681850|C0332152|C0011900|C0006826|C0369718|C0038454|C0369718|C0018787|C0012634|C0369718|C0205191|C0549186|C0024109|C0012634|C0369718|C0004096|C0369718|C0041296|C0369718|C0443277|C0041582|C0369718|C0011847|C0369718|C0020538|C0369718|C0022646|C0012634|C0369718|C0023890|C0369718|C0205191|C0019158|C0369718
The study population includes adults (18 years or over) with stage 4 or 5 CKD (on dialysis or estimated GFR < 30 ml/min/1.73 m2) who are able to give informed consent and who have a haemoglobin concentration < 110 g/L for at least 3 months in spite of EPO dosage ≥ 200 IU/kg/week or DPO dosage ≥ 1 μg/kg/week for at least 1 month.,The study population includes adults (18 over) stage 4 5 CKD (on dialysis estimated GFR < 30 ml/min/1.73 m2) informed consent haemoglobin concentration < 110 g/L 3 months spite EPO dosage ≥ 200 IU/kg/week DPO dosage ≥ 1 μg/kg/week 1 month.,G0000000|C0557651|C0032659|C0332257|C0001675|C0450371|C0205136|C0205390|G0000000|G0000000|C1561643|G0000000|C0011945|C0750572|C0017654|G0000000|C0450371|C0439445|C0025885|C1522154|C1511481|C0019046|C0004268|G0000000|C1442061|C0439294|G0000000|C0439231|G0000000|G0000000|C0178602|G0000000|C1442061|C0439463|G0000000|C0178602|G0000000|G0000000|G0000000|G0000000|C0332177
"A prospective, randomized, single-center, blinded study was conducted to compare traditional and Swim cast treatment in children aged 5–15 years with greenstick or torus fractures of the distal radius.","A prospective, randomized, single-center, blinded study conducted compare traditional Swim cast treatment children aged 5–15 greenstick torus fractures distal radius.",G0000000|C0023981|C0034656|C0037179|C0150108|C0557651|C0004927|C1707455|C0443324|C0039003|C0179686|C0039798|C0008059|C0001779|G0000000|C0332716|C0332567|C0016658|C0205108|C0034627
"The inclusion criteria were that the patients must be at around the age from 2 to 7, and have ASA class 1.","The inclusion criteria patients age 2 7, ASA class 1.",G0000000|C0007637|C0243161|C0030705|C0001779|G0000000|G0000000|C0004057|C0456387|G0000000
Objective To determine whether the provision of single lens distance glasses to older wearers of multifocal glasses reduces falls.,Objective To determine provision single lens distance glasses wearers multifocal glasses reduces falls.,C0018017|C0040363|G0000000|C1549071|C0037179|C0023317|C0012751|C0015421|G0000000|C0205292|C0015421|G0000000|C0000921
"Exclusion criteria include: inability to provide informed consent, not independent before the stroke as determined by a score of >1 on the Modified Rankin Scale, sensory loss ≥2 on the sensory item of the National Institutes of Health Stroke Scale, hemispatial neglect as determined by asymmetry > 3 errors on the Star Cancellation Test, spastic hypertonus of hemiparetic hand or wrist musculature ≥ 3 on Modified Ashworth Scale, Botox injection in hemiparetic upper extremity within 6 months of enrolment, and life expectancy ≤ one year.","Exclusion criteria include: inability provide informed consent, independent stroke determined score >1 Modified Rankin Scale, sensory loss ≥2 sensory item National Institutes Health Stroke Scale, hemispatial neglect determined asymmetry > 3 errors Star Cancellation Test, spastic hypertonus hemiparetic hand wrist musculature ≥ 3 Modified Ashworth Scale, Botox injection hemiparetic upper extremity 6 months enrolment, life expectancy ≤ year.",C0680251|C0243161|C0332257|G0000000|C1999230|C1522154|C1511481|C0085862|C0038454|G0000000|C0449820|G0000000|C0392747|G0000000|C0175659|C0445254|C1517945|G0000000|C0445254|C1551338|C3245503|C0021622|C0018684|C0038454|C0175659|G0000000|C0521874|G0000000|C0332514|G0000000|G0000000|C0743559|C0995242|C0205544|C0022885|C0026838|C0026826|G0000000|C0018563|C0043262|C1995013|G0000000|G0000000|C0392747|G0000000|C0175659|C0700702|C0021485|G0000000|C1282910|C0015385|G0000000|C0439231|C1516879|C0376558|C0679138|G0000000|C0439234
Exclusion criteria included deformity or distortion of the cubital tunnel due to previous trauma to the elbow and recurrent cubital tunnel syndrome after previous surgery.,Exclusion criteria included deformity distortion cubital tunnel previous trauma elbow recurrent cubital tunnel syndrome previous surgery.,C0680251|C0243161|C0332257|C0000768|C0332482|C0013769|C0337138|C0205156|C0043251|C0013769|C2945760|C0013769|C0337138|C0039082|C0205156|C0038894
"Samples who showed allergy to the fenugreek when consuming it, did not use the capsule properly, used any other herbal drug during the intervention, stopped taking the capsule, and used 4 capsules or less daily were excluded from the study.","Samples allergy fenugreek consuming it, capsule properly, herbal drug intervention, stopped capsule, 4 capsules daily excluded study.",C0370003|C0002111|C0060207|G0000000|G0000000|C0006935|G0000000|C3146288|C0013227|C0886296|C1272691|C0006935|G0000000|C0006935|C0332173|C1554077|C0557651
"The NIH-AARP Diet and Health study began in 1995–1996 with the mailing of an extensive baseline questionnaire to 3.5 million AARP members aged 50–71 years old and residing in six U.S. states (California, Florida, Louisiana, North Carolina, New Jersey, and Pennsylvania) or two U.S. metropolitan areas (Atlanta, Georgia and Detroit, Michigan).","The NIH-AARP Diet Health study 1995–1996 mailing extensive baseline questionnaire 3.5 AARP aged 50–71 residing U.S. (California, Florida, Louisiana, North Carolina, New Jersey, Pennsylvania) U.S. metropolitan (Atlanta, Georgia Detroit, Michigan).",G0000000|C0027468|C0012155|C0018684|C0557651|G0000000|C0024492|C0205231|C0168634|C0034394|G0000000|G0000000|C0001779|G0000000|C2982691|C0041703|C0006754|C0016253|C0024024|C1709269|G0000000|C0205314|C0454673|C0030853|C0041703|C0599587|C2993063|C0017452|G0000000|C0025939
Here we report the clinical characteristics and outcomes of hospitalized patients in Gujarat with confirmed H1N1 infection during 2009 influenza season.,Here report clinical characteristics outcomes hospitalized patients Gujarat confirmed H1N1 infection 2009 influenza season.,G0000000|C0684224|C0205210|C1521970|C1274040|C0701159|C0030705|G0000000|C0521093|G0000000|C0009450|G0000000|C0021400|C0036497
Participants will include all stroke survivors in AKTH referred for physiotherapy by consulting physicians.,Participants stroke survivors AKTH referred physiotherapy consulting physicians.,C0679646|C0038454|C0206194|G0000000|C0205543|C0949766|C0009818|C0031831
"Prenatal care is run by public health nurses (PHN), formally supervised by general practitioners.","Prenatal care public health nurses (PHN), formally supervised practitioners.",C0678804|C1947933|G0000000|C0018684|C0028661|C0032768|G0000000|G0000000|C1709627
The study population comprised the 169 families with children aged ⩽5 years that were registered with a single handed general practice in an urban area of Nottingham.,The study population comprised 169 families children aged ⩽5 registered single handed practice urban Nottingham.,G0000000|C0557651|C0032659|C2700400|C1442061|C0015576|C0008059|C0001779|G0000000|C1514821|C0037179|C0018563|C0237607|C0442529|G0000000
This study is a randomized controlled trial conducted on 43 Children (2–18 years old) with Bell’s palsy.,This study randomized controlled trial conducted 43 Children (2–18 old) Bell’s palsy.,G0000000|C0557651|C0034656|C2587213|C0008976|C0004927|C0450371|C0008059|G0000000|C0580836|G0000000|C0522224
"We studied the inpatient general medicine wards of Wishard Memorial Hospital, an inner-city public teaching hospital.","We studied inpatient medicine wards Wishard Memorial Hospital, inner-city public teaching hospital.",G0000000|C0557651|C0021562|C0013227|C1305702|G0000000|G0000000|C0019994|C0557849|G0000000|C0039401|C0019994
"Patients were randomised (n = 416, mean age 63 years) to receive either indacaterol 150 μg o.d.","Patients randomised (n = 416, age 63 years) receive indacaterol 150 μg o.d.",C0030705|G0000000|C0369718|G0000000|C1442061|C0001779|C0450371|C0439234|C1514756|C1722260|C1442061|G0000000|C0483204
Control participants enrolled in the 8th grade TAAG study cohort were invited to participate in a longitudinal follow-up.,Control participants enrolled 8th grade TAAG study cohort invited participate longitudinal follow-up.,C0243148|C0679646|G0000000|G0000000|C0441800|G0000000|C0557651|C0599755|G0000000|G0000000|C0205127|C0589120
"The patients with Diabetes mellitus, Hypertension, a history of peptic ulcer disease or hypersensitivity to corticosteroids and total leukocyte counts of more than 11000/cumm were excluded from the study.","The patients Diabetes mellitus, Hypertension, history peptic ulcer disease hypersensitivity corticosteroids total leukocyte counts 11000/cumm excluded study.",G0000000|C0030705|C0011847|G0000000|C0020538|C0019664|C0443277|C0041582|C0012634|C0020517|C0001617|C0439175|C0023516|C0439157|G0000000|C1554077|C0557651
A one-week inpatient SMP has been part of the rheumatology service at the Hospital for Rheumatic Diseases in Lillehammer for several years; therefore it was desirable to study whether it had any effects.,A one-week inpatient SMP rheumatology service Hospital Rheumatic Diseases Lillehammer years; desirable study effects.,G0000000|C4082116|C0021562|C1428758|C0035452|C0557854|C0019994|G0000000|C0012634|G0000000|C0439234|G0000000|C0557651|C1280500
"Women were eligible for inclusion in the trial if they were 18 years of age or older, were premenopausal with follicle-stimulating hormone (FSH) level less than 10 mIU/L, had reported at least moderately severe leiomyoma-related symptoms (a score of ≥25 on the UF quality-of-life symptom severity subscale), had a total uterine volume of ≥160 mL by vaginal and abdominal ultrasound and at least one UF/leiomyoma that was ≥2 cm3.","Women eligible inclusion trial 18 age older, premenopausal follicle-stimulating hormone (FSH) level 10 mIU/L, reported moderately severe leiomyoma-related symptoms (a score ≥25 UF quality-of-life symptom severity subscale), total uterine volume ≥160 mL vaginal abdominal ultrasound UF/leiomyoma ≥2 cm3.",C0043210|C1548635|C0007637|C0008976|C0450371|C0001779|C0580836|C0279752|C0018120|C0019932|G0000000|C0441889|C0450371|C0439462|C0684224|C0205081|C0205082|C0023267|C0683368|G0000000|C0449820|G0000000|G0000000|C0332306|C1457887|C0439793|G0000000|C0439175|C0042149|C0449468|G0000000|C0439526|C0042232|C0000726|C0041618|C0023267|G0000000|G0000000
"Also excluded were patients with abnormal hepatic or renal laboratory parameters such as serum-alanine aminotransferase or serum-aspartate-aminotransferase twice the normal reference range or higher, respectively; serum-creatinine levels higher than 130 μmol/L or glomerular filtration rate lower than 30 mL/minute; or with bone metabolic disorders such as primary hyperparathyroidism, osteogenesis imperfecta, Paget’s disease, or myeloma.","Also excluded patients abnormal hepatic renal laboratory parameters serum-alanine aminotransferase serum-aspartate-aminotransferase normal reference range higher, respectively; serum-creatinine levels 130 μmol/L glomerular filtration rate lower 30 mL/minute; bone metabolic disorders primary hyperparathyroidism, osteogenesis imperfecta, Paget’s disease, myeloma.",G0000000|C1554077|C0030705|C0205161|C0205054|C0022646|C0022877|C0449381|C0229671|C0002594|C0229671|C0205307|C1514811|C1514721|C0205250|G0000000|C0201976|C0441889|C1442061|G0000000|C0022663|C0016107|C0871208|C0441994|C0450371|C0439526|C0262950|C0311400|C0012634|C0205225|C0020502|C0029433|G0000000|G0000000|C0012634|C0026764
"In addition, there was no medical restriction to continue exclusive breastfeeding for up to 6 months of age.","In addition, medical restriction continue exclusive breastfeeding 6 months age.",G0000000|C0332287|C0199168|C0443288|C0549178|C1548966|C0006147|G0000000|C0439231|C0001779
The loose control group spent 90% of the first 24 hours in target and the tight group 44% of time in target.,The loose control spent 90% 24 hours target tight 44% time target.,G0000000|C0205407|C0243148|C0680968|C0450371|C0450371|C0439227|C1521840|C0439816|C0450371|C0040223|C1521840
"544 smokers (59% women, 86% White) recruited during primary care visits and motivated to quit.","544 smokers (59% women, 86% White) recruited primary care visits motivated quit.",C1442061|C0337664|C0450371|C0043210|C0450371|C0007457|G0000000|C0205225|C1947933|C0545082|G0000000|C0748223
Baseline Characteristics of the 1247 Study Participants during the 2004–2005 Influenza Season in Michigan.,Baseline Characteristics 1247 Study Participants 2004–2005 Influenza Season Michigan.,C0168634|C1521970|G0000000|C0557651|C0679646|G0000000|C0021400|C0036497|C0025939
"Inclusion criteria were as follows: age ≥18 years with Eastern Cooperative Oncology Group performance status (ECOG PS) 0 or 1, with histologically confirmed, inoperable, metastatic adenocarcinoma of the stomach or GEJ.","Inclusion criteria follows: age ≥18 Eastern Cooperative Oncology Group performance status (ECOG PS) 0 1, histologically confirmed, inoperable, metastatic adenocarcinoma stomach GEJ.",C0007637|C0243161|C0332283|C0001779|G0000000|C1707877|C0679729|C0027651|C0441833|C0597198|C0449438|C0430797|C0242397|G0000000|G0000000|C0205462|C0521093|C0205187|C0036525|C0001418|C0038351|G0000000
A total of 14 patients who received intra-arterial (i.a.),A total 14 patients received intra-arterial (i.a.),G0000000|C0439175|C0450371|C0030705|C1514756|C0694634|C0021966
The birth prevalence of severe congenital heart defects was determined annually as the number of infants (live births and stillbirths) born with severe congenital heart defects per 1000 births in Quebec.,The birth prevalence severe congenital heart defects determined annually infants (live births stillbirths) born severe congenital heart defects 1000 births Quebec.,G0000000|C0005615|C0033105|C0205082|C0009678|C0018787|C0243067|G0000000|C0332181|C0021270|C1548795|C0005615|C0595939|C0005615|C0205082|C0009678|C0018787|C0243067|G0000000|C0005615|C0034390
"Results: Of 144 eligible patients, urine culture was positive in 54 of 72 (75%) women in group A and 51 of 72 (71%) in group B.","Results: Of 144 eligible patients, urine culture positive 54 72 (75%) women A 51 72 (71%) B.",C1274040|G0000000|C1442061|C1548635|C0030705|C0042036|C0010453|C0439178|C0450371|C0450371|C0450371|C0043210|G0000000|C0450371|C0450371|C0450371|G0000000
"A contemporaneous study, undertaken in Newcastle, utilised dental hygienists to give advice in a hospital periodontal department.","A contemporaneous study, undertaken Newcastle, utilised dental hygienists advice hospital periodontal department.",G0000000|G0000000|C0557651|G0000000|G0000000|G0000000|C0011365|C0011369|C0150600|C0019994|C2960678|C1704729
"AHI was calculated in accordance with the AASM rules, terminology and technical specifications[11].","AHI calculated AASM rules, terminology technical specifications[11].",G0000000|C0444686|G0000000|C0870077|C0028275|C0449851|C2348235
"In stage 2, the second paediatric hospital will randomise implementation of a modified eMM and outcomes will be assessed.","In stage 2, paediatric hospital randomise implementation modified eMM outcomes assessed.",G0000000|C0205390|G0000000|C0030755|C0019994|G0000000|C1708476|C0392747|G0000000|C1274040|C1516048
There is no consensus on the specific treatment for this subset of children with GBS.,There consensus specific treatment subset children GBS.,G0000000|C0376298|C0205369|C0039798|C1515021|C0008059|C0018378
MRI was normal or showed heterotopia.,MRI normal heterotopia.,C0024485|C0205307|C0008519
The inclusion criteria were: male or female patients ≥40 years old; an established COPD clinical history [1]; a post-salbutamol FEV1/forced vital capacity (FVC) ratio <0.70 and a post-salbutamol FEV1 of ≥30 % and ≤70 % of predicted normal values; a dyspnoea score of ≥2 (modified Medical Research Council [mMRC] Dyspnoea Scale); current or former (stopped smoking for ≥6 months) cigarette smokers with a history of cigarette smoking of ≥10 pack-years.,The inclusion criteria were: male female patients ≥40 old; established COPD clinical history [1]; post-salbutamol FEV1/forced vital capacity (FVC) ratio <0.70 post-salbutamol FEV1 ≥30 % ≤70 % predicted normal values; dyspnoea score ≥2 (modified Medical Research Council [mMRC] Dyspnoea Scale); current (stopped smoking ≥6 months) cigarette smokers history cigarette smoking ≥10 pack-years.,G0000000|C0007637|C0243161|G0000000|C0086582|C0015780|C0030705|G0000000|C0580836|C0443211|C0024117|C0205210|C0019664|G0000000|C0687676|C0441722|C0442732|C1516240|C3714541|C0456603|C0450371|C0687676|G0000000|G0000000|G0000000|G0000000|G0000000|C0681842|C0205307|C0042295|C0013404|C0449820|G0000000|C0392747|C0199168|C0035168|C1551807|C3826977|C0013404|C0175659|C0521116|C1272691|C0037369|G0000000|C0439231|C0677453|C0337664|C0019664|C0677453|C0037369|G0000000|C1277691
"As a result of a vicious circle, an average 30-50% of pregnant women do not refer to any health centre unless symptoms are present [22].","As result vicious circle, average 30-50% pregnant women refer health centre symptoms [22].",G0000000|C1274040|G0000000|C1282913|C1510992|C0450371|C0549206|C0043210|C0205543|C0018684|C0205099|C0683368|C0450371
"Results: In the intervention group, 9.6% of non-smokers started to smoke, in the control group 14.2%.","Results: In intervention group, 9.6% non-smokers started smoke, control 14.2%.",C1274040|G0000000|C0886296|C0441833|G0000000|C0337672|C1272689|C0037366|C0243148|C0450371
"Newspaper, radio, television, community magazines, flyers, direct mail postcards, health fairs, community-based focus groups, and word of mouth were sources of advertising and promotion.","Newspaper, radio, television, community magazines, flyers, direct mail postcards, health fairs, community-based focus groups, word mouth sources advertising promotion.",C0027989|C0034546|C0039461|C0009462|C0162443|C0683877|C0439851|C0024492|C2717852|C0018684|C2911689|C0009462|C0205234|C0441833|C1705313|C0226896|C0449416|C0001690|C0033414
A video fluoroscopic swallowing study (VFSS) identified dysphagia and then severity at the time of participation (between four and 12 days after stroke) was rated using the Dysphagia Outcome Severity Scale (DOSS).,A video fluoroscopic swallowing study (VFSS) identified dysphagia severity time participation (between 12 days stroke) rated Dysphagia Outcome Severity Scale (DOSS).,G0000000|C0042655|C0016356|C0011167|C0557651|G0000000|C0205396|C0011168|C0439793|C0040223|C0679823|G0000000|C0450371|C0439228|C0038454|C0871208|C0011168|C1274040|C0439793|C0175659|C1692318
"Children were eligible for randomization when they were between 2 and 12 years of age, had physician-diagnosed asthma, had 2 ED visits or 1 hospitalization for asthma in the preceding year, resided in Baltimore city, and were prescribed an asthma controller medication.","Children eligible randomization 2 12 age, physician-diagnosed asthma, 2 ED visits 1 hospitalization asthma preceding year, resided Baltimore city, prescribed asthma controller medication.",C0008059|C1548635|C0034656|G0000000|C0450371|C0001779|C0031831|C0004096|G0000000|C3538926|C0545082|G0000000|C0019993|C0004096|C0332152|C0439234|C2982691|C0004716|C0008848|C0278329|C0004096|C0180112|C0013227
"Sixty one percent and 39% of patients in the first group, and 45% and 55% of patients in the second group were male and female, respectively.","Sixty percent 39% patients group, 45% 55% patients male female, respectively.",C3816724|C0439165|C0450371|C0030705|C0441833|C0450371|C0450371|C0030705|C0086582|C0015780|G0000000
Consort Diagram Patients who were a part of MCI-caregiver dyads were recruited from the Indiana University Alzheimer Disease Center Clinical Core Registry and Clinic in Indianapolis.,Consort Diagram Patients MCI-caregiver dyads recruited Indiana University Alzheimer Disease Center Clinical Core Registry Clinic Indianapolis.,G0000000|C0681494|C0030705|C0560005|C0870454|G0000000|C0021206|C0041740|G0000000|C0012634|C0205099|C0205210|C0444669|C0034975|C0002424|G0000000
"The overall and substitution effects varied between venues and product types, suggesting that consumers of drinks specifically marketed for children were more likely to reduce consumption and switch to alternatives.","The substitution effects varied venues product types, suggesting consumers drinks marketed children reduce consumption switch alternatives.",G0000000|C1555721|C1280500|G0000000|G0000000|C1514468|C0332307|C1705535|C1707496|C0452428|C1318228|C0008059|G0000000|C0009830|C1707719|C1523987
"The inclusion criteria relating to ‘exacerbation history’ initially required that patients had experienced one or more exacerbations within the past year (requiring treatment with antibiotics and/or oral steroids), but not within the six weeks before entering the study.","The inclusion criteria relating ‘exacerbation history’ initially required patients experienced exacerbations (requiring treatment antibiotics and/or oral steroids), weeks entering study.",G0000000|C0007637|C0243161|C0163712|G0000000|G0000000|C0205265|C1514873|C0030705|C0237607|G0000000|G0000000|C0039798|C0003232|G0000000|C0442027|C0038317|C0439230|C1522196|C0557651
"Thus, these findings indicate that each study contained patients with severe brain injury.","Thus, findings study contained patients severe brain injury.",G0000000|C2607943|C0557651|C0332256|C0030705|C0205082|C0006104|C3263722
Patients were included they if were aged newborn (>38 weeks corrected gestational age) to 17 years and had been receiving any dose of any vasoactive infusion for between one and six hours.,Patients included aged newborn (>38 weeks corrected gestational age) 17 receiving dose vasoactive infusion hours.,C0030705|C0332257|C0001779|C0021289|C0450371|C0439230|C0205202|C0439671|C0001779|C0450371|C1514756|C0178602|C1980011|C0574032|C0439227
"Overall, the results of this study demonstrate that the DETP is an effective analgesic for local treatment of pain in mild acute ankle sprain.","Overall, study demonstrate DETP effective analgesic local treatment pain mild acute ankle sprain.",C0282416|C0557651|G0000000|C0069209|C1280519|C0002771|C0205276|C0039798|C0030193|C2945599|C0205178|C0003086|C0038045
"A third limitation is that patients with dementia are known to have poor drug compliance [33], reducing the measured effectiveness.","A limitation patients dementia poor drug compliance [33], reducing measured effectiveness.",G0000000|C0449295|C0030705|C0011265|C0032854|C0013227|C0009563|C0450371|C0392756|C0444706|C1280519
Inclusion criteria are adult patients with stage 4 or 5 chronic kidney disease (including dialysis patients) with significant anaemia (haemoglobin ≤ 110 g/L) for at least 3 months for which there is no clear identifiable cause and that is unresponsive to large doses of either erythropoietin (≥ 200 IU/kg/week) or darbepoetin (≥ 1 μg/kg/week).,Inclusion criteria adult patients stage 4 5 chronic kidney disease (including dialysis patients) anaemia (haemoglobin ≤ 110 g/L) 3 months identifiable unresponsive doses erythropoietin (≥ 200 IU/kg/week) darbepoetin (≥ 1 μg/kg/week).,C0007637|C0243161|C0001675|C0030705|C0205390|G0000000|G0000000|C0205191|C0022646|C0012634|C0332257|C0011945|C0030705|C0002871|C0019046|G0000000|C1442061|C0439294|G0000000|C0439231|C0205396|C0205269|C0178602|C0014822|G0000000|C1442061|C0439463|G0000000|G0000000|G0000000|G0000000
The patients on each treatment arm may either be on treatment or on maintenance therapy.,The patients treatment arm treatment maintenance therapy.,G0000000|C0030705|C0039798|C0446516|C0039798|C0024501|C0039798
"GMT ratios for these 2 groups of subjects have consistently been close to 1 at all previous evaluations, including one month after the last vaccine dose when non-inferiority was formally demonstrated.19,20 An appropriately powered Phase III trial of the HPV-16/18 vaccine ({""type"":""clinical-trial"",""attrs"":{""text"":""NCT01381575"",""term_id"":""NCT01381575""}}NCT01381575) with a larger sample size also demonstrated non-inferiority of HPV-16 and −18 antibody responses for a 2D M0,12 and 2D M0,6 schedule in girls aged 9-14 y compared with the 3D schedule in women aged 15-25 y one and 6 months after the last vaccine dose, respectively.26 Additionally, this larger study showed descriptively similar cross-reacting HPV-31 and −45 antibody titers and cell-mediated immune responses between 2D and 3D groups one month after the last vaccine dose.27 On the basis of data from the current study, and the larger Phase III study, a 2D schedule of the HPV-16/18 AS04-adjuvanted vaccine is now approved for girls aged 9–14 y in a number of countries, with flexibility around administration of the second vaccine dose from 5 to 13 months after first vaccination.","GMT ratios 2 subjects consistently close 1 previous evaluations, including month vaccine dose non-inferiority formally demonstrated.19,20 An appropriately powered Phase III trial HPV-16/18 vaccine ({""type"":""clinical-trial"",""attrs"":{""text"":""NCT01381575"",""term_id"":""NCT01381575""}}NCT01381575) larger sample size demonstrated non-inferiority HPV-16 −18 antibody responses 2D M0,12 2D M0,6 schedule girls aged 9-14 compared 3D schedule women aged 15-25 6 months vaccine dose, respectively.26 Additionally, larger study descriptively cross-reacting HPV-31 −45 antibody titers cell-mediated immune responses 2D 3D month vaccine dose.27 On basis data current study, larger Phase III study, 2D schedule HPV-16/18 AS04-adjuvanted vaccine approved girls aged 9–14 countries, flexibility administration vaccine dose 5 13 months vaccination.",G0000000|C0456603|G0000000|C0681850|G0000000|C0587267|G0000000|C0205156|C0220825|C0332257|C0332177|C0042210|C0178602|C1518422|G0000000|C0450371|G0000000|G0000000|C0032863|C0205390|C0439070|C0008976|C0021344|C0042210|C0332307|C0549177|C0370003|C0456389|G0000000|C1518422|C0021344|G0000000|C0003241|C0871261|C0043316|C0025885|C0043316|C0025885|C0086960|C0870604|C0001779|C0450371|C1707455|C0043316|C0086960|C0043210|C0001779|C0450371|G0000000|C0439231|C0042210|C0178602|C0450371|G0000000|C0549177|C0557651|G0000000|C2828360|C0021344|G0000000|C0003241|C0475208|C0007634|C0439662|C0871261|C0043316|C0043316|C0332177|C0042210|C0178602|G0000000|C1527178|C1511726|C0521116|C0557651|C0549177|C0205390|C0439070|C0557651|C0043316|C0086960|C0021344|C0001551|C0042210|C0205540|C0870604|C0001779|G0000000|C0454664|C0242808|C0001554|C0042210|C0178602|G0000000|C0450371|C0439231|C0042196
"Women aged 75-85 living in the community were eligible if they had diminished balance or gait capacities, as assessed by the time they took to walk a 6 metre course (average of two measures) and the tandem walk test (ability to do four consecutive tandem steps).","Women aged 75-85 living community eligible diminished balance gait capacities, assessed time walk 6 metre (average measures) tandem walk test (ability consecutive tandem steps).",C0043210|C0001779|C0450371|C0376558|C0009462|C1548635|C0205216|C0014653|C0016928|C1516240|C1516048|C0040223|C0080331|G0000000|C0475209|C1510992|C0079809|C0075804|C0080331|C0022885|C0085732|C1707491|C0075804|C1261552
This paper describes the protocol for a study which aims to test the efficacy of a family-centred tobacco control program about ETS to improve the respiratory health of Indigenous infants in Australia and New Zealand.,This paper describes protocol study aims test efficacy family-centred tobacco control program ETS improve respiratory health Indigenous infants Australia New Zealand.,G0000000|C0030351|G0000000|C0442711|C0557651|C1947946|C0022885|C1280519|C0015576|C0040329|C0243148|C1709697|G0000000|G0000000|C0521346|C0018684|C1512704|C0021270|C0004340|C0205314|G0000000
"From June 2013 to June 2015 three project nurses daily screen in- and outpatients from the Department of Oncology, Copenhagen University Hospital, and contact selected patients after having examined medical records to determine whether the patients are eligible for inclusion in the trial.","From June 2013 June 2015 project nurses daily screen in- outpatients Department Oncology, Copenhagen University Hospital, contact selected patients examined medical records determine patients eligible inclusion trial.",G0000000|C3829443|G0000000|C3829443|G0000000|C1709701|C0028661|C0332173|C0220908|G0000000|C0029921|C1704729|C0027651|G0000000|C0041740|C0019994|C0332158|C1707391|C0030705|C0332128|C0199168|C0034869|G0000000|C0030705|C1548635|C0007637|C0008976
Federal and provincial governments started providing one-time and recurring increases in budgets for additional open heart surgeries to reduce the number of patients waiting for coronary artery bypass grafting (CABG) and their waiting times.,Federal provincial governments started providing one-time recurring increases budgets additional heart surgeries reduce patients waiting coronary artery bypass grafting (CABG) waiting times.,G0000000|G0000000|C0018104|C1272689|C1999230|C3241998|C0034897|C0205217|C0006347|C1524062|C0018787|C0543467|G0000000|C0030705|C1610166|C0018787|C0003842|C0741847|C0332835|C0010055|C1610166|C0040223
"This study is a randomised, parallel group, superiority trial, with all participating primary carers of infants aged 2 to 12 weeks, receiving access to the online program.","This study randomised, parallel group, superiority trial, participating primary carers infants aged 2 12 weeks, receiving access online program.",G0000000|C0557651|G0000000|C2348042|C0441833|C0680218|C0008976|C0679823|C0205225|C0085537|C0021270|C0001779|G0000000|C0450371|C0439230|C1514756|C0444454|G0000000|C1709697
"However, stage IB patients were eligible to participate in each trial.","However, stage IB patients eligible participate trial.",G0000000|C0205390|C2744579|C0030705|C1548635|G0000000|C0008976
"PLWH at an HIV clinic in Mombasa, Kenya, were screened according to the following eligibility criteria: adults on ART for at least 1 month, with a pain or symptom score of 3–5 (from a possible range of 0 (best) to 5 (worst)) on the African Palliative Care Association Palliative Outcome Scale (APOS) [15, 16].","PLWH HIV clinic Mombasa, Kenya, screened eligibility criteria: adults ART 1 month, pain symptom score 3–5 (from range 0 (best) 5 (worst)) African Palliative Care Association Palliative Outcome Scale (APOS) [15, 16].",G0000000|C0019682|C0002424|G0000000|C0022558|C0220908|C0013893|C0243161|C0001675|C0003826|G0000000|C0332177|C0030193|C1457887|C0449820|G0000000|G0000000|C1514721|G0000000|C1522427|G0000000|C1522166|C0027567|C0587605|C1947933|C0004083|C0587605|C1274040|C0175659|G0000000|C0450371|C0450371
Maternal mortality in referral hospitals in Mali and Senegal surpasses 1% of obstetrical admissions.,Maternal mortality referral hospitals Mali Senegal surpasses 1% obstetrical admissions.,C2347083|C0026565|C0034927|C0019994|C0024581|C0036644|G0000000|G0000000|C0028773|C0184666
"This young age might account for lower levels, as the typical pattern in children's BLLs is an increase around one year of age, with a peak between 18 and 36 months of age.22 These low values may reflect the decrease in geometric mean BLLs nationally (1.9 μg/dL for children aged 1–5 years with data from the 1991–2004 National Health and Nutrition Examination Survey)29 and in Philadelphia (3.0 μg/dL in 2008) (Personal communication, Peter Palermo, Philadelphia Department of Public Health, Childhood Lead Poisoning Prevention Program, August 2009).","This age account lower levels, typical pattern children's BLLs increase age, peak 18 36 months age.22 These low values reflect decrease geometric BLLs nationally (1.9 μg/dL children aged 1–5 data 1991–2004 National Health Nutrition Examination Survey)29 Philadelphia (3.0 μg/dL 2008) (Personal communication, Peter Palermo, Philadelphia Department Public Health, Childhood Lead Poisoning Prevention Program, August 2009).",G0000000|C0001779|C2741673|C0441994|C0441889|C3538928|C0449774|C0008059|G0000000|C0442805|C0001779|C0444505|C0450371|C0450371|C0439231|C0001779|G0000000|C0205251|C0042295|C0558058|C0392756|C0449829|G0000000|G0000000|G0000000|G0000000|C0008059|C0001779|G0000000|C1511726|G0000000|C3245503|C0018684|C0028707|G0000000|C0038951|C0031525|G0000000|G0000000|G0000000|C1519021|C0009452|G0000000|G0000000|C0031525|C1704729|G0000000|C0018684|C0231335|C0023175|C0032343|C0199176|C1709697|C3831448|G0000000
"Finally, thirty patients each in rosuvastatin and placebo group were taken for analysis.","Finally, thirty patients rosuvastatin placebo analysis.",G0000000|C3816446|C0030705|C0965129|C0032042|C0002778
The mean (±SD) age for all groups was 21.1 (±9.7) years.,The (±SD) age 21.1 (±9.7) years.,G0000000|G0000000|C0001779|C0450371|G0000000|C0439234
"Clinical manifestations of OA of the knee include pain in and around the joint, stiffness of the joint after rest, crepitating on motion and limited joint motion, among others [4].","Clinical manifestations OA knee pain joint, stiffness joint rest, crepitating motion limited joint motion, [4].",C0205210|C0205319|C0029408|C0022742|C0030193|C0022417|C0427008|C0022417|C0035253|C0231879|C0026597|C0439801|C0022417|C0026597|G0000000
"Maternal inclusion criteria for the MDIG trial include being at least 18 years of age, 17 to 24 completed weeks of gestation based on a combination of recalled last menstrual period (LMP) and ultrasound, according to a conventional algorithm (per the Society of Obstetricians and Gynecologists of Canada), and intention to permanently reside in the trial catchment area for the duration of the study.","Maternal inclusion criteria MDIG trial 18 age, 17 24 completed weeks gestation based combination recalled menstrual period (LMP) ultrasound, conventional algorithm (per Society Obstetricians Gynecologists Canada), intention permanently reside trial catchment duration study.",C2347083|C0007637|C0243161|C1426245|C0008976|C0450371|C0001779|C0450371|C0450371|C0205197|C0439230|C0032961|C1527178|C0205195|C0034770|C0025344|C0439531|C0425932|C0041618|C0439858|C0002045|G0000000|C0037455|C0334897|C0237419|C0006823|C0162425|G0000000|C2982691|C0008976|G0000000|C0449238|C0557651
"Exclusion criteria were moderate to severe cognitive problems (<two errors on the short portable mental status questionnaire), no conversational English, inability to ambulate independently, a neurological condition which severely influenced their gait and mobility (for example, Parkinson’s disease that results in very specific patterns of movements, mobility and visuospatial disturbances that indicate specific interventions), resident in a nursing home or hostel, or any unstable or terminal illness that would preclude the planned exercises and was unlikely to resolve (for example, aortic aneurysm, malignant arrhythmias, critical aortic stenosis, rotator cuff tear, and active hernias).","Exclusion criteria moderate severe cognitive (<two errors short portable mental status questionnaire), conversational English, inability ambulate independently, neurological condition severely influenced gait mobility (for example, Parkinson’s disease specific patterns movements, mobility visuospatial disturbances specific interventions), resident nursing hostel, unstable terminal illness preclude planned exercises resolve (for example, aortic aneurysm, malignant arrhythmias, critical aortic stenosis, rotator cuff tear, active hernias).",C0680251|C0243161|C0205081|C0205082|C1516691|C0205448|C0743559|C1282927|G0000000|C0229992|C0449438|C0034394|C0871703|C0376245|G0000000|C4036205|G0000000|C0205494|C0012634|C0205082|G0000000|C0016928|C0425245|G0000000|C1707959|G0000000|C0012634|C0205369|C0449774|C0026649|C0425245|G0000000|C2699787|C0205369|C0886296|C1320928|C0006147|C0442518|C0443343|C0205088|C0221423|G0000000|C1301732|C0015259|C2699488|G0000000|C1707959|C0003483|C0002940|C0205282|C0003811|C1511545|C0003483|C0678234|C0183065|C0441107|C0039409|C0205177|C0019270
"Patients with primary squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma located in the cervix were included.","Patients primary squamous cell carcinoma, adenocarcinoma, adenosquamous carcinoma located cervix included.",C0030705|C0205225|C1182670|C0007634|C0007097|C0001418|G0000000|C0007097|G0000000|C0007874|C0332257
SoP = social phobia; SAD = separation anxiety disorder; OCD = obsessive-compulsive disorder; GAD = generalized anxiety disorder; ADHD = attention deficit hyperactivity disorder; MDD = major depressive disorder; ODD = oppositional defiant disorder; CD = conduct disorder; PTSD = posttraumatic stress disorder.,SoP = social phobia; SAD = separation anxiety disorder; OCD = obsessive-compulsive disorder; GAD = generalized anxiety disorder; ADHD = attention deficit hyperactivity disorder; MDD = major depressive disorder; ODD = oppositional defiant disorder; CD = conduct disorder; PTSD = posttraumatic stress disorder.,C1710183|G0000000|C0728831|C0349231|C3536794|G0000000|C0036679|C0003467|C0012634|C0028768|G0000000|G0000000|C0012634|C0270549|G0000000|C0205246|C0003467|C0012634|C1263846|G0000000|C0004268|C0162429|C0424295|C0012634|C1269683|G0000000|C0205082|G0000000|C0012634|C1415068|G0000000|C0860661|C0424348|C0012634|C0007928|G0000000|C0004927|C0012634|C0038436|G0000000|G0000000|C0038435|C0012634
We included both Syrian refugee and Jordanian youth.,We included Syrian refugee Jordanian youth.,G0000000|C0332257|C0018561|C0034961|G0000000|C0001578
The primary objective of this study is to determine if a novel perturbation-based training program focused on improving reactive stepping in individuals with chronic stroke will reduce the risk for falls in the community.,The primary objective study determine perturbation-based training program focused improving reactive stepping individuals chronic stroke reduce risk falls community.,G0000000|C0205225|C0018017|C0557651|G0000000|C0332453|C0040607|C1709697|C0205234|C1272745|C0205332|C0427149|C0027361|C0205191|C0038454|G0000000|C0035647|C0000921|C0009462
The present study investigates the long-term effects of intravenous immunoglobulin (IVIg) therapy for the treatment of moderate to severe childhood atopic dermatitis (AD).,The study investigates long-term effects intravenous immunoglobulin (IVIg) therapy treatment moderate severe childhood atopic dermatitis (AD).,G0000000|C0557651|C1292732|C0443252|C1280500|C0348016|C0021027|C0085297|C0039798|C0039798|C0205081|C0205082|C0231335|C0392707|C0011603|G0000000
"Nursing homes had to be Medicare and Medicaid certified, have 50 or more geriatric beds, agree to random assignment, have stable contracts with Omnicare, and have few shortstay residents.","Nursing homes Medicare Medicaid certified, 50 geriatric beds, agree random assignment, stable contracts Omnicare, shortstay residents.",C0006147|C0442519|C0018717|C0025071|C0007836|C0450371|C1704440|C0004916|C3641827|C0034656|C1516050|C0205360|C0332522|G0000000|G0000000|C1320928
"Study participants were adults with documented HIV infection, neuropathic pain refractory to a least two previous analgesics, and an average score of 5 or higher on the pain intensity subscale of the Descriptor Differential Scale (DDS), described below.","Study participants adults documented HIV infection, neuropathic pain refractory previous analgesics, average score 5 pain intensity subscale Descriptor Differential Scale (DDS), below.",C0557651|C0679646|C0001675|C1301725|C0019682|C0009450|C0442874|C0030193|C0205269|C0205156|C0002771|C1510992|C0449820|G0000000|C0030193|C0522510|G0000000|C0282354|C0443199|C0175659|G0000000|G0000000
The standard treatment pathway for locally advanced rectal cancer is neoadjuvant chemoradiotherapy (CRT) followed by surgery.,The standard treatment pathway locally advanced rectal cancer neoadjuvant chemoradiotherapy (CRT) surgery.,G0000000|C1442989|C0039798|C1704259|C1517927|C0205179|C0205052|C0006826|C0600558|C0436307|G0000000|C0038894
All children were discharged from the trial at age 36 mo.,All children discharged trial age 36 mo.,G0000000|C0008059|C0030685|C0008976|C0001779|C0450371|C0026544
"Patients should have acute cough due to viral upper airway infection, thus considered due to the presence of mild fever or fever associated with hyaline or catarrhal rhinorrhea, lasting less than 72hours, without clinical manifestations of associated bronchospasm.","Patients acute cough viral upper airway infection, considered presence mild fever fever hyaline catarrhal rhinorrhea, lasting 72hours, clinical manifestations bronchospasm.",C0030705|C0205178|C0010200|C0521026|C1282910|C0178987|C0009450|C0750591|C0150312|C2945599|C0015967|C0015967|C0020191|C1384493|C1260880|C1517741|G0000000|C0205210|C0205319|C0006266
The study comprised patients over 18 years of age clinically diagnosed with BMS who reported a history of continuous oral burning pain for more than 4 months with no clinical signs that could justify the syndrome (13).,The study comprised patients 18 age clinically diagnosed BMS reported history continuous oral burning pain 4 months clinical signs justify syndrome (13).,G0000000|C0557651|C2700400|C0030705|C0450371|C0001779|G0000000|C0011900|G0000000|C0684224|C0019664|C0549178|C0442027|C0000912|C0030193|G0000000|C0439231|C0205210|C0220912|C1552821|C0039082|C0450371
"Baseline characteristics at randomization The six month biologically-confirmed smoking cessations rate was 4% for usual care, 0% for lung age, 14% for contingency management and 0% for combined lung age and contingency management.","Baseline characteristics randomization The month biologically-confirmed smoking cessations rate 4% usual care, 0% lung age, 14% contingency management 0% combined lung age contingency management.",C0168634|C1521970|C0034656|G0000000|C0332177|C0205460|C0037369|C1880019|C0871208|G0000000|C3538928|C1947933|G0000000|C0024109|C0001779|C0450371|C1701901|C0001554|G0000000|C0205195|C0024109|C0001779|C1701901|C0001554
"Background: Long term non-invasive ventilation (NIV) reduces morbidity and mortality in patients with neuromuscular and chest wall disease with hypercapnic ventilatory failure, but preventive use has not produced benefit in normocapnic patients with Duchenne muscular dystrophy.","Background: Long term non-invasive ventilation (NIV) reduces morbidity mortality patients neuromuscular chest wall disease hypercapnic ventilatory failure, preventive produced benefit normocapnic patients Duchenne muscular dystrophy.",C1706907|C0205166|C0233324|C0205303|C0035203|C0598902|G0000000|C0026538|C0026565|C0030705|C1979768|C0817096|C0677535|C0012634|C0020440|G0000000|C0231174|C0445202|G0000000|C0814225|G0000000|C0030705|G0000000|C0026845|C0333606
Treatment was repeated every 8 weeks for a total of 6 courses.,Treatment repeated 8 weeks total 6 courses.,C0039798|C0205341|G0000000|C0439230|C0439175|G0000000|C0750729
We included adult patients with CT- or MRI-confirmed ischemic stroke within 48 h of symptom onset who were admitted on weekdays from March to November 2012 to the acute vascular unit (AVU) or general emergency unit of a large urban emergency department (ED).,We included adult patients CT- MRI-confirmed ischemic stroke 48 symptom onset admitted weekdays March November 2012 acute vascular unit (AVU) emergency unit urban emergency department (ED).,G0000000|C0332257|C0001675|C0030705|C0007673|C0024485|C0475224|C0038454|C0450371|C1457887|C0206132|C0184666|C0680189|C3829202|C3828767|G0000000|C0205178|C0005847|C0439148|G0000000|C0013956|C0439148|C0442529|C0013956|C1704729|C3538926
"Patients were also excluded if they met one of the following prespecified glycemic criteria: visit 2, FPG >260 mg/dL, unlikely to improve with diet/exercise; visit 3, FPG >250 mg/dL consistently (i.e., measurement repeated and confirmed within 7 days); visit 4, FPG >240 mg/dL consistently; and visit 5, finger-stick glucose >240 or <120 mg/dL.","Patients excluded met prespecified glycemic criteria: visit 2, FPG >260 mg/dL, improve diet/exercise; visit 3, FPG >250 mg/dL consistently (i.e., measurement repeated confirmed 7 days); visit 4, FPG >240 mg/dL consistently; visit 5, finger-stick glucose >240 <120 mg/dL.",C0030705|C1554077|C0268621|G0000000|C0005802|C0243161|C0545082|G0000000|G0000000|C1442061|C0439269|G0000000|C0012155|C0545082|G0000000|G0000000|C1442061|C0439269|G0000000|C0683454|C0242485|C0205341|C0521093|G0000000|C0439228|C0545082|G0000000|G0000000|C1442061|C0439269|G0000000|C0545082|G0000000|C0457575|C0017725|C1442061|C1442061|C0439269
"In patients with advanced gastric cancer, chemotherapy improves overall survival compared with best supportive care (Wagner et al, 2010), but there is no single accepted standard chemotherapy regimen.","In patients advanced gastric cancer, chemotherapy improves survival compared supportive care (Wagner al, 2010), single accepted standard chemotherapy regimen.",G0000000|C0030705|C0205179|C0038351|C0006826|C0013216|C0184511|C0038952|C1707455|C1521721|C1947933|G0000000|C0202311|G0000000|C0037179|C1272684|C1442989|C0013216|C0040808
Patients: Twenty patients with collagenous colitis (collagen layer >10 μm) and diarrhoea (>4 stools/day and/or stool weight >200 g/day).,Patients: Twenty patients collagenous colitis (collagen layer >10 μm) diarrhoea (>4 stools/day and/or stool weight >200 g/day).,C0030705|C0724000|C0030705|C0439689|C0009319|C0009325|C0934502|C0450371|G0000000|C0011991|G0000000|C0015733|G0000000|C0015733|C0005910|C1442061|C0439417
This is the first prospective study to record community and hospital managed respiratory exacerbations and their association with chest CT scan and lung function outcomes in children with CF diagnosed through newborn screening and followed to age 5 years.,This prospective study record community hospital managed respiratory exacerbations association chest CT scan lung function outcomes children CF diagnosed newborn screening age 5 years.,G0000000|C0023981|C0557651|C0034869|C0009462|C0019994|C1273870|C0521346|G0000000|C0004083|C0817096|C0007673|C0034606|C0024109|C0031843|C1274040|C0008059|C0009738|C0011900|C0021289|C0220908|C0001779|G0000000
All patients had the ability to move the affected limb (at least partial range antigravity movement) and had completed 3 to 6 months of conventional rehabilitation therapy.,All patients ability move limb (at partial range antigravity movement) completed 3 6 months conventional rehabilitation therapy.,G0000000|C0030705|C0085732|C0560560|C0015385|G0000000|C0728938|C1514721|G0000000|C0026649|C0205197|G0000000|G0000000|C0439231|C0439858|C0034991|C0039798
"Inclusion criteria: 1) Member of the WTCHP at NYU SOM or Rutgers RWJMS, 2) OSA diagnosed on the basis of a 2-night home sleep study.","Inclusion criteria: 1) Member WTCHP NYU SOM Rutgers RWJMS, 2) OSA diagnosed basis 2-night sleep study.",C0007637|C0243161|G0000000|C0680022|G0000000|G0000000|C0037640|G0000000|G0000000|G0000000|C0520679|C0011900|C1527178|C0240526|C0037313|C0557651
"The following exclusion criteria were applied: presence of diagnosed or perceived chronic disease or other conditions likely to interfere with anthelminthic treatment (e.g., hypersensitivity to anthelminthics), pregnancy (verbally assessed at enrolment and again before treatment), recent history of anthelminthic treatment, and participation in other trials (within 1 month).","The exclusion criteria applied: presence diagnosed perceived chronic disease conditions interfere anthelminthic treatment (e.g., hypersensitivity anthelminthics), pregnancy (verbally assessed enrolment treatment), history anthelminthic treatment, participation trials (within 1 month).",G0000000|C0680251|C0243161|C4048755|C0150312|C0011900|C0030971|C0205191|C0012634|C0012634|C0521102|C0003158|C0039798|G0000000|C0020517|C0003158|C0032961|G0000000|C1516048|C1516879|C0039798|C0019664|C0003158|C0039798|C0679823|C0008976|G0000000|G0000000|C0332177
"In this randomized controlled study, patients over age 50 with an acute fragility hip fracture were enrolled from two hospital sites in Ontario, Canada.","In randomized controlled study, patients age 50 acute fragility hip fracture enrolled hospital sites Ontario, Canada.",G0000000|C0034656|C2587213|C0557651|C0030705|C0001779|C0450371|C0205178|C0302113|C0019552|C0016658|G0000000|C0019994|C0205145|C0029040|C0006823
Eligibility required serum be drawn within 1 calendar day of the lumpectomy/mastectomy for women who underwent a one-stage procedure and within 1 calendar day of each stage for women who underwent a two-stage procedure.,Eligibility required serum drawn 1 calendar day lumpectomy/mastectomy women underwent one-stage procedure 1 calendar day stage women underwent two-stage procedure.,C0013893|C1514873|C0229671|C0013113|G0000000|C1516147|C0332173|C0851238|C0043210|G0000000|C0205447|C0184661|G0000000|C1516147|C0332173|C0205390|C0043210|G0000000|C0205448|C0184661
"We are enrolling patients with chronic stroke with mild-to-moderate impairments in upper limb function [46,47], who fulfill the following prerequisites: The inclusion criteria are: age ≥21 years; chronic phase of recovery (>6 months) after first-ever stroke up to 20 years post-stroke; ability to extend fingers or thumb or wrist ≥10° and chief complaint of inadequate ability to use the paretic hand compared to its use prior to a single (ischemic or hemorrhagic) stroke.","We enrolling patients chronic stroke mild-to-moderate impairments upper limb function [46,47], fulfill prerequisites: The inclusion criteria are: age ≥21 years; chronic phase recovery (>6 months) first-ever stroke 20 post-stroke; ability extend fingers thumb wrist ≥10° chief complaint inadequate ability paretic hand compared prior single (ischemic hemorrhagic) stroke.",G0000000|G0000000|C0030705|C0205191|C0038454|C1299392|C0684336|C1282910|C0015385|C0031843|C0450371|C1550543|C0679209|G0000000|C0007637|C0243161|G0000000|C0001779|G0000000|C0439234|C0205191|C0205390|C0237820|G0000000|C0439231|C0205435|C0038454|C0450371|C0687676|C0085732|C0231448|C0016129|C0040067|C0043262|G0000000|G0000000|C0277786|C0205412|C0085732|G0000000|C0018563|C1707455|C0332152|C0037179|C0475224|C0333275|C0038454
"Villages were eligible for selection into the study if they were rural, relied on communal water sources, had unimproved sanitation facilities, and there were no other ongoing WSH or nutrition programmes.","Villages eligible selection study rural, relied communal water sources, unimproved sanitation facilities, ongoing WSH nutrition programmes.",C0562518|C1548635|C0036576|C0557651|C0240919|G0000000|C0598781|C0043047|C0449416|G0000000|C0036172|C1547538|C0549178|G0000000|C0028707|G0000000
"The inclusion criteria were: a moderate to severe Scoring Atopic Dermatitis (SCORAD) index score6,7; being 1~13 years of age; absence of any other disease; having used no medication including antihistamines and corticosteroids for fourteen days prior to the study; and absence of gastrointestinal malabsorption.","The inclusion criteria were: moderate severe Scoring Atopic Dermatitis (SCORAD) score6,7; 1~13 age; absence disease; medication including antihistamines corticosteroids fourteen days prior study; absence gastrointestinal malabsorption.",G0000000|C0007637|C0243161|G0000000|C0205081|C0205082|C0449820|C0392707|C0011603|G0000000|G0000000|C0450371|C0001779|C0332197|C0012634|C0013227|C0332257|C0003360|C0001617|C3715152|C0439228|C0332152|C0557651|C0332197|C0521362|C0024523
They will then start a 2-week observation period with documentation of seizure frequency.,They start 2-week observation period documentation seizure frequency.,G0000000|C0439659|C0332174|C0302523|C0439531|C0175636|C0036572|C0376249
"In the Federal Republic of Germany, up to 3-5% of all malignant tumors are found within the oral cavity and the oropharynx, with 7.500 new cases annually.","In Federal Republic Germany, 3-5% malignant tumors oral cavity oropharynx, 7.500 annually.",G0000000|G0000000|G0000000|C0017480|G0000000|C0205282|C0027651|C0442027|C0011334|C0521367|C1442061|C0332181
AIMS—To test the hypothesis that inhaled salbutamol or beclomethasone will reduce the frequency of cough in children with recurrent cough.,AIMS—To test hypothesis inhaled salbutamol beclomethasone reduce frequency cough children recurrent cough.,G0000000|C0022885|C1512571|C0004048|C0001927|C0004905|G0000000|C0376249|C0010200|C0008059|C2945760|C0010200
"Nevertheless, because a significant proportion of patients in our study still developed progression/recurrence of disease, we question the potential mechanisms of immune escape in the ovarian cancer population.","Nevertheless, proportion patients study developed progression/recurrence disease, question potential mechanisms immune escape ovarian cancer population.",G0000000|C1709707|C0030705|C0557651|G0000000|C0242656|C0012634|C1522634|C3245505|C0441712|C0439662|C0870509|C0205065|C0006826|C0032659
"DESIGN—A prospective study involving 38 CF patients, mean age 10.9 (SD 4.3) years (range 4.3 to 22.2 years), presenting with pulmonary exacerbations of P aeruginosa infection.","DESIGN—A prospective study involving 38 CF patients, age 10.9 (SD 4.3) (range 4.3 22.2 years), pulmonary exacerbations P aeruginosa infection.",G0000000|C0023981|C0557651|C1314939|C0450371|C0009738|C0030705|C0001779|C0450371|G0000000|G0000000|C1514721|G0000000|C0450371|C0439234|C0024109|G0000000|C0369773|G0000000|C0009450
"Patients who had conditions known to increase PCT levels (ie, trauma, renal failure, and pancreatitis) or who received antibiotics prior to admission were excluded.","Patients conditions increase PCT levels (ie, trauma, renal failure, pancreatitis) received antibiotics prior admission excluded.",C0030705|C0012634|C0442805|C1535922|C0441889|G0000000|C0043251|C0022646|C0231174|C0030305|C1514756|C0003232|C0332152|C0184666|C1554077
The number of dippers also increased from 4 to 8 in the active acupuncture group.,The dippers increased 4 8 active acupuncture group.,G0000000|C0326561|C0205217|G0000000|G0000000|C0205177|C0001299|C0441833
"Patients were excluded if evidence was found of inflammatory rheumatic disease, autoimmune disease or other painful disorders that might confound the assessment of fibromyalgia pain or a history of substance abuse.","Patients excluded evidence inflammatory rheumatic disease, autoimmune disease painful disorders confound assessment fibromyalgia pain history substance abuse.",C0030705|C1554077|C3887511|C0333348|G0000000|C0012634|C0443146|C0012634|C0030193|C0012634|G0000000|C1261322|C0016053|C0030193|C0019664|C0439861|C0013146
Trough FEV1 after one dose was significantly higher with indacaterol than placebo (p < 0.001).,Trough FEV1 dose indacaterol placebo (p < 0.001).,C0444506|G0000000|C0178602|C1722260|C0032042|C0369773|G0000000|C1442061
"[25] Therefore, with regard to high prevalence of CS in Iran and the effect of fear of childbirth on selection of this method, as well as the restricted research in this field and the mode of research (descriptive research), this study aimed to investigate the effect of role play education on primiparous women's fear of natural delivery and their decision on the mode of delivery.","[25] Therefore, regard prevalence CS Iran fear childbirth selection method, restricted field mode (descriptive research), study aimed investigate role play education primiparous women's fear natural delivery decision mode delivery.",C0450371|G0000000|G0000000|C0033105|C0010182|C0022065|C0015726|C0005615|C0036576|C0025663|C0443288|C0440042|C1513371|C0678257|C0035168|C0557651|C1947946|C1292732|C0035820|C0032214|C0013621|C0033150|C0043210|C0015726|C0205296|C0011209|C0679006|C1513371|C0011209
The findings indicate that yoga may have beneficial effects on QOL issues in women with stage I–III breast cancer during (neo)adjuvant cytotoxic and endocrine therapy.,The findings yoga beneficial effects QOL issues women stage I–III breast cancer (neo)adjuvant cytotoxic endocrine therapy.,G0000000|C2607943|C0043418|G0000000|C1280500|C0518214|C0033213|C0043210|C0205390|G0000000|C0006141|C0006826|C1366752|C0677881|C0014136|C0039798
"Exclusion criteria included diagnosis of a nonepilepsy medical disorder requiring daily medication, a significant developmental disorder (e.g., autism), or the family living >90 miles away from the hospital.","Exclusion criteria included diagnosis nonepilepsy medical disorder requiring daily medication, developmental disorder (e.g., autism), family living >90 miles hospital.",C0680251|C0243161|C0332257|C0011900|G0000000|C0199168|C0012634|G0000000|C0332173|C0013227|C0458003|C0012634|G0000000|C0004352|C0015576|C0376558|C0450371|C0331865|C0019994
"Participating kindergartens were recruited from all kindergartens in southwest Germany, which have received written information about programme and study, asking interested kindergarten teachers to participate.","Participating kindergartens recruited kindergartens southwest Germany, received written programme study, kindergarten teachers participate.",C0679823|C0681406|G0000000|C0681406|C1710136|C0017480|C1514756|C0043266|C1709697|C0557651|C0681406|C0221457|G0000000
Patients age ≥ 18 years were required to have locally advanced or metastatic pancreatic adenocarcinoma with measurable or assessable disease.,Patients age ≥ 18 required locally advanced metastatic pancreatic adenocarcinoma measurable assessable disease.,C0030705|C0001779|G0000000|C0450371|C1514873|C1517927|C0205179|C0036525|C0030274|C0001418|C1513040|G0000000|C0012634
To compare immediate with delayed prescribing of antibiotics for acute otitis media.,To compare delayed prescribing antibiotics acute otitis media.,C0040363|C1707455|C0205421|C0278329|C0003232|C0205178|C0029877|C0009458
Entry criteria included: over 18 years of age; a biopsy-confirmed diagnosis of ulcerative colitis; previous need for corticosteroids to obtain remission; in clinical remission off corticosteroids for at least one month; SCCAI score of 2 or less; on no medications or stable dose of maintenance medication; and willingness to follow a carrageenan-free diet for 12 months.,Entry criteria included: 18 age; biopsy-confirmed diagnosis ulcerative colitis; previous corticosteroids remission; clinical remission corticosteroids month; SCCAI score 2 less; medications stable dose maintenance medication; willingness follow carrageenan-free diet 12 months.,C1705654|C0243161|C0332257|C0450371|C0001779|C0005558|C0011900|C0041582|C0009319|C0205156|C0001617|C0544452|C0205210|C0544452|C0001617|C0332177|G0000000|C0449820|G0000000|C0439092|C0013227|C0205360|C0178602|C0024501|C0013227|C0600109|C0332283|C0007289|C0012155|C0450371|C0439231
Persistence with clopidogrel treatment.,Persistence clopidogrel treatment.,C0546816|C0070166|C0039798
There was no difference in the baseline characteristics between the treatment and control group.,There difference baseline characteristics treatment control group.,G0000000|C1705241|C0168634|C1521970|C0039798|C0243148|C0441833
"JDC eligibility required that participants were: (a) between the ages of 13 and 18; (b) diagnosed with substance abuse or dependence based on a structured interview; (c) not actively suicidal, demonstrating psychotic symptoms, or diagnosed with pervasive developmental disorder, or mental retardation; (d) not currently charged for sale of drugs, weapons, or violent offenses, or sexual battery; and (e) after consultation with their attorney, voluntarily enrolled in drug court.","JDC eligibility required participants were: (a) ages 13 18; (b) diagnosed substance abuse dependence based structured interview; (c) actively suicidal, demonstrating psychotic symptoms, diagnosed pervasive developmental disorder, mental retardation; (d) charged sale drugs, weapons, violent offenses, sexual battery; (e) consultation attorney, voluntarily enrolled drug court.",G0000000|C0013893|C1514873|C0679646|G0000000|G0000000|C0001779|C0450371|C0450371|G0000000|C0011900|C0439861|C0013146|C0011546|C1527178|C0678594|C0021822|G0000000|G0000000|C0438696|G0000000|C0004936|C0683368|C0011900|C0205391|C0458003|C0012634|C0229992|C0521111|C0073187|C1706211|C0036070|C0013227|C0336663|C0242151|G0000000|C0036864|C0337088|G0000000|C0009818|C0086530|G0000000|G0000000|C0013227|C0178572
This mechanism explains how both treatments reduce the nasal symptoms of patients treated for allergic conjunctivitis.,This mechanism explains treatments reduce nasal symptoms patients treated allergic conjunctivitis.,G0000000|C0441712|G0000000|C0087111|G0000000|C0028429|C0683368|C0030705|C1522326|C0700624|C0009763
Fourteen untrained young men (24 ± 1 years) performed 50 maximal isokinetic (120°/s) eccentric contractions of the elbow flexors of one arm on an isokinetic dynamometer and the same exercise with the other arm 4 weeks later.,Fourteen untrained (24 ± 1 years) performed 50 maximal isokinetic (120°/s) eccentric contractions elbow flexors arm isokinetic dynamometer exercise arm 4 weeks later.,C3715152|G0000000|C0450371|G0000000|G0000000|C0439234|C0884358|C0450371|C0205289|G0000000|G0000000|C0439740|C1140999|C0013769|C1879367|C0446516|G0000000|C0180572|C0015259|C0446516|G0000000|C0439230|C0205087
"We also excluded pregnant patients and lactating female patients, and those for whom there was doubt whether the neurological status resulted from head trauma or acute or chronic spinal cord injury.","We excluded pregnant patients lactating female patients, doubt neurological status head trauma acute chronic spinal cord injury.",G0000000|C1554077|C0549206|C0030705|C2828358|C0015780|C0030705|C0870444|C0205494|C0449438|C0018670|C0043251|C0205178|C0205191|C0521329|C1550235|C3263722
"CA is calculated by subtracting the number of weeks born before 40 weeks of gestation from the chronological age, therefore for term infants, CA is identical to chronological age.71 CP children (n=72): Inclusion criteria will be diagnosis of hemiparetic or asymmetric CP as determined by published algorithms72 and neurological examinatiom,73 with CA between 12 and 24 months.","CA calculated subtracting weeks born 40 weeks gestation chronological age, term infants, CA identical chronological age.71 CP children (n=72): Inclusion criteria diagnosis hemiparetic asymmetric CP determined published algorithms72 neurological examinatiom,73 CA 12 24 months.",C3887642|C0444686|C1719767|C0439230|C0005615|G0000000|C0032961|C0008717|C0001779|C0233324|C0021270|C3887642|C0205280|C0008717|C0001779|C4050020|C0008059|C0369718|C0007637|C0243161|C0011900|G0000000|C0332514|C4050020|G0000000|C0034037|G0000000|C0205494|C0450371|C3887642|C0450371|G0000000
Exclusion criteria were congenital heart disease and CNS abnormalities.,Exclusion criteria congenital heart disease CNS abnormalities.,C0680251|C0243161|C0009678|C0018787|C0012634|C3714787|C0000768
"Eligible participants must meet all of the following criteria within four weeks prior to the week 0 (baseline) visit to be considered eligible for entry into the study: 1) documented HIV infection by western blot, enzyme immunoassays or viral load assay; 2) aged 21 years or older; 3) viral load <50 copies/mL for the last three months; 4) CD4+ T-cell count ≤350 cells/μL; and 5) on stable ART (ART unchanged for treatment failure (rebound in viral load)) for more than 12 months.","Eligible participants meet criteria weeks prior week 0 (baseline) visit considered eligible entry study: 1) documented HIV infection western blot, enzyme immunoassays viral load assay; 2) aged 21 older; 3) viral load <50 copies/mL months; 4) CD4+ T-cell count ≤350 cells/μL; 5) stable ART (ART unchanged treatment failure (rebound viral load)) 12 months.",C1548635|C0679646|C1550543|C0243161|C0439230|C0332152|C0332174|G0000000|C0168634|C0545082|C0750591|C1548635|C1705654|C0557651|G0000000|C1301725|C0019682|C0009450|C1705493|G0000000|C0014442|C0020980|C0521026|C1550025|C0005507|G0000000|C0001779|C0450371|C0580836|G0000000|C0521026|C1550025|C0450371|C1531853|C0439231|G0000000|C0285590|C0039194|C0750480|G0000000|G0000000|G0000000|C0205360|C0003826|C0003826|C0442739|C0039798|C0231174|G0000000|C0521026|C1550025|C0450371|C0439231
"Our results suggest that exercise programs in older adults with chronic stroke should include dynamic balance training, with emphasis on multi-sensory and agility tasks.","Our exercise programs adults chronic stroke dynamic balance training, emphasis multi-sensory agility tasks.",G0000000|C0015259|C0376691|C0001675|C0205191|C0038454|C0729333|C0014653|C0040607|G0000000|C0439064|G0000000|C3540678
The median age of the participants was 52 ± 15 years (DEDG) versus 50 ± 12 years (CG); 59% of the DEDG and 58% of the CG were older than 45 years.,The median age participants 52 ± 15 (DEDG) versus 50 ± 12 (CG); 59% DEDG 58% CG 45 years.,G0000000|C0549183|C0001779|C0679646|C0450371|G0000000|C0450371|G0000000|G0000000|C0450371|G0000000|C0450371|C0043444|C0450371|G0000000|C0450371|C0043444|C0450371|C0439234
RESULTS—Seventy nine infants were randomised to the oral group and 77 to the IM group.,RESULTS—Seventy infants randomised oral 77 IM group.,G0000000|C0021270|G0000000|C0442027|C0450371|C3539078|C0441833
"Although this will not be a hindrance in the main WASH Benefits study that will last 2 years, because of the short duration of our pilot study, we chose an eligibility criteria of 4–16 months of age in the Kakamega study area to better assess use of interventions clearly aimed at toddlers, whereas in Bungoma, we used eligibility criteria closer to those that will be used in the main WASH Benefits study (pregnant women in first or second trimester and additionally, for the pilot study, caregivers of children under 3 months of age) to get practice with enrollment protocols.","Although hindrance main WASH Benefits study 2 years, short duration pilot study, chose eligibility criteria 4–16 months age Kakamega study assess interventions aimed toddlers, Bungoma, eligibility criteria closer main WASH Benefits study (pregnant women trimester additionally, pilot study, caregivers children 3 months age) practice enrollment protocols.",G0000000|G0000000|C0205225|C0441648|C0814225|C0557651|G0000000|C0439234|C1282927|C0449238|C0473169|C0557651|C1707391|C0013893|C0243161|G0000000|C0439231|C0001779|C1221116|C0557651|C1516048|C0886296|C1947946|C0682053|G0000000|C0013893|C0243161|G0000000|C0205225|C0441648|C0814225|C0557651|C0549206|C0043210|C0032982|G0000000|C0473169|C0557651|C0085537|C0008059|G0000000|C0439231|C0001779|C0237607|C1516879|C0442711
"Adult Clinical Trials Group (ACTG) A5298 was conducted to test the hypothesis that qHPV prevents persistent anal infection with vaccine types not detected at study entry in HIV-infected men and women aged ≥27 years, a population with high levels of prevalent and prior HPV infections.","Adult Clinical Trials Group (ACTG) A5298 conducted test hypothesis qHPV prevents persistent anal infection vaccine types detected study entry HIV-infected women aged ≥27 years, population levels prevalent prior HPV infections.",C0001675|C0205210|C0008976|C0441833|C1412149|G0000000|C0004927|C0022885|C1512571|G0000000|C0309872|C0205322|C0003461|C0009450|C0042210|C0332307|C0442726|C0557651|C1705654|C0019682|C0043210|C0001779|G0000000|C0439234|C0032659|C0441889|C0033105|C0332152|C0021344|C3714514
The data used in the present study represents a subset of 384 children aged 9–10 years (mean 9.7 years) at baseline.,The data study represents subset 384 children aged 9–10 (mean 9.7 years) baseline.,G0000000|C1511726|C0557651|C1882932|C1515021|C1442061|C0008059|C0001779|G0000000|C0444504|G0000000|C0439234|C0168634
The majority of patients were Caucasian (95.8%) and female (93.7%) with a mean age of ~49 years.,The majority patients Caucasian (95.8%) female (93.7%) age ~49 years.,G0000000|C0680220|C0030705|C0007457|C0450371|C0015780|C0450371|C0001779|C0450371|C0439234
All patients were treated with standard TB treatment and corticosteroids in accordance with the South African Tuberculosis Treatment Guidelines.,All patients treated standard TB treatment corticosteroids South African Tuberculosis Treatment Guidelines.,G0000000|C0030705|C1522326|C1442989|G0000000|C0039798|C0001617|C1710133|C0027567|C0041296|C0039798|C0162791
"We therefore examined the association between dietary intake of micronutrients and thyroid cancer risk in the U.S. National Institutes of Health-American Association of Retired Persons (NIH-AARP) Diet and Health Study, a large prospective cohort of 566,398 men and women ages 50–71 years at baseline.","We examined association dietary intake micronutrients thyroid cancer risk U.S. National Institutes Health-American Association Retired Persons (NIH-AARP) Diet Health Study, prospective cohort 566,398 women ages 50–71 baseline.",G0000000|C0332128|C0004083|C0012155|C1512806|C0282575|C0040132|C0006826|C0035647|C0041703|C3245503|C0021622|C0018684|C0004083|C0035345|C0027361|C0027468|C0012155|C0018684|C0557651|C0023981|C0599755|C1442061|C0043210|C0001779|G0000000|C0168634
"Exclusion criteria were: current alcohol dependence; more than twice weekly use of drugs other than cannabis, caffeine or tobacco, and/or injecting drug use more than once per week in the prior 30 days, current prescriptions (methadone, buprenorphine, mood stabilizing, antidepressant and/or antipsychotic medications); history of schizophrenia, bipolar affective disorder, recent psychosis, significant suicide risk or admission to mental health unit within the 3 months prior to recruitment; significant renal, thyroid, or hepatic disease; abnormal electrocardiogram in subjects aged over 45 years; lactose or lithium intolerance; and for females, current breastfeeding, pregnant, or planning to become pregnant in the month following study entry.","Exclusion criteria were: current alcohol dependence; weekly drugs cannabis, caffeine tobacco, and/or injecting drug week prior 30 days, current prescriptions (methadone, buprenorphine, mood stabilizing, antidepressant and/or antipsychotic medications); history schizophrenia, bipolar affective disorder, psychosis, suicide risk admission mental health unit 3 months prior recruitment; renal, thyroid, hepatic disease; abnormal electrocardiogram subjects aged 45 years; lactose lithium intolerance; females, current breastfeeding, pregnant, planning pregnant month study entry.",C0680251|C0243161|G0000000|C0521116|C0001962|C0011546|C0332174|C0013227|C0024808|C0006644|C0040329|G0000000|C1720154|C0013227|C0332174|C0332152|C0450371|C0439228|C0521116|C0033080|C0025605|C0006405|C0026516|C0184512|C0003289|G0000000|C0040615|C0013227|C0019664|C0036341|C0443156|G0000000|C0012634|C0033975|C0038661|C0035647|C0184666|C0229992|C0018684|C0439148|G0000000|C0439231|C0332152|C2949735|C0022646|C0040132|C0205054|C0012634|C0205161|C0013798|C0681850|C0001779|C0450371|C0439234|C0022949|C0023870|C0231199|C0015780|C0521116|C0006147|C0549206|C0032074|C0549206|C0332177|C0557651|C1705654
"Exclusion criteria were children who had significant cardiorespiratory comorbidity, were using regular oral corticosteroid, or had an asthma exacerbation in the month before treatment with pranlukast started.","Exclusion criteria children cardiorespiratory comorbidity, regular oral corticosteroid, asthma exacerbation month treatment pranlukast started.",C0680251|C0243161|C0008059|G0000000|C0009488|C0205272|C0442027|C0001617|C0004096|G0000000|C0332177|C0039798|C0526058|C1272689
This is particularly relevant in diseases such as advanced gastric cancer where survival rates are similar across treatment regimens.,This relevant diseases advanced gastric cancer survival rates treatment regimens.,G0000000|C2347946|C0012634|C0205179|C0038351|C0006826|C0038952|C0871208|C0039798|C2945654
Eighty-five recently diagnosed women with stage II and III breast cancer from two different urban cancer centers were recruited for this study over a 2-year period from January 2004 to June 2006.,Eighty-five diagnosed women stage II III breast cancer urban cancer centers recruited study 2-year period January 2004 June 2006.,C3816958|C0011900|C0043210|C0205390|G0000000|C0439070|C0006141|C0006826|C0442529|C0006826|C0205099|G0000000|C0557651|C0439234|C0439531|C3829466|G0000000|C3829443|G0000000
"Although chronic therapy with non-steroidal anti-inflammatory drug was an exclusion criterion, prophylactic stable low dose of aspirin was permitted and aspirin intake during study was recorded in approximately 42% of patients in both treatment groups (Table 1).","Although chronic therapy non-steroidal anti-inflammatory drug exclusion criterion, prophylactic stable low dose aspirin permitted aspirin intake study recorded 42% patients treatment (Table 1).",G0000000|C0205191|C0039798|C1518422|C0003209|C0013227|C0680251|C0243161|C0355642|C0205360|C0205251|C0178602|C0004057|C0329040|C0004057|C1512806|C0557651|C0034869|C0450371|C0030705|C0039798|C0039224|G0000000
CONCLUSIONS: AMP is an effective treatment in some patients with mild to moderate OSA and is associated with greater patient satisfaction than nCPAP.,CONCLUSIONS: AMP effective treatment patients mild moderate OSA patient satisfaction nCPAP.,C1707478|G0000000|C1280519|C0039798|C0030705|C2945599|C0205081|C0520679|C0030705|C0242428|G0000000
"Inclusion criteria were that the participants consisted of a parent and his/her 4- to 6-year-old child presenting at an outpatient pediatric practice for preschool immunizations (i.e., Diptheria, Tetanus, Pertussis and Polio; Measles, Mumps, and Rubella, Varicella).","Inclusion criteria participants consisted parent his/her 4- 6-year-old child outpatient pediatric practice preschool immunizations (i.e., Diptheria, Tetanus, Pertussis Polio; Measles, Mumps, Rubella, Varicella).",C0007637|C0243161|C0679646|C0332529|C0030551|G0000000|G0000000|C0439234|C0008059|C0029921|C0030755|C0237607|C0424930|C0020971|C0683454|C0012546|C0039614|C0043167|C0032371|C0025007|C0026780|C0035920|C0008049
"Patients with any of the following conditions were excluded from the study: (1) residing >70 miles from the research site or unavailable to attend the intervention at one of the scheduled times; (2) engaged in intensive yoga practice (practice >3 d/wk); (3) actively contemplating suicide (none was excluded on this basis); (4) undergoing disability application, determination, or litigation; (5) scheduled for elective surgery during the study period; (6) physically disabled in a manner that precluded meaningful participation in the intervention (eg, quadriplegic paralysis); (7) unwilling to forgo changing their voluntary pharmacological and/or nonpharmacological treatments for the length of their participation in the study; or (8) non-English speaking.","Patients conditions excluded study: (1) residing >70 miles site unavailable attend intervention scheduled times; (2) engaged intensive yoga practice (practice >3 d/wk); (3) actively contemplating suicide (none excluded basis); (4) undergoing disability application, determination, litigation; (5) scheduled elective surgery study period; (6) physically disabled manner precluded meaningful participation intervention (eg, quadriplegic paralysis); (7) unwilling forgo changing voluntary pharmacological and/or nonpharmacological treatments length participation study; (8) non-English speaking.",C0030705|C0012634|C1554077|C0557651|G0000000|C2982691|C0450371|C0331865|C0205145|C0686905|C1999232|C0886296|C0086960|C0040223|G0000000|C0425152|C0162425|C0043418|C0237607|C0237607|G0000000|C0332174|G0000000|G0000000|G0000000|C0038661|G0000000|C1554077|C1527178|G0000000|G0000000|C0231170|C0185125|C1148554|C0079706|G0000000|C0086960|C0206058|C0038894|C0557651|C0439531|G0000000|G0000000|C0018576|G0000000|G0000000|C0876919|C0679823|C0886296|C0013715|G0000000|C0522224|G0000000|C0558080|G0000000|C0392747|C0439656|C0031330|G0000000|G0000000|C0087111|C1444754|C0679823|C0557651|G0000000|C1518422|C0234856
"Enrolled subjects consisted of 16 males and 4 females [Age 24.1±7.1 (MET), 29.7±11.9 (control); height 174.6 ±12.8 cm (MET), 174.0 ±9.2 cm (control); mass 75.9 ± 19.0 kg (MET), 81.6 ± 9.8 kg (control)] (see mean scores in Table Table1).1).","Enrolled subjects consisted 16 males 4 females [Age 24.1±7.1 (MET), 29.7±11.9 (control); height 174.6 ±12.8 cm (MET), 174.0 ±9.2 cm (control); mass 75.9 ± 19.0 (MET), 81.6 ± 9.8 (control)] (see scores Table Table1).1).",G0000000|C0681850|C0332529|C0450371|C0086582|G0000000|C0015780|C0001779|G0000000|C0268621|G0000000|C0243148|C0489786|C1442061|G0000000|G0000000|C0268621|C1442061|G0000000|G0000000|C0243148|C0577559|C0450371|G0000000|C0450371|C0268621|C0450371|G0000000|G0000000|C0243148|C0042789|C0449820|C0039224|G0000000
Consecutive patients aged 18 years or older with liver cirrhosis who presented with septic shock were eligible within 72 hours of the onset of hypotension for this randomized double-blind placebo-controlled trial.,Consecutive patients aged 18 liver cirrhosis septic shock eligible 72 hours onset hypotension randomized double-blind placebo-controlled trial.,C1707491|C0030705|C0001779|C0450371|C0023884|C0023890|C0333534|C0036974|C1548635|C0450371|C0439227|C0206132|C0020649|C0034656|C0013072|C1706408|C0008976
"Subjects were excluded if they were carrying more than one fetus, had preexisting diabetes mellitus or systolic blood pressure ≥140 mm Hg at enrollment, or had any serious health condition likely to affect the prenatal or postnatal growth and development of their offspring, including cancer, lupus, hepatitis, HIV/AIDS, or a diagnosed alcohol or chemical dependency.","Subjects excluded carrying fetus, preexisting diabetes mellitus systolic blood pressure ≥140 mm Hg enrollment, health condition affect prenatal postnatal growth development offspring, including cancer, lupus, hepatitis, HIV/AIDS, diagnosed alcohol chemical dependency.",C0681850|C1554077|C0206243|C0015965|C2347662|C0011847|G0000000|C0039155|C0005767|C0033095|G0000000|G0000000|C0025424|C1516879|C0018684|C0012634|C0001721|C0678804|C0443281|C0018270|C0243107|C0680063|C0332257|C0006826|C0024131|C0019158|C0497169|C0011900|C0001962|C0220806|C0011546
"Median follow-up time was 18.3 years (range=5.0–58.2), and median age was 26.9 years (17.8–65.8).","Median follow-up time 18.3 (range=5.0–58.2), median age 26.9 (17.8–65.8).",C0549183|C0589120|C0040223|C0450371|G0000000|C0549183|C0001779|C0450371|G0000000
"The mean age of the sample was 52 years; 38.9% of participants were African American, and 67.4% were women; the mean clinic-measured BP was 138/86 mm Hg.","The age sample 52 years; 38.9% participants African American, 67.4% women; clinic-measured BP 138/86 mm Hg.",G0000000|C0001779|C0370003|C0450371|C0439234|C0450371|C0679646|C0027567|C0596070|C0450371|C0043210|C0002424|C0037623|C1442061|G0000000|C0025424
A total of 59 participants randomly performed PPE donning and doffing.,A total 59 participants randomly performed PPE donning doffing.,G0000000|C0439175|C0450371|C0679646|G0000000|C0884358|G0000000|C0012020|G0000000
"Participants were adolescents between the ages of 14 to 17 years who smoked at least 6 cigarettes a day, exhaled carbon monoxide levels of over 10 ppm, had at least 2 past quit attempts, and met other inclusion criteria(13).","Participants adolescents ages 14 17 smoked 6 cigarettes day, exhaled carbon monoxide levels 10 ppm, 2 quit attempts, met inclusion criteria(13).",C0679646|C0205653|C0001779|C0450371|C0450371|C0037366|G0000000|C0677453|C0332173|C0231800|C0007009|G0000000|C0441889|C0450371|C0439187|G0000000|C0748223|C1516084|C0268621|C0007637|C0243161
"Criteria for selection of the initial pool of schools were as follows: eligibility for the free and reduced-cost school lunch program (approximately 20% or more of households in the school districts within 185% of the federal poverty level), school district enrollment under 1,200, and all middle school grades (Grades 6–8) taught at only one location.","Criteria selection initial pool schools follows: eligibility free reduced-cost school lunch program (approximately 20% households school districts 185% federal poverty level), school district enrollment 1,200, middle school grades (Grades 6–8) taught location.",C0243161|C0036576|C0205265|C0337051|C0036375|C0332283|C0013893|C0332296|C0392756|C0036375|C2697949|C1709697|C0332232|C0450371|C0020052|C0036375|G0000000|C1442061|G0000000|C0032854|C0441889|C0036375|G0000000|C1516879|C1442061|C0444598|C0036375|C0441800|C0441800|G0000000|C0348054|C0450429
"In the UK people, regardless of age, are registered with a general practice and consult with that practice for their primary care unless there are unusual circumstances such as being away from home or direct attendance at an emergency department, usually in the event of an acute more serious illness.","In UK people, age, registered practice consult practice primary care unusual circumstances direct attendance emergency department, event acute illness.",G0000000|C0041700|C0027361|C0001779|C1514821|C0237607|C0009818|C0237607|C0205225|C1947933|C2700116|G0000000|C0439851|C2827364|C0013956|C1704729|C0441471|C0205178|C0221423
One hundred and thirty-seven women with two or more antibiotic-treated UTIs in the previous 12 months were randomized to receive either 500 mg of cranberry extract or 100 mg of trimethoprim for 6 months.,One thirty-seven women antibiotic-treated UTIs previous 12 months randomized receive 500 cranberry extract 100 trimethoprim 6 months.,C0205447|C3816446|C0043210|C0003232|C0042029|C0205156|C0450371|C0439231|C0034656|C1514756|C1442061|C0453273|C2828366|C1442061|C0041041|G0000000|C0439231
In all cases absence from a survey was because the child was travelling.,In absence survey child travelling.,G0000000|C0332197|C0038951|C0008059|C0040802
"The present study included subacute stroke patients with upper extremity spasticity of ≥1 point on the MAS, who were admitted to Department of Rehabilitation Medicine of Dong-A University Hospital from April 2014 to January 2016.","The study included subacute stroke patients upper extremity spasticity ≥1 MAS, admitted Department Rehabilitation Medicine Dong-A University Hospital April 2014 January 2016.",G0000000|C0557651|C0332257|C0205365|C0038454|C0030705|C1282910|C0015385|C0026838|G0000000|C1096155|C0184666|C1704729|C0034991|C0013227|G0000000|C0041740|C0019994|C3715024|G0000000|C3829466|G0000000
Five major cessation services in Hong Kong will be involved.,Five major cessation services Hong Kong involved.,C0205451|C0205082|C1880019|C0557854|G0000000|G0000000|C1314939
"EPs-7630 is effective in acute bronchitis outside the strict indication for antibiotics in 6–18 years old patients, with a dose of 60 mg or 90 mg daily offering the best benefit/risk ratio.","EPs-7630 effective acute bronchitis strict indication antibiotics 6–18 patients, dose 60 90 daily offering benefit/risk ratio.",G0000000|C1280519|C0205178|C0006277|G0000000|C0392360|C0003232|G0000000|C0030705|C0178602|C0450371|C0450371|C0332173|G0000000|C0687742|C0456603
"In non-small-cell lung cancer (NSCLC) patients not suitable for surgery or radical (chemo)radiotherapy, the main aim of treatment is palliation.","In non-small-cell lung cancer (NSCLC) patients suitable surgery radical (chemo)radiotherapy, main aim treatment palliation.",G0000000|C0445128|C0024109|C0006826|C0007131|C0030705|C3900053|C0038894|C0302912|C0392920|C0205225|C1947946|C0039798|C0030231
Children who were randomized to the IT group began the 8-week intervention directly after initial assessments.,Children randomized IT 8-week intervention directly initial assessments.,C0008059|C0034656|G0000000|C0332174|C0886296|C1947931|C0205265|C1261322
Exclusion criteria were (1) current DSM-IV substance use disorders; (2) lifetime history of dependence on cannabis; (3) previous psychosis with or intolerance to cannabinoids; (4) concurrent use of approved cannabinoid medications (ie Marinol); (5) positive urine toxicology screen for cannabinoids during the wash-in week before initiating study treatment; and (6) serious medical conditions that might affect participant safety or the conduct of the trial.,Exclusion criteria (1) current DSM-IV substance disorders; (2) lifetime history dependence cannabis; (3) previous psychosis intolerance cannabinoids; (4) concurrent approved cannabinoid medications (ie Marinol); (5) positive urine toxicology screen cannabinoids wash-in week initiating study treatment; (6) medical conditions affect participant safety conduct trial.,C0680251|C0243161|G0000000|C0521116|C0220952|C0439861|C0012634|G0000000|C4071830|C0019664|C0011546|C0024808|G0000000|C0205156|C0033975|C0231199|C0006864|G0000000|C0205420|C0205540|C0006864|C0013227|G0000000|C0728767|G0000000|C0439178|C0042036|C0040541|C0220908|C0006864|C0441648|C0332174|C1548602|C0557651|C0039798|G0000000|C0199168|C0012634|C0001721|C0679646|C0036043|C0004927|C0008976
"Participants were outpatients 6.0 to 15.11 years old with a DSM-IV diagnosis of bipolar I disorder, manic or mixed episode, for at least 4 consecutive weeks immediately preceding baseline, with a Children’s Global Assessment Scale (CGAS)15 score of 60 or less at baseline and in good physical health.","Participants outpatients 6.0 15.11 DSM-IV diagnosis bipolar I disorder, manic mixed episode, 4 consecutive weeks preceding baseline, Children’s Global Assessment Scale (CGAS)15 score 60 baseline physical health.",C0679646|C0029921|G0000000|C0450371|C0220952|C0011900|C0443156|C0021966|C0012634|C0338831|C0205430|C0332189|G0000000|C1707491|C0439230|C0332152|C0168634|G0000000|C0205246|C1261322|C0175659|C0055633|C0449820|C0450371|C0168634|C0031809|C0018684
"This open, randomized, controlled study was conducted in a group of 50 highly dependent smokers seen in the Department of Ambulatory care and Community Medicine in Lausanne, Switzerland.","This open, randomized, controlled study conducted 50 highly dependent smokers Department Ambulatory care Community Medicine Lausanne, Switzerland.",G0000000|C0175566|C0034656|C2587213|C0557651|C0004927|C0450371|C0205250|C0851827|C0337664|C1704729|C0439841|C1947933|C0009462|C0013227|G0000000|C0039021
"Data for 140 children (3–10 years) enrolled in the School Based Asthma Therapy trial, randomized to the treatment condition and living with one or more smoker, were analyzed.","Data 140 children (3–10 years) enrolled School Based Asthma Therapy trial, randomized treatment condition living smoker, analyzed.",C1511726|C1442061|C0008059|G0000000|C0439234|G0000000|C0036375|C1527178|C0004096|C0039798|C0008976|C0034656|C0039798|C0012634|C0376558|C0337664|C0936012
613 patients with a diagnosis of possible or probable Alzheimer's disease of mild-to-moderate severity defined as a Mini-Mental State Examination (MMSE) total score between 12 and 26 inclusive who were taking an acetylcholinesterase inhibitor.,613 patients diagnosis probable Alzheimer's disease mild-to-moderate severity defined Mini-Mental State Examination (MMSE) total score 12 26 inclusive acetylcholinesterase inhibitor.,C1442061|C0030705|C0011900|C0033204|G0000000|C0012634|C1299392|C0439793|C1704788|C0445542|C1301808|G0000000|C0451306|C0439175|C0449820|C0450371|C0450371|C0332257|C0001044|C1999216
"Asthma severity scores at baseline, 4 hr and 8 hr.","Asthma severity scores baseline, 4 hr 8 hr.",C0004096|C0439793|C0449820|C0168634|G0000000|G0000000|G0000000
"Patients must have had contact with their primary health care team at least once within the past 2 years and speak English, Spanish or Cantonese.","Patients contact primary health care team 2 speak English, Spanish Cantonese.",C0030705|C0332158|C0205225|C0018684|C1947933|C0871489|G0000000|C0234856|C0376245|C0086409|G0000000
A cluster randomised school drug education trial will be conducted with 1746 junior high school students in 21 Victorian secondary schools over a period of three years.,A cluster randomised school drug education trial conducted 1746 junior school students 21 Victorian secondary schools period years.,G0000000|C1555715|G0000000|C0036375|C0013227|C0013621|C0008976|C0004927|G0000000|C1708595|C0036375|C0038492|C0450371|G0000000|C0027627|C0036375|C0439531|C0439234
No significant differences in nighttime sleep variables were found between groups.,No differences nighttime sleep variables groups.,G0000000|C1705241|C0240526|C0037313|C0439828|C0441833
"Exclusion criteria were (1) severely impaired communication due to native language or aphasia, (2) impaired cardiorespiratory capacity, (3) severe multimodal neglect, (4) history of severe infection or history of infection with multiresistant bacteria, (5) complete paralysis of the leg, (6) history of more than 1 stroke, (7) decubital ulcer of the lower extremities and the sacral region, (8) severe osteoporosis and fractures, (9) history of deep vein thrombosis and pulmonary embolism, (10) contracture of the leg, (11) body weight > 100 kg, (12) epilepsy, (13) electric medical devices like cardiac pacemaker, (14) metal implants like ventriculoperitoneal shunt.","Exclusion criteria (1) severely impaired communication native language aphasia, (2) impaired cardiorespiratory capacity, (3) severe multimodal neglect, (4) history severe infection history infection multiresistant bacteria, (5) complete paralysis leg, (6) history 1 stroke, (7) decubital ulcer lower extremities sacral region, (8) severe osteoporosis fractures, (9) history deep vein thrombosis pulmonary embolism, (10) contracture leg, (11) body weight > 100 kg, (12) epilepsy, (13) electric medical devices cardiac pacemaker, (14) metal implants ventriculoperitoneal shunt.",C0680251|C0243161|G0000000|C0205082|C0221099|C0009452|C0302891|C0023008|C0003537|G0000000|C0221099|G0000000|C1516240|G0000000|C0205082|C1513743|C0521874|G0000000|C0019664|C0205082|C0009450|C0019664|C0009450|G0000000|C0004611|G0000000|C0205197|C0522224|C0023216|G0000000|C0019664|G0000000|C0038454|G0000000|C0011127|C0041582|C0441994|C0015385|C0036037|C0017446|G0000000|C0205082|C0029456|C0016658|G0000000|C0019664|C0205125|C0042449|C0040053|C0024109|C0013922|C0450371|C0009917|C0023216|C0450371|C0242821|C0005910|G0000000|C1442061|C0022718|C0450371|C0014544|C0450371|C0013790|C0199168|C0025080|C0018787|C0030163|C0450371|C0025552|C0021102|G0000000|C0232180
"Children’s mean age at arrival was 33.18 months (SD = 16.83 months, age range 1–68 months) and children’s mean age at assessment was 43.15 (SD = 15.70, age range 17.45–75 months).","Children’s age arrival 33.18 months (SD = 16.83 months, age range 1–68 months) children’s age assessment 43.15 (SD = 15.70, age range 17.45–75 months).",G0000000|C0001779|C1555577|C0450371|C0439231|G0000000|G0000000|C0450371|C0439231|C0001779|C1514721|G0000000|C0439231|G0000000|C0001779|C1261322|C0450371|G0000000|G0000000|C0450371|C0001779|C1514721|G0000000|C0439231
"The range of eligible population sizes were set so that villages were large enough to have local facilities suitable for physical activity, but limited in the amount of activity opportunities they could offer.","The range eligible population sizes set villages local facilities suitable physical activity, limited amount activity opportunities offer.",G0000000|C1514721|C1548635|C0032659|C0456389|C0036849|C0562518|C0205276|C1547538|C3900053|C0031809|C0205177|C0439801|C1265611|C0205177|G0000000|G0000000
"Therefore, use of nondrug methods privileged to overcome depression and anxiety in patients with cancer.","Therefore, nondrug methods privileged overcome depression anxiety patients cancer.",G0000000|G0000000|C0025663|C1547898|C2983310|C0011570|C0003467|C0030705|C0006826
"In the current study, the mean age of women, maternal occupation, education, construction features of living abode, gestational age, delivery mode and serum 25(OH)D3 concentration at baseline were similar among the pregnant women in the vitD and placebo groups (Table 1).","In current study, age women, maternal occupation, education, construction features living abode, gestational age, delivery mode serum 25(OH)D3 concentration baseline pregnant women vitD placebo (Table 1).",G0000000|C0521116|C0557651|C0001779|C0043210|C2347083|C0028811|C0013621|C0441513|C1521970|C0376558|G0000000|C0439671|C0001779|C0011209|C1513371|C0229671|C0450371|C0004268|C0168634|C0549206|C0043210|C0042866|C0032042|C0039224|G0000000
"None of the patients had a history of previous anesthesia, cardiovascular disease, pulmonary or neurologic disease and/or current upper respiratory infection.","None patients history previous anesthesia, cardiovascular disease, pulmonary neurologic disease and/or current upper respiratory infection.",G0000000|C0030705|C0019664|C0205156|C0002903|C0007226|C0012634|C0024109|C0205494|C0012634|G0000000|C0521116|C1282910|C0521346|C0009450
"Excluded individuals were those with any active untreated or unstable major mental illness that would interfere with study participation (e.g., active mania or psychosis), inability or unwillingness to provide informed consent, or current participation in cognitive behavioral therapy (CBT) for depression.","Excluded individuals active untreated unstable major mental illness interfere study participation (e.g., active mania psychosis), inability unwillingness provide informed consent, current participation cognitive behavioral therapy (CBT) depression.",C1554077|C0027361|C0205177|C0332155|C0443343|C0205082|C0229992|C0221423|C0521102|C0557651|C0679823|G0000000|C0205177|C0338831|C0033975|G0000000|C0558080|C1999230|C1522154|C1511481|C0521116|C0679823|C1516691|C0004927|C0039798|C0009244|C0011570
"Recruitment of research sites into the trial was staggered, with the first site recruited in September 2014 and the final site recruited in September 2015.","Recruitment sites trial staggered, site recruited September 2014 final site recruited September 2015.",C2949735|C0205145|C0008976|C0344191|C0205145|G0000000|C3828193|G0000000|C0205088|C0205145|G0000000|C3828193|G0000000
Abstinence from any alternative medications or vitamin supplements for 6 mo prior to initiation of therapy was stipulated.,Abstinence alternative medications vitamin supplements 6 mo prior initiation therapy stipulated.,C3843422|C1523987|C0013227|C0042890|C0242295|G0000000|C0026544|C0332152|C0589507|C0039798|G0000000
[1] regarding the effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis managed in their intensive care unit.,[1] effects IgM-enriched immunoglobulin preparations patients severe sepsis managed intensive care unit.,G0000000|C1280500|C1706005|C0021027|C1521827|C0030705|C0205082|C0036690|C1273870|C0162425|C1947933|C0439148
"Baseline and follow-up characteristics of the study population Study subjects were followed through the National Health Service Central Register (NHSCR) in England and Wales to ascertain their vital status, and to obtain information on site-specific cancer incidence, cause-specific mortality and migrations.","Baseline follow-up characteristics study population Study subjects National Health Service Central Register (NHSCR) England Wales ascertain vital status, site-specific cancer incidence, cause-specific mortality migrations.",C0168634|C0589120|C1521970|C0557651|C0032659|C0557651|C0681850|C3245503|C0018684|C0557854|C0205099|G0000000|G0000000|C0014282|C0043015|G0000000|C0442732|C0449438|C0449604|C0006826|C0021149|C0015127|C0026565|C0600210
The trial will enrol 100 adult (aged 18 years or older) trauma patients judged by treating clinicians to have clinically significant haemorrhage or potential for significant transfusion requirements with an Assessment of Blood Consumption Score (ABC Score) ≥2.,The trial enrol 100 adult (aged 18 older) trauma patients judged treating clinicians clinically haemorrhage potential transfusion requirements Assessment Blood Consumption Score (ABC Score) ≥2.,G0000000|C0008976|G0000000|C1442061|C0001675|C0001779|C0450371|C0580836|C0043251|C0030705|C0221191|C1522326|C0871685|G0000000|C0019080|C3245505|C0005841|C1514873|C1261322|C0005767|C0009830|C0449820|C0152244|C0449820|G0000000
"Pre-existing diabetes or HbA1c at booking ≥ 50 mmol/mol [50], taking probiotic supplements, known congenital abnormality, medications or medical conditions which alter glucose metabolism, multiple pregnancy, bariatric surgery, and severe hyperemesis.","Pre-existing diabetes HbA1c booking ≥ 50 mmol/mol [50], probiotic supplements, congenital abnormality, medications medical conditions alter glucose metabolism, multiple pregnancy, bariatric surgery, severe hyperemesis.",C2347662|C0011847|G0000000|G0000000|C3829066|C0450371|C0525033|C0242295|C0009678|C1704258|C0013227|C0199168|C0012634|C0392747|C0017725|C0025519|C0439064|C0032961|G0000000|C0038894|C0205082|C0020450
"Women with breast cancer and radiologic, scintigraphic, and/or biopsy confirmed bone metastases who had received at least 3 months of 3–4 weekly IV pamidronate were enrolled.","Women breast cancer radiologic, scintigraphic, and/or biopsy confirmed bone metastases received 3 months 3–4 weekly IV pamidronate enrolled.",C0043210|C0006141|C0006826|C0034599|C0034606|G0000000|C0005558|C0521093|C0262950|C0027627|C1514756|G0000000|C0439231|G0000000|C0332174|C0022326|C0043603|G0000000
"Exclusion criteria were jaw-winking phenomena, abnormal ocular motility, or absent Bell’s phenomena.","Exclusion criteria jaw-winking phenomena, abnormal ocular motility, absent Bell’s phenomena.",C0680251|C0243161|C0266521|C1882365|C0205161|C0015392|C0007608|C0332197|G0000000|C1882365
Randomized occurred after session 4 because the first pills were administered prior to session 5.,Randomized occurred session 4 pills administered prior session 5.,C0034656|C1709305|C1883016|G0000000|C0994475|C1521801|C0332152|C1883016|G0000000
"During the study period, 15 882 eligible ICU adult patients who were expected to stay in the ICU for at least 2 days in the participating ICUs.","During study period, 15 882 eligible ICU adult patients expected stay ICU 2 days participating ICUs.",G0000000|C0557651|C0439531|G0000000|C1548635|C0021708|C0001675|C0030705|C1517001|G0000000|C0021708|G0000000|C0439228|C0679823|C0021708
METHODS—Infants with birth weight < 1000 g were randomised at birth to receive oral vitamin A supplementation (5000 IU/day) or placebo for 28 days.,METHODS—Infants birth weight < 1000 randomised birth receive oral vitamin A supplementation (5000 IU/day) placebo 28 days.,G0000000|C0005615|C0005910|G0000000|G0000000|G0000000|C0005615|C1514756|C0442027|C0042890|G0000000|C0242297|G0000000|C0439465|C0032042|C0450371|C0439228
Participants 606 regular wearers of multifocal glasses (mean age 80 (SD 7) years).,Participants 606 regular wearers multifocal glasses (mean age 80 (SD 7) years).,C0679646|C1442061|C0205272|G0000000|C0205292|C0015421|C0444504|C0001779|C0450371|G0000000|G0000000|C0439234
"EGFR gene copy number was measured by FISH in baseline tumor tissue samples.19 Patient eligibility included: age ≥ 18 years old, chemotherapy naïve, histologically or cytologically confirmed locally advanced or metastatic NSCLC not amenable to curative surgery or radiotherapy, WHO PS of 2 or 3, measurable disease (RECIST), no prior EGFR inhibitor therapy, and considered unfit for chemotherapy.","EGFR gene copy measured FISH baseline tumor tissue samples.19 Patient eligibility included: age ≥ 18 old, chemotherapy naïve, histologically cytologically confirmed locally advanced metastatic NSCLC amenable curative surgery radiotherapy, WHO PS 2 3, measurable disease (RECIST), prior EGFR inhibitor therapy, considered unfit chemotherapy.",C1739039|C0017337|C1948062|C0444706|C0016163|C0168634|C0027651|C0040300|C0370003|C0030705|C0013893|C0332257|C0001779|G0000000|C0450371|C0580836|C0013216|G0000000|C0205462|G0000000|C0521093|C1517927|C0205179|C0036525|C0007131|C3900053|C1880198|C0038894|C0034619|G0000000|C0242397|G0000000|G0000000|C1513040|C0012634|C1709926|C0332152|C1739039|C1999216|C0039798|C0750591|G0000000|C0013216
Adult patients who were prescribed antibiotics for 3-14 days were enrolled from eight Canadian centers.,Adult patients prescribed antibiotics 3-14 days enrolled Canadian centers.,C0001675|C0030705|C0278329|C0003232|C0450371|C0439228|G0000000|C0238884|C0205099
Postmenstrual age is defined as the gestational age plus the postnatal age.,Postmenstrual age defined gestational age postnatal age.,G0000000|C0001779|C1704788|C0439671|C0001779|C0443281|C0001779
"The inclusion criteria were healthy children with 4-9 years of age who referred to dental operating room and needed dental treatment on left upper teeth, with negative medical history of allergy, hepatic failure, renal failure, heart problems, chronic pulmonary disease, seizures, asthma, and psychological problems.","The inclusion criteria healthy children 4-9 age referred dental operating dental treatment left upper teeth, negative medical history allergy, hepatic failure, renal failure, heart problems, chronic pulmonary disease, seizures, asthma, psychological problems.",G0000000|C0007637|C0243161|C3898900|C0008059|G0000000|C0001779|C0205543|C0011365|C3242339|C0011365|C0039798|C0205091|C1282910|C0040426|C0205160|C0199168|C0019664|C0002111|C0205054|C0231174|C0022646|C0231174|C0018787|C1546466|C0205191|C0024109|C0012634|C0036572|C0004096|C0205486|C1546466
Patients were eligible for randomization if their asthma was still not fully controlled at the end of a 2-week run-in period.,Patients eligible randomization asthma controlled 2-week run-in period.,C0030705|C1548635|C0034656|C0004096|C2587213|C0332174|C3274438|C0439531
The Positive Action program intervention took place in 20 public elementary (kindergarten to fifth or sixth grade) schools on 3 Hawaiian islands.,The Positive Action program intervention 20 public elementary (kindergarten sixth grade) schools 3 Hawaiian islands.,G0000000|C0439178|C0441472|C1709697|C0886296|C0450371|G0000000|C0013879|C0681406|C0205440|C0441800|C0036375|G0000000|C0337920|C0022130
"The target population for this study is all individuals/adults who sustained a first ""mild"" stroke and who are discharged home within three weeks of being admitted to an acute care hospital.","The target population study individuals/adults sustained ""mild"" stroke discharged weeks admitted acute care hospital.",G0000000|C1521840|C0032659|C0557651|C0027361|C0443318|C2945599|C0038454|C0030685|C0439230|C0184666|C0205178|C1947933|C0019994
"The schools will be stratified by Government, Catholic, and Independent sectors and geographical location, with up to 20 schools recruited in each of two states, Western Australia (WA) and South Australia (SA), and randomly allocated to intervention or control (usual practice).","The schools stratified Government, Catholic, Independent sectors geographical location, 20 schools recruited states, Western Australia (WA) South Australia (SA), randomly allocated intervention control (usual practice).",G0000000|C0036375|C0205363|C0018104|C0242211|C0085862|C1708237|C0017447|C0450429|C0450371|C0036375|G0000000|C1301808|C1705493|C0004340|C0027366|C1710133|C0004340|C0036243|G0000000|G0000000|C0886296|C0243148|C3538928|C0237607
"Between March 13, 2007 and May 28, 2010, a total of 1,741 PD participants from 45 sites in the U.S. and Canada were randomized 1:1 to either 10-gm creatine/day or matching placebo.","Between March 13, 2007 May 28, 2010, total 1,741 PD participants 45 sites U.S. Canada randomized 1:1 10-gm creatine/day matching placebo.",G0000000|C3829202|C0450371|G0000000|G0000000|C0450371|G0000000|C0439175|C1442061|G0000000|C0679646|C0450371|C0205145|C0041703|C0006823|C0034656|G0000000|C0450371|C0010286|C0150103|C0032042
"Healthcare staff in NSC participated in a pilot survey in September 2003, and staff in TTSH were surveyed in April 2004.","Healthcare staff NSC participated pilot survey September 2003, staff TTSH surveyed April 2004.",C0086388|C0851286|G0000000|G0000000|C0473169|C0038951|C3828193|G0000000|C0851286|G0000000|C0038951|C3715024|G0000000
"Each of the cross-sectional surveys will include an independent sample of 770 individuals, 385 children 6–71 months of age and 385 individuals 60 months and over.","Each cross-sectional surveys independent sample 770 individuals, 385 children 6–71 months age 385 individuals 60 months over.",G0000000|C0552389|C0038951|C0085862|C0370003|C1442061|C0027361|C1442061|C0008059|G0000000|C0439231|C0001779|C1442061|C0027361|C0450371|C0439231|C0205136
"To identify the earliest possible date of PD diagnosis, we set as the index date the first hospital or outpatient record that ever mentioned PD or the first prescription of PD medication (anatomical therapeutic chemical (ATC) code N04B)14, whichever was earlier.","To identify earliest PD diagnosis, set hospital outpatient record mentioned PD prescription PD medication (anatomical therapeutic chemical (ATC) code N04B)14, whichever earlier.",C0040363|G0000000|C1279919|G0000000|C0011900|C0036849|C0019994|C0029921|C0034869|G0000000|G0000000|C0033080|G0000000|C0013227|C0220784|C0087111|C0220806|C0004135|C0009219|C0450371|G0000000|C1279919
"This study is part of an epidemiologic survey of epilepsy conducted in 2008, in which 738 people of all ages had active convulsive epilepsy, defined as at least two unprovoked convulsions, with one in the 12 months prior to being assessed.12 Recruitment of PWE involved in this study started in August 2009.","This study epidemiologic survey epilepsy conducted 2008, 738 people ages active convulsive epilepsy, defined unprovoked convulsions, 12 months prior assessed.12 Recruitment PWE involved study started August 2009.",G0000000|C0557651|C0014507|C0038951|C0014544|C0004927|G0000000|C1442061|C0027361|C0001779|C0205177|C0234531|C0014544|C1704788|G0000000|C0036572|C0450371|C0439231|C0332152|C1516048|C2949735|G0000000|C1314939|C0557651|C1272689|C3831448|G0000000
"For the control group, staff called parents of children noted to have exposure to secondhand smoke in the electronic medical record during the visit prior to the 12- or 24-month visit (9- and 18-month visits, respectively).","For control group, staff called parents children exposure secondhand smoke electronic medical record visit prior 12- 24-month visit (9- 18-month visits, respectively).",G0000000|C0243148|C0441833|C0851286|C0679006|C0030551|C0008059|C0274281|G0000000|C0037366|C0013850|C0199168|C0034869|C0545082|C0332152|C0450371|C0450371|C0545082|G0000000|C0450371|C0545082|G0000000
"Only patients meeting the following criteria will be considered for trial enrollment: (i) GOLD stage 2 COPD or higher, defined as forced expiratory volume in the first second of expiration (FEV1)/forced vital capacity <0.70 and FEV1 <80% predicted by pulmonary function testing done within 12 months of recruitment, and (ii) PH documented by invasive hemodynamic assessment (right heart catheterization) to diagnose PH within 6 months of TADA-PHiLD screening according to the following hemodynamic criteria: mPAP >30 mmHg, PVR >2.5 Wood units, and pulmonary capillary wedge pressure ≤18 mmHg at rest.","Only patients meeting criteria considered trial enrollment: (i) GOLD stage 2 COPD higher, defined forced expiratory volume expiration (FEV1)/forced vital capacity <0.70 FEV1 <80% predicted pulmonary function testing 12 months recruitment, (ii) PH documented invasive hemodynamic assessment (right heart catheterization) diagnose PH 6 months TADA-PHiLD screening hemodynamic criteria: mPAP >30 mmHg, PVR >2.5 Wood units, pulmonary capillary wedge pressure ≤18 mmHg rest.",C0205171|C0030705|C0556656|C0243161|C0750591|C0008976|C1516879|C0021966|C0018026|C0205390|G0000000|C0024117|C0205250|C1704788|C0441722|C0231800|C0449468|C0231800|C0441722|C0442732|C1516240|C0450371|G0000000|C0450371|C0681842|C0024109|C0031843|C0039593|C0450371|C0439231|C2949735|G0000000|C0450407|C1301725|C0205281|C0019010|C1261322|C0205090|C0018787|C0007430|C0011900|C0450407|G0000000|C0439231|G0000000|C0220908|C0019010|C0243161|C3854605|C0450371|C0439475|C0242852|G0000000|C0043217|C0439148|C0024109|C0006901|C0439639|C0033095|G0000000|C0439475|C0035253
"The first gate employed teacher-reported classroom conduct problems, using the Teacher Observation of Child Adjustment-Revised Authority Acceptance score (27).","The gate employed teacher-reported classroom conduct problems, Teacher Observation Child Adjustment-Revised Authority Acceptance score (27).",G0000000|G0000000|C0014003|C0221457|C0870287|C0004927|C1546466|C0221457|C0302523|C0008059|C0376209|C0599437|G0000000|C0449820|C0450371
Controls were randomly selected from the general population of Shanghai using the Shanghai Resident Registry and matched to cases according to the age distribution (in 5-year intervals) of endometrial cancer cases in 1996.,Controls randomly selected population Shanghai Shanghai Resident Registry matched age distribution (in 5-year intervals) endometrial cancer 1996.,C0243148|G0000000|C1707391|C0032659|G0000000|G0000000|C1320928|C0034975|C0150103|C0001779|C0520511|G0000000|C0439234|C1272706|C0227843|C0006826|G0000000
[1] The iron store is low in preterm infants and rapidly gets depleted during the first 6 to 8 weeks.,[1] The iron store low preterm infants rapidly depleted 6 8 weeks.,G0000000|G0000000|C0302583|C1698986|C0205251|C0151526|C0021270|C0456962|C0333668|G0000000|G0000000|C0439230
"Toenail selenium, in the absence of supplementation, was not associated with PCa risk.","Toenail selenium, absence supplementation, PCa risk.",C0222007|C0036581|C0332197|C0242297|G0000000|C0035647
"Women were eligible if they were premenopausal or postmenopausal, 60 years of age or younger, had axillary node-positive or high-risk node-negative breast cancer, and had undergone complete resection of all known disease by total or partial mastectomy, including axillary node clearance.","Women eligible premenopausal postmenopausal, 60 age younger, axillary node-positive high-risk node-negative breast cancer, undergone complete resection disease total partial mastectomy, including axillary node clearance.",C0043210|C1548635|C0279752|C0232970|C0450371|C0001779|C0332239|C0004454|C0746319|C0332167|C0678034|C0006141|C0006826|G0000000|C0205197|C0015252|C0012634|C0439175|C0728938|C0024881|C0332257|C0004454|C0746922|C0449297
"Exclusion criteria included: infants with major congenital anomalies or chromosomal syndromes incompatible with life, infants of mothers not willing to provide colostrum for their infant in the first week of life, or infants of mothers with known human immunodeficiency virus, hepatitis B, or hepatitis C as these infections may be transmitted through breast milk.","Exclusion criteria included: infants major congenital anomalies chromosomal syndromes incompatible life, infants mothers provide colostrum infant week life, infants mothers human immunodeficiency virus, hepatitis B, hepatitis C infections transmitted breast milk.",C0680251|C0243161|C0332257|C0021270|C0205082|C0009678|C0000769|C0008633|C0039082|C0679426|C0376558|C0021270|C0026591|C1999230|C0009413|C0021270|C0332174|C0376558|C0021270|C0026591|C0086418|C0021051|C0042776|C0019158|G0000000|C0019158|G0000000|C3714514|C0242781|C0006141|C0026131
and placebo was greatest in girls with a spontaneous calcium intake below the median of 880 mg/d.,placebo girls spontaneous calcium intake median 880 mg/d.,C0032042|C0870604|C0205359|C0006675|C1512806|C0549183|C1442061|C0439422
There are currently no agreed strategies for vitamin D replenishment after hip fracture surgery.,There agreed strategies vitamin D replenishment hip fracture surgery.,G0000000|C3641827|C0679199|C0042890|C0073187|G0000000|C0019552|C0016658|C0038894
"Although the diagnosis and treatment of any type of cancer can cause problems in sexual functioning [3], breast cancer raises particular concerns because of the importance of the breast in feminine sexuality and the breast as a source of erotic pleasure and stimulation [33].","Although diagnosis treatment type cancer sexual functioning [3], breast cancer raises concerns breast feminine sexuality breast source erotic pleasure stimulation [33].",G0000000|C0011900|C0039798|C0332307|C0006826|C0036864|C0205245|G0000000|C0006141|C0006826|G0000000|C2699424|C0006141|C0229990|C0036864|C0006141|C0449416|C0242276|C0679105|C1292856|C0450371
LAI data.,LAI data.,C0443021|C1511726
"Residents enrolled in internal medicine, gastroenterology or general surgery subspecialties between postgraduate years 2 and 4 were eligible to participate.","Residents enrolled internal medicine, gastroenterology surgery subspecialties postgraduate 2 4 eligible participate.",C1320928|G0000000|C0205102|C0013227|C0017163|C0038894|G0000000|C2983146|G0000000|G0000000|C1548635|G0000000
"The risk determination was based on the Gail model, as modified and applied in the Breast Cancer Prevention Trial (BCPT P-1) (10).","The risk determination based Gail model, modified applied Breast Cancer Prevention Trial (BCPT P-1) (10).",G0000000|C0035647|C1148554|C1527178|G0000000|C3161035|C0392747|C4048755|C0006141|C0006826|C0199176|C0008976|C1511293|C0369773|C0450371
Twenty-four worksites were randomized to 6 conditions that differed in cessation program format and the use of incentives.,Twenty-four worksites randomized 6 conditions differed cessation program format incentives.,C3715070|C0162579|C0034656|G0000000|C0012634|G0000000|C1880019|C1709697|C1301627|C0021147
"Two hundred twenty-two patients had adenocarcinoma (91%), and 23 patients had squamous cell carcinoma (9%).","Two twenty-two patients adenocarcinoma (91%), 23 patients squamous cell carcinoma (9%).",C0205448|C0724000|C0030705|C0001418|C0450371|C0450371|C0030705|C1182670|C0007634|C0007097|G0000000
"Children were eligible for enrolment if they had a radiographic score of at least 2.5 on a validated 10-point scoring method that assessed the severity of rickets in the growth plates of the distal radius and ulna and around the knee.5 Approval for the study was obtained from the Ethical Committee of the Jos University Teaching Hospital and the Institutional Review Board of Mayo Clinic, and written informed consent was obtained from a parent of each enrolled child.","Children eligible enrolment radiographic score 2.5 validated 10-point scoring method assessed severity rickets growth plates distal radius ulna knee.5 Approval study Ethical Committee Jos University Teaching Hospital Institutional Review Board Mayo Clinic, written informed consent parent enrolled child.",C0008059|C1548635|C1516879|C0444708|C0449820|G0000000|G0000000|C0450371|C0449820|C0025663|C1516048|C0439793|C0035579|C0018270|C1139930|C0205108|C0034627|C0041600|C0022742|C0205540|C0557651|C0026531|C2699414|C1538301|C0041740|C0039401|C0019994|C0018704|C0282443|C0972401|C0454788|C0002424|C0043266|C1522154|C1511481|C0030551|G0000000|C0008059
"Twenty-eight enrolled and 23 completed the randomized, controlled trial (13 intervention, 10 control).","Twenty-eight enrolled 23 completed randomized, controlled trial (13 intervention, 10 control).",C0724000|G0000000|C0450371|C0205197|C0034656|C2587213|C0008976|C0450371|C0886296|C0450371|C0243148
"Secondly, this study used a single-blind method to assess the patients’ risk of falls.","Secondly, study single-blind method assess patients’ risk falls.",C0205436|C0557651|C0242570|C0025663|C1516048|G0000000|C0035647|C0000921
"Ten male wheelchair athletes (8 with spinal cord injuries, 1 with a neurological disorder, and 1 with postpolio syndrome), were matched by lesion level and/or track rating before random assignment to either a RRT group (n = 5) or a control group (CON, n = 5).","Ten male wheelchair athletes (8 spinal cord injuries, 1 neurological disorder, 1 postpolio syndrome), matched lesion level and/or track rating random assignment RRT (n = 5) control (CON, = 5).",C0014518|C0086582|C0043143|C0238703|G0000000|C0521329|C1550235|C1510467|G0000000|C0205494|C0012634|G0000000|G0000000|C0039082|C0150103|C0221198|C0441889|G0000000|C0040594|C0871208|C0034656|C1516050|G0000000|C0369718|G0000000|G0000000|C0243148|G0000000|G0000000|G0000000
"Thus we split our cohort into three groups: women with a punch biopsy, women with excisional treatment, and women with a record of cervical histology but missing treatment status.","Thus split cohort groups: women punch biopsy, women excisional treatment, women record cervical histology missing treatment status.",G0000000|C1534709|C0599755|C0441833|C0043210|C0182555|C0005558|C0043210|C0728940|C0039798|C0043210|C0034869|C0027530|C0019638|C1551393|C0039798|C0449438
An ad hoc programme will be written in SAS to carry out this procedure (see Fig.,An ad hoc programme written SAS carry procedure (see Fig.,G0000000|G0000000|G0000000|C1709697|C0043266|C0605290|C0206243|C0184661|C0042789|C0349966
"The present study recruited 14 healthy, untrained young men who had not been involved in any regular resistance training for at least 1 year before this study.","The study recruited 14 healthy, untrained involved regular resistance training 1 study.",G0000000|C0557651|G0000000|C0450371|C3898900|G0000000|C1314939|C0205272|C0237834|C0040607|G0000000|C0557651
"They were recruited according to the modified WHO inclusion criteria (absence of severe malnutrition, axillary temperature of ≥37.5°C or history of fever in the last 24 hours, asexual P. falciparum density 1,000–200,000/μl, P. vivax and other malaria density ≥250/μl, and ability to swallow oral medication), and exclusion criteria [severe vomiting, history or evidence of clinically systematic significant disorders, other febrile conditions, hypersensitivity or adverse reactions to anti-malarials, history of use of any other anti-malarial agent within four weeks prior to start of the study and confirmed by urine test (Dill Glazko and Lignin tests), and pregnancy or lactating] for therapeutic efficacy study [14].","They recruited modified WHO inclusion criteria (absence severe malnutrition, axillary temperature ≥37.5°C history fever 24 hours, asexual P. falciparum density 1,000–200,000/μl, P. vivax malaria density ≥250/μl, ability swallow oral medication), exclusion criteria [severe vomiting, history evidence clinically systematic disorders, febrile conditions, hypersensitivity adverse reactions anti-malarials, history anti-malarial agent weeks prior start study confirmed urine test (Dill Glazko Lignin tests), pregnancy lactating] therapeutic efficacy study [14].",G0000000|G0000000|C0392747|G0000000|C0007637|C0243161|C0332197|C0205082|C0162429|C0004454|C0005903|G0000000|C0019664|C0015967|C0450371|C0439227|C0599655|C0369773|G0000000|C0178587|G0000000|C0369773|G0000000|C0024530|C0178587|G0000000|C0085732|C0326374|C0442027|C0013227|C0680251|C0243161|C0205082|C0042963|C0019664|C3887511|G0000000|C0220922|C0012634|C0015967|C0012634|C0020517|G0000000|C0443286|C0003374|C0019664|C0003374|C0450442|C0439230|C0332152|C0439659|C0557651|C0521093|C0042036|C0022885|C1256256|G0000000|C0023705|C0022885|C0032961|C2828358|C0087111|C1280519|C0557651|C0450371
Forty tobacco smokers currently undergoing treatment for opioid addiction.,Forty tobacco smokers undergoing treatment opioid addiction.,C3816449|C0040329|C0337664|G0000000|C0039798|C0242402|C0085281
The aim of the present study was to investigate the association between vitamin D supplement and preeclampsia in pregnant women.,The aim study investigate association vitamin D supplement preeclampsia pregnant women.,G0000000|C1947946|C0557651|C1292732|C0004083|C0042890|C0073187|C0242295|C0032914|C0549206|C0043210
"Design: This phase III, double-blind, randomized controlled trial was conducted between January 2006 and October 2011.","Design: This phase III, double-blind, randomized controlled trial conducted January 2006 October 2011.",C1707689|G0000000|C0205390|C0439070|C0013072|C0034656|C2587213|C0008976|C0004927|C3829466|G0000000|C3828732|G0000000
All adult patients (aged 18 years or older) admitted to the ICU with chronic liver failure and an indication for bedside central venous line placement for intravenous (I.V.),All adult patients (aged 18 older) admitted ICU chronic liver failure indication bedside central venous placement intravenous (I.V.),G0000000|C0001675|C0030705|C0001779|C0450371|C0580836|C0184666|C0021708|C0205191|C0023884|C0231174|C0392360|G0000000|C0205099|C0042449|C0441587|C0348016|C0021966
We approached 89 schools and 53 agreed to participate.,We approached 89 schools 53 agreed participate.,G0000000|C0449445|C0450371|C0036375|C0450371|C3641827|G0000000
We studied changes in apathy among 77 community-dwelling older persons with mild memory loss in a randomized clinical trial comparing two nonpharmacological interventions over four weeks.,We studied apathy 77 community-dwelling persons mild memory loss randomized clinical trial comparing nonpharmacological interventions weeks.,G0000000|C0557651|C0085632|C0450371|C4045975|C0027361|C2945599|C0025260|C1517945|C0034656|C0205210|C0008976|C1707455|G0000000|C0886296|C0439230
We followed defined treatment algorithms for the medication of ADHD.,We defined treatment algorithms medication ADHD.,G0000000|C1704788|C0039798|C0002045|C0013227|C1263846
"Most of them were between the age of 3 and 9 years, with six patients up to 13 years.","Most age 3 9 years, patients 13 years.",C0205393|C0001779|G0000000|G0000000|C0439234|C0030705|C0450371|C0439234
"Inclusion criteria were: a diagnosis of probable AD [22], with a SMMSE score of ≤19, Hachinski Score ≤4, [23] being aged ≥45, and a history ≥two weeks of clinically significant agitation (requiring treatment) with a CMAI score of ≥45.","Inclusion criteria were: diagnosis probable AD [22], SMMSE score ≤19, Hachinski Score ≤4, [23] aged ≥45, history ≥two weeks clinically agitation (requiring treatment) CMAI score ≥45.",C0007637|C0243161|G0000000|C0011900|C0033204|G0000000|C0450371|G0000000|C0449820|G0000000|G0000000|C0449820|G0000000|C0450371|C0001779|G0000000|C0019664|G0000000|C0439230|G0000000|C0085631|G0000000|C0039798|G0000000|C0449820|G0000000
"The rest (22%) were diagnosed with more atypical types of dementia (vascular or mixed dementia, alcohol-induced dementia, Lewy body dementia or frontotemporal dementia) and were all but one randomly allocated to music therapy first.","The rest (22%) diagnosed atypical types dementia (vascular mixed dementia, alcohol-induced dementia, Lewy body dementia frontotemporal dementia) randomly allocated music therapy first.",G0000000|C0035253|C0450371|C0011900|C0205182|C0332307|C0011265|C0005847|C0205430|C0011265|C0001962|C0011265|G0000000|C0242821|C0011265|G0000000|C0011265|G0000000|G0000000|C0026867|C0039798|C0205435
Participants will be recruited from antenatal clinics of two major Victorian women’s hospitals.,Participants recruited antenatal clinics major Victorian women’s hospitals.,C0679646|G0000000|C2828394|C0442592|C0205082|G0000000|G0000000|C0019994
"Eligible individuals will be all those admitted with a diagnosis of PFF confirmed by radiology report, aged 70 years and over and residing in the community, within existing local service boundaries.","Eligible individuals admitted diagnosis PFF confirmed radiology report, aged 70 residing community, existing local service boundaries.",C1548635|C0027361|C0184666|C0011900|G0000000|C0521093|C0034599|C0684224|C0001779|C0450371|C2982691|C0009462|C2987476|C0205276|C0557854|G0000000
"Inclusion criteria consisted of being HIV-positive ≥ 6 months, 18 to 65 years old, clean and sober from drug/alcohol abuse for ≥ 6 months, and ability to comprehend English.","Inclusion criteria consisted HIV-positive ≥ 6 months, 18 65 old, clean sober drug/alcohol abuse ≥ 6 months, ability comprehend English.",C0007637|C0243161|C0332529|C0019699|G0000000|G0000000|C0439231|C0450371|C0450371|C0580836|C1947930|C0680686|C3845889|C0013146|G0000000|G0000000|C0439231|C0085732|G0000000|C0376245
"Ethnicity breakdown for the JHCP health care centers (2005-2006) was as follows: Black 48%, White 35%, Asian 2%, Hispanic 2%, Indian 0%, Multiracial 0%, others 6%, and unknown 7%.","Ethnicity breakdown JHCP health care centers (2005-2006) follows: Black 48%, White 35%, Asian 2%, Hispanic 2%, Indian 0%, Multiracial 0%, 6%, unknown 7%.",C0015031|C0443161|G0000000|C0018684|C1947933|C0205099|G0000000|C0332283|C0005680|C0450371|C0007457|C0450371|C0078988|G0000000|C0086409|G0000000|C1524069|G0000000|C1881928|G0000000|G0000000|C0439673|G0000000
"Participants were 18-70 years old, reporting either (a) sleep latency > 30 min and sleep efficiency < 85% at least 4 nights per week, or (b) Research Diagnostic Criteria (RDC) insomnia criteria ≥ 4 nights per week.14 Phone screening confirmed a likely diagnosis of MDE with a Patient Health Questionnaire (PHQ9) score ≥ 10,15 body mass index (BMI) ≤ 35, absence of habitual snoring or daytime sleepiness, absence of significant restless leg symptoms,16 and absence of substance abuse or medical illnesses likely to interfere with sleep.","Participants 18-70 old, reporting (a) sleep latency > 30 min sleep efficiency < 85% 4 nights week, (b) Research Diagnostic Criteria (RDC) insomnia criteria ≥ 4 nights week.14 Phone screening confirmed diagnosis MDE Patient Health Questionnaire (PHQ9) score ≥ 10,15 body mass (BMI) ≤ 35, absence habitual snoring daytime sleepiness, absence restless leg symptoms,16 absence substance abuse medical illnesses interfere sleep.",C0679646|C0450371|C0580836|C0700287|G0000000|C0037313|C0205275|G0000000|C0450371|C0702093|C0037313|C0013682|G0000000|C0450371|G0000000|C0240526|C0332174|G0000000|C0035168|C0011900|C0243161|C0207800|C0917801|C0243161|G0000000|G0000000|C0240526|C0332174|C1515258|C0220908|C0521093|C0011900|G0000000|C0030705|C0018684|C0034394|G0000000|C0449820|G0000000|C0450371|C0242821|C0577559|G0000000|G0000000|C0450371|C0332197|C0205353|C0037384|C0332169|C0013144|C0332197|C0085631|C0023216|C0683368|C0332197|C0439861|C0013146|C0199168|C0221423|C0521102|C0037313
No side effects due to ultrasound treatment were reported.,No effects ultrasound treatment reported.,G0000000|C1280500|C0041618|C0039798|C0684224
"Inclusion criteria were ages 4–12 years, diagnosis of CF by sweat test, pancreatic insufficient, and ≤40th percentile weight for age and sex or weight for height at the time of the chart review.","Inclusion criteria ages 4–12 years, diagnosis CF sweat test, pancreatic insufficient, ≤40th percentile weight age sex weight height time chart review.",C0007637|C0243161|C0001779|G0000000|C0439234|C0011900|C0009738|C0038984|C0022885|C0030274|C0205412|G0000000|C1264641|C0005910|C0001779|C0009253|C0005910|C0489786|C0040223|C0007963|C0282443
This randomized controlled pilot trial prospectively enrolled 107 patients with knee OA with vitamin D insufficiency (25(OH)D ≤ 50 nmol/L) to receive oral vitamin D or placebo.,This randomized controlled pilot trial prospectively enrolled 107 patients knee OA vitamin D insufficiency (25(OH)D ≤ 50 nmol/L) receive oral vitamin D placebo.,G0000000|C0034656|C2587213|C0473169|C0008976|G0000000|G0000000|C1442061|C0030705|C0022742|C0029408|C0042890|C0073187|C0231179|C0450371|G0000000|C0450371|C0439282|C1514756|C0442027|C0042890|C0073187|C0032042
Randomised controlled trial.,Randomised controlled trial.,G0000000|C2587213|C0008976
"Patients with multiple fractures (n = 3), type II or III open fractures (n = 2), pathological fractures (n = 1), neuromuscular disease (n = 1), or incomplete clinical or radiographic data (n = 4) were excluded.","Patients multiple fractures (n = 3), type II III fractures (n = 2), pathological fractures (n = 1), neuromuscular disease (n = 1), incomplete clinical radiographic data (n = 4) excluded.",C0030705|C0439064|C0016658|G0000000|C0332307|G0000000|C0439070|C0016658|G0000000|C0030664|C0016658|G0000000|C1979768|C0012634|G0000000|C0205257|C0205210|C0444708|C1511726|G0000000|C1554077
Participants 579 patients with chronic or recurrent low back pain recruited from primary care.,Participants 579 patients chronic recurrent low pain recruited primary care.,C0679646|C1442061|C0030705|C0205191|C2945760|C0205251|C0030193|G0000000|C0205225|C1947933
"The primary efficacy endpoint was the mean pain score at final assessment as recorded by patients in their daily pain diaries over the past seven days, measured using an 11-point (0 (no pain) to 10 (worst possible pain)) numeric rating of the amount of pain over the past 24 hours [17,18].","The primary efficacy endpoint pain score final assessment recorded patients daily pain diaries days, measured 11-point (0 (no pain) 10 (worst pain)) numeric rating amount pain 24 hours [17,18].",G0000000|C0205225|C1280519|C2349179|C0030193|C0449820|C0205088|C1261322|C0034869|C0030705|C0332173|C0030193|C0376660|C0439228|C0444706|C0450371|G0000000|G0000000|C0030193|C0450371|C1522166|C0030193|C0237753|C0871208|C1265611|C0030193|C0450371|C0439227|C0450371
Subjects were required to have radiographic evidence of a new pulmonary infiltrate or consolidation that could not be attributed to a process other than pneumonia.,Subjects required radiographic evidence pulmonary infiltrate consolidation attributed process pneumonia.,C0681850|C1514873|C0444708|C3887511|C0024109|C0332448|C0702116|C0449234|C1184743|C0032285
"The application of newer, targeted radiation techniques is able to decrease post-treatment xerostomia compared with conventional radiation but does not eliminate the problem.30–32 Available therapies for xerostomia have modest efficacy and adverse effects33–35; preliminary data suggest that acupuncture may alleviate these symptoms.36–38 The primary objective of the study was to determine whether acupuncture reduces pain or dysfunction in patients with cancer with a history of neck dissection.","The application newer, targeted radiation techniques decrease post-treatment xerostomia compared conventional radiation eliminate problem.30–32 Available therapies xerostomia modest efficacy adverse effects33–35; preliminary data acupuncture alleviate symptoms.36–38 The primary objective study determine acupuncture reduces pain dysfunction patients cancer history neck dissection.",G0000000|C0185125|C0205314|C1521840|C0034519|C0025664|C0392756|C2709088|C0043352|C1707455|C0439858|C0034519|G0000000|G0000000|C0470187|C0087111|C0043352|C4054480|C1280519|G0000000|G0000000|C0439611|C1511726|C0001299|G0000000|G0000000|G0000000|C0205225|C0018017|C0557651|G0000000|C0001299|G0000000|C0030193|C0031847|C0030705|C0006826|C0019664|C0027530|C0012737
"We recruited residents within 12 nursing homes, four each in London, Newcastle, and Oxford.","We recruited residents 12 nursing homes, London, Newcastle, Oxford.",G0000000|G0000000|C1320928|C0450371|C0006147|C0442519|C0023973|G0000000|G0000000
There were no group differences in male condom use.,There differences male condom use.,G0000000|C1705241|C0086582|C0009653|C0042153
"Determined by a power analysis, 252 molars of 152 children were recruited.","Determined power analysis, 252 molars 152 children recruited.",G0000000|C0032863|C0002778|C1442061|C0026367|C1442061|C0008059|G0000000
"Children 3–10 years of age (N = 530) with physician-confirmed persistent asthma at the time of screening (per expert criteria at SBAT initiation [40]) attending preschool or elementary school in Rochester, NY were enrolled over 3 years (2006–09).","Children 3–10 age (N = 530) physician-confirmed persistent asthma time screening (per expert criteria SBAT initiation [40]) attending preschool elementary school Rochester, NY enrolled 3 (2006–09).",C0008059|G0000000|C0001779|G0000000|C0031831|C0205322|C0004096|C0040223|C0220908|G0000000|G0000000|C0243161|G0000000|C0589507|C0450371|C1547429|C0424930|C0013879|C0036375|G0000000|C0027976|G0000000|G0000000|G0000000
"Inclusion: To be eligible, patients must (1) have a histologically confirmed diagnosis of colon or rectal cancer, (2) have stage I–III disease, (3) have completed treatment with curative intent with surgery with or without radiation with or without chemotherapy within 2 months, (4) be over 18 years of age, (5) be able to understand English, and (6) have a PCP who is willing to participate in the study.","Inclusion: To eligible, patients (1) histologically confirmed diagnosis colon rectal cancer, (2) stage I–III disease, (3) completed treatment curative intent surgery radiation chemotherapy 2 months, (4) 18 age, (5) understand English, (6) PCP participate study.",C0007637|C0040363|C1548635|C0030705|G0000000|C0205462|C0521093|C0011900|C0009368|C0205052|C0006826|G0000000|C0205390|G0000000|C0012634|G0000000|C0205197|C0039798|C1880198|C0162425|C0038894|C0034519|C0013216|G0000000|C0439231|G0000000|C0450371|C0001779|G0000000|C0162340|C0376245|G0000000|C1535939|G0000000|C0557651
Subjects were screened by telephone with Inclusion criteria of 1) diagnosis of fibromyalgia by a physician and 2) history of cervical or lumbar pain.,Subjects screened telephone Inclusion criteria 1) diagnosis fibromyalgia physician 2) history cervical lumbar pain.,C0681850|C0220908|C0039457|C0007637|C0243161|G0000000|C0011900|C0016053|C0031831|G0000000|C0019664|C0027530|C0024090|C0030193
A history of epilepsy was reported by 48 women who no longer took antiepileptic drugs.,A history epilepsy reported 48 women antiepileptic drugs.,G0000000|C0019664|C0014544|C0684224|C0450371|C0043210|C0003299|C0013227
We conducted a pilot randomized controlled trial to determine the feasibility and initial safety and efficacy of omega-3 fatty acids (1.3 g/day) for the treatment of hyperactivity in 27 children ages 3–8 with autism spectrum disorder (ASD).,We conducted pilot randomized controlled trial determine feasibility initial safety efficacy omega-3 fatty acids (1.3 g/day) treatment hyperactivity 27 children ages 3–8 autism spectrum disorder (ASD).,G0000000|C0004927|C0473169|C0034656|C2587213|C0008976|G0000000|G0000000|C0205265|C0036043|C1280519|C1719844|G0000000|C0001128|G0000000|C0439417|C0039798|C0424295|C0450371|C0008059|C0001779|G0000000|C0004352|C1883073|C0012634|C0003516
Specialized nurses successfully completed at least an additional 1-year training in care of breast cancer (oncology) patients [32–34].,Specialized nurses completed additional 1-year training care breast cancer (oncology) patients [32–34].,C0205555|C0028661|C0205197|C1524062|C0439234|C0040607|C1947933|C0006141|C0006826|C0027651|C0030705|G0000000
"At the beginning, 16,811 women were recruited as the intervention group and 7260 women were recruited as the control group.","At beginning, 16,811 women recruited intervention 7260 women recruited control group.",G0000000|C0439659|C0450371|C0043210|G0000000|C0886296|G0000000|C0043210|G0000000|C0243148|C0441833
"The study population is comprised of care providing personnel in the experimental and control hospitals, both of which offer general and specialised short term care.","The study population comprised care providing personnel experimental control hospitals, offer specialised short term care.",G0000000|C0557651|C0032659|C2700400|C1947933|C1999230|C0024752|C1517586|C0243148|C0019994|G0000000|C0205555|C1282927|C0233324|C1947933
"The exclusion criteria will be not interested to continue participation in the study, take weight control medication, any disease or condition required special medical care or hospitalization and multifetal pregnancies.","The exclusion criteria continue participation study, weight control medication, disease condition required special medical care hospitalization multifetal pregnancies.",G0000000|C0680251|C0243161|C0549178|C0679823|C0557651|C0005910|C0243148|C0013227|C0012634|C0012634|C1514873|C0205555|C0199168|C1947933|C0019993|G0000000|C0032961
"Inclusion criteria were as follows: 1) The presence of pain /paresthesia in the distribution of the median nerve, 2) A positive clinical provocative tests for CTS (Tinel, Phalen), 3) The electrophysiological evidence of mild or moderate median nerve lesion at wrist (mild: sensory nerve latency >3.5 ms at third digit, moderate: sensory nerve latency >3.5 ms at third digit and median motor latency>4.2 ms).","Inclusion criteria follows: 1) The presence pain /paresthesia distribution median nerve, 2) A positive clinical provocative tests CTS (Tinel, Phalen), 3) The electrophysiological evidence mild moderate median nerve lesion wrist (mild: sensory nerve latency >3.5 ms digit, moderate: sensory nerve latency >3.5 ms digit median motor latency>4.2 ms).",C0007637|C0243161|C0332283|G0000000|G0000000|C0150312|C0030193|C0030554|C0520511|C0549183|C0027740|G0000000|G0000000|C0439178|C0205210|C0449428|C0022885|C0007286|G0000000|G0000000|G0000000|G0000000|C0013865|C3887511|C2945599|C0205081|C0549183|C0027740|C0221198|C0043262|C2945599|C0445254|C0027740|C0205275|G0000000|C0039676|C0582802|C0205081|C0445254|C0027740|C0205275|G0000000|C0039676|C0582802|C0549183|C1513492|C0205275|C0039676
"The criteria include first-time referrals, clear-cut signs or symptoms of cervical or lumbar neural compromise, and no obvious underlying disease that might require spinal fixation (e.g.","The criteria first-time referrals, clear-cut signs symptoms cervical lumbar neural compromise, obvious underlying disease require spinal fixation (e.g.",G0000000|C0243161|C0205435|C0034927|C1709157|C0220912|C0683368|C0027530|C0024090|C3714606|C2945640|G0000000|G0000000|C0012634|G0000000|C0521329|C0185023|G0000000
The primary outcome is the number of general practitioner referrals of young people with first episode psychosis to Early Intervention Services.,The primary outcome practitioner referrals people episode psychosis Early Intervention Services.,G0000000|C0205225|C1274040|C1709627|C0034927|C0027361|C0332189|C0033975|C1279919|C0886296|C0557854
"The inclusion criteria were (1) a diagnosis of COPD and being clinically stable for at least 1 month; (2) spirometry results showing at least mild obstructive disease defined as post-bronchodilator forced expiratory volume in 1 s (FEV1) to forced vital capacity (FVC) ratio < 0.70 with FEV1 < 80% predicted, or FEV1/FVC < 0.60 with FEV1 > 80% predicted; (3) ADL limited by dyspnea; (4) use of the Internet and/or checking email at least once per week with a Windows operating system; (5) oxygen saturation > 85% on room air or ≤ 6 L/min of nasal oxygen at the end of a 6-minute walk test.","The inclusion criteria (1) diagnosis COPD clinically stable 1 month; (2) spirometry mild obstructive disease defined post-bronchodilator forced expiratory volume 1 (FEV1) forced vital capacity (FVC) ratio < 0.70 FEV1 < 80% predicted, FEV1/FVC < 0.60 FEV1 > 80% predicted; (3) ADL limited dyspnea; (4) Internet and/or checking email week Windows operating system; (5) oxygen saturation > 85% air ≤ 6 L/min nasal oxygen 6-minute walk test.",G0000000|C0007637|C0243161|G0000000|C0011900|C0024117|G0000000|C0205360|G0000000|C0332177|G0000000|C0037981|C2945599|C0549186|C0012634|C1704788|C2599594|C0441722|C0231800|C0449468|G0000000|G0000000|C0441722|C0442732|C1516240|C3714541|C0456603|G0000000|C0450371|G0000000|G0000000|C0450371|C0681842|C3714541|G0000000|C0450371|G0000000|G0000000|C0450371|C0681842|G0000000|C0001288|C0439801|C0013404|G0000000|C0282111|G0000000|C1283174|C0013849|C0332174|C0557702|C3242339|C0449913|G0000000|C0030054|C0522534|G0000000|C0450371|C0001861|G0000000|G0000000|C0439393|C0028429|C0030054|C0439232|C0080331|C0022885
Inclusion criteria for study participation are (1) daily or occasional cigarette smoking (at least 4 cigarettes in the preceding month and at least one cigarette during the preceding week) and (2) ownership of a mobile phone.,Inclusion criteria study participation (1) daily occasional cigarette smoking (at 4 cigarettes preceding month cigarette preceding week) (2) ownership mobile phone.,C0007637|C0243161|C0557651|C0679823|G0000000|C0332173|C0521114|C0677453|C0037369|G0000000|G0000000|C0677453|C0332152|C0332177|C0677453|C0332152|C0332174|G0000000|C0029981|C0231435|C1515258
"Participants were excluded if they were unable to understand English, aged less than 40 years (to avoid overlap in diagnoses with late onset asthma), had respiratory failure or were too unwell to participate, had signs of confusion or dementia (abbreviated mental state score < 8/10 and/or mini-mental status examination score < 25/30), or diagnosis of a pre-existing psychiatric disorder.","Participants excluded unable understand English, aged 40 (to avoid overlap diagnoses late onset asthma), respiratory failure unwell participate, signs confusion dementia (abbreviated mental score < 8/10 and/or mini-mental status examination score < 25/30), diagnosis pre-existing psychiatric disorder.",C0679646|C1554077|C1299582|C0162340|C0376245|C0001779|C0450371|G0000000|G0000000|C0185027|C0011900|C0205087|C0206132|C0004096|C0521346|C0231174|C0683320|G0000000|C0220912|C0009676|C0011265|G0000000|C0229992|C0449820|G0000000|C0450371|G0000000|C0445542|C0449438|G0000000|C0449820|G0000000|C0450371|C0011900|C2347662|C0205487|C0012634
"Free-standing, not-for-profit, comprehensive rehabilitation center specializing in SCI rehabilitation Forty adults ages 18 years and older undergoing acute rehabilitation following spinal cord injury reporting any type of pain.","Free-standing, not-for-profit, comprehensive rehabilitation center specializing SCI rehabilitation Forty adults ages 18 undergoing acute rehabilitation spinal cord injury reporting type pain.",C0332296|C3841601|C1880156|C0034991|C0205099|C0205555|C3642273|C0034991|C3816449|C0001675|C0001779|C0450371|G0000000|C0205178|C0034991|C0521329|C1550235|C3263722|C0700287|C0332307|C0030193
"Twenty-one subjects completed the study (12 subjects in the BWSTT group, 9 control subjects- see Table 1).","Twenty-one subjects completed study (12 subjects BWSTT group, 9 control subjects- Table 1).",C3715213|C0681850|C0205197|C0557651|C0450371|C0681850|G0000000|C0441833|G0000000|C0243148|C0681850|C0039224|G0000000
(i) Inclusion Criteria: Only mothers or guardians who are permanent residents (resident in the area >6 months) and currently having children of <5 yrs of age living with them were included in the study.,(i) Inclusion Criteria: Only mothers guardians permanent residents (resident >6 months) children <5 yrs age living included study.,C0021966|C0007637|C0243161|C0205171|C0026591|C1274041|C0205355|C1320928|C1320928|G0000000|C0008059|G0000000|C0001779|C0376558|C0332257|C0557651
"Inclusion criteria were age 18–55 years, biopsy confirmed (within the past year) IgAN of Lee's grade II–IV, proteinuria of 0.5–3.5 g/d, serum creatinine <265 μmol/L, and blood pressure between 90/60 and 130/80 mmHg with or without antihypertensive treatments.","Inclusion criteria age 18–55 years, biopsy confirmed (within year) IgAN Lee's grade II–IV, proteinuria 0.5–3.5 g/d, serum creatinine <265 μmol/L, blood pressure 90/60 130/80 mmHg antihypertensive treatments.",C0007637|C0243161|C0001779|G0000000|C0439234|C0005558|C0521093|G0000000|C0439234|C3160719|G0000000|C0441800|G0000000|C0033687|G0000000|C0439417|C0229671|C0010294|C1442061|G0000000|C0005767|C0033095|C0450371|C1442061|C0439475|C0003364|C0087111
"To be included, participants had to be: a) at least 18 years of age, b) smoking at least 10 cigarettes per day for at least one year; c) in a heterosexual marriage or cohabiting romantic relationship for more than one year; and, d) willing to use and have no contraindications for transdermal nicotine patch (TNP).","To included, participants be: a) 18 age, b) smoking 10 cigarettes day year; c) heterosexual marriage cohabiting romantic relationship year; and, d) contraindications transdermal nicotine patch (TNP).",C0040363|C0332257|C0679646|G0000000|G0000000|C0450371|C0001779|G0000000|C0037369|C0450371|C0677453|C0332173|C0439234|G0000000|C0019421|C0024841|C0221179|C0683275|C0439849|C0439234|G0000000|C0073187|C0079164|C0040652|C0028040|C0332461|G0000000
"Eligibility criteria included type 1 diabetes preceding pregnancy, a singleton pregnancy, and being aged ≥16 years (19).","Eligibility criteria included type 1 diabetes preceding pregnancy, singleton pregnancy, aged ≥16 (19).",C0013893|C0243161|C0332257|C0332307|G0000000|C0011847|C0332152|C0032961|C0481462|C0032961|C0001779|G0000000|C0450371
"A history of stool incontinence, perianal fistulae, major colonic surgery, colorectal carcinoma, or stenoses too, led to exclusion just as other severe accompanying diseases.","A history stool incontinence, perianal fistulae, major colonic surgery, colorectal carcinoma, stenoses too, led exclusion severe accompanying diseases.",G0000000|C0019664|C0015733|C0021167|C0442158|C0016169|C0205082|C0009368|C0038894|C0555952|C0007097|C1261287|G0000000|C1708698|C0680251|C0205082|G0000000|C0012634
"On the other hand, subjects were excluded if they had participated in another clinical research during the past 3 months, had an experience or knowledge of reflexology, were pregnant or lactating, used other methods of complementary therapy during the study, or had a vascular disease, thrombophlebitis or diseases such as urinary tract infection or kidney stones (with pain in the lower back).","On hand, subjects excluded participated clinical 3 months, experience knowledge reflexology, pregnant lactating, methods complementary therapy study, vascular disease, thrombophlebitis diseases urinary tract infection kidney stones (with pain lower back).",G0000000|C0018563|C0681850|C1554077|G0000000|C0205210|G0000000|C0439231|C0237607|C0376554|C0034945|C0549206|C2828358|C0025663|G0000000|C0039798|C0557651|C0005847|C0012634|C0040046|C0012634|C0042027|C1185740|C0009450|C0022646|C0006736|G0000000|C0030193|C0441994|C0004600
Malarial parasitemia and malaria-like symptoms were assessed in participants older than four years of age while skin prick test (SPT) to allergens as well as reported symptoms of allergy in children aged 5–15 years.,Malarial parasitemia malaria-like symptoms assessed participants age skin prick test (SPT) allergens reported symptoms allergy children aged 5–15 years.,C0024530|C0242723|C0024530|C0683368|C1516048|C0679646|C0001779|C0444099|C0033119|C0022885|G0000000|C0002092|C0684224|C0683368|C0002111|C0008059|C0001779|G0000000|C0439234
Surgical resection of the infected lobe or lung was carried out in eight (10.2%) patients.,Surgical resection infected lobe lung carried (10.2%) patients.,C0543467|C0015252|C0439663|C0796494|C0024109|C0206243|C0450371|C0030705
"A pragmatic cluster-randomized, cross-over study of 9,340 patients admitted to five adult intensive care units of a tertiary medical center in Nashville, Tennessee Units performed once-daily bathing of all patients with disposable cloths impregnated with 2% chlorhexidine or non-antimicrobial cloths as a control.","A pragmatic cluster-randomized, cross-over study 9,340 patients admitted adult intensive care units tertiary medical center Nashville, Tennessee Units performed once-daily bathing patients disposable cloths impregnated 2% chlorhexidine non-antimicrobial cloths control.",G0000000|C0871858|C1555715|C0010366|C0557651|C1442061|C0030705|C0184666|C0001675|C0162425|C1947933|C0439148|C0205372|C0199168|C0205099|G0000000|C0039514|C0439148|C0884358|C0332173|C0150141|C0030705|C0725865|C0039717|G0000000|G0000000|C0008196|C1518422|C0039717|C0243148
Standard treatment for locally advanced rectal cancer includes 5–6 weeks of neoadjuvant chemoradiotherapy (NACRT) followed by total mesorectal excision 6–8 weeks later.,Standard treatment locally advanced rectal cancer includes 5–6 weeks neoadjuvant chemoradiotherapy (NACRT) total mesorectal excision 6–8 weeks later.,C1442989|C0039798|C1517927|C0205179|C0205052|C0006826|C0332257|G0000000|C0439230|C0600558|C0436307|G0000000|C0439175|C1513155|C0015252|G0000000|C0439230|C0205087
"Four of the 21 eligible FMGs were enrolled and randomized either to the experimental group (FMGs = 2, FPs = 18, patients = 245) or to the control group (FMGs = 2, FPs = 15, patients = 214).","Four 21 eligible FMGs enrolled randomized experimental (FMGs = 2, FPs = 18, patients = 245) control (FMGs = 2, FPs = 15, patients = 214).",C0205450|C0450371|C1548635|G0000000|G0000000|C0034656|C1517586|G0000000|G0000000|G0000000|C0243148|G0000000|G0000000|G0000000
"In 2005–2006, more participants than projected were enrolled; however, the influenza season was protracted and of low intensity.","In 2005–2006, participants projected enrolled; however, influenza season protracted low intensity.",G0000000|G0000000|C0679646|C0016538|G0000000|G0000000|C0021400|C0036497|G0000000|C0205251|C0522510
The aim of this study was to evaluate the rationale for prescribing oxygen to patients with COPD with moderate hypoxaemia.,The aim study evaluate rationale prescribing oxygen patients COPD moderate hypoxaemia.,G0000000|C1947946|C0557651|C0220825|C0392360|C0278329|C0030054|C0030705|C0024117|C0205081|C0700292
"Participants were also required to be able to walk without human assistance prior to the fracture and were required to score ≥ 20 on the Folstein Mini Mental State Exam (Folstein, Folstein, & McHugh, 1975).","Participants required walk human assistance prior fracture required score ≥ 20 Folstein Mini Mental State Exam (Folstein, Folstein, & McHugh, 1975).",C0679646|C1514873|C0080331|C0086418|C0018896|C0332152|C0016658|C1514873|C0449820|G0000000|C0450371|G0000000|C0445542|C0229992|C1301808|C0582103|G0000000|G0000000|G0000000|G0000000|G0000000
"Patients were not permitted to take any investigational drug, non-topical beta-blockers or other asthma therapies within 4 weeks prior to enrolment and/or during the screening period, or anti-immunoglobulin E antibodies within 6 months of enrolment and/or during the screening period.","Patients permitted investigational drug, non-topical beta-blockers asthma therapies 4 weeks prior enrolment and/or screening period, anti-immunoglobulin E antibodies 6 months enrolment and/or screening period.",C0030705|C0329040|C1517586|C0013227|C1518422|C0001645|C0004096|C0087111|G0000000|C0439230|C0332152|C1516879|G0000000|C0220908|C0439531|C0003242|G0000000|C0003241|G0000000|C0439231|C1516879|G0000000|C0220908|C0439531
One CR was seen with radiotherapy alone in a stage IIIB patient.,One CR radiotherapy stage IIIB patient.,C0205447|C0201975|C0034619|C0205390|G0000000|C0030705
An increasing proportion of sphincter-saving operations is used in modern rectal cancer surgery.,An increasing proportion sphincter-saving operations modern rectal cancer surgery.,G0000000|C0442808|C1709707|C1409894|C0038895|G0000000|C0205052|C0006826|C0038894
"Effect of use (finger) versus nonuse (arm) sites and concentration of acid on antirhinoviral activity of salicylic and pyroglutamic acidc  In the first study, 85 volunteers applied either the vehicle (n = 31), 3.5% salicylic acid (n = 27), or 1% salicylic acid formulated with 3.5% pyroglutamic acid (n = 27).","Effect (finger) versus nonuse (arm) sites concentration acid antirhinoviral activity salicylic pyroglutamic acidc In study, 85 volunteers applied vehicle (n = 31), 3.5% salicylic acid (n = 27), 1% salicylic acid formulated 3.5% pyroglutamic acid (n = 27).",C1280500|C0016129|G0000000|G0000000|C0446516|C0205145|C0004268|C0001128|G0000000|C0205177|C0036079|G0000000|G0000000|G0000000|C0557651|C0450371|C0042960|C4048755|C0042444|C0369718|G0000000|C0450371|G0000000|C0036079|C0001128|C0369718|G0000000|C0450371|G0000000|C0036079|C0001128|G0000000|G0000000|G0000000|C0001128|C0369718|G0000000|C0450371
"Eligible participants were at least 18 years of age, reported smoking at least 5 cigarettes per day, had Internet access, and indicated an interest in learning about ways to stop smoking.","Eligible participants 18 age, reported smoking 5 cigarettes day, Internet access, learning smoking.",C1548635|C0679646|C0450371|C0001779|C0684224|C0037369|G0000000|C0677453|C0332173|C0282111|C0444454|C0013621|C0037369
"A total of 48 participants were randomized into the trial, 26 into the auto-bilevel group and 22 into the CPAP group.","A total 48 participants randomized trial, 26 auto-bilevel 22 CPAP group.",G0000000|C0439175|C0450371|C0679646|C0034656|C0008976|C0450371|C1441488|C0450371|C0199451|C0441833
"BNHS, Chinese herb control and Western medicine control) at Day 0, the scores were very similar at Day 28.","BNHS, Chinese herb control Western medicine control) Day 0, scores Day 28.",C1859093|C0008120|C0019240|C0243148|C1705493|C0013227|C0243148|C0332173|G0000000|C0449820|C0332173|C0450371
Twenty-three (92%) of 25 AE group participants (withdrawals unrelated to the intervention) and all BF group participants completed the program.,Twenty-three (92%) 25 AE participants (withdrawals unrelated intervention) BF participants completed program.,C0724000|C0450371|C0450371|C3887670|C0679646|C2349954|C0445356|C0886296|C0004683|C0679646|C0205197|C1709697
"The inclusion criteria for enrollment into the study was children aged 6 to 9 years attending selected schools, who were likely to remain in the same school and parents providing consent.","The inclusion criteria enrollment study children aged 6 9 attending selected schools, remain school parents providing consent.",G0000000|C0007637|C0243161|C1516879|C0557651|C0008059|C0001779|G0000000|G0000000|C1547429|C1707391|C0036375|G0000000|C0036375|C0030551|C1999230|C1511481
The primary exclusion criteria are current involvement in a structured weight loss program or a medical-risk pregnancy based on VA/DoD Management of Pregnancy Guidelines [43].,The primary exclusion criteria current involvement structured weight loss program medical-risk pregnancy based VA/DoD Management Pregnancy Guidelines [43].,G0000000|C0205225|C0680251|C0243161|C0521116|C1314939|C0678594|C0005910|C1517945|C1709697|C0199168|C0032961|C1527178|C1549054|C0001554|C0032961|C0162791|C0450371
"SPS3 is a randomised, multicentre clinical trial, sponsored by the US NINDS/NIH, being conducted in clinical centres throughout North America, Latin America, and Spain.","SPS3 randomised, multicentre clinical trial, sponsored US NINDS/NIH, conducted clinical centres North America, Latin America, Spain.",G0000000|G0000000|C0439743|C0205210|C0008976|C1711305|G0000000|C2350584|C0004927|C0205210|C0205099|C1709269|C0002454|G0000000|C0002454|C0037747
"Exclusion criteria were high reported intake of DHA foods (i.e., more than one fish meal per week or use of any supplements that contain DHA), concurrent inflammatory, vascular, or metabolic disease, including diabetes, polycystic ovary disease, collagen vascular disease, inflammatory bowel disease, or infection, and any plans to leave the area.","Exclusion criteria reported intake DHA foods (i.e., fish meal week supplements DHA), concurrent inflammatory, vascular, metabolic disease, including diabetes, polycystic ovary disease, collagen vascular disease, inflammatory bowel disease, infection, plans leave area.",C0680251|C0243161|C0684224|C1512806|C0142831|C0016452|C0683454|C0016163|C1998602|C0332174|C0242295|C0142831|C0205420|C0333348|C0005847|C0311400|C0012634|C0332257|C0011847|C3273362|C0029939|C0012634|C0009325|C0005847|C0012634|C0333348|C0021853|C0012634|C0009450|C0270724|G0000000|C0017446
"The initial onset of INS is at between 1 and 18 years of age, and the patient is 2 years of age or older at assignment.","The initial onset INS 1 18 age, patient 2 age assignment.",G0000000|C0205265|C0206132|G0000000|G0000000|C0450371|C0001779|C0030705|G0000000|C0001779|C1516050
"Patients had to have all of Epworth Sleepiness Score10≥ 10 or history of troublesome sleepiness when driving AHI ≥ 15 on polysomnograph with Profusion PSG2 (Compumedics, Australia) or ≥ 25 apneas + hypopneas/h in bed11 on a limited sleep study using Hypno PTT (Tyco Healthcare, Gosport, Hampshire).","Patients Epworth Sleepiness Score10≥ 10 history troublesome sleepiness driving AHI ≥ 15 polysomnograph Profusion PSG2 (Compumedics, Australia) ≥ 25 apneas + hypopneas/h bed11 limited sleep study Hypno PTT (Tyco Healthcare, Gosport, Hampshire).",C0030705|G0000000|C0013144|G0000000|C0450371|C0019664|G0000000|C0013144|C0004379|G0000000|G0000000|C0450371|C0182339|G0000000|G0000000|G0000000|C0004340|G0000000|C0450371|C0003578|G0000000|C0235546|G0000000|C0439801|C0037313|C0557651|C1458438|C0030605|G0000000|C0086388|G0000000|C0324247
Characteristics of patients with non specific chronic low back pain before treatment in continuous ultrasound and placebo ultrasound groups * Ultrasound.,Characteristics patients specific chronic low pain treatment continuous ultrasound placebo ultrasound * Ultrasound.,C1521970|C0030705|C0205369|C0205191|C0205251|C0030193|C0039798|C0549178|C0041618|C0032042|C0041618|G0000000|C0041618
Demographic characteristics were generally similar between the vaccine and placebo groups (Table (Table1)1) and between participants from Senegal and Tanzania (data not shown).,Demographic characteristics vaccine placebo (Table (Table1)1) participants Senegal Tanzania (data shown).,C0011298|C1521970|C0042210|C0032042|C0039224|G0000000|C0679646|C0036644|C0039298|C1511726|C1547282
"Groups were similar in demographic and disease characteristics, disease-modifying therapy, pretreatment cognition, and emotional symptomatology (table 1).","Groups demographic disease characteristics, disease-modifying therapy, pretreatment cognition, emotional symptomatology (table 1).",C0441833|C0011298|C0012634|C1521970|C0012634|C0039798|C1550147|C0009240|C0013987|G0000000|C0039224|G0000000
From here only children not excluded from the analysis are described.,From children excluded analysis described.,G0000000|C0008059|C1554077|C0002778|C1552738
Sixty seven infants in each group completed eight weeks of the study.,Sixty infants completed weeks study.,C3816724|C0021270|C0205197|C0439230|C0557651
"Demographic and anamnestic patient data (n = 36) Inclusion criteria were the following: Chronic low-back pain (symptoms duration: >6 months, mean: 13 ± 6 months) due to disc prolapse, lumbar spondylosis, and/or spinal stenosis; Minimum VAS at recruitment: >40 mm Age: >18 years, <75 years; Informed consent.","Demographic anamnestic patient data (n = 36) Inclusion criteria following: Chronic low-back pain (symptoms duration: >6 months, mean: 13 ± 6 months) disc prolapse, lumbar spondylosis, and/or spinal stenosis; Minimum VAS recruitment: >40 mm Age: >18 years, <75 years; Informed consent.",C0011298|G0000000|C0030705|C1511726|C0369718|G0000000|C0450371|C0007637|C0243161|C0231290|C0205191|C0205251|C0030193|C0683368|C0449238|G0000000|C0439231|C0444504|C0450371|G0000000|G0000000|C0439231|C0180459|C0033377|C0024090|C0038019|G0000000|C0521329|C0678234|C1524031|C0042815|C2949735|C0450371|G0000000|C0001779|C0450371|C0439234|C0450371|C0439234|C1522154|C1511481
"• Active movement of the shoulder, elbow, wrist, digits and thumb of the affected upper limb, such that the: • child is able to reach forward to an elevated position in front with mid range shoulder flexion.","• Active movement shoulder, elbow, wrist, digits thumb upper limb, the: • child reach forward elevated position front mid range shoulder flexion.",G0000000|C0205177|C0026649|C0037004|C0013769|C0043262|C0582802|C0040067|C1282910|C0015385|G0000000|G0000000|C0008059|C2584321|C0439780|C0205250|C0733755|C0205094|C0444598|C1514721|C0037004|C0231452
Management of thromboembolism was at the discretion of the treating physician.,Management thromboembolism discretion treating physician.,C0001554|C0040038|G0000000|C1522326|C0031831
Two hundred and one children were randomised at admission to either an intervention group (n = 96) which received the teaching programme or a control group (n = 105).,Two children randomised admission intervention (n = 96) received teaching programme control (n = 105).,C0205448|C0008059|G0000000|C0184666|C0886296|C0369718|G0000000|C0450371|C1514756|C0039401|C1709697|C0243148|C0369718|G0000000|C1442061
Preterm infants are highly sensitive to early gut dysbiosis.,Preterm infants highly sensitive gut dysbiosis.,C0151526|C0021270|C0205250|C0020517|C0017189|C3658208
"Exclusion criteria included major uncontrolled medical or psychiatric conditions; prior CPAP or bilevel use; chronic respiratory failure or insufficiency; surgery on the upper airway, nose, sinus, or middle ear within 90 days of participation; the presence of any untreated and diagnosable non-OSA sleep disorder (e.g., restless legs syndrome, insomnia); current shift workers; known history of alcohol or drug abuse within the past 3 years; chronic nightly hypnotic use for < 3 months; and periodic limb movement (PLM) arousal index ≥ 10/h.","Exclusion criteria included major uncontrolled medical psychiatric conditions; prior CPAP bilevel use; chronic respiratory failure insufficiency; surgery upper airway, nose, sinus, middle ear 90 days participation; presence untreated diagnosable non-OSA sleep disorder (e.g., restless legs syndrome, insomnia); current shift workers; history alcohol drug abuse 3 years; chronic nightly hypnotic < 3 months; periodic limb movement (PLM) arousal ≥ 10/h.",C0680251|C0243161|C0332257|C0205082|C0205318|C0199168|C0205487|C0012634|C0332152|C0199451|G0000000|C0042153|C0205191|C0521346|C0231174|C0231179|C0038894|C1282910|C0178987|C0028429|C0016169|C0444598|C0013443|C0450371|C0439228|C0679823|C0150312|C0332155|G0000000|C1518422|C0037313|C0012634|G0000000|C0085631|C1140621|C0039082|C0917801|C0521116|C0333051|C0024752|C0019664|C0001962|C0013227|C0013146|G0000000|C0439234|C0205191|G0000000|C0020591|G0000000|G0000000|C0439231|C0332182|C0015385|C0026649|C1414874|C0003808|G0000000|C0450371
"Major exclusion criteria were: women of childbearing potential, a creatinine level greater than 176.8 μmol/L (2.0 mg/dL), platelet count less than 100,000/μL, abnormal liver function studies, blood pressure greater than 160/100 mm Hg, past intolerance to the chelation or vitamin components, chelation therapy within 5 years, or revascularization within 6 months.","Major exclusion criteria were: women childbearing potential, creatinine level 176.8 μmol/L (2.0 mg/dL), platelet count 100,000/μL, abnormal liver function studies, blood pressure 160/100 mm Hg, intolerance chelation vitamin components, chelation therapy 5 years, revascularization 6 months.",C0205082|C0680251|C0243161|G0000000|C0043210|G0000000|C3245505|C0010294|C0441889|C1442061|G0000000|G0000000|C0439269|C0005821|C0750480|G0000000|C0205161|C0023884|C0031843|C0947630|C0005767|C0033095|C1442061|G0000000|C0025424|C0231199|C3537131|C0042890|C0449432|C3537131|C0039798|G0000000|C0439234|C0581603|G0000000|C0439231
"We excluded women who were less than 5 years after their menopause, weighed more than 130% of ideal body weight, had other contraindications to participating in an exercise program, were already doing moderate or hard exercise for more than 8 hours per week or were planning to be absent from the city for more than 4 weeks during the 20-week trial.","We excluded women 5 menopause, weighed 130% ideal body weight, contraindications participating exercise program, moderate hard exercise 8 hours week planning absent city 4 weeks 20-week trial.",G0000000|C1554077|C0043210|G0000000|C0025320|G0000000|C1442061|C1512612|C0242821|C0005910|C0079164|C0679823|C0015259|C1709697|C0205081|C0018599|C0015259|G0000000|C0439227|C0332174|C0032074|C0332197|C0008848|G0000000|C0439230|C0450371|C0008976
"Patients were excluded if they were younger than 18 years-old, were pregnant, needed deep levels of sedation (intracranial hypertension, status epilepticus, hypothermia after cardiac arrest, severe asthma exacerbations, and severe hypoxemic respiratory failure (PaO2/FiO2 ratio < 50), were not expected to survive for more than six months (for example, metastatic cancer, NY functional class IV heart failure, Child C hepatic cirrhosis, oxygen-dependent chronic obstructive pulmonary disease), were previously cognitive impaired (for example, advanced dementia), or were readmitted to the ICU after participating in the trial.","Patients excluded 18 years-old, pregnant, deep levels sedation (intracranial hypertension, status epilepticus, hypothermia cardiac arrest, severe asthma exacerbations, severe hypoxemic respiratory failure (PaO2/FiO2 ratio < 50), expected survive months (for example, metastatic cancer, NY functional class IV heart failure, Child C hepatic cirrhosis, oxygen-dependent chronic obstructive pulmonary disease), cognitive impaired (for example, advanced dementia), readmitted ICU participating trial.",C0030705|C1554077|C0450371|C0439234|C0549206|C0205125|C0441889|C0235195|C0524466|C0020538|C0449438|G0000000|C0020672|C0018787|C0237477|C0205082|C0004096|G0000000|C0205082|G0000000|C0521346|C0231174|C1427155|G0000000|C1517001|C0310255|C0439231|G0000000|C1707959|C0036525|C0006826|C0027976|C0205245|C0456387|C0022326|C0018787|C0231174|C0008059|G0000000|C0205054|C0023890|C0030054|C0205191|C0549186|C0024109|C0012634|C1516691|C0221099|G0000000|C1707959|C0205179|C0011265|G0000000|C0021708|C0679823|C0008976
"(Confidence level = 95%, test power = 80%) Women were eligible for enrollment if they were nulliparous and had the following features, 39 to 41 weeks of gestational age confirmed by first-trimester ultrasound or normal last menstrual period, normal non-stress test, age of 18 - 35 years old, low risk pregnancy, Bishop score of ≤ 4, single cephalic presentation, not taking herbal or chemical drugs 36 hours before and up to the end of the study, and not having sexual intercourse 24 hours before and up to the end of study.","(Confidence level = 95%, test power = 80%) Women eligible enrollment nulliparous features, 39 41 weeks gestational age confirmed first-trimester ultrasound normal menstrual period, normal non-stress test, age 18 - 35 old, low risk pregnancy, Bishop score ≤ 4, single cephalic presentation, herbal chemical drugs 36 hours study, sexual intercourse 24 hours study.",C0237529|C0441889|G0000000|C0450371|C0022885|C0032863|G0000000|C0450371|C0043210|C1548635|C1516879|C0425979|C1521970|C0450371|C0450371|C0439230|C0439671|C0001779|C0521093|C0032979|C0041618|C0205307|C0025344|C0439531|C0205307|C1518422|C0022885|C0001779|C0450371|G0000000|C0450371|C0580836|C0205251|C0035647|C0032961|C1551458|C0449820|G0000000|G0000000|C0037179|C0205096|C0449450|C3146288|C0220806|C0013227|C0450371|C0439227|C0557651|C0036864|C0009253|C0450371|C0439227|C0557651
"The wait-list control participants were reassessed by study personnel 3 months after randomization, and were then offered the intervention if they still met eligibility criteria (i.e., were not in current ongoing psychotherapy, or had a change in psychotropic medication in the last 6 months).","The wait-list control participants reassessed study personnel 3 months randomization, offered intervention met eligibility criteria (i.e., current ongoing psychotherapy, change psychotropic medication 6 months).",G0000000|C0043010|C0243148|C0679646|G0000000|C0557651|C0024752|G0000000|C0439231|C0034656|C1444648|C0886296|C0268621|C0013893|C0243161|C0683454|C0521116|C0549178|C0033968|C0392747|C0033978|C0013227|G0000000|C0439231
"Additionally, they had to have had at least 3 years of heavy use (smoke 5 out of 7 days per week or greater than 25 times per month) and have experienced 2 or more negative symptoms in previous quit attempts.","Additionally, 3 heavy (smoke 5 7 days week 25 times month) experienced 2 negative symptoms previous quit attempts.",G0000000|G0000000|C0439539|C0037366|G0000000|G0000000|C0439228|C0332174|C0450371|C0040223|C0332177|C0237607|G0000000|C0205160|C0683368|C0205156|C0748223|C1516084
"400 children, aged (median (25th–75th centile)) 12 (6–25) months, were enrolled.","400 children, aged (median (25th–75th centile)) 12 (6–25) months, enrolled.",C1442061|C0008059|C0001779|C0549183|G0000000|G0000000|C0450371|G0000000|G0000000
"In the study, 252 children were randomised to the magnesium group and 256 to the placebo group.","In study, 252 children randomised magnesium 256 placebo group.",G0000000|C0557651|C1442061|C0008059|G0000000|C0024467|C1442061|C0032042|C0441833
"Eligibility criteria for participation were a viable fetus, gestational age less than 14 weeks by ultrasound examination, no severe illness and written consent.","Eligibility criteria participation viable fetus, gestational age 14 weeks ultrasound examination, severe illness written consent.",C0013893|C0243161|C0679823|C0443348|C0015965|C0439671|C0001779|C0450371|C0439230|C0041618|G0000000|C0205082|C0221423|C0043266|C1511481
Conclusions: Hypoxaemia is an under recognised complication of non-ALRI illnesses in children and in sick neonates in developing countries.,Conclusions: Hypoxaemia recognised complication non-ALRI illnesses children sick neonates developing countries.,C1707478|C0700292|G0000000|C0009566|C1518422|C0221423|C0008059|C0221423|C0021289|G0000000|C0454664
Patients were deemed eligible for the study if they were aged 17–70 years and on the practice asthma list.,Patients deemed eligible study aged 17–70 practice asthma list.,C0030705|G0000000|C1548635|C0557651|C0001779|G0000000|C0237607|C0004096|C0745732
"KPS ≥ 60 points; No other disease interfering patients to complete the treatment; enrolled patients without brain metastases, with good compliance and signing informed consent.","KPS ≥ 60 points; No disease interfering patients complete treatment; enrolled patients brain metastases, compliance signing informed consent.",C0206065|G0000000|C0450371|C1552961|G0000000|C0012634|C0521102|C0030705|C0205197|C0039798|G0000000|C0030705|C0006104|C0027627|C0009563|C0311392|C1522154|C1511481
Women registered in the Medical Birth Registry of Norway (MBRN) as having given birth in Norway between 1 January 1984 and 31 December 2010 constituted the study cohort (n = 812 986).,Women registered Medical Birth Registry Norway (MBRN) birth Norway 1 January 1984 31 December 2010 constituted study cohort (n = 812 986).,C0043210|C1514821|C0199168|C0005615|C0034975|C0028423|G0000000|C0005615|C0028423|G0000000|C3829466|G0000000|C0450371|C3830550|G0000000|G0000000|C0557651|C0599755|C0369718|G0000000|C1442061|C1442061
Mother-infant pairs in WIC in Hawai‘i and Puerto Rico were recruited.,Mother-infant pairs WIC Hawai‘i Puerto Rico recruited.,C0026591|C1709450|G0000000|G0000000|G0000000|G0000000|G0000000
"The exclusion criteria were pre-existing arm impairment, any painful condition affecting the upper limbs, difficulty in sitting for at least 20 minutes, severe cognitive impairment (mini-mental state examination score less than 10 points), and severe aphasia.","The exclusion criteria pre-existing arm impairment, painful condition upper limbs, difficulty sitting 20 minutes, severe cognitive impairment (mini-mental examination score 10 points), severe aphasia.",G0000000|C0680251|C0243161|C2347662|C0446516|C0221099|C0030193|C0012634|C1282910|C0015385|C1299586|C0277814|C0450371|C0439232|C0205082|C1516691|C0221099|C0445542|G0000000|C0449820|C0450371|C1552961|C0205082|C0003537
"Eszopiclone 3 mg has previously been demonstrated to be efficacious and safe during long-term, nightly use in primary insomnia.6,7 Men and women aged 21 to 64 years meeting DSM-IV criteria for primary insomnia1 and reporting ≤6.5 hours sleep and/or >30 minutes to fall asleep on a typical night for at least the past month were recruited via advertisements and physician referrals.","Eszopiclone 3 demonstrated efficacious safe long-term, nightly primary insomnia.6,7 Men women aged 21 64 meeting DSM-IV criteria primary insomnia1 reporting ≤6.5 hours sleep and/or >30 minutes fall asleep typical night month recruited advertisements physician referrals.",C1436328|G0000000|G0000000|C1280519|G0000000|C0443252|G0000000|C0205225|C0917801|C0025266|C0043210|C0001779|C0450371|C0450371|C0556656|C0220952|C0243161|C0205225|G0000000|C0700287|G0000000|C0439227|C0037313|G0000000|C0450371|C0439232|C0085639|C0424522|C3538928|C0240526|C0332177|G0000000|C0949214|C0031831|C0034927
The prevalence of occult AI (a cortisol increment after a short ACTH test of less than 9 mg/dl) in severe sepsis was estimated at about 50% and the 28-day mortality rate at about 75% [17].,The prevalence occult AI (a cortisol increment short ACTH test 9 mg/dl) severe sepsis estimated 50% 28-day mortality rate 75% [17].,G0000000|C0033105|C0028794|C0003353|G0000000|C0020268|C1705117|C1282927|C3539087|C0022885|G0000000|C0439269|C0205082|C0036690|C0750572|C0450371|C0450371|C0026565|C0871208|C0450371|C0450371
"As shown in table 1, the randomization balanced the groups well except for gender.","As table 1, randomization balanced gender.",G0000000|C0039224|G0000000|C0034656|C0205415|C0079399
Children aged <18 years were interviewed by proxy.,Children aged <18 interviewed proxy.,C0008059|C0001779|C0450371|C0021822|C0600420
"Seven hundred thirty-eight people with epilepsy (PWE) were randomized, but analysis was done for the 581 who were observed at both the beginning and end of the study.","Seven thirty-eight people epilepsy (PWE) randomized, analysis 581 observed study.",C0205453|C3816446|C0027361|C0014544|G0000000|C0034656|C0002778|C1442061|C1441672|C0557651
"Participants were eligible to participate if they were: 1) females aged 18–72 years, 2) diagnosed with invasive breast cancer (Stage I–III) within two years of enrolment, 3) post-surgery and had no surgery planned for the next six months at least, 4) had fully completed adjuvant therapy (radiotherapy and/or chemotherapy) not including hormonal therapy, 5) no previous malignancy, 6) willing to be randomised 7) and willing to maintain contact with the investigators over the six months.","Participants eligible participate were: 1) females aged 18–72 years, 2) diagnosed invasive breast cancer (Stage I–III) enrolment, 3) post-surgery surgery planned months least, 4) completed adjuvant therapy (radiotherapy and/or chemotherapy) including hormonal therapy, 5) previous malignancy, 6) randomised 7) maintain contact investigators months.",C0679646|C1548635|G0000000|G0000000|G0000000|C0015780|C0001779|G0000000|C0439234|G0000000|C0011900|C0205281|C0006141|C0006826|C0205390|G0000000|C1516879|G0000000|C0032790|C0038894|C1301732|C0439231|C0439092|G0000000|C0205197|C0001551|C0039798|C0034619|G0000000|C0013216|C0332257|C0458083|C0039798|G0000000|C0205156|C0006826|G0000000|G0000000|G0000000|C0024501|C0332158|C0035173|C0439231
"Patients were excluded if they had any recent respiratory tract infection, were hospitalised for a COPD exacerbation (6 weeks prior to Visit 1 or during the run-in period), had a history of asthma (indicated by, but not limited to, blood eosinophil count >400/mm3 or onset of respiratory symptoms prior to age 40 years) or any significant pulmonary disease or cardiovascular abnormality.","Patients excluded respiratory tract infection, hospitalised COPD exacerbation (6 weeks prior Visit 1 run-in period), history asthma (indicated by, limited to, blood eosinophil count >400/mm3 onset respiratory symptoms prior age 40 years) pulmonary disease cardiovascular abnormality.",C0030705|C1554077|C0521346|C1185740|C0009450|G0000000|C0024117|G0000000|G0000000|C0439230|C0332152|C0545082|G0000000|C3274438|C0439531|C0019664|C0004096|C1444656|G0000000|C0439801|G0000000|C0005767|C0014467|C0750480|C1442061|C0206132|C0521346|C0683368|C0332152|C0001779|C0450371|C0439234|C0024109|C0012634|C0007226|C1704258
"The study sample will be composed of 325 women, younger than 50 years of age, with histologically confirmed primary breast cancer (stages: T1 – T4, N0 – N1 and M0).","The study sample composed 325 women, 50 age, histologically confirmed primary breast cancer (stages: T1 – T4, N0 – N1 M0).",G0000000|C0557651|C0370003|G0000000|C1442061|C0043210|C0450371|C0001779|C0205462|C0521093|C0205225|C0006141|C0006826|C1306673|C0041403|G0000000|C0041403|C0445085|G0000000|C0445085|C0025885
"For CFRD FH− patients, the 90-min postprandial glucose was 116 ± 4 mg/dl (6.4 ± 0.2 mmol/l) in the insulin group, 138 ± 12 mg/dl (7.7 ± 0.7 mmol/l) in the placebo group, and 131 ± 7 mg/dl (7.3 ± 0.4 mmol/l) in the repaglinide group (P = 0.06, insulin vs. placebo and P = 0.81, repaglinide vs. placebo).","For CFRD FH− patients, 90-min postprandial glucose 116 ± 4 mg/dl (6.4 ± 0.2 mmol/l) insulin group, 138 ± 12 mg/dl (7.7 ± 0.7 mmol/l) placebo group, 131 ± 7 mg/dl (7.3 ± 0.4 mmol/l) repaglinide (P = 0.06, insulin vs. placebo P = 0.81, repaglinide vs. placebo).",G0000000|G0000000|G0000000|C0030705|C0450371|C0376674|C0017725|C1442061|G0000000|G0000000|C0439269|G0000000|G0000000|G0000000|C1532563|C0021641|C0441833|C1442061|G0000000|C0450371|C0439269|G0000000|G0000000|G0000000|C1532563|C0032042|C0441833|C1442061|G0000000|G0000000|C0439269|G0000000|G0000000|G0000000|C1532563|C0246689|C0369773|G0000000|C0450371|C0021641|G0000000|C0032042|C0369773|G0000000|C0450371|C0246689|G0000000|C0032042
"Qualified participants also reported that during the month prior to screening, their total sleep times (TST) were ≤ 6 h per night for ≥ 3 nights per week, and their wake time after sleep onset (WASO) was ≥ 45 min per night for ≥ 3 nights per week.","Qualified participants reported month prior screening, total sleep times (TST) ≤ 6 night ≥ 3 nights week, wake time sleep onset (WASO) ≥ 45 min night ≥ 3 nights week.",G0000000|C0679646|C0684224|C0332177|C0332152|C0220908|C0439175|C0037313|C0040223|C1421210|G0000000|G0000000|C0240526|G0000000|G0000000|C0240526|C0332174|C0442696|C0040223|C0037313|C0206132|G0000000|G0000000|C0450371|C0702093|C0240526|G0000000|G0000000|C0240526|C0332174
"Furthermore, no differences in lung function were detected between the treatment groups, despite lower use of bronchodilator therapy (maintenance and as needed) in the SMART group.","Furthermore, differences lung function detected treatment groups, lower bronchodilator therapy (maintenance needed) SMART group.",G0000000|C1705241|C0024109|C0031843|C0442726|C0039798|C0441833|C0441994|C0006280|C0039798|C0024501|C0027552|G0000000|C0441833
"Inclusion criteria were: hemiparesis caused by a first-ever unilateral stroke, subacute phase (<90 days from stroke), age between 18 and 80 years, ability to perform assisted walking training on the parallel bar (Functional Ambulation Classification [23], FAC ≥ 2), presence of some degree of muscular activity in each shoulder/elbow/hand (Medical Research Council scale [24] MRC ≥ 3).","Inclusion criteria were: hemiparesis caused first-ever unilateral stroke, subacute phase (<90 days stroke), age 18 80 years, ability perform assisted walking training parallel bar (Functional Ambulation Classification [23], FAC ≥ 2), presence degree muscular activity shoulder/elbow/hand (Medical Research Council scale [24] MRC ≥ 3).",C0007637|C0243161|G0000000|C0018989|C0015127|C0205435|C0205092|C0038454|C0205365|C0205390|C0450371|C0439228|C0038454|C0001779|C0450371|C0450371|C0439234|C0085732|C0884358|C1269765|C0080331|C0040607|C2348042|C0687760|C0205245|C0080331|C0008902|C0450371|G0000000|C0150312|C0441889|C0026845|C0205177|C0037004|C0199168|C0035168|C1551807|C0175659|C0450371|G0000000
"Inclusion criteria were: age 7–12 years old, last meal at least 3 h before venipuncture, no verbal difficulty, no neurodevelopmental delay, and no frequent venipunctures (more than 1/year).","Inclusion criteria were: age 7–12 years old, meal 3 h venipuncture, verbal difficulty, neurodevelopmental delay, frequent venipunctures (more 1/year).",C0007637|C0243161|G0000000|C0001779|G0000000|C0580836|C1998602|G0000000|C0190979|C0439824|C1299586|C0599855|C0205421|C0332183|C0600406|C0205172|C0439234
Dilation of intercellular space may be an important histologic marker of erosive esophagitis in children.,Dilation intercellular space histologic marker erosive esophagitis children.,C0012359|G0000000|C1883067|C0205462|C0005516|C0439679|C0014868|C0008059
"A total of 88 dysphagic patients within the first 2 weeks of acute stroke were recruited, of whom 56 were male and 32 were female.","A total 88 dysphagic patients 2 weeks acute stroke recruited, 56 male 32 female.",G0000000|C0439175|C0450371|G0000000|C0030705|G0000000|C0439230|C0205178|C0038454|G0000000|C0450371|C0086582|C0450371|C0015780
All patients requiring antibiotic therapy based on confirmed or highly suspected bacterial infections and at least two concomitant SIRS criteria were eligible [2].,All patients requiring antibiotic therapy based confirmed highly suspected bacterial infections concomitant SIRS criteria eligible [2].,G0000000|C0030705|G0000000|C0003232|C0039798|C1527178|C0521093|C0205250|C0332147|C0521009|C3714514|C0521115|C0242966|C0243161|C1548635|G0000000
"Affiliated to Kashan University of Medical Sciences, Kashan, Iran.","Affiliated Kashan University Medical Sciences, Kashan, Iran.",C1510825|G0000000|C0041740|C0199168|C0036397|G0000000|C0022065
Only mothers planning to breastfeed for at least 6 months were eligible to enter the study.,Only mothers planning breastfeed 6 months eligible enter study.,C0205171|C0026591|C0032074|C0006147|G0000000|C0439231|C1548635|C1522196|C0557651
"The intervention group assignment was preprogrammed into the CATI with participants being randomized into one of 4 conditions: 1) rhetorical questions (RQ) plus one-sided message, 2) RQ plus two-sided message, 3) no RQ plus one-sided message, and 4) no RQ plus two-sided message.","The intervention assignment preprogrammed CATI participants randomized 4 conditions: 1) rhetorical questions (RQ) one-sided message, 2) RQ two-sided message, 3) RQ one-sided message, 4) RQ two-sided message.",G0000000|C0886296|C1516050|G0000000|G0000000|C0679646|C0034656|G0000000|C0012634|G0000000|C0814791|C1522634|C0034044|C0205092|C0470166|G0000000|C0034044|C0205448|C0470166|G0000000|C0034044|C0205092|C0470166|G0000000|C0034044|C0205448|C0470166
Both pre- and postmenopausal women were included in this pilot study to explore the feasibility aspect of the study in both populations.,Both pre- postmenopausal women included pilot study explore feasibility aspect study populations.,G0000000|C0332152|C0232970|C0043210|C0332257|C0473169|C0557651|G0000000|G0000000|C1547011|C0557651|C0032659
"Thirty-five (83.3%) were diagnosed prior to age 4, with the median age at diagnosis being 2.2 (range: 0.3-10.8) years.","Thirty-five (83.3%) diagnosed prior age 4, median age diagnosis 2.2 (range: 0.3-10.8) years.",C3816446|C0450371|C0011900|C0332152|C0001779|G0000000|C0549183|C0001779|C0011900|G0000000|C1514721|C0450371|C0439234
A total of 815 patients were enrolled.,A total 815 patients enrolled.,G0000000|C0439175|C1442061|C0030705|G0000000
The IFSQ was pretested and validated with 150 African American first-time mothers with children ≤ 2 years of age [43].,The IFSQ pretested validated 150 African American first-time mothers children ≤ 2 age [43].,G0000000|G0000000|C0033101|G0000000|C1442061|C0027567|C0596070|C0205435|C0026591|G0000000|C0001779|C0450371
"176 children aged 5–10 years with newly detected asthma were randomly assigned to three treatment groups: (1) continuous budesonide (400 μg twice daily for 1 month, 200 μg twice daily for months 2–6, 100 μg twice daily for months 7–18); (2) budesonide, identical treatment to group 1 during months 1–6, then budesonide for exacerbations as needed for months 7–18; and (3) disodium cromoglycate (DSCG) 10 mg three times daily for months 1–18.","176 children aged 5–10 newly detected asthma randomly assigned treatment groups: (1) continuous budesonide (400 μg daily 1 month, 200 μg daily months 2–6, 100 μg daily months 7–18); (2) budesonide, identical treatment 1 months 1–6, budesonide exacerbations months 7–18; (3) disodium cromoglycate (DSCG) 10 times daily months 1–18.",C1442061|C0008059|C0001779|G0000000|C0750546|C0442726|C0004096|G0000000|C1516050|C0039798|C0441833|G0000000|C0549178|C0054201|C1442061|G0000000|C0332173|G0000000|C0332177|C1442061|G0000000|C0332173|C0439231|G0000000|C1442061|G0000000|C0332173|C0439231|G0000000|G0000000|C0054201|C0205280|C0039798|G0000000|C0439231|G0000000|C0054201|G0000000|C0439231|G0000000|G0000000|G0000000|C0010347|C0012694|C0450371|C0040223|C0332173|C0439231|G0000000
"For the CPM PPTs we therefore had 34 participants in the active TENS group, 35 participants in the placebo TENS group and 33 participants in the no TENS.","For CPM PPTs 34 participants active TENS group, 35 participants placebo TENS 33 participants TENS.",G0000000|G0000000|G0000000|C0450371|C0679646|C0205177|C0014518|C0441833|C0450371|C0679646|C0032042|C0014518|C0450371|C0679646|C0014518
"The baseline questionnaire included sociodemographic variables (age, sex, educational level, marital status and income level) and tobacco consumption (eg, number of cigarettes smoked per day and nicotine dependence as measured by the Fageström test).20 The study app automatically randomised eligible participants (daily cigarette smokers, aged 18 years and above and from the four countries) to either the intervention or the control sub-app using stratified block (age, gender, country) randomisation.","The baseline questionnaire included sociodemographic variables (age, sex, educational level, marital status income level) tobacco consumption (eg, cigarettes smoked day nicotine dependence measured Fageström test).20 The study app automatically randomised eligible participants (daily cigarette smokers, aged 18 countries) intervention control sub-app stratified block (age, gender, country) randomisation.",G0000000|C0168634|C0034394|C0332257|G0000000|C0439828|C0001779|C0009253|C0587721|C0441889|C0024841|C0449438|C0021162|C0441889|C0040329|C0009830|C0013715|C0677453|C0037366|C0332173|C0028040|C0011546|C0444706|G0000000|C0022885|G0000000|C0557651|G0000000|C3842331|G0000000|C1548635|C0679646|C0332173|C0677453|C0337664|C0001779|C0450371|C0454664|C0886296|C0243148|C0542339|C0205363|C0028778|C0001779|C0079399|C0454664|C0034656
"Patients with acute heart failure, accompanied with hypovolemic shock, other organ system failure, systemic immune system diseases or malignant tumor, whose estimated survival time was within 24 h or who refused to be enrolled in the study, were excluded.","Patients acute heart failure, accompanied hypovolemic shock, organ system failure, systemic immune system diseases malignant tumor, estimated survival time 24 refused enrolled study, excluded.",C0030705|C0205178|C0018787|C0231174|G0000000|C0752266|C0036974|C0178784|C0449913|C0231174|C0205373|C0439662|C0449913|C0012634|C0205282|C0027651|C0750572|C0038952|C0040223|C0450371|C1548564|G0000000|C0557651|C1554077
Our trial however selected patients with a relatively milder disease because of the exclusion criteria: patients who needed antibiotics or who were unable to stop steroids after surgery were excluded from the trial.,Our trial selected patients milder disease exclusion criteria: patients antibiotics unable steroids surgery excluded trial.,G0000000|C0008976|C1707391|C0030705|C2945599|C0012634|C0680251|C0243161|C0030705|C0003232|C1299582|C0038317|C0038894|C1554077|C0008976
"Surveillance for influenza was conducted between 14 November 2005 through 30 April 2006 (Season 1), and 13 November 2006 through 30 April 2007 (Season 2).","Surveillance influenza conducted 14 November 2005 30 April 2006 (Season 1), 13 November 2006 30 April 2007 (Season 2).",C0220920|C0021400|C0004927|C0450371|C3828767|G0000000|C0450371|C3715024|G0000000|C0036497|G0000000|C0450371|C3828767|G0000000|C0450371|C3715024|G0000000|C0036497|G0000000
"Qualified subjects were randomized to treatment with vehicle (62% ethanol, 1% ammonium lauryl sulfate, and 1% Klucel), vehicle containing 3.5% salicylic acid, or vehicle containing 1% salicylic acid and 3.5% pyroglutamic acid.","Qualified subjects randomized treatment vehicle (62% ethanol, 1% ammonium lauryl sulfate, 1% Klucel), vehicle 3.5% salicylic acid, vehicle 1% salicylic acid 3.5% pyroglutamic acid.",G0000000|C0681850|C0034656|C0039798|C0042444|C0450371|C0001962|G0000000|C0002611|G0000000|C0038720|G0000000|C1512542|C0042444|G0000000|C0036079|C0001128|C0042444|G0000000|C0036079|C0001128|G0000000|G0000000|C0001128
The survival benefit is seen in the stage II patients.,The survival benefit stage II patients.,G0000000|C0038952|C0814225|C0205390|G0000000|C0030705
"The study was based on two sets of cases (216 male single and 35 male multiple stomach cancer cases newly diagnosed and of adenocarcinoma type), and 483 male controls derived from residents of Saitama Prefecture.","The study based sets (216 male single 35 male multiple stomach cancer newly diagnosed adenocarcinoma type), 483 male controls derived residents Saitama Prefecture.",G0000000|C0557651|C1527178|C0036849|C1442061|C0086582|C0037179|C0450371|C0086582|C0439064|C0038351|C0006826|C0750546|C0011900|C0001418|C0332307|C1442061|C0086582|C0243148|C1441547|C1320928|G0000000|C1709636
"Vitamin D supplementation in doses ranging from 400 to 800 IU/d increased the serum level of 25-(OH)D by 27 nmol/liter per year in 7,964 men and women from five studies [43].","Vitamin D supplementation doses ranging 400 800 IU/d increased serum level 25-(OH)D 27 nmol/liter 7,964 women studies [43].",C0042890|C0073187|C0242297|C0178602|C1514721|C1442061|G0000000|C0205217|C0229671|C0441889|C0450371|G0000000|C1442061|C0043210|C0947630|C0450371
After 1 month 23 of the 30 participants in the intervention group had no or only minor symptoms versus 6 of the 30 participants in the control group (P<0.001).,After 1 month 23 30 participants intervention minor symptoms versus 6 30 participants control (P<0.001).,G0000000|G0000000|C0332177|C0450371|C0450371|C0679646|C0886296|C0026193|C0683368|G0000000|G0000000|C0450371|C0679646|C0243148|C0369773
Most of the participants (62.2%) reported consuming at least one can of energy drink in a week.,Most participants (62.2%) reported consuming energy drink week.,C0205393|C0679646|C0450371|C0684224|G0000000|C0424589|C0452428|C0332174
"Patients with clinically significant cardiovascular events, cardiac arrhythmias including QT prolongation or left bundle branch block, significant intratumoral or peritumoral hemorrhage, or those taking enzyme inducing antiepileptics or coumadin were excluded.","Patients clinically cardiovascular events, cardiac arrhythmias including QT prolongation left bundle branch block, intratumoral peritumoral hemorrhage, enzyme inducing antiepileptics coumadin excluded.",C0030705|G0000000|C0007226|C0441471|C0018787|C0003811|C0332257|C1552934|C0439590|C0205091|G0000000|C1253959|C0028778|C1517564|C3897941|C0019080|C0014442|C0205263|C0003299|C0699129|C1554077
"Further study with more patients, either in our study or that of Tugrul et al., is necessary before we decide whether to use this type of immunotherapy in the treatment of severe sepsis.","Further study patients, study Tugrul al., decide type immunotherapy treatment severe sepsis.",C1517331|C0557651|C0030705|C0557651|G0000000|C0202311|G0000000|C0332307|C0021083|C0039798|C0205082|C0036690
Entry criteria were being single and educating in Nursing and Midwifery School and Paramedical Faculty of Qom University of Medical Sciences in 2011 (Qom city is almost situated in the center of Iran with about 150 km2 distance from Tehran [metropolis of Iran]).,Entry criteria single educating Nursing Midwifery School Paramedical Faculty Qom University Medical Sciences 2011 (Qom city situated center Iran 150 km2 distance Tehran [metropolis Iran]).,C1705654|C0243161|C0037179|C0039401|C0006147|C0026082|C0036375|G0000000|C0015535|G0000000|C0041740|C0199168|C0036397|G0000000|G0000000|C0008848|G0000000|C0205099|C0022065|C1442061|G0000000|C0012751|G0000000|G0000000|C0022065
"The criteria for diagnosis were the classic symptoms of buphthalmos, photophobia and tearing, in addition to the signs of a large corneal diameter and IOP >21 mm Hg.","The criteria diagnosis classic symptoms buphthalmos, photophobia tearing, addition signs corneal diameter IOP >21 mm Hg.",G0000000|C0243161|C0011900|C0439658|C0683368|C0020302|C0085636|C0039409|C0332287|C0220912|C0010031|C1301886|C0595921|G0000000|C0025424
"As per the inclusion and exclusion criteria, 62 patients were randomized into rosuvastatin (32) and placebo (30) group.","As inclusion exclusion criteria, 62 patients randomized rosuvastatin (32) placebo (30) group.",G0000000|C0007637|C0680251|C0243161|C0450371|C0030705|C0034656|C0965129|C0450371|C0032042|C0450371|C0441833
These results are of clinical importance and suggest that optimal glycemic control (A1C <6.1%) during early pregnancy and later in pregnancy may reduce the risk of pre-eclampsia in women with type 1 diabetes.,These clinical optimal glycemic control (A1C <6.1%) pregnancy pregnancy reduce risk pre-eclampsia women type 1 diabetes.,G0000000|C0205210|C2698651|C0005802|C0243148|G0000000|G0000000|C0032961|C0032961|G0000000|C0035647|C0032914|C0043210|C0332307|G0000000|C0011847
"In Africa, fewer than half of patients receiving therapy for multidrug-resistant TB (MDR TB) are successfully treated, with poor outcomes reported for HIV-coinfected patients.","In Africa, fewer half patients receiving therapy multidrug-resistant TB (MDR TB) treated, poor outcomes reported HIV-coinfected patients.",G0000000|C0001737|C0205388|C2825407|C0030705|C1514756|C0039798|C0332325|G0000000|G0000000|G0000000|C1522326|C0032854|C1274040|C0684224|C0019682|C0030705
Patients' oncologist asked patients if they were interested in the study.,Patients' oncologist patients study.,C0030705|C0259990|C0030705|C0557651
"Families were recruited over a 4-year period from 2005–2009 through physician referral from the pediatric GI clinics at Seattle Children's Hospital and the Atlantic Health System in Morristown, New Jersey.","Families recruited 4-year period 2005–2009 physician referral pediatric GI clinics Seattle Children's Hospital Atlantic Health System Morristown, New Jersey.",C0015576|G0000000|C0439234|C0439531|G0000000|C0031831|C0034927|C0030755|C1708130|C0442592|G0000000|C0008059|C0019994|G0000000|C0018684|C0449913|G0000000|C0205314|C0454673
"The main reasons for not being enrolled in the study were lack of consent (n = 608; 37%), history of taking anti-malarial drugs in the past month (n = 394; 24%), home too far away for follow-up (n = 337; 20%), concomitant disease (n = 228; 14%), pregnancy or lactation (n = 113; 7%), mixed infection with P. falciparum (n = 44) and severe malaria (n = 12).","The main reasons enrolled study lack consent (n = 608; 37%), history anti-malarial drugs month (n = 394; 24%), follow-up (n = 337; 20%), concomitant disease (n = 228; 14%), pregnancy lactation (n = 113; 7%), mixed infection P. falciparum (n = 44) severe malaria (n = 12).",G0000000|C0205225|C0392360|G0000000|C0557651|C0332268|C1511481|C0369718|G0000000|C1442061|C0450371|C0019664|C0003374|C0013227|C0332177|C0369718|G0000000|C1442061|C0450371|C0589120|C0369718|G0000000|C1442061|C0450371|C0521115|C0012634|C0369718|G0000000|C1442061|C0450371|C0032961|C0006147|C0369718|G0000000|C1442061|G0000000|C0205430|C0009450|C0369773|G0000000|C0369718|G0000000|C0450371|C0205082|C0024530|C0369718|G0000000|C0450371
"Primary cesarean delivery rates among nulliparous, term, singleton, vertex women and vaginal birth after cesarean delivery (VBAC) rates among women with prior cesarean were compared before and after the change.","Primary cesarean delivery rates nulliparous, term, singleton, vertex women vaginal birth cesarean delivery (VBAC) rates women prior cesarean compared change.",C0205225|C3841297|C0011209|C0871208|C0425979|C0233324|C0481462|C0230003|C0043210|C0042232|C0005615|C3841297|C0011209|C0080301|C0871208|C0043210|C0332152|C3841297|C1707455|C0392747
"The placebo and the red clover groups had a larger percentage of African American women (72.7% and 59.1%, respectively) compared with the black cohosh (38.1%) and CEE/MPA (30.4%) groups.","The placebo red clover larger percentage African American women (72.7% 59.1%, respectively) compared black cohosh (38.1%) CEE/MPA (30.4%) groups.",G0000000|C0032042|C0332575|C0950074|C0549177|C0439165|C0027567|C0596070|C0043210|C0450371|C0450371|G0000000|C1707455|C0005680|G0000000|C0450371|C0046018|C0450371|C0441833
"Methods: Three hundred forty-five primarily Latino/a (46%) and African American (31%) high school students (mean age = 15.1 yr; 70% female) reporting an asthma diagnosis, symptoms of moderate to severe persistent asthma, and asthma medication use in the last 12 months were randomized to ASMA, an 8-week school-based intervention, or a wait-list control group.","Methods: Three forty-five Latino/a (46%) African American (31%) school students (mean age = 15.1 yr; 70% female) reporting asthma diagnosis, symptoms moderate severe persistent asthma, asthma medication 12 months randomized ASMA, 8-week school-based intervention, wait-list control group.",C0025663|C0205449|C3816449|C0086528|C0450371|C0027567|C0596070|C0450371|C0036375|C0038492|C0444504|C0001779|G0000000|C0450371|C0439234|C0450371|C0015780|C0700287|C0004096|C0011900|C0683368|C0205081|C0205082|C0205322|C0004096|C0004096|C0013227|C0450371|C0439231|C0034656|C0066992|C0332174|C0036375|C0886296|C0043010|C0243148|C0441833
Children aged 6–59 mo with MAM (WHZ <−2 and ≥−3 without bipedal edema) were recruited at 18 rural therapeutic feeding clinics in southern Malawi.,Children aged 6–59 mo MAM (WHZ <−2 ≥−3 bipedal edema) recruited 18 rural therapeutic feeding clinics southern Malawi.,C0008059|C0001779|G0000000|C0026544|C0024671|G0000000|G0000000|G0000000|G0000000|C0013604|G0000000|C0450371|C0240919|C0087111|C0204695|C0442592|C1710133|C0024548
Intervention Acupressure or physical therapy for one month.,Intervention Acupressure physical therapy month.,C0886296|C0282614|C0031809|C0039798|C0332177
"We screened the MICU and SICU censuses daily to identify adult patients (≥18 years old) being treated for respiratory failure and/or septic, cardiogenic or hemorrhagic shock who resided within 120 miles of Nashville, TN.","We screened MICU SICU censuses daily identify adult patients (≥18 old) treated respiratory failure and/or septic, cardiogenic hemorrhagic shock resided 120 miles Nashville, TN.",G0000000|C0220908|G0000000|G0000000|C0007663|C0332173|G0000000|C0001675|C0030705|G0000000|C0580836|C1522326|C0521346|C0231174|G0000000|C0333534|C1749797|C0333275|C0036974|C2982691|C1442061|C0331865|G0000000|C0040407
People with chronic insomnia who had been taking a benzodiazepine every night for more than 3 months were recruited through media advertisements or were referred by their family doctors.,People chronic insomnia benzodiazepine night 3 months recruited media advertisements referred family doctors.,C0027361|C0205191|C0917801|C0005064|C0240526|G0000000|C0439231|G0000000|C0009458|C0949214|C0205543|C0015576|C0031831
"We developed manual-guided, replicable interventions based on common needs and cultural preferences of White and African American family caregivers (CGs) of individuals with dementia, and we evaluated these interventions after a 6-month follow-up.","We developed manual-guided, replicable interventions based common cultural preferences White African American family caregivers (CGs) individuals dementia, evaluated interventions 6-month follow-up.",G0000000|G0000000|C0024763|G0000000|C0886296|C1527178|C0205214|C0010453|C0558295|C0007457|C0027567|C0596070|C0015576|C0085537|C1707127|C0027361|C0011265|C0220825|C0886296|C0332177|C0589120
One hundred and forty pregnant women with a gestational age of <16 weeks who had symptoms of nausea and vomiting were selected.,One forty pregnant women gestational age <16 weeks symptoms nausea vomiting selected.,C0205447|C3816449|C0549206|C0043210|C0439671|C0001779|C0450371|C0439230|C0683368|C0027497|C0042963|C1707391
"In case parents request more information on passive smoke exposure in children, they are encouraged to contact their general practitioner.","In parents request passive smoke exposure children, encouraged contact practitioner.",G0000000|C0030551|C1272683|C3686820|C0037366|C0274281|C0008059|G0000000|C0332158|C1709627
"Subjects were excluded if they: (1) had any symptoms suggestive of specific sleep disorders, as assessed by Insomnia Interview Schedule, a semi-structured face-to-face interview19; (2) had a significant risk of suicide; (3) had previous diagnosis of schizophrenia, other psychotic disorders, bipolar disorder, or alcohol or substance use disorder; (4) were pregnant, breast-feeding, or a woman of childbearing potential not using adequate contraception; (5) had valvular heart defects or bleeding disorders or were taking anticoagulant drugs; (6) had infection or abscess close to the site of selected acupoints; (7) had any serious physical illness; or (8) were taking Chinese herbal medicine or over-the-counter drugs intended for insomnia.","Subjects excluded they: (1) symptoms suggestive specific sleep disorders, assessed Insomnia Interview Schedule, semi-structured face-to-face interview19; (2) risk suicide; (3) previous diagnosis schizophrenia, psychotic disorders, bipolar disorder, alcohol substance disorder; (4) pregnant, breast-feeding, woman childbearing potential adequate contraception; (5) valvular heart defects bleeding disorders anticoagulant drugs; (6) infection abscess close site selected acupoints; (7) physical illness; (8) Chinese herbal medicine over-the-counter drugs intended insomnia.",C0681850|C1554077|G0000000|G0000000|C0683368|C0332299|C0205369|C0037313|C0012634|C1516048|C0917801|C0021822|C0086960|C0678594|C1553514|G0000000|G0000000|C0035647|C0038661|G0000000|C0205156|C0011900|C0036341|C0004936|C0012634|C0443156|C0012634|C0001962|C0439861|C0012634|G0000000|C0549206|C0006147|C0043210|G0000000|C3245505|C0205410|C0700589|G0000000|C0184252|C0018787|C0243067|C0019080|C0012634|C0003280|C0013227|G0000000|C0009450|C0000833|C0587267|C0205145|C1707391|C0001302|G0000000|C0031809|C0221423|G0000000|C0008120|C3146288|C0013227|C0013231|C0013227|C1283828|C0917801
Written informed consent for study participation is obtained at 5 to 45 days post-stroke (see above).,Written informed consent study participation 5 45 days post-stroke (see above).,C0043266|C1522154|C1511481|C0557651|C0679823|G0000000|C0450371|C0439228|C0687676|C0042789|C1282910
"Eligibility criteria included histological or cytological confirmation of advanced NSCLC; recurrent or refractory disease after at least one previous regimens; achievement of SD after one-month of gefitinib 250 mg/d therapy; measurable lesions defined by Response Evaluation Criteria in Solid Tumors (RECIST)16; Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 to 2; and satisfactory renal, hematological and cardiac function.","Eligibility criteria included histological cytological confirmation advanced NSCLC; recurrent refractory disease previous regimens; achievement SD one-month gefitinib 250 mg/d therapy; measurable lesions defined Response Evaluation Criteria Solid Tumors (RECIST)16; Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 2; satisfactory renal, hematological cardiac function.",C0013893|C0243161|C0332257|C0205462|C0205471|C0521091|C0205179|C0007131|C2945760|C0205269|C0012634|C0205156|C2945654|C0001072|C2699239|C4082115|C1122962|G0000000|C0039798|C1513040|C0221198|C1704788|C0871261|C0220825|C0243161|C0205208|C0027651|C1709926|C1707877|C0679729|C0027651|C0441833|C0430797|C0597198|C0449438|C0242397|G0000000|G0000000|C0205410|C0022646|C0018943|C0018787|C0031843
"The groups, although small, were well balanced in terms of the initial characteristics, except for more frequent malnutrition observed in the mDCF arm (18.5 vs. 3.5 %; p = 0.064) and more frequent liver metastases in this group of patients (48.1 vs. 17.2 %; p = 0.029).","The groups, small, balanced terms initial characteristics, frequent malnutrition observed mDCF arm (18.5 vs. 3.5 %; = 0.064) frequent liver metastases patients (48.1 vs. 17.2 %; = 0.029).",G0000000|C0441833|C0700321|C0205415|C0233324|C0205265|C1521970|C0332183|C0162429|C1441672|G0000000|C0446516|C0450371|G0000000|G0000000|G0000000|G0000000|C1442061|C0332183|C0023884|C0027627|C0030705|C0450371|G0000000|C0450371|G0000000|G0000000|C1442061
"Exclusion Criteria are aged < 18 years, guardianship order in place, or inability to provide informed consent (e.g.","Exclusion Criteria aged < 18 years, guardianship place, inability provide informed consent (e.g.",C0680251|C0243161|C0001779|G0000000|C0439234|C0870627|C0442504|G0000000|C1999230|C1522154|C1511481|G0000000
Living in their own familiar environment may enable people with dementia to maintain their social networks and enjoy a better quality of life [2].,Living familiar environment enable people dementia maintain social networks enjoy quality life [2].,C0376558|C0205309|C0014406|C0562342|C0027361|C0011265|C0024501|C0728831|C1882071|G0000000|C0332306|C0376558|G0000000
To examine the efficacy of web-based CBT for severely fatigued breast cancer survivors on fatigue severity compared to care as usual.,To examine efficacy web-based CBT severely fatigued breast cancer survivors fatigue severity compared care usual.,C0040363|G0000000|C1280519|C0282111|C0009244|C0205082|C0015672|C0006141|C0006826|C0206194|C0015672|C0439793|C1707455|C1947933|C3538928
"Comparison of cases and controls by selected demographic factors, major risk factors and CYP19A1 genotypes, Shanghai Endometrial Cancer Study, 1997–2003.","Comparison controls selected demographic factors, major risk factors CYP19A1 genotypes, Shanghai Endometrial Cancer Study, 1997–2003.",C1707455|C0243148|C1707391|C0011298|C1521761|C0205082|C0035647|C1521761|G0000000|C0017431|G0000000|C0227843|C0006826|C0557651|G0000000
"Convenience sample of 61 persons (34 treatment, 27 wait list control) with MS (mean age 47.9 years, SD 8.8).","Convenience sample 61 persons (34 treatment, 27 wait list control) MS (mean age 47.9 years, SD 8.8).",C3831015|C0370003|C0450371|C0027361|C0450371|C0039798|C0450371|C1610166|C0745732|C0243148|C0039676|C0444504|C0001779|C0450371|C0439234|C2699239|G0000000
Retention in treatment was defined as number of nights of inpatient treatment completed (range: 0–7).,Retention treatment defined nights inpatient treatment completed (range: 0–7).,C0035280|C0039798|C1704788|C0240526|C0021562|C0039798|C0205197|C1514721|G0000000
FIGURE 2.,FIGURE 2.,G0000000|G0000000
The target population chosen for this study was healthcare staff in the National Skin Centre (NSC) and the Departments of Emergency (A&E) and Intensive Care (ICU) in TTSH.,The target population chosen study healthcare staff National Skin Centre (NSC) Departments Emergency (A&E) Intensive Care (ICU) TTSH.,G0000000|C1521840|C0032659|C1707391|C0557651|C0086388|C0851286|C3245503|C0444099|C0205099|G0000000|C1704729|C0013956|G0000000|C0162425|C1947933|C0021708|G0000000
Newly admitted (within past 1 week) patients with a diagnosis of functional non-affective psychosis formed the study population.,Newly admitted (within 1 week) patients diagnosis functional non-affective psychosis formed study population.,C0750546|C0184666|G0000000|G0000000|C0332174|C0030705|C0011900|C0205245|C1518422|C0033975|C0205431|C0557651|C0032659
"Logistic regression with systematic inclusion and exclusion based on significances was performed with the following predictors: level of education of the guardian, age of the guardian, weight-for-height z-scores of the under five, whether the household was in an intervention or control village, and whether the result was pre or post intervention.","Logistic regression systematic inclusion exclusion based significances performed predictors: level education guardian, age guardian, weight-for-height z-scores five, household intervention control village, result pre post intervention.",C0242415|C0684320|C0220922|C0007637|C0680251|C1527178|C0237881|C0884358|C2698872|C0441889|C0013621|C0023226|C0001779|C0023226|C0005910|C0871421|C0205451|C0020052|C0886296|C0243148|C0562518|C1274040|C0332152|C0687676|C0886296
Parents rate their children’s symptoms and children their own.,Parents rate children’s symptoms children own.,C0030551|C0871208|G0000000|C0683368|C0008059|G0000000
"Infants excluded were those who received RBC transfusions 3 days before study entry or during the study, those with an active, culture-proven infection, a major malformation, electroencephalographic-proven seizures, hypertension, intraventricular hemorrhage ≥ grade III, immune hemolytic disease, necrotizing enterocolitis, or surgery.","Infants excluded received RBC transfusions 3 days study entry study, active, culture-proven infection, major malformation, electroencephalographic-proven seizures, hypertension, intraventricular hemorrhage ≥ grade III, immune hemolytic disease, necrotizing enterocolitis, surgery.",C0021270|C1554077|C1514756|C0014792|C0005841|G0000000|C0439228|C0557651|C1705654|C0557651|C0205177|C0010453|C0009450|C0205082|C0000768|C0013819|C0036572|C0020538|C1517569|C0019080|G0000000|C0441800|C0439070|C0439662|C0312853|C0012634|C0439664|C0014356|C0038894
The only exception is as follows: borderline significantly better mean contrast sensitivity at three cycles per degree in the right eyes of subjects randomised to placebo (p=0.05).,The exception follows: borderline contrast sensitivity cycles degree eyes subjects randomised placebo (p=0.05).,G0000000|C1554961|C0332283|C0205189|C0009924|C0020517|C1511572|C0441889|C0015392|C0681850|G0000000|C0032042|C0369773
Patients appraise the communication skills of the physicians of the IG better than the ones of the CG assessed by a questionnaire.,Patients appraise communication skills physicians IG CG assessed questionnaire.,C0030705|G0000000|C0009452|C0678856|C0031831|C0021027|C0043444|C1516048|C0034394
"There was no significant association of ALDH1(+) cases with any other parameters, such as patients’ age, tumor stage, tumor grade or breast cancer subtype, though there were relatively higher ALDH1(+) cases in HER2 (59%) and triple negative (55%) subtypes compared to luminal subtypes (41%).","There association ALDH1(+) parameters, patients’ age, tumor stage, tumor grade breast cancer subtype, ALDH1(+) HER2 (59%) triple negative (55%) subtypes compared luminal subtypes (41%).",G0000000|C0004083|C1412338|C0449381|G0000000|C0001779|C0027651|C0205390|C0027651|C0441800|C0006141|C0006826|C0449560|C1412338|G0000000|C0450371|C0205174|C0205160|C0450371|C0449560|C1707455|C0524462|C0449560|C0450371
"Patients with ischaemic and/or congestive heart disease, hypertension, diabetes mellitus, chronic obstructive pulmonary disease, hepatic and renal dysfunction were excluded from the study.","Patients ischaemic and/or congestive heart disease, hypertension, diabetes mellitus, chronic obstructive pulmonary disease, hepatic renal dysfunction excluded study.",C0030705|C0475224|G0000000|C0742742|C0018787|C0012634|C0020538|C0011847|G0000000|C0205191|C0549186|C0024109|C0012634|C0205054|C0022646|C0031847|C1554077|C0557651
"Eligible caregivers were living with individuals with a physician diagnosis of dementia or a Mini-mental State Examination (MMSE) score <24;25 at least >21 years; English speaking; planning to live in area for 6 months, not actively seeking nursing home placement; managing problem behaviors; and reporting upset (>5 on 10 point scale).","Eligible caregivers living individuals physician diagnosis dementia Mini-mental State Examination (MMSE) score <24;25 >21 years; English speaking; planning live 6 months, actively seeking nursing placement; managing behaviors; reporting upset (>5 10 scale).",C1548635|C0085537|C0376558|C0027361|C0031831|C0011900|C0011265|C0445542|C1301808|G0000000|C0451306|C0449820|C0450371|C0450371|C0439234|C0376245|C0234856|C0032074|C1548795|G0000000|C0439231|G0000000|G0000000|C0006147|C0441587|C1273870|C0004927|C0700287|C3887804|G0000000|C0450371|C0175659
Asthma entry criteria included (1) physician-diagnosed disease and (2) evidence of either bronchodilator reversibility (forced expiratory volume in the first second of expiration [FEV1≥12% following 180 µg [4 puffs] of levalbuterol) or airway hyperresponsiveness (provocative concentration of methacholine at which FEV1 decreased by 20% [PC20] <8 mg/mL if not receiving inhaled corticosteroids or ≤16 mg/mL if receiving inhaled corticosteroids).,Asthma entry criteria included (1) physician-diagnosed disease (2) evidence bronchodilator reversibility (forced expiratory volume expiration [FEV1≥12% 180 µg [4 puffs] levalbuterol) airway hyperresponsiveness (provocative concentration methacholine FEV1 decreased 20% [PC20] <8 mg/mL receiving inhaled corticosteroids ≤16 mg/mL receiving inhaled corticosteroids).,C0004096|C1705654|C0243161|C0332257|G0000000|C0031831|C0012634|G0000000|C3887511|C0006280|C0449261|C0441722|C0231800|C0449468|C0231800|G0000000|C1442061|G0000000|G0000000|C1533107|C0772501|C0178987|G0000000|C0449428|C0004268|C0600370|G0000000|C0205216|C0450371|G0000000|G0000000|C0439294|C1514756|C0004048|C0001617|G0000000|C0439294|C1514756|C0004048|C0001617
"As it was difficult to find villages that satisfied our a priori eligibility criteria of 50–150 households and minimum 60% latrine coverage, we allowed villages outside the size range and below the minimum coverage provided that we maintained adequate statistical power.","As difficult villages satisfied priori eligibility criteria 50–150 households minimum 60% latrine coverage, allowed villages size range minimum coverage provided maintained adequate statistical power.",G0000000|C0332218|C0562518|C0242428|G0000000|C0013893|C0243161|G0000000|C0020052|C1524031|C0450371|C0023124|C1551362|C0683607|C0562518|C0456389|C1514721|C1524031|C1551362|C1999230|C1314677|C0205410|C0038215|C0032863
"Eligibility criteria included prior diagnosis of malignancy, body mass index (BMI) >25.0 kg/m2, completion of all surgery, chemotherapy, and/or radiation at least one month prior to study enrollment (concurrent treatment with adjuvant hormonal or biologic therapies was acceptable); ECOG performance status of 0 (fully active without restriction) or 1 (restricted in physically strenuous activity, but ambulatory); and the ability to both walk two city blocks and to speak and read English.","Eligibility criteria included prior diagnosis malignancy, body mass (BMI) >25.0 kg/m2, completion surgery, chemotherapy, and/or radiation month prior study enrollment (concurrent treatment adjuvant hormonal biologic therapies acceptable); ECOG performance status 0 (fully active restriction) 1 (restricted physically strenuous activity, ambulatory); ability walk city blocks speak read English.",C0013893|C0243161|C0332257|C0332152|C0011900|C0006826|C0242821|C0577559|G0000000|C0450371|C0022718|C0205197|C0038894|C0013216|G0000000|C0034519|C0332177|C0332152|C0557651|C1516879|C0205420|C0039798|C0001551|C0458083|C0005515|C0087111|C1879533|C0430797|C0597198|C0449438|G0000000|G0000000|C0205177|C0443288|G0000000|C0443288|G0000000|G0000000|C0205177|C0439841|C0085732|C0080331|C0008848|C0028778|C0234856|C0034754|C0376245
"The proportions of patients with one, two, and three target risk factors were 43%, 48%, and 9% respectively.","The proportions patients one, two, target risk factors 43%, 48%, 9% respectively.",G0000000|C1709707|C0030705|C0205447|C0205448|C1521840|C0035647|C1521761|C0450371|C0450371|G0000000|G0000000
The change of migraine days outside the menstrual cycle [15] 2.,The change migraine days menstrual cycle [15] 2.,G0000000|C0392747|C0149931|C0439228|C0025344|C1511572|C0450371|G0000000
Exclusions included children with asthma and those with serious ongoing medical conditions such as malignancy or cystic fibrosis.,Exclusions included children asthma ongoing medical conditions malignancy cystic fibrosis.,C0680251|C0332257|C0008059|C0004096|C0549178|C0199168|C0012634|C0006826|C0205207|C0016059
"Women who entered the study but had a miscarriage, abortion, intrauterine fetal death, sudden infant death syndrome, duplex pregnancy, or delivery before pregnancy week 34 were excluded from this analysis.","Women entered study miscarriage, abortion, intrauterine fetal death, sudden infant death syndrome, duplex pregnancy, delivery pregnancy week 34 excluded analysis.",C0043210|C1521975|C0557651|C0000786|C0156543|C0694756|C0015965|C0011065|C1276802|C0021270|C0011065|C0039082|C0444916|C0032961|C0011209|C0032961|C0332174|C0450371|C1554077|C0002778
"Using a computer-generated randomization schedule, patients were given either melatonin 3 mg tablet (Melatonin, Nature Made/Pharmavite LLC USA) (M group; n = 30) or a placebo tablet (P group; n = 30) sublingually 60 min before surgery.","Using computer-generated randomization schedule, patients melatonin 3 tablet (Melatonin, Nature Made/Pharmavite LLC USA) (M group; = 30) placebo tablet (P group; = 30) sublingually 60 min surgery.",C1524063|C0009622|C0034656|C0086960|C0030705|C0025219|G0000000|C0039225|C0025219|C0349590|C1881534|C3271738|C0041703|C0369637|C0441833|G0000000|C0450371|C0032042|C0039225|C0369773|C0441833|G0000000|C0450371|G0000000|C0450371|C0702093|C0038894
"Adult (aged 21 to 69 years) nonpregnant individuals with low back pain for at least 3 months were telephonically screened for the following exclusion criteria: red flag conditions (cancer, spinal osteomyelitis, spinal fracture, herniated disc, ankylosing spondylitis, or cauda equina syndrome); low back surgery in the past year; workers’ compensation benefits in the past 3 months; ongoing litigation involving back problems; angina or congestive heart failure symptoms with minimal activity, history of a stroke, or transient ischemic attack in the past year; implanted biomedical devices (such as cardiac pacemakers or artificial joints); active bleeding or infection in the lower back, or other conditions impeding protocol implementation; use of corticosteroids in the past month; or use of manual treatment (OMT or manual therapies delivered by chiropractors or physical therapists) or UST in the past 3 months or more than 3 times in the past year.","Adult (aged 21 69 years) nonpregnant individuals low pain 3 months telephonically screened exclusion criteria: red flag conditions (cancer, spinal osteomyelitis, spinal fracture, herniated disc, ankylosing spondylitis, cauda equina syndrome); low surgery year; workers’ compensation benefits 3 months; ongoing litigation involving problems; angina congestive heart failure symptoms minimal activity, history stroke, transient ischemic attack year; implanted biomedical devices (such cardiac pacemakers artificial joints); active bleeding infection lower back, conditions impeding protocol implementation; corticosteroids month; manual treatment (OMT manual therapies delivered chiropractors physical therapists) UST 3 months 3 times year.",C0001675|C0001779|C0450371|C0450371|C0439234|G0000000|C0027361|C0205251|C0030193|G0000000|C0439231|G0000000|C0220908|C0680251|C0243161|C0332575|C1708067|C0012634|C0006826|C0521329|C0029443|C0521329|C0016658|G0000000|C0180459|G0000000|C0038012|C0205097|C0017589|C0039082|C0205251|C0038894|C0439234|G0000000|C0152057|C0814225|G0000000|C0439231|C0549178|C0079706|C1314939|C1546466|C0002962|C0742742|C0018787|C0231174|C0683368|C0547040|C0205177|C0019664|C0038454|C0040704|C0475224|C0277793|C0439234|C0021102|C1879848|C0025080|G0000000|C0018787|C0810633|C2004457|C0022417|C0205177|C0019080|C0009450|C0441994|C0004600|C0012634|G0000000|C0442711|C1708476|C0001617|C0332177|C0024763|C0039798|G0000000|C0024763|C0087111|C1705822|C0334952|C0031809|C0871525|C1424835|G0000000|C0439231|G0000000|C0040223|C0439234
"One child failed to have blood drawn, yielding 40 child-parent pairs in the intervention group.","One child failed blood drawn, yielding 40 child-parent pairs intervention group.",C0205447|C0008059|C0231175|C0005767|C0013113|G0000000|C0450371|C0260096|C1709450|C0886296|C0441833
Between April 2010 and June 2013 a total of 875 women were enrolled in the ENID trial.,Between April 2010 June 2013 total 875 women enrolled ENID trial.,G0000000|C3715024|G0000000|C3829443|G0000000|C0439175|C1442061|C0043210|G0000000|G0000000|C0008976
"Subjects were excluded from participation if they had any of following: (1) A severe physical impairment that precluded receiving/using the website or using the self-management skills contained on the website, (2) Co-morbid medical illnesses capable of causing a worsening of physical functional status independent of FM (e.g., cardiopulmonary disorders, uncontrolled endocrine or allergic disorders, malignancy within 2 years, (3) Any present psychiatric disorder involving a history of psychosis, current suicide risk or attempt within 2 years of the study, or substance abuse within 2 years, (4) Prior CBT for pain management, and (5) A pending status associated with disability compensation or the receipt of disability compensation for less than two years.","Subjects excluded participation following: (1) A severe physical impairment precluded receiving/using website self-management skills contained website, (2) Co-morbid medical illnesses capable causing worsening physical functional status independent FM (e.g., cardiopulmonary disorders, uncontrolled endocrine allergic disorders, malignancy 2 years, (3) Any psychiatric disorder involving history psychosis, current suicide risk attempt 2 study, substance abuse 2 years, (4) Prior CBT pain management, (5) A pending status disability compensation receipt disability compensation years.",C0681850|C1554077|C0679823|C0231290|G0000000|G0000000|C0205082|C0031809|C0221099|G0000000|C1514756|C2349146|C0086969|C0678856|C0332256|C2349146|G0000000|C0009488|C0199168|C0221423|C2698977|C0678227|C0332271|C0031809|C0205245|C0449438|C0085862|C3540627|G0000000|C0553534|C0012634|C0205318|C0014136|C0700624|C0012634|C0006826|G0000000|C0439234|G0000000|G0000000|C0205487|C0012634|C1314939|C0019664|C0033975|C0521116|C0038661|C0035647|C1516084|G0000000|C0557651|C0439861|C0013146|G0000000|C0439234|G0000000|C0332152|C0009244|C0030193|C0001554|G0000000|G0000000|G0000000|C0449438|C0231170|C0152057|G0000000|C0231170|C0152057|C0439234
Pregnant females and participants suffering from upper respiratory tract infection and respiratory diseases requiring treatment were excluded.,Pregnant females participants suffering upper respiratory tract infection respiratory diseases requiring treatment excluded.,C0549206|C0015780|C0679646|C0683278|C1282910|C0521346|C1185740|C0009450|C0521346|C0012634|G0000000|C0039798|C1554077
Three hundred received the 23‐valent pneumococcal vaccine and the other 300 were followed clinically during the same period.,Three received 23‐valent pneumococcal vaccine 300 clinically period.,C0205449|C1514756|G0000000|C0038410|C0042210|C1442061|G0000000|C0439531
To test the hypothesis that untreated partners of pregnant women receiving a prenatal lifestyle intervention (vs. standard care) would lose more weight during pregnancy and postpartum.,To test hypothesis untreated partners pregnant women receiving prenatal lifestyle intervention (vs. standard care) lose weight pregnancy postpartum.,C0040363|C0022885|C1512571|C0332155|C0682323|C0549206|C0043210|C1514756|C0678804|C0023676|C0886296|G0000000|C1442989|C1947933|G0000000|C0005910|C0032961|C0086839
"Exclusion criteria were delirium (identified by the Confusion Assessment Method [24]), severe somatic or mental illness, terminal disease, moderate to severe aphasia (except amnestic aphasia) or severe apraxia, insufficient hearing ability for receiving calls or no telephone accessibility, insufficient knowledge of German language, and place of residence outside the Stuttgart and Heidelberg area, respectively.","Exclusion criteria delirium (identified Confusion Assessment Method [24]), severe somatic mental illness, terminal disease, moderate severe aphasia (except amnestic aphasia) severe apraxia, insufficient hearing ability receiving calls telephone accessibility, insufficient knowledge German language, residence Stuttgart Heidelberg area, respectively.",C0680251|C0243161|C0011206|C0205396|C0009676|C1261322|C0025663|C0450371|C0205082|C1257909|C0229992|C0221423|C0205088|C0012634|C0205081|C0205082|C0003537|G0000000|G0000000|C0003537|C0205082|C0003635|C0205412|C0018767|C0085732|C1514756|C0679006|C0039457|C0814423|C0205412|C0376554|C1556085|C0023008|C0237096|G0000000|G0000000|C0017446|G0000000
"Participants with prevalent PD and stroke were excluded, resulting in a study population of 120,530 women and 50,825 men included in the analyses.","Participants prevalent PD stroke excluded, study population 120,530 women 50,825 included analyses.",C0679646|C0033105|G0000000|C0038454|C1554077|C0557651|C0032659|C1442061|C0043210|C0450371|C0332257|C0002778
"One ward in Guangzhou and 2 wards in Hong Kong did not participate, and they were excluded from the analysis.","One ward Guangzhou 2 wards Hong Kong participate, excluded analysis.",C0205447|C1305702|G0000000|G0000000|C1305702|G0000000|G0000000|G0000000|C1554077|C0002778
Private homes and long-term care facilities.,Private homes long-term care facilities.,C0033175|C0442519|C0443252|C1947933|C1547538
"Of the 3,942 remaining participants, there were 83 incident ET cases, 30 incident PD cases and 161 participants with incident dementia.","Of 3,942 remaining participants, 83 incident ET cases, 30 incident PD 161 participants incident dementia.",G0000000|C1442061|C1527428|C0679646|C0450371|C1551358|G0000000|C0868928|C0450371|C1551358|G0000000|C1442061|C0679646|C1551358|C0011265
"Patients were eligible if they were aged 50 or more, had been clinically diagnosed with osteoarthritis of the hips or knees (or both) for at least a year, and had had associated pain or functional disability (or both) during the past month.","Patients eligible aged 50 more, clinically diagnosed osteoarthritis hips knees (or both) year, pain functional disability (or both) month.",C0030705|C1548635|C0001779|C0450371|C0205172|G0000000|C0011900|C0029408|C0019552|C0022742|G0000000|G0000000|C0439234|C0030193|C0205245|C0231170|G0000000|G0000000|C0332177
"Thus, PedaTyph™ was found to be well tolerated in children of all age groups from 6 months to 12 years of age.","Thus, PedaTyph™ tolerated children age 6 months 12 age.",G0000000|G0000000|G0000000|C0008059|C0001779|G0000000|C0439231|C0450371|C0001779
"We aim to recruit 146 people with dementia and their carers to be randomized into two groups; one will be trained in a structured, tailored walking programme, while the other will continue with treatment as usual.","We aim recruit 146 people dementia carers randomized groups; trained structured, tailored walking programme, continue treatment usual.",G0000000|C1947946|G0000000|C1442061|C0027361|C0011265|C0085537|C0034656|C0441833|C0336809|C0678594|C0402883|C0080331|C1709697|C0549178|C0039798|C3538928
Eligible participants were adults with haemorrhagic or ischaemic stroke who were able to sit unsupported for greater than 10 s (Motor Assessment Scale - Sitting Balance ≥ 2 [30]).,Eligible participants adults haemorrhagic ischaemic stroke sit unsupported 10 (Motor Assessment Scale - Sitting Balance ≥ 2 [30]).,C1548635|C0679646|C0001675|C0333275|C0475224|C0038454|C0277814|G0000000|C0450371|C1513492|C1261322|C0175659|G0000000|C0277814|G0000000|C0450371
Participants Children aged 3-36 months visiting a family paediatrician for acute diarrhoea.,Participants Children aged 3-36 months visiting family paediatrician acute diarrhoea.,C0679646|C0008059|C0001779|C0450371|C0439231|C0545082|C0015576|C0237433|C0205178|C0011991
"Other eligibility requirements were an age at diagnosis of under 31 years; completion of induction therapy, autologous stem-cell transplantation, and radiotherapy; achievement of at least a partial response at the time of evaluation before autologous stem-cell transplantation; autologous stem-cell transplantation performed within 9 months after the initiation of induction therapy; enrollment between day 50 and day 100 after the final autologous stem-cell transplantation; absence of progressive disease; and adequate organ function and a life expectancy of at least 2 months.","Other eligibility requirements age diagnosis 31 years; completion induction therapy, autologous stem-cell transplantation, radiotherapy; achievement partial response time evaluation autologous stem-cell transplantation; autologous stem-cell transplantation performed 9 months initiation induction therapy; enrollment day 50 day 100 final autologous stem-cell transplantation; absence progressive disease; adequate organ function life expectancy 2 months.",G0000000|C0013893|C1514873|C0001779|C0011900|C0450371|C0439234|C0205197|C0205263|C0039798|C0439859|C0038250|C0040732|C0034619|C0001072|C0728938|C0871261|C0040223|C0220825|C0439859|C0038250|C0040732|C0439859|C0038250|C0040732|C0884358|G0000000|C0439231|C0589507|C0205263|C0039798|C1516879|C0332173|C0450371|C0332173|C1442061|C0205088|C0439859|C0038250|C0040732|C0332197|C0205329|C0012634|C0205410|C0178784|C0031843|C0376558|C0679138|G0000000|C0439231
"Overall, and in all other subsets defined by baseline blood selenium levels, selenium supplementation had no effect on PC risk.","Overall, subsets defined baseline blood selenium levels, selenium supplementation PC risk.",C0282416|C1515021|C1704788|C0168634|C0005767|C0036581|C0441889|C0036581|C0242297|C0031995|C0035647
This is surprising given that upwards of 80% of people with dementia will experience BPSD at some point during the course of their illness [6].,This surprising upwards 80% people dementia experience BPSD illness [6].,G0000000|G0000000|G0000000|C0450371|C0027361|C0011265|C0237607|G0000000|C0221423|G0000000
"Major exclusion criteria were: (i) haemodynamically significant residual valvular or prosthesis dysfunction (patient-prosthesis mismatch or more than mild valvular or prosthetic valve stenosis or regurgitation, as assessed by the investigators according to current practice guidelines),19 (ii) systolic blood pressure < 90 mmHg, (iii) myocardial infarction, stroke, or life-threatening arrhythmia within the last 6 months, (iv) severe renal impairment (creatinine clearance <30 mL/min) or hepatic dysfunction, (v) life expectancy <2 years, or (vi) any established contraindication for sildenafil (see Supplementary Material S1, Table S1).","Major exclusion criteria were: (i) haemodynamically residual valvular prosthesis dysfunction (patient-prosthesis mismatch mild valvular prosthetic valve stenosis regurgitation, assessed investigators current practice guidelines),19 (ii) systolic blood pressure < 90 mmHg, (iii) myocardial infarction, stroke, life-threatening arrhythmia 6 months, (iv) severe renal impairment (creatinine clearance <30 mL/min) hepatic dysfunction, (v) life expectancy <2 years, (vi) established contraindication sildenafil (see Supplementary Material S1, Table S1).",C0205082|C0680251|C0243161|G0000000|C0021966|G0000000|C1609982|C0184252|C0175649|C0031847|C0030705|C1881865|C2945599|C0184252|G0000000|C0184252|C0678234|C0232605|C1516048|C0035173|C0521116|C0237607|C0162791|G0000000|C0039155|C0005767|C0033095|G0000000|C0439070|C0027061|C0021308|C0038454|C1517874|C0003811|G0000000|C0022326|C0205082|C0022646|C0221099|C0010294|C0449297|G0000000|C0205054|C0031847|G0000000|C0376558|C0679138|G0000000|C0205999|C0443211|C0522473|C0529793|C0042789|G0000000|C0520510|C1519428|C0039224|C1519428
"All women receiving prenatal care at these clinics completed a brief questionnaire regarding basic sociodemographics and smoking status, including age, race, years of education, estimated gestational age (EGA), and smoking frequency in the past 7 days.","All women receiving prenatal care clinics completed questionnaire basic sociodemographics smoking status, including age, race, education, estimated gestational age (EGA), smoking frequency 7 days.",G0000000|C0043210|C1514756|C0678804|C1947933|C0442592|C0205197|C0034394|C1527178|G0000000|C0037369|C0449438|C0332257|C0001779|C0034510|C0013621|C0750572|C0439671|C0001779|G0000000|C0037369|C0376249|G0000000|C0439228
The intervention is conducted in childcare services across New South Wales which may limit national generalisability of study findings.,The intervention conducted childcare services New South Wales limit national generalisability study findings.,G0000000|C0886296|C0004927|C0008067|C0557854|C0205314|C1710133|C0043015|C0439801|C3245503|G0000000|C0557651|C2607943
"Respondents, residing in Sydney, available for follow-up and able to provide informed consent, were eligible.","Respondents, residing Sydney, follow-up provide informed consent, eligible.",C0282122|C2982691|G0000000|C0589120|C1999230|C1522154|C1511481|C1548635
This randomized controlled pilot trial included outpatients who were over 45 years of age with atherothrombotic cardiovascular disease.,This randomized controlled pilot trial included outpatients 45 age atherothrombotic cardiovascular disease.,G0000000|C0034656|C2587213|C0473169|C0008976|C0332257|C0029921|C0450371|C0001779|G0000000|C0007226|C0012634
"Around 650 patients were admitted with suspected stroke or transcient ischaemic attack during an 18 month period, of whom 523 were admitted for at least three days with functional problems; we excluded 385 patients, and we randomised 67 patients to the intervention group and 71 to the control group, representing 58% (138/237) of patients with residual stroke disability who returned to a local private address (figure).","Around 650 patients admitted suspected stroke transcient ischaemic attack 18 month period, 523 admitted days functional problems; excluded 385 patients, randomised 67 patients intervention 71 control group, representing 58% (138/237) patients residual stroke disability returned local private address (figure).",G0000000|C1442061|C0030705|C0184666|C0332147|C0038454|G0000000|C0475224|C0277793|C0450371|C0332177|C0439531|C1442061|C0184666|C0439228|C0205245|C1546466|C1554077|C1442061|C0030705|G0000000|C0450371|C0030705|C0886296|C0450371|C0243148|C0441833|C1882932|C0450371|C1442061|C0030705|C1609982|C0038454|C0231170|C0332156|C0205276|C0033175|C0376649|G0000000
Usual care clinics had significantly fewer non-Hispanic Black patients compared to clinics in the other intervention arms (Table 2).,Usual care clinics fewer non-Hispanic Black patients compared clinics intervention arms (Table 2).,C3538928|C1947933|C0442592|C0205388|C1518424|C0005680|C0030705|C1707455|C0442592|C0886296|C0206655|C0039224|G0000000
"Those excluded were patients with severe axis I psychiatric disorders (dementia, schizophrenia, paranoid disorder and alcohol and/or drug abuse); patients with severe axis II psychiatric disorders or other medical disorders that, from the clinician's point of view, prevented the patient from following the treatment protocol; women who were pregnant or nursing; and those who declined to participate.","Those excluded patients severe axis I psychiatric disorders (dementia, schizophrenia, paranoid disorder alcohol and/or drug abuse); patients severe axis II psychiatric disorders medical disorders that, clinician's view, prevented patient treatment protocol; women pregnant nursing; declined participate.",G0000000|C1554077|C0030705|C0205082|C0004457|C0021966|C0205487|C0012634|C0011265|C0036341|G0000000|C0012634|C0001962|G0000000|C0013227|C0013146|C0030705|C0205082|C0004457|G0000000|C0205487|C0012634|C0199168|C0012634|G0000000|C0871685|C0449911|C0309872|C0030705|C0039798|C0442711|C0043210|C0549206|C0006147|G0000000|G0000000
Four children (two in each group) had an end-of-treatment or follow-up assessment in which the glomerular filtration rate was less than 60 ml per minute per 1.73 m2.,Four children (two group) end-of-treatment follow-up assessment glomerular filtration rate 60 minute 1.73 m2.,C0205450|C0008059|C0205448|C0441833|C0444930|C0589120|C1261322|C0022663|C0016107|C0871208|C0450371|C0439232|C0450371|C0025885
We reviewed entry screening policies adopted by different nations and ascertained dates of official report of the first laboratory-confirmed imported H1N1 case and the first laboratory-confirmed untraceable or 'local' H1N1 case.,We reviewed entry screening policies nations ascertained dates official report laboratory-confirmed imported H1N1 laboratory-confirmed untraceable 'local' H1N1 case.,G0000000|C0282443|C1705654|C0220908|C0242456|C1555720|G0000000|C0011008|C2347387|C0684224|C0022877|C0699788|G0000000|C0022877|G0000000|C0205276|G0000000|C0868928
"In conclusion, modified balloon dilatation therapy can increase the excitability of affected projection in patients with unilateral brainstem stroke.","In conclusion, modified balloon dilatation therapy increase excitability projection patients unilateral brainstem stroke.",G0000000|C1707478|C0392747|C0336867|C0012359|C0039798|C0442805|C0235169|C0016538|C0030705|C0205092|C0006121|C0038454
One hundred and twenty subjects including 57 males and 63 females participated in this study.,One twenty subjects including 57 males 63 females participated study.,C0205447|C0724000|C0681850|C0332257|C0450371|C0086582|C0450371|C0015780|G0000000|C0557651
Adolescents were recruited by neurologist (a headache specialist) referral and community advertisement.,Adolescents recruited neurologist (a headache specialist) referral community advertisement.,C0205653|G0000000|C0237426|G0000000|C0018681|C0087009|C0034927|C0009462|C0949214
"NS affects 1 to 3 per 100,000 children less than 16 years of age [1].","NS 1 3 100,000 children 16 years age [1].",C0038944|G0000000|G0000000|C1442061|C0008059|G0000000|C0001779|G0000000
Inclusion criteria were age at least 18 years and suitability for elective surgery.,Inclusion criteria age 18 suitability elective surgery.,C0007637|C0243161|C0001779|C0450371|C3900053|C0206058|C0038894
"Furthermore, knee joint swelling after operation was significantly suppressed in the TXA group compared to the control group.","Furthermore, knee joint swelling operation suppressed TXA compared control group.",G0000000|C0022742|C0022417|C0013604|C0543467|C1260953|G0000000|C1707455|C0243148|C0441833
Day 0 is defined as the time period between onset of stroke and inclusion in the study.,Day 0 defined time period onset stroke inclusion study.,C0332173|G0000000|C1704788|C0040223|C0439531|C0206132|C0038454|C0007637|C0557651
"We conducted a comparative case‐control study of colorectal cancer and adenoma involving 221 cases with colorectal cancer, 525 cases with colorectal adenoma and 578 neighborhood controls.","We conducted comparative case‐control study colorectal cancer adenoma involving 221 colorectal cancer, 525 colorectal adenoma 578 neighborhood controls.",G0000000|C0004927|G0000000|G0000000|C0557651|C0555952|C0006826|C0001430|C1314939|C1442061|C0555952|C0006826|C1442061|C0555952|C0001430|C1442061|C0027569|C0243148
The same children were interviewed at baseline and endline.,The children interviewed baseline endline.,G0000000|C0008059|C0021822|C0168634|G0000000
"In the present analyses, polio serotype–specific neutralizing activity and IgA concentrations were evaluated in 364 stool samples from 152 infants, representing approximately one-third of the participants in the per-protocol analysis of the primary study.","In analyses, polio serotype–specific neutralizing activity IgA concentrations evaluated 364 stool samples 152 infants, representing one-third participants per-protocol analysis primary study.",G0000000|C0002778|C0032371|G0000000|G0000000|C0205177|C2825347|C0086045|C0220825|C1442061|C0015733|C0370003|C1442061|C0021270|C1882932|C0205447|C0679646|C1698058|C0002778|C0205225|C0557651
Standard demographic and socio-economic information will be collected by parental report at baseline (3 months).,Standard demographic socio-economic collected parental report baseline (3 months).,C1442989|C0011298|C0013556|C1516695|C0030551|C0684224|C0168634|G0000000|C0439231
"Using the CHCs’ electronic medical records, we identified patients seen in the last 2 years with a low back pain diagnosis and generated recruitment letters for their providers to sign and send.","Using CHCs’ electronic medical records, identified patients 2 low pain diagnosis generated recruitment letters providers sign send.",C1524063|G0000000|C0013850|C0199168|C0034869|C0205396|C0030705|G0000000|C0205251|C0030193|C0011900|C3146294|C2949735|C0282413|C1138603|C0311392|C1519246
"Between 10/2002 and 03/2005, 135 patients with locally advanced or metastasised HCC (Karnofsky ≥60%/Child-Pugh ≤ 12) were randomised to receive thymostimulin 75 mg s.c. 5×/week or placebo stratified according to liver function.","Between 10/2002 03/2005, 135 patients locally advanced metastasised HCC (Karnofsky ≥60%/Child-Pugh ≤ 12) randomised receive thymostimulin 75 s.c. 5×/week placebo stratified liver function.",G0000000|C0450371|C0450371|C1442061|C0030705|C1517927|C0205179|G0000000|C2239176|C0206065|G0000000|G0000000|C0450371|G0000000|C1514756|C0076625|C0450371|C0565930|G0000000|C0032042|C0205363|C0023884|C0031843
These data show that daily use of 40 mg of simvastatin has no role in preventing exacerbations in moderate-to-severe COPD.,These data daily 40 simvastatin role preventing exacerbations moderate-to-severe COPD.,G0000000|C1511726|C0332173|C0450371|C0074554|C0035820|C0309872|G0000000|C0205081|C0024117
Participants were all following their first stroke and over 60 years of age with ability to give informed consent.,Participants stroke 60 age ability informed consent.,C0679646|C0038454|C0450371|C0001779|C0085732|C1522154|C1511481
A total of 2382 participants were randomised into the trial from December 1990 to March 1992 at nine clinic sites.,A total 2382 participants randomised trial December 1990 March 1992 clinic sites.,G0000000|C0439175|G0000000|C0679646|G0000000|C0008976|C3830550|G0000000|C3829202|G0000000|C0002424|C0205145
We recruited people with chronic insomnia through referral by family physicians and media advertisements.,We recruited people chronic insomnia referral family physicians media advertisements.,G0000000|G0000000|C0027361|C0205191|C0917801|C0034927|C0015576|C0031831|C0009458|C0949214
"Therefore, its results are difficult to generalize to stroke patients.","Therefore, difficult generalize stroke patients.",G0000000|C0332218|G0000000|C0038454|C0030705
Patients' ≥18 years old undergoing laparoscopic transperitoneal renal procedures were invited to participate in the study.,Patients' ≥18 undergoing laparoscopic transperitoneal renal procedures invited participate study.,C0030705|G0000000|G0000000|C0031150|C0205501|C0022646|C0025664|G0000000|G0000000|C0557651
Patients have been excluded with diagnosis of type 1 diabetes or diabetic keto-acidosis (blood glucose > 350 mg/dl and arterial pH < 7.25).,Patients excluded diagnosis type 1 diabetes diabetic keto-acidosis (blood glucose > 350 mg/dl arterial pH < 7.25).,C0030705|C1554077|C0011900|C0332307|G0000000|C0011847|C0241863|C0022638|C0005767|G0000000|C0439269|C0003842|G0000000
"Incomplete-crossover study: four of five treatments given once daily in random order (placebo, O 5 µg, T 5 µg, T/O 2.5/5 µg or T/O 5/5 µg), all via the Respimat inhaler.","Incomplete-crossover study: treatments daily random (placebo, O 5 µg, T 5 µg, T/O 2.5/5 µg T/O 5/5 µg), Respimat inhaler.",C0205257|C0557651|C0087111|C0332173|C0034656|C0032042|C0483204|G0000000|C2603360|G0000000|C2603360|G0000000|C2603360|G0000000|G0000000|C0021461
Patients with recurrent disease often receive additional second- and third-line chemotherapy regimens.,Patients recurrent disease receive additional second- third-line chemotherapy regimens.,C0030705|C2945760|C0012634|C1514756|C1524062|C0205436|C0205437|C0013216|C2945654
gambiae s.s from Yaokoffikro.,gambiae s.s Yaokoffikro.,G0000000|C0565930|G0000000
To assess efficacy and safety of a new dry powder formulation of inhaled colistimethate sodium in patients with cystic fibrosis (CF) aged ≥6 years with chronic Pseudomonas aeruginosa lung infection.,To assess efficacy safety dry powder formulation inhaled colistimethate sodium patients cystic fibrosis (CF) aged ≥6 years chronic Pseudomonas aeruginosa lung infection.,C0040363|C1516048|C1280519|C0036043|C0011682|C0032861|C0524527|C0004048|C0009315|C0037473|C0030705|C0205207|C0016059|C0009738|C0001779|G0000000|C0205191|C0033808|G0000000|C0024109|C0009450
Exclusion criteria were: i) a Southwest Oncology Group performance status score >1 (i.e.,Exclusion criteria were: i) Southwest Oncology Group performance status score >1 (i.e.,C0680251|C0243161|G0000000|C0021966|C1710136|C0027651|C0441833|C0597198|C0449438|C0449820|G0000000|C0683454
"Patients must have no opportunistic infections, a CD4 count >200 cells/mm3, a stable weight (<5% loss between last three visits) and be virally suppressed (two consecutive viral loads <400 copies/ml).","Patients opportunistic infections, CD4 count >200 cells/mm3, stable weight (<5% loss visits) virally suppressed (two consecutive viral loads <400 copies/ml).",C0030705|G0000000|C3714514|C0285590|C0750480|C1442061|C0007634|C0205360|C0005910|G0000000|C1517945|C0545082|G0000000|C1260953|C0205448|C1707491|C0521026|C1550025|C1442061|C1531853
"In addition, 4 patients (1 BC and 3 OC) affected by recurrent/metastatic disease requested vaccination for compassionate use and were subjected to the same treatment.","In addition, 4 patients (1 BC 3 OC) recurrent/metastatic disease requested vaccination compassionate subjected treatment.",G0000000|C0332287|G0000000|C0030705|G0000000|C0006041|G0000000|C1412791|C2945760|C0012634|C1272683|C0042196|C0242270|C0681850|C0039798
"Patients with Kawasaki disease or idiopathic thrombocytopenic purpura and concomitant AD who received IVIg showed improvement of their dermatitis.14,15 One study gave mixed results, with the best response occurring in patients with extremely high IgE levels.16 Reports on severe childhood AD suggest that IVIg can lead to improved symptoms when used as a monotherapy; nine out of 10 children improved when given 2 g/kg IVIg.17 However, most published research has evaluated only the short-term effects of IVIg.","Patients Kawasaki disease idiopathic thrombocytopenic purpura concomitant AD received IVIg improvement dermatitis.14,15 One study mixed results, response occurring patients extremely IgE levels.16 Reports severe childhood AD IVIg lead improved symptoms monotherapy; 10 children improved 2 g/kg IVIg.17 However, published evaluated short-term effects IVIg.",C0030705|G0000000|C0012634|C0332240|G0000000|C0034150|C0521115|G0000000|C1514756|C0085297|C2986411|C0011603|C0205447|C0557651|C0205430|C1274040|C0871261|C1709305|C0030705|C0205403|G0000000|C0441889|C0684224|C0205082|C0231335|G0000000|C0085297|C0023175|C0184511|C0683368|G0000000|C0450371|C0008059|C0184511|G0000000|C1300563|C0085297|G0000000|C0034037|C0220825|C0443303|C1280500|C0085297
NCS inclusion criteria consisted of median nerve sensory latency greater than 3.7 ms or median nerve sensory latency greater than 0.5 ms compared to ulnar nerve.,NCS inclusion criteria consisted median nerve sensory latency 3.7 ms median nerve sensory latency 0.5 ms compared ulnar nerve.,C0027597|C0007637|C0243161|C0332529|C0549183|C0027740|C0445254|C0205275|G0000000|C0549183|C0027740|C0445254|C0205275|G0000000|C1707455|C0442044|C0027740
"Eighty-one percent of the treated group had compliance greater than or equal to 80%, as compared with 76% of the control group.","Eighty-one percent treated compliance equal 80%, compared 76% control group.",C3816958|C0439165|C1522326|C0009563|C0205163|C0450371|C1707455|C0450371|C0243148|C0441833
"Patients aged 18–70 years with primary idiopathic carpal tunnel syndrome who fulfilled the following criteria were included: satisfying classic or probable criteria for carpal tunnel syndrome by Katz hand diagram (tingling or numbness in ≥ 2 of 4 radial fingers),26 positive in at least 2 of 3 clinical tests (i.e., Phalen maneuver test, Tinel sign test, and the wrist flexion and median nerve compression test),27 able to respond to questionnaires in Cantonese and able to provide written informed consent.","Patients aged 18–70 primary idiopathic carpal tunnel syndrome fulfilled criteria included: satisfying classic probable criteria carpal tunnel syndrome Katz hand diagram (tingling numbness ≥ 2 4 radial fingers),26 positive 2 3 clinical tests (i.e., Phalen maneuver test, Tinel sign test, wrist flexion median nerve compression test),27 respond questionnaires Cantonese provide written informed consent.",C0030705|C0001779|G0000000|C0205225|C0332240|C0007285|C0337138|C0039082|C1550543|C0243161|C0332257|G0000000|C0439658|C0033204|C0243161|C0007285|C0337138|C0039082|G0000000|C0018563|C0681494|C2242996|C0020580|G0000000|G0000000|G0000000|C0442038|C0016129|C0439178|G0000000|G0000000|C0205210|C0022885|C0683454|G0000000|G0000000|C0022885|G0000000|C0311392|C0022885|C0043262|C0231452|C0549183|C0027740|C0332459|C0022885|G0000000|C0034394|G0000000|C1999230|C0043266|C1522154|C1511481
"Of the 94 individuals (39% male; mean [SD] age, 64.9 [11.1] years) randomly assigned to magnesium oxide (48) or placebo (46), 6 did not complete the study protocol (3 in each group).","Of 94 individuals (39% male; [SD] age, 64.9 [11.1] years) randomly assigned magnesium oxide (48) placebo (46), 6 complete study protocol (3 group).",G0000000|C0450371|C0027361|C0450371|C0086582|C2699239|C0001779|C0450371|C0450371|C0439234|G0000000|C1516050|C0024467|C0030015|C0450371|C0032042|C0450371|G0000000|C0205197|C0557651|C0442711|G0000000|C0441833
"The student body is diverse: 37% of students are black, 39% are Hispanic, 13% are white, and 9% are Asian, and approximately 74% of students are eligible for free or reduced-price meals.","The student body diverse: 37% students black, 39% Hispanic, 13% white, 9% Asian, 74% students eligible free reduced-price meals.",G0000000|C0038492|C0242821|C1880371|C0450371|C0038492|C0005680|C0450371|C0086409|C0450371|C0007457|G0000000|C0078988|C0450371|C0038492|C1548635|C0332296|C0392756|C1998602
"Since yoga and pranayama can be easily adopted as supportive therapies and encouraged by the results of the above-mentioned studies, this study tested the effectiveness of pranayama on cancer-related fatigue among breast cancer patients undergoing radiation therapy in Shirdi Sai Baba Cancer Hospital and Research Center, Manipal.","Since yoga pranayama easily supportive therapies encouraged above-mentioned studies, study tested effectiveness pranayama cancer-related fatigue breast cancer patients undergoing radiation therapy Shirdi Sai Baba Cancer Hospital Research Center, Manipal.",C1711239|C0043418|G0000000|C0332219|C1521721|C0087111|G0000000|C1282910|C0947630|C0557651|C0392366|C1280519|G0000000|C2826292|C0015672|C0006141|C0006826|C0030705|G0000000|C0034519|C0039798|G0000000|G0000000|G0000000|C0006826|C0019994|C0035168|C0205099|G0000000
The persistence with treatment is shown in Figure Figure1.1.,The persistence treatment Figure Figure1.1.,G0000000|C0546816|C0039798|G0000000|G0000000
"Childhood nutritional status in Malawi is poor: 19% of children <5 y of age are underweight (HZ < −2), 4% are wasted (WHZ < −2), and 2% are severely malnourished (WHZ < −3 or with edema) (1).","Childhood nutritional status Malawi poor: 19% children <5 age underweight (HZ < −2), 4% wasted (WHZ < −2), 2% severely malnourished (WHZ < −3 edema) (1).",C0231335|C1521739|C0449438|C0024548|C0032854|C0450371|C0008059|G0000000|C0001779|C0041667|C0439482|G0000000|G0000000|G0000000|C0235394|G0000000|G0000000|G0000000|G0000000|C0205082|C0162429|G0000000|G0000000|G0000000|C0013604|G0000000
A total of 443 smokers each received 5 telephone counseling calls and nicotine replacement therapy by mail for 4 weeks.,A total 443 smokers received 5 telephone counseling calls nicotine replacement therapy mail 4 weeks.,G0000000|C0439175|C1442061|C0337664|C1514756|G0000000|C0039457|C0010210|C0679006|C0028040|C0035139|C0039798|C0024492|G0000000|C0439230
Forty patients (24 female) with a median age of 4.3 years (3 months–11.8 years) at diagnosis were studied.,Forty patients (24 female) median age 4.3 (3 months–11.8 years) diagnosis studied.,C3816449|C0030705|C0450371|C0015780|C0549183|C0001779|G0000000|G0000000|G0000000|C0439234|C0011900|C0557651
Fruit and vegetable intakes were not restricted.,Fruit vegetable intakes restricted.,C0016767|C0042440|C1512806|C0443288
"The exclusion criteria were 1) psychiatric and neurologic disorders (eg, bipolar disorder, schizophrenia, stroke, Parkinson’s disease, epilepsy and so on), 2) history of alcohol or other substance abuse, and 3) sensory and/or motor deficits affecting the use of a tablet-PC.","The exclusion criteria 1) psychiatric neurologic disorders (eg, bipolar disorder, schizophrenia, stroke, Parkinson’s disease, epilepsy on), 2) history alcohol substance abuse, 3) sensory and/or motor deficits tablet-PC.",G0000000|C0680251|C0243161|G0000000|C0205487|C0205494|C0012634|C0013715|C0443156|C0012634|C0036341|C0038454|G0000000|C0012634|C0014544|G0000000|G0000000|C0019664|C0001962|C0439861|C0013146|G0000000|C0445254|G0000000|C1513492|C2987487|C0039225
"Exclusion: Exclusion criteria are patients (1) with demonstrated cognitive or psychological difficulties that would preclude study participation as defined by the treatment team, (2) who are too unwell to participate in the study as determined by the patient’s treatment team, (3) who have received treatment for a prior cancer (excluding non-melanoma skin cancer), and (4) who have a PCP who is already participating in the study (to avoid contamination between randomisation groups).","Exclusion: Exclusion criteria patients (1) demonstrated cognitive psychological difficulties preclude study participation defined treatment team, (2) unwell participate study determined patient’s treatment team, (3) received treatment prior cancer (excluding non-melanoma skin cancer), (4) PCP participating study (to avoid contamination randomisation groups).",C0680251|C0680251|C0243161|C0030705|G0000000|G0000000|C1516691|C0205486|C1299586|G0000000|C0557651|C0679823|C1704788|C0039798|C0871489|G0000000|C0683320|G0000000|C0557651|G0000000|G0000000|C0039798|C0871489|G0000000|C1514756|C0039798|C0332152|C0006826|C0332196|C1518422|C0444099|C0006826|G0000000|C1535939|C0679823|C0557651|G0000000|G0000000|C0259846|C0034656|C0441833
"Exclusion criteria were: age under 14 yrs (lower age of patients admitted to Sri Lankan adult medical wards); prior treatment with activated charcoal during this episode of poisoning; known pregnancy; ingestion of a corrosive; ingestion of a hydrocarbon alone; requirement for oral medication; inability of the medical staff to intubate the patient with Glasgow Coma Score (GCS) <13; presentation >72 hrs post-ingestion, and previous recruitment to the RCT.","Exclusion criteria were: age 14 yrs (lower age patients admitted Sri Lankan adult medical wards); prior treatment activated charcoal episode poisoning; pregnancy; ingestion corrosive; ingestion hydrocarbon alone; requirement oral medication; inability medical staff intubate patient Glasgow Coma Score (GCS) <13; presentation >72 hrs post-ingestion, previous recruitment RCT.",C0680251|C0243161|G0000000|C0001779|C0450371|G0000000|C0441994|C0001779|C0030705|C0184666|C1420401|G0000000|C0001675|C0199168|C1305702|C0332152|C0039798|C1879547|C0007955|C0332189|C0032343|C0032961|C0232478|C0524525|C0232478|C0020242|C0205171|C1514873|C0442027|C0013227|G0000000|C0199168|C0851286|G0000000|C0030705|G0000000|C0009421|C0449820|G0000000|C0450371|C0449450|C0450371|G0000000|C0687676|C0205156|C2949735|G0000000
Advanced breast cancer (BC) and ovarian cancer (OC) are two of the most lethal gynaecologic malignancies in developed countries (1).,Advanced breast cancer (BC) ovarian cancer (OC) lethal gynaecologic malignancies developed countries (1).,C0205179|C0006141|C0006826|C0006041|C0205065|C0006826|C1412791|C3151529|C0205480|C0006826|G0000000|C0454664|G0000000
"Women at 34-36.5 weeks of gestation with a singleton breech presentation (confirmed by ultrasound), were randomised to moxibustion plus usual care or usual care alone.","Women 34-36.5 weeks gestation singleton breech presentation (confirmed ultrasound), randomised moxibustion usual care usual care alone.",C0043210|C0450371|C0439230|C0032961|C0481462|C3841404|C0449450|C0521093|C0041618|G0000000|C0026652|C3538928|C1947933|C3538928|C1947933|C0205171
"During deep relaxation, the participants were given suggestions targeted at switching their self-image from that of smokers to non-smokers.","During deep relaxation, participants suggestions targeted switching self-image smokers non-smokers.",G0000000|C0205125|C0035028|C0679646|C0038659|C1521840|C1707719|C0242498|C0337664|C0337672
A total of 110 mother–infant dyads completed the year-long study.,A total 110 mother–infant dyads completed year-long study.,G0000000|C0439175|C1442061|G0000000|C0870454|C0205197|C0439234|C0557651
Patients who smoke less than 10 cigarettes/day and patients who did not wish to have a genetic test or do not wish to take part in a research study will be referred to the practice nurse for smoking cessation.,Patients smoke 10 cigarettes/day patients genetic test study referred practice nurse smoking cessation.,C0030705|C0037366|C0450371|C0677453|C0030705|C0017296|C0022885|C0557651|C0205543|C0237607|C0028661|C0037369|C1880019
Recruits who are unable to train because they are sick or lack physical conditioning are removed from training and are placed in either the medical convalescent unit (MCU) or the physical conditioning unit (PCU).,Recruits unable train sick lack physical conditioning removed training medical convalescent unit (MCU) physical conditioning unit (PCU).,G0000000|C1299582|C0336809|C0221423|C0332268|C0031809|C0009647|C0849355|C0040607|C0199168|C0740326|C0439148|C1532565|C0031809|C0009647|C0439148|G0000000
Other eligibility criteria included: not currently receiving (and not planning to receive during the study duration) chemotherapy or radiation therapy; ≥ 8 weeks post-surgery; English speaking; medical clearance for participation provided by physician.,Other eligibility criteria included: receiving (and planning receive study duration) chemotherapy radiation therapy; ≥ 8 weeks post-surgery; English speaking; medical clearance participation provided physician.,G0000000|C0013893|C0243161|C0332257|C1514756|G0000000|C0032074|C1514756|C0557651|C0449238|C0013216|C0034519|C0039798|G0000000|G0000000|C0439230|C0032790|C0376245|C0234856|C0199168|C0449297|C0679823|C1999230|C0031831
Two patients who received the DC vaccine pulsed with peptides eluted from autologous OCs were also excluded.,Two patients received DC vaccine pulsed peptides eluted autologous OCs excluded.,C0205448|C0030705|C1514756|G0000000|C0042210|C1947910|C0030956|G0000000|C0439859|G0000000|C1554077
Score range for patients to be included was between 40 and 60 of grasp and dissociated movement items on QUEST.,Score range patients included 40 60 grasp dissociated movement items QUEST.,C0449820|C1514721|C0030705|C0332257|C0450371|C0450371|C0220843|G0000000|C0026649|C1551338|C0750565
"Moreover, for children that age (kindergarten: 3 to 6 years), the SCT is an ideal framework since its implementation strategies such as model learning can be accomplished very well in the kindergarten setting [28].","Moreover, children age (kindergarten: 3 6 years), SCT ideal framework implementation strategies model learning accomplished kindergarten setting [28].",G0000000|C0008059|C0001779|C0681406|G0000000|G0000000|C0439234|C0860888|C1512612|G0000000|C1708476|C0679199|C3161035|C0013621|G0000000|C0681406|C0542559|C0450371
Data for the primary outcome were available for all of these patients (Figure 1▶).,Data primary outcome patients (Figure 1▶).,C1511726|C0205225|C1274040|C0030705|G0000000|G0000000
"Completers had a mean age of 50.3 years (range from 23 to 72), had been diagnosed with FM for a mean of 5.9 years (range 1 to 20 years), and averaged 2.6 years of college (all had at least a 10th grade education).","Completers age 50.3 (range 23 72), diagnosed FM 5.9 (range 1 20 years), averaged 2.6 college (all 10th grade education).",G0000000|C0001779|C0450371|C1514721|C0450371|C0450371|C0011900|C3540627|G0000000|C1514721|G0000000|C0450371|C0439234|C1510992|G0000000|C0557806|G0000000|G0000000|C0441800|C0013621
"The trial will involve people expected to be on intensive care and high dependency units (levels 2 and 3 care) under the care of the intensive care unit consultants for at least 48 hours, aged 16 years or over, who require parenteral nutrition and are expected to have at least half of daily nutritional requirements given by that route.","The trial involve people expected intensive care dependency units (levels 2 3 care) care intensive care unit consultants 48 hours, aged 16 over, require parenteral nutrition expected half daily nutritional requirements route.",G0000000|C0008976|G0000000|C0027361|C1517001|C0162425|C1947933|C0011546|C0439148|C0441889|G0000000|G0000000|C1947933|C1947933|C0162425|C1947933|C0439148|C0009817|C0450371|C0439227|C0001779|C0450371|C0205136|G0000000|C0030547|C0028707|C1517001|C2825407|C0332173|C1521739|C1514873|C0013153
© 2001 Cancer Research Campaign http://www.bjcancer.com,© 2001 Cancer Research Campaign http://www.bjcancer.com,G0000000|G0000000|C0006826|C0035168|G0000000|C1555015
"Women with psychiatric (bipolar affective disorder, major depression, psychosis, alcohol and/or substance dependence), neuropsychiatric (dementia), or medical conditions (current hospitalization) that might interfere with them benefiting from the intervention were temporarily excluded pending treatment.","Women psychiatric (bipolar affective disorder, major depression, psychosis, alcohol and/or substance dependence), neuropsychiatric (dementia), medical conditions (current hospitalization) interfere benefiting intervention temporarily excluded pending treatment.",C0043210|C0205487|C0443156|G0000000|C0012634|C0205082|C0011570|C0033975|C0001962|G0000000|C0439861|C0011546|G0000000|C0011265|C0199168|C0012634|C0521116|C0019993|C0521102|C0814225|C0886296|G0000000|C1554077|G0000000|C0039798
Information on patients' hospital admissions and presentations at the emergency department during the three months after the index admission was obtained from hospital records.,Information patients' hospital admissions presentations emergency department months admission hospital records.,C1533716|C0030705|C0019994|C0184666|C0449450|C0013956|C1704729|C0439231|C0184666|C0019994|C0034869
"Peripheral systolic BP was reduced by mean 10 [95% CI 1–20] mm Hg from mean ± SD 159 ± 14 mm Hg at the high sodium period to 148 ± 21 mm Hg at the low sodium period (p = 0.04), while diastolic BP was reduced by 6 [95% CI 1–10] mm Hg from 87 ± 10 mm Hg at the high sodium to 82 ± 12 mm Hg at the low sodium period (p = 0.03).","Peripheral systolic BP reduced 10 [95% CI 1–20] mm Hg mean ± SD 159 ± 14 mm Hg sodium period 148 ± 21 mm Hg low sodium period (p = 0.04), diastolic BP reduced 6 [95% CI 1–10] mm Hg 87 ± 10 mm Hg sodium 82 ± 12 mm Hg low sodium period (p = 0.03).",C0205100|C0039155|C0037623|C0392756|C0450371|C0450371|C0008107|G0000000|G0000000|C0025424|G0000000|C2699239|G0000000|G0000000|C0025424|C0037473|C0439531|G0000000|C0450371|G0000000|C0025424|C0205251|C0037473|C0439531|G0000000|C0012000|C0037623|C0392756|G0000000|C0450371|C0008107|G0000000|G0000000|C0025424|G0000000|G0000000|C0025424|C0037473|G0000000|G0000000|C0025424|C0205251|C0037473|C0439531|G0000000
"Patients will be excluded in case of previous incontinence surgery, in case of pelvic organ prolapse 1 centimeter beyond the level of the hymen and/or in case of residual bladder volume of more than 150 ml on ultrasound or catheterization [see figure figure22].","Patients excluded previous incontinence surgery, pelvic organ prolapse 1 centimeter level hymen and/or residual bladder volume 150 ultrasound catheterization [see figure figure22].",C0030705|C1554077|C0205156|C0021167|C0038894|C0030797|C0178784|C0033377|G0000000|C0475210|C0441889|C0020412|G0000000|C1609982|C0005682|C0449468|C1442061|C0041618|C0007430|C0042789|G0000000|G0000000
"Phase-3, randomized, double-blind, placebo-controlled, multinational trial conducted from November 2009 to July 2012 in eligible untreated patients with Gaucher disease type 1 who had splenomegaly plus thrombocytopenia and/or anemia.","Phase-3, randomized, double-blind, placebo-controlled, multinational trial conducted November 2009 July 2012 eligible untreated patients Gaucher disease type 1 splenomegaly thrombocytopenia and/or anemia.",C3272459|C0034656|C0013072|C1706408|G0000000|C0008976|C0004927|C3828767|G0000000|C3829447|G0000000|C1548635|C0332155|C0030705|G0000000|C0012634|C0332307|G0000000|C0038002|C0040034|G0000000|C0002871
"Other exclusion criteria also included a history of cardiac insufficiency (NY Heart Association Status ≥2), active, untreated infection, prior or concomitant malignancy (other than curatively treated in situ cervical carcinoma or basal/squamous cell skin carcinoma) or sensitivity to E.Coli derived proteins that would preclude use of granulocyte colony stimulating factor (G-CSF).","Other exclusion criteria included history cardiac insufficiency (NY Heart Association Status ≥2), active, untreated infection, prior concomitant malignancy (other curatively treated situ cervical carcinoma basal/squamous cell skin carcinoma) sensitivity E.Coli derived proteins preclude granulocyte colony stimulating factor (G-CSF).",G0000000|C0680251|C0243161|C0332257|C0019664|C0018787|C0231179|C0027976|C0018787|C0004083|C0449438|G0000000|C0205177|C0332155|C0009450|C0332152|C0521115|C0006826|G0000000|G0000000|C1522326|G0000000|C0027530|C0007097|C0205112|C0007634|C0444099|C0007097|C0020517|C0014834|C1441547|C0033684|G0000000|C0018183|C0439158|C1948023|C1521761|C0079459
A randomized clinical trial was designed.,A randomized clinical trial designed.,G0000000|C0034656|C0205210|C0008976|C1707689
"The exclusion criteria were: time from pain onset to randomization >24 hours, known history of renal disease (basal creatinine >2 mg/dl, patient under chronic hemodialysis), greater than New York Heart Association class II heart failure, chronic lung disease requiring supplemental home oxygen, active acute infection (including acute cholecystitis and acute cholangitis), hypernatremia (serum sodium>145 mEq/l) or hyponatremia (<135 mEq/l), rhabdomyolysis, metastatic malignant disease, autoimmune diseases associated with inflammation (including inflammatory bowel disease), chronic infection (e.g.","The exclusion criteria were: time pain onset randomization >24 hours, history renal disease (basal creatinine >2 mg/dl, patient chronic hemodialysis), New York Heart Association class II heart failure, chronic lung disease requiring supplemental oxygen, active acute infection (including acute cholecystitis acute cholangitis), hypernatremia (serum sodium>145 mEq/l) hyponatremia (<135 mEq/l), rhabdomyolysis, metastatic malignant disease, autoimmune diseases inflammation (including inflammatory bowel disease), chronic infection (e.g.",G0000000|C0680251|C0243161|G0000000|C0040223|C0030193|C0206132|C0034656|C0450371|C0439227|C0019664|C0022646|C0012634|C0205112|C0010294|G0000000|C0030705|C0205191|C0019004|C0205314|G0000000|C0018787|C0004083|C0456387|G0000000|C0018787|C0231174|C0205191|C0024109|C0012634|G0000000|C2348609|C0030054|C0205177|C0205178|C0009450|C0332257|C0205178|C0008325|C0205178|C0008311|C0020488|C0229671|G0000000|C0020625|G0000000|C0035410|C0036525|C0205282|C0012634|C0443146|C0012634|C0021368|C0332257|C0333348|C0021853|C0012634|C0205191|C0009450|G0000000
"Patients—Children eligible for inclusion in our study were those who had had recurrent otitis media and who had been either referred by their general practitioner or a paediatrician to the open care unit of the ear, nose, and throat department at Lundby Hospital or were directly seeking medical advice for ear pain.","Patients—Children eligible inclusion study recurrent otitis media referred practitioner paediatrician care unit ear, nose, throat department Lundby Hospital directly seeking medical advice ear pain.",G0000000|C1548635|C0007637|C0557651|C2945760|C0029877|C0009458|C0205543|C1709627|C0237433|C1947933|C0439148|C0013443|C0028429|C0031354|C1704729|G0000000|C0019994|C1947931|G0000000|C0199168|C0150600|C0013443|C0030193
Most participants were heavy smokers who smoked their first cigarette each morning within 30 minutes of waking up.,Most participants heavy smokers smoked cigarette morning 30 minutes waking up.,C0205393|C0679646|C0439539|C0337664|C0037366|C0677453|C0332170|C0450371|C0439232|C0442696|G0000000
"Evaluations of physical activity and pain scores, serum biochemistry, hematology, and urine biochemistry were done at baseline (day 0) and on days 7, 30, 60 and 90 during follow up.","Evaluations physical activity pain scores, serum biochemistry, hematology, urine biochemistry baseline (day 0) days 7, 30, 60 90 follow up.",C0220825|C0031809|C0205177|C0030193|C0449820|C0229671|C0005477|C0018943|C0042036|C0005477|C0168634|C0332173|G0000000|C0439228|G0000000|C0450371|C0450371|C0450371|C0332283|G0000000
A psychiatrist confirmed the diagnosis of schizophrenia according to Diagnostic and Statistical Manual IV (DSM-IV)[7] criteria before allocating the random number.,A psychiatrist confirmed diagnosis schizophrenia Diagnostic Statistical Manual IV (DSM-IV)[7] criteria allocating random number.,G0000000|C0033872|C0521093|C0011900|C0036341|C0011900|C0038215|C0024763|C0022326|C0220952|C0243161|G0000000|C0034656|C0237753
"Between February 2012 and July 2014, 680 patients were enrolled.","Between February 2012 July 2014, 680 patients enrolled.",G0000000|C3830166|G0000000|C3829447|G0000000|C1442061|C0030705|G0000000
"The SARS case definition criteria for SARS cases, used by Hong Kong Hospital Authority, is as follows: radiographic evidence of infiltrates consistent with pneumonia and current temperature >38°C or a history of such at any time in the preceding 2 days, and at least two of the following: history of chills in the past 2 days, new or increased cough, breathing difficulty, general malaise or myalgia, typical signs of consolidation, and known exposure.","The SARS definition criteria SARS cases, Hong Kong Hospital Authority, follows: radiographic evidence infiltrates consistent pneumonia current temperature >38°C history time preceding 2 days, following: history chills 2 days, increased cough, breathing difficulty, malaise myalgia, typical signs consolidation, exposure.",G0000000|C1175175|C1550452|C0243161|C1175175|C0868928|G0000000|G0000000|C0019994|C0599437|C0332283|C0444708|C3887511|C0332448|C0332290|C0032285|C0521116|C0005903|G0000000|C0019664|C0040223|C0332152|G0000000|C0439228|C0231290|C0019664|C0085593|G0000000|C0439228|C0205217|C0010200|C0004048|C1299586|C0231218|C0231528|C3538928|C0220912|C0702116|C0274281
Kenya had the highest proportion of households without access to any facility (30% case and 29% control households).,Kenya proportion households access facility (30% 29% control households).,C0022558|C1709707|C0020052|C0444454|C1547538|C0450371|C0450371|C0243148|C0020052
A possible interaction between COPD and heart disease was tested in model 1 and an interaction between heart disease and FEV1 in the later models.,A interaction COPD heart disease tested model 1 interaction heart disease FEV1 models.,G0000000|C1704675|C0024117|C0018787|C0012634|C0392366|C3161035|G0000000|C1704675|C0018787|C0012634|G0000000|C3161035
Antibiotic pretreatment before hospital admission and radiographic signs of pneumonia did not preclude eligibility for the study.,Antibiotic pretreatment hospital admission radiographic signs pneumonia preclude eligibility study.,C0003232|C1550147|C0019994|C0184666|C0444708|C0220912|C0032285|G0000000|C0013893|C0557651
"This study was a randomized clinical trial study with Iranian registry of clinical trials code of IRCT201309277513N4, which was carried out on pregnant women referred to obstetric clinics of Alzahra Hospital and Shahid Beheshti Hospital in Isfahan, Iran.","This study randomized clinical trial study Iranian registry clinical trials code IRCT201309277513N4, carried pregnant women referred obstetric clinics Alzahra Hospital Shahid Beheshti Hospital Isfahan, Iran.",G0000000|C0557651|C0034656|C0205210|C0008976|C0557651|C1553355|C0034975|C0205210|C0008976|C0009219|G0000000|C0206243|C0549206|C0043210|C0205543|C0205484|C0442592|G0000000|C0019994|G0000000|G0000000|C0019994|G0000000|C0022065
"Women were considered for inclusion in the study if they were in gestation week 18 to 22, were aged 18 to 35 years, planned to deliver at the IMSS General Hospital in Cuernavaca, planned to predominantly breastfeed for at least 3 months, and planned to live in the area for 2 years after delivery.","Women considered inclusion study gestation week 18 22, aged 18 35 years, planned deliver IMSS General Hospital Cuernavaca, planned breastfeed 3 months, planned live 2 delivery.",C0043210|C0750591|C0007637|C0557651|C0032961|C0332174|C0450371|C0450371|C0001779|C0450371|C0450371|C0439234|C1301732|C0308779|G0000000|C0205246|C0019994|G0000000|C1301732|C0006147|G0000000|C0439231|C1301732|C1548795|G0000000|C0011209
"A randomized, double-blind, placebo-controlled, parallel-group trial conducted across 9 academic US medical centers in the National Heart, Lung, and Blood Institute’s AsthmaNet network, with enrollment starting in April 2011 and follow-up complete by December 2014.","A randomized, double-blind, placebo-controlled, parallel-group trial conducted 9 academic US medical centers National Heart, Lung, Blood Institute’s AsthmaNet network, enrollment starting April 2011 follow-up complete December 2014.",G0000000|C0034656|C0013072|C1706408|C2348042|C0008976|C0004927|G0000000|C1510747|G0000000|C0199168|C0205099|C3245503|C0018787|C0024109|C0005767|G0000000|G0000000|C0150775|C1516879|C0439659|C3715024|G0000000|C0589120|C0205197|C3830550|G0000000
"history of contact with a scabies patient, complaint of nocturnal itching, history of involvement of family members, presence of classical burrows on clinical examination, and presence of typical scabetic lesions like papules, nodules, or vesicles.","history contact scabies patient, complaint nocturnal itching, history involvement family members, presence classical burrows clinical examination, presence typical scabetic lesions papules, nodules, vesicles.",C0019664|C0332158|C0036262|C0030705|C0277786|C0240526|C0033774|C0019664|C1314939|C0015576|C0680022|C0150312|C0439858|C0332816|C0205210|G0000000|C0150312|C3538928|G0000000|C0221198|C0332563|C0028259|C0333262
Enrollment screening occurred Mondays through Thursdays from approximately 11 AM to 8 PM beginning 1/7/2014 through 2/14/2014.,Enrollment screening occurred Mondays Thursdays 11 AM 8 PM 1/7/2014 2/14/2014.,C1516879|C0220908|C1709305|C0585024|C0585028|C0450371|G0000000|G0000000|C0030266|G0000000|C0450371
"We examined the risk of lung cancer in relation to green tea consumption in a population-based cohort study in Japan among 41 440 men and women, aged 40–79 years, who completed a questionnaire in 1994 regarding green tea consumption and other health-related lifestyle factors.","We examined risk lung cancer relation green tea consumption population-based cohort study Japan 41 440 women, aged 40–79 years, completed questionnaire 1994 green tea consumption health-related lifestyle factors.",G0000000|C0332128|C0035647|C0024109|C0006826|C0080103|C0332583|C0039400|C0009830|C0032659|C0599755|C0557651|C0022341|G0000000|C0043210|C0001779|G0000000|C0439234|C0205197|C0034394|G0000000|C0332583|C0039400|C0009830|C0018684|C0023676|C1521761
Data on the prevalence and severity of erosive esophagitis (EE) in young children are limited.,Data prevalence severity erosive esophagitis (EE) children limited.,C1511726|C0033105|C0439793|C0439679|C0014868|G0000000|C0008059|C0439801
Exclusion criteria: patients who were not volunteer to abide by the agreement; patients with chronic obstructive lung disease; patients with associated lung disease (diagnosed to be with active tuberculosis; patients with severe asthmatic attack since they can not sit comfortable to attend the yoga practice; patients who are diagnosed to have cardiac disease were excluded.,Exclusion criteria: patients volunteer abide agreement; patients chronic obstructive lung disease; patients lung disease (diagnosed active tuberculosis; patients severe asthmatic attack sit comfortable attend yoga practice; patients diagnosed cardiac disease excluded.,C0680251|C0243161|C0030705|C0042960|G0000000|C0680240|C0030705|C0205191|C0549186|C0024109|C0012634|C0030705|C0024109|C0012634|C0011900|C0205177|C0041296|C0030705|C0205082|C0004096|C0277793|C0277814|G0000000|C1999232|C0043418|C0237607|C0030705|C0011900|C0018787|C0012634|C1554077
"Patients who were pregnant and those with diabetes mellitus, cirrhosis of the liver, chronic renal failure, myasthenia gravis, a bleeding tendency, history of allergy to macrolides, antibiotic treatment within 2 weeks of the study, or long-term immunosuppression were excluded from the study.","Patients pregnant diabetes mellitus, cirrhosis liver, chronic renal failure, myasthenia gravis, bleeding tendency, history allergy macrolides, antibiotic treatment 2 weeks study, long-term immunosuppression excluded study.",C0030705|C0549206|C0011847|G0000000|C0023890|C0023884|C0205191|C0022646|C0231174|C0947912|C0205082|C0019080|G0000000|C0019664|C0002111|C0003240|C0003232|C0039798|G0000000|C0439230|C0557651|C0443252|C0021079|C1554077|C0557651
Women confirmed as being <20 wk pregnant and with a singleton pregnancy were randomly assigned into the trial.,Women confirmed <20 wk pregnant singleton pregnancy randomly assigned trial.,C0043210|C0521093|C0450371|C0332174|C0549206|C0481462|C0032961|G0000000|C1516050|C0008976
"); (3) contraindication to participation in regular physical activity; (4) metastatic or recurrent breast cancer; (5) inability to ambulate; (6) elective surgery anticipated during the intervention which would interfere with participation (e.g., breast reconstructive surgery); (7) travel plans interfering with the scheduled study sessions; and 8) participating in another exercise study.","); (3) contraindication participation regular physical activity; (4) metastatic recurrent breast cancer; (5) inability ambulate; (6) elective surgery anticipated intervention interfere participation (e.g., breast reconstructive surgery); (7) travel plans interfering scheduled study sessions; 8) participating exercise study.",G0000000|G0000000|C0522473|C0679823|C0205272|C0031809|C0205177|G0000000|C0036525|C2945760|C0006141|C0006826|G0000000|G0000000|C4036205|G0000000|C0206058|C0038894|C3840775|C0886296|C0521102|C0679823|G0000000|C0006141|C0020912|C0038894|G0000000|C0040802|C0270724|C0521102|C0086960|C0557651|C1883016|G0000000|C0679823|C0015259|C0557651
"Over a period of about 2 1/2 years, all women in the 9 Cree communities who recently had given birth or were between about the 12th and 34th week of their pregnancy were asked to participate in the study.","Over period 2 1/2 years, women 9 Cree communities birth 12th 34th week pregnancy participate study.",C0205136|C0439531|G0000000|G0000000|C0439234|C0043210|G0000000|C0574533|C0009462|C0005615|G0000000|G0000000|C0332174|C0032961|G0000000|C0557651
"HIV-infected children (N = 126)—age >7 to <12 years, with a CD4% ≥15—and on stable antiretroviral therapy if CD4% was <25—were blindly assigned to receive a dose of QHPV or placebo (3:1 ratio) at 0, 8, and 24 weeks.","HIV-infected children (N = 126)—age >7 <12 years, CD4% ≥15—and stable antiretroviral therapy CD4% <25—were blindly assigned receive dose QHPV placebo (3:1 ratio) 0, 8, 24 weeks.",C0019682|C0008059|C0369718|G0000000|G0000000|G0000000|C0450371|C0439234|C0285590|G0000000|C0205360|G0000000|C0039798|C0285590|G0000000|G0000000|C1516050|C1514756|C0178602|G0000000|C0032042|G0000000|C0456603|G0000000|G0000000|C0450371|C0439230
"Children were eligible if they were between 5 and 12 years of age, had open growth plates and presented to the emergency department with a minimally angulated or a minimally displaced acute greenstick or transverse fracture of the metaphyseal portion of the distal radius (see radiographs in Appendix 1, available at www.cmaj.ca/cgi/content/full/cmaj.100119/DC1).","Children eligible 5 12 age, growth plates emergency department minimally angulated minimally displaced acute greenstick transverse fracture metaphyseal portion distal radius (see radiographs Appendix 1, www.cmaj.ca/cgi/content/full/cmaj.100119/DC1).",C0008059|C1548635|G0000000|C0450371|C0001779|C0018270|C1139930|C0013956|C1704729|G0000000|C0333179|G0000000|C0012727|C0205178|C0332716|C0205106|C0016658|C0222671|C0449719|C0205108|C0034627|C0042789|C1306645|C0003617|G0000000|C0282111
"The mean patient age in both groups was 21 years, Almost all (99%) participants had a history of ≥1 UTI; 200 (62.7%) participants reported ≥4 UTIs in their life, and 149 (46.7%) reported ≥3 UTIs in the previous 12 months.","The patient age 21 years, Almost (99%) participants history ≥1 UTI; 200 (62.7%) participants reported ≥4 UTIs life, 149 (46.7%) reported ≥3 UTIs previous 12 months.",G0000000|C0030705|C0001779|C0450371|C0439234|C3828842|C0450371|C0679646|C0019664|G0000000|C0042029|C1442061|C0450371|C0679646|C0684224|G0000000|C0042029|C0376558|C1442061|C0450371|C0684224|G0000000|C0042029|C0205156|C0450371|C0439231
Only women with uncomplicated PID were recruited into this study.,Only women uncomplicated PID recruited study.,C0205171|C0043210|C0443334|C0242172|G0000000|C0557651
"Myotonic dystrophy (MD) is a multi-system disorder, the most well known symptoms being muscle weakness and myotonia.","Myotonic dystrophy (MD) multi-system disorder, symptoms muscle weakness myotonia.",G0000000|C0333606|G0000000|C0439064|C0012634|C0683368|C0026845|C3714552|C0027125
"Subjects in Cohort 1 with higher intake tended to be postmenopausal, while such women in Cohort 2 tended to be slightly older, postmenopausal and have a higher body mass index.","Subjects Cohort 1 intake tended postmenopausal, women Cohort 2 tended older, postmenopausal body mass index.",C0681850|C0599755|G0000000|C1512806|G0000000|C0232970|C0043210|C0599755|G0000000|G0000000|C0580836|C0232970|C0242821|C0577559|C0918012
"The inclusion criteria are as follows: over 18 years of age, absolutely homeless or in precarious housing, and possessing a ‘high’ level of need: diagnosis of schizophrenia or bipolar disorder and moderate to severe disability according to the Multnomah Community Ability Scale (score ≤ 62) and at least one of the following three criteria: 1) having been hospitalized for mental illness two or more times in any one year during the preceding five years; 2) co-morbid alcohol or substance use; and 3) having been recently arrested or incarcerated.","The inclusion criteria follows: 18 age, absolutely homeless precarious housing, possessing ‘high’ level need: diagnosis schizophrenia bipolar disorder moderate severe disability Multnomah Community Ability Scale (score ≤ 62) criteria: 1) hospitalized mental illness times preceding years; 2) co-morbid alcohol substance use; 3) arrested incarcerated.",G0000000|C0007637|C0243161|C0332283|C0450371|C0001779|G0000000|C0237154|G0000000|C0020056|C0850310|G0000000|C0441889|C0027552|C0011900|C0036341|C0443156|C0012634|C0205081|C0205082|C0231170|G0000000|C0009462|C0085732|C0175659|G0000000|C0243161|G0000000|C0701159|C0229992|C0221423|C0040223|C0332152|C0439234|G0000000|C0009488|C0001962|C0439861|C0042153|G0000000|C0018790|C0392751
"Participants were required to be between 18 and 70 years, to have been smoking at least 10 but no more than 40 cigarettes/day for more than 3 years, have a Fagerström Score of at least 5 at screening [15], and willing to quit smoking.","Participants required 18 70 years, smoking 10 40 cigarettes/day 3 years, Fagerström Score 5 screening [15], quit smoking.",C0679646|C1514873|C0450371|C0450371|C0439234|C0037369|C0450371|C0450371|C0677453|G0000000|C0439234|G0000000|C0449820|G0000000|C0220908|C0450371|C0748223|C0037369
"Preterm infants of gestation 28 weeks 0 days to 33 weeks 6 days delivered by elective caesarean section were included, if insufficient breathing efforts [heart rate (HR) <100 beats per minute (bpm) or irregular breathing] and/or pronounced signs of respiratory distress (grunting, tachypnea and increased work of breathing) were present.","Preterm infants gestation 28 weeks 0 days 33 weeks 6 days delivered elective caesarean included, insufficient breathing efforts [heart rate (HR) <100 beats minute (bpm) irregular breathing] and/or pronounced signs respiratory distress (grunting, tachypnea increased breathing) present.",C0151526|C0021270|C0032961|C0450371|C0439230|G0000000|C0439228|C0450371|C0439230|G0000000|C0439228|C1705822|C0206058|C3841297|C0332257|C0205412|C0004048|C0015264|C0018787|C0871208|G0000000|C1442061|G0000000|C0439232|G0000000|C0205271|C0004048|G0000000|G0000000|C0220912|C0521346|C0231303|C0234892|C0231835|C0205217|C0004048|C0150312
Interventions Monitoring of cerebral oxygenation using NIRS in combination with a dedicated treatment guideline during the first 72 hours of life (experimental) compared with blinded NIRS oxygenation monitoring with standard care (control).,Interventions Monitoring cerebral oxygenation NIRS combination dedicated treatment guideline 72 hours life (experimental) compared blinded NIRS oxygenation monitoring standard care (control).,C0886296|C0150369|G0000000|C0231940|C1826446|C0205195|C0011129|C0039798|C0162791|C0450371|C0439227|C0376558|C1517586|C1707455|C0150108|C1826446|C0231940|C0150369|C1442989|C1947933|C0243148
"Intermittent 7-day courses of high-dose nebulized budesonide, as compared with placebo, initiated during respiratory tract illnesses led to significant reductions in the severity of respiratory symptoms, without affecting linear growth, in the CARE Network Acute Intervention Management Strategies (AIMS) study (NCT00000622); benefits were most apparent in children with positive values on the modified API.11 In confirmation of these findings, preemptive use of intermittent high-dose fluticasone during upper respiratory illness reduced exacerbations requiring oral glucocorticoids in young children with moderate-to-severe, virus-induced wheezing.12 We conducted the Maintenance and Intermittent Inhaled Corticosteroids in Wheezing Toddlers (MIST) trial to determine whether a daily low-dose regimen of budesonide would be superior to an intermittent high-dose regimen in young children who had positive values on the modified API, along with recurrent wheezing, high-risk asthma (≥1 exacerbation in the previous year), and low impairment (infrequent use of albuterol and infrequent night awakenings between episodes).","Intermittent 7-day courses high-dose nebulized budesonide, compared placebo, initiated respiratory tract illnesses led reductions severity respiratory symptoms, linear growth, CARE Network Acute Intervention Management Strategies (AIMS) study (NCT00000622); benefits apparent children positive values modified API.11 In confirmation findings, preemptive intermittent high-dose fluticasone upper respiratory illness reduced exacerbations requiring oral glucocorticoids children moderate-to-severe, virus-induced wheezing.12 We conducted Maintenance Intermittent Inhaled Corticosteroids Wheezing Toddlers (MIST) trial determine daily low-dose regimen budesonide superior intermittent high-dose regimen children positive values modified API, recurrent wheezing, high-risk asthma (≥1 exacerbation previous year), low impairment (infrequent albuterol infrequent night awakenings episodes).",C0205267|C0332173|C0750729|C0444956|C1549531|C0054201|C1707455|C0032042|C1548602|C0521346|C1185740|C0221423|C1708698|C0301630|C0439793|C0521346|C0683368|C0205132|C0018270|C1947933|C0150775|C0205178|C0886296|C0001554|C0679199|C1947946|C0557651|G0000000|C0814225|C0750489|C0008059|C0439178|C0042295|C0392747|C0450371|G0000000|C0521091|C2607943|G0000000|C0205267|C0444956|C0082607|C1282910|C0521346|C0221423|C0392756|G0000000|G0000000|C0442027|C0017710|C0008059|C0205081|C0042776|C0043144|G0000000|C0004927|C0024501|C0205267|C0004048|C0001617|C0043144|C0682053|C0205430|C0008976|G0000000|C0332173|C0445550|C0040808|C0054201|C1282910|C0205267|C0444956|C0040808|C0008059|C0439178|C0042295|C0392747|G0000000|C2945760|C0043144|C0332167|C0004096|G0000000|G0000000|C0205156|C0439234|C0205251|C0221099|C0521114|C0001927|C0521114|C0240526|C1720052|C0332189
"Patients with metastatic, Her-2 negative esophagogastric adenocarcinoma will be registered before or after the initiation of a firstline chemotherapy regimen.","Patients metastatic, Her-2 negative esophagogastric adenocarcinoma registered initiation firstline chemotherapy regimen.",C0030705|C0036525|G0000000|C0205160|C0475468|C0001418|C1514821|C0589507|G0000000|C0013216|C0040808
"If effective, the Healthy Babies project will result in a targeted baby-centered feeding support-education intervention targeting economically and educationally disadvantaged mothers of infants under the age of 1 year.","If effective, Healthy Babies project result targeted baby-centered feeding support-education intervention targeting economically educationally disadvantaged mothers infants age 1 year.",G0000000|C1280519|C3898900|C0021270|C1709701|C1274040|C1521840|C0021270|C0204695|C0183683|C0886296|C1521840|C0013556|G0000000|C0012613|C0026591|C0021270|C0001779|G0000000|C0439234
Women were eligible for the study if they were pregnant with a singleton and had low back pain of unknown origin that began during pregnancy and was reproducible by manual palpation.,Women eligible study pregnant singleton low pain unknown origin pregnancy reproducible manual palpation.,C0043210|C1548635|C0557651|C0549206|C0481462|C0205251|C0030193|C0439673|C0079946|C0032961|C1514863|C0024763|C0030247
"As an educational intervention, can smoking hygiene reduce the frequency of respiratory symptoms experienced by infants whose mothers smoke and breastfeed?","As educational intervention, smoking hygiene reduce frequency respiratory symptoms experienced infants mothers smoke breastfeed?",G0000000|C0587721|C0886296|C0037369|C0020405|G0000000|C0376249|C0521346|C0683368|C0237607|C0021270|C0026591|C0037366|C0006147
"Four patients were not tested for C difficile (one in probiotic group, three in control group) and thus were not included in the analysis for occurrence of diarrhoea associated with C difficile.","Four patients tested C difficile (one probiotic group, control group) included analysis occurrence diarrhoea C difficile.",C0205450|C0030705|C0392366|G0000000|G0000000|C0205447|C0525033|C0441833|C0243148|C0441833|C0332257|C0002778|C0243132|C0011991|G0000000|G0000000
Lung function did not change.,Lung function change.,C0024109|C0031843|C0392747
Single oral dose of 10 mg of dexamethasone (n = 293) or identical placebo (n = 283).,Single oral dose 10 dexamethasone (n = 293) identical placebo (n = 283).,C0037179|C0442027|C0178602|C0450371|C0011777|G0000000|C0205280|C0032042|G0000000
"We previously reported the noninferiority 1 month after the last dose of 2-dose human papillomavirus 16/18 AS04-adjuvanted (AS04-HPV-16/18) vaccine schedules at months 0 and 6 (2D_M0,6) and months 0 and 12 (2D_M0,12) in girls aged 9–14 years compared with a 3-dose schedule at months 0, 1, and 6 (3D_M0,1,6) in women aged 15–25 years.","We reported noninferiority 1 month dose 2-dose human papillomavirus 16/18 AS04-adjuvanted (AS04-HPV-16/18) vaccine schedules months 0 6 (2D_M0,6) months 0 12 (2D_M0,12) girls aged 9–14 compared 3-dose schedule months 0, 1, 6 (3D_M0,1,6) women aged 15–25 years.",G0000000|C0684224|G0000000|G0000000|C0332177|C0178602|C0178602|C0086418|C0030358|C0450371|C0001551|C0021344|C0042210|C0086960|C0439231|G0000000|G0000000|C0043316|C0439231|G0000000|C0450371|C0043316|C0870604|C0001779|G0000000|C1707455|C0178602|C0086960|C0439231|G0000000|G0000000|G0000000|C0043316|C0043210|C0001779|G0000000|C0439234
"The study consisted of patients in the age group 3–9 years, requiring dental treatment (extractions, pulpectomy, and restorations) exhibiting negative behavior according to Frankl's behavior rating scale in their first visit attending the outpatient Department of Paediatric and Preventive Dentistry, Himachal Pradesh Government Dental College and Hospital, Shimla.","The study consisted patients age 3–9 years, requiring dental treatment (extractions, pulpectomy, restorations) exhibiting negative behavior Frankl's behavior rating scale visit attending outpatient Department Paediatric Preventive Dentistry, Himachal Pradesh Government Dental College Hospital, Shimla.",G0000000|C0557651|C0332529|C0030705|C0001779|G0000000|C0439234|G0000000|C0011365|C0039798|C0185115|C0034102|C0449982|C0015272|C0205160|C0004927|G0000000|C0004927|C0871208|C0175659|C0545082|C1547429|C0029921|C1704729|C0030755|C0445202|C0011438|G0000000|G0000000|C0018104|C0011365|C0557806|C0019994|G0000000
"Adolescent participants were all non-Hispanic White, 83% were female, and ranged in age from 11 to 18 years (M = 15.7, SD = 2.23).","Adolescent participants non-Hispanic White, 83% female, ranged age 11 18 (M = 15.7, SD = 2.23).",C0205653|C0679646|C1518424|C0007457|C0450371|C0015780|C1514721|C0001779|C0450371|C0450371|C0369637|G0000000|C0450371|C2699239|G0000000|C0450371
"• Toxicity  ○ Assessed by the National Cancer Institute Common Toxicity Criteria (NCI-CTC) version 4 • Swallowing function, measured by:  ○ Feeding tube rate at 1-year  ○ MDADI  ○ CTC-AE Dysphagia scores • Age 18 or older, providing informed consent • ECOG performance status 0–2 • Histologically confirmed squamous cell carcinoma • Primary tumor site in the oropharynx (includes tonsil, soft palate, base of tongue, walls of oropharynx) • Tumor stage: T1 or T2, with likely negative resection margins at surgery • Nodal stage: N0, N1 (≤ 3 cm), or N2 (between 1–3 cm, on either side of the neck), without extranodal extension on pre-randomization imaging.","• Toxicity  ○ Assessed National Cancer Institute Common Toxicity Criteria (NCI-CTC) version 4 • Swallowing function, measured by:  ○ Feeding tube rate 1-year  ○ MDADI  ○ CTC-AE Dysphagia scores • Age 18 older, providing informed consent • ECOG performance status 0–2 • Histologically confirmed squamous cell carcinoma • Primary tumor site oropharynx (includes tonsil, soft palate, base tongue, walls oropharynx) • Tumor stage: T1 T2, negative resection margins surgery • Nodal stage: N0, N1 (≤ 3 cm), N2 (between 1–3 cm, neck), extranodal extension pre-randomization imaging.",G0000000|G0000000|C3245503|C0006826|C0021622|C0205214|C0040539|C0243161|C1513882|C0333052|G0000000|G0000000|C0031843|C0444706|G0000000|G0000000|C0175730|C0871208|C0439234|G0000000|G0000000|C0011168|C0449820|G0000000|C0450371|C0580836|C1999230|C1522154|C1511481|G0000000|C0597198|C0449438|G0000000|G0000000|C0521093|C1182670|C0007634|C0007097|G0000000|C0027651|C0205145|C0521367|C0332257|C0040421|C0205358|C0700374|C0002055|C0040408|C0677535|C0521367|G0000000|C0205390|C0041403|C0041403|C0205160|C0015252|C0205284|C0038894|G0000000|C0205390|C0445085|C0445085|G0000000|G0000000|C0445085|G0000000|G0000000|C0027530|C1517067|C0231448|C0332152|C0011923
"Seventy treatment-emergent adverse events were reported (33 in biofilm group, 37 in conventional group).","Seventy treatment-emergent adverse events reported (33 biofilm group, 37 conventional group).",C3816957|C0039798|G0000000|C0441471|C0684224|C0450371|C0081786|C0441833|C0450371|C0439858|C0441833
Brain tumor patients who experience tumor-related seizures are often placed on phenytoin (PHT) therapy.,Brain tumor patients experience tumor-related seizures phenytoin (PHT) therapy.,C0006104|C0027651|C0030705|C0237607|C0027651|C0036572|C0031507|C1324698|C0039798
"Accordingly, digoxin is one of the medications frequently seen in patients admitted to hospital due to adverse reactions [36].","Accordingly, digoxin medications frequently patients admitted hospital adverse reactions [36].",G0000000|C0012265|C0013227|C0332183|C0030705|C0184666|C0019994|G0000000|C0443286|C0450371
"After anterior resection for cancer, patients were allocated to either J-pouch or CP-anal anastomoses.","After anterior resection cancer, patients allocated J-pouch CP-anal anastomoses.",G0000000|C0205094|C0015252|C0006826|C0030705|G0000000|C0086492|C4050020|C0332853
"Further studies in CR2 ovarian cancer patients are warranted ({""type"":""clinical-trial"",""attrs"":{""text"":""NCT01068509"",""term_id"":""NCT01068509""}}NCT01068509).","Further studies CR2 ovarian cancer patients warranted ({""type"":""clinical-trial"",""attrs"":{""text"":""NCT01068509"",""term_id"":""NCT01068509""}}NCT01068509).",C1517331|C0947630|C1413723|C0205065|C0006826|C0030705|G0000000|C0332307
c) Classified as having poor asthma control by their doctor d) Access to the internet e) Smoking < 20 pack-years f) Can speak and understand English or French a) Diagnosis of COPD b) Other serious medical diagnoses (e.g.,c) Classified poor asthma control doctor d) Access internet e) Smoking < 20 pack-years f) Can speak understand English French a) Diagnosis COPD b) Other medical diagnoses (e.g.,G0000000|C0008902|C0032854|C0004096|C0243148|C0031831|C0073187|C0444454|C0282111|G0000000|C0037369|G0000000|C0450371|C1277691|C0016327|G0000000|C0234856|C0162340|C0376245|C0376246|G0000000|C0011900|C0024117|G0000000|G0000000|C0199168|C0011900|G0000000
"placenta praevia, persistent bleeding, cervical incompetence etc.","placenta praevia, persistent bleeding, cervical incompetence etc.",C0032043|G0000000|C0205322|C0019080|C0027530|C0231189|C1548556
Patients will not be eligible for the intervention if they meet the following exclusion criteria: previously diagnosed with cancer; those who currently exceed the recommended guidelines of 30 minutes of moderate intensity exercise five times a week; breast cancer is a secondary diagnosis and have a current psychiatric disorder.,Patients eligible intervention meet exclusion criteria: diagnosed cancer; exceed recommended guidelines 30 minutes moderate intensity exercise times week; breast cancer secondary diagnosis current psychiatric disorder.,C0030705|C1548635|C0886296|C1550543|C0680251|C0243161|C0011900|C0006826|G0000000|C0034866|C0162791|C0450371|C0439232|C0205081|C0522510|C0015259|C0040223|C0332174|C0006141|C0006826|C0027627|C0011900|C0521116|C0205487|C0012634
Six services allocated to the intervention and 17 services allocated to the control group did not provide baseline data and were therefore excluded.,Six services allocated intervention 17 services allocated control provide baseline data excluded.,C0205452|C0557854|G0000000|C0886296|C0450371|C0557854|G0000000|C0243148|C1999230|C0168634|C1511726|C1554077
"Finally, 199 patients were assigned randomly to the early oral feeding group (Group 1, n  = 99) or regular feeding group (Group 2, n = 100).","Finally, 199 patients assigned randomly oral feeding (Group 1,  = 99) regular feeding (Group 2, n = 100).",G0000000|C1442061|C0030705|C1516050|G0000000|C0442027|C0204695|C0441833|G0000000|G0000000|C0205272|C0204695|C0441833|G0000000|G0000000
"Application-site pain appeared to be delayed and, at the end of the treatment day, the mean maximum change in “average pain for the past 24 hours” NPRS score from baseline was 2.2 for those treated with NGX-4010 for 60 minutes and 1.5 for those treated with NGX-4010 for 30 minutes.","Application-site pain appeared delayed and, treatment day, maximum change “average pain 24 hours” NPRS score baseline 2.2 treated NGX-4010 60 minutes 1.5 treated NGX-4010 30 minutes.",C0229986|C0030193|C0700364|C0205421|G0000000|C0039798|C0332173|C0806909|C0392747|G0000000|C0030193|C0450371|G0000000|C1417814|C0449820|C0168634|G0000000|C1522326|G0000000|C0450371|C0439232|G0000000|C1522326|G0000000|C0450371|C0439232
"Exclusion criteria included patients having undergone intestinal resection, patients with serious co-morbidity including neurological, rheumatological, respiratory, nephrological, cardiovascular, psychiatric disease, patients with alcohol or drug addiction or dependency problems (within the last 5 years) and pregnant or lactating women.","Exclusion criteria included patients undergone intestinal resection, patients co-morbidity including neurological, rheumatological, respiratory, nephrological, cardiovascular, psychiatric disease, patients alcohol drug addiction dependency (within 5 years) pregnant lactating women.",C0680251|C0243161|C0332257|C0030705|G0000000|C0021853|C0015252|C0030705|C0009488|C0332257|C0205494|C0035452|C0521346|C0027712|C0007226|C0205487|C0012634|C0030705|C0001962|C0013227|C0085281|C0011546|G0000000|G0000000|C0439234|C0549206|C2828358|C0043210
Median age was 55 years (IQR 52–62).,Median age 55 (IQR 52–62).,C0549183|C0001779|C0450371|G0000000|G0000000
A total of 48 children who met the inclusion criteria requiring pulpotomy procedure in sixty teeth involving primary molars were included in the study after screening 127 children in the age group of 4–10 years who reported to the department of pedodontics and preventive dentistry.,A total 48 children met inclusion criteria requiring pulpotomy procedure sixty teeth involving primary molars included study screening 127 children age 4–10 reported department pedodontics preventive dentistry.,G0000000|C0439175|C0450371|C0008059|C0268621|C0007637|C0243161|G0000000|C0034104|C0184661|C3816724|C0040426|C1314939|C0205225|C0026367|C0332257|C0557651|C0220908|C1442061|C0008059|C0001779|G0000000|C0684224|C1704729|C0030763|C0445202|C0011438
SCI: spinal cord injury; TENS: transcutaneous electrical nerve stimulation.,SCI: spinal cord injury; TENS: transcutaneous electrical nerve stimulation.,C3642273|C0521329|C1550235|C3263722|C0014518|G0000000|C0013790|C0027740|C1292856
CONCLUSIONS: Domiciliary oxygen treatment does not prolong survival in patients with COPD with moderate hypoxaemia.,CONCLUSIONS: Domiciliary oxygen treatment prolong survival patients COPD moderate hypoxaemia.,C1707478|C0338047|C0030054|C0039798|G0000000|C0038952|C0030705|C0024117|C0205081|C0700292
The records of 216 women were available for analysis.,The records 216 women analysis.,G0000000|C0034869|C1442061|C0043210|C0002778
"At 12 months of age, the proportion of infants who had no evidence of hindbrain herniation was higher in the prenatal-surgery group (36%) than in the postnatal-surgery group (4%).","At 12 months age, proportion infants evidence hindbrain herniation prenatal-surgery (36%) postnatal-surgery (4%).",G0000000|C0450371|C0439231|C0001779|C1709707|C0021270|C3887511|C0035507|C0019270|C0678804|C0450371|C0443281|G0000000
The study involved 3999 patients in 24 hospital wards: 12 acute and 12 rehabilitation elderly care wards (figure(figure).).,The study involved 3999 patients 24 hospital wards: 12 acute 12 rehabilitation elderly care wards (figure(figure).).,G0000000|C0557651|C1314939|G0000000|C0030705|C0450371|C0019994|C1305702|C0450371|C0205178|C0450371|C0034991|C0001792|C1947933|C1305702|G0000000
The duration of both intra- and postoperative respiratory support as well as the overall duration of surgery were not different between all the three groups.,The duration intra- postoperative respiratory support duration surgery groups.,G0000000|C0449238|C0347985|C0032790|C0521346|C0183683|C0449238|C0038894|C0441833
"Then, participants were randomly assigned to either the TSM or WLC group by a form of adaptive randomization called minimization [63] so that the groups were evenly balanced according to age, time since diagnosis, menopausal status, receptor status, stage of disease, surgical procedure, type of hormone treatment (e.g., tamoxifen vs. AIs), other medications with possible cognitive effects (e.g., Effexor), and baseline subjective reports of cognitive function (FACT-Cog total score).","Then, participants randomly assigned TSM WLC form adaptive randomization called minimization [63] balanced age, time diagnosis, menopausal status, receptor status, stage disease, surgical procedure, type hormone treatment (e.g., tamoxifen vs. AIs), medications cognitive effects (e.g., Effexor), baseline subjective reports cognitive function (FACT-Cog total score).",C1883708|C0679646|G0000000|C1516050|G0000000|G0000000|C0348078|C0231193|C0034656|C0679006|G0000000|C0450371|C0205415|C0001779|C0040223|C0011900|C0025320|C0449438|C0597357|C0449438|C0205390|C0012634|C0543467|C0184661|C0332307|C0019932|C0039798|G0000000|C0039286|G0000000|G0000000|C0013227|C1516691|C1280500|G0000000|C0591437|C0168634|C0439655|C0684224|C1516691|C0031843|C3641649|C0439175|C0449820
"If the potential participant expressed an interest in the study, they were asked if they were ambulatory (being able to walk independently and thus complete the physical assessment required for the exercise intervention), if they had sought medical advice due to unexplained weight loss of greater than 3 kg in the past three months (which may suggest an underlying pathology), or if they intended to move house (to a different health centre catchment area) within the next three months.","If potential participant expressed study, ambulatory (being walk independently complete physical assessment required exercise intervention), sought medical advice unexplained weight loss 3 months (which underlying pathology), intended move house (to health centre catchment area) months.",G0000000|C3245505|C0679646|G0000000|C0557651|C0439841|G0000000|C0080331|G0000000|C0205197|C0031809|C1261322|C1514873|C0015259|C0886296|G0000000|C0199168|C0150600|G0000000|C0005910|C1517945|G0000000|C0439231|G0000000|G0000000|C0030664|C1283828|C0560560|C0442519|G0000000|C0018684|C0205099|G0000000|C0017446|C0439231
"Participants must receive their care within the Military Health System, plan to reside in the study area for at least 18 months, not at elevated risk of complications due to BMI on determination of pregnancy; BMI > 18 and < 30 kg/m2) not be actively involved in another weight management program, and speak English.","Participants receive care Military Health System, plan reside study 18 months, elevated risk complications BMI determination pregnancy; BMI > 18 < 30 kg/m2) actively involved weight management program, speak English.",C0679646|C1514756|C1947933|C0026126|C0018684|C0449913|C0270724|C2982691|C0557651|C0450371|C0439231|C0205250|C0035647|C0009566|G0000000|C1148554|C0032961|G0000000|G0000000|C0450371|G0000000|C0450371|C0022718|G0000000|C1314939|C0005910|C0001554|C1709697|C0234856|C0376245
"Abbreviations: GEMS, Global Enteric Multicenter Study; Demographics described as number (%) per case or control group.","Abbreviations: GEMS, Global Enteric Multicenter Study; Demographics (%) control group.",C0000723|C2350423|C0205246|C1304890|C0439743|C0557651|C0011298|G0000000|C0243148|C0441833
"Infants were excluded on the basis of prematurity (<34 weeks), chronic infection requiring prophylactic antibiotic therapy, craniofacial abnormalities or immune deficiency syndromes.","Infants excluded basis prematurity (<34 weeks), chronic infection requiring prophylactic antibiotic therapy, craniofacial abnormalities immune deficiency syndromes.",C0021270|C1554077|C1527178|C0021294|C0450371|C0439230|C0205191|C0009450|G0000000|C0355642|C0003232|C0039798|C0596392|C0000768|C0439662|C0011155|C0039082
"*p < 0.05, exercise training group (EG) versus control group (CG).","*p < 0.05, exercise training (EG) versus control (CG).",G0000000|C0015259|C0040607|C0013715|G0000000|C0243148|C0043444
"This randomized controlled trial compared comprehensive massage therapy (soft-tissue manipulation, remedial exercise and posture education), 2 components of massage therapy and placebo in the treatment of subacute (between 1 week and 8 months) low-back pain.","This randomized controlled trial compared comprehensive massage therapy (soft-tissue manipulation, remedial exercise posture education), 2 components massage therapy placebo treatment subacute (between 1 week 8 months) low-back pain.",G0000000|C0034656|C2587213|C0008976|C1707455|C1880156|C0024875|C0039798|C0225317|C0185111|G0000000|C0015259|C1262869|C0013621|G0000000|C0449432|C0024875|C0039798|C0032042|C0039798|C0205365|G0000000|G0000000|C0332174|G0000000|C0439231|C0205251|C0030193
The subjects were recruited from patients diagnosed with hemiplegia due to stroke who had gait disturbance.,The subjects recruited patients diagnosed hemiplegia stroke gait disturbance.,G0000000|C0681850|G0000000|C0030705|C0011900|C0018991|C0038454|C0016928|C2699787
Eligible patients were those who required mechanical ventilation within the last 24 hours and were expected to need mechanical ventilation for more than 24 hours.,Eligible patients required mechanical ventilation 24 hours expected mechanical ventilation 24 hours.,C1548635|C0030705|C1514873|C0443254|C0035203|C0450371|C0439227|C1517001|C0443254|C0035203|C0450371|C0439227
"To be eligible for this study, individuals had to meet the following inclusion criteria: (1) current daily smoker, (2) interested in quitting smoking in the next 30 days, (3) have a mobile phone with SMS text messaging capability, and (4) use SMS text messaging at least once monthly.","To eligible study, individuals meet inclusion criteria: (1) current daily smoker, (2) quitting smoking 30 days, (3) mobile phone SMS text messaging capability, (4) SMS text messaging monthly.",C0040363|C1548635|C0557651|C0027361|C1550543|C0007637|C0243161|G0000000|C0521116|C0332173|C0337664|G0000000|C0748223|C0037369|C0450371|C0439228|G0000000|C0231435|C1515258|G0000000|C1527021|C0470166|C2698977|G0000000|G0000000|C1527021|C0470166|C0332177
"From the HDSS database of the National Institute of Public Health (NIOPH), 367 eligible pre-school age children were identified.","From HDSS database National Institute Public Health (NIOPH), 367 eligible pre-school age children identified.",G0000000|C1427027|C0242356|C3245503|C0021622|G0000000|C0018684|G0000000|C1442061|C1548635|C0424930|C0001779|C0008059|C0205396
AIM—To assess outcome at 5-6 years in a cohort of very preterm infants (<34 weeks of gestation) who had been randomly allocated within a controlled clinical trial to receive morphine or non-morphine treatment in the neonatal period.,AIM—To assess outcome 5-6 cohort preterm infants (<34 weeks gestation) randomly allocated controlled clinical trial receive morphine non-morphine treatment neonatal period.,G0000000|C1516048|C1274040|G0000000|C0599755|C0151526|C0021270|C0450371|C0439230|C0032961|G0000000|G0000000|C2587213|C0205210|C0008976|C1514756|C0026549|C1518422|C0039798|C1552240|C0439531
"All subjects performed a 30 minute tolerance test of Pulmosal inhalation from the tPAD device prior to the overnight visits and were excluded if they demonstrated a ≥10% reduction from pre-dose value in FEV1, measured 30 minutes after completion.","All subjects performed 30 minute tolerance test Pulmosal inhalation tPAD device prior overnight visits excluded demonstrated ≥10% reduction pre-dose FEV1, measured 30 minutes completion.",G0000000|C0681850|C0884358|C0450371|C0439232|C0013220|C0022885|C3692789|C0004048|G0000000|C0025080|C0332152|C0439583|C0545082|C1554077|G0000000|G0000000|C0301630|C0439565|G0000000|C0444706|C0450371|C0439232|C0205197
"Of 36 patients, 20 had LANSS pain scale score <12, while the remaining 16/36 were rated >12.","Of 36 patients, 20 LANSS pain scale score <12, remaining 16/36 rated >12.",G0000000|C0450371|C0030705|C0450371|G0000000|C0030193|C0175659|C0449820|C0450371|C1527428|C0450371|C0871208|C0450371
The participant may enter the study if ALL of the following apply: ○ Participant (or parent/guardian of children below age of consent) is willing and able to give written informed consent to participate in the trial; verbal consent in the presence of a literate witness is required for illiterate patients.,The participant enter study ALL apply: ○ Participant (or parent/guardian children age consent) written informed consent participate trial; verbal consent presence literate witness required illiterate patients.,G0000000|C0679646|C1522196|C0557651|C0444868|C1632850|G0000000|C0679646|G0000000|C0030551|C0008059|C0001779|C1511481|C0043266|C1522154|C1511481|G0000000|C0008976|C0439824|C1511481|C0150312|C0023864|C0682356|C1514873|C0020899|C0030705
"Following the completion of baseline data collection, childcare services were randomly allocated to either the intervention or control condition by a research assistant using a random number function in a 1:1 (intervention: control) ratio.","Following completion baseline data collection, childcare services randomly allocated intervention control condition assistant random function 1:1 (intervention: control) ratio.",C0231290|C0205197|C0168634|C1511726|C1516698|C0008067|C0557854|G0000000|G0000000|C0886296|C0243148|C0012634|C0011327|C0034656|C0031843|G0000000|C0886296|C0243148|C0456603
"The study population consisted of all patients 16 years of age or older who had been injured by any mechanism, whose injury severity score was more than 12, who had been transported by land ambulance and who had been treated at one of the 13 lead trauma hospitals in Ontario.","The study population consisted patients 16 age injured mechanism, injury severity score 12, transported land ambulance treated 13 lead trauma hospitals Ontario.",G0000000|C0557651|C0032659|C0332529|C0030705|C0450371|C0001779|C0332664|C0441712|C3263722|C0439793|C0449820|C0450371|C0005528|C0557668|C0002422|C1522326|C0450371|C0023175|C0043251|C0019994|C0029040
Adults (aged over 14) on ART for at least four weeks who had a CD4 count over 100 were included in the study once they were assessed as clinically suitable for nurse led follow-up by a medical officer.,Adults (aged 14) ART weeks CD4 count 100 included study assessed clinically suitable nurse led follow-up medical officer.,C0001675|C0001779|C0450371|C0003826|C0439230|C0285590|C0750480|C1442061|C0332257|C0557651|C1516048|G0000000|C3900053|C0028661|C1708698|C0589120|C0199168|G0000000
"With these facts, it might be that our included study group is a bit more active than the average post-stroke individuals with risk of falls.","With facts, included study bit active average post-stroke individuals risk falls.",G0000000|G0000000|C0332257|C0557651|C1553019|C0205177|C1510992|C0687676|C0027361|C0035647|C0000921
Consecutive adult (> 18yrs) patients were approached as they arrived approximately 1 hour prior to scheduled elective diagnostic cardiac catheterization.,Consecutive adult (> 18yrs) patients approached arrived 1 hour prior scheduled elective diagnostic cardiac catheterization.,C1707491|C0001675|G0000000|G0000000|C0030705|C0449445|C1706079|G0000000|C0439227|C0332152|C0086960|C0206058|C0011900|C0018787|C0007430
"Additionally, the patients were required to be chemotherapy naive or more than 6 months past the last adjuvant chemotherapy and to possess favorable bone marrow reservation (hemoglobin ≥80 g/L, platelet count ≥100 × 109, leukocyte count = 3 to 10 × 109, neutrophil count ≥1.5 × 109).","Additionally, patients required chemotherapy naive 6 months adjuvant chemotherapy possess favorable bone marrow reservation (hemoglobin ≥80 g/L, platelet count ≥100 × 109, leukocyte count = 3 10 × 109, neutrophil count ≥1.5 × 109).",G0000000|C0030705|C1514873|C0013216|G0000000|G0000000|C0439231|C0001551|C0013216|C0850310|C3640814|C0262950|C0086590|C1514889|C0019046|G0000000|C0439294|C0005821|C0750480|G0000000|C0023516|G0000000|G0000000|C0027950|C0750480|G0000000
A total of 780 pregnant women and their respective child will be recruited into the study.,A total 780 pregnant women respective child recruited study.,G0000000|C0439175|C1442061|C0549206|C0043210|G0000000|C0008059|G0000000|C0557651
"The inclusion criteria were a diagnosis of CF (established by genotype or sweat sodium >70 mmol/l or sweat chloride of >60 mmol/l), FEV1 ≥ 20% predicted, age ≥16 years and an infective pulmonary exacerbation as defined by Thornton et al.21 Exclusion criteria were current severe haemoptysis, rib fractures, pregnancy, inability to give consent and those whose usual ACT was HFCWO.","The inclusion criteria diagnosis CF (established genotype sweat sodium >70 mmol/l sweat chloride >60 mmol/l), FEV1 ≥ 20% predicted, age ≥16 years infective pulmonary exacerbation defined Thornton al.21 Exclusion criteria current severe haemoptysis, rib fractures, pregnancy, inability consent usual ACT HFCWO.",G0000000|C0007637|C0243161|C0011900|C0009738|C0443211|C0017431|C0038984|C0037473|G0000000|C0038984|C0008203|G0000000|G0000000|G0000000|C0450371|C0681842|C0001779|G0000000|G0000000|C0024109|G0000000|C1704788|G0000000|C0202311|C0680251|C0243161|C0521116|C0205082|C0019079|C0035561|C0016658|C0032961|G0000000|C1511481|C3538928|C0079613|G0000000
Our aim is to enrol 850 adult patients with an expected ICU length of stay (LOS) of 72 h or more.,Our aim enrol 850 adult patients expected ICU length stay (LOS) 72 more.,G0000000|C1947946|G0000000|C1442061|C0001675|C0030705|C1517001|C0021708|C1444754|G0000000|G0000000|C0450371|C0205172
"In the spring quarter of each year, from sixth through eighth grade, students were surveyed with a questionnaire that measures a variety of problem behaviors.","In spring quarter year, sixth eighth grade, students surveyed questionnaire measures variety behaviors.",G0000000|C0241232|C2825406|C0439234|C0205440|C0205442|C0441800|C0038492|C0038951|C0034394|C0079809|C1883525|C0004927
Participants (N = 195) met DSM-IV criteria for a history of alcohol abuse or dependence and had at least 1 year of continuous abstinence from alcohol and drugs.,Participants (N = 195) met DSM-IV criteria history alcohol abuse dependence 1 continuous abstinence alcohol drugs.,C0679646|G0000000|C0268621|C0220952|C0243161|C0019664|C0001962|C0013146|C0011546|G0000000|C0549178|C3843422|C0001962|C0013227
"In all, 680 women were randomised, three in error.","In all, 680 women randomised, error.",G0000000|G0000000|C1442061|C0043210|G0000000|C0743559
"Women > 34 and < 39 weeks gestation, planning a vaginal birth, not in active labour, with a singleton, viable fetus of vertex presentation, are eligible to participate.","Women > 34 < 39 weeks gestation, planning vaginal birth, active labour, singleton, viable fetus vertex presentation, eligible participate.",C0043210|G0000000|C0450371|G0000000|C0450371|C0439230|C0032961|C0032074|C0042232|C0005615|C0205177|C0022864|C0481462|C0443348|C0015965|C0230003|C0449450|C1548635|G0000000
"The district has an estimated 57,397 total populations of these 8,960 are under five children and 11,714 households of these 2,390 are model families for health extension programme.","The district estimated 57,397 total populations 8,960 children 11,714 households 2,390 model families health extension programme.",G0000000|G0000000|C0750572|C0450371|C0439175|C0032659|C1442061|C0008059|C0450371|C0020052|C1442061|C3161035|C0015576|C0018684|C0231448|C1709697
"Eleven villages were random selected: eight villages from Zhongyang and Jiaokou Counties, representing the intervention group, and three villages from Liulin County, representing the control group.","Eleven villages random selected: villages Zhongyang Jiaokou Counties, representing intervention group, villages Liulin County, representing control group.",C0205457|C0562518|C0034656|C1707391|C0562518|G0000000|G0000000|C0079170|C1882932|C0886296|C0441833|C0562518|G0000000|C0079170|C1882932|C0243148|C0441833
"As part of a randomized clinical trial on postpartum smoking relapse prevention, pregnant women who quit smoking during pregnancy reported their motivation to continue smoking abstinence at a prepartum baseline session.","As randomized clinical trial postpartum smoking relapse prevention, pregnant women quit smoking pregnancy reported motivation continue smoking abstinence prepartum baseline session.",G0000000|C0034656|C0205210|C0008976|C0086839|C0037369|C0035020|C0199176|C0549206|C0043210|C0748223|C0037369|C0032961|C0684224|C0026605|C0549178|C0037369|C3843422|C1439924|C0168634|C1883016
Thirty-six CF patients were enrolled.,Thirty-six CF patients enrolled.,C3816446|C0009738|C0030705|G0000000
All had a screening serum neutralizing antibody titer of ⩽2 to type 39 rhinovirus and normal nasal examination results.,All screening serum neutralizing antibody titer ⩽2 type 39 rhinovirus normal nasal examination results.,G0000000|C0220908|C0229671|G0000000|C0003241|C0475208|G0000000|C0332307|C0450371|C0035473|C0205307|C0028429|G0000000|C1274040
"OS was the time from randomization to death from any cause, and PFS was the time from randomization to progression or death.","OS time randomization death cause, PFS time randomization progression death.",C0229090|C0040223|C0034656|C0011065|C0015127|C0242792|C0040223|C0034656|C0242656|C0011065
This study includes off-label use of botulinum toxin type A for management of sleep bruxism.,This study includes off-label botulinum toxin type A management sleep bruxism.,G0000000|C0557651|C0332257|C0181496|C0006055|C0040549|C0332307|G0000000|C0001554|C0037313|C0006325
"Eligibility criteria included: Glycosylated hemoglobin levels in the normal range (HbA1C level ≤ 6.0%), normal lifestyle based on Mediterranean diet, mild-moderate physical exercise, abstinence of alcohol and tobacco products, no systemic hypertension or dyslipidemia, and no excessive exposure to the ultraviolet rays.","Eligibility criteria included: Glycosylated hemoglobin levels normal range (HbA1C level ≤ 6.0%), normal lifestyle based Mediterranean diet, mild-moderate physical exercise, abstinence alcohol tobacco products, systemic hypertension dyslipidemia, excessive exposure ultraviolet rays.",C0013893|C0243161|C0332257|G0000000|C0019046|C0441889|C0205307|C1514721|G0000000|C0441889|G0000000|G0000000|C0205307|C0023676|C1527178|C0240321|C0012155|C1299392|C0031809|C0015259|C3843422|C0001962|C0040329|C1514468|C0205373|C0020538|C0242339|C0442802|C0274281|C1532472|C0086894
"The probiotic and placebo groups contained 37 and 32 preterm infants, respectively.","The probiotic placebo contained 37 32 preterm infants, respectively.",G0000000|C0525033|C0032042|C0332256|C0450371|C0450371|C0151526|C0021270|G0000000
"For example, for some women, quitting smoking during pregnancy may represent “suspension” of smoking, rather than a more generalized, long-term motivation to quit (Stotts, DiClemente, Carbonari, & Mullen, 2000).","For example, women, quitting smoking pregnancy represent “suspension” smoking, generalized, long-term motivation quit (Stotts, DiClemente, Carbonari, & Mullen, 2000).",G0000000|C1707959|C0043210|C0748223|C0037369|C0032961|C1882932|G0000000|C0037369|C0205246|C0443252|C0026605|C0748223|G0000000|G0000000|G0000000|G0000000|C0885014|G0000000
"The inclusion criteria for the stroke subjects include: (1) being diagnosed by physicians, computed tomography, or magnetic resonance imaging scan of the brain as having experienced a right hemispheric stroke, including hemorrhagic or ischemic strokes, and first-time stroke with a duration of less than 6 months from the stroke onset; (2) meeting the conditions for neglect on any of the two scales within the Behavioral Inattention Test Conventional (BITC) subtest; and (3) capable of communicating in Mandarin Chinese or Taiwanese, and understanding instructions.","The inclusion criteria stroke subjects include: (1) diagnosed physicians, computed tomography, magnetic resonance imaging scan brain experienced hemispheric stroke, including hemorrhagic ischemic strokes, first-time stroke duration 6 months stroke onset; (2) meeting conditions neglect scales Behavioral Inattention Test Conventional (BITC) subtest; (3) capable communicating Mandarin Chinese Taiwanese, understanding instructions.",G0000000|C0007637|C0243161|C0038454|C0681850|C0332257|G0000000|C0011900|C0031831|C1441526|C0040395|C0024488|C0231881|C0011923|C0034606|C0006104|C0237607|C0205139|C0038454|C0332257|C0333275|C0475224|C0038454|C0205435|C0038454|C0449238|G0000000|C0439231|C0038454|C0206132|G0000000|C0556656|C0012634|C0521874|C0175659|C0004927|C0424101|C0022885|C0439858|G0000000|G0000000|G0000000|C2698977|C0205196|G0000000|C0008120|C1556096|C0162340|C0302828
There were 354 mother/child pairs enrolled in the study; 21 women (5.9%) were dropped out prior to completing their pregnancy.,There 354 mother/child pairs enrolled study; 21 women (5.9%) dropped prior completing pregnancy.,G0000000|C1442061|C0260023|C1709450|G0000000|C0557651|C0450371|C0043210|G0000000|C1705648|C0332152|C0205197|C0032961
"Patients were included if they were independent in daily living activities before the stroke, medically and neurologically stable at the time of baseline assessments, and expected to return home with residual disability (defined as the need for supervision or physical assistance for core activities of daily living).","Patients included independent daily living activities stroke, medically neurologically stable time baseline assessments, expected return residual disability (defined supervision physical assistance core activities daily living).",C0030705|C0332257|C0085862|C0332173|C0376558|C0441655|C0038454|G0000000|G0000000|C0205360|C0040223|C0168634|C1261322|C1517001|C0332156|C1609982|C0231170|C1704788|C0038842|C0031809|C0018896|C0444669|C0441655|C0332173|C0376558
Screening for cutaneous nociceptor function may help distinguish candidates for topical therapy for neuropathic pain.,Screening cutaneous nociceptor function distinguish candidates topical therapy neuropathic pain.,C0220908|C0221912|C0028246|C0031843|G0000000|G0000000|C0332237|C0039798|C0442874|C0030193
Ambulant participants with Parkinson's disease (PD) (n = 210) were randomized into three groups: (1) progressive strength training (PST); (2) movement strategy training (MST); or (3) control (“life skills”).,Ambulant participants Parkinson's disease (PD) (n = 210) randomized groups: (1) progressive strength training (PST); (2) movement strategy training (MST); (3) control (“life skills”).,C4035885|C0679646|C1021144|C0012634|G0000000|C0369718|G0000000|C1442061|C0034656|C0441833|G0000000|C0205329|C0237897|C0040607|C1152487|G0000000|C0026649|C0679199|C0040607|C3891283|G0000000|C0243148|G0000000|G0000000
"Parent-reported adherence to treatment was high in both groups (mean [SD], 96.1% [7.8%] for the citalopram-treated group and 98.6% [3.1%] for the placebo group; P=.03).","Parent-reported adherence treatment (mean [SD], 96.1% [7.8%] citalopram-treated 98.6% [3.1%] placebo group; P=.03).",C4054215|C1510802|C0039798|C0444504|C2699239|C0450371|G0000000|C0008845|C0450371|G0000000|C0032042|C0441833|C0369773
Then the samples were randomized to skin-to-skin (n = 48) and routine care (n = 48) groups via a random number table.,Then samples randomized skin-to-skin (n = 48) routine care (n = 48) random table.,C1883708|C0370003|C0034656|C0444099|C0369718|G0000000|C0450371|C0205547|C1947933|C0369718|G0000000|C0450371|C0034656|C0039224
"All patients had to be partly or not controlled (based on GINA asthma control parameters) and with an asthma control questionnaire (ACQ) > 0.75, despite previous treatment with high dose of ICS in monotherapy (BDP non-extrafine >1000 μg/day, or equivalent) or medium dose of ICS (BDP non-extrafine 500–1000 μg/day or equivalent) in combination with LABA.","All patients partly controlled (based GINA asthma control parameters) asthma control questionnaire (ACQ) > 0.75, previous treatment dose ICS monotherapy (BDP non-extrafine >1000 μg/day, equivalent) medium dose ICS (BDP non-extrafine 500–1000 μg/day equivalent) combination LABA.",G0000000|C0030705|G0000000|C2587213|C1527178|G0000000|C0004096|C0243148|C0449381|C0004096|C0243148|C0034394|G0000000|C0205156|C0039798|C0178602|C0022521|G0000000|C0004906|C1518422|G0000000|G0000000|C0205163|C0009458|C0178602|C0022521|C0004906|C1518422|G0000000|G0000000|C0205163|C0205195|G0000000
The women in this group did not use any special technique for pain.,The women special technique pain.,G0000000|C0043210|C0205555|C0449851|C0030193
HRQoL even allowed a prediction of survival in patients with CF [3].,HRQoL allowed prediction survival patients CF [3].,G0000000|C0683607|C0681842|C0038952|C0030705|C0009738|G0000000
"This was a single center open-label exploratory Phase I/II randomized parallel-group clinical trial to evaluate the effect of oral high-dose vitamin D3 on the serum 25(OH)D levels, EDSS, and number of relapse events in pregnant women with MS.","This single center open-label exploratory Phase I/II randomized parallel-group clinical trial evaluate oral high-dose vitamin D3 serum 25(OH)D levels, EDSS, relapse events pregnant women MS.",G0000000|C0037179|C0205099|C1709323|G0000000|C0205390|C0021966|C0034656|C2348042|C0205210|C0008976|C0220825|C0442027|C0444956|C0042890|C3538936|C0229671|C0450371|C0441889|C0451246|C0035020|C0441471|C0549206|C0043210|C0039676
"The study was conducted between June 2011 and July 2012 in Istanbul in a family health center providing services for a population of approximately 21,000 people.","The study conducted June 2011 July 2012 Istanbul family health center providing services population 21,000 people.",G0000000|C0557651|C0004927|C3829443|G0000000|C3829447|G0000000|G0000000|C0015576|C0018684|C0205099|C1999230|C0557854|C0032659|C0450371|C0027361
"METHODS—A prospective, randomised, single blind, placebo controlled, crossover trial of daytime function after CPAP was conducted in 23 patients with SAHS, all with ⩾15 apnoeas+hypopnoeas/hour and ⩾2 symptoms of SAHS.","METHODS—A prospective, randomised, single blind, placebo controlled, crossover trial daytime function CPAP conducted 23 patients SAHS, ⩾15 apnoeas+hypopnoeas/hour ⩾2 symptoms SAHS.",G0000000|C0023981|G0000000|C0037179|C0150108|C0032042|C2587213|C0010366|C0008976|C0332169|C0031843|C0199451|C0004927|C0450371|C0030705|C0520679|G0000000|C0003578|G0000000|C0683368|C0520679
"The randomized patients had a lower proportion of TNM stage IV cancer and more often had preoperative radiotherapy compared with those not randomized, but in all other respects there were no differences between the groups (Table 2).","The randomized patients lower proportion TNM stage IV cancer preoperative radiotherapy compared randomized, respects differences (Table 2).",G0000000|C0034656|C0030705|C0441994|C1709707|C0039694|C0205390|C0022326|C0006826|C0445204|C0034619|C1707455|C0034656|C0679133|C1705241|C0039224|G0000000
"A case was confirmed if a diagnosis of PD was considered definite or probable by the treating neurologist or internist, or if the medical record included either a final diagnosis of PD made by a neurologist, or evidence of at least 2 of the 3 cardinal signs (rest tremor, rigidity, bradykinesia) in the absence of features suggesting other diagnoses.","A confirmed diagnosis PD considered definite probable treating neurologist internist, medical record included final diagnosis PD neurologist, evidence 2 3 cardinal signs (rest tremor, rigidity, bradykinesia) absence features suggesting diagnoses.",G0000000|C0521093|C0011900|G0000000|C0750591|C0439544|C0033204|C1522326|C0237426|C0278602|C0199168|C0034869|C0332257|C0205088|C0011900|G0000000|C0237426|C3887511|G0000000|G0000000|C0326926|C0220912|C0035253|C0040822|C0026837|C0233565|C0332197|C1521970|C1705535|C0011900
"Women who were pregnant or breastfeeding, had a confirmed or suspected immunosuppressive or immunodeficient condition, an allergic disease likely to be exacerbated by any component of the vaccine, or previously received HPV vaccination or 3-O-desacyl-4’-monophosphoryl lipid A were excluded.","Women pregnant breastfeeding, confirmed suspected immunosuppressive immunodeficient condition, allergic disease exacerbated component vaccine, received HPV vaccination 3-O-desacyl-4’-monophosphoryl lipid A excluded.",C0043210|C0549206|C0006147|C0521093|C0332147|C0021081|C0021051|C0012634|C0700624|C0012634|C0436331|C0449432|C0042210|C1514756|C0021344|C0042196|G0000000|C0023779|G0000000|C1554077
One hundred and eighteen patients who attended consultant clinics in an outpatient dental hospital department (Periodontology) were recruited into a trial.,One eighteen patients attended consultant clinics outpatient dental hospital department (Periodontology) recruited trial.,C0205447|C3715206|C0030705|C1456498|C0009817|C0442592|C0029921|C0011365|C0019994|C1704729|C0031098|G0000000|C0008976
Cancer patients often suffer from anxiety and depression.,Cancer patients suffer anxiety depression.,C0006826|C0030705|C0683278|C0003467|C0011570
Patients with obvious infection were excluded from the present study.,Patients obvious infection excluded study.,C0030705|G0000000|C0009450|C1554077|C0557651
All patients were assessed for their swallowing function by the water swallow test before and after the treatment.,All patients assessed swallowing function water swallow test treatment.,G0000000|C0030705|C1516048|C0011167|C0031843|C0043047|C0326374|C0022885|C0039798
"One hundred forty-two treatment seeking cannabis dependent adults, with no significant medical, psychiatric or other substance use disorders.","One forty-two treatment seeking cannabis dependent adults, medical, psychiatric substance disorders.",C0205447|C3816449|C0039798|G0000000|C0024808|C0851827|C0001675|C0199168|C0205487|C0439861|C0012634
"We first did a feasibility study to refine the methods, determine which outcome measures to use, and allow consumers and collaborators to be involved in the development of the CALICO trial.14 We recruited children with cystic fibrosis aged between 2 and 15 years if they met one of the following criteria: body mass index of less than the 25th centile and more than the 0.4th centile, no increase in weight over the previous three months, a 5% decrease in weight from baseline over a period of less than six months.","We feasibility study refine methods, determine outcome measures use, consumers collaborators involved development CALICO trial.14 We recruited children cystic fibrosis aged 2 15 met criteria: body mass 25th centile 0.4th centile, increase weight previous months, 5% decrease weight baseline period months.",G0000000|G0000000|C0557651|C1947930|C0025663|G0000000|C1274040|C0079809|C0042153|C1707496|C2827395|C1314939|C0243107|G0000000|C0008976|G0000000|G0000000|C0008059|C0205207|C0016059|C0001779|G0000000|C0450371|C0268621|C0243161|C0242821|C0577559|G0000000|G0000000|G0000000|G0000000|C0442805|C0005910|C0205156|C0439231|G0000000|C0392756|C0005910|C0168634|C0439531|C0439231
Persons with a recent stroke or TIA are at increased risk of a future stroke.,Persons stroke TIA increased risk future stroke.,C0027361|C0038454|C0007787|C0205217|C0035647|C0016884|C0038454
"Children were eligible to participate in the study if they were 6–18 months at the time of recruitment, had a caregiver >16 years of age, were free of medical conditions, had weight‐for‐height z‐score ≥−2 SD and had no known peanut allergy.","Children eligible participate study 6–18 months time recruitment, caregiver >16 age, free medical conditions, weight‐for‐height z‐score ≥−2 SD peanut allergy.",C0008059|C1548635|G0000000|C0557651|G0000000|C0439231|C0040223|C2949735|C0085537|C0450371|C0001779|C0332296|C0199168|C0012634|G0000000|G0000000|G0000000|C2699239|C0030736|C0002111
There were some limitations in this study.,There limitations study.,G0000000|C0449295|C0557651
It is possible that higher doses of either agent could be administered and will be considered in other cancers with activating BRAF mutations.,It doses agent administered considered cancers activating BRAF mutations.,G0000000|C0178602|C0450442|C1521801|C0750591|C0006826|C1879547|C0104940|C0026882
1715 children aged 6–59 months were included in the pre-intervention survey and 2169 in the post-intervention survey.,1715 children aged 6–59 months included pre-intervention survey 2169 post-intervention survey.,G0000000|C0008059|C0001779|G0000000|C0439231|C0332257|C2347663|C0038951|G0000000|C2347647|C0038951
"Potential participants were excluded if they did not expect to remain in the area for two years (except for short absences); had participated in regular to moderate physical activity with a balance improvement component in the previous two months; could not walk 10-20 metres without rest, help, or having angina; had severe respiratory or cardiac disease; had a psychiatric illness prohibiting participation; had dysphasia; had had recent major home modifications; had an education and language adjusted score >4 on the short portable mental status questionnaire5; or did not have the approval of their general practitioner.","Potential participants excluded expect remain (except short absences); participated regular moderate physical activity balance improvement component previous months; walk 10-20 metres rest, help, angina; severe respiratory cardiac disease; psychiatric illness prohibiting participation; dysphasia; major modifications; education language adjusted score >4 short portable mental status questionnaire5; approval practitioner.",C3245505|C0679646|C1554077|G0000000|G0000000|G0000000|C1282927|C0424530|G0000000|C0205272|C0205081|C0031809|C0205177|C0014653|C2986411|C0449432|C0205156|C0439231|C0080331|C0450371|C0475209|C0035253|C1269765|C0002962|C0205082|C0521346|C0018787|C0012634|C0205487|C0221423|C0138547|C0679823|C0973461|C0205082|C0392747|C0013621|C0023008|C0456081|C0449820|G0000000|C1282927|G0000000|C0229992|C0449438|G0000000|C0205540|C1709627
Sixty two children aged 3 months to 6 years with mild to severe AD were recruited from outpatient clinics.,Sixty children aged 3 months 6 mild severe AD recruited outpatient clinics.,C3816724|C0008059|C0001779|G0000000|C0439231|G0000000|C2945599|C0205082|G0000000|G0000000|C0029921|C0442592
Patients were excluded if they had: secondary hypertension; hypertension being managed in secondary care; a surgery measured BP of ≤120/60 mmHg or ≥220 mmHg systolic at the baseline research visit; terminal illness or major concurrent illness where treatment was likely to affect the ability to self-monitor; stroke within the last 3 months; major surgery within the last 3 months; atrial fibrillation (which would cause error messages from the automatic oscillometric monitors used); or inability to consent or use self-monitoring equipment alone and with no easy access to help.,Patients excluded had: secondary hypertension; hypertension managed secondary care; surgery measured BP ≤120/60 mmHg ≥220 mmHg systolic baseline visit; terminal illness major concurrent illness treatment affect ability self-monitor; stroke 3 months; major surgery 3 months; atrial fibrillation (which error messages automatic oscillometric monitors used); inability consent self-monitoring equipment easy access help.,C0030705|C1554077|G0000000|C0027627|C0020538|C0020538|C1273870|C0027627|C1947933|C0038894|C0444706|C0037623|G0000000|C0439475|G0000000|C0439475|C0039155|C0168634|C0545082|C0205088|C0221423|C0205082|C0205420|C0221423|C0039798|C0001721|C0085732|C0588436|C0038454|G0000000|C0439231|C0205082|C0038894|G0000000|C0439231|C0018792|C0232197|G0000000|C0743559|C0470166|C0205554|C0029375|C0181904|C1273517|G0000000|C1511481|C0588436|C0014672|C0332219|C0444454|C1269765
"Therefore, 97 control children were included in the analysis.","Therefore, 97 control children included analysis.",G0000000|C0450371|C0243148|C0008059|C0332257|C0002778
"Where women with a history of ovarian cancer were previously eligible for PM, at the moment this is not discussed anymore in this setting, because the prognosis is mainly dictated by the ovarian cancer.","Where women history ovarian cancer eligible PM, moment discussed setting, prognosis dictated ovarian cancer.",G0000000|C0043210|C0019664|C0205065|C0006826|C1548635|C0030266|G0000000|C2584313|C0542559|C0033325|C1548384|C0205065|C0006826
"Exclusion criteria included severe systemic diseases such as liver cirrhosis, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, vasculitis, and malignancy.","Exclusion criteria included severe systemic diseases liver cirrhosis, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, vasculitis, malignancy.",C0680251|C0243161|C0332257|C0205082|C0205373|C0012634|C0023884|C0023890|C0205373|C0024131|G0000000|G0000000|C0003864|C0333348|C0021853|C0012634|C0042384|C0006826
"At 2-year follow-up, the sample was obviously 2 years older and more distal from diagnosis.","At 2-year follow-up, sample 2 distal diagnosis.",G0000000|C0439234|C0589120|C0370003|G0000000|C0205108|C0011900
"The inclusion criteria for the study children were: (a) apparently healthy without a history of chronic illness; (b) without hookworm infection, and (c) willing to take daily β-carotene capsule and two doses of albendazole during the study.","The inclusion criteria study children were: (a) healthy history chronic illness; (b) hookworm infection, (c) daily β-carotene capsule doses albendazole study.",G0000000|C0007637|C0243161|C0557651|C0008059|G0000000|G0000000|C3898900|C0019664|C0205191|C0221423|G0000000|C0002830|C0009450|G0000000|C0332173|G0000000|C0006935|C0178602|C0001911|C0557651
"All of the pancreatic necrosis and colonic surgery patients were managed in the same general surgery SICU of EUH, and all of the cardiac and vascular surgery patients were managed in the same cardiac-vascular SICU of EUH.","All pancreatic necrosis colonic surgery patients managed surgery SICU EUH, cardiac vascular surgery patients managed cardiac-vascular SICU EUH.",G0000000|C0030274|C0027540|C0009368|C0038894|C0030705|C1273870|C0038894|G0000000|G0000000|C0018787|C0005847|C0038894|C0030705|C1273870|C3686473|G0000000|G0000000
"In the HPFS, blood was collected from 18,159 participants (35% of the cohort) free from prostate cancer between 1993 and 1995, as previously described [11].","In HPFS, blood collected 18,159 participants (35% cohort) free prostate cancer 1993 1995, [11].",G0000000|C0439530|C0005767|C1516695|C0450371|C0679646|C0450371|C0599755|C0332296|C0033572|C0006826|G0000000|G0000000|C0450371
"Individuals were excluded from participation if they were pregnant, were allergic to any vaccine component, had received any blood product or component in the previous 6 months, had any known immune or coagulation disorder, or had received any inactivated vaccine product within 14 d before enrollment or any live vaccine product within 21 d before enrollment.","Individuals excluded participation pregnant, allergic vaccine component, received blood product component previous 6 months, immune coagulation disorder, received inactivated vaccine product 14 enrollment live vaccine product 21 enrollment.",C0027361|C1554077|C0679823|C0549206|C0700624|C0042210|C0449432|C1514756|C0005767|C1514468|C0449432|C0205156|G0000000|C0439231|C0439662|C0005778|C0012634|C1514756|G0000000|C0042210|C1514468|C0450371|C1516879|C1548795|C0042210|C1514468|C0450371|C1516879
"Exclusion criteria were: (a) severe visual impairment, (b) inability to ambulate independently with a cane or walker, (c) inability to stand unaided for 60 seconds, (d) score of <22/30 in the Mini-Mental State Examination,16 (e) Parkinson’s disease or any neuromuscular conditions, (f) Geriatric Depression Scale (GDS) > 8/15,17 and (g) inability to understand or answer the study questionnaires.","Exclusion criteria were: (a) severe visual impairment, (b) inability ambulate independently cane walker, (c) inability stand unaided 60 seconds, (d) score <22/30 Mini-Mental State Examination,16 (e) Parkinson’s disease neuromuscular conditions, (f) Geriatric Depression Scale (GDS) > 8/15,17 (g) inability understand answer study questionnaires.",C0680251|C0243161|G0000000|G0000000|C0205082|C0234621|C0221099|G0000000|G0000000|C4036205|G0000000|C0006856|C0043016|G0000000|G0000000|C0596013|C0439846|C0450371|C0457385|C0073187|C0449820|C0450371|C0445542|C1301808|C0450371|G0000000|G0000000|C0012634|C1979768|C0012634|C0016327|C1704440|C0011570|C0175659|C0451184|G0000000|C0450371|C0439267|G0000000|C0162340|C1706817|C0557651|C0034394
The primary analyses focused on the percentage of infants in each group who survived to 36 weeks of postmenstrual age without bronchopulmonary dysplasia.,The primary analyses focused percentage infants survived 36 weeks postmenstrual age bronchopulmonary dysplasia.,G0000000|C0205225|C0002778|C0205234|C0439165|C0021270|C0310255|C0450371|C0439230|G0000000|C0001779|C0545675|C0334044
"Patients were excluded from the trial if they were suspected of having an infection by bacteria or a noninfluenza virus within 1 week before enrollment, reported any influenza-like symptoms within 1 week before the onset of influenza, had any chronic respiratory disease, cardiovascular disease, central nervous disorder, renal dysfunction, metabolic disorder, immune dysfunction, or other severe disorder, had a history of abnormal behavior while infected with influenza virus, or had been treated with amantadine, zanamivir, or oseltamivir within the previous 4 weeks.","Patients excluded trial suspected infection bacteria noninfluenza virus 1 week enrollment, reported influenza-like symptoms 1 week onset influenza, chronic respiratory disease, cardiovascular disease, central nervous disorder, renal dysfunction, metabolic disorder, immune dysfunction, severe disorder, history abnormal behavior infected influenza virus, treated amantadine, zanamivir, oseltamivir previous 4 weeks.",C0030705|C1554077|C0008976|C0332147|C0009450|C0004611|G0000000|C0042776|G0000000|C0332174|C1516879|C0684224|C0021400|C0683368|G0000000|C0332174|C0206132|C0021400|C0205191|C0521346|C0012634|C0007226|C0012634|C0205099|C0027769|C0012634|C0022646|C0031847|C0311400|C0012634|C0439662|C0031847|C0205082|C0012634|C0019664|C0205161|C0004927|C0439663|C0021400|C0042776|C1522326|C0002403|C0216660|C0874161|C0205156|G0000000|C0439230
Other three long term care facilities belonged to large-scale institutions with more than 300 residents.,Other term care facilities belonged large-scale institutions 300 residents.,G0000000|C0233324|C1947933|C1547538|G0000000|C0549177|C1272753|C1442061|C1320928
"Exclusion criteria: Patients unable to read or write, patients with locomotors problems, cognitive impairment, ischemic heart disease, aortic valve disease, cancer or lung diseases other than COPD were excluded.","Exclusion criteria: Patients unable read write, patients locomotors problems, cognitive impairment, ischemic heart disease, aortic valve disease, cancer lung diseases COPD excluded.",C0680251|C0243161|C0030705|C1299582|C0034754|C0043266|C0030705|G0000000|C1546466|C1516691|C0221099|C0475224|C0018787|C0012634|C0003483|C0184252|C0012634|C0006826|C0024109|C0012634|C0024117|C1554077
Subjects 18 years of age and older with diabetes (type 1 or type 2) for at least 1 year and neuropathic pain of diabetic origin were invited to participate in the study.,Subjects 18 age diabetes (type 1 type 2) 1 neuropathic pain diabetic origin invited participate study.,C0681850|C0450371|C0001779|C0011847|C0332307|G0000000|C0332307|G0000000|G0000000|C0442874|C0030193|C0241863|C0079946|G0000000|G0000000|C0557651
"Men who were recently treated for prostate cancer (N = 250) were randomly assigned to a control group, a group education intervention (GE), or a group education-plus-discussion intervention (GED).","Men treated prostate cancer (N = 250) randomly assigned control group, education intervention (GE), education-plus-discussion intervention (GED).",C0025266|C1522326|C0033572|C0006826|C0369718|G0000000|C1442061|G0000000|C1516050|C0243148|C0441833|C0013621|C0886296|C1292300|C0013621|C0886296|C1880947
Subjects were required to ambulate ≥ 30-ft without an ankle foot orthosis (AF0) and score ≥ 24 on the Berg Balance Scale.,Subjects required ambulate ≥ 30-ft ankle foot orthosis (AF0) score ≥ 24 Berg Balance Scale.,C0681850|C1514873|C4036205|G0000000|C0450371|C0003086|C0016504|C0006086|C1333634|C0449820|G0000000|C0450371|G0000000|C0014653|C0175659
Inner-city academic general internal medicine practice.,Inner-city academic internal medicine practice.,C0557849|C1510747|C0205102|C0013227|C0237607
Results indicated that smokers who received the intervention were more likely to be abstinent than were control group participants at the 12-month follow-up.,Results smokers received intervention abstinent control participants 12-month follow-up.,C1274040|C0337664|C1514756|C0886296|C0457801|C0243148|C0679646|C0450371|C0589120
"Methods: Whole mount sections of 393 radical prostatectomy specimens were evaluated: 128 patients had immediate surgery, 143 were treated for 12 weeks and 122 for 24 weeks with complete androgen blockade.","Methods: Whole mount sections 393 radical prostatectomy specimens evaluated: 128 patients surgery, 143 treated 12 weeks 122 24 weeks complete androgen blockade.",C0025663|C0444667|C0181909|C0152060|C1442061|C0302912|C0033573|C0370003|C0220825|C1442061|C0030705|C0038894|C1442061|C1522326|C0450371|C0439230|C1442061|C0450371|C0439230|C0205197|C0002844|C0332206
Pregnant women living in a large and racially diverse metropolitan area within the Northeast U.S. between the ages of 18 and 35 were invited to participate in a study to promote healthy pregnancy.,Pregnant women living racially diverse metropolitan Northeast U.S. ages 18 35 invited participate study promote healthy pregnancy.,C0549206|C0043210|C0376558|G0000000|C1880371|C0599587|C1709272|C0041703|C0001779|C0450371|C0450371|G0000000|G0000000|C0557651|C0033414|C3898900|C0032961
They were an average of 56.7 years of age and had been smoking for 37.8 years.,They average 56.7 age smoking 37.8 years.,G0000000|C1510992|C0450371|C0001779|C0037369|C0450371|C0439234
"Participants met the following criteria: HIV-1 infection; age ≥27 years; safety laboratory tests; for men, receptive penile–anal sex or oral–anal sex with another man within 1 year; and ability to provide informed consent.","Participants met criteria: HIV-1 infection; age ≥27 years; safety laboratory tests; men, receptive penile–anal sex oral–anal sex 1 year; ability provide informed consent.",C0679646|C0268621|C0243161|C0019682|C0009450|C0001779|G0000000|C0439234|C0036043|C0022877|C0022885|C0025266|C0544683|G0000000|C0009253|G0000000|C0009253|G0000000|C0439234|C0085732|C1999230|C1522154|C1511481
"In the latter, although a dose response for lung function was observed with increasing doses of tiotropium added to a fixed dose of olodaterol, the increase with tiotropium 2.5 µg when added to olodaterol was smaller than the increase with 5 µg when added to olodaterol [21, 22].","In latter, dose response lung function observed increasing doses tiotropium fixed dose olodaterol, increase tiotropium 2.5 µg olodaterol increase 5 µg olodaterol [21, 22].",G0000000|G0000000|C0178602|C0871261|C0024109|C0031843|C1441672|C0442808|C0178602|C0213771|C0443218|C0178602|C2934193|C0442805|C0213771|G0000000|C2934193|C0442805|G0000000|C2934193|C0450371|C0450371
Eligible participants were staff physicians practising in an urban tertiary care centre.,Eligible participants staff physicians practising urban tertiary care centre.,C1548635|C0679646|C0851286|C0031831|G0000000|C0442529|C0205372|C1947933|C0205099
Participants were willing to take part in the study within 14 days of acute stroke and felt that this was a reasonable time to be approached.,Participants study 14 days acute stroke reasonable time approached.,C0679646|C0557651|C0450371|C0439228|C0205178|C0038454|G0000000|C0040223|C0449445
Women were excluded if they had a high-risk pregnancy—multi-fetal pregnancy (confirmed on palpation or ultrasound) or a significant medical condition—or if they had severe anemia (hemoglobin concentration [Hb] <80 g/l) at enrolment.,Women excluded high-risk pregnancy—multi-fetal pregnancy (confirmed palpation ultrasound) medical condition—or severe anemia (hemoglobin concentration [Hb] <80 g/l) enrolment.,C0043210|C1554077|C0332167|G0000000|C0032961|C0521093|C0030247|C0041618|C0199168|G0000000|C0205082|C0002871|C0019046|C0004268|C0019046|C0450371|C0439294|C1516879
All identified smokers were offered the opportunity to participate.,All identified smokers offered opportunity participate.,G0000000|C0205396|C0337664|C1444648|G0000000|G0000000
"Eligible participants were women presenting at 27 weeks gestation for routine glucose challenge test from the following ethnic groups: Asian, Middle Eastern, Black and White.","Eligible participants women 27 weeks gestation routine glucose challenge test ethnic groups: Asian, Middle Eastern, Black White.",C1548635|C0679646|C0043210|C0450371|C0439230|C0032961|C0205547|C0017725|C0798503|C0022885|C0015031|C0441833|C0078988|C0444598|C1707877|C0005680|C0007457
"(3) Even if one parent quits, another parent or household resident may continue to smoke, still leaving the child exposed, and (4) even if both parents quit, the child may still be exposed by others inside or outside the home.","(3) Even parent quits, parent household resident continue smoke, leaving child exposed, (4) parents quit, child exposed inside home.",G0000000|G0000000|C0030551|C0748223|C0030551|C0020052|C1320928|C0549178|C0037366|G0000000|C0008059|C0332157|G0000000|C0030551|C0748223|C0008059|C0332157|G0000000|C0442519
"Thirty patients between the age of 4 and 10 years were randomly selected from the Outpatient Department of Pediatric Dentistry of Subharti Dental College, Meerut.","Thirty patients age 4 10 randomly selected Outpatient Department Pediatric Dentistry Subharti Dental College, Meerut.",C3816446|C0030705|C0001779|G0000000|C0450371|G0000000|C1707391|C0029921|C1704729|C0030755|C0011438|G0000000|C0011365|C0557806|G0000000
"Forty patients with sepsis, severe sepsis and septic shock were included in this study.","Forty patients sepsis, severe sepsis septic shock included study.",C3816449|C0030705|C0036690|C0205082|C0036690|C0333534|C0036974|C0332257|C0557651
Infants were ineligible if they did not have respiratory distress or had significant pulmonary hypoplasia.,Infants ineligible respiratory distress pulmonary hypoplasia.,C0021270|C1512714|C0521346|C0231303|C0024109|C0243069
We identified a retrospective cohort of 44 patients with a nonlesional modern “seizure protocol” MRI who underwent anterior temporal lobectomy for treatment of medically refractory partial epilepsy.,We identified retrospective cohort 44 patients nonlesional modern “seizure protocol” MRI underwent anterior temporal lobectomy treatment medically refractory partial epilepsy.,G0000000|C0205396|C0035363|C0599755|C0450371|C0030705|G0000000|G0000000|G0000000|G0000000|C0024485|G0000000|C0205094|C0442043|C0023928|C0039798|G0000000|C0205269|C0728938|C0014544
"However, the prevalence of HIV was higher in the WPC‐RUTF group than in the P‐RUTF group.","However, prevalence HIV WPC‐RUTF P‐RUTF group.",G0000000|C0033105|C0019682|G0000000|G0000000|C0441833
"The exclusion criteria were as follows: (1) participation in another interventional research study within the last 30 days; (2) the need for more than one titration PSG; (3) the use of sedatives or hypnotics during the titration PSG; (4) a major medical or psychiatric condition that would interfere with the demands of the study, adherence to PAP, or the ability to commit to follow-up assessment; (5) prior prescription for, or exposure to PAP therapy within the previous year; (6) chronic respiratory failure or insufficiency with suspected or known neuromuscular disease, moderate or severe COPD or other pulmonary disorders, or any condition with an elevation of arterial carbon dioxide levels (> 45 mm Hg) while awake or participants qualifying for oxygen therapy (arterial saturation ≤ 88% for > 5 min); (7) surgery of the upper airway, nose, sinus, or middle ear within the previous 90 days; (8) surgery at any time for the treatment of OSA; (9) presence of untreated or poorly managed (i.e., symptomatic despite treatment), non-OSA related sleep disorders; (10) use of medications with hypnotic or sedative effects or regular use of nighttime sedatives or sleeping aids ≥ 1 night per week; (11) consumption of ethanol > 4 nights per week; (12) shift workers.","The exclusion criteria follows: (1) participation interventional study 30 days; (2) titration PSG; (3) sedatives hypnotics titration PSG; (4) major medical psychiatric condition interfere demands study, adherence PAP, ability commit follow-up assessment; (5) prior prescription for, exposure PAP therapy previous year; (6) chronic respiratory failure insufficiency suspected neuromuscular disease, moderate severe COPD pulmonary disorders, condition elevation arterial carbon dioxide levels (> 45 mm Hg) awake participants qualifying oxygen therapy (arterial saturation ≤ 88% > 5 min); (7) surgery upper airway, nose, sinus, middle ear previous 90 days; (8) surgery time treatment OSA; (9) presence untreated managed (i.e., symptomatic treatment), non-OSA sleep disorders; (10) medications hypnotic sedative effects regular nighttime sedatives sleeping aids ≥ 1 night week; (11) consumption ethanol > 4 nights week; (12) shift workers.",G0000000|C0680251|C0243161|C0332283|G0000000|C0679823|C1948041|C0557651|C0450371|C0439228|G0000000|C0162621|C0162701|G0000000|C0036557|C0020591|C0162621|C0162701|G0000000|C0205082|C0199168|C0205487|C0012634|C0521102|C0441516|C0557651|C1510802|C1740167|C0085732|C1171947|C0589120|C1261322|G0000000|C0332152|C0033080|G0000000|C0274281|C1740167|C0039798|C0205156|C0439234|G0000000|C0205191|C0521346|C0231174|C0231179|C0332147|C1979768|C0012634|C0205081|C0205082|C0024117|C0024109|C0012634|C0012634|C0439775|C0003842|C0007009|C0678717|C0441889|G0000000|C0450371|G0000000|C0025424|C0234422|C0679646|C1514624|C0030054|C0039798|C0003842|C0522534|G0000000|C0450371|G0000000|G0000000|C0702093|G0000000|C0038894|C1282910|C0178987|C0028429|C0016169|C0444598|C0013443|C0205156|C0450371|C0439228|G0000000|C0038894|C0040223|C0039798|C0520679|G0000000|C0150312|C0332155|C1273870|C0683454|C0231220|C0039798|C1518422|C0037313|C0012634|C0450371|C0013227|C0020591|C0020592|C1280500|C0205272|C0240526|C0036557|C0037313|C0001175|G0000000|G0000000|C0240526|C0332174|C0450371|C0009830|C0001962|G0000000|G0000000|C0240526|C0332174|C0450371|C0333051|C0024752
"During this period (March 8–April 3, 2003), almost all (96%) probable SARS patients reported close contact with a known SARS patient.","During period (March 8–April 3, 2003), (96%) probable SARS patients reported close contact SARS patient.",G0000000|C0439531|C3829202|G0000000|G0000000|G0000000|C0450371|C0033204|C1175175|C0030705|C0684224|C0587267|C0332158|C1175175|C0030705
"Participants were 146 male, White undergraduates recruited from the psychology undergraduate subject pool (96.6%) or through campus advertisements (3.4%) at a large northwestern university.","Participants 146 male, White undergraduates recruited psychology undergraduate subject pool (96.6%) campus advertisements (3.4%) northwestern university.",C0679646|C1442061|C0086582|C0007457|C0682177|G0000000|C0033909|C0682177|C0681850|C0337051|C0450371|G0000000|C0949214|G0000000|C1709274|C0041740
"Exclusion criteria were as follows: the subject was under other medical treatment during the research period, had metabolic, renal, anaphylactic or endocrine disease, or suffered from primary hypertension, primary hypotension, chronic anemia, tuberculosis, a mental disorder or a chronic affection; the body mass index (BMI) of the subject was more than 24 or she was a cigarette smoker.","Exclusion criteria follows: subject medical treatment period, metabolic, renal, anaphylactic endocrine disease, suffered primary hypertension, primary hypotension, chronic anemia, tuberculosis, mental disorder chronic affection; body mass (BMI) subject 24 cigarette smoker.",C0680251|C0243161|C0332283|C0681850|C0199168|C0039798|C0439531|C0311400|C0022646|C0002792|C0014136|C0012634|C0683278|C0205225|C0020538|C0205225|C0020649|C0205191|C0002871|C0041296|C0229992|C0012634|C0205191|C0871641|C0242821|C0577559|G0000000|C0681850|C0450371|C0677453|C0337664
"Groups were statistically equal in all respects, with the exception that the flaxseed oil group had more visible meibomian gland orifices and patients in the flaxseed group were slightly younger at baseline compared to the olive oil group.","Groups statistically equal respects, exception flaxseed oil visible meibomian gland orifices patients flaxseed baseline compared olive oil group.",C0441833|C0038215|C0205163|C0679133|C1554961|C0023753|C0028908|C0205379|G0000000|C1285092|C0444567|C0030705|C0023753|C0168634|C1707455|C0228539|C0028908|C0441833
"Mean ages were 7.3 ± 0.3 years and 10.0 ± 0.4 years, respectively.","Mean ages 7.3 ± 0.3 10.0 ± 0.4 years, respectively.",C0444504|C0001779|G0000000|G0000000|G0000000|C0450371|G0000000|G0000000|C0439234|G0000000
"Ninety children, aged 3-8 years, undergoing adenotonsillectomy were randomized into two groups: the propofol group (n = 45) and the saline group (n = 45), of which 88 children completed the study.","Ninety children, aged 3-8 years, undergoing adenotonsillectomy randomized groups: propofol (n = 45) saline (n = 45), 88 children completed study.",C3816959|C0008059|C0001779|G0000000|C0439234|G0000000|C0193959|C0034656|C0441833|C0033487|C0369718|G0000000|C0450371|C0036082|C0369718|G0000000|C0450371|C0450371|C0008059|C0205197|C0557651
"The participants were required to meet the following criteria: suffering from recurrent and improving type of MS, 18 to 50 years old, not having had any MS attack in the last three months and consuming various types of interferon for prevention of MS attacks (1).","The participants required meet criteria: suffering recurrent improving type MS, 18 50 old, MS attack months consuming types interferon prevention MS attacks (1).",G0000000|C0679646|C1514873|C1550543|C0243161|C0683278|C2945760|C1272745|C0332307|C0039676|C0450371|C0450371|C0580836|C0039676|C0277793|C0439231|G0000000|C0332307|C0021747|C0199176|C0039676|C1261512|G0000000
"The remaining facilities were selected in the same manner until the cumulative number of residents met the estimated sample size required (n = 20 facilities, 10 hostels – low level care and 10 nursing homes – high level care).","The remaining facilities selected manner cumulative residents met estimated sample size required (n = 20 facilities, 10 hostels – low level care 10 nursing homes – level care).",G0000000|C1527428|C1547538|C1707391|G0000000|C1511559|C1320928|C0268621|C0750572|C0370003|C0456389|C1514873|C0369718|G0000000|C0450371|C1547538|C0450371|C0442518|G0000000|C0205251|C0441889|C1947933|C0450371|C0006147|C0442519|G0000000|C0441889|C1947933
Patients > 65 years admitted to hospital with a hip fracture will be eligible to participate.,Patients > 65 admitted hospital hip fracture eligible participate.,C0030705|G0000000|C0450371|C0184666|C0019994|C0019552|C0016658|C1548635|G0000000
"In a randomized placebo-controlled trial in Kampala, Uganda, 2,736 purified protein derivative (PPD)-positive and anergic HIV-infected adults were randomly assigned to four and two regimens, respectively.","In randomized placebo-controlled trial Kampala, Uganda, 2,736 purified protein derivative (PPD)-positive anergic HIV-infected adults randomly assigned regimens, respectively.",G0000000|C0034656|C1706408|C0008976|G0000000|C0041573|C1442061|C1998793|C0033684|C1527240|C0032739|C0206120|C0019682|C0001675|G0000000|C1516050|C2945654|G0000000
"Inclusion criteria are as follows: meet diagnostic criteria for PTSD; computer, internet and printer access; Australian resident; fluent in written and spoken English; willing to provide name, phone number and address, and to provide the name and address of a local general practitioner.","Inclusion criteria follows: meet diagnostic criteria PTSD; computer, internet printer access; Australian resident; fluent written spoken English; provide name, phone address, provide address local practitioner.",C0007637|C0243161|C0332283|C1550543|C0011900|C0243161|C0038436|C0009622|C0282111|C1709679|C0444454|C0238711|C1320928|C0870569|C0043266|C0234856|C0376245|C1999230|C0027365|C1515258|C0376649|C1999230|C0376649|C0205276|C1709627
"Women were also excluded if they had severe cognitive impairment (e.g., dementia, Alzheimer’s disease), or abused alcohol or drugs.","Women excluded severe cognitive impairment (e.g., dementia, Alzheimer’s disease), abused alcohol drugs.",C0043210|C1554077|C0205082|C1516691|C0221099|G0000000|C0011265|G0000000|C0012634|C0013146|C0001962|C0013227
"Regarding baseline beverage consumption (Table 2), there were no significant differences between groups for milk and SSB consumption, but the intervention group consumed more diet beverages than did the control group (P = 0.02).","Regarding baseline beverage consumption (Table 2), differences milk SSB consumption, intervention consumed diet beverages control (P = 0.02).",G0000000|C0168634|C0005329|C0009830|C0039224|G0000000|C1705241|C0026131|C1420423|C0009830|C0886296|G0000000|C0012155|C0005329|C0243148|C0369773|G0000000|C0450371
"Of 3625 patients screened, 2144 patients were randomised to receive QVA149 (n = 475), indacaterol (n = 477), glycopyrronium (n = 475), tiotropium (n = 483), and placebo (n = 234).","Of 3625 patients screened, 2144 patients randomised receive QVA149 (n = 475), indacaterol (n = 477), glycopyrronium (n = 475), tiotropium (n = 483), placebo (n = 234).",G0000000|G0000000|C0030705|C0220908|G0000000|C0030705|G0000000|C1514756|G0000000|C0369718|G0000000|C1442061|C1722260|C0369718|G0000000|C1442061|C0017970|C0369718|G0000000|C1442061|C0213771|C0369718|G0000000|C1442061|C0032042|C0369718|G0000000|C1442061
"Inclusion Criteria: (1) ≥18 years, (2) expected MV>48 h with diagnosis of sepsis or severe sepsis as defined by ACCP Consensus Conference Criteria55 and (3) predicted ICU LOS ≥4 days.","Inclusion Criteria: (1) ≥18 years, (2) expected MV>48 h diagnosis sepsis severe sepsis defined ACCP Consensus Conference Criteria55 (3) predicted ICU LOS ≥4 days.",C0007637|C0243161|G0000000|G0000000|G0000000|C1517001|G0000000|C0011900|C0036690|C0205082|C0036690|C1704788|G0000000|C0376298|C0086047|G0000000|G0000000|C0681842|C0021708|G0000000|G0000000
"Patients with metastatic RCC, a clear cell histologic component, and no prior systemic therapy for RCC were enrolled as previously described.21 Major eligibility criteria included a Karnofsky performance status of ≥ 70%; adequate end organ function; blood pressure less than 160/90 mmHg; and lack of CNS metastases, significant cardiac comorbidity, or recent history of bleeding or clotting.","Patients metastatic RCC, cell histologic component, prior systemic therapy RCC enrolled described.21 Major eligibility criteria included Karnofsky performance status ≥ 70%; adequate organ function; blood pressure 160/90 mmHg; lack CNS metastases, cardiac comorbidity, history bleeding clotting.",C0030705|C0036525|C0279702|C0007634|C0205462|C0449432|C0332152|C0205373|C0039798|C0279702|G0000000|C1552738|C0205082|C0013893|C0243161|C0332257|C0206065|C0597198|C0449438|G0000000|C0450371|C0205410|C0178784|C0031843|C0005767|C0033095|C1442061|C0439475|C0332268|C3714787|C0027627|C0018787|C0009488|C0019664|C0019080|C0005778
All previously healthy children 2 and 17 years of age with acute asthma have a PRAM score measured in triage.,All healthy children 2 17 age acute asthma PRAM score measured triage.,G0000000|C3898900|C0008059|G0000000|C0450371|C0001779|C0205178|C0004096|C0441454|C0449820|C0444706|C0040861
"Of the ~ 11% of babies born preterm each year, > 80% are born moderate- to late-preterm (MLPT) between 32+ 0 and 36 completed weeks’ gestation [1].","Of ~ 11% babies born preterm year, > 80% born moderate- late-preterm (MLPT) 32+ 0 36 completed weeks’ gestation [1].",G0000000|G0000000|C0021270|C0005615|C0151526|C0439234|G0000000|C0005615|C0205081|C0205087|G0000000|G0000000|C0450371|C0205197|G0000000|C0032961|G0000000
"Patients were excluded according to a diagnosis of acute cholecystitis, previous upper-abdominal surgery, current/anticipated pregnancy, current breast-feeding, preoperative indication for endoscopic retrograde cholangiopancreatography, or indication for intraoperative imaging of the biliary tract.","Patients excluded diagnosis acute cholecystitis, previous upper-abdominal surgery, current/anticipated pregnancy, current breast-feeding, preoperative indication endoscopic retrograde cholangiopancreatography, indication intraoperative imaging biliary tract.",C0030705|C1554077|C0011900|C0205178|C0008325|C0205156|C1282910|C0038894|C0521116|C0032961|C0521116|C0006147|C0445204|C0392360|C0014245|C0439784|G0000000|C0392360|C0456904|C0011923|C0521378|C1185740
It was conducted to compare the efficacy and safety of the dosage-modified DCF regimen versus CF regimes in patients with advanced gastric cancer or gastroesophageal junction cancer.,It conducted compare efficacy safety dosage-modified DCF regimen versus CF regimes patients advanced gastric cancer gastroesophageal junction cancer.,G0000000|C0004927|C1707455|C1280519|C0036043|C0178602|C0030896|C0040808|G0000000|C0009738|G0000000|C0030705|C0205179|C0038351|C0006826|C0744316|C0205144|C0006826
Pregnant women who quit smoking were randomly assigned to 2 intervention arms: FFB or usual care control (UCC).,Pregnant women quit smoking randomly assigned 2 intervention arms: FFB usual care control (UCC).,C0549206|C0043210|C0748223|C0037369|G0000000|C1516050|G0000000|C0886296|C0206655|G0000000|C3538928|C1947933|C0243148|G0000000
"The major inclusion criterion was the presence of one or more histologically confirmed, bidimensionally measurable OPLs that could be sampled by biopsy and had at least one of the following high-risk features of malignant transformation: harboring at least mild dysplasia, located in a high-risk area (i.e., floor of mouth, ventrolateral tongue, and soft palate), significant extent of OPL tissue involvement, and presence of symptoms (pain or substantial discomfort).","The major inclusion criterion presence histologically confirmed, bidimensionally measurable OPLs sampled biopsy high-risk features malignant transformation: harboring mild dysplasia, located high-risk (i.e., floor mouth, ventrolateral tongue, soft palate), extent OPL tissue involvement, presence symptoms (pain substantial discomfort).",G0000000|C0205082|C0007637|C0243161|C0150312|C0205462|C0521093|G0000000|C1513040|G0000000|C0441621|C0005558|C0332167|C1521970|C0205282|C0040682|C0475311|C2945599|C0334044|G0000000|C0332167|C0683454|C0016249|C0226896|C3266730|C0040408|C0205358|C0700374|C0439792|G0000000|C0040300|C1314939|C0150312|C0683368|C0030193|G0000000|C0231218
"METHODS—Fourteen patients with chronic obstructive pulmonary disease (COPD) and arterial oxygen desaturation on exercise (mean (SD) forced expiratory volume in one second (FEV1) 0.83 (0.28) l, arterial oxygen pressure (PaO2) 8.38 (1.24) kPa, arterial carbon dioxide pressure (PaCO2) 5.95 (0.86) kPa) were randomised to perform a walking test using air administered via a cylinder or continuous flow oxygen at 2 l/min or by a PDOD system.","METHODS—Fourteen patients chronic obstructive pulmonary disease (COPD) arterial oxygen desaturation exercise (mean (SD) forced expiratory volume (FEV1) 0.83 (0.28) l, arterial oxygen pressure (PaO2) 8.38 (1.24) kPa, arterial carbon dioxide pressure (PaCO2) 5.95 (0.86) kPa) randomised perform walking test air administered cylinder continuous flow oxygen 2 l/min PDOD system.",G0000000|C0030705|C0205191|C0549186|C0024109|C0012634|C0024117|C0003842|C0030054|C0746961|C0015259|C0444504|G0000000|C0441722|C0231800|C0449468|G0000000|C0450371|C0450371|C0439394|C0003842|C0030054|C0033095|C1427155|C0450371|C0450371|C0439474|C0003842|C0007009|C0678717|C0033095|G0000000|C0450371|C0450371|C0439474|G0000000|C0884358|C0080331|C0022885|C0001861|C1521801|C0181797|C0549178|C0806140|C0030054|G0000000|C0439393|G0000000|C0449913
"Baseline patient characteristics were balanced between the two treatment groups: the average age was 66 years (standard deviation [SD] = 9.0), 79% of the patients were male, and the average number of tablets used was 16 (SD = 9.3).","Baseline patient characteristics balanced treatment groups: average age 66 (standard deviation [SD] = 9.0), 79% patients male, average tablets 16 (SD = 9.3).",C0168634|C0030705|C1521970|C0205415|C0039798|C0441833|C1510992|C0001779|C0450371|C1442989|C0012727|C2699239|G0000000|G0000000|C0450371|C0030705|C0086582|C1510992|C0039225|C0450371|G0000000|G0000000|G0000000
He helped develop the original treatment-based classification system for low back pain.,He helped develop original treatment-based classification system low pain.,G0000000|C1269765|G0000000|C0205313|C0039798|C0008902|C0449913|C0205251|C0030193
"The amendment of inclusion criteria allowed for a higher birth weight (from up to 1,500 to 1,800 g), higher gestation age (from week 32 up to week 34), and longer study inclusion time (from up to 12 h to 48 h).","The amendment inclusion criteria allowed birth weight (from 1,500 1,800 g), gestation age (from week 32 week 34), study inclusion time (from 12 48 h).",G0000000|C0680532|C0007637|C0243161|C0683607|C0005615|C0005910|G0000000|C1442061|C1442061|C0439267|C0032961|C0001779|G0000000|C0332174|C0450371|C0332174|C0450371|C0557651|C0007637|C0040223|G0000000|C0450371|C0450371|C0033727
"The effects of added intravenous ketamine were evaluated in 93 children, ASA I-II, 2-14 years old, undergoing an adenotonsillectomy.","The effects intravenous ketamine evaluated 93 children, ASA I-II, 2-14 old, undergoing adenotonsillectomy.",G0000000|C1280500|C0348016|C0022614|C0220825|C0450371|C0008059|C0004057|C0021966|C0450371|C0580836|G0000000|C0193959
Children aged 0.5–5 y presenting with an axillary temperature >37.5°C or a history of fever during the previous 24 h were screened using on-site blood film microscopy.,Children aged 0.5–5 axillary temperature >37.5°C history fever previous 24 screened on-site blood film microscopy.,C0008059|C0001779|G0000000|C0004454|C0005903|G0000000|C0019664|C0015967|C0205156|C0450371|C0220908|C1720176|C0005767|C0086296|C0026018
"CONSORT diagram of enrollment and 6-months follow up Patients diagnosed with hepatocellular, cholangiocarcinoma, gallbladder, neuroendocrine, and pancreatic carcinoma or other primary cancers that have metastasized to the liver (e.g., ovarian, breast, colorectal) were enrolled in the study.","CONSORT diagram enrollment 6-months follow Patients diagnosed hepatocellular, cholangiocarcinoma, gallbladder, neuroendocrine, pancreatic carcinoma primary cancers metastasized liver (e.g., ovarian, breast, colorectal) enrolled study.",G0000000|C0681494|C1516879|C0439231|C0332283|C0030705|C0011900|C2697585|C0206698|C0016976|C0027912|C0030274|C0007097|C0205225|C0006826|C0027627|C0023884|G0000000|C0205065|C0006141|C0555952|G0000000|C0557651
Diabetic patients with high CVD risk according to the Framingham general CVD risk score (>15%) 2.,Diabetic patients CVD risk Framingham CVD risk score (>15%) 2.,C0241863|C0030705|C0007222|C0035647|C3166866|C0007222|C0035647|C0449820|C0450371|G0000000
All inpatients presumed to have delirium and needing consultation–liaison services from the psychiatric department were evaluated.,All inpatients presumed delirium consultation–liaison services psychiatric department evaluated.,G0000000|C0021562|G0000000|C0011206|G0000000|C0557854|C0205487|C1704729|C0220825
"48 patients were randomised; (25 azithromycin, 23 placebo).","48 patients randomised; (25 azithromycin, 23 placebo).",C0450371|C0030705|G0000000|C0450371|C0052796|C0450371|C0032042
"Inclusion criteria were: diagnosis of pregnancy confirmed serologically by B-HCG reagent test along with referred last menstrual period (LMP) not exceeding the past three months, aged at least 18.","Inclusion criteria were: diagnosis pregnancy confirmed serologically B-HCG reagent test referred menstrual period (LMP) exceeding months, aged 18.",C0007637|C0243161|G0000000|C0011900|C0032961|C0521093|G0000000|G0000000|C0034760|C0022885|C0205543|C0025344|C0439531|C0425932|G0000000|C0439231|C0001779|C0450371
"From March 2003 to November 2005, 92 patients with cervical cancer stage IA2 to IIA were randomly assigned for surgical treatment with conventional radical hysterectomy (CRH) or NSRH, and 86 patients finally included in the analysis.","From March 2003 November 2005, 92 patients cervical cancer stage IA2 IIA randomly assigned surgical treatment conventional radical hysterectomy (CRH) NSRH, 86 patients finally included analysis.",G0000000|C3829202|G0000000|C3828767|G0000000|C0450371|C0030705|C0027530|C0006826|C0205390|G0000000|G0000000|G0000000|C1516050|C0543467|C0039798|C0439858|C0302912|C0020699|G0000000|G0000000|C0450371|C0030705|G0000000|C0332257|C0002778
To determine the effect of exercise on quality of life in (a) a randomized controlled trial of exercise among recently diagnosed breast cancer survivors undergoing adjuvant therapy and (b) a similar trial among post-treatment survivors.,To determine exercise quality life (a) randomized controlled trial exercise diagnosed breast cancer survivors undergoing adjuvant therapy (b) trial post-treatment survivors.,C0040363|G0000000|C0015259|C0332306|C0376558|G0000000|C0034656|C2587213|C0008976|C0015259|C0011900|C0006141|C0006826|C0206194|G0000000|C0001551|C0039798|G0000000|C0008976|C2709088|C0206194
Subjects were recruited from previously healthy children visiting the Emergency Room (ER) and Out-Patient Department (OPD) of Kanti Children Hospital with the following inclusion criteria: Age between 6 weeks and 2 years First Episode of Wheezing Meets Clinical Definition of Bronchiolitis Clinical severity (CS) scores (Wang et al [26]) between 1 and 9 (Table 1).,Subjects recruited healthy children visiting Emergency Room (ER) Out-Patient Department (OPD) Kanti Children Hospital inclusion criteria: Age 6 weeks 2 First Episode Wheezing Meets Clinical Definition Bronchiolitis Clinical severity (CS) scores (Wang al [26]) 1 9 (Table 1).,C0681850|G0000000|C3898900|C0008059|C0545082|C0013956|C1547703|C3810541|C0029921|C1704729|C3810599|G0000000|C0008059|C0019994|C0007637|C0243161|C0001779|G0000000|C0439230|G0000000|C0205435|C0332189|C0043144|C1550543|C0205210|C1550452|C0006271|C0205210|C0439793|C0010182|C0449820|G0000000|C0202311|C0450371|G0000000|G0000000|C0039224|G0000000
"Overall and disease-free survivals for patients randomized to percutaneous local ablative therapy (PLAT, n = 90, including 19 patients who withdrew their consent after randomization and received surgical resection) or surgical resection (SR).","Overall disease-free survivals patients randomized percutaneous local ablative therapy (PLAT, = 90, including 19 patients withdrew consent randomization received surgical resection) surgical resection (SR).",C0282416|C0012634|C0038952|C0030705|C0034656|C0522523|C0205276|G0000000|C0039798|G0000000|G0000000|C0450371|C0332257|C0450371|C0030705|C2349954|C1511481|C0034656|C1514756|C0543467|C0015252|C0543467|C0015252|C3813610
Twenty four patients diagnosed to have asthma and being supported in the Missionary of Charity who volunteered to take part in the study participated.,Twenty patients diagnosed asthma supported Missionary Charity volunteered study participated.,C0724000|C0030705|C0011900|C0004096|C1521721|C0079844|C0007962|C0042960|C0557651|G0000000
"ClinicalTrials.gov Registry: {""type"":""clinical-trial"",""attrs"":{""text"":""NCT02416479"",""term_id"":""NCT02416479""}}NCT02416479 Registered April 3, 2015 For adults who have a kidney transplant, the leading predictor of rejection, kidney loss, death and their attendant costs is immunosuppressive medications non-adherence [1–5] with an alarming one-third of kidney transplant recipients experiencing this preventable problem [6–8].","ClinicalTrials.gov Registry: {""type"":""clinical-trial"",""attrs"":{""text"":""NCT02416479"",""term_id"":""NCT02416479""}}NCT02416479 Registered April 3, 2015 For adults kidney transplant, leading predictor rejection, kidney loss, death attendant costs immunosuppressive medications non-adherence [1–5] alarming one-third kidney transplant recipients experiencing preventable [6–8].",C1419208|C0034975|C0332307|C1514821|C3715024|G0000000|G0000000|G0000000|C0001675|C0022646|C0040732|C0332152|C2698872|C0035015|C0022646|C1517945|C0011065|C0237485|C0010186|C0021081|C0013227|C1518422|G0000000|C0336648|C0205447|C0022646|C0040732|C1709854|C0237607|C1547273|G0000000
Treatment failure was considered if parasitaemia did not fall by >75% of the admission value within 48 hours and intravenous quinine (20 mg/kg followed by 10 mg/kg 8 hourly) was given.,Treatment failure considered parasitaemia fall >75% admission 48 hours intravenous quinine (20 mg/kg 10 mg/kg 8 hourly) given.,C0039798|C0231174|C0750591|C0242723|C0085639|C0450371|C0184666|C0450371|C0439227|C0348016|C0034417|C0450371|C0439272|C0450371|C0439272|G0000000|C0558292|C1442162
"The subjects met the following inclusion criteria: history of stroke onset of >6 months prior to the study, in order to minimize the effects of natural recovery; ability to walk without using a walking aid for a minimum of 15 m; Mini-Mental State Examination score of >24 out of 30; and ability to comprehend and follow simple instructions.","The subjects met inclusion criteria: history stroke onset >6 months prior study, minimize effects natural recovery; ability walk walking aid minimum 15 m; Mini-Mental State Examination score >24 30; ability comprehend follow simple instructions.",G0000000|C0681850|C0268621|C0007637|C0243161|C0019664|C0038454|C0206132|G0000000|C0439231|C0332152|C0557651|G0000000|C1280500|C0205296|C0237820|C0085732|C0080331|C0080331|C0449435|C1524031|C0450371|C0369637|C0445542|C1301808|G0000000|C0449820|C0450371|C0450371|C0085732|G0000000|C0332283|C0205352|C0302828
Subjects will be recruited if they meet the following criteria: • 2 or more falls within 6 months prior to the beginning of the study • Aged 60–85 years • Able to walk for 5 minutes unassisted • Adequate hearing (as evaluated by the whisper test) and vision capabilities (as measured using a Snellen chart).,Subjects recruited meet criteria: • 2 falls 6 months prior study • Aged 60–85 • Able walk 5 minutes unassisted • Adequate hearing (as evaluated whisper test) vision capabilities (as measured Snellen chart).,C0681850|G0000000|C1550543|C0243161|G0000000|G0000000|C0000921|G0000000|C0439231|C0332152|C0557651|G0000000|C0001779|G0000000|G0000000|C0085732|C0080331|G0000000|C0439232|G0000000|G0000000|C0205410|C0018767|G0000000|C0220825|G0000000|C0022885|C0042789|C2698977|G0000000|C0444706|G0000000|C0007963
"However, the effectiveness of these interventions has not been evaluated in stroke patients.","However, effectiveness interventions evaluated stroke patients.",G0000000|C1280519|C0886296|C0220825|C0038454|C0030705
Among the 157 participants taking hypericum mean scores on the Hamilton depression scale decreased from 22.4 at baseline to 12.00 at end point; among the 167 participants taking imipramine they fell from 22.1 to 12.75.,Among 157 participants hypericum scores Hamilton depression scale decreased 22.4 baseline 12.00 point; 167 participants imipramine fell 22.1 12.75.,G0000000|C1442061|C0679646|C1256259|C0449820|G0000000|C0011570|C0175659|C0205216|C0450371|C0168634|C0450371|C1552961|C1442061|C0679646|C0020934|C0085639|C0450371|C0450371
In order to take part the care homes must be for older people (average age >65 years) and have been registered with the Care Quality Commission (CQC) for at least six months.,In care homes people (average age >65 years) registered Care Quality Commission (CQC) months.,G0000000|C1947933|C0442519|C0027361|C1510992|C0001779|C0450371|C0439234|C1514821|C1947933|C0332306|G0000000|G0000000|C0439231
"Exclusion criteria included bronchial asthma, unstable concomitant disease (cardiovascular, renal, hepatic, gastrointestinal, neurological, metabolic, musculoskeletal, neoplastic, respiratory or other disease), pregnancy and breastfeeding, clinically significant laboratory abnormalities suggestive of unstable concomitant disease, survival for 1 year unlikely, and inability to give written consent.","Exclusion criteria included bronchial asthma, unstable concomitant disease (cardiovascular, renal, hepatic, gastrointestinal, neurological, metabolic, musculoskeletal, neoplastic, respiratory disease), pregnancy breastfeeding, clinically laboratory abnormalities suggestive unstable concomitant disease, survival 1 unlikely, inability written consent.",C0680251|C0243161|C0332257|C0205039|C0004096|C0443343|C0521115|C0012634|C0007226|C0022646|C0205054|C0521362|C0205494|C0311400|C0497254|C1709160|C0521346|C0012634|C0032961|C0006147|G0000000|C0022877|C0000768|C0332299|C0443343|C0521115|C0012634|C0038952|G0000000|C0750558|G0000000|C0043266|C1511481
"The inclusion criteria for the study were being non-wasted (weight-for-height ≥80% of the NCHS reference median, and lack of bilateral pitting edema) and being from a “vulnerable” household, as described above.","The inclusion criteria study non-wasted (weight-for-height ≥80% NCHS reference median, lack bilateral pitting edema) “vulnerable” household, above.",G0000000|C0007637|C0243161|C0557651|C1518422|C0005910|G0000000|C0027450|C1514811|C0549183|C0332268|C0238767|C0205323|C0013604|G0000000|C0020052|C1282910
"Participants were aged 6 to 60 months with SAM defined as either MUAC <11.5 cm, weight-for-height/length z-score < −3, or bilateral pedal edema (kwashiorkor), had been medically and nutritionally stabilized, and were eligible to receive RUTF according to national guidelines.","Participants aged 6 60 months SAM defined MUAC <11.5 cm, weight-for-height/length z-score < −3, bilateral pedal edema (kwashiorkor), medically nutritionally stabilized, eligible receive RUTF national guidelines.",C0679646|C0001779|G0000000|C0450371|C0439231|C0036002|C1704788|G0000000|C0450371|G0000000|C0005910|G0000000|C0238767|C0016504|C0013604|C0022806|G0000000|G0000000|C0184512|C1548635|C1514756|G0000000|C3245503|C0162791
There is a clear need for new anti-inflammatory medications in CF.,There anti-inflammatory medications CF.,G0000000|C0003209|C0013227|C0009738
Subjects 300 stroke patients and their care givers.,Subjects 300 stroke patients care givers.,C0681850|C1442061|C0038454|C0030705|C1947933|G0000000
"When the intervention protocol was completed, the patients were followed in the 8th week after treatment.","When intervention protocol completed, patients 8th week treatment.",G0000000|C0886296|C0442711|C0205197|C0030705|G0000000|C0332174|C0039798
"The study population consisted of male and female subjects, aged 18 years and over with acute NP originating from cervical joints and accompanying soft tissues.","The study population consisted male female subjects, aged 18 acute NP originating cervical joints accompanying soft tissues.",G0000000|C0557651|C0032659|C0332529|C0086582|C0015780|C0681850|C0001779|C0450371|C0205178|C0065827|G0000000|C0027530|C0022417|G0000000|C0205358|C0040300
"Exclusion criteria were not meeting inclusion criteria, decline to participate, enrollment in competing studies, or Spanish-speaking only.","Exclusion criteria meeting inclusion criteria, decline participate, enrollment competing studies, Spanish-speaking only.",C0680251|C0243161|C0556656|C0007637|C0243161|G0000000|G0000000|C1516879|G0000000|C0947630|C0086409|C0205171
"Adult kidney transplant recipients meeting the following criteria will be included: 1) age 18 years or older, 2) prescribed at least 1 immunosuppressive medication taken twice a day, 3) functioning kidney transplant (not on dialysis), 4) has received a kidney-only transplant, 5) agreement from the transplant physician and nephrologist that the individual is able to participate in the study, 6) able to speak, hear, and understand English as determined by the ability to participate and comprehend conversation about potential inclusion in the study, 7) able to open an electronic medication monitoring cap as assessed by the RA asking if there is any problem with opening pill bottle caps, 8) able to administer immunosuppressive medications to self, 9) has a telephone or has access to a telephone, 10) has no cognitive impairment as determined by a score of 4 or greater on the 6-item Telephone Mental Status Screen Derived from the Mini-Mental Status Exam, 11) has no other diagnoses that may shorten life span, such as metastatic cancer, 12) is not currently hospitalized, 13) receives post-transplant care by the Missouri or Tennessee transplant programs.","Adult kidney transplant recipients meeting criteria included: 1) age 18 older, 2) prescribed 1 immunosuppressive medication day, 3) functioning kidney transplant (not dialysis), 4) received kidney-only transplant, 5) agreement transplant physician nephrologist individual participate study, 6) speak, hear, understand English determined ability participate comprehend conversation potential inclusion study, 7) electronic medication monitoring cap assessed RA pill bottle caps, 8) administer immunosuppressive medications self, 9) telephone access telephone, 10) cognitive impairment determined score 4 6-item Telephone Mental Status Screen Derived Mini-Mental Status Exam, 11) diagnoses shorten life span, metastatic cancer, 12) hospitalized, 13) receives post-transplant care Missouri Tennessee transplant programs.",C0001675|C0022646|C0040732|C1709854|C0556656|C0243161|C0332257|G0000000|C0001779|C0450371|C0580836|G0000000|C0278329|G0000000|C0021081|C0013227|C0332173|G0000000|C0205245|C0022646|C0040732|C1518422|C0011945|G0000000|C1514756|C0022646|C0040732|G0000000|C0680240|C0040732|C0031831|C0260039|C0027361|G0000000|C0557651|G0000000|C0234856|C0018767|C0162340|C0376245|G0000000|C0085732|G0000000|G0000000|C0871703|C3245505|C0007637|C0557651|G0000000|C0013850|C0013227|C0150369|C0179586|C1516048|C3538806|C0009905|C0179376|C0179586|G0000000|C1621583|C0021081|C0013227|C0036588|G0000000|C0039457|C0444454|C0039457|C0450371|C1516691|C0221099|G0000000|C0449820|G0000000|C1551338|C0039457|C0229992|C0449438|C0220908|C1441547|C0445542|C0449438|C0582103|C0450371|C0011900|C0441636|C0376558|C1711300|C0036525|C0006826|C0450371|C0701159|C0450371|C1514756|C0687676|C1947933|C0026222|C0039514|C0040732|C0376691
"The goal was to approach interested participants during the final 2–3 weeks of their PR program in order to allow a two-week run-in period; however, due to scheduling challenges, some participants did not start their run-in until they completed PR.","The goal approach participants final 2–3 weeks PR program two-week run-in period; however, scheduling challenges, participants start run-in completed PR.",G0000000|C0018017|C0449445|C0679646|C0205088|G0000000|C0439230|C0279759|C1709697|C0205448|C3274438|C0439531|G0000000|C0205539|C0805586|C0679646|C0439659|C3274438|C0205197|C0279759
The breast cancer patients enrolled in this trial were well educated and most were non-Hispanic white.,The breast cancer patients enrolled trial educated non-Hispanic white.,G0000000|C0006141|C0006826|C0030705|G0000000|C0008976|C0039401|C1518424|C0007457
"Patients were excluded if they had any of the following: an endocrine, metabolic, infectious, or neurologic disease, cancer, connective tissue disorder, a cardiac, respiratory, or orthopedic disease that might have hindered AE, hormonal dysfunction, pregnancy, menopause, or a cognitive function that might have hampered the assessments.","Patients excluded following: endocrine, metabolic, infectious, neurologic disease, cancer, connective tissue disorder, cardiac, respiratory, orthopedic disease hindered AE, hormonal dysfunction, pregnancy, menopause, cognitive function hampered assessments.",C0030705|C1554077|C0231290|C0014136|C0311400|C0009450|C0205494|C0012634|C0006826|G0000000|C0040300|C0012634|C0018787|C0521346|C0029355|C0012634|G0000000|C3887670|C0458083|C0031847|C0032961|C0025320|C1516691|C0031843|C0181113|C1261322
"Children with mental, neurologic disease, or those using sedative medication were excluded.","Children mental, neurologic disease, sedative medication excluded.",C0008059|C0229992|C0205494|C0012634|C0020592|C0013227|C1554077
"Data from 2 randomized, double-blind, placebo-controlled studies enrolling 274 male and female patients aged 18 to 65 years with acute ankle sprain were pooled and evaluated.","Data 2 randomized, double-blind, placebo-controlled studies enrolling 274 male female patients aged 18 65 acute ankle sprain pooled evaluated.",C1511726|G0000000|C0034656|C0013072|C1706408|C0947630|G0000000|C1442061|C0086582|C0015780|C0030705|C0001779|C0450371|C0450371|C0205178|C0003086|C0038045|C1709595|C0220825
We recruited 127 participants with dementia from four group homes and a special dementia hospital in Kobe City.,We recruited 127 participants dementia homes special dementia hospital Kobe City.,G0000000|G0000000|C1442061|C0679646|C0011265|C0442519|C0205555|C0011265|C0019994|G0000000|C0008848
"The entrance criteria were as follows: confirmed diagnosis of COPD (by the hospital consultant) for at least 1 year, having a forced expiratory volume in 1 s (FEV1) of 30–80% of the predicted normal value and >45 years old.","The entrance criteria follows: confirmed diagnosis COPD (by hospital consultant) 1 year, forced expiratory volume 1 (FEV1) 30–80% predicted normal >45 old.",G0000000|C0337095|C0243161|C0332283|C0521093|C0011900|C0024117|G0000000|C0019994|C0009817|G0000000|C0439234|C0441722|C0231800|C0449468|G0000000|G0000000|G0000000|C0681842|C0205307|C0450371|C0580836
"The revised Project ALERT yielded positive results for all 3 risk groups—baseline nonusers, experimenters, and users.","The revised Project ALERT yielded positive 3 risk groups—baseline nonusers, experimenters, users.",G0000000|C1527075|C1709701|C0239110|G0000000|C0439178|G0000000|C0035647|G0000000|G0000000|G0000000|C1706077
"The inclusion criteria for the present study were as follows: i) Patients were pathologically diagnosed with adenocarcinoma, squamous cell carcinoma or adenosquamous-mixed NSCLC; ii) patients were at stage IIIA according to the International Union Against Cancer NSCLC criteria (7); iii) patients were aged 30–78 years; iv) patients exhibited normal function of the hematopoietic system, liver, kidney and heart; v) Karnofsky performance status score of the patients was >60 points; and vi) patients provided a signed informed consent sheet.","The inclusion criteria study follows: i) Patients pathologically diagnosed adenocarcinoma, squamous cell carcinoma adenosquamous-mixed NSCLC; ii) patients stage IIIA International Union Against Cancer NSCLC criteria (7); iii) patients aged 30–78 years; iv) patients exhibited normal function hematopoietic system, liver, kidney heart; v) Karnofsky performance status score patients >60 points; vi) patients provided signed informed consent sheet.",G0000000|C0007637|C0243161|C0557651|C0332283|C0021966|C0030705|G0000000|C0011900|C0001418|C1182670|C0007634|C0007097|C0205430|C0007131|G0000000|C0030705|C0205390|G0000000|C1512888|C2825217|G0000000|C0006826|C0007131|C0243161|G0000000|C0439070|C0030705|C0001779|G0000000|C0439234|C0022326|C0030705|C0015272|C0205307|C0031843|C0018957|C0449913|C0023884|C0022646|C0018787|G0000000|C0206065|C0597198|C0449438|C0449820|C0030705|C0450371|C1552961|C0205999|C0030705|C1999230|C1519316|C1522154|C1511481|C2349187
A number of additional potential benefits to vitamin D supplementation may be of particular importance to HIV-infected children and adolescents.,A additional potential benefits vitamin D supplementation HIV-infected children adolescents.,G0000000|C1524062|C3245505|C0814225|C0042890|C0073187|C0242297|C0019682|C0008059|C0205653
Aim: To study the efficacy of rofecoxib in migraine.,Aim: To study efficacy rofecoxib migraine.,C1947946|C0040363|C0557651|C1280519|C0762662|C0149931
"relative, unpaid or paid carer, care home manager) who has a minimum of once a month face-to-face or telephone contact with the patient and is able, and consents to, provide information on proxy measures Patient and a suitable informant must be recruited into the trial within 7 days of the hip fracture operation Patient must spend a minimum of 5 days on the study ward  Patient exclusion criteria: Decision taken not to undergo hip surgery Patient not expected to survive beyond 4 weeks Patient already enrolled in a clinical trial of an investigational medicinal product (CTIMP)  Suitable informant inclusion criteria: Individual has a minimum of once a month face-to-face or telephone contact with the patient Individual is able, and consents to provide information on proxy measures  Suitable informant exclusion criteria: Individual not over 16 years of age.","relative, unpaid paid carer, care manager) minimum month face-to-face telephone contact patient able, consents to, provide proxy measures Patient suitable informant recruited trial 7 days hip fracture operation Patient spend minimum 5 days study ward Patient exclusion criteria: Decision undergo hip surgery Patient expected survive 4 weeks Patient enrolled clinical trial investigational medicinal product (CTIMP) Suitable informant inclusion criteria: Individual minimum month face-to-face telephone contact patient Individual able, consents provide proxy measures Suitable informant exclusion criteria: Individual 16 age.",C0080103|G0000000|C0871051|C0085537|C1947933|C0335141|C1524031|C0332177|C1553514|C0039457|C0332158|C0030705|C0085732|C1511481|G0000000|C1999230|C0600420|C0079809|C0030705|C3900053|C1550484|G0000000|C0008976|G0000000|C0439228|C0019552|C0016658|C0543467|C0030705|C0680968|C1524031|G0000000|C0439228|C0557651|C1305702|C0030705|C0680251|C0243161|C0679006|G0000000|C0019552|C0038894|C0030705|C1517001|C0310255|G0000000|C0439230|C0030705|G0000000|C0205210|C0008976|C1517586|G0000000|C1514468|G0000000|C3900053|C1550484|C0007637|C0243161|C0027361|C1524031|C0332177|C1553514|C0039457|C0332158|C0030705|C0027361|C0085732|C1511481|C1999230|C0600420|C0079809|C3900053|C1550484|C0680251|C0243161|C0027361|C0450371|C0001779
"The students were in grades 5 through 12, with grade 9 as the mode and grade 10 as the median; the ages ranged from 11 to 20 years, with a median of 15.","The students grades 5 12, grade 9 mode grade 10 median; ages ranged 11 20 years, median 15.",G0000000|C0038492|C0441800|G0000000|C0450371|C0441800|G0000000|C1513371|C0441800|C0450371|C0549183|C0001779|C1514721|C0450371|C0450371|C0439234|C0549183|C0450371
Participants are candidates for epilepsy surgery who are referred to the Dutch Collaborative Epilepsy Surgery Program (DCESP) and are selected to undergo epilepsy surgery with ioECoG-based tailoring.,Participants candidates epilepsy surgery referred Dutch Collaborative Epilepsy Surgery Program (DCESP) selected undergo epilepsy surgery ioECoG-based tailoring.,C0679646|G0000000|C0014544|C0038894|C0205543|C0013331|C0282116|C0014544|C0038894|C1709697|G0000000|C1707391|G0000000|C0014544|C0038894|C1527178|C0402883
"Of 205 randomized subjects, 73 (36%) were in the preparation stage at study entry.","Of 205 randomized subjects, 73 (36%) preparation stage study entry.",G0000000|C1442061|C0034656|C0681850|C0450371|C0450371|C1521827|C0205390|C0557651|C1705654
"A range of races/ethnicities was represented; intervention schools had 21% African American students, 41% Hispanic students, 25% White students, and 11% Asian American students.","A range races/ethnicities represented; intervention schools 21% African American students, 41% Hispanic students, 25% White students, 11% Asian American students.",G0000000|C1514721|C0034510|C1882932|C0886296|C0036375|C0450371|C0027567|C0596070|C0038492|C0450371|C0086409|C0038492|C0450371|C0007457|C0038492|C0450371|C0078988|C0596070|C0038492
"Inclusion criteria were: age 18–65 years, a new episode of non-specific low back pain lasting more than 12 weeks, inability to resume daily activities in the last 3 weeks, health insurance with one insurance company.","Inclusion criteria were: age 18–65 years, episode non-specific low pain lasting 12 weeks, inability resume daily activities 3 weeks, health insurance insurance company.",C0007637|C0243161|G0000000|C0001779|G0000000|C0439234|C0332189|C0205370|C0205251|C0030193|C1517741|C0450371|C0439230|G0000000|C1550028|C0332173|C0441655|G0000000|C0439230|C0018684|C0021672|C0021672|C0683757
"Median age was 62 years, Karnofsky performance 90%, and disease status was comparable for both arms.","Median age 62 years, Karnofsky performance 90%, disease status comparable arms.",C0549183|C0001779|C0450371|C0439234|C0206065|C0597198|C0450371|C0012634|C0449438|G0000000|C0206655
"Within Kongwa district, 96 balozis which had not been treated with azithromycin since 2009 and were predicted from prior prevalence surveys to have TF between 5 and 9.9% were selected for study.","Within Kongwa district, 96 balozis treated azithromycin 2009 predicted prior prevalence surveys TF 5 9.9% selected study.",G0000000|G0000000|G0000000|C0450371|G0000000|C1522326|C0052796|G0000000|C0681842|C0332152|C0033105|C0038951|C4048299|G0000000|G0000000|C1707391|C0557651
"Overall, the incidence of drug-related AEs was low across both UMEC/VI treatment groups (UMEC/VI 125/25 μg, 5%; UMEC/VI 62.5/25 μg, 4%) and similar to placebo (5%).","Overall, incidence drug-related AEs low UMEC/VI treatment (UMEC/VI 125/25 μg, 5%; UMEC/VI 62.5/25 μg, 4%) placebo (5%).",C0282416|C0021149|C0013227|C1412268|C0205251|C0205999|C0039798|C0205999|C1442061|G0000000|G0000000|C0205999|C0450371|G0000000|G0000000|C0032042|G0000000
"(4) Brunnstrom stage III or higher of the affected upper limb and hand, and the elbow can perform a few stretching movements (Liu et al., 2014b).","(4) Brunnstrom stage III upper limb hand, elbow perform stretching movements (Liu al., 2014b).",G0000000|G0000000|C0205390|C0439070|C1282910|C0015385|C0018563|C0013769|C0884358|C0600080|C0026649|G0000000|C0202311|G0000000
"Exclusion criteria were treatment for SAM in the previous 6 months, the presence of a chronic, debilitating condition such as cerebral palsy or congenital heart disease, or peanut allergy.","Exclusion criteria treatment SAM previous 6 months, presence chronic, debilitating condition cerebral palsy congenital heart disease, peanut allergy.",C0680251|C0243161|C0039798|C0036002|C0205156|G0000000|C0439231|C0150312|C0205191|G0000000|C0012634|G0000000|C0522224|C0009678|C0018787|C0012634|C0030736|C0002111
"Main eligibility criteria: male or female individuals aged 18–70 years with chronic tinnitus (duration > 6 months), tinnitus-handicap-inventory-score ≥ 38, age-adjusted normal sensorineural hearing (i.e.","Main eligibility criteria: male female individuals aged 18–70 chronic tinnitus (duration > 6 months), tinnitus-handicap-inventory-score ≥ 38, age-adjusted normal sensorineural hearing (i.e.",C0205225|C0013893|C0243161|C0086582|C0015780|C0027361|C0001779|G0000000|C0205191|C0040264|C0449238|G0000000|G0000000|C0439231|C0040264|G0000000|C0450371|C0001779|C0205307|G0000000|C0018767|C0683454
"Maternal venous blood was obtained at 10 and 32 weeks of gestation, among numerous other measurements.","Maternal venous blood 10 32 weeks gestation, numerous measurements.",C2347083|C0042449|C0005767|C0450371|C0450371|C0439230|C0032961|C0439064|C0242485
"Exclusion criteria (eg, history of seizure; ferromagnetic material in the cranium; cardiac, neural, or medication implants; severe spasticity and/or decubitus ulcer(s) interfering with the LT-RGO harness; cognitive deficit severe enough to preclude informed consent) were largely structured to ensure subjects’ safety in all aspects of participation.","Exclusion criteria (eg, history seizure; ferromagnetic material cranium; cardiac, neural, medication implants; severe spasticity and/or decubitus ulcer(s) interfering LT-RGO harness; cognitive deficit severe preclude informed consent) structured ensure subjects’ safety aspects participation.",C0680251|C0243161|C0013715|C0019664|C0036572|C3178787|C0520510|C0037303|C0018787|C3714606|C0013227|C0021102|C0205082|C0026838|G0000000|C0442303|C0041582|C0521102|C0023376|C3873748|C1516691|C0162429|C0205082|G0000000|C1522154|C1511481|C0678594|C0218063|G0000000|C0036043|C1547011|C0679823
Patients were randomly assigned to receive one of four treatments for 30 months: 1) fluticasone propionate 500 µg bid; 2) fluticasone/salmeterol 500/50 µg bid; 3) fluticasone 500 µg bid (6 months) and followed by placebo (24 months); or 4) placebo bid.,Patients randomly assigned receive treatments 30 months: 1) fluticasone propionate 500 µg bid; 2) fluticasone/salmeterol 500/50 µg bid; 3) fluticasone 500 µg bid (6 months) placebo (24 months); 4) placebo bid.,C0030705|G0000000|C1516050|C1514756|C0087111|C0450371|C0439231|G0000000|C0082607|C0033474|C1442061|G0000000|G0000000|G0000000|C0939232|C1442061|G0000000|G0000000|G0000000|C0082607|C1442061|G0000000|G0000000|G0000000|C0439231|C0032042|C0450371|C0439231|G0000000|C0032042|G0000000
Parents of children with asthma were recruited from Emergency Departments and urgent care.,Parents children asthma recruited Emergency Departments urgent care.,C0030551|C0008059|C0004096|G0000000|C0013956|C1704729|C0439609|C1947933
"With appropriate counselling, provision of single lens glasses for older wearers of multifocal glasses who take part in regular outdoor activities is an effective falls prevention strategy.","With counselling, provision single lens glasses wearers multifocal glasses regular outdoor activities effective falls prevention strategy.",G0000000|C0010210|C1549071|C0037179|C0023317|C0015421|G0000000|C0205292|C0015421|C0205272|G0000000|C0441655|C1280519|C0000921|C0199176|C0679199
"The mean birth weight in the intervention group was 136 g higher than in the control group, with a larger difference of 201 g observed in the nutritionally poor hungry season, relative to a mean 40-wk birth weight of ∼2850 g in the control group.","The birth weight intervention 136 control group, larger difference 201 observed nutritionally poor hungry season, relative 40-wk birth weight ∼2850 control group.",G0000000|C0005615|C0005910|C0886296|C1442061|C0243148|C0441833|C0549177|C1705241|C1442061|C1441672|G0000000|C0032854|C0020175|C0036497|C0080103|C0450371|C0005615|C0005910|G0000000|C0243148|C0441833
It is difficult to explain why the combinations of gemcitabine with a second anticancer drug cannot significantly improve the overall survival of patients with locally advanced/metastatic pancreatic cancer.,It difficult explain combinations gemcitabine anticancer drug improve survival patients locally advanced/metastatic pancreatic cancer.,G0000000|C0332218|G0000000|C0453882|C0045093|G0000000|C0013227|G0000000|C0038952|C0030705|C1517927|C0205179|C0030274|C0006826
"On 11 June 2009, the WHO announced the emergence of an influenza pandemic.3 By 14 February 2010, laboratory confirmed cases of pandemic H1N1 influenza were reported in more than 212 countries and overseas territories, with a death toll of at least 15 921.4 Influenza viruses belong to the family Orthomyxoviridae.","On 11 June 2009, WHO announced emergence influenza pandemic.3 By 14 February 2010, laboratory confirmed pandemic H1N1 influenza reported 212 countries overseas territories, death toll 15 921.4 Influenza viruses belong family Orthomyxoviridae.",G0000000|C0450371|C3829443|G0000000|G0000000|G0000000|C0750573|C0021400|C1615608|G0000000|C0450371|C3830166|G0000000|C0022877|C0521093|C1615608|G0000000|C0021400|C0684224|C1442061|C0454664|G0000000|C1301808|C0011065|C1321919|G0000000|C0021400|C0042776|G0000000|C0015576|C0029341
"Calls for research participants will be made on Google, Facebook, Twitter, and other online/social media on a regular basis, as well as on an online notice board (Gumtree Australia).","Calls participants Google, Facebook, Twitter, online/social media regular basis, online notice board (Gumtree Australia).",C0679006|C0679646|G0000000|G0000000|G0000000|C0728831|C0009458|C0205272|C1527178|G0000000|G0000000|C0972401|G0000000|C0004340
"Preoperative anaemia is common, affecting 30–60 % of all patients undergoing major elective surgery [3].","Preoperative anaemia common, 30–60 % patients undergoing major elective surgery [3].",C0445204|C0002871|C0205214|G0000000|G0000000|C0030705|G0000000|C0205082|C0206058|C0038894|G0000000
In rectal cancer a non-significant difference in disease-free or overall survival was observed.,In rectal cancer non-significant difference disease-free survival observed.,G0000000|C0205052|C0006826|C1518422|C1705241|C0012634|C0038952|C1441672
"Patients were eligible if aged 60 years or over with previously untreated, bulky stage IA or stages IB-IV aggressive NHL.","Patients eligible aged 60 untreated, bulky stage IA stages IB-IV aggressive NHL.",C0030705|C1548635|C0001779|C0450371|C0332155|C0012173|C0205390|C0694634|C1306673|C2744579|C0001807|C0024305
We randomly assigned 50 participants with moderate to severe COPD who were current Internet users to either the eDSMP (n = 26) or fDSMP (n = 24) group.,We randomly assigned 50 participants moderate severe COPD current Internet users eDSMP (n = 26) fDSMP (n = 24) group.,G0000000|G0000000|C1516050|C0450371|C0679646|C0205081|C0205082|C0024117|C0521116|C0282111|C1706077|G0000000|C0369718|G0000000|C0450371|G0000000|C0369718|G0000000|C0450371|C0441833
"Students were asked to supply their telephone number on the baseline survey; never-smokers who supplied their home phone number (n = 3547) were eligible for follow-up, and 2603 were successfully contacted and had complete data for all variables in this analysis.","Students supply telephone baseline survey; never-smokers supplied phone (n = 3547) eligible follow-up, 2603 contacted complete data variables analysis.",C0038492|C0243163|C0039457|C0168634|C0038951|C0425293|C1999230|C1515258|C0369718|G0000000|G0000000|C1548635|C0589120|G0000000|C0332158|C0205197|C1511726|C0439828|C0002778
"This study will focus on patients between 20 and 65 years of age with non-radicular chronic low back pain of mechanical origin (as opposed to infectious, neoplastic, or inflammatory causes).","This study focus patients 20 65 age non-radicular chronic low pain mechanical origin (as opposed infectious, neoplastic, inflammatory causes).",G0000000|C0557651|C0205234|C0030705|C0450371|C0450371|C0001779|C1518422|C0205191|C0205251|C0030193|C0443254|C0079946|G0000000|G0000000|C0009450|C1709160|C0333348|C0015127
Stroke subtype will be confirmed by imaging.,Stroke subtype confirmed imaging.,C0038454|C0449560|C0521093|C0011923
Minorities and people with low socioeconomic status are more likely to have undertreated back pain and are also less likely to use practices such as yoga.,Minorities people low socioeconomic status undertreated pain practices yoga.,C0026192|C0027361|C0205251|C0748878|C0449438|G0000000|C0030193|C0237607|C0043418
"Inclusion criteria were being primiparous in 26-32 weeks of gestational age, spouses’ literacy, having adequate physical and physiological health to actively attend the workshop, and absence of the following: Severe midwifery problems related to pregnancy, any baseline specific diseases, any diagnosable contraindication for CS during pregnancy, any psychological diseases, and an unexpected pregnancy.","Inclusion criteria primiparous 26-32 weeks gestational age, spouses’ literacy, adequate physical physiological health actively attend workshop, absence following: Severe midwifery pregnancy, baseline specific diseases, diagnosable contraindication CS pregnancy, psychological diseases, unexpected pregnancy.",C0007637|C0243161|C0033150|C0450371|C0439230|C0439671|C0001779|G0000000|C0023864|C0205410|C0031809|C0205463|C0018684|G0000000|C1999232|C0242262|C0332197|C0231290|C0205082|C0026082|C0032961|C0168634|C0205369|C0012634|G0000000|C0522473|C0010182|C0032961|C0205486|C0012634|C4055646|C0032961
"Two populations of children between 3 months and 18 years of age were recruited: children with medical illnesses admitted via the emergency department (medical), and children admitted following elective surgery (surgical).","Two populations children 3 months 18 age recruited: children medical illnesses admitted emergency department (medical), children admitted elective surgery (surgical).",C0205448|C0032659|C0008059|G0000000|C0439231|C0450371|C0001779|G0000000|C0008059|C0199168|C0221423|C0184666|C0013956|C1704729|C0199168|C0008059|C0184666|C0206058|C0038894|C0543467
Operators with less than 6 years of experience were classified as ‘registrars’ and those with more than 6 years of experience in the field of anesthesia and critical care were classified as ‘consultants.’ The right internal jugular vein (IJV) was the first choice for cannulation.,Operators 6 experience classified ‘registrars’ 6 experience field anesthesia critical care classified ‘consultants.’ The internal jugular vein (IJV) choice cannulation.,C1705273|G0000000|C0237607|C0008902|G0000000|G0000000|C0237607|C0440042|C0002903|C1511545|C1947933|C0008902|G0000000|G0000000|C0205102|G0000000|C0042449|G0000000|C0008300|C0917707
"The secondary outcome considered is Entomologic Inoculation Rate (EIR), estimated through routine programmatic entomological surveillance of vector mosquito densities in fixed, non-randomly chosen locations combined with subsequent laboratory analysis of captured specimens for sporozoite-stage parasite infection prevalence.","The secondary outcome considered Entomologic Inoculation Rate (EIR), estimated routine programmatic entomological surveillance vector mosquito densities fixed, non-randomly chosen locations combined subsequent laboratory analysis captured specimens sporozoite-stage parasite infection prevalence.",G0000000|C0027627|C1274040|C0750591|C0014386|C0042196|C0871208|G0000000|C0750572|C0205547|G0000000|C0014386|C0220920|C0086022|C0026584|C0178587|C0443218|C1518422|C1707391|C0450429|C0205195|C0332282|C0022877|C0002778|G0000000|C0370003|C0562648|C0030498|C0009450|C0033105
"In a parallel single-blinded randomized clinical trial, sixty 1-10 year old children referred to EEG Unit of Shahid Sadoughi Hospital from January 2010 to February 2011 in Yazd, Iran, were evaluated.","In parallel single-blinded randomized clinical trial, sixty 1-10 children referred EEG Unit Shahid Sadoughi Hospital January 2010 February 2011 Yazd, Iran, evaluated.",G0000000|C2348042|C0037179|C0034656|C0205210|C0008976|C3816724|C0450371|C0008059|C0205543|C0013819|C0439148|G0000000|G0000000|C0019994|C3829466|G0000000|C3830166|G0000000|G0000000|C0022065|C0220825
"Some 5626 German adolescents were surveyed at time 1 (T1), of whom 4603 (82%) were re-surveyed 1 year later (T2), and of whom 4384 (78%) had complete data for the analysis.","Some 5626 German adolescents surveyed time 1 (T1), 4603 (82%) re-surveyed 1 (T2), 4384 (78%) complete data analysis.",G0000000|G0000000|C1556085|C0205653|C0038951|C0040223|G0000000|C0041403|G0000000|C0450371|C0556581|G0000000|C0041403|G0000000|C0450371|C0205197|C1511726|C0002778
The participating students attended the 21 Victorian government secondary schools that had agreed to participate in this project.,The participating students attended 21 Victorian government secondary schools agreed participate project.,G0000000|C0679823|C0038492|C1456498|C0450371|G0000000|C0018104|C0027627|C0036375|C3641827|G0000000|C1709701
"The relatively young age was included because of the early progression of cataracts in south India, previously reported by others and observed in this study's pilot study.6,51,52 Visual acuity was evaluated using the National Eye Institute Early Treatment of Diabetic Retinopathy Study logMAR (EDTRS) chart, using standard ETDRS methology.50 On eye examination, no evidence of significant traumatic or congenital cataract, active infectious keratitis, nor narrow anterior chamber angle could be present.","The age included progression cataracts south India, reported observed study's pilot study.6,51,52 Visual acuity evaluated National Eye Institute Early Treatment Diabetic Retinopathy Study logMAR (EDTRS) chart, standard ETDRS methology.50 On eye examination, evidence traumatic congenital cataract, active infectious keratitis, narrow anterior chamber angle present.",G0000000|C0001779|C0332257|C0242656|C0086543|C1710133|C0021201|C0684224|C1441672|C0557651|C0473169|C0557651|C0234621|C0750509|C0220825|C3245503|C0015392|C0021622|C1279919|C0039798|C0241863|C0035309|C0557651|G0000000|G0000000|C0007963|C1442989|G0000000|C0450371|G0000000|C0015392|G0000000|C3887511|C0332663|C0009678|C0086543|C0205177|C0009450|C0022568|C0205168|C0205094|C0179874|C0205143|C0150312
"Their average ± SD age, height and body mass were 23.5 ± 2.3 years, 172.1 ± 7.5 cm and 65.2 ± 11.3 kg, respectively.","Their average ± SD age, height body mass 23.5 ± 2.3 years, 172.1 ± 7.5 cm 65.2 ± 11.3 kg, respectively.",G0000000|C1510992|G0000000|C2699239|C0001779|C0489786|C0242821|C0577559|C0450371|G0000000|G0000000|C0439234|C1442061|G0000000|G0000000|G0000000|C0450371|G0000000|C0450371|C0022718|G0000000
All infants born at a gestational age of less than 32 weeks and or a birth weight less than 1600 g at two neonatal intensive care units were included.,All infants born gestational age 32 weeks birth weight 1600 g neonatal intensive care units included.,G0000000|C0021270|C0005615|C0439671|C0001779|G0000000|C0005615|C0005910|G0000000|C1552240|C0162425|C1947933|C0439148|C0332257
"The criteria for enrollment included the following: histologically- or cytologically-proven advanced (stage IIIB or IV) or recurrent NSCLC; disease progression after first-line or second-line chemotherapy; age ≥ 18 years; Eastern Cooperative Oncology Group (ECOG) performance status (PS) ≤ 2; at least one measurable lesion; adequate bone marrow (absolute neutrophil count ≥ 1,500/mL and platelet count ≥ 100,000/mL), normal hepatic (bilirubin ≤ 1.25 upper limit of normal [ULN] and hepatic transaminase ≤ 2.5 ULN), and renal (serum creatinine < 1.5 mg/dL) functions; and an estimated life expectancy of at least 3 months.","The criteria enrollment included following: histologically- cytologically-proven advanced (stage IIIB IV) recurrent NSCLC; disease progression first-line second-line chemotherapy; age ≥ 18 years; Eastern Cooperative Oncology Group (ECOG) performance status (PS) ≤ 2; measurable lesion; adequate bone marrow (absolute neutrophil count ≥ 1,500/mL platelet count ≥ 100,000/mL), normal hepatic (bilirubin ≤ 1.25 upper limit normal [ULN] hepatic transaminase ≤ 2.5 ULN), renal (serum creatinine < 1.5 mg/dL) functions; estimated life expectancy 3 months.",G0000000|C0243161|C1516879|C0332257|C0231290|C0205462|C0456369|C0205179|C0205390|G0000000|C0022326|C2945760|C0007131|C0012634|C0242656|C0205435|C0205436|C0013216|C0001779|G0000000|C0450371|C0439234|C1707877|C0679729|C0027651|C0441833|C0430797|C0597198|C0449438|C0242397|G0000000|G0000000|C1513040|C0221198|C0205410|C0262950|C0086590|C0205344|C0027950|C0750480|G0000000|C1442061|C0005821|C0750480|G0000000|C1442061|C0205307|C0205054|C0005437|G0000000|C0450371|C1282910|C0439801|C0205307|C1519815|C0205054|C0002594|G0000000|G0000000|C1519815|C0022646|C0229671|C0010294|G0000000|G0000000|C0439269|C0542341|C0750572|C0376558|C0679138|G0000000|C0439231
"The randomization was balanced between treatment groups in terms of sex, age, nodal involvement, tumor grade and size, local invasion at operation, invasion of contiguous structures at histology, and postoperative complications.","The randomization balanced treatment terms sex, age, nodal involvement, tumor grade size, local invasion operation, invasion contiguous structures histology, postoperative complications.",G0000000|C0034656|C0205415|C0039798|C0233324|C0009253|C0001779|C0443268|C1314939|C0027651|C0441800|C0456389|C0205276|C1269955|C0543467|C1269955|C0205283|C0678594|C0019638|C0032790|C0009566
"Patients were excluded if they satisfied any of the following exclusion criteria: there was doubt about the diagnosis of scabies; pruritus due to insect bites was present; the case patient or a member of his or her family had chickenpox; or the patient had been treated for scabies less than 1 month before the consultation; was under 5 years or over 65 years of age; weighed less than 15 kg; was pregnant or breastfeeding; was a women who used bleaching products for cosmetic purposes; had crusted scabies; had a general condition such as diabetes, high blood pressure or cardiovascular or neurological disease; or lived outside of the Dakar district.","Patients excluded satisfied exclusion criteria: doubt diagnosis scabies; pruritus insect bites present; patient family chickenpox; patient treated scabies 1 month consultation; 5 65 age; weighed 15 kg; pregnant breastfeeding; women bleaching products cosmetic purposes; crusted scabies; condition diabetes, blood pressure cardiovascular neurological disease; lived Dakar district.",C0030705|C1554077|C0242428|C0680251|C0243161|C0870444|C0011900|C0036262|C0033774|C0021585|C0005658|C0150312|C0030705|C0015576|C0008049|C0030705|C1522326|C0036262|G0000000|C0332177|C0009818|G0000000|C0450371|C0001779|G0000000|C0450371|C0022718|C0549206|C0006147|C0043210|C0303749|C1514468|C0010164|C1285529|C0392749|C0036262|C0012634|C0011847|C0005767|C0033095|C0007226|C0205494|C0012634|C1548795|C1424714|G0000000
"During the 5-month study period 3005 patients with fever, of whom 75 were excluded, consulted the 22 CHWs (Figure 1).","During 5-month study period 3005 patients fever, 75 excluded, consulted 22 CHWs (Figure 1).",G0000000|C0332177|C0557651|C0439531|G0000000|C0030705|C0015967|C0450371|C1554077|C0009818|C0450371|G0000000|G0000000|G0000000
We thank participants for their one-year commitment to the study.,We participants one-year commitment study.,G0000000|C0679646|C4082117|C0870312|C0557651
"During a mean follow-up of 13.9 years, 7,115 incident cases were identified among 75,216 white, African American, Native Hawaiian, Japanese American, and Latino men.","During follow-up 13.9 years, 7,115 incident identified 75,216 white, African American, Native Hawaiian, Japanese American, Latino men.",G0000000|C0589120|C0450371|C0439234|C1442061|C1551358|C0205396|C0450371|C0007457|C0027567|C0596070|C0302891|C0337920|C1556094|C0596070|C0086528|C0025266
"Patients were excluded if they 1) could not be interviewed in privacy from accompanying family members, 2) planned to leave the area in the next three months, 3) could not provide reliable contact information to complete the follow-up procedures, 4) were currently in a residential substance abuse treatment facility, 5) were in custody or institutionalized; 6) presented for a rape exam or psychiatric evaluation for suicide precautions, or 7) if parents opted out for patients younger than age 18.","Patients excluded 1) interviewed privacy accompanying family members, 2) planned leave months, 3) provide reliable contact complete follow-up procedures, 4) residential substance abuse treatment facility, 5) custody institutionalized; 6) rape exam psychiatric evaluation suicide precautions, 7) parents opted patients age 18.",C0030705|C1554077|G0000000|C0021822|C0080048|G0000000|C0015576|C0680022|G0000000|C1301732|G0000000|C0439231|G0000000|C1999230|C3858758|C0332158|C0205197|C0589120|C0025664|G0000000|C0237096|C0439861|C0013146|C0039798|C1547538|G0000000|G0000000|C0562359|G0000000|C0034668|C0582103|C0205487|C0220825|C0038661|C1882442|G0000000|C0030551|C1412930|C0030705|C0001779|C0450371
Methods: The study was conducted in 96 sub-village units (balozis) in the Kongwa district of Tanzania which were predicted from prior prevalence surveys to have TF between 5 and 9.9%.,Methods: The study conducted 96 sub-village units (balozis) Kongwa district Tanzania predicted prior prevalence surveys TF 5 9.9%.,C0025663|G0000000|C0557651|C0004927|C0450371|C0542339|C0439148|G0000000|G0000000|G0000000|C0039298|C0681842|C0332152|C0033105|C0038951|C4048299|G0000000|G0000000
"Improvements over placebo in daytime use ranged from −0.008 (olodaterol 5 μg, week 7, Study 1222.14; P=0.9410) to −0.574 (olodaterol 5 μg, week 15, Study 1222.13; P<0.0001), and from −0.125 (olodaterol 5 μg, week 37, Study 1222.14; P=0.4234) to −0.852 (olodaterol 5 μg, week 15, Study 1222.13; P<0.0001) for nighttime use.","Improvements placebo daytime ranged −0.008 (olodaterol 5 μg, week 7, Study 1222.14; P=0.9410) −0.574 (olodaterol 5 μg, week 15, Study 1222.13; P<0.0001), −0.125 (olodaterol 5 μg, week 37, Study 1222.14; P=0.4234) −0.852 (olodaterol 5 μg, week 15, Study 1222.13; P<0.0001) nighttime use.",C2986411|C0032042|C0332169|C1514721|G0000000|C2934193|G0000000|G0000000|C0332174|G0000000|C0557651|C0450371|C0369773|G0000000|C2934193|G0000000|G0000000|C0332174|C0450371|C0557651|C0450371|C0369773|G0000000|C2934193|G0000000|G0000000|C0332174|C0450371|C0557651|C0450371|C0369773|G0000000|C2934193|G0000000|G0000000|C0332174|C0450371|C0557651|C0450371|C0369773|C0240526|C0042153
The role of adjuvant whole brain radiotherapy (WBRT) following local treatment of intracranial melanoma metastases is controversial.,The role adjuvant brain radiotherapy (WBRT) local treatment intracranial melanoma metastases controversial.,G0000000|C0035820|C0001551|C0006104|C0034619|C1520143|C0205276|C0039798|C0524466|C0025202|C0027627|C0680243
"In addition to calories, we also focus on other major macro-nutrients—protein and fat.","In addition calories, focus major macro-nutrients—protein fat.",G0000000|C0332287|C1556156|C0205234|C0205082|G0000000|C0424612
"Previous exploratory research in a pilot study of a prototype of the game demonstrated improvement of time management (KCMB, unpublished data, 2016).","Previous exploratory pilot study prototype game demonstrated improvement time management (KCMB, unpublished data, 2016).",C0205156|G0000000|C0473169|C0557651|G0000000|C0150593|G0000000|C2986411|C0040223|C0001554|G0000000|G0000000|C1511726|G0000000
"Various operative and diagnostic laparoscopic procedures were performed by seven different surgeons on 87 consecutive women (age range: 18–54 years) undergoing surgery at the Ernst Moritz Arndt University Hospital in Greifswald, Germany and at the Women's Hospital of Texas in Houston, Texas.","Various operative diagnostic laparoscopic procedures performed surgeons 87 consecutive women (age range: 18–54 years) undergoing surgery Ernst Moritz Arndt University Hospital Greifswald, Germany Women's Hospital Texas Houston, Texas.",C0440102|C1882154|C0011900|C0031150|C0025664|C0884358|C0582175|C0450371|C1707491|C0043210|C0001779|C1514721|G0000000|C0439234|G0000000|C0038894|G0000000|G0000000|G0000000|C0041740|C0019994|G0000000|C0017480|C0043210|C0019994|C0039711|G0000000|C0039711
"The children with spastic hemiplegia, age between 1.5 and 12 year and having 10 degrees of wrist extension and 10 degrees of finger extension were included in study.","The children spastic hemiplegia, age 1.5 12 10 degrees wrist extension 10 degrees finger extension included study.",G0000000|C0008059|C0026838|C0018991|C0001779|G0000000|C0450371|C0450371|C0449286|C0043262|C0231448|C0450371|C0449286|C0016129|C0231448|C0332257|C0557651
"We excluded children if they required hospital admission; were clinically dehydrated; had recently participated in another trial; had previously participated in PITCH; had a known intolerance, allergy, or contraindication to a trial drug18; had a chronic neurological, cardiac, pulmonary (except asthma), liver, or renal disease; or had parents who could not read or write in English.","We excluded children required hospital admission; clinically dehydrated; participated trial; participated PITCH; intolerance, allergy, contraindication trial drug18; chronic neurological, cardiac, pulmonary (except asthma), liver, renal disease; parents read write English.",G0000000|C1554077|C0008059|C1514873|C0019994|C0184666|G0000000|C0011175|G0000000|C0008976|G0000000|C0137137|C0231199|C0002111|C0522473|C0008976|G0000000|C0205191|C0205494|C0018787|C0024109|G0000000|C0004096|C0023884|C0022646|C0012634|C0030551|C0034754|C0043266|C0376245
"From a governmental economic perspective, it is favorable for people with dementia to remain at home with their family caregivers for as long as possible rather than being institutionalized (Brodaty and Donkin, 2009).","From governmental economic perspective, favorable people dementia remain family caregivers institutionalized (Brodaty Donkin, 2009).",G0000000|C0018104|C0013556|G0000000|C3640814|C0027361|C0011265|G0000000|C0015576|C0085537|C0562359|G0000000|G0000000|G0000000
"Antibiotic treatment decreased significantly in the supplementation group from 14.5 (14.9) days/patient during the three months before the study to 9.8 (10.3) days/patient during high dose supplementation (p=0.0368) and to 10.5 (9.9) days/patient during low dose supplementation, but increased in the placebo group.","Antibiotic treatment decreased supplementation 14.5 (14.9) days/patient months study 9.8 (10.3) days/patient dose supplementation (p=0.0368) 10.5 (9.9) days/patient low dose supplementation, increased placebo group.",C0003232|C0039798|C0205216|C0242297|C0450371|C0450371|C0439228|C0439231|C0557651|G0000000|C0450371|C0439228|C0178602|C0242297|C0369773|C0450371|G0000000|C0439228|C0205251|C0178602|C0242297|C0205217|C0032042|C0441833
"The patients having major physical problems, co-morbid psychiatric disorder, history suggestive of MR, epilepsy, head injury, concurrent active medical disorder and active psychopathology that interfere with following and understanding instructions were excluded from the study.","The patients major physical problems, co-morbid psychiatric disorder, history suggestive MR, epilepsy, head injury, concurrent active medical disorder active psychopathology interfere understanding instructions excluded study.",G0000000|C0030705|C0205082|C0031809|C1546466|C0009488|C0205487|C0012634|C0019664|C0332299|C1417249|C0014544|C0018670|C3263722|C0205420|C0205177|C0199168|C0012634|C0205177|C0033927|C0521102|C0162340|C0302828|C1554077|C0557651
"At baseline, a majority of these participants was aged 18 to 24 years (77%; mean, 22 years), never married (98%), and college educated (58%).","At baseline, majority participants aged 18 24 (77%; mean, 22 years), married (98%), college educated (58%).",G0000000|C0168634|C0680220|C0679646|C0001779|C0450371|C0450371|C0450371|C0444504|C0450371|C0439234|C0024841|C0450371|C0557806|C0039401|C0450371
"Inclusion criteria included (1) first ischemic or hemorrhagic stroke; (2) residual LE hemiparesis involving the ankle, defined by manual muscle testing (strength range grade 1/5 to 4/5, capable of generating at least trace muscle activation in PF-DF; (3) adequate language and neurocognitive function (e.g., follow two-step commands) to participate in training, testing, and to give informed consent; and (4) clinical, neurological, and hemodynamic stability to sit in the chair for 30–60 minutes per session of ankle training.","Inclusion criteria included (1) ischemic hemorrhagic stroke; (2) residual LE hemiparesis involving ankle, defined manual muscle testing (strength range grade 1/5 4/5, capable generating trace muscle activation PF-DF; (3) adequate language neurocognitive function (e.g., follow two-step commands) participate training, testing, informed consent; (4) clinical, neurological, hemodynamic stability sit chair 30–60 minutes session ankle training.",C0007637|C0243161|C0332257|G0000000|C0475224|C0333275|C0038454|G0000000|C1609982|C0023190|C0018989|C1314939|C0003086|C1704788|C0024763|C0026845|C0039593|C0237897|C1514721|C0441800|G0000000|G0000000|C2698977|G0000000|C0442822|C0026845|C1879547|C3815179|G0000000|C0205410|C0023008|C0518895|C0031843|G0000000|C0332283|C0205448|C3639196|G0000000|C0040607|C0039593|C1522154|C1511481|G0000000|C0205210|C0205494|C0019010|C0205360|C0277814|C0179847|G0000000|C0439232|C1883016|C0003086|C0040607
"Four patients (1 in the BATRAC group and 3 in the DMTE group) discontinued the intervention and 1 BATRAC patient cancelled baseline MRI due to claustrophobia, leaving 9 patients in the BATRAC group and 12 in the DMTE group for analysis (12 men and 9 women; mean [SD] age, 61.5 [12.6] years) a median (interquartile range [IQR]) of 50.3 (34.8-77.3) months (range, 10 months–39 years) after stroke (Figure 1).","Four patients (1 BATRAC 3 DMTE group) discontinued intervention 1 BATRAC patient cancelled baseline MRI claustrophobia, leaving 9 patients BATRAC 12 DMTE analysis (12 9 women; [SD] age, 61.5 [12.6] years) median (interquartile range [IQR]) 50.3 (34.8-77.3) months (range, 10 months–39 years) stroke (Figure 1).",C0205450|C0030705|G0000000|G0000000|G0000000|G0000000|C0441833|C1444662|C0886296|G0000000|G0000000|C0030705|C0205544|C0168634|C0024485|C0008909|G0000000|G0000000|C0030705|G0000000|C0450371|G0000000|C0002778|C0450371|G0000000|C0043210|C2699239|C0001779|C0450371|C0450371|C0439234|C0549183|G0000000|C1514721|G0000000|C0450371|C0450371|C0439231|C1514721|C0450371|G0000000|C0439234|C0038454|G0000000|G0000000
"For each health worker, child care centers had an equal chance of being assigned to CCHP + HAP or CCHP + HAP Delayed.","For health worker, child care centers equal chance assigned CCHP + HAP CCHP + HAP Delayed.",G0000000|C0018684|C1306056|C0008059|C1947933|C0205099|C0205163|C0237506|C1516050|G0000000|G0000000|C0205421
"The mean (±SD, range) age of the study patients in the CTTM group and in the combined trabeculotomy–trabeculectomy with mitomycin C with deep sclerectomy (CTTM-DS) group was 4.7 (±2.0, 2–8) and 7.0 (±3.8, 3–13) months, respectively.","The (±SD, range) age study patients CTTM combined trabeculotomy–trabeculectomy mitomycin C deep sclerectomy (CTTM-DS) 4.7 (±2.0, 2–8) 7.0 (±3.8, 3–13) months, respectively.",G0000000|G0000000|C1514721|C0001779|C0557651|C0030705|G0000000|C0205195|G0000000|C0002475|G0000000|C0205125|C0197557|C3714751|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|C0439231|G0000000
We therefore hypothesize that xenon anesthesia reduces the incidence of POD in elderly patients undergoing cardiac surgery with the use of cardiopulmonary bypass.,We hypothesize xenon anesthesia reduces incidence POD elderly patients undergoing cardiac surgery cardiopulmonary bypass.,G0000000|G0000000|C0043339|C0002903|G0000000|C0021149|G0000000|C0001792|C0030705|G0000000|C0018787|C0038894|C0553534|C0741847
"1,258 pregnant women (<16 wk gestation) in 104 communes were assigned to daily iron–folic acid (IFA), twice weekly IFA, or twice weekly multiple micronutrient (MMN) supplementation.","1,258 pregnant women (<16 wk gestation) 104 communes assigned daily iron–folic acid (IFA), weekly IFA, weekly multiple micronutrient (MMN) supplementation.",C1442061|C0549206|C0043210|C0450371|C0332174|C0032961|C1442061|C0598781|C1516050|C0332173|G0000000|C0001128|C0281643|C0332174|C0281643|C0332174|C0439064|C0040577|G0000000|C0242297
Participants were smokers with head and neck or thoracic malignancies undergoing radiation.,Participants smokers head neck thoracic malignancies undergoing radiation.,C0679646|C0337664|C0018670|C0027530|G0000000|C0006826|G0000000|C0034519
Preterm infants were randomly assigned to receive rhEPO (500IU/kg; n = 366) or placebo (n = 377) intravenously within 72 hours after birth and then once every other day for 2 weeks.,Preterm infants randomly assigned receive rhEPO (500IU/kg; = 366) placebo (n = 377) intravenously 72 hours birth day 2 weeks.,C0151526|C0021270|G0000000|C1516050|C1514756|G0000000|C0022718|G0000000|C1442061|C0032042|C0369718|G0000000|C1442061|G0000000|C0450371|C0439227|C0005615|C0332173|G0000000|C0439230
"In 1995–1996, we identified a nationwide historical cohort of 19 861 subfertile women who received at least one IVF cycle with ovarian stimulation between 1983 and 1995 in 1 of the 12 IVF hospitals with legal permission to provide IVF treatment in the Netherlands.","In 1995–1996, identified nationwide historical cohort 19 861 subfertile women received IVF cycle ovarian stimulation 1983 1995 1 12 IVF hospitals legal permission provide IVF treatment Netherlands.",G0000000|G0000000|C0205396|G0000000|C1552658|C0599755|C0450371|C1442061|C0729353|C0043210|C1514756|C0872104|C1511572|C0205065|C1292856|G0000000|G0000000|G0000000|C0450371|C0872104|C0019994|C1301860|C0521104|C1999230|C0872104|C0039798|C0027778
The fear avoidance beliefs questionnaire (FABQ) was used to measure the fear of lower back pain.,The fear avoidance beliefs questionnaire (FABQ) measure fear lower pain.,G0000000|C0015726|C0870186|C0004951|C0034394|G0000000|C0079809|C0015726|C0441994|C0030193
We will recruit 160 breast cancer survivors (aged 18-65 years) with a formal DSM-IV diagnosis of sexual dysfunction from general and academic hospitals in the Netherlands.,We recruit 160 breast cancer survivors (aged 18-65 years) formal DSM-IV diagnosis sexual dysfunction academic hospitals Netherlands.,G0000000|G0000000|C1442061|C0006141|C0006826|C0206194|C0001779|C0450371|C0439234|C0348078|C0220952|C0011900|C0036864|C0031847|C1510747|C0019994|C0027778
"Eligible patients were adults who had severe, moderate-to-severe, or moderate TBI due to a blunt mechanism, with a Glasgow Coma Scale8 (GCS) score of 4 to 12 (on a scale of 3 to 15, with lower scores indicating a lower level of consciousness).","Eligible patients adults severe, moderate-to-severe, moderate TBI blunt mechanism, Glasgow Coma Scale8 (GCS) score 4 12 (on scale 3 15, lower scores indicating lower level consciousness).",C1548635|C0030705|C0001675|C0205082|C0205081|C0205081|C0876926|C1997138|C0441712|G0000000|C0009421|G0000000|G0000000|C0449820|G0000000|C0450371|G0000000|C0175659|G0000000|C0450371|C0441994|C0449820|G0000000|C0441994|C0441889|C0009791
Women who were either prenatal or had just delivered a baby were screened for eligibility for the NFN program using the Revised Early Identification Screening Tool (Reid).,Women prenatal delivered baby screened eligibility NFN program Revised Early Identification Screening Tool (Reid).,C0043210|C0678804|C1705822|C0021270|C0220908|C0013893|C2931482|C1709697|C1527075|C1279919|C0020792|C0220908|C0336791|G0000000
"Subjects were eligible for this study if they met the following criteria: age ⩾40 and ⩽75 years; smoking history (⩾10 pack‐years); post‐bronchodilator FEV1 ⩾25% of predicted value and FEV1/forced vital capacity (FVC) ⩽0.70; no history of asthma, atopy (as assessed by an allergy skin prick test during screening) or any other active lung disease.","Subjects eligible study met criteria: age ⩾40 ⩽75 years; smoking history (⩾10 pack‐years); post‐bronchodilator FEV1 ⩾25% predicted FEV1/forced vital capacity (FVC) ⩽0.70; history asthma, atopy (as assessed allergy skin prick test screening) active lung disease.",C0681850|C1548635|C0557651|C0268621|C0243161|C0001779|G0000000|G0000000|C0037369|C0019664|G0000000|G0000000|G0000000|G0000000|G0000000|C0681842|C0441722|C0442732|C1516240|C3714541|G0000000|C0019664|C0004096|C0392707|G0000000|C1516048|C0002111|C0444099|C0033119|C0022885|C0220908|C0205177|C0024109|C0012634
"The 2009 H1N1 virus is a triple-reassortant influenza virus containing genes from human, swine, and avian influenza viruses[4,5] and thus has been labeled “swine flu.” Most cases of pandemic influenza H1N1 infection have been mild or subclinical, some patients experienced severe illness and complications from H1N1 influenza infection.","The 2009 H1N1 virus triple-reassortant influenza virus genes human, swine, avian influenza viruses[4,5] labeled “swine flu.” Most pandemic influenza H1N1 infection mild subclinical, patients experienced severe illness complications H1N1 influenza infection.",G0000000|G0000000|G0000000|C0042776|C0205174|C0021400|C0042776|C0017337|C0086418|C0039005|C0005595|C0021400|C0042776|C1708632|G0000000|G0000000|C0205393|C1615608|C0021400|G0000000|C0009450|C2945599|C0205211|C0030705|C0237607|C0205082|C0221423|C0009566|G0000000|C0021400|C0009450
All adolescent girls visiting ‘Urban Health and Training Centre’ were investigated for the hemoglobin estimation by Sahli’s Hemoglobinometer.,All adolescent girls visiting ‘Urban Health Training Centre’ investigated hemoglobin estimation Sahli’s Hemoglobinometer.,G0000000|C0205653|C0870604|C0545082|G0000000|C0018684|C0040607|G0000000|C1292732|C0019046|C0680844|G0000000|C0181183
"Women were required to be 18 years or older, meet the CDC classification for case-defined AIDS (i.e.","Women required 18 older, meet CDC classification case-defined AIDS (i.e.",C0043210|C1514873|C0450371|C0580836|C1550543|C0007670|C0008902|C0868928|C0001175|C0683454
The median age at diagnosis was 4.3 (years) (3 months–11.8 years).,The median age diagnosis 4.3 (years) (3 months–11.8 years).,G0000000|C0549183|C0001779|C0011900|G0000000|C0439234|G0000000|G0000000|C0439234
"Seventy-five percent of patients received RT in the Stanford V arm, whereas in the ABVD arm, 41% received RT for bulky mediastinal disease only.","Seventy-five percent patients received RT Stanford V arm, ABVD arm, 41% received RT bulky mediastinal disease only.",C3816957|C0439165|C0030705|C1514756|C0230425|G0000000|G0000000|C0446516|C0050380|C0446516|C0450371|C1514756|C0230425|C0012173|C0025066|C0012634|C0205171
"This study showed decreased risk of TB recurrence, increased CD4 cell count, and decreased incidence of peripheral neuropathy.26 Supplementation with selenium alone compared with placebo for 9 months significantly reduced HIV viral load and indirectly improved CD4 cell count in our earlier study of drug users in the United States.15 This study, however, also differs from the current clinical trial, because a single nutrient was supplemented, all the participants were illicit drug users, and many were taking ART.","This study decreased risk TB recurrence, increased CD4 cell count, decreased incidence peripheral neuropathy.26 Supplementation selenium compared placebo 9 months reduced HIV viral load indirectly improved CD4 cell count earlier study drug users United States.15 This study, however, differs current clinical trial, single nutrient supplemented, participants illicit drug users, ART.",G0000000|C0557651|C0205216|C0035647|G0000000|C0034897|C0205217|C0285590|C0007634|C0750480|C0205216|C0021149|C0205100|C0442874|C0242297|C0036581|C1707455|C0032042|G0000000|C0439231|C0392756|C0019682|C0521026|C1550025|G0000000|C0184511|C0285590|C0007634|C0750480|C1279919|C0557651|C0013227|C1706077|C0166872|C1301808|G0000000|C0557651|G0000000|G0000000|C0521116|C0205210|C0008976|C0037179|C0678695|C0242295|C0679646|C0332266|C0013227|C1706077|C0003826
"It also had a 94% power to detect a 1 unit difference in Epworth score at the 5% level based on the data of Massie et al.8 This study is registered as a clinical trial with number ISRCTN43085025 A total of 368 patients with OSAHS were invited to participate in the study (Figure 1), and 200 patients (46 F) were recruited (mean age 50 SD ± 10 y; BMI 34.5 ± 7.8 kg/m2; Epworth Score 14 ± 3).","It 94% power detect 1 unit difference Epworth score 5% level based data Massie al.8 This study registered clinical trial ISRCTN43085025 A total 368 patients OSAHS invited participate study (Figure 1), 200 patients (46 F) recruited (mean age 50 SD ± 10 y; BMI 34.5 ± 7.8 kg/m2; Epworth Score 14 ± 3).",G0000000|C0450371|C0032863|C0442726|G0000000|C0439148|C1705241|G0000000|C0449820|G0000000|C0441889|C1527178|C1511726|G0000000|C0202311|G0000000|C0557651|C1514821|C0205210|C0008976|G0000000|G0000000|C0439175|C1442061|C0030705|C0520679|G0000000|G0000000|C0557651|G0000000|G0000000|C1442061|C0030705|C0450371|C0016327|G0000000|C0444504|C0001779|C0450371|C2699239|G0000000|C0450371|G0000000|G0000000|C0450371|G0000000|G0000000|C0022718|G0000000|C0449820|C0450371|G0000000|G0000000
The principal investigator or another paediatrician enrolled children aged one to five years whose mothers or caretakers gave informed written consent to participate and who had attended the clinic at least once.,The principal investigator paediatrician enrolled children aged mothers caretakers informed written consent participate attended clinic once.,G0000000|C0205225|C0035173|C0237433|G0000000|C0008059|C0001779|C0026591|C0335350|C1522154|C0043266|C1511481|G0000000|C1456498|C0002424|G0000000
Urea reduction ratio < 65% or single pool Kt/V < 1.0 (haemodialysis patients) or total weekly Kt/V < 1.7 (peritoneal dialysis patients).,Urea reduction ratio < 65% single pool Kt/V < 1.0 (haemodialysis patients) total weekly Kt/V < 1.7 (peritoneal dialysis patients).,C0041942|C0301630|C0456603|G0000000|C0450371|C0037179|C0337051|C0429662|G0000000|G0000000|C0019004|C0030705|C0439175|C0332174|C0429662|G0000000|G0000000|C0031153|C0011945|C0030705
"FEV1: forced expiratory volume in 1 s; AUC0–3: area under the curve from 0 to 3 h. #: number of patients contributing to the mixed model for repeated measurements for adjusted mean FEV1 AUC0–3 Study 1237.5: tiotropium+olodaterol 5/5 μg n=522, tiotropium+olodaterol 2.5/5 μg n=521, tiotropium 5 μg n=526, tiotropium 2.5 μg n=524, olodaterol 5 μg n=525; Study 1237.6: tiotropium+olodaterol 5/5 μg n=502, tiotropium+olodaterol 2.5/5 μg n=506, tiotropium 5 μg n=500, tiotropium 2.5 μg n=504, olodaterol 5 μg n=507.","FEV1: forced expiratory volume 1 s; AUC0–3: curve 0 3 h. #: patients contributing mixed model repeated measurements adjusted FEV1 AUC0–3 Study 1237.5: tiotropium+olodaterol 5/5 μg n=522, tiotropium+olodaterol 2.5/5 μg n=521, tiotropium 5 μg n=526, tiotropium 2.5 μg n=524, olodaterol 5 μg n=525; Study 1237.6: tiotropium+olodaterol 5/5 μg n=502, tiotropium+olodaterol 2.5/5 μg n=506, tiotropium 5 μg n=500, tiotropium 2.5 μg n=504, olodaterol 5 μg n=507.",G0000000|C0441722|C0231800|C0449468|G0000000|G0000000|C0205134|G0000000|G0000000|G0000000|C0030705|C1880177|C0205430|C3161035|C0205341|C0242485|C0456081|G0000000|G0000000|C0557651|G0000000|C0213771|G0000000|C0369718|C0213771|G0000000|C0369718|C0213771|G0000000|C0369718|C0213771|G0000000|C0369718|C2934193|G0000000|C0369718|C0557651|G0000000|C0213771|G0000000|C0369718|C0213771|G0000000|C0369718|C0213771|G0000000|C0369718|C0213771|G0000000|C0369718|C2934193|G0000000|C0369718
Study design All hip and pelvic fracture patients admitted to the geriatric rehabilitation departments of the Robert-Bosch-Hospital Stuttgart and the Agaplesion Bethanien Hospital Heidelberg (both Germany) were assessed for eligibility from July 2015 to February 2018.,Study design All hip pelvic fracture patients admitted geriatric rehabilitation departments Robert-Bosch-Hospital Stuttgart Agaplesion Bethanien Hospital Heidelberg (both Germany) assessed eligibility July 2015 February 2018.,C0557651|C1707689|G0000000|C0019552|C0030797|C0016658|C0030705|C0184666|C1704440|C0034991|C1704729|C0019994|G0000000|G0000000|G0000000|C0019994|G0000000|G0000000|C0017480|C1516048|C0013893|C3829447|G0000000|C3830166|G0000000
Low back pain (LBP) is a symptom experienced by 80% of adults at least once in their life time.,Low pain (LBP) symptom experienced 80% adults life time.,C0205251|C0030193|C1505993|C1457887|C0237607|C0450371|C0001675|C0376558|C0040223
"On the basis of these values, we anticipate detecting a difference of −264 dyn·s·cm5 and −5.2 mmHg for PVR and mPAP, respectively, which are within the range reported previously as clinically meaningful changes in response to PH treatment.","On basis values, anticipate detecting difference −264 dyn·s·cm5 −5.2 mmHg PVR mPAP, respectively, range reported clinically meaningful response PH treatment.",G0000000|C1527178|C0042295|G0000000|C0442726|C1705241|G0000000|G0000000|G0000000|C0439475|C0242852|C3854605|G0000000|C1514721|C0684224|G0000000|C0876919|C0871261|C0450407|C0039798
"Of our cohort, 30% were previously under surveillance (prior to 1995) and thus had preexisting knowledge of their condition when they were recruited to this study, whereas the remaining proportion of participants entered into the cohort at the same time as their diagnosis of Barrett’s esophagus.","Of cohort, 30% surveillance (prior 1995) preexisting knowledge condition recruited study, remaining proportion participants entered cohort time diagnosis Barrett’s esophagus.",G0000000|C0599755|C0450371|C0220920|C0332152|G0000000|C2347662|C0376554|C0012634|G0000000|C0557651|C1527428|C1709707|C0679646|C1521975|C0599755|C0040223|C0011900|G0000000|C0014876
"Eligible pregnant women from the West Kiang region of The Gambia (pregnancy dated by ultrasound examination) are randomized on entry to 4 intervention groups (Iron-folate (FeFol = standard care), multiple micronutrients (MMN), protein-energy (PE), PE + MMN).","Eligible pregnant women West Kiang region The Gambia (pregnancy dated ultrasound examination) randomized entry 4 intervention (Iron-folate (FeFol = standard care), multiple micronutrients (MMN), protein-energy (PE), PE + MMN).",C1548635|C0549206|C0043210|C1705493|C0325167|C0017446|G0000000|C0016993|C0032961|G0000000|C0041618|G0000000|C0034656|C1705654|G0000000|C0886296|C0302583|G0000000|C1947933|C0439064|C0282575|G0000000|C0033684|C0070939|G0000000
"Eligibility criteria, described in detail elsewhere (Wolchik, West et al., 2000), included the following: 1) divorce occurred within the past two years; 2) there was at least one child between 9 and 12 in the family; 3) the mother was the primary residential parent; and 4) the mother was not remarried or living with a partner and was not planning to remarry during the trial.","Eligibility criteria, detail (Wolchik, West al., 2000), included following: 1) divorce occurred years; 2) child 9 12 family; 3) mother primary residential parent; 4) mother remarried living partner planning remarry trial.",C0013893|C0243161|C1522508|G0000000|C1705493|C0202311|G0000000|C0332257|C0231290|G0000000|C0012828|C1709305|C0439234|G0000000|C0008059|G0000000|C0450371|C0015576|G0000000|C0026591|C0205225|C0237096|C0030551|G0000000|C0026591|C0425380|C0376558|C0682323|C0032074|G0000000|C0008976
"A research midwife recruited women during their initial booking visit at the antenatal clinic, usually at around 10-20 weeks' gestation.","A midwife recruited women initial booking visit antenatal clinic, 10-20 weeks' gestation.",G0000000|C0026083|G0000000|C0043210|C0205265|C0006002|C0545082|C2828394|C0002424|C0450371|C0439230|C0032961
"In medical patients, this was done when the IV catheter was inserted; surgical patients had their blood drawn upon completion of the surgical procedure.","In medical patients, IV catheter inserted; surgical patients blood drawn completion surgical procedure.",G0000000|C0199168|C0030705|C0022326|C0085590|C0441587|C0543467|C0030705|C0005767|C0013113|C0205197|C0543467|C0184661
"Participants with the following characteristics are being recruited: low-income (≤ 185% federal poverty level in the US and eligible for federal food assistance programs); 18 years of age or over; mothers of infants less than 4 months of age who have not started solid foods; a primary caregiver of the infant, and neither mother nor infant has a diagnosed eating, physical, or chronic health problem.","Participants characteristics recruited: low-income (≤ 185% federal poverty level US eligible federal food assistance programs); 18 age over; mothers infants 4 months age started solid foods; primary caregiver infant, mother infant diagnosed eating, physical, chronic health problem.",C0679646|C1521970|G0000000|C0032854|G0000000|C1442061|G0000000|C0032854|C0441889|G0000000|C1548635|G0000000|C0016452|C0018896|C0376691|C0450371|C0001779|C0205136|C0026591|C0021270|G0000000|C0439231|C0001779|C1272689|C0205208|C0016452|C0205225|C0085537|C0021270|C0026591|C0021270|C0011900|C0013470|C0031809|C0205191|C0018684|C0033213
"The exclusion criteria comprised a history of conditions or diseases affecting bone, pregnancy or lactation the past 6 months, use of bone-active medications other than intravenous methylprednisolone for treatment of MS relapses, a history of nephrolithiasis during the previous 5 years, or menopause.","The exclusion criteria comprised history conditions diseases bone, pregnancy lactation 6 months, bone-active medications intravenous methylprednisolone treatment MS relapses, history nephrolithiasis previous 5 years, menopause.",G0000000|C0680251|C0243161|C2700400|C0019664|C0012634|C0012634|C0262950|C0032961|C0006147|G0000000|C0439231|C0262950|C0013227|C0348016|C0025815|C0039798|C0039676|C0035020|C0019664|C0022650|C0205156|G0000000|C0439234|C0025320
"Patients had to meet the following criteria: (1) a diagnosis of COPD according to the GOLD-criteria; (2) current or ex-smoker; (3) age 40–80 years; (4) presenting at the outpatient clinic with an AECOPD, defined as an acute negative change in dyspnoea and/or sputum volume and/or colour of sputum (yellowish or greenish) and/or cough, which warrants additional treatment with prednisolone with or without antibiotics by a physician; (5) no requirement of hospitalisation (6) no pneumonia based on chest X-ray;22 (7) ability to produce a spontaneous sputum sample; (8) presenting with one or two of the clinical characteristics: a positive Gram's stain of sputum, a clinically relevant lung function decrease (decrease in FEV1 of >200 mL and >12% from baseline), or >2 AECOPDs in the previous year;21 (9) no AECOPD or use of antibiotics or prednisolone 4 weeks prior to enrolment, except for low-dose prednisolone (≤5 mg) as maintenance therapy; (10) no disease that influences bronchial symptoms or lung function; (11) no maintenance therapy with antibiotics; (12) no known hypersensitivity to amoxicillin/ clavulanic acid; (13) no medical condition with low survival or serious psychiatric morbidity; (14) no uncontrolled diabetes mellitus; (15) no need for domiciliary oxygen therapy; and (16) no participation in another clinical trial.","Patients meet criteria: (1) diagnosis COPD GOLD-criteria; (2) current ex-smoker; (3) age 40–80 years; (4) outpatient clinic AECOPD, defined acute negative change dyspnoea and/or sputum volume and/or colour sputum (yellowish greenish) and/or cough, warrants additional treatment prednisolone antibiotics physician; (5) requirement hospitalisation (6) pneumonia based chest X-ray;22 (7) ability produce spontaneous sputum sample; (8) clinical characteristics: positive Gram's stain sputum, clinically relevant lung function decrease (decrease FEV1 >200 mL >12% baseline), >2 AECOPDs previous year;21 (9) AECOPD antibiotics prednisolone 4 weeks prior enrolment, low-dose prednisolone (≤5 mg) maintenance therapy; (10) disease influences bronchial symptoms lung function; (11) maintenance therapy antibiotics; (12) hypersensitivity amoxicillin/ clavulanic acid; (13) medical condition low survival psychiatric morbidity; (14) uncontrolled diabetes mellitus; (15) domiciliary oxygen therapy; (16) participation clinical trial.",C0030705|C1550543|C0243161|G0000000|C0011900|C0024117|C0018026|G0000000|C0521116|C0337671|G0000000|C0001779|G0000000|G0000000|C0029921|C0002424|G0000000|C1704788|C0205178|C0205160|C0392747|C0013404|G0000000|C0038056|C0449468|G0000000|C0009393|C0038056|G0000000|G0000000|G0000000|C0010200|G0000000|C1524062|C0039798|C0032950|C0003232|C0031831|G0000000|C1514873|C0019993|G0000000|C0032285|C1527178|C0817096|C0034571|G0000000|C0085732|G0000000|C0205359|C0038056|C0370003|G0000000|C0205210|C1521970|C0439178|C0439208|C0038128|C0038056|G0000000|C2347946|C0024109|C0031843|C0392756|C0392756|G0000000|G0000000|C0450371|C0168634|G0000000|G0000000|C0205156|C0439234|G0000000|G0000000|C0003232|C0032950|G0000000|C0332152|C1516879|C0445550|C0032950|G0000000|C0024501|C0039798|C0450371|C0012634|C4054723|C0205039|C0683368|C0024109|C0031843|C0450371|C0024501|C0039798|C0003232|C0450371|C0020517|C0002645|G0000000|C0001128|C0450371|C0199168|C0012634|C0205251|C0038952|C0205487|C0026538|C0450371|C0205318|C0011847|G0000000|C0450371|C0338047|C0030054|C0039798|C0450371|C0679823|C0205210|C0008976
Conclusion Penicillin treatment had no beneficial effect in children with sore throat on the average duration of symptoms.,Conclusion Penicillin treatment beneficial children sore throat average duration symptoms.,C1707478|C0030827|C0039798|G0000000|C0008059|C0234233|C0031354|C1510992|C0449238|C0683368
"This multicenter, randomized, placebo-controlled clinical study enrolled adult patients (n = 134) with acute ankle pain (due to a minor sprain) occurring less than 48 hours prior to entering the study.","This multicenter, randomized, placebo-controlled clinical study enrolled adult patients (n = 134) acute ankle pain (due minor sprain) occurring 48 hours prior entering study.",G0000000|C0439743|C0034656|C1706408|C0205210|C0557651|G0000000|C0001675|C0030705|C0369718|G0000000|C1442061|C0205178|C0003086|C0030193|C0678226|C0026193|C0038045|C1709305|C0450371|C0439227|C0332152|C1522196|C0557651
The participants were timed and videotaped whilst donning and doffing the PPE.,The participants timed videotaped whilst donning doffing PPE.,G0000000|C0679646|C0392761|C0042655|G0000000|C0012020|G0000000|G0000000
Inclusion criteria: Patients who are diagnosed at hospital level to have bronchial asthma; patients who are on regular follow up at chest clinic; patient with mild to moderate asthma and those who were able to come to missionary of charity for the yoga practice were included in the study based on their consent.,Inclusion criteria: Patients diagnosed hospital level bronchial asthma; patients regular follow chest clinic; patient mild moderate asthma missionary charity yoga practice included study based consent.,C0007637|C0243161|C0030705|C0011900|C0019994|C0441889|C0205039|C0004096|C0030705|C0205272|C0332283|C0817096|C0002424|C0030705|C2945599|C0205081|C0004096|C0079844|C0007962|C0043418|C0237607|C0332257|C0557651|C1527178|C1511481
"Six-month biologically-confirmed smoking cessations rates were 4% usual care, 0% lung age, 14% contingency management and 0% for combined lung age and contingency management (p = 0.13).","Six-month biologically-confirmed smoking cessations rates 4% usual care, 0% lung age, 14% contingency management 0% combined lung age contingency management (p = 0.13).",C0585339|C0205460|C0037369|C1880019|C0871208|G0000000|C3538928|C1947933|G0000000|C0024109|C0001779|C0450371|C1701901|C0001554|G0000000|C0205195|C0024109|C0001779|C1701901|C0001554|G0000000
"PGC-1α1-4 and PGC-1αB1-5 [15,23].","PGC-1α1-4 PGC-1αB1-5 [15,23].",G0000000|G0000000|C0450371
"As in the previous publication [7] the main statistical analysis was based on a stepwise, fixed-effects analysis of covariance using an iterative procedure including the change from baseline as response variable, treatment and country factors as fixed effects, baseline value as covariate and following potential cofactors: smoking history (current/ex-smokers vs. never-smokers), age (<65 years vs. ≥ 65 years), duration of disease since diagnosis (≤ 6 vs. >6 months), DLco(≤ 40% vs. >40% predicted), VC (≤ 60% vs. >60% predicted), sex (male vs. female), and whether a biopsy had been performed.","As previous publication [7] main statistical analysis based stepwise, fixed-effects analysis covariance iterative procedure including change baseline response variable, treatment country factors fixed effects, baseline covariate potential cofactors: smoking history (current/ex-smokers vs. never-smokers), age (<65 vs. ≥ 65 years), duration disease diagnosis (≤ 6 vs. >6 months), DLco(≤ 40% vs. >40% predicted), VC (≤ 60% vs. >60% predicted), sex (male vs. female), biopsy performed.",G0000000|C0205156|C0034036|G0000000|C0205225|C0038215|C0002778|C1527178|G0000000|C0443218|C0002778|G0000000|C1854293|C0184661|C0332257|C0392747|C0168634|C0871261|C0439828|C0039798|C0454664|C1521761|C0443218|C1280500|C0168634|G0000000|C3245505|C0178555|C0037369|C0019664|C0521116|G0000000|C0425293|C0001779|C0450371|G0000000|G0000000|C0450371|C0439234|C0449238|C0012634|C0011900|G0000000|G0000000|G0000000|G0000000|C0439231|G0000000|C0450371|G0000000|C0450371|C0681842|G0000000|G0000000|C0450371|G0000000|C0450371|C0681842|C0009253|C0086582|G0000000|C0015780|C0005558|C0884358
Exclusion criteria were: complication by common bile duct or intrahepatic bile duct stones; acute cholecystitis; suspicion of complicated cholecystitis; BMI ≥ 35 kg/m2; drug addiction; ASA physical classification > 3; previous upper abdominal surgery; pregnancy; presence of umbilical hernia; or previous umbilical hernia repair.,Exclusion criteria were: complication common bile duct intrahepatic bile duct stones; acute cholecystitis; suspicion complicated cholecystitis; BMI ≥ 35 kg/m2; drug addiction; ASA physical classification > 3; previous upper abdominal surgery; pregnancy; presence umbilical hernia; previous umbilical hernia repair.,C0680251|C0243161|G0000000|C0009566|C0205214|C0005388|C0687028|C1512948|C0005388|C0687028|C0006736|C0205178|C0008325|C0242114|C0231242|C0008325|G0000000|G0000000|C0450371|C0022718|C0013227|C0085281|C0004057|C0031809|C0008902|G0000000|G0000000|C0205156|C1282910|C0000726|C0038894|C0032961|C0150312|C0041638|C0019270|C0205156|C0041638|C0019270|C0043240
"Persons with MS by McDonald's criteria20 (Expanded Disability Status Scale [EDSS] score 0−7.5) who were stable for at least 30 days, scored 1 SD or more below the mean of established normative samples on one or more of the 4 tests in the neuropsychological test battery, and did not have contraindications for ginkgo or problems that would interfere with testing were eligible for the study (table e-1).","Persons MS McDonald's criteria20 (Expanded Disability Status Scale [EDSS] score 0−7.5) stable 30 days, scored 1 SD established normative samples 4 tests neuropsychological test battery, contraindications ginkgo interfere testing eligible study (table e-1).",C0027361|C0039676|G0000000|G0000000|C0205229|C0231170|C0449438|C0175659|C0451246|C0449820|G0000000|C0205360|C0450371|C0439228|C0449820|G0000000|C2699239|C0443211|G0000000|C0370003|G0000000|C0022885|G0000000|C0022885|C0337088|C0079164|C0330205|C0521102|C0039593|C1548635|C0557651|C0039224|G0000000
"Previously untreated patients with a diagnosis of AML according to the criteria of the French-American-British group16,17 were eligible for entry onto the trial provided they met the following requirements (1): age 15 to 60 years (2); diagnosis of primary or secondary AML (including AML after myelodysplastic syndrome) other than French-American-British M3 (3); no evidence of severe concurrent cardiac, pulmonary, neurologic, and metabolic diseases or uncontrolled infections; and (4) adequate liver (serum bilirubin level < 2× upper normal limit) and renal (serum creatinine < 2× upper normal limit) function tests.","Previously untreated patients diagnosis AML criteria French-American-British group16,17 eligible entry trial provided met requirements (1): age 15 60 (2); diagnosis primary secondary AML (including AML myelodysplastic syndrome) French-American-British M3 (3); evidence severe concurrent cardiac, pulmonary, neurologic, metabolic diseases uncontrolled infections; (4) adequate liver (serum bilirubin level < 2× upper normal limit) renal (serum creatinine < 2× upper normal limit) function tests.",G0000000|C0332155|C0030705|C0011900|C0023467|C0243161|C0376246|C0450371|C1548635|C1705654|C0008976|C1999230|C0268621|C1514873|G0000000|C0001779|C0450371|C0450371|G0000000|C0011900|C0205225|C0027627|C0023467|C0332257|C0023467|G0000000|C0039082|C0376246|C0025885|G0000000|C3887511|C0205082|C0205420|C0018787|C0024109|C0205494|C0311400|C0012634|C0205318|C3714514|G0000000|C0205410|C0023884|C0229671|C0005437|C0441889|G0000000|G0000000|C1282910|C0205307|C0439801|C0022646|C0229671|C0010294|G0000000|G0000000|C1282910|C0205307|C0439801|C0031843|C0022885
All of the participants were evaluated with the use the 6MWT before and after the pulmonary rehabilitation.,All participants evaluated 6MWT pulmonary rehabilitation.,G0000000|C0679646|C0220825|G0000000|C0024109|C0034991
"Baseline characteristics of the study population NPC nasopharyngeal carcinoma, RN radiation-induced brain necrosis, RT radiotherapy MRI scan was obtained at the baseline prior to the entry of the trial and 3 months after completing the trial.","Baseline characteristics study population NPC nasopharyngeal carcinoma, RN radiation-induced brain necrosis, RT radiotherapy MRI scan baseline prior entry trial 3 months completing trial.",C0168634|C1521970|C0557651|C0032659|G0000000|C0027442|C0007097|C2827110|C0034519|C0006104|C0027540|C0230425|C0034619|C0024485|C0034606|C0168634|C0332152|C1705654|C0008976|G0000000|C0439231|C0205197|C0008976
"Inclusion criteria included age ≥ 18 years, pathologic diagnosis of glioblastoma, prior treatment with a temozolomide-containing chemotherapy regimen, prior treatment with radiation, Karnofsky performance status (KPS) ≥ 70, Mini-Mental Status Examination score ≥ 15, and life expectancy ≥ 12 weeks.","Inclusion criteria included age ≥ 18 years, pathologic diagnosis glioblastoma, prior treatment temozolomide-containing chemotherapy regimen, prior treatment radiation, Karnofsky performance status (KPS) ≥ 70, Mini-Mental Status Examination score ≥ 15, life expectancy ≥ 12 weeks.",C0007637|C0243161|C0332257|C0001779|G0000000|C0450371|C0439234|C1521733|C0011900|C0017636|C0332152|C0039798|C0076080|C0013216|C0040808|C0332152|C0039798|C0034519|C0206065|C0597198|C0449438|C0206065|G0000000|C0450371|C0445542|C0449438|G0000000|C0449820|G0000000|C0450371|C0376558|C0679138|G0000000|C0450371|C0439230
"If the combined effects of CBT and physical exercise are cumulative, or if the effect of CBT varies as a function of exposure to exercise or vice versa, (i.e.","If combined effects CBT physical exercise cumulative, CBT varies function exposure exercise vice versa, (i.e.",G0000000|C0205195|C1280500|C0009244|C0031809|C0015259|C1511559|C0009244|C1548673|C0031843|C0274281|C0015259|C0814670|G0000000|C0683454
"20 There were 64 men (74.5%) with a mean age of 70 years (range 41–84) and 22 women (25.5%), with a mean age of 72 years (range 54–82).","20 There 64 (74.5%) age 70 (range 41–84) 22 women (25.5%), age 72 (range 54–82).",C0450371|G0000000|C0450371|C0450371|C0001779|C0450371|C1514721|G0000000|C0450371|C0043210|C0450371|C0001779|C0450371|C1514721|G0000000
"Thirty individuals completed the study, and baseline characteristics were similar between the two study groups: mean age 37.9 ± 8.1 years, years since diagnosis 16.5 ± 10.6, BMI 24.3 ± 2.6 kg/m2, A1C 7.2 ± 0.7%, dietary carbohydrates 45.5 ± 10.7%, total fat 36.9 ± 10.5%, monounsaturated fat 15.5 ± 5.7%, and saturated fat 11.7 ± 4.3%.","Thirty individuals completed study, baseline characteristics study groups: age 37.9 ± 8.1 years, diagnosis 16.5 ± 10.6, BMI 24.3 ± 2.6 kg/m2, A1C 7.2 ± 0.7%, dietary carbohydrates 45.5 ± 10.7%, total fat 36.9 ± 10.5%, monounsaturated fat 15.5 ± 5.7%, saturated fat 11.7 ± 4.3%.",C3816446|C0027361|C0205197|C0557651|C0168634|C1521970|C0557651|C0441833|C0001779|C0450371|G0000000|G0000000|C0439234|C0011900|C0450371|G0000000|C0450371|G0000000|C0450371|G0000000|G0000000|C0022718|G0000000|G0000000|G0000000|G0000000|C0012155|C0007004|C0450371|G0000000|C0450371|C0439175|C0424612|C0450371|G0000000|C0450371|G0000000|C0424612|C0450371|G0000000|G0000000|C0522534|C0424612|C0450371|G0000000|G0000000
Schools were eligible if they participated in the WFP school meal program and all children were served breakfast daily.,Schools eligible participated WFP school meal program children served breakfast daily.,C0036375|C1548635|G0000000|G0000000|C0036375|C1998602|C1709697|C0008059|G0000000|C2698559|C0332173
"The inclusion criteria are age below 18 years at time of study enrolment; diagnosed with bronchiectasis by a respiratory physician following high resolution computed tomography in the five years immediately prior to study entry or, if diagnosed earlier, have been followed regularly by a respiratory physician for treatment of bronchiectasis; and has experienced two or more respiratory exacerbations in the 18 months prior to study entry.","The inclusion criteria age 18 years time study enrolment; diagnosed bronchiectasis respiratory physician resolution computed tomography prior study entry or, diagnosed earlier, regularly respiratory physician treatment bronchiectasis; experienced respiratory exacerbations 18 months prior study entry.",G0000000|C0007637|C0243161|C0001779|G0000000|C0040223|C0557651|C1516879|C0011900|C0006267|C0521346|C0031831|C1514893|C1441526|C0040395|C0332152|C0557651|C1705654|G0000000|C0011900|C1279919|G0000000|C0521346|C0031831|C0039798|C0006267|C0237607|C0521346|G0000000|G0000000|C0332152|C0557651|C1705654
"Among post-menopausal women, there were no SNPs significantly associated with breast cancer risk.","Among post-menopausal women, SNPs breast cancer risk.",G0000000|C0232970|C0043210|C0752046|C0006141|C0006826|C0035647
Our phase III randomised controlled trial will recruit 215 adults with moderate to severe limitations of walking and ADL 5 to 45 days after stroke onset.,Our phase III randomised controlled trial recruit 215 adults moderate severe limitations walking ADL 5 45 days stroke onset.,G0000000|C0205390|C0439070|G0000000|C2587213|C0008976|G0000000|C1442061|C0001675|C0205081|C0205082|C0449295|C0080331|C0001288|G0000000|C0450371|C0439228|C0038454|C0206132
Honesty pledge.,Honesty pledge.,C0870663|G0000000
Physicians and nurses will be trained.,Physicians nurses trained.,C0031831|C0028661|C0336809
Psychiatric diagnosis revealed that 42% of the patients had at least one psychiatric disorder.,Psychiatric diagnosis revealed 42% patients psychiatric disorder.,C0205487|C0011900|C0443289|C0450371|C0030705|C0205487|C0012634
"Exclusion criteria were previous use of the AD or mAD for > 1 week, previous use of the ketogenic diet within the past year, patients with kidney, heart, renal disease or hypercholesterolemia, patients with history of coronary heart disease, cerebrovascular disease, peripheral vascular disease, atherosclerosis, previous myocardial infarctions, or renal dysfunction, pregnant individuals, body mass index (BMI) below 18.5, status epilepticus within the past 6 months, 2 week seizure-free period within the past 6 months.","Exclusion criteria previous AD mAD > 1 week, previous ketogenic diet year, patients kidney, heart, renal disease hypercholesterolemia, patients history coronary heart disease, cerebrovascular disease, peripheral vascular disease, atherosclerosis, previous myocardial infarctions, renal dysfunction, pregnant individuals, body mass (BMI) 18.5, status epilepticus 6 months, 2 week seizure-free period 6 months.",C0680251|C0243161|C0205156|G0000000|C0002957|G0000000|G0000000|C0332174|C0205156|C0599817|C0012155|C0439234|C0030705|C0022646|C0018787|C0022646|C0012634|C0020443|C0030705|C0019664|C0018787|C0018787|C0012634|C1880018|C0012634|C0205100|C0005847|C0012634|C0003850|C0205156|C0027061|C0021308|C0022646|C0031847|C0549206|C0027361|C0242821|C0577559|G0000000|C0450371|C0449438|G0000000|G0000000|C0439231|G0000000|C0332174|C1299590|C0439531|G0000000|C0439231
All data were collected at the National Pediatric hospital.,All data collected National Pediatric hospital.,G0000000|C1511726|C1516695|C3245503|C0030755|C0019994
Primary care providers are randomized to one of two arms: access to an electronic CKD registry or usual care.,Primary care providers randomized arms: access electronic CKD registry usual care.,C0205225|C1947933|C1138603|C0034656|C0206655|C0444454|C0013850|C1561643|C0034975|C3538928|C1947933
The researcher will assess patients to ensure they meet the following inclusion criteria: to be female; aged 18–75 at diagnosis; have a primary diagnosis of stage I to III breast cancer; receiving chemotherapy and are able to speak and read English.,The researcher assess patients ensure meet inclusion criteria: female; aged 18–75 diagnosis; primary diagnosis stage I III breast cancer; receiving chemotherapy speak read English.,G0000000|C0035173|C1516048|C0030705|C0218063|C1550543|C0007637|C0243161|C0015780|C0001779|G0000000|C0011900|C0205225|C0011900|C0205390|C0021966|C0439070|C0006141|C0006826|C1514756|C0013216|C0234856|C0034754|C0376245
"The total number of chemotherapy cycles administered in cohort I was 257 (median 6, range 1–10) and in cohort II was 247 (median 4, range 1–10).","The total chemotherapy cycles administered cohort I 257 (median 6, range 1–10) cohort II 247 (median 4, range 1–10).",G0000000|C0439175|C0013216|C1511572|C1521801|C0599755|C0021966|C1442061|C0549183|G0000000|C1514721|G0000000|C0599755|G0000000|C1442061|C0549183|G0000000|C1514721|G0000000
The eligible participants must meet all the following criteria: (1) be confirmed as people with high risk of ischemic stroke; (2) have not conducted regular physical exercise for at least one year (regular exercise means lasting more than three months with a frequency of three to four times a week and at least 30 minutes per session); (3) be male or female aged from 50 to 70 years old; (4) have signed the informed consent document.,The eligible participants meet criteria: (1) confirmed people risk ischemic stroke; (2) conducted regular physical exercise (regular exercise lasting months frequency times week 30 minutes session); (3) male female aged 50 70 old; (4) signed informed consent document.,G0000000|C1548635|C0679646|C1550543|C0243161|G0000000|C0521093|C0027361|C0035647|C0475224|C0038454|G0000000|C0004927|C0205272|C0031809|C0015259|C0205272|C0015259|C1517741|C0439231|C0376249|C0040223|C0332174|C0450371|C0439232|C1883016|G0000000|C0086582|C0015780|C0001779|C0450371|C0450371|C0580836|G0000000|C1519316|C1522154|C1511481|C1301746
"The Food and Drug Administration and the National Institute on Drug Abuse Institutional Review Board approved the protocol for adolescents smoking at least 10 cigarettes/day for 6 months and scoring ≥5 on the Fagerström Test for Nicotine Dependence (FTND; Heatherton, Kozlowski, Frecker, & Fagerström, 1991).","The Food Drug Administration National Institute Drug Abuse Institutional Review Board approved protocol adolescents smoking 10 cigarettes/day 6 months scoring ≥5 Fagerström Test Nicotine Dependence (FTND; Heatherton, Kozlowski, Frecker, & Fagerström, 1991).",G0000000|C0016452|C0013227|C0001554|C3245503|C0021622|C0013227|C0013146|C0018704|C0282443|C0972401|C0205540|C0442711|C0205653|C0037369|C0450371|C0677453|G0000000|C0439231|C0449820|G0000000|G0000000|C0022885|C0028040|C0011546|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000
"Eligible participants had to be (1) 18 years or older; (2) able to speak and understand English; (3) a smoker living with at least 1 child or other nonsmoker, or a nonsmoker living with a smoker; and (4) allow smoking in the home.","Eligible participants (1) 18 older; (2) speak understand English; (3) smoker living 1 child nonsmoker, nonsmoker living smoker; (4) smoking home.",C1548635|C0679646|G0000000|C0450371|C0580836|G0000000|C0234856|C0162340|C0376245|G0000000|C0337664|C0376558|G0000000|C0008059|C0337672|C0337672|C0376558|C0337664|G0000000|C0037369|C0442519
"This prospective randomized clinical trial of 1,608 patients suggests that there is no significant detrimental effect on pCR, sphincter-sparing surgery, or surgical downstaging when radiation therapy is combined with capecitabine instead of CVI FU for the neoadjuvant treatment of stage II and III rectal cancer among patients eligible for this clinical trial.","This prospective randomized clinical trial 1,608 patients suggests detrimental pCR, sphincter-sparing surgery, surgical downstaging radiation therapy combined capecitabine CVI FU neoadjuvant treatment stage II III rectal cancer patients eligible clinical trial.",G0000000|C0023981|C0034656|C0205210|C0008976|C1442061|C0030705|C1705535|G0000000|C0032520|C1409894|C0038894|C0543467|G0000000|C0034519|C0039798|C0205195|C0671970|G0000000|C0016360|C0600558|C0039798|C0205390|G0000000|C0439070|C0205052|C0006826|C0030705|C1548635|C0205210|C0008976
"Participants were one thousand 16- to 18-year-old girls: 500 had not yet received an invitation to attend the vaccination program (first-time invitees), and 500 had previously received an invitation to get vaccinated, but had failed to attend the first vaccination appointment (previous nonattenders).","Participants 16- 18-year-old girls: 500 received invitation attend vaccination program (first-time invitees), 500 received invitation vaccinated, failed attend vaccination appointment (previous nonattenders).",C0679646|C0450371|C0450371|C0870604|C1442061|C1514756|C2826348|C1999232|C0042196|C1709697|C0205435|G0000000|C1442061|C1514756|C2826348|C1116171|C0231175|C1999232|C0042196|C0003629|C0205156|G0000000
"Patients were not allowed to have had previous anticancer treatment, except for adjuvant radiotherapy or chemotherapy completed at least 12 months before.","Patients allowed previous anticancer treatment, adjuvant radiotherapy chemotherapy completed 12 months before.",C0030705|C0683607|C0205156|G0000000|C0039798|C0001551|C0034619|C0013216|C0205197|C0450371|C0439231|C0332152
"All patients attending the clinic were screened for the presence of the malaria parasite by examining thick and thin smears of peripheral blood, followed by Giemsa staining, to identify patients who might meet the inclusion criteria according to the WHO protocol (23).","All patients attending clinic screened presence malaria parasite examining thick thin smears peripheral blood, Giemsa staining, identify patients meet inclusion criteria WHO protocol (23).",G0000000|C0030705|C1547429|C0002424|C0220908|C0150312|C0024530|C0030498|C0332128|C1280412|C0205168|C0444186|C0205100|C0005767|C0017542|C0487602|G0000000|C0030705|C1550543|C0007637|C0243161|G0000000|C0442711|C0450371
"In 2011, privately insured women changed from a private practice model to one that included 24-hour midwifery and laborist coverage.","In 2011, privately insured women changed private practice model included 24-hour midwifery laborist coverage.",G0000000|G0000000|G0000000|C1548605|C0043210|C0392747|C0033175|C0237607|C3161035|C0332257|C0450371|C0026082|G0000000|C1551362
"Other key eligibility criteria were the following: Karnofsky performance status (KPS)⩾70%, life expectancy >12 weeks, and adequate haematological, renal and hepatic function.","Other key eligibility criteria following: Karnofsky performance status (KPS)⩾70%, life expectancy >12 weeks, adequate haematological, renal hepatic function.",G0000000|G0000000|C0013893|C0243161|C0231290|C0206065|C0597198|C0449438|G0000000|C0376558|C0679138|C0450371|C0439230|C0205410|C0018943|C0022646|C0205054|C0031843
The New Zealand Ministry of Health supplied a listing of all residential care homes (subsequently termed “homes”) in the two centres.,The New Zealand Ministry Health supplied listing residential care homes (subsequently termed “homes”) centres.,G0000000|C0205314|G0000000|G0000000|C0018684|C1999230|C0745732|C0237096|C1947933|C0442519|G0000000|C0233324|G0000000|C0205099
"They had completed cancer treatment within the past 3 years (except for tamoxifen/aromatase inhibitors) and were at least 2 months post-surgery or adjuvant therapy or radiation, whichever occurred last.","They completed cancer treatment 3 (except tamoxifen/aromatase inhibitors) 2 months post-surgery adjuvant therapy radiation, whichever occurred last.",G0000000|C0205197|C0006826|C0039798|G0000000|G0000000|C0039286|C0243077|G0000000|C0439231|C0032790|C0001551|C0039798|C0034519|G0000000|C1709305|C1517741
* No Parkinson's disease = patient is diagnosed with parkinsonism or patient declared to have no gratifying and sustained response to dopaminergic therapy; ** No sedentary lifestyle = > 3 times a week vigorous-intensity physical activity > 60 minutes; or > 3 times a week moderate-intensity physical activity > 150 minutes; *** Severe disease = H&Y > III; MMSE < 24; severe co-morbidity interfering with daily functioning; use of daily care in an institution; or deep brain stimulation.,* No Parkinson's disease = patient diagnosed parkinsonism patient declared gratifying sustained response dopaminergic therapy; ** No sedentary lifestyle = > 3 times week vigorous-intensity physical activity > 60 minutes; > 3 times week moderate-intensity physical activity > 150 minutes; *** Severe disease = H&Y > III; MMSE < 24; severe co-morbidity interfering daily functioning; daily care institution; deep brain stimulation.,G0000000|G0000000|C1021144|C0012634|G0000000|C0030705|C0011900|C0242422|C0030705|G0000000|G0000000|C0443318|C0871261|C0282151|C0039798|G0000000|G0000000|C0205254|C0023676|G0000000|G0000000|G0000000|C0040223|C0332174|C0522510|C0031809|C0205177|G0000000|C0450371|C0439232|G0000000|G0000000|C0040223|C0332174|C0205081|C0031809|C0205177|G0000000|C1442061|C0439232|G0000000|C0205082|C0012634|G0000000|C0033727|G0000000|C0439070|C0451306|G0000000|C0450371|C0205082|C0009488|C0521102|C0332173|C0205245|C0332173|C1947933|C0018704|C0205125|C0006104|C1292856
"With a minimally clinical relevant difference of 4 points between the intervention group and the control group on the Conner’s 3rd Edition Rating Scale ‘hyperactivity-impulsivity’ subindex (the primary outcome) and an assumed standard deviation of 5 points on the same scale [43]; [44], a sample size of 26 participants in each group was needed.","With minimally clinical relevant difference 4 intervention control Conner’s 3rd Edition Rating Scale ‘hyperactivity-impulsivity’ subindex (the primary outcome) assumed standard deviation 5 scale [43]; [44], sample size 26 participants needed.",G0000000|G0000000|C0205210|C2347946|C1705241|G0000000|C0886296|C0243148|G0000000|G0000000|C0441792|C0871208|C0175659|G0000000|G0000000|G0000000|C0205225|C1274040|C3242379|C1442989|C0012727|G0000000|C0175659|C0450371|C0450371|C0370003|C0456389|C0450371|C0679646|C0027552
"We excluded patients living in a nursing home or unable to give informed consent, due to mental incapacity or terminal illness.","We excluded patients living nursing unable informed consent, mental incapacity terminal illness.",G0000000|C1554077|C0030705|C0376558|C0006147|C1299582|C1522154|C1511481|C0229992|G0000000|C0205088|C0221423
"We hypothesized that, during the first two weeks of life, premature infants fed with PF, as alternative to OMM insufficient or unavailable, would have a feeding tolerance not inferior to that seen in infants fed with PDHM.","We hypothesized that, weeks life, premature infants fed PF, alternative OMM insufficient unavailable, feeding tolerance inferior infants fed PDHM.",G0000000|G0000000|G0000000|C0439230|C0376558|C0151526|C0021270|C0342895|C3815179|C1523987|G0000000|C0205412|C0686905|C0204695|C0013220|C0542339|C0021270|C0342895|G0000000
"One hundred patients were enrolled, 74 with CFRD FH− and 26 with severe IGT.","One patients enrolled, 74 CFRD FH− 26 severe IGT.",C0205447|C0030705|G0000000|C0450371|G0000000|G0000000|C0450371|C0205082|G0000000
"Patients were excluded in case of prior use of melatonin, use of hypnotics that could not be stopped during the study, and severe psychological or neurological disease.","Patients excluded prior melatonin, hypnotics stopped study, severe psychological neurological disease.",C0030705|C1554077|C0332152|C0025219|C0020591|C1272691|C0557651|C0205082|C0205486|C0205494|C0012634
In 2001–2002 a total of 490 patients with slide confirmed uncomplicated P. falciparum malaria were randomly assigned to receive artemether-lumefantrine (n = 245) or artesunate and mefloquine (n = 245) and were followed for 42 days.,In 2001–2002 total 490 patients slide confirmed uncomplicated P. falciparum malaria randomly assigned receive artemether-lumefantrine (n = 245) artesunate mefloquine (n = 245) 42 days.,G0000000|G0000000|C0439175|C1442061|C0030705|C0444330|C0521093|C0443334|C0369773|G0000000|C0024530|G0000000|C1516050|C1514756|C0936150|C0369718|G0000000|C1442061|C0052432|C0025153|C0369718|G0000000|C1442061|C0450371|C0439228
We included outpatients who were over 45 years of age with established or previous atherothrombotic CVD occurring in the past 10 years and who were at high CVD risk.,We included outpatients 45 age established previous atherothrombotic CVD occurring 10 CVD risk.,G0000000|C0332257|C0029921|C0450371|C0001779|C0443211|C0205156|G0000000|C0007222|C1709305|C0450371|C0007222|C0035647
"Patients aged at least 18 and not more than 65 years old, with FIGO stage IIB-IIIB squamous cell carcinoma of cervix, who were planned to receive the standard treatment for locally advanced cervical cancer of external beam whole pelvis radiotherapy and brachytherapy plus weekly cisplatin 40 mg/m2, with ECOG performance status 0-1 and negative anti-HIV were included.","Patients aged 18 65 old, FIGO stage IIB-IIIB squamous cell carcinoma cervix, planned receive standard treatment locally advanced cervical cancer external beam pelvis radiotherapy brachytherapy weekly cisplatin 40 mg/m2, ECOG performance status 0-1 negative anti-HIV included.",C0030705|C0001779|C0450371|C0450371|C0580836|C2983134|C0205390|G0000000|C1182670|C0007634|C0007097|C0007874|C1301732|C1514756|C1442989|C0039798|C1517927|C0205179|C0027530|C0006826|C0205101|C0338248|C0030797|C0034619|C0006098|C0332174|C0008838|C0450371|C0026410|C0430797|C0597198|C0449438|G0000000|C0205160|C0019682|C0332257
"We compared the tolerability and efficacy of lithium carbonate and divalproex in 224 inpatients and outpatients aged ≥ 60 years with bipolar disorder (BD) type I, presenting with a manic, hypomanic or mixed episode.","We compared tolerability efficacy lithium carbonate divalproex 224 inpatients outpatients aged ≥ 60 bipolar disorder (BD) type I, manic, hypomanic mixed episode.",G0000000|C1707455|C3274448|C1280519|C0023870|C0007026|C0042291|C1442061|C0021562|C0029921|C0001779|G0000000|C0450371|C0443156|C0012634|C0005126|C0332307|C0021966|C0338831|C0241934|C0205430|C0332189
"The length of time since diagnosis with MS ranged from 1 to 29 years (mean ± SD, 12.2 ± 7.4 years).","The length time diagnosis MS ranged 1 29 (mean ± SD, 12.2 ± 7.4 years).",G0000000|C1444754|C0040223|C0011900|C0039676|C1514721|G0000000|C0450371|C0444504|G0000000|C2699239|C0450371|G0000000|G0000000|C0439234
"Most of the tumors were positive for estrogen receptors (73/119, 61%) while 30% (36/119) were HER2 positive and 24% (29/119) had a triple negative phenotype.","Most tumors positive estrogen receptors (73/119, 61%) 30% (36/119) HER2 positive 24% (29/119) triple negative phenotype.",C0205393|C0027651|C0439178|C0014939|C0597357|C0450371|C0450371|C0450371|C0450371|G0000000|C0439178|C0450371|C0450371|C0205174|C0205160|C0031437
The inclusion criteria for the longitudinal study were: i) a child 6–6.9 months (Mali) or 0–1.4 months of age (Burkina Faso); ii) child not being in a state of AM; iii) child’s main caregiver living the study area since the child’s delivery; iv) child without congenital malformations that hinder the measurement of anthropometry.,The inclusion criteria longitudinal study were: i) child 6–6.9 months (Mali) 0–1.4 months age (Burkina Faso); ii) child AM; iii) child’s main caregiver living study child’s delivery; iv) child congenital malformations hinder measurement anthropometry.,G0000000|C0007637|C0243161|C0205127|C0557651|G0000000|C0021966|C0008059|G0000000|C0439231|C0024581|G0000000|C0439231|C0001779|G0000000|G0000000|G0000000|C0008059|G0000000|C0439070|G0000000|C0205225|C0085537|C0376558|C0557651|G0000000|C0011209|C0022326|C0008059|C0009678|C0000768|G0000000|C0242485|C0003188
"However, an effective neuroprotective treatment for acute stroke in humans remains elusive.","However, effective neuroprotective treatment acute stroke humans remains elusive.",G0000000|C1280519|C0598958|C0039798|C0205178|C0038454|C0086418|G0000000|G0000000
"Taken together, these results underscore the concept that mucosal and systemic immune responses to polio are separate in their induction, functionality, and potential impacts on transmission and, specifically, provide evidence that primary vaccine regimens lacking homologous live vaccine components are likely to induce only modest, type-specific intestinal immunity.","Taken together, underscore concept mucosal systemic immune responses polio separate induction, functionality, potential impacts transmission and, specifically, provide evidence primary vaccine regimens lacking homologous live vaccine components induce modest, type-specific intestinal immunity.",C1883727|C1883357|G0000000|C0178566|C0026724|C0205373|C0439662|C0871261|C0032371|C0443299|C0205263|C0205245|C3245505|C1825598|C0040722|G0000000|G0000000|C1999230|C3887511|C0205225|C0042210|C2945654|C0332268|C1334043|C1548795|C0042210|C0449432|C0205263|C4054480|C0332307|C0021853|C0020964
We hypothesized that eszopiclone would increase the arousal threshold and lower the AHI in patients with a low arousal threshold (0 to −15 cmH2O).,We hypothesized eszopiclone increase arousal threshold lower AHI patients low arousal threshold (0 −15 cmH2O).,G0000000|G0000000|C1436328|C0442805|C0003808|C0449864|C0441994|G0000000|C0030705|C0205251|C0003808|C0449864|G0000000|G0000000|G0000000
"The inclusion criteria were as follows: (1) Age of 15–40 years, (2) the existence of mild to moderate acne on the face skin (not more than five pustule forms and no cysts, nodules, and colloidal deep scar observed in the affected area), (3) no history of drug allergy, and (4) no use of isotretinoin (at least 6 months before the baseline).","The inclusion criteria follows: (1) Age 15–40 years, (2) existence mild moderate acne skin (not pustule forms cysts, nodules, colloidal deep scar observed area), (3) history drug allergy, (4) isotretinoin (at 6 months baseline).",G0000000|C0007637|C0243161|C0332283|G0000000|C0001779|G0000000|C0439234|G0000000|C0015276|C2945599|C0205081|C0001144|C0444099|C1518422|C0241157|C0348078|C0010709|C0028259|G0000000|C0205125|C0241158|C1441672|C0017446|G0000000|C0019664|C0013227|C0002111|G0000000|C0022265|G0000000|G0000000|C0439231|C0168634
● Years of experience in primary care.,● Years experience primary care.,G0000000|C0237607|C0205225|C1947933
"Both trials were carried out in Guangzhou, Peoples’ Republic of China, and all subjects were of Chinese ethnicity, with baseline myopia of −0.75 D to −3.50 D sphere and astigmatism ≤−1.50 D. The control group children, n = 37 in trial A and 48 in trial B for a total of 85 subjects, were fit with traditional single-vision spectacles and were encouraged to wear them for all waking hours.","Both trials carried Guangzhou, Peoples’ Republic China, subjects Chinese ethnicity, baseline myopia −0.75 D −3.50 D sphere astigmatism ≤−1.50 D. The control children, = 37 trial A 48 trial B total 85 subjects, fit traditional single-vision spectacles encouraged wear waking hours.",G0000000|C0008976|C0206243|G0000000|G0000000|G0000000|C0008115|C0681850|C0008120|C0015031|C0168634|C0027092|G0000000|C0073187|G0000000|C0073187|C0332501|C0004106|G0000000|C0073187|G0000000|C0243148|C0008059|G0000000|C0450371|C0008976|G0000000|C0450371|C0008976|G0000000|C0439175|C0450371|C0681850|C0036572|C0443324|C0037179|C0015421|G0000000|G0000000|C0442696|C0439227
"Participants will be excluded if they have neurological conditions other than PD, musculoskeletal or cardiopulmonary conditions that affect the ability to safely walk, had surgery for PD such as deep brain stimulation, score < 24 on the Mini-Mental Status Examination (MMSE) [27]; or sensory system pathology affecting walking or communication (e.g.","Participants excluded neurological conditions PD, musculoskeletal cardiopulmonary conditions affect ability safely walk, surgery PD deep brain stimulation, score < 24 Mini-Mental Status Examination (MMSE) [27]; sensory system pathology walking communication (e.g.",C0679646|C1554077|C0205494|C0012634|G0000000|C0497254|C0553534|C0012634|C0001721|C0085732|G0000000|C0080331|C0038894|G0000000|C0205125|C0006104|C1292856|C0449820|G0000000|C0450371|C0445542|C0449438|G0000000|C0451306|C0450371|C0445254|C0449913|C0030664|C0080331|C0009452|G0000000
"Mean followup in this group was 94.8 months (range, 32–312 months).","Mean followup 94.8 months (range, 32–312 months).",C0444504|C0589120|C0450371|C0439231|C1514721|G0000000|C0439231
It is clear that patients who relapse immediately (within 6 months) after remission by PSL treatment for the first episode of NS tend to shift to FRNS [2].,It patients relapse (within 6 months) remission PSL treatment episode NS tend shift FRNS [2].,G0000000|C0030705|C0035020|G0000000|G0000000|C0439231|C0544452|G0000000|C0039798|C0332189|C0038944|G0000000|C0333051|C0220730|G0000000
"Children aged 9–12 years who met the inclusion criteria were enrolled by field investigators for a baseline assessment involving parasitological examination, physical fitness and strength tests, and anthropometric and hemoglobin measurements.","Children aged 9–12 met inclusion criteria enrolled field investigators baseline assessment involving parasitological examination, physical fitness strength tests, anthropometric hemoglobin measurements.",C0008059|C0001779|G0000000|C0268621|C0007637|C0243161|G0000000|C0440042|C0035173|C0168634|C1261322|C1314939|C0205468|G0000000|C0031809|C1456706|C0237897|C0022885|C0003188|C0019046|C0242485
The histological types of cervical cancer were squamous cell carcinoma in 18 patients and adenosquamous carcinoma in 2.,The histological types cervical cancer squamous cell carcinoma 18 patients adenosquamous carcinoma 2.,G0000000|C0205462|C0332307|C0027530|C0006826|C1182670|C0007634|C0007097|C0450371|C0030705|G0000000|C0007097|G0000000
All patients with mid- and low rectal adenocarcinomas who would normally undergo ultralow anterior resection without leaving residual local disease were included.,All patients mid- low rectal adenocarcinomas undergo ultralow anterior resection leaving residual local disease included.,G0000000|C0030705|C0444598|C0205251|C0205052|C0001418|G0000000|G0000000|C0205094|C0015252|G0000000|C1609982|C0205276|C0012634|C0332257
"Subjects were excluded if they had other medical causes of dementia, other neurological disorders that might impact cognition, evidence of major psychiatric disorder, or major functional limitations that precluded them from participating in the study.","Subjects excluded medical dementia, neurological disorders impact cognition, evidence major psychiatric disorder, major functional limitations precluded participating study.",C0681850|C1554077|C0199168|C0011265|C0205494|C0012634|C1825598|C0009240|C3887511|C0205082|C0205487|C0012634|C0205082|C0205245|C0449295|G0000000|C0679823|C0557651
The mean age of the study participants was 51.7 years (range = 27– 75 years).,The age study participants 51.7 (range = 27– 75 years).,G0000000|C0001779|C0557651|C0679646|C0450371|C1514721|G0000000|G0000000|C0450371|C0439234
Participants will be allocated a reference code.,Participants allocated reference code.,C0679646|G0000000|C1514811|C0009219
"Sixty-three percent had a comorbid disorder; the most common comorbid disorders were GAD (25%), SOP (25%), SP (22%), SAD (13%), major depressive disorder (3%), oppositional defiant disorder (ODD, 3%) and enuresis (3%).","Sixty-three percent comorbid disorder; common comorbid disorders GAD (25%), SOP (25%), SP (22%), SAD (13%), major depressive disorder (3%), oppositional defiant disorder (ODD, 3%) enuresis (3%).",C3816724|C0439165|C0009488|C0012634|C0205214|C0009488|C0012634|C0270549|C0450371|C1710183|C0450371|C0037747|C0450371|C3536794|C0450371|C0205082|G0000000|C0012634|G0000000|C0860661|C0424348|C0012634|C1415068|G0000000|C0014394|G0000000
"Each study was conducted independently; however, because of their identical design and for ease of reading, we present the combined results of MORACTO 1 and 2 (individual trial data are included in the supplementary material).","Each study conducted independently; however, identical design ease reading, combined MORACTO 1 2 (individual trial data included supplementary material).",G0000000|C0557651|C0004927|G0000000|G0000000|C0205280|C1707689|C1331418|C0034754|C0205195|G0000000|G0000000|G0000000|C0027361|C0008976|C1511726|C0332257|G0000000|C0520510
36 general practices in Nottingham.,36 practices Nottingham.,C0450371|C0237607|G0000000
"Patients with any of the following conditions were excluded: (i) rapidly progressive IgA nephropathy (IgAN with rapid decline in renal function characterized histologically by necrotizing capillaritis or > 50% active crescents on biopsy) (ii) secondary IgA nephropathy due to systemic diseases such as Henoch-Schönlein purpura nephritis, hepatitis-associated nephritis, lupus nephritis, etc.","Patients conditions excluded: (i) rapidly progressive IgA nephropathy (IgAN rapid decline renal function characterized histologically necrotizing capillaritis > 50% active crescents biopsy) (ii) secondary IgA nephropathy systemic diseases Henoch-Schönlein purpura nephritis, hepatitis-associated nephritis, lupus nephritis, etc.",C0030705|C0012634|C1554077|C0021966|C0456962|C0205329|C2825347|C0022658|C3160719|C0456962|G0000000|C0022646|C0031843|C1880022|C0205462|C0439664|C0006902|G0000000|C0450371|C0205177|C0444628|C0005558|G0000000|C0027627|C2825347|C0022658|C0205373|C0012634|G0000000|C0034150|C0027697|C0019158|C0027697|C0024131|C0027697|C1548556
"Exclusion criteria were an unwillingness to follow a prescribed diet, pre-GDM (either type 1 or type 2 DM), the need for insulin treatment, and pregnancy comorbidities other than obesity, hypertension, and/or dyslipidemia.","Exclusion criteria unwillingness follow prescribed diet, pre-GDM (either type 1 type 2 DM), insulin treatment, pregnancy comorbidities obesity, hypertension, and/or dyslipidemia.",C0680251|C0243161|C0558080|C0332283|C0278329|C0012155|C0332152|C3844638|C0332307|G0000000|C0332307|G0000000|C3250443|C0021641|C0039798|C0032961|C0009488|C0028754|C0020538|G0000000|C0242339
"Patients older than 18 years and hospitalized in participating intensive care units (ICUs) were enrolled in the study if they met the following criteria: severe documented infection, as evidenced by one or more of a positive culture or Gram stain of a normally sterile body fluid, of a clinical patent focus of infection (for example, faecal peritonitis, community pneumonia) and of a nosocomial documented infection (for example, ventilation-acquired nosocomial pneumonia or catheter-related infection); a need for mechanical ventilation; severe septic shock, defined as circulatory failure that required at least 1,000 ml fluid replacement in the previous 24 hours and was treated for at least 1 hour with more than 15 μg/kg/min dopamine or more than 0.2 μg/kg/min epinephrine or norepinephrine corresponding to class 4 of cardiovascular failure in the Sequential Organ Failure Assessment (SOFA) score; a Simplified Acute Physiologic Score II of 25 or more; and written informed consent from the patients themselves or their representatives.","Patients 18 hospitalized participating intensive care units (ICUs) enrolled study met criteria: severe documented infection, evidenced positive culture Gram stain sterile body fluid, clinical patent focus infection (for example, faecal peritonitis, community pneumonia) nosocomial documented infection (for example, ventilation-acquired nosocomial pneumonia catheter-related infection); mechanical ventilation; severe septic shock, defined circulatory failure required 1,000 fluid replacement previous 24 hours treated 1 hour 15 μg/kg/min dopamine 0.2 μg/kg/min epinephrine norepinephrine class 4 cardiovascular failure Sequential Organ Failure Assessment (SOFA) score; Simplified Acute Physiologic Score II 25 more; written informed consent patients representatives.",C0030705|C0450371|C0701159|C0679823|C0162425|C1947933|C0439148|C0021708|G0000000|C0557651|C0268621|C0243161|C0205082|C1301725|C0009450|C3887511|C0439178|C0010453|C0439208|C0038128|C0021359|C0242821|C0005889|C0205210|C0030650|C0205234|C0009450|G0000000|C1707959|C0015733|C0031154|C0009462|C0032285|C0019994|C1301725|C0009450|G0000000|C1707959|C0035203|C0019994|C0032285|C0085590|C0009450|C0443254|C0035203|C0205082|C0333534|C0036974|C1704788|C0005775|C0231174|C1514873|C1442061|C0005889|C0035139|C0205156|C0450371|C0439227|C1522326|G0000000|C0439227|C0450371|G0000000|C0013030|G0000000|G0000000|C0014563|C0028351|C0456387|G0000000|C0007226|C0231174|C1548958|C0178784|C0231174|C1261322|G0000000|C0449820|G0000000|C0205178|C0205463|C0449820|G0000000|C0450371|C0205172|C0043266|C1522154|C1511481|C0030705|C1882932
"Exclusion criteria were as follows: 1) Patient underwent any kind of eye surgery in last 6 months, 2) patients currently using eyedrops other than artificial tears, 3) patients who had eyelid scrubbing treatment previously or currently.","Exclusion criteria follows: 1) Patient underwent eye surgery 6 months, 2) patients eyedrops artificial tears, 3) patients eyelid scrubbing treatment currently.",C0680251|C0243161|C0332283|G0000000|C0030705|G0000000|C0015392|C0038894|G0000000|C0439231|G0000000|C0030705|C0015399|C2004457|C0039409|G0000000|C0030705|C0015426|G0000000|C0039798|C0521116
The need for phototherapy was determined using the Malaysian clinical practice guidelines for management of jaundice in healthy term newborns.5 Babies who had serum bilirubin levels close to the exchange transfusion limit were excluded from the study.,The phototherapy determined Malaysian clinical practice guidelines management jaundice healthy term newborns.5 Babies serum bilirubin levels close exchange transfusion limit excluded study.,G0000000|C0031765|G0000000|C0240293|C0205210|C0237607|C0162791|C0001554|C0022346|C3898900|C0233324|C0021289|C0021270|C0229671|C0005437|C0441889|C0587267|C0678640|C0005841|C0439801|C1554077|C0557651
A total of 329 patients were included.,A total 329 patients included.,G0000000|C0439175|C1442061|C0030705|C0332257
Centers were randomly assigned (1:1) to receive either immediate access (intervention arm) or delayed access (control arm) to Go NAPSACC.,Centers randomly assigned (1:1) receive access (intervention arm) delayed access (control arm) Go NAPSACC.,C0205099|G0000000|C1516050|G0000000|C1514756|C0444454|C0886296|C0446516|C0205421|C0444454|C0243148|C0446516|C1822658|G0000000
Approximately 25% of patients present with cognitive impairment 3 months after a stroke.,Approximately 25% patients cognitive impairment 3 months stroke.,C0332232|C0450371|C0030705|C1516691|C0221099|G0000000|C0439231|C0038454
"Adults with traumatic brain injury and a Glasgow Coma Scale score of 12 or less, who had a CT scan showing an intracranial abnormality consistent with trauma, and were within eight hours of their injury were randomly allocated to low, medium or high dose Anatibant or to placebo.","Adults traumatic brain injury Glasgow Coma Scale score 12 less, CT scan intracranial abnormality consistent trauma, hours injury randomly allocated low, medium dose Anatibant placebo.",C0001675|C0332663|C0006104|C3263722|G0000000|C0009421|C0175659|C0449820|C0450371|C0439092|C0007673|C0034606|C0524466|C1704258|C0332290|C0043251|C0439227|C3263722|G0000000|G0000000|C0205251|C0009458|C0178602|C2718119|C0032042
balance issues were purely vestibular) as determined by their physical therapist.,balance issues purely vestibular) determined physical therapist.,C0014653|C0033213|G0000000|C0042606|G0000000|C0031809|C0871525
"A double-blind, randomized, placebo-controlled study carried on 240 high schools female students with dysmenorrhea in Urmia city by dividing into four groups with 60 members.","A double-blind, randomized, placebo-controlled study carried 240 schools female students dysmenorrhea Urmia city dividing 60 members.",G0000000|C0013072|C0034656|C1706408|C0557651|C0206243|C1442061|C0036375|C0015780|C0038492|C0013390|G0000000|C0008848|C0332849|C0450371|C0680022
"Kasturba Hospital, Manipal and Dr Pai Hospital, Udupi, record malaria incidence across the year with over 200 malaria cases per annum, each comprising > 55% P. vivax cases.","Kasturba Hospital, Manipal Dr Pai Hospital, Udupi, record malaria incidence 200 malaria annum, comprising > 55% P. vivax cases.",G0000000|C0019994|G0000000|C0013014|C1620101|C0019994|G0000000|C0034869|C0024530|C0021149|C1442061|C0024530|C0439234|G0000000|C0369773|G0000000|C0868928
"Children’s principal anxiety disorders were moderately severe with a mean of 5.7 (SD = 1.0, range = 4 to 7) on a 0 to 8 clinical rating scale.","Children’s principal anxiety disorders moderately severe 5.7 (SD = 1.0, range = 4 7) 0 8 clinical rating scale.",G0000000|C0205225|C0003467|C0012634|C0205081|C0205082|G0000000|G0000000|G0000000|G0000000|C1514721|G0000000|G0000000|G0000000|G0000000|G0000000|C0205210|C0871208|C0175659
Patients from the INCan with histologically confirmed stage IIIB/IV NSCLC were enrolled in the study.,Patients INCan histologically confirmed stage IIIB/IV NSCLC enrolled study.,C0030705|C0337871|C0205462|C0521093|C0205390|C0022326|C0007131|G0000000|C0557651
"OBJECTIVES: Activation of latent tuberculosis infection into tuberculosis disease (TB), the primary killer among infectious diseases worldwide, can be prevented with six months of anti-TB medication.","OBJECTIVES: Activation latent tuberculosis infection tuberculosis disease (TB), primary killer infectious diseases worldwide, prevented months anti-TB medication.",C0018017|C1879547|C0205275|C0041296|C0009450|C0041296|C0012634|G0000000|C0205225|C1336644|C0009450|C0012634|G0000000|C0309872|C0439231|G0000000|C0013227
Medical exclusions included evidence of cardiovascular disease and neuromuscular conditions that would increase the risk of exercising while alone at home.,Medical exclusions included evidence cardiovascular disease neuromuscular conditions increase risk exercising home.,C0199168|C0680251|C0332257|C3887511|C0007226|C0012634|C1979768|C0012634|C0442805|C0035647|C0015259|C0442519
"Exclusion criteria were as follows: contraindications for RAGT therapy[23]; cerebellar or brainstem lesions that may affect autonomic or balance function; musculoskeletal disease involving the lower limbs, such as severe painful arthritis, osteoporosis, amputation, or joint contracture; and other concurrent neurological diseases (e.g., Parkinson disease, multiple sclerosis, etc.).","Exclusion criteria follows: contraindications RAGT therapy[23]; cerebellar brainstem lesions affect autonomic balance function; musculoskeletal disease involving lower limbs, severe painful arthritis, osteoporosis, amputation, joint contracture; concurrent neurological diseases (e.g., Parkinson disease, multiple sclerosis, etc.).",C0680251|C0243161|C0332283|C0079164|G0000000|C0039798|C0007765|C0006121|C0221198|C0001721|C0004388|C0014653|C0031843|C0497254|C0012634|C1314939|C0441994|C0015385|C0205082|C0030193|C0003864|C0029456|C0002688|C0022417|C0009917|C0205420|C0205494|C0012634|G0000000|C1021144|C0012634|C0439064|C0036429|C1548556
"The patients who had surgery related complications like vascular injury, massive intraoperative bleeding or injury to vital structures necessitating elective postoperative mechanical ventilation were excluded from the study.","The patients surgery complications vascular injury, massive intraoperative bleeding injury vital structures necessitating elective postoperative mechanical ventilation excluded study.",G0000000|C0030705|C0038894|C0009566|C0005847|C3263722|C0522501|C0456904|C0019080|C3263722|C0442732|C0678594|G0000000|C0206058|C0032790|C0443254|C0035203|C1554077|C0557651
"Eligible patients were defined as those aged 18–65 years, who had been consulting their GP for IBS for more than 6 weeks, and who had failed to manage symptoms using one or more conventional treatments.","Eligible patients defined aged 18–65 years, consulting GP IBS 6 weeks, failed manage symptoms conventional treatments.",C1548635|C0030705|C1704788|C0001779|G0000000|C0439234|C0009818|C3811116|C0022104|G0000000|C0439230|C0231175|G0000000|C0683368|C0439858|C0087111
"To enroll in the RCT each subject must: (1) be 18–74 years of age, (2) self-identify as Black or White race, (3) currently be on dialysis, (4) have a household income at or below 250 % of the federal poverty level, and (5) be able to speak and read in English.","To enroll RCT subject must: (1) 18–74 age, (2) self-identify Black White race, (3) dialysis, (4) household income 250 % federal poverty level, (5) speak read English.",C0040363|G0000000|G0000000|C0681850|G0000000|G0000000|G0000000|C0001779|G0000000|C0036588|C0005680|C0007457|C0034510|G0000000|C0011945|G0000000|C0020052|C0021162|C1442061|G0000000|G0000000|C0032854|C0441889|G0000000|C0234856|C0034754|C0376245
"This is a secondary data analysis of a randomised controlled trial conducted among women attending the antenatal clinic of the University College Hospital, Ibadan, Nigeria in 2007.","This secondary data analysis randomised controlled trial conducted women attending antenatal clinic University College Hospital, Ibadan, Nigeria 2007.",G0000000|C0027627|C1511726|C0002778|G0000000|C2587213|C0008976|C0004927|C0043210|C1547429|C2828394|C0002424|C0041740|C0557806|C0019994|G0000000|C0028075|G0000000
"Exclusion criteria included yoga use in the previous year; new pain medicine or other low back pain treatments started within the previous month or anticipated to begin in the next 6 months; pregnancy; back surgery in the previous 3 years; nonmuscular pathologies (eg, spinal canal stenosis, spondylolisthesis, infection, malignancy, fracture); severe or progressive neurological deficits; sciatica pain equal to or greater than back pain; active substance or alcohol abuse; serious systemic disease, medical, or psychiatric comorbidities precluding yoga practice; active or planned worker’s compensation, disability, or personal injury claims; and inability to attend classes at the times and location offered.","Exclusion criteria included yoga previous year; pain medicine low pain treatments started previous month anticipated 6 months; pregnancy; surgery previous 3 years; nonmuscular pathologies (eg, spinal canal stenosis, spondylolisthesis, infection, malignancy, fracture); severe progressive neurological deficits; sciatica pain equal pain; active substance alcohol abuse; systemic disease, medical, psychiatric comorbidities precluding yoga practice; active planned worker’s compensation, disability, personal injury claims; inability attend classes times location offered.",C0680251|C0243161|C0332257|C0043418|C0205156|C0439234|C0030193|C0013227|C0205251|C0030193|C0087111|C1272689|C0205156|C0332177|C3840775|G0000000|C0439231|C0032961|C0038894|C0205156|G0000000|C0439234|G0000000|C0030664|C0013715|C0521329|C0086881|C0678234|C0038016|C0009450|C0006826|C0016658|C0205082|C0205329|C0205494|C2987487|C0036396|C0030193|C0205163|C0030193|C0205177|C0439861|C0001962|C0013146|C0205373|C0012634|C0199168|C0205487|C0009488|G0000000|C0043418|C0237607|C0205177|C1301732|G0000000|C0152057|C0231170|C1519021|C3263722|G0000000|G0000000|C1999232|C0456387|C0040223|C0450429|C1444648
"Inclusion criteria are as follows: pregnant women with mild, moderate, or severe asthma and currently using inhaled corticosteroids (ICS) (see Assessment of asthma below); >18 years of age, and poor diet quality (<3 servings/d fruit and vegetable).","Inclusion criteria follows: pregnant women mild, moderate, severe asthma inhaled corticosteroids (ICS) (see Assessment asthma below); >18 age, poor diet quality (<3 servings/d fruit vegetable).",C0007637|C0243161|C0332283|C0549206|C0043210|C2945599|C0205081|C0205082|C0004096|C0004048|C0001617|C0022521|C0042789|C1261322|C0004096|G0000000|C0450371|C0001779|C0032854|C0012155|C0332306|G0000000|C1519269|C0016767|C0042440
Subjects who had respiratory failure requiring urgent treatment and those who declined to participate or could not give written informed consent were excluded from the study.,Subjects respiratory failure requiring urgent treatment declined participate written informed consent excluded study.,C0681850|C0521346|C0231174|G0000000|C0439609|C0039798|G0000000|G0000000|C0043266|C1522154|C1511481|C1554077|C0557651
"Inclusion criteria were living at home in the Municipality of Bergen prior to having a stroke, stroke within the previous seven days, being admitted to the stroke unit within the previous five days, and a National Institutes of Health Stroke Scale (NIHSS) score of 2–26.","Inclusion criteria living Municipality Bergen prior stroke, stroke previous days, admitted stroke unit previous days, National Institutes Health Stroke Scale (NIHSS) score 2–26.",C0007637|C0243161|C0376558|C0600182|G0000000|C0332152|C0038454|C0038454|C0205156|C0439228|C0184666|C0038454|C0439148|C0205156|C0439228|C3245503|C0021622|C0018684|C0038454|C0175659|C3476804|C0449820|G0000000
"Briefly, men between ages 30–80 with a biopsy-proven diagnosis of HGPIN and/or ASAP less than 3 months before randomization, with no history of cancer, hepatic or renal disease, restricted from taking steroid or other supplements, or more than 6–12 cups of green tea a day, were eligible.","Briefly, ages 30–80 biopsy-proven diagnosis HGPIN and/or ASAP 3 months randomization, history cancer, hepatic renal disease, restricted steroid supplements, 6–12 cups green tea day, eligible.",G0000000|C0001779|G0000000|C0005558|C0011900|C1168327|G0000000|G0000000|G0000000|C0439231|C0034656|C0019664|C0006826|C0205054|C0022646|C0012634|C0443288|C0038317|C0242295|G0000000|C0180231|C0332583|C0039400|C0332173|C1548635
Forty-four massively burned children were enrolled between 1999 and 2004 in a double-blinded randomized study to test the efficacy of rhGH administered after hospital discharge to 12 months after burn with the patients studied for an additional 12 months after treatment was stopped.,Forty-four massively burned children enrolled 1999 2004 double-blinded randomized study test efficacy rhGH administered hospital discharge 12 months burn patients studied additional 12 months treatment stopped.,C3816449|C0522501|C0006434|C0008059|G0000000|G0000000|G0000000|C0205173|C0034656|C0557651|C0022885|C1280519|C0169964|C1521801|C0019994|C0012621|C0450371|C0439231|C0006434|C0030705|C0557651|C1524062|C0450371|C0439231|C0039798|C1272691
"FINDINGS: Prior to treatment, 16% of the study participants had active trachoma.","FINDINGS: Prior treatment, 16% study participants active trachoma.",C2607943|C0332152|C0039798|C0450371|C0557651|C0679646|C0205177|C0040592
"The study was approved by Ethik-Kommission der Landesaerztekammer Hessen (Frankfurt-am-Main), as well as each relevant national, regional, or independent ethics committee or institutional review boards and was performed in accordance with the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Good Clinical Practice (ICH-GCP) guidelines and all applicable patient privacy requirements and the ethical principles outlined in the Declaration of Helsinki, 2013.9,10 Patients eligible for inclusion in the run-in period were ≥40 years of age with a diagnosis of COPD according to the American Thoracic Society/European Respiratory Society definition,11 had a post-salbutamol forced expiratory volume in 1 s (FEV1) of ≤70% and ≥50% of normal predicted values (moderate airflow limitation), had a modified Medical Research Council (mMRC) Dyspnea Scale score of ≥1 at screening, and were prescribed TIO for at least 3 months prior to screening.","The study approved Ethik-Kommission der Landesaerztekammer Hessen (Frankfurt-am-Main), relevant national, regional, independent ethics committee institutional review boards performed International Conference Harmonisation Technical Requirements Registration Pharmaceuticals Human Use Good Clinical Practice (ICH-GCP) guidelines applicable patient privacy requirements ethical principles outlined Declaration Helsinki, 2013.9,10 Patients eligible inclusion run-in period ≥40 age diagnosis COPD American Thoracic Society/European Respiratory Society definition,11 post-salbutamol forced expiratory volume 1 (FEV1) ≤70% ≥50% normal predicted values (moderate airflow limitation), modified Medical Research Council (mMRC) Dyspnea Scale score ≥1 screening, prescribed TIO 3 months prior screening.",G0000000|C0557651|C0205540|G0000000|C1511780|G0000000|G0000000|C3813124|C2347946|C3245503|C0205147|C0085862|C0015000|C2699414|C0018704|C0282443|C0972401|C0884358|C1512888|C0086047|G0000000|C0449851|C1514873|C1514821|C1135440|C0086418|C0042153|C0205170|C0205210|C0237607|C0019191|C0162791|C1272460|C0030705|C0080048|C1514873|C0026531|G0000000|G0000000|G0000000|G0000000|C0450371|C0030705|C1548635|C0007637|C3274438|C0439531|G0000000|C0001779|C0011900|C0024117|C0596070|G0000000|C0037455|C0521346|C0037455|C1550452|C0687676|C0441722|C0231800|C0449468|G0000000|G0000000|G0000000|G0000000|C0205307|C0681842|C0042295|C0205081|C0231999|C0449295|C0392747|C0199168|C0035168|C1551807|C3826977|C0013404|C0175659|C0449820|G0000000|C0220908|C0278329|G0000000|G0000000|C0439231|C0332152|C0220908
Confirmation of the history of stroke or TIA was completed through patient self-report.,Confirmation history stroke TIA completed patient self-report.,C0521091|C0019664|C0038454|C0007787|C0205197|C0030705|C0681906
"Study participants were prematurely withdrawn from the study for (1) movement out of the study area, (2) failure to be seen in the study clinic for >60 consecutive days, (3) withdrawal of informed consent, or (4) inability to comply with the study schedule and procedures.","Study participants prematurely withdrawn study (1) movement study area, (2) failure study clinic >60 consecutive days, (3) withdrawal informed consent, (4) inability comply study schedule procedures.",C0557651|C0679646|G0000000|C0424092|C0557651|G0000000|C0026649|C0557651|C0017446|G0000000|C0231174|C0557651|C0002424|C0450371|C1707491|C0439228|G0000000|C2349954|C1522154|C1511481|G0000000|G0000000|C0725694|C0557651|C0086960|C0025664
All censused children under the age of 15 years and present at the time of sampling were invited to participate.,All censused children age 15 time sampling invited participate.,G0000000|C0007663|C0008059|C0001779|C0450371|C0040223|C0441621|G0000000|G0000000
"Patients with any of the following were excluded: age under 18 years, immunosuppression, absolute neutrophile count under 500/mm3, gastrointestinal bleeding, contraindication to enteral feeding, and isolation of P. aeruginosa from gastric aspirates or respiratory tract specimens during the first 4 days after admission.","Patients excluded: age 18 years, immunosuppression, absolute neutrophile count 500/mm3, gastrointestinal bleeding, contraindication enteral feeding, isolation P. aeruginosa gastric aspirates respiratory tract specimens 4 days admission.",C0030705|C1554077|C0001779|C0450371|C0439234|C0021079|C0205344|C0027950|C0750480|C1442061|C0521362|C0019080|C0522473|C1304890|C0204695|C0204727|C0369773|G0000000|C0038351|C0370199|C0521346|C1185740|C0370003|G0000000|C0439228|C0184666
"Exclusion criteria were kidney and/or urinary tract congenital abnormalities, congenital heart defects, prenatal exposure to inhibitors of angiotensin converting enzyme or non‐steroidal anti‐inflammatory drugs (NSAIDs), and chromosomal disorders or multiple malformations.","Exclusion criteria kidney and/or urinary tract congenital abnormalities, congenital heart defects, prenatal exposure inhibitors angiotensin converting enzyme non‐steroidal anti‐inflammatory drugs (NSAIDs), chromosomal disorders multiple malformations.",C0680251|C0243161|C0022646|G0000000|C0042027|C1185740|C0009678|C0000768|C0009678|C0018787|C0243067|C0678804|C0274281|C0243077|C0003018|G0000000|C0014442|G0000000|G0000000|C0013227|C0003211|C0008633|C0012634|C0439064|C0000768
The results of this study support consideration of CPAP as an alternative to intubation and surfactant in preterm infants.,The study support consideration CPAP alternative intubation surfactant preterm infants.,G0000000|C0557651|C0183683|C0518609|C0199451|C1523987|C0021925|C0034085|C0151526|C0021270
"Participants currently employed as a HCW, enrolled in a respiratory protection program, and experienced in wearing an FFR were preferred.","Participants employed HCW, enrolled respiratory protection program, experienced wearing FFR preferred.",C0679646|C0014003|G0000000|G0000000|C0521346|C1545588|C1709697|C0237607|G0000000|C1412871|C0558295
The patients were eligible for the study if they had between 6 and 12 migraine attacks with or without aura per year.,The patients eligible study 6 12 migraine attacks aura year.,G0000000|C0030705|C1548635|C0557651|G0000000|C0450371|C0149931|C1261512|C0236018|C0439234
"Immigration flows have increased in Italy, meaning rising numbers of pregnant immigrant women [14].","Immigration flows increased Italy, meaning rising pregnant immigrant women [14].",C0020942|C0806140|C0205217|C0022277|C0876919|G0000000|C0549206|C0282163|C0043210|C0450371
"Other patient characteristics (age, gender, BMI, previous AHI, CPAP level, previously estimated CPAP use, days from initial diagnosis) did not differ between compliant and noncompliant patients and were not predictive of CPAP compliance.","Other patient characteristics (age, gender, BMI, previous AHI, CPAP level, estimated CPAP use, days initial diagnosis) compliant noncompliant patients predictive CPAP compliance.",G0000000|C0030705|C1521970|C0001779|C0079399|G0000000|C0205156|G0000000|C0199451|C0441889|C0750572|C0199451|C0042153|C0439228|C0205265|C0011900|C0566588|C0457432|C0030705|C0681890|C0199451|C0009563
Twenty-three patients had undergone one or more surveillance colonoscopies before the diagnosis of CRC and were analysed as the surveillance group.,Twenty-three patients undergone surveillance colonoscopies diagnosis CRC analysed surveillance group.,C0724000|C0030705|G0000000|C0220920|C0009378|C0011900|C0009402|G0000000|C0220920|C0441833
"The PDE was prospectively defined as abnormalities in four of the following nine symptoms, signs, or laboratory findings: (1) change in sputum production (consistency, color, volume, or hemoptysis); (2) increased dyspnea (chest congestion or shortness of breath); (3) increased cough; (4) fever (≥38°C); (5) increased wheezing; (6) decreased exercise tolerance, malaise, fatigue, or lethargy; (7) forced expiratory volume in 1 second or forced vital capacity decreasing 10% from a previously recorded value; (8) radiographic changes indicative of a new pulmonary process; or (9) changes in chest sounds.","The PDE prospectively defined abnormalities symptoms, signs, laboratory findings: (1) change sputum production (consistency, color, volume, hemoptysis); (2) increased dyspnea (chest congestion shortness breath); (3) increased cough; (4) fever (≥38°C); (5) increased wheezing; (6) decreased exercise tolerance, malaise, fatigue, lethargy; (7) forced expiratory volume 1 forced vital capacity decreasing 10% recorded value; (8) radiographic indicative pulmonary process; (9) chest sounds.",G0000000|G0000000|G0000000|C1704788|C0000768|C0683368|C0220912|C0022877|C2607943|G0000000|C0392747|C0038056|C0033268|C0332529|C0009393|C0449468|C0019079|G0000000|C0205217|C0013404|C0817096|C0700148|C1282927|C0225386|G0000000|C0205217|C0010200|G0000000|C0015967|G0000000|G0000000|C0205217|C0043144|G0000000|C0205216|C0015259|C0013220|C0231218|C0015672|C0023380|G0000000|C0441722|C0231800|C0449468|G0000000|C0441722|C0442732|C1516240|C0442797|C0450371|C0034869|C1522609|G0000000|C0444708|G0000000|C0024109|C1184743|G0000000|C0817096|C0037709
"dementia patients and caregivers, whose main inclusion criteria are: prescription for routine OT, patients with mild or moderate dementia, living at home, receiving support from an informal caregiver.","dementia patients caregivers, main inclusion criteria are: prescription routine OT, patients mild moderate dementia, living home, receiving support informal caregiver.",C0011265|C0030705|C0085537|C0205225|C0007637|C0243161|G0000000|C0033080|C0205547|C1318464|C0030705|C2945599|C0205081|C0011265|C0376558|C0442519|C1514756|C0183683|G0000000|C0085537
"Extremely preterm infants <28 weeks of gestation have a high risk of short-term morbidities, which might interfere with analysis on host-microbial interactions.","Extremely preterm infants <28 weeks gestation risk short-term morbidities, interfere analysis host-microbial interactions.",C0205403|C0151526|C0021270|C0450371|C0439230|C0032961|C0035647|C0443303|C0026538|C0521102|C0002778|C1167395|C1704675
Women will also be asked to consent to a post-intervention study approximately six weeks after delivery.,Women consent post-intervention study weeks delivery.,C0043210|C1511481|C2347647|C0557651|C0439230|C0011209
"Of the 103 participants, 37 were men and 66 were women ranging in age from 40 to 74 years (mean, 54.11 years).","Of 103 participants, 37 66 women ranging age 40 74 (mean, 54.11 years).",G0000000|C1442061|C0679646|C0450371|C0450371|C0043210|C1514721|C0001779|C0450371|C0450371|C0444504|C0450371|C0439234
CHD risk versus usual total cholesterol in people with and without diabetes mellitus.,CHD risk versus usual total cholesterol people diabetes mellitus.,C0280604|C0035647|G0000000|C3538928|C0439175|C0008377|C0027361|C0011847|G0000000
"Women were excluded if they were identified through interviews to be on any other form of zinc supplements at any dosage level or were severely anaemic (that is, Hb less than 7.0 g/dl).","Women excluded identified interviews form zinc supplements dosage level severely anaemic (that is, Hb 7.0 g/dl).",C0043210|C1554077|C0205396|C0021822|C0348078|C0043481|C0242295|C0178602|C0441889|C0205082|C0857322|G0000000|G0000000|C0019046|G0000000|C0439267
"Support for the team-based approach is provided by literature regarding weight control and exercise in healthy populations in which having a “buddy” results in increased communication, reinforcement, and support,13 and in cancer populations in which dyadic-based interventions have been shown to promote joint problem-solving and reciprocal coping, leading to superior self-efficacy and quality of life, as well as higher rates of adherence and retention.14–16 The DAMES trial was a 2-center, single-blind, parallel group RCT in which a total of 68 dyads (each comprised of an overweight or obese postmenopausal survivor of breast cancer and her overweight or obese adult daughter) underwent baseline assessment and were then randomly assigned to 1 of 3 study conditions: 1) a tailored diet and exercise intervention that was delivered in parallel and individually to mothers and daughters (25 dyads) (INDIVIDUAL); 2) a tailored diet and exercise intervention that emphasized the mother-daughter bond in a team-based approach (25 dyads) (TEAM); or 3) an attention control arm that received standardized diet and exercise materials (18 dyads) (CONTROL).","Support team-based approach provided literature weight control exercise healthy populations “buddy” increased communication, reinforcement, support,13 cancer populations dyadic-based interventions promote joint problem-solving reciprocal coping, leading superior self-efficacy quality life, rates adherence retention.14–16 The DAMES trial 2-center, single-blind, parallel RCT total 68 dyads (each comprised overweight obese postmenopausal survivor breast cancer overweight obese adult daughter) underwent baseline assessment randomly assigned 1 3 study conditions: 1) tailored diet exercise intervention delivered parallel individually mothers daughters (25 dyads) (INDIVIDUAL); 2) tailored diet exercise intervention emphasized mother-daughter bond team-based approach (25 dyads) (TEAM); 3) attention control arm received standardized diet exercise materials (18 dyads) (CONTROL).",C0183683|C0871489|C0449445|C1999230|C0023866|C0005910|C0243148|C0015259|C3898900|C0032659|G0000000|C0205217|C0009452|C0035007|C0183683|C0006826|C0032659|C0870454|C0886296|C0033414|C0022417|C0033213|C1882911|C0009967|C0332152|C1282910|C0600564|C0332306|C0376558|C0871208|C1510802|G0000000|G0000000|C0112088|C0008976|C0205099|C0242570|C2348042|G0000000|C0439175|C0450371|C0870454|G0000000|C2700400|C0497406|C0028754|C0232970|C0206194|C0006141|C0006826|C0497406|C0028754|C0001675|C0011011|G0000000|C0168634|C1261322|G0000000|C1516050|G0000000|G0000000|C0557651|C0012634|G0000000|C0402883|C0012155|C0015259|C0886296|C1705822|C2348042|G0000000|C0026591|C0011011|C0450371|C0870454|C0027361|G0000000|C0402883|C0012155|C0015259|C0886296|G0000000|C0026591|G0000000|C0871489|C0449445|C0450371|C0870454|C0871489|G0000000|C0004268|C0243148|C0446516|C1514756|G0000000|C0012155|C0015259|C0520510|C0450371|C0870454|C0243148
"Fifteen individuals with SCI, C6 or lower, who were manual wheelchair users with shoulder pain were randomly assigned to 1 of 2 interventions.","Fifteen individuals SCI, C6 lower, manual wheelchair users shoulder pain randomly assigned 1 2 interventions.",C3715153|C0027361|C3642273|G0000000|C0441994|C0024763|C0043143|C1706077|C0037004|C0030193|G0000000|C1516050|G0000000|G0000000|C0886296
"Anthropometric indicators of children before and after 11 months of MNP supplementation MNP, micronutrient powders; EHFP, enhanced homestead food production; WAZ, weight‐for‐age z‐score; HAZ, length‐for‐age z‐score; WHZ, weight‐for‐length z‐score.","Anthropometric indicators children 11 months MNP supplementation MNP, micronutrient powders; EHFP, enhanced homestead food production; WAZ, weight‐for‐age z‐score; HAZ, length‐for‐age z‐score; WHZ, weight‐for‐length z‐score.",C0003188|C0021212|C0008059|C0450371|C0439231|C0282245|C0242297|C0282245|C0040577|C0032861|G0000000|C2349975|G0000000|C0016452|C0033268|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000
"To answer these questions, we used the data from a randomized, controlled trial (VITACOG) assessing the effect of B-vitamin treatment (folic acid 0.8 mg/d, vitamin B12 0.5 mg/d, vitamin B6 20 mg/d) on elderly volunteers with memory complaint who fulfilled the Petersen criteria for mild cognitive impairment (MCI) (18) over a period of 24 mo.","To answer questions, data randomized, controlled trial (VITACOG) assessing B-vitamin treatment (folic acid 0.8 mg/d, vitamin B12 0.5 mg/d, vitamin B6 20 mg/d) elderly volunteers memory complaint fulfilled Petersen criteria mild cognitive impairment (MCI) (18) period 24 mo.",C0040363|C1706817|C1522634|C1511726|C0034656|C2587213|C0008976|G0000000|C1516048|C1704763|C0039798|G0000000|C0001128|G0000000|C0439422|C0042890|G0000000|G0000000|C0439422|C0042890|C0005558|C0450371|C0439422|C0001792|C0042960|C0025260|C0277786|C1550543|G0000000|C0243161|C2945599|C1516691|C0221099|C0560005|C0450371|C0439531|C0450371|C0026544
"Patients with operable breast cancer with 0 to 3 positive nodes were enrolled onto the study to address the noninferiority of single-agent T to AC, defined as the one-sided 95% upper-bound CI (UCB) of hazard ratio (HR) of T versus AC less than 1.30 for the primary end point of relapse-free survival (RFS).","Patients operable breast cancer 0 3 positive nodes enrolled study address noninferiority single-agent T AC, defined one-sided 95% upper-bound CI (UCB) hazard ratio (HR) T versus AC 1.30 primary relapse-free survival (RFS).",C0030705|C0205188|C0006141|C0006826|G0000000|G0000000|C0439178|C0746922|G0000000|C0557651|C0376649|G0000000|C0037179|C2603360|C0003354|C1704788|C0205092|C0450371|C1282910|C0008107|G0000000|C0598697|C0456603|G0000000|C2603360|G0000000|C0003354|C0450371|C0205225|C0035020|C0038952|C0341703
"However, many patients suffer ongoing symptoms.","However, patients suffer ongoing symptoms.",G0000000|C0030705|C0683278|C0549178|C0683368
"However, during the peak of the epidemic (April 4–May 4), the percentage of probable SARS patients who reported no contact with another SARS patient and who were not healthcare workers rose to 42%; as the number of cases fell during the last part of the epidemic (May 5–June), this percentage increased to 65%.","However, peak epidemic (April 4–May 4), percentage probable SARS patients reported contact SARS patient healthcare workers rose 42%; fell epidemic (May 5–June), percentage increased 65%.",G0000000|C0444505|C0014499|C3715024|G0000000|G0000000|C0439165|C0033204|C1175175|C0030705|C0684224|C0332158|C1175175|C0030705|C0086388|C0024752|C0035853|C0450371|C0085639|C0014499|C3812381|G0000000|C0439165|C0205217|C0450371
"Participants allocated to the control group received the same brochure describing the provincial physician wellness support program and were contacted twice weekly by a research assistant to measure stress and well-being, heart rate and blood pressure.","Participants allocated control received brochure describing provincial physician wellness support program contacted weekly assistant measure stress well-being, heart rate blood pressure.",C0679646|G0000000|C0243148|C1514756|C0030258|G0000000|G0000000|C0031831|C0018684|C0183683|C1709697|C0332158|C0332174|C0011327|C0079809|C0038435|C0018684|C0018787|C0871208|C0005767|C0033095
"Details of the methods are published elsewhere.16 Men and women aged 70-89 were eligible if they were sedentary (reported <20 min/week in past month performing structured physical activity (that is, exercise), and <125 min/week of moderate physical activity); had functional limitations, as evidenced by a short physical performance battery score 9 or less out of 12 (the short physical performance battery is an integrative measure of gait, balance and lower extremity strength)17; could walk 400 m in 15 minutes or less without the help of someone or a walker; had no major cognitive impairment (modified mini-mental state examination18 score 1.5 standard deviations below education specific and race specific norms); and could safely participate in the intervention as determined by medical history, physical exam, and electrocardiography.","Details methods published elsewhere.16 Men women aged 70-89 eligible sedentary (reported <20 min/week month performing structured physical activity (that is, exercise), <125 min/week moderate physical activity); functional limitations, evidenced short physical performance battery score 9 12 (the short physical performance battery integrative measure gait, balance lower extremity strength)17; walk 400 15 minutes walker; major cognitive impairment (modified mini-mental examination18 score 1.5 standard deviations education specific race specific norms); safely participate intervention determined medical history, physical exam, electrocardiography.",C1522508|C0025663|C0034037|C0450371|C0025266|C0043210|C0001779|C0450371|C1548635|C0205254|C0684224|C0450371|C0702093|C0332177|C0884358|C0678594|C0031809|C0205177|G0000000|G0000000|C0015259|C1442061|C0702093|C0205081|C0031809|C0205177|C0205245|C0449295|C3887511|C1282927|C0031809|C0597198|C0337088|C0449820|G0000000|C0450371|G0000000|C1282927|C0031809|C0597198|C0337088|C1158478|C0079809|C0016928|C0014653|C0441994|C0015385|C0237897|C0080331|C1442061|C0450371|C0439232|C0043016|C0205082|C1516691|C0221099|C0392747|C0445542|G0000000|C0449820|G0000000|C1442989|C0012727|C0013621|C0205369|C0034510|C0205369|C0205307|G0000000|G0000000|C0886296|G0000000|C0199168|C0019664|C0031809|C0582103|C0013798
"The eligibility criteria for participation are being able to read, write and speak Persian; the gestational age of 6-10 weeks and having no disease or condition that require special medical care or drug consuming.","The eligibility criteria participation read, write speak Persian; gestational age 6-10 weeks disease condition require special medical care drug consuming.",G0000000|C0013893|C0243161|C0679823|C0034754|C0043266|C0234856|C0699776|C0439671|C0001779|C0450371|C0439230|C0012634|C0012634|G0000000|C0205555|C0199168|C1947933|C0013227|G0000000
Flow-diagram of randomised participants into the HI-Light trial.,Flow-diagram randomised participants HI-Light trial.,C0806140|G0000000|C0679646|C0018619|C0008976
"In a nested case–control study of 380 women with incident breast cancer and 662 controls within the Singapore Chinese Health Study, we found no association between either green tea intake or gene polymorphisms of MTHFR (C677T and A1298C) and TYMS (1494 ins/del) and breast cancer risk.","In nested case–control study 380 women incident breast cancer 662 controls Singapore Chinese Health Study, association green tea intake gene polymorphisms MTHFR (C677T A1298C) TYMS (1494 ins/del) breast cancer risk.",G0000000|G0000000|G0000000|C0557651|C1442061|C0043210|C1551358|C0006141|C0006826|C1442061|C0243148|C0037173|C0008120|C0018684|C0557651|C0004083|C0332583|C0039400|C1512806|C0017337|C0032529|C0066357|G0000000|G0000000|C0040085|G0000000|C0008628|C0006141|C0006826|C0035647
Do they communicate with friends with CF on-line?,Do communicate friends CF on-line?,G0000000|C0566001|C0079382|C0009738|C1720176
"Positional OSA was defined as an overall AHI of at least 5 events per hour with symptoms of excessive daytime sleepiness or an AHI of at least 15 events per hour with a 50% decrease in the AHI when the patient was sleeping in the nonsupine position, as compared with in the supine position.","Positional OSA defined AHI 5 events hour symptoms excessive daytime sleepiness AHI 15 events hour 50% decrease AHI patient sleeping nonsupine position, compared supine position.",C0240795|C0520679|C1704788|G0000000|G0000000|C0441471|C0439227|C0683368|C0442802|C0332169|C0013144|G0000000|C0450371|C0441471|C0439227|C0450371|C0392756|G0000000|C0030705|C0037313|G0000000|C0733755|C1707455|C0038846|C0733755
Target numbers of patients were calculated as follows.,Target patients calculated follows.,C1521840|C0030705|C0444686|C0332283
"Inclusion criteria were (1) confirmed IBD diagnosis with mild and moderate symptoms as per the current standards in China, (2) no previous probiotic treatment, (3) no allergy to drugs used in the present study, and (4) cognizance of the purpose of the present study and willingness to sign an informed consent.","Inclusion criteria (1) confirmed IBD diagnosis mild moderate symptoms current standards China, (2) previous probiotic treatment, (3) allergy drugs study, (4) cognizance purpose study willingness sign informed consent.",C0007637|C0243161|G0000000|C0521093|G0000000|C0011900|C2945599|C0205081|C0683368|C0521116|C0038137|C0008115|G0000000|C0205156|C0525033|C0039798|G0000000|C0002111|C0013227|C0557651|G0000000|G0000000|C1285529|C0557651|C0600109|C0311392|C1522154|C1511481
"In this study, 126 pregnant women with leg cramps from July 2013 to January 2014 entered the study and their conditions were followed up to April 2014.","In study, 126 pregnant women leg cramps July 2013 January 2014 entered study conditions April 2014.",G0000000|C0557651|C1442061|C0549206|C0043210|C0023216|C0026821|C3829447|G0000000|C3829466|G0000000|C1521975|C0557651|C0012634|C3715024|G0000000
"Exclusion criteria were: (1) recent (within the past 6 months) psychotic episode or (2) clinically significant acute unstable neurological, psychiatric, hepatic, renal, cardiovascular, or respiratory disease that prevented participation in the study.","Exclusion criteria were: (1) (within 6 months) psychotic episode (2) clinically acute unstable neurological, psychiatric, hepatic, renal, cardiovascular, respiratory disease prevented participation study.",C0680251|C0243161|G0000000|G0000000|G0000000|G0000000|C0439231|C0004936|C0332189|G0000000|G0000000|C0205178|C0443343|C0205494|C0205487|C0205054|C0022646|C0007226|C0521346|C0012634|C0309872|C0679823|C0557651
"High school of Urmia city, between March 2008 and June 2008.","High school Urmia city, March 2008 June 2008.",C0205250|C0036375|G0000000|C0008848|C3829202|G0000000|C3829443|G0000000
"Sample sizes in the azithromycin and placebo groups were, respectively, 40 and 42 for the total population, 31 and 32 for patients not infected with PA, and 9 and 10 for patients infected with PA.","Sample sizes azithromycin placebo were, respectively, 40 42 total population, 31 32 patients infected PA, 9 10 patients infected PA.",C0370003|C0456389|C0052796|C0032042|G0000000|G0000000|C0450371|C0450371|C0439175|C0032659|C0450371|C0450371|C0030705|C0439663|C0030428|G0000000|C0450371|C0030705|C0439663|C0030428
"Feeding of sample child by age and experimental arm1 Data are presented as % (n) for categorical variables 1 We only collected detail information of diet for cohort 2 in the baseline (child aged 6–11 months), but for child aged 12–30 months, we collected detailed information of diet for cohort 1 and cohort 2 2MNP = Multiple Micronutrient Powder 3 P-values from tests of the null hypothesis of no difference between MNP and control groups, adjusted for cohort and county fixed effects and clustering within villages *p-value < 0.05 significant How feeding practices transition as children age is also evident in Table Table5.5.","Feeding sample child age experimental arm1 Data % (n) categorical variables 1 We collected detail diet cohort 2 baseline (child aged 6–11 months), child aged 12–30 months, collected detailed diet cohort 1 cohort 2 2MNP = Multiple Micronutrient Powder 3 P-values tests null hypothesis difference MNP control groups, adjusted cohort county fixed effects clustering villages *p-value < 0.05 How feeding practices transition children age evident Table Table5.5.",C0204695|C0370003|C0008059|C0001779|C1517586|G0000000|C1511726|G0000000|C0369718|C0683312|C0439828|G0000000|G0000000|C1516695|C1522508|C0012155|C0599755|G0000000|C0168634|C0008059|C0001779|G0000000|C0439231|C0008059|C0001779|G0000000|C0439231|C1516695|C1522508|C0012155|C0599755|G0000000|C0599755|G0000000|G0000000|G0000000|C0439064|C0040577|C0032861|G0000000|C1709380|C0022885|C0456148|C1512571|C1705241|C0282245|C0243148|C0441833|C0456081|C0599755|C0079170|C0443218|C1280500|C0009085|C0562518|C1709380|G0000000|C0450371|G0000000|C0204695|C0237607|C0599156|C0008059|C0001779|C3887511|C0039224|G0000000
"Group mean estimates and 95% CI of mobility, balance confidence, leg extensor muscle power, and thigh muscle lean tissue cross sectional area across the four time points MCEFRP multi-component exercise fall reduction program, RENEW resistance exercise via negative, eccentrically-induced, work, TRAD traditional resistance exercise, CI confidence interval, CSA cross sectional area Older adults who experienced one or more falls in the previous year, n = 134 (47 males, 87 females) with a mean age of 76.1 years (range 65–93 years); a BMI >25 kg*m−2 and managing more than five comorbid conditions met the criteria for inclusion as high fall risk and volunteered to participate in this 1 year trial.","Group estimates 95% CI mobility, balance confidence, leg extensor muscle power, thigh muscle lean tissue cross sectional time MCEFRP multi-component exercise fall reduction program, RENEW resistance exercise negative, eccentrically-induced, work, TRAD traditional resistance exercise, CI confidence interval, CSA cross sectional Older adults experienced falls previous year, = 134 (47 males, 87 females) age 76.1 (range 65–93 years); BMI >25 kg*m−2 managing comorbid conditions met criteria inclusion fall risk volunteered participate 1 trial.",C0441833|C0750572|C0450371|C0008107|C0425245|C0014653|C0237529|C0023216|C1184148|C0026845|C0032863|C0039866|C0026845|G0000000|C0040300|C2828360|C0205155|C0040223|G0000000|C0439064|C0015259|C0085639|C0301630|C1709697|G0000000|C0237834|C0015259|C0205160|C0205263|C0043227|C1419242|C0443324|C0237834|C0015259|C0008107|C0237529|C1272706|G0000000|C2828360|C0205155|C0580836|C0001675|C0237607|C0000921|C0205156|C0439234|G0000000|C1442061|C0450371|C0086582|C0450371|C0015780|C0001779|C0450371|C1514721|G0000000|C0439234|G0000000|C0450371|G0000000|C1273870|C0009488|C0012634|C0268621|C0243161|C0007637|C0085639|C0035647|C0042960|G0000000|G0000000|C0008976
"However, all 344 patients are included in the intent-to-treat analysis.","However, 344 patients included intent-to-treat analysis.",G0000000|C1442061|C0030705|C0332257|C0162425|C0002778
"Preterm children were eligible to participate if the gestational age was ≤35 weeks and the chronologic age was ≤6 months at the time of entry into the study, or if they were ≤24 months of age at the time of entry into the study and had a diagnosis of CLD of prematurity requiring medical management within 6 months before randomization.","Preterm children eligible participate gestational age ≤35 weeks chronologic age ≤6 months time entry study, ≤24 months age time entry study diagnosis CLD prematurity requiring medical management 6 months randomization.",C0151526|C0008059|C1548635|G0000000|C0439671|C0001779|G0000000|C0439230|C0008717|C0001779|G0000000|C0439231|C0040223|C1705654|C0557651|G0000000|C0439231|C0001779|C0040223|C1705654|C0557651|C0011900|G0000000|C0021294|G0000000|C0199168|C0001554|G0000000|C0439231|C0034656
"Stroke patients will be screened and invited to participate if they: • are within 3 weeks of their first stroke • are aged between 50 and 85 years of age • are diagnosed clinically with hemiparesis or hemiplegia of acute onset, and • are non-ambulatory defined as scoring 0 or 1 on the Motor Assessment Scale for stroke.","Stroke patients screened invited participate they: • 3 weeks stroke • aged 50 85 age • diagnosed clinically hemiparesis hemiplegia acute onset, • non-ambulatory defined scoring 0 1 Motor Assessment Scale stroke.",C0038454|C0030705|C0220908|G0000000|G0000000|G0000000|G0000000|G0000000|C0439230|C0038454|G0000000|C0001779|C0450371|C0450371|C0001779|G0000000|C0011900|G0000000|C0018989|C0018991|C0205178|C0206132|G0000000|C0560046|C1704788|C0449820|G0000000|G0000000|C1513492|C1261322|C0175659|C0038454
Smokers with alcohol problems might have a greater need for pharmacotherapy to assist cessation compared to smokers without alcohol problems.,Smokers alcohol pharmacotherapy assist cessation compared smokers alcohol problems.,C0337664|C0001962|C0013216|C0018896|C1880019|C1707455|C0337664|C0001962|C1546466
The difference of baseline QoL score between the two groups was tested by two-sample t-test.,The difference baseline QoL score tested two-sample t-test.,G0000000|C1705241|C0168634|C0518214|C0449820|C0392366|C0205448|C0871472
"Twins were eligible for participation if they had the same gender, if their parents were fluent in Dutch and if their parents and grandparents were born in Europe.","Twins eligible participation gender, parents fluent Dutch parents grandparents born Europe.",C0041427|C1548635|C0679823|C0079399|C0030551|C0870569|C0013331|C0030551|C0337471|C0005615|C0015176
"Inclusion criteria were woman with stage I–III breast cancer, undergoing cytotoxic (neo)adjuvant or endocrine adjuvant therapy, signed informed consent.","Inclusion criteria woman stage I–III breast cancer, undergoing cytotoxic (neo)adjuvant endocrine adjuvant therapy, signed informed consent.",C0007637|C0243161|C0043210|C0205390|G0000000|C0006141|C0006826|G0000000|C0677881|C1366752|C0014136|C0001551|C0039798|C1519316|C1522154|C1511481
"In the early weeks of life, very low birth weight (VLBW) infants experience intense laboratory blood sampling leading to clinically significant anemia and the need for red blood cell transfusion.","In weeks life, low birth weight (VLBW) infants experience intense laboratory blood sampling leading clinically anemia red blood cell transfusion.",G0000000|C0439230|C0376558|C0205251|C0005615|C0005910|C0282666|C0021270|C0237607|C0522510|C0022877|C0005767|C0441621|C0332152|G0000000|C0002871|C0332575|C0005767|C0007634|C0005841
Virus was detected on the hands of 30 out of 30 control volunteers tested 15 min after application of 62% ethanol.,Virus detected hands 30 30 control volunteers tested 15 min application 62% ethanol.,C0042776|C0442726|C0018563|C0450371|C0450371|C0243148|C0042960|C0392366|C0450371|C0702093|C0185125|C0450371|C0001962
The children ranged in chronological age from 21 to 36 months old with an average age of 30.82 months.,The children ranged chronological age 21 36 months average age 30.82 months.,G0000000|C0008059|C1514721|C0008717|C0001779|C0450371|C0450371|C0439231|C1510992|C0001779|C0450371|C0439231
"Patients were excluded if they refused to take part in the trial, if their permanent address was outside the catchment area of the corresponding health centre, or if they planned to be elsewhere during the follow-up period, if they required hospitalisation during the sampling period, if they were terminally ill or if they already had PU.","Patients excluded refused trial, permanent address catchment health centre, planned follow-up period, required hospitalisation sampling period, terminally ill PU.",C0030705|C1554077|C1548564|C0008976|C0205355|C0376649|G0000000|C0018684|C0205099|C1301732|C0589120|C0439531|C1514873|C0019993|C0441621|C0439531|G0000000|C0231218|C0018387
"3B) between the memantine arm and the placebo arm, respectively.","3B) memantine arm placebo arm, respectively.",C1420850|C0025242|C0446516|C0032042|C0446516|G0000000
"93 women newly diagnosed with early breast cancer were randomized into an intervention group (IG) and a control group (waiting group, WG).","93 women newly diagnosed breast cancer randomized intervention (IG) control (waiting group, WG).",C0450371|C0043210|C0750546|C0011900|C0006141|C0006826|C0034656|C0886296|C0021027|C0243148|C1610166|C0441833|C3495801
We will randomly allocate 249 participants to three groups of 83.,We randomly allocate 249 participants 83.,G0000000|G0000000|G0000000|C1442061|C0679646|C0450371
food allergies and following medically prescribed diets that conflicted with the interventions) were also excluded.,food allergies medically prescribed diets conflicted interventions) excluded.,C0016452|C0020517|G0000000|C0278329|C0012155|C0009671|C0886296|C1554077
Residents were recruited according to the following inclusion criteria: They should: Reside within one of the units identified for the project Have a diagnosis of dementia Display at least two neuropsychiatric symptoms of dementia Be at least 40 years of age Display no significant health problems  Residents were recruited from the home’s pool of music therapy referrals.,Residents recruited inclusion criteria: They should: Reside units identified project Have diagnosis dementia Display neuropsychiatric symptoms dementia Be 40 age Display health Residents recruited home’s pool music therapy referrals.,C1320928|G0000000|C0007637|C0243161|G0000000|G0000000|C2982691|C0439148|C0205396|C1709701|G0000000|C0011900|C0011265|C1705417|G0000000|C0683368|C0011265|G0000000|C0450371|C0001779|C1705417|C0018684|C1320928|G0000000|G0000000|C0337051|C0026867|C0039798|C0034927
Participants with a diagnosis of a dust-related respiratory disease including asbestosis and asbestos related pleural disease were recruited and randomised to an eight-week exercise training group (EG) or a control group (CG) of usual care.,Participants diagnosis dust-related respiratory disease including asbestosis asbestos pleural disease recruited randomised eight-week exercise training (EG) control (CG) usual care.,C0679646|C0011900|C0013330|C0521346|C0012634|C0332257|C0003949|C0003947|C0032225|C0012634|G0000000|G0000000|C0205454|C0015259|C0040607|C0013715|C0243148|C0043444|C3538928|C1947933
"A total of 90 primary molar teeth in 90 patients aged from 3 to 10 years were assessed for enrollment in the study, out of which 15 patients were excluded (10, not meeting the inclusion criteria; 5, refusal to participate).","A total 90 primary molar teeth 90 patients aged 3 10 assessed enrollment study, 15 patients excluded (10, meeting inclusion criteria; 5, refusal participate).",G0000000|C0439175|C0450371|C0205225|C0026367|C0040426|C0450371|C0030705|C0001779|G0000000|C0450371|C1516048|C1516879|C0557651|C0450371|C0030705|C1554077|C0450371|C0556656|C0007637|C0243161|G0000000|G0000000|G0000000
"Patients in the intervention group (n = 30) listened to their preferred music by headphones for 30 minutes, whereas those in the control group (n = 30) did not listen to music.","Patients intervention (n = 30) listened preferred music headphones 30 minutes, control (n = 30) listen music.",C0030705|C0886296|C0369718|G0000000|C0450371|C0004309|C0558295|C0026867|C1708331|C0450371|C0439232|C0243148|C0369718|G0000000|C0450371|C0004309|C0026867
"The exclusion criteria were: (1) previous acupuncture treatment; (2) pregnant or planning pregnancy; (3) implanted pacemaker; (4) implanted neurostimulator; (5) cardiac arrhythmia; (6) epilepsy; (7) severe heart, brain, lung, or other major organ disease; (8) acid-base or electrolyte imbalance; (9) history of severe kidney disease, hydronephrosis, bladder stoma, sphincterotomy, or severe exaggeration of autonomic nervous system reflexes; (10) urinary tract infection; (11) cognitive disorder; and (12) acupuncture syncope.","The exclusion criteria were: (1) previous acupuncture treatment; (2) pregnant planning pregnancy; (3) implanted pacemaker; (4) implanted neurostimulator; (5) cardiac arrhythmia; (6) epilepsy; (7) severe heart, brain, lung, major organ disease; (8) acid-base electrolyte imbalance; (9) history severe kidney disease, hydronephrosis, bladder stoma, sphincterotomy, severe exaggeration autonomic nervous system reflexes; (10) urinary tract infection; (11) cognitive disorder; (12) acupuncture syncope.",G0000000|C0680251|C0243161|G0000000|G0000000|C0205156|C0001299|C0039798|G0000000|C0549206|C0032074|C0032961|G0000000|C0021102|C0030163|G0000000|C0021102|C0582124|G0000000|C0018787|C0003811|G0000000|C0014544|G0000000|C0205082|C0018787|C0006104|C0024109|C0205082|C0178784|C0012634|G0000000|C0001128|C0013832|C1397014|G0000000|C0019664|C0205082|C0022646|C0012634|C0020295|C0005682|C1955856|C0748895|C0205082|G0000000|C0004388|C0027769|C0449913|C0034929|C0450371|C0042027|C1185740|C0009450|C0450371|C1516691|C0012634|C0450371|C0001299|C0039070
We randomly assigned 885 participants with COPD to the two study groups.,We randomly assigned 885 participants COPD study groups.,G0000000|G0000000|C1516050|C1442061|C0679646|C0024117|C0557651|C0441833
"We assessed behaviour using age appropriate behavioural screening questionnaires, which we and others have used in similar settings.21 23 We used the Bayley scale18 for those aged ≤2 years and the Richman behavioural assessment questionnaire for those aged 2 years 1 month to 3 years 11 months.24 Many similar studies have used Conners' rating scale-revised for children aged 5-15.25 We reassessed behaviour after 12 months of treatment or at drug withdrawal using the same assessment scale.","We assessed behaviour age behavioural screening questionnaires, settings.21 23 We Bayley scale18 aged ≤2 Richman behavioural assessment questionnaire aged 2 1 month 3 11 months.24 Many studies Conners' rating scale-revised children aged 5-15.25 We reassessed behaviour 12 months treatment drug withdrawal assessment scale.",G0000000|C1516048|C0004927|C0001779|C0004927|C0220908|C0034394|C0542559|C0450371|G0000000|G0000000|G0000000|C0001779|G0000000|G0000000|C0004927|C1261322|C0034394|C0001779|G0000000|G0000000|C0332177|G0000000|C0450371|C0439231|G0000000|C0947630|G0000000|C0871208|C0175659|C0008059|C0001779|C0450371|G0000000|G0000000|C0004927|C0450371|C0439231|C0039798|C0013227|C2349954|C1261322|C0175659
Sixty-one (n = 61) infants born at a postmenstrual age > 23 weeks but ≤ 32 weeks with a birth weight ≤1250 g and without congenital or chromosomal anomalies or gastrointestinal malformations who were receiving some enteral nutrition by 48 h of age were enrolled in the study.,Sixty-one (n = 61) infants born postmenstrual age > 23 weeks ≤ 32 weeks birth weight ≤1250 congenital chromosomal anomalies gastrointestinal malformations receiving enteral nutrition 48 age enrolled study.,C3816724|C0369718|G0000000|C0450371|C0021270|C0005615|G0000000|C0001779|G0000000|C0450371|C0439230|G0000000|C0450371|C0439230|C0005615|C0005910|G0000000|C0009678|C0008633|C0000769|C0521362|C0000768|C1514756|C1304890|C0028707|C0450371|C0001779|G0000000|C0557651
"Infants with a gestational age <34 weeks, birth weights between 500 and 2000 g, and an estimated requirement of PN of at least 7 days were to be included.","Infants gestational age <34 weeks, birth weights 500 2000 g, estimated requirement PN 7 days included.",C0021270|C0439671|C0001779|C0450371|C0439230|C0005615|C0043100|C1442061|G0000000|C0439267|C0750572|C1514873|C0219433|G0000000|C0439228|C0332257
gambiae s.l.,gambiae s.l.,G0000000|C0439394
"Exclusion criteria were long-term use of supplemental oxygen; associated locomotor or neurological conditions; malignancy; cardiac failure; distal arteriopathy; α1-antiprotease deficiency; recent surgery; a severe endocrine, hepatic or renal disorder; use of anticoagulant medication and regular physical activity.","Exclusion criteria long-term supplemental oxygen; locomotor neurological conditions; malignancy; cardiac failure; distal arteriopathy; α1-antiprotease deficiency; surgery; severe endocrine, hepatic renal disorder; anticoagulant medication regular physical activity.",C0680251|C0243161|C0443252|C2348609|C0030054|G0000000|C0205494|C0012634|C0006826|C0018787|C0231174|C0205108|C0852949|G0000000|C0011155|C0038894|C0205082|C0014136|C0205054|C0022646|C0012634|C0003280|C0013227|C0205272|C0031809|C0205177
"– CNS progression - was defined as a defined increase in perpendicular bi-dimensional tumor area for any of the 1–3 tracked brain metastases, or the appearance of any new brain metastasis on a follow-up MRI.","– CNS progression - defined defined increase perpendicular bi-dimensional tumor 1–3 tracked brain metastases, appearance brain metastasis follow-up MRI.",G0000000|C0242656|G0000000|C1704788|C1704788|C0442805|C1295725|C0439534|C0027651|G0000000|C0040594|C0006104|C0027627|C0233426|C0006104|C0027627|C0589120|C0024485
"Regarding gender, men and women accounted for 28% and 72% of the DEDG versus 32% and 68% of the CG, respectively.","Regarding gender, women accounted 28% 72% DEDG versus 32% 68% CG, respectively.",G0000000|C0079399|C0043210|C2741673|C0450371|C0450371|G0000000|G0000000|C0450371|C0450371|C0043444|G0000000
"OBJECTIVES: To determine whether a two hour training programme for general practice reception staff could improve uptake in patients who had failed to attend for breast screening, and whether women from different ethnic groups benefited equally.","OBJECTIVES: To determine hour training programme practice reception staff improve uptake patients failed attend breast screening, women ethnic benefited equally.",C0018017|C0040363|G0000000|C0439227|C0040607|C1709697|C0237607|C0544683|C0851286|G0000000|C0243144|C0030705|C0231175|C1999232|C0006141|C0220908|C0043210|C0015031|C0814225|G0000000
"Brain metastases (BMs) are common in patients with metastatic melanoma [1,2] and are the cause of death in the majority of them [2,3].","Brain metastases (BMs) common patients metastatic melanoma [1,2] death majority [2,3].",C0006104|C0027627|G0000000|C0205214|C0030705|C0036525|C0025202|G0000000|C0011065|C0680220|G0000000
"Patients scheduled for primary pancreaticoduodenectomy or distal pancreatic resection in participating centres Aged 18 years or older Signed informed consent provided  No pancreatic resection performed: nonresectable tumour Total pancreatectomy, central pancreatectomy or enucleation Multivisceral resection Laparoscopic procedure Resection of the portal vein and reconstruction with a graft Lack of compliance, informed consent not provided or refusal to participate  The sample size calculation is based on the expected rate of POPF from our previous experience, as there exist no pilot data comparing the closed-suction drain and closed passive gravity drain in pancreatic surgery.","Patients scheduled primary pancreaticoduodenectomy distal pancreatic resection participating centres Aged 18 Signed informed consent provided No pancreatic resection performed: nonresectable tumour Total pancreatectomy, central pancreatectomy enucleation Multivisceral resection Laparoscopic procedure Resection portal vein reconstruction graft Lack compliance, informed consent provided refusal participate The sample size calculation based expected rate POPF previous experience, exist pilot data comparing closed-suction drain closed passive gravity drain pancreatic surgery.",C0030705|C0086960|C0205225|C0085162|C0205108|C0030274|C0015252|C0679823|C0205099|C0001779|C0450371|C1519316|C1522154|C1511481|C1999230|G0000000|C0030274|C0015252|C0884358|G0000000|C0027651|C0439175|C0030279|C0205099|C0030279|C0014392|G0000000|C0015252|C0031150|C0184661|C0015252|C0205054|C0042449|C0020912|C0181074|C0332268|C0009563|C1522154|C1511481|C1999230|G0000000|G0000000|G0000000|C0370003|C0456389|C1441506|C1527178|C1517001|C0871208|G0000000|C0205156|C0237607|C2987476|C0473169|C1511726|C1707455|C0587267|C0013103|C0587267|C3686820|C0282189|C0013103|C0030274|C0038894
"CLAS = Child Life and Attention Skills Program; PFT = Parent Focused Treatment, TAU = Treatment As Usual  Although the χ2 test was significant, the overall model fit the data very well according to all other indices of model fit, χ2(91) = 138.35, p = .001; CFI = .95, RMSEA = .05; SRMR = .04.","CLAS = Child Life Attention Skills Program; PFT = Parent Focused Treatment, TAU = Treatment As Usual Although χ2 test significant, model fit data indices model fit, χ2(91) = 138.35, = .001; CFI = .95, RMSEA = .05; SRMR = .04.",C0456387|G0000000|C0008059|C0376558|C0004268|C0678856|C1709697|C0024119|G0000000|C0030551|C0205234|C0039798|C1720655|G0000000|C0039798|G0000000|C3538928|G0000000|G0000000|C0022885|C0237881|C3161035|C0036572|C1511726|C4033634|C3161035|C0036572|G0000000|G0000000|C1442061|G0000000|C1442061|G0000000|G0000000|C0450371|G0000000|G0000000|C0450371|G0000000|G0000000|C0450371
AIM: To assess delayed antibiotic prescribing as a strategy for reducing the unnecessary use of antibiotics for cough in primary care.,AIM: To assess delayed antibiotic prescribing strategy reducing unnecessary antibiotics cough primary care.,C1947946|C0040363|C1516048|C0205421|C0003232|C0278329|C0679199|C0392756|G0000000|C0003232|C0010200|C0205225|C1947933
"Male or female subjects between three and 60 years of age with acute uncomplicated P. vivax mono-infection confirmed by positive microscopy of P. vivax with a parasite density ≥250 µL−1 of blood (including at least 50% asexual parasites) and fever or documented history of fever in the previous 24 h, and with a body weight between 20 and 90 kg (with no clinical evidence of severe malnutrition) were eligible for enrollment.","Male female subjects 60 age acute uncomplicated P. vivax mono-infection confirmed positive microscopy P. vivax parasite density ≥250 µL−1 blood (including 50% asexual parasites) fever documented history fever previous 24 h, body weight 20 90 (with clinical evidence severe malnutrition) eligible enrollment.",C0086582|C0015780|C0681850|C0450371|C0001779|C0205178|C0443334|C0369773|G0000000|C1551432|C0521093|C0439178|C0026018|C0369773|G0000000|C0030498|C0178587|G0000000|G0000000|C0005767|C0332257|C0450371|C0599655|C0030498|C0015967|C1301725|C0019664|C0015967|C0205156|C0450371|C0033727|C0242821|C0005910|C0450371|C0450371|G0000000|C0205210|C3887511|C0205082|C0162429|C1548635|C1516879
Inclusion criteria; women with a BMI ≥30 kg/m2 and a singleton pregnancy between 15+0 weeks and 18+6 weeks’ gestation.,Inclusion criteria; women BMI ≥30 kg/m2 singleton pregnancy 15+0 weeks 18+6 weeks’ gestation.,C0007637|C0243161|C0043210|G0000000|G0000000|C0022718|C0481462|C0032961|C0450371|C0439230|C0450371|G0000000|C0032961
Forty-one (93%) of 44 patients had ictal HFOs determined with time-frequency analysis of intracranial EEG.,Forty-one (93%) 44 patients ictal HFOs determined time-frequency analysis intracranial EEG.,C3816449|C0450371|C0450371|C0030705|C0038454|G0000000|G0000000|C0439603|C0002778|C0524466|C0013819
Cognitive impairment was present in 59.2% of the patients in the melatonin group and 66.0% in the placebo group (p = 0.4).,Cognitive impairment 59.2% patients melatonin 66.0% placebo (p = 0.4).,C1516691|C0221099|C0450371|C0030705|C0025219|C0450371|C0032042|C0369773|G0000000|G0000000
"Baseline data were similar in all three groups, except that more children were admitted to hospital in the combined group (13/36) compared to the ibuprofen (3/35) and paracetamol groups (5/35).","Baseline data groups, children admitted hospital combined (13/36) compared ibuprofen (3/35) paracetamol (5/35).",C0168634|C1511726|C0441833|C0008059|C0184666|C0019994|C0205195|C0450371|C1707455|C0020740|C0450371|C0000970|C0450371
"Briefly, between March 1997 to May 2000, a total of 74941women aged 40 to 70 years were recruited for the SWHS (participation rate: 92.7%), and between April 2002 to June 2006, a total of 61480 men aged 40–74 years with no previous history of cancer were recruited for the SMHS (participation rate: 74.1%).","Briefly, March 1997 May 2000, total 74941women aged 40 70 recruited SWHS (participation rate: 92.7%), April 2002 June 2006, total 61480 aged 40–74 previous history cancer recruited SMHS (participation rate: 74.1%).",G0000000|C3829202|G0000000|G0000000|G0000000|C0439175|G0000000|C0001779|C0450371|C0450371|G0000000|G0000000|C0679823|C0871208|C0450371|C3715024|G0000000|C3829443|G0000000|C0439175|G0000000|C0001779|G0000000|C0205156|C0019664|C0006826|G0000000|C1824631|C0679823|C0871208|C0450371
The NEADL has proved to be a reliable and valid outcome measure in patients with stroke [54].,The NEADL proved reliable valid outcome measure patients stroke [54].,G0000000|G0000000|G0000000|C3858758|C2349099|C1274040|C0079809|C0030705|C0038454|C0450371
"As of the start of the Rotterdam Family Cancer Clinic in 1991, PM and/or PBSO are being discussed as risk-reducing strategies with women at increased risk of hereditary BC and/or ovarian cancer.","As start Rotterdam Family Cancer Clinic 1991, PM and/or PBSO discussed risk-reducing strategies women increased risk hereditary BC and/or ovarian cancer.",G0000000|C0439659|G0000000|C0015576|C0006826|C0002424|G0000000|C0030266|G0000000|G0000000|C2584313|C0035647|C0679199|C0043210|C0205217|C0035647|C0439660|C0006041|G0000000|C0205065|C0006826
"In Madison, 396 letters of invitation were sent; 66 parents indicated an interest in enrolling by telephone, return of a form to the school, or e-mail; 57 were eligible for the study; and 55 consented to participate, for an enrollment rate of 14%.","In Madison, 396 letters invitation sent; 66 parents enrolling telephone, return form school, e-mail; 57 eligible study; 55 consented participate, enrollment rate 14%.",G0000000|G0000000|C1442061|C0282413|C2826348|C1519246|C0450371|C0030551|G0000000|C0039457|C0332156|C0348078|C0036375|C0013849|C0450371|C1548635|C0557651|C0450371|C2711213|G0000000|C1516879|C0871208|C0450371
"Eligible individuals (a) were female, (b) were 65 years of age or older, (c) were community-dwelling at the time of fracture, (d) had to have sustained a nonpathologic fracture, and (e) must have undergone surgical repair of the hip fracture within 72 hours of admission (for further description of eligibility and recruitment, see Resnick et al., 2007).","Eligible individuals (a) female, (b) 65 age older, (c) community-dwelling time fracture, (d) sustained nonpathologic fracture, (e) undergone surgical repair hip fracture 72 hours admission (for description eligibility recruitment, Resnick al., 2007).",C1548635|C0027361|G0000000|C0015780|G0000000|C0450371|C0001779|C0580836|G0000000|C4045975|C0040223|C0016658|C0073187|C0443318|G0000000|C0016658|G0000000|G0000000|C0543467|C0043240|C0019552|C0016658|C0450371|C0439227|C0184666|G0000000|C0678257|C0013893|C2949735|G0000000|C0202311|G0000000
Key exclusion criteria were: a history of asthma; myocardial infarction within 1 year of screening; clinically relevant cardiac arrhythmia; known active tuberculosis; cystic fibrosis or life-threatening pulmonary obstruction; hospitalized for heart failure within the past year; clinically evident bronchiectasis or diagnosed thyrotoxicosis or paroxysmal tachycardia; previous thoracotomy with pulmonary resection; regular use of daytime oxygen if patients were unable to abstain during clinic visits; and currently enrolled in a pulmonary rehabilitation program (or completed in the 6 weeks before screening).,Key exclusion criteria were: history asthma; myocardial infarction 1 screening; clinically relevant cardiac arrhythmia; active tuberculosis; cystic fibrosis life-threatening pulmonary obstruction; hospitalized heart failure year; clinically evident bronchiectasis diagnosed thyrotoxicosis paroxysmal tachycardia; previous thoracotomy pulmonary resection; regular daytime oxygen patients unable abstain clinic visits; enrolled pulmonary rehabilitation program (or completed 6 weeks screening).,G0000000|C0680251|C0243161|G0000000|C0019664|C0004096|C0027061|C0021308|G0000000|C0220908|G0000000|C2347946|C0018787|C0003811|C0205177|C0041296|C0205207|C0016059|C1517874|C0024109|C0028778|C0701159|C0018787|C0231174|C0439234|G0000000|C3887511|C0006267|C0011900|C0040156|C0205311|C0039231|C0205156|C0039991|C0024109|C0015252|C0205272|C0332169|C0030054|C0030705|C1299582|G0000000|C0002424|C0545082|G0000000|C0024109|C0034991|C1709697|G0000000|C0205197|G0000000|C0439230|C0220908
We included patients with witnessed cardiac arrest in whom resuscitation was attempted.,We included patients witnessed cardiac arrest resuscitation attempted.,G0000000|C0332257|C0030705|C0682356|C0018787|C0237477|C0035273|C1516084
"CONSORT Trial Flow Diagram Participants will be primary carers of infants aged 2 to 12 weeks, recruited by one of two recruitment modalities: advertising on the Raising Children Network (www.raisingchildren.net.au), or recommendation from their MCH nurse.","CONSORT Trial Flow Diagram Participants primary carers infants aged 2 12 weeks, recruited recruitment modalities: advertising Raising Children Network (www.raisingchildren.net.au), recommendation MCH nurse.",G0000000|C0008976|C0806140|C0681494|C0679646|C0205225|C0085537|C0021270|C0001779|G0000000|C0450371|C0439230|G0000000|C2949735|C0695347|C0001690|G0000000|C0008059|C0150775|C0282111|C0034866|C0369183|C0028661
"In March–April 2012, we recruited mothers or female legal guardians (hereafter collectively called “mothers”) with daughters aged 9–12 years to attend dinners on the Hopi Reservation.","In March–April 2012, recruited mothers female legal guardians (hereafter collectively called “mothers”) daughters aged 9–12 attend dinners Hopi Reservation.",G0000000|G0000000|G0000000|G0000000|C0026591|C0015780|C1301860|C1274041|G0000000|G0000000|C0679006|G0000000|C0011011|C0001779|G0000000|C1999232|C4048877|C0574606|C1514889
"The five investigations consist of patients with severe traumatic brain injury and were published during the last eight years, except for the older D’Amelio study.","The investigations consist patients severe traumatic brain injury published years, D’Amelio study.",G0000000|C1261322|C0332529|C0030705|C0205082|C0332663|C0006104|C3263722|C0034037|C0439234|G0000000|C0557651
Baseline characteristics of the study patients were similar between the two groups (Table 1).,Baseline characteristics study patients (Table 1).,C0168634|C1521970|C0557651|C0030705|C0039224|G0000000
Inclusion Criteria were: Age ≥ 18 years ; assigned to initiate IFN-β treatment (n = 1) or patients who continued to suffer from FLS beyond 4 months of treatment with IFN-β (n = 44); 25-OH-D blood levels < 75 nmol/l and EDSS score < 7.,Inclusion Criteria were: Age ≥ 18 ; assigned initiate IFN-β treatment (n = 1) patients continued suffer FLS 4 months treatment IFN-β (n = 44); 25-OH-D blood levels < 75 nmol/l EDSS score < 7.,C0007637|C0243161|G0000000|G0000000|G0000000|C1516050|C1548602|G0000000|C0039798|G0000000|C0030705|C0549178|C0683278|G0000000|G0000000|C0439231|C0039798|G0000000|G0000000|C0450371|C0005767|G0000000|C0439282|C0451246|G0000000
"Inclusion criteria were: age >18 years, severe brain damage (Glasgow Coma Score <8) with cerebral edema – visualized by CT scan and continuous monitoring of ICP.","Inclusion criteria were: age >18 years, severe brain damage (Glasgow Coma Score <8) cerebral edema – visualized CT scan continuous monitoring ICP.",C0007637|C0243161|G0000000|C0001779|C0450371|C0439234|C0205082|C0006104|C0010957|G0000000|C0009421|C0449820|G0000000|G0000000|C0013604|G0000000|C0234621|C0007673|C0034606|C0549178|C0150369|C1881201
Patients were randomised if they met the following main inclusion criteria: outpatients aged ≥40 years with a history of moderate to very severe COPD (GOLD stage 2–4) [23]; post-bronchodilator FEV1 <80% of predicted normal; post-bronchodilator FEV1/forced vital capacity (FVC) <70%; current or ex-smokers with a smoking history of >10 pack–years.,Patients randomised met main inclusion criteria: outpatients aged ≥40 years history moderate severe COPD (GOLD stage 2–4) [23]; post-bronchodilator FEV1 <80% predicted normal; post-bronchodilator FEV1/forced vital capacity (FVC) <70%; current ex-smokers smoking history >10 pack–years.,C0030705|G0000000|C0268621|C0205225|C0007637|C0243161|C0029921|C0001779|G0000000|C0019664|C0205081|C0205082|C0024117|C0018026|C0205390|G0000000|C0450371|C2599594|G0000000|C0450371|C0681842|C0205307|C2599594|C0441722|C0442732|C1516240|C3714541|C0450371|C0521116|C0337671|C0037369|C0019664|G0000000
"From January 2009 to December 2011, consecutive patients ages 18 to 65 years who were hospitalized in the Fifth People’s Hospital of Shanghai with severe acute exacerbations of asthma were eligible for enrollment in the study.","From January 2009 December 2011, consecutive patients ages 18 65 hospitalized Fifth People’s Hospital Shanghai severe acute exacerbations asthma eligible enrollment study.",G0000000|C3829466|G0000000|C3830550|G0000000|C1707491|C0030705|C0001779|C0450371|C0450371|C0701159|C0205439|G0000000|C0019994|G0000000|C0205082|C0205178|G0000000|C0004096|C1548635|C1516879|C0557651
"Following transoral surgery and neck dissection, patients are allocated into three groups based on pathological risk factors for recurrence.","Following transoral surgery neck dissection, patients allocated based pathological risk factors recurrence.",C0231290|C0442366|C0038894|C0027530|C0012737|C0030705|G0000000|C1527178|C0030664|C0035647|C1521761|C0034897
"We excluded patients with serum creatinine above the upper age-related normal range, significant proteinuria (urinary protein/creatinine ratio > 1.0 in a non–first-void urine sample at baseline), elevated alanine aminotransferase (ALT) more than three-fold of the upper limit of normal, gastrointestinal diseases, clinically relevant auditory and/or ocular toxicity related to iron chelation therapy, cardiac disease, and/or serious adverse events with DFO or DFX, and absolute neutrophilic count < 1500/mm3 or platelet count < 100,000/mm3.","We excluded patients serum creatinine upper age-related normal range, proteinuria (urinary protein/creatinine ratio > 1.0 non–first-void urine sample baseline), elevated alanine aminotransferase (ALT) three-fold upper limit normal, gastrointestinal diseases, clinically relevant auditory and/or ocular toxicity iron chelation therapy, cardiac disease, and/or adverse events DFO DFX, absolute neutrophilic count < 1500/mm3 platelet count < 100,000/mm3.",G0000000|C1554077|C0030705|C0229671|C0010294|C1282910|C0001779|C0205307|C1514721|C0033687|C0042027|C0369901|C0456603|G0000000|G0000000|G0000000|C0042036|C0370003|C0168634|C0205250|C0001898|C0002594|C1266129|C0205449|C1282910|C0439801|C0205307|C0521362|C0012634|G0000000|C2347946|C0439825|G0000000|C0015392|C0040539|C0302583|C3537131|C0039798|C0018787|C0012634|G0000000|G0000000|C0441471|G0000000|G0000000|C0205344|C0746885|C0750480|G0000000|G0000000|C0005821|C0750480|G0000000|C1442061
Positional OSA patients (overall AHI ≥ 15/h; supine AHI ≥ twice the non-supine AHI; ≥ 20 min of sleep in supine and non-supine postures; and non-supine AHI < 15/h) identified from diagnostic sleep studies conducted at the Adelaide Institute for Sleep Health between January and July 2009 were invited to participate.,Positional OSA patients (overall AHI ≥ 15/h; supine AHI ≥ non-supine AHI; ≥ 20 min sleep supine non-supine postures; non-supine AHI < 15/h) identified diagnostic sleep studies conducted Adelaide Institute Sleep Health January July 2009 invited participate.,C0240795|C0520679|C0030705|C0282416|G0000000|G0000000|C0450371|C0038846|G0000000|G0000000|C1518422|G0000000|G0000000|C0450371|C0702093|C0037313|C0038846|C1518422|C1262869|C1518422|G0000000|G0000000|C0450371|C0205396|C0011900|C0037313|C0947630|C0004927|G0000000|C0021622|C0037313|C0018684|C3829466|C3829447|G0000000|G0000000|G0000000
Volunteers also had to be >18 years old.,Volunteers >18 old.,C0042960|C0450371|C0580836
Neonates weighing less than 1500 g or a gestational age under 34 weeks were included in this study.,Neonates weighing 1500 gestational age 34 weeks included study.,C0021289|C1305866|G0000000|C0439671|C0001779|C0450371|C0439230|C0332257|C0557651
"Exclusion criteria included: pregnancy or no use of a medically accepted means of contraception in women of child bearing potential; breastfeeding; a current, serious suicidal or homicidal risk; serious or unstable medical illness including cardiovascular, hepatic, renal, respiratory, endocrine, neurologic, or hematologic disease; history of unstable seizure disorder; use of anticoagulants such as heparin or warfarin; DSM-IV diagnoses including organic mental disorders, substance use disorders, including alcohol (active within the last six months), schizophrenia, delusional disorder, psychotic disorders not elsewhere classified; bipolar disorder; history of multiple adverse drug reactions or allergy to the study drugs; psychotic features; current use of antidepressants, lithium, or anticonvulsants for mood stabilization; clinical or laboratory evidence of hypothyroidism; current use of other psychotropic drugs; having failed to respond during the course of their current major depressive episode to at least one adequate antidepressant trial, defined as six weeks or more of treatment with citalopram 40mg/day (or its antidepressant equivalent); having taken at least 1 g/day of an omega-3 product, or any current use of supplements enriched with n-3 fatty acids, e.g.","Exclusion criteria included: pregnancy medically accepted contraception women child bearing potential; breastfeeding; current, suicidal homicidal risk; unstable medical illness including cardiovascular, hepatic, renal, respiratory, endocrine, neurologic, hematologic disease; history unstable seizure disorder; anticoagulants heparin warfarin; DSM-IV diagnoses including organic mental disorders, substance disorders, including alcohol (active months), schizophrenia, delusional disorder, psychotic disorders classified; bipolar disorder; history multiple adverse drug reactions allergy study drugs; psychotic features; current antidepressants, lithium, anticonvulsants mood stabilization; clinical laboratory evidence hypothyroidism; current psychotropic drugs; failed respond current major depressive episode adequate antidepressant trial, defined weeks treatment citalopram 40mg/day (or antidepressant equivalent); 1 g/day omega-3 product, current supplements enriched n-3 fatty acids, e.g.",C0680251|C0243161|C0332257|C0032961|G0000000|C1272684|C0700589|C0043210|C0008059|C1704689|C3245505|C0006147|C0521116|C0438696|C0745031|C0035647|C0443343|C0199168|C0221423|C0332257|C0007226|C0205054|C0022646|C0521346|C0014136|C0205494|C0018943|C0012634|C0019664|C0443343|C0036572|C0012634|C0003280|C0019134|C0043031|C0220952|C0011900|C0332257|C0747055|C0229992|C0012634|C0439861|C0012634|C0332257|C0001962|C0205177|C0439231|C0036341|C0011253|C0012634|C0004936|C0012634|C0008902|C0443156|C0012634|C0019664|C0439064|G0000000|C0013227|C0443286|C0002111|C0557651|C0013227|C0004936|C1521970|C0521116|C0003289|C0023870|C0003286|C0026516|C1293130|C0205210|C0022877|C3887511|C0020676|C0521116|C0033978|C0013227|C0231175|G0000000|C0521116|C0205082|G0000000|C0332189|C0205410|C0003289|C0008976|C1704788|C0439230|C0039798|C0008845|C0332173|G0000000|C0003289|C0205163|G0000000|C0439417|C1719844|C1514468|C0521116|C0242295|C0359583|C0369718|G0000000|C0001128|G0000000
"In this randomized controlled trial, over 12 months (October 2009 – September 2010), 182 term neonates with uncomplicated jaundice, admitted to neonatal unit of Imam Reza Hospital (AS) in Kermanshah province of Iran, were selected.","In randomized controlled trial, 12 months (October 2009 – September 2010), 182 term neonates uncomplicated jaundice, admitted neonatal unit Imam Reza Hospital (AS) Kermanshah province Iran, selected.",G0000000|C0034656|C2587213|C0008976|C0450371|C0439231|C3828732|G0000000|G0000000|C3828193|G0000000|C1442061|C0233324|C0021289|C0443334|C0022346|C0184666|C1552240|C0439148|C0521321|G0000000|C0019994|G0000000|G0000000|C1514578|C0022065|C1707391
"Cases and controls were children in the age group of 0–59 months with and without diarrhea in the preceding of 2 weeks during a house to house survey, respectively.","Cases controls children age 0–59 months diarrhea preceding 2 weeks house house survey, respectively.",C0868928|C0243148|C0008059|C0001779|G0000000|C0439231|C0011991|C0332152|G0000000|C0439230|C0442519|C0442519|C0038951|G0000000
"Patients were required to have stabile inactive clinical disease, as defined by < 5 points on Harvey Bradshaw score (Harvey and Bradshaw 1980) (which corresponded to a score of ≤ 4 on the Truelove-Witts criteria (Truelove and Witts 1955) for ulcerative colitis, without a change in medication for 4 months.","Patients required stabile inactive clinical disease, defined < 5 Harvey Bradshaw score (Harvey Bradshaw 1980) (which corresponded score ≤ 4 Truelove-Witts criteria (Truelove Witts 1955) ulcerative colitis, change medication 4 months.",C0030705|C1514873|G0000000|C0205254|C0205210|C0012634|C1704788|G0000000|G0000000|G0000000|C0449820|G0000000|G0000000|G0000000|G0000000|G0000000|C0449820|G0000000|G0000000|G0000000|C0243161|G0000000|G0000000|G0000000|C0041582|C0009319|C0392747|C0013227|G0000000|C0439231
"As illustrated in Figure Figure1,1, 12 of the 25 medical patients and 25 of the 34 surgical patients who enrolled completed the study.","As illustrated Figure Figure1,1, 12 25 medical patients 25 34 surgical patients enrolled completed study.",G0000000|G0000000|G0000000|G0000000|C0450371|C0450371|C0199168|C0030705|C0450371|C0450371|C0543467|C0030705|G0000000|C0205197|C0557651
"At the first stage, 312 pregnant women were interviewed from whom 170 entered the study based on the written informed consent and the following inclusion criteria: single fetus, no chronic disease such as diabetes, heart and lung chronic diseases, no infertility, no high risk pregnancy and no history of psychiatrist visit, do not use specific drugs, gestational age of 20 weeks.","At stage, 312 pregnant women interviewed 170 entered study based written informed consent inclusion criteria: single fetus, chronic disease diabetes, heart lung chronic diseases, infertility, risk pregnancy history psychiatrist visit, specific drugs, gestational age 20 weeks.",G0000000|C0205390|C1442061|C0549206|C0043210|C0021822|C1442061|C1521975|C0557651|C1527178|C0043266|C1522154|C1511481|C0007637|C0243161|C0037179|C0015965|C0205191|C0012634|C0011847|C0018787|C0024109|C0205191|C0012634|C0021359|C0035647|C0032961|C0019664|C0033872|C0545082|C0205369|C0013227|C0439671|C0001779|C0450371|C0439230
"A 1:2 frequency-matched case control study of 285 patients and 570 controls was conducted from June 2010 to May 2011 in AnXi of Fujian province, China.","A 1:2 frequency-matched control study 285 patients 570 controls conducted June 2010 May 2011 AnXi Fujian province, China.",G0000000|G0000000|C0376249|C0243148|C0557651|C1442061|C0030705|C1442061|C0243148|C0004927|C3829443|G0000000|G0000000|G0000000|G0000000|G0000000|C1514578|C0008115
"The inclusion criteria are that the individual is: (i) aged 14–25 years; (ii) has a clinical diagnosis of an anxiety, unipolar, bipolar or psychotic disorder according to Diagnostic and Statistical Manual of Mental Disorders, version IV (DSM-IV) criteria [14]; (iii) is willing and able to give independent written informed consent to participate in the study (in addition, parental consent is required for those aged 14–16 years).","The inclusion criteria individual is: (i) aged 14–25 years; (ii) clinical diagnosis anxiety, unipolar, bipolar psychotic disorder Diagnostic Statistical Manual Mental Disorders, version IV (DSM-IV) criteria [14]; (iii) independent written informed consent participate study (in addition, parental consent required aged 14–16 years).",G0000000|C0007637|C0243161|C0027361|G0000000|C0021966|C0001779|G0000000|C0439234|G0000000|C0205210|C0011900|C0003467|C0443340|C0443156|C0004936|C0012634|C0011900|C0038215|C0024763|C0229992|C0012634|C0333052|C0022326|C0220952|C0243161|C0450371|C0439070|C0085862|C0043266|C1522154|C1511481|G0000000|C0557651|G0000000|C0332287|C0030551|C1511481|C1514873|C0001779|G0000000|C0439234
"Exclusion criteria were an unwillingness to follow a prescribed diet, inability to understand the Spanish language, and pregnancy comorbidities other than obesity, hypertension, and/or dyslipidemia.","Exclusion criteria unwillingness follow prescribed diet, inability understand Spanish language, pregnancy comorbidities obesity, hypertension, and/or dyslipidemia.",C0680251|C0243161|C0558080|C0332283|C0278329|C0012155|G0000000|C0162340|C0086409|C0023008|C0032961|C0009488|C0028754|C0020538|G0000000|C0242339
There were no formal caregiver exclusion criteria.,There formal caregiver exclusion criteria.,G0000000|C0348078|C0085537|C0680251|C0243161
Our randomised clinical trial on functional unilateral posterior crossbite in the late deciduous and early mixed dentition showed the clinical efficacy of an early orthodontic treatment protocol in a one-year period.,Our randomised clinical trial functional unilateral posterior crossbite late deciduous mixed dentition clinical efficacy orthodontic treatment protocol one-year period.,G0000000|G0000000|C0205210|C0008976|C0205245|C0205092|C0205095|C0242385|C0205087|G0000000|C0205430|C0011443|C0205210|C1280519|C0332276|C0039798|C0442711|C4082117|C0439531
"Eligible patients met the criteria for down-referral (undetectable viral load <10-months, ART >11-months, CD4 ≥200cells/mm3, stable weight and no opportunistic infections) regardless of whether they were down-referred to a PHC for treatment maintenance between February 2008-January 2009.","Eligible patients met criteria down-referral (undetectable viral load <10-months, ART >11-months, CD4 ≥200cells/mm3, stable weight opportunistic infections) down-referred PHC treatment maintenance February 2008-January 2009.",C1548635|C0030705|C0268621|C0243161|C0034927|C3827727|C0521026|C1550025|C0450371|C0003826|C0450371|C0285590|G0000000|C0205360|C0005910|G0000000|C3714514|C0205543|C1420160|C0039798|C0024501|C3830166|C3829466|G0000000
Mothers were eligible for the trial if elective caesarean section was planned at 37 weeks' gestation or beyond.,Mothers eligible trial elective caesarean planned 37 weeks' gestation beyond.,C0026591|C1548635|C0008976|C0206058|C3841297|C1301732|C0450371|C0439230|C0032961|G0000000
Participants 108 children aged 2-15 with generalised tonic-clonic (n=51) or partial and secondary generalised seizures (n=57).,Participants 108 children aged 2-15 generalised tonic-clonic (n=51) partial secondary generalised seizures (n=57).,C0679646|C1442061|C0008059|C0001779|C0450371|C0205246|C3543842|C0369718|C0728938|C0027627|C0205246|C0036572|C0369718
Participants consisted of 21 women (mean age: 30 ± 6.6 range 26-47) in the exercise group and 17 women (mean age: 30 ± 8.6 range 26-47) in the control group.,Participants consisted 21 women (mean age: 30 ± 6.6 range 26-47) exercise 17 women (mean age: 30 ± 8.6 range 26-47) control group.,C0679646|C0332529|C0450371|C0043210|C0444504|C0001779|C0450371|G0000000|G0000000|C1514721|C0450371|C0015259|C0450371|C0043210|C0444504|C0001779|C0450371|G0000000|G0000000|C1514721|C0450371|C0243148|C0441833
"By focusing on GOLD Stage II COPD patients who had not yet been treated with maintenance pharmacotherapy, we expect to recruit a relatively large proportion of patients with an FEV1 >60% predicted normal who were more recently diagnosed/symptomatic, current smokers, younger and consequently still employed [28, 45] (thereby enabling exploration of a work productivity outcome) [19], and a higher proportion of female patients, reflecting demographic changes reported in COPD [46, 47].","By focusing GOLD Stage II COPD patients treated maintenance pharmacotherapy, expect recruit proportion patients FEV1 >60% predicted normal diagnosed/symptomatic, current smokers, employed [28, 45] (thereby enabling exploration productivity outcome) [19], proportion female patients, reflecting demographic reported COPD [46, 47].",G0000000|C0000936|C0018026|C0205390|G0000000|C0024117|C0030705|C1522326|C0024501|C0013216|G0000000|G0000000|C1709707|C0030705|G0000000|C0450371|C0681842|C0205307|C0011900|C0521116|C0337664|C0014003|C0450371|C0450371|G0000000|C1171285|C1280903|C0033269|C1274040|C0450371|C1709707|C0015780|C0030705|C0558058|C0011298|C0684224|C0024117|C0450371|C0450371
"The intent-to-treat sample included 40 children with ASD and an anxiety disorder living in a major metropolitan area of the western United States, ranging in age from 7–11 years (M = 9.20, SD = 1.49), and their primary parents (defined as parents who were primarily responsible for overseeing the child's daily activities).","The intent-to-treat sample included 40 children ASD anxiety disorder living major metropolitan western United States, ranging age 7–11 (M = 9.20, SD = 1.49), primary parents (defined parents responsible overseeing child's daily activities).",G0000000|C0162425|C0370003|C0332257|C0450371|C0008059|C0003516|C0003467|C0012634|C0376558|C0205082|C0599587|C1705493|C0166872|C1301808|C1514721|C0001779|G0000000|C0369637|G0000000|C0450371|C2699239|G0000000|C0450371|C0205225|C0030551|C1704788|C0030551|C1273518|G0000000|C0008059|C0332173|C0441655
"Those in the control group (unvaccinated) were defined as pregnant women who resided in the same or adjacent village/community, had an age difference of ≤3 years compared to the women in the vaccinated group, had a gestational age of <3 weeks, and had the same numbers of pregnancies as those in the vaccinated group.","Those control (unvaccinated) defined pregnant women resided adjacent village/community, age difference ≤3 compared women vaccinated group, gestational age <3 weeks, pregnancies vaccinated group.",G0000000|C0243148|G0000000|C1704788|C0549206|C0043210|C2982691|C0205117|C0562518|C0001779|C1705241|G0000000|C1707455|C0043210|C1116171|C0441833|C0439671|C0001779|G0000000|C0439230|C0032961|C1116171|C0441833
The protocol did not specify the nature of the support offered as this was a trial designed to test NHS practice and protocols and hence fidelity checks were left to the NHS stop smoking services.,The protocol nature support offered trial designed test NHS practice protocols fidelity checks left NHS smoking services.,G0000000|C0442711|C0349590|C0183683|C1444648|C0008976|C1707689|C0022885|C0796085|C0237607|C0442711|C0680011|C1283174|C0205091|C0796085|C0037369|C0557854
"We excluded anyone with comorbid sleep disorders (significant insomnia, uncontrolled restless legs syndrome, chronic insufficient sleep intake, or pathological excessive daytime sleepiness, i.e., Epworth Sleepiness Score >11), significant medical comorbidities including decompensated cardiopulmonary disease and chronic rhinitis, self-reported average of 3 or more alcoholic drinks per day, or significant daily opioid use.","We excluded comorbid sleep disorders (significant insomnia, uncontrolled restless legs syndrome, chronic insufficient sleep intake, pathological excessive daytime sleepiness, i.e., Epworth Sleepiness Score >11), medical comorbidities including decompensated cardiopulmonary disease chronic rhinitis, self-reported average 3 alcoholic drinks day, daily opioid use.",G0000000|C1554077|C0009488|C0037313|C0012634|C0237881|C0917801|C0205318|C0085631|C1140621|C0039082|C0205191|C0205412|C0037313|C1512806|C0030664|C0442802|C0332169|C0013144|C0683454|G0000000|C0013144|C0449820|C0450371|C0199168|C0009488|C0332257|C0205434|C0553534|C0012634|C0205191|C0035455|C0681906|C1510992|G0000000|C0687725|C0452428|C0332173|C0332173|C0242402|C0042153
Text messaging programs on mobile phones have shown some promise in helping people quit smoking.,Text messaging programs mobile phones promise helping people quit smoking.,C1527021|C0470166|C0376691|C0231435|C1515258|C1555307|G0000000|C0027361|C0748223|C0037369
"Patients were excluded if they met any of the following criteria: 1) severe cognitive dysfunction or aphasia, 2) contraindications for tDCS, such as history of previous seizure, major head trauma, previous brain operation, a metal implant in the brain, or a pacemaker, or 3) systemic disease or ongoing neoplasia.","Patients excluded met criteria: 1) severe cognitive dysfunction aphasia, 2) contraindications tDCS, history previous seizure, major head trauma, previous brain operation, metal implant brain, pacemaker, 3) systemic disease ongoing neoplasia.",C0030705|C1554077|C0268621|C0243161|G0000000|C0205082|C1516691|C0031847|C0003537|G0000000|C0079164|C3850024|C0019664|C0205156|C0036572|C0205082|C0018670|C0043251|C0205156|C0006104|C0543467|C0025552|C0021102|C0006104|C0030163|G0000000|C0205373|C0012634|C0549178|C0027651
"Most patients (213/268, 80%) were malnourished, with almost one in three in WHO’s severely malnourished range (body mass index (BMI) <16.0).17 A relatively small proportion (79/270, 29%) of patients had positive results on sputum smear tests; this was similar in both groups and consistent with previous studies in Timor-Leste.14  Baseline characteristics of study participants.","Most patients (213/268, 80%) malnourished, WHO’s severely malnourished range (body mass (BMI) <16.0).17 A proportion (79/270, 29%) patients positive sputum smear tests; consistent previous studies Timor-Leste.14  Baseline characteristics study participants.",C0205393|C0030705|C1442061|C0450371|C0162429|G0000000|C0205082|C0162429|C1514721|C0242821|C0577559|G0000000|C0450371|G0000000|C1709707|C0450371|C0450371|C0030705|C0439178|C0038056|C0444186|C0022885|C0332290|C0205156|C0947630|C1452561|G0000000|C1521970|C0557651|C0679646
"They were eligible for inclusion in the study if the differential diagnosis included an exacerbation of COPD, but were excluded if other medical conditions or acidotic respiratory failure required inpatient investigation or management.","They eligible inclusion study differential diagnosis included exacerbation COPD, excluded medical conditions acidotic respiratory failure required inpatient investigation management.",G0000000|C1548635|C0007637|C0557651|C0443199|C0011900|C0332257|G0000000|C0024117|C1554077|C0199168|C0012634|C0001122|C0521346|C0231174|C1514873|C0021562|C0220825|C0001554
"When possible, the trial was discussed with parents antenatally, and written informed consent was sought within 24 h of birth.","When possible, trial discussed parents antenatally, written informed consent sought 24 birth.",G0000000|C0332149|C0008976|C2584313|C0030551|G0000000|C0043266|C1522154|C1511481|G0000000|C0450371|C0005615
"Children who had mucous bloody stools, major systemic illness, severe malnutrition (weight for age <60% and/or weight for height <70%), severe dehydration requiring intravenous infusion, severe vomiting, or history of antibiotic therapy were not included.","Children mucous bloody stools, major systemic illness, severe malnutrition (weight age <60% and/or weight height <70%), severe dehydration requiring intravenous infusion, severe vomiting, history antibiotic therapy included.",C0008059|C0026727|C0333275|C0015733|C0205082|C0205373|C0221423|C0205082|C0162429|C0005910|C0001779|C0450371|G0000000|C0005910|C0489786|C0450371|C0205082|C0011175|G0000000|C0348016|C0574032|C0205082|C0042963|C0019664|C0003232|C0039798|C0332257
Foster families with a foster child of 1 to 6 years of age were eligible for participation.,Foster families foster child 1 6 age eligible participation.,C0242298|C0015576|C0242298|C0008059|G0000000|G0000000|C0001779|C1548635|C0679823
DIT was measured for 90 minutes.,DIT measured 90 minutes.,G0000000|C0444706|C0450371|C0439232
"The exclusion criteria included dissatisfaction to continue her cooperation with the study, absence in the class, incidence of stressful events during the study for the study subjects, abnormalities and fetal and neonatal death.","The exclusion criteria included dissatisfaction continue cooperation study, absence class, incidence stressful events study study subjects, abnormalities fetal neonatal death.",G0000000|C0680251|C0243161|C0332257|C0870433|C0549178|C0392337|C0557651|C0332197|C0456387|C0021149|C0231297|C0441471|C0557651|C0557651|C0681850|C0000768|C0015965|C1552240|C0011065
"Inclusion criteria for survey enrolment were child’s age above 6 months and below 18 months, half of whom were 6–11·9 months of age and the other half were 12–18 months of age.","Inclusion criteria survey enrolment child’s age 6 months 18 months, half 6–11·9 months age half 12–18 months age.",C0007637|C0243161|C0038951|C1516879|G0000000|C0001779|G0000000|C0439231|C0450371|C0439231|C2825407|G0000000|C0439231|C0001779|C2825407|G0000000|C0439231|C0001779
"All students enrolled in regular public school in the fifth and sixth grades in school year 2006–2007, and in the sixth and seventh grades in school year 2007–2008, were asked to be included in the survey.","All students enrolled regular public school sixth grades school 2006–2007, sixth seventh grades school 2007–2008, included survey.",G0000000|C0038492|G0000000|C0205272|G0000000|C0036375|C0205440|C0441800|C0036375|G0000000|C0205440|C0205441|C0441800|C0036375|G0000000|C0332257|C0038951
A total of 32 patients with a mean (± SD) age of 18.5±8.6 years were included in the study.,A total 32 patients (± SD) age 18.5±8.6 included study.,G0000000|C0439175|C0450371|C0030705|G0000000|C2699239|C0001779|G0000000|C0332257|C0557651
"Children were similar in the three groups regarding sex, age, and weight with mean age (4.60 ± 1.99) and weight (15.62 ± 4.21).","Children sex, age, weight age (4.60 ± 1.99) weight (15.62 ± 4.21).",C0008059|C0009253|C0001779|C0005910|C0001779|C0450371|G0000000|C0450371|C0005910|C0450371|G0000000|C0450371
A total of 368 primary school children and their families were enrolled at baseline.,A total 368 primary school children families enrolled baseline.,G0000000|C0439175|C1442061|C0205225|C0036375|C0008059|C0015576|G0000000|C0168634
"This double-blind, randomized, clinical trial study was conducted on 75 single female students between 18 and 28 years old educating in Nursing and Midwifery School and Paramedical Faculty of Qom University of Medical Sciences of Iran in 2011.","This double-blind, randomized, clinical trial study conducted 75 single female students 18 28 educating Nursing Midwifery School Paramedical Faculty Qom University Medical Sciences Iran 2011.",G0000000|C0013072|C0034656|C0205210|C0008976|C0557651|C0004927|C0450371|C0037179|C0015780|C0038492|C0450371|C0450371|C0039401|C0006147|C0026082|C0036375|G0000000|C0015535|G0000000|C0041740|C0199168|C0036397|C0022065|G0000000
"Prediagnostic toenail selenium level and baseline characteristics of nested bladder cancer cases and matched controls from the NHS and HPFS cohort studies In a conditional regression model, higher toenail selenium concentrations were associated with significantly lower risk of bladder cancer in women (P for trend=0.02), but not in men (Table 2).","Prediagnostic toenail selenium level baseline characteristics nested bladder cancer matched controls NHS HPFS cohort studies In conditional regression model, toenail selenium concentrations lower risk bladder cancer women (P trend=0.02), (Table 2).",G0000000|C0222007|C0036581|C0441889|C0168634|C1521970|G0000000|C0005682|C0006826|C0150103|C0243148|C0796085|C0439530|C0599755|C0947630|G0000000|C1701901|C0684320|C3161035|C0222007|C0036581|C0086045|C0441994|C0035647|C0005682|C0006826|C0043210|C0369773|C1521798|C0039224|G0000000
"Women were excluded if they had evidence of recurrent disease or had other musculoskeletal involvement such as low back pain, disc problems, osteoarthritis, rheumatoid arthritis, or shoulder problems.","Women excluded evidence recurrent disease musculoskeletal involvement low pain, disc problems, osteoarthritis, rheumatoid arthritis, shoulder problems.",C0043210|C1554077|C3887511|C2945760|C0012634|C0497254|C1314939|C0205251|C0030193|C0180459|C1546466|C0029408|G0000000|C0003864|C0037004|C1546466
"Women were eligible for WACS if they were 40 years or older, postmenopausal or had no intention of becoming pregnant, and had a reported history of CVD or had at least three cardiac risk factors.","Women eligible WACS 40 older, postmenopausal intention pregnant, reported history CVD cardiac risk factors.",C0043210|C1548635|C1424905|C0450371|C0580836|C0232970|C0162425|C0549206|C0684224|C0019664|C0007222|C0018787|C0035647|C1521761
"The majority reported belonging to a racial/ethnic minority group, having low income (≤$20 000/y), and low educational attainment (high school graduate or less).","The majority reported belonging racial/ethnic minority group, low income (≤$20 000/y), low educational attainment (high school graduate less).",G0000000|C0680220|C0684224|G0000000|C0034510|C0026192|C0441833|C0205251|C0021162|G0000000|C0205251|C0587721|G0000000|C0205250|C0036375|C0588053|C0439092
Subjects who meet any of the following criteria will be excluded: 1) prior history of hypersensitivity reaction to niacin or any other component of the study drug; 2) prior history of flushing; 3) liver disease (including co-infection with hepatitis B or C virus) or unexplained persistent elevations of serum transaminases; 4) alanine aminotransferase (ALT) or aspartate aminotransferase (AST) or alkaline phosphatase >2.5 times the upper limit of normal (ULN); 5) active duodenal or gastric peptic ulcer; 6) active bleeding disorders; 7) history of gout; 8) active AIDS events in the last three months as determined by the treating physician; 9) unstable angina or acute phase myocardial infarction; 10) diabetic or potentially diabetic with hypercholesterolemia; 11) renal dysfunction; 12) co-enrollment in another study involving neurocognitive evaluation; or 13) pregnant or nursing or planning to become pregnant.,Subjects meet criteria excluded: 1) prior history hypersensitivity reaction niacin component study drug; 2) prior history flushing; 3) liver disease (including co-infection hepatitis B C virus) unexplained persistent elevations serum transaminases; 4) alanine aminotransferase (ALT) aspartate aminotransferase (AST) alkaline phosphatase >2.5 times upper limit normal (ULN); 5) active duodenal gastric peptic ulcer; 6) active bleeding disorders; 7) history gout; 8) active AIDS events months determined treating physician; 9) unstable angina acute phase myocardial infarction; 10) diabetic diabetic hypercholesterolemia; 11) renal dysfunction; 12) co-enrollment study involving neurocognitive evaluation; 13) pregnant nursing planning pregnant.,C0681850|C1550543|C0243161|C1554077|G0000000|C0332152|C0019664|C0020517|C0443286|C0027996|C0449432|C0557651|C0013227|G0000000|C0332152|C0019664|C0016382|G0000000|C0023884|C0012634|C0332257|C0275524|C0019158|G0000000|G0000000|C0042776|G0000000|C0205322|C0702240|C0229671|C0002594|G0000000|C0001898|C0002594|C1266129|C0085845|C0002594|C3891303|C1979842|C0031678|G0000000|C0040223|C1282910|C0439801|C0205307|C1519815|G0000000|C0205177|C0013303|C0038351|C0443277|C0041582|G0000000|C0205177|C0019080|C0012634|G0000000|C0019664|C0018099|G0000000|C0205177|C0001175|C0441471|C0439231|G0000000|C1522326|C0031831|G0000000|C0443343|C0002962|C0205178|C0205390|C0027061|C0021308|C0450371|C0241863|C0241863|C0020443|C0450371|C0022646|C0031847|C0450371|C3245499|C0557651|C1314939|C0518895|C0220825|C0450371|C0549206|C0006147|C0032074|C0549206
"Patients receiving adjuvant chemotherapy for breast or colon cancer (n = 360) are being recruited from twelve hospitals in the Netherlands, and randomly allocated to one of the two treatment groups or to a 'usual care' control group.","Patients receiving adjuvant chemotherapy breast colon cancer (n = 360) recruited twelve hospitals Netherlands, randomly allocated treatment 'usual care' control group.",C0030705|C1514756|C0001551|C0013216|C0006141|C0009368|C0006826|C0369718|G0000000|C1442061|G0000000|C0205458|C0019994|C0027778|G0000000|G0000000|C0039798|C3538928|C1947933|C0243148|C0441833
"To detect a true difference in the change in 6MWD in subjects with IPF, a total of 72 subjects, 36 in each group, is required.","To detect true difference change 6MWD subjects IPF, total 72 subjects, 36 group, required.",C0040363|C0442726|C0205238|C1705241|C0392747|G0000000|C0681850|C0034069|C0439175|C0450371|C0681850|C0450371|C0441833|C1514873
Details of the population have been previously published.17 18 From a regularly updated demographic database we invited all permanently resident families with children aged 1-3 years to participate in the study and sought their consent.,Details population published.17 18 From regularly updated demographic database invited permanently resident families children aged 1-3 participate study sought consent.,C1522508|C0032659|C0034037|C0450371|G0000000|G0000000|C1519814|C0011298|C0242356|G0000000|G0000000|C1320928|C0015576|C0008059|C0001779|G0000000|G0000000|C0557651|G0000000|C1511481
Seattle participants were also recruited through local area clinics and community-posted flyers.,Seattle participants recruited local clinics community-posted flyers.,G0000000|C0679646|G0000000|C0205276|C0442592|C0009462|C0683877
They were identified by daily searching of medical records in haematology wards at two teaching hospitals of Zhejiang University in 2005–2006; all medical records and laboratory reports were also reviewed to ensure complete ascertainment of cases.,They identified daily searching medical records haematology wards teaching hospitals Zhejiang University 2005–2006; medical records laboratory reports reviewed ensure complete ascertainment cases.,G0000000|C0205396|C0332173|C1552603|C0199168|C0034869|C0018943|C1305702|C0039401|C0019994|G0000000|C0041740|G0000000|C0199168|C0034869|C0022877|C0684224|C0282443|C0218063|C0205197|G0000000|C0868928
"Children who have been using Sprinkles, CSB++ or similar supplementary foods or supplements will be excluded, in order to ensure that the interventions are equally unfamiliar and that children will not be likely to reject or accept based on their unfamiliarity/familiarity with a given food.","Children Sprinkles, CSB++ or similar supplementary foods supplements excluded, ensure interventions equally unfamiliar children reject accept based unfamiliarity/familiarity food.",C0008059|C1720266|C1707866|G0000000|G0000000|C0016452|C0242295|C1554077|C0218063|C0886296|G0000000|G0000000|C0008059|C1548437|C1272684|C1527178|C0600269|C0016452
Patients aged between 14 years and 60 years[34] with skin types II-V reference for Fitzpatrick is essential who had bilateral facial involvement with SD entered the study.,Patients aged 14 60 years[34] skin types II-V reference Fitzpatrick essential bilateral facial involvement SD entered study.,C0030705|C0001779|C0450371|C0450371|C0439234|C0444099|C0332307|G0000000|C1514811|G0000000|C0205224|C0238767|C0015450|C1314939|C2699239|C1521975|C0557651
We included 14 adults with a supratentorial tumor suspect for glioblastoma and an indication for gross total resection in this randomized controlled trial of which the interim analysis is presented here.,We included 14 adults supratentorial tumor suspect glioblastoma indication gross total resection randomized controlled trial interim analysis here.,G0000000|C0332257|C0450371|C0001675|C0441938|C0027651|C0750491|C0017636|C0392360|C0439806|C0439175|C0015252|C0034656|C2587213|C0008976|C2827738|C0002778|G0000000
"Exclusion criteria were chronic diarrhoea, current use or need for prophylaxis with isoniazid, previous hypersensitivity reaction to isoniazid or to sulphur drugs, severe anaemia (haemoglobin <70 g/l), neutropenia (absolute neutrophil count <400 cells/µl), thrombocytopenia (platelet count <50 000×109/l), or non-reversible renal failure.","Exclusion criteria chronic diarrhoea, current prophylaxis isoniazid, previous hypersensitivity reaction isoniazid sulphur drugs, severe anaemia (haemoglobin <70 g/l), neutropenia (absolute neutrophil count <400 cells/µl), thrombocytopenia (platelet count <50 000×109/l), non-reversible renal failure.",C0680251|C0243161|C0205191|C0011991|C0521116|C0033107|C0022209|C0205156|C0020517|C0443286|C0022209|C0038774|C0013227|C0205082|C0002871|C0019046|C0450371|C0439294|C0023530|C0205344|C0027950|C0750480|C1442061|G0000000|C0040034|C0005821|C0750480|G0000000|C1518422|C0022646|C0231174
"Relative risks (95% confidence intervals) of bladder cancer associated with prediagnostic toenail selenium concentrations in a nested case–control study of the NHS and HPFS cohorts Median selenium concentrations varied by smoking status (HPFS (μg g−1): never 0.825, past 0.814, current 0.739; NHS (μg g−1): never 0.777, past 0.785, current 0.716).","Relative risks (95% confidence intervals) bladder cancer prediagnostic toenail selenium concentrations nested case–control study NHS HPFS cohorts Median selenium concentrations varied smoking status (HPFS (μg g−1): 0.825, 0.814, current 0.739; NHS (μg g−1): 0.777, 0.785, current 0.716).",C0080103|C0035647|C0450371|C0237529|C1272706|C0005682|C0006826|G0000000|C0222007|C0036581|C0086045|G0000000|G0000000|C0557651|C0796085|C0439530|C0599755|C0549183|C0036581|C0086045|G0000000|C0037369|C0449438|C0439530|G0000000|C1442061|C1442061|C0521116|C1442061|C0796085|G0000000|C1442061|C1442061|C0521116|C1442061
Key exclusion criteria were: creatinine clearance (CrCl) below contraindication limit as per local label (<60 mL/min or <40 mL/min); serum creatinine (SCr) >1.5 × upper limit of normal (ULN); alanine aminotransferase (ALT) >5 × ULN (unless liver iron concentration confirmed as >10 mg Fe/g dry weight ≤6 months prior to screening); urine protein/creatinine ratio (UPCR) >0.5 mg/mg; or impaired GI function.,Key exclusion criteria were: creatinine clearance (CrCl) contraindication limit local label (<60 mL/min <40 mL/min); serum creatinine (SCr) >1.5 × upper limit normal (ULN); alanine aminotransferase (ALT) >5 × ULN (unless liver iron concentration confirmed >10 Fe/g dry weight ≤6 months prior screening); urine protein/creatinine ratio (UPCR) >0.5 mg/mg; impaired GI function.,G0000000|C0680251|C0243161|G0000000|C0010294|C0449297|C1846718|C0522473|C0439801|C0205276|C0181496|C0450371|C0439445|C0450371|C0439445|C0229671|C0010294|C1539487|G0000000|G0000000|C1282910|C0439801|C0205307|C1519815|C0001898|C0002594|C1266129|G0000000|G0000000|C1519815|G0000000|C0023884|C0302583|C0004268|C0521093|C0450371|C2346593|C0011682|C0005910|G0000000|C0439231|C0332152|C0220908|C0042036|C0369901|C0456603|G0000000|G0000000|C1319635|C0221099|C1708130|C0031843
There were three testable hypotheses:  Viewers' (intervention group) knowledge about memory loss associated with Alzheimer's disease will be significantly greater than that of non-viewers (control group) (primary outcome).,There testable hypotheses: Viewers' (intervention group) knowledge memory loss Alzheimer's disease non-viewers (control group) (primary outcome).,G0000000|G0000000|C1512571|C1710633|C0886296|C0441833|C0376554|C0025260|C1517945|G0000000|C0012634|C1518422|C0243148|C0441833|C0205225|C1274040
"Eligibility criteria included: stage 0–III BC, on AI for at least 4 weeks, ≥3 on a 5‐point scale inquiring about joint symptom intensity “at its worst,” and exercising ≤150 minutes per week.","Eligibility criteria included: stage 0–III BC, AI 4 weeks, ≥3 5‐point scale inquiring joint symptom intensity “at worst,” exercising ≤150 minutes week.",C0013893|C0243161|C0332257|C0205390|G0000000|C0006041|C0003353|G0000000|C0439230|G0000000|G0000000|C0175659|G0000000|C0022417|C1457887|C0522510|G0000000|G0000000|C0015259|G0000000|C0439232|C0332174
"More recently, data have identified that positional OSA, where sleep-disordered breathing events occur predominantly in the supine position, is quite prevalent in patients with mild and moderate OSA.14 Using the definitions for OSA severity from the American Academy of Sleep Medicine (AASM),15 Mador et al.14 found that 50% of patients with mild OSA (apnea-hypopnea index [AHI] of 5-15 events/h) and 19% of patients with moderate OSA (AHI of 15-30 events/h) both normalized their AHI to less than 5 events per hour and reduced their AHI by more than 50% when in the nonsupine position.","More recently, data identified positional OSA, sleep-disordered breathing events occur supine position, prevalent patients mild moderate OSA.14 Using definitions OSA severity American Academy Sleep Medicine (AASM),15 Mador al.14 50% patients mild OSA (apnea-hypopnea [AHI] 5-15 events/h) 19% patients moderate OSA (AHI 15-30 events/h) normalized AHI 5 events hour reduced AHI 50% nonsupine position.",C0205172|C0332185|C1511726|C0205396|C0240795|C0520679|C0037317|C0004048|C0441471|C1709305|C0038846|C0733755|C0033105|C0030705|C2945599|C0205081|C0520679|C1524063|C1550452|C0520679|C0439793|C0596070|C0000876|C0037313|C0013227|C0450371|G0000000|C0202311|C0450371|C0030705|C2945599|C0520679|C0003578|G0000000|C0450371|C0441471|C0450371|C0030705|C0205081|C0520679|G0000000|C0450371|C0441471|C1882115|G0000000|G0000000|C0441471|C0439227|C0392756|G0000000|C0450371|G0000000|C0733755
Our study comprised patients who had experienced a first-ever unilateral middle cerebral artery infarction.,Our study comprised patients experienced first-ever unilateral middle cerebral artery infarction.,G0000000|C0557651|C2700400|C0030705|C0237607|C0205435|C0205092|C0444598|G0000000|C0003842|C0021308
Patients needed to fulfil the following inclusion criteria: (i) 10–18 yr of age; (ii) good general health; (iii) no use of medication; and (iv) no demineralizations in need of restoration present at a buccal surface.,Patients fulfil inclusion criteria: (i) 10–18 yr age; (ii) health; (iii) medication; (iv) demineralizations restoration buccal surface.,C0030705|C1550543|C0007637|C0243161|C0021966|G0000000|C0439234|C0001779|G0000000|C0018684|C0439070|C0013227|C0022326|C0700185|C0449982|C0442010|C0205148
To determine the long-term efficacy of anterior temporal lobectomy for medically refractory temporal lobe epilepsy in patients with nonlesional magnetic resonance imaging (MRI).,To determine long-term efficacy anterior temporal lobectomy medically refractory temporal lobe epilepsy patients nonlesional magnetic resonance imaging (MRI).,C0040363|G0000000|C0443252|C1280519|C0205094|C0442043|C0023928|G0000000|C0205269|C0442043|C0796494|C0014544|C0030705|G0000000|C0024488|C0231881|C0011923|C0024485
"Patients with known allergy to the study drugs, suspected coagulopathy, infection at the site of caudal block, history of developmental delay, neurological diseases and skeletal deformities were excluded.","Patients allergy study drugs, suspected coagulopathy, infection site caudal block, history developmental delay, neurological diseases skeletal deformities excluded.",C0030705|C0002111|C0557651|C0013227|C0332147|C0005779|C0009450|C0205145|C0205097|C0028778|C0019664|C0458003|C0205421|C0205494|C0012634|C0037253|C0000768|C1554077
"The 2-year survival rates were 14% (95% CI, 8–20%) for the ECF arm, and 5% (95% CI, 2–10%) for the FAMTX arm (P = 0.03).","The 2-year survival rates 14% (95% CI, 8–20%) ECF arm, 5% (95% CI, 2–10%) FAMTX arm (P = 0.03).",G0000000|C0439234|C0038952|C0871208|C0450371|C0450371|C0008107|G0000000|G0000000|C0446516|G0000000|C0450371|C0008107|G0000000|C0051571|C0446516|C0369773|G0000000|C0450371
"The majority of smokers relapse early in their quit attempts [4], but even those who achieve abstinence face a meaningful risk of relapse for many months (e.g., [5]).","The majority smokers relapse quit attempts [4], achieve abstinence meaningful risk relapse months (e.g., [5]).",G0000000|C0680220|C0337664|C0035020|C0748223|C1516084|G0000000|G0000000|C3843422|C0876919|C0035647|C0035020|C0439231|G0000000|G0000000
Subgroup analysis of improvement in trough FEV1 at week 26 by COPD severity (GOLD FEV1 categories) confirmed a significantly greater improvement with QVA149 versus placebo and monobronchodilators in patients with both moderate (LSM treatment differences versus placebo 0.24 L; indacaterol 0.06 L; glycopyrronium 0.09 L; and tiotropium 0.07 L; all p<0.001) and severe (LSM treatment differences versus placebo 0.12 L; indacaterol 0.08 L; glycopyrronium 0.08 L; and tiotropium 0.08 L; all p<0.001) COPD (online supplementary fig.,Subgroup analysis improvement trough FEV1 week 26 COPD severity (GOLD FEV1 categories) confirmed improvement QVA149 versus placebo monobronchodilators patients moderate (LSM treatment differences versus placebo 0.24 L; indacaterol 0.06 L; glycopyrronium 0.09 L; tiotropium 0.07 L; p<0.001) severe (LSM treatment differences versus placebo 0.12 L; indacaterol 0.08 L; glycopyrronium 0.08 L; tiotropium 0.08 L; p<0.001) COPD (online supplementary fig.,C1079230|C0002778|C2986411|C0444506|G0000000|C0332174|C0450371|C0024117|C0439793|C0018026|G0000000|C0683312|C0521093|C2986411|G0000000|G0000000|C0032042|G0000000|C0030705|C0205081|G0000000|C0039798|C1705241|G0000000|C0032042|C0450371|C0439394|C1722260|C0450371|C0439394|C0017970|C0450371|C0439394|C0213771|C0450371|C0439394|C0369773|C0205082|G0000000|C0039798|C1705241|G0000000|C0032042|C0450371|C0439394|C1722260|C0450371|C0439394|C0017970|C0450371|C0439394|C0213771|C0450371|C0439394|C0369773|C0024117|G0000000|G0000000|C0349966
Objectives: To perform a randomized placebo-controlled study assessing the efficacy and safety of inhaled colistin in patients with bronchiectasis and chronic P. aeruginosa infection.,Objectives: To perform randomized placebo-controlled study assessing efficacy safety inhaled colistin patients bronchiectasis chronic P. aeruginosa infection.,C0018017|C0040363|C0884358|C0034656|C1706408|C0557651|C1516048|C1280519|C0036043|C0004048|C0009316|C0030705|C0006267|C0205191|C0369773|G0000000|C0009450
"After unilateral brainstem stroke, the synchronization of hemi-CPGs as well as ipsilateral oropharyngeal swallowing muscle can be impaired.","After unilateral brainstem stroke, synchronization hemi-CPGs ipsilateral oropharyngeal swallowing muscle impaired.",G0000000|C0205092|C0006121|C0038454|C0439580|C1285521|C0441989|C0521367|C0011167|C0026845|C0221099
"Inclusion criteria included all children aged 0–16 sequentially attending our treatment centre, at the University Hospitals of Coventry and Warwickshire, who had sustained a minimally angulated greenstick or torus fracture of the distal third of the radius, as confirmed by either X-ray or ultrasound.","Inclusion criteria included children aged 0–16 sequentially attending treatment centre, University Hospitals Coventry Warwickshire, sustained minimally angulated greenstick torus fracture distal radius, confirmed X-ray ultrasound.",C0007637|C0243161|C0332257|C0008059|C0001779|G0000000|G0000000|C1547429|C0039798|C0205099|C0041740|C0019994|G0000000|C0454881|C0443318|G0000000|C0333179|C0332716|C0332567|C0016658|C0205108|C0034627|C0521093|C0034571|C0041618
Participants were 251 English-speaking pregnant women who quit smoking during pregnancy or within 2 months prior to pregnancy.,Participants 251 English-speaking pregnant women quit smoking pregnancy 2 months prior pregnancy.,C0679646|C1442061|C0376245|C0549206|C0043210|C0748223|C0037369|C0032961|G0000000|C0439231|C0332152|C0032961
Our objective was to determine whether oral etoposide and cisplatin combination (EoP) is superior to paclitaxel in the treatment of advanced breast cancer (ABC) patients pretreated with anthracyclines.,Our objective determine oral etoposide cisplatin combination (EoP) superior paclitaxel treatment advanced breast cancer (ABC) patients pretreated anthracyclines.,G0000000|C0018017|G0000000|C0442027|C0015133|C0008838|C0205195|C0280124|C1282910|C0144576|C0039798|C0205179|C0006141|C0006826|C0152244|C0030705|G0000000|C0003234
"• naïve regarding rTMS • Objective Tinnitus • Other forms of tinnitus treatments at the same time • Clinically relevant psychiatric co-morbidity as judged by an experienced psychiatrist, especially diagnose groups F1-3 according to the International Classification of diseases (ICD-10) • Concomitant treatment with psychotropic drugs • History or evidence of significant brain malformation or neoplasm, head injury, cerebral vascular events, neurodegenerative disorder affecting the brain or prior brain surgery • Severe unstable somatic co-morbidity • Cardiac pace makers, other electronic implants, intracranial metallic particles • History of seizures or epileptic activity • Pregnancy and lactation • Women in child-bearing-age without contraception • Patients who cannot communicate reliably with the investigator or who are not likely to cope with the requirements of the trial • Participation in a clinical trial within the last 30 days before start of this clinical trial This study will be conducted by otorhinolaryngologists and psychiatrists with wide experience in the treatment of patients with chronic tinnitus from seven university hospitals and one municipal hospital all over Germany.","• naïve rTMS • Objective Tinnitus • Other forms tinnitus treatments time • Clinically relevant psychiatric co-morbidity judged experienced psychiatrist, diagnose F1-3 International Classification diseases (ICD-10) • Concomitant treatment psychotropic drugs • History evidence brain malformation neoplasm, head injury, cerebral vascular events, neurodegenerative disorder brain prior brain surgery • Severe unstable somatic co-morbidity • Cardiac pace makers, electronic implants, intracranial metallic particles • History seizures epileptic activity • Pregnancy lactation • Women child-bearing-age contraception • Patients communicate reliably investigator cope requirements trial • Participation clinical trial 30 days start clinical trial This study conducted otorhinolaryngologists psychiatrists wide experience treatment patients chronic tinnitus university hospitals municipal hospital Germany.",G0000000|G0000000|G0000000|G0000000|C0018017|C0040264|G0000000|G0000000|C0348078|C0040264|C0087111|C0040223|G0000000|G0000000|C2347946|C0205487|C0009488|C0221191|C0237607|C0033872|C0011900|G0000000|C1512888|C0008902|C0012634|C0021122|G0000000|C0521115|C0039798|C0033978|C0013227|G0000000|C0019664|C3887511|C0006104|C0000768|C0027651|C0018670|C3263722|G0000000|C0005847|C0441471|G0000000|C0012634|C0006104|C0332152|C0006104|C0038894|G0000000|C0205082|C0443343|C1257909|C0009488|G0000000|C0018787|C0287990|C0554244|C0013850|C0021102|C0524466|C2986473|C0597177|G0000000|C0019664|C0036572|C0014544|C0205177|G0000000|C0032961|C0006147|G0000000|C0043210|C0008059|C0700589|G0000000|C0030705|C0566001|G0000000|C0035173|C0009967|C1514873|C0008976|G0000000|C0679823|C0205210|C0008976|C0450371|C0439228|C0439659|C0205210|C0008976|G0000000|C0557651|C0004927|C0334893|C0033872|C0332464|C0237607|C0039798|C0030705|C0205191|C0040264|C0041740|C0019994|G0000000|C0019994|C0017480
The study population is made up of smokers ≥18 years that attend a primary care consultation for any medical problem.,The study population smokers ≥18 years attend primary care consultation medical problem.,G0000000|C0557651|C0032659|C0337664|G0000000|C1999232|C0205225|C1947933|C0009818|C0199168|C0033213
"Within the HEALS cohort, we observed a significant inverse association between blood selenium and arsenical skin lesion incidence [32]; an inverse association between dietary intake of vitamin E and risk of arsenical skin lesions [33]; a positive association of arsenic exposure with peripheral blood leukocyte DNA methylation [34] and an inverse association with plasma selenium concentrations [35].","Within HEALS cohort, observed inverse association blood selenium arsenical skin lesion incidence [32]; inverse association dietary intake vitamin E risk arsenical skin lesions [33]; positive association arsenic exposure peripheral blood leukocyte DNA methylation [34] inverse association plasma selenium concentrations [35].",G0000000|C0043240|C0599755|C1441672|C0439850|C0004083|C0005767|C0036581|C0003819|C0444099|C0221198|C0021149|C0450371|C0439850|C0004083|C0012155|C1512806|C0042890|G0000000|C0035647|C0003819|C0444099|C0221198|C0450371|C0439178|C0004083|C0003818|C0274281|C0205100|C0005767|C0023516|C0012854|C0025723|C0450371|C0439850|C0004083|C0032105|C0036581|C0086045|C0450371
"A total of 41 patients who had recently had their first ischemic cerebrovascular accident (CVA) (24 men and 17 women) were recruited from K, H, and O rehabilitation centers in Korea.","A total 41 patients ischemic cerebrovascular accident (CVA) (24 17 women) recruited K, H, O rehabilitation centers Korea.",G0000000|C0439175|C0450371|C0030705|C0475224|C1880018|C0000924|C0038454|C0450371|C0450371|C0043210|G0000000|C0597277|C0033727|C0483204|C0034991|C0205099|C0022771
Templates are available but not required for admissions to other services.,Templates required admissions services.,C0728990|C1514873|C0184666|C0557854
"Patients were eligible for inclusion if they had a history of migraine of at least 1 year duration, an age at onset of migraine < 50 years and had experienced from one to six attacks per month during the month of screening.","Patients eligible inclusion history migraine 1 duration, age onset migraine < 50 experienced attacks month month screening.",C0030705|C1548635|C0007637|C0019664|C0149931|G0000000|C0449238|C0001779|C0206132|C0149931|G0000000|C0450371|C0237607|C1261512|C0332177|C0332177|C0220908
Exclusion criteria were: (i) having fever or any illnesses on the day of enrolment; (ii) baseline level of haemoglobin less than 70 g/L; and (iii) currently receiving iron supplementation.,Exclusion criteria were: (i) fever illnesses day enrolment; (ii) baseline level haemoglobin 70 g/L; (iii) receiving iron supplementation.,C0680251|C0243161|G0000000|C0021966|C0015967|C0221423|C0332173|C1516879|G0000000|C0168634|C0441889|C0019046|C0450371|C0439294|C0439070|C1514756|C0302583|C0242297
Few trials have adequately studied the effect of TCAs on global relief of symptoms in patients with IBS.,Few trials adequately studied TCAs global relief symptoms patients IBS.,C0205388|C0008976|G0000000|C0557651|C0041405|C0205246|C0564405|C0683368|C0030705|C0022104
"Patients were eligible for the intervention if they met all the following criteria: 1) ≥ 18 years old; 2) has any, or all, of the following clinical features as defined by the Global Initiative for National Asthma (GINA) Guidelines: dyspnea, wheeze, acute cough, increased work of breathing, increased requirement for beta2-agonist from baseline use, O2 saturation <95%, a peak expiratory flow (PEF) at randomization ≤80% of their known best (within the last 12 months) or, in the absence of this information, of their predicted PEF [1].","Patients eligible intervention met criteria: 1) ≥ 18 old; 2) any, all, clinical features defined Global Initiative National Asthma (GINA) Guidelines: dyspnea, wheeze, acute cough, increased breathing, increased requirement beta2-agonist baseline use, O2 saturation <95%, peak expiratory flow (PEF) randomization ≤80% (within 12 months) or, absence information, predicted PEF [1].",C0030705|C1548635|C0886296|C0268621|C0243161|G0000000|C0580836|G0000000|G0000000|G0000000|C0205210|C1521970|C1704788|C0205246|C0424093|C3245503|C0004096|G0000000|C0162791|C0013404|C0043144|C0205178|C0010200|C0205217|C0004048|C0205217|C1514873|C2987634|C0168634|C0042153|C0300971|C0522534|C0450371|C0444505|C0231800|C0806140|C0030771|C0034656|G0000000|G0000000|C0450371|C0439231|G0000000|C0332197|C1533716|C0681842|C0030771|G0000000
"For those patients who did not enter the study but received non-standard chemotherapy, the majority, 29 patients (85%), received either three- or two-drug chemotherapy regimens (Figure 1).","For patients enter study received non-standard chemotherapy, majority, 29 patients (85%), received three- two-drug chemotherapy regimens (Figure 1).",G0000000|C0030705|C1522196|C0557651|C1514756|C1518422|C0013216|C0680220|C0450371|C0030705|C0450371|C1514756|C0205449|C0205448|C0013216|C2945654|G0000000|G0000000
"To be eligible for the folic acid/vitamin B6/B12 component, potential participants in the ongoing eight arm trial had to be additionally willing to forgo individual supplements of folic acid, vitamin B6, and vitamin B12 at levels beyond the U.S. recommended daily allowance (RDA) of 400 mcg of folic acid, 2 mg of vitamin B6, or 6 mg of vitamin B12 2 during the trial.","To eligible folic acid/vitamin B6/B12 component, potential participants ongoing arm trial additionally forgo individual supplements folic acid, vitamin B6, vitamin B12 levels U.S. recommended daily allowance (RDA) 400 mcg folic acid, 2 vitamin B6, 6 vitamin B12 2 trial.",C0040363|C1548635|G0000000|C0001128|C0005558|C0449432|C3245505|C0679646|C0549178|C0446516|C0008976|G0000000|G0000000|C0027361|C0242295|G0000000|C0001128|C0042890|C0005558|C0042890|G0000000|C0441889|C0041703|C0034866|C0332173|C0556660|G0000000|C1442061|C0439211|G0000000|C0001128|G0000000|C0042890|C0005558|G0000000|C0042890|G0000000|G0000000|C0008976
The study population includes patients aged 30–80 who have suffered an ischemic stroke (≤7 days).,The study population includes patients aged 30–80 suffered ischemic stroke (≤7 days).,G0000000|C0557651|C0032659|C0332257|C0030705|C0001779|G0000000|C0683278|C0475224|C0038454|G0000000
"The inclusion criteria included the following: (1) age between 18 and 70 years; (2) fulfillment of the DSM-IV criteria (American Psychiatric Association, 1994) based on the Standard Clinical Interview for DSM-IV; and (3) a score of 20 or greater on the 24-item Hamilton Depression Rating Scale for each symptom, as evaluated by a trained physician.14 The exclusion criteria were concomitant psychiatric illnesses, mental retardation, alcohol or drug abuse, severe somatic illnesses, positive medical history for cerebral diseases, and obesity.","The inclusion criteria included following: (1) age 18 70 years; (2) fulfillment DSM-IV criteria (American Psychiatric Association, 1994) based Standard Clinical Interview DSM-IV; (3) score 20 24-item Hamilton Depression Rating Scale symptom, evaluated trained physician.14 The exclusion criteria concomitant psychiatric illnesses, mental retardation, alcohol drug abuse, severe somatic illnesses, positive medical history cerebral diseases, obesity.",G0000000|C0007637|C0243161|C0332257|C0231290|G0000000|C0001779|C0450371|C0450371|C0439234|G0000000|C0242428|C0220952|C0243161|C0596070|C0205487|C0004083|G0000000|C1527178|C1442989|C0205210|C0021822|C0220952|G0000000|C0449820|C0450371|C0450371|G0000000|C0011570|C0871208|C0175659|C1457887|C0220825|C0336809|C0031831|G0000000|C0680251|C0243161|C0521115|C0205487|C0221423|C0229992|C0521111|C0001962|C0013227|C0013146|C0205082|C1257909|C0221423|C0439178|C0199168|C0019664|G0000000|C0012634|C0028754
Weekly means of “average pain over the last 24 hours” rated on 0-10 numerical pain rating scale (NPRS).,Weekly “average pain 24 hours” rated 0-10 numerical pain rating scale (NPRS).,C0332174|G0000000|C0030193|C0450371|G0000000|C0871208|C0450371|C0237753|C0030193|C0871208|C0175659|C1417814
"Among the excluded patients, 11 did not meet the inclusion criteria and six refused to participate.","Among excluded patients, 11 meet inclusion criteria refused participate.",G0000000|C1554077|C0030705|C0450371|C1550543|C0007637|C0243161|C1548564|G0000000
"Patients with the following characteristics were included: cancer diagnosis of lung, prostate, bladder, rectum, breast, cervix, skin, endometrial or non-Hodgkin lymphoma; age over 18 years; patients without metastases; and able to provide written informed consent.","Patients characteristics included: cancer diagnosis lung, prostate, bladder, rectum, breast, cervix, skin, endometrial non-Hodgkin lymphoma; age 18 years; patients metastases; provide written informed consent.",C0030705|C1521970|C0332257|C0006826|C0011900|C0024109|C0033572|C0005682|C0034896|C0006141|C0007874|C0444099|C0227843|C0024305|C0024299|C0001779|C0450371|C0439234|C0030705|C0027627|C1999230|C0043266|C1522154|C1511481
We were able to reach 92.2% (n = 107) of participants from the hypnosis group and 94.4% (n = 101) of participants from the relaxation group for the first follow-up.,We reach 92.2% (n = 107) participants hypnosis 94.4% (n = 101) participants relaxation follow-up.,G0000000|C2584321|C0450371|C0369718|G0000000|C0679646|C0020587|C0450371|C0369718|G0000000|C0679646|C0035028|C0589120
The primary hypotheses were that village-level supplementation with RUTF in the months preceding the annual harvest would prevent declines in individual weight-for-height and reduce the incidence of wasting in children 6 to 60 mo of age over a period of 8 mo.,The primary hypotheses village-level supplementation RUTF months preceding annual harvest prevent declines individual weight-for-height reduce incidence wasting children 6 60 mo age period 8 mo.,G0000000|C0205225|C1512571|C0562518|C0242297|G0000000|C0439231|C0332152|C0332181|C1512335|C0309872|G0000000|C0027361|C0005910|G0000000|C0021149|C0006625|C0008059|G0000000|C0450371|C0026544|C0001779|C0439531|G0000000|C0026544
Birth partners were eligible to take part if they returned a consent form.,Birth partners eligible returned consent form.,C0005615|C0682323|C1548635|C0332156|C1511481|C0348078
"Between January 2012 and June 2014, a total of 398 patients were enrolled in this retrospective study.","Between January 2012 June 2014, total 398 patients enrolled retrospective study.",G0000000|C3829466|G0000000|C3829443|G0000000|C0439175|C1442061|C0030705|G0000000|C0035363|C0557651
"Four patients withdrew in each group, and the numbers resolving pain crisis were 65 and 64 for the iNO and placebo groups, respectively.","Four patients withdrew group, resolving pain crisis 65 64 iNO placebo groups, respectively.",C0205450|C0030705|C2349954|C0441833|C3714811|C0030193|C0231224|C0450371|C0450371|G0000000|C0032042|C0441833|G0000000
"Patient characteristics, including age, sex, race, ethnicity, insurance, number of medications, income and comorbidities were similar across study arms (Table 1).","Patient characteristics, including age, sex, race, ethnicity, insurance, medications, income comorbidities study arms (Table 1).",C0030705|C1521970|C0332257|C0001779|C0009253|C0034510|C0015031|C0021672|C0013227|C0021162|C0009488|C0557651|C0206655|C0039224|G0000000
"With regards to the HSCT population, Xenocostas et al [2] reported that patients undergoing allogeneic transplantation required an average of 6.8 ± 6.4 units of red cells between 0 - 60 days after transplant and the frequency of red cell transfusion decreased significantly thereafter.","With HSCT population, Xenocostas al [2] reported patients undergoing allogeneic transplantation required average 6.8 ± 6.4 units red cells 0 - 60 days transplant frequency red cell transfusion decreased thereafter.",G0000000|C0472699|C0032659|G0000000|C0202311|G0000000|C0684224|C0030705|G0000000|C1515895|C0040732|C1514873|C1510992|G0000000|G0000000|G0000000|C0439148|C0332575|C0007634|G0000000|G0000000|C0450371|C0439228|C0040732|C0376249|C0332575|C0007634|C0005841|C0205216|G0000000
"Inclusion criteria for enrolment included: (1) uncomplicated malaria at day 0, defined as a history of fever 48 h prior to presentation or a measured temperature of 37.5°C or more with peripheral parasitaemia (asexual forms of Plasmodium falciparum ≥500/μL by microscopy) on day 0 of the study and (2) for randomisation to the postmalarial intervention, children had to have an Hb between 69 and 110 g/L on day 3 with no peripheral parasitaemia.","Inclusion criteria enrolment included: (1) uncomplicated malaria day 0, defined history fever 48 h prior presentation measured temperature 37.5°C peripheral parasitaemia (asexual forms Plasmodium falciparum ≥500/μL microscopy) day 0 study (2) randomisation postmalarial intervention, children Hb 69 110 g/L day 3 peripheral parasitaemia.",C0007637|C0243161|C1516879|C0332257|G0000000|C0443334|C0024530|C0332173|G0000000|C1704788|C0019664|C0015967|G0000000|C0332152|C0449450|C0444706|C0005903|G0000000|C0205100|C0242723|C0599655|C0348078|C0032148|G0000000|G0000000|C0026018|C0332173|G0000000|C0557651|G0000000|C0034656|G0000000|C0886296|C0008059|C0019046|C0450371|G0000000|C0332173|G0000000|C0205100|C0242723
"Patients were excluded on the basis of having another advanced illness at diagnosis that might interfere with the ability to participate, ongoing major depression, ongoing Herceptin therapy, or who had previously, as well as during the intervention, used MBSR and other mind‐body programs (including yoga).","Patients excluded basis advanced illness diagnosis interfere ability participate, ongoing major depression, ongoing Herceptin therapy, previously, intervention, MBSR mind‐body programs (including yoga).",C0030705|C1554077|C1527178|C0205179|C0221423|C0011900|C0521102|C0085732|G0000000|C0549178|C0205082|C0011570|C0549178|C0338204|C0039798|G0000000|C0886296|G0000000|G0000000|C0376691|C0332257|C0043418
"We sought to promote cervical cancer screening among Vietnamese American women in Santa Clara County, Calif. Methods.","We sought promote cervical cancer screening Vietnamese American women Santa Clara County, Calif. Methods.",G0000000|G0000000|C0033414|C0027530|C0006826|C0220908|C0042660|C0596070|C0043210|G0000000|G0000000|C0079170|C1418757|C0025663
A total of 116 nurses were included in the study.,A total 116 nurses included study.,G0000000|C0439175|C1442061|C0028661|C0332257|C0557651
"; ulcers surrounded by an advancing, indurated red border, warm or tender, with purulent exudate, or accompanied by a bad odor [18,19].","; ulcers surrounded advancing, indurated red border, warm tender, purulent exudate, accompanied bad odor [18,19].",G0000000|C0041582|C1282914|C0725066|C0702114|C0332575|C0205284|C0184348|C0234234|C0439665|C0015388|G0000000|C0205169|C0028884|C0450371
"Patients were not included if they were younger than 14 years, were pregnant in the first trimester, were known intravenous drug abusers, had received more than 3 g of quinine or 2 doses of any artemisinin derivatives in the previous 48 hours before admission, had a past history of allergy to any artemisinin derivatives, or if known to be HIV positive.","Patients included 14 years, pregnant trimester, intravenous drug abusers, received 3 quinine 2 doses artemisinin derivatives previous 48 hours admission, history allergy artemisinin derivatives, HIV positive.",C0030705|C0332257|C0450371|C0439234|C0549206|C0032982|C0348016|C0013227|G0000000|C1514756|G0000000|C0034417|G0000000|C0178602|C0052430|C0243072|C0205156|C0450371|C0439227|C0184666|C0019664|C0002111|C0052430|C0243072|C0019682|C0439178
"coeliac) Have contraindications included bulimia nervosa, substance abuse, clinically significant depression, or current psychiatric care; Have had a recent (within 3 months) of change in dose/regime or introduction of vitamin E, C or high dose vitamin D (>3000 IU), fish oil or probiotics.","coeliac) Have contraindications included bulimia nervosa, substance abuse, clinically depression, current psychiatric care; Have (within 3 months) change dose/regime introduction vitamin E, C dose vitamin D (>3000 IU), fish oil probiotics.",G0000000|G0000000|C0079164|C0332257|C0006370|G0000000|C0439861|C0013146|G0000000|C0011570|C0521116|C0205487|C1947933|G0000000|G0000000|G0000000|C0439231|C0392747|C0178602|C1293116|C0042890|G0000000|G0000000|C0178602|C0042890|C0073187|G0000000|C0049272|C0016163|C0028908|C0525033
The order in which risk factors were targeted was determined after negotiation between nurse and patient.,The risk factors targeted determined negotiation nurse patient.,G0000000|C0035647|C1521761|C1521840|G0000000|C0680727|C0028661|C0030705
"Respiratory distress was diagnosed if at least 2 of the following conditions were met: (1) altered general condition and/or reduced alimentary intake, (2) respiratory rate greater than 50/min, (3) oxygen saturation less than 95% while awake, and (4) at least 1 severe or 2 moderate retraction signs according to the Respiratory Distress Assessment Instrument (RDAI) score (see Supplement 1 for more details about the RDAI score).18 Infants were not eligible if they had any of the following: premature birth (defined as birth before 37 weeks of gestation); immunologic, cardiac, or chronic pulmonary disease; bone malformation of the chest; previous use of nebulized HS; or inability to communicate with the family (a language barrier or lack of telephone on the part of the parent or guardian).","Respiratory distress diagnosed 2 conditions met: (1) altered condition and/or reduced alimentary intake, (2) respiratory rate 50/min, (3) oxygen saturation 95% awake, (4) 1 severe 2 moderate retraction signs Respiratory Distress Assessment Instrument (RDAI) score (see Supplement 1 details RDAI score).18 Infants eligible following: premature birth (defined birth 37 weeks gestation); immunologic, cardiac, chronic pulmonary disease; bone malformation chest; previous nebulized HS; inability communicate family (a language barrier lack telephone parent guardian).",C0521346|C0231303|C0011900|G0000000|C0012634|C0268621|G0000000|C0392747|C0012634|G0000000|C0392756|C0016452|C1512806|G0000000|C0521346|C0871208|C0450371|G0000000|C0030054|C0522534|C0450371|C0234422|G0000000|G0000000|C0205082|G0000000|C0205081|C0332523|C0220912|C0521346|C0231303|C1261322|C0348000|G0000000|C0449820|C0042789|C0242295|G0000000|C1522508|G0000000|C0449820|C0021270|C1548635|C0231290|C0151526|C0005615|C1704788|C0005615|C0450371|C0439230|C0032961|C0152036|C0018787|C0205191|C0024109|C0012634|C0262950|C0000768|C0817096|C0205156|C1549531|G0000000|G0000000|C0566001|C0015576|G0000000|C0023008|C1706912|C0332268|C0039457|C0030551|C0023226
Both partial responders and non-responders were enrolled.,Both partial responders non-responders enrolled.,G0000000|C0728938|G0000000|C1518422|G0000000
Complementary feeding from the age of 6 months along with breastfeeding is essential for the health of infants.,Complementary feeding age 6 months breastfeeding essential health infants.,G0000000|C0204695|C0001779|G0000000|C0439231|C0006147|C0205224|C0018684|C0021270
"Of 561 patients screened, 484 patients were randomized (pregabalin n = 242; gabapentin n = 242), 482 (pregabalin n = 241; gabapentin n = 241) were treated, and 359 (pregabalin n =187, gabapentin n = 172) completed the maintenance phase of the study (figure 2).","Of 561 patients screened, 484 patients randomized (pregabalin = 242; gabapentin = 242), 482 (pregabalin = 241; gabapentin = 241) treated, 359 (pregabalin =187, gabapentin = 172) completed maintenance phase study (figure 2).",G0000000|C1442061|C0030705|C0220908|C1442061|C0030705|C0034656|C0657912|G0000000|C1442061|C0060926|G0000000|C1442061|C1442061|C0657912|G0000000|C1442061|C0060926|G0000000|C1442061|C1522326|C1442061|C0657912|C1442061|C0060926|G0000000|C1442061|C0205197|C0024501|C0205390|C0557651|G0000000|G0000000
Pregnant women with a history of diabetes or subjects who consumed vitamin D supplements during the previous 6 months and women with thyroid or parathyroid disorders were excluded from the study.,Pregnant women history diabetes subjects consumed vitamin D supplements previous 6 months women thyroid parathyroid disorders excluded study.,C0549206|C0043210|C0019664|C0011847|C0681850|G0000000|C0042890|C0073187|C0242295|C0205156|G0000000|C0439231|C0043210|C0040132|C0030518|C0012634|C1554077|C0557651
Subjects with new onset habitual snoring will be screened for OSA using home sleep studies and rhinomanometry will be used to determine nasal resistance.,Subjects onset habitual snoring screened OSA sleep studies rhinomanometry determine nasal resistance.,C0681850|C0206132|C0205353|C0037384|C0220908|C0520679|C0037313|C0947630|C0430615|G0000000|C0028429|C0237834
; manual online at www.oup.com/us/ pediatricpsych) to a nutrition education intervention alone were recruited from five CF Centers located in the US.,; manual online www.oup.com/us/ pediatricpsych) nutrition education intervention recruited CF Centers located US.,G0000000|C0024763|G0000000|C0282111|G0000000|C0028707|C0013621|C0886296|G0000000|C0009738|C0205099|G0000000|G0000000
"Of the children classified with nonsevere pneumonia, 13.3% of those in the control arm received early and appropriate treatment with amoxicillin compared to 68.2% of those in the intervention arm, a 5-fold increase in the timely treatment for pneumonia.","Of children classified nonsevere pneumonia, 13.3% control arm received treatment amoxicillin compared 68.2% intervention arm, 5-fold increase timely treatment pneumonia.",G0000000|C0008059|C0008902|G0000000|C0032285|C0450371|C0243148|C0446516|C1514756|C0039798|C0002645|C1707455|C0450371|C0886296|C0446516|C0332462|C0442805|C3827828|C0039798|C0032285
"METHODS—Twenty seven ventilated preterm infants were randomly assigned to receive a mean fentanyl infusion of 1.1 (0.08 SE) µg/kg/h for 75 (5) hours, and 28 untreated infants were considered a control group.","METHODS—Twenty ventilated preterm infants randomly assigned receive fentanyl infusion 1.1 (0.08 SE) µg/kg/h 75 (5) hours, 28 untreated infants considered control group.",G0000000|C0231923|C0151526|C0021270|G0000000|C1516050|C1514756|C0015846|C0574032|G0000000|C0450371|C0036919|G0000000|C0450371|G0000000|C0439227|C0450371|C0332155|C0021270|C0750591|C0243148|C0441833
"The study was conducted in a single rural general practice with a population of approximately 4000 in Norfolk, England.","The study conducted single rural practice population 4000 Norfolk, England.",G0000000|C0557651|C0004927|C0037179|C0240919|C0237607|C0032659|G0000000|C0454866|C0014282
There were 328 children and adolescents cared for by 170 caregivers enrolled in the study.,There 328 children adolescents cared 170 caregivers enrolled study.,G0000000|C1442061|C0008059|C0205653|C1947933|C1442061|C0085537|G0000000|C0557651
"A total of 600 patients were randomized (voriconazole, N = 305; fluconazole, N = 295) from November 2003 through September 2006.","A total 600 patients randomized (voriconazole, N = 305; fluconazole, N = 295) November 2003 September 2006.",G0000000|C0439175|C1442061|C0030705|C0034656|C0393080|C0369718|G0000000|C1442061|C0016277|C0369718|G0000000|C1442061|C3828767|G0000000|C3828193|G0000000
"Our investigation, the first randomized, double-blind, placebo-controlled trial to evaluate the prophylactic use of low-dose haloperidol in mechanically ventilated, critically ill adults, suggests that the early initiation of scheduled, low-dose, haloperidol does not prevent delirium among patients with subsyndromal delirium and who are at high risk for developing delirium, and may in fact lead to greater delirium.","Our investigation, randomized, double-blind, placebo-controlled trial evaluate prophylactic low-dose haloperidol mechanically ventilated, critically ill adults, suggests initiation scheduled, low-dose, haloperidol prevent delirium patients subsyndromal delirium risk developing delirium, lead delirium.",G0000000|C0220825|C0034656|C0013072|C1706408|C0008976|C0220825|C0355642|C0445550|C0018546|G0000000|C0231923|G0000000|C0231218|C0001675|C1705535|C0589507|C0086960|C0445550|C0018546|C0309872|C0011206|C0030705|G0000000|C0011206|C0035647|G0000000|C0011206|C0023175|C0011206
"Infants with known allergy to any of the study drugs, receiving cotrimoxazole prophylaxis for opportunistic infections, suffering concomitant illness requiring hospitalization or transfusion, or planning to be away from the study area for more than 6 months were excluded.","Infants allergy study drugs, receiving cotrimoxazole prophylaxis opportunistic infections, suffering concomitant illness requiring hospitalization transfusion, planning study 6 months excluded.",C0021270|C0002111|C0557651|C0013227|C1514756|C0041044|C0033107|G0000000|C3714514|C0683278|C0521115|C0221423|G0000000|C0019993|C0005841|C0032074|C0557651|G0000000|C0439231|C1554077
Over a 13 month period 200 children aged 18 months to 5 years at the time of admission to a children's ward or attendance at an accident and emergency department or children's (emergency) assessment unit (A&E/CAU) with a primary diagnosis of acute severe asthma or wheezing were recruited.,Over 13 month period 200 children aged 18 months 5 time admission children's ward attendance accident emergency department children's (emergency) assessment unit (A&E/CAU) primary diagnosis acute severe asthma wheezing recruited.,C0205136|C0450371|C0332177|C0439531|C1442061|C0008059|C0001779|C0450371|C0439231|G0000000|C0040223|C0184666|C0008059|C1305702|C2827364|C0000924|C0013956|C1704729|C0008059|C0013956|C1261322|C0439148|C0444892|C0205225|C0011900|C0205178|C0205082|C0004096|C0043144|G0000000
"We randomised 867 women aged 67–70 years attending for their final routine appointment on the National Health Service Breast Screening Programme to receive the PEP Intervention, a booklet alone or usual care.","We randomised 867 women aged 67–70 attending final routine appointment National Health Service Breast Screening Programme receive PEP Intervention, booklet usual care.",G0000000|G0000000|C1442061|C0043210|C0001779|G0000000|C1547429|C0205088|C0205547|C0003629|C3245503|C0018684|C0557854|C0006141|C0220908|C1709697|C1514756|C1335057|C0886296|C0030258|C3538928|C1947933
"We excluded children aged <2 months (they were too young to be enrolled in the vaccine trial), those with signs of structural heart disease, those with Down’s syndrome, and those who had been included in a previous case-control study of hypoxaemia.","We excluded children aged <2 months (they enrolled vaccine trial), signs structural heart disease, Down’s syndrome, included previous case-control study hypoxaemia.",G0000000|C1554077|C0008059|C0001779|G0000000|C0439231|G0000000|G0000000|C0042210|C0008976|C0220912|C0678594|C0018787|C0012634|G0000000|C0039082|C0332257|C0205156|C0872128|C0557651|C0700292
"Demographic and baseline patient characteristics (treated population): combined data (n=5162) Data are presented as n (%) or mean±sd, unless otherwise stated.","Demographic baseline patient characteristics (treated population): combined data (n=5162) Data (%) mean±sd, stated.",C0011298|C0168634|C0030705|C1521970|C1522326|C0032659|C0205195|C1511726|C0369718|C1511726|G0000000|G0000000|C1301808
Among participants who smoked ⩾20 cigarettes a day and among pre-contemplators there were no differences between either the tailored letter group or the non-tailored letter group and the no letter group.,Among participants smoked ⩾20 cigarettes day pre-contemplators differences tailored letter non-tailored letter letter group.,G0000000|C0679646|C0037366|G0000000|C0677453|C0332173|C0332152|C1705241|C0402883|C1096774|C1518422|C1096774|C1096774|C0441833
"In brief, a baseline self-administered questionnaire was distributed to all NHI beneficiaries aged 40–79 years living in the catchment area of the Ohsaki Public Health Center, Miyagi Prefecture, in northeastern Japan from October to December 1994.","In brief, baseline self-administered questionnaire distributed NHI beneficiaries aged 40–79 living catchment Ohsaki Public Health Center, Miyagi Prefecture, northeastern Japan October December 1994.",G0000000|C1282927|C0168634|C1519231|C0034394|C1704711|G0000000|C1550502|C0001779|G0000000|C0376558|G0000000|G0000000|G0000000|C0018684|C0205099|G0000000|C1709636|C1709272|C0022341|C3828732|C3830550|G0000000
"Due to lower screening rates among Hispanic women and the historically lower rates among women living in rural areas [15], Celebremos La Salud (Celebrating Health), a community randomized trial of cancer prevention set out to increase cancer screening behaviors (related to colon, breast, and cervical cancers), increase smoking cessation and healthy dietary changes in a two and a half year intervention among residents in rural communities especially among Hispanics.","Due lower screening rates Hispanic women historically lower rates women living rural [15], Celebremos La Salud (Celebrating Health), community randomized trial cancer prevention set increase cancer screening behaviors (related colon, breast, cervical cancers), increase smoking cessation healthy dietary half intervention residents rural communities Hispanics.",C0678226|C0441994|C0220908|C0871208|C0086409|C0043210|G0000000|C0441994|C0871208|C0043210|C0376558|C0240919|C0450371|G0000000|C0023031|G0000000|G0000000|C0018684|C0009462|C0034656|C0008976|C0006826|C0199176|C0036849|C0442805|C0006826|C0220908|C0004927|C0439849|C0009368|C0006141|C0027530|C0006826|C0442805|C0037369|C1880019|C3898900|C0012155|C2825407|C0886296|C1320928|C0240919|C0009462|C0086409
"The inclusion criteria were (1) a diagnosis of hemiplegia due to stroke within 6 months, (2) a score of 24 points or more on the Korean version of Mini-Mental State Examination, and (3) Brunnstrom stage of upper extremity recovery of 3 to 4.","The inclusion criteria (1) diagnosis hemiplegia stroke 6 months, (2) score 24 Korean version Mini-Mental State Examination, (3) Brunnstrom stage upper extremity recovery 3 4.",G0000000|C0007637|C0243161|G0000000|C0011900|C0018991|C0038454|G0000000|C0439231|G0000000|C0449820|C0450371|C1556095|C0333052|C0445542|C1301808|G0000000|G0000000|G0000000|C0205390|C1282910|C0015385|C0237820|G0000000|G0000000
The validity and reliability of the LOS test in people with neurological disease has been well established [25–27].,The validity reliability LOS test people neurological disease established [25–27].,G0000000|C2349101|C2347947|G0000000|C0022885|C0027361|C0205494|C0012634|C0443211|G0000000
"Participants are eligible for inclusion if they want to quit smoking (complete abstinence), are aged between 18 and 65 years, undergoing pharmacological treatment for opioid addiction, smoke a minimum of 10 cigarettes per day and provide informed consent.","Participants eligible inclusion quit smoking (complete abstinence), aged 18 65 years, undergoing pharmacological treatment opioid addiction, smoke minimum 10 cigarettes day provide informed consent.",C0679646|C1548635|C0007637|C0748223|C0037369|C0205197|C3843422|C0001779|C0450371|C0450371|C0439234|G0000000|C0031330|C0039798|C0242402|C0085281|C0037366|C1524031|C0450371|C0677453|C0332173|C1999230|C1522154|C1511481
ASA I/II patients between 6 months and 6 years of age undergoing lower abdominal surgeries were included.,ASA I/II patients 6 months 6 age undergoing lower abdominal surgeries included.,C0004057|C0021966|C0030705|G0000000|C0439231|G0000000|C0001779|G0000000|C0441994|C0000726|C0543467|C0332257
"Overall, 350 caregivers of children who reported a smoker living in the home were consented, 336 completed the baseline assessment, and 330 were randomized to either the intervention arm (MI + education) or to the control arm (education alone).","Overall, 350 caregivers children reported smoker living consented, 336 completed baseline assessment, 330 randomized intervention arm (MI + education) control arm (education alone).",C0282416|C1442061|C0085537|C0008059|C0684224|C0337664|C0376558|C2711213|C1442061|C0205197|C0168634|C1261322|C1442061|C0034656|C0886296|C0446516|C3810814|G0000000|C0013621|C0243148|C0446516|C0013621|C0205171
"The term “severe congenital heart defects” included tetralogy of Fallot, endocardial cushion defects, univentricular hearts, truncus arteriosus, and transposition complexes.","The term “severe congenital heart defects” included tetralogy Fallot, endocardial cushion defects, univentricular hearts, truncus arteriosus, transposition complexes.",G0000000|C0233324|G0000000|C0009678|C0018787|G0000000|C0332257|G0000000|G0000000|C0014124|C0180249|C0243067|G0000000|C0018787|C0460005|G0000000|C0040674|C1704241
"Women who required an interpreter, or had a fetal diagnosis of major abnormality or incompatibility with life were excluded.","Women required interpreter, fetal diagnosis major abnormality incompatibility life excluded.",C0043210|C1514873|C0150646|C0015965|C0011900|C0205082|C1704258|C0679426|C0376558|C1554077
"The exclusion criteria were: 1) severe neglect (Bell Test [25], Letter Cancellation Test: minimum omission score of 15% [26]), 2) hemianopsia, 3) severe spasticity (Modified Ashworth Scale total arm >3), 4) severe additional neurological, orthopaedic or rheumatoid impairments which could interfere with task performance, 5) Broca aphasia, Wernicke aphasia, global aphasia (determined by the Akense Afasie Test [27], 6) apraxia (Apraxiatest of van Heugten [28]) and 7) attending another study/therapy to improve arm-hand function.","The exclusion criteria were: 1) severe neglect (Bell Test [25], Letter Cancellation Test: minimum omission score 15% [26]), 2) hemianopsia, 3) severe spasticity (Modified Ashworth Scale total arm >3), 4) severe additional neurological, orthopaedic rheumatoid impairments interfere task performance, 5) Broca aphasia, Wernicke aphasia, global aphasia (determined Akense Afasie Test [27], 6) apraxia (Apraxiatest van Heugten [28]) 7) attending study/therapy improve arm-hand function.",G0000000|C0680251|C0243161|G0000000|G0000000|C0205082|C0521874|C1706917|C0022885|C0450371|C1096774|C0205544|C0022885|C1524031|C3845736|C0449820|C0450371|C0450371|G0000000|C0018979|G0000000|C0205082|C0026838|C0392747|G0000000|C0175659|C0439175|C0446516|G0000000|G0000000|C0205082|C1524062|C0205494|C0029355|G0000000|C0684336|C0521102|C3540678|C0597198|G0000000|G0000000|C0003537|C0043121|C0003537|C0205246|C0003537|C0680730|G0000000|G0000000|C0022885|C0450371|G0000000|C0003635|G0000000|C0557775|G0000000|C0450371|G0000000|C1547429|C0557651|G0000000|C0446516|C0031843
"For neonates assigned to the LM group, endotracheal intubation was performed if the heart rate remained less than 60 bpm after 30 s of LM ventilation.","For neonates assigned LM group, endotracheal intubation performed heart rate remained 60 bpm 30 LM ventilation.",G0000000|C0021289|C1516050|C1261082|C0441833|C0599554|C0021925|C0884358|C0018787|C0871208|G0000000|C0450371|G0000000|C0450371|C1261082|C0035203
The population under study was all male and female nurses with B. Sc.,The population study male female nurses B. Sc.,G0000000|C0032659|C0557651|C0086582|C0015780|C0028661|G0000000|C0282380
"Patients with mild to moderate cardiac iron loading who satisfied the trial entry criteria (myocardial T2* 8-20 ms, n = 86) were invited for further detailed assessment by CMR.","Patients mild moderate cardiac iron loading satisfied trial entry criteria (myocardial T2* 8-20 ms, = 86) invited detailed assessment CMR.",C0030705|C2945599|C0205081|C0018787|C0302583|C1708715|C0242428|C0008976|C1705654|C0243161|C0027061|C0041403|C0450371|C0039676|G0000000|C0450371|G0000000|C1522508|C1261322|C0006802
Children with severe malnutrition needing nutritional rehabilitation or chronic/severe illness requiring hospitalization or special treatment were excluded and referred for treatment.,Children severe malnutrition nutritional rehabilitation chronic/severe illness requiring hospitalization special treatment excluded referred treatment.,C0008059|C0205082|C0162429|C1521739|C0034991|C0205191|C0221423|G0000000|C0019993|C0205555|C0039798|C1554077|C0205543|C0039798
"Similarly, the RRT group was comprised of 1 sedentary, 1 moderately active, and 2 very active athletes.","Similarly, RRT comprised 1 sedentary, 1 moderately active, 2 active athletes.",G0000000|G0000000|C2700400|G0000000|C0205254|G0000000|C0205081|C0205177|G0000000|C0205177|C0238703
Less than 1% of the time (2 of 255 sessions) participants reported forgetting to take the study medication; in these instances the session was rescheduled.,Less 1% time (2 255 sessions) participants reported forgetting study medication; instances session rescheduled.,C0439092|G0000000|C0040223|G0000000|C1442061|C1883016|C0679646|C0684224|C0598853|C0557651|C0013227|C1550608|C1883016|C0205541
"Lastly, the patients were asked to choose which medication they would like to have as a prescription to continue treating their allergic conjunctivitis.","Lastly, patients choose medication prescription continue treating allergic conjunctivitis.",G0000000|C0030705|C1707391|C0013227|C0033080|C0549178|C1522326|C0700624|C0009763
"We excluded only patients for whom the service might be inappropriate (full recovery, discharge to institutional care, terminal illness), those living outside the hospital area, and those unable to take part in the trial (severe cognitive or communication problems preventing consent, completion of outcome measures, or the agreement of simple goals for recovery).","We excluded patients service inappropriate (full recovery, discharge institutional care, terminal illness), living hospital area, unable trial (severe cognitive communication preventing consent, completion outcome measures, agreement simple goals recovery).",G0000000|C1554077|C0030705|C0557854|C1548788|C0443225|C0237820|C0012621|C0018704|C1947933|C0205088|C0221423|C0376558|C0019994|C0017446|C1299582|C0008976|C0205082|C1516691|C0009452|C0309872|C1511481|C0205197|C1274040|C0079809|C0680240|C0205352|C0018017|C0237820
"Participants were excluded after enrolment if any of the following occurred: (1) use of antimalarial drugs outside of the study protocol; (2) parasitaemia in the presence of a concomitant febrile illness; (3) withdrawal of consent; (4) loss to follow-up, (5) protocol violation, or (6) death due to a non-malaria illness.","Participants excluded enrolment occurred: (1) antimalarial drugs study protocol; (2) parasitaemia presence concomitant febrile illness; (3) withdrawal consent; (4) loss follow-up, (5) protocol violation, (6) death non-malaria illness.",C0679646|C1554077|C1516879|C1709305|G0000000|C0003374|C0013227|C0557651|C0442711|G0000000|C0242723|C0150312|C0521115|C0015967|C0221423|G0000000|C2349954|C1511481|G0000000|C1517945|C0589120|G0000000|C0442711|G0000000|G0000000|C0011065|C1518422|C0221423
All the patients enrolled in the study were blind to the treatment (PEA or placebo).,All patients enrolled study blind treatment (PEA placebo).,G0000000|C0030705|G0000000|C0557651|C0150108|C0039798|C0030738|C0032042
Adults hospitalized with acute coronary syndromes or acute decompensated heart failure.,Adults hospitalized acute coronary syndromes acute decompensated heart failure.,C0001675|C0701159|C0205178|C0018787|C0039082|C0205178|C0205434|C0018787|C0231174
The patients were 2 months to 15 years old children coming to our emergency department suffering from an acute seizure episode.,The patients 2 months 15 children coming emergency department suffering acute seizure episode.,G0000000|C0030705|G0000000|C0439231|C0450371|C0008059|G0000000|C0013956|C1704729|C0683278|C0205178|C0036572|C0332189
"Exclusion criteria were as follows: past duloxetine treatment; serious or medically unstable disease, clinically significant abnormal laboratory values, or abnormal electrocardiogram (ECG) findings; pain caused by non-fibromyalgia diseases; poorly controlled thyroid dysfunction; rheumatoid, inflammatory, or infectious arthritis; autoimmune disorders other than thyroid dysfunction; psychiatric disorders other than major depressive disorder within the past year; and suicidal tendencies as assessed using the Columbia-Suicide Severity Rating Scale (C-SSRS) [28].","Exclusion criteria follows: duloxetine treatment; medically unstable disease, clinically abnormal laboratory values, abnormal electrocardiogram (ECG) findings; pain caused non-fibromyalgia diseases; controlled thyroid dysfunction; rheumatoid, inflammatory, infectious arthritis; autoimmune disorders thyroid dysfunction; psychiatric disorders major depressive disorder year; suicidal tendencies assessed Columbia-Suicide Severity Rating Scale (C-SSRS) [28].",C0680251|C0243161|C0332283|C0245561|C0039798|G0000000|C0443343|C0012634|G0000000|C0205161|C0022877|C0042295|C0205161|C0013798|C1623258|C2607943|C0030193|C0015127|C1518422|C0012634|C2587213|C0040132|C0031847|G0000000|C0333348|C0009450|C0003864|C0443146|C0012634|C0040132|C0031847|C0205487|C0012634|C0205082|G0000000|C0012634|C0439234|C0438696|G0000000|C1516048|C1551442|C0439793|C0871208|C0175659|C2754414|C0450371
We carried out an online survey and antibody testing of oral fluid samples from 268 individuals who returned to the UK and Ireland after working in West Africa during the Ebola outbreak.,We carried online survey antibody testing oral fluid samples 268 individuals returned UK Ireland West Africa Ebola outbreak.,G0000000|C0206243|G0000000|C0038951|C0003241|C0039593|C0442027|C0005889|C0370003|C1442061|C0027361|C0332156|C0041700|C0022067|C1705493|C0001737|C0282687|C0012652
Cases were infants hospitalized for influenza with documentation of either a nasal swab or aspirate sample that was positive for influenza by direct fluorescent antibody (DFA) test.,Cases infants hospitalized influenza documentation nasal swab aspirate sample positive influenza direct fluorescent antibody (DFA) test.,C0868928|C0021270|C0701159|C0021400|C0175636|C0028429|C0183753|C0370199|C0370003|C0439178|C0021400|C0439851|C0303920|C0003241|C1707759|C0022885
These additional metrics are similar to the OMERACT-OARSI criteria with the exception that these normally include a VAS for function as well as pain.,These additional metrics OMERACT-OARSI criteria exception VAS function pain.,G0000000|C1524062|C0699680|G0000000|C0243161|C1554961|C0042815|C0031843|C0030193
An early relapse within 6 months after initial remission in patients with SSNS is a definitive risk for the shift to FRNS.,An relapse 6 months initial remission patients SSNS definitive risk shift FRNS.,G0000000|C0035020|G0000000|C0439231|C0205265|C0544452|C0030705|C1301821|C0443196|C0035647|C0333051|C0220730
OFC responses also indicated that cognitive challenges associated with MS contributed to disability in 76% of the placebo and 65% of the donepezil group.,OFC responses cognitive challenges MS contributed disability 76% placebo 65% donepezil group.,C1861537|C0871261|C1516691|C0805586|C0039676|C1880177|C0231170|C0450371|C0032042|C0450371|C0527316|C0441833
"In the Netherlands, all epilepsy surgery is performed in three medical centers and is embedded in the Dutch Collaborative Epilepsy Surgery Program (DCESP) [36].","In Netherlands, epilepsy surgery performed medical centers embedded Dutch Collaborative Epilepsy Surgery Program (DCESP) [36].",G0000000|C0027778|C0014544|C0038894|C0884358|C0199168|C0205099|C1707903|C0013331|C0282116|C0014544|C0038894|C1709697|G0000000|C0450371
In gastric cancer the role of laparoscopic surgery remains unclear.,In gastric cancer role laparoscopic surgery remains unclear.,G0000000|C0038351|C0006826|C0035820|C0031150|C0038894|G0000000|G0000000
"Eligible patients were aged 18–55 years and had a diagnosis of relapsing MS,17 an Expanded Disability Status Scale (EDSS) score of 0 to 5.0,18 had been treated with GA for ≥12 months before randomization and experienced one or more relapses during that time, and had cranial MRI lesions consistent with MS.","Eligible patients aged 18–55 diagnosis relapsing MS,17 Expanded Disability Status Scale (EDSS) score 0 5.0,18 treated GA ≥12 months randomization experienced relapses time, cranial MRI lesions consistent MS.",C1548635|C0030705|C0001779|G0000000|C0011900|C0035020|C0039676|C0205229|C0231170|C0449438|C0175659|C0451246|C0449820|G0000000|C0450371|C1522326|C0016993|G0000000|C0439231|C0034656|C0237607|C0035020|C0040223|C0037303|C0024485|C0221198|C0332290|C0039676
Consented participants had baseline measures taken and were then randomised to either the intervention or control group.,Consented participants baseline measures randomised intervention control group.,C2711213|C0679646|C0168634|C0079809|G0000000|C0886296|C0243148|C0441833
"The current clinical trial was done in Kashan, Iran, from March 2012 to September 2012.","The current clinical trial Kashan, Iran, March 2012 September 2012.",G0000000|C0521116|C0205210|C0008976|G0000000|C0022065|C3829202|G0000000|C3828193|G0000000
"METHODS—Forty preterm infants with gestational ages of less than 33 weeks, with respiratory distress syndrome (RDS) and echocardiographically confirmed PDA, were randomly assigned at days 2 to 3 of life to receive either intravenous indomethacin 3 × 0.2 mg/kg at 12 hour intervals or intravenous ibuprofen 1 × 10 mg/kg, followed by 5 mg/kg 24 and 48 hours later.","METHODS—Forty preterm infants gestational ages 33 weeks, respiratory distress syndrome (RDS) echocardiographically confirmed PDA, randomly assigned days 2 3 life receive intravenous indomethacin 3 × 0.2 mg/kg 12 hour intervals intravenous ibuprofen 1 × 10 mg/kg, 5 mg/kg 24 48 hours later.",G0000000|C0151526|C0021270|C0439671|C0001779|C0450371|C0439230|C0521346|C0231303|C0039082|C0035220|G0000000|C0521093|C0013274|G0000000|C1516050|C0439228|G0000000|G0000000|C0376558|C1514756|C0348016|C0021246|G0000000|G0000000|G0000000|C0439272|C0450371|C0439227|C1272706|C0348016|C0020740|G0000000|G0000000|C0450371|C0439272|G0000000|C0439272|C0450371|C0450371|C0439227|C0205087
"Women will be able to participate if they provide informed consent, have a BMI > 18.5 (US IOM cut-off for normal weight), are 18 years of age or older, English speaking and less than 18 weeks gestation at recruitment with no history of disordered eating or diabetes.","Women participate provide informed consent, BMI > 18.5 (US IOM cut-off normal weight), 18 age older, English speaking 18 weeks gestation recruitment history disordered eating diabetes.",C0043210|G0000000|C1999230|C1522154|C1511481|G0000000|G0000000|C0450371|G0000000|C1955637|C1442160|C0205307|C0005910|C0450371|C0001779|C0580836|C0376245|C0234856|C0450371|C0439230|C0032961|C2949735|C0019664|C0012634|C0013470|C0011847
"All patients were diagnosed with poststroke hemiparesis (<6 months from onset) and were unable to walk independently (Functional Ambulation Classification scores<4) (Masiero et al., 2007).","All patients diagnosed poststroke hemiparesis (<6 months onset) unable walk independently (Functional Ambulation Classification scores<4) (Masiero al., 2007).",G0000000|C0030705|C0011900|G0000000|C0018989|G0000000|C0439231|C0206132|C1299582|C0080331|G0000000|C0205245|C0080331|C0008902|C0449820|G0000000|C0202311|G0000000
The largest study [6] is a post hoc analysis of 177 patients with ARDS from a trial of vasopressor-dependent septic shock investigating hydrocortisone (dosage similar to our trial) and fludrocortisone (50 μg daily) treatment [28].,The largest study [6] post hoc analysis 177 patients ARDS trial vasopressor-dependent septic shock investigating hydrocortisone (dosage trial) fludrocortisone (50 μg daily) treatment [28].,G0000000|C0443228|C0557651|G0000000|C0687676|G0000000|C0002778|C1442061|C0030705|C0035222|C0008976|C0042397|C0333534|C0036974|C1292732|C0020268|C0178602|C0008976|C0016280|C0450371|G0000000|C0332173|C0039798|C0450371
The patients included in the study were recruited from patients undergoing elective surgery and urgent surgery in the emergency room.,The patients included study recruited patients undergoing elective surgery urgent surgery emergency room.,G0000000|C0030705|C0332257|C0557651|G0000000|C0030705|G0000000|C0206058|C0038894|C0439609|C0038894|C0013956|C1547703
"One hundred two pregnant women with gestation ≤12 weeks, age ≥18 years, gravidity ≤2, and who did not intend to lose weight in prepregnancy period were randomly included in this study as intervention (n = 51) and control (n = 51) groups.","One pregnant women gestation ≤12 weeks, age ≥18 years, gravidity ≤2, intend lose weight prepregnancy period randomly included study intervention (n = 51) control (n = 51) groups.",C0205447|C0549206|C0043210|C0032961|G0000000|C0439230|C0001779|G0000000|C0439234|C0549206|G0000000|G0000000|G0000000|C0005910|C2709093|C0439531|G0000000|C0332257|C0557651|C0886296|G0000000|C0243148|G0000000|C0441833
Patients had a mean age of 58 years and 80% were men.,Patients age 58 years 80% men.,C0030705|C0001779|G0000000|C0450371|C0025266
Coverage and effects on malaria and anemia were estimated through a representative survey in 2006 with 600 children aged 2–11 months.,Coverage effects malaria anemia estimated representative survey 2006 600 children aged 2–11 months.,C1551362|C1280500|C0024530|C0002871|C0750572|C1882932|C0038951|G0000000|C1442061|C0008059|C0001779|G0000000|C0439231
"Prior to the study, some of the messages were pre-tested with five women in Puerto Rico, who all reported that the utility and frequency of messages were excellent [32].","Prior study, messages pre-tested women Puerto Rico, reported utility frequency messages excellent [32].",C0332152|C0557651|C0470166|C0332152|C0043210|G0000000|G0000000|C0684224|C0582205|C0376249|C0470166|C1548784|C0450371
Treatment delay in first episode psychosis is common.,Treatment delay episode psychosis common.,C0039798|C0205421|C0332189|C0033975|C0205214
This then lead to further studies and Porter himself carried out a randomised double-blind trial [10] of salmon calcitonin subcuticular injections and found that there was no statistically significant difference in the response rate to salmon calcitonin compared to placebo in a group of 42 patients (5/20 patients in the salmon calcitonin group and 1/22 in the placebo group responded).,This lead studies Porter carried randomised double-blind trial [10] salmon calcitonin subcuticular injections statistically difference response rate salmon calcitonin compared placebo 42 patients (5/20 patients salmon calcitonin 1/22 placebo responded).,G0000000|C0023175|C0947630|C0402671|C0206243|G0000000|C0013072|C0008976|C0450371|C0036110|C0006668|C0563304|C0021485|C0038215|C1705241|C0871261|C0871208|C0036110|C0006668|C1707455|C0032042|C0450371|C0030705|C0450371|C0030705|C0036110|C0006668|C0450371|C0032042|G0000000
"The study was conducted at the department of cardiology of a teaching hospital in Tilburg, the Netherlands between May 2007 and July 2008.","The study conducted department cardiology teaching hospital Tilburg, Netherlands May 2007 July 2008.",G0000000|C0557651|C0004927|C1704729|C0007189|C0039401|C0019994|G0000000|C0027778|G0000000|G0000000|C3829447|G0000000
"HEWs conducted house-to-house visits, identified individuals with a cough for two or more weeks, with or without other symptoms, collected sputum, prepared smears and supervised treatment.","HEWs conducted house-to-house visits, identified individuals cough weeks, symptoms, collected sputum, prepared smears supervised treatment.",G0000000|C0004927|C0442519|C0545082|C0205396|C0027361|C0010200|C0439230|C0683368|C1516695|C0038056|C4082130|C0444186|G0000000|C0039798
A recent study demonstrated a significant improvement of tolerance with increased doses of dexamethasone and antihistamine [23].,A study demonstrated improvement tolerance increased doses dexamethasone antihistamine [23].,G0000000|C0557651|G0000000|C2986411|C0013220|C0205217|C0178602|C0011777|C0003360|C0450371
"This study investigated the safety, efficacy, and tolerability of ADS‐5102 in Parkinson's disease (PD) patients with levodopa‐induced dyskinesia.","This study investigated safety, efficacy, tolerability ADS‐5102 Parkinson's disease (PD) patients levodopa‐induced dyskinesia.",G0000000|C0557651|C1292732|C0036043|C1280519|C3274448|G0000000|C1021144|C0012634|G0000000|C0030705|G0000000|C0013384
“Relapse” was defined as a new SAM event (MUAC < 115 or WHZ score < −3 or bilateral pitting edema) during home visits at 2 or 6 months after a successful discharge.,“Relapse” defined SAM event (MUAC < 115 WHZ score < −3 bilateral pitting edema) visits 2 6 months successful discharge.,G0000000|C1704788|C0036002|C0441471|G0000000|G0000000|C1442061|G0000000|C0449820|G0000000|G0000000|C0238767|C0205323|C0013604|C0545082|G0000000|G0000000|C0439231|C0597535|C0012621
"The amount of calcium dosage, gestational age, birth weight, sex, use of surfactants, and mechanical ventilation did not have any significant association with NC.","The amount calcium dosage, gestational age, birth weight, sex, surfactants, mechanical ventilation association NC.",G0000000|C1265611|C0006675|C0178602|C0439671|C0001779|C0005615|C0005910|C0009253|C0038891|C0443254|C0035203|C0004083|C0027964
High risk for a future cardiovascular event: Myocardial infarction ≥30 days prior to randomization.,High risk future cardiovascular event: Myocardial infarction ≥30 days prior randomization.,C0205250|C0035647|C0016884|C0007226|C0441471|C0027061|C0021308|G0000000|C0439228|C0332152|C0034656
"We selected subjects based on the following criteria: Physician diagnosis of COPD FEV1 < 65% of predicted, and ratio of FEV1 to forced vital capacity (FVC) < 0.70 ≥ 45 y of age  We excluded subjects who had: A COPD exacerbation that required systemic steroids, antibiotics, emergency-department visit, or hospitalization within the past month Any planned major pulmonary intervention in the coming 3 months (eg, lung-volume-reduction surgery) Severe peripheral vascular disease and claudication or other physical condition that would preclude a 6-min walk test Inability to perform bicycle ergometry Severe cognitive dysfunction (Mini Mental State Examination score ≤ 24) Inability to speak English Current participation in a conventional pulmonary rehabilitation program or regular practice of tai chi  The intervention consisted of 1-hour group tai chi classes customized for patients with respiratory disease, and held twice weekly for 12 weeks.","We selected subjects based criteria: Physician diagnosis COPD FEV1 < 65% predicted, ratio FEV1 forced vital capacity (FVC) < 0.70 ≥ 45 age We excluded subjects had: A COPD exacerbation required systemic steroids, antibiotics, emergency-department visit, hospitalization month Any planned major pulmonary intervention coming 3 months (eg, lung-volume-reduction surgery) Severe peripheral vascular disease claudication physical condition preclude 6-min walk test Inability perform bicycle ergometry Severe cognitive dysfunction (Mini Mental State Examination score ≤ 24) Inability speak English Current participation conventional pulmonary rehabilitation program regular practice tai chi The intervention consisted 1-hour tai chi classes customized patients respiratory disease, held weekly 12 weeks.",G0000000|C1707391|C0681850|C1527178|C0243161|C0031831|C0011900|C0024117|G0000000|G0000000|C0450371|C0681842|C0456603|G0000000|C0441722|C0442732|C1516240|C3714541|G0000000|C0450371|G0000000|C0450371|C0001779|G0000000|C1554077|C0681850|G0000000|G0000000|C0024117|G0000000|C1514873|C0205373|C0038317|C0003232|C0562508|C0545082|C0019993|C0332177|G0000000|C1301732|C0205082|C0024109|C0886296|G0000000|G0000000|C0439231|C0013715|C0524689|C0038894|C0205082|C0205100|C0005847|C0012634|C0311395|C0031809|C0012634|G0000000|C0702093|C0080331|C0022885|G0000000|C0884358|C0005375|C0085143|C0205082|C1516691|C0031847|C0445542|C0229992|C1301808|G0000000|C0449820|G0000000|C0450371|G0000000|C0234856|C0376245|C0521116|C0679823|C0439858|C0024109|C0034991|C1709697|C0205272|C0237607|G0000000|C1720589|G0000000|C0886296|C0332529|C0439227|G0000000|C1720589|C0456387|C1880202|C0030705|C0521346|C0012634|C0675390|C0332174|C0450371|C0439230
"Paracetamol or ibuprofen given in the previous six hours Severe or life threatening infection Suspected chicken pox Cellulitis or other spreading skin infection Known to be immunosuppressed Allergy to either ibuprofen or paracetamol Medicated with warfarin, heparin, or antihypertensives Symptoms of active gastrointestinal bleeding Known coagulopathy Acute jaundice Likely dehydration, defined as more than four episodes of diarrhoea or vomiting in the previous 24 hours Asthma, defined as a need for regular “preventer” medication Chronic renal, liver, or cardiac failure Combined paracetamol and ibuprofen were better at reducing fever after one hour than paracetamol alone.","Paracetamol ibuprofen previous hours Severe life threatening infection Suspected chicken pox Cellulitis spreading skin infection Known immunosuppressed Allergy ibuprofen paracetamol Medicated warfarin, heparin, antihypertensives Symptoms active gastrointestinal bleeding Known coagulopathy Acute jaundice Likely dehydration, defined episodes diarrhoea vomiting previous 24 hours Asthma, defined regular “preventer” medication Chronic renal, liver, cardiac failure Combined paracetamol ibuprofen reducing fever hour paracetamol alone.",C0000970|C0020740|C0205156|C0439227|C0205082|C0376558|G0000000|C0009450|C0332147|C0008051|C1418945|C0007642|C0332261|C0444099|C0009450|C0205309|C0085393|C0002111|C0020740|C0000970|C3812868|C0043031|C0019134|C0003364|C0683368|C0205177|C0521362|C0019080|C0205309|C0005779|C0205178|C0022346|C0332148|C0011175|C1704788|C0332189|C0011991|C0042963|C0205156|G0000000|C0004096|C1704788|C0205272|G0000000|C0013227|C0205191|C0022646|C0023884|C0018787|C0231174|C0205195|C0000970|C0020740|C0392756|C0015967|C0439227|C0000970|C0205171
"Study partner and patient interviews did not always occur on the same day, and the ordering of the two was at the discretion of the participants.","Study partner patient interviews occur day, discretion participants.",C0557651|C0682323|C0030705|C0021822|C1709305|C0332173|G0000000|C0679646
Inclusion criteria are a clinical diagnosis of hemorrhagic or ischemic stroke and the possibility to start treatment within 12 hours from onset of symptoms.,Inclusion criteria clinical diagnosis hemorrhagic ischemic stroke possibility start treatment 12 hours onset symptoms.,C0007637|C0243161|C0205210|C0011900|C0333275|C0475224|C0038454|C0332149|C0439659|C0039798|C0450371|C0439227|C0206132|C0683368
Patients could participate when they suffered from subjective sleep problems at baseline according to the Epworth Sleepiness Scale (ESS) questionnaire and their mean sleep onset latency measured by means of actigraphy was longer than 15 min.,Patients participate suffered subjective sleep baseline Epworth Sleepiness Scale (ESS) questionnaire sleep onset latency measured actigraphy 15 min.,C0030705|G0000000|C0683278|C0439655|C0037313|C0168634|G0000000|C0013144|C0175659|C0206630|C0034394|C0037313|C0206132|C0205275|C0444706|C1171301|C0450371|C0702093
"Eligible cases were defined as Chinese, over 15 years old and resident in Zhejiang Province with leukaemia, histopathologically confirmed according to the haematological standards (Zhang, 1998).","Eligible defined Chinese, 15 resident Zhejiang Province leukaemia, histopathologically confirmed haematological standards (Zhang, 1998).",C1548635|C1704788|C0008120|C0450371|C1320928|G0000000|C1514578|C0023418|G0000000|C0521093|C0018943|C0038137|G0000000|G0000000
"amean±SD, *p<0.05, **p<0.01, EG: experimental group, CG: control group Within 6 months after stroke onset, motor function can be recovered naturally.","amean±SD, *p<0.05, **p<0.01, EG: experimental group, CG: control Within 6 months stroke onset, motor function recovered naturally.",G0000000|C0369773|C0369773|C0013715|C1517586|C0441833|C0043444|C0243148|G0000000|G0000000|C0439231|C0038454|C0206132|C1513492|C0031843|C0521108|G0000000
"Index date for cases and their corresponding controls was advanced to date of first recorded prescription for anti-Parkinson drugs, if prior to first PD diagnosis in the hospital records.","Index controls advanced recorded prescription anti-Parkinson drugs, prior PD diagnosis hospital records.",C0918012|C0243148|C0205179|C0034869|C0033080|C1021144|C0013227|C0332152|G0000000|C0011900|C0019994|C0034869
"within 9 hours from onset), in patients with ischemic stroke (as opposed to hemorrhagic stroke), and in patients with non-lacunar ischemic stroke.","9 hours onset), patients ischemic stroke (as opposed hemorrhagic stroke), patients non-lacunar ischemic stroke.",G0000000|C0439227|C0206132|C0030705|C0475224|C0038454|G0000000|G0000000|C0333275|C0038454|C0030705|C1518422|C0475224|C0038454
The study population is the stroke patients at the Sahlgrenska stroke care unit.,The study population stroke patients Sahlgrenska stroke care unit.,G0000000|C0557651|C0032659|C0038454|C0030705|G0000000|C0038454|C1947933|C0439148
Many more people are being diagnosed earlier in the course of memory loss because of improving sensitivity and specificity of diagnostic techniques and increased awareness of Alzheimer's disease and related disorders.,Many people diagnosed earlier memory loss improving sensitivity specificity diagnostic techniques increased awareness Alzheimer's disease disorders.,G0000000|C0027361|C0011900|C1279919|C0025260|C1517945|C1272745|C0020517|C0037791|C0011900|C0025664|C0205217|C0004448|G0000000|C0012634|C0012634
Subjects then rated the capsaicin induced pain on a 0-10 scale (NPRS) for each leg independently.,Subjects rated capsaicin induced pain 0-10 scale (NPRS) leg independently.,C0681850|C0871208|C0006931|C0205263|C0030193|C0450371|C0175659|C1417814|C0023216|G0000000
"DESIGN—Neonates (⩽ 28 days) in intensive care, with birth weights of 500-1500 g, absolute neutrophil count (ANC) of ⩽ 5 × 109/l, and clinical evidence of sepsis, were randomly assigned to receive either rhG-CSF (10 µg/kg/day) administered intravenously (n = 13), or placebo (n = 15) for a maximum of 14 days, in addition to standard treatment and antibiotics.","DESIGN—Neonates (⩽ 28 days) intensive care, birth weights 500-1500 g, absolute neutrophil count (ANC) ⩽ 5 × 109/l, clinical evidence sepsis, randomly assigned receive rhG-CSF (10 µg/kg/day) administered intravenously (n = 13), placebo (n = 15) maximum 14 days, addition standard treatment antibiotics.",G0000000|G0000000|C0450371|C0439228|C0162425|C1947933|C0005615|C0043100|C1442061|C0439267|C0205344|C0027950|C0750480|C0948762|G0000000|G0000000|G0000000|C1442061|C0205210|C3887511|C0036690|G0000000|C1516050|C1514756|C0376562|C0450371|G0000000|C1521801|G0000000|C0369718|G0000000|C0450371|C0032042|C0369718|G0000000|C0450371|C0806909|C0450371|C0439228|C0332287|C1442989|C0039798|C0003232
"In the Erasmus MC, treatment of pain in the acute phase of GBS is standardized following the WHO’s pain ladder.","In Erasmus MC, treatment pain acute phase GBS standardized WHO’s pain ladder.",G0000000|G0000000|C0024403|C0039798|C0030193|C0205178|C0205390|C0018378|G0000000|G0000000|C0030193|C0336762
"The exclusion criteria were: hospitalization; COPD instability; presence of neuromuscular disease, associated respiratory disease, orthopedic or neurological disease that affected gait; recent impairment due to comorbidities, such as myocardial infarction, heart failure, stroke or neoplasm; prior pneumonectomy or other thoracic surgery.","The exclusion criteria were: hospitalization; COPD instability; presence neuromuscular disease, respiratory disease, orthopedic neurological disease gait; impairment comorbidities, myocardial infarction, heart failure, stroke neoplasm; prior pneumonectomy thoracic surgery.",G0000000|C0680251|C0243161|G0000000|C0019993|C0024117|C1444783|C0150312|C1979768|C0012634|C0521346|C0012634|C0029355|C0205494|C0012634|C0016928|C0221099|C0009488|C0027061|C0021308|C0018787|C0231174|C0038454|C0027651|C0332152|C0032284|G0000000|C0038894
"Eligibility requirements were 18 years of age, HIV-positive serostatus, and experience of sexual abuse as a child (0–12 years) or adolescent (13–17 years).","Eligibility requirements 18 age, HIV-positive serostatus, experience sexual abuse child (0–12 years) adolescent (13–17 years).",C0013893|C1514873|C0450371|C0001779|C0019699|G0000000|C0237607|C0036864|C0013146|C0008059|G0000000|C0439234|C0205653|G0000000|C0439234
"The inclusion criteria of the study were being primiparous with intrauterine pregnancy over 20 weeks, obtaining a score of 14 to 19 in BDI, being above 18 years old, not consuming fish twice a week (those who regularly used fish were removed from the study and were replaced by the next individual), not suffering from schizophrenia, bipolar disorders, blood disorders, such as VonWillebrand, hypertension, and hyperlipidemia, and renal and thyroid diseases, not taking anticoagulants and antidepressants, not smoking or using narcotics, and not participating in activities such as yoga, relaxation, and psychological consultations.","The inclusion criteria study primiparous intrauterine pregnancy 20 weeks, obtaining score 14 19 BDI, 18 old, consuming fish week (those regularly fish removed study replaced individual), suffering schizophrenia, bipolar disorders, blood disorders, VonWillebrand, hypertension, hyperlipidemia, renal thyroid diseases, anticoagulants antidepressants, smoking narcotics, participating activities yoga, relaxation, psychological consultations.",G0000000|C0007637|C0243161|C0557651|C0033150|C0694756|C0032961|C0450371|C0439230|C1301820|C0449820|C0450371|C0450371|C0006448|C0450371|C0580836|G0000000|C0016163|C0332174|G0000000|G0000000|C0016163|C0849355|C0557651|C0559956|C0027361|C0683278|C0036341|C0443156|C0012634|C0005767|C0012634|G0000000|C0020538|C0020473|C0022646|C0040132|C0012634|C0003280|C0003289|C0037369|C0027415|C0679823|C0441655|C0043418|C0035028|C0205486|C0009818
"Women aged 18–45 years diagnosed with GDM by a 75-g oral glucose tolerance test at 20–32 weeks’ gestation, with an otherwise healthy singleton pregnancy, were eligible for the study.","Women aged 18–45 diagnosed GDM 75-g oral glucose tolerance test 20–32 weeks’ gestation, healthy singleton pregnancy, eligible study.",C0043210|C0001779|G0000000|C0011900|C0085207|C0450371|C0442027|C0017725|C0013220|C0022885|G0000000|G0000000|C0032961|C3898900|C0481462|C0032961|C1548635|C0557651
"Exclusion criteria included: a significant acute or chronic, or medical or psychiatric illness requiring institution of new medical or surgical treatment, or a significant dose alteration for uncontrolled symptoms or drug toxicity within 3 months; diagnosis of cancer, or treatment for cancer, within 3 years; systolic blood pressure ≥ 140 mmHg, diastolic blood pressure ≥ 90 mmHg; a health condition placing the potential subject in a risk group recommended for routine influenza immunization by Advisory Committee on Immunization Practices (ACIP), e.g.","Exclusion criteria included: acute chronic, medical psychiatric illness requiring institution medical surgical treatment, dose alteration uncontrolled symptoms drug toxicity 3 months; diagnosis cancer, treatment cancer, 3 years; systolic blood pressure ≥ 140 mmHg, diastolic blood pressure ≥ 90 mmHg; health condition placing potential subject risk recommended routine influenza immunization Advisory Committee Immunization Practices (ACIP), e.g.",C0680251|C0243161|C0332257|C0205178|C0205191|C0199168|C0205487|C0221423|G0000000|C0018704|C0199168|C0543467|C0039798|C0178602|C1515926|C0205318|C0683368|C0013227|C0040539|G0000000|C0439231|C0011900|C0006826|C0039798|C0006826|G0000000|C0439234|C0039155|C0005767|C0033095|G0000000|C1442061|C0439475|C0012000|C0005767|C0033095|G0000000|C0450371|C0439475|C0018684|C0012634|C0442504|C3245505|C0681850|C0035647|C0034866|C0205547|C0021400|C0020971|G0000000|C2699414|C0020971|C0237607|G0000000|G0000000
"Moreover, it may contribute towards increasing the value of the presence of a companion of the woman's choice.","Moreover, contribute increasing presence companion woman's choice.",G0000000|C1880177|C0442808|C0150312|C0031268|C0043210|C0008300
"Of the 841 patients, 42% had at least one psychiatric disorder.","Of 841 patients, 42% psychiatric disorder.",G0000000|C1442061|C0030705|C0450371|C0205487|C0012634
Map of study area and 40 candidate study villages Community consent to participate in the study will be obtained through meetings with village leaders and inhabitants.,Map study 40 candidate study villages Community consent participate study meetings village leaders inhabitants.,C0024779|C0557651|C0450371|G0000000|C0557651|C0562518|C0009462|C1511481|G0000000|C0557651|C0556656|C0562518|G0000000|G0000000
Withdrawals from and time on randomised treatment  Reasons for withdrawal from treatment.,Withdrawals time randomised treatment  Reasons withdrawal treatment.,C2349954|C0040223|G0000000|C0039798|G0000000|C2349954|C0039798
"In this prospective, randomized, double-blinded and placebo-controlled trial, 38 critically ill patients with multiple organ failure (MOF), systemic inflammatory response syndrome (SIRS)/sepsis, and early clinical signs of CIPNM were included.","In prospective, randomized, double-blinded placebo-controlled trial, 38 critically ill patients multiple organ failure (MOF), systemic inflammatory response syndrome (SIRS)/sepsis, clinical signs CIPNM included.",G0000000|C0023981|C0034656|C0205173|C1706408|C0008976|C0450371|G0000000|C0231218|C0030705|C0439064|C0178784|C0231174|G0000000|C0205373|C0333348|C0871261|C0039082|C0242966|C0205210|C0220912|G0000000|C0332257
Both of these videos featured African American children and adolescents and were selected as a culturally appropriate tool because 88% of the homeless caregivers in the study were African American.3 Demographic information and HBV vaccine history were then obtained by interview of caregivers and adolescents.,Both videos featured African American children adolescents selected culturally tool 88% homeless caregivers study African American.3 Demographic HBV vaccine history interview caregivers adolescents.,G0000000|C0042655|C1521970|C0027567|C0596070|C0008059|C0205653|C1707391|C0010453|C0336791|C0450371|C0237154|C0085537|C0557651|C0027567|C0596070|C0011298|G0000000|C0042210|C0019664|C0021822|C0085537|C0205653
"We identified 514 incident cases of PD (324 men, 190 women) during follow-up.","We identified 514 incident PD (324 men, 190 women) follow-up.",G0000000|C0205396|C1442061|C1551358|G0000000|C1442061|C0025266|C1442061|C0043210|C0589120
"Moreover, they should not be colonized with Burkholderia Cepacia, or have respiratory infections during the treatment or 2 weeks before and therapy with rhDNase or routinely use of antibiotics.","Moreover, colonized Burkholderia Cepacia, respiratory infections treatment 2 weeks therapy rhDNase routinely antibiotics.",G0000000|G0000000|C0282676|G0000000|C0521346|C3714514|C0039798|G0000000|C0439230|C0039798|C1135662|G0000000|C0003232
Women were eligible for participation if they had undergone RRSO before the age of 52 years and reported at least two moderate‐to‐severe menopausal symptoms in the two preceding weeks.,Women eligible participation undergone RRSO age 52 reported moderate‐to‐severe menopausal symptoms preceding weeks.,C0043210|C1548635|C0679823|G0000000|G0000000|C0001779|C0450371|C0684224|G0000000|C0025320|C0683368|C0332152|C0439230
Full consent and collaboration of pregnant women and their husbands in order to participate in the intervention.,Full consent collaboration pregnant women husbands participate intervention.,C0443225|C1511481|C0282116|C0549206|C0043210|C0242664|G0000000|C0886296
Exclusion criteria included any condition or medication that could affect glucose levels and unwillingness to follow the prescribed diet.,Exclusion criteria included condition medication affect glucose levels unwillingness follow prescribed diet.,C0680251|C0243161|C0332257|C0012634|C0013227|C0001721|C0017725|C0441889|C0558080|C0332283|C0278329|C0012155
They were nonsmokers or exsmokers who have not smoked for at least 6 months and reversible airflow limitation >12% and >200 mL (postbronchodilator FEV1 >12% and >200 mL).,They nonsmokers exsmokers smoked 6 months reversible airflow limitation >12% >200 mL (postbronchodilator FEV1 >12% >200 mL).,G0000000|C0337672|G0000000|C0037366|G0000000|C0439231|C0205343|C0231999|C0449295|C0450371|C1442061|C0439526|C2599594|G0000000|C0450371|C1442061|C0439526
"Adults with traumatic brain injury, who are within 8 h of injury and have any intracranial bleeding on computerized tomography (CT scan) or Glasgow Coma Score (GCS) of 12 or less can be included if the responsible doctor is substantially uncertain as to whether or not to use TXA in this patient.","Adults traumatic brain injury, 8 injury intracranial bleeding computerized tomography (CT scan) Glasgow Coma Score (GCS) 12 included responsible doctor uncertain TXA patient.",C0001675|C0332663|C0006104|C3263722|G0000000|C3263722|C0524466|C0019080|G0000000|C0040395|C0007673|C0034606|G0000000|C0009421|C0449820|G0000000|C0450371|C0332257|C1273518|C0031831|C0087130|G0000000|C0030705
"Patients with the following criteria were excluded: (a) Penetrating brain injury; (b) significant drop in blood pressure (systolic blood pressure of <90 or diastolic blood pressure of <60 mmHg) and/or significant hypoxia prior to admission; (c) bilateral fixed and dilated pupils; (d) severe injury to other organ systems which may lead to marked morbidity or even mortality; (e) concomitant traumatic spinal cord injury; (f) known pre-morbid immune or neurological diseases; (g) severe head injury with only extradural hematoma, and (h) known pre-morbid condition prior to the accident, including history of seizures.","Patients criteria excluded: (a) Penetrating brain injury; (b) drop blood pressure (systolic blood pressure <90 diastolic blood pressure <60 mmHg) and/or hypoxia prior admission; (c) bilateral fixed dilated pupils; (d) severe injury organ systems lead marked morbidity mortality; (e) concomitant traumatic spinal cord injury; (f) pre-morbid immune neurological diseases; (g) severe head injury extradural hematoma, (h) pre-morbid condition prior accident, including history seizures.",C0030705|C0243161|C1554077|G0000000|C0205321|C0006104|C3263722|G0000000|C1321095|C0005767|C0033095|C0039155|C0005767|C0033095|C0450371|C0012000|C0005767|C0033095|C0450371|C0439475|G0000000|C0242184|C0332152|C0184666|G0000000|C0238767|C0443218|C0700124|C0034121|C0073187|C0205082|C3263722|C0178784|C0449913|C0023175|C0522501|C0026538|C0026565|G0000000|C0521115|C0332663|C0521329|C1550235|C3263722|C0016327|C0332152|C0439662|C0205494|C0012634|C0439267|C0205082|C0018670|C3263722|G0000000|C0018944|C0033727|C0332152|C0012634|C0332152|C0000924|C0332257|C0019664|C0036572
"The Institute of Medicine has also stated that electronic medical record systems are “an essential technology for health care” (Institute of Medicine, Committee on Improving the Medical Record 1991) that could improve medical practice (Johnston et al.","The Institute Medicine stated electronic medical record systems “an essential technology health care” (Institute Medicine, Committee Improving Medical Record 1991) improve medical practice (Johnston al.",G0000000|C0021622|C0013227|C1301808|C0013850|C0199168|C0034869|C0449913|G0000000|C0205224|C0039421|C0018684|G0000000|C0021622|C0013227|C2699414|C1272745|C0199168|C0034869|G0000000|G0000000|C0199168|C0237607|G0000000|C0202311
"We analyzed data collected over 25 years from 416 adult men enrolled in the Veterans Affairs Dental Longitudinal Study to evaluate the association of retained asymptomatic third molars with risk of adjacent second molar pathology (caries and/or periodontitis), based on third molar status (i.e., absent, erupted, or unerupted).","We analyzed data collected 25 416 adult enrolled Veterans Affairs Dental Longitudinal Study evaluate association retained asymptomatic molars risk adjacent molar pathology (caries and/or periodontitis), based molar status (i.e., absent, erupted, unerupted).",G0000000|C0936012|C1511726|C1516695|C0450371|C1442061|C0001675|G0000000|C0042610|G0000000|C0011365|C0205127|C0557651|C0220825|C0004083|C0333118|C0231221|C0026367|C0035647|C0205117|C0026367|C0030664|C0011334|G0000000|C0031099|C1527178|C0026367|C0449438|C0683454|C0332197|G0000000|G0000000
"The participants are excluded if they have other diseases limiting their physical or cognitive function, epilepsy, or they are not able to communicate in Finnish, Swedish or English.","The participants excluded diseases limiting physical cognitive function, epilepsy, communicate Finnish, Swedish English.",G0000000|C0679646|C1554077|C0012634|C0439801|C0031809|C1516691|C0031843|C0014544|C0566001|C1711254|C1710263|C0376245
Participants were 96 men and women with a diagnosis of alcohol abuse or dependence and smoking 15 or more cigarettes per day.,Participants 96 women diagnosis alcohol abuse dependence smoking 15 cigarettes day.,C0679646|C0450371|C0043210|C0011900|C0001962|C0013146|C0011546|C0037369|C0450371|C0677453|C0332173
Kaplan–Meier curve for time to recurrence detected in patients with curative therapy for colon or rectal cancer.,Kaplan–Meier curve time recurrence detected patients curative therapy colon rectal cancer.,G0000000|C0205134|C0040223|C0034897|C0442726|C0030705|C1880198|C0039798|C0009368|C0205052|C0006826
"However, in both studies, non-significant increases in CO were observed with bosentan compared to placebo.","However, studies, non-significant increases CO observed bosentan compared placebo.",G0000000|C0947630|C1518422|C0205217|C3245499|C1441672|C0252643|C1707455|C0032042
"When the omnibus treatment by time interaction was statistically significant (P<0.05, two tailed), we did six pairwise comparisons with Bonferroni correction (P<0.0083) at month 10, the primary end point, and, to evaluate longer term treatment effects, at month 16.","When omnibus treatment time interaction statistically (P<0.05, tailed), pairwise comparisons Bonferroni correction (P<0.0083) month 10, primary point, and, evaluate term treatment effects, month 16.",G0000000|G0000000|C0039798|C0040223|C1704675|C0038215|C0369773|C0039259|G0000000|C1707455|G0000000|C1705565|C0369773|C0332177|C0450371|C0205225|C1552961|G0000000|C0220825|C0233324|C0039798|C1280500|C0332177|C0450371
"CONCLUSION: Compared with placebo, cefixime can improve the rate of resolution of symptoms in patients with a sore throat who are selected for antibiotic treatment by their GP.","CONCLUSION: Compared placebo, cefixime improve rate resolution symptoms patients sore throat selected antibiotic treatment GP.",C1707478|C1707455|C0032042|C0060400|G0000000|C0871208|C1514893|C0683368|C0030705|C0234233|C0031354|C1707391|C0003232|C0039798|C3811116
Significant differences between White and African American CGs were noted on several characteristics.,Significant differences White African American CGs characteristics.,C0237881|C1705241|C0007457|C0027567|C0596070|C1707127|C1521970
"The study enrolled preterm infants with a gestational age 28-32 weeks, birth weight ≤2000g, postnatal age 48-96 hours, respiratory distress syndrome (RDS) treated with mechanical ventilation (CPAP [continuous positive airway pressure] or IPPV [intermittent positive pressure ventilation]) with additional oxygen requirements above 30% and one of the following echocardiographic criteria: a ductal size >1.5 mm, a left atrium-to-aorta ratio >1.4, and a left-to-right shunting of blood in addition to signs of PDA.","The study enrolled preterm infants gestational age 28-32 weeks, birth weight ≤2000g, postnatal age 48-96 hours, respiratory distress syndrome (RDS) treated mechanical ventilation (CPAP [continuous positive airway pressure] IPPV [intermittent positive pressure ventilation]) additional oxygen requirements 30% echocardiographic criteria: ductal size >1.5 mm, left atrium-to-aorta ratio >1.4, left-to-right shunting blood addition signs PDA.",G0000000|C0557651|G0000000|C0151526|C0021270|C0439671|C0001779|C0450371|C0439230|C0005615|C0005910|G0000000|C0443281|C0001779|C0450371|C0439227|C0521346|C0231303|C0039082|C0035220|C1522326|C0443254|C0035203|C0199451|C0549178|C0439178|C0178987|C0033095|C0021778|C0205267|C0439178|C0033095|C0035203|C1524062|C0030054|C1514873|C0450371|C0013516|C0243161|C1512083|C0456389|G0000000|G0000000|C0205091|C0018792|C0456603|G0000000|C0439757|C0813207|C0005767|C0332287|C0220912|C0013274
"To compare the healing of chronic wounds with honey dressing vs. Povidone iodine dressing in adult subjects with chronic wounds of ≥6 weeks of duration, attending wound care clinic in Surgical Out Patient Department of All India Institute of Medical Sciences, Surgical Out Patient Department of Jai Prakash Narayan Apex Trauma center, New Delhi.","To compare healing chronic wounds honey dressing vs. Povidone iodine dressing adult subjects chronic wounds ≥6 weeks duration, attending wound care clinic Surgical Out Patient Department All India Institute Medical Sciences, Surgical Out Patient Department Jai Prakash Narayan Apex Trauma center, New Delhi.",C0040363|C1707455|C0043240|C0205191|C0021501|C0019906|C0013119|G0000000|C0032856|C0021966|C0013119|C0001675|C0681850|C0205191|C0021501|G0000000|C0439230|C0449238|C1547429|C0043250|C1947933|C0002424|C0543467|C0439787|C0030705|C1704729|G0000000|C0021201|C0021622|C0199168|C0036397|C0543467|C0439787|C0030705|C1704729|C0326402|G0000000|G0000000|C1522410|C0043251|C0205099|C0205314|G0000000
"99.1% of the children in the control arm received AL compared with 27.5% of the children in the intervention arm, a 4-fold reduction in treatment for malaria.","99.1% children control arm received AL compared 27.5% children intervention arm, 4-fold reduction treatment malaria.",C0450371|C0008059|C0243148|C0446516|C1514756|C0202311|C1707455|C0450371|C0008059|C0886296|C0446516|C0332462|C0301630|C0039798|C0024530
"Data on sex, age, BMI, questionnaire answers and food item leftovers, for each participant.","Data sex, age, BMI, questionnaire answers food item leftovers, participant.",C1511726|C0009253|C0001779|G0000000|C0034394|C1706817|C0016452|C1551338|G0000000|C0679646
"In Niger, 1 community refused to participate, and 20 were excluded due to being misspelled duplicates, nonexistent at the time of census, or indistinguishable from larger neighboring communities.","In Niger, 1 community refused participate, 20 excluded misspelled duplicates, nonexistent time census, indistinguishable larger neighboring communities.",G0000000|C0028074|G0000000|C0009462|C1548564|G0000000|C0450371|C1554077|G0000000|C0205173|G0000000|C0040223|C0007663|G0000000|C0549177|C0205107|C0009462
"If duplicates were detected, the individual was excluded from the study.","If duplicates detected, individual excluded study.",G0000000|C0205173|C0442726|C0027361|C1554077|C0557651
METHODS: Massachusetts adolescents (n = 529) who at baseline had smoked no more than 1 cigarette were reinterviewed by telephone in 1997.,METHODS: Massachusetts adolescents (n = 529) baseline smoked 1 cigarette reinterviewed telephone 1997.,C0025663|C0024874|C0205653|C0369718|G0000000|C1442061|C0168634|C0037366|G0000000|C0677453|G0000000|C0039457|G0000000
Recruitment occurred primarily in response to advertisements in the local newspaper.,Recruitment occurred response advertisements local newspaper.,C2949735|C1709305|C0871261|C0949214|C0205276|C0027989
"Any patients with previous stroke or previous epilepsy/seizure, family history of epilepsy/seizure, any metal substance inserted into the cranial cavity, permanent pacemaker, previous and present other neurological disorders, stroke lesion in cerebellum and contracture of the lower limb on the affected side of the lesion were excluded [10] (Table 1).","Any patients previous stroke previous epilepsy/seizure, family history epilepsy/seizure, metal substance inserted cranial cavity, permanent pacemaker, previous neurological disorders, stroke lesion cerebellum contracture lower limb lesion excluded [10] (Table 1).",G0000000|C0030705|C0205156|C0038454|C0205156|C0014544|C0015576|C0019664|C0014544|C0025552|C0439861|C0441587|C0037303|C0011334|C0205355|C0030163|C0205156|C0205494|C0012634|C0038454|C0221198|C0007765|C0009917|C0441994|C0015385|C0221198|C1554077|C0450371|C0039224|G0000000
Patients between the ages of 18 and 50 were eligible if a sore throat was among their chief complaints.,Patients ages 18 50 eligible sore throat chief complaints.,C0030705|C0001779|C0450371|C0450371|C1548635|C0234233|C0031354|G0000000|C0277786
"Outcomes among patients with cirrhosis and sepsis receiving low-dose hydrocortisone Note: CI = confidence interval, ICU = intensive care unit, SD = standard deviation.","Outcomes patients cirrhosis sepsis receiving low-dose hydrocortisone Note: CI = confidence interval, ICU = intensive care unit, SD = standard deviation.",C1274040|C0030705|C0023890|C0036690|C1514756|C0445550|C0020268|C1316572|C0008107|G0000000|C0237529|C1272706|C0021708|G0000000|C0162425|C1947933|C0439148|C2699239|G0000000|C1442989|C0012727
"Patients in the control group (n = 18) received standard sepsis therapy, but no immunoglobulin administration.","Patients control (n = 18) received standard sepsis therapy, immunoglobulin administration.",C0030705|C0243148|C0369718|G0000000|C0450371|C1514756|C1442989|C0036690|C0039798|C0021027|C0001554
"In the intervening years, more active MAP kinase pathway inhibitors (targeting BRAF and MEK) and antiangiogenic drugs have emerged that appear to be of higher priority for further evaluation, particularly in subsets of patients with melanoma.","In intervening years, active MAP kinase pathway inhibitors (targeting BRAF MEK) antiangiogenic drugs emerged priority evaluation, subsets patients melanoma.",G0000000|G0000000|C0439234|C0205177|C0024779|C0031727|C1704259|C0243077|C1521840|C0104940|C0169101|C0596087|C0013227|G0000000|C0549179|C0220825|C1515021|C0030705|C0025202
"Exclusion criteria included lower respiratory tract infection within 6 weeks, concomitant pulmonary disease, history of asthma, lung cancer or long QT syndrome or QTc > 450 ms (males) or > 470 (females), symptomatic prostatic hyperplasia, bladder-neck obstruction, moderate/severe renal impairment, urinary retention, narrow-angle glaucoma and history of alpha-1 antitrypsin deficiency.","Exclusion criteria included lower respiratory tract infection 6 weeks, concomitant pulmonary disease, history asthma, lung cancer QT syndrome QTc > 450 ms (males) > 470 (females), symptomatic prostatic hyperplasia, bladder-neck obstruction, moderate/severe renal impairment, urinary retention, narrow-angle glaucoma history alpha-1 antitrypsin deficiency.",C0680251|C0243161|C0332257|C0441994|C0521346|C1185740|C0009450|G0000000|C0439230|C0521115|C0024109|C0012634|C0019664|C0004096|C0024109|C0006826|C1552934|C0039082|G0000000|G0000000|C1442061|C0039676|C0086582|G0000000|C1442061|C0015780|C0231220|C0033572|C0020507|C0227716|C0028778|C0205081|C0022646|C0221099|C0042027|C0035280|C0205168|C0017601|C0019664|C0439095|C0072348|C0011155
"(2) Confirmation by computed tomography or magnetic resonance imaging (MRI) of cerebral infarction accompanied by right limb motor dysfunction, meeting the diagnostic criteria for stroke of the Fourth National Cerebrovascular Disease Conference of 1995 (Chinese Society of Neurology and Chinese Society of Neurosurgery, 1996).","(2) Confirmation computed tomography magnetic resonance imaging (MRI) cerebral infarction accompanied limb motor dysfunction, meeting diagnostic criteria stroke Fourth National Cerebrovascular Disease Conference 1995 (Chinese Society Neurology Chinese Society Neurosurgery, 1996).",G0000000|C0521091|C1441526|C0040395|C0024488|C0231881|C0011923|C0024485|G0000000|C0021308|G0000000|C0015385|C1513492|C0031847|C0556656|C0011900|C0243161|C0038454|C0205438|C3245503|C1880018|C0012634|C0086047|G0000000|C0008120|C0037455|C0027855|C0008120|C0037455|C0027926|G0000000
"The minimum followup was 32 months (mean, 99 months; range, 32–312 months) for the patients who remained alive in the end of the study.","The minimum followup 32 months (mean, 99 months; range, 32–312 months) patients remained alive study.",G0000000|C1524031|C0589120|C0450371|C0439231|C0444504|C0450371|C0439231|C1514721|G0000000|C0439231|C0030705|G0000000|C0376558|C0557651
"Exclusion criteria were: any pre-existing ocular disease other than DES; patients on oral tetracycline or corticosteroids and; past history of herpetic eye disease, liver disease, diabetes or laser in situ keratomileusis (LASIK).","Exclusion criteria were: pre-existing ocular disease DES; patients oral tetracycline corticosteroids and; history herpetic eye disease, liver disease, diabetes laser situ keratomileusis (LASIK).",C0680251|C0243161|G0000000|C2347662|C0015392|C0012634|G0000000|C0030705|C0442027|C0039644|C0001617|G0000000|C0019664|C0019340|C0015392|C0012634|C0023884|C0012634|C0011847|C0023089|G0000000|C0339022|C0752094
"Children were eligible to participate if they were 6 months to 12 years of age, weighed at least 5 kg, lived within 10 km from the study clinic and had microscopically confirmed P. falciparum mono-infection with 1000–200,000 asexual parasites/µL.","Children eligible participate 6 months 12 age, weighed 5 kg, lived 10 study clinic microscopically confirmed P. falciparum mono-infection 1000–200,000 asexual parasites/µL.",C0008059|C1548635|G0000000|G0000000|C0439231|C0450371|C0001779|G0000000|G0000000|C0022718|C1548795|C0450371|C0557651|C0002424|G0000000|C0521093|C0369773|G0000000|C1551432|G0000000|C0599655|G0000000
"The following eligibility criteria were required: 40 years of age or older; digital rectal examination; biopsy- confirmed diagnosis of HGPIN with no evidence of cancer; upper limit of prostate-specific antigen (PSA) of 10 ng/mL (as measured locally); American Urological Association (AUA) symptom score of less than 20 (41), signifying no debilitating urinary problems; ambulatory and able to carry out work of a light or sedentary nature.","The eligibility criteria required: 40 age older; digital rectal examination; biopsy- confirmed diagnosis HGPIN evidence cancer; upper limit prostate-specific antigen (PSA) 10 ng/mL (as measured locally); American Urological Association (AUA) symptom score 20 (41), signifying debilitating urinary problems; ambulatory carry light sedentary nature.",G0000000|C0013893|C0243161|C1514873|C0450371|C0001779|C0580836|C0442015|C0205052|G0000000|C0005558|C0521093|C0011900|C1168327|C3887511|C0006826|C1282910|C0439801|C0033572|C0003320|C3810537|C0450371|C0439275|G0000000|C0444706|C1517927|C0596070|G0000000|C0004083|G0000000|C1457887|C0449820|C0450371|C0450371|G0000000|G0000000|C0042027|C1546466|C0439841|C0206243|C0023693|C0205254|C0349590
"Although hormonal treatment is preferred for advanced breast cancer (ABC), chemotherapy (CT) is required for hormone receptor-negative and hormone refractory disease.","Although hormonal treatment preferred advanced breast cancer (ABC), chemotherapy (CT) required hormone receptor-negative hormone refractory disease.",G0000000|C0458083|C0039798|C0558295|C0205179|C0006141|C0006826|C0152244|C0013216|C0007673|C1514873|C0019932|C0597357|C0019932|C0205269|C0012634
"This program is intended to target middle school students in 7th grade and above, rather than 5th grade students with whom it was implemented in these schools (for more detail, see http://nrepp.samhsa.gov/programfulldetails.asp?PROGRAM_ID=109).","This program intended target middle school students 7th grade above, 5th grade students implemented schools (for detail, http://nrepp.samhsa.gov/programfulldetails.asp?PROGRAM_ID=109).",G0000000|C1709697|C1283828|C1521840|C0444598|C0036375|C0038492|G0000000|C0441800|C1282910|G0000000|C0441800|C0038492|G0000000|C0036375|G0000000|C1522508|C1555015
One patient dropped out during terminal ECP treatment (due to pregnancy) and fours patients chose to leave the study during the terminal course of CsA.,One patient dropped terminal ECP treatment (due pregnancy) fours patients chose leave study terminal CsA.,C0205447|C0030705|C1705648|C0205088|C3889675|C0039798|C0678226|C0032961|C0205450|C0030705|C1707391|G0000000|C0557651|C0205088|C0520680
"Exclusion criteria were as follows: history of neurological disease or major surgery in the year preceding the study, auditory or visual impairments that were not corrected, smoking, severe mobility limitations, and any other contraindication to perform physical activity, being currently engaged in any type of structured physical activity.","Exclusion criteria follows: history neurological disease major surgery preceding study, auditory visual impairments corrected, smoking, severe mobility limitations, contraindication perform physical activity, engaged type structured physical activity.",C0680251|C0243161|C0332283|C0019664|C0205494|C0012634|C0205082|C0038894|C0332152|C0557651|C0439825|C0234621|C0684336|C0205202|C0037369|C0205082|C0425245|C0449295|C0522473|C0884358|C0031809|C0205177|C0425152|C0332307|C0678594|C0031809|C0205177
"The criteria for MetS include having ≥3 of the following clinical indicators: increased waist circumference, fasting glucose, triglycerides, and blood pressure (BP) and decreased HDL cholesterol (2).","The criteria MetS ≥3 clinical indicators: increased waist circumference, fasting glucose, triglycerides, blood pressure (BP) decreased HDL cholesterol (2).",G0000000|C0243161|C0812270|G0000000|C0205210|C0021212|C0205217|C0230097|C0332520|C0015663|C0017725|C0041004|C0005767|C0033095|C0037623|C0205216|C3715113|C0008377|G0000000
"Among Hispanic centers, 5 were in each BMI group.","Among Hispanic centers, 5 BMI group.",G0000000|C0086409|C0205099|G0000000|G0000000|C0441833
"A skillful speech therapist evaluated cognitive function and speech function using evaluation tools such as the Korean version of the Western Aphasia Battery, and patients who had aphasia, apraxia of speech, cognitive impairment (MMSE<20), poor mental status, vocal cord palsy, history of epilepsy, or bilateral infarction were excluded.","A skillful speech therapist evaluated cognitive function speech function evaluation tools Korean version Western Aphasia Battery, patients aphasia, apraxia speech, cognitive impairment (MMSE<20), poor mental status, vocal cord palsy, history epilepsy, bilateral infarction excluded.",G0000000|C0678856|C0037817|C0871525|C0220825|C1516691|C0031843|C0037817|C0031843|C0220825|C0336791|C1556095|C0333052|C1705493|C0003537|C0337088|C0030705|C0003537|C0003635|C0037817|C1516691|C0221099|C0451306|C0032854|C0229992|C0449438|C0205382|C1550235|C0522224|C0019664|C0014544|C0238767|C0021308|C1554077
"DESIGN—A prospective, controlled trial was conducted in four TV regions in central and northern England.","DESIGN—A prospective, controlled trial conducted TV regions central northern England.",G0000000|C0023981|C2587213|C0008976|C0004927|C0040210|C0017446|C0205099|C1709269|C0014282
"Baseline visual function (contrast sensitivity, colour error score and visual field mean sensitivity), MPOD, mean foveal and RNFL thickness and serum laboratory values (glycohaemoglobin (HbA1c), serum lipids, 25-OH-vitamin D3, hsCRP and TNF-α) were all without significant difference.","Baseline visual function (contrast sensitivity, colour error score visual field sensitivity), MPOD, foveal RNFL thickness serum laboratory values (glycohaemoglobin (HbA1c), serum lipids, 25-OH-vitamin D3, hsCRP TNF-α) difference.",C0168634|C0234621|C0031843|C0009924|C0020517|C0009393|C0743559|C0449820|C0234621|C0440042|C0020517|C0398595|C0016622|G0000000|C1280412|C0229671|C0022877|C0042295|C0696092|G0000000|C0229671|C0023779|C0450371|C3538936|G0000000|G0000000|C1705241
"Patients aged 18 years or older who were delirium free, with an anticipated ICU stay of at least 2 days as estimated by the attending intensivist, were eligible for study participation.","Patients aged 18 delirium free, anticipated ICU stay 2 days estimated attending intensivist, eligible study participation.",C0030705|C0001779|C0450371|C0011206|C0332296|C3840775|C0021708|G0000000|G0000000|C0439228|C0750572|C1547429|G0000000|C1548635|C0557651|C0679823
The project will involve care homes for older people (average age > 65 years) registered with a GP in the local area.,The project involve care homes people (average age > 65 years) registered GP local area.,G0000000|C1709701|G0000000|C1947933|C0442519|C0027361|C1510992|C0001779|G0000000|C0450371|C0439234|C1514821|C3811116|C0205276|C0017446
"The criteria for enrolment were a diagnosis of CF (sweat chloride >60 mmol/l or a genotype known to cause the disease), age 6–21 years, ability to perform reproducible pulmonary function tests with spirometry, forced expiratory volume in 1 second (FEV1) >40% of the predicted value, and ability to swallow tablets.","The criteria enrolment diagnosis CF (sweat chloride >60 mmol/l genotype disease), age 6–21 years, ability perform reproducible pulmonary function tests spirometry, forced expiratory volume 1 second (FEV1) >40% predicted value, ability swallow tablets.",G0000000|C0243161|C1516879|C0011900|C0009738|C0038984|C0008203|G0000000|C0017431|C0012634|C0001779|G0000000|C0085732|C0884358|C1514863|C0024109|C0031843|C0022885|C0037981|C0441722|C0231800|C0449468|G0000000|G0000000|C0450371|C0681842|C1522609|C0085732|C0326374|C0039225
All participants were seeking outpatient treatment for problems related to cannabis use and were recruited by local advertising or by referrals in the New York City metropolitan area.,All participants seeking outpatient treatment cannabis recruited local advertising referrals New York City metropolitan area.,G0000000|C0679646|G0000000|C0029921|C0039798|C0024808|G0000000|C0205276|C0001690|C0034927|C0205314|G0000000|C0008848|C0599587|C0017446
In the Southern nursing home two wards will be the intervention group and two wards in the same location will be the comparison group.,In Southern nursing wards intervention wards location comparison group.,G0000000|C1710133|C0006147|C1305702|C0886296|C1305702|C0450429|C1707455|C0441833
"Thus, 115 nurses were valuable for the purpose of the study.","Thus, 115 nurses valuable purpose study.",G0000000|C1442061|C0028661|G0000000|C1285529|C0557651
No serious adverse events were reported.,No adverse events reported.,G0000000|G0000000|C0441471|C0684224
"Patients were enrolled within 84 days of complete surgical excision of the primary tumor (lumpectomy or mastectomy) and an axillary dissection (with at least six nodes removed), or a sentinel node biopsy alone (if the sentinel node was negative).","Patients enrolled 84 days complete surgical excision primary tumor (lumpectomy mastectomy) axillary dissection (with nodes removed), sentinel node biopsy (if sentinel node negative).",C0030705|G0000000|C0450371|C0439228|C0205197|C0543467|C0015252|C0205225|C0027651|C0851238|C0024881|C0004454|C0012737|G0000000|C0746922|C0849355|C0950580|C0746922|C0005558|G0000000|C0950580|C0746922|C0205160
"Stratification factors were smoking status (current, former, or never), sex, and stage (IA v IB with other therapy v IB without other therapy).","Stratification factors smoking status (current, former, never), sex, stage (IA IB therapy IB therapy).",C1514983|C1521761|C0037369|C0449438|C0521116|C0205156|C2003901|C0009253|C0205390|C0694634|C2744579|C0039798|C2744579|C0039798
"Patients with severe sepsis or septic shock receiving mechanical ventilation (MV) for hypoxemic respiratory failure were eligible if, within 12 h of study entry, they met the diagnostic criteria for acute lung injury-ARDS according to the American-European Consensus definition [12], as later reclassified on the basis of the 2012 Berlin criteria for the diagnosis of ARDS [13].","Patients severe sepsis septic shock receiving mechanical ventilation (MV) hypoxemic respiratory failure eligible if, 12 study entry, met diagnostic criteria acute lung injury-ARDS American-European Consensus definition [12], reclassified basis 2012 Berlin criteria diagnosis ARDS [13].",C0030705|C0205082|C0036690|C0333534|C0036974|C1514756|C0443254|C0035203|C0428679|G0000000|C0521346|C0231174|C1548635|G0000000|C0450371|C0557651|C1705654|C0268621|C0011900|C0243161|C0205178|C0024109|C3263722|C0596070|C0376298|C1550452|C0450371|C0205542|C1527178|G0000000|C0005125|C0243161|C0011900|C0035222|C0450371
Asthma was diagnosed by primary care doctors based on the Japanese pediatric guidelines for the treatment and management of bronchial asthma 2005 [10].,Asthma diagnosed primary care doctors based Japanese pediatric guidelines treatment management bronchial asthma 2005 [10].,C0004096|C0011900|C0205225|C1947933|C0031831|C1527178|C1556094|C0030755|C0162791|C0039798|C0001554|C0205039|C0004096|G0000000|C0450371
Chronic pain patients (N=115; mean age = 48±14; 68% female) were randomized to 8 weeks of MORE or a Support Group (SG).,Chronic pain patients (N=115; age = 48±14; 68% female) randomized 8 weeks MORE Support Group (SG).,C0205191|C0030193|C0030705|C0369718|C0001779|G0000000|G0000000|C0450371|C0015780|C0034656|G0000000|C0439230|C0205172|C0183683|C0441833|C0036644
Smokers who were physically or mentally unable to communicate or currently following other forms of smoking cessation programme were excluded from this RCT.,Smokers physically mentally unable communicate forms smoking cessation programme excluded RCT.,C0337664|G0000000|G0000000|C1299582|C0566001|C0348078|C0037369|C1880019|C1709697|C1554077|G0000000
A total of 69 patients aged 18 years and older with an expected ICU length of stay >48 hours will be recruited from 3 Canadian ICUs.,A total 69 patients aged 18 years expected ICU length stay >48 hours recruited 3 Canadian ICUs.,G0000000|C0439175|C0450371|C0030705|C0001779|G0000000|C1517001|C0021708|C1444754|G0000000|G0000000|G0000000|G0000000|C0238884|C0021708
"Breast cancer was confirmed using pathological methods, and cases with evidence of distant metastasis were excluded from the study.","Breast cancer confirmed pathological methods, evidence distant metastasis excluded study.",C0006141|C0006826|C0521093|C0030664|C0025663|C3887511|C0443203|C0027627|C1554077|C0557651
"A total of 39 participants were randomized, placebo (n = 18) and omega-3 fatty acids (n = 21).","A total 39 participants randomized, placebo (n = 18) omega-3 fatty acids (n = 21).",G0000000|C0439175|C0450371|C0679646|C0034656|C0032042|C0369718|G0000000|C0450371|C1719844|G0000000|C0001128|C0369718|G0000000|C0450371
"Patients manifesting schizophrenia-like symptoms due to any organic disorder such as dementia or any other cognitive impairment, abuse of alcohol or of drugs acting on the central nervous system and those with clinical evidence of epilepsy or intellectual disability were excluded.","Patients manifesting schizophrenia-like symptoms organic disorder dementia cognitive impairment, abuse alcohol drugs acting central nervous system clinical evidence epilepsy intellectual disability excluded.",C0030705|C0205319|C0036341|C0683368|C0747055|C0012634|C0011265|C1516691|C0221099|C0013146|C0001962|C0013227|G0000000|C0205099|C0027769|C0449913|C0205210|C3887511|C0014544|G0000000|C0231170|C1554077
"Subjects were 7 to 11 years old, had −0.75 to −5.00 spherical component and less than 1.00 diopter (D) astigmatism, and had 20/25 or better logMAR distance visual acuity with manifest refraction in each eye and with +2.50-D add soft bifocal contact lenses on both eyes.","Subjects 7 11 old, −0.75 −5.00 spherical component 1.00 diopter (D) astigmatism, 20/25 logMAR distance visual acuity manifest refraction eye +2.50-D add soft bifocal contact lenses eyes.",C0681850|G0000000|C0450371|C0580836|G0000000|G0000000|C0332501|C0449432|C0450371|C0439484|C0073187|C0004106|C0450371|G0000000|C0012751|C0234621|C0750509|C0205319|C0429585|C0015392|C0450371|C1883712|C0205358|C1275647|C0332158|C0023317|C0015392
"One possible explanation for the higher rate of periprocedural stroke in this trial as compared with the registries is that all the patients in this study had stenosis of 70 to 99% and recent symptoms, whereas the registries included patients with stenosis of 50 to 99% and symptoms that had occurred more than 30 days before enrollment.","One explanation rate periprocedural stroke trial compared registries patients study stenosis 70 99% symptoms, registries included patients stenosis 50 99% symptoms occurred 30 days enrollment.",C0205447|C0681841|C0871208|G0000000|C0038454|C0008976|C1707455|C0034975|C0030705|C0557651|C0678234|C0450371|C0450371|C0683368|C0034975|C0332257|C0030705|C0678234|C0450371|C0450371|C0683368|C1709305|C0450371|C0439228|C1516879
"METHODS—The physiological actions and patient self-assessment of manually assisted cough and mechanical insufflation were investigated in 29 subjects (nine normal subjects, eight patients with chronic obstructive pulmonary disease (COPD), four subjects with respiratory muscle weakness (RMW) with scoliosis, and eight subjects with RMW without scoliosis).","METHODS—The physiological actions patient self-assessment manually assisted cough mechanical insufflation investigated 29 subjects (nine normal subjects, patients chronic obstructive pulmonary disease (COPD), subjects respiratory muscle weakness (RMW) scoliosis, subjects RMW scoliosis).",G0000000|C0205463|C0441472|C0030705|C0036591|C3842330|C1269765|C0010200|C0443254|C0021634|C1292732|C0450371|C0681850|C0205455|C0205307|C0681850|C0030705|C0205191|C0549186|C0024109|C0012634|C0024117|C0681850|C0521346|C0026845|C3714552|G0000000|C0036439|C0681850|G0000000|C0036439
"Patients were provided with two inhalers: one for fluticasone/formoterol, formoterol or placebo (which were identical in appearance), and one for fluticasone or a visually identical fluticasone placebo.","Patients provided inhalers: fluticasone/formoterol, formoterol placebo (which identical appearance), fluticasone visually identical fluticasone placebo.",C0030705|C1999230|C0021461|C3849509|C0060657|C0032042|G0000000|C0205280|C0233426|C0082607|G0000000|C0205280|C0082607|C0032042
It is currently unclear how to maximise arm recovery after stroke.,It unclear maximise arm recovery stroke.,G0000000|G0000000|G0000000|C0446516|C0237820|C0038454
A total number of 100 cases of superficial thermal burns involving less than 40% of the total body surface area (TBSA) treated in our unit over the period 20 March 2010 to 20 March 2011 provided the material for this study.,A total 100 superficial thermal burns involving 40% total body surface (TBSA) treated unit period 20 March 2010 20 March 2011 provided material study.,G0000000|C0439175|C1442061|C0205124|G0000000|C0006434|C1314939|C0450371|C0439175|C0242821|C0205148|G0000000|C1522326|C0439148|C0439531|C0450371|C3829202|G0000000|C0450371|C3829202|G0000000|C1999230|C0520510|C0557651
"Symptomatic snoring children with an apnea–hypopnea index (AHI) greater than 2/hour total sleep time (TST) on overnight polysomnography and for whom adenotonsillectomy was contemplated, with or without a history of allergic rhinitis, were deemed eligible for inclusion.","Symptomatic snoring children apnea–hypopnea (AHI) 2/hour total sleep time (TST) overnight polysomnography adenotonsillectomy contemplated, history allergic rhinitis, deemed eligible inclusion.",C0231220|C0037384|C0008059|G0000000|G0000000|C0439227|C0439175|C0037313|C0040223|C1421210|C0439583|C0162701|C0193959|G0000000|C0019664|C0700624|C0035455|G0000000|C1548635|C0007637
"In gastric cancer, the role of laparoscopic surgery remains unclear.","In gastric cancer, role laparoscopic surgery remains unclear.",G0000000|C0038351|C0006826|C0035820|C0031150|C0038894|G0000000|G0000000
A total of 38 critically ill patients were included and randomized to receive either IgM-enriched IVIG (n = 19) or placebo (n = 19).,A total 38 critically ill patients included randomized receive IgM-enriched IVIG (n = 19) placebo (n = 19).,G0000000|C0439175|C0450371|G0000000|C0231218|C0030705|C0332257|C0034656|C1514756|C1706005|C0085297|C0369718|G0000000|C0450371|C0032042|C0369718|G0000000|C0450371
"The inclusion criteria are as follows: over 18 years of age; absolutely homelessb or precariously housedc; living in the city in question for more than six months and intending to stay in that same city for the coming two years; possessing a ‘higher’ level of need, defined as having a diagnosis of schizophrenia or bipolar disorder according to Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV-TR) criteria [31] and moderate to severe disability according the Multnomah Community Ability Scale (score ≤ 62) [32,33] and meet at least one of the following three criteria: 1) having been hospitalized for mental illness two or more times in any one year over the last five years, or 2) having co-morbid alcohol or substance use, or 3) having been arrested or incarcerated over the last two years; being covered by French government health insurance including free state aid; and speaking French.","The inclusion criteria follows: 18 age; absolutely homelessb precariously housedc; living city question months intending stay city coming years; possessing ‘higher’ level need, defined diagnosis schizophrenia bipolar disorder Diagnostic Statistical Manual Mental Disorders, fourth edition (DSM-IV-TR) criteria [31] moderate severe disability Multnomah Community Ability Scale (score ≤ 62) [32,33] meet criteria: 1) hospitalized mental illness times years, 2) co-morbid alcohol substance use, 3) arrested incarcerated years; covered French government health insurance including free aid; speaking French.",G0000000|C0007637|C0243161|C0332283|C0450371|C0001779|G0000000|G0000000|G0000000|G0000000|C0376558|C0008848|C1522634|C0439231|G0000000|G0000000|C0008848|G0000000|C0439234|C0850310|G0000000|C0441889|C0027552|C1704788|C0011900|C0036341|C0443156|C0012634|C0011900|C0038215|C0024763|C0229992|C0012634|C0205438|C0441792|C0220952|C0243161|C0450371|C0205081|C0205082|C0231170|G0000000|C0009462|C0085732|C0175659|G0000000|C0450371|C1550543|C0243161|G0000000|C0701159|C0229992|C0221423|C0040223|C0439234|G0000000|C0009488|C0001962|C0439861|C0042153|G0000000|C0018790|C0392751|C0439234|C0439844|C0376246|C0018104|C0018684|C0021672|C0332257|C0332296|C0449435|C0234856|C0376246
BACKGROUND—Previous studies suggest that recurrent episodes of coughing and wheezing occur in up to 75% of infants after acute viral bronchiolitis.,BACKGROUND—Previous studies recurrent episodes coughing wheezing occur 75% infants acute viral bronchiolitis.,G0000000|C0947630|C2945760|C0332189|C0010200|C0043144|C1709305|C0450371|C0021270|C0205178|C0521026|C0006271
"Exclusion criteria were as follows: (1) symptoms and/or signs of severe malaria; (2) any danger sign (persistent vomiting; inability to sit, stand, drink or breastfeed; (3) recent history of convulsions and/or lethargy or otherwise impaired consciousness; (4) haemoglobin concentration ≤ 6 mg/dl; (5) serious underlying disease or known allergy to the study drugs.","Exclusion criteria follows: (1) symptoms and/or signs severe malaria; (2) danger sign (persistent vomiting; inability sit, stand, drink breastfeed; (3) history convulsions and/or lethargy impaired consciousness; (4) haemoglobin concentration ≤ 6 mg/dl; (5) underlying disease allergy study drugs.",C0680251|C0243161|C0332283|G0000000|C0683368|G0000000|C0220912|C0205082|C0024530|G0000000|G0000000|C0311392|C0205322|C0042963|G0000000|C0277814|C0596013|C0452428|C0006147|G0000000|C0019664|C0036572|G0000000|C0023380|C0221099|C0009791|G0000000|C0019046|C0004268|G0000000|G0000000|C0439269|G0000000|G0000000|C0012634|C0002111|C0557651|C0013227
"Vaccination histories were compared in 439 children (ages 0–14) diagnosed with acute lymphoblastic leukaemia (ALL) in nine Midwestern and Mid-Atlantic states (USA) between 1 January 1989 and 30 June 1993 and 439 controls selected by random-digit dialing and individually matched to cases on age, race and telephone exchange.","Vaccination histories compared 439 children (ages 0–14) diagnosed acute lymphoblastic leukaemia (ALL) Midwestern Mid-Atlantic (USA) 1 January 1989 30 June 1993 439 controls selected random-digit dialing individually matched age, race telephone exchange.",C0042196|C0019664|C1707455|C1442061|C0008059|C0001779|G0000000|C0011900|C0205178|C0229613|C0023418|C0444868|G0000000|C0444598|C0041703|G0000000|C3829466|G0000000|C0450371|C3829443|G0000000|C1442061|C0243148|C1707391|C0034656|C1707733|G0000000|C0150103|C0001779|C0034510|C0039457|C0678640
But at 48 hours significantly more in the dexamethasone group experienced complete resolution than did those in the placebo group.,But 48 hours dexamethasone experienced complete resolution placebo group.,G0000000|C0450371|C0439227|C0011777|C0237607|C0205197|C1514893|C0032042|C0441833
"Patients—A population based, nested case control study comprising 142 patients with a definite UC diagnosis, derived from a study population of 4664 patients with UC, was conducted.","Patients—A population based, nested control study comprising 142 patients definite UC diagnosis, derived study population 4664 patients UC, conducted.",G0000000|C0032659|C1527178|G0000000|C0243148|C0557651|C2700400|C1442061|C0030705|C0439544|G0000000|C0011900|C1441547|C0557651|C0032659|G0000000|C0030705|G0000000|C0004927
The ages of the admitted patients ranged from 25 days to 67 years (median = 23 years).,The ages admitted patients ranged 25 days 67 (median = 23 years).,G0000000|C0001779|C0184666|C0030705|C1514721|C0450371|C0439228|C0450371|C0549183|G0000000|C0450371|C0439234
"Participants were eligible if they could provide informed consent and met all of the following criteria: (1) current smokers aged 16 years or older, (2) self-identification as an Aboriginal and/or Torres Strait Islander person, (3) willing to make an attempt to quit smoking in the next month, and (4) had access to an iPhone or Android smartphone.","Participants eligible provide informed consent met criteria: (1) current smokers aged 16 older, (2) self-identification Aboriginal and/or Torres Strait Islander person, (3) attempt quit smoking month, (4) access iPhone Android smartphone.",C0679646|C1548635|C1999230|C1522154|C1511481|C0268621|C0243161|G0000000|C0521116|C0337664|C0001779|C0450371|C0580836|G0000000|C0036588|C0935542|G0000000|G0000000|G0000000|G0000000|C0027361|G0000000|C1516084|C0748223|C0037369|C0332177|G0000000|C0444454|G0000000|C0336541|C3204335
"The sample was predominantly Black (70%), and the majority of sample members had a high school education or lower.","The sample Black (70%), majority sample school education lower.",G0000000|C0370003|C0005680|C0450371|C0680220|C0370003|C0036375|C0013621|C0441994
"Inclusion in the study required the presence of active manifestations of HCV-associated cryoglobulinemic vasculitis as evidenced by one or more of the following: cutaneous vasculitis, peripheral neuropathy, or glomerulonephritis.","Inclusion study required presence active manifestations HCV-associated cryoglobulinemic vasculitis evidenced following: cutaneous vasculitis, peripheral neuropathy, glomerulonephritis.",C0007637|C0557651|C1514873|C0150312|C0205177|C0205319|C0220847|C0010403|C0042384|C3887511|C0231290|C0221912|C0042384|C0205100|C0442874|C0017658
INTERPRETATION: Insulin adjustment according to advice from a diabetes nurse educator is an effective method of improving glucose control in insulin-requiring diabetic patients.,INTERPRETATION: Insulin adjustment advice diabetes nurse educator effective method improving glucose control insulin-requiring diabetic patients.,C0459471|C0021641|C0376209|C0150600|C0011847|C0028661|C0221457|C1280519|C0025663|C1272745|C0017725|C0243148|C0021641|C0241863|C0030705
Participants were included at Lillehammer Hospital for Rheumatic Diseases from November 2008 to January 2010.,Participants included Lillehammer Hospital Rheumatic Diseases November 2008 January 2010.,C0679646|C0332257|G0000000|C0019994|G0000000|C0012634|C3828767|G0000000|C3829466|G0000000
"The exclusion criteria also included significant weight change in the six months prior to the current study, intolerance or food allergy to key components of the intervention diets, and excessive alcohol consumption (>2 drinks/day).","The exclusion criteria included weight change months prior current study, intolerance food allergy key components intervention diets, excessive alcohol consumption (>2 drinks/day).",G0000000|C0680251|C0243161|C0332257|C0005910|C0392747|C0439231|C0332152|C0521116|C0557651|C0231199|C0016452|C0002111|G0000000|C0449432|C0886296|C0012155|C0442802|C0001962|C0009830|G0000000|C0452428
"Studies among South African patients on TB treatment have found that financial constraints are major obstacles to the completion of TB treatment [7,8] and TB preventive therapy [9].","Studies South African patients TB treatment financial constraints major obstacles completion TB treatment [7,8] TB preventive therapy [9].",C0947630|C1710133|C0027567|C0030705|G0000000|C0039798|C0376243|C0443288|C0205082|G0000000|C0205197|G0000000|C0039798|G0000000|G0000000|C0445202|C0039798|G0000000
An intervention based on peer group pressure and social influence may therefore be useful to prevent smoking among these students.,An intervention based peer pressure social influence prevent smoking students.,G0000000|C0886296|C1527178|C0679739|C0033095|C0728831|C4054723|C0309872|C0037369|C0038492
"Additionally, subjects were only included if, under conditions of pronation, and flexing of the wrist, they could display function of at least 20° extension of the wrist, and at least 10° extension of the metacarpophalangeal joint, while being able to hold and put down an object with the affected side.","Additionally, subjects included if, conditions pronation, flexing wrist, display function 20° extension wrist, 10° extension metacarpophalangeal joint, hold object side.",G0000000|C0681850|C0332257|G0000000|C0012634|C0033421|G0000000|C0043262|C1705417|C0031843|G0000000|C0231448|C0043262|G0000000|C0231448|G0000000|C0022417|C1553387|C0347997|C0441987
It is crucial that new mothers who smoke be told or informed that it may be better to smoke and breastfeed than to smoke and bottle-feed.,It crucial mothers smoke told informed smoke breastfeed smoke bottle-feed.,G0000000|G0000000|C0026591|C0037366|G0000000|C1522154|C0037366|C0006147|C0037366|C0006042
The objective of this study was to reduce postpartum smoking relapse and prolong breastfeeding duration during the first 8 weeks postpartum in mothers who quit smoking just before or during pregnancy and have newborns admitted to the Neonatal Intensive Care Unit (NICU).,The objective study reduce postpartum smoking relapse prolong breastfeeding duration 8 weeks postpartum mothers quit smoking pregnancy newborns admitted Neonatal Intensive Care Unit (NICU).,G0000000|C0018017|C0557651|G0000000|C0086839|C0037369|C0035020|G0000000|C0006147|C0449238|G0000000|C0439230|C0086839|C0026591|C0748223|C0037369|C0032961|C0021289|C0184666|C1552240|C0162425|C1947933|C0439148|C0021709
"Participants included 200 children and teens, aged 7–17 years, with chronic abdominal pain, and their parents.","Participants included 200 children teens, aged 7–17 years, chronic abdominal pain, parents.",C0679646|C0332257|C1442061|C0008059|C0205653|C0001779|G0000000|C0439234|C0205191|C0000726|C0030193|C0030551
"561 patients, aged 15-60 years, with sore throat for less than seven days and at least three of the four Centor criteria—that is, history of fever, absence of cough, swollen tender anterior cervical lymph nodes, and tonsillar exudate.","561 patients, aged 15-60 years, sore throat days Centor criteria—that is, history fever, absence cough, swollen tender anterior cervical lymph nodes, tonsillar exudate.",C1442061|C0030705|C0001779|C0450371|C0439234|C0234233|C0031354|C0439228|G0000000|G0000000|G0000000|C0019664|C0015967|C0332197|C0010200|C0038999|C0234234|C0205094|C0027530|C0024202|C0746922|C0040421|C0015388
This may also be the reason for the mean duration of asthma attack of more than four days before presentation.,This reason duration asthma attack days presentation.,G0000000|C0392360|C0449238|C0004096|C0277793|C0439228|C0449450
Thirty patients with upper esophageal sphincter (UES) dysfunction due to unilateral brainstem stroke were recruited into two groups.,Thirty patients upper esophageal sphincter (UES) dysfunction unilateral brainstem stroke recruited groups.,C3816446|C0030705|C1282910|C1522619|C1409894|C0855073|C0031847|C0205092|C0006121|C0038454|G0000000|C0441833
"This study aimed to test the effectiveness of yoga for women with stage I–III breast cancer during (neo)adjuvant cytotoxic and endocrine therapy on HRQOL, life satisfaction, cancer-related fatigue, mindfulness, and spirituality compared to conventional physical exercise.","This study aimed test effectiveness yoga women stage I–III breast cancer (neo)adjuvant cytotoxic endocrine therapy HRQOL, life satisfaction, cancer-related fatigue, mindfulness, spirituality compared conventional physical exercise.",G0000000|C0557651|C1947946|C0022885|C1280519|C0043418|C0043210|C0205390|G0000000|C0006141|C0006826|C1366752|C0677881|C0014136|C0039798|G0000000|C0376558|C0242428|C2826292|C0015672|C0086045|C0237104|C1707455|C0439858|C0031809|C0015259
"The very large price elasticity for these products may suggest that the policy is more effective for young people and, more specifically, when parents are purchasing drinks for their children.","The price elasticity products policy effective people and, specifically, parents purchasing drinks children.",G0000000|C0080045|C0013764|C1514468|C0242456|C1280519|C0027361|G0000000|G0000000|C0030551|C0870238|C0452428|C0008059
Malaria is a leading public health problem in Luangwa District.,Malaria leading public health Luangwa District.,C0024530|C0332152|G0000000|C0018684|G0000000|G0000000
"Individuals were excluded if they had practiced Tai chi within the past 6 months, had exercised >30 min three times weekly for past 3 months, could not independently ambulate without assistive devices, had BPI pain severity or interference scores less than 5, had planned elective surgery during study period, were actively involved in health-related litigation, or were unwilling to keep all treatments/medications steady throughout the study period.","Individuals excluded practiced Tai chi 6 months, exercised >30 min times weekly 3 months, independently ambulate assistive devices, BPI pain severity interference scores 5, planned elective surgery study period, actively involved health-related litigation, unwilling treatments/medications steady study period.",C0027361|C1554077|C0237607|G0000000|C1720589|G0000000|C0439231|C0015259|C0450371|C0702093|C0040223|C0332174|G0000000|C0439231|G0000000|C4036205|G0000000|C0025080|C1443145|C0030193|C0439793|C0521102|C0449820|G0000000|C1301732|C0206058|C0038894|C0557651|C0439531|G0000000|C1314939|C0018684|C0079706|C0558080|C3469597|C0205361|C0557651|C0439531
"Children with severe inter-current illnesses, severe diarrhoea and dehydration requiring hospitalisation and intravenous therapy, presenting with temperature above 38.5°C, who were treated by any other anti-diarrhoeal/antibiotics in last 24 h as well as severely malnourished children were excluded from the trial.","Children severe inter-current illnesses, severe diarrhoea dehydration requiring hospitalisation intravenous therapy, temperature 38.5°C, treated anti-diarrhoeal/antibiotics 24 severely malnourished children excluded trial.",C0008059|C0205082|C0205103|C0221423|C0205082|C0011991|C0011175|G0000000|C0019993|C0348016|C0039798|C0005903|G0000000|C1522326|C0718565|C0450371|C0205082|C0162429|C0008059|C1554077|C0008976
"A total of 30 chronic schizophrenic male patients, age range of 20-50 years with minimum primary level education, diagnosed according to International Classification of Diseases-10 criteria with minimum duration of illness 2 years, positive and negative syndrome scale (PANSS) scores ranging from mild to moderate, admitted in different wards of Ranchi Institute of Neuro-Psychiatry and Allied Sciences, Kanke, Ranchi constituted the sample.","A total 30 chronic schizophrenic male patients, age range 20-50 minimum primary level education, diagnosed International Classification Diseases-10 criteria minimum duration illness 2 years, positive negative syndrome scale (PANSS) scores ranging mild moderate, admitted wards Ranchi Institute Neuro-Psychiatry Allied Sciences, Kanke, Ranchi constituted sample.",G0000000|C0439175|C0450371|C0205191|G0000000|C0086582|C0030705|C0001779|C1514721|C0450371|C1524031|C0205225|C0441889|C0013621|C0011900|C1512888|C0008902|C0012634|C0243161|C1524031|C0449238|C0221423|G0000000|C0439234|C0439178|C0205160|C0039082|C0175659|G0000000|C0449820|C1514721|C2945599|C0205081|C0184666|C1305702|G0000000|C0021622|C0027855|C1098293|C0036397|G0000000|G0000000|G0000000|C0370003
"Inclusion criteria were a) metastatic cancer, b) 18 years or older, c) no prior contact with SPC, and d) a palliative need according to the screening questionnaire.","Inclusion criteria a) metastatic cancer, b) 18 older, c) prior contact SPC, d) palliative screening questionnaire.",C0007637|C0243161|G0000000|C0036525|C0006826|G0000000|C0450371|C0580836|G0000000|C0332152|C0332158|C1425074|C0073187|C0587605|C0220908|C0034394
"Abbreviations: FES-cycling, functional electrical stimulation-cycling; ICU, intensive care unit; MV, mechanical ventilation; n, number.","Abbreviations: FES-cycling, functional electrical stimulation-cycling; ICU, intensive care unit; MV, mechanical ventilation; n, number.",C0000723|C1511572|C0205245|C0013790|C1292856|C0021708|C0162425|C1947933|C0439148|C0428679|C0443254|C0035203|C0369718|C0237753
"Inclusion criteria for randomization were: (i) age older than 18 years, (ii) unequivocal demonstration of PH (a mean pulmonary arterial pressure ≥ 30 mmHg by catheterization within the 30 days prior to randomization), (iii) a successful surgical or percutaneous valvular replacement or repair procedure (leading to a complete correction of left heart valve disease and performed at least 1 year before inclusion), and (iv) a stable clinical condition [no changes in concomitant medication or hospital admissions for heart failure (HF) in the previous month].","Inclusion criteria randomization were: (i) age 18 years, (ii) unequivocal demonstration PH (a pulmonary arterial pressure ≥ 30 mmHg catheterization 30 days prior randomization), (iii) successful surgical percutaneous valvular replacement repair procedure (leading complete correction left heart valve disease performed 1 year inclusion), (iv) stable clinical condition [no concomitant medication hospital admissions heart failure (HF) previous month].",C0007637|C0243161|C0034656|G0000000|C0021966|C0001779|G0000000|G0000000|C4053896|G0000000|C0450407|G0000000|C0024109|C0003842|G0000000|C0007430|G0000000|C0332152|C0034656|C0439070|C0597535|C0543467|C0522523|C0184252|C0035139|C0043240|C0184661|C0332152|C0205197|C1705565|C0205091|C0018787|C0184252|C0012634|C0884358|G0000000|C0007637|C0022326|C0205360|C0205210|C0012634|G0000000|C0521115|C0013227|C0019994|C0184666|C0018787|C0231174|C0018488|C0205156|C0332177
"The inclusion criteria were subjects aged 45 years or older, meeting spirometric criteria for COPD (FEV1 ≤ 70 % predicted, ratio of FEV1 over FVC (FEV1/FVC) ≤ 60 %, reversibility of ≤ 10 % of predicted FEV1 or ≤ 200 ml if predicted FEV1 ≤ 2 L); smoking history ≥ 20 pack years; and at least three confirmed moderate or severe COPD exacerbations in the past two years (i.e.","The inclusion criteria subjects aged 45 older, meeting spirometric criteria COPD (FEV1 ≤ 70 % predicted, ratio FEV1 FVC (FEV1/FVC) ≤ 60 %, reversibility of ≤ 10 % predicted FEV1 or ≤ 200 predicted FEV1 ≤ 2 L); smoking history ≥ 20 pack years; confirmed moderate severe COPD exacerbations (i.e.",G0000000|C0007637|C0243161|C0681850|C0001779|C0450371|C0580836|C0556656|C0037981|C0243161|C0024117|G0000000|G0000000|C0681842|C0456603|G0000000|C3714541|G0000000|G0000000|C0449261|G0000000|G0000000|C0681842|G0000000|G0000000|C0681842|G0000000|C0439394|C0037369|G0000000|C1968515|C0439234|C0521093|C0205081|C0205082|C0024117|G0000000|C0683454
"Between August 2007 and January 2009, 400 pregnant women attending the St. Mary’s Health Centre in Kyeibuza (Kiruhura District, southwest of Uganda) for their first trimester antenatal visit (4 to 12 gestational weeks) met the inclusion criteria and were enrolled consecutively in the present study after providing written informed consent.","Between August 2007 January 2009, 400 pregnant women attending St. Mary’s Health Centre Kyeibuza (Kiruhura District, southwest Uganda) trimester antenatal visit (4 12 gestational weeks) met inclusion criteria enrolled consecutively study providing written informed consent.",G0000000|C3831448|G0000000|C3829466|G0000000|C1442061|C0549206|C0043210|C1547429|C0036056|G0000000|C0018684|C0205099|G0000000|G0000000|G0000000|C1710136|C0041573|C0032982|C2828394|C0545082|G0000000|C0450371|C0439671|C0439230|C0268621|C0007637|C0243161|G0000000|G0000000|C0557651|C1999230|C0043266|C1522154|C1511481
Hypertensive patients with high CVD risk according to the Framingham general CVD risk score (>15%) 3.,Hypertensive patients CVD risk Framingham CVD risk score (>15%) 3.,C0857121|C0030705|C0007222|C0035647|C3166866|C0007222|C0035647|C0449820|C0450371|G0000000
"Thirty-two consecutive patients (22 males and 10 females; mean age 62.1 years; range, 39–82 years) admitted for rehabilitation at the department of rehabilitation in Asan Medical Center between October 2013 and December 2014 were recruited according to the following criteria: 1) first ever stroke, 2) left visuospatial neglect, defined as >6.33 mm average deviation from the center line on the line bisection test (LBT) [11], and 3) diagnosed as right cerebral ischemic or hemorrhagic stroke.","Thirty-two consecutive patients (22 males 10 females; age 62.1 years; range, 39–82 years) admitted rehabilitation department rehabilitation Asan Medical Center October 2013 December 2014 recruited criteria: 1) stroke, 2) left visuospatial neglect, defined >6.33 mm average deviation center bisection test (LBT) [11], 3) diagnosed cerebral ischemic hemorrhagic stroke.",C3816446|C1707491|C0030705|C0450371|C0086582|C0450371|C0015780|C0001779|C0450371|C0439234|C1514721|G0000000|C0439234|C0184666|C0034991|C1704729|C0034991|G0000000|C0199168|C0205099|C3828732|G0000000|C3830550|G0000000|G0000000|C0243161|G0000000|C0038454|G0000000|C0205091|G0000000|C0521874|C1704788|C0450371|G0000000|C1510992|C0012727|C0205099|C0184905|C0022885|C1879922|C0450371|G0000000|C0011900|G0000000|C0475224|C0333275|C0038454
Inclusion criteria were: 1) originally diagnosed with Stage 0 – II breast cancer; 2) completed local and/or adjuvant cancer therapy (with the exception of hormonal therapy) at least 6 months previously; 3) age 40 – 65; 4) post-menopausal; 5) no other cancer in last 5 years; and 6) experiencing persistent cancer-related fatigue.,Inclusion criteria were: 1) originally diagnosed Stage 0 – II breast cancer; 2) completed local and/or adjuvant cancer therapy (with exception hormonal therapy) 6 months previously; 3) age 40 – 65; 4) post-menopausal; 5) cancer 5 years; 6) experiencing persistent cancer-related fatigue.,C0007637|C0243161|G0000000|G0000000|G0000000|C0011900|C0205390|G0000000|G0000000|G0000000|C0006141|C0006826|G0000000|C0205197|C0205276|G0000000|C0001551|C0006826|C0039798|G0000000|C1554961|C0458083|C0039798|G0000000|C0439231|G0000000|G0000000|C0001779|C0450371|G0000000|C0450371|G0000000|C0232970|G0000000|C0006826|G0000000|C0439234|G0000000|C0237607|C0205322|C2826292|C0015672
"The life expectancy for smokers is at least 10 years shorter than for nonsmokers [1, 2].","The life expectancy smokers 10 shorter nonsmokers [1, 2].",G0000000|C0376558|C0679138|C0337664|C0450371|C1282927|C0337672|G0000000|G0000000
"To be eligible, a patient had to be intubated and receiving mechanical ventilation, have bilateral pulmonary infiltrates consistent with edema on frontal chest radiograph, have a ratio of PaO2 to FiO2 (fraction of inspired oxygen) of 300 or less (adjusted for altitude as appropriate), and not have clinical evidence of left atrial hypertension.","To eligible, patient intubated receiving mechanical ventilation, bilateral pulmonary infiltrates consistent edema frontal chest radiograph, ratio PaO2 FiO2 (fraction inspired oxygen) 300 (adjusted altitude appropriate), clinical evidence left atrial hypertension.",C0040363|C1548635|C0030705|G0000000|C1514756|C0443254|C0035203|C0238767|C0024109|C0332448|C0332290|C0013604|C0205123|C0817096|C1306645|C0456603|C1427155|G0000000|C1264633|C0004048|C0030054|C1442061|C0456081|C0002349|C1548787|C0205210|C3887511|C0205091|C0018792|C0020538
"2) They attend a year 1 to 6 class in one of the included schools, at the beginning of the second school term in 2009 (the end of April).","2) They attend 1 6 class included schools, school term 2009 (the April).",G0000000|G0000000|C1999232|G0000000|G0000000|C0456387|C0332257|C0036375|C0036375|C0233324|G0000000|G0000000|C3715024
HIV-infected children and adolescents who were aged 6 to 16 years were randomly assigned to receive vitamin D (100 000 IU bimonthly) and calcium (1 g/day; n = 29) or double placebo (n = 27).,HIV-infected children adolescents aged 6 16 randomly assigned receive vitamin D (100 000 IU bimonthly) calcium (1 g/day; = 29) double placebo (n = 27).,C0019682|C0008059|C0205653|C0001779|G0000000|C0450371|G0000000|C1516050|C1514756|C0042890|C0073187|C1442061|C1442061|C0049272|C0585337|C0006675|G0000000|C0439417|G0000000|C0450371|C0205173|C0032042|C0369718|G0000000|C0450371
"Intracranial EEG recordings were collected with a sampling rate of 2,000 Hz.","Intracranial EEG recordings collected sampling rate 2,000 Hz.",C0524466|C0013819|G0000000|C1516695|C0441621|C0871208|C1442061|C0439482
"For this analysis, we consider dietary assessment conducted at baseline (before random assignment), 1 year, and 4 years.","For analysis, dietary assessment conducted baseline (before random assignment), 1 year, 4 years.",G0000000|C0002778|C0012155|C1261322|C0004927|C0168634|C0332152|C0034656|C1516050|G0000000|C0439234|G0000000|C0439234
"168 participants were randomized, and 140 completed the 180-day study.","168 participants randomized, 140 completed 180-day study.",C1442061|C0679646|C0034656|C1442061|C0205197|C1442061|C0557651
"Exclusion criteria will be CP with Gross Motor Function Classification Score (GMFCS)74 of 4–5, corresponding to poor or absent mobility and neck control; receipt of Botox to the affected extremity within 3 months of study entry; or scores of <70 on the Bayley Scales of Infant Development (Bayley III) cognitive composite.75 TD children (n=144): Inclusion criteria will be GA and sex-matched compared to the CP group, with CA at assessment matched to the CP group at baseline (72 children) and at the 7-month assessment (72 children).","Exclusion criteria CP Gross Motor Function Classification Score (GMFCS)74 4–5, poor absent mobility neck control; receipt Botox extremity 3 months study entry; scores <70 Bayley Scales Infant Development (Bayley III) cognitive composite.75 TD children (n=144): Inclusion criteria GA sex-matched compared CP group, CA assessment matched CP baseline (72 children) 7-month assessment (72 children).",C0680251|C0243161|C4050020|C0439806|C1513492|C0031843|C0008902|C0449820|C0450371|G0000000|C0032854|C0332197|C0425245|C0027530|C0243148|G0000000|C0700702|C0015385|G0000000|C0557651|C1705654|C0449820|C0450371|G0000000|C0175659|C0021270|C0243107|G0000000|C0439070|C1516691|C0205199|C0041061|C0008059|C0369718|C0007637|C0243161|C0016993|C0009253|C1707455|C4050020|C0441833|C3887642|C1261322|C0150103|C4050020|C0168634|C0450371|C0008059|C0332177|C1261322|C0450371|C0008059
Participants were included in the study if they (1) were able to understand and follow simple verbal instructions; (2) had a Mini Mental State Examination (MMSE) score over 21; (3) had a Brunnstrom score between stage I and IV; (4) had no apraxia or hemineglect and; (5) had no orthopedic and neurologic conditions such as fractures and digital neuropathy on their lower extremities.,Participants included study (1) understand follow simple verbal instructions; (2) Mini Mental State Examination (MMSE) score 21; (3) Brunnstrom score stage I IV; (4) apraxia hemineglect and; (5) orthopedic neurologic conditions fractures digital neuropathy lower extremities.,C0679646|C0332257|C0557651|G0000000|C0162340|C0332283|C0205352|C0439824|C0302828|G0000000|C0445542|C0229992|C1301808|G0000000|C0451306|C0449820|C0450371|G0000000|G0000000|C0449820|C0205390|C0021966|C0022326|G0000000|C0003635|C0150088|G0000000|G0000000|C0029355|C0205494|C0012634|C0016658|C0442015|C0442874|C0441994|C0015385
"Patients were excluded if they were being discharged within 3 hours; were too ill to participate; could not communicate in English or Spanish; had active psychosis, bipolar disorder, delirium, or severe dementia; had hearing or vision impairment; did not manage their own medications; were unlikely to be discharged to home; lacked a telephone; or were in police custody.","Patients excluded discharged 3 hours; ill participate; communicate English Spanish; active psychosis, bipolar disorder, delirium, severe dementia; hearing vision impairment; manage medications; discharged home; lacked telephone; police custody.",C0030705|C1554077|C0030685|G0000000|C0439227|C0231218|G0000000|C0566001|C0376245|C0086409|C0205177|C0033975|C0443156|C0012634|C0011206|C0205082|C0011265|C0018767|C0042789|C0221099|G0000000|C0013227|C0030685|C0442519|C0332268|C0039457|C0085098|G0000000
A total of 710 women will be recruited; 177 and 532 pregnant women with a pre-pregnancy BMI of 18.5–24.9 kg/m2 (healthy range) and ≥25.0 kg/m2 (overweight or obese range) respectively.,A total 710 women recruited; 177 532 pregnant women pre-pregnancy BMI 18.5–24.9 kg/m2 (healthy range) ≥25.0 kg/m2 (overweight obese range) respectively.,G0000000|C0439175|C1442061|C0043210|G0000000|C1442061|C1442061|C0549206|C0043210|C2709093|G0000000|G0000000|C0022718|C3898900|C1514721|G0000000|C0022718|C0497406|C0028754|C1514721|G0000000
"This discrepancy may be explained by the difference in definitions; in the other studies, operators were classified as experienced if they had performed more than 25 cannulations, whereas we categorized operators on the basis of years of experience: i.e., ‘registrars’ with 0–6 years experience and ‘consultants’ with more than 6 years of experience in the field of anesthesia and critical care.","This discrepancy explained difference definitions; studies, operators classified experienced performed 25 cannulations, categorized operators basis experience: i.e., ‘registrars’ 0–6 experience ‘consultants’ 6 experience field anesthesia critical care.",G0000000|C1290905|G0000000|C1705241|C1550452|C0947630|C1705273|C0008902|C0237607|C0884358|C0450371|C0917707|C0871968|C1705273|C1527178|C0237607|C0683454|G0000000|G0000000|C0237607|G0000000|G0000000|C0237607|C0440042|C0002903|C1511545|C1947933
gambiae and An.,gambiae An.,G0000000|G0000000
"Using MRI, we reported that, in cross-sectional analysis, serum 25-(OH)D level was significantly and positively associated with knee cartilage volume in older men and women, and vitamin D insufficiency was positively associated with medial and lateral tibial bone area in women.","Using MRI, reported that, cross-sectional analysis, serum 25-(OH)D level positively knee cartilage volume women, vitamin D insufficiency positively medial lateral tibial bone women.",C1524063|C0024485|C0684224|G0000000|C0552389|C0002778|C0229671|C0450371|C0441889|G0000000|C0022742|C0007301|C0449468|C0043210|C0042890|C0073187|C0231179|G0000000|C0205098|C0205093|C0040184|C0262950|C0043210
"Inclusion and exclusion criteria Abbreviation: MGD, meibomian gland dysfunction.","Inclusion exclusion criteria Abbreviation: MGD, meibomian gland dysfunction.",C0007637|C0680251|C0243161|C0000723|G0000000|G0000000|C1285092|C0031847
"Between June 2004 and May 2006, 106 patients were randomised (wTCF, 50 patients; wTX, 56 patients) from 19 institutions in Australia and 1 in New Zealand.","Between June 2004 May 2006, 106 patients randomised (wTCF, 50 patients; wTX, 56 patients) 19 institutions Australia 1 New Zealand.",G0000000|C3829443|G0000000|G0000000|G0000000|C1442061|C0030705|G0000000|G0000000|C0450371|C0030705|C1825263|C0450371|C0030705|C0450371|C1272753|C0004340|G0000000|C0205314|G0000000
Patients using systemic corticosteroids or with respiratory infections affecting asthma control within 30 days of study entry were excluded.,Patients systemic corticosteroids respiratory infections asthma control 30 days study entry excluded.,C0030705|C0205373|C0001617|C0521346|C3714514|C0004096|C0243148|C0450371|C0439228|C0557651|C1705654|C1554077
"Overall, patients with IB disease did not benefit (HR, 1.03; P = .87).","Overall, patients IB disease benefit (HR, 1.03; P = .87).",C0282416|C0030705|C2744579|C0012634|C0814225|G0000000|C0450371|C0369773|G0000000|C0450371
The study population is children and adolescents diagnosed with ALL or other cancer outside the central nervous system (e.g.,The study population children adolescents diagnosed ALL cancer central nervous system (e.g.,G0000000|C0557651|C0032659|C0008059|C0205653|C0011900|C0444868|C0006826|C0205099|C0027769|C0449913|G0000000
Our objective was to determine the fetal metabolic factors that influence regional neonatal adiposity in a cohort of women with previous large for gestational age offspring.,Our objective determine fetal metabolic factors influence regional neonatal adiposity cohort women previous gestational age offspring.,G0000000|C0018017|G0000000|C0015965|C0311400|C1521761|C4054723|C0205147|C1552240|C0028754|C0599755|C0043210|C0205156|C0439671|C0001779|C0680063
"Eligible subjects must meet the following inclusion criteria: a) men or women aged >=18 years old, b) HIV-positive, c) initiating anti-retroviral therapy at the time of randomization or have been on HAART for no longer than 6 months, d) have no intention of migrating, or re-locating more than 20 km outside of the IDI within the next 18 months after enrollment, e) agree to allow home visit(s) and subsequent follow-up contacts as part of the study, and f) provide written informed consent.","Eligible subjects meet inclusion criteria: a) women aged >=18 old, b) HIV-positive, c) initiating anti-retroviral therapy time randomization HAART 6 months, d) intention migrating, re-locating 20 IDI 18 months enrollment, e) agree visit(s) subsequent follow-up contacts study, f) provide written informed consent.",C1548635|C0681850|C1550543|C0007637|C0243161|G0000000|C0043210|C0001779|C0450371|C0580836|G0000000|C0019699|G0000000|C1548602|C0035366|C0039798|C0040223|C0034656|C0887947|G0000000|C0439231|C0073187|C0162425|C0232902|C0556581|C0450371|C3476796|C0450371|C0439231|C1516879|G0000000|C3641827|C0545082|C0332282|C0589120|C4036459|C0557651|C0016327|C1999230|C0043266|C1522154|C1511481
"This pragmatic, real-life, double-blind, randomized study of parallel groups was carried out in the pediatric service of Clinica Amaury Coutinho, linked to Recife City Hall.","This pragmatic, real-life, double-blind, randomized study parallel carried pediatric service Clinica Amaury Coutinho, linked Recife City Hall.",G0000000|C0871858|C0237400|C0013072|C0034656|C0557651|C2348042|C0206243|C0030755|C0557854|G0000000|G0000000|G0000000|C1517892|G0000000|C0008848|G0000000
"Premenopausal women undergoing adjuvant chemotherapy for early stage breast cancer (BC) experience significant bone loss over the course of the first year after the initiation of treatment (1,2).","Premenopausal women undergoing adjuvant chemotherapy stage breast cancer (BC) experience bone loss initiation treatment (1,2).",C0279752|C0043210|G0000000|C0001551|C0013216|C0205390|C0006141|C0006826|C0006041|C0237607|C0262950|C1517945|C0589507|C0039798|G0000000
"However, behaviour changes were not translated into differences in biological risk factors.","However, behaviour translated differences biological risk factors.",G0000000|C0004927|C0040710|C1705241|C0005532|C0035647|C1521761
All subjects aged 18 years and older gave written informed consent.,All subjects aged 18 written informed consent.,G0000000|C0681850|C0001779|C0450371|C0043266|C1522154|C1511481
"The inclusion criteria were as follows: the patient had to have a diagnosis of CF defined by a positive sweat test or genotyping, patients over 5 years of age had to be able to perform lung function assessments reliably, the patient had to have had a pulmonary infection with P. aeruginosa on at least one occasion, the patient had to have experienced a pulmonary exacerbation that required 10 to 14 days of intravenous antibiotic therapy, and the latest isolate of P. aeruginosa had to be sensitive to tobramycin and/or ceftazidime (all patients received ceftazidime as a second antibiotic).","The inclusion criteria follows: patient diagnosis CF defined positive sweat test genotyping, patients 5 age perform lung function assessments reliably, patient pulmonary infection P. aeruginosa occasion, patient experienced pulmonary exacerbation required 10 14 days intravenous antibiotic therapy, isolate P. aeruginosa sensitive tobramycin and/or ceftazidime (all patients received ceftazidime antibiotic).",G0000000|C0007637|C0243161|C0332283|C0030705|C0011900|C0009738|C1704788|C0439178|C0038984|C0022885|C1285573|C0030705|G0000000|C0001779|C0884358|C0024109|C0031843|C1261322|G0000000|C0030705|C0024109|C0009450|C0369773|G0000000|C0521114|C0030705|C0237607|C0024109|G0000000|C1514873|C0450371|C0450371|C0439228|C0348016|C0003232|C0039798|C1875400|C0369773|G0000000|C0020517|C0040341|G0000000|C0007559|G0000000|C0030705|C1514756|C0007559|C0003232
"The SECS is a population-based case-control study of 1,204 incident cases diagnosed between the ages of 30 and 69 years from 1997 to 2003 and 1,212 age-frequency matched controls.","The SECS population-based case-control study 1,204 incident diagnosed ages 30 69 1997 2003 1,212 age-frequency matched controls.",G0000000|C0457385|C0032659|C0872128|C0557651|C1442061|C1551358|C0011900|C0001779|C0450371|C0450371|G0000000|G0000000|C1442061|C0001779|C0150103|C0243148
"Potential participants were deemed ineligible if: they had a progressive diagnosed neurologic disease (e.g., Parkinson’s, multiple sclerosis, Guillain-Barre, Alzheimers), any dystrophies or rheumatologic conditions that primarily affects muscle (e.g., muscular dystrophy, polymyalgia rheumatica), already participated in a MCEFRP or if they were currently performing (or had performed) regular (3×/week) aerobic (defined as hiking, fast-walking, jogging, running swimming or cycling) or resistance (defined as weight training with bands, cable, free-weights or weight-machines) exercise over the past 12 months.","Potential participants deemed ineligible if: progressive diagnosed neurologic disease (e.g., Parkinson’s, multiple sclerosis, Guillain-Barre, Alzheimers), dystrophies rheumatologic conditions muscle (e.g., muscular dystrophy, polymyalgia rheumatica), participated MCEFRP performing (or performed) regular (3×/week) aerobic (defined hiking, fast-walking, jogging, running swimming cycling) resistance (defined weight training bands, cable, free-weights weight-machines) exercise 12 months.",C3245505|C0679646|G0000000|C1512714|G0000000|C0205329|C0011900|C0205494|C0012634|G0000000|G0000000|C0439064|C0036429|G0000000|G0000000|C0333606|C0035452|C0012634|C0026845|G0000000|C0026845|C0333606|C0521516|G0000000|G0000000|G0000000|C0884358|G0000000|C0884358|C0205272|G0000000|C1510824|C1704788|G0000000|C0015663|C0022400|C0035953|C0039003|C1511572|C0237834|C1704788|C0005910|C0040607|C0175723|C0492124|C2712429|C0005910|C0015259|C0450371|C0439231
"Patients who refused study consent, whose antibiotic treatment had been initiated before intensive care admission, or who had therapy limitations were excluded from the study.","Patients refused study consent, antibiotic treatment initiated intensive care admission, therapy limitations excluded study.",C0030705|C1548564|C0557651|C1511481|C0003232|C0039798|C1548602|C0162425|C1947933|C0184666|C0039798|C0449295|C1554077|C0557651
"Furthermore, approximately 50% of children with SSNS develop frequently-relapsing nephrotic syndrome (FRNS) or steroid-dependent nephrotic syndrome (SDNS).","Furthermore, 50% children SSNS develop frequently-relapsing nephrotic syndrome (FRNS) steroid-dependent nephrotic syndrome (SDNS).",G0000000|C0450371|C0008059|C1301821|G0000000|C0332183|G0000000|C0039082|C0220730|C0038317|G0000000|C0039082|C0038642
"A total of 11 patients were with moderate to active Crohn's disease (CDAI 150–300) were enrolled in this randomized, double-blind, placebo-controlled trial.","A total 11 patients moderate active Crohn's disease (CDAI 150–300) enrolled randomized, double-blind, placebo-controlled trial.",G0000000|C0439175|C0450371|C0030705|C0205081|C0205177|C0010346|C0012634|C0683448|G0000000|G0000000|C0034656|C0013072|C1706408|C0008976
Subjects: 98% (165/169) of families with children aged under 5 years registered with the practice.,Subjects: 98% (165/169) families children aged 5 registered practice.,C0681850|C0450371|C1442061|C0015576|C0008059|C0001779|G0000000|C1514821|C0237607
"A potential limit to the comparison with the results of the Dalakas trial is the choice of the inclusion criteria concerning disability: ISS ≥ 4 and VAS >4 or ataxia score ≥2 in our trial, vs INCAT disability score ≥1 in the previous trial.","A potential limit comparison Dalakas trial choice inclusion criteria disability: ISS ≥ 4 VAS >4 ataxia score ≥2 trial, INCAT disability score ≥1 previous trial.",G0000000|C3245505|C0439801|C1707455|G0000000|C0008976|C0008300|C0007637|C0243161|C0231170|C1845118|G0000000|G0000000|C0042815|G0000000|C0004134|C0449820|G0000000|C0008976|G0000000|C0231170|C0449820|G0000000|C0205156|C0008976
Chronic low back pain causes substantial morbidity and cost to society while disproportionately impacting low-income and minority adults.,Chronic low pain substantial morbidity cost society disproportionately impacting low-income minority adults.,C0205191|C0205251|C0030193|G0000000|C0026538|C0010186|C0037455|G0000000|C1825598|C0032854|C0026192|C0001675
"Briefly, the study compared the effectiveness of three versus one round of azithromycin MDA in reducing the prevalence of active trachoma and ocular C. trachomatis infection.","Briefly, study compared effectiveness versus round azithromycin MDA reducing prevalence active trachoma ocular C. trachomatis infection.",G0000000|C0557651|C1707455|C1280519|G0000000|C0332490|C0052796|C0000379|C0392756|C0033105|C0205177|C0040592|C0015392|G0000000|C2893398|C0009450
A significant improvement in weight (1.3 kg) was observed in this trial in the azithromycin group as compared with the placebo group.,A improvement weight (1.3 kg) observed trial azithromycin compared placebo group.,G0000000|C2986411|C0005910|G0000000|C0022718|C1441672|C0008976|C0052796|C1707455|C0032042|C0441833
Mixed infections with P. vivax and P. falciparum can be enrolled in countries which use an artemisinin combination therapy.,Mixed infections P. vivax P. falciparum enrolled countries artemisinin combination therapy.,C0205430|C3714514|C0369773|G0000000|C0369773|G0000000|G0000000|C0454664|C0052430|C0205195|C0039798
"Advanced pancreatic cancer (APC), beside its high mortality, causes the highest rates of venous thromboembolic events (VTE).","Advanced pancreatic cancer (APC), mortality, rates venous thromboembolic events (VTE).",C0205179|C0030274|C0006826|C0032580|C0026565|C0871208|C0042449|C0333214|C0441471|C0630906
"We selected 188 participants from among the outpatients of a specialist orthopaedic clinic in Kaoshiung, Taiwan, which offered standardised physical therapy.","We selected 188 participants outpatients specialist orthopaedic clinic Kaoshiung, Taiwan, offered standardised physical therapy.",G0000000|C1707391|C1442061|C0679646|C0029921|C0087009|C0029355|C0002424|G0000000|C0039260|C1444648|G0000000|C0031809|C0039798
"So, (5 × 0.6 × €24.60 + 6 × 0.75 × €24.60) × 0.07 = €13.43 Unit costs of healthcare resources were obtained from the SOIKOS health database and have been described in detail elsewhere [25].","So, (5 × 0.6 × €24.60 + 6 × 0.75 × €24.60) × 0.07 = €13.43 Unit costs healthcare resources SOIKOS health database detail [25].",C0037640|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|C0450371|G0000000|G0000000|G0000000|C0450371|G0000000|G0000000|C0439148|C0010186|C0086388|C0035201|G0000000|C0018684|C0242356|C1522508|C0450371
"The density of adult vectors collected varied between zones with the lowest levels in zone 1 and highest in zone 3, except in the year of the intervention (Figure 4 and Table 3).","The density adult vectors collected varied zones lowest levels zone 1 zone 3, intervention (Figure 4 Table 3).",G0000000|C0178587|C0001675|C0086022|C1516695|G0000000|C1710706|C1708760|C0441889|C1710706|G0000000|C1710706|G0000000|C0886296|G0000000|G0000000|C0039224|G0000000
186 of 205 control patients (91%) and 165 of 191 intervention patients (86%) completed the study.,186 205 control patients (91%) 165 191 intervention patients (86%) completed study.,C1442061|C1442061|C0243148|C0030705|C0450371|C1442061|C1442061|C0886296|C0030705|C0450371|C0205197|C0557651
This index has been developed and validated for stroke outcomes research.,This developed validated stroke outcomes research.,G0000000|G0000000|G0000000|C0038454|C1274040|C0035168
These effects warrant further investigation in patients with chronic HF.,These effects warrant investigation patients chronic HF.,G0000000|C1280500|G0000000|C0220825|C0030705|C0205191|C0018488
"The first case of 2009 pandemic influenza A (H1N1) virus in Gujarat, India, was reported in August 2009.","The 2009 pandemic influenza A (H1N1) virus Gujarat, India, reported August 2009.",G0000000|G0000000|C1615608|C0021400|G0000000|G0000000|C0042776|G0000000|C0021201|C0684224|C3831448|G0000000
The post-1997 group included patients operated from January 1998 to December 2008 (n = 379).,The post-1997 included patients operated January 1998 December 2008 (n = 379).,G0000000|C0687676|C0332257|C0030705|C3242339|C3829466|G0000000|C3830550|G0000000|C0369718|G0000000|C1442061
"Care homes will also be excluded if they have received a medication review service from the PCT in the last 6 months, if they receive the services of a community geriatrician or if they are subject to investigation of the safeguarding of vulnerable adults.","Care homes excluded received medication review service PCT 6 months, receive services community geriatrician subject investigation safeguarding vulnerable adults.",C1947933|C0442519|C1554077|C1514756|C0013227|C0282443|C0557854|C1535922|G0000000|C0439231|C1514756|C0557854|C0009462|C0586872|C0681850|C0220825|G0000000|G0000000|C0001675
Patients ≥45 years of age with a history of ≥10 pack-years of smoking were also excluded from the study.,Patients ≥45 age history ≥10 pack-years smoking excluded study.,C0030705|G0000000|C0001779|C0019664|G0000000|C1277691|C0037369|C1554077|C0557651
They saw the patients more frequently and often called them between appointments.,They patients frequently called appointments.,G0000000|C0030705|C0332183|C0679006|C0003629
"Eligible patients had a TIA or nondisabling stroke within 30 days before enrollment, attributed to angiographically verified stenosis of 70 to 99% of the diameter of a major intracranial artery.","Eligible patients TIA nondisabling stroke 30 days enrollment, attributed angiographically verified stenosis 70 99% diameter major intracranial artery.",C1548635|C0030705|C0007787|G0000000|C0038454|C0450371|C0439228|C1516879|C0449234|G0000000|C1711411|C0678234|C0450371|C0450371|C1301886|C0205082|C0524466|C0003842
"Adhering to the general safety considerations, we excluded extremely immature neonates and/or those with the following abnormalities requiring therapeutic interventions that would interfere with the treatment regimen: severe congenital malformations, congenital heart failure, anuria due to circulation failure, liver/hemolytic disease, thrombocytopenia, oxygen saturation SO2 <80% longer than 2 hours, previous inclusion in other trials, severe acidosis, application of catecholamines, multiorgan failure, or hypoxic-ischemic encephalopathy.","Adhering safety considerations, excluded extremely immature neonates and/or abnormalities requiring therapeutic interventions interfere treatment regimen: severe congenital malformations, congenital heart failure, anuria circulation failure, liver/hemolytic disease, thrombocytopenia, oxygen saturation SO2 <80% 2 hours, previous inclusion trials, severe acidosis, application catecholamines, multiorgan failure, hypoxic-ischemic encephalopathy.",C3714578|C0036043|C0518609|C1554077|C0205403|C0205252|C0021289|G0000000|C0000768|G0000000|C0087111|C0886296|C0521102|C0039798|C0040808|C0205082|C0009678|C0000768|C0009678|C0018787|C0231174|C0003460|C0005775|C0231174|C0023884|C0012634|C0040034|C0030054|C0522534|G0000000|C0450371|G0000000|C0439227|C0205156|C0007637|C0008976|C0205082|C0001122|C0185125|C0007412|G0000000|C0231174|C0242184|C0006111
Study sample—The families of children attending preschool Head Start programs in two regions were eligible.,Study sample—The families children attending preschool Head Start programs regions eligible.,C0557651|G0000000|C0015576|C0008059|C1547429|C0424930|C0018670|C0439659|C0376691|C0017446|C1548635
"For 212 patients, data were available for analysis.","For 212 patients, data analysis.",G0000000|C1442061|C0030705|C1511726|C0002778
"As shown in Table 1, at baseline, in Kakamega, respondents reported that 20% of children 0–36 months old suffered from diarrhea the week before the survey.","As Table 1, baseline, Kakamega, respondents reported 20% children 0–36 months suffered diarrhea week survey.",G0000000|C0039224|G0000000|C0168634|C1221116|C0282122|C0684224|C0450371|C0008059|G0000000|C0439231|C0683278|C0011991|C0332174|C0038951
"Patients >10 kg in weight who had slide-confirmed acute P. falciparum malaria were included in the study, provided that they or their guardians gave fully informed written consent intheir own language, they were not pregnant, they had not received mefloquine in the previous 63 days and there were no other clinical or laboratory signs of severe illness and/or severe and complicated malaria [13].","Patients >10 weight slide-confirmed acute P. falciparum malaria included study, provided guardians informed written consent intheir language, pregnant, received mefloquine previous 63 days clinical laboratory signs severe illness and/or severe complicated malaria [13].",C0030705|C0450371|C0005910|C0444330|C0205178|C0369773|G0000000|C0024530|C0332257|C0557651|C1999230|C1274041|C1522154|C0043266|C1511481|G0000000|C0023008|C0549206|C1514756|C0025153|C0205156|C0450371|C0439228|C0205210|C0022877|C0220912|C0205082|C0221423|G0000000|C0205082|C0231242|C0024530|C0450371
"PHE conducted routine screening of all individuals who returned to the UK from West Africa at the peak of the epidemic, between 14 October 2014 and 4 December 2015.","PHE conducted routine screening individuals returned UK West Africa peak epidemic, 14 October 2014 4 December 2015.",C0031453|C0004927|C0205547|C0220908|C0027361|C0332156|C0041700|C1705493|C0001737|C0444505|C0014499|C0450371|C3828732|G0000000|G0000000|C3830550|G0000000
"Therefore, an effective sample size of about 780 mother-child pairs was estimated.","Therefore, effective sample size 780 mother-child pairs estimated.",G0000000|C1280519|C0370003|C0456389|C1442061|C0260023|C1709450|C0750572
"Exclusion criteria were pregnancy, history of bulimia or anorexia, unstable angina or arrhythmia, untreated thyroid disease, symptomatic liver or gall bladder disorder, any other severe disease, insulin treatment, systemic steroid treatment, or history of food allergy or of intolerance to any component of the very low energy dietary preparation that would be used in the study—such as soya, fish, chocolate, or lactose.","Exclusion criteria pregnancy, history bulimia anorexia, unstable angina arrhythmia, untreated thyroid disease, symptomatic liver gall bladder disorder, severe disease, insulin treatment, systemic steroid treatment, history food allergy intolerance component low energy dietary preparation study—such soya, fish, chocolate, lactose.",C0680251|C0243161|C0032961|C0019664|C0006370|C0003123|C0443343|C0002962|C0003811|C0332155|C0040132|C0012634|C0231220|C0023884|C2700230|C0005682|C0012634|C0205082|C0012634|C0021641|C0039798|C0205373|C0038317|C0039798|C0019664|C0016452|C0002111|C0231199|C0449432|C0205251|C0424589|C0012155|C1521827|G0000000|C0037733|C0016163|C0006622|C0022949
The purpose of this study was to evaluate the efficacy of 40 weeks of maintenance varenicline and CBT in smokers with serious mental illness who achieved abstinence with 12 weeks of open-label varenicline and CBT.,The purpose study evaluate efficacy 40 weeks maintenance varenicline CBT smokers mental illness achieved abstinence 12 weeks open-label varenicline CBT.,G0000000|C1285529|C0557651|C0220825|C1280519|C0450371|C0439230|C0024501|C1569608|C0009244|C0337664|C0229992|C0221423|G0000000|C3843422|C0450371|C0439230|C1709323|C1569608|C0009244
Children between 6 months and 10 years of age were enrolled in the study because their complete or partial lack of protective immunity against malaria put them at the greatest risk.,Children 6 months 10 age enrolled study complete partial lack protective immunity malaria risk.,C0008059|G0000000|C0439231|C0450371|C0001779|G0000000|C0557651|C0205197|C0728938|C0332268|G0000000|C0020964|C0024530|C0035647
"As patients registered at a practice can be managed by any of the clinicians in the practice, we considered the practice as the unit for randomisation and analysis.","As patients registered practice managed clinicians practice, considered practice unit randomisation analysis.",G0000000|C0030705|C1514821|C0237607|C1273870|C0871685|C0237607|C0750591|C0237607|C0439148|C0034656|C0002778
The intervention group had slightly higher depression and anxiety scores.,The intervention depression anxiety scores.,G0000000|C0886296|C0011570|C0003467|C0449820
"However, these studies were small and conducted with populations that do not include ICU patients.","However, studies conducted populations ICU patients.",G0000000|C0947630|C0004927|C0032659|C0021708|C0030705
"However, parents will be excluded from the study if they are under the age of 18 years, have a child over the age of 12 weeks at the time of enrolment into the study, have insufficient English comprehension to complete the questionnaires, have an infant born before 33 weeks gestation, or if the parent and/or infant suffer from a serious medical condition.","However, parents excluded study age 18 years, child age 12 weeks time enrolment study, insufficient English comprehension complete questionnaires, infant born 33 weeks gestation, parent and/or infant suffer medical condition.",G0000000|C0030551|C1554077|C0557651|C0001779|C0450371|C0439234|C0008059|C0001779|C0450371|C0439230|C0040223|C1516879|C0557651|C0205412|C0376245|C0162340|C0205197|C0034394|C0021270|C0005615|C0450371|C0439230|C0032961|C0030551|G0000000|C0021270|C0683278|C0199168|C0012634
Parents of asthmatic (n=341) or healthy (n=219) children who did not have to want to quit smoking to enroll.,Parents asthmatic (n=341) healthy (n=219) children quit smoking enroll.,C0030551|C0004096|C0369718|C3898900|C0369718|C0008059|C0748223|C0037369|G0000000
"The eligibility criteria were: a clinical diagnosis of a first stroke confirmed by neuroimaging (computed tomography or magnetic resonance imaging); a hemiparesis; a time interval between stroke and recruitment of 3 months or less; the ability to comprehend the instructions for the testing procedures; and mild to moderate walking deficit, as indicated by Functional Ambulation Category (FAC) between 3 and 46, 7).","The eligibility criteria were: clinical diagnosis stroke confirmed neuroimaging (computed tomography magnetic resonance imaging); hemiparesis; time interval stroke recruitment 3 months less; ability comprehend instructions testing procedures; mild moderate walking deficit, Functional Ambulation Category (FAC) 3 46, 7).",G0000000|C0013893|C0243161|G0000000|C0205210|C0011900|C0038454|C0521093|C0679575|C1441526|C0040395|C0024488|C0231881|C0011923|C0018989|C0040223|C1272706|C0038454|C2949735|G0000000|C0439231|C0439092|C0085732|G0000000|C0302828|C0039593|C0025664|C2945599|C0205081|C0080331|C0162429|C0205245|C0080331|C0683312|G0000000|G0000000|C0450371|G0000000
Patients were excluded if they had previously received chemotherapy for gastric or oesophageal cancer; had another malignancy that in the opinion of the treating consultant would potentially impede interpretation of the outcome of 321GO therapy; had treatment with another investigational agent within 30 days of commencing treatment; and had previously been treated with anthracyclines to a total cumulative dose of epirubicin of 900 mg m−2 (or equivalent) including the treatment to be administered within this trial.,Patients excluded received chemotherapy gastric oesophageal cancer; malignancy opinion treating consultant impede interpretation outcome 321GO therapy; treatment investigational agent 30 days commencing treatment; treated anthracyclines total cumulative dose epirubicin 900 mg m−2 (or equivalent) including treatment administered trial.,C0030705|C1554077|C1514756|C0013216|C0038351|C1522619|C0006826|C0006826|C0871010|C1522326|C0009817|G0000000|C0459471|C1274040|G0000000|C0039798|C0039798|C1517586|C0450442|C0450371|C0439228|C3274784|C0039798|C1522326|C0003234|C0439175|C1511559|C0178602|C0014582|G0000000|G0000000|C0205163|C0332257|C0039798|C1521801|C0008976
The study reported in this issue of Critical Care [1] also targeted high-risk patients by examining those ventilated for at least 48 hours and with a CLV below 110 ml.,The study reported issue Critical Care [1] targeted high-risk patients examining ventilated 48 hours CLV 110 ml.,G0000000|C0557651|C0684224|C0033213|C1511545|C1947933|G0000000|C1521840|C0332167|C0030705|C0332128|C0231923|C0450371|C0439227|G0000000|C1442061|C0439526
"After a median of 12 years since cancer diagnosis and at a median age of 18 years, almost 30% of all survivors had impaired GFR or tubular function or an elevated BP.","After median 12 cancer diagnosis median age 18 years, 30% survivors impaired GFR tubular function elevated BP.",G0000000|C0549183|C0450371|C0006826|C0011900|C0549183|C0001779|C0450371|C0439234|C0450371|C0206194|C0221099|C0017654|C0332208|C0031843|C0205250|C0037623
"The stratified stepped-care approach assigns individuals to treatments of varying intensity based on the severity of their symptoms.33 PHQ-9 scores within the range of 5–19, are considered indicative of mild to moderately severe symptoms of depression.31 Likewise, GAD-7 scores within the range of 5–14 indicate the presence of mild to moderately severe anxiety.29 Individuals with mild to moderately severe symptoms of depression and/or anxiety will be considered appropriate for treatment with the iDiD online CBT programme, and for inclusion in this study.","The stratified stepped-care approach assigns individuals treatments varying intensity based severity symptoms.33 PHQ-9 scores range 5–19, considered indicative mild moderately severe symptoms depression.31 Likewise, GAD-7 scores range 5–14 presence mild moderately severe anxiety.29 Individuals mild moderately severe symptoms depression and/or anxiety considered treatment iDiD online CBT programme, inclusion study.",G0000000|C0205363|C1261552|C0449445|C1516050|C0027361|C0087111|G0000000|C0522510|C1527178|C0439793|C0683368|C1879301|C0449820|C1514721|G0000000|C0750591|G0000000|C2945599|C0205081|C0205082|C0683368|C0011570|G0000000|C0270549|C0449820|C1514721|G0000000|C0150312|C2945599|C0205081|C0205082|C0003467|C0027361|C2945599|C0205081|C0205082|C0683368|C0011570|G0000000|C0003467|C0750591|C0039798|G0000000|G0000000|C0009244|C1709697|C0007637|C0557651
"Although the combination of cisplatin and gemcitabine (GEM) is considered the standard first-line chemotherapy against unresectable hilar cholangiocarcinoma (HC), its efficacy is discouraging.","Although combination cisplatin gemcitabine (GEM) considered standard first-line chemotherapy unresectable hilar cholangiocarcinoma (HC), efficacy discouraging.",G0000000|C0205195|C0008838|C0045093|G0000000|C0750591|C1442989|C0205435|C0013216|C1519810|C0205150|C0206698|C0020268|C1280519|G0000000
"Because of the modest number of pharmacies registered in South Bronx, the Bedford-Stuyvesant community in Brooklyn (with similar demographics) was added to the comparison community, which yielded 106 pharmacies in the comparison community and 45 in the intervention community.","Because modest pharmacies registered South Bronx, Bedford-Stuyvesant community Brooklyn (with demographics) comparison community, yielded 106 pharmacies comparison community 45 intervention community.",G0000000|C4054480|C0031322|C1514821|C1710133|G0000000|G0000000|C0009462|G0000000|G0000000|C0011298|C1707455|C0009462|G0000000|C1442061|C0031322|C1707455|C0009462|C0450371|C0886296|C0009462
Mothers with advanced disease (CD4 < 200 or WHO stage 3 and 4) requiring ART and those not resident in the area were not eligible for recruitment.,Mothers advanced disease (CD4 < 200 WHO stage 3 4) requiring ART resident eligible recruitment.,C0026591|C0205179|C0012634|C0285590|G0000000|C1442061|G0000000|C0205390|G0000000|G0000000|G0000000|C0003826|C1320928|C1548635|C2949735
*None of the baseline characteristics were significantly different between the treatment groups.,*None baseline characteristics treatment groups.,G0000000|C0168634|C1521970|C0039798|C0441833
"We found no differences in median survival between the treatment arms for patients <75 years (VG: 6.9 months, VC: 6.8 months; HR=0.89, CI=0.72–1.10; P=0.296).","We differences median survival treatment arms patients <75 (VG: 6.9 months, VC: 6.8 months; HR=0.89, CI=0.72–1.10; P=0.296).",G0000000|C1705241|C0549183|C0038952|C0039798|C0206655|C0030705|C0450371|C0205999|G0000000|C0439231|G0000000|G0000000|C0439231|C0450371|G0000000|C0369773
"The exclusion criteria were recurrent stroke with duration of more than 6 months from stroke onset, less than two subtests (BITC) of diagnosed neglect, incapability to communicate, and lack of primary caregivers.","The exclusion criteria recurrent stroke duration 6 months stroke onset, subtests (BITC) diagnosed neglect, incapability communicate, lack primary caregivers.",G0000000|C0680251|C0243161|C2945760|C0038454|C0449238|G0000000|C0439231|C0038454|C0206132|G0000000|G0000000|C0011900|C0521874|C1550518|C0566001|C0332268|C0205225|C0085537
Both arms of the study were very well tolerated.,Both arms study tolerated.,G0000000|C0206655|C0557651|G0000000
"Patients with symptoms of the carpal tunnel syndrome for more than 3 months, confirmed by electrophysiological tests and aged over 18 years.","Patients symptoms carpal tunnel syndrome 3 months, confirmed electrophysiological tests aged 18 years.",C0030705|C0683368|C0007285|C0337138|C0039082|G0000000|C0439231|C0521093|C0013865|C0022885|C0001779|C0450371|C0439234
As a strategy of the programme; households have been graduated as model families after training and implementing the intervention packages.,As strategy programme; households graduated model families training implementing intervention packages.,G0000000|C0679199|C1709697|C0020052|C0588053|C3161035|C0015576|C0040607|G0000000|C0886296|C0013194
"Exclusion criteria were: 1) having nerve root symptoms, 2) having systemic disease and specific conditions such as neoplasm, fractures, spondylolysthesis, spondylolysis, spinal stenosis, ankylosing spondylitis, previous low back surgery, 3) taking medication for specific psychological problems, and 4) being pregnant.","Exclusion criteria were: 1) nerve root symptoms, 2) systemic disease specific conditions neoplasm, fractures, spondylolysthesis, spondylolysis, spinal stenosis, ankylosing spondylitis, previous low surgery, 3) medication specific psychological problems, 4) pregnant.",C0680251|C0243161|G0000000|G0000000|C0027740|C0040452|C0683368|G0000000|C0205373|C0012634|C0205369|C0012634|C0027651|C0016658|G0000000|C0038018|C0521329|C0678234|G0000000|C0038012|C0205156|C0205251|C0038894|G0000000|C0013227|C0205369|C0205486|C1546466|G0000000|C0549206
"With regard to adherence to aerobic physical activity (based on accelerometer), improvement was noted in the weekly minutes of ≥ moderate intensity physical activity for the intervention versus the usual care group [i.e., +45.4 versus −37.7; mean between group difference = +83.1; effect size (d) =.76; P = .097].","With regard adherence aerobic physical activity (based accelerometer), improvement weekly minutes ≥ moderate intensity physical activity intervention versus usual care [i.e., +45.4 versus −37.7; difference = +83.1; size (d) =.76; P = .097].",G0000000|G0000000|C1510802|C1510824|C0031809|C0205177|C1527178|C0178951|C2986411|C0332174|C0439232|G0000000|C0205081|C0522510|C0031809|C0205177|C0886296|G0000000|C3538928|C1947933|C0683454|C0450371|G0000000|G0000000|C1705241|G0000000|C0450371|C0456389|C0073187|C0450371|C0369773|G0000000|C1442061
Thromboprophylaxis was started on day 8 and ended on day 33 of induction chemotherapy (Online Supplementary Figure S1).,Thromboprophylaxis started day 8 day 33 induction chemotherapy (Online Supplementary Figure S1).,G0000000|C1272689|C0332173|G0000000|C0332173|C0450371|C0205263|C0013216|G0000000|G0000000|G0000000|C1519428
"They were excluded from the research in case of any problems or complications during pregnancy, failure to attend more than one session of training.","They excluded complications pregnancy, failure attend session training.",G0000000|C1554077|C0009566|C0032961|C0231174|C1999232|C1883016|C0040607
"During October 2008 and June 2011, we prospectively recruited AGC patients all over China.","During October 2008 June 2011, prospectively recruited AGC patients China.",G0000000|C3828732|G0000000|C3829443|G0000000|G0000000|G0000000|C1455888|C0030705|C0008115
The inclusion criteria were: History of nLBP with symptoms persisting for 3 months.,The inclusion criteria were: History nLBP symptoms persisting 3 months.,G0000000|C0007637|C0243161|G0000000|C0019664|C1427868|C0683368|G0000000|G0000000|C0439231
"Fifteen minutes later, when the fingers were completely dry, the fingertips of each hand of the 30 control subjects and 30 of the volunteers in the active treatment group were contaminated with 106 TCID50 of rhinovirus type 39 in a volume of 100 μl.","Fifteen minutes later, fingers completely dry, fingertips hand 30 control subjects 30 volunteers active treatment contaminated 106 TCID50 rhinovirus type 39 volume 100 μl.",C3715153|C0439232|C0205087|C0016129|C0205197|C0011682|C2348675|C0018563|C0450371|C0243148|C0681850|C0450371|C0042960|C0205177|C0039798|C0205279|C1442061|G0000000|C0035473|C0332307|C0450371|C0449468|C1442061|G0000000
"Patients with uncontrolled hypertension (BP>160/110 mmHg) at the time of screening, pregnant women, and patients with serum potassium >5.5 mEq/L, a malignancy, a diagnosis of CVD (cerebral infarction, hemorrhagic infarction, acute myocardial infarction or unstable angina, coronary angioplasty, or coronary artery bypass surgery) within the last 6 months, contraindication for angiotensin II receptor blockers (ARBs), and diabetes mellitus were excluded as well as continuous users of steroids or other immunosuppressive agents at the time of registration.","Patients uncontrolled hypertension (BP>160/110 mmHg) time screening, pregnant women, patients serum potassium >5.5 mEq/L, malignancy, diagnosis CVD (cerebral infarction, hemorrhagic infarction, acute myocardial infarction unstable angina, coronary angioplasty, coronary artery bypass surgery) 6 months, contraindication angiotensin II receptor blockers (ARBs), diabetes mellitus excluded continuous users steroids immunosuppressive agents time registration.",C0030705|C0205318|C0020538|C0037623|C0439475|C0040223|C0220908|C0549206|C0043210|C0030705|C0229671|C0032821|G0000000|C0439375|C0006826|C0011900|C0007222|G0000000|C0021308|C0333275|C0021308|C0205178|C0027061|C0021308|C0443343|C0002962|C0018787|C0162577|C0018787|C0003842|C0741847|C0038894|G0000000|C0439231|C0522473|C0003018|G0000000|C0597357|G0000000|C3888198|C0011847|G0000000|C1554077|C0549178|C1706077|C0038317|C0021081|C0450442|C0040223|C1514821
"The study was conducted between June 2008 and March 2010 in primary schools of Gabtali town of Bogra district in the Rajshahi Division, Northern Bangladesh.","The study conducted June 2008 March 2010 primary schools Gabtali town Bogra district Rajshahi Division, Northern Bangladesh.",G0000000|C0557651|C0004927|C3829443|G0000000|C3829202|G0000000|C0205225|C0036375|G0000000|C0557750|G0000000|G0000000|G0000000|C0152060|C1709269|C0004732
"(3) Stable vital signs, stable condition, and no disease progression for over 48 hours.","(3) Stable vital signs, stable condition, disease progression 48 hours.",G0000000|C0205360|C0442732|C0220912|C0205360|C0012634|C0012634|C0242656|C0450371|C0439227
"Girls of childbearing potential could be enrolled if they were abstinent or practiced adequate contraception for 30 d prior to vaccination, had a negative pregnancy test on the day of each vaccination, and agreed to continue contraception up to 2 months after completion of the vaccination series.","Girls childbearing potential enrolled abstinent practiced adequate contraception 30 prior vaccination, negative pregnancy test day vaccination, agreed continue contraception 2 months completion vaccination series.",C0870604|G0000000|C3245505|G0000000|C0457801|C0237607|C0205410|C0700589|C0450371|C0332152|C0042196|C0205160|C0032961|C0022885|C0332173|C0042196|C3641827|C0549178|C0700589|G0000000|C0439231|C0205197|C0042196|C0205549
"Individuals were identified primarily from a community health center's patient panel, screened for study eligibility, randomized to either a usual care or a lifestyle intervention condition, and followed for one year.","Individuals identified community health center's patient panel, screened study eligibility, randomized usual care lifestyle intervention condition, year.",C0027361|C0205396|C0009462|C0018684|C0205099|C0030705|C0441833|C0220908|C0557651|C0013893|C0034656|C3538928|C1947933|C0023676|C0886296|C0012634|C0439234
"For the heterosexual subjects, eligibility criteria were an age between 16 and 23 years and one to five female sexual partners during their lifetime; for the subjects who had sex with male partners, the criteria were an age between 16 and 26 years and one to five male or female partners during their lifetime.","For heterosexual subjects, eligibility criteria age 16 23 female sexual partners lifetime; subjects sex male partners, criteria age 16 26 male female partners lifetime.",G0000000|C0019421|C0681850|C0013893|C0243161|C0001779|C0450371|C0450371|C0015780|C0036864|C0682323|C4071830|C0681850|C0009253|C0086582|C0682323|C0243161|C0001779|C0450371|C0450371|C0086582|C0015780|C0682323|C4071830
Survey A = 2 mo after first intervention spray.,Survey A = 2 mo intervention spray.,C0038951|G0000000|C0026544|C0886296|C1704413
"The age of patients at recall, in both genders, ranged from 2½ to 10 years, with a mean of 5.5±1.5 years.","The age patients recall, genders, ranged 2½ 10 years, 5.5±1.5 years.",G0000000|C0001779|C0030705|C0034770|C0079399|C1514721|G0000000|C0450371|C0439234|G0000000|C0439234
"Women who had special dietary requirements (including vegetarianism/veganism), preexisting diabetes, or pregnancy achieved by assisted reproduction and those who smoked or consumed alcohol during pregnancy were excluded.","Women special dietary requirements (including vegetarianism/veganism), preexisting diabetes, pregnancy achieved assisted reproduction smoked consumed alcohol pregnancy excluded.",C0043210|C0205555|C0012155|C1514873|C0332257|C0311164|C2347662|C0011847|C0032961|G0000000|C1269765|C0035150|C0037366|G0000000|C0001962|C0032961|C1554077
"The number of treatment-related deaths was the same in the pembrolizumab group and the chemotherapy group, which probably reflects the poor prognosis of patients in this population.","The treatment-related deaths pembrolizumab chemotherapy group, reflects poor prognosis patients population.",G0000000|C0039798|C0011065|C3658706|C0013216|C0441833|C0558058|C0032854|C0033325|C0030705|C0032659
"Standard therapy for ovarian cancer is cytoreductive surgery, followed in most cases by platinum/paclitaxel combination chemotherapy (Harries and Gore, 2002a).","Standard therapy ovarian cancer cytoreductive surgery, platinum/paclitaxel combination chemotherapy (Harries Gore, 2002a).",C1442989|C0039798|C0205065|C0006826|G0000000|C0038894|C0032207|C0205195|C0013216|G0000000|G0000000|G0000000
"Nine items were used to record the frequency of the following behaviors over the past 3 months: unprotected and protected vaginal and anal intercourse, giving and receiving oral sex, the number of male and female sexual partners in the past 3 months, and number of times talked with partner about safer sex.","Nine items record frequency behaviors 3 months: unprotected protected vaginal anal intercourse, receiving oral sex, male female sexual partners 3 months, times talked partner safer sex.",C0205455|C1551338|C0034869|C0376249|C0004927|G0000000|C0439231|G0000000|G0000000|C0042232|C0003461|C0009253|C1514756|C0442027|C0009253|C0086582|C0015780|C0036864|C0682323|G0000000|C0439231|C0040223|C0037817|C0682323|C0036043|C0009253
"Patients interested in participating were instructed to sign an enclosed consent form and complete a screening survey designed to exclude individuals who (1) had conditions that precluded unsupervised exercise (uncontrolled congestive heart failure or angina, recent myocardial infarction, or breathing difficulties requiring oxygen use or hospitalization; the use of a mobility aid other than a cane; or plans to have hip or knee replacement) or a high F&V diet (kidney failure or chronic warfarin use); (2) had progressive malignant disease or additional primary tumors; (3) were unable to participate fully in the telephone counseling or mailed material interventions (severe hearing or speaking impairments, inability to speak/write English, or mental incompetence); (4) reported less than two PF deficits,15,21 (unlikely to experience change in PF); or (5) were already routinely exercising or adhering to a low-fat, high F&V diet.","Patients participating instructed sign enclosed consent form complete screening survey designed exclude individuals (1) conditions precluded unsupervised exercise (uncontrolled congestive heart failure angina, myocardial infarction, breathing difficulties requiring oxygen hospitalization; mobility aid cane; plans hip knee replacement) F&V diet (kidney failure chronic warfarin use); (2) progressive malignant disease additional primary tumors; (3) unable participate telephone counseling mailed material interventions (severe hearing speaking impairments, inability speak/write English, mental incompetence); (4) reported PF deficits,15,21 (unlikely experience change PF); (5) routinely exercising adhering low-fat, F&V diet.",C0030705|C0679823|G0000000|C0311392|C0205380|C1511481|C0348078|C0205197|C0220908|C0038951|C1707689|C0332196|C0027361|G0000000|C0012634|G0000000|G0000000|C0015259|C0205318|C0742742|C0018787|C0231174|C0002962|C0027061|C0021308|C0004048|C1299586|G0000000|C0030054|C0019993|C0425245|C0449435|C0006856|C0270724|C0019552|C0022742|C0035139|C0016327|C0012155|C0022646|C0231174|C0205191|C0043031|C0042153|G0000000|C0205329|C0205282|C0012634|C1524062|C0205225|C0027651|G0000000|C1299582|G0000000|C0039457|C0010210|C0024492|C0520510|C0886296|C0205082|C0018767|C0234856|C0684336|G0000000|C0234856|C0376245|C0229992|C0231189|G0000000|C0684224|C3815179|C2987487|C0750558|C0237607|C0392747|C3815179|G0000000|G0000000|C0015259|C3714578|C0242970|C0016327|C0012155
"Between October 1997 and April 2002, 416 patients with metastatic melanoma were entered into this study.","Between October 1997 April 2002, 416 patients metastatic melanoma entered study.",G0000000|C3828732|G0000000|C3715024|G0000000|C1442061|C0030705|C0036525|C0025202|C1521975|C0557651
All patients had histologically confirmed bladder cancer with no prior treatment of chemotherapy or radiotherapy at the time of recruitment.,All patients histologically confirmed bladder cancer prior treatment chemotherapy radiotherapy time recruitment.,G0000000|C0030705|C0205462|C0521093|C0005682|C0006826|C0332152|C0039798|C0013216|C0034619|C0040223|C2949735
"Patients are cared for by one of six independent services (Red service, Green service, and so on).","Patients cared independent services (Red service, Green service, on).",C0030705|C1947933|C0085862|C0557854|C0332575|C0557854|C0332583|C0557854|G0000000
Rapid early responders (RERs) to 3 ABVE-PC cycles received 21 Gy radiation to involved regions; RER was documented in 63% of patients.,Rapid responders (RERs) 3 ABVE-PC cycles received 21 Gy radiation involved regions; RER documented 63% patients.,C0456962|G0000000|C0230779|G0000000|C1879497|C1511572|C1514756|C0450371|C0018408|C0034519|C1314939|C0017446|C0230779|C1301725|C0450371|C0030705
"Inclusion criteria included documented HIV infection, age >18 years, and an HIV load of <400 copies/mL at the most recent measurement.","Inclusion criteria included documented HIV infection, age >18 years, HIV load <400 copies/mL measurement.",C0007637|C0243161|C0332257|C1301725|C0019682|C0009450|C0001779|C0450371|C0439234|C0019682|C1550025|C1442061|C1531853|C0242485
"Patients with identifiable LUTS other than NE and those with other physical disorders, such as diabetes; with abnormal urine analysis results; with renal, urological, cardiovascular, or neurological diseases; or previously treated with an enuresis alarm or desmopressin were excluded from study.","Patients identifiable LUTS NE physical disorders, diabetes; abnormal urine analysis results; renal, urological, cardiovascular, neurological diseases; treated enuresis alarm desmopressin excluded study.",C0030705|C0205396|C0574785|C0028219|C0031809|C0012634|C0011847|C0205161|C0042036|C0002778|C1274040|C0022646|G0000000|C0007226|C0205494|C0012634|C1522326|C0014394|C0336648|C0011701|C1554077|C0557651
"The number of responders was significantly higher in the cerebrolysin-treated group compared with the placebo group on day 90 (8 versus 0, P=0.002) (Figure 2).","The responders cerebrolysin-treated compared placebo day 90 (8 versus 0, P=0.002) (Figure 2).",G0000000|G0000000|C0055108|C1707455|C0032042|C0332173|C0450371|G0000000|G0000000|G0000000|C0369773|G0000000|G0000000
All children aged 3-12 months registered with participating practices.,All children aged 3-12 months registered participating practices.,G0000000|C0008059|C0001779|C0450371|C0439231|C1514821|C0679823|C0237607
"Participants were excluded if they consumed multivitamins containing more than 400 international unit (IU) per day of vitamin D3; used anticonvulsants; and had history of chronic diseases like diabetes, hypertension, renal dysfunction, liver diseases, and complicated medical or obstetrical history.","Participants excluded consumed multivitamins 400 international unit (IU) day vitamin D3; anticonvulsants; history chronic diseases diabetes, hypertension, renal dysfunction, liver diseases, complicated medical obstetrical history.",C0679646|C1554077|G0000000|C0301532|C1442061|C1512888|C0439148|C0049272|C0332173|C0042890|C3538936|C0003286|C0019664|C0205191|C0012634|C0011847|C0020538|C0022646|C0031847|C0023884|C0012634|C0231242|C0199168|C0028773|C0019664
"The differences between the numbers of enrolled men and the numbers of RP specimens, in addition to the small difference in the three treatment arms (see below), result from the fact that 24 of the 431 patients did not undergo surgical treatment, and 14 did not comply with the protocol and therefore were excluded.","The differences enrolled RP specimens, addition difference treatment arms (see below), result 24 431 patients undergo surgical treatment, 14 comply protocol excluded.",G0000000|C1705241|G0000000|C0031529|C0370003|C0332287|C1705241|C0039798|C0206655|C0042789|G0000000|C1274040|C0450371|C1442061|C0030705|G0000000|C0543467|C0039798|C0450371|C0725694|C0442711|C1554077
The risk for pneumonia is highest in the acute state of stroke [9] and in patients with non-lacunar strokes in the MCA territory [7].,The risk pneumonia acute stroke [9] patients non-lacunar strokes MCA territory [7].,G0000000|C0035647|C0032285|C0205178|C0038454|G0000000|C0030705|C1518422|C0038454|C0149566|C1301808|G0000000
All patients requiring FV DC insertion for initiation of dialysis as part of their management between April and November 2008 were enrolled for the study.,All patients requiring FV DC insertion initiation dialysis management April November 2008 enrolled study.,G0000000|C0030705|G0000000|G0000000|G0000000|C0021107|C0589507|C0011945|C0001554|C3715024|C3828767|G0000000|G0000000|C0557651
"Subjects also had at least 1 year of abstinence from alcohol and drugs, corroborated by a significant other and a negative urine drug and alcohol screening test.","Subjects 1 abstinence alcohol drugs, corroborated negative urine drug alcohol screening test.",C0681850|G0000000|C3843422|C0001962|C0013227|G0000000|C0205160|C0042036|C0013227|C0001962|C0220908|C0022885
"Seventy-five paediatric patients belonging to American Society of Anaesthesiologists physical status I–II, of either sex, between 4 months and 7 years of age, scheduled for elective subumbilical surgery under general anaesthesia, were included after obtaining written informed consent from the parents/guardians.","Seventy-five paediatric patients belonging American Society Anaesthesiologists physical status I–II, sex, 4 months 7 age, scheduled elective subumbilical surgery anaesthesia, included obtaining written informed consent parents/guardians.",C3816957|C0030755|C0030705|G0000000|C0596070|C0037455|C0334910|C0031809|C0449438|G0000000|C0009253|G0000000|C0439231|G0000000|C0001779|C0086960|C0206058|G0000000|C0038894|C0002903|C0332257|C1301820|C0043266|C1522154|C1511481|C0030551
There was no difference across the categories in terms of the proportion of income spent on food (represented as percent spent on food: 67%-83%).,There difference categories terms proportion income spent food (represented percent spent food: 67%-83%).,G0000000|C1705241|C0683312|C0233324|C1709707|C0021162|C0680968|C0016452|C1882932|C0439165|C0680968|C0016452|C0450371
Patients with the diagnosis of invasive cancer within one year from initial diagnosis of IN were also excluded in order to minimize falsely detecting preexisting invasive disease due to incorrect initial diagnosis.,Patients diagnosis invasive cancer initial diagnosis IN excluded minimize falsely detecting preexisting invasive disease incorrect initial diagnosis.,C0030705|C0011900|C0205281|C0006826|C0205265|C0011900|G0000000|C1554077|G0000000|G0000000|C0442726|C2347662|C0205281|C0012634|C3827420|C0205265|C0011900
"The inclusion criteria were being a term girl infant aged between 0 and 4 months, having a birth weight between 2500 and 4000 g, normal ability of sucking, and not consuming infant formula, herbal and chemical galactogogues, non-initiation of complementary feeding, and mother and infant not infected by any diseases that have contradiction with breastfeeding.","The inclusion criteria term girl infant aged 0 4 months, birth weight 2500 4000 g, normal ability sucking, consuming infant formula, herbal chemical galactogogues, non-initiation complementary feeding, mother infant infected diseases contradiction breastfeeding.",G0000000|C0007637|C0243161|C0233324|C0870604|C0021270|C0001779|G0000000|G0000000|C0439231|C0005615|C0005910|G0000000|G0000000|C0439267|C0205307|C0085732|C0233927|G0000000|C0021270|C0489829|C3146288|C0220806|C2717873|C1518422|G0000000|C0204695|C0026591|C0021270|C0439663|C0012634|G0000000|C0006147
"Patients had to be medically fit for radical prostatectomy and to have histologically confirmed, clinically localized prostate cancer (stage T1-T2NxM0 in the tumor–node–metastasis classification system according to the American Joint Committee on Cancer10) of any grade diagnosed within the previous 12 months.","Patients medically fit radical prostatectomy histologically confirmed, clinically localized prostate cancer (stage T1-T2NxM0 tumor–node–metastasis classification system American Joint Committee Cancer10) grade diagnosed previous 12 months.",C0030705|G0000000|C0036572|C0302912|C0033573|C0205462|C0521093|G0000000|C0392752|C0033572|C0006826|C0205390|C0041403|G0000000|C0008902|C0449913|C0596070|C0022417|C2699414|G0000000|C0441800|C0011900|C0205156|C0450371|C0439231
"Of the 40 participants approached for study participation, 30 families agreed to participate and enrolled in the current study.","Of 40 participants approached study participation, 30 families agreed participate enrolled current study.",G0000000|C0450371|C0679646|C0449445|C0557651|C0679823|C0450371|C0015576|C3641827|G0000000|G0000000|C0521116|C0557651
Thirty two schools in disadvantaged areas will be allocated to either an intervention or a control group.,Thirty schools disadvantaged allocated intervention control group.,C3816446|C0036375|C0012613|G0000000|C0886296|C0243148|C0441833
"In total, there were 86 rehospitalisations in the intervention group against 132 in the control group (p=0.023).","In total, 86 rehospitalisations intervention 132 control (p=0.023).",G0000000|C0439175|C0450371|G0000000|C0886296|C1442061|C0243148|C0369773
Each academic year new physicians were randomly assigned to the practice sessions and patient panels of departing physicians.,Each academic physicians randomly assigned practice sessions patient panels departing physicians.,G0000000|C1510747|C0031831|G0000000|C1516050|C0237607|C1883016|C0030705|C0441833|C1706081|C0031831
"Participants were randomized to Traditional Self-Help (TSH, n = 638), Standard Repeated Mailings (SRM, n = 614), or Intensive Repeated Mailings (IRM, n = 622).","Participants randomized Traditional Self-Help (TSH, = 638), Standard Repeated Mailings (SRM, = 614), Intensive Repeated Mailings (IRM, = 622).",C0679646|C0034656|C0443324|C0597431|G0000000|G0000000|C1442061|C1442989|C0205341|C0024492|C1420404|G0000000|C1442061|C0162425|C0205341|C0024492|C1422766|G0000000|C1442061
Comparisons will be made post-test between Grade 10 students in intervention and control schools to determine intervention effectiveness across all measures.,Comparisons post-test Grade 10 students intervention control schools determine intervention effectiveness measures.,C1707455|C0687676|C0441800|C0450371|C0038492|C0886296|C0243148|C0036375|G0000000|C0886296|C1280519|C0079809
"Three patients in the intervention group were incorrectly diagnosed with stroke (all had malignancies), and one patient in the intervention group and one in the control group were given a discharge date but never discharged.","Three patients intervention incorrectly diagnosed stroke (all malignancies), patient intervention control discharge discharged.",C0205449|C0030705|C0886296|G0000000|C0011900|C0038454|G0000000|C0006826|C0030705|C0886296|C0243148|C0012621|C0030685
"Patients were also excluded if they were participating in a supervised pulmonary rehabilitation programme, had contraindications for tiotropium or ipratropium or had experienced adverse reactions to inhaled anticholinergics.","Patients excluded participating supervised pulmonary rehabilitation programme, contraindications tiotropium ipratropium experienced adverse reactions inhaled anticholinergics.",C0030705|C1554077|C0679823|G0000000|C0024109|C0034991|C1709697|C0079164|C0213771|C0027235|C0237607|G0000000|C0443286|C0004048|C0242896
"Only women who were postmenopausal, at least 35 years of age, and who had a 5-year predicted breast cancer risk of at least 1.66% were eligible for STAR.","Only women postmenopausal, 35 age, 5-year predicted breast cancer risk 1.66% eligible STAR.",C0205171|C0043210|C0232970|C0450371|C0001779|C0439234|C0681842|C0006141|C0006826|C0035647|C0450371|C1548635|C0995242
"All pregnant women with asthma attending antenatal outpatient clinics who are in their first or second trimester, and who can communicate in English will be considered.","All pregnant women asthma attending antenatal outpatient clinics trimester, communicate English considered.",G0000000|C0549206|C0043210|C0004096|C1547429|C2828394|C0029921|C0442592|C0032982|C0566001|C0376245|C0750591
"At baseline, the infants of mothers who had received DHA in the last trimester of pregnancy had a mean [95% CI] level of 45.5.","At baseline, infants mothers received DHA trimester pregnancy [95% CI] level 45.5.",G0000000|C0168634|C0021270|C0026591|C1514756|C0142831|C0032982|C0032961|C0450371|C0008107|C0441889|C0450371
"After caregivers understood and signed informed consent form, children were screened for CD4% if they were 1–12 years old, had CDC clinical stage A or B and had never received ART other than zidovudine as part of PMTCT.","After caregivers understood signed informed consent form, children screened CD4% 1–12 old, CDC clinical stage A B received ART zidovudine PMTCT.",G0000000|C0085537|C0162340|C1519316|C1522154|C1511481|C0348078|C0008059|C0220908|C0285590|G0000000|C0580836|C0007670|C0205210|C0205390|G0000000|G0000000|C1514756|C0003826|C0043474|C3845698
The lack of toxicity observed in this study might indicate that too low a dose of huachansu was chosen for combination with gemcitabine.,The lack toxicity observed study low dose huachansu chosen combination gemcitabine.,G0000000|C0332268|C0040539|C1441672|C0557651|C0205251|C0178602|C2745673|C1707391|C0205195|C0045093
"The practice experience of the 4 evaluators ranged from 4 to 22 years, with a mean of 15 years.","The practice experience 4 evaluators ranged 4 22 years, 15 years.",G0000000|C0237607|C0237607|G0000000|C1707957|C1514721|G0000000|C0450371|C0439234|C0450371|C0439234
Participants also had to meet DSM-IV criteria for Attention-Deficit Hyperactivity Disorder with the exception of the criterion that the age of onset of symptoms had to be prior to seven years of age.,Participants meet DSM-IV criteria Attention-Deficit Hyperactivity Disorder exception criterion age onset symptoms prior age.,C0679646|C1550543|C0220952|C0243161|C0041671|C0424295|C0012634|C1554961|C0243161|C0001779|C0206132|C0683368|C0332152|C0001779
"Patients were excluded from the study if they had: any other condition requiring hospitalization; anemia (hemoglobin <8 g/dL); hepatic or renal impairment; presence or history of clinically significant disorders; known hypersensitivity to study drugs or excipients; known active hepatitis A IgM, hepatitis B surface antigen, hepatitis C antibody or seropositive for HIV antibody; used an antimalarial within the previous two weeks (urine test required); used an antibacterial with anti-malarial activity within the previous two weeks; received an investigational drug within the past four weeks; previously participated in the study.","Patients excluded study had: condition requiring hospitalization; anemia (hemoglobin <8 g/dL); hepatic renal impairment; presence history clinically disorders; hypersensitivity study drugs excipients; active hepatitis A IgM, hepatitis B surface antigen, hepatitis C antibody seropositive HIV antibody; antimalarial previous weeks (urine test required); antibacterial anti-malarial activity previous weeks; received investigational drug weeks; participated study.",C0030705|C1554077|C0557651|G0000000|C0012634|G0000000|C0019993|C0002871|C0019046|G0000000|C0439267|C0205054|C0022646|C0221099|C0150312|C0019664|G0000000|C0012634|C0020517|C0557651|C0013227|C0015237|C0205177|C0019158|G0000000|G0000000|C0019158|G0000000|C0205148|C0003320|C0019158|G0000000|C0003241|C0521143|C0019682|C0003241|C0003374|C0205156|C0439230|C0042036|C0022885|C1514873|C0279516|C0003374|C0205177|C0205156|C0439230|C1514756|C1517586|C0013227|C0439230|G0000000|C0557651
"Previously, we clarified that a relapse within 6 months after initial treatment for NS is a predictive risk factor for FRNS [2].","Previously, clarified relapse 6 months initial treatment NS predictive risk factor FRNS [2].",G0000000|C2986669|C0035020|G0000000|C0439231|C0205265|C0039798|C0038944|C0681890|C0035647|C1521761|C0220730|G0000000
Caucasian mothers 21 years old or younger with children between 3 and 6 months old and who receive support from the local youth welfare system and agree to participate will be included in the study.,Caucasian mothers 21 children 3 6 months receive support local youth welfare system agree participate included study.,C0007457|C0026591|C0450371|C0008059|G0000000|G0000000|C0439231|C1514756|C0183683|C0205276|C0001578|C0037440|C0449913|C3641827|G0000000|C0332257|C0557651
The mean age and the body mass index for the remaining 17 patients (seven females) were 45 ± 4 (overall range 19–62) years and 33 ± 2 (overall range 19–45) kg/m2 respectively (see Table 1 for baseline sleep data).,The age body mass remaining 17 patients (seven females) 45 ± 4 (overall range 19–62) 33 ± 2 (overall range 19–45) kg/m2 (see Table 1 baseline sleep data).,G0000000|C0001779|C0242821|C0577559|C1527428|C0450371|C0030705|C0205453|C0015780|C0450371|G0000000|G0000000|C0282416|C1514721|G0000000|C0450371|G0000000|G0000000|C0282416|C1514721|G0000000|C0022718|C0042789|C0039224|G0000000|C0168634|C0037313|C1511726
It has been reported that only half of the non-ambulatory stroke patients admitted to inpatient rehabilitation in Australia learn to walk again [1].,It reported half non-ambulatory stroke patients admitted inpatient rehabilitation Australia learn walk [1].,G0000000|C0684224|C2825407|C0560046|C0038454|C0030705|C0184666|C0021562|C0034991|C0004340|C0023185|C0080331|G0000000
"Exclusion criteria were: memantine usage in the four weeks before study commencement; use of a cholinesterase inhibitor for <3 months; dose alteration in the two weeks pre-study of any anti-psychotic, antidepressant, benzodiazepine, hypnotic or lithium; use of antiparkinsonian medication; hypersensitivity to memantine; severe renal impairment; epilepsy, history of convulsions or seizure, or receiving any anti-epileptic treatment; concomitant usage of NMDA antagonists such as amantadine, ketamine or dextromethorphan; recent myocardial infarction, uncompensated congestive heart failure, uncontrolled hypertension; severe, unstable or poorly controlled medical illness; and any disability interfering with the participant completing the study as judged by the recruiting physician.","Exclusion criteria were: memantine usage weeks study commencement; cholinesterase inhibitor <3 months; dose alteration weeks pre-study anti-psychotic, antidepressant, benzodiazepine, hypnotic lithium; antiparkinsonian medication; hypersensitivity memantine; severe renal impairment; epilepsy, history convulsions seizure, receiving anti-epileptic treatment; concomitant usage NMDA antagonists amantadine, ketamine dextromethorphan; myocardial infarction, uncompensated congestive heart failure, uncontrolled hypertension; severe, unstable controlled medical illness; disability interfering participant completing study judged recruiting physician.",C0680251|C0243161|G0000000|C0025242|C0457083|C0439230|C0557651|G0000000|C0008429|C1999216|G0000000|C0439231|C0178602|C1515926|C0439230|C1527048|C0004936|C0003289|C0005064|C0020591|C0023870|C0003405|C0013227|C0020517|C0025242|C0205082|C0022646|C0221099|C0014544|C0019664|C0036572|C0036572|C1514756|C0003299|C0039798|C0521115|C0457083|C0079883|C0243076|C0002403|C0022614|C0011816|C0027061|C0021308|C0205433|C0742742|C0018787|C0231174|C0205318|C0020538|C0205082|C0443343|C2587213|C0199168|C0221423|C0231170|C0521102|C0679646|C0205197|C0557651|C0221191|G0000000|C0031831
No difference in local recurrence rate between curettage and segmental resection of central grade 1 CS of long bones was reported also by Aarons et al.,No difference local recurrence rate curettage segmental resection central grade 1 CS bones reported Aarons al.,G0000000|C1705241|C0205276|C0034897|C0871208|C0010468|C0205122|C0015252|C0205099|C0441800|G0000000|C0010182|C0262950|C0684224|G0000000|C0202311
"Women who were pregnant or breastfeeding, had an immunosuppressive or immunodeficient condition, a history of colposcopy, an allergic disease likely to be exacerbated by any component of the vaccine or previously received HPV vaccination or 3-O-desacyl-4′-monophosphoryl lipid A (MPL) or AS04 adjuvant were excluded.","Women pregnant breastfeeding, immunosuppressive immunodeficient condition, history colposcopy, allergic disease exacerbated component vaccine received HPV vaccination 3-O-desacyl-4′-monophosphoryl lipid A (MPL) AS04 adjuvant excluded.",C0043210|C0549206|C0006147|C0021081|C0021051|C0012634|C0019664|C0009417|C0700624|C0012634|C0436331|C0449432|C0042210|C1514756|C0021344|C0042196|G0000000|C0023779|G0000000|C0066776|G0000000|C0001551|C1554077
"Primary Inclusion Criteria for Participant Selection either Trial Patient age ≥35 years old (no upper age limit) Carotid stenosis defined as: Stenosis ≥70% by catheter angiography (NASCET Criteria); OR by Doppler ultrasonography with ≥70% stenosis defined by a peak systolic velocity of at least 230 cm/s plus at least one of the following: an end diastolic velocity ≥100 cm/s, or internal carotid/common carotid artery peak systolic velocity ratio ≥4.0, or computed tomography angiography with ≥ 70% stenosis, or magnetic resonance angiography with ≥ 70% stenosis.","Primary Inclusion Criteria Participant Selection Trial Patient age ≥35 (no upper age limit) Carotid stenosis defined as: Stenosis ≥70% catheter angiography (NASCET Criteria); OR Doppler ultrasonography ≥70% stenosis defined peak systolic velocity 230 cm/s following: diastolic velocity ≥100 cm/s, internal carotid/common carotid artery peak systolic velocity ratio ≥4.0, computed tomography angiography ≥ 70% stenosis, magnetic resonance angiography ≥ 70% stenosis.",C0205225|C0007637|C0243161|C0679646|C0036576|C0008976|C0030705|C0001779|G0000000|G0000000|C1282910|C0001779|C0439801|C0741968|C0678234|C1704788|G0000000|C0678234|G0000000|C0085590|C0002978|G0000000|C0243161|G0000000|C0554756|C0041618|G0000000|C0678234|C1704788|C0444505|C0039155|C0439830|C1442061|C0439392|C0231290|C0012000|C0439830|G0000000|C0439392|C0205102|C0741968|C0741968|C0003842|C0444505|C0039155|C0439830|C0456603|G0000000|C1441526|C0040395|C0002978|G0000000|C0450371|C0678234|C0024488|C0231881|C0002978|G0000000|C0450371|C0678234
"Primary informal carers will be invited to participate in this study if it is envisaged that they will provide at least five hours per week assistance to the patient participant with personal, domestic, or community activities of daily living.","Primary informal carers invited participate study envisaged provide hours week assistance patient participant personal, domestic, community activities daily living.",C0205225|G0000000|C0085537|G0000000|G0000000|C0557651|G0000000|C1999230|C0439227|C0332174|C0018896|C0030705|C0679646|C1519021|C0003063|C0009462|C0441655|C0332173|C0376558
"Individuals were considered eligible if they were at least 18, had a cancer diagnosis, reported experiencing persistent CRF for the previous 8 weeks or longer, and reported clinically significant CRF at the time of eligibility screening.","Individuals considered eligible 18, cancer diagnosis, reported experiencing persistent CRF previous 8 weeks longer, reported clinically CRF time eligibility screening.",C0027361|C0750591|C1548635|C0450371|C0006826|C0011900|C0684224|C0237607|C0205322|G0000000|C0205156|G0000000|C0439230|C0205166|C0684224|G0000000|G0000000|C0040223|C0013893|C0220908
Relapse was defined as an increase in CDAI of >100 points.,Relapse defined increase CDAI >100 points.,C0035020|C1704788|C0442805|C0683448|C1442061|C1552961
"Inclusion and exclusion criteria Follow 3-step commands Sit independently without back or arm support for 5 minutes Stand without support of AD for 5 minutes with no more than Min A Walk 20 ft with occasional Mod A for balance Independently advance AD and bilateral LEs during ambulation Health problems judged by screening physician to put individual at significant risk of harm during study History of serious COPD or oxygen dependence Severe weight-bearing pain Weight-bearing restrictions LE amputation Nonhealing LE ulcers Renal dialysis or end-stage liver disease Severe visual or hearing impairment History of significant psychiatric illness Life expectancy <1 year Knee flexion contracture > −10°, knee flexion ROM < 90°, hip flexion contracture > 25°, ankle plantar flexion contracture > 15° History of DVT or PE within 6 months Uncontrollable diabetes with recent weight loss, diabetic coma, or frequent insulin reactions Severe hypertension with systolic > 200 mm Hg and diastolic > 110 mm Hg at rest Intracranial hemorrhage related to aneurysm rupture or arteriovenous malformation History of seizure disorder Neurological conditions other than stroke Pain > 5 out of 10 on visual analog scale that limits daily activity Note: AD = assistive device; COPD = chronic obstructive pulmonary disease; DVT = deep venous thrombosis; LE = lower extremity; Min A = minimal assistance; Mod A = moderate assistance; PE = pulmonary embolism; ROM, range of motion.","Inclusion exclusion criteria Follow 3-step commands Sit independently arm support 5 minutes Stand support AD 5 minutes Min A Walk 20 ft occasional Mod A balance Independently advance AD bilateral LEs ambulation Health judged screening physician individual risk harm study History COPD oxygen dependence Severe weight-bearing pain Weight-bearing restrictions LE amputation Nonhealing LE ulcers Renal dialysis end-stage liver disease Severe visual hearing impairment History psychiatric illness Life expectancy <1 Knee flexion contracture > −10°, knee flexion ROM < 90°, hip flexion contracture > 25°, ankle plantar flexion contracture > 15° History DVT PE 6 months Uncontrollable diabetes weight loss, diabetic coma, frequent insulin reactions Severe hypertension systolic > 200 mm Hg diastolic > 110 mm Hg rest Intracranial hemorrhage aneurysm rupture arteriovenous malformation History seizure disorder Neurological conditions stroke Pain > 5 10 visual analog scale limits daily activity Note: AD = assistive device; COPD = chronic obstructive pulmonary disease; DVT = deep venous thrombosis; LE = lower extremity; Min A = minimal assistance; Mod A = moderate assistance; PE = pulmonary embolism; ROM, range motion.",C0007637|C0680251|C0243161|C0332283|C1261552|C3639196|C0277814|G0000000|C0446516|C0183683|G0000000|C0439232|C0596013|C0183683|G0000000|G0000000|C0439232|C0702093|G0000000|C0080331|C0450371|C1881534|C0521114|C0011860|G0000000|C0014653|G0000000|C0725066|G0000000|C0238767|C0227192|C0080331|C0018684|C0221191|C0220908|C0031831|C0027361|C0035647|G0000000|C0557651|C0019664|C0024117|C0030054|C0011546|C0205082|C0085086|C0030193|C0085086|C0443288|C0023190|C0002688|C0205301|C0023190|C0041582|C0022646|C0011945|C0205088|C0023884|C0012634|C0205082|C0234621|C0018767|C0221099|C0019664|C0205487|C0221423|C0376558|C0679138|G0000000|C0022742|C0231452|C0009917|G0000000|G0000000|C0022742|C0231452|C4048784|G0000000|G0000000|C0019552|C0231452|C0009917|G0000000|G0000000|C0003086|C0230463|C0231452|C0009917|G0000000|G0000000|C0019664|C0149871|C0070939|G0000000|C0439231|G0000000|C0011847|C0005910|C1517945|C0241863|C0009421|C0332183|C0021641|C0443286|C0205082|C0020538|C0039155|G0000000|C1442061|G0000000|C0025424|C0012000|G0000000|C1442061|G0000000|C0025424|C0035253|C0524466|C0019080|C0002940|C1881712|C0450109|C0000768|C0019664|C0036572|C0012634|C0205494|C0012634|C0038454|C0030193|G0000000|G0000000|C0450371|C0234621|C0243071|C0175659|C0439801|C0332173|C0205177|C1316572|G0000000|G0000000|G0000000|C0025080|C0024117|G0000000|C0205191|C0549186|C0024109|C0012634|C0149871|G0000000|C0205125|C0042449|C0040053|C0023190|G0000000|C0441994|C0015385|C0702093|G0000000|G0000000|C0547040|C0018896|C0011860|G0000000|G0000000|C0205081|C0018896|C0070939|G0000000|C0024109|C0013922|C4048784|C1514721|C0026597
"The percentage of patients with Z scores below −1.0 changed from 23% at baseline to 18% at 12 months and to 29% at 24 months in the ZA group, and from 21% to 37% to 43% in the placebo group.","The percentage patients Z scores −1.0 changed 23% baseline 18% 12 months 29% 24 months ZA group, 21% 37% 43% placebo group.",G0000000|C0439165|C0030705|G0000000|C0449820|G0000000|C0392747|C0450371|C0168634|C0450371|C0450371|C0439231|C0450371|C0450371|C0439231|C0037712|C0441833|C0450371|C0450371|C0450371|C0032042|C0441833
"The subjects were selected from participants of the Singapore Chinese Health Study (SCHS), a population-based prospective cohort investigation to elucidate the role of diet and its interaction with genetic factors in risk of cancer.","The subjects selected participants Singapore Chinese Health Study (SCHS), population-based prospective cohort investigation elucidate role diet interaction genetic factors risk cancer.",G0000000|C0681850|C1707391|C0679646|C0037173|C0008120|C0018684|C0557651|C0085114|C0032659|C0023981|C0599755|C0220825|G0000000|C0035820|C0012155|C1704675|C0017296|C1521761|C0035647|C0006826
"They were between 40 and 80 years of age, and had been suffering from unilateral or bilateral OA of the knee according to the criteria of the American College of Rheumatology 20 for more than 3 months.","They 40 80 age, suffering unilateral bilateral OA knee criteria American College Rheumatology 20 3 months.",G0000000|C0450371|C0450371|C0001779|C0683278|C0205092|C0238767|C0029408|C0022742|C0243161|C0596070|C0557806|C0035452|C0450371|G0000000|C0439231
Inclusion criteria were as follows: (1) dialysis vintage of at least 6 months; (2) age between 18 and 70 years; (3) diagnosis of OSA by overnight PSG; and (4) residual diuresis lower than 500 ml/day.,Inclusion criteria follows: (1) dialysis vintage 6 months; (2) age 18 70 years; (3) diagnosis OSA overnight PSG; (4) residual diuresis lower 500 ml/day.,C0007637|C0243161|C0332283|G0000000|C0011945|G0000000|G0000000|G0000000|C0001779|C0450371|G0000000|G0000000|C0011900|C0520679|C0439583|C0162701|G0000000|C1609982|C0012797|C0441994|G0000000
"The inclusion criteria were (1) diagnosis of a stroke (within 1 month), (2) partial anterior circulation infarction (PACI), (3) upper extremity motor functional level according to Brunnstrom stages between 1 and 4, and (4) no musculoskeletal injury history in the affected upper extremity.","The inclusion criteria (1) diagnosis stroke (within 1 month), (2) partial anterior circulation infarction (PACI), (3) upper extremity motor functional level Brunnstrom stages 1 4, (4) musculoskeletal injury history upper extremity.",G0000000|C0007637|C0243161|G0000000|C0011900|C0038454|G0000000|G0000000|C0332177|G0000000|C0728938|C0205094|C0005775|C0021308|C1165245|G0000000|C1282910|C0015385|C1513492|C0205245|C0441889|G0000000|C1306673|G0000000|G0000000|G0000000|C0497254|C3263722|C0019664|C1282910|C0015385
"Subjects were excluded if they had any of the following: cancer, liver disease, kidney disease, diabetes, active heart disease, heart block or arrhythmias, bleeding disorders, concurrent diuretic use, anticoagulant or antiplatelet use, psychosis or other psychiatric disorders likely to impact ability to comply with study procedures, or any change in prescription medication for mental health problems such as depression or anxiety during the 3 months preceding enrollment.","Subjects excluded following: cancer, liver disease, kidney disease, diabetes, active heart disease, heart block arrhythmias, bleeding disorders, concurrent diuretic use, anticoagulant antiplatelet use, psychosis psychiatric disorders impact ability comply study procedures, change prescription medication mental health depression anxiety 3 months preceding enrollment.",C0681850|C1554077|C0231290|C0006826|C0023884|C0012634|C0022646|C0012634|C0011847|C0205177|C0018787|C0012634|C0018787|C0028778|C0003811|C0019080|C0012634|C0205420|C0012798|C0042153|C0003280|G0000000|C0042153|C0033975|C0205487|C0012634|C1825598|C0085732|C0725694|C0557651|C0025664|C0392747|C0033080|C0013227|C0229992|C0018684|C0011570|C0003467|G0000000|C0439231|C0332152|C1516879
This vitamin supplement is available on prescription in The Netherlands.,This vitamin supplement prescription The Netherlands.,G0000000|C0042890|C0242295|C0033080|G0000000|C0027778
"The pneumonia was defined as having an early-onset if the patient had been ventilated for more than 24 hours and less than 8 days [23], [24], [25].","The pneumonia defined early-onset patient ventilated 24 hours 8 days [23], [24], [25].",G0000000|C0032285|C1704788|C1833334|C0030705|C0231923|C0450371|C0439227|G0000000|C0439228|C0450371|C0450371|C0450371
"Participants were excluded if they met any of the following criteria: (1) participation in other clinical trials within the past 12 months, (2) forced vital capacity (FVC) of <40% of the predicted value, (3) presence of any comorbidity that might interfere with the outcome, (4) tracheostomy or noninvasive ventilation, (5) any hemorrhagic tendency, and (6) administration of any drug that could affect the bone marrow.","Participants excluded met criteria: (1) participation clinical trials 12 months, (2) forced vital capacity (FVC) <40% predicted value, (3) presence comorbidity interfere outcome, (4) tracheostomy noninvasive ventilation, (5) hemorrhagic tendency, (6) administration drug affect bone marrow.",C0679646|C1554077|C0268621|C0243161|G0000000|C0679823|C0205210|C0008976|C0450371|C0439231|G0000000|C0441722|C0442732|C1516240|C3714541|C0450371|C0681842|C1522609|G0000000|C0150312|C0009488|C0521102|C1274040|G0000000|C0040590|C0205303|C0035203|G0000000|C0333275|G0000000|G0000000|C0001554|C0013227|C0001721|C0262950|C0086590
"SUBJECTS—Twenty three children from a regional cystic fibrosis centre were enrolled into the study, with mean age 10.3 years (range 7 to 17 years) and mean baseline forced expiratory volume in one second (FEV1) of 64% (range 21% to 102%) predicted for sex and height.","SUBJECTS—Twenty children regional cystic fibrosis centre enrolled study, age 10.3 (range 7 17 years) baseline forced expiratory volume (FEV1) 64% (range 21% 102%) predicted sex height.",G0000000|C0008059|C0205147|C0205207|C0016059|C0205099|G0000000|C0557651|C0001779|C0450371|C1514721|G0000000|C0450371|C0439234|C0168634|C0441722|C0231800|C0449468|G0000000|C0450371|C1514721|C0450371|C1442061|C0681842|C0009253|C0489786
A school-based survey included 1681 adolescents (aged 11–14 years) who had never smoked.,A school-based survey included 1681 adolescents (aged 11–14 years) smoked.,G0000000|C0036375|C0038951|C0332257|G0000000|C0205653|C0001779|G0000000|C0439234|C0037366
The study recruited patients aged 18–70 years with a diagnosis of asthma and currently prescribed 400–1000 μg/day of beclometasone dipropionate or equivalent.,The study recruited patients aged 18–70 diagnosis asthma prescribed 400–1000 μg/day beclometasone dipropionate equivalent.,G0000000|C0557651|G0000000|C0030705|C0001779|G0000000|C0011900|C0004096|C0278329|G0000000|G0000000|C0004905|G0000000|C0205163
"Mean follow‐up times were similar for Grade I at 24.8 months (range, 4–131) and Grade II chondrosarcomas at 31.1 months (range, 3–150).","Mean follow‐up times Grade I 24.8 months (range, 4–131) Grade II chondrosarcomas 31.1 months (range, 3–150).",C0444504|G0000000|C0040223|C0441800|C0021966|C0450371|C0439231|C1514721|G0000000|C0441800|G0000000|C0008479|C0450371|C0439231|C1514721|G0000000
"Patients with a score less than 12 were considered unlikely to have neuropathic low-back pain, whereas patients with a score of 12 or more were considered to have a neuropathic element that contributed to their low-back pain.","Patients score 12 considered neuropathic low-back pain, patients score 12 considered neuropathic element contributed low-back pain.",C0030705|C0449820|C0450371|C0750591|C0442874|C0205251|C0030193|C0030705|C0449820|C0450371|C0750591|C0442874|C0013879|C1880177|C0205251|C0030193
"Main exclusion criteria were as follows: AF secondary to reversible disorders; contraindication to VKA treatment; valvular heart disease or any condition other than AF requiring chronic anticoagulation treatment; myocardial infarction; stroke or transient ischaemic attack, and/or systemic embolism within the last 30 days; conditions associated with increased risk of major bleeding within the last year; major surgical procedure or trauma within the last 2 weeks; renal impairment (calculated creatinine clearance <30 mL/min); known hepatic disease and/or alanine transaminase (ALT) > 3× upper limit of normal (ULN); treatment with antiplatelet agent other than aspirin ≤100 mg/day or fibrinolytic agents within the last 10 days; or planned cardioversion or surgery during the study.","Main exclusion criteria follows: AF secondary reversible disorders; contraindication VKA treatment; valvular heart disease condition AF requiring chronic anticoagulation treatment; myocardial infarction; stroke transient ischaemic attack, and/or systemic embolism 30 days; conditions increased risk major bleeding year; major surgical procedure trauma 2 weeks; renal impairment (calculated creatinine clearance <30 mL/min); hepatic disease and/or alanine transaminase (ALT) > 3× upper limit normal (ULN); treatment antiplatelet agent aspirin ≤100 mg/day fibrinolytic agents 10 days; planned cardioversion surgery study.",C0205225|C0680251|C0243161|C0332283|C0344434|C0027627|C0205343|C0012634|C0522473|G0000000|C0039798|C0184252|C0018787|C0012634|C0012634|C0344434|G0000000|C0205191|C0003281|C0039798|C0027061|C0021308|C0038454|C0040704|C0475224|C0277793|G0000000|C0205373|C0013922|C0450371|C0439228|C0012634|C0205217|C0035647|C0205082|C0019080|C0439234|C0205082|C0543467|C0184661|C0043251|G0000000|C0439230|C0022646|C0221099|C0444686|C0010294|C0449297|C0450371|C0439445|C0205054|C0012634|G0000000|C0001898|C0002594|C1266129|G0000000|G0000000|C1282910|C0439801|C0205307|C1519815|C0039798|G0000000|C0450442|C0004057|G0000000|C0439422|C0040044|C0450442|C0450371|C0439228|C1301732|C0013778|C0038894|C0557651
Inclusion criteria were adults (men and women) aged 18–75 years; diagnosis of migraine headache; onset >6 months previously; and >3 headache days per month (assessed by headache diary; including both episodic and chronic migraine).,Inclusion criteria adults (men women) aged 18–75 years; diagnosis migraine headache; onset >6 months previously; >3 headache days month (assessed headache diary; including episodic chronic migraine).,C0007637|C0243161|C0001675|C0025266|C0043210|C0001779|G0000000|C0439234|C0011900|C0149931|C0018681|C0206132|G0000000|C0439231|G0000000|G0000000|C0018681|C0439228|C0332177|C1516048|C0018681|C0376660|C0332257|C1455761|C0205191|C0149931
Women with an anticipated vaginal birth were enrolled and allocated to either the experimental or control group using a randomisation sequence between 30 to 32 weeks after informing them in detail about the study during ANC.,Women anticipated vaginal birth enrolled allocated experimental control randomisation sequence 30 32 weeks informing detail study ANC.,C0043210|C3840775|C0042232|C0005615|G0000000|G0000000|C1517586|C0243148|C0034656|C0004793|C0450371|C0450371|C0439230|C0700287|C1522508|C0557651|C0948762
A total of 491 sick neonates and children were then studied on presentation to the paediatric department at Goroka Hospital.,A total 491 sick neonates children studied presentation paediatric department Goroka Hospital.,G0000000|C0439175|C1442061|C0221423|C0021289|C0008059|C0557651|C0449450|C0030755|C1704729|G0000000|C0019994
"The study was conducted in accordance with Helsinki declaration.9 The inclusion criteria were the following: Age >18 years Systemically healthy Plaque-induced gingivitis Halitosis  The exclusion criteria were the following: Mouthwash use in past 3 months Antibiotic therapy in past 3 months Orthodontic and prosthetic appliances use Systemic disorders like diabetes mellitus, renal failure, and so on Pregnancy Smoking Chemotherapy and radiotherapy Patients with established periodontitis  Standard protocol followed for preparation of Triphala and Ela decoction under in-house pharmacy of Ayurvedic Center of Swami Rama Himalayan University under expert guidance of an ayurvedic physician.","The study conducted Helsinki declaration.9 The inclusion criteria following: Age >18 Systemically healthy Plaque-induced gingivitis Halitosis The exclusion criteria following: Mouthwash 3 months Antibiotic therapy 3 months Orthodontic prosthetic appliances Systemic disorders diabetes mellitus, renal failure, Pregnancy Smoking Chemotherapy radiotherapy Patients established periodontitis Standard protocol preparation Triphala Ela decoction in-house pharmacy Ayurvedic Center Swami Rama Himalayan University expert guidance ayurvedic physician.",G0000000|C0557651|C0004927|G0000000|G0000000|G0000000|C0007637|C0243161|C0231290|C0001779|C0450371|G0000000|C3898900|C0011389|C0017574|C0018520|G0000000|C0680251|C0243161|C0231290|C0026647|G0000000|C0439231|C0003232|C0039798|G0000000|C0439231|C0332276|G0000000|C0243112|C0205373|C0012634|C0011847|G0000000|C0022646|C0231174|C0032961|C0037369|C0013216|C0034619|C0030705|C0443211|C0031099|C1442989|C0442711|C1521827|C1958185|C3810054|G0000000|C0150312|C0031321|G0000000|C0205099|G0000000|C0445586|G0000000|C0041740|G0000000|C0150600|G0000000|C0031831
"Second, the strict exclusion criteria (such as >75 years, presence of severe immunosuppression, presence of shock, pre-mortem status, aspiration pneumonia or the need for MV prior to inclusion in the study) may explain the low mortality observed in our study.","Second, strict exclusion criteria (such >75 years, presence severe immunosuppression, presence shock, pre-mortem status, aspiration pneumonia MV prior inclusion study) explain low mortality observed study.",C0205436|G0000000|C0680251|C0243161|G0000000|C0450371|C0439234|C0150312|C0205082|C0021079|C0150312|C0036974|C0332152|C0449438|C0220787|C0032285|C0428679|C0332152|C0007637|C0557651|G0000000|C0205251|C0026565|C1441672|C0557651
Shaoyang acupoints are the most frequently used in migraine treatment.,Shaoyang acupoints frequently migraine treatment.,G0000000|C0001302|C0332183|C0149931|C0039798
There is a need for more effective treatment approaches for cannabis dependent patients who are unable to discontinue their illicit use through psychosocial interventions alone.,There effective treatment approaches cannabis dependent patients unable discontinue illicit psychosocial interventions alone.,G0000000|C1280519|C0039798|C0449445|C0024808|C0851827|C0030705|C1299582|C1444662|C0332266|C0542298|C0886296|C0205171
The primary endpoint was based on the composite clinical score at 6 months.,The primary endpoint based composite clinical score 6 months.,G0000000|C0205225|C2349179|C1527178|C0205199|C0205210|C0449820|G0000000
The recruitment period lasted from October 2007 to December 2008.,The recruitment period lasted October 2007 December 2008.,G0000000|C2949735|C0439531|C1517741|C3828732|G0000000|C3830550|G0000000
Inclusion criteria were: Patients diagnosed with P. vivax parasitaemia at study BHUs; Patients over 3 years of age; Patient permanently resident in the village.,Inclusion criteria were: Patients diagnosed P. vivax parasitaemia study BHUs; Patients 3 age; Patient permanently resident village.,C0007637|C0243161|G0000000|C0030705|C0011900|C0369773|G0000000|C0242723|C0557651|G0000000|C0030705|G0000000|C0001779|C0030705|G0000000|C1320928|C0562518
"Sweden is a multicultural country: almost a third of all children under the age of 18 years have an immigrant background.28 The Swedish upper secondary school, which the vast majority of students attend, conducts both theoretical and vocational programmes that reach out to adolescents aged 16–19 years.","Sweden multicultural country: children age 18 years immigrant background.28 The Swedish upper secondary school, vast majority students attend, conducts theoretical vocational programmes reach adolescents aged 16–19 years.",C0038995|C0282495|C0454664|C0008059|C0001779|G0000000|C0282163|C1706907|G0000000|C1710263|C1282910|C0027627|C0036375|C0814230|C0680220|C0038492|C1999232|C0004927|C0871935|C0087164|G0000000|C2584321|C0205653|C0001779|G0000000
"[29] We enrolled women aged 18–40 years carrying singleton pregnancy at week 25 of their pregnancy, who were attended to at the maternity clinics in Kashan.","[29] We enrolled women aged 18–40 carrying singleton pregnancy week 25 pregnancy, attended maternity clinics Kashan.",C0450371|G0000000|G0000000|C0043210|C0001779|G0000000|C0206243|C0481462|C0032961|C0332174|C0450371|C0032961|C1456498|C0681108|C0442592|G0000000
Patients with history of dark urine or significant hemoglobinuria related to previous primaquine treatment or those with history of methemoglobinemia were not included in the study.,Patients history dark urine hemoglobinuria previous primaquine treatment history methemoglobinemia included study.,C0030705|C0019664|C0332582|C0042036|C0019048|C0205156|C0033126|C0039798|C0019664|C0025637|C0332257|C0557651
"There were 114 (80.3%) isolated fractures of the radius, 2 (1.4%) isolated fractures of the ulna and 26 (18.3%) fractures of both radius and ulna.","There 114 (80.3%) isolated fractures radius, 2 (1.4%) isolated fractures ulna 26 (18.3%) fractures radius ulna.",G0000000|C1442061|C0450371|C0205409|C0016658|C0034627|G0000000|G0000000|C0205409|C0016658|C0041600|C0450371|C0450371|C0016658|C0034627|C0041600
"Patients were enrolled if they had the following high-risk factors: Acute onset respiration frequency or respiration distress; hypoxemia, defined as arterial partial pressure of oxygen (PaO2) of <60 mmHg or fraction of inspiration oxygen (FiO2) of ≤200 mmHg; invasive shallows observed in both lungs using a chest X-ray; pulmonary artery wedge pressure of ≤18 mmHg.","Patients enrolled high-risk factors: Acute onset respiration frequency respiration distress; hypoxemia, defined arterial partial pressure oxygen (PaO2) <60 mmHg fraction inspiration oxygen (FiO2) ≤200 mmHg; invasive shallows observed lungs chest X-ray; pulmonary artery wedge pressure ≤18 mmHg.",C0030705|G0000000|C0332167|C1521761|C0205178|C0206132|C0035203|C0376249|C0035203|C0231303|C0700292|C1704788|C0003842|C0728938|C0033095|C0030054|C1427155|C0450371|C0439475|C1264633|C0004048|C0030054|G0000000|G0000000|C0439475|C0205281|G0000000|C1441672|C0024109|C0817096|C0034571|C0024109|C0003842|C0439639|C0033095|G0000000|C0439475
Oncology clinicians invited their patients to enroll in the study.,Oncology clinicians invited patients enroll study.,C0027651|C0871685|G0000000|C0030705|G0000000|C0557651
"The other carotenoids, tochopherols, and fatty acids required no transformation.","The carotenoids, tochopherols, fatty acids required transformation.",G0000000|C0007271|G0000000|G0000000|C0001128|C1514873|C0040682
"Criteria for exclusion will include twin pregnancy, pelvic defect, previous uterine surgery, foetal malformation or chromosome disorder, uterine malformation, risk of premature birth (preterm uterine contractions and/or initial dilation or shortening of the cervix with a Bishop's score of 4), uterine fibromas > 4 cm, treatment with tocolytic drugs, heart or kidney disease affecting the mother, other pregnancy-related complications, or incapacity to complete the questionnaire or respond to the assessor's questions.","Criteria exclusion twin pregnancy, pelvic defect, previous uterine surgery, foetal malformation chromosome disorder, uterine malformation, risk premature birth (preterm uterine contractions and/or initial dilation shortening cervix Bishop's score 4), uterine fibromas > 4 cm, treatment tocolytic drugs, heart kidney disease mother, pregnancy-related complications, incapacity complete questionnaire respond assessor's questions.",C0243161|C0680251|C0041427|C0032961|C0030797|C1457869|C0205156|C0042149|C0038894|C0015965|C0000768|C0008633|C0012634|C0042149|C0000768|C0035647|C0151526|C0005615|C0151526|C0042149|C1140999|G0000000|C0205265|C0012359|C0441636|C0007874|C1551458|C0449820|G0000000|C0042149|C0016045|G0000000|G0000000|G0000000|C0039798|C0040349|C0013227|C0018787|C0022646|C0012634|C0026591|C0747919|C0009566|G0000000|C0205197|C0034394|G0000000|C1707957|C1522634
"Patient inclusion criteria at baseline were: genetically proven DMD diagnosis, patient still ambulant and able to walk independently for at least 75 m, no severe or moderate learning difficulties or behavioral problems.","Patient inclusion criteria baseline were: genetically proven DMD diagnosis, patient ambulant walk independently 75 m, severe moderate learning difficulties behavioral problems.",C0030705|C0007637|C0243161|C0168634|G0000000|G0000000|C0456369|G0000000|C0011900|C0030705|C4035885|C0080331|G0000000|C0450371|C0369637|C0205082|C0205081|C0013621|C1299586|C0004927|C1546466
"Men and women, ages 18 to 70, who met ACR criteria for FM, as diagnosed by their rheumatologists and confirmed by a medical history review, were eligible for the study.","Men women, ages 18 70, met ACR criteria FM, diagnosed rheumatologists confirmed medical history review, eligible study.",C0025266|C0043210|C0001779|C0450371|C0450371|C0268621|C1412134|C0243161|C3540627|C0011900|C0334889|C0521093|C0199168|C0019664|C0282443|C1548635|C0557651
"pre-eclampsia, intrauterine growth restriction, non-reassuring fetal testing) were not included in the primary outcome.","pre-eclampsia, intrauterine growth restriction, non-reassuring fetal testing) included primary outcome.",C0032914|C0694756|C0018270|C0443288|C1518422|C0015965|C0039593|C0332257|C0205225|C1274040
The mean duration of labour within each group was found to be shorter for those women who had four or more reflexology treatments[19].,The duration labour shorter women reflexology treatments[19].,G0000000|C0449238|C0022864|C1282927|C0043210|C0034945|C0087111
Demographic information is presented (Table 1).,Demographic (Table 1).,C0011298|C0039224|G0000000
• Children with GBS requiring MV respond favorably to both IVIG and PE.,• Children GBS requiring MV respond favorably IVIG PE.,G0000000|C0008059|C0018378|G0000000|C0428679|G0000000|G0000000|C0085297|C0070939
"Participants were eligible if they (i) were ≥ 18 years old, (ii) had been diagnosed with a histologically confirmed glioma or meningioma (collectively called PBT throughout this report), and (iii) had no signs of tumor recurrence in the last 6 months.","Participants eligible (i) ≥ 18 old, (ii) diagnosed histologically confirmed glioma meningioma (collectively called PBT report), (iii) signs tumor recurrence 6 months.",C0679646|C1548635|C0021966|G0000000|C0450371|C0580836|G0000000|C0011900|C0205462|C0521093|C0017638|C0025286|G0000000|C0679006|C0080024|C0684224|C0439070|C0220912|C0027651|C0034897|G0000000|C0439231
Eligible patients were: 1) physically able to use a treadmill; 2) willing to randomize; and 3) willing to participate in a phone interview three months after discharge from PT.,Eligible patients were: 1) physically treadmill; 2) randomize; 3) participate phone interview months discharge PT.,C1548635|C0030705|G0000000|G0000000|G0000000|C0184069|G0000000|G0000000|G0000000|G0000000|C1515258|C0021822|C0439231|C0012621|C0699718
"Making biopsies mandatory before study entry is, unfortunately, not feasible in patients with recurrent GBM.","Making biopsies mandatory study entry is, unfortunately, feasible patients recurrent GBM.",C1881534|C0005558|C1514873|C0557651|C1705654|G0000000|G0000000|G0000000|C0030705|C2945760|G0000000
Participants: 300 women aged 20 to 64 attending the practices during a one month period.,Participants: 300 women aged 20 64 attending practices month period.,C0679646|C1442061|C0043210|C0001779|C0450371|C0450371|C1547429|C0237607|C0332177|C0439531
"The exclusion criteria were; anisometropia ≥1.0 D, presence of strabismus, ocular diseases other than refractive errors, and history of orthokeratologic lens, bifocal, or progressive-addition spectacle wear in the past 12 months.","The exclusion criteria were; anisometropia ≥1.0 D, presence strabismus, ocular diseases refractive errors, history orthokeratologic lens, bifocal, progressive-addition spectacle wear 12 months.",G0000000|C0680251|C0243161|G0000000|C0003081|G0000000|C0073187|C0150312|C0038379|C0015392|C0012634|C0429585|C0743559|C0019664|G0000000|C0023317|C1275647|C0205329|C0015421|G0000000|C0450371|C0439231
On the second day after admission (24 to 48 hours after admission) patients with an APACHE II admission score of 13 or more were randomized after stratification in the intervention group (EMS group) or the control group.,On day admission (24 48 hours admission) patients APACHE II admission score 13 randomized stratification intervention (EMS group) control group.,G0000000|C0332173|C0184666|C0450371|C0450371|C0439227|C0184666|C0030705|C0243030|G0000000|C0184666|C0449820|C0450371|C0034656|C1514983|C0886296|G0000000|C0441833|C0243148|C0441833
The questionnaire evaluator (AS) was also blinded as to whether patients had received AC or SAC.,The questionnaire evaluator (AS) blinded patients received AC SAC.,G0000000|C0034394|C1707957|G0000000|C0150108|C0030705|C1514756|C0003354|C1325744
"Their choice was made in part because the population of East Harlem is the poorest and most obese in Manhattan, and its adults have the highest diabetes prevalence and mortality rates in the city.29,30 As a pastor on our board said, “I feel like the people in our community are walking toward a cliff, and we need to join together, put our arms around them and pull them back.” The board used a community-based participatory research (CBPR) approach to develop and pilot a randomized controlled trial to measure the effectiveness of a peer-led lifestyle intervention (Project HEED, or Help Educate to Eliminate Diabetes) in promoting weight loss among overweight adults with prediabetes in East Harlem.","Their choice population East Harlem poorest obese Manhattan, adults diabetes prevalence mortality rates city.29,30 As pastor board said, “I feel people community walking cliff, join together, arms pull back.” The board community-based participatory (CBPR) approach develop pilot randomized controlled trial measure effectiveness peer-led lifestyle intervention (Project HEED, Help Educate Eliminate Diabetes) promoting weight loss overweight adults prediabetes East Harlem.",G0000000|C0008300|C0032659|C1707877|G0000000|C0032854|C0028754|G0000000|C0001675|C0011847|C0033105|C0026565|C0871208|C0008848|G0000000|C0684012|C0972401|G0000000|G0000000|C0013987|C0027361|C0009462|C0080331|C0442530|G0000000|C1883357|C0206655|C0580846|G0000000|G0000000|C0972401|C0009462|G0000000|G0000000|C0449445|G0000000|C0473169|C0034656|C2587213|C0008976|C0079809|C1280519|C0679739|C0023676|C0886296|C1709701|C1414269|C1269765|C0039401|G0000000|C0011847|C0033414|C0005910|C1517945|C0497406|C0001675|C0362046|C1707877|G0000000
"Developmental Milestones Checklist II (DMC-II) scores for children aged 6–18 months at baseline and endline for the multiple micronutrient powders (MNP) intervention group and the control group* (Mean values and standard deviations; adjusted means and 95 % confidence intervals) In children aged 12–18 months, there was no significant impact of the intervention on executive function outcomes.","Developmental Milestones Checklist II (DMC-II) scores children aged 6–18 months baseline endline multiple micronutrient powders (MNP) intervention control group* (Mean values standard deviations; adjusted 95 % confidence intervals) In children aged 12–18 months, impact intervention executive function outcomes.",C0458003|C2347129|C1707357|G0000000|G0000000|C0449820|C0008059|C0001779|G0000000|C0439231|C0168634|G0000000|C0439064|C0040577|C0032861|C0282245|C0886296|C0243148|C0441833|C0444504|C0042295|C1442989|C0012727|C0456081|C0450371|G0000000|C0237529|C1272706|G0000000|C0008059|C0001779|G0000000|C0439231|C1825598|C0886296|C0871735|C0031843|C1274040
Only informing parents that their childrens' ETS exposure were confirmed by a laboratory test seems to be very promising in preventing children from ETS.,Only informing parents childrens' ETS exposure confirmed laboratory test promising preventing children ETS.,C0205171|C0700287|C0030551|G0000000|G0000000|C0274281|C0521093|C0022877|C0022885|C1555307|C0309872|C0008059|G0000000
"Exclusion criteria were 1) respiratory insufficiency, defined as PaO2 <55 mm Hg and/or PaCO2 >50 mm Hg breathing room air, 2) manifest cardiac insufficiency, 3) uncontrolled arterial hypertension, 4) active malignant disease, 5) symptomatic coronary heart disease or pathological test results in cycle ergometry, 6) limited physical capabilities caused by musculoskeletal disorders, 7) unwillingness to return for follow-up, 8) previous or ongoing participation in exercise training programmes, and 9) expected inability to attend at least 75% of sessions.","Exclusion criteria 1) respiratory insufficiency, defined PaO2 <55 mm Hg and/or PaCO2 >50 mm Hg breathing air, 2) manifest cardiac insufficiency, 3) uncontrolled arterial hypertension, 4) active malignant disease, 5) symptomatic coronary heart disease pathological test cycle ergometry, 6) limited physical capabilities caused musculoskeletal disorders, 7) unwillingness return follow-up, 8) previous ongoing participation exercise training programmes, 9) expected inability attend 75% sessions.",C0680251|C0243161|G0000000|C0521346|C0231179|C1704788|C1427155|C0450371|G0000000|C0025424|G0000000|G0000000|C0450371|G0000000|C0025424|C0004048|C0001861|G0000000|C0205319|C0018787|C0231179|G0000000|C0205318|C0003842|C0020538|G0000000|C0205177|C0205282|C0012634|G0000000|C0231220|C0018787|C0018787|C0012634|C0030664|C0022885|C1511572|C0085143|G0000000|C0439801|C0031809|C2698977|C0015127|C0497254|C0012634|G0000000|C0558080|C0332156|C0589120|G0000000|C0205156|C0549178|C0679823|C0015259|C0040607|G0000000|G0000000|C1517001|G0000000|C1999232|C0450371|C1883016
"METHODS A randomized controlled trial was conducted in practices in London, Hamilton, and Toronto, Canada, with 17 family physicians, 16 surgeons, and 18 oncologists, and with 102 patients of the surgeons and oncologists.","METHODS A randomized controlled trial conducted practices London, Hamilton, Toronto, Canada, 17 family physicians, 16 surgeons, 18 oncologists, 102 patients surgeons oncologists.",C0025663|G0000000|C0034656|C2587213|C0008976|C0004927|C0237607|C0023973|G0000000|G0000000|C0006823|C0450371|C0015576|C0031831|C0450371|C0582175|C0450371|C0259990|C1442061|C0030705|C0582175|C0259990
This follow-up study was designed to evaluate the clinical outcome of therapy with PANVAC vaccine in metastatic breast and ovarian cancer patients.,This follow-up study designed evaluate clinical outcome therapy PANVAC vaccine metastatic breast ovarian cancer patients.,G0000000|C0589120|C0557651|C1707689|C0220825|C0205210|C1274040|C0039798|G0000000|C0042210|C0036525|C0006141|C0205065|C0006826|C0030705
The lesions should not be more than 3 months old and the patients should not be treated with the drugs that had interaction with glucantime.,The lesions 3 months patients treated drugs interaction glucantime.,G0000000|C0221198|G0000000|C0439231|C0030705|C1522326|C0013227|C1704675|C0061366
"Stable patients aged ≥45 years with chronic bronchitis (self-reported sputum expectoration on most days when clinically stable) and spirometrically confirmed COPD (defined by FEV1<80% predicted, FEV1 to FVC ratio <0.7 and a history of smoking) were included.","Stable patients aged ≥45 years chronic bronchitis (self-reported sputum expectoration days clinically stable) spirometrically confirmed COPD (defined FEV1<80% predicted, FEV1 FVC ratio <0.7 history smoking) included.",C0205360|C0030705|C0001779|G0000000|C0205191|C0006277|C0681906|C0038056|C0038056|C0439228|G0000000|C0205360|G0000000|C0521093|C0024117|C1704788|C0450371|C0681842|G0000000|C3714541|C0456603|G0000000|C0019664|C0037369|C0332257
Nine subjects with classic CAH (8 with salt-wasting and 1 with simple virilizing) aged 8.1 ± 2.3 years (range: 4.8–11.6 years) completed the study.,Nine subjects classic CAH (8 salt-wasting 1 simple virilizing) aged 8.1 ± 2.3 (range: 4.8–11.6 years) completed study.,C0205455|C0681850|C0439658|C0520463|G0000000|C1846347|G0000000|C0205352|G0000000|C0001779|G0000000|C1514721|G0000000|C0439234|C0205197|C0557651
"Exclusion criteria are (1) current treatment for recurrent BC, (2) a history of schizophrenia or schizo-affective disorder [24], and (3) current alcohol or drug abuse.","Exclusion criteria (1) current treatment recurrent BC, (2) history schizophrenia schizo-affective disorder [24], (3) current alcohol drug abuse.",C0680251|C0243161|G0000000|C0521116|C0039798|C2945760|C0006041|G0000000|C0019664|C0036341|G0000000|C0012634|C0450371|G0000000|C0521116|C0001962|C0013227|C0013146
"Patients were ≥18 years with severe unilateral persistent inguinal postherniorrhaphy pain (numerical rating scale [NRS, 0–10] ≥5) for more than 6 months.","Patients ≥18 severe unilateral persistent inguinal postherniorrhaphy pain (numerical rating scale [NRS, 0–10] ≥5) 6 months.",C0030705|G0000000|C0205082|C0205092|C0205322|C0018246|G0000000|C0030193|C0237753|C0871208|C0175659|C2240043|G0000000|G0000000|G0000000|C0439231
A flow diagram can be found in Figure 1.,A flow diagram Figure 1.,G0000000|C0806140|C0681494|G0000000|G0000000
"Participants (n=80) aged ≥18 years, with a diagnosis of sepsis or severe sepsis, who are expected to be mechanically ventilated for ≥48 h and remain in the intensive care ≥4 days will be randomised within 72 h of admission to (1) standard care or (2) intervention where participants will receive functional electrical muscle stimulation-assisted supine cycling on one leg while the other leg undergoes cycling alone.","Participants (n=80) aged ≥18 years, diagnosis sepsis severe sepsis, expected mechanically ventilated ≥48 h remain intensive care ≥4 days randomised 72 h admission (1) standard care (2) intervention participants receive functional electrical muscle stimulation-assisted supine cycling leg leg undergoes cycling alone.",C0679646|C0369718|C0001779|G0000000|C0011900|C0036690|C0205082|C0036690|C1517001|G0000000|C0231923|G0000000|G0000000|C0162425|C1947933|G0000000|G0000000|G0000000|C0184666|G0000000|C1442989|C1947933|G0000000|C0886296|C0679646|C1514756|C0205245|C0013790|C0026845|C1292856|C0038846|C1511572|C0023216|C0023216|G0000000|C1511572|C0205171
The mother-child pair will be followed up until the child is one year old.,The mother-child pair child old.,G0000000|C0260023|C1709450|C0008059|C0580836
Results will address a significant gap in the current Australian community-support base for people living with dementia and their caregivers.,Results address gap current Australian community-support base people living dementia caregivers.,C1274040|C0376649|C3887622|C0521116|C0238711|C0009462|C0002055|C0027361|C0376558|C0011265|C0085537
This sample may have been more motivated to learn new strategies than non-volunteers.50 We purposely targeted caregivers exposed to problem behaviors and reporting high upset; ACT may not be beneficial to those with minimal distress.,This sample motivated learn strategies non-volunteers.50 We purposely targeted caregivers exposed behaviors reporting upset; ACT beneficial minimal distress.,G0000000|C0370003|G0000000|C0023185|C0679199|C1518422|G0000000|G0000000|C1521840|C0085537|C0332157|C0004927|C0700287|C3887804|C0079613|G0000000|C0547040|C0231303
"Methods.In a cluster-randomized trial of HPV vaccination conducted in Tanzania, 134 primary schools were randomly assigned to class-based (girls enrolled in primary school grade [class] 6) or age-based (girls born in 1998; 67 schools per arm) vaccine delivery.","Methods.In cluster-randomized trial HPV vaccination conducted Tanzania, 134 primary schools randomly assigned class-based (girls enrolled primary school grade [class] 6) age-based (girls born 1998; 67 schools arm) vaccine delivery.",C0025663|C1555715|C0008976|C0021344|C0042196|C0004927|C0039298|C1442061|C0205225|C0036375|G0000000|C1516050|C0456387|C0870604|G0000000|C0205225|C0036375|C0441800|C0456387|G0000000|C0001779|C0870604|C0005615|G0000000|C0450371|C0036375|C0446516|C0042210|C0011209
We used data from a previous study (Project CARES [35]) in which home health care nurses were randomized to deliver one of two smoking cessation interventions to their medically ill patients who smoke.,We data previous study (Project CARES [35]) health care nurses randomized deliver smoking cessation interventions medically ill patients smoke.,G0000000|C1511726|C0205156|C0557651|C1709701|C1947933|C0450371|C0018684|C1947933|C0028661|C0034656|C0308779|C0037369|C1880019|C0886296|G0000000|C0231218|C0030705|C0037366
"Exclusion criteria included children having any procedure in addition to the BM&T, chronic medical issues (ASA class 3 or higher), developmental delay making agitation and pain scoring harder, or any allergy or contraindication to study medications.","Exclusion criteria included children procedure addition BM&T, chronic medical issues (ASA class 3 higher), developmental delay agitation pain scoring harder, allergy contraindication study medications.",C0680251|C0243161|C0332257|C0008059|C0184661|C0332287|C0006416|C0205191|C0199168|C0033213|C0004057|C0456387|G0000000|C0205250|C0458003|C0205421|C0085631|C0030193|C0449820|C0018599|C0002111|C0522473|C0557651|C0013227
"Inclusion requirements comprised, among others, an estimated glomerular filtration rate13 (eGFR) greater than 80 mL/min/1.73 m2, current proteinuria remission, no previous exposure to a corticosteroid-sparing agent, and exclusion of a secondary form of nephrotic syndrome and active infection.","Inclusion requirements comprised, others, estimated glomerular filtration rate13 (eGFR) 80 mL/min/1.73 m2, current proteinuria remission, previous exposure corticosteroid-sparing agent, exclusion secondary form nephrotic syndrome active infection.",C0007637|C1514873|C2700400|C1955473|C0750572|C0022663|C0016107|G0000000|C1739039|C0450371|C0439445|C0025885|C0521116|C0033687|C0544452|C0205156|C0274281|C0001617|C0450442|C0680251|C0027627|C0348078|G0000000|C0039082|C0205177|C0009450
Mepolizumab therapy reduces exacerbations and improves AQLQ scores in patients with refractory eosinophilic asthma.,Mepolizumab therapy reduces exacerbations improves AQLQ scores patients refractory eosinophilic asthma.,C0969324|C0039798|G0000000|G0000000|C0184511|C4055434|C0449820|C0030705|C0205269|C0333930|C0004096
"However, due to a slow recruitment, after 1 year an amendment allowing the inclusion of primary diagnosed patients was added.","However, slow recruitment, 1 amendment allowing inclusion primary diagnosed patients added.",G0000000|C0439834|C2949735|G0000000|C0680532|C0683607|C0007637|C0205225|C0011900|C0030705|C1524062
"Patients were excluded if they had severe GI disorders, major GI surgery, bowel obstruction, swallowing disorders, significant primary valvular disease, known obstructive or restrictive cadiomyopathy, uncontrolled or unstable arrhythmia, episode of unstable angina within 3 months prior to baseline, acute coronary syndrome, transient ischaemic attack, a QTc value of >500 ms (using Bazett's correction formula), recent or anticipated cardiac surgery or intervention, kidney transplantation or need for transplantation, receiving dialysis or anticipated need for dialysis during the study, sustained systolic blood pressure >170 or < 90 mmHg, elevated liver enzymes (more than three times the upper limit of normal), or any condition that had the potential to interfere with study compliance or jeopardize the safety of the patient.","Patients excluded severe GI disorders, major GI surgery, bowel obstruction, swallowing disorders, primary valvular disease, obstructive restrictive cadiomyopathy, uncontrolled unstable arrhythmia, episode unstable angina 3 months prior baseline, acute coronary syndrome, transient ischaemic attack, QTc >500 ms (using Bazett's correction formula), anticipated cardiac surgery intervention, kidney transplantation transplantation, receiving dialysis anticipated dialysis study, sustained systolic blood pressure >170 < 90 mmHg, elevated liver enzymes (more times upper limit normal), condition potential interfere study compliance jeopardize safety patient.",C0030705|C1554077|C0205082|C1708130|C0012634|C0205082|C1708130|C0038894|C0021853|C0028778|C0011167|C0012634|C0205225|C0184252|C0012634|C0549186|C0443288|G0000000|C0205318|C0443343|C0003811|C0332189|C0443343|C0002962|G0000000|C0439231|C0332152|C0168634|C0205178|C0018787|C0039082|C0040704|C0475224|C0277793|G0000000|C1442061|C0039676|C1524063|G0000000|C1705565|C0489829|C3840775|C0018787|C0038894|C0886296|C0022646|C0040732|C0040732|C1514756|C0011945|C3840775|C0011945|C0557651|C0443318|C0039155|C0005767|C0033095|C1442061|G0000000|C0450371|C0439475|C0205250|C0023884|C0014442|C0205172|C0040223|C1282910|C0439801|C0205307|C0012634|C3245505|C0521102|C0557651|C0009563|G0000000|C0036043|C0030705
"Major depressive disorder (MDD) is prevalent after traumatic brain injury (TBI); however, there is a lack of evidence regarding effective treatment approaches.","Major depressive disorder (MDD) prevalent traumatic brain injury (TBI); however, lack evidence effective treatment approaches.",C0205082|G0000000|C0012634|C1269683|C0033105|C0332663|C0006104|C3263722|C0876926|G0000000|C0332268|C3887511|C1280519|C0039798|C0449445
Pregnant women represent a typical group susceptible to dietary and mineral deficiencies.,Pregnant women represent typical susceptible dietary mineral deficiencies.,C0549206|C0043210|C1882932|C3538928|C0220898|C0012155|C0006660|C0011155
We recruited 2188 patients from August 2000 to December 2002 and randomised 1095 to three days of amoxicillin treatment and 1093 to five days of treatment (figure).,We recruited 2188 patients August 2000 December 2002 randomised 1095 days amoxicillin treatment 1093 days treatment (figure).,G0000000|G0000000|G0000000|C0030705|C3831448|G0000000|C3830550|G0000000|G0000000|G0000000|C0439228|C0002645|C0039798|G0000000|C0439228|C0039798|G0000000
China between October 2011 and May 2012 among 194 children aged 9–12 years.,China October 2011 May 2012 194 children aged 9–12 years.,C0008115|C3828732|G0000000|G0000000|G0000000|C1442061|C0008059|C0001779|G0000000|C0439234
"During the 3-y period from June 1, 2012–May 31, 2015, there were 643 episodes of malaria in 7,529 cohort children who were followed up cumulatively for 17,284 person-years.","During 3-y period June 1, 2012–May 31, 2015, 643 episodes malaria 7,529 cohort children cumulatively 17,284 person-years.",G0000000|G0000000|C0439531|C3829443|G0000000|G0000000|C0450371|G0000000|C1442061|C0332189|C0024530|C1442061|C0599755|C0008059|G0000000|C0450371|C0027361
"Inclusion criteria were: No experience of acute psychological emotions, delivery and childbirth fear score >28, primiparous, single pregnancy, gestational age of 34–36 weeks, age of 18–35 years, no history of infertility, no indication for CS, and not having passed educational course for delivery methods.","Inclusion criteria were: No experience acute psychological emotions, delivery childbirth fear score >28, primiparous, single pregnancy, gestational age 34–36 weeks, age 18–35 years, history infertility, indication CS, passed educational delivery methods.",C0007637|C0243161|G0000000|G0000000|C0237607|C0205178|C0205486|C0013987|C0011209|C0005615|C0015726|C0449820|C0450371|C0033150|C0037179|C0032961|C0439671|C0001779|G0000000|C0439230|C0001779|G0000000|C0439234|C0019664|C0021359|C0392360|C0010182|C2828386|C0587721|C0011209|C0025663
"All of the patients had at least one measurable lesion by the Response Evaluation Criteria in Solid Tumors (RECIST) criteria, were ECOG performance status (PS) 0 to 2 and had anticipated life expectancies >3 months.","All patients measurable lesion Response Evaluation Criteria Solid Tumors (RECIST) criteria, ECOG performance status (PS) 0 2 anticipated life expectancies >3 months.",G0000000|C0030705|C1513040|C0221198|C0871261|C0220825|C0243161|C0205208|C0027651|C1709926|C0243161|C0430797|C0597198|C0449438|C0242397|G0000000|G0000000|C3840775|C0376558|C0679138|G0000000|C0439231
Additional exclusion criteria were: diagnosis of prepregnancy diabetes and uncontrolled chronic diseases that may affect weight development like thyroid dysfunction or psychiatric diseases.,Additional exclusion criteria were: diagnosis prepregnancy diabetes uncontrolled chronic diseases affect weight development thyroid dysfunction psychiatric diseases.,C1524062|C0680251|C0243161|G0000000|C0011900|C2709093|C0011847|C0205318|C0205191|C0012634|C0001721|C0005910|C0243107|C0040132|C0031847|C0205487|C0012634
Inclusion criteria include a TIA or ischemic stroke within the past 90 days and a systolic blood pressure (SBP) greater than 120 mm Hg.,Inclusion criteria TIA ischemic stroke 90 days systolic blood pressure (SBP) 120 mm Hg.,C0007637|C0243161|C0007787|C0475224|C0038454|C0450371|C0439228|C0039155|C0005767|C0033095|G0000000|C1442061|G0000000|C0025424
"[2-6] In Italy about 4–5,000 RSV-infected, high-risk, preterm infants (gestational age < 36 weeks, with or without bronchopulmonary dysplasia [BPD]) are hospitalized every year.","[2-6] In Italy 4–5,000 RSV-infected, high-risk, preterm infants (gestational age < 36 weeks, bronchopulmonary dysplasia [BPD]) hospitalized year.",G0000000|G0000000|C0022277|G0000000|C0439663|C0332167|C0151526|C0021270|C0439671|C0001779|G0000000|C0450371|C0439230|C0545675|C0334044|G0000000|C0701159|C0439234
"Adults with relapsed, refractory, or recurrent solid tumors or lymphoma enrolled onto phase 1 or 2, or phase 3 trials that compared therapy for advanced cancer were eligible.","Adults relapsed, refractory, recurrent solid tumors lymphoma enrolled phase 1 2, phase 3 trials compared therapy advanced cancer eligible.",C0001675|C0205336|C0205269|C2945760|C0205208|C0027651|C0024299|G0000000|C0205390|G0000000|G0000000|C0205390|G0000000|C0008976|C1707455|C0039798|C0205179|C0006826|C1548635
aThe intervention group is considered as the reference.,aThe intervention considered reference.,G0000000|C0886296|C0750591|C1514811
Participants were randomly assigned to one of three conditions: 1) contingent behavioral incentives for cigarette smoking reductions (CBI: n=42); 2) behavioral incentives that were not contingent on cigarette smoking reduction (NCBI: n=28); or 3) treatment as usual (TAU: n=32).,Participants randomly assigned conditions: 1) contingent behavioral incentives cigarette smoking reductions (CBI: n=42); 2) behavioral incentives contingent cigarette smoking reduction (NCBI: n=28); 3) treatment usual (TAU: n=32).,C0679646|G0000000|C1516050|C0012634|G0000000|C1701901|C0004927|C0021147|C0677453|C0037369|C0301630|G0000000|C0369718|G0000000|C0004927|C0021147|C1701901|C0677453|C0037369|C0301630|C0995203|C0369718|G0000000|C0039798|C3538928|C1720655|C0369718
The inclusion criteria were inflammatory neuropathy cause and treatment (INCAT) sensory score (ISS) ≥4 and visual analog pain scale >4 or ataxia score ≥2.,The inclusion criteria inflammatory neuropathy treatment (INCAT) sensory score (ISS) ≥4 visual analog pain scale >4 ataxia score ≥2.,G0000000|C0007637|C0243161|C0333348|C0442874|C0039798|G0000000|C0445254|C0449820|C1845118|G0000000|C0234621|C0243071|C0030193|C0175659|G0000000|C0004134|C0449820|G0000000
"Those who had major systemic illness, severe malnutrition, severe dehydration, severe vomiting, or history of antibiotic therapy were not included.","Those major systemic illness, severe malnutrition, severe dehydration, severe vomiting, history antibiotic therapy included.",G0000000|C0205082|C0205373|C0221423|C0205082|C0162429|C0205082|C0011175|C0205082|C0042963|C0019664|C0003232|C0039798|C0332257
"Participants on psychotropic medications (which included Paxil, Xanax, Klonopin, Lexapro, Prozac, Wellbutrin, Effexor, Ativan, Nortriptyline, Celexa, Cymbalta, and Zoloft) had to be on a stable dose for at least 2 months before enrollment and maintain their medication regimen throughout the study.","Participants psychotropic medications (which included Paxil, Xanax, Klonopin, Lexapro, Prozac, Wellbutrin, Effexor, Ativan, Nortriptyline, Celexa, Cymbalta, Zoloft) stable dose 2 months enrollment maintain medication regimen study.",C0679646|C0033978|C0013227|G0000000|C0332257|C0376414|C0699034|C0699315|C1170371|C0162373|C0085934|C0591437|C0699194|C0028420|C0719199|C1505021|C0284660|C0205360|C0178602|G0000000|C0439231|C1516879|C0024501|C0013227|C0040808|C0557651
"Exclusion criteria were: Presence of conditions affecting nerve conduction or abnormal findings in other nerves such as the presence of polyneuropathies, as well as proximal neuropathies affecting nerve trunks, plexus or cervical roots diagnosed by physical examinations and comprehensive electrodiagnostic studies.","Exclusion criteria were: Presence conditions nerve conduction abnormal findings nerves presence polyneuropathies, proximal neuropathies nerve trunks, plexus cervical roots diagnosed physical examinations comprehensive electrodiagnostic studies.",C0680251|C0243161|G0000000|C0150312|C0012634|C0027740|C0232217|C0205161|C2607943|C0027740|C0150312|C0152025|C0205107|C0442874|C0027740|C0225442|C1184808|C0027530|C0242726|C0011900|C0031809|C0031809|C1880156|G0000000|C0947630
"Exclusion criteria were, severe depression with BDI > 30 and MADRS > 30 [13–15], MS exacerbation or corticosteroid therapy within one month prior of enrollment, Mini-Mental State Examination (MMSE) ≤ 24, pregnancy, current or past history of significant ventricular arrhythmia, and general health status that would interfere with study participation.","Exclusion criteria were, severe depression BDI > 30 MADRS > 30 [13–15], MS exacerbation corticosteroid therapy month prior enrollment, Mini-Mental State Examination (MMSE) ≤ 24, pregnancy, current history ventricular arrhythmia, health status interfere study participation.",C0680251|C0243161|G0000000|C0205082|C0011570|C0006448|G0000000|C0450371|C4054475|G0000000|C0450371|G0000000|C0039676|G0000000|C0001617|C0039798|C0332177|C0332152|C1516879|C0445542|C1301808|G0000000|C0451306|G0000000|C0450371|C0032961|C0521116|C0019664|C0018827|C0003811|C0018684|C0449438|C0521102|C0557651|C0679823
"Of the 131 participants who were screened for phase II, 119 were randomized.","Of 131 participants screened phase II, 119 randomized.",G0000000|C1442061|C0679646|C0220908|C0205390|G0000000|C1442061|C0034656
A total of 110 surgical intensive care patients receiving antibiotic therapy after confirmed or high-grade suspected infections were enrolled in this study.,A total 110 surgical intensive care patients receiving antibiotic therapy confirmed high-grade suspected infections enrolled study.,G0000000|C0439175|C1442061|C0543467|C0162425|C1947933|C0030705|C1514756|C0003232|C0039798|C0521093|C0205082|C0332147|C3714514|G0000000|C0557651
"Given our data collection procedures, we excluded patients with a less than 10 Mb/s wifi connection where they sleep, inability to sleep in a quiet environment, or a loud snorer as a bed partner.","Given data collection procedures, excluded patients 10 Mb/s wifi connection sleep, inability sleep quiet environment, loud snorer bed partner.",C1442162|C1511726|C1516698|C0025664|C1554077|C0030705|C0450371|C0024853|G0000000|C0449379|C0037313|G0000000|C0037313|C0439654|C0014406|C0178733|G0000000|C0004916|C0682323
Withdrawal prior to the first event that is not completely at random also affects estimates of time to first exacerbation.,Withdrawal prior event completely random estimates time exacerbation.,C2349954|C0332152|C0441471|C0205197|C0034656|C0750572|C0040223|G0000000
The following patients are also excluded: patients who cannot read or write English sufficiently well to participate in treatment or complete the assessment measures; patients who are incapable of giving informed consent; patients who are currently undertaking systematic psychological therapies for CFS/ME or who have received pragmatic rehabilitation therapy within the past year.,The patients excluded: patients read write English participate treatment complete assessment measures; patients incapable informed consent; patients undertaking systematic psychological therapies CFS/ME received pragmatic rehabilitation therapy year.,G0000000|C0030705|C1554077|C0030705|C0034754|C0043266|C0376245|G0000000|C0039798|C0205197|C1261322|C0079809|C0030705|C1550518|C1522154|C1511481|C0030705|C0041666|C0220922|C0205486|C0087111|C0015674|C1514756|C0871858|C0034991|C0039798|C0439234
Fifty-six patients undergoing transperitoneal laparoscopic renal surgery were randomized and blinded to one of the 4 trocar types.,Fifty-six patients undergoing transperitoneal laparoscopic renal surgery randomized blinded 4 trocar types.,C3816723|C0030705|G0000000|C0205501|C0031150|C0022646|C0038894|C0034656|C0150108|G0000000|C0041158|C0332307
"Exclusion criteria included: 1) unstable cardiovascular, orthopedic, or neurological conditions, 2) uncontrolled diabetes that would preclude exercise of moderate intensity, or 3) significant cognitive impairment affecting the ability to follow directions.","Exclusion criteria included: 1) unstable cardiovascular, orthopedic, neurological conditions, 2) uncontrolled diabetes preclude exercise moderate intensity, 3) cognitive impairment ability follow directions.",C0680251|C0243161|C0332257|G0000000|C0443343|C0007226|C0029355|C0205494|C0012634|G0000000|C0205318|C0011847|G0000000|C0015259|C0205081|C0522510|G0000000|C1516691|C0221099|C0085732|C0332283|C0439755
"Differences between groups 1 and 3 in severe acne patients was significant (P = 0.013) As presented in Table 2, the most common side effects were dry, chapped lips (73% in group 1, 95% in group 2, 100% in group 3) and dry skin (59% in group 1, 65% in group 2, 78% in group 3) in all groups.","Differences 1 3 severe acne patients (P = 0.013) As Table 2, common effects dry, chapped lips (73% 1, 95% 2, 100% 3) dry skin (59% 1, 65% 2, 78% 3) groups.",C1705241|G0000000|G0000000|C0205082|C0001144|C0030705|C0369773|G0000000|C1442061|G0000000|C0039224|G0000000|C0205214|C1280500|C0011682|C0950540|C0023759|C0450371|G0000000|C0450371|G0000000|C1442061|G0000000|C0011682|C0444099|C0450371|G0000000|C0450371|G0000000|C0450371|G0000000|C0441833
"Hitherto, three randomized, double-blinded, placebo-controlled trials of the oral ETEC vaccine have been performed with Egyptian adults (18) and children ages 2 to 12 years (19) living in areas where ETEC infections are highly endemic.","Hitherto, randomized, double-blinded, placebo-controlled trials oral ETEC vaccine performed Egyptian adults (18) children ages 2 12 (19) living ETEC infections highly endemic.",G0000000|C0034656|C0205173|C1706408|C0008976|C0442027|C0580797|C0042210|C0884358|C0013717|C0001675|C0450371|C0008059|C0001779|G0000000|C0450371|C0450371|C0376558|C0580797|C3714514|C0205250|G0000000
"Therefore, 5435 participants were included in the final analysis (Fig.","Therefore, 5435 participants included final analysis (Fig.",G0000000|G0000000|C0679646|C0332257|C0205088|C0002778|C0349966
"Inclusion criteria were age 18–85 years, diagnosed with MS by McDonald criteria [11], all types of MS (relapsing remitting and progressive types), major depressive disorder (MDD) by Diagnostic and Statistical Manual of Mental Disorder-IV criteria (DSM-IV) based on Structured Clinical Interview for DSM (SCID) for Axis I disorders [12], mild to moderate depression (BDI-I score 10–30) [13–14], stable dose of antidepressant medication three months prior to study enrollment, and if on a MS disease modifying medication, on stable dose for 6 months prior to study enrollment.","Inclusion criteria age 18–85 years, diagnosed MS McDonald criteria [11], types MS (relapsing remitting progressive types), major depressive disorder (MDD) Diagnostic Statistical Manual Mental Disorder-IV criteria (DSM-IV) based Structured Clinical Interview DSM (SCID) Axis I disorders [12], mild moderate depression (BDI-I score 10–30) [13–14], stable dose antidepressant medication months prior study enrollment, MS disease modifying medication, stable dose 6 months prior study enrollment.",C0007637|C0243161|C0001779|G0000000|C0439234|C0011900|C0039676|G0000000|C0243161|C0450371|C0332307|C0039676|C0035020|C0439600|C0205329|C0332307|C0205082|G0000000|C0012634|C1269683|C0011900|C0038215|C0024763|C0229992|C0012634|C0243161|C0220952|C1527178|C0678594|C0205210|C0021822|G0000000|C0085110|C0004457|C0021966|C0012634|C0450371|C2945599|C0205081|C0011570|C0006448|C0449820|G0000000|G0000000|C0205360|C0178602|C0003289|C0013227|C0439231|C0332152|C0557651|C1516879|C0039676|C0012634|C0392747|C0013227|C0205360|C0178602|G0000000|C0439231|C0332152|C0557651|C1516879
"SASP is still widely used in the treatment of chronic relapse type ulcerative colitis, with advantages such as quick effect and high clinical remission rate.","SASP treatment chronic relapse type ulcerative colitis, advantages quick clinical remission rate.",C1504637|C0039798|C0205191|C0035020|C0332307|C0041582|C0009319|G0000000|C0456962|C0205210|C0544452|C0871208
"Of the remaining 6 children, 5 met criteria for Autism Spectrum Disorder on the ADOS-G, and one child was not administered this measure due to time constraints.","Of remaining 6 children, 5 met criteria Autism Spectrum Disorder ADOS-G, child administered measure time constraints.",G0000000|C1527428|G0000000|C0008059|G0000000|C0268621|C0243161|C0004352|C1883073|C0012634|C0670018|C0008059|C1521801|C0079809|C0040223|C0443288
"Totally, 64 women including 32 in the case and 32 in the control group were involved in the study.","Totally, 64 women including 32 32 control involved study.",G0000000|C0450371|C0043210|C0332257|C0450371|C0450371|C0243148|C1314939|C0557651
"The Indiana University Institutional Review Board approved this study, which was performed in IU Medical Group-Primary Care (IUMG-PC),25 an academic primary care group practice affiliated with an inner-city public teaching hospital.","The Indiana University Institutional Review Board approved study, performed IU Medical Group-Primary Care (IUMG-PC),25 academic primary care practice affiliated inner-city public teaching hospital.",G0000000|C0021206|C0041740|C0018704|C0282443|C0972401|C0205540|C0557651|C0884358|C0049272|C0199168|C0441833|C1947933|C0031995|C1510747|C0205225|C1947933|C0237607|C1510825|C0557849|G0000000|C0039401|C0019994
The objective of this study was to evaluate whether glutamine supplementation alters the expression and functionality of TLR2 and TLR4 in circulating monocytes of trauma patients admitted to the intensive care unit (ICU).,The objective study evaluate glutamine supplementation alters expression functionality TLR2 TLR4 circulating monocytes trauma patients admitted intensive care unit (ICU).,G0000000|C0018017|C0557651|C0220825|C0017797|C0242297|C0392747|C0185117|C0205245|G0000000|G0000000|C0175630|C0026473|C0043251|C0030705|C0184666|C0162425|C1947933|C0439148|C0021708
The specific ‘integrated yoga therapy module for low back pain’ was developed by a team of two yoga experts and a physiatrist.,The specific ‘integrated yoga therapy module low pain’ developed team yoga experts physiatrist.,G0000000|C0205369|G0000000|C0043418|C0039798|C1709061|C0205251|G0000000|G0000000|C0871489|C0043418|G0000000|C0260138
"The study population comprised all probable SARS patients whose cases were reported to the Department of Health on or before May 16, 2003 (n = 1,690).","The study population comprised probable SARS patients reported Department Health May 16, 2003 (n = 1,690).",G0000000|C0557651|C0032659|C2700400|C0033204|C1175175|C0030705|C0684224|C1704729|C0018684|G0000000|C0450371|G0000000|C0369718|G0000000|C1442061
The Freedom study was set up to investigate the efficacy and safety of this new dry powder formulation of inhaled colistimethate sodium (CDPI) compared with tobramycin nebuliser solution for inhalation (TIS) in patients with CF aged ≥6 years with chronic P aeruginosa lung infection.,The Freedom study set investigate efficacy safety dry powder formulation inhaled colistimethate sodium (CDPI) compared tobramycin nebuliser solution inhalation (TIS) patients CF aged ≥6 years chronic P aeruginosa lung infection.,G0000000|C0016694|C0557651|C0036849|C1292732|C1280519|C0036043|C0011682|C0032861|C0524527|C0004048|C0009315|C0037473|G0000000|C1707455|C0040341|C0027524|C0037633|C0004048|C0475413|C0030705|C0009738|C0001779|G0000000|C0205191|C0369773|G0000000|C0024109|C0009450
"Overall, 3819 women (mean age 34.3±6.3 years) were enrolled into the study and randomised to receive either qHPV vaccine or placebo.","Overall, 3819 women (mean age 34.3±6.3 years) enrolled study randomised receive qHPV vaccine placebo.",C0282416|G0000000|C0043210|C0444504|C0001779|G0000000|C0439234|G0000000|C0557651|G0000000|C1514756|G0000000|C0042210|C0032042
We found that mepolizumab treatment significantly reduced the number of asthma exacerbations that resulted in the prescription of corticosteroid therapy and increased asthma-related quality of life in subjects who had refractory eosinophilic asthma and a history of recurrent exacerbations.,We mepolizumab treatment reduced asthma exacerbations prescription corticosteroid therapy increased asthma-related quality life subjects refractory eosinophilic asthma history recurrent exacerbations.,G0000000|C0969324|C0039798|C0392756|C0004096|G0000000|C0033080|C0001617|C0039798|C0205217|C0004096|C0332306|C0376558|C0681850|C0205269|C0333930|C0004096|C0019664|C2945760|G0000000
"Consequently our study sample included women at higher obstetric and possibly higher psychological risk than the previous two trials, and included women with lower fear levels (WDEQ-A ≥ 66).","Consequently study sample included women obstetric psychological risk previous trials, included women lower fear levels (WDEQ-A ≥ 66).",G0000000|C0557651|C0370003|C0332257|C0043210|C0205484|C0205486|C0035647|C0205156|C0008976|C0332257|C0043210|C0441994|C0015726|C0441889|G0000000
"Patients with asthma, other significant lung disease, and certain other significant and uncontrolled disorders were excluded.","Patients asthma, lung disease, uncontrolled disorders excluded.",C0030705|C0004096|C0024109|C0012634|C0205318|C0012634|C1554077
"All study participants, whether they were randomized to ramelteon or placebo, received APAP therapy for their sleep apnea using an autotitrating unit.","All study participants, randomized ramelteon placebo, received APAP therapy sleep apnea autotitrating unit.",G0000000|C0557651|C0679646|C0034656|C1565316|C0032042|C1514756|C0000970|C0039798|C0037313|C0003578|G0000000|C0439148
"Lung function of 5 and 10 μg olodaterol was examined in two sets of replicate pivotal studies in patients with moderate to very severe COPD: one set investigated the efficacy of olodaterol versus placebo after 12 weeks in a population including US patients ({""type"":""clinical-trial"",""attrs"":{""text"":""NCT00782210"",""term_id"":""NCT00782210""}}NCT00782210; {""type"":""clinical-trial"",""attrs"":{""text"":""NCT00782509"",""term_id"":""NCT00782509""}}NCT00782509), while the other set, described here, compared the efficacy of olodaterol with placebo and formoterol after 24 weeks in a population not including US patients (Study 1222.13: {""type"":""clinical-trial"",""attrs"":{""text"":""NCT00793624"",""term_id"":""NCT00793624""}}NCT00793624; Study 1222.14: {""type"":""clinical-trial"",""attrs"":{""text"":""NCT00796653"",""term_id"":""NCT00796653""}}NCT00796653).","Lung function 5 10 μg olodaterol examined sets replicate pivotal studies patients moderate severe COPD: set investigated efficacy olodaterol versus placebo 12 weeks population including US patients ({""type"":""clinical-trial"",""attrs"":{""text"":""NCT00782210"",""term_id"":""NCT00782210""}}NCT00782210; {""type"":""clinical-trial"",""attrs"":{""text"":""NCT00782509"",""term_id"":""NCT00782509""}}NCT00782509), set, here, compared efficacy olodaterol placebo formoterol 24 weeks population including US patients (Study 1222.13: {""type"":""clinical-trial"",""attrs"":{""text"":""NCT00793624"",""term_id"":""NCT00793624""}}NCT00793624; Study 1222.14: {""type"":""clinical-trial"",""attrs"":{""text"":""NCT00796653"",""term_id"":""NCT00796653""}}NCT00796653).",C0024109|C0031843|G0000000|C0450371|G0000000|C2934193|C0332128|C0036849|C0205173|C1709557|C0947630|C0030705|C0205081|C0205082|C0024117|C0036849|C1292732|C1280519|C2934193|G0000000|C0032042|C0450371|C0439230|C0032659|C0332257|G0000000|C0030705|C0332307|C0332307|C0036849|G0000000|C1707455|C1280519|C2934193|C0032042|C0060657|C0450371|C0439230|C0032659|C0332257|G0000000|C0030705|C0557651|C0450371|C0332307|C0557651|C0450371|C0332307
"Participants were eligible for inclusion if they were between the ages of 14 and 21, had attended or were currently attending high school in the local public school system, and were not currently enrolled in a self-contained classroom (indicating the receipt of intense special education services).","Participants eligible inclusion ages 14 21, attended attending school local public school system, enrolled self-contained classroom (indicating receipt intense special education services).",C0679646|C1548635|C0007637|C0001779|C0450371|C0450371|C1456498|C1547429|C0036375|C0205276|G0000000|C0036375|C0449913|G0000000|C0036588|C0870287|G0000000|G0000000|C0522510|C0205555|C0013621|C0557854
"Exclusion criteria were as follows: mixed infection with Plasmodium falciparum; pregnancy and lactation; evidence of significant hepatic, renal, or cardiac disease as diagnosed by history, clinical examination, and laboratory tests whenever necessary; any other condition which would interfere with patient's participation in the study or compliance with the treatment.","Exclusion criteria follows: mixed infection Plasmodium falciparum; pregnancy lactation; evidence hepatic, renal, cardiac disease diagnosed history, clinical examination, laboratory tests necessary; condition interfere patient's participation study compliance treatment.",C0680251|C0243161|C0332283|C0205430|C0009450|C0032148|G0000000|C0032961|C0006147|C3887511|C0205054|C0022646|C0018787|C0012634|C0011900|C0019664|C0205210|G0000000|C0022877|C0022885|G0000000|C0012634|C0521102|C0030705|C0679823|C0557651|C0009563|C0039798
"To compare the DASH diet alone or combined with a weight management program with usual diet controls among participants with prehypertension or stage 1 hypertension (systolic BP, 130–159 mm Hg; or diastolic BP, 85–99 mm Hg).","To compare DASH diet combined weight management program usual diet controls participants prehypertension stage 1 hypertension (systolic BP, 130–159 mm Hg; diastolic BP, 85–99 mm Hg).",C0040363|C1707455|C2827624|C0012155|C0205195|C0005910|C0001554|C1709697|C3538928|C0012155|C0243148|C0679646|C1696708|C0205390|G0000000|C0020538|C0039155|C0037623|G0000000|G0000000|C0025424|C0012000|C0037623|G0000000|G0000000|C0025424
"As the pregnant women contacted their maternity clinic, which was determined by their place of residence, to set the first appointment at 8-12 weeks’ gestation, the public health nurses in INT (N = 23) and in UC (N = 30) recruited those with at least one risk factor for gestational diabetes (BMI ≥ 25 kg/m2, gestational diabetes or any signs of glucose intolerance or macrosomic newborn (≥ 4500 g) in any earlier pregnancy, type 1 or 2 diabetes in first or second grade relatives, age ≥ 40 years).","As pregnant women contacted maternity clinic, determined residence, set appointment 8-12 weeks’ gestation, public health nurses INT (N = 23) UC (N = 30) recruited risk factor gestational diabetes (BMI ≥ 25 kg/m2, gestational diabetes signs glucose intolerance macrosomic newborn (≥ 4500 g) earlier pregnancy, type 1 2 diabetes grade relatives, age ≥ 40 years).",G0000000|C0549206|C0043210|C0332158|C0681108|C0002424|G0000000|C0237096|C0036849|C0003629|G0000000|C0032961|G0000000|C0018684|C0028661|C0063789|G0000000|G0000000|G0000000|G0000000|C0035647|C1521761|C0439671|C0011847|G0000000|C0439671|C0011847|C0220912|C0017725|C0231199|G0000000|C0021289|G0000000|G0000000|C1279919|C0032961|C0332307|G0000000|G0000000|C0011847|C0441800|C0080103|G0000000
"We performed sample size calculations for each of the three conditions, i.e., back pain, migraine and ankle sprain, using both the equivalence (between acupuncture and pharmacotherapy) and non-inferiority (between combined and pharmacotherapy) approaches, assuming that a difference of 1.5 units in Visual Analogue Scale (VAS) score is clinically relevant.","We performed sample size calculations conditions, i.e., pain, migraine ankle sprain, equivalence (between acupuncture pharmacotherapy) non-inferiority (between combined pharmacotherapy) approaches, assuming difference 1.5 units Visual Analogue Scale (VAS) score clinically relevant.",G0000000|C0884358|C0370003|C0456389|C1441506|C0012634|C0683454|C0030193|C0149931|C0003086|C0038045|C0205163|G0000000|C0001299|C0013216|C1518422|G0000000|C0205195|C0013216|C0449445|G0000000|C1705241|G0000000|C0439148|C0234621|C0243071|C0175659|C0042815|C0449820|G0000000|C2347946
Women were excluded if they were unable to read and speak English at a level that allowed completion of pen-and-paper surveys.,Women excluded unable read speak English level allowed completion pen-and-paper surveys.,C0043210|C1554077|C1299582|C0034754|C0234856|C0376245|C0441889|C0683607|C0205197|C3273588|C0038951
(ii) Exclusion Criteria: Mothers or guardians whose <5 yrs old children were not living with them at the time of the study were not included in the study.,(ii) Exclusion Criteria: Mothers guardians <5 yrs children living time study included study.,G0000000|C0680251|C0243161|C0026591|C1274041|G0000000|C0008059|C0376558|C0040223|C0557651|C0332257|C0557651
The original study was approved by the National Cancer Institute (NCI) institutional review board (IRB) [10].,The original study approved National Cancer Institute (NCI) institutional review board (IRB) [10].,G0000000|C0205313|C0557651|C0205540|C3245503|C0006826|C0021622|C1513882|C0018704|C0282443|C0972401|C0086911|C0450371
"With regards to patients undergoing autologous transplantation, reduced hemoglobin prior to HSCT was associated with increased red cell transfusion requirements in a study recently published by our group.","With patients undergoing autologous transplantation, reduced hemoglobin prior HSCT increased red cell transfusion requirements study published group.",G0000000|C0030705|G0000000|C0439859|C0040732|C0392756|C0019046|C0332152|C0472699|C0205217|C0332575|C0007634|C0005841|C1514873|C0557651|C0034037|C0441833
The 2 trials were launched simultaneously in July 2004.,The 2 trials launched simultaneously July 2004.,G0000000|G0000000|C0008976|G0000000|C0521115|C3829447|G0000000
Ninety-nine women (age 26–42 years; mean ± SD prepregnancy BMI 24 ± 5 kg/m2) diagnosed with GDM at 20–32 weeks’ gestation were randomized to follow either an LGI (n = 50; target glycemic index [GI] ~50) or a high-fiber moderate-GI diet (HF) (n = 49; target GI ~60).,Ninety-nine women (age 26–42 years; ± SD prepregnancy BMI 24 ± 5 kg/m2) diagnosed GDM 20–32 weeks’ gestation randomized follow LGI (n = 50; target glycemic [GI] ~50) high-fiber moderate-GI diet (HF) (n = 49; target GI ~60).,C3828813|C0043210|C0001779|G0000000|C0439234|G0000000|C2699239|C2709093|G0000000|C0450371|G0000000|G0000000|C0022718|C0011900|C0085207|G0000000|G0000000|C0032961|C0034656|C0332283|G0000000|C0369718|G0000000|C0450371|C1521840|C0005802|C1708130|C0450371|C0205250|C0205081|C0012155|C0018488|C0369718|G0000000|C0450371|C1521840|C1708130|C0450371
"Children were aged 2-15 years with “active epilepsy” defined as two or more generalised tonic-clonic, partial or secondary generalised seizures during the previous year.","Children aged 2-15 “active epilepsy” defined generalised tonic-clonic, partial secondary generalised seizures previous year.",C0008059|C0001779|C0450371|G0000000|G0000000|C1704788|C0205246|C3543842|C0728938|C0027627|C0205246|C0036572|C0205156|C0439234
The mean age of the treatment group patients was 25.31 years (SD 7.02) and for control group was 27.00 years (SD 7.29).,The age treatment patients 25.31 (SD 7.02) control 27.00 (SD 7.29).,G0000000|C0001779|C0039798|C0030705|C0450371|G0000000|C0450371|C0243148|C0450371|G0000000|C0450371
"The mean of age in nicotinamide gel and clindamycin gel were 20.83 ± 3.34 years and 21.17 ± 3.53 years, respectively, and this difference was not statistically significant (P > 0.05).","The age nicotinamide gel clindamycin gel 20.83 ± 3.34 21.17 ± 3.53 years, respectively, difference statistically (P > 0.05).",G0000000|C0001779|C0027996|C0017243|C0008947|C0017243|C0450371|G0000000|C0450371|C0450371|G0000000|C0450371|C0439234|G0000000|C1705241|C0038215|C0369773|G0000000|C0450371
Lung function assessed as FEV1 significantly deteriorated over time (Fig.,Lung function assessed FEV1 deteriorated time (Fig.,C0024109|C0031843|C1516048|G0000000|C1457868|C0040223|C0349966
One hundred and thirty-five women returned to follow-up.,One thirty-five women returned follow-up.,C0205447|C3816446|C0043210|C0332156|C0589120
"Stenosis is defined as high-grade if catheter angiography documents ≥70% stenosis per criteria used in NASCET5 or duplex ultrasonography (DU) documents peak systolic velocity (PSV) of ≥230 cm/s in combination with at least one of the following four criteria: end diastolic velocity of ≥100 cm/s, internal carotid artery-to-common carotid artery PSV ratio ≥4.0, CT angiogram showing ≥70% stenosis, or a magnetic resonance angiogram (MRA) showing ≥70% stenosis.","Stenosis defined high-grade catheter angiography documents ≥70% stenosis criteria NASCET5 duplex ultrasonography (DU) documents peak systolic velocity (PSV) ≥230 cm/s combination criteria: diastolic velocity ≥100 cm/s, internal carotid artery-to-common carotid artery PSV ratio ≥4.0, CT angiogram ≥70% stenosis, magnetic resonance angiogram (MRA) ≥70% stenosis.",C0678234|C1704788|C0205082|C0085590|C0002978|C1301746|G0000000|C0678234|C0243161|G0000000|C0444916|C0041618|C0011535|C1301746|C0444505|C0039155|C0439830|G0000000|G0000000|C0439392|C0205195|C0243161|C0012000|C0439830|G0000000|C0439392|C0205102|C0741968|C0003842|C0741968|C0003842|G0000000|C0456603|G0000000|C0007673|C0002978|G0000000|C0678234|C0024488|C0231881|C0002978|C0243032|G0000000|C0678234
"Seventy-five children with severe malnutrition, clinical vitamin A deficiency (as indicated by corneal involvement), chronic diseases, or persistent diarrhoea were referred to the Children's Hospital, Dhaka or ICDDR,B and were excluded from the study.","Seventy-five children severe malnutrition, clinical vitamin A deficiency (as corneal involvement), chronic diseases, persistent diarrhoea referred Children's Hospital, Dhaka ICDDR,B excluded study.",C3816957|C0008059|C0205082|C0162429|C0205210|C0042890|G0000000|C0011155|G0000000|C0010031|C1314939|C0205191|C0012634|C0205322|C0011991|C0205543|C0008059|C0019994|G0000000|G0000000|C1554077|C0557651
"We enrolled the urban participants from Gonbad City, the second largest city of Golestan, with 126 797 inhabitants (28 102 aged 40–75), and the rural participants from villages in Gonbad, Kalaleh and Aq-Qala counties (Figure 1), with 347 683 inhabitants (53 121 aged 40–75).","We enrolled urban participants Gonbad City, largest city Golestan, 126 797 inhabitants (28 102 aged 40–75), rural participants villages Gonbad, Kalaleh Aq-Qala counties (Figure 1), 347 683 inhabitants (53 121 aged 40–75).",G0000000|G0000000|C0442529|C0679646|G0000000|C0008848|C0443228|C0008848|G0000000|G0000000|G0000000|G0000000|C0001779|G0000000|C0240919|C0679646|C0562518|G0000000|G0000000|C0242536|C0079170|G0000000|G0000000|G0000000|G0000000|G0000000|C0001779|G0000000
101 children were randomised into the control group and received usual care and 99 were assigned to the intervention group and received: (1) a pre-school asthma booklet; (2) a written guided self-management plan; and (3) two 20 minute structured educational sessions between a specialist respiratory nurse and the parent(s) and child.,101 children randomised control received usual care 99 assigned intervention received: (1) pre-school asthma booklet; (2) written guided self-management plan; (3) 20 minute structured educational sessions specialist respiratory nurse parent(s) child.,C1442061|C0008059|G0000000|C0243148|C1514756|C3538928|C1947933|C0450371|C1516050|C0886296|C1514756|G0000000|C0424930|C0004096|C0030258|G0000000|C0043266|C0181090|C0086969|C0270724|G0000000|C0450371|C0439232|C0678594|C0587721|C1883016|C0087009|C0521346|C0028661|C0030551|C0008059
A high proportion (46.7%) of the study participants were within the age category of 21 to 23 years.,A proportion (46.7%) study participants age category 21 23 years.,G0000000|C1709707|C0450371|C0557651|C0679646|C0001779|C0683312|C0450371|C0450371|C0439234
"In this study, pregnant women in London, England were randomized at 27 weeks gestation to receive either no vitamin D, 800 IU ergocalciferol daily until delivery, or a single bolus of 200,000 IU cholecalciferol.","In study, pregnant women London, England randomized 27 weeks gestation receive vitamin D, 800 IU ergocalciferol daily delivery, single bolus 200,000 IU cholecalciferol.",G0000000|C0557651|C0549206|C0043210|C0023973|C0014282|C0034656|C0450371|C0439230|C0032961|C1514756|C0042890|C0073187|C1442061|C0049272|C0014695|C0332173|C0011209|C0037179|C1511237|C1442061|C0049272|C0008318
"A patient information sheet (Additional file 1) is shared with the patient and nominated caregiver, and outlines the study objectives and risks and benefits to the patient or caregiver.","A patient sheet (Additional file 1) shared patient nominated caregiver, outlines study objectives risks benefits patient caregiver.",G0000000|C0030705|C2349187|C1524062|C0016094|G0000000|C0237876|C0030705|G0000000|C0085537|C0600661|C0557651|C0018017|C0035647|C0814225|C0030705|C0085537
Twenty matched pairs of deprived neighbourhoods in London were randomised to receive the Well London programme or be a control area.,Twenty matched pairs deprived neighbourhoods London randomised receive Well London programme control area.,C0724000|C0150103|C1709450|G0000000|G0000000|C0023973|G0000000|C1514756|C0205170|C0023973|C1709697|C0243148|C0017446
"Although this figure is not very high, the impact of smoking habit on the probability of cardiovascular events in the follow-up of kidney transplant recipients is clinically relevant.","Although figure high, impact smoking habit probability cardiovascular events follow-up kidney transplant recipients clinically relevant.",G0000000|G0000000|C0205250|C1825598|C0037369|C0018464|C0033204|C0007226|C0441471|C0589120|C0022646|C0040732|C1709854|G0000000|C2347946
"Results: Twenty nine of 31 enrolled patients (age 25–67 years, seven women, mean (SD) body mass index 31.5 (6) kg/m2) completed the protocol.","Results: Twenty 31 enrolled patients (age 25–67 years, women, (SD) body mass 31.5 (6) kg/m2) completed protocol.",C1274040|C0724000|C0450371|G0000000|C0030705|C0001779|G0000000|C0439234|C0043210|G0000000|C0242821|C0577559|C0450371|G0000000|C0022718|C0205197|C0442711
"A total of 12 children (six males, mean age ± SD: 5.7 ± 0.8 years) with a confirmed diagnosis of cystic fibrosis were enrolled (Table (Table11).","A total 12 children (six males, age ± SD: 5.7 ± 0.8 years) confirmed diagnosis cystic fibrosis enrolled (Table (Table11).",G0000000|C0439175|C0450371|C0008059|C0205452|C0086582|C0001779|G0000000|C2699239|G0000000|G0000000|G0000000|C0439234|C0521093|C0011900|C0205207|C0016059|G0000000|C0039224|G0000000
Patient inclusion criteria: Patient must have had confirmed proximal hip fracture requiring an operation and be aged ≥ 60 years at the time of the operation Patient has a preoperative AMTS ≤8 in England (including those with zero because of an inability to answer questions) or a 4AT score ≥1 in Scotland Patient must have a “suitable informant” (e.g.,Patient inclusion criteria: Patient confirmed proximal hip fracture requiring operation aged ≥ 60 time operation Patient preoperative AMTS ≤8 England (including inability answer questions) 4AT score ≥1 Scotland Patient “suitable informant” (e.g.,C0030705|C0007637|C0243161|C0030705|C0521093|C0205107|C0019552|C0016658|G0000000|C0543467|G0000000|C0040223|C0543467|C0030705|C0445204|C1412390|G0000000|C0014282|C0332257|G0000000|C1706817|C1522634|G0000000|C0449820|G0000000|C0036453|C0030705|G0000000|G0000000|G0000000
‡4/113 patients not tested for C difficile.,‡4/113 patients tested C difficile.,G0000000|C0030705|C0392366|G0000000|G0000000
"Parents of adolescents in the two-sided message condition received this additional statement, which has been identified as a common concern about HPV vaccination21: “Some parents want to wait until more adolescent boys/girls have been given this vaccine before getting their own son/daughter vaccinated.","Parents adolescents two-sided message condition received additional statement, identified common concern HPV vaccination21: “Some parents wait adolescent boys/girls vaccine son/daughter vaccinated.",C0030551|C0205653|C0205448|C0470166|C0012634|C1514756|C1524062|C1710187|C0205396|C0205214|C2699424|C0021344|G0000000|G0000000|C0030551|C1610166|C0205653|C0870221|C0042210|C0037683|C1116171
Patients undergoing laparotomy for resection of peritoneal metastases from recurrence of previous cancer between 1992–2003 were reviewed retrospectively.,Patients undergoing laparotomy resection peritoneal metastases recurrence previous cancer 1992–2003 reviewed retrospectively.,C0030705|G0000000|C0023038|C0015252|C0031153|C0027627|C0034897|C0205156|C0006826|G0000000|C0282443|G0000000
These data suggest a therapeutic advantage of adding eformoterol to inhaled corticosteroids in patients with mild to moderate asthma.,These data therapeutic advantage adding eformoterol inhaled corticosteroids patients mild moderate asthma.,G0000000|C1511726|C0087111|G0000000|C1883712|C0060657|C0004048|C0001617|C0030705|C2945599|C0205081|C0004096
"As a result of funding limitations, the 1999 follow-up of adolescents first interviewed in 1996 was restricted to those who were aged 12 to 15 years at baseline.","As result funding limitations, 1999 follow-up adolescents interviewed 1996 restricted aged 12 15 baseline.",G0000000|C1274040|C0243098|C0449295|G0000000|C0589120|C0205653|C0021822|G0000000|C0443288|C0001779|C0450371|C0450371|C0168634
"Randomization was not stratified because of the sample size, unknown prognostic factors, and grouping by age to optimize psychosocial benefits.","Randomization stratified sample size, unknown prognostic factors, age optimize psychosocial benefits.",C0034656|C0205363|C0370003|C0456389|C0439673|C0220901|C1521761|C0001779|G0000000|C0542298|C0814225
"33 Patients were treated with either fluticasone or placebo for 30 months (19/19 and 13/14 adherent in fluticasone and placebo group, respectively).","33 Patients treated fluticasone placebo 30 months (19/19 13/14 adherent fluticasone placebo group, respectively).",C0450371|C0030705|C1522326|C0082607|C0032042|C0450371|C0439231|C0450371|C0450371|C0334154|C0082607|C0032042|C0441833|G0000000
"The criteria for selecting the participants were a minimum age of 18 years, being under HD for at least six months, three times a week HD, each time for four hours under maintenance HD treatment, living at home, no participation in other training programs in this area before formal training and during the study, and reluctancy to participate in the study.","The criteria selecting participants minimum age 18 years, HD months, times week HD, time hours maintenance HD treatment, living home, participation training programs formal training study, reluctancy participate study.",G0000000|C0243161|C1707391|C0679646|C1524031|C0001779|C0450371|C0439234|G0000000|C0439231|C0040223|C0332174|G0000000|C0040223|C0439227|C0024501|G0000000|C0039798|C0376558|C0442519|C0679823|C0040607|C0376691|C0348078|C0040607|C0557651|C2347948|G0000000|C0557651
"1200 children were recruited from the Royal Victoria Teaching Hospital (RVTH), Banjul, the Medical Research Council (MRC) Hospital, Fajara, or from the major health centres at Brikama, Essau and Faji Kunda, 600 children during the 2003 transmission season (July to December), and another 600 children in the 2004 malaria transmission season.","1200 children recruited Royal Victoria Teaching Hospital (RVTH), Banjul, Medical Research Council (MRC) Hospital, Fajara, major health centres Brikama, Essau Faji Kunda, 600 children 2003 transmission season (July December), 600 children 2004 malaria transmission season.",G0000000|C0008059|G0000000|G0000000|C0042645|C0039401|C0019994|G0000000|G0000000|C0199168|C0035168|C1551807|C1540289|C0019994|G0000000|C0205082|C0018684|C0205099|G0000000|G0000000|G0000000|G0000000|C1442061|C0008059|G0000000|C0040722|C0036497|C3829447|C3830550|C1442061|C0008059|G0000000|C0024530|C0040722|C0036497
"For residents with advanced dementia who cannot speak for themselves, case conferences can facilitate the sharing of different perspectives regarding what each resident would have wanted were (s)he able to choose.","For residents advanced dementia speak themselves, conferences facilitate sharing perspectives resident (s)he choose.",G0000000|C1320928|C0205179|C0011265|C0234856|G0000000|C0086047|G0000000|C0237876|G0000000|C1320928|G0000000|C1707391
"PREADVISE enrolled 7,540 non-demented SELECT men between 2002 and 2008 (Appendix, CONSORT diagram).","PREADVISE enrolled 7,540 non-demented SELECT 2002 2008 (Appendix, CONSORT diagram).",G0000000|G0000000|C1442061|C1518422|C1707391|G0000000|G0000000|C0003617|G0000000|C0681494
"Men or women age ≥45 years with established CVD (CV risk stratum 1, Table Table1)1) or age ≥50 years with diabetes mellitus in combination with 1 additional risk factor for CVD (CV risk stratum 2, Table Table1)1) were eligible for inclusion.","Men women age ≥45 years established CVD (CV risk stratum 1, Table Table1)1) age ≥50 years diabetes mellitus combination 1 additional risk factor CVD (CV risk stratum 2, Table Table1)1) eligible inclusion.",C0025266|C0043210|C0001779|G0000000|C0443211|C0007222|C3538987|C0035647|G0000000|G0000000|C0039224|G0000000|C0001779|G0000000|C0011847|G0000000|C0205195|G0000000|C1524062|C0035647|C1521761|C0007222|C3538987|C0035647|G0000000|G0000000|C0039224|G0000000|C1548635|C0007637
"ICU patients planned for bedside PDT with: (i) a prothrombin time (PT) between 14.7–20.0 seconds, (ii) a platelet count between 40–100×109/L and/or (iii) active treatment with acetylsalicylic acid were randomised to receive infusion with fresh-frozen plasma (FFP) and/or platelets (“correction”) versus no transfusion (“no correction”) before PDT.","ICU patients planned bedside PDT with: (i) prothrombin time (PT) 14.7–20.0 seconds, (ii) platelet count 40–100×109/L and/or (iii) active treatment acetylsalicylic acid randomised receive infusion fresh-frozen plasma (FFP) and/or platelets (“correction”) versus transfusion (“no correction”) PDT.",C0021708|C0030705|C1301732|G0000000|C0031740|G0000000|C0021966|C0033706|C0040223|C0699718|G0000000|C0457385|G0000000|C0005821|C0750480|G0000000|G0000000|C0439070|C0205177|C0039798|G0000000|C0001128|G0000000|C1514756|C0574032|C0443224|C0032105|C0016709|G0000000|C0005821|G0000000|G0000000|C0005841|G0000000|G0000000|C0031740
"Inclusion Criteria: Women with a singleton pregnancy, 15+0- 18+6 weeks’ gestation and body mass index ≥30 kg/m2 at first antenatal appointment.","Inclusion Criteria: Women singleton pregnancy, 15+0- 18+6 weeks’ gestation body mass ≥30 kg/m2 antenatal appointment.",C0007637|C0243161|C0043210|C0481462|C0032961|C0450371|C0450371|G0000000|C0032961|C0242821|C0577559|G0000000|C0022718|C2828394|C0003629
"Exception was made for insulin, for which dose modifications occurring >7 days before randomization were accepted or if more recent modifications were not >10% of the total daily dose up to a maximum variation of five units.","Exception insulin, dose modifications occurring >7 days randomization accepted modifications >10% total daily dose maximum variation units.",C1554961|C0021641|C0178602|C0392747|C1709305|G0000000|C0439228|C0034656|C1272684|C0392747|C0450371|C0439175|C0332173|C0178602|C0806909|C0205419|C0439148
"Other eligibility criteria included breast cancer survivors who were also post-menopausal, 40 years of age, and older, ≥1-year post-treatment which included chemotherapy for primary non-metastatic breast cancer, disease-free, and able to understand, speak, read, and write English.","Other eligibility criteria included breast cancer survivors post-menopausal, 40 age, older, ≥1-year post-treatment included chemotherapy primary non-metastatic breast cancer, disease-free, understand, speak, read, write English.",G0000000|C0013893|C0243161|C0332257|C0006141|C0006826|C0206194|C0232970|C0450371|C0001779|C0580836|G0000000|C2709088|C0332257|C0013216|C0205225|C1518422|C0006141|C0006826|C0012634|C0162340|C0234856|C0034754|C0043266|C0376245
This left 57 of 72 practices in the urinary tract infection arm and 56 of 70 practices in the sore throat arm for the main analyses.,This left 57 72 practices urinary tract infection arm 56 70 practices sore throat arm main analyses.,G0000000|C0205091|C0450371|C0450371|C0237607|C0042027|C1185740|C0009450|C0446516|C0450371|C0450371|C0237607|C0234233|C0031354|C0446516|C0205225|C0002778
"Exclusion criteria included substantial cognitive impairment (score < 24 Mini-Mental State Examination, MMSE [15]); history of stroke, encephalitis, traumatic brain injury, brain surgery, dementia, Alzheimer’s disease, or Parkinson’s disease; history of cranial radiation therapy or intrathecal therapy; current active major depression or substance abuse or history of bipolar disorder, psychosis, schizophrenia, or learning disability; history of or current other cancer except for basal cell skin cancer; history of other cognitive training; or uncorrected vision problems (worse than 20/70).","Exclusion criteria included substantial cognitive impairment (score < 24 Mini-Mental State Examination, MMSE [15]); history stroke, encephalitis, traumatic brain injury, brain surgery, dementia, Alzheimer’s disease, Parkinson’s disease; history cranial radiation therapy intrathecal therapy; current active major depression substance abuse history bipolar disorder, psychosis, schizophrenia, learning disability; history current cancer basal cell skin cancer; history cognitive training; uncorrected vision (worse 20/70).",C0680251|C0243161|C0332257|G0000000|C1516691|C0221099|C0449820|G0000000|C0450371|C0445542|C1301808|G0000000|C0451306|C0450371|C0019664|C0038454|C0014038|C0332663|C0006104|C3263722|C0006104|C0038894|C0011265|G0000000|C0012634|G0000000|C0012634|C0019664|C0037303|C0034519|C0039798|C1370196|C0039798|C0521116|C0205177|C0205082|C0011570|C0439861|C0013146|C0019664|C0443156|C0012634|C0033975|C0036341|C0013621|C0231170|C0019664|C0521116|C0006826|C0205112|C0007634|C0444099|C0006826|C0019664|C1516691|C0040607|C4072785|C0042789|C0332271|C0450371
Gastric cancer was diagnosed in the recent 1 month Referring to the Oncology Department affiliated to Babol University of Medical Sciences Physician’s planning on chemotherapy treatment protocol for the patient Informed consent of the patient for participation in the study.,Gastric cancer diagnosed 1 month Referring Oncology Department affiliated Babol University Medical Sciences Physician’s planning chemotherapy treatment protocol patient Informed consent patient participation study.,C0038351|C0006826|C0011900|G0000000|C0332177|C0205543|C0027651|C1704729|C1510825|G0000000|C0041740|C0199168|C0036397|G0000000|C0032074|C0013216|C0039798|C0442711|C0030705|C1522154|C1511481|C0030705|C0679823|C0557651
Exclusion criteria include type I and II diabetes because vitamin E has been shown to affect glucose tolerance [78-82] and diabetic retinopathy may confound the results.,Exclusion criteria type I II diabetes vitamin E affect glucose tolerance [78-82] diabetic retinopathy confound results.,C0680251|C0243161|C0332307|C0021966|G0000000|C0011847|C0042890|G0000000|C0001721|C0017725|C0013220|C0450371|C0241863|C0035309|G0000000|C1274040
"Exclusion criteria were presence of other systemic rheumatologic conditions or, a major communicative disorder.","Exclusion criteria presence systemic rheumatologic conditions or, major communicative disorder.",C0680251|C0243161|C0150312|C0205373|C0035452|C0012634|G0000000|C0205082|C0009452|C0012634
"Similarly, the activity of irinotecan has been established in advanced gastric cancer.","Similarly, activity irinotecan established advanced gastric cancer.",G0000000|C0205177|C0123931|C0443211|C0205179|C0038351|C0006826
"Patients were excluded for prematurity (<34 wk gestation); critical illness on presentation requiring ICU admission for intravenous bronchodilator therapy, noninvasive or invasive ventilation, etc; if they were transferred from another institution; a history of hypersensitivity to magnesium sulfate; a history of neuromuscular, cardiac, or renal disease; underlying structural lung disease; receiving systemic steroid, theophylline, or ipratropium within the prior 72 hr; pneumonic consolidation on chest radiograph at presentation; receipt of intravenous magnesium sulfate prior to randomization; prior participation in this study; or hemodynamic instability.","Patients excluded prematurity (<34 wk gestation); critical illness presentation requiring ICU admission intravenous bronchodilator therapy, noninvasive invasive ventilation, etc; transferred institution; history hypersensitivity magnesium sulfate; history neuromuscular, cardiac, renal disease; underlying structural lung disease; receiving systemic steroid, theophylline, ipratropium prior 72 hr; pneumonic consolidation chest radiograph presentation; receipt intravenous magnesium sulfate prior randomization; prior participation study; hemodynamic instability.",C0030705|C1554077|C0021294|C0450371|C0332174|C0032961|C1511545|C0221423|C0449450|G0000000|C0021708|C0184666|C0348016|C0006280|C0039798|C0205303|C0205281|C0035203|C1548556|C0348011|C0018704|C0019664|C0020517|C0024467|C0038720|C0019664|C1979768|C0018787|C0022646|C0012634|G0000000|C0678594|C0024109|C0012634|C1514756|C0205373|C0038317|C0039771|C0027235|C0332152|G0000000|C0024109|C0702116|C0817096|C1306645|C0449450|G0000000|C0348016|C0024467|C0038720|C0332152|C0034656|C0332152|C0679823|C0557651|C0019010|C1444783
METHODS—Children under the age of 12 months admitted to hospital with acute viral bronchiolitis were randomised to receive either budesonide or placebo (200 µg or one puff twice daily) for the next eight weeks.,METHODS—Children age 12 months admitted hospital acute viral bronchiolitis randomised receive budesonide placebo (200 µg puff daily) weeks.,G0000000|C0001779|C0450371|C0439231|C0184666|C0019994|C0205178|C0521026|C0006271|G0000000|C1514756|C0054201|C0032042|C1442061|G0000000|C1533107|C0332173|C0439230
"The mean (±SD) FEV1 was 92.1±17.1% of the predicted value, but the mean ratio of FEV1 to forced vital capacity (FVC) was 77.0±9.9%, reflecting airflow obstruction.","The (±SD) FEV1 92.1±17.1% predicted value, ratio FEV1 forced vital capacity (FVC) 77.0±9.9%, reflecting airflow obstruction.",G0000000|G0000000|G0000000|G0000000|C0681842|C1522609|C0456603|G0000000|C0441722|C0442732|C1516240|C3714541|G0000000|C0558058|C0231999|C0028778
"Briefly, in 427 participating sites across the United States, Canada, and Puerto Rico, black men aged 50 years or older or all other men aged 55 years or older, who had no history of PCa, and who had a serum prostate-specific antigen (PSA) of 4ng/mL or less and nonsuspicious digital rectal exam were eligible to participate.","Briefly, 427 participating sites United States, Canada, Puerto Rico, black aged 50 aged 55 older, history PCa, serum prostate-specific antigen (PSA) 4ng/mL nonsuspicious digital rectal exam eligible participate.",G0000000|C1442061|C0679823|C0205145|C0166872|C1301808|C0006823|G0000000|G0000000|C0005680|C0001779|C0450371|C0001779|C0450371|C0580836|C0019664|G0000000|C0229671|C0033572|C0003320|C3810537|C0439526|G0000000|C0442015|C0205052|C0582103|C1548635|G0000000
"In conclusion, this study confirms the positive effects of n-3 PUFA supplementation in the treatment of elderly depression.","In conclusion, study confirms positive effects n-3 PUFA supplementation treatment elderly depression.",G0000000|C1707478|C0557651|C0521093|C0439178|C1280500|C0369718|C0032615|C0242297|C0039798|C0001792|C0011570
Non-responding patients received one reminder.,Non-responding patients received reminder.,C1518422|C0030705|C1514756|C1709896
"Of the 132 patients, 67 (50.8%) were males and 109 (82.6%) were white, and the mean age was 55.6 years (range, 18 to 87 years).","Of 132 patients, 67 (50.8%) males 109 (82.6%) white, age 55.6 (range, 18 87 years).",G0000000|C1442061|C0030705|C0450371|C0450371|C0086582|C1442061|C0450371|C0007457|C0001779|C0450371|C1514721|C0450371|C0450371|C0439234
"Nine chronic stroke patients with single unilateral cortical or subcortical lesions (5 women, age range 40-74 years; online only Table) gave written informed consent to participate in the study.","Nine chronic stroke patients single unilateral cortical subcortical lesions (5 women, age range 40-74 years; online Table) written informed consent participate study.",C0205455|C0205191|C0038454|C0030705|C0037179|C0205092|C0001613|C0815275|C0221198|G0000000|C0043210|C0001779|C1514721|C0450371|C0439234|G0000000|C0039224|C0043266|C1522154|C1511481|G0000000|C0557651
Children aged newborn to 17 years inclusive with suspected septic shock.,Children aged newborn 17 inclusive suspected septic shock.,C0008059|C0001779|C0021289|C0450371|C0332257|C0332147|C0333534|C0036974
"Prospective randomized multicenter study involving three hospitals in The Netherlands, including Diakonessenhuis, Utrecht (level 2 traumacenter); Medisch Centrum Haaglanden, The Hague and St. Elisabeth Hospital, Tilburg (both level 1 traumacenters).","Prospective randomized multicenter study involving hospitals The Netherlands, including Diakonessenhuis, Utrecht (level 2 traumacenter); Medisch Centrum Haaglanden, The Hague St. Elisabeth Hospital, Tilburg (both level 1 traumacenters).",C0023981|C0034656|C0439743|C0557651|C1314939|C0019994|G0000000|C0027778|C0332257|G0000000|G0000000|C0441889|G0000000|G0000000|G0000000|C0305578|G0000000|G0000000|G0000000|C0036056|G0000000|C0019994|G0000000|G0000000|C0441889|G0000000|G0000000
"The inclusion criteria specified: age ≧ 60 years; meeting DSM IV criteria for bipolar disorder type I with a current manic, mixed, or hypomanic episode (17) based on the SCID (18); and Young Mania Rating Scale (YMRS)(19) score ≧ 18.","The inclusion criteria specified: age ≧ 60 years; meeting DSM IV criteria bipolar disorder type I current manic, mixed, hypomanic episode (17) based SCID (18); Young Mania Rating Scale (YMRS)(19) score ≧ 18.",G0000000|C0007637|C0243161|C0205369|C0001779|G0000000|C0450371|C0439234|C0556656|G0000000|C0022326|C0243161|C0443156|C0012634|C0332307|C0021966|C0521116|C0338831|C0205430|C0241934|C0332189|C0450371|C1527178|C0085110|C0450371|C0332239|C0338831|C0871208|C0175659|C3640523|C0449820|G0000000|C0450371
"Prior to randomization, all patients were evaluated using cranial computed tomographic (CT) or magnetic resonance imaging (MRI) scanning and were followed with serial neurological examinations to confirm AIS.","Prior randomization, patients evaluated cranial computed tomographic (CT) magnetic resonance imaging (MRI) scanning serial neurological examinations confirm AIS.",C0332152|C0034656|C0030705|C0220825|C0037303|C1441526|C0040395|C0007673|C0024488|C0231881|C0011923|C0024485|C0034606|C0031082|C0205494|C0031809|C0521093|G0000000
Subjects were excluded if 1) acute episode of low back pain (LBP) lasted longer than 6 weeks; 2) pain radiated past the knee; 3) they had a history of previous back surgery; or 4) they had been diagnosed by a physician with a specific cause of LPP.,Subjects excluded 1) acute episode low pain (LBP) lasted 6 weeks; 2) pain radiated knee; 3) history previous surgery; 4) diagnosed physician specific LPP.,C0681850|C1554077|G0000000|C0205178|C0332189|C0205251|C0030193|C1505993|C1517741|G0000000|C0439230|G0000000|C0030193|C0332301|C0022742|G0000000|C0019664|C0205156|C0038894|G0000000|C0011900|C0031831|C0205369|C1416904
Nevertheless we did control for breastfeeding duration in our analyses.,Nevertheless control breastfeeding duration analyses.,G0000000|C0243148|C0006147|C0449238|C0002778
"Study entry criteria were the occurrence of an acute ischemic stroke (between 9 and 36 h after onset) in the MCA territory with a score of at least 12 on the National Institute of Health Stroke Scale (NIHSS), and patient age of at least 18 years.","Study entry criteria occurrence acute ischemic stroke (between 9 36 onset) MCA territory score 12 National Institute Health Stroke Scale (NIHSS), patient age 18 years.",C0557651|C1705654|C0243161|C0243132|C0205178|C0475224|C0038454|G0000000|G0000000|C0450371|C0206132|C0149566|C1301808|C0449820|C0450371|C3245503|C0021622|C0018684|C0038454|C0175659|C3476804|C0030705|C0001779|C0450371|C0439234
The decision to initiation and discontinuation phototherapy was based on 2004 AAP guidelines for management of hyperbilirubinemia in term and near-term newborns.,The decision initiation discontinuation phototherapy based 2004 AAP guidelines management hyperbilirubinemia term near-term newborns.,G0000000|C0679006|C0589507|C0457454|C0031765|C1527178|G0000000|C0054943|C0162791|C0001554|C0020433|C0233324|C0475806|C0021289
"METHODS: Three hundred patients with gallstones or gallbladder polyps were admitted to two clinical centers from January 2013 to January 2014 and were randomized into three groups of 100: single-incision three-device group, X-Cone group, and conventional group.","METHODS: Three patients gallstones gallbladder polyps admitted clinical centers January 2013 January 2014 randomized 100: single-incision three-device group, X-Cone group, conventional group.",C0025663|C0205449|C0030705|C0008350|C0016976|C0032584|C0184666|C0205210|C0205099|C3829466|G0000000|C3829466|G0000000|C0034656|C1442061|C0037179|C0205449|C0441833|C0206428|C0441833|C0439858|C0441833
"Funding/Support: The study was funded by grants HL098102, HL098096, HL098075, HL098090, HL098177, HL098098, HL098107, HL098112, HL098103, HL098115, TR001082, TR000439, TR000448, and TR000454 from the National Heart, Lung, and Blood Institute (NHLBI) as part of AsthmaNet, a clinical trials network supported by a cooperative agreement with NHLBI.","Funding/Support: The study funded grants HL098102, HL098096, HL098075, HL098090, HL098177, HL098098, HL098107, HL098112, HL098103, HL098115, TR001082, TR000439, TR000448, TR000454 National Heart, Lung, Blood Institute (NHLBI) AsthmaNet, clinical trials network supported cooperative agreement NHLBI.",C0243098|G0000000|C0557651|C0016820|C0018173|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|C3245503|C0018787|C0024109|C0005767|C0021622|C1955970|G0000000|C0205210|C0008976|C0150775|C1521721|C0679729|C0680240|C1955970
"Additional eligibility criteria included: consented at or before 20 weeks gestation, available for a 24 month intervention, planned to carry their pregnancy to term and keep their baby, read and understood English, and had a valid email address.","Additional eligibility criteria included: consented 20 weeks gestation, 24 month intervention, planned carry pregnancy term baby, read understood English, valid email address.",C1524062|C0013893|C0243161|C0332257|C2711213|C0450371|C0439230|C0032961|C0450371|C0332177|C0886296|C1301732|C0206243|C0032961|C0233324|C0021270|C0034754|C0162340|C0376245|C2349099|C0013849|C0376649
The present study focuses primarily on the students with active consents.,The study focuses students active consents.,G0000000|C0557651|C0205234|C0038492|C0205177|C1511481
"All participants were community-dwelling older adults, meeting the MCI criteria according to Petersen et al.30,31 They were aged 60 or over; had a Mini-Mental Status Examination32 (MMSE) score >24; reported a subjective memory complaint, preferably corroborated by an informant; performed at/or below 1.5 standard deviations (SDs) from the mean for age and education on more than one of the neuropsychological tests; had preserved or minimal impairments in functional abilities and absence of dementia.","All participants community-dwelling adults, meeting MCI criteria Petersen al.30,31 They aged 60 over; Mini-Mental Status Examination32 (MMSE) score >24; reported subjective memory complaint, preferably corroborated informant; performed at/or 1.5 standard deviations (SDs) age education neuropsychological tests; preserved minimal impairments functional abilities absence dementia.",G0000000|C0679646|C4045975|C0001675|C0556656|C0560005|C0243161|G0000000|C0202311|G0000000|C0001779|C0450371|C0205136|C0445542|C0449438|G0000000|C0451306|C0449820|C0450371|C0684224|C0439655|C0025260|C0277786|G0000000|G0000000|C1550484|C0884358|G0000000|G0000000|C1442989|C0012727|C3813719|C0001779|C0013621|G0000000|C0022885|C0033085|C0547040|C0684336|C0205245|C0085732|C0332197|C0011265
Sufficient understanding of English to follow class instructions and complete surveys was required.,Sufficient understanding English follow class instructions complete surveys required.,C0205410|C0162340|C0376245|C0332283|C0456387|C0302828|C0205197|C0038951|C1514873
"To reflect the heterogeneity of children who are congenitally deaf and prelingual, the only exclusion criterion was children who were not at a prelinguistic stage of development and could produce more than 50 signed/spoken words as reported by the parent on the Vineland Adaptive Behavior Scales (Sparrow, Balla, & Cicchetti, 1984).","To reflect heterogeneity children congenitally deaf prelingual, exclusion criterion children prelinguistic stage development produce 50 signed/spoken reported parent Vineland Adaptive Behavior Scales (Sparrow, Balla, & Cicchetti, 1984).",C0040363|C0558058|C0019409|C0008059|G0000000|C0525064|G0000000|C0680251|C0243161|C0008059|G0000000|C0205390|C0243107|G0000000|C0450371|C1519316|C0684224|C0030551|C0332020|C0231193|C0004927|C0175659|C0326914|G0000000|G0000000|G0000000|G0000000
"Patient who were found to have both a 4% oxygen desaturation index (4% ODI) ≥5 hour−1 and typical symptoms of sleep apnoea [Epworth Sleepiness Scale (ESS) >10 points] (14) or a 4% ODI greater than 15 hour−1 were invited for CPAP treatment and issued with an autoset CPAP device (APAP, S8/S9, ResMed Ltd, Sydney, Australia) for home use.","Patient 4% oxygen desaturation (4% ODI) ≥5 hour−1 typical symptoms sleep apnoea [Epworth Sleepiness Scale (ESS) >10 points] (14) 4% ODI 15 hour−1 invited CPAP treatment issued autoset CPAP device (APAP, S8/S9, ResMed Ltd, Sydney, Australia) use.",C0030705|G0000000|C0030054|C0746961|G0000000|G0000000|G0000000|G0000000|C3538928|C0683368|C0037313|C0003578|G0000000|C0013144|C0175659|C0206630|C0450371|C1552961|C0450371|G0000000|G0000000|C0450371|G0000000|G0000000|C0199451|C0039798|C0033213|G0000000|C0199451|C0025080|C0000970|C1519428|G0000000|C1136140|G0000000|C0004340|C0042153
"Patients on home oxygen or with raised carbon dioxide tension (>44 mm Hg), α1‐antitrypsin deficiency, recent exacerbation (in the last 4 weeks), uncontrolled medical condition or hypersensitivity to inhaled corticosteroids and bronchodilators were not eligible for the study.","Patients oxygen raised carbon dioxide tension (>44 mm Hg), α1‐antitrypsin deficiency, exacerbation (in 4 weeks), uncontrolled medical condition hypersensitivity inhaled corticosteroids bronchodilators eligible study.",C0030705|C0030054|C0442818|C0007009|C0678717|C0233494|G0000000|G0000000|C0011155|G0000000|G0000000|G0000000|C0205318|C0199168|C0012634|C0020517|C0004048|C0001617|C0006280|C1548635|C0557651
"SB diagnosis was confirmed if subjects met the standard polysomnographic research criteria (> 4 episodes of RMMA/hour of sleep) in the second night of sleep recording.22 The experimental protocol was approved by the research ethics board of the Hôpital du Sacré-Coeur, Montreal.","SB diagnosis confirmed subjects met standard polysomnographic criteria (> 4 episodes RMMA/hour sleep) night sleep recording.22 The experimental protocol approved ethics board Hôpital du Sacré-Coeur, Montreal.",C0038111|C0011900|C0521093|C0681850|C0268621|C1442989|G0000000|C0243161|G0000000|G0000000|C0332189|C0439227|C0037313|C0240526|C0037313|C0450371|G0000000|C1517586|C0442711|C0205540|C0015000|C0972401|G0000000|C0011535|G0000000|G0000000
Richmond Agitation Sedation Scale (RASS) [15] score ≥ 2) required such a high dose of sedative medication that extubation was not possible.,Richmond Agitation Sedation Scale (RASS) [15] score ≥ 2) required dose sedative medication extubation possible.,G0000000|C0085631|C0235195|C0175659|C0034678|C0450371|C0449820|G0000000|G0000000|C1514873|C0178602|C0020592|C0013227|C0553891|C0332149
Treatment was repeated every 8 weeks for a total of six courses.,Treatment repeated 8 weeks total courses.,C0039798|C0205341|G0000000|C0439230|C0439175|C0750729
Those diagnosed with P. vivax infection were asked to participate in the study following informed consent and if they met the inclusion and exclusion criteria.,Those diagnosed P. vivax infection participate study informed consent met inclusion exclusion criteria.,G0000000|C0011900|C0369773|G0000000|C0009450|G0000000|C0557651|C1522154|C1511481|C0268621|C0007637|C0680251|C0243161
Prevalence of trachomatous inflammation—follicular (TF) in children aged 0–5 years in communities randomized to standard (A) or enhanced (B) coverage.,Prevalence trachomatous inflammation—follicular (TF) children aged 0–5 communities randomized standard (A) enhanced (B) coverage.,C0033105|C0040592|G0000000|C4048299|C0008059|C0001779|G0000000|C0009462|C0034656|C1442989|G0000000|C2349975|G0000000|C1551362
"The majority (56%) lived in informal settlements, and all attended public health facilities.","The majority (56%) lived informal settlements, attended public health facilities.",G0000000|C0680220|C0450371|C1548795|G0000000|G0000000|C1456498|G0000000|C0018684|C1547538
This study aimed to evaluate Iyengar yoga therapy on chronic low back pain.,This study aimed evaluate Iyengar yoga therapy chronic low pain.,G0000000|C0557651|C1947946|C0220825|G0000000|C0043418|C0039798|C0205191|C0205251|C0030193
To assess the efficacy of an intervention that includes the assistance of a smoking cessation smartphone application targeted to young people aged 18 to 30 years who are motivated to stop smoking.,To assess efficacy intervention includes assistance smoking cessation smartphone application targeted people aged 18 30 motivated smoking.,C0040363|C1516048|C1280519|C0886296|C0332257|C0018896|C0037369|C1880019|C3204335|C0185125|C1521840|C0027361|C0001779|C0450371|C0450371|G0000000|C0037369
Metastatic melanoma is a highly aggressive disease with few treatment options and relatively short survival.,Metastatic melanoma highly aggressive disease treatment options short survival.,C0036525|C0025202|C0205250|C0001807|C0012634|C0039798|C1518601|C1282927|C0038952
Exclusion criteria were a prior history of asthma; use of intravenous or oral corticosteroids and/or antibiotics for an exacerbation three weeks before inclusion; other relevant lung or liver diseases at the discretion of the treating physician; pregnancy or lactation; use of macrolides in the last six weeks prior to inclusion; allergy or intolerance to macrolides; or use of other investigational medication started two months prior to inclusion.,Exclusion criteria prior history asthma; intravenous oral corticosteroids and/or antibiotics exacerbation weeks inclusion; relevant lung liver diseases discretion treating physician; pregnancy lactation; macrolides weeks prior inclusion; allergy intolerance macrolides; investigational medication started months prior inclusion.,C0680251|C0243161|C0332152|C0019664|C0004096|C0348016|C0442027|C0001617|G0000000|C0003232|G0000000|C0439230|C0007637|C2347946|C0024109|C0023884|C0012634|G0000000|C1522326|C0031831|C0032961|C0006147|C0003240|C0439230|C0332152|C0007637|C0002111|C0231199|C0003240|C1517586|C0013227|C1272689|C0439231|C0332152|C0007637
"Characteristics of children enrolled by study zones, The Gambia* Impact of the intervention on malarial indices in children 6 months to 10 years of age, The Gambia* Data on risk factors were available for > 94% of children for both years of the study.","Characteristics children enrolled study zones, The Gambia* Impact intervention malarial indices children 6 months 10 age, The Gambia* Data risk factors > 94% children study.",C1521970|C0008059|G0000000|C0557651|C1710706|G0000000|C0016993|C1825598|C0886296|C0024530|C4033634|C0008059|G0000000|C0439231|C0450371|C0001779|G0000000|C0016993|C1511726|C0035647|C1521761|G0000000|C0450371|C0008059|C0557651
"The average age was 68.40 ± 7.45 years (range, 49–79 years) and the forced expiratory volume 1 (FEV1) (% predicted) value was 44.46 ± 12.00%.","The average age 68.40 ± 7.45 (range, 49–79 years) forced expiratory volume 1 (FEV1) (% predicted) 44.46 ± 12.00%.",G0000000|C1510992|C0001779|C0450371|G0000000|C0450371|C1514721|G0000000|C0439234|C0441722|C0231800|C0449468|G0000000|G0000000|G0000000|C0681842|C0450371|G0000000|C0450371
"Women will be excluded from the study if they: are diagnosed with GDM on oral glucose tolerance testing, before randomization, using IADPSG criteria defined as fasting venous plasma glucose ≥ 5.1 mmol/l and/or 1 hour glucose ≥10 mmol/l and/or 2 hour glucose ≥ 8.5 mmol/l at baseline measurement [18]; have pre-existing diabetes; are not able to walk at least 100 meter safely; require complex diets; have chronic medical conditions (e.g.","Women excluded study they: diagnosed GDM oral glucose tolerance testing, randomization, IADPSG criteria defined fasting venous plasma glucose ≥ 5.1 mmol/l and/or 1 hour glucose ≥10 mmol/l and/or 2 hour glucose ≥ 8.5 mmol/l baseline measurement [18]; pre-existing diabetes; walk 100 meter safely; require complex diets; chronic medical conditions (e.g.",C0043210|C1554077|C0557651|G0000000|C0011900|C0085207|C0442027|C0017725|C0013220|C0039593|C0034656|G0000000|C0243161|C1704788|C0015663|C0042449|C0032105|C0017725|G0000000|G0000000|C1532563|G0000000|G0000000|C0439227|C0017725|G0000000|C1532563|G0000000|G0000000|C0439227|C0017725|G0000000|G0000000|C1532563|C0168634|C0242485|C0450371|C2347662|C0011847|C0080331|C1442061|C0475209|G0000000|G0000000|C0439855|C0012155|C0205191|C0199168|C0012634|G0000000
"The study was designed as a single blinded, cluster randomised, controlled trial involving 12,765 12–13-year-old children attending all 65 state Secondary schools in Lothian and Fife during the academic year 2003/4.","The study designed single blinded, cluster randomised, controlled trial involving 12,765 12–13-year-old children attending 65 Secondary schools Lothian Fife academic 2003/4.",G0000000|C0557651|C1707689|C0037179|C0150108|C1555715|G0000000|C2587213|C0008976|C1314939|C0450371|G0000000|C0008059|C1547429|C0450371|C0027627|C0036375|C0454912|C0454909|C1510747|G0000000
This electronic health record–based intervention improved smoking status documentation and increased counseling assistance to smokers but not the prescription of cessation medication.,This electronic health record–based intervention improved smoking status documentation increased counseling assistance smokers prescription cessation medication.,G0000000|C0013850|C0018684|G0000000|C0886296|C0184511|C0037369|C0449438|C0175636|C0205217|C0010210|C0018896|C0337664|C0033080|C1880019|C0013227
"The combined list size of study practices was 55,687, of whom 6095 patients were aged 5–14 years of whom 1157 (19%) had a recorded diagnosis of asthma.","The combined list size study practices 55,687, 6095 patients aged 5–14 1157 (19%) recorded diagnosis asthma.",G0000000|C0205195|C0745732|C0456389|C0557651|C0237607|C0450371|G0000000|C0030705|C0001779|G0000000|G0000000|C0450371|C0034869|C0011900|C0004096
"Eligibility criteria included age of 18 to 75 years; confirmed UC with disease extent (proctitis to pancolitis) confirmed by endoscopy or radiography within 24 months before the baseline visit; and mildly to moderately active disease at entry, with a physician’s global assessment (PGA) score of 1 or 2 at baseline (7,8,12).","Eligibility criteria included age 18 75 years; confirmed UC disease extent (proctitis pancolitis) confirmed endoscopy radiography 24 months baseline visit; mildly moderately active disease entry, physician’s global assessment (PGA) score 1 2 baseline (7,8,12).",C0013893|C0243161|C0332257|C0001779|C0450371|C0450371|C0439234|C0521093|G0000000|C0012634|C0439792|C0033246|C0868908|C0521093|C0014245|C0034571|C0450371|C0439231|C0168634|C0545082|C0750532|C0205081|C0205177|C0012634|C1705654|G0000000|C0205246|C1261322|C3541266|C0449820|G0000000|G0000000|C0168634|C0450371
"Patients with an admission diagnosis of TBI admitted to the ICUs of two university-affiliated trauma centres in Australia within 72 hours of injury were screened to meet the following inclusion criteria: (i) age > 18 and < 65 years; (ii) non-penetrating TBI, defined by a brain injury due to mechanical forces and the presence of haemorrhage, contusion, swelling, compression of basal cisterns or herniation on cerebral CT scan; (iii) requirement for mechanical ventilation (iv) serum alanine transferase level < 100 iU/l.","Patients admission diagnosis TBI admitted ICUs university-affiliated trauma centres Australia 72 hours injury screened meet inclusion criteria: (i) age > 18 < 65 years; (ii) non-penetrating TBI, defined brain injury mechanical forces presence haemorrhage, contusion, swelling, compression basal cisterns herniation cerebral CT scan; (iii) requirement mechanical ventilation (iv) serum alanine transferase level < 100 iU/l.",C0030705|C0184666|C0011900|C0876926|C0184666|C0021708|C0041740|C0043251|C0205099|C0004340|C0450371|C0439227|C3263722|C0220908|C1550543|C0007637|C0243161|C0021966|C0001779|G0000000|C0450371|G0000000|C0450371|C0439234|G0000000|C1518422|C0876926|C1704788|C0006104|C3263722|C0443254|C0441722|C0150312|C0019080|C0009938|C0013604|C0332459|C0205112|C1185718|C0019270|G0000000|C0007673|C0034606|C0439070|C1514873|C0443254|C0035203|C0022326|C0229671|C0001898|C0040676|C0441889|G0000000|C1442061|C0439457
"CONSORT flow diagram Participants met the following inclusion criteria: (a) met research criteria for a diagnosis of autism, Asperger syndrome, or PDD-NOS (see below); (b) met research criteria for one of the following anxiety disorders: separation anxiety disorder (SAD), social phobia, or obsessive compulsive disorder (OCD) (see below);1 (c) were not taking any psychiatric medication at the baseline assessment, or were taking a stable dose of psychiatric medication (i.e., at least one month at the same dosage prior to the baseline assessment), and (d) if medication was being used, children maintained the same dosage throughout the study.","CONSORT flow diagram Participants met inclusion criteria: (a) met criteria diagnosis autism, Asperger syndrome, PDD-NOS (see below); (b) met criteria anxiety disorders: separation anxiety disorder (SAD), social phobia, obsessive compulsive disorder (OCD) (see below);1 (c) psychiatric medication baseline assessment, stable dose psychiatric medication (i.e., month dosage prior baseline assessment), (d) medication used, children maintained dosage study.",G0000000|C0806140|C0681494|C0679646|C0268621|C0007637|C0243161|G0000000|C0268621|C0243161|C0011900|C0004352|G0000000|C0039082|C0008838|C0042789|G0000000|G0000000|C0268621|C0243161|C0003467|C0012634|C0036679|C0003467|C0012634|C3536794|C0728831|C0349231|G0000000|G0000000|C0012634|C0028768|C0042789|G0000000|G0000000|C0205487|C0013227|C0168634|C1261322|C0205360|C0178602|C0205487|C0013227|C0683454|C0332177|C0178602|C0332152|C0168634|C1261322|C0073187|C0013227|C1273517|C0008059|C1314677|C0178602|C0557651
Unfavorable oral health behaviors are defined as “brush teeth less often than twice a day” and/or “snack three times or more a day”.,Unfavorable oral health behaviors defined “brush teeth day” and/or “snack times day”.,C3640815|C0442027|C0018684|C0004927|C1704788|G0000000|C0040426|G0000000|G0000000|G0000000|C0040223|G0000000
"This adjustment was made based on the DSM-IV field trial which found that the use of the seven years of age criterion diminished the reliability of clinical diagnosis.21 Further, data suggests that late-onset ADHD (in which individuals meet all DSM-IV ADHD criteria with the exception of age of onset), especially when the age of onset is no later than age 12, have similar patterns of functional impairment and psychiatric comorbidity as individuals meeting all criteria for childhood-onset ADHD.22,23 Participants were therefore included if symptoms of ADHD were present prior to the age of 12.","This adjustment based DSM-IV field trial age criterion diminished reliability clinical diagnosis.21 Further, data suggests late-onset ADHD (in individuals meet DSM-IV ADHD criteria exception age onset), age onset age 12, patterns functional impairment psychiatric comorbidity individuals meeting criteria childhood-onset ADHD.22,23 Participants included symptoms ADHD prior age 12.",G0000000|C0376209|C1527178|C0220952|C0440042|C0008976|C0001779|C0243161|C0205216|C2347947|C0205210|C0011900|C1517331|C1511726|C1705535|C4025592|C1263846|G0000000|C0027361|C1550543|C0220952|C1263846|C0243161|C1554961|C0001779|C0206132|C0001779|C0206132|C0001779|C0450371|C0449774|C0205245|C0221099|C0205487|C0009488|C0027361|C0556656|C0243161|C1837352|C1263846|C0679646|C0332257|C0683368|C1263846|C0332152|C0001779|C0450371
"Exclusion criteria were presence of major congenital malformations, inherited disorders of metabolism and necessity of primary intubation within the first 15 minutes after birth.","Exclusion criteria presence major congenital malformations, inherited disorders metabolism necessity primary intubation 15 minutes birth.",C0680251|C0243161|C0150312|C0205082|C0009678|C0000768|C0439660|C0012634|C0025519|G0000000|C0205225|C0021925|C0450371|C0439232|C0005615
The most common adverse effect was hypokinesia (3 patients in the lorazepam + haloperidol group [19%] and 4 patients in the placebo + haloperidol group [27%]).,The common adverse hypokinesia (3 patients lorazepam + haloperidol [19%] 4 patients placebo + haloperidol [27%]).,G0000000|C0205214|G0000000|C0086439|G0000000|C0030705|C0024002|G0000000|C0018546|C0450371|G0000000|C0030705|C0032042|G0000000|C0018546|C0450371
About half of the students were female.,About half students female.,G0000000|C2825407|C0038492|C0015780
"Extremely premature (birth weight < 1250 g) infants are at high risk for acquiring late-onset sepsis and necrotizing enterocolitis, which are associated with significant mortality and morbidity.","Extremely premature (birth weight < 1250 g) infants risk acquiring late-onset sepsis necrotizing enterocolitis, mortality morbidity.",C0205403|C0151526|C0005615|G0000000|C0439267|C0021270|C0035647|C0439661|C4025592|C0036690|C0439664|C0014356|C0026565|C0026538
At least 30 Gy was delivered to residual masses or sites of original bulky disease (mediastinal mass ratio > one third) at presentation.,At 30 Gy delivered residual masses sites original bulky disease (mediastinal mass ratio > third) presentation.,G0000000|C0450371|C0018408|C1705822|C1609982|C0577559|C0205145|C0205313|C0012173|C0012634|C0025066|C0577559|C0456603|G0000000|C0205437|C0449450
Spirometry is the recommended method of testing pulmonary function to detect restricted respiratory flow in smokers susceptible to chronic obstructive pulmonary disease (COPD) [15].,Spirometry recommended method testing pulmonary function detect restricted respiratory flow smokers susceptible chronic obstructive pulmonary disease (COPD) [15].,C0037981|C0034866|C0025663|C0039593|C0024109|C0031843|C0442726|C0443288|C0521346|C0806140|C0337664|C0220898|C0205191|C0549186|C0024109|C0012634|C0024117|C0450371
We excluded children with established intravenous lines or those who had received anticonvulsants before admission.,We excluded children established intravenous lines received anticonvulsants admission.,G0000000|C1554077|C0008059|C0443211|C0348016|C0205132|C1514756|C0003286|C0184666
"The inclusion criteria were as follows: confirmed COPD diagnosis registered in the patient’s clinical record, clinical assistance at primary care centres in the Malaga area, prescription of scheduled inhalation therapy and written informed consent.","The inclusion criteria follows: confirmed COPD diagnosis registered patient’s clinical record, clinical assistance primary care centres Malaga area, prescription scheduled inhalation therapy written informed consent.",G0000000|C0007637|C0243161|C0332283|C0521093|C0024117|C0011900|C1514821|G0000000|C0205210|C0034869|C0205210|C0018896|C0205225|C1947933|C0205099|G0000000|C0017446|C0033080|C0086960|C0004048|C0039798|C0043266|C1522154|C1511481
Heads of the households were selected to be trained on the proper use of LLITN.,Heads households selected trained proper LLITN.,C0018670|C0020052|C1707391|C0336809|G0000000|G0000000
"Exclusion criteria were uncontrolled or untreatable systemic opportunistic infection, severe cerebral palsy, obvious dysmorphic features, general mental health problems, or participation in other clinical trials.","Exclusion criteria uncontrolled untreatable systemic opportunistic infection, severe cerebral palsy, obvious dysmorphic features, mental health problems, participation clinical trials.",C0680251|C0243161|C0205318|G0000000|C0205373|G0000000|C0009450|C0205082|G0000000|C0522224|G0000000|C0000768|C1521970|C0229992|C0018684|C1546466|C0679823|C0205210|C0008976
"Participants were also excluded if they had a diagnosable eating disorder or were taking any medications or dietary supplements (including CrPic) that could influence appetite, hunger, or satiety.","Participants excluded diagnosable eating disorder medications dietary supplements (including CrPic) influence appetite, hunger, satiety.",C0679646|C1554077|G0000000|C0013470|C0012634|C0013227|C0012155|C0242295|C0332257|G0000000|C4054723|C0003618|C0020175|C0036239
"With regard to preventive health measures, exclusive breastfeeding in children aged 2–6 months was reported by 11% of mothers from intervention and 15% of mothers from comparison divisions (P = 0.62).","With regard preventive health measures, exclusive breastfeeding children aged 2–6 months reported 11% mothers intervention 15% mothers comparison divisions (P = 0.62).",G0000000|G0000000|C0445202|C0018684|C0079809|C1548966|C0006147|C0008059|C0001779|G0000000|C0439231|C0684224|C0450371|C0026591|C0886296|C0450371|C0026591|C1707455|C0152060|C0369773|G0000000|C0450371
"Recipients were excluded from the study if they had a previous history of skin cancer as self-reported or noted in their medical record, received education about sun protection or participated in our previous educational sun protection study, experienced kidney rejection, if they were visually impaired, or comorbid diseases prevented participation.","Recipients excluded study previous history skin cancer self-reported medical record, received education sun protection participated previous educational sun protection study, experienced kidney rejection, visually impaired, comorbid diseases prevented participation.",C1709854|C1554077|C0557651|C0205156|C0019664|C0444099|C0006826|C0681906|C0199168|C0034869|C1514756|C0013621|C0038817|C1545588|G0000000|C0205156|C0587721|C0038817|C1545588|C0557651|C0237607|C0022646|C0035015|G0000000|C0221099|C0009488|C0012634|C0309872|C0679823
"Eligibility criteria included age between 21 and 75 years, completion of breast cancer treatment (Stage 0–III) at least 3 months prior (with the possible exception of ongoing hormonal therapies such as tamoxifen or aromatase inhibitors), and a body mass index (BMI) ≥ 24 kg/m2 (or ≥23 kg/m2 if of Asian descent).","Eligibility criteria included age 21 75 years, completion breast cancer treatment (Stage 0–III) 3 months prior (with exception ongoing hormonal therapies tamoxifen aromatase inhibitors), body mass (BMI) ≥ 24 kg/m2 (or ≥23 kg/m2 Asian descent).",C0013893|C0243161|C0332257|C0001779|C0450371|C0450371|C0439234|C0205197|C0006141|C0006826|C0039798|C0205390|G0000000|G0000000|C0439231|C0332152|G0000000|C1554961|C0549178|C0458083|C0087111|C0039286|C0003805|C0243077|C0242821|C0577559|G0000000|G0000000|C0450371|C0022718|G0000000|G0000000|C0022718|C0078988|C0205386
Vietnamese American women aged 18 years or older who lived in Santa Clara County were eligible to participate.,Vietnamese American women aged 18 lived Santa Clara County eligible participate.,C0042660|C0596070|C0043210|C0001779|C0450371|C1548795|G0000000|G0000000|C0079170|C1548635|G0000000
All patients had undergone neck dissection for cancer; expressed complaints of pain and/or dysfunction in the neck and/or shoulders that the investigator attributed to neck dissection; were at least 3 months since neck dissection and radiation; and had moderate or severe pain and dysfunction (Constant-Murley score ≤ 70).,All patients undergone neck dissection cancer; expressed complaints pain and/or dysfunction neck and/or shoulders investigator attributed neck dissection; 3 months neck dissection radiation; moderate severe pain dysfunction (Constant-Murley score ≤ 70).,G0000000|C0030705|G0000000|C0027530|C0012737|C0006826|G0000000|C0277786|C0030193|G0000000|C0031847|C0027530|G0000000|C0037004|C0035173|C0449234|C0027530|C0012737|G0000000|C0439231|C0027530|C0012737|C0034519|C0205081|C0205082|C0030193|C0031847|C1547014|C0449820|G0000000|C0450371
"During a 12-month period, 30 patients with episodes of fever and granulocytopenia were enrolled in this study.","During 12-month period, 30 patients episodes fever granulocytopenia enrolled study.",G0000000|C0450371|C0439531|C0450371|C0030705|C0332189|C0015967|C0001824|G0000000|C0557651
"Ninety three children, aged between 2-14 years, with American Society of Anesthesiologists (ASA) physical status I-II, who were scheduled to undergo an adenotonsillectomy (or adenoidectomy) under general anesthesia, were enrolled this study.","Ninety children, aged 2-14 years, American Society Anesthesiologists (ASA) physical status I-II, scheduled undergo adenotonsillectomy (or adenoidectomy) anesthesia, enrolled study.",C3816959|C0008059|C0001779|C0450371|C0439234|C0596070|C0037455|C0334910|C0004057|C0031809|C0449438|C0021966|C0086960|G0000000|C0193959|G0000000|C0001425|C0002903|G0000000|C0557651
The study was conducted on stroke patients who were diagnosed as unilateral spatial neglect through the line bisection test or star cancellation test out of those admitted to the Department of Rehabilitation from September 2008 to October 2009.,The study conducted stroke patients diagnosed unilateral spatial neglect bisection test star cancellation test admitted Department Rehabilitation September 2008 October 2009.,G0000000|C0557651|C0004927|C0038454|C0030705|C0011900|C0205092|C1428114|C0521874|C0184905|C0022885|C0995242|C0205544|C0022885|C0184666|C1704729|C0034991|C3828193|G0000000|C3828732|G0000000
"For LRTI15,17 patients made their first consultation for the current episode of cough (duration less than 4 weeks) regarded by the physician to be caused by an acute LRTI with at least 1 of following 4 focal signs and symptoms: (1) shortness of breath, (2) wheezing, (3) chest pain, and (4) auscultation abnormalities.","For LRTI15,17 patients consultation current episode cough (duration 4 weeks) regarded physician caused acute LRTI 1 4 focal signs symptoms: (1) shortness breath, (2) wheezing, (3) chest pain, (4) auscultation abnormalities.",G0000000|C0450371|C0030705|C0009818|C0521116|C0332189|C0010200|C0449238|G0000000|C0439230|G0000000|C0031831|C0015127|C0205178|C0149725|G0000000|G0000000|C0205234|C0220912|C0683368|G0000000|C1282927|C0225386|G0000000|C0043144|G0000000|C0817096|C0030193|G0000000|C0004339|C0000768
"We examined the effect on 3 behavioral risk factors for heart disease and diabetes (low fruit and vegetable consumption, low physical activity, and cigarette smoking) of an intervention in an African American community in North Carolina.","We examined 3 behavioral risk factors heart disease diabetes (low fruit vegetable consumption, low physical activity, cigarette smoking) intervention African American community North Carolina.",G0000000|C0332128|G0000000|C0004927|C0035647|C1521761|C0018787|C0012634|C0011847|C0205251|C0016767|C0042440|C0009830|C0205251|C0031809|C0205177|C0677453|C0037369|C0886296|C0027567|C0596070|C0009462|C1709269|G0000000
Infants born from this time until January 2006 were also eligible for the trial when they reached 1 mo of age.,Infants born time January 2006 eligible trial reached 1 mo age.,C0021270|C0005615|C0040223|C3829466|G0000000|C1548635|C0008976|C2584321|G0000000|C0026544|C0001779
"The investigation was designed as a double-blind, randomized, multi-institutional clinical trial to compare the effect of the common food additive carrageenan on the interval to relapse in adult patients with biopsy-proven ulcerative colitis (UC) in clinical remission for at least one month prior to study entry.","The investigation designed double-blind, randomized, multi-institutional clinical trial compare common food additive carrageenan interval relapse adult patients biopsy-proven ulcerative colitis (UC) clinical remission month prior study entry.",G0000000|C0220825|C1707689|C0013072|C0034656|C0439064|C0205210|C0008976|C1707455|C0205214|C0016452|C0442796|C0007289|C1272706|C0035020|C0001675|C0030705|C0005558|C0041582|C0009319|G0000000|C0205210|C0544452|C0332177|C0332152|C0557651|C1705654
"Exclusion criteria were 1) other rheumatic disease, such as juvenile arthritis or lupus; 2) documented developmental delay; 3) current panic disorder or major depression, or lifetime bipolar disorder or psychosis; and 4) use of opioids.","Exclusion criteria 1) rheumatic disease, juvenile arthritis lupus; 2) documented developmental delay; 3) current panic disorder major depression, lifetime bipolar disorder psychosis; 4) opioids.",C0680251|C0243161|G0000000|G0000000|C0012634|C3146221|C0003864|C0024131|G0000000|C1301725|C0458003|C0205421|G0000000|C0521116|C0030318|C0012634|C0205082|C0011570|C4071830|C0443156|C0012634|C0033975|G0000000|C0242402
"Participants: motivated smokers of 10 or more cigarettes per day, aged 18 to 30 years, consulting PHCCs for any reason and who provide written informed consent to participate in the trial.","Participants: motivated smokers 10 cigarettes day, aged 18 30 years, consulting PHCCs reason provide written informed consent participate trial.",C0679646|G0000000|C0337664|C0450371|C0677453|C0332173|C0001779|C0450371|C0450371|C0439234|C0009818|G0000000|C0392360|C1999230|C0043266|C1522154|C1511481|G0000000|C0008976
"24 MS subjects (EDSS 4.89 ± 0.54, 17 female and 7 male, 52.58 ± 11.21 years, MS duration 15.21 ± 8.68 years) have been enrolled and randomly assigned to 2 treatment groups: (i) experimental group received 10 TOCT sessions over 2 weeks (2 hours/each session) followed by a 3 months home exercise program, whereas control group did not receive any specific rehabilitation intervention.","24 MS subjects (EDSS 4.89 ± 0.54, 17 female 7 male, 52.58 ± 11.21 years, MS duration 15.21 ± 8.68 years) enrolled randomly assigned 2 treatment groups: (i) experimental received 10 TOCT sessions 2 weeks (2 hours/each session) 3 months exercise program, control receive specific rehabilitation intervention.",C0450371|C0039676|C0681850|C0451246|G0000000|C0450371|C0015780|G0000000|C0086582|G0000000|C0439234|C0039676|C0449238|G0000000|C0439234|G0000000|G0000000|C1516050|G0000000|C0039798|C0441833|C0021966|C1517586|C1514756|C0450371|G0000000|C1883016|G0000000|C0439230|G0000000|C0439227|C1883016|G0000000|C0439231|C0015259|C1709697|C0243148|C1514756|C0205369|C0034991|C0886296
"They could not be hospitalized (unless discharge was expected within 10 days); be receiving chronic oxygen therapy or any ventilatory support; have significant congenital heart disease; have evidence of infection with hepatitis A, B, or C virus or HIV; have any acute illness, including acute RSV infection; known renal impairment, hepatic dysfunction, chronic seizure disorder, or immunodeficiency; have suspected serious allergic or immune-mediated events in association with prior receipt of immunoglobulins, blood products, or other foreign proteins; have received within the past 120 days or currently be receiving immunoglobulin products, palivizumab, or any investigational agent.","They hospitalized (unless discharge expected 10 days); receiving chronic oxygen therapy ventilatory support; congenital heart disease; evidence infection hepatitis A, B, C virus HIV; acute illness, including acute RSV infection; renal impairment, hepatic dysfunction, chronic seizure disorder, immunodeficiency; suspected allergic immune-mediated events association prior receipt immunoglobulins, blood products, foreign proteins; received 120 days receiving immunoglobulin products, palivizumab, investigational agent.",G0000000|C0701159|G0000000|C0012621|C1517001|C0450371|C0439228|C1514756|C0205191|C0030054|C0039798|G0000000|C0183683|C0009678|C0018787|C0012634|C3887511|C0009450|C0019158|G0000000|G0000000|G0000000|C0042776|C0019682|C0205178|C0221423|C0332257|C0205178|G0000000|C0009450|C0022646|C0221099|C0205054|C0031847|C0205191|C0036572|C0012634|C0021051|C0332147|C0700624|C0439662|C0441471|C0004083|C0332152|G0000000|C0021027|C0005767|C1514468|C0376327|C0033684|C1514756|C1442061|C0439228|C1514756|C0021027|C1514468|C0672596|C1517586|C0450442
"The eligibility criteria for girls’ participation included living with both biological parents, the absence of severe food allergies or chronic medical problems affecting food intake, and the absence of dietary restrictions involving animal products.","The eligibility criteria girls’ participation included living biological parents, absence severe food allergies chronic medical food intake, absence dietary restrictions involving animal products.",G0000000|C0013893|C0243161|G0000000|C0679823|C0332257|C0376558|C0005532|C0030551|C0332197|C0205082|C0016452|C0020517|C0205191|C0199168|C0016452|C1512806|C0332197|C0012155|C0443288|C1314939|C0003062|C1514468
"Exclusion criteria were: active UC; proctitis with up to 10 cm proximal spread; Crohn’s disease; infectious colitis; severe accompanying illnesses or major colonic surgery; use of antibiotics, sulphonamides, steroids, or other therapies for UC at entry into the trial; administration of EcN within the previous six months before trial entry; as well as known intolerance to salicylates.","Exclusion criteria were: active UC; proctitis 10 cm proximal spread; Crohn’s disease; infectious colitis; severe accompanying illnesses major colonic surgery; antibiotics, sulphonamides, steroids, therapies UC entry trial; administration EcN previous months trial entry; intolerance salicylates.",C0680251|C0243161|G0000000|C0205177|G0000000|C0033246|C0450371|G0000000|C0205107|C0332261|G0000000|C0012634|C0009450|C0009319|C0205082|G0000000|C0221423|C0205082|C0009368|C0038894|C0003232|C0038760|C0038317|C0087111|G0000000|C1705654|C0008976|C0001554|C0760481|C0205156|C0439231|C0008976|C1705654|C0231199|C0036077
"A total of 481 consecutive patients, newly diagnosed with cancer, were randomly assigned to one of the four alternatives.","A total 481 consecutive patients, newly diagnosed cancer, randomly assigned alternatives.",G0000000|C0439175|C1442061|C1707491|C0030705|C0750546|C0011900|C0006826|G0000000|C1516050|C1523987
"Included in the trial were adult patients (age, >14 years) with suspected leptospirosis or scrub typhus—that is, patients who presented with acute fever (oral temperature, ≥38.0°C for <15 days) in the absence of an obvious focus of infection and who in the opinion of the attending physician could receive oral antimicrobial treatment.","Included trial adult patients (age, >14 years) suspected leptospirosis scrub typhus—that is, patients acute fever (oral temperature, ≥38.0°C <15 days) absence obvious focus infection opinion attending physician receive oral antimicrobial treatment.",C0332257|C0008976|C0001675|C0030705|C0001779|C0450371|C0439234|C0332147|C0023364|G0000000|G0000000|G0000000|C0030705|C0205178|C0015967|C0442027|C0005903|G0000000|C0450371|C0439228|C0332197|G0000000|C0205234|C0009450|C0871010|C1547429|C0031831|C1514756|C0442027|C1136254|C0039798
"Participants with a history of skin cancer, sensitivity to Ultra Violet (UV) light, or burns from a black light were excluded from the study.","Participants history skin cancer, sensitivity Ultra Violet (UV) light, burns black light excluded study.",C0679646|C0019664|C0444099|C0006826|C0020517|C0728475|C0330463|C0006409|C0023693|C0006434|C0005680|C0023693|C1554077|C0557651
"To integrate yoga as supportive treatment during therapy in women with breast cancer, it will be necessary to spend more research activities on safety aspects [10].","To integrate yoga supportive treatment therapy women breast cancer, spend activities safety aspects [10].",C0040363|G0000000|C0043418|C1521721|C0039798|C0039798|C0043210|C0006141|C0006826|C0680968|C0441655|C0036043|C1547011|C0450371
"Key exclusion criteria were: history or current diagnosis of asthma, allergic rhinitis or atopy; blood eosinophil count >600 cell/mm3; respiratory tract infection or COPD exacerbation within 6 weeks prior to screening or during the run-in period; hospitalisation for an acute COPD exacerbation within 3 months prior to screening; use of long-term oxygen therapy; clinically significant respiratory diseases other than COPD; unstable cardiac conditions.","Key exclusion criteria were: history current diagnosis asthma, allergic rhinitis atopy; blood eosinophil count >600 cell/mm3; respiratory tract infection COPD exacerbation 6 weeks prior screening run-in period; hospitalisation acute COPD exacerbation 3 months prior screening; long-term oxygen therapy; clinically respiratory diseases COPD; unstable cardiac conditions.",G0000000|C0680251|C0243161|G0000000|C0019664|C0521116|C0011900|C0004096|C0700624|C0035455|C0392707|C0005767|C0014467|C0750480|C1442061|C0007634|C0521346|C1185740|C0009450|C0024117|G0000000|G0000000|C0439230|C0332152|C0220908|C3274438|C0439531|C0019993|C0205178|C0024117|G0000000|G0000000|C0439231|C0332152|C0220908|C0443252|C0030054|C0039798|G0000000|C0521346|C0012634|C0024117|C0443343|C0018787|C0012634
Psychosocial interventions are a high priority for people with dementia and family carers.,Psychosocial interventions priority people dementia family carers.,C0542298|C0886296|C0549179|C0027361|C0011265|C0015576|C0085537
"Of the 300 patients randomised, 33 patients died before completing the study.","Of 300 patients randomised, 33 patients died completing study.",G0000000|C1442061|C0030705|G0000000|C0450371|C0030705|C0011065|C0205197|C0557651
"Women were excluded from participating in the study if they had used any investigational or non-registered drug or vaccine, were pregnant or lactating or planning/ likely to conceive during the study.","Women excluded participating study investigational non-registered drug vaccine, pregnant lactating planning/ conceive study.",C0043210|C1554077|C0679823|C0557651|C1517586|C1518422|C0013227|C0042210|C0549206|C2828358|C0032074|G0000000|C0557651
"To be eligible, participants had to be 18 years or older, to smoke at least 10 cigarettes per day, and to be interested in smoking cessation.","To eligible, participants 18 older, smoke 10 cigarettes day, smoking cessation.",C0040363|C1548635|C0679646|C0450371|C0580836|C0037366|C0450371|C0677453|C0332173|C0037369|C1880019
"The present study, registered in the Iranian website for registration of clinical trials (http://www.irct.ir: IRCT201701305623N106), was a 6-week randomized double-blind placebo controlled clinical trial that was carried out among 120 GDM women at 24–28 weeks’ gestation, aged 18–40 years without prior diabetes diagnosed based on the American Diabetes Association guidelines [19] from September 2016 to March 2017.","The study, registered Iranian website registration clinical trials (http://www.irct.ir: IRCT201701305623N106), 6-week randomized double-blind placebo controlled clinical trial carried 120 GDM women 24–28 weeks’ gestation, aged 18–40 prior diabetes diagnosed based American Diabetes Association guidelines [19] September 2016 March 2017.",G0000000|C0557651|C1514821|C1553355|C2349146|C1514821|C0205210|C0008976|C1555015|G0000000|C0332174|C0034656|C0013072|C0032042|C2587213|C0205210|C0008976|C0206243|C1442061|C0085207|C0043210|G0000000|G0000000|C0032961|C0001779|G0000000|C0332152|C0011847|C0011900|C1527178|C0596070|C0011847|C0004083|C0162791|C0450371|C3828193|G0000000|C3829202|G0000000
"We recruited and randomised 116 culture positive eyes of 116 patients of fungal keratitis who presented to the cornea clinic from March to October 2002, to either 2% econazole or 5% natamycin.","We recruited randomised 116 culture positive eyes 116 patients fungal keratitis cornea clinic March October 2002, 2% econazole 5% natamycin.",G0000000|G0000000|G0000000|C1442061|C0010453|C0439178|C0015392|C1442061|C0030705|C0016832|C0022568|C0010031|C0002424|C3829202|C3828732|G0000000|G0000000|C0013547|G0000000|C0027444
the mothers with a low BMI were not being more compromised.,mothers low BMI compromised.,C0026591|C0205251|G0000000|C2945640
Collegiate baseball players with a lower substance-use principal component were about twice as likely to remain ST nonusers.,Collegiate baseball players lower substance-use principal component remain ST nonusers.,C0557806|C0004795|G0000000|C0441994|C0237123|C0205225|C0449432|G0000000|C0036056|G0000000
Tobacco cessation services delivered in public dental clinics have the potential to improve the health and well-being of millions of Americans.,Tobacco cessation services delivered public dental clinics potential improve health well-being millions Americans.,C0040329|C1880019|C0557854|C1705822|G0000000|C0011365|C0442592|C3245505|G0000000|C0018684|C0018684|C1881839|C0596070
"Exclusion criteria Patients with positive laboratory test of HIV, positiveness of serum anti-HCV and/or HCV RNA, uncompensable liver diseases, suggestive of autoimmune diseases with antinuclear antibody (ANA) titer greater than a 1:160 dilution, abnormality of serum creatinine with a value of 1.5 times greater than normal, concurrence of other associated severe diseases which might affect the present treatment, hypersensitive to oxymatrine capsule, women with pregnancy and during breast-feeding period.","Exclusion criteria Patients positive laboratory test HIV, positiveness serum anti-HCV and/or HCV RNA, uncompensable liver diseases, suggestive autoimmune diseases antinuclear antibody (ANA) titer 1:160 dilution, abnormality serum creatinine 1.5 times normal, concurrence severe diseases affect treatment, hypersensitive oxymatrine capsule, women pregnancy breast-feeding period.",C0680251|C0243161|C0030705|C0439178|C0022877|C0022885|C0019682|C0439178|C0229671|C0166049|G0000000|C0220847|C0035668|G0000000|C0023884|C0012634|C0332299|C0443146|C0012634|G0000000|C0003241|G0000000|C0475208|C1442061|C0079240|C1704258|C0229671|C0010294|G0000000|C0040223|C0205307|C0205420|C0205082|C0012634|C0001721|C0039798|C0020517|C0069821|C0006935|C0043210|C0032961|C0006147|C0439531
"These findings support use of epoetin alfa to increase Hb levels, reduce transfusion use, and improve QOL in anaemic ovarian cancer patients receiving platinum chemotherapy.","These findings support epoetin alfa increase Hb levels, reduce transfusion use, improve QOL anaemic ovarian cancer patients receiving platinum chemotherapy.",G0000000|C2607943|C0183683|C0014822|C0439095|C0442805|C0019046|C0441889|G0000000|C0005841|C0042153|G0000000|C0518214|C0857322|C0205065|C0006826|C0030705|C1514756|C0032207|C0013216
"Exclusion criteria were pain and symptoms caused entirely by an acute problem (duration <2 weeks), receiving ART for prevention of mother-to-child transmission of HIV, and not speaking Swahili or English.","Exclusion criteria pain symptoms caused acute (duration <2 weeks), receiving ART prevention mother-to-child transmission HIV, speaking Swahili English.",C0680251|C0243161|C0030193|C0683368|C0015127|C0205178|C0449238|G0000000|C0439230|C1514756|C0003826|C0199176|C0260023|C0040722|C0019682|C0234856|G0000000|C0376245
"Patients must: have an upper GI metastatic cancer, including pancreatic cancer, biliary tract cancer or gastric cancer (including junctional Siewert 2 and 3 cancers) (an amendment is being submitted to our ethic committee in order to include other oesophageal cancers, too), be 18 years of age or older, have an ECOG performance status ≤2, be planned for treatment with first-line Ct, have a life expectancy of more than 4 weeks, have a good understanding of the French language, have health insurance coverage, sign and date a written informed consent form.","Patients must: upper GI metastatic cancer, including pancreatic cancer, biliary tract cancer gastric cancer (including junctional Siewert 2 3 cancers) (an amendment submitted ethic committee oesophageal cancers, too), 18 age older, ECOG performance status ≤2, planned treatment first-line Ct, life expectancy 4 weeks, understanding French language, health insurance coverage, sign written informed consent form.",C0030705|G0000000|C1282910|C1708130|C0036525|C0006826|C0332257|C0030274|C0006826|C0521378|C1185740|C0006826|C0038351|C0006826|C0332257|C0205144|G0000000|G0000000|G0000000|C0006826|G0000000|C0680532|C1515023|C0015000|C2699414|C1522619|C0006826|G0000000|C0450371|C0001779|C0580836|C0430797|C0597198|C0449438|G0000000|C1301732|C0039798|C0205435|C0007673|C0376558|C0679138|G0000000|C0439230|C0162340|C0376246|C0023008|C0018684|C0021672|C1551362|C0311392|C0043266|C1522154|C1511481|C0348078
"The exclusion criteria were: the time to admission from the onset is within 14 days, difficult communication due to severe cognitive disorder, comorbidity index of 4 or higher11), necessity of high-level consideration and caution for rehabilitation, and scores of Hip-flexion, Knee-extension, and Foot-pat items of the Stroke Impairment Assessment Set (SIAS)12) lower than 2.","The exclusion criteria were: time admission onset 14 days, difficult communication severe cognitive disorder, comorbidity 4 higher11), necessity high-level consideration caution rehabilitation, scores Hip-flexion, Knee-extension, Foot-pat items Stroke Impairment Assessment Set (SIAS)12) lower 2.",G0000000|C0680251|C0243161|G0000000|C0040223|C0184666|C0206132|C0450371|C0439228|C0332218|C0009452|C0205082|C1516691|C0012634|C0009488|G0000000|G0000000|G0000000|C0205250|C0518609|G0000000|C0034991|C0449820|C0019552|C0022742|C0016504|C1551338|C0038454|C0221099|C1261322|C0036849|C1225105|C0441994|G0000000
"Participants with fasting capillary blood glucose ≥126 mg/dl or 2-hour post capillary blood glucose ≥220 mg/dl (Deepa et al., 2009) will be deemed ineligible and not further screened for the study.","Participants fasting capillary blood glucose ≥126 mg/dl 2-hour post capillary blood glucose ≥220 mg/dl (Deepa al., 2009) deemed ineligible screened study.",C0679646|C0015663|C0006901|C0005767|C0017725|G0000000|C0439269|C0439227|C0687676|C0006901|C0005767|C0017725|G0000000|C0439269|G0000000|C0202311|G0000000|G0000000|C1512714|C0220908|C0557651
SUBJECTS: 104 children aged 7 to 9 years who had had wheezing in association with symptoms of upper and lower respiratory tract infection in the preceding 12 months.,SUBJECTS: 104 children aged 7 9 wheezing association symptoms upper lower respiratory tract infection preceding 12 months.,C0681850|C1442061|C0008059|C0001779|G0000000|G0000000|C0043144|C0004083|C0683368|C1282910|C0441994|C0521346|C1185740|C0009450|C0332152|C0450371|C0439231
"Medically stable post ichaemic stroke or (> 3 months) post TIA, referred from specialist tertiary centres.","Medically stable post ichaemic stroke (> 3 months) post TIA, referred specialist tertiary centres.",G0000000|C0205360|C0687676|G0000000|C0038454|G0000000|G0000000|C0439231|C0687676|C0007787|C0205543|C0087009|C0205372|C0205099
"Children, between the ages of 3 and 8 years, with American Society of Anesthesiologists physical status I, who were scheduled to undergo adenotonsillectomy without myringotomy at the department of otolaryngology, were prospectively enrolled in this study.","Children, ages 3 8 years, American Society Anesthesiologists physical status I, scheduled undergo adenotonsillectomy myringotomy department otolaryngology, prospectively enrolled study.",C0008059|C0001779|G0000000|G0000000|C0439234|C0596070|C0037455|C0334910|C0031809|C0449438|C0021966|C0086960|G0000000|C0193959|C0087123|C1704729|C0029892|G0000000|G0000000|C0557651
"To allow for deaths and withdrawals (30%), 460 participants will be recruited, 230 per group.","To deaths withdrawals (30%), 460 participants recruited, 230 group.",C0040363|C0011065|C2349954|C0450371|C1442061|C0679646|G0000000|C1442061|C0441833
A total of 75 healthy 3 to 10 yr old children each having at least one carious primary molar tooth were selected.,A total 75 healthy 3 10 yr children carious primary molar tooth selected.,G0000000|C0439175|C0450371|C3898900|G0000000|C0450371|C0439234|C0008059|G0000000|C0205225|C0026367|C0040426|C1707391
All such additional breast cancer events reported in semiannual telephone interviews were confirmed by medical record review.,All additional breast cancer events reported semiannual telephone interviews confirmed medical record review.,G0000000|C1524062|C0006141|C0006826|C0441471|C0684224|C0585339|C0039457|C0021822|C0521093|C0199168|C0034869|C0282443
"Three-hundred-and-forty in- and outpatients in the Department of Oncology, Copenhagen University Hospital, will be randomly assigned to either an accelerated transition from oncological treatment to standard care plus continuing SPC enriched with a manualized psychological intervention at home (including nursing home) or standard care alone (Figure 1).","Three-hundred-and-forty in- outpatients Department Oncology, Copenhagen University Hospital, randomly assigned accelerated transition oncological treatment standard care continuing SPC enriched manualized psychological intervention (including nursing home) standard care (Figure 1).",C0205449|G0000000|C0029921|C1704729|C0027651|G0000000|C0041740|C0019994|G0000000|C1516050|C0521110|C0599156|C0027651|C0039798|C1442989|C1947933|C0549178|C1425074|C0359583|G0000000|C0205486|C0886296|C0332257|C0006147|C0442519|C1442989|C1947933|G0000000|G0000000
"Policy interventions such as price increases and smoking bans have led to decreased tobacco use across racial and ethnic groups.27,28 From 1999 to 2007, the Centers for Disease Control and Prevention funded community-based interventions through the Racial and Ethnic Approaches to Community Health (REACH) 2010 program to address health disparities in minority communities.29 The Charlotte REACH 2010 project was designed to apply and expand promising strategies to improve health disparities in cardiovascular disease and diabetes in an urban, African American community.","Policy interventions price increases smoking bans led decreased tobacco racial ethnic groups.27,28 From 1999 2007, Centers Disease Control Prevention funded community-based interventions Racial Ethnic Approaches Community Health (REACH) 2010 program address health disparities minority communities.29 The Charlotte REACH 2010 project designed apply expand promising strategies improve health disparities cardiovascular disease diabetes urban, African American community.",C0242456|C0886296|C0080045|C0205217|C0037369|C0105185|C1708698|C0205216|C0040329|C0034510|C0015031|C0441833|G0000000|G0000000|G0000000|C0205099|C0012634|C0243148|C0199176|C0016820|C0009462|C0886296|C0034510|C0015031|C0449445|C0009462|C0018684|C2584321|G0000000|C1709697|C0376649|C0018684|G0000000|C0026192|C0009462|G0000000|G0000000|C2584321|G0000000|C1709701|C1707689|C1632850|C0205229|C1555307|C0679199|G0000000|C0018684|G0000000|C0007226|C0012634|C0011847|C0442529|C0027567|C0596070|C0009462
Physically and mentally healthy as their own claim and tendency to participate in the study and recently not confronted with stressful events based on short form of Holmes and Rahe Questionnaire.,Physically mentally healthy claim tendency participate study confronted stressful events based short form Holmes Rahe Questionnaire.,G0000000|G0000000|C3898900|G0000000|G0000000|G0000000|C0557651|G0000000|C0231297|C0441471|C1527178|C1282927|C0348078|G0000000|G0000000|C0034394
gambiae in the IRS area were significantly reduced in both 2010 and 2011.,gambiae IRS reduced 2010 2011.,G0000000|G0000000|C0392756|G0000000|G0000000
"Instead, the majority of children with persistent complaints of abdominal pain meet criteria for pediatric functional abdominal pain (FAP), which is defined as episodic or continuous abdominal pain without evidence of an inflammatory, anatomic, metabolic, or neoplastic process that explains the subject's symptoms (3).","Instead, majority children persistent complaints abdominal pain meet criteria pediatric functional abdominal pain (FAP), defined episodic continuous abdominal pain evidence inflammatory, anatomic, metabolic, neoplastic process explains subject's symptoms (3).",G0000000|C0680220|C0008059|C0205322|C0277786|C0000726|C0030193|C1550543|C0243161|C0030755|C0205245|C0000726|C0030193|C1413336|C1704788|C1455761|C0549178|C0000726|C0030193|C3887511|C0333348|C0220784|C0311400|C1709160|C1184743|G0000000|C0681850|C0683368|G0000000
"All participants demonstrated moderate to severe weakness of their affected upper extremities, defined by the upper extremity Fugl-Meyer Motor Scale (score of 10 to 35 out of 66).19 Exclusion criteria included significant pain, instability or subluxation of the affected shoulder, severe elbow or wrist contractures, concurrent severe medical problems, cognitive dysfunction to the extent that would interfere with therapy participation, visual deficits, severe neglect or apraxia, and current enrollment in ongoing upper extremity therapy.","All participants demonstrated moderate severe weakness upper extremities, defined upper extremity Fugl-Meyer Motor Scale (score 10 35 66).19 Exclusion criteria included pain, instability subluxation shoulder, severe elbow wrist contractures, concurrent severe medical problems, cognitive dysfunction extent interfere therapy participation, visual deficits, severe neglect apraxia, current enrollment ongoing upper extremity therapy.",G0000000|C0679646|G0000000|C0205081|C0205082|C3714552|C1282910|C0015385|C1704788|C1282910|C0015385|G0000000|C1513492|C0175659|C0449820|C0450371|C0450371|C0450371|C0680251|C0243161|C0332257|C0030193|C1444783|C0332768|C0037004|C0205082|C0013769|C0043262|C0009917|C0205420|C0205082|C0199168|C1546466|C1516691|C0031847|C0439792|C0521102|C0039798|C0679823|C0234621|C2987487|C0205082|C0521874|C0003635|C0521116|C1516879|C0549178|C1282910|C0015385|C0039798
"At enrollment, patients in both study groups were similar regarding sociodemographic characteristics, disease severity (Table 1), VAS pain scores, presence or absence of fever, exudate, dysphagia and lymphadenopathy.","At enrollment, patients study sociodemographic characteristics, disease severity (Table 1), VAS pain scores, presence absence fever, exudate, dysphagia lymphadenopathy.",G0000000|C1516879|C0030705|C0557651|G0000000|C1521970|C0012634|C0439793|C0039224|G0000000|C0042815|C0030193|C0449820|C0150312|C0332197|C0015967|C0015388|C0011168|C0497156
"Patients attending outpatient services on follow-up with a diagnosis of schizophrenia were screened for the following: (a) receiving antipsychotic medication without change in dosages in the last three months, (b) rated as moderately symptomatic with a score of 3 or more on clinical global impression,[6] and (c) not received Electro Convulsive Therapy (ECT) in the past three months.","Patients attending outpatient services follow-up diagnosis schizophrenia screened following: (a) receiving antipsychotic medication change dosages months, (b) rated moderately symptomatic score 3 clinical global impression,[6] (c) received Electro Convulsive Therapy (ECT) months.",C0030705|C1547429|C0029921|C0557854|C0589120|C0011900|C0036341|C0220908|C0231290|G0000000|C1514756|C0040615|C0013227|C0392747|C0178602|C0439231|G0000000|C0871208|C0205081|C0231220|C0449820|G0000000|C0205210|C0205246|C0596764|G0000000|C1514756|G0000000|C0234531|C0039798|C0013806|C0439231
"However, starting in June 2011, to enhance recruitment and retention, participants with comorbid attention-deficit/hyperactivity disorder were able to receive psychostimulants after 4 weeks of double-blind therapy at the treating physician’s discretion.","However, starting June 2011, enhance recruitment retention, participants comorbid attention-deficit/hyperactivity disorder receive psychostimulants 4 weeks double-blind therapy treating physician’s discretion.",G0000000|C0439659|C3829443|G0000000|C2349975|C2949735|C0035280|C0679646|C0009488|C1399930|C0012634|C1514756|C0304403|G0000000|C0439230|C0013072|C0039798|C1522326|G0000000|G0000000
"One study found that after rehabilitation, 62% of stroke patients were still dependent regarding daily living activities (ADL) and 32% were inactive regarding Instrumental ADLs at three years post stroke[3].","One study rehabilitation, 62% stroke patients dependent daily living activities (ADL) 32% inactive Instrumental ADLs post stroke[3].",C0205447|C0557651|C0034991|C0450371|C0038454|C0030705|C0851827|C0332173|C0376558|C0441655|C0001288|C0450371|C0205254|G0000000|C0001288|C0687676|C0038454
We included German speaking participants aged > 18 years with self reported snoring and an apnoea-hypopnoea index of 15-30 (determined by a specialist in sleep medicine within the past year).,We included German speaking participants aged > 18 reported snoring apnoea-hypopnoea 15-30 (determined specialist sleep medicine year).,G0000000|C0332257|C1556085|C0234856|C0679646|C0001779|G0000000|C0450371|C0684224|C0037384|C0003578|C0450371|C0680730|C0087009|C0037313|C0013227|C0439234
Units were eligible if they had a match and were not involved in other performance improvement efforts specific to fall prevention.,Units eligible match involved performance improvement efforts specific fall prevention.,C0439148|C1548635|C0150103|C1314939|C0597198|C2986411|C0015264|C0205369|C0085639|C0199176
Patients who had suffered a close personal bereavement or given birth during the previous 12 months were excluded.,Patients suffered close personal bereavement birth previous 12 months excluded.,C0030705|C0683278|C0587267|C1519021|C0005119|C0005615|C0205156|C0450371|C0439231|C1554077
"Onset of anxiety symptoms occurred within 3 years prior to the onset of menopause or peri-menopause, or within 5 years after cessation of menstruation, and the anxiety symptoms were not better accounted for by another medical or psychiatric condition.","Onset anxiety symptoms occurred 3 prior onset menopause peri-menopause, 5 cessation menstruation, anxiety symptoms accounted medical psychiatric condition.",C0206132|C0003467|C0683368|C1709305|G0000000|C0332152|C0206132|C0025320|C0993589|G0000000|C1880019|C0025344|C0003467|C0683368|C2741673|C0199168|C0205487|C0012634
Population All people registered in Stockholm county on 1 October 2009 and who had lived in this region since 1 January 1998; 1 024 019 were vaccinated against H1N1 and 921 005 remained unvaccinated.,Population All people registered Stockholm county 1 October 2009 lived region 1 January 1998; 1 024 019 vaccinated H1N1 921 005 remained unvaccinated.,C0032659|G0000000|C0027361|C1514821|G0000000|C0079170|G0000000|C3828732|G0000000|C1548795|C0017446|G0000000|C3829466|G0000000|G0000000|C1116171|G0000000|G0000000|G0000000|G0000000
We evaluated 158 of 180 (88%) offspring at age 3 years for the primary outcome.,We evaluated 158 180 (88%) offspring age 3 primary outcome.,G0000000|C0220825|C1442061|C1442061|C0450371|C0680063|C0001779|G0000000|C0205225|C1274040
"Additional exclusion criterion was an apnea-hypopnea index ≥ 10 or a periodic limb movement disorder index with arousal ≥ 15, as assessed by overnight polysomnography in a subgroup of participants who consented to the investigation.","Additional exclusion criterion apnea-hypopnea ≥ 10 periodic limb movement disorder arousal ≥ 15, assessed overnight polysomnography subgroup participants consented investigation.",C1524062|C0680251|C0243161|C0003578|G0000000|C0450371|C0332182|C0015385|C0026649|C0012634|C0003808|G0000000|C0450371|C1516048|C0439583|C0162701|C1079230|C0679646|C2711213|C0220825
"The subject selection criteria were as follows: 1) a diagnosis of hemiplegia due to stroke; 2) scores of ≥ 24 points on the Mini-Mental State Exam-Korean (MMSE-K), which indicated the patients had no difficulty with cognitive functions; 3) paretic upper-extremity movements corresponding to Brunnstrom’s stage IV classification; 4) no difficulties with perceptual abilities, including hemineglect based on the Motor-free Visual Perception Test (MVPT); 5) stroke of at least a 6 month duration; and 6) voluntary consent to participate in the study.","The subject selection criteria follows: 1) diagnosis hemiplegia stroke; 2) scores ≥ 24 Mini-Mental State Exam-Korean (MMSE-K), patients difficulty cognitive functions; 3) paretic upper-extremity movements Brunnstrom’s stage IV classification; 4) difficulties perceptual abilities, including hemineglect based Motor-free Visual Perception Test (MVPT); 5) stroke 6 month duration; 6) voluntary consent participate study.",G0000000|C0681850|C0036576|C0243161|C0332283|G0000000|C0011900|C0018991|C0038454|G0000000|C0449820|G0000000|C0450371|C0445542|C1301808|C0582103|C0451306|C0030705|C1299586|C1516691|C0542341|G0000000|G0000000|C1140618|C0026649|G0000000|C0205390|C0022326|C0008902|G0000000|C1299586|G0000000|C0085732|C0332257|C0150088|C1527178|C1513492|C0234621|C0030971|C0022885|G0000000|G0000000|C0038454|G0000000|C0332177|C0449238|G0000000|C0439656|C1511481|G0000000|C0557651
Characteristics associated with smoking intensity (number of total cigarettes smoked in the previous 7 days) during the first 8 weeks of the study.,Characteristics smoking intensity (number total cigarettes smoked previous 7 days) 8 weeks study.,C1521970|C0037369|C0522510|C0237753|C0439175|C0677453|C0037366|C0205156|G0000000|C0439228|G0000000|C0439230|C0557651
Children aged 6 to 10 years old were enrolled in a study in which Duchenne muscular dystrophy (DMD) was diagnosed and approved in them by DNA analysis and muscle biopsy (quadriceps or biceps).,Children aged 6 10 enrolled study Duchenne muscular dystrophy (DMD) diagnosed approved DNA analysis muscle biopsy (quadriceps biceps).,C0008059|C0001779|G0000000|C0450371|G0000000|C0557651|G0000000|C0026845|C0333606|G0000000|C0011900|C0205540|C0012854|C0002778|C0026845|C0005558|C0224440|C0559499
"For morbidity, there will be a case history until discharge or term age (for preterm infants).","For morbidity, history discharge term age (for preterm infants).",G0000000|C0026538|C0019664|C0012621|C0233324|C0001779|G0000000|C0151526|C0021270
"Briefly, between 2002 and 2006, the SMHS recruited 61 500 men who were aged 40–74 years, were free of cancer, and lived in one of the eight selected urban communities in Shanghai (participation rate: 74.1%).","Briefly, 2002 2006, SMHS recruited 61 500 aged 40–74 years, free cancer, lived selected urban communities Shanghai (participation rate: 74.1%).",G0000000|G0000000|G0000000|C1824631|G0000000|G0000000|C0001779|G0000000|C0439234|C0332296|C0006826|C1548795|C1707391|C0442529|C0009462|G0000000|C0679823|C0871208|C0450371
"Asymmetric brain lesion identified on cranial ultrasound or MRI including asymmetric (one-sided or more involved on one side) or unilateral brain injury including: Preterm or term arterial stroke; Grade III or IV intraventricular haemorrhage; Asymmetric periventricular leucomalacia; Asymmetric deep grey matter lesions;  and 2(a): Absent Fidgety Movements on General Movements Assessment (GMs) at 12 weeks ca; or 2(b): Abnormal Hammersmith Infant Neurological Examination (HINE) between 18 to 26 weeks ca; the Hammersmith Infant Neurological Evaluation (HINE) is a standardised neurological examination of cranial nerve function, posture, quality and quantity of movement, tone and reflexes and reactions, which has numeric scoring.","Asymmetric brain lesion identified cranial ultrasound MRI including asymmetric (one-sided involved side) unilateral brain injury including: Preterm term arterial stroke; Grade III IV intraventricular haemorrhage; Asymmetric periventricular leucomalacia; Asymmetric deep grey matter lesions; 2(a): Absent Fidgety Movements General Movements Assessment (GMs) 12 weeks ca; 2(b): Abnormal Hammersmith Infant Neurological Examination (HINE) 18 26 weeks ca; Hammersmith Infant Neurological Evaluation (HINE) standardised neurological examination cranial nerve function, posture, quality quantity movement, tone reflexes reactions, numeric scoring.",C0332514|C0006104|C0221198|C0205396|C0037303|C0041618|C0024485|C0332257|C0332514|C0205092|C1314939|C0441987|C0205092|C0006104|C3263722|C0332257|C0151526|C0233324|C0003842|C0038454|C0441800|C0439070|C0022326|C1517569|C0019080|C0332514|G0000000|G0000000|C0332514|C0205125|C0556636|G0000000|C0221198|G0000000|C0332197|C0424235|C0026649|C0205246|C0026649|C1261322|G0000000|G0000000|C3887642|G0000000|C0205161|C0335933|C0021270|C0205494|G0000000|G0000000|C0450371|G0000000|C3887642|C0335933|C0021270|C0205494|C0220825|G0000000|G0000000|C0205494|G0000000|C0037303|C0027740|C0031843|C1262869|C0332306|C1265611|C0026649|C3543842|C0034929|C0443286|C0237753|C0449820
"The engagement strategy for the behavior change component of the interventions targeted first the respondents/primary caregivers of study children with monthly visits and second, their siblings and fathers.","The engagement strategy behavior change component interventions targeted respondents/primary caregivers study children monthly visits second, siblings fathers.",G0000000|C0425152|C0679199|C0004927|C0392747|C0449432|C0886296|C1521840|C0282122|C0085537|C0557651|C0008059|C0332177|C0545082|C0205436|C0037047|C0015671
"Because the primary aim of the study was to examine the effect of yoga on sleep disturbance, randomization of each cohort was stratified by gender and baseline level of sleep disturbance (two levels: ≤5 or >5 on an 11-point symptom inventory scale anchored by “0” = no sleep disturbance and “10” = worst possible sleep disturbance).","Because primary aim study examine yoga sleep disturbance, randomization cohort stratified gender baseline level sleep disturbance (two levels: ≤5 >5 11-point symptom inventory scale anchored “0” = sleep disturbance “10” = worst sleep disturbance).",G0000000|C0205225|C1947946|C0557651|G0000000|C0043418|C0037313|C2699787|C0034656|C0599755|C0205363|C0079399|C0168634|C0441889|C0037313|C2699787|C0205448|C0441889|G0000000|G0000000|C0450371|C1457887|C0021941|C0175659|C1293132|G0000000|G0000000|C0037313|C2699787|G0000000|G0000000|C1522166|C0037313|C2699787
"Exclusion criteria were taking omega-3 fatty acids supplements, insulin therapy, placenta abruption, pre-eclampsia, eclampsia, hypo and hyperthyroidism, and smokers.","Exclusion criteria omega-3 fatty acids supplements, insulin therapy, placenta abruption, pre-eclampsia, eclampsia, hypo hyperthyroidism, smokers.",C0680251|C0243161|C1719844|G0000000|C0001128|C0242295|C0021641|C0039798|C0032043|G0000000|C0032914|C0013537|G0000000|C0020550|C0337664
237 smokers aged 22-66 years living in or around Reykjavik.,237 smokers aged 22-66 living Reykjavik.,C1442061|C0337664|C0001779|C0450371|C0376558|G0000000
Subjects were each provided with a calibrated thermometer to measure temperature and a diary card to record temperatures and symptoms during the influenza like illness episode.,Subjects provided calibrated thermometer measure temperature diary card record temperatures symptoms influenza illness episode.,C0681850|C1999230|G0000000|C0039818|C0079809|C0005903|C0376660|C3275277|C0034869|C0039476|C0683368|C0021400|C0221423|C0332189
"Eligible subjects had a prebronchodilator FEV1/FVC (forced vital capacity) ratio ≤ 70%, postbronchodilator FEV1 between 30% and 70% predicted, and low postbronchodilator FEV1 reversibility (< 10% of predicted normal).","Eligible subjects prebronchodilator FEV1/FVC (forced vital capacity) ratio ≤ 70%, postbronchodilator FEV1 30% 70% predicted, low postbronchodilator FEV1 reversibility (< 10% predicted normal).",C1548635|C0681850|C2599602|C3714541|C0441722|C0442732|C1516240|C0456603|G0000000|C0450371|C2599594|G0000000|C0450371|C0450371|C0681842|C0205251|C2599594|G0000000|C0449261|G0000000|C0450371|C0681842|C0205307
"The STOP II trial has been described in detail.19 Briefly, children with SCD who had a high risk of stroke on the basis of a TCD screening examination and who had received transfusions for 30 months or longer, during which time the TCD readings became normal, were evaluated.","The STOP II trial detail.19 Briefly, children SCD risk stroke basis TCD screening examination received transfusions 30 months longer, time TCD readings normal, evaluated.",G0000000|C1947925|G0000000|C0008976|C1522508|G0000000|C0008059|G0000000|C0035647|C0038454|C1527178|C0007928|C0220908|G0000000|C1514756|C0005841|C0450371|C0439231|C0205166|C0040223|C0007928|C0034754|C0205307|C0220825
"A total of 910 daily or occasional (≥ 4 cigarettes in the preceding month and ≥ 1 cigarette in the preceding week) smoking apprentices will be proactively recruited in vocational school classes and, using school class as a randomisation unit, randomly assigned to an intervention group (n = 455) receiving the SMS based intervention or an assessment only control group (n = 455).","A total 910 daily occasional (≥ 4 cigarettes preceding month ≥ 1 cigarette preceding week) smoking apprentices proactively recruited vocational school classes and, school class randomisation unit, randomly assigned intervention (n = 455) receiving SMS based intervention assessment control (n = 455).",G0000000|C0439175|C1442061|C0332173|C0521114|G0000000|G0000000|C0677453|C0332152|C0332177|G0000000|G0000000|C0677453|C0332152|C0332174|C0037369|G0000000|G0000000|G0000000|C0087164|C0036375|C0456387|G0000000|C0036375|C0456387|C0034656|C0439148|G0000000|C1516050|C0886296|C0369718|G0000000|C1442061|C1514756|G0000000|C1527178|C0886296|C1261322|C0243148|C0369718|G0000000|C1442061
Patients were excluded if they had any medical conditions that would impair their ability to participate in the study or to provide informed consent or if they were receiving hospice care.,Patients excluded medical conditions impair ability participate study provide informed consent receiving hospice care.,C0030705|C1554077|C0199168|C0012634|G0000000|C0085732|G0000000|C0557651|C1999230|C1522154|C1511481|C1514756|C0019947|C1947933
Individuals with chronic stroke will be recruited.,Individuals chronic stroke recruited.,C0027361|C0205191|C0038454|G0000000
"The sample was made up of individuals with chronic sequelae stemming from a stroke who met the following inclusion criteria: weekly physical therapy sessions at the institution, the ability to remain in an orthostatic position without support, absence of osteoarticular deformities, and the ability to understand the visual biofeedback.","The sample individuals chronic sequelae stemming stroke met inclusion criteria: weekly physical therapy sessions institution, ability remain orthostatic position support, absence osteoarticular deformities, ability understand visual biofeedback.",G0000000|C0370003|C0027361|C0205191|C0243088|C0242767|C0038454|C0268621|C0007637|C0243161|C0332174|C0031809|C0039798|C1883016|C0018704|C0085732|G0000000|C0231472|C0733755|C0183683|C0332197|G0000000|C0000768|C0085732|C0162340|C0234621|C0005491
"Conclusions: When compared with placebo, montelukast for 16 weeks effectively reduced the severity of obstructive sleep apnea in children 2–10 years of age.","Conclusions: When compared placebo, montelukast 16 weeks effectively reduced severity obstructive sleep apnea children 2–10 age.",C1707478|G0000000|C1707455|C0032042|C0298130|C0450371|C0439230|G0000000|C0392756|C0439793|C0549186|C0037313|C0003578|C0008059|G0000000|C0001779
"Finally, a lack of cooperation, inadequate contraception, pregnancy or breast feeding, drug or alcohol dependency, neurotic personality, and obesity were reasons for exclusion.","Finally, lack cooperation, inadequate contraception, pregnancy breast feeding, drug alcohol dependency, neurotic personality, obesity reasons exclusion.",G0000000|C0332268|C0392337|C0205412|C0700589|C0032961|C0006141|C0204695|C0013227|C0001962|C0011546|C0260048|C0003944|C0028754|C0392360|C0680251
"Much of the housing is poor, unfinished, and lacking in sanitation, water, and public power.","Much housing poor, unfinished, lacking sanitation, water, public power.",C0205393|C0020056|C0032854|G0000000|C0332268|C0036172|C0043047|G0000000|C0032863
"During the rainy season, the area is vulnerable to flooding because of the topography and lack of waste and drain-water management infrastructure.","During rainy season, vulnerable flooding topography lack waste drain-water management infrastructure.",G0000000|C0034640|C0036497|G0000000|C0016248|C0205627|C0332268|G0000000|C0013103|C0001554|C1514880
"After excluding patients at Hoehn and Yahr stage 3, we observed that the study group showed significantly better improvement in all parameters.","After excluding patients Hoehn Yahr stage 3, observed study improvement parameters.",G0000000|C0332196|C0030705|G0000000|G0000000|C0205390|G0000000|C1441672|C0557651|C2986411|C0449381
"Exclusion criteria included taking chemical or herbal drugs, having sexual intercourse and being suspected of high-risk pregnancy.","Exclusion criteria included chemical herbal drugs, sexual intercourse suspected high-risk pregnancy.",C0680251|C0243161|C0332257|C0220806|C3146288|C0013227|C0036864|C0009253|C0332147|C0332167|C0032961
To compare the effect of sargramostim plus ipilimumab vs ipilimumab alone on overall survival in patients with metastatic melanoma.,To compare sargramostim ipilimumab ipilimumab survival patients metastatic melanoma.,C0040363|C1707455|C0216231|C1367202|C1367202|C0038952|C0030705|C0036525|C0025202
"Parents of children aged 5–14 years with a recorded diagnosis of asthma and who had been prescribed one or more asthma treatments in the preceding six months, were contacted by telephone.","Parents children aged 5–14 recorded diagnosis asthma prescribed asthma treatments preceding months, contacted telephone.",C0030551|C0008059|C0001779|G0000000|C0034869|C0011900|C0004096|C0278329|C0004096|C0087111|C0332152|C0439231|C0332158|C0039457
"In this study, all participants met the following inclusion criteria: diagnosis of LM, defined as a spherical equivalent (SE) ranging from -0.50 to −2.00 diopters (D), as measured by cycloplegic autorefraction; age between 5 and 10 years; normal intraocular pressure (IOP; <21 mm Hg); no treatments administered, including atropine eye drops within 1 month before enrollment in the study; and provision of informed consent before enrollment in the study.","In study, participants met inclusion criteria: diagnosis LM, defined spherical equivalent (SE) ranging -0.50 −2.00 diopters (D), measured cycloplegic autorefraction; age 5 10 years; normal intraocular pressure (IOP; <21 mm Hg); treatments administered, including atropine eye drops 1 month enrollment study; provision informed consent enrollment study.",G0000000|C0557651|C0679646|C0268621|C0007637|C0243161|C0011900|C1261082|C1704788|C0332501|C0205163|C0036919|C1514721|C0450371|G0000000|C0073187|C0444706|C0010586|G0000000|C0001779|G0000000|C0450371|C0439234|C0205307|C3282905|C0033095|C0595921|G0000000|C0025424|C0087111|C1521801|C0332257|C0004259|C0015392|C0991568|G0000000|C0332177|C1516879|C0557651|C1549071|C1522154|C1511481|C1516879|C0557651
"Between October 2008 and June 2011, 255 patients were randomly assigned to either CS or CF group at 15 centers in China.","Between October 2008 June 2011, 255 patients randomly assigned CS CF 15 centers China.",G0000000|C3828732|G0000000|C3829443|G0000000|C1442061|C0030705|G0000000|C1516050|C0010182|C0009738|C0450371|C0205099|C0008115
"The current study aims to assess the efficacy of acupuncture for providing effective analgesia to patients presenting with acute low back pain, migraine and ankle sprain at the EDs of four hospitals in Melbourne, Australia.","The current study aims assess efficacy acupuncture providing effective analgesia patients acute low pain, migraine ankle sprain EDs hospitals Melbourne, Australia.",G0000000|C0521116|C0557651|C1947946|C1516048|C1280519|C0001299|C1999230|C1280519|C0002766|C0030705|C0205178|C0205251|C0030193|C0149931|C0003086|C0038045|G0000000|C0019994|G0000000|C0004340
Children aged 4 to 60 months with AGE received LGG 6 × 109 colony forming units/day plus randomly either smectite (3 g) or placebo as an adjuvant to the standard rehydration therapy.,Children aged 4 60 months AGE received LGG 6 × 109 colony forming units/day randomly smectite (3 g) placebo adjuvant standard rehydration therapy.,C0008059|C0001779|G0000000|C0450371|C0439231|C0001779|C1514756|C1629836|G0000000|C0439158|C0205431|C0456683|G0000000|C0074690|G0000000|C0439267|C0032042|C0001551|C1442989|C0034997|C0039798
"Of these, 13 declined to participate and 7 were excluded due to incomplete information or withdrawal from the study.","Of these, 13 declined participate 7 excluded incomplete withdrawal study.",G0000000|G0000000|C0450371|G0000000|G0000000|G0000000|C1554077|C0205257|C2349954|C0557651
Participants (N=102) were randomly assigned to: 1) contingent behavioral incentives (CBI: n=42); 2) non-contingent behavioral incentives (NCBI: n=28); or 3) treatment as usual (TAU: n=32).,Participants (N=102) randomly assigned to: 1) contingent behavioral incentives (CBI: n=42); 2) non-contingent behavioral incentives (NCBI: n=28); 3) treatment usual (TAU: n=32).,C0679646|C0369718|G0000000|C1516050|G0000000|G0000000|C1701901|C0004927|C0021147|G0000000|C0369718|G0000000|C1518422|C0004927|C0021147|C0995203|C0369718|G0000000|C0039798|C3538928|C1720655|C0369718
Our study confirmed the beneficial effects of VRRT on balance and gait ability in people with chronic stroke.,Our study confirmed beneficial effects VRRT balance gait ability people chronic stroke.,G0000000|C0557651|C0521093|G0000000|C1280500|G0000000|C0014653|C0016928|C0085732|C0027361|C0205191|C0038454
Eighty two patients of mean (SD) age 11.0 (3.3) years and mean (SD) FEV1 85 (22)% predicted were randomised: 40 in the azithromycin group and 42 in the placebo group.,Eighty patients (SD) age 11.0 (3.3) years (SD) FEV1 85 (22)% predicted randomised: 40 azithromycin 42 placebo group.,C3816958|C0030705|G0000000|C0001779|C0450371|G0000000|G0000000|G0000000|C0450371|C0450371|C0681842|G0000000|C0450371|C0052796|C0450371|C0032042|C0441833
"Patients who regularly used daytime oxygen therapy for more than 1 hour per day and, in the investigator’s opinion, were unable to abstain from its use during clinic visits were excluded, as were those who were either currently on a pulmonary rehabilitation program or who had completed such a program in the previous 6 weeks.","Patients regularly daytime oxygen therapy 1 hour day and, investigator’s opinion, unable abstain clinic visits excluded, pulmonary rehabilitation program completed program previous 6 weeks.",C0030705|G0000000|C0332169|C0030054|C0039798|G0000000|C0439227|C0332173|G0000000|G0000000|C0871010|C1299582|G0000000|C0002424|C0545082|C1554077|C0024109|C0034991|C1709697|C0205197|C1709697|C0205156|G0000000|C0439230
The participants were 203 women with breast cancer with 177 completing the 6-month follow-up.,The participants 203 women breast cancer 177 completing 6-month follow-up.,G0000000|C0679646|C1442061|C0043210|C0006141|C0006826|C1442061|C0205197|C0332177|C0589120
Newborn screening allows novel treatments for cystic fibrosis (CF) to be trialled in early childhood before irreversible lung injury occurs.,Newborn screening treatments cystic fibrosis (CF) trialled childhood irreversible lung injury occurs.,C0021289|C0220908|C0087111|C0205207|C0016059|C0009738|G0000000|C0231335|G0000000|C0024109|C3263722|C1709305
"• Patients for whom survival to 28 days is unlikely due to an uncontrollable comorbidity (cardiac, pulmonary or hepatic end-stage disease; hepatorenal syndrome; poorly controlled cancer; severe post-anoxic encephalopathy; etc.).","• Patients survival 28 days uncontrollable comorbidity (cardiac, pulmonary hepatic end-stage disease; hepatorenal syndrome; controlled cancer; severe post-anoxic encephalopathy; etc.).",G0000000|C0038952|C0450371|C0439228|G0000000|C0009488|C0018787|C0024109|C0205054|C0205088|C0012634|C0545792|C0039082|C2587213|C0006826|C0205082|C0687676|C0006111|C1548556
A total of 131 services were randomised among which 68 were allocated to intervention and 63 to the control.,A total 131 services randomised 68 allocated intervention 63 control.,G0000000|C0439175|C1442061|C0557854|G0000000|C0450371|G0000000|C0886296|C0450371|C0243148
"Of the target area injuries, 47% resulted from fires started by children playing with fire (fireplay).","Of target injuries, 47% fires started children playing fire (fireplay).",G0000000|C1521840|C1510467|C0450371|C0016141|C1272689|C0008059|C0032214|C0016141|G0000000
"Subjects were excluded from the study if they were unlikely to survive 5 days, if there was evidence that the patient was unlikely to be neutropenic for at least 5 days, or if they had previously enrolled in this study.","Subjects excluded study survive 5 days, evidence patient neutropenic 5 days, enrolled study.",C0681850|C1554077|C0557651|C0310255|G0000000|C0439228|C3887511|C0030705|G0000000|G0000000|C0439228|G0000000|C0557651
A total of 800 infants of ≤32‐week gestational age who had been in an intensive care unit within 72 hours after birth were included in the trial between January 2009 and June 2013.,A total 800 infants ≤32‐week gestational age intensive care unit 72 hours birth included trial January 2009 June 2013.,G0000000|C0439175|C1442061|C0021270|G0000000|C0439671|C0001779|C0162425|C1947933|C0439148|C0450371|C0439227|C0005615|C0332257|C0008976|C3829466|G0000000|C3829443|G0000000
"The study population comprised 1.98 million people, of whom 52.6% (1 024 019) had been vaccinated.","The study population comprised 1.98 people, 52.6% (1 024 019) vaccinated.",G0000000|C0557651|C0032659|C2700400|C0450371|C0027361|C0450371|G0000000|C1116171
"Patients were excluded with concomitant or past malignancy within 5 years (except for basal cell carcinoma or SCC of the skin or in situ carcinoma of the cervix), tumour within 2 cm of cricopharyngeus, tumour including >2 cm of gastric wall or previous treatment that compromised the ability to deliver definitive chemoradiotherapy or surgery.","Patients excluded concomitant malignancy 5 (except basal cell carcinoma SCC skin situ carcinoma cervix), tumour 2 cm cricopharyngeus, tumour including >2 cm gastric wall previous treatment compromised ability deliver definitive chemoradiotherapy surgery.",C0030705|C1554077|C0521115|C0006826|G0000000|G0000000|C0205112|C0007634|C0007097|G0000000|C0444099|G0000000|C0007097|C0007874|C0027651|G0000000|C0224214|C0027651|C0332257|G0000000|C0038351|C0677535|C0205156|C0039798|C2945640|C0085732|C0308779|C0443196|C0436307|C0038894
"In accordance with the secondary prevention aims of the intervention (i.e., targeting symptoms of psychological distress and common mental disorders, and strengthening protective factors), this 7-item screening procedure assesses, with both children and teachers: a) the existence of risk factors (i.e., reporting exposure to war-related events, distress during such exposure, current psychological symptoms, and affected school functioning); b) the absence of protective factors (i.e., reporting a lack of social support and coping capacity).","In secondary prevention aims intervention (i.e., targeting symptoms psychological distress common mental disorders, strengthening protective factors), 7-item screening procedure assesses, children teachers: a) existence risk factors (i.e., reporting exposure war-related events, distress exposure, current psychological symptoms, school functioning); b) absence protective factors (i.e., reporting lack social support coping capacity).",G0000000|C0027627|C0199176|C1947946|C0886296|C0683454|C1521840|C0683368|C0205486|C0231303|C0205214|C0229992|C0012634|G0000000|G0000000|C1521761|C1551338|C0220908|C0184661|C1516048|C0008059|C0221457|G0000000|C0015276|C0035647|C1521761|C0683454|C0700287|C0274281|C0043027|C0441471|C0231303|C0274281|C0521116|C0205486|C0683368|C0036375|C0205245|G0000000|C0332197|G0000000|C1521761|C0683454|C0700287|C0332268|C0728831|C0183683|C0009967|C1516240
"A total of 102 patients with histopathologically proven squamous cell carcinoma, adenocarcinoma, or adenosquamous cell carcinoma, and radiologic negative PALN locally advanced cervical cancer, stage IIB-IVA, were accrued between July 2007 and April 2008 and were randomly assigned to WP-CCRT (50 patients) or EF-CCRT (52 patients), followed by high-dose rate brachytherapy.","A total 102 patients histopathologically proven squamous cell carcinoma, adenocarcinoma, adenosquamous cell carcinoma, radiologic negative PALN locally advanced cervical cancer, stage IIB-IVA, accrued July 2007 April 2008 randomly assigned WP-CCRT (50 patients) EF-CCRT (52 patients), high-dose rate brachytherapy.",G0000000|C0439175|C1442061|C0030705|G0000000|C0456369|C1182670|C0007634|C0007097|C0001418|G0000000|C0007634|C0007097|C0034599|C0205160|G0000000|C1517927|C0205179|C0027530|C0006826|C0205390|C0268575|G0000000|C3829447|G0000000|C3715024|G0000000|G0000000|C1516050|G0000000|C0450371|C0030705|G0000000|C0450371|C0030705|C0444956|C0871208|C0006098
"Early stage disease is treated with either surgery or radiotherapy (RT) alone, whilst locally advanced disease requires multimodality treatment with primary chemoradiotherapy (CRT) +/- neck dissection or primary surgical resection followed by post-operative RT/CRT.","Early stage disease treated surgery radiotherapy (RT) alone, whilst locally advanced disease requires multimodality treatment primary chemoradiotherapy (CRT) +/- neck dissection primary surgical resection post-operative RT/CRT.",C1279919|C0205390|C0012634|C1522326|C0038894|C0034619|C0230425|C0205171|G0000000|C1517927|C0205179|C0012634|G0000000|C1513743|C0039798|C0205225|C0436307|G0000000|G0000000|C0027530|C0012737|C0205225|C0543467|C0015252|C0032790|C0230425
"Inclusion criteria were a diagnosis of relapsing-remitting MS,14 age 18–55 years, and screening (within 1 month of baseline) serum 25(OH)D level of 20–50 ng/mL.","Inclusion criteria diagnosis relapsing-remitting MS,14 age 18–55 years, screening (within 1 month baseline) serum 25(OH)D level 20–50 ng/mL.",C0007637|C0243161|C0011900|C0035020|C0039676|C0001779|G0000000|C0439234|C0220908|G0000000|G0000000|C0332177|C0168634|C0229671|C0450371|C0441889|G0000000|C0439275
"Exclusion criteria were cold symptoms in the 2 weeks before virus challenge; history of allergic rhinitis, bronchial asthma, chronic sinusitis, or chronic lung disease; and allergy to the study medications.","Exclusion criteria cold symptoms 2 weeks virus challenge; history allergic rhinitis, bronchial asthma, chronic sinusitis, chronic lung disease; allergy study medications.",C0680251|C0243161|C0009264|C0683368|G0000000|C0439230|C0042776|C0798503|C0019664|C0700624|C0035455|C0205039|C0004096|C0205191|C0037199|C0205191|C0024109|C0012634|C0002111|C0557651|C0013227
Outcomes are similar with hospitalizations for MS or WR when combined with FBT.,Outcomes hospitalizations MS WR combined FBT.,C1274040|C0019993|C0039676|C1420193|C0205195|G0000000
ESRD patients will be recruited into the study during transplant medical evaluation if they meet inclusion criteria: (i) 18 to 70 years of age; (ii) no previous solid organ or multiorgan transplant; (iii) English speaking; and (iv) no severe cognitive or visual impairment.,ESRD patients recruited study transplant medical evaluation meet inclusion criteria: (i) 18 70 age; (ii) previous solid organ multiorgan transplant; (iii) English speaking; (iv) severe cognitive visual impairment.,C0022661|C0030705|G0000000|C0557651|C0040732|C0199168|C0220825|C1550543|C0007637|C0243161|C0021966|C0450371|C0450371|C0001779|G0000000|C0205156|C0205208|C0178784|G0000000|C0040732|C0439070|C0376245|C0234856|C0022326|C0205082|C1516691|C0234621|C0221099
"They also were well balanced in body mass index, baseline blood selenium, performance status, and number of cores revealing HGPIN.","They balanced body mass index, baseline blood selenium, performance status, cores revealing HGPIN.",G0000000|C0205415|C0242821|C0577559|C0918012|C0168634|C0005767|C0036581|C0597198|C0449438|C0444669|C0443289|C1168327
"Participants 314 patients with ischaemic stroke aged ≥40 years who were able to walk—157 (mean age 69.7 years) randomised to the intervention, 157 (mean age 69.4 years) in the control group.","Participants 314 patients ischaemic stroke aged ≥40 walk—157 (mean age 69.7 years) randomised intervention, 157 (mean age 69.4 years) control group.",C0679646|C1442061|C0030705|C0475224|C0038454|C0001779|G0000000|G0000000|C0444504|C0001779|C0450371|C0439234|G0000000|C0886296|C1442061|C0444504|C0001779|C0450371|C0439234|C0243148|C0441833
"MCI is considered to be a potential transitional stage between normal cognitive function and Alzheimer’s disease, characterized by (1) subjective memory complaint (2) objective memory impairment (3) normal mental status (4) intact activities of daily living (ADL) (5) absence of dementia [1].","MCI considered potential transitional stage normal cognitive function Alzheimer’s disease, characterized (1) subjective memory complaint (2) objective memory impairment (3) normal mental status (4) intact activities daily living (ADL) (5) absence dementia [1].",C0560005|C0750591|C3245505|C1182674|C0205390|C0205307|C1516691|C0031843|G0000000|C0012634|C1880022|G0000000|C0439655|C0025260|C0277786|G0000000|C0018017|C0025260|C0221099|G0000000|C0205307|C0229992|C0449438|G0000000|C0205266|C0441655|C0332173|C0376558|C0001288|G0000000|C0332197|C0011265|G0000000
Main outcome measures Complete clearance of all plantar warts at 12 weeks.,Main outcome measures Complete clearance plantar warts 12 weeks.,C0205225|C1274040|C0079809|C0205197|C0449297|C0230463|C1367460|C0450371|C0439230
"Setting 24 elderly care wards in 12 hospitals in Sydney, Australia.","Setting 24 elderly care wards 12 hospitals Sydney, Australia.",C0542559|C0450371|C0001792|C1947933|C1305702|C0450371|C0019994|G0000000|C0004340
The majority of people with dementia live at home.,The majority people dementia live home.,G0000000|C0680220|C0027361|C0011265|C1548795|C0442519
The inclusion criteria were healthy males or females aged between 18 and 65 years.,The inclusion criteria healthy males females aged 18 65 years.,G0000000|C0007637|C0243161|C3898900|C0086582|C0015780|C0001779|C0450371|C0450371|C0439234
Patients had bone metastases for a median of 15 months (range 3–106) and received IV bisphosphonates for a median of 14 months (range 3–106).,Patients bone metastases median 15 months (range 3–106) received IV bisphosphonates median 14 months (range 3–106).,C0030705|C0262950|C0027627|C0549183|C0450371|C0439231|C1514721|G0000000|C1514756|C0022326|C0012544|C0549183|C0450371|C0439231|C1514721|G0000000
"Thus, women for whom there are suspicions of any of the following disorders will be excluded: osteoarthritis, bursitis, tendinitis, rheumatoid arthritis, palindromic rheumatism, polymyalgic rheumatic disease, hydroxyapatite crystal diseases, systemic lupus erythematous, dermatomyositis-polymyositis complex, Lyme disease, hypothyroidism or hyperthyroidism, hyperparathyroidism, previous history of hepatitis, and history for Epstein-Barr virus infection.","Thus, women suspicions disorders excluded: osteoarthritis, bursitis, tendinitis, rheumatoid arthritis, palindromic rheumatism, polymyalgic rheumatic disease, hydroxyapatite crystal diseases, systemic lupus erythematous, dermatomyositis-polymyositis complex, Lyme disease, hypothyroidism hyperthyroidism, hyperparathyroidism, previous history hepatitis, history Epstein-Barr virus infection.",G0000000|C0043210|C0242114|C0012634|C1554077|C0029408|C0006444|C0039503|G0000000|C0003864|G0000000|C0009326|G0000000|G0000000|C0012634|C0115137|C0427896|C0012634|C0205373|C0024131|C0332476|C0011633|C0439855|G0000000|C0012634|C0020676|C0020550|C0020502|C0205156|C0019664|C0019158|C0019664|C1396851|C0042776|C0009450
Average parasite prevalence in different areas and different months in 2010 (A) and 2011 (B).,Average parasite prevalence months 2010 (A) 2011 (B).,C1510992|C0030498|C0033105|C0439231|G0000000|G0000000|G0000000|G0000000
"Recurrent wheezing episodes in pre-school-age children are usually triggered by respiratory tract infections,1,2 which often progress to severe exacerbations requiring systemic glucocorticoids3 and frequent use of health care services.4,5 In children under the age of 5 years who had at least four wheezing episodes during the previous year and positive values on the modified asthma predictive index (API) (indicating an increased likelihood of persistent asthma in the future),6,7 the National Asthma Education and Prevention Program Expert Panel Report 3 (EPR-3) recommends the initiation of long-term daily inhaled glucocorticoid therapy8 on the basis of the results of the Childhood Asthma Research and Education (CARE) Network Prevention of Early Asthma in Kids (PEAK) trial (ClinicalTrials.gov number, {""type"":""clinical-trial"",""attrs"":{""text"":""NCT00272441"",""term_id"":""NCT00272441""}}NCT00272441).9 In a post hoc analysis, investigators in the PEAK trial found that daily therapy with inhaled glucocorticoids most benefited children who had had at least one exacerbation requiring emergency or hospital care during the previous year.10 Daily use of inhaled glucocorticoids in the PEAK trial was associated with a small but significant reduction in height growth, as compared with placebo, a reduction that was only partially reversed during a 1-year observation period after the discontinuation of study treatments.9 Concern about growth retardation and parental resistance to a daily regimen of inhaled glucocorticoids for young children, who usually have only episodic but often severe symptoms, stimulated a search for alternative strategies — specifically, intermittent therapy with inhaled glucocorticoids.","Recurrent wheezing episodes pre-school-age children triggered respiratory tract infections,1,2 progress severe exacerbations requiring systemic glucocorticoids3 frequent health care services.4,5 In children age 5 wheezing episodes previous positive values modified asthma predictive (API) (indicating increased likelihood persistent asthma future),6,7 National Asthma Education Prevention Program Expert Panel Report 3 (EPR-3) recommends initiation long-term daily inhaled glucocorticoid therapy8 basis Childhood Asthma Research Education (CARE) Network Prevention Early Asthma Kids (PEAK) trial (ClinicalTrials.gov number, {""type"":""clinical-trial"",""attrs"":{""text"":""NCT00272441"",""term_id"":""NCT00272441""}}NCT00272441).9 In post hoc analysis, investigators PEAK trial daily therapy inhaled glucocorticoids benefited children exacerbation requiring emergency hospital care previous year.10 Daily inhaled glucocorticoids PEAK trial reduction height growth, compared placebo, reduction partially reversed 1-year observation period discontinuation study treatments.9 Concern growth retardation parental resistance daily regimen inhaled glucocorticoids children, episodic severe symptoms, stimulated search alternative strategies — specifically, intermittent therapy inhaled glucocorticoids.",C2945760|C0043144|C0332189|C0424930|C0008059|C0032930|C0521346|C1185740|C3714514|C1272688|C0205082|G0000000|G0000000|C0205373|G0000000|C0332183|C0018684|C1947933|C0557854|G0000000|C0008059|C0001779|G0000000|C0043144|C0332189|C0205156|C0439178|C0042295|C0392747|C0004096|C0681890|G0000000|G0000000|C0205217|C0033204|C0205322|C0004096|C0016884|C3245503|C0004096|C0013621|C0199176|C1709697|G0000000|C0441833|C0684224|G0000000|G0000000|C0034866|C0589507|C0443252|C0332173|C0004048|C0017710|G0000000|C1527178|C0231335|C0004096|C0035168|C0013621|C1947933|C0150775|C0199176|C1279919|C0004096|C0680063|C0444505|C0008976|C1419208|C0237753|C0332307|G0000000|C0687676|G0000000|C0002778|C0035173|C0444505|C0008976|C0332173|C0039798|C0004048|C0017710|C0814225|C0008059|G0000000|G0000000|C0013956|C0019994|C1947933|C0205156|C0439234|C0332173|C0004048|C0017710|C0444505|C0008976|C0301630|C0489786|C0018270|C1707455|C0032042|C0301630|G0000000|C1555029|C0439234|C0302523|C0439531|C0457454|C0557651|C0087111|C2699424|C0018270|C0521111|C0030551|C0237834|C0332173|C0040808|C0004048|C0017710|C0008059|C1455761|C0205082|C0683368|C1948023|C1552603|C1523987|C0679199|G0000000|G0000000|C0205267|C0039798|C0004048|C0017710
Patients were randomized 2:1 to paracentesis plus catumaxomab or paracentesis alone (control) and stratified by cancer type (ovarian and nonovarian).,Patients randomized 2:1 paracentesis catumaxomab paracentesis (control) stratified cancer type (ovarian nonovarian).,C0030705|C0034656|G0000000|C0034115|C1831854|C0034115|C0243148|C0205363|C0006826|C0332307|C0205065|G0000000
Mean age of participants was 20.4 years; 80% were African American.,Mean age participants 20.4 years; 80% African American.,C0444504|C0001779|C0679646|C0450371|C0439234|C0450371|C0027567|C0596070
"In the nephrology setting, home telemonitoring has been evaluated in home dialysis patients but data are scarce concerning chronic kidney disease (CKD) patients before and after renal replacement therapy.","In nephrology setting, telemonitoring evaluated dialysis patients data scarce chronic kidney disease (CKD) patients renal replacement therapy.",G0000000|C0027712|C0542559|G0000000|C0220825|C0011945|C0030705|C1511726|G0000000|C0205191|C0022646|C0012634|C1561643|C0030705|C0022646|C0035139|C0039798
"Postmenopausal women with amenorrhea for at least 12 months to be considered of non-childbearing potential; 2) No target lesion; 3) No CT evaluation; 4) Prior systemic therapy for advanced or metastatic disease (for instance, cytotoxic chemotherapy or history of another malignancy within the last five years except cured basal cell carcinoma of skin and cured carcinoma in-situ of uterine cervix.","Postmenopausal women amenorrhea 12 months considered non-childbearing potential; 2) No target lesion; 3) No CT evaluation; 4) Prior systemic therapy advanced metastatic disease (for instance, cytotoxic chemotherapy history malignancy cured basal cell carcinoma skin cured carcinoma in-situ uterine cervix.",C0232970|C0043210|C0002453|C0450371|C0439231|C0750591|C1518422|C3245505|G0000000|G0000000|C1521840|C0221198|G0000000|G0000000|C0007673|C0220825|G0000000|C0332152|C0205373|C0039798|C0205179|C0036525|C0012634|G0000000|C1550608|C0677881|C0013216|C0019664|C0006826|C1880198|C0205112|C0007634|C0007097|C0444099|C1880198|C0007097|C0444498|C0042149|C0007874
"Eligibility criteria for the RCT (and also for the current analysis) included age ≥ 18 years, singleton pregnancy, gestational age at enrollment <23 weeks, and plans to stay in the Boston area through delivery.","Eligibility criteria RCT (and current analysis) included age ≥ 18 years, singleton pregnancy, gestational age enrollment <23 weeks, plans stay Boston delivery.",C0013893|C0243161|G0000000|G0000000|C0521116|C0002778|C0332257|C0001779|G0000000|C0450371|C0439234|C0481462|C0032961|C0439671|C0001779|C1516879|C0450371|C0439230|C0270724|G0000000|C0006037|C0011209
Inclusion criteria will include smokers ≥18 years in the pre-contemplation or contemplation phases described by Prochaska and DiClemente.,Inclusion criteria smokers ≥18 years pre-contemplation contemplation phases Prochaska DiClemente.,C0007637|C0243161|C0337664|G0000000|C0332152|G0000000|C0585064|G0000000|G0000000
"Child care centers with funding from Head Start, the San Francisco Unified School District, or Community College District were ineligible to receive CCHP screenings, and excluded from the HAP pilot.","Child care centers funding Head Start, San Francisco Unified School District, Community College District ineligible receive CCHP screenings, excluded HAP pilot.",C0008059|C1947933|C0205099|C0243098|C0018670|C0439659|C1826357|G0000000|C1548174|C0036375|G0000000|C0009462|C0557806|G0000000|C1512714|C1514756|G0000000|C0220908|C1554077|G0000000|C0473169
"Trial participants received antimicrobial treatment for tuberculosis and antiretroviral treatment for HIV according to World Health Organization (WHO) guidelines; management during the course of the trial was revised as recommended treatment practices evolved.13,26–28 No routine testing for drug resistance of either M. tuberculosis isolates or HIV isolates was performed before or during treatment.","Trial participants received antimicrobial treatment tuberculosis antiretroviral treatment HIV World Health Organization (WHO) guidelines; management trial revised recommended treatment practices evolved.13,26–28 No routine testing drug resistance M. tuberculosis isolates HIV isolates performed treatment.",C0008976|C0679646|C1514756|C1136254|C0039798|C0041296|G0000000|C0039798|C0019682|C2700280|C0018684|C0029237|G0000000|C0162791|C0001554|C0008976|C1527075|C0034866|C0039798|C0237607|G0000000|G0000000|C0205547|C0039593|C0013227|C0237834|C0369637|C0041296|C1764827|C0019682|C1764827|C0884358|C0039798
"The following inclusion criteria had to be fulfilled: Postmenopausal women and men, non-smoking, between 40 and 65 years old, BMI between 20 and 32 kg/m2, homocysteine level above or equal to 10 μmol/l, elevated systolic blood pressure (mean of 130–149 mmHg measured during a period of 7 days before visit 1) but without requiring medical therapy.","The inclusion criteria fulfilled: Postmenopausal women men, non-smoking, 40 65 old, BMI 20 32 kg/m2, homocysteine level equal 10 μmol/l, elevated systolic blood pressure (mean 130–149 mmHg measured period 7 days visit 1) requiring medical therapy.",G0000000|C0007637|C0243161|C1550543|C0232970|C0043210|C0025266|C1518422|C0450371|C0450371|C0580836|G0000000|C0450371|C0450371|C0022718|C0019878|C0441889|C0205163|C0450371|G0000000|C0205250|C0039155|C0005767|C0033095|C0444504|G0000000|C0439475|C0444706|C0439531|G0000000|C0439228|C0545082|G0000000|G0000000|C0199168|C0039798
"Adult men and women meeting clinical criteria for PI were studied (n=20, body mass index 25.1±2.7 kg/m2, age 39.7±7.9) in a randomized, double-blind, placebo-controlled clinical trial.","Adult women meeting clinical criteria PI studied (n=20, body mass 25.1±2.7 kg/m2, age 39.7±7.9) randomized, double-blind, placebo-controlled clinical trial.",C0001675|C0043210|C0556656|C0205210|C0243161|C0429863|C0557651|C0369718|C0242821|C0577559|G0000000|C0022718|C0001779|G0000000|C0034656|C0013072|C1706408|C0205210|C0008976
"; (iii) use of CS or other immunosuppressive agents within 6 months prior to randomization; (iv) serum creatinine (Scr) > 250umol/L; (v) severe infections; (vi) hepatitis B virus carriers and other chronic liver diseases; (vii) presence of malignancy, HIV infection, or acute central nervous system diseases; (viii) abnormal glucose metabolism; (ix) pregnancy or lactation; (x) poor compliance or allergy to study drugs.","; (iii) CS immunosuppressive agents 6 months prior randomization; (iv) serum creatinine (Scr) > 250umol/L; (v) severe infections; (vi) hepatitis B virus carriers chronic liver diseases; (vii) presence malignancy, HIV infection, acute central nervous system diseases; (viii) abnormal glucose metabolism; (ix) pregnancy lactation; (x) poor compliance allergy study drugs.",G0000000|C0439070|C0010182|C0021081|C0450442|G0000000|C0439231|C0332152|C0034656|C0022326|C0229671|C0010294|C1539487|G0000000|C0439394|G0000000|C0205082|C3714514|C0205999|C0019158|G0000000|C0042776|C0007294|C0205191|C0023884|C0012634|C0445385|C0150312|C0006826|C0019682|C0009450|C0205178|C0205099|C0027769|C0449913|C0012634|C0445599|C0205161|C0017725|C0025519|C0015491|C0032961|C0006147|G0000000|C0032854|C0009563|C0002111|C0557651|C0013227
A total of 90 molars from 42 children aged 4–8 years were selected for pulpotomy procedure.,A total 90 molars 42 children aged 4–8 selected pulpotomy procedure.,G0000000|C0439175|C0450371|C0026367|C0450371|C0008059|C0001779|G0000000|C1707391|C0034104|C0184661
"Pregnant women aged over 18, who had no health problem, did not intend to lose weight in prepregnancy period, got pregnant in natural ways for two times at most, and were pregnant for a period of 3 months or less, were included in the study.","Pregnant women aged 18, health problem, intend lose weight prepregnancy period, pregnant natural times most, pregnant period 3 months less, included study.",C0549206|C0043210|C0001779|C0450371|C0018684|C0033213|G0000000|G0000000|C0005910|C2709093|C0439531|C0549206|C0205296|C0040223|C0205393|C0549206|C0439531|G0000000|C0439231|C0439092|C0332257|C0557651
"The overall target sample is 40 schools with year-8 enrolments above 100 students, stratified by Government, Catholic, and Independent sectors and geographical location, with up to 20 schools recruited in each of two states, Western Australia (WA) and South Australia (SA).","The target sample 40 schools year-8 enrolments 100 students, stratified Government, Catholic, Independent sectors geographical location, 20 schools recruited states, Western Australia (WA) South Australia (SA).",G0000000|C1521840|C0370003|C0450371|C0036375|C0439234|G0000000|C1442061|C0038492|C0205363|C0018104|C0242211|C0085862|C1708237|C0017447|C0450429|C0450371|C0036375|G0000000|C1301808|C1705493|C0004340|C0027366|C1710133|C0004340|C0036243
"A total of 1,741 PD participants from 45 sites in the U.S. and Canada were randomized 1:1 to either 10-gm creatine/day or matching placebo.","A total 1,741 PD participants 45 sites U.S. Canada randomized 1:1 10-gm creatine/day matching placebo.",G0000000|C0439175|C1442061|G0000000|C0679646|C0450371|C0205145|C0041703|C0006823|C0034656|G0000000|C0450371|C0010286|C0150103|C0032042
We randomly assigned patients who had a recent transient ischemic attack or stroke attributed to stenosis of 70 to 99% of the diameter of a major intracranial artery to aggressive medical management alone or aggressive medical management plus PTAS with the use of the Wingspan stent system.,We randomly assigned patients transient ischemic attack stroke attributed stenosis 70 99% diameter major intracranial artery aggressive medical management aggressive medical management PTAS Wingspan stent system.,G0000000|G0000000|C1516050|C0030705|C0040704|C0475224|C0277793|C0038454|C0449234|C0678234|C0450371|C0450371|C1301886|C0205082|C0524466|C0003842|C0001807|C0199168|C0001554|C0001807|C0199168|C0001554|C3274435|G0000000|C0038257|C0449913
Women with stages 0 to III breast cancer were recruited before XRT.,Women stages 0 III breast cancer recruited XRT.,C0043210|C1306673|G0000000|C0439070|C0006141|C0006826|G0000000|G0000000
"able-bodied, 11–14 years age) were included in the study.","able-bodied, 11–14 age) included study.",C0085732|G0000000|C0001779|C0332257|C0557651
"Exclusion criteria included current acute illness, pregnancy, or history of allergic reaction to any component of IPV.","Exclusion criteria included current acute illness, pregnancy, history allergic reaction component IPV.",C0680251|C0243161|C0332257|C0521116|C0205178|C0221423|C0032961|C0019664|C0700624|C0443286|C0449432|G0000000
"In stage II and III adenocarcinoma, in contrast, no difference in survival was seen either overall, or by ploidy.","In stage II III adenocarcinoma, contrast, difference survival overall, ploidy.",G0000000|C0205390|G0000000|C0439070|C0001418|C0009924|C1705241|C0038952|C0282416|C0032246
"Patients taking medications with possible effects on alcohol use (e.g., naltrexone, disulfiram or topiramate) were excluded, as were patients with active, serious medical illness, suicidality, or severe psychiatric instability.","Patients medications effects alcohol (e.g., naltrexone, disulfiram topiramate) excluded, patients active, medical illness, suicidality, severe psychiatric instability.",C0030705|C0013227|C1280500|C0001962|G0000000|C0027360|C0012772|C0076829|C1554077|C0030705|C0205177|C0199168|C0221423|C3166387|C0205082|C0205487|C1444783
"A total of 104 subjects with both type 1 and 2 diabetes were screened between February 2007 and March 2009, and 83 were enrolled and randomized.","A total 104 subjects type 1 2 diabetes screened February 2007 March 2009, 83 enrolled randomized.",G0000000|C0439175|C1442061|C0681850|C0332307|G0000000|G0000000|C0011847|C0220908|C3830166|G0000000|C3829202|G0000000|C0450371|G0000000|C0034656
At 12 months participants were telephoned.,At 12 months participants telephoned.,G0000000|C0450371|C0439231|C0679646|C0039457
"A total of 1577 subjects were screened; 1142 (72%) were randomly assigned to receive azithromycin, at a dose of 250 mg daily (570 participants), or placebo (572 participants) for 1 year in addition to their usual care.","A total 1577 subjects screened; 1142 (72%) randomly assigned receive azithromycin, dose 250 daily (570 participants), placebo (572 participants) 1 addition usual care.",G0000000|C0439175|G0000000|C0681850|C0220908|G0000000|C0450371|G0000000|C1516050|C1514756|C0052796|C0178602|C1442061|C0332173|C1442061|C0679646|C0032042|C1442061|C0679646|G0000000|C0332287|C3538928|C1947933
Most were boys (84%); the average age was 17.10 years (SD = 1.11).,Most boys (84%); average age 17.10 (SD = 1.11).,C0205393|C0870221|C0450371|C1510992|C0001779|C0450371|G0000000|G0000000|C0450371
"Patients were excluded if they resided outside the region, had insufficient English speaking skills, were resident in a nursing home, or were confused or demented.","Patients excluded resided region, insufficient English speaking skills, resident nursing home, confused demented.",C0030705|C1554077|C2982691|C0017446|C0205412|C0376245|C0234856|C0678856|C1320928|C0006147|C0442519|C0009676|C0860630
"Use of antihypertensive agents in essential tremor, Parkinson's disease, dementia and controls Some participants were taking more than one antihypertensive agent.","Use antihypertensive agents essential tremor, Parkinson's disease, dementia controls Some participants antihypertensive agent.",C0042153|C0003364|C0450442|C0205224|C0040822|C1021144|C0012634|C0011265|C0243148|G0000000|C0679646|C0003364|C0450442
"For exclusion criteria were considered other forms of dementia, alternative feeding requirement (tube feeding), type 1 and 2 diabetes mellitus, and renal diseases.","For exclusion criteria considered forms dementia, alternative feeding requirement (tube feeding), type 1 2 diabetes mellitus, renal diseases.",G0000000|C0680251|C0243161|C0750591|C0348078|C0011265|C1523987|C0204695|C1514873|C0175730|C0204695|C0332307|G0000000|G0000000|C0011847|G0000000|C0022646|C0012634
"We conducted a zinc supplementation trial among 1295 Peruvian pregnant women from 1995 to 1997 and reported no effect on birth outcomes, including newborn anthropometry, by maternal prenatal supplement type (15).","We conducted zinc supplementation trial 1295 Peruvian pregnant women 1995 1997 reported birth outcomes, including newborn anthropometry, maternal prenatal supplement type (15).",G0000000|C0004927|C0043481|C0242297|C0008976|G0000000|C1553375|C0549206|C0043210|G0000000|G0000000|C0684224|C0005615|C1274040|C0332257|C0021289|C0003188|C2347083|C0678804|C0242295|C0332307|C0450371
"The analytic sample consisted of 147 mothers (71 from control, and 76 from the intervention group) who completed interviews when children were 6 months old (wave 2), interviewed from 2004 to 2006.","The analytic sample consisted 147 mothers (71 control, 76 intervention group) completed interviews children 6 months (wave 2), interviewed 2004 2006.",G0000000|G0000000|C0370003|C0332529|C1442061|C0026591|C0450371|C0243148|C0450371|C0886296|C0441833|C0205197|C0021822|C0008059|G0000000|C0439231|C0678544|G0000000|C0021822|G0000000|G0000000
"From 100 cases of histologically confirmed PC, followed at the service of urology and at the emergency department in Clinic of Urology-Nephrology and Kidney Transplant Daksi, Constantine, one patient refused to participate and 9 were too ill to be interviewed.","From 100 histologically confirmed PC, service urology emergency department Clinic Urology-Nephrology Kidney Transplant Daksi, Constantine, patient refused participate 9 ill interviewed.",G0000000|C1442061|C0205462|C0521093|C0031995|C0557854|C0042077|C0013956|C1704729|C0002424|C0042077|C0022646|C0040732|G0000000|G0000000|C0030705|C1548564|G0000000|G0000000|C0231218|C0021822
Participants of the study were living in six residential and extended care facilities in the North-Western part of The Netherlands (i.e.,Participants study living residential extended care facilities North-Western The Netherlands (i.e.,C0679646|C0557651|C0376558|C0237096|C0231448|C1947933|C1547538|C1709269|G0000000|C0027778|C0683454
Intervention adherence and attendance was measured by the total number of planned CR classes attended by participants allocated to the intervention group.,Intervention adherence attendance measured total planned CR classes attended participants allocated intervention group.,C0886296|C1510802|C2827364|C0444706|C0439175|C1301732|C0201975|C0456387|C1456498|C0679646|G0000000|C0886296|C0441833
"In this context, it is important that the proportion of patients who are excluded from clinical trials because of a lack of measurable disease be minimised.","In context, proportion patients excluded clinical trials lack measurable disease minimised.",G0000000|C0449255|C1709707|C0030705|C1554077|C0205210|C0008976|C0332268|C1513040|C0012634|G0000000
"Forty electoral wards in two boroughs of inner London, United Kingdom.","Forty electoral wards boroughs London, United Kingdom.",C3816449|G0000000|C1305702|G0000000|C0023973|C0166872|C1708611
"Study participants are randomized to: •Intensive versus guideline BP lowering - all participants •Intensive versus guideline lipid lowering - ischaemic stroke only As a result, patients can be randomised to one of six groups: 1.","Study participants randomized to: •Intensive versus guideline BP lowering - participants •Intensive versus guideline lipid lowering - ischaemic stroke As result, patients randomised groups: 1.",C0557651|C0679646|C0034656|G0000000|G0000000|G0000000|C0162791|C0037623|C0441994|G0000000|C0679646|G0000000|G0000000|C0162791|C0023779|C0441994|G0000000|C0475224|C0038454|G0000000|C1274040|C0030705|G0000000|C0441833|G0000000
Four patients in the verum group and 5 patients in the placebo group reached remission during the observation period but 2 patients receiving L. GG and 3 patients on placebo relapsed.,Four patients verum 5 patients placebo reached remission observation period 2 patients receiving L. GG 3 patients placebo relapsed.,C0205450|C0030705|G0000000|G0000000|C0030705|C0032042|C2584321|C0544452|C0302523|C0439531|G0000000|C0030705|C1514756|C0439394|C0017454|G0000000|C0030705|C0032042|C0205336
We enrolled 41 patients between August 2002 and March 2008 in order to achieve 36 evaluable patients (9 per arm).,We enrolled 41 patients August 2002 March 2008 achieve 36 evaluable patients (9 arm).,G0000000|G0000000|C0450371|C0030705|C3831448|G0000000|C3829202|G0000000|G0000000|C0450371|C1516986|C0030705|G0000000|C0446516
Patients with an adequate follow-up duration of more than one year after the surgery were included in the analysis.,Patients adequate follow-up duration surgery included analysis.,C0030705|C0205410|C0589120|C0449238|C0038894|C0332257|C0002778
(14) showed in their study from 2002 that depressive symptoms predict falls after stroke.,(14) study 2002 depressive symptoms predict falls stroke.,C0450371|C0557651|G0000000|G0000000|C0683368|G0000000|C0000921|C0038454
"Descriptive Statistics at Baseline for Total Sample (n = 1096): African American and Latino Mother–Adolescent Dyads, New York, NY, 2004–2007  Of the dyads who were interviewed at baseline, 22% were not located for the final interview or did not participate in it.","Descriptive Statistics Baseline Total Sample (n = 1096): African American Latino Mother–Adolescent Dyads, New York, NY, 2004–2007 Of dyads interviewed baseline, 22% located final interview participate it.",C0678257|C0038215|C0168634|C0439175|C0370003|C0369718|G0000000|G0000000|C0027567|C0596070|C0086528|G0000000|C0870454|C0205314|G0000000|C0027976|G0000000|G0000000|C0870454|C0021822|C0168634|C0450371|G0000000|C0205088|C0021822|G0000000|G0000000
"Inclusion criteria were as follows: clinical diagnosis of stroke <3 months after stroke onset, first-ever stroke, dependent ambulation with severe gait impairment (functional ambulation category [FAC] < 2), and sufficient cognition to understand procedures and provide informed consent.","Inclusion criteria follows: clinical diagnosis stroke <3 months stroke onset, first-ever stroke, dependent ambulation severe gait impairment (functional ambulation category [FAC] < 2), sufficient cognition understand procedures provide informed consent.",C0007637|C0243161|C0332283|C0205210|C0011900|C0038454|G0000000|C0439231|C0038454|C0206132|C0205435|C0038454|C0851827|C0080331|C0205082|C0016928|C0221099|C0205245|C0080331|C0683312|G0000000|C0205410|C0009240|C0162340|C0025664|C1999230|C1522154|C1511481
"Participants in the present study were 128 boys and 138 girls (mean age = 13.4 years, SD = 0.68) and their primary caregivers (34 men, 232 women; mean age = 40.9 years, SD = 6.2).","Participants study 128 boys 138 girls (mean age = 13.4 years, SD = 0.68) primary caregivers (34 men, 232 women; age = 40.9 years, SD = 6.2).",C0679646|C0557651|C1442061|C0870221|C1442061|C0870604|C0444504|C0001779|G0000000|C0450371|C0439234|C2699239|G0000000|C0450371|C0205225|C0085537|C0450371|C0025266|C1442061|C0043210|C0001779|G0000000|C0450371|C0439234|C2699239|G0000000|G0000000
"Parents of 36/150 of the children given delayed prescriptions used antibiotics, and 77% were very satisfied.","Parents 36/150 children delayed prescriptions antibiotics, 77% satisfied.",C0030551|C0450371|C0008059|C0205421|C0033080|C0003232|C0450371|C0242428
"Inclusion criteria were a singleton pregnancy, myelomeningocele with the upper boundary located between T1 and S1, evidence of hindbrain herniation, a gestational age of 19.0 to 25.9 weeks at randomization, a normal karyotype, U.S. residency, and maternal age of at least 18 years.","Inclusion criteria singleton pregnancy, myelomeningocele upper boundary located T1 S1, evidence hindbrain herniation, gestational age 19.0 25.9 weeks randomization, normal karyotype, U.S. residency, maternal age 18 years.",C0007637|C0243161|C0481462|C0032961|C0025312|C1282910|G0000000|G0000000|C0041403|C1519428|C3887511|C0035507|C0019270|C0439671|C0001779|C0450371|C0450371|C0439230|C0034656|C0205307|C0022526|C0041703|C0035182|C2347083|C0001779|C0450371|C0439234
"Exclusion criteria included diagnosed neuropathies (n = 3, clinically examined by a neurologist) or reasons for being in a catabolic state (n = 2, opportunistic infections and active inflammation), within 3 months prior to the start of the study, or with C-reactive protein blood levels above 3.0 mg/l (n = 1), unable to exercise (n = 3) or refuse to participate for personal reasons (n = 4).","Exclusion criteria included diagnosed neuropathies (n = 3, clinically examined neurologist) reasons catabolic (n = 2, opportunistic infections active inflammation), 3 months prior start study, C-reactive protein blood levels 3.0 mg/l (n = 1), unable exercise (n = 3) refuse participate personal reasons (n = 4).",C0680251|C0243161|C0332257|C0011900|C0442874|G0000000|G0000000|C0332128|C0237426|C0392360|C0311402|G0000000|G0000000|C3714514|C0205177|C0021368|G0000000|C0439231|C0332152|C0439659|C0557651|C0205332|C0033684|C0005767|C0441889|G0000000|C0439268|G0000000|C1299582|C0015259|G0000000|C0017095|G0000000|C1519021|C0392360|G0000000
Then all patients were allocated to one of two groups; TXA group or control group (Figure 1).,Then patients allocated groups; TXA control (Figure 1).,C1883708|C0030705|G0000000|C0441833|G0000000|C0243148|G0000000|G0000000
"On admission to the outpatient surgery setting, parents of children ages 6 to 15 years who were to undergo tonsillectomy, with or without other concurrent minor procedures such as myringotomy tube placement, were approached to participate in the study.","On admission outpatient surgery setting, parents children ages 6 15 undergo tonsillectomy, concurrent minor procedures myringotomy tube placement, approached participate study.",G0000000|C0184666|C0029921|C0038894|C0542559|C0030551|C0008059|C0001779|G0000000|C0450371|G0000000|C0040423|C0205420|C0026193|C0025664|C0087123|C0175730|C0441587|C0449445|G0000000|C0557651
To determine the predictors of participation in a smoking-cessation program among patients with head and neck cancer.,To determine predictors participation smoking-cessation program patients head neck cancer.,C0040363|G0000000|C2698872|C0679823|C0085134|C1709697|C0030705|C0018670|C0027530|C0006826
Objective To determine the effectiveness of glucosamine in reducing pain from osteoarthritis of the knee.,Objective To determine effectiveness glucosamine reducing pain osteoarthritis knee.,C0018017|C0040363|G0000000|C1280519|C0017718|C0392756|C0030193|C0029408|C0022742
"The selection criteria were as follows: a score of 24 or higher on the Mini Mental State Examination-K (MMSE-K) indicating no cognitive impairment, stroke onset more than 6 months earlier, and no orthopedic or neurological disease history.","The selection criteria follows: score 24 Mini Mental State Examination-K (MMSE-K) indicating cognitive impairment, stroke onset 6 months earlier, orthopedic neurological disease history.",G0000000|C0036576|C0243161|C0332283|C0449820|C0450371|C0445542|C0229992|C1301808|C0597277|C0451306|G0000000|C1516691|C0221099|C0038454|C0206132|G0000000|C0439231|C1279919|C0029355|C0205494|C0012634|C0019664
"Exclusion criteria were as follows: (1) diagnosed heart failure, atrial fibrillation, chronic obstructive pulmonary disease or neoplasia; (2) inferior limbs prosthesis or amputation; (3) current CPAP treatment; (4) negative screening by the Berlin scale; (5) thrombosis of superior vena cava; (6) presence of ascites or pleural effusion.","Exclusion criteria follows: (1) diagnosed heart failure, atrial fibrillation, chronic obstructive pulmonary disease neoplasia; (2) inferior limbs prosthesis amputation; (3) current CPAP treatment; (4) negative screening Berlin scale; (5) thrombosis superior vena cava; (6) presence ascites pleural effusion.",C0680251|C0243161|C0332283|G0000000|C0011900|C0018787|C0231174|C0018792|C0232197|C0205191|C0549186|C0024109|C0012634|C0027651|G0000000|C0542339|C0015385|C0175649|C0002688|G0000000|C0521116|C0199451|C0039798|G0000000|C0205160|C0220908|C0005125|C0175659|G0000000|C0040053|C1282910|C0447122|C0521083|G0000000|C0150312|C0003962|C0032225|C0013687
Stratified block randomization for AD severity is performed to ensure equal distribution of patients with moderate and severe AD over the treatment arms (EASI 7.1–21 and EASI 21.1–50).,Stratified block randomization AD severity performed ensure equal distribution patients moderate severe AD treatment arms (EASI 7.1–21 EASI 21.1–50).,C0205363|C0028778|C0034656|G0000000|C0439793|C0884358|C0218063|C0205163|C0520511|C0030705|C0205081|C0205082|G0000000|C0039798|C0206655|C1516931|G0000000|C1516931|G0000000
"Eligible subjects had a diagnosis of laboratory-supported, probable or definite ALS according to El Escorial criteria [18], were between the ages of 21 and 80 years, and had a disease duration of less than five years from symptom onset.","Eligible subjects diagnosis laboratory-supported, probable definite ALS El Escorial criteria [18], ages 21 80 years, disease duration symptom onset.",C1548635|C0681850|C0011900|C0022877|C0033204|C0439544|G0000000|C1416870|G0000000|C0243161|C0450371|C0001779|C0450371|C0450371|C0439234|C0012634|C0449238|C1457887|C0206132
"Predefined clinical features were pain in the knees, swelling, stiffness and joint tenderness in persons of age more than 45 years, complaining of difficulty in walking for more than 2 years.","Predefined clinical features pain knees, swelling, stiffness joint tenderness persons age 45 years, complaining difficulty walking 2 years.",G0000000|C0205210|C1521970|C0030193|C0022742|C0013604|C0427008|C0022417|C0234233|C0027361|C0001779|C0450371|C0439234|G0000000|C1299586|C0080331|G0000000|C0439234
"Inclusion criteria were age between 2 months and 15 years, suffering from acute seizure episode and presence of parents (in order to acquire consent).","Inclusion criteria age 2 months 15 years, suffering acute seizure episode presence parents (in acquire consent).",C0007637|C0243161|C0001779|G0000000|C0439231|C0450371|C0439234|C0683278|C0205178|C0036572|C0332189|C0150312|C0030551|G0000000|C1706701|C1511481
"The inclusion criteria included: patients with poststroke UI; patients who were stable, cooperative, and could effectively communicate (to accomplish therapy); and patients who could finish the survey on urination and pre- and posttreatment.","The inclusion criteria included: patients poststroke UI; patients stable, cooperative, effectively communicate (to accomplish therapy); patients finish survey urination pre- posttreatment.",G0000000|C0007637|C0243161|C0332257|C0030705|G0000000|C1421312|C0030705|C0205360|C0679729|G0000000|C0566001|G0000000|G0000000|C0039798|C0030705|C1706059|C0038951|C0042034|C0332152|C2709088
"Twenty three IBS patients (18 women, mean age 39 (3) years) participated in the study.","Twenty IBS patients (18 women, age 39 (3) years) participated study.",C0724000|C0022104|C0030705|C0450371|C0043210|C0001779|C0450371|G0000000|G0000000|C0557651
"The basis for this design was a needs assessment conducted from 1997 to 1999, which found very low levels of breast cancer screening knowledge among Hmong women in all 3 cities.11 In Long Beach, however, preexisting educational efforts were already being conducted through a community agency.","The basis design assessment conducted 1997 1999, low levels breast cancer screening knowledge Hmong women 3 cities.11 In Long Beach, however, preexisting educational efforts conducted community agency.",G0000000|C1527178|C1707689|C1261322|C0004927|G0000000|G0000000|C0205251|C0441889|C0006141|C0006826|C0220908|C0376554|C1553324|C0043210|G0000000|C0008848|G0000000|C0205166|C0331781|G0000000|C2347662|C0587721|C0015264|C0004927|C0009462|C0237463
One hundred patients were randomised to hospital at home and 50 to hospital admission.,One patients randomised hospital 50 hospital admission.,C0205447|C0030705|G0000000|C0019994|C0450371|C0019994|C0184666
"One limitation of this project is that it involved only two clinics, one healthcare system, one quitline vendor, and one EHR vendor.","One limitation project involved clinics, healthcare system, quitline vendor, EHR vendor.",C0205447|C0449295|C1709701|C1314939|C0442592|C0086388|C0449913|G0000000|C0042462|G0000000|C0042462
"Inclusion criteria included pathologically confirmed metastatic clear cell (conventional) RCC, no prior systemic therapy, an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, no brain metastases, measurable disease according to Response Evaluation Criteria in Solid Tumors (RECIST), a serum creatinine level ≤2.0 mg/dL, normal serum calcium levels, and a serum bilirubin ≤1.5 times the upper limit of normal.","Inclusion criteria included pathologically confirmed metastatic cell (conventional) RCC, prior systemic therapy, Eastern Cooperative Oncology Group (ECOG) performance status 0 1, brain metastases, measurable disease Response Evaluation Criteria Solid Tumors (RECIST), serum creatinine level ≤2.0 mg/dL, normal serum calcium levels, serum bilirubin ≤1.5 times upper limit normal.",C0007637|C0243161|C0332257|G0000000|C0521093|C0036525|C0007634|C0439858|C0279702|C0332152|C0205373|C0039798|C1707877|C0679729|C0027651|C0441833|C0430797|C0597198|C0449438|G0000000|G0000000|C0006104|C0027627|C1513040|C0012634|C0871261|C0220825|C0243161|C0205208|C0027651|C1709926|C0229671|C0010294|C0441889|G0000000|C0439269|C0205307|C0229671|C0006675|C0441889|C0229671|C0005437|G0000000|C0040223|C1282910|C0439801|C0205307
We previously reported that cancer-specific variables were unimportant in understanding which women treated for breast cancer would experience clinically significant depression.,We reported cancer-specific variables unimportant understanding women treated breast cancer experience clinically depression.,G0000000|C0684224|C0006826|C0439828|G0000000|C0162340|C0043210|C1522326|C0006141|C0006826|C0237607|G0000000|C0011570
"The relation between primary headaches (PH) and pain related to spontaneous cervical artery dissection (SCAD) is still unclear, as well as the progress of PH after dissection.","The relation primary headaches (PH) pain spontaneous cervical artery dissection (SCAD) unclear, progress PH dissection.",G0000000|C0080103|C0205225|C0018681|C0450407|C0030193|C0205359|C0027530|C0003842|C0012737|G0000000|G0000000|C1272688|C0450407|C0012737
A total of 220 non-diabetic obese women with a singleton pregnancy will be recruited between 120 and 176 weeks.,A total 220 non-diabetic obese women singleton pregnancy recruited 120 176 weeks.,G0000000|C0439175|C1442061|C1518422|C0028754|C0043210|C0481462|C0032961|G0000000|C1442061|C1442061|C0439230
"Students were on average 11.5 years old (age range, 8.0–16.6 years).","Students average 11.5 (age range, 8.0–16.6 years).",C0038492|C1510992|C0450371|C0001779|C1514721|G0000000|C0439234
A total of 162 early stage breast and colorectal cancer survivors who completed primary and adjuvant treatments were recruited for this study.,A total 162 stage breast colorectal cancer survivors completed primary adjuvant treatments recruited study.,G0000000|C0439175|C1442061|C0205390|C0006141|C0555952|C0006826|C0206194|C0205197|C0205225|C0001551|C0087111|G0000000|C0557651
"This explains the statistically significant country effect, with lower cure rates in Pakistan than in Guinea.","This explains statistically country effect, lower cure rates Pakistan Guinea.",G0000000|G0000000|C0038215|C0454664|C1280500|C0441994|C1880198|C0871208|C0030211|C0018381
"The communities can be described as frontier, or isolated, rural communities.","The communities frontier, isolated, rural communities.",G0000000|C0009462|G0000000|C0205409|C0240919|C0009462
"Eligible individuals (1) were age 18 or older and living in the community, (2) had a spinal cord injury with C6 (preserved) or lower of 2 or more years duration, (3) used a manual wheelchair 30 hours per week or more, and (4) had musculoskeletal pain in the shoulder girdle region (neck, shoulder, upper back) rated as 3 to 8 (on a scale of 0 to 10) that was experienced during, or increased by, performance of daily activities.","Eligible individuals (1) age 18 living community, (2) spinal cord injury C6 (preserved) lower 2 duration, (3) manual wheelchair 30 hours week more, (4) musculoskeletal pain shoulder girdle region (neck, shoulder, upper back) rated 3 8 (on scale 0 10) experienced during, increased by, performance daily activities.",C1548635|C0027361|G0000000|C0001779|C0450371|C0376558|C0009462|G0000000|C0521329|C1550235|C3263722|G0000000|C0033085|C0441994|G0000000|C0449238|G0000000|C0024763|C0043143|C0450371|C0439227|C0332174|C0205172|G0000000|C0497254|C0030193|C0037004|C0453903|C0017446|C0027530|C0037004|C1282910|C0004600|C0871208|G0000000|G0000000|G0000000|C0175659|G0000000|C0450371|C0237607|G0000000|C0205217|G0000000|C0597198|C0332173|C0441655
"Exclusion criteria were: Presence of coronary artery disease (CAD) or family history of CAD, prior treatment with Vitamin C or any other antioxidant dietary supplements, steroid or nonsteroid anti-inflammatory drugs, history of acute or chronic infections, fever, cancer or organ failure, peripheral vascular disease, thrombotic events, urinary microalbumin > 300 mg/day.","Exclusion criteria were: Presence coronary artery disease (CAD) family history CAD, prior treatment Vitamin C antioxidant dietary supplements, steroid nonsteroid anti-inflammatory drugs, history acute chronic infections, fever, cancer organ failure, peripheral vascular disease, thrombotic events, urinary microalbumin > 300 mg/day.",C0680251|C0243161|G0000000|C0150312|C0018787|C0003842|C0012634|C3813548|C0015576|C0019664|C3813548|C0332152|C0039798|C0042890|G0000000|C0003402|C0012155|C0242295|C0038317|G0000000|C0003209|C0013227|C0019664|C0205178|C0205191|C3714514|C0015967|C0006826|C0178784|C0231174|C0205100|C0005847|C0012634|C0087086|C0441471|C0042027|C0201838|G0000000|C1442061|C0439422
Duloxetine prescriptions had to be for the management of fibromyalgia and not for the treatment of depression or another pain syndrome.,Duloxetine prescriptions management fibromyalgia treatment depression pain syndrome.,C0245561|C0033080|C0001554|C0016053|C0039798|C0011570|C0030193|C0039082
Study participants were 236 girls from 42 states and 4 Canadian provinces.,Study participants 236 girls 42 4 Canadian provinces.,C0557651|C0679646|C1442061|C0870604|C0450371|G0000000|C0238884|C1514578
"Consequently, the groups differed somewhat at baseline with, for example, more girls in the intervention group and more boys in the control group.","Consequently, differed baseline with, example, girls intervention boys control group.",G0000000|G0000000|C0168634|G0000000|C1707959|C0870604|C0886296|C0870221|C0243148|C0441833
"Cytotoxic agents included taxanes (109), cisplatin (8), carboplatin (2), oxaliplatin (50), or combination (20).","Cytotoxic agents included taxanes (109), cisplatin (8), carboplatin (2), oxaliplatin (50), combination (20).",C0677881|C0450442|C0332257|C0796419|C1442061|C0008838|G0000000|C0079083|G0000000|C0069717|C0450371|C0205195|C0450371
All confirmed HIV‐positive children and caregivers were linked with the HIV treatment clinic.,All confirmed HIV‐positive children caregivers linked HIV treatment clinic.,G0000000|C0521093|G0000000|C0008059|C0085537|C1517892|C0019682|C0039798|C0002424
"They had no contraindications for MRI, no central neurological disorder excepting stroke, no drug/alcohol abuse (last 12 months), no major psychiatric disorder, and no hearing loss>75 dB HL at 500–4,000 Hz.","They contraindications MRI, central neurological disorder excepting stroke, drug/alcohol abuse (last 12 months), major psychiatric disorder, hearing loss>75 dB HL 500–4,000 Hz.",G0000000|C0079164|C0024485|C0205099|C0205494|C0012634|C0332300|C0038454|C3845889|C0013146|C1517741|C0450371|C0439231|C0205082|C0205487|C0012634|C0018767|C1517945|C1418892|C1453952|G0000000|C0439482
"The inclusion criteria were (1) incomplete paresis of the leg after single incident of ischemic or hemorrhagic stroke, at least 6 months prior and (2) age between 18 and 75 years.","The inclusion criteria (1) incomplete paresis leg single incident ischemic hemorrhagic stroke, 6 months prior (2) age 18 75 years.",G0000000|C0007637|C0243161|G0000000|C0205257|C0030552|C0023216|C0037179|C1551358|C0475224|C0333275|C0038454|G0000000|C0439231|C0332152|G0000000|C0001779|C0450371|C0450371|C0439234
These three patients were all included in the intention-to-treat analysis.,These patients included intention-to-treat analysis.,G0000000|C0030705|C0332257|C0162425|C0002778
Adults admitted to Vanderbilt University Hospital (VUH) or Brigham and Women’s Hospital (BWH) for acute coronary syndromes (15) or acute decompensated heart failure (16) were enrolled between May 2008 and September 2009.,Adults admitted Vanderbilt University Hospital (VUH) Brigham Women’s Hospital (BWH) acute coronary syndromes (15) acute decompensated heart failure (16) enrolled May 2008 September 2009.,C0001675|C0184666|G0000000|C0041740|C0019994|G0000000|G0000000|G0000000|C0019994|G0000000|C0205178|C0018787|C0039082|C0450371|C0205178|C0205434|C0018787|C0231174|C0450371|G0000000|G0000000|G0000000|C3828193|G0000000
The trial is registered with Current Controlled Trials (identifier: ISRCTN 25371788).,The trial registered Current Controlled Trials (identifier: ISRCTN 25371788).,G0000000|C0008976|C1514821|C0521116|C2587213|C0008976|C0600091|G0000000|G0000000
"Currently, there is no effective treatment available for the neurological manifestations of patients with type 3 Gaucher’s disease (GD3).","Currently, effective treatment neurological manifestations patients type 3 Gaucher’s disease (GD3).",C0521116|C1280519|C0039798|C0205494|C0205319|C0030705|C0332307|G0000000|G0000000|C0012634|C1823579
Resident mothers were eligible if they were aged 18 years or older and were primarily responsible for providing care for the target child.,Resident mothers eligible aged 18 responsible providing care target child.,C1320928|C0026591|C1548635|C0001779|C0450371|C1273518|C1999230|C1947933|C1521840|C0008059
"With the use of a cluster randomized design, all pregnant women in 28 villages were assigned to a group who received either 2 protein-energy–fortified biscuits/d from 20 wk of gestation to delivery or a control group who received the biscuits for 20 wk postpartum.","With cluster randomized design, pregnant women 28 villages assigned received 2 protein-energy–fortified biscuits/d 20 wk gestation delivery control received biscuits 20 wk postpartum.",G0000000|C1555715|C0034656|C1707689|C0549206|C0043210|C0450371|C0562518|C1516050|C1514756|G0000000|G0000000|C0452501|C0450371|C0332174|C0032961|C0011209|C0243148|C1514756|C0452501|C0450371|C0332174|C0086839
"Individuals who had (i) shoulder pain between 1-3, as measured by the CMSA pain inventory scale, i.e., severe constant pain and/or (ii) the presence of other pathology in the affected shoulder or elbow.","Individuals (i) shoulder pain 1-3, measured CMSA pain inventory scale, i.e., severe constant pain and/or (ii) presence pathology shoulder elbow.",C0027361|C0021966|C0037004|C0030193|G0000000|C0444706|G0000000|C0030193|C0021941|C0175659|C0683454|C0205082|C1547014|C0030193|G0000000|G0000000|C0150312|C0030664|C0037004|C0013769
"Among phase II participants, no deaths were considered to be treatment-related.","Among phase II participants, deaths considered treatment-related.",G0000000|C0205390|G0000000|C0679646|C0011065|C0750591|C0039798
Preterm children with a gestational age of 32–34 weeks are given direct bottle feeding.,Preterm children gestational age 32–34 weeks direct bottle feeding.,C0151526|C0008059|C0439671|C0001779|G0000000|C0439230|C0439851|C0179376|C0204695
"At randomization, 4.5% of youth were taking medication (all but one received stimulant medication) to address ADHD-related symptoms.","At randomization, 4.5% youth medication (all received stimulant medication) address ADHD-related symptoms.",G0000000|C0034656|G0000000|C0001578|C0013227|G0000000|C1514756|C0002763|C0013227|C0376649|C1263846|C0683368
A total of 121 women were interviewed and 100 consenting women who fulfilled the inclusion criteria were recruited for the study.,A total 121 women interviewed 100 consenting women fulfilled inclusion criteria recruited study.,G0000000|C0439175|C1442061|C0043210|C0021822|C1442061|C1511481|C0043210|C1550543|C0007637|C0243161|G0000000|C0557651
Results: A total of 257 sick neonates and children (52%) were hypoxaemic.,Results: A total 257 sick neonates children (52%) hypoxaemic.,C1274040|G0000000|C0439175|C1442061|C0221423|C0021289|C0008059|C0450371|C0700292
"The antifraud process included automated duplication checks of phone numbers, email addresses, and IP addresses.","The antifraud process included automated duplication checks phone numbers, email addresses, IP addresses.",G0000000|G0000000|C1184743|C0332257|C0205554|C0332597|C1283174|C1515258|C0237753|C0013849|C0376649|C1308226|C0376649
"Participants 48 participants who had not previously been treated with opioids (mean age 76, SD 5) with predominantly chronic obstructive pulmonary disease (42, 88%) were randomised to four days of 20 mg oral morphine with sustained release followed by four days of identically formulated placebo, or vice versa.","Participants 48 participants treated opioids (mean age 76, SD 5) chronic obstructive pulmonary disease (42, 88%) randomised days 20 oral morphine sustained release days identically formulated placebo, vice versa.",C0679646|C0450371|C0679646|C1522326|C0242402|C0444504|C0001779|C0450371|C2699239|G0000000|C0205191|C0549186|C0024109|C0012634|C0450371|C0450371|G0000000|C0439228|C0450371|C0442027|C0026549|C0443318|C0030685|C0439228|G0000000|G0000000|C0032042|C0814670|G0000000
The eligibility criteria were an age of 18–65; a diagnosis of relapsing–remitting MS according to the McDonald criteria; a score of 0.0–5.5 on the Expanded Disability Status Scale (EDSS); MRI showing lesions consistent with MS; at least one documented clinical relapse and either receiving or not a disease-modifying treatment within the 24-month period before enrolment in the study.,The eligibility criteria age 18–65; diagnosis relapsing–remitting MS McDonald criteria; score 0.0–5.5 Expanded Disability Status Scale (EDSS); MRI lesions consistent MS; documented clinical relapse receiving disease-modifying treatment 24-month period enrolment study.,G0000000|C0013893|C0243161|C0001779|G0000000|C0011900|G0000000|C0039676|G0000000|C0243161|C0449820|G0000000|C0205229|C0231170|C0449438|C0175659|C0451246|C0024485|C0221198|C0332290|C0039676|C1301725|C0205210|C0035020|C1514756|C0012634|C0039798|C0450371|C0439531|C1516879|C0557651
"A total of 100 participants, aged 18 years or older, diagnosed with moderate to severe AD and using a topical corticosteroid in the weeks before enrolment are included in the study.","A total 100 participants, aged 18 older, diagnosed moderate severe AD topical corticosteroid weeks enrolment included study.",G0000000|C0439175|C1442061|C0679646|C0001779|C0450371|C0580836|C0011900|C0205081|C0205082|G0000000|C0332237|C0001617|C0439230|C1516879|C0332257|C0557651
"Considered to be at high risk for a future cardiovascular event, defined by the presence of: Established atherosclerotic cardiovascular disease involving the coronary, peripheral, carotid, or aortic vascular territories (secondary prevention).","Considered risk future cardiovascular event, defined presence of: Established atherosclerotic cardiovascular disease involving coronary, peripheral, carotid, aortic vascular territories (secondary prevention).",C0750591|C0035647|C0016884|C0007226|C0441471|C1704788|C0150312|G0000000|C0443211|C0333482|C0007226|C0012634|C1314939|C0018787|C0205100|C0741968|C0003483|C0005847|C1301808|C0027627|C0199176
Subgroup analyses of participants with lacunar infarcts (vaguely defined) in four randomised trials support the use of antiplatelet therapy in this stroke subtype (35–38) and suggest that antiplatelet therapy may be particularly efficacious for patients with S3.,Subgroup analyses participants lacunar infarcts (vaguely defined) randomised trials support antiplatelet therapy stroke subtype (35–38) antiplatelet therapy efficacious patients S3.,C1079230|C0002778|C0679646|C0241970|C0021308|G0000000|C1704788|G0000000|C0008976|C0183683|G0000000|C0039798|C0038454|C0449560|G0000000|G0000000|C0039798|C1280519|C0030705|C1519428
"The exclusion criteria were acute infectious oral lesions, furcation defects, use of antibiotics for any reason within the last 4 weeks, periodontal treatment within the last 6 months, and pregnancy or lactation.","The exclusion criteria acute infectious oral lesions, furcation defects, antibiotics reason 4 weeks, periodontal treatment 6 months, pregnancy lactation.",G0000000|C0680251|C0243161|C0205178|C0009450|C0442027|C0221198|C2825929|C0243067|C0003232|C0392360|G0000000|C0439230|C2960678|C0039798|G0000000|C0439231|C0032961|C0006147
"Inclusion criteria consisted of the following: (1) adults ≥18 years old, newly diagnosed with AML or ALL; (2) admission to begin induction chemotherapy, with an expected hospital stay of 4 to 6 weeks; and (3) able to speak and understand English.","Inclusion criteria consisted following: (1) adults ≥18 old, newly diagnosed AML ALL; (2) admission induction chemotherapy, expected hospital stay 4 6 weeks; (3) speak understand English.",C0007637|C0243161|C0332529|C0231290|G0000000|C0001675|G0000000|C0580836|C0750546|C0011900|C0023467|C0444868|G0000000|C0184666|C0205263|C0013216|C1517001|C0019994|G0000000|G0000000|G0000000|C0439230|G0000000|C0234856|C0162340|C0376245
A minimum value of 10 on the BDI-II was used to ensure that participants had a minimally elevated number of depressive symptoms that had the potential to be reduced by the interventions.,A minimum 10 BDI-II ensure participants minimally elevated depressive symptoms potential reduced interventions.,G0000000|C1524031|C0450371|C0006448|C0218063|C0679646|G0000000|C0205250|G0000000|C0683368|C3245505|C0392756|C0886296
"Subjects were 18 years of age or older, smoked ≥15 cigarettes/day, had exhaled CO ≥10 ppm; wanted to quit smoking, and were in good general physical and mental health.","Subjects 18 age older, smoked ≥15 cigarettes/day, exhaled CO ≥10 ppm; quit smoking, physical mental health.",C0681850|C0450371|C0001779|C0580836|C0037366|G0000000|C0677453|C0231800|C3245499|G0000000|C0439187|C0748223|C0037369|C0031809|C0229992|C0018684
The intervention began when infants were 3 months of age because pregnant women in these communities give birth in their natal villages and return home when their infants are about 3 months old.,The intervention infants 3 months age pregnant women communities birth natal villages return infants 3 months old.,G0000000|C0886296|C0021270|G0000000|C0439231|C0001779|C0549206|C0043210|C0009462|C0005615|C0454729|C0562518|C0332156|C0021270|G0000000|C0439231|C0580836
"clinicaltrials.gov Identifier: {""type"":""clinical-trial"",""attrs"":{""text"":""NCT00000541"",""term_id"":""NCT00000541""}}NCT00000541 Homocysteine levels have been directly associated with cardiovascular risk in observational studies1; and daily supplementation with folic acid, vitamin B6, and/or vitamin B12 have been shown to reduce homocysteine levels to varying degrees in intervention studies2.","clinicaltrials.gov Identifier: {""type"":""clinical-trial"",""attrs"":{""text"":""NCT00000541"",""term_id"":""NCT00000541""}}NCT00000541 Homocysteine levels directly cardiovascular risk observational studies1; daily supplementation folic acid, vitamin B6, and/or vitamin B12 reduce homocysteine levels varying degrees intervention studies2.",C1419208|C0600091|C0332307|C0019878|C0441889|C1947931|C0007226|C0035647|C1518527|G0000000|C0332173|C0242297|G0000000|C0001128|C0042890|C0005558|G0000000|C0042890|G0000000|G0000000|C0019878|C0441889|G0000000|C0449286|C0886296|G0000000
"Planned sample size is 100 (50 in each arm), which is appropriate for this trial.","Planned sample size 100 (50 arm), trial.",C1301732|C0370003|C0456389|C1442061|C0450371|C0446516|C0008976
"Participants will be eligible for inclusion if: aged 18 years or over, and receive hospital haemodialysis three times weekly; they have mild to moderately severe depressive symptoms (based on PHQ-928 scores of 5–19; a self-report measure of depression) and/or presence of mild to moderately severe anxiety symptoms (based on self-report GAD-729 scores of 5–14); they speak English sufficiently well to engage with screening tools; they have a basic understanding of how to use the internet and an email address.","Participants eligible inclusion if: aged 18 years over, receive hospital haemodialysis times weekly; mild moderately severe depressive symptoms (based PHQ-928 scores 5–19; self-report measure depression) and/or presence mild moderately severe anxiety symptoms (based self-report GAD-729 scores 5–14); speak English engage screening tools; basic understanding internet email address.",C0679646|C1548635|C0007637|G0000000|C0001779|G0000000|C0205136|C1514756|C0019994|C0019004|C0040223|C0332174|C2945599|C0205081|C0205082|G0000000|C0683368|C1527178|C1879301|C0449820|G0000000|C0681906|C0079809|C0011570|G0000000|C0150312|C2945599|C0205081|C0205082|C0003467|C0683368|C1527178|C0681906|C0270549|C0449820|G0000000|C0234856|C0376245|G0000000|C0220908|C0336791|C1527178|C0162340|C0282111|C0013849|C0376649
Methods: A total of 639 patients aged 18–70 years with forced expiratory volume in 1 second (FEV1) ≥55% predicted and a minimum predefined level of asthma symptoms during a 2 week placebo run in period were randomised to receive montelukast 10 mg (n=326) or placebo (n=313) once daily for 16 weeks.,Methods: A total 639 patients aged 18–70 forced expiratory volume 1 (FEV1) ≥55% predicted minimum predefined level asthma symptoms 2 week placebo period randomised receive montelukast 10 (n=326) placebo (n=313) daily 16 weeks.,C0025663|G0000000|C0439175|C1442061|C0030705|C0001779|G0000000|C0441722|C0231800|C0449468|G0000000|G0000000|G0000000|C0681842|C1524031|G0000000|C0441889|C0004096|C0683368|G0000000|C0332174|C0032042|C0439531|G0000000|C1514756|C0298130|C0450371|C0369718|C0032042|C0369718|C0332173|C0450371|C0439230
Kruskal-Wallis test was applied to compare the differences of age and global rating scale scores.,Kruskal-Wallis test applied compare differences age global rating scale scores.,G0000000|C0022885|C4048755|C1707455|C1705241|C0001779|C0205246|C0871208|C0175659|C0449820
A number of studies have explored the impact of fortification among primary school children in South Africa and Vietnam.,A studies explored impact fortification primary school children South Africa Vietnam.,G0000000|C0947630|G0000000|C1825598|G0000000|C0205225|C0036375|C0008059|C1710133|C0001737|C0042658
"renal, hepatic or gastrointestinal disease).","renal, hepatic gastrointestinal disease).",C0022646|C0205054|C0521362|C0012634
"We evaluated the following inclusion criteria among 7213 patients identified: age between 18 and 65 years, Karnofsky performance score [14] ≥40%, plan to stay in Dar es Salaam for 2 years, not being pregnant, and not having received anti-TB treatment for more than 4 weeks during the previous year.","We evaluated inclusion criteria 7213 patients identified: age 18 65 years, Karnofsky performance score [14] ≥40%, plan stay Dar es Salaam 2 years, pregnant, received anti-TB treatment 4 weeks previous year.",G0000000|C0220825|C0007637|C0243161|G0000000|C0030705|C0205396|C0001779|C0450371|C0450371|C0439234|C0206065|C0597198|C0449820|C0450371|G0000000|C0270724|G0000000|C0022595|C0013754|G0000000|G0000000|C0439234|C0549206|C1514756|G0000000|C0039798|G0000000|C0439230|C0205156|C0439234
60 adults with stable HIV infection on antiretroviral treatment and low-density lipoprotein cholesterol >3 mmol/L will be recruited from 3 West Midlands HIV services.,60 adults stable HIV infection antiretroviral treatment low-density lipoprotein cholesterol >3 mmol/L recruited 3 West Midlands HIV services.,C0450371|C0001675|C0205360|C0019682|C0009450|G0000000|C0039798|C0205251|C0023820|C0008377|G0000000|G0000000|G0000000|C1705493|G0000000|C0019682|C0557854
Early parenteral iron supplementations with EPO were beneficial for the preterm infants.,Early parenteral iron supplementations EPO beneficial preterm infants.,C1279919|C0030547|C0302583|C0242297|G0000000|G0000000|C0151526|C0021270
"The soft contact lenses and GP lenses were rated “always comfortable” or “usually comfortable” similarly over the study (Table 4) (GEE model, p-value = 0.09).","The soft contact lenses GP lenses rated “always comfortable” “usually comfortable” study (Table 4) (GEE model, p-value = 0.09).",G0000000|C0205358|C0332158|C0023317|C3811116|C0023317|C0871208|G0000000|G0000000|G0000000|G0000000|C0557651|C0039224|G0000000|G0000000|C3161035|C1709380|G0000000|C0450371
"Management is mostly non-operative, but spinal fusion has been used for nearly 90 years.","Management non-operative, spinal fusion 90 years.",C0001554|C1518422|C0521329|C0332466|C0450371|C0439234
"These diseases include infection with human immunity deficiency virus (HIV), addiction to narcotic substances and alcohol, untreated active tuberculosis, using special medicines such as phenobarbital and ergotamine and so on, women under breast cancer treatment, breast problems such as breast nipple indentation, abscess, mastitis, and mother’s underlying disease such as asthma, cardiac diseases, blood clotting diseases and diabetes.","These diseases infection human immunity deficiency virus (HIV), addiction narcotic substances alcohol, untreated active tuberculosis, special medicines phenobarbital ergotamine on, women breast cancer treatment, breast breast nipple indentation, abscess, mastitis, mother’s underlying disease asthma, cardiac diseases, blood clotting diseases diabetes.",G0000000|C0012634|C0009450|C0086418|C0020964|C0011155|C0042776|C0019682|C0085281|C0027415|C0439861|C0001962|C0332155|C0205177|C0041296|C0205555|C0013227|C0031412|C0014710|G0000000|C0043210|C0006141|C0006826|C0039798|C0006141|C0006141|C0028109|C0332467|C0000833|C0024894|G0000000|G0000000|C0012634|C0004096|C0018787|C0012634|C0005767|C0005778|C0012634|C0011847
"The percentage of heavy smokers was significantly higher in the tailored letter group than in the non-tailored letter group, which had the lowest proportion of heavy smokers.","The percentage heavy smokers tailored letter non-tailored letter group, lowest proportion heavy smokers.",G0000000|C0439165|C0439539|C0337664|C0402883|C1096774|C1518422|C1096774|C0441833|C1708760|C1709707|C0439539|C0337664
A randomized clinical trial was performed on 500 pregnant women with gestational age 12-16 weeks who had serum 25 (OH) D less than 30 ng/ml.,A randomized clinical trial performed 500 pregnant women gestational age 12-16 weeks serum 25 (OH) D 30 ng/ml.,G0000000|C0034656|C0205210|C0008976|C0884358|C1442061|C0549206|C0043210|C0439671|C0001779|C0450371|C0439230|C0229671|C0450371|C0220853|C0073187|C0450371|C0439275
"Patients with disorders that could impact their ability to participate in exercise testing, such as obesity (body mass index >30 kg/m2), and cardiovascular or musculoskeletal disease were excluded.","Patients disorders impact ability participate exercise testing, obesity (body mass >30 kg/m2), cardiovascular musculoskeletal disease excluded.",C0030705|C0012634|C1825598|C0085732|G0000000|C0015259|C0039593|C0028754|C0242821|C0577559|C0450371|C0022718|C0007226|C0497254|C0012634|C1554077
"Inclusion and exclusion criteria AHI, Apnoea–Hypopnoea Index; OSA, obstructive sleep apnoea.","Inclusion exclusion criteria AHI, Apnoea–Hypopnoea Index; OSA, obstructive sleep apnoea.",C0007637|C0680251|C0243161|G0000000|G0000000|C0918012|C0520679|C0549186|C0037313|C0003578
"The exclusion criteria included: patients with urinary retention; patients having various reasons for UI in the past (Parkinson’s disease, spinal cord disease, dementia, urinary tract tumors, urolithiasis, unhealed urinary tract infections, or history of urinary tract surgery); patients with severe cognitive function disorders (Mini-Mental State Examination14 <22 points); patients who were unable to communicate effectively; patients with concurrent serious organic diseases; patients who needed massive fluid infusion or usage of drugs that affected urination; and patients who were unable to provide accurate survey information or to complete the treatment period.","The exclusion criteria included: patients urinary retention; patients reasons UI (Parkinson’s disease, spinal cord disease, dementia, urinary tract tumors, urolithiasis, unhealed urinary tract infections, history urinary tract surgery); patients severe cognitive function disorders (Mini-Mental State Examination14 <22 points); patients unable communicate effectively; patients concurrent organic diseases; patients massive fluid infusion usage drugs urination; patients unable provide accurate survey complete treatment period.",G0000000|C0680251|C0243161|C0332257|C0030705|C0042027|C0035280|C0030705|C0392360|C1421312|G0000000|C0012634|C0521329|C1550235|C0012634|C0011265|C0042027|C1185740|C0027651|C0451641|G0000000|C0042027|C1185740|C3714514|C0019664|C0042027|C1185740|C0038894|C0030705|C0205082|C1516691|C0031843|C0012634|C0445542|C1301808|G0000000|C0450371|C1552961|C0030705|C1299582|C0566001|G0000000|C0030705|C0205420|C0747055|C0012634|C0030705|C0522501|C0005889|C0574032|C0457083|C0013227|C0042034|C0030705|C1299582|C1999230|C0443131|C0038951|C0205197|C0039798|C0439531
Recruitment announcements were sent to various email distribution lists and online support groups for patients with COPD and older adults.,Recruitment announcements email distribution lists online support patients COPD adults.,C2949735|G0000000|C0013849|C0520511|C0745732|G0000000|C0183683|C0030705|C0024117|C0001675
"Patients with multiple clinical strokes, a history of other neurological disease, chronic pain, or emotional disorders were excluded.","Patients multiple clinical strokes, history neurological disease, chronic pain, emotional disorders excluded.",C0030705|C0439064|C0205210|C0038454|C0019664|C0205494|C0012634|C0205191|C0030193|C0013987|C0012634|C1554077
"Among the 30 patients who were treated for MDR TB in our center between 2008 and 2014, 23 patients were treated from the start with LNZ.","Among 30 patients treated MDR TB center 2008 2014, 23 patients treated start LNZ.",G0000000|C0450371|C0030705|C1522326|G0000000|G0000000|C0205099|G0000000|G0000000|C0450371|C0030705|C1522326|C0439659|G0000000
The results of REPORT may have greater implications for overall health service policy concerning long‐term conditions than for individual clinical decisions.,The REPORT implications health service policy long‐term conditions individual clinical decisions.,G0000000|C0684224|G0000000|C0018684|C0557854|C0242456|G0000000|C0012634|C0027361|C0205210|C0679006
"This group was referred to as the ""Control Group"" because this procedure is the most common way of informing patient in Germany.","This referred ""Control Group"" procedure common informing patient Germany.",G0000000|C0205543|C0243148|C0441833|C0184661|C0205214|C0700287|C0030705|C0017480
"Method: One thousand 16- to 18-year-old girls were invited to participate in an HPV vaccination program: 500 previously uninvited, and 500 unresponsive to previous invitations.","Method: One 16- 18-year-old girls invited participate HPV vaccination program: 500 uninvited, 500 unresponsive previous invitations.",C0025663|C0205447|C0450371|C0450371|C0870604|G0000000|G0000000|C0021344|C0042196|C1709697|C1442061|G0000000|C1442061|C0205269|C0205156|C2826348
c. Patients with a physical/psychiatric impairment that would seriously impair their physical mobility.,c. Patients physical/psychiatric impairment impair physical mobility.,G0000000|C0030705|C0031809|C0221099|G0000000|C0031809|C0425245
We were committed to keeping all the participants’ information confidential.,We committed keeping participants’ confidential.,G0000000|C1171947|C0333118|G0000000|C3846676
"The exclusion criteria were: MS-related conditions, such as current clinical relapse (defined as newly developing symptoms or reactivation of pre-existing deficits for a minimum of 24 h occurring at least 30 days after the preceding episode, in the absence of increased body temperature or infections) [28], steroid therapy 30 days prior to study entry, concomitant diseases precluding the IFN-β1a treatment; pregnancy or breastfeeding, cognitive decline preventing informed consent, pathological conditions interfering with MS evolution, nonsteroidal anti-inflammatory drugs allergy, or intolerance to IFN-β1a.","The exclusion criteria were: MS-related conditions, current clinical relapse (defined newly developing symptoms reactivation pre-existing deficits minimum 24 occurring 30 days preceding episode, absence increased body temperature infections) [28], steroid therapy 30 days prior study entry, concomitant diseases precluding IFN-β1a treatment; pregnancy breastfeeding, cognitive decline preventing informed consent, pathological conditions interfering MS evolution, nonsteroidal anti-inflammatory drugs allergy, intolerance IFN-β1a.",G0000000|C0680251|C0243161|G0000000|C0039676|C0012634|C0521116|C0205210|C0035020|C1704788|C0750546|G0000000|C0683368|G0000000|C2347662|C2987487|C1524031|C0450371|C1709305|C0450371|C0439228|C0332152|C0332189|C0332197|C0205217|C0242821|C0005903|C3714514|C0450371|C0038317|C0039798|C0450371|C0439228|C0332152|C0557651|C1705654|C0521115|C0012634|G0000000|G0000000|C0039798|C0032961|C0006147|C1516691|G0000000|C0309872|C1522154|C1511481|C0030664|C0012634|C0521102|C0039676|C0015219|G0000000|C0003209|C0013227|C0002111|C0231199|G0000000
"Patients who have previously attended a PACE centre specialist fatigue clinic and received a course of treatment, from a specialist, considered to be similar to SSMC or any of the supplementary therapies of APT, CBT, or GET as delivered in the trial will be excluded from taking part in the trial.","Patients attended PACE centre specialist fatigue clinic received treatment, specialist, considered SSMC supplementary therapies APT, CBT, GET delivered trial excluded trial.",C0030705|C1456498|C0287990|C0205099|C0087009|C0015672|C0002424|C1514756|C0039798|C0087009|C0750591|G0000000|G0000000|C0087111|C0003645|C0009244|G0000000|C1705822|C0008976|C1554077|C0008976
"Inclusion criteria: renal transplant patients who smoke in the precontemplation, contemplation or preparation stages according to the Prochaska and DiClemente’s Stages of Change model, and who give their consent to participate.","Inclusion criteria: renal transplant patients smoke precontemplation, contemplation preparation stages Prochaska DiClemente’s Stages Change model, consent participate.",C0007637|C0243161|C0022646|C0040732|C0030705|C0037366|G0000000|G0000000|C1521827|C1306673|G0000000|G0000000|C1306673|C0392747|C3161035|C1511481|G0000000
"Infants were excluded if they had current or planned formula use, had low birth weight, used vitamin-mineral supplements (except vitamin D), or had significant congenital anomalies or known chronic conditions that would affect feeding, growth, or the developmental potential.","Infants excluded current planned formula use, low birth weight, vitamin-mineral supplements (except vitamin D), congenital anomalies chronic conditions affect feeding, growth, developmental potential.",C0021270|C1554077|C0521116|C1301732|C0489829|C0042153|C0205251|C0005615|C0005910|C0042890|C0242295|G0000000|C0042890|C0073187|C0009678|C0000769|C0205191|C0012634|C0001721|C0204695|C0018270|C0458003|C3245505
"Patients with fulminant hepatic failure, and/or stage 3 or 4 hepatic coma and those patients with underlying hepatic malignancies who received preoperative chemotherapy were excluded so as to minimize potential additive toxicities.","Patients fulminant hepatic failure, and/or stage 3 4 hepatic coma patients underlying hepatic malignancies received preoperative chemotherapy excluded minimize potential additive toxicities.",C0030705|G0000000|C0205054|C0231174|G0000000|C0205390|G0000000|G0000000|C0205054|C0009421|C0030705|G0000000|C0205054|C0006826|C1514756|C0445204|C0013216|C1554077|G0000000|C3245505|C0442796|C0600688
"In this randomized clinical trial 42 deciduous molars in 21 patients who had at least two teeth requiring DPC, were treated.","In randomized clinical trial 42 deciduous molars 21 patients teeth requiring DPC, treated.",G0000000|C0034656|C0205210|C0008976|C0450371|G0000000|C0026367|C0450371|C0030705|C0040426|G0000000|G0000000|C1522326
"The study population included all male and female nursing students who were studying in Isfahan Nursing and Midwifery university in 2010-2011, in the second and third years (third, fourth, fifth and sixth semesters).","The study population included male female nursing students studying Isfahan Nursing Midwifery university 2010-2011, (third, fourth, sixth semesters).",G0000000|C0557651|C0032659|C0332257|C0086582|C0015780|C0006147|C0038492|C0557651|G0000000|C0006147|C0026082|C0041740|G0000000|C0205437|C0205438|C0205440|C2348178
Patients were eligible for the study if they provide written informed consent and if they: (i) are aged 18 years or over; (ii) have had a stroke at least 6 weeks previously and (iii) wish to get out of the house more often.,Patients eligible study provide written informed consent they: (i) aged 18 years over; (ii) stroke 6 weeks (iii) house often.,C0030705|C1548635|C0557651|C1999230|C0043266|C1522154|C1511481|G0000000|C0021966|C0001779|G0000000|C0205136|G0000000|C0038454|G0000000|C0439070|C0442519|C0332183
All patients will receive conventional treatment.,All patients receive conventional treatment.,G0000000|C0030705|C1514756|C0439858|C0039798
"In all, 170 women aged 30–70 years with low- or medium-risk endometrial hyperplasia who met inclusion criteria.","In all, 170 women aged 30–70 low- medium-risk endometrial hyperplasia met inclusion criteria.",G0000000|G0000000|C1442061|C0043210|C0001779|G0000000|C0205251|C3272282|C0227843|C0020507|C0268621|C0007637|C0243161
"Patients with COPD, diagnosed according to the GOLD guidelines, who were attending respiratory clinics at Royal Brompton and Harefield NHS Foundation Trust, were invited to participate.","Patients COPD, diagnosed GOLD guidelines, attending respiratory clinics Royal Brompton Harefield NHS Foundation Trust, invited participate.",C0030705|C0024117|C0011900|C0018026|C0162791|C1547429|C0521346|C0442592|G0000000|G0000000|G0000000|C0796085|C0016617|C0237935|G0000000|G0000000
"In a randomized, double-blind, placebo-controlled study, 40 infants and children aged 3 months to 6 years with AD received either a synbiotic or placebo for 8 weeks.","In randomized, double-blind, placebo-controlled study, 40 infants children aged 3 months 6 AD received synbiotic placebo 8 weeks.",G0000000|C0034656|C0013072|C1706408|C0557651|C0450371|C0021270|C0008059|C0001779|G0000000|C0439231|G0000000|G0000000|C1514756|C2936470|C0032042|G0000000|C0439230
"They were aged between 2 and 16 years, had severe acute asthma and did not respond to standard inhaled treatment.","They aged 2 16 years, severe acute asthma respond standard inhaled treatment.",G0000000|C0001779|G0000000|C0450371|C0439234|C0205082|C0205178|C0004096|G0000000|C1442989|C0004048|C0039798
All patients had either chronic neck or back pain with or without other pain sites.,All patients chronic neck pain pain sites.,G0000000|C0030705|C0205191|C0027530|C0030193|C0030193|C0205145
"Several retrospective studies have demonstrated that ventilation with high tidal volumes may lead to ALI, presumably secondary to ventilator-induced lung injury.4–6 A number of studies has examined biochemical markers of lung injury among patients undergoing anesthesia for major surgery, mainly cardiac surgery.","Several retrospective studies demonstrated ventilation tidal volumes lead ALI, secondary ventilator-induced lung injury.4–6 A studies examined biochemical markers lung injury patients undergoing anesthesia major surgery, cardiac surgery.",C0439064|C0035363|C0947630|G0000000|C0035203|G0000000|C0449468|C0023175|G0000000|C0027627|C0087153|C0024109|G0000000|G0000000|C0947630|C0332128|C0205474|C0005516|C0024109|C3263722|C0030705|G0000000|C0002903|C0205082|C0038894|C0018787|C0038894
"[5] This study describes the epidemiology, clinical features and outcome of patients admitted with confirmed H1N1 influenza in intensive care unit (ICU) of a tertiary level hospital in New Delhi, India during 2009 and 2010.","[5] This study describes epidemiology, clinical features outcome patients admitted confirmed H1N1 influenza intensive care unit (ICU) tertiary level hospital New Delhi, India 2009 2010.",G0000000|G0000000|C0557651|G0000000|C0014507|C0205210|C1521970|C1274040|C0030705|C0184666|C0521093|G0000000|C0021400|C0162425|C1947933|C0439148|C0021708|C0205372|C0441889|C0019994|C0205314|G0000000|C0021201|G0000000|G0000000
Data presented reflect the findings from the 18 initial general internal medicine and family practice clinics.,Data reflect findings 18 initial internal medicine family practice clinics.,C1511726|C0558058|C2607943|C0450371|C0205265|C0205102|C0013227|C0015576|C0237607|C0442592
"Additional inclusion criteria were weight ≥2.5 kg, access to transport, and informed consent from a parent or legal guardian.","Additional inclusion criteria weight ≥2.5 kg, access transport, informed consent parent legal guardian.",C1524062|C0007637|C0243161|C0005910|G0000000|C0022718|C0444454|C0005528|C1522154|C1511481|C0030551|C1301860|C0023226
Participants who had history of a recent illness were excluded from the study.,Participants history illness excluded study.,C0679646|C0019664|C0221423|C1554077|C0557651
This study was conducted on 35-70 years old patients with diabetes and hypertension Type 2 referred to Firoozgar Hospital from March 2011 to February 2012.,This study conducted 35-70 patients diabetes hypertension Type 2 referred Firoozgar Hospital March 2011 February 2012.,G0000000|C0557651|C0004927|C0450371|C0030705|C0011847|C0020538|C0332307|G0000000|C0205543|G0000000|C0019994|C3829202|G0000000|C3830166|G0000000
"Any underlying disease (e.g., cystic fibrosis, bronchopulmonary dysplasia and cardiac or renal disease), Prior history of wheezing, Diagnosed case of asthma, Oxygen saturation (SpO2) <85 % on room air, CS score > 9, Progressive respiratory distress requiring mechanical ventilation, Previous treatment with bronchodilators within last 4 h, and Any steroid therapy within 48 h  The study was carried out in the ER, Observation room (OR) and OPD.","Any underlying disease (e.g., cystic fibrosis, bronchopulmonary dysplasia cardiac renal disease), Prior history wheezing, Diagnosed asthma, Oxygen saturation (SpO2) <85 % air, CS score > 9, Progressive respiratory distress requiring mechanical ventilation, Previous treatment bronchodilators 4 h, Any steroid therapy 48 The study carried ER, Observation (OR) OPD.",G0000000|G0000000|C0012634|G0000000|C0205207|C0016059|C0545675|C0334044|C0018787|C0022646|C0012634|C0332152|C0019664|C0043144|C0011900|C0004096|C0030054|C0522534|G0000000|C0450371|G0000000|C0001861|C0010182|C0449820|G0000000|C0205329|C0521346|C0231303|G0000000|C0443254|C0035203|C0205156|C0039798|C0006280|G0000000|C0033727|G0000000|C0038317|C0039798|C0450371|G0000000|C0557651|C0206243|C3810541|C0302523|G0000000|C3810599
"Patients (n=78) of both sexes, with age group between 10 and 50 years and with first and second degree of burn of less than 50% of TBSA (Total body surface area) were included in the study, over a period of 2 years (2006-08).","Patients (n=78) sexes, age 10 50 degree burn 50% TBSA (Total body surface area) included study, period 2 (2006-08).",C0030705|C0369718|C0009253|C0001779|C0450371|C0450371|C0441889|C0006434|C0450371|G0000000|C0439175|C0242821|C0205148|C0017446|C0332257|C0557651|C0439531|G0000000|C0450371
"In order to be eligible to participate in this study, an employee needs to be a current tobacco smoker and at least 18 years old.","In eligible participate study, employee current tobacco smoker 18 old.",G0000000|C1548635|G0000000|C0557651|C0599987|C0521116|C0040329|C0337664|C0450371|C0580836
The study population included women who were referred to the obstetrical clinic in Besat Hospital of Sanandaj City who were receiving prenatal care and had a history of preeclampsia in previous pregnancies.,The study population included women referred obstetrical clinic Besat Hospital Sanandaj City receiving prenatal care history preeclampsia previous pregnancies.,G0000000|C0557651|C0032659|C0332257|C0043210|C0205543|C0028773|C0002424|G0000000|C0019994|G0000000|C0008848|C1514756|C0678804|C1947933|C0019664|C0032914|C0205156|C0032961
"Smoking prevalence among kidney transplant recipients is more difficult to estimate, and varies greatly across studies [11].","Smoking prevalence kidney transplant recipients difficult estimate, varies greatly studies [11].",C0037369|C0033105|C0022646|C0040732|C1709854|C0332218|C0750572|C1548673|C3840786|C0947630|C0450371
"One hundred and seventy pregnant women with 14 weeks gestational age and the history of at least one PPROM with singleton pregnancy were enrolled in this clinical trial, after being completely explained about study conditions and signing informed consent.","One seventy pregnant women 14 weeks gestational age history PPROM singleton pregnancy enrolled clinical trial, completely explained study conditions signing informed consent.",C0205447|C3816957|C0549206|C0043210|C0450371|C0439230|C0439671|C0001779|C0019664|C0729264|C0481462|C0032961|G0000000|C0205210|C0008976|C0205197|G0000000|C0557651|C0012634|C0311392|C1522154|C1511481
"Other exclusion criteria are patients with immunodeficiency, diseases requiring a prolonged steroid usage, previous radiation therapy or chemotherapy, patients with metabolic bone diseases or uncontrolled endocrine disorders, alcohol or drug abuse as well as pregnancy.","Other exclusion criteria patients immunodeficiency, diseases requiring prolonged steroid usage, previous radiation therapy chemotherapy, patients metabolic bone diseases uncontrolled endocrine disorders, alcohol drug abuse pregnancy.",G0000000|C0680251|C0243161|C0030705|C0021051|C0012634|G0000000|C0439590|C0038317|C0457083|C0205156|C0034519|C0039798|C0013216|C0030705|C0311400|C0262950|C0012634|C0205318|C0014136|C0012634|C0001962|C0013227|C0013146|C0032961
This study was designed to explore the effects of acupuncture and auricular acupressure in relieving menopausal hot flashes of bilaterally ovariectomized Chinese women.,This study designed explore effects acupuncture auricular acupressure relieving menopausal hot flashes bilaterally ovariectomized Chinese women.,G0000000|C0557651|C1707689|G0000000|C1280500|C0001299|C1522191|C0282614|C0332303|C0025320|C0444519|C0085635|G0000000|G0000000|C0008120|C0043210
A self-completion written survey was administered in 2005 to adolescents (aged 10–15 years) and repeated 1 year later.,A self-completion written survey administered 2005 adolescents (aged 10–15 years) repeated 1 later.,G0000000|C0036588|C0043266|C0038951|C1521801|G0000000|C0205653|C0001779|G0000000|C0439234|C0205341|G0000000|C0205087
Individuals were excluded if they had the ability to walk outdoors independently (i.e.,Individuals excluded ability walk outdoors independently (i.e.,C0027361|C1554077|C0085732|C0080331|C1709359|G0000000|C0683454
"The primary reasons for ineligibility were cancer-related, including diagnosis with Stage 3 or 4 breast cancer (n = 23), no previous breast cancer diagnosis (n = 19), less than 6 months post treatment completion (n = 11), and other cancer in last 5 years (n = 3).","The primary reasons ineligibility cancer-related, including diagnosis Stage 3 4 breast cancer (n = 23), previous breast cancer diagnosis (n = 19), 6 months post treatment completion (n = 11), cancer 5 (n = 3).",G0000000|C0205225|C0392360|C1512714|C2826292|C0332257|C0011900|C0205390|G0000000|G0000000|C0006141|C0006826|C0369718|G0000000|C0450371|C0205156|C0006141|C0006826|C0011900|C0369718|G0000000|C0450371|G0000000|C0439231|C0687676|C0039798|C0205197|C0369718|G0000000|C0450371|C0006826|G0000000|C0369718|G0000000|G0000000
"To increase generalizability, we had few exclusion criteria: serious co-morbid medical conditions that could confound the influence of fibromyalgia in the next 6 months (e.g., cancer, heart disease); current, serious psychiatric disorders involving psychotic symptoms, recent suicide risk or substance abuse, as determined by a structured interview based on DSM-IV criteria41; and changes in pain medication within 1 month prior to enrollment, to maintain stability in medical care.","To increase generalizability, exclusion criteria: co-morbid medical conditions confound influence fibromyalgia 6 months (e.g., cancer, heart disease); current, psychiatric disorders involving psychotic symptoms, suicide risk substance abuse, determined structured interview based DSM-IV criteria41; pain medication 1 month prior enrollment, maintain stability medical care.",C0040363|C0442805|G0000000|C0680251|C0243161|C0009488|C0199168|C0012634|G0000000|C4054723|C0016053|G0000000|C0439231|G0000000|C0006826|C0018787|C0012634|C0521116|C0205487|C0012634|C1314939|C0004936|C0683368|C0038661|C0035647|C0439861|C0013146|G0000000|C0678594|C0021822|C1527178|C0220952|G0000000|C0030193|C0013227|G0000000|C0332177|C0332152|C1516879|C0024501|C0205360|C0199168|C1947933
"In the present study, some housing units were closed to the introduction of any new recruits after being formed (hereafter referred to as “closed units”).","In study, housing units closed introduction recruits formed (hereafter referred “closed units”).",G0000000|C0557651|C0020056|C0439148|C0587267|C1293116|G0000000|C0205431|G0000000|C0205543|G0000000|G0000000
General practitioners and practice nurses in the study practices and their patients aged 18 or over with angina or asthma.,General practitioners practice nurses study practices patients aged 18 angina asthma.,C0205246|C1709627|C0237607|C0028661|C0557651|C0237607|C0030705|C0001779|C0450371|C0002962|C0004096
"A total of 335 patients met exclusion criteria for standard anticoagulation only (age ⩾78 years (258), history of bleeding or ulcer,33 severe hypertension,32 and retinopathy12) and were randomised in stratum 2.","A total 335 patients met exclusion criteria standard anticoagulation (age ⩾78 (258), history bleeding ulcer,33 severe hypertension,32 retinopathy12) randomised stratum 2.",G0000000|C0439175|C1442061|C0030705|C0268621|C0680251|C0243161|C1442989|C0003281|C0001779|G0000000|C1442061|C0019664|C0019080|C0041582|C0205082|C0020538|G0000000|G0000000|G0000000|G0000000
"Inclusion criteria included the following: stage I, II, or III invasive breast cancer; >3 months after completion of active treatment; body mass index (BMI) >25; confirmed ER/PR/HER2neu-negative status (per pathology report); and age less than 80 years.","Inclusion criteria included following: stage I, II, III invasive breast cancer; >3 months completion active treatment; body mass (BMI) >25; confirmed ER/PR/HER2neu-negative status (per pathology report); age 80 years.",C0007637|C0243161|C0332257|C0231290|C0205390|C0021966|G0000000|C0439070|C0205281|C0006141|C0006826|G0000000|C0439231|C0205197|C0205177|C0039798|C0242821|C0577559|G0000000|C0450371|C0521093|C3810541|C0449438|G0000000|C0030664|C0684224|C0001779|C0450371|C0439234
"Because a large program of rollout of antiretroviral therapy began in 2004 (21), use of highly active antiretroviral therapy (HAART) was accounted for by stratification of HIV status: HIV negative, HIV positive with high CD4 count, HIV positive with CD4 count < 200 cells/μL, and HIV positive taking HAART.","Because program rollout antiretroviral therapy 2004 (21), highly active antiretroviral therapy (HAART) accounted stratification HIV status: HIV negative, HIV positive CD4 count, HIV positive CD4 count < 200 cells/μL, HIV positive HAART.",G0000000|C1709697|G0000000|G0000000|C0039798|G0000000|C0450371|C0205250|C0205177|G0000000|C0039798|C0887947|C2741673|C1514983|C0019682|C0449438|C0019682|C0205160|C0019682|C0439178|C0285590|C0750480|C0019682|C0439178|C0285590|C0750480|G0000000|C1442061|G0000000|C0019682|C0439178|C0887947
"All patients will be scheduled for assessment of their lung function, using spirometry, at their primary care centre.","All patients scheduled assessment lung function, spirometry, primary care centre.",G0000000|C0030705|C0086960|C1261322|C0024109|C0031843|C0037981|C0205225|C1947933|C0205099
"Specifically, we assumed mortality rates of between 14 and 20 per 1000 child-years, average community sizes of 600 to 799 people (16.7% to 19.0% of which were children aged 1- 59 months), coefficients of variation of between 0.40 and 0.51, and loss to follow-up of 10% (SAP).","Specifically, assumed mortality rates 14 20 1000 child-years, average community sizes 600 799 people (16.7% 19.0% children aged 1- 59 months), coefficients variation 0.40 0.51, loss follow-up 10% (SAP).",G0000000|C3242379|C0026565|C0871208|C0450371|C0450371|G0000000|C0008059|C1510992|C0009462|C0456389|C1442061|C1442061|C0027361|C0450371|C0450371|C0008059|C0001779|G0000000|C0450371|C0439231|C1707429|C0205419|C0450371|C0450371|C1517945|C0589120|C0450371|C1420017
[4] The objectives of this study were to compare the effects of dexmedetomidine combined with ropivacaine to provide postoperative analgesia and also determine the other effects of dexmedetomidine when added to ropivacaine for caudal analgesia in children undergoing lower abdominal surgeries.,[4] The objectives study compare effects dexmedetomidine combined ropivacaine provide postoperative analgesia determine effects dexmedetomidine ropivacaine caudal analgesia children undergoing lower abdominal surgeries.,G0000000|G0000000|C0018017|C0557651|C1707455|C1280500|C0113293|C0205195|C0073571|C1999230|C0032790|C0002766|G0000000|C1280500|C0113293|C0073571|C0205097|C0002766|C0008059|G0000000|C0441994|C0000726|C0543467
Eligible participants were aged 18 years or older with asthma and a serum 25-hydroxyvitamin D level of less than 30 ng/mL.,Eligible participants aged 18 asthma serum 25-hydroxyvitamin D level 30 ng/mL.,C1548635|C0679646|C0001779|C0450371|C0004096|C0229671|C0450371|C0073187|C0441889|C0450371|C0439275
"During the recruitment period, or until the required quota of patients is reached, the family doctor and/or primary care nurse will invite patients aged 18 to 30 years who smoke 10 or more cigarettes per day to participate in the study.","During recruitment period, required quota patients reached, family doctor and/or primary care nurse invite patients aged 18 30 smoke 10 cigarettes day participate study.",G0000000|C2949735|C0439531|C1514873|G0000000|C0030705|C2584321|C0015576|C0031831|G0000000|C0205225|C1947933|C0028661|G0000000|C0030705|C0001779|C0450371|C0450371|C0037366|C0450371|C0677453|C0332173|G0000000|C0557651
PATIENTS: 716 patients aged 4 and over with sore throat and an abnormal physical sign: 84% had tonsillitis or pharyngitis.,PATIENTS: 716 patients aged 4 sore throat abnormal physical sign: 84% tonsillitis pharyngitis.,C0030705|C1442061|C0030705|C0001779|G0000000|C0234233|C0031354|C0205161|C0031809|C0311392|C0450371|C0040425|C0031350
"Patients at a tertiary cancer center with chronic pain or dysfunction attributed to neck dissection were randomly assigned to weekly acupuncture versus usual care (eg, physical therapy, analgesia, and/or anti-inflammatory drugs, per patient preference or physician recommendation) for 4 weeks.","Patients tertiary cancer center chronic pain dysfunction attributed neck dissection randomly assigned weekly acupuncture versus usual care (eg, physical therapy, analgesia, and/or anti-inflammatory drugs, patient preference physician recommendation) 4 weeks.",C0030705|C0205372|C0006826|C0205099|C0205191|C0030193|C0031847|C0449234|C0027530|C0012737|G0000000|C1516050|C0332174|C0001299|G0000000|C3538928|C1947933|C0013715|C0031809|C0039798|C0002766|G0000000|C0003209|C0013227|C0030705|C0558295|C0031831|C0034866|G0000000|C0439230
"Young, healthy participants aged 18–40 years (M = 24.13, SD = 4.47), residing in Melbourne, Australia, were recruited through magazine and social media advertisements, phone calls, and emails.","Young, healthy participants aged 18–40 (M = 24.13, SD = 4.47), residing Melbourne, Australia, recruited magazine social media advertisements, phone calls, emails.",C0332239|C3898900|C0679646|C0001779|G0000000|C0369637|G0000000|C0450371|C2699239|G0000000|C0450371|C2982691|G0000000|C0004340|G0000000|C0162443|C0728831|C0009458|C0949214|C1515258|C0679006|C0013849
"a forced expiratory volume in the first second (FEV1)/forced vital capacity (FVC) ratio of less than 0.7, or if FEV1 is equal to or above 80% predicted normal with other respiratory symptoms being present such as breathlessness or cough); a self-rating breathlessness score on the Medical Research Council (MRC) dyspnoea scale31 of 3 or more; willingness to participate; ability to provide informed consent; and ability to read and write in English or with assistance.","forced expiratory volume (FEV1)/forced vital capacity (FVC) ratio 0.7, FEV1 equal 80% predicted normal respiratory symptoms breathlessness cough); self-rating breathlessness score Medical Research Council (MRC) dyspnoea scale31 3 more; willingness participate; ability provide informed consent; ability read write English assistance.",C0441722|C0231800|C0449468|C0441722|C0442732|C1516240|C3714541|C0456603|G0000000|G0000000|C0205163|C0450371|C0681842|C0205307|C0521346|C0683368|C0013404|C0010200|C4054119|C0013404|C0449820|C0199168|C0035168|C1551807|C1540289|C0013404|G0000000|G0000000|C0205172|C0600109|G0000000|C0085732|C1999230|C1522154|C1511481|C0085732|C0034754|C0043266|C0376245|C0018896
"The protocol design was based on the guidelines published by the Immunocompromised Host Society Consensus Panel (8) Neutropenic patients (age, >18 years) with underlying hematological malignancies (acute leukemia, non-Hodgkin's lymphoma) or aplastic anemia who became febrile were eligible to enter the study.","The protocol design based guidelines published Immunocompromised Host Society Consensus Panel (8) Neutropenic patients (age, >18 years) underlying hematological malignancies (acute leukemia, non-Hodgkin's lymphoma) aplastic anemia febrile eligible enter study.",G0000000|C0442711|C1707689|C1527178|C0162791|C0034037|C0085393|C1167395|C0037455|C0376298|C0441833|G0000000|G0000000|C0030705|C0001779|C0450371|C0439234|G0000000|C0018943|C0006826|C0205178|C0023418|C0024305|C0024299|C0334079|C0002871|C0015967|C1548635|C1522196|C0557651
"COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; IND/GLY, indacaterol/glycopyrronium; LABA, long-acting β2-agonist; LAMA, long-acting muscarinic antagonist; mMRC, modified Medical Research Council; q.d., once daily; SABA, short-acting β2-agonist; SAMA, short-acting muscarinic antagonist CRYSTAL included patients aged ≥40 years with a clinical diagnosis of COPD [7], current or ex-smokers with a smoking history of ≥10 pack-years, a modified Medical Research Council (mMRC) score ≥1, a moderate post-bronchodilator airflow limitation (forced expiratory volume in 1 s [FEV1] ≥50% and <80% predicted and FEV1/forced vital capacity (FVC) ratio <0.7) and patients who have been on a stable dose of baseline treatment with any short-acting β2-agonists (SABA) and/or short-acting muscarinic antagonists (SAMA) or LABA or LAMA or LABA + ICS in free or FDCs for at least 3 months before screening.","COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; IND/GLY, indacaterol/glycopyrronium; LABA, long-acting β2-agonist; LAMA, long-acting muscarinic antagonist; mMRC, modified Medical Research Council; q.d., daily; SABA, short-acting β2-agonist; SAMA, short-acting muscarinic antagonist CRYSTAL included patients aged ≥40 clinical diagnosis COPD [7], current ex-smokers smoking history ≥10 pack-years, modified Medical Research Council (mMRC) score ≥1, moderate post-bronchodilator airflow limitation (forced expiratory volume 1 [FEV1] ≥50% <80% predicted FEV1/forced vital capacity (FVC) ratio <0.7) patients stable dose baseline treatment short-acting β2-agonists (SABA) and/or short-acting muscarinic antagonists (SAMA) LABA LAMA LABA + ICS free FDCs 3 months screening.",C0024117|C0205191|C0549186|C0024109|C0012634|C0022521|C0004048|C0001617|C4049864|C1722260|G0000000|C0205166|G0000000|C0999593|C0205166|C0026815|C0231491|C3826977|C0392747|C0199168|C0035168|C1551807|C0073187|C0332173|G0000000|C1282927|G0000000|C1075468|C1282927|C0026815|C0231491|C0427896|C0332257|C0030705|C0001779|G0000000|C0205210|C0011900|C0024117|G0000000|C0521116|C0337671|C0037369|C0019664|G0000000|C1277691|C0392747|C0199168|C0035168|C1551807|C3826977|C0449820|G0000000|C0205081|C2599594|C0231999|C0449295|C0441722|C0231800|C0449468|G0000000|G0000000|G0000000|C0450371|C0681842|C0441722|C0442732|C1516240|C3714541|C0456603|G0000000|C0030705|C0205360|C0178602|C0168634|C0039798|C1282927|G0000000|G0000000|G0000000|C1282927|C0026815|C0243076|C1075468|G0000000|C0999593|G0000000|G0000000|C0022521|C0332296|C0340427|G0000000|C0439231|C0220908
"Exclusion criteria were prior to cerebral radiotherapy and/or surgery of cerebral metastases (except stereotactic biopsy), missing histologically proven nature of cancer, solitary intracerebral metastases suitable for neurosurgery, meningeosis carcinomatosa, active uncontrolled infection, concomitant or previous malignancies, except basal or squamous cell carcinoma or carcinoma in situ of the cervix and history of therapy with and/or known allergy to topoisomerase I inhibitors, pregnant or breast-feeding women.","Exclusion criteria prior cerebral radiotherapy and/or surgery cerebral metastases (except stereotactic biopsy), missing histologically proven nature cancer, solitary intracerebral metastases suitable neurosurgery, meningeosis carcinomatosa, active uncontrolled infection, concomitant previous malignancies, basal squamous cell carcinoma carcinoma situ cervix history therapy and/or allergy topoisomerase I inhibitors, pregnant breast-feeding women.",C0680251|C0243161|C0332152|G0000000|C0034619|G0000000|C0038894|G0000000|C0027627|G0000000|C0729296|C0005558|C1551393|C0205462|C0456369|C0349590|C0006826|C0205171|C0442111|C0027627|C3900053|C0027926|G0000000|G0000000|C0205177|C0205318|C0009450|C0521115|C0205156|C0006826|C0205112|C1182670|C0007634|C0007097|C0007097|G0000000|C0007874|C0019664|C0039798|G0000000|C0002111|C1336767|C0021966|C0243077|C0549206|C0006147|C0043210
"If the intervention in this study is shown to be of benefit to both the patient and carer, it would provide the basis for a model of community-based rehabilitation management for people who have had a stroke and their carers, that adopts a robust client-centred approach.","If intervention study benefit patient carer, provide basis model community-based rehabilitation management people stroke carers, adopts robust client-centred approach.",G0000000|C0886296|C0557651|C0814225|C0030705|C0085537|C1999230|C1527178|C3161035|C0009462|C0034991|C0001554|C0027361|C0038454|C0085537|C0425382|C2986815|C0008942|C0449445
"Intervention effects on smoking cessation, smoke-free homes enforcement, and other related outcomes among fathers of newborn at 6 months.","Intervention effects smoking cessation, smoke-free homes enforcement, outcomes fathers newborn 6 months.",C0886296|C1280500|C0037369|C1880019|C0037366|C0442519|G0000000|C1274040|C0015671|C0021289|G0000000|C0439231
"There were no statistically significant differences between the two groups of patients as regards the preoperative variables, including IOP, corneal diameter, cup/disc ratio, and axial length (the P-values for the age at surgery and the axial length were 0.155 and 0.233, respectively, between the two groups), as well as along all the follow-up periods until the end of follow-up in both the groups.","There statistically differences patients preoperative variables, including IOP, corneal diameter, cup/disc ratio, axial length (the P-values age surgery axial length 0.155 0.233, respectively, groups), follow-up periods follow-up groups.",G0000000|C0038215|C1705241|C0030705|C0445204|C0439828|C0332257|C0595921|C0010031|C1301886|C1533124|C0456603|C0205131|C1444754|G0000000|C1709380|C0001779|C0038894|C0205131|C1444754|C1442061|C1442061|G0000000|C0441833|C0589120|C0439531|C0589120|C0441833
"Baseline characteristics of randomized participants, n (%)a a Unless otherwise stated.","Baseline characteristics randomized participants, (%)a Unless stated.",C0168634|C1521970|C0034656|C0679646|G0000000|G0000000|C1301808
"After neurologic assessments, subjects over 1‐year old with active epilepsy were invited to enroll in the trial regardless of prior treatment status (see Box S1, for operational definitions).","After neurologic assessments, subjects 1‐year active epilepsy invited enroll trial prior treatment status (see Box S1, operational definitions).",G0000000|C0205494|C1261322|C0681850|G0000000|C0205177|C0014544|G0000000|G0000000|C0008976|C0332152|C0039798|C0449438|C0042789|C0179400|C1519428|C0038895|C1550452
"Eligible patients were aged 32–67 year-old, with a diagnosis of cancer, documented history of moderate/severe, chronic cancer pain, classified as Tumour-Node-Metastasis stage III or IV, requiring round-the-clock opioid, and capacity to understand the study protocol.","Eligible patients aged 32–67 year-old, diagnosis cancer, documented history moderate/severe, chronic cancer pain, classified Tumour-Node-Metastasis stage III IV, requiring round-the-clock opioid, capacity understand study protocol.",C1548635|C0030705|C0001779|G0000000|C0439234|C0011900|C0006826|C1301725|C0019664|C0205081|C0205191|C0006826|C0030193|C0008902|C0027627|C0205390|C0439070|C0022326|G0000000|C0332490|C0242402|C1516240|C0162340|C0557651|C0442711
Patients were recruited among those referred by primary care doctors because of symptoms of carpal tunnel syndrome.,Patients recruited referred primary care doctors symptoms carpal tunnel syndrome.,C0030705|G0000000|C0205543|C0205225|C1947933|C0031831|C0683368|C0007285|C0337138|C0039082
"MET, metabolic equivalent; SD, standard deviation; SMHS, Shanghai Men's Health Study; SWHS, Shanghai Women's Health Study.","MET, metabolic equivalent; SD, standard deviation; SMHS, Shanghai Men's Health Study; SWHS, Shanghai Women's Health Study.",C0268621|C0311400|C0205163|C2699239|C1442989|C0012727|C1824631|G0000000|C0025266|C0018684|C0557651|G0000000|G0000000|C0043210|C0018684|C0557651
To avoid medicalising a self limiting illness doctors should avoid antibiotics or offer a delayed prescription for most patients with sore throat.,To avoid medicalising limiting illness doctors avoid antibiotics offer delayed prescription patients sore throat.,C0040363|G0000000|G0000000|C0439801|C0221423|C0031831|G0000000|C0003232|G0000000|C0205421|C0033080|C0030705|C0234233|C0031354
"As previously reported, patients were predominantly male, 62% had ECOG performance status of 0, and 85% had prior nephrectomy.","As reported, patients male, 62% ECOG performance status 0, 85% prior nephrectomy.",G0000000|C0684224|C0030705|C0086582|C0450371|C0430797|C0597198|C0449438|G0000000|C0450371|C0332152|C0027695
"Criteria for inclusion are completion of treatment for breast cancer in terms of surgery, radiotherapy and chemotherapy at least 6 months previously; unilateral secondary lymphoedema stage one related to surgery for breast cancer, as confirmed by a registered lymphoedema therapist; good English comprehension in order to understand the written forms and oral instructions and be able to give informed consent; aged > 18 years.","Criteria inclusion completion treatment breast cancer terms surgery, radiotherapy chemotherapy 6 months previously; unilateral secondary lymphoedema stage surgery breast cancer, confirmed registered lymphoedema therapist; English comprehension understand written forms oral instructions informed consent; aged > 18 years.",C0243161|C0007637|C0205197|C0039798|C0006141|C0006826|C0233324|C0038894|C0034619|C0013216|G0000000|G0000000|C0205092|C0027627|C0024236|C0205390|C0038894|C0006141|C0006826|C0521093|C1514821|C0024236|C0871525|C0376245|C0162340|C0162340|C0043266|C0348078|C0442027|C0302828|C1522154|C1511481|G0000000
"Patients 270 adult trauma patients with, or at risk of, significant extracranial bleeding within 8 hours of injury, who also had traumatic brain injury.","Patients 270 adult trauma patients with, risk of, extracranial bleeding 8 hours injury, traumatic brain injury.",C0030705|C1442061|C0001675|C0043251|C0030705|G0000000|C0035647|G0000000|C0580586|C0019080|G0000000|C0439227|C3263722|C0332663|C0006104|C3263722
250 adults within 90 days of being diagnosed with NDS/TIA will be randomly allocated to a 12-week program of exercise and education (PREVENT) or to an outpatient clinic assessment and discussion of secondary prevention recommendations with return clinic visits as indicated (USUAL CARE).,250 adults 90 days diagnosed NDS/TIA randomly allocated 12-week program exercise education (PREVENT) outpatient clinic assessment discussion secondary prevention recommendations return clinic visits (USUAL CARE).,C1442061|C0001675|C0450371|C0439228|C0011900|C0057753|G0000000|G0000000|C0450371|C1709697|C0015259|C0013621|C0309872|C0029921|C0002424|C1261322|C0557061|C0027627|C0199176|C0034866|C0332156|C0002424|C0545082|C3538928|C1947933
"From these clusters, children were eligible to participate in the study if they were between the ages of 12 and 24 months at pre‐test (exclusion criteria, namely that the child be physically or mentally handicapped, or not yet started on complementary foods, did not apply to anyone).","From clusters, children eligible participate study ages 12 24 months pre‐test (exclusion criteria, child physically mentally handicapped, started complementary foods, apply anyone).",G0000000|C1555715|C0008059|C1548635|G0000000|C0557651|C0001779|C0450371|C0450371|C0439231|G0000000|C0680251|C0243161|C0008059|G0000000|G0000000|C0018576|C1272689|G0000000|C0016452|C1632850|G0000000
"A total of 243 patients were excluded for the following reasons: 66 were not diagnosed with hemiplegia, 36 could not walk, 48 were within six months of onset, 5 wore a pacemaker, 40 had a modified Ashworth scale (MAS) score below 2, 38 had osteoarthritis, and 6 were discharged from the hospital.","A total 243 patients excluded reasons: 66 diagnosed hemiplegia, 36 walk, 48 months onset, 5 wore pacemaker, 40 modified Ashworth scale (MAS) score 2, 38 osteoarthritis, 6 discharged hospital.",G0000000|C0439175|C1442061|C0030705|C1554077|C0392360|C0450371|C0011900|C0018991|C0450371|C0080331|C0450371|C0439231|C0206132|G0000000|G0000000|C0030163|C0450371|C0392747|G0000000|C0175659|C1096155|C0449820|G0000000|C0450371|C0029408|G0000000|C0030685|C0019994
"The current phase III confirmatory study evaluated the immunogenicity and safety of the AS04-HPV-16/18 vaccine administered as 2 alternative 2-dose schedules: a 2-dose schedule at months 0 and 6 (2D_M0,6) or a 2-dose schedule at months 0 and 12 (2D_M0,12) in girls aged 9–14 years compared with the standard 3D_M0,1,6 schedule in women aged 15–25 years.","The current phase III confirmatory study evaluated immunogenicity safety AS04-HPV-16/18 vaccine administered 2 alternative 2-dose schedules: 2-dose schedule months 0 6 (2D_M0,6) 2-dose schedule months 0 12 (2D_M0,12) girls aged 9–14 compared standard 3D_M0,1,6 schedule women aged 15–25 years.",G0000000|C0521116|C0205390|C0439070|C0750484|C0557651|C0220825|C4054739|C0036043|C0021344|C0042210|C1521801|G0000000|C1523987|C0178602|C0086960|C0178602|C0086960|C0439231|G0000000|G0000000|C0043316|C0178602|C0086960|C0439231|G0000000|C0450371|C0043316|C0870604|C0001779|G0000000|C1707455|C1442989|C0043316|C0086960|C0043210|C0001779|G0000000|C0439234
"Also, the study participants had no history of medical, surgical, or mental problems and had faced no special problems during pregnancy.","Also, study participants history medical, surgical, mental faced special pregnancy.",G0000000|C0557651|C0679646|C0019664|C0199168|C0543467|C0229992|C0015450|C0205555|C0032961
"Twenty patients (13 males and 7 females; mean age, 65.6 ± 9.2 years) with subacute stroke (i.e., within 3 months of stroke) were selected for this study.","Twenty patients (13 males 7 females; age, 65.6 ± 9.2 years) subacute stroke (i.e., 3 months stroke) selected study.",C0724000|C0030705|C0450371|C0086582|G0000000|C0015780|C0001779|C0450371|G0000000|G0000000|C0205365|C0038454|C0683454|G0000000|C0439231|C0038454|C1707391|C0557651
A diagnosis of PTSD is made only when a patient reports the minimum number of symptoms required by DSM-IV for each of the symptom clusters.,A diagnosis PTSD patient reports minimum symptoms required DSM-IV symptom clusters.,G0000000|C0011900|C0038436|C0030705|C0684224|C1524031|C0683368|C1514873|C0220952|C1457887|C1555715
"A total of 417 women were initially screened by phone for study eligibility (being female, having physician-diagnosed FMS for at least 6 months, being 20 to 75 years of age, and willing to participate in an 8-month study involving classes, phone support and data collection).","A total 417 women initially screened phone study eligibility (being female, physician-diagnosed FMS 6 months, 20 75 age, participate 8-month study involving classes, phone support data collection).",G0000000|C0439175|C1442061|C0043210|C0205265|C0220908|C1515258|C0557651|C0013893|G0000000|C0015780|C0031831|G0000000|G0000000|C0439231|C0450371|C0450371|C0001779|G0000000|C0332177|C0557651|C1314939|C0456387|C1515258|C0183683|C1511726|C1516698
Prior the randomization informed consent will be obtained from all patients.,Prior randomization informed consent patients.,C0332152|C0034656|C1522154|C1511481|C0030705
"Patients were also required to receive their care at MGH, be ≥ 18 years of age, have no history of therapy for metastatic disease, have an Eastern Cooperative Oncology Group performance status of 0 to 2, and be able to read and respond to questions in English or complete questionnaires with minimal assistance.","Patients required receive care MGH, ≥ 18 age, history therapy metastatic disease, Eastern Cooperative Oncology Group performance status 0 2, read respond questions English complete questionnaires minimal assistance.",C0030705|C1514873|C1514756|C1947933|G0000000|G0000000|C0450371|C0001779|C0019664|C0039798|C0036525|C0012634|C1707877|C0679729|C0027651|C0441833|C0597198|C0449438|G0000000|G0000000|C0034754|G0000000|C1522634|C0376245|C0205197|C0034394|C0547040|C0018896
"In this modest-sized phase II study, DRCFI was also well tolerated and delayed time to first pulmonary exacerbation in the per protocol population.","In modest-sized phase II study, DRCFI tolerated delayed time pulmonary exacerbation protocol population.",G0000000|C4054480|C0205390|G0000000|C0557651|G0000000|G0000000|C0205421|C0040223|C0024109|G0000000|C0442711|C0032659
The study simultaneously enrolled respondents into two separate trials: caregivers of 4- to 16-month-old children in the first study area (all 38 villages in Shianda Location near the town of Kakamega) and pregnant women in their second or third trimester and caregivers of children under 3 months of age in the second study area (all 34 villages in Kibingei Location near the town of Bungoma).,The study simultaneously enrolled respondents separate trials: caregivers 4- 16-month-old children study (all 38 villages Shianda Location town Kakamega) pregnant women trimester caregivers children 3 months age study (all 34 villages Kibingei Location town Bungoma).,G0000000|C0557651|C0521115|G0000000|C0282122|C0443299|C0008976|C0085537|G0000000|C0450371|C0008059|C0557651|G0000000|C0450371|C0562518|G0000000|C0450429|C0557750|C1221116|C0549206|C0043210|C0032982|C0085537|C0008059|G0000000|C0439231|C0001779|C0557651|G0000000|C0450371|C0562518|G0000000|C0450429|C0557750|G0000000
"We performed a prospective study in patients undergoing urologic laparoscopy, specifically transperitoneal laparoscopic renal surgery, to compare 4 currently available disposable trocars with different tip varieties for postoperative pain and complications in a randomized double-blind (ie, patient and postoperative evaluator) setting.","We performed prospective study patients undergoing urologic laparoscopy, transperitoneal laparoscopic renal surgery, compare 4 disposable trocars varieties postoperative pain complications randomized double-blind (ie, patient postoperative evaluator) setting.",G0000000|C0884358|C0023981|C0557651|C0030705|G0000000|C0042077|C0031150|C0205501|C0031150|C0022646|C0038894|C1707455|G0000000|C0725865|C0041158|C1883525|C0032790|C0030193|C0009566|C0034656|C0013072|G0000000|C0030705|C0032790|C1707957|C0542559
Only 1 person per household was invited to participate in the study.,Only 1 person household invited participate study.,C0205171|G0000000|C0027361|C0020052|G0000000|G0000000|C0557651
Background: The relative efficacies of aminophylline and salbutamol in severe acute childhood asthma are currently unclear.,Background: The relative efficacies aminophylline salbutamol severe acute childhood asthma unclear.,C1706907|G0000000|C0080103|C1280519|C0002575|C0001927|C0205082|C0205178|C0231335|C0004096|G0000000
We selected 215 patients with stage IB2 and IIA2 cervical cancer (tumor diameter > 4 cm on magnetic resonance imaging) who underwent RH followed by tailored adjuvant therapy (n=147) or primary CRT (n=68) at two tertiary referral centers between 2001 and 2010.,We selected 215 patients stage IB2 IIA2 cervical cancer (tumor diameter > 4 cm magnetic resonance imaging) underwent RH tailored adjuvant therapy (n=147) primary CRT (n=68) tertiary referral centers 2001 2010.,G0000000|C1707391|C1442061|C0030705|C0205390|G0000000|G0000000|C0027530|C0006826|C0027651|C1301886|G0000000|G0000000|G0000000|C0024488|C0231881|C0011923|G0000000|C0035493|C0402883|C0001551|C0039798|C0369718|C0205225|G0000000|C0369718|C0205372|C0034927|C0205099|G0000000|G0000000
"Although the overall incidence of stroke has been recently declining, the incidence of stroke in young adults is increasing.","Although incidence stroke declining, incidence stroke adults increasing.",G0000000|C0021149|C0038454|C1511741|C0021149|C0038454|C0001675|C0442808
"SFP 10–14 UK is designed for delivery to families with children aged 10–14, and in the Wales adaptation is targeted towards a mix of children and their families.","SFP 10–14 UK designed delivery families children aged 10–14, Wales adaptation targeted mix children families.",C0075029|G0000000|C0041700|C1707689|C0011209|C0015576|C0008059|C0001779|G0000000|C0043015|C0000934|C1521840|C0205430|C0008059|C0015576
The inclusion criteria were as follows: (1) stable COPD according to the GOLD diagnostic criteria (GOLD stages II–IV) of 2006 (FEV in 1 second [FEV1] < 80% predicted and FEV1/forced vital capacity (FVC) < 70% after bronchial relaxation); (2) no acute exacerbation; (3) no change in therapeutic schedule; and (4) no treatment with any antibiotics or glucocorticoids in the previous 4 weeks.,The inclusion criteria follows: (1) stable COPD GOLD diagnostic criteria (GOLD stages II–IV) 2006 (FEV 1 [FEV1] < 80% predicted FEV1/forced vital capacity (FVC) < 70% bronchial relaxation); (2) acute exacerbation; (3) change therapeutic schedule; (4) treatment antibiotics glucocorticoids previous 4 weeks.,G0000000|C0007637|C0243161|C0332283|G0000000|C0205360|C0024117|C0018026|C0011900|C0243161|C0018026|C1306673|G0000000|G0000000|C3714541|G0000000|G0000000|G0000000|C0450371|C0681842|C0441722|C0442732|C1516240|C3714541|G0000000|C0450371|C0205039|C0035028|G0000000|C0205178|G0000000|G0000000|C0392747|C0087111|C0086960|G0000000|C0039798|C0003232|C0017710|C0205156|G0000000|C0439230
This study was supported by a grant from the Centers for Disease Control and Prevention SIP 14-007 1U48DP005030.,This study supported grant Centers Disease Control Prevention SIP 14-007 1U48DP005030.,G0000000|C0557651|C1521721|C0018173|C0205099|C0012634|C0243148|C0199176|C1823796|C0450371|G0000000
"The inclusion criteria were: males and females, age 18 to 75, diagnosis of MS (primary or secondary progressive, relapsing-remitting), without relapses in the preceding 3 months, mild to moderate gait impairments referred to Expanded Disability Status Scale (EDSS) score between 4 and 5.5.","The inclusion criteria were: males females, age 18 75, diagnosis MS (primary secondary progressive, relapsing-remitting), relapses preceding 3 months, mild moderate gait impairments referred Expanded Disability Status Scale (EDSS) score 4 5.5.",G0000000|C0007637|C0243161|G0000000|C0086582|C0015780|C0001779|C0450371|C0450371|C0011900|C0039676|C0205225|C0027627|C0205329|C0035020|C0035020|C0332152|G0000000|C0439231|C2945599|C0205081|C0016928|C0684336|C0205543|C0205229|C0231170|C0449438|C0175659|C0451246|C0449820|G0000000|G0000000
The mothers or caretakers also had to adhere to a regular study follow-up schedule for one year.,The mothers caretakers adhere regular study follow-up schedule year.,G0000000|C0026591|C0335350|C3714578|C0205272|C0557651|C0589120|C0086960|C0439234
"Consequently, we suggest that ISS and INCAT disability scale are not the most appropriate primary outcome measures for assessing paresthesia, pain, and ataxia, which seem to respond better to treatment in these patients.","Consequently, ISS INCAT disability scale primary outcome measures assessing paresthesia, pain, ataxia, respond treatment patients.",G0000000|C1845118|G0000000|C0231170|C0175659|C0205225|C1274040|C0079809|C1516048|C0030554|C0030193|C0004134|G0000000|C0039798|C0030705
Health-related QoL is affected significantly in patients with IBS compared to the general population.,Health-related QoL patients IBS compared population.,C0018684|C0518214|C0030705|C0022104|C1707455|C0032659
"All patients admitted acutely to Oslo University Hospital with a hip fracture (a femoral neck fracture, a trochanteric or a sub-trochanteric fracture) were eligible for inclusion.","All patients admitted acutely Oslo University Hospital hip fracture (a femoral neck fracture, trochanteric sub-trochanteric fracture) eligible inclusion.",G0000000|C0030705|C0184666|G0000000|G0000000|C0041740|C0019994|C0019552|C0016658|G0000000|C0015811|C0027530|C0016658|C0162370|C0542339|C0016658|C1548635|C0007637
"Inclusion criteria were: 1) age between 50 and 80 years, 2) COPD GOLD stages II-IV, 3) smoking history of >20 pack years, 4) pharmacological therapy according to the current guidelines, 5) written informed consent.","Inclusion criteria were: 1) age 50 80 years, 2) COPD GOLD stages II-IV, 3) smoking history >20 pack years, 4) pharmacological therapy current guidelines, 5) written informed consent.",C0007637|C0243161|G0000000|G0000000|C0001779|C0450371|C0450371|C0439234|G0000000|C0024117|C0018026|C1306673|C0022326|G0000000|C0037369|C0019664|C0450371|C1968515|C0439234|G0000000|C0031330|C0039798|C0521116|C0162791|G0000000|C0043266|C1522154|C1511481
"The sample comprised pregnant women with one previous lower segment caesarean section, no current obstetric problems, and delivery expected at ≥37 weeks.","The sample comprised pregnant women previous lower segment caesarean section, current obstetric problems, delivery expected ≥37 weeks.",G0000000|C0370003|C2700400|C0549206|C0043210|C0205156|C0441994|C0441635|C3841297|C0152060|C0521116|C0205484|C1546466|C0011209|C1517001|G0000000|C0439230
Patients without WMA's were not included in this trial.,Patients WMA's included trial.,C0030705|G0000000|C0332257|C0008976
"Additionally, the participants exhibited mild to moderate hand impairment as evidenced by a score of 5 or 6 on the Stage of Hand subsection of the Chedoke-McMaster Stroke Assessment scale (CMSA-H)[15].","Additionally, participants exhibited mild moderate hand impairment evidenced score 5 6 Stage Hand subsection Chedoke-McMaster Stroke Assessment scale (CMSA-H)[15].",G0000000|C0679646|C0015272|C2945599|C0205081|C0018563|C0221099|C3887511|C0449820|G0000000|G0000000|C0205390|C0018563|C1552859|G0000000|C0038454|C1261322|C0175659|C0033727
"Renal function was acceptable in these young children, with four children having a glomerular filtration rate of less than 60 ml per minute per 1.73 m2 at the end of treatment or follow-up.","Renal function acceptable children, children glomerular filtration rate 60 minute 1.73 m2 treatment follow-up.",C0022646|C0031843|C1879533|C0008059|C0008059|C0022663|C0016107|C0871208|C0450371|C0439232|C0450371|C0025885|C0039798|C0589120
"The study included 34 participants, 15 subjects in the IG and 19 subjects in the CG.","The study included 34 participants, 15 subjects IG 19 subjects CG.",G0000000|C0557651|C0332257|C0450371|C0679646|C0450371|C0681850|C0021027|C0450371|C0681850|C0043444
Participants came to the laboratory daily Monday through Friday.,Participants laboratory daily Monday Friday.,C0679646|C0022877|C0332173|C0585024|C0585029
"If the score was <450, patients with CD were admitted to the study.","If score <450, patients CD admitted study.",G0000000|C0449820|C1442061|C0030705|C0007928|C0184666|C0557651
"Participants had autistic spectrum disorders, Asperger disorder, or pervasive developmental disorder, not otherwise specified; had illness severity ratings of at least moderate on the Clinical Global Impressions, Severity of Illness Scale; and scored at least moderate on compulsive behaviors measured with the Children's Yale-Brown Obsessive Compulsive Scales modified for pervasive developmental disorders.","Participants autistic spectrum disorders, Asperger disorder, pervasive developmental disorder, specified; illness severity ratings moderate Clinical Global Impressions, Severity Illness Scale; scored moderate compulsive behaviors measured Children's Yale-Brown Obsessive Compulsive Scales modified pervasive developmental disorders.",C0679646|C0004352|C1883073|C0012634|G0000000|C0012634|C0205391|C0458003|C0012634|C0205369|C0221423|C0439793|C0871208|C0205081|C0205210|C0205246|C0596764|C0439793|C0221423|C0175659|C0449820|C0205081|G0000000|C0004927|C0444706|C0008059|C0678579|G0000000|G0000000|C0175659|C0392747|C0205391|C0458003|C0012634
"Forty-four adults with non-segmental vitiligo affecting 20% or less of the body surface area were included and randomized to receive topical clobetasol propionate 0.05% cream (group 1) or placebo (group 2) for 12 weeks, with a maximum dose of 50 g per week.","Forty-four adults non-segmental vitiligo 20% body surface included randomized receive topical clobetasol propionate 0.05% cream (group 1) placebo (group 2) 12 weeks, maximum dose 50 week.",C3816449|C0001675|C1518422|C0042900|C0450371|C0242821|C0205148|C0332257|C0034656|C1514756|C0332237|C0008992|C0033474|C0450371|C0700385|C0441833|G0000000|C0032042|C0441833|G0000000|C0450371|C0439230|C0806909|C0178602|C0450371|C0332174
"All participants lived in either southwest Detroit, where residents were predominantly Latino of Mexican origin (70%) and had an annual median household income of $11 500, or eastside Detroit, which is largely African American (80%) with a median household income of $25 020.40 Participants from southwest Detroit received medical care at a federally qualified community health center, whereas participants from eastside Detroit received medical care at a major local health system.","All participants lived southwest Detroit, residents Latino Mexican origin (70%) annual median household income $11 500, eastside Detroit, African American (80%) median household income $25 020.40 Participants southwest Detroit received medical care federally qualified community health center, participants eastside Detroit received medical care major local health system.",G0000000|C0679646|C1548795|C1710136|G0000000|C1320928|C0086528|C0240339|C0079946|C0450371|C0332181|C0549183|C0020052|C0021162|C0450371|C1442061|G0000000|G0000000|C0027567|C0596070|C0450371|C0549183|C0020052|C0021162|C0450371|C1442061|C0679646|C1710136|G0000000|C1514756|C0199168|C1947933|G0000000|G0000000|C0009462|C0018684|C0205099|C0679646|G0000000|G0000000|C1514756|C0199168|C1947933|C0205082|C0205276|C0018684|C0449913
"NPC cases were restricted to individuals less than 75 years old, no previous diagnosis for NPC and residence in Taipei city/county for more than 6 months.","NPC restricted individuals 75 old, previous diagnosis NPC residence Taipei city/county 6 months.",G0000000|C0443288|C0027361|C0450371|C0580836|C0205156|C0011900|G0000000|C0237096|G0000000|C0008848|G0000000|C0439231
Complications were defined as either medical or the absence of appetite.,Complications defined medical absence appetite.,C0009566|C1704788|C0199168|C0332197|C0003618
Children born to women with epilepsy who did not use antiepileptic drugs had no increased risks.,Children born women epilepsy antiepileptic drugs increased risks.,C0008059|C0005615|C0043210|C0014544|C0003299|C0013227|C0205217|C0035647
All patients underwent relaparotomy for elective small intestinal anastomosis for the closure of stoma that was made earlier as a temporary diversion in selected cases of typhoid perforation peritonitis.,All patients underwent relaparotomy elective intestinal anastomosis closure stoma earlier temporary diversion selected typhoid perforation peritonitis.,G0000000|C0030705|G0000000|G0000000|C0206058|C0021853|C0332853|C0185003|C1955856|C1279919|C0205374|C0185033|C1707391|C0041466|C0549099|C0031154
"Pain was reported less frequently in both vaccine and placebo groups in Senegal (39.5% and 22.2%, respectively) than in Tanzania (73.2% and 55.5%, respectively).","Pain reported frequently vaccine placebo Senegal (39.5% 22.2%, respectively) Tanzania (73.2% 55.5%, respectively).",C0030193|C0684224|C0332183|C0042210|C0032042|C0036644|C0450371|C0450371|G0000000|C0039298|C0450371|C0450371|G0000000
"Of the 915 women who were randomized, 1 was excluded because of an invalid gestational age and 1 because she was found to be not pregnant.","Of 915 women randomized, 1 excluded invalid gestational age 1 pregnant.",G0000000|C1442061|C0043210|C0034656|G0000000|C1554077|C0231173|C0439671|C0001779|G0000000|C0549206
"If the score was higher, patients with UC were not admitted to the study.","If score higher, patients UC admitted study.",G0000000|C0449820|C0205250|C0030705|G0000000|C0184666|C0557651
The inclusion criteria refer to all term and preterm infants > 28+ 0 by best obstetrical estimate who require CPR at birth due to bradycardia (< 60/min) or asystole.,The inclusion criteria refer term preterm infants > 28+ 0 obstetrical estimate require CPR birth bradycardia (< 60/min) asystole.,G0000000|C0007637|C0243161|C0205543|C0233324|C0151526|C0021270|G0000000|C0028773|C0750572|G0000000|C0007203|C0005615|C0428977|G0000000|C0018790
Patients treated with antibiotics during the previous 2 weeks were excluded.,Patients treated antibiotics previous 2 weeks excluded.,C0030705|C1522326|C0003232|C0205156|G0000000|C0439230|C1554077
"Patients were excluded if they were known to have an allergy to chlorhexidine, were admitted with burns or toxic epidermal necrolysis/Stevens-Johnson syndrome, or if the treating physician felt bathing would be unsafe.","Patients excluded allergy chlorhexidine, admitted burns toxic epidermal necrolysis/Stevens-Johnson syndrome, treating physician bathing unsafe.",C0030705|C1554077|C0002111|C0008196|C0184666|C0006434|C0600688|C0014520|C1551756|C0039082|C1522326|C0031831|C0150141|G0000000
"The direct costs included drug costs, hospitalization costs, monitoring costs, and physician visits costs.","The direct costs included drug costs, hospitalization costs, monitoring costs, physician visits costs.",G0000000|C0439851|C0010186|C0332257|C0013227|C0010186|C0019993|C0010186|C0150369|C0010186|C0031831|C0545082|C0010186
"The immediate and delayed intervention groups were similar in gender, race, and school grade.","The delayed intervention gender, race, school grade.",G0000000|C0205421|C0886296|C0079399|C0034510|C0036375|C0441800
"Women who were pregnant, at risk of or planning to become pregnant, or breast-feeding were excluded.","Women pregnant, risk planning pregnant, breast-feeding excluded.",C0043210|C0549206|C0035647|C0032074|C0549206|C0006147|C1554077
"Exclusions were as follows: (1) additional neurologic abnormality; (2) multifocal stroke; (3) severe hemiparesis (Manual Ability Classification System V or <20° finger/wrist extension) or predominant dystonia; (4) developmental delay precluding compliance; (5) unstable epilepsy; (6) TMS contraindication16; or (7) CIMT within 6 months, upper limb surgery, or botulinum toxin within 12 months.","Exclusions follows: (1) additional neurologic abnormality; (2) multifocal stroke; (3) severe hemiparesis (Manual Ability Classification System V <20° finger/wrist extension) predominant dystonia; (4) developmental delay precluding compliance; (5) unstable epilepsy; (6) TMS contraindication16; (7) CIMT 6 months, upper limb surgery, botulinum toxin 12 months.",C0680251|C0332283|G0000000|C1524062|C0205494|C1704258|G0000000|C0205292|C0038454|G0000000|C0205082|C0018989|C0024763|C0085732|C0008902|C0449913|G0000000|G0000000|C0016129|C0231448|C1542147|C0013421|G0000000|C0458003|C0205421|G0000000|C0009563|G0000000|C0443343|C0014544|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|C0439231|C1282910|C0015385|C0038894|C0006055|C0040549|C0450371|C0439231
"A Phase 3 randomized, double-blind, placebo-controlled clinical trial was conducted in 699 men at high risk for prostate cancer (prostate specific antigen (PSA) >4 ng/ml and/or suspicious digital rectal examination and/or PSA velocity >0.75ng/ml/year), but with a negative prostate biopsy.","A Phase 3 randomized, double-blind, placebo-controlled clinical trial conducted 699 risk prostate cancer (prostate specific antigen (PSA) >4 ng/ml and/or suspicious digital rectal examination and/or PSA velocity >0.75ng/ml/year), negative prostate biopsy.",G0000000|C0205390|G0000000|C0034656|C0013072|C1706408|C0205210|C0008976|C0004927|C1442061|C0035647|C0033572|C0006826|C0033572|C0205369|C0003320|C3810537|G0000000|C0439275|G0000000|C0750493|C0442015|C0205052|G0000000|G0000000|C3810537|C0439830|C0439526|C0205160|C0033572|C0005558
"Patients had clinically definite and magnetic resonance image supported MS, at least one relapse in the year before entry into the study, and a baseline EDSS score of 0–5 and were treated with subcutaneous 250 μg interferon beta-1b (Betaseron, Bayer) every other day at least one year before the trial [18, 19].","Patients clinically definite magnetic resonance image supported MS, relapse entry study, baseline EDSS score 0–5 treated subcutaneous 250 μg interferon beta-1b (Betaseron, Bayer) day trial [18, 19].",C0030705|G0000000|C0439544|C0024488|C0231881|C1704254|C1521721|C0039676|C0035020|C1705654|C0557651|C0168634|C0451246|C0449820|G0000000|C1522326|C0443315|G0000000|C0021747|C0330390|C0284968|G0000000|C0332173|C0008976|C0450371|C0450371
"Study participants were male or female, ≥18 years of age, current or former smokers, and diagnosed with COPD stages I-IV as defined by GOLD guidelines available at the time the study was designed, with protocol deviation [22].","Study participants male female, ≥18 age, current smokers, diagnosed COPD stages I-IV defined GOLD guidelines time study designed, protocol deviation [22].",C0557651|C0679646|C0086582|C0015780|G0000000|C0001779|C0521116|C0337664|C0011900|C0024117|C1306673|C0021966|C1704788|C0018026|C0162791|C0040223|C0557651|C1707689|C0442711|C0012727|C0450371
The “null” results of our trial suggest that a minimal intervention with limited contact may not suffice to achieve a reduction in household tobacco exposure among low income minority families that have children with asthma.,The “null” trial minimal intervention limited contact suffice achieve reduction household tobacco exposure low income minority families children asthma.,G0000000|G0000000|C0008976|C0547040|C0886296|C0439801|C0332158|G0000000|G0000000|C0301630|C0020052|C0040329|C0274281|C0205251|C0021162|C0026192|C0015576|C0008059|C0004096
"Female and male subjects aged 18 to 70 years are eligible for study participation if they meet the following criteria: • Written informed consent • Diagnosis of chronic tinnitus • Patient has a score of ≥ 38 on the Tinnitus Handicap Inventory (assessed during routine clinical diagnostics in the last 12 weeks before start of treatment) • Tinnitus duration of more than 6 months • Age-adjusted normal sensorineural hearing determined by an audiogram within the last 12 weeks before start of treatment, i.e.","Female male subjects aged 18 70 eligible study participation meet criteria: • Written informed consent • Diagnosis chronic tinnitus • Patient score ≥ 38 Tinnitus Handicap Inventory (assessed routine clinical diagnostics 12 weeks start treatment) • Tinnitus duration 6 months • Age-adjusted normal sensorineural hearing determined audiogram 12 weeks start treatment, i.e.",C0015780|C0086582|C0681850|C0001779|C0450371|C0450371|C1548635|C0557651|C0679823|C1550543|C0243161|G0000000|C0043266|C1522154|C1511481|G0000000|C0011900|C0205191|C0040264|G0000000|C0030705|C0449820|G0000000|C0450371|C0040264|C0231172|C0021941|C1516048|C0205547|C0205210|C0011900|C0450371|C0439230|C0439659|C0039798|G0000000|C0040264|C0449238|G0000000|C0439231|G0000000|C0001779|C0205307|G0000000|C0018767|G0000000|C0018786|C0450371|C0439230|C0439659|C0039798|C0683454
The therapist monitored the consistency of medication use throughout the study.,The therapist monitored consistency medication study.,G0000000|C0871525|C0030695|C0332529|C0013227|C0557651
629 patients with a wide range of self‐defined long‐term conditions were studied.,629 patients wide range self‐defined long‐term conditions studied.,C1442061|C0030705|C0332464|C1514721|G0000000|G0000000|C0012634|C0557651
We hypothesized that such a strategy in patients undergoing elective surgery would reduce ventilator-associated lung injury and that this improvement would lead to a shortened time to extubation A single-center randomized controlled trial was undertaken in 149 patients undergoing elective cardiac surgery.,We hypothesized strategy patients undergoing elective surgery reduce ventilator-associated lung injury improvement lead shortened time extubation A single-center randomized controlled trial undertaken 149 patients undergoing elective cardiac surgery.,G0000000|G0000000|C0679199|C0030705|G0000000|C0206058|C0038894|G0000000|C0087153|C0024109|C3263722|C2986411|C0023175|C1282927|C0040223|C0553891|G0000000|C0037179|C0034656|C2587213|C0008976|G0000000|C1442061|C0030705|G0000000|C0206058|C0018787|C0038894
"Rationale: Lengthy, multidrug, toxic, and low-efficacy regimens limit management of pulmonary nontuberculous mycobacterial disease.","Rationale: Lengthy, multidrug, toxic, low-efficacy regimens limit management pulmonary nontuberculous mycobacterial disease.",C0392360|C1444754|G0000000|C0600688|C0205251|C2945654|C0439801|C0001554|C0024109|G0000000|C0521015|C0012634
Smokers who want to quit attend these services and get counseling and treatment support for their quit attempt.,Smokers quit attend services counseling treatment support quit attempt.,C0337664|C0748223|C1999232|C0557854|C0010210|C0039798|C0183683|C0748223|C1516084
The trial will take place in London and other parts of South-East England.,The trial London South-East England.,G0000000|C0008976|C0023973|C1710133|C0014282
Remission was defined as a CDAI ⩽150 and response as a fall in CDAI of ⩾70 or a CRP <10 mg/l.,Remission defined CDAI ⩽150 response fall CDAI ⩾70 CRP <10 mg/l.,C0544452|C1704788|C0683448|G0000000|C0871261|C0085639|C0683448|G0000000|C3890735|C0450371|C0439268
Clinic workflow diagram for adult patients who smoke presenting to primary care clinics.,Clinic workflow diagram adult patients smoke primary care clinics.,C0002424|C1710679|C0681494|C0001675|C0030705|C0037366|C0205225|C1947933|C0442592
Probiotics are widely used in extremely preterm infants as a prophylaxis for NEC.,Probiotics extremely preterm infants prophylaxis NEC.,C0525033|C0205403|C0151526|C0021270|C0033107|C0206695
"For example, among the 3682 higher-risk patients who were documented smokers, 4.1% (112/2715) of patients in the intervention group and .3% (12/3668) of patients in the control group achieved the primary outcome (P<.001).","For example, 3682 higher-risk patients documented smokers, 4.1% (112/2715) patients intervention .3% (12/3668) patients control achieved primary outcome (P<.001).",G0000000|C1707959|G0000000|C0332167|C0030705|C1301725|C0337664|G0000000|C1442061|C0030705|C0886296|G0000000|C0450371|C0030705|C0243148|G0000000|C0205225|C1274040|C0369773
"A severe asthma exacerbation was defined as at least one of the following [18]: (1) need for systemic corticosteroids, or an increase from a stable maintenance dose, for at least 3 days and/or (2) hospitalization or ED visit because of asthma requiring systemic corticosteroids.","A severe asthma exacerbation defined [18]: (1) systemic corticosteroids, increase stable maintenance dose, 3 days and/or (2) hospitalization ED visit asthma requiring systemic corticosteroids.",G0000000|C0205082|C0004096|G0000000|C1704788|C0450371|G0000000|C0205373|C0001617|C0442805|C0205360|C0024501|C0178602|G0000000|C0439228|G0000000|G0000000|C0019993|C3538926|C0545082|C0004096|G0000000|C0205373|C0001617
"On day 1 of mask use, 36 (38%) of the 94 surgical mask users and 42 (46%) of the 92 P2 mask users stated that they were wearing the mask “most or all” of the time.","On day 1 mask use, 36 (38%) 94 surgical mask users 42 (46%) 92 P2 mask users stated wearing mask “most all” time.",G0000000|C0332173|G0000000|C0024861|C0042153|C0450371|C0450371|C0450371|C0543467|C0024861|C1706077|C0450371|C0450371|C0450371|C0332132|C0024861|C1706077|C1301808|G0000000|C0024861|G0000000|G0000000|C0040223
Significantly more patients in the mDCF arm presented with metastases in the liver (48.1 vs. 17.2 %; p = 0.029).,Significantly patients mDCF arm metastases liver (48.1 vs. 17.2 %; = 0.029).,G0000000|C0030705|G0000000|C0446516|C0027627|C0023884|C0450371|G0000000|C0450371|G0000000|G0000000|C1442061
"Metabolic syndrome was defined according to the modified NCEP ATP III criteria [11], which requires at least three of the following: abdominal obesity (waist circumference): men > 90 cm (36 inches), women > 80 cm (32 inches); triglyceride levels ≥ 150 mg/dL (1.70 mmol/L); HDL-C levels: men < 40 mg/dL (1.04 mmol/L) and women < 50 mg/dL (1.3 mmol/L); BP ≥ 130 / ≥ 85 mmHg or subject receiving antihypertensive treatment; and fasting blood glucose 110 mg/dL (6.11 mmol/L) to 125 mg/dL (6.94 mmol/L).","Metabolic syndrome defined modified NCEP ATP III criteria [11], requires following: abdominal obesity (waist circumference): > 90 cm (36 inches), women > 80 cm (32 inches); triglyceride levels ≥ 150 mg/dL (1.70 mmol/L); HDL-C levels: < 40 mg/dL (1.04 mmol/L) women < 50 mg/dL (1.3 mmol/L); BP ≥ 130 / ≥ 85 mmHg subject receiving antihypertensive treatment; fasting blood glucose 110 mg/dL (6.11 mmol/L) 125 mg/dL (6.94 mmol/L).",C0311400|C0039082|C1704788|C0392747|G0000000|G0000000|C0439070|C0243161|C0450371|G0000000|C0231290|C0000726|C0028754|C0230097|C0332520|G0000000|C0450371|G0000000|C0450371|C0439204|C0043210|G0000000|C0450371|G0000000|C0450371|C0439204|C0041004|C0441889|G0000000|C1442061|C0439269|C0450371|C1532563|C3715113|C0441889|G0000000|C0450371|C0439269|C0450371|C1532563|C0043210|G0000000|C0450371|C0439269|G0000000|C1532563|C0037623|G0000000|C1442061|G0000000|G0000000|C0450371|C0439475|C0681850|C1514756|C0003364|C0039798|C0015663|C0005767|C0017725|C1442061|C0439269|C0450371|C1532563|C1442061|C0439269|C0450371|C1532563
Lateral retinacular releases were performed for seven TKAs in the control group and ten in the TXA group.,Lateral retinacular releases performed TKAs control ten TXA group.,C0205093|G0000000|C1963578|C0884358|G0000000|C0243148|C0014518|G0000000|C0441833
"The Western Australian Bowel Health Study (WABOHS) was a population-based case-control study of CRC.29,30 The cases were histologically confirmed incident cases of CRC, aged 40 to 79 years, that were reported to the Western Australian Cancer Registry between June 1, 2005 and August 31, 2007.","The Western Australian Bowel Health Study (WABOHS) population-based case-control study CRC.29,30 The histologically confirmed incident CRC, aged 40 79 years, reported Western Australian Cancer Registry June 1, 2005 August 31, 2007.",G0000000|C1705493|C0238711|C0021853|C0018684|C0557651|G0000000|C0032659|C0872128|C0557651|C0009402|G0000000|C0205462|C0521093|C1551358|C0009402|C0001779|C0450371|C0450371|C0439234|C0684224|C1705493|C0238711|C0006826|C0034975|C3829443|G0000000|G0000000|C3831448|C0450371|G0000000
"Inclusion criteria: infants aged 5 to 16 weeks who were resident in Asembo (study area), when they attended a Mother and Child Health clinic prior to their first OPV/PENT vaccination at any one of the 4 study clinics located in 3 large outpatient healthcare units and 1 mission hospital within the study area were offered enrolment in the study.","Inclusion criteria: infants aged 5 16 weeks resident Asembo (study area), attended Mother Child Health clinic prior OPV/PENT vaccination 4 study clinics located 3 outpatient healthcare units 1 mission hospital study offered enrolment study.",C0007637|C0243161|C0021270|C0001779|G0000000|C0450371|C0439230|C1320928|G0000000|C0557651|C0017446|C1456498|C0026591|C0008059|C0018684|C0002424|C0332152|C0032375|C0042196|G0000000|C0557651|C0442592|G0000000|G0000000|C0029921|C0086388|C0439148|G0000000|C0026219|C0019994|C0557651|C1444648|C1516879|C0557651
Our randomized controlled trial concludes that below-elbow plaster cast is equally effective compared to above-elbow plaster cast for the immobilization of distal both bone fracture in children aged 4–12 years and is also cost-effective in the developing countries.,Our randomized controlled trial concludes below-elbow plaster cast equally effective compared above-elbow plaster cast immobilization distal bone fracture children aged 4–12 cost-effective developing countries.,G0000000|C0034656|C2587213|C0008976|C0917903|C0013769|C0460977|C0179686|G0000000|C1280519|C1707455|C1282910|C0460977|C0179686|C0020944|C0205108|C0262950|C0016658|C0008059|C0001779|G0000000|C0010181|G0000000|C0454664
Eligible and consenting patients were randomly assigned to receive olanzapine (7.5–20 mg/day) or quetiapine (300–800 mg/day).,Eligible consenting patients randomly assigned receive olanzapine (7.5–20 mg/day) quetiapine (300–800 mg/day).,C1548635|C1511481|C0030705|G0000000|C1516050|C1514756|C0171023|G0000000|C0439422|C0123091|G0000000|C0439422
"Members of the control group (8 females, 7 males) and the treatment group (7 females, 8 males) were aged 6 months to 17 years (mean: treatment—10.7 years; control—9.3 years).","Members control (8 females, 7 males) treatment (7 females, 8 males) aged 6 months 17 (mean: treatment—10.7 years; control—9.3 years).",C0680022|C0243148|G0000000|C0015780|G0000000|C0086582|C0039798|G0000000|C0015780|G0000000|C0086582|C0001779|G0000000|C0439231|C0450371|C0444504|G0000000|C0439234|G0000000|C0439234
"In conclusion, 200 µg of selenium taken daily from 12–27 weeks of gestation until 6 months postpartum did not have an effect on hemoglobin concentrations among HIV-1–infected Tanzanian women but decreased the risk of diarrheal morbidity.","In conclusion, 200 µg selenium daily 12–27 weeks gestation 6 months postpartum hemoglobin concentrations HIV-1–infected Tanzanian women decreased risk diarrheal morbidity.",G0000000|C1707478|C1442061|G0000000|C0036581|C0332173|G0000000|C0439230|C0032961|G0000000|C0439231|C0086839|C0019046|C0086045|G0000000|G0000000|C0043210|C0205216|C0035647|C0011991|C0026538
"Weight was measured to 10 g using an electronic scale (SECA Corporation, Columbia, MD), and the Capurro method was used to determine gestational age.36 Infants were eligible for enrollment when their gestational age was >36 weeks; their birth weight was below the 10th percentile for gestational age37; and they had no congenital problems, disabilities, or severe illnesses.","Weight measured 10 electronic scale (SECA Corporation, Columbia, MD), Capurro method determine gestational age.36 Infants eligible enrollment gestational age >36 weeks; birth weight 10th percentile gestational age37; congenital problems, disabilities, severe illnesses.",C0005910|C0444706|C0450371|C0013850|C0175659|G0000000|C0683758|C1551442|G0000000|G0000000|C0025663|G0000000|C0439671|C0001779|C0021270|C1548635|C1516879|C0439671|C0001779|C0450371|C0439230|C0005615|C0005910|G0000000|C1264641|C0439671|G0000000|C0009678|C1546466|C0231170|C0205082|C0221423
Threshold analysis: group of infants with gestational age between 33 and 35 weeks.,Threshold analysis: infants gestational age 33 35 weeks.,C0449864|C0002778|C0021270|C0439671|C0001779|C0450371|C0450371|C0439230
Participants who used macrolide antibiotics within 30 days of baseline were excluded.,Participants macrolide antibiotics 30 days baseline excluded.,C0679646|C0003240|C0003232|C0450371|C0439228|C0168634|C1554077
"Males and females between 18 and 75 years of age and diagnosed with schizophrenia or schizoaffective disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) were enrolled in this study.","Males females 18 75 age diagnosed schizophrenia schizoaffective disorder Diagnostic Statistical Manual Mental Disorders, Fourth Edition (DSM-IV) enrolled study.",C0086582|C0015780|C0450371|C0450371|C0001779|C0011900|C0036341|G0000000|C0012634|C0011900|C0038215|C0024763|C0229992|C0012634|C0205438|C0441792|C0220952|G0000000|C0557651
All women who meet the selection criteria will be informed of the study by the general practitioner (GP) or Practice Nurse (PN).,All women meet selection criteria informed study practitioner (GP) Practice Nurse (PN).,G0000000|C0043210|C1550543|C0036576|C0243161|C1522154|C0557651|C1709627|C3811116|C0237607|C0028661|C0219433
"This trial took a different approach with the focus on breaking the pattern of apathy during early stages of memory loss, which other studies have shown to lead to premature functional decline.","This trial approach focus breaking pattern apathy stages memory loss, studies lead premature functional decline.",G0000000|C0008976|C0449445|C0205234|C1881704|C0449774|C0085632|C1306673|C0025260|C1517945|C0947630|C0023175|C0151526|C0205245|G0000000
"Eligible patients were adults meeting the 1990 ACR criteria for fibromyalgia [4] who entered directly from a long-term, open-label, flexible-dose, lead-in study in which they received milnacipran 50 mg/day to 200 mg/day for up to 3.25 years [22].","Eligible patients adults meeting 1990 ACR criteria fibromyalgia [4] entered directly long-term, open-label, flexible-dose, lead-in study received milnacipran 50 mg/day 200 mg/day 3.25 [22].",C1548635|C0030705|C0001675|C0556656|G0000000|C1412134|C0243161|C0016053|G0000000|C1521975|C1947931|C0443252|C1709323|C0443220|C0023175|C0557651|C1514756|C1533126|C0450371|C0439422|C1442061|C0439422|C0450371|C0450371
"We included stroke patients aged between 25 and 85 years admitted to the stroke unit who had some residual disability in the form of an initial Functional Independence Measure (FIM)17 of up to 100, no significant previous neurological disability and who resided within the district of Aveiro.","We included stroke patients aged 25 85 years admitted stroke unit residual disability form initial Functional Independence Measure (FIM)17 100, previous neurological disability resided district Aveiro.",G0000000|C0332257|C0038454|C0030705|C0001779|C0450371|G0000000|C0184666|C0038454|C0439148|C1609982|C0231170|C0348078|C0205265|C0205245|C0085862|C0079809|C3273671|C1442061|C0205156|C0205494|C0231170|C2982691|G0000000|G0000000
Bloodstream infection was defined as a positive blood culture (not resulting from contamination) in the presence of sepsis.,Bloodstream infection defined positive blood culture (not contamination) presence sepsis.,C0005775|C0009450|C1704788|C0439178|C0005767|C0010453|C1518422|C0259846|C0150312|C0036690
"This randomized controlled clinical trial was conducted from October 2013 to June 2015 in Fatemieh Hospital, Shahroud.","This randomized controlled clinical trial conducted October 2013 June 2015 Fatemieh Hospital, Shahroud.",G0000000|C0034656|C2587213|C0205210|C0008976|C0004927|C3828732|G0000000|C3829443|G0000000|G0000000|C0019994|G0000000
Participants 275 patients aged 18-65 years with irritable bowel syndrome.,Participants 275 patients aged 18-65 irritable bowel syndrome.,C0679646|C1442061|C0030705|C0001779|C0450371|C0022107|C0021853|C0039082
"Women with health conditions that contraindicated exercise (heart disease, diabetes, thyroid disease, hypertension, Body Mass Index greater than 40, infection, incompetent cervix, bleeding, ruptured membranes, severe anemia, intrauterine growth restriction, poorly controlled seizure disorder, thrombophlebitis, decreased fetal movement, amniotic fluid leakage) [26] or manipulation (unrelenting fever, unrelenting night pain, loss of bowel or bladder control, progressive neurological deficit, direct trauma, unexplained weight loss, radiating pain below the knee, cancer, spinal fracture or tumors, blood dyscrasias) [27] were excluded from consideration along with women who smoked, consumed alcohol, were medicated with anti-depressants, or had a Roland Morris score above 20 or below 4 [28].","Women health conditions contraindicated exercise (heart disease, diabetes, thyroid disease, hypertension, Body Mass Index 40, infection, incompetent cervix, bleeding, ruptured membranes, severe anemia, intrauterine growth restriction, controlled seizure disorder, thrombophlebitis, decreased fetal movement, amniotic fluid leakage) [26] manipulation (unrelenting fever, unrelenting night pain, loss bowel bladder control, progressive neurological deficit, direct trauma, unexplained weight loss, radiating pain knee, cancer, spinal fracture tumors, blood dyscrasias) [27] excluded consideration women smoked, consumed alcohol, medicated anti-depressants, Roland Morris score 20 4 [28].",C0043210|C0018684|C0012634|C1444657|C0015259|C0018787|C0012634|C0011847|C0040132|C0012634|C0020538|C0242821|C0577559|C0918012|C0450371|C0009450|C0231190|C0007874|C0019080|C0443294|C0025255|C0205082|C0002871|C0694756|C0018270|C0443288|C2587213|C0036572|C0012634|C0040046|C0205216|C0015965|C0026649|C0002630|C0005889|C0015376|C0450371|C0185111|G0000000|C0015967|G0000000|C0240526|C0030193|C1517945|C0021853|C0005682|C0243148|C0205329|C0205494|C0162429|C0439851|C0043251|G0000000|C0005910|C1517945|C0332301|C0030193|C0022742|C0006826|C0521329|C0016658|C0027651|C0005767|C0334044|C0450371|C1554077|C0518609|C0043210|C0037366|G0000000|C0001962|C3812868|G0000000|G0000000|G0000000|C0449820|C0450371|G0000000|C0450371
2) Those with pressure ulcers of grades ranging from III to IV [17] according to the NPUAP pressure ulcer staging system.,2) Those pressure ulcers grades ranging III IV [17] NPUAP pressure ulcer staging system.,G0000000|G0000000|C0033095|C0041582|C0441800|C1514721|C0439070|C0022326|C0450371|C3534328|C0033095|C0041582|C0332305|C0449913
"Inclusion criteria were: aged between 18 and 65, ability to give informed consent, meeting Diagnostic and Statistical Manual of Mental Disorders, fourth edition text revision (DSM-IV-TR) criteria for schizophrenia, experiencing auditory hallucinations at least five times per day, and taking a stable antipsychotic medication for at least 1 month prior to enrollment.","Inclusion criteria were: aged 18 65, ability informed consent, meeting Diagnostic Statistical Manual Mental Disorders, fourth edition text revision (DSM-IV-TR) criteria schizophrenia, experiencing auditory hallucinations times day, stable antipsychotic medication 1 month prior enrollment.",C0007637|C0243161|G0000000|C0001779|C0450371|C0450371|C0085732|C1522154|C1511481|C0556656|C0011900|C0038215|C0024763|C0229992|C0012634|C0205438|C0441792|C1527021|C0439617|C0220952|C0243161|C0036341|C0237607|C0439825|C0018524|C0040223|C0332173|C0205360|C0040615|C0013227|G0000000|C0332177|C0332152|C1516879
"At that time, a total of 4,312 patients were enrolled, which included 212 patients who did not fulfill all eligibility criteria upon retrospective review (Table 2).","At time, total 4,312 patients enrolled, included 212 patients fulfill eligibility criteria retrospective review (Table 2).",G0000000|C0040223|C0439175|C1442061|C0030705|G0000000|C0332257|C1442061|C0030705|C1550543|C0013893|C0243161|C0035363|C0282443|C0039224|G0000000
"Children were excluded if they were simultaneously involved in another research trial or supplementary feeding program, had a chronic debilitating illness (not including HIV or tuberculosis), or had a history of peanut allergy.","Children excluded simultaneously involved trial supplementary feeding program, chronic debilitating illness (not including HIV tuberculosis), history peanut allergy.",C0008059|C1554077|C0521115|C1314939|C0008976|G0000000|C0204695|C1709697|C0205191|G0000000|C0221423|C1518422|C0332257|C0019682|C0041296|C0019664|C0030736|C0002111
"A total of 139 patients were included (73 in the intervention group, 66 in the control group).","A total 139 patients included (73 intervention group, 66 control group).",G0000000|C0439175|C1442061|C0030705|C0332257|C0450371|C0886296|C0441833|C0450371|C0243148|C0441833
The RASS score threshold for blinded study medication administration was revised to 1 or more in September 2014 to ensure that patients who had any agitation could proceed to the blinded phase.,The RASS score threshold blinded study medication administration revised 1 September 2014 ensure patients agitation proceed blinded phase.,G0000000|C0034678|C0449820|C0449864|C0150108|C0557651|C0013227|C0001554|C1527075|G0000000|C3828193|G0000000|C0218063|C0030705|C0085631|G0000000|C0150108|C0205390
"Partners HealthCare System is an integrated health care network consisting of outpatient clinics, community hospitals, and two academic teaching hospitals (Brigham and Women's Hospital and Massachusetts General Hospital) in the Boston area.","Partners HealthCare System integrated health care network consisting outpatient clinics, community hospitals, academic teaching hospitals (Brigham Women's Hospital Massachusetts General Hospital) Boston area.",C0682323|C0086388|C0449913|G0000000|C0018684|C1947933|C0150775|C0332529|C0029921|C0442592|C0009462|C0019994|C1510747|C0039401|C0019994|G0000000|C0043210|C0019994|C0024874|C0205246|C0019994|C0006037|C0017446
Smokers who were at least 50 years of age and smoked at least 10 cigarettes a day were recruited from the general public.,Smokers 50 age smoked 10 cigarettes day recruited public.,C0337664|C0450371|C0001779|C0037366|C0450371|C0677453|C0332173|G0000000|G0000000
"Exclusion criteria were: referred pregnancy of more than three months by LMP, concomitant HIV infection status, active or recent (< two weeks) sexually transmitted disease (STD) infection, medical record of any severe organ disease such as heart, liver or renal failure at the time of assessment, diagnosis of pregnancy during inpatient admission for any other reason, recent history of multivitamin supplementation (<12 weeks) for any reason, except for pregnancy, and patients incapable to read and write.","Exclusion criteria were: referred pregnancy months LMP, concomitant HIV infection status, active (< weeks) sexually transmitted disease (STD) infection, medical record severe organ disease heart, liver renal failure time assessment, diagnosis pregnancy inpatient admission reason, history multivitamin supplementation (<12 weeks) reason, pregnancy, patients incapable read write.",C0680251|C0243161|G0000000|C0205543|C0032961|C0439231|C0425932|C0521115|C0019682|C0009450|C0449438|C0205177|G0000000|C0439230|C0036864|C0242781|C0012634|G0000000|C0009450|C0199168|C0034869|C0205082|C0178784|C0012634|C0018787|C0023884|C0022646|C0231174|C0040223|C1261322|C0011900|C0032961|C0021562|C0184666|C0392360|C0019664|C0301532|C0242297|C0450371|C0439230|C0392360|C0032961|C0030705|C1550518|C0034754|C0043266
"Individuals were excluded if their LBP was due to nerve root compression, disc prolapse, spinal stenosis, tumor, spinal infection, ankylosing spondylosis, spondylolisthesis, kyphosis or structural scoliosis, or a widespread neurological disorder.","Individuals excluded LBP nerve root compression, disc prolapse, spinal stenosis, tumor, spinal infection, ankylosing spondylosis, spondylolisthesis, kyphosis structural scoliosis, widespread neurological disorder.",C0027361|C1554077|C1505993|C0027740|C0040452|C0332459|C0180459|C0033377|C0521329|C0678234|C0027651|C0521329|C0009450|G0000000|C0038019|C0038016|C0022821|C0678594|C0036439|C0205219|C0205494|C0012634
"Inclusion criteria are; age above 18 years, high anorectal fistula of cryptoglandular origin (transsphincteric, upper 2/3 of the sphinctercomplex which is confined by the puborectal sling and the end of the anal canal), and informed consent.","Inclusion criteria are; age 18 years, anorectal fistula cryptoglandular origin (transsphincteric, upper 2/3 sphinctercomplex confined puborectal sling anal canal), informed consent.",C0007637|C0243161|G0000000|C0001779|C0450371|C0439234|C0178825|C0016169|G0000000|C0079946|C0457838|C1282910|G0000000|G0000000|G0000000|G0000000|C0183346|C0003461|C0086881|C1522154|C1511481
"All subjects had to meet the following inclusion criteria: 1- ANB>4º, SNB<78º, overjet>5 mm in the initial lateral cephalograms; 2- No syndromic or medically compromised patients; 3- No surgical intervention; 4- No use of other appliances before or during the period of functional treatment; 5- Normal growth pattern of the mandible (MP-SN); 6- Symmetric relationship between maxilla and mandible.","All subjects meet inclusion criteria: 1- ANB>4º, SNB<78º, overjet>5 mm initial lateral cephalograms; 2- No syndromic medically compromised patients; 3- No surgical intervention; 4- No appliances period functional treatment; 5- Normal growth pattern mandible (MP-SN); 6- Symmetric relationship maxilla mandible.",G0000000|C0681850|C1550543|C0007637|C0243161|G0000000|G0000000|G0000000|C0596028|G0000000|C0205265|C0205093|C1962944|G0000000|G0000000|C0039082|G0000000|C2945640|C0030705|G0000000|G0000000|C0543467|C0886296|G0000000|G0000000|C0243112|C0439531|C0205245|C0039798|G0000000|C0205307|C0018270|C0449774|C0024687|C0024944|G0000000|C0332516|C0439849|C0024947|C0024687
"Briefly, study staff assessed oncology patients with cancer chemotherapy–associated fever (≥ 100.5°F) and neutropenia (absolute neutrophil count < 500/μL) for eligibility within 24 to 48 hours after initial presentation.","Briefly, study staff assessed oncology patients cancer chemotherapy–associated fever (≥ 100.5°F) neutropenia (absolute neutrophil count < 500/μL) eligibility 24 48 hours initial presentation.",G0000000|C0557651|C0851286|C1516048|C0027651|C0030705|C0006826|G0000000|C0015967|G0000000|G0000000|C0023530|C0205344|C0027950|C0750480|G0000000|G0000000|C0013893|C0450371|C0450371|C0439227|C0205265|C0449450
"Study subjects are paired surrogate decision-makers and residents with advanced dementia and feeding problems, enrolled from nursing homes in North Carolina.","Study subjects paired surrogate decision-makers residents advanced dementia feeding problems, enrolled nursing homes North Carolina.",C0557651|C0681850|C1709450|C4053457|C0679006|C1320928|C0205179|C0011265|C0204695|C1546466|G0000000|C0006147|C0442519|C1709269|G0000000
"Patients also had to have the following: (1) a history of excessive somnolence; (2) at least one of the REM sleep-related symptoms of sleep paralysis, hypnagogic hallucinations, or cataplexy; (3) nocturnal polysomnography ruling out sleep apnea syndrome; and (4) two or more transitions to REM sleep on the MSLT.","Patients following: (1) history excessive somnolence; (2) REM sleep-related symptoms sleep paralysis, hypnagogic hallucinations, cataplexy; (3) nocturnal polysomnography ruling sleep apnea syndrome; (4) transitions REM sleep MSLT.",C0030705|C0231290|G0000000|C0019664|C0442802|C0013144|G0000000|G0000000|C0037313|C0683368|C0037313|C0522224|G0000000|C0018524|C0007384|G0000000|C0240526|C0162701|C1446409|C0037313|C0003578|C0039082|G0000000|C0599156|G0000000|C0037313|C0519186
Baseline comparisons of the three study groups' characteristics *Control group (CG): n = 199.,Baseline comparisons study groups' characteristics *Control (CG): n = 199.,C0168634|C1707455|C0557651|C0441833|C1521970|C0243148|C0043444|G0000000
"Patients with a renal tumor other than WT were excluded from the study, as were patients with associated syndromes such as WAGR (WT, aniridia, genitourinary malformation, and mental retardation) and Denys–Drash syndrome.","Patients renal tumor WT excluded study, patients syndromes WAGR (WT, aniridia, genitourinary malformation, mental retardation) Denys–Drash syndrome.",C0030705|C0022646|C0027651|C2700323|C1554077|C0557651|C0030705|C0039082|G0000000|C2700323|C0003076|C0042066|C0000768|C0229992|C0521111|G0000000|C0039082
"Anopheles gambiae s.s. was predominant in Malanville (95%) and Vallée du Kou (100%), whereas An.","Anopheles gambiae s.s. predominant Malanville (95%) Vallée du Kou (100%), An.",C0003117|G0000000|C0565930|C1542147|G0000000|C0450371|G0000000|C0011535|C1077817|C1442061|G0000000
"Participants were recruited from the Breast Cancer Clinic at Mayo Clinic in Rochester, Minnesota, where they received preoperative education and counseling regarding potential breast cancer surgical options.","Participants recruited Breast Cancer Clinic Mayo Clinic Rochester, Minnesota, received preoperative education counseling potential breast cancer surgical options.",C0679646|G0000000|C0006141|C0006826|C0002424|C0454788|C0002424|G0000000|C0026183|C1514756|C0445204|C0013621|C0010210|C3245505|C0006141|C0006826|C0543467|C1518601
"Participants were adults diagnosed with FM who were recruited by fliers in rheumatology clinics, announcements at FM support groups, and advertisements in an Arthritis Foundation newsletter.","Participants adults diagnosed FM recruited fliers rheumatology clinics, announcements FM support groups, advertisements Arthritis Foundation newsletter.",C0679646|C0001675|C0011900|C3540627|G0000000|C0328806|C0035452|C0442592|G0000000|C3540627|C0183683|C0441833|C0949214|C0003864|C0016617|C0027988
Eighty one patients were randomised to receive conventional inpatient care (n=40) or to planned early discharge the next working day (n=41).,Eighty patients randomised receive conventional inpatient care (n=40) planned discharge day (n=41).,C3816958|C0030705|G0000000|C1514756|C0439858|C0021562|C1947933|C0369718|C1301732|C0012621|C0332173|C0369718
"The PCFP procedure was completed again at Times 2 and 3, which occurred approximately 5 (M = 5.3, SD = .47 months) and 9 months (M = 9.3, SD = .56 months) after the Time 1 visit, respectively.","The PCFP procedure completed Times 2 3, occurred 5 (M = 5.3, SD = .47 months) 9 months (M = 9.3, SD = .56 months) Time 1 visit, respectively.",G0000000|G0000000|C0184661|C0205197|C0040223|G0000000|G0000000|C1709305|G0000000|C0369637|G0000000|G0000000|C2699239|G0000000|C0450371|C0439231|G0000000|C0439231|C0369637|G0000000|G0000000|C2699239|G0000000|C0450371|C0439231|C0040223|G0000000|C0545082|G0000000
The pilot data presented here suggest that it is safe to switch patients from PHT to LEV monotherapy following craniotomy for supratentorial glioma.,The pilot data safe switch patients PHT LEV monotherapy craniotomy supratentorial glioma.,G0000000|C0473169|C1511726|G0000000|C1707719|C0030705|C1324698|C0023556|G0000000|C0010280|C0441938|C0017638
A pilot study has been conducted with 9 adults including 3 participants with asthma.,A pilot study conducted 9 adults including 3 participants asthma.,G0000000|C0473169|C0557651|C0004927|G0000000|C0001675|C0332257|G0000000|C0679646|C0004096
Selection criteria: Subjects who were willing to participate in this trial and whose VSCs and hydrocarbon gas levels were more than 3 (Breath Alert Tanita®) and who had periodontal pockets ≤4 mm (after a comprehensive periodontal examination) were included in the study.,Selection criteria: Subjects participate trial VSCs hydrocarbon gas levels 3 (Breath Alert Tanita®) periodontal pockets ≤4 mm (after comprehensive periodontal examination) included study.,C0036576|C0243161|C0681850|G0000000|C0008976|G0000000|C0020242|C0017110|C0441889|G0000000|C0225386|C0239110|G0000000|C2960678|G0000000|G0000000|G0000000|G0000000|C1880156|C2960678|G0000000|C0332257|C0557651
"Patients with impaired level of consciousness, acute confusion, acute changes on radiography, or an arterial pH of <7.35 or with other serious medical or social reasons for admission were excluded.","Patients impaired level consciousness, acute confusion, acute radiography, arterial pH <7.35 medical social reasons admission excluded.",C0030705|C0221099|C0441889|C0009791|C0205178|C0009676|C0205178|C0034571|C0003842|C0450407|C0450371|C0199168|C0728831|C0392360|C0184666|C1554077
"Patients were eligible if they met the NINCDS/ADRDA criteria for the clinical diagnosis of probable AD, [25] had mild or moderate dementia as measured by a Mini-Mental State Examination (MMSE) [26] score between 10 and 26 inclusive, and were living at home or in a home for the elderly.","Patients eligible met NINCDS/ADRDA criteria clinical diagnosis probable AD, [25] mild moderate dementia measured Mini-Mental State Examination (MMSE) [26] score 10 26 inclusive, living elderly.",C0030705|C1548635|C0268621|G0000000|C0243161|C0205210|C0011900|C0033204|G0000000|C0450371|C2945599|C0205081|C0011265|C0444706|C0445542|C1301808|G0000000|C0451306|C0450371|C0449820|C0450371|C0450371|C0332257|C0376558|C0001792
"These subjects were the following: 1 of 7 in the 25-mg group (14%), 5 of 15 in the 75-mg group (33%), 10 of 16 in the 150-mg group (62%), and 3 of 7 in the 250-mg group (43%).","These subjects following: 1 7 25-mg (14%), 5 15 75-mg (33%), 10 16 150-mg (62%), 3 7 250-mg (43%).",G0000000|C0681850|C0231290|G0000000|G0000000|C0450371|C0450371|G0000000|C0450371|C0450371|C0450371|C0450371|C0450371|C1442061|C0450371|G0000000|G0000000|C1442061|C0450371
"We recruited 290 adults from 145 families; 47 households (94 enrolled adults and 180 children) were randomized to the surgical mask group, 46 (92 enrolled adults and 172 children) to the P2 mask group, and 52 (104 enrolled adults and 192 children) to the no-mask (control) group.","We recruited 290 adults 145 families; 47 households (94 enrolled adults 180 children) randomized surgical mask group, 46 (92 enrolled adults 172 children) P2 mask group, 52 (104 enrolled adults 192 children) no-mask (control) group.",G0000000|G0000000|C1442061|C0001675|C1442061|C0015576|C0450371|C0020052|C0450371|G0000000|C0001675|C1442061|C0008059|C0034656|C0543467|C0024861|C0441833|C0450371|C0450371|G0000000|C0001675|C1442061|C0008059|C0332132|C0024861|C0441833|C0450371|C1442061|G0000000|C0001675|C1442061|C0008059|C0024861|C0243148|C0441833
"The model was populated with Spanish epidemiological data on COPD, Spanish healthcare utilisation, and unit costs and utilities based on Spanish population values.","The model populated Spanish epidemiological data COPD, Spanish healthcare utilisation, unit costs utilities based Spanish population values.",G0000000|C3161035|G0000000|C0086409|C0014507|C1511726|C0024117|C0086409|C0086388|C0042153|C0439148|C0010186|C0582205|C1527178|C0086409|C0032659|C0042295
"The Sexual Dysfunction scale consisted of 25 questions, several of which were developed specifically for this project.","The Sexual Dysfunction scale consisted 25 questions, developed project.",G0000000|C0036864|C0031847|C0175659|C0332529|C0450371|C1522634|G0000000|C1709701
The following will be used as the inclusion criteria: male or female patients aged 18 to 80 years; chronic kidney failure; candidate for kidney transplant with indication for dialysis; cognitive level sufficient for understanding the procedures and following the instructions; and agreement to participate by signing a statement of informed consent.,The inclusion criteria: male female patients aged 18 80 years; chronic kidney failure; candidate kidney transplant indication dialysis; cognitive level sufficient understanding procedures instructions; agreement participate signing statement informed consent.,G0000000|C0007637|C0243161|C0086582|C0015780|C0030705|C0001779|C0450371|C0450371|C0439234|C0205191|C0022646|C0231174|G0000000|C0022646|C0040732|C0392360|C0011945|C1516691|C0441889|C0205410|C0162340|C0025664|C0302828|C0680240|G0000000|C0311392|C1710187|C1522154|C1511481
"Study personnel screened all adult (>18 years of age) mechanically ventilated medical and surgical ICU patients who had an abnormal level of consciousness or were receiving sedative or analgesic medications in six tertiary care medical centers: Vanderbilt University Medical Center, Saint Thomas Hospital, and the Department of Veterans Affairs Medical Center in Nashville, TN; University of North Carolina Hospitals in Chapel Hill, NC; University of Iowa Hospitals in Iowa City, IA; and Moses H. Cone Memorial Hospital in Greensboro, NC.","Study personnel screened adult (>18 age) mechanically ventilated medical surgical ICU patients abnormal level consciousness receiving sedative analgesic medications tertiary care medical centers: Vanderbilt University Medical Center, Saint Thomas Hospital, Department Veterans Affairs Medical Center Nashville, TN; University North Carolina Hospitals Chapel Hill, NC; University Iowa Hospitals Iowa City, IA; Moses H. Cone Memorial Hospital Greensboro, NC.",C0557651|C0024752|C0220908|C0001675|C0450371|C0001779|G0000000|C0231923|C0199168|C0543467|C0021708|C0030705|C0205161|C0441889|C0009791|C1514756|C0020592|C0002771|C0013227|C0205372|C1947933|C0199168|C0205099|G0000000|C0041740|C0199168|C0205099|C0242823|G0000000|C0019994|C1704729|C0042610|G0000000|C0199168|C0205099|G0000000|C0040407|C0041740|C1709269|G0000000|C0019994|C0558275|C0442532|C0027964|C0041740|C0022037|C0019994|C0022037|C0008848|C0694634|G0000000|C0033727|C0206428|G0000000|C0019994|G0000000|C0027964
Eligibility criteria were: (a) age 6–12 months; (b) ingesting any type of semi‐solid weaning food; (c) ⩾1 episode of diarrhoea within the past two weeks; (d) intent to reside in the area for ⩾2 months; and (e) parental consent.,Eligibility criteria were: (a) age 6–12 months; (b) ingesting type semi‐solid weaning food; (c) ⩾1 episode diarrhoea weeks; (d) intent reside ⩾2 months; (e) parental consent.,C0013893|C0243161|G0000000|G0000000|C0001779|G0000000|G0000000|C0232478|C0332307|G0000000|C0043084|C0016452|G0000000|G0000000|C0332189|C0011991|C0439230|C0073187|C0162425|C2982691|G0000000|G0000000|C0030551|C1511481
[9] This was later confirmed using the Mini International Neuropsychiatric Interview by the first author.,[9] This confirmed Mini International Neuropsychiatric Interview author.,G0000000|G0000000|C0521093|C0445542|C1512888|G0000000|C0021822|C3812881
A multiple logistic regression model was used to control known confounders.,A multiple logistic regression model control confounders.,G0000000|C0439064|C0242415|C0684320|C3161035|C0243148|G0000000
The authors concluded that intralesional curettage should be reserved for central grade 1 CS of long bones without aggressive imaging features such as soft tissue mass and cortical disruption.,The authors concluded intralesional curettage reserved central grade 1 CS bones aggressive imaging features soft tissue mass cortical disruption.,G0000000|C3812881|C0917903|C1512954|C0010468|C2347957|C0205099|C0441800|G0000000|C0010182|C0262950|C0001807|C0011923|C1521970|C0205358|C0040300|C0577559|C0001613|C0332453
These initial positive findings support further research into community-based and OT-based interventions for people living with dementia and their caregivers.,These initial positive findings support community-based OT-based interventions people living dementia caregivers.,G0000000|C0205265|C0439178|C2607943|C0183683|C0009462|C1318464|C0886296|C0027361|C0376558|C0011265|C0085537
"Children enrolled in other studies, those residing more than 15 kilometres from the clinic and those whose parents or caretakers were anticipating moving from the study area were excluded.","Children enrolled studies, residing 15 kilometres clinic parents caretakers anticipating moving study excluded.",C0008059|G0000000|C0947630|C2982691|C0450371|C0439198|C0002424|C0030551|C0335350|G0000000|C0560560|C0557651|C1554077
"Patients were enrolled with ages between 18–75 years, and at least one measurable lesion in the brain was confirmed by computed tomography (CT) or magnetic resonance imaging.","Patients enrolled ages 18–75 years, measurable lesion brain confirmed computed tomography (CT) magnetic resonance imaging.",C0030705|G0000000|C0001779|G0000000|C0439234|C1513040|C0221198|C0006104|C0521093|C1441526|C0040395|C0007673|C0024488|C0231881|C0011923
"SETTING: Two family medicine clinics (1 urban, 1 rural) affiliated with Memorial University of Newfoundland, St. John's.","SETTING: Two family medicine clinics (1 urban, 1 rural) affiliated Memorial University Newfoundland, St. John's.",C0542559|C0205448|C0015576|C0013227|C0442592|G0000000|C0442529|G0000000|C0240919|C1510825|G0000000|C0041740|C0027985|C0036056|G0000000
Exclusion criteria were asthma and ICS use in the previous 6 months.,Exclusion criteria asthma ICS previous 6 months.,C0680251|C0243161|C0004096|C0022521|C0205156|G0000000|C0439231
Study participants were then sent home with the APAP unit and the study medication (ramelteon or placebo).,Study participants APAP unit study medication (ramelteon placebo).,C0557651|C0679646|C0000970|C0439148|C0557651|C0013227|C1565316|C0032042
"Participants subsequently received either a computer tailored or a non-tailored, standard letter on smoking cessation, or no letter.","Participants subsequently received computer tailored non-tailored, standard letter smoking cessation, letter.",C0679646|G0000000|C1514756|C0009622|C0402883|C1518422|C1442989|C1096774|C0037369|C1880019|C1096774
"At least 1 eye of each participant was free from eye disease that could complicate assessment of AMD, lens opacity progression, or visual acuity (eg, optic atrophy or acute uveitis), and that eye could not have had previous ocular surgery (other than cataract surgery).","At 1 eye participant free eye disease complicate assessment AMD, lens opacity progression, visual acuity (eg, optic atrophy acute uveitis), eye previous ocular surgery (other cataract surgery).",G0000000|G0000000|C0015392|C0679646|C0332296|C0015392|C0012634|C0231242|C1261322|C3539530|C0023317|C0029053|C0242656|C0234621|C0750509|C0013715|C0015392|C0333641|C0205178|C0042164|C0015392|C0205156|C0015392|C0038894|G0000000|C0086543|C0038894
"Exclusion criteria included treatment with interferons, glatiramer acetate, or other immune-modifying reagents within the previous 3 months, or corticosteroids within 1 month of the initial baseline MRI assessment.","Exclusion criteria included treatment interferons, glatiramer acetate, immune-modifying reagents previous 3 months, corticosteroids 1 month initial baseline MRI assessment.",C0680251|C0243161|C0332257|C0039798|C0021747|C0717787|C0000975|C0439662|C0034760|C0205156|G0000000|C0439231|C0001617|G0000000|C0332177|C0205265|C0168634|C0024485|C1261322
Subjects with child bearing potential were required either to be taking effective contraception or abstinent from sexual relations.,Subjects child bearing potential required effective contraception abstinent sexual relations.,C0681850|C0008059|C1704689|C3245505|C1514873|C1280519|C0700589|C0457801|C0036864|C0439849
"The vagus nerve stimulator (VNS Therapy System, Cyberonics, Houston, TX) provides scheduled (open-loop) stimulation to a peripheral nerve and reduced partial seizure frequency by 24.5%–28% during the blinded period of randomized controlled trials1,2 and demonstrated median seizure reductions in a prospective open-label study of 35% at 1 year and 43% at 3 years.3,4 A randomized controlled trial of scheduled deep brain stimulation (DBS) of the anterior nucleus of the thalamus showed reductions in partial seizures of 41% at 13 months and 56% at 26 months.5 The RNS System is the first responsive (closed-loop) focal cortical stimulator for use as an adjunctive therapy indicated for adults (18 years or older, refractory to 2 or more antiepileptic drugs) having frequent and disabling partial onset seizures localized to no more than 2 epileptogenic foci by diagnostic testing.","The vagus nerve stimulator (VNS Therapy System, Cyberonics, Houston, TX) scheduled (open-loop) stimulation peripheral nerve reduced partial seizure frequency 24.5%–28% blinded period randomized controlled trials1,2 demonstrated median seizure reductions prospective open-label study 35% 1 43% 3 years.3,4 A randomized controlled trial scheduled deep brain stimulation (DBS) anterior nucleus thalamus reductions partial seizures 41% 13 months 56% 26 months.5 The RNS System responsive (closed-loop) focal cortical stimulator adjunctive therapy adults (18 older, refractory 2 antiepileptic drugs) frequent disabling partial onset seizures localized 2 epileptogenic foci diagnostic testing.",G0000000|C0042276|C0027740|C0175727|G0000000|C0039798|C0449913|G0000000|G0000000|C0041403|C0086960|C0559530|C1292856|C0205100|C0027740|C0392756|C0728938|C0036572|C0376249|G0000000|C0150108|C0439531|C0034656|C2587213|G0000000|G0000000|C0549183|C0036572|C0301630|C0023981|C1709323|C0557651|C0450371|G0000000|C0450371|G0000000|C0439234|G0000000|C0034656|C2587213|C0008976|C0086960|C0205125|C0006104|C1292856|C3811119|C0205094|C0007610|C0039729|C0301630|C0728938|C0036572|C0450371|C0450371|C0439231|C0450371|C0450371|C0439231|G0000000|C1850106|C0449913|C0205342|C0443183|C0205234|C0001613|C0175727|C2825951|C0039798|C0001675|C0450371|C0580836|C0205269|G0000000|C0003299|C0013227|C0332183|G0000000|C0728938|C0206132|C0036572|C0392752|G0000000|G0000000|C0205234|C0011900|C0039593
"The participants were 58 children—32 males and 26 females between 5 and 9 years of age—at the University of Marmara, Department of Paediatric Dentistry, in Istanbul.","The participants 58 children—32 males 26 females 5 9 age—at University Marmara, Department Paediatric Dentistry, Istanbul.",G0000000|C0679646|C0450371|G0000000|C0086582|C0450371|C0015780|G0000000|G0000000|G0000000|C0041740|C1065108|C1704729|C0030755|C0011438|G0000000
"Therefore, we sought to examine the efficacy of epilepsy surgery and noninvasive predictors of favorable outcome for patients with medically refractory temporal lobe epilepsy and a nonlesional high-resolution seizure protocol MRI.","Therefore, sought examine efficacy epilepsy surgery noninvasive predictors favorable outcome patients medically refractory temporal lobe epilepsy nonlesional high-resolution seizure protocol MRI.",G0000000|G0000000|G0000000|C1280519|C0014544|C0038894|C0205303|C2698872|C3640814|C1274040|C0030705|G0000000|C0205269|C0442043|C0796494|C0014544|G0000000|C1719039|C0036572|C0442711|C0024485
Exclusion criteria: medical problems or cognitive deficit (mini mental status examination score <24)20 that could interfere with study completion; aphasia or hemineglect; intended or actual participation in any other study; significant pain (≥4 in the visual analog scale) in any joint; upper limb treatment with anti-spasticity drugs in the previous 6 months; and severe upper limb spasticity (≥3 in the Modified Ashworth Scale).21 The protocol was approved by the institutional review board for human studies of Federal University of Rio de Janeiro.,Exclusion criteria: medical cognitive deficit (mini mental status examination score <24)20 interfere study completion; aphasia hemineglect; intended actual participation study; pain (≥4 visual analog scale) joint; upper limb treatment anti-spasticity drugs previous 6 months; severe upper limb spasticity (≥3 Modified Ashworth Scale).21 The protocol approved institutional review board human studies Federal University Rio de Janeiro.,C0680251|C0243161|C0199168|C1516691|C0162429|C0445542|C0229992|C0449438|G0000000|C0449820|C0450371|C0521102|C0557651|C0205197|C0003537|C0150088|C1283828|C0237400|C0679823|C0557651|C0030193|G0000000|C0234621|C0243071|C0175659|C0022417|C1282910|C0015385|C0039798|C0026838|C0013227|C0205156|G0000000|C0439231|C0205082|C1282910|C0015385|C0026838|G0000000|C0392747|G0000000|C0175659|G0000000|C0442711|C0205540|C0018704|C0282443|C0972401|C0086418|C0947630|G0000000|C0041740|C0445581|C0011198|G0000000
"In brief, this combined aerobic with strength training intervention included supervised, on-site sessions twice a week (treadmill aerobic walking of moderate intensity and resistance bands) and unsupervised, home-based sessions twice a week (aerobic walking, not necessarily on a treadmill).","In brief, combined aerobic strength training intervention included supervised, on-site sessions week (treadmill aerobic walking moderate intensity resistance bands) unsupervised, home-based sessions week (aerobic walking, treadmill).",G0000000|C1282927|C0205195|C1510824|C0237897|C0040607|C0886296|C0332257|G0000000|C1720176|C1883016|C0332174|C0184069|C1510824|C0080331|C0205081|C0522510|C0237834|C0175723|G0000000|C0442519|C1883016|C0332174|C1510824|C0080331|C0184069
"A study conducted on vocational school students revealed that while 81% of smokers drank hazardously, only 49% of non-smokers drank hazardously [11].","A study conducted vocational school students revealed 81% smokers drank hazardously, 49% non-smokers drank hazardously [11].",G0000000|C0557651|C0004927|C0087164|C0036375|C0038492|C0443289|C0450371|C0337664|C0452428|G0000000|C0450371|C0337672|C0452428|G0000000|C0450371
"This study built upon previous interventions using SMS text messaging by using less study staff support, greater reliance on participants for providing group support, having a rigorous control condition which received daily SMS text messaging (non-smoking related) and the same individual smoking cessation counseling session as the intervention group.","This study built previous interventions SMS text messaging study staff support, reliance participants providing support, rigorous control condition received daily SMS text messaging (non-smoking related) individual smoking cessation counseling session intervention group.",G0000000|C0557651|C1707059|C0205156|C0886296|G0000000|C1527021|C0470166|C0557651|C0851286|C0183683|C0290627|C0679646|C1999230|C0183683|C0026837|C0243148|C0012634|C1514756|C0332173|G0000000|C1527021|C0470166|C1518422|C0439849|C0027361|C0037369|C1880019|C0010210|C1883016|C0886296|C0441833
We prospectively screened patients aged 18 years or older meeting the criteria for severe sepsis or septic shock [11].,We prospectively screened patients aged 18 meeting criteria severe sepsis septic shock [11].,G0000000|G0000000|C0220908|C0030705|C0001779|C0450371|C0556656|C0243161|C0205082|C0036690|C0333534|C0036974|C0450371
"Exclusion criteria included existing acute malnutrition, especially wasting, with weight for length ≤ 2 SD by World Health Organization (WHO) infant growth standards; current or planned use of infant formula or other nutrient fortified products; current or planned use of iron or zinc supplements; anemia (defined as Hb < 10 g/dL); previous hospitalization for malaria within the last four weeks; and persistent diarrhea (per WHO, >3 loose stools/day lasting ≥14 days).","Exclusion criteria included existing acute malnutrition, wasting, weight length ≤ 2 SD World Health Organization (WHO) infant growth standards; current planned infant formula nutrient fortified products; current planned iron zinc supplements; anemia (defined Hb < 10 g/dL); previous hospitalization malaria weeks; persistent diarrhea (per WHO, >3 loose stools/day lasting ≥14 days).",C0680251|C0243161|C0332257|C2987476|C0205178|C0162429|C0006625|C0005910|C1444754|G0000000|G0000000|C2699239|C2700280|C0018684|C0029237|G0000000|C0021270|C0018270|C0038137|C0521116|C1301732|C0021270|C0489829|C0678695|G0000000|C1514468|C0521116|C1301732|C0302583|C0043481|C0242295|C0002871|C1704788|C0019046|G0000000|C0450371|C0439267|C0205156|C0019993|C0024530|C0439230|C0205322|C0011991|G0000000|G0000000|G0000000|C0205407|C0015733|C1517741|G0000000|C0439228
"Subjects were eligible for study inclusion if they were 18 years of age or older, had smoked at least 20 cigarettes/day for the previous year, and were generally in good health.","Subjects eligible study inclusion 18 age older, smoked 20 cigarettes/day previous year, health.",C0681850|C1548635|C0557651|C0007637|C0450371|C0001779|C0580836|C0037366|C0450371|C0677453|C0205156|C0439234|C0018684
"Of the original 431 patients enrolled in the trial, 379 patients (87.9%) had accessible medical records for the follow-up period and were included in the current analyses (203 in the CRP test group vs 176 in the no CRP test group; and 178 in the training in enhanced communication skills group vs 201 in the no training group).","Of original 431 patients enrolled trial, 379 patients (87.9%) accessible medical records follow-up period included current analyses (203 CRP test 176 CRP test group; 178 training enhanced communication skills 201 training group).",G0000000|C0205313|C1442061|C0030705|G0000000|C0008976|C1442061|C0030705|C0450371|C0814423|C0199168|C0034869|C0589120|C0439531|C0332257|C0521116|C0002778|C1442061|C3890735|C0022885|C1442061|C3890735|C0022885|C0441833|C1442061|C0040607|C2349975|C0009452|C0678856|C1442061|C0040607|C0441833
"Abbreviation: Q, quintiles; SMHS, Shanghai Men's Health Study; SWHS, Shanghai Women's Health Study.","Abbreviation: Q, quintiles; SMHS, Shanghai Men's Health Study; SWHS, Shanghai Women's Health Study.",C0000723|G0000000|C1508496|C1824631|G0000000|C0025266|C0018684|C0557651|G0000000|G0000000|C0043210|C0018684|C0557651
The messages build upon each other but can be delivered separately or together and in any order.,The messages build delivered separately order.,G0000000|C0470166|C1707059|C1705822|G0000000|C1705175
"We investigated the relationship between black and green tea intake and prostate cancer risk among 27,293 men in the Singapore Chinese Health Study, a population-based prospective cohort study.","We investigated relationship black green tea intake prostate cancer risk 27,293 Singapore Chinese Health Study, population-based prospective cohort study.",G0000000|C1292732|C0439849|C0005680|C0332583|C0039400|C1512806|C0033572|C0006826|C0035647|C0450371|C0037173|C0008120|C0018684|C0557651|C0032659|C0023981|C0599755|C0557651
Exclusion criteria will be any motor or sensory impairment as defined by neurological examination and/or scaled motor scores below 8 for CA on the Bayley III and cognitive impairment or delays as described for the CP group.,Exclusion criteria motor sensory impairment defined neurological examination and/or scaled motor scores 8 CA Bayley III cognitive impairment delays CP group.,C0680251|C0243161|C1513492|C0445254|C0221099|C1704788|C0205494|G0000000|G0000000|C0175659|C1513492|C0449820|G0000000|C3887642|G0000000|C0439070|C1516691|C0221099|C0205421|C4050020|C0441833
"Fifteen patients were recruited per FP: five at baseline (T0), five after the FPs in the experimental group were exposed to DECISION+ (T1), and five after the FPs in the control group were exposed to DECISION+ (T2).","Fifteen patients recruited FP: baseline (T0), FPs experimental exposed DECISION+ (T1), FPs control exposed DECISION+ (T2).",C3715153|C0030705|G0000000|C0016704|C0168634|C0041403|C1708010|C1517586|C0332157|C0679006|C0041403|C1708010|C0243148|C0332157|C0679006|C0041403
"quit-lines, clinics) are available in Hong Kong, the utility rate is low and only 14.2% of smokers had ever used [2].","quit-lines, clinics) Hong Kong, utility rate low 14.2% smokers [2].",C0748223|C0442592|G0000000|G0000000|C0582205|C0871208|C0205251|C0450371|C0337664|G0000000
"Investigators attempted to contact a total of 644 potential participants: 30% were referred by other professionals (from 15 clinicians, five social service agencies, three child advocacy centers, and 349 schools that had been made aware of the project), 14% referred themselves from radio and television advertisements, and 56% were contacted from the local level I trauma center registry.","Investigators attempted contact total 644 potential participants: 30% referred professionals (from 15 clinicians, social service agencies, child advocacy centers, 349 schools aware project), 14% referred radio television advertisements, 56% contacted local level I trauma center registry.",C0035173|C1516084|C0332158|C0439175|C1442061|C3245505|C0679646|C0450371|C0205543|C0679924|G0000000|C0450371|C0871685|C0728831|C0557854|C0237463|C0008059|C0150446|C0205099|C1442061|C0036375|C0004448|C1709701|C0450371|C0205543|C0034546|C0039461|C0949214|C0450371|C0332158|C0205276|C0441889|C0021966|C0043251|C0205099|C0034975
Women of childbearing potential were to be abstinent or to have used adequate contraceptive precautions for 30 days prior to first vaccination and agreed to continue such precautions for 2 months after completion of the vaccination series.,Women childbearing potential abstinent adequate contraceptive precautions 30 days prior vaccination agreed continue precautions 2 months completion vaccination series.,C0043210|G0000000|C3245505|C0457801|C0205410|C0009871|C1882442|C0450371|C0439228|C0332152|C0042196|C3641827|C0549178|C1882442|G0000000|C0439231|C0205197|C0042196|C0205549
SETTING: 11 general practices in the South and West region.,SETTING: 11 practices South West region.,C0542559|C0450371|C0237607|C1710133|C1705493|C0017446
"Patients were excluded if, in the first two sessions of hemodialysis, the catheter did not allow a pump blood flow rate of >200 ml/min for nontunneled catheters and >250 ml/min for tunneled catheters.","Patients excluded if, sessions hemodialysis, catheter pump blood flow rate >200 ml/min nontunneled catheters >250 ml/min tunneled catheters.",C0030705|C1554077|G0000000|C1883016|C0019004|C0085590|C0182537|C0005767|C0806140|C0871208|C1442061|C0439445|G0000000|C0085590|C1442061|C0439445|C0445346|C0085590
"To obtain a large enough comparison group of subfertile women not treated with IVF, we identified women who were diagnosed with fertility problems shortly before IVF became a routine procedure for subfertile patients.","To comparison subfertile women treated IVF, identified women diagnosed fertility shortly IVF routine procedure subfertile patients.",C0040363|C1707455|C0729353|C0043210|C1522326|C0872104|C0205396|C0043210|C0011900|C0015895|G0000000|C0872104|C0205547|C0184661|C0729353|C0030705
Belonging to the strength training group was associated with a lower HRQoL-scale ‘Vitality’ (data not shown).,Belonging strength training lower HRQoL-scale ‘Vitality’ (data shown).,G0000000|C0237897|C0040607|C0441994|C0175659|G0000000|C1511726|C1547282
"Exclusion criteria included the subjects who were smokers, were undergoing antibiotic therapy, had any medically compromised conditions contraindicating the oral examination or had active periodontitis and multiple carious lesions.","Exclusion criteria included subjects smokers, undergoing antibiotic therapy, medically compromised conditions contraindicating oral examination active periodontitis multiple carious lesions.",C0680251|C0243161|C0332257|C0681850|C0337664|G0000000|C0003232|C0039798|G0000000|C2945640|C0012634|G0000000|C0442027|G0000000|C0205177|C0031099|C0439064|G0000000|C0221198
"In this double blind placebo controlled study, 55 preterm infants (31 males, 24 females), born between 25 and 33 weeks of gestation, were recruited from the Neonatal and Intensive Care Department of the Medical University of Warsaw, Poland.","In double blind placebo controlled study, 55 preterm infants (31 males, 24 females), born 25 33 weeks gestation, recruited Neonatal Intensive Care Department Medical University Warsaw, Poland.",G0000000|C0205173|C0150108|C0032042|C2587213|C0557651|C0450371|C0151526|C0021270|C0450371|C0086582|C0450371|C0015780|C0005615|C0450371|C0450371|C0439230|C0032961|G0000000|C1552240|C0162425|C1947933|C1704729|C0199168|C0041740|G0000000|C0032356
Participants were not shown their previous response.,Participants previous response.,C0679646|C0205156|C0871261
"Male and female, 3 to 75 years old Residence in an endemic area (RHZ Nsona-Mpangu) Informed consent by patient or guardian Previous treatment by rifampicin or streptomycin Previous diagnosis of leprosy or tuberculosis Pregnancy Presence of cardiovascular, hepatic or renal disease, detected during a complete physical examination Loss to follow-up  We used the following methods to document the size of the lesions before, during and after treatment.","Male female, 3 75 Residence endemic (RHZ Nsona-Mpangu) Informed consent patient guardian Previous treatment rifampicin streptomycin Previous diagnosis leprosy tuberculosis Pregnancy Presence cardiovascular, hepatic renal disease, detected complete physical examination Loss follow-up We methods document size lesions before, treatment.",C0086582|C0015780|G0000000|C0450371|C0237096|G0000000|G0000000|G0000000|C1522154|C1511481|C0030705|C0023226|C0205156|C0039798|C0035608|C0038425|C0205156|C0011900|C0023343|C0041296|C0032961|C0150312|C0007226|C0205054|C0022646|C0012634|C0442726|C0205197|C0031809|G0000000|C1517945|C0589120|G0000000|C0025663|C1301746|C0456389|C0221198|C0332152|C0039798
"The key exclusion criteria included significant disease other than COPD (ie, a disease that, in the opinion of the investigator, may put the patient at risk because of participation in the study, may influence the results of the study, or may affect the patient’s ability to participate in the study), a history of asthma, thyrotoxicosis, paroxysmal tachycardia, unstable or life-threatening cardiac arrhythmia, myocardial infarction within the previous year, or hospitalization for heart failure within the past year.","The key exclusion criteria included disease COPD (ie, disease that, opinion investigator, patient risk participation study, influence study, affect patient’s ability participate study), history asthma, thyrotoxicosis, paroxysmal tachycardia, unstable life-threatening cardiac arrhythmia, myocardial infarction previous year, hospitalization heart failure year.",G0000000|G0000000|C0680251|C0243161|C0332257|C0012634|C0024117|G0000000|C0012634|G0000000|C0871010|C0035173|C0030705|C0035647|C0679823|C0557651|C4054723|C0557651|C0001721|G0000000|C0085732|G0000000|C0557651|C0019664|C0004096|C0040156|C0205311|C0039231|C0443343|C1517874|C0018787|C0003811|C0027061|C0021308|C0205156|C0439234|C0019993|C0018787|C0231174|C0439234
The planned sample size is 340 in- and outpatients treated at the Department of Oncology at Copenhagen University Hospital.,The planned sample size 340 in- outpatients treated Department Oncology Copenhagen University Hospital.,G0000000|C1301732|C0370003|C0456389|C1442061|G0000000|C0029921|C1522326|C1704729|C0027651|G0000000|C0041740|C0019994
"Participants were aged 21 to 85 years with a clinical diagnosis of definite, probable, or laboratory-supported probable ALS, either sporadic or familial, by El Escorial guidelines29.","Participants aged 21 85 clinical diagnosis definite, probable, laboratory-supported probable ALS, sporadic familial, El Escorial guidelines29.",C0679646|C0001779|C0450371|C0450371|C0205210|C0011900|C0439544|C0033204|C0022877|C0033204|G0000000|C0205422|C0015576|C1416870|G0000000|G0000000
"Patients were excluded if they had fractures with marked comminution or that were older than 4 weeks, ipsilateral injuries that could influence the recovery and the scoring systems, pathological fractures, open fractures, a congenital anomaly or bone disease, or if there was cellulites around the incision site for open reduction.","Patients excluded fractures marked comminution 4 weeks, ipsilateral injuries influence recovery scoring systems, pathological fractures, fractures, congenital anomaly bone disease, cellulites incision site reduction.",C0030705|C1554077|C0016658|C0522501|C0476171|G0000000|C0439230|C0441989|C1510467|C4054723|C0237820|C0449820|C0449913|C0030664|C0016658|C0016658|C0009678|C0332447|C0262950|C0012634|C0424624|C0184898|C0205145|C0301630
"Patients were excluded if glucose-6-phosphate dehydrogenase (G6PD) deficient by the fluorescent spot test (FST), were pregnant or breastfeeding an infant ≤ 6 months, had a hematocrit ≤25%, or received a blood transfusion within 3 months.","Patients excluded glucose-6-phosphate dehydrogenase (G6PD) deficient fluorescent spot test (FST), pregnant breastfeeding infant ≤ 6 months, hematocrit ≤25%, received blood transfusion 3 months.",C0030705|C1554077|C0017761|C0030016|G0000000|C0011155|C0303920|C0329155|C0022885|C0118175|C0549206|C0006147|C0021270|G0000000|G0000000|C0439231|C0018935|G0000000|C1514756|C0005767|C0005841|G0000000|C0439231
Children 6–59 months with uncomplicated acute malnutrition are eligible for inclusion in the study per the following criteria: MUAC <125 mm  and/or Bilateral pitting oedema (+/++)  and Passes the appetite test (consumption of 30 g of RUTF within 20 min)  and No medical complications (i.e.,Children 6–59 months uncomplicated acute malnutrition eligible inclusion study criteria: MUAC <125 mm and/or Bilateral pitting oedema (+/++) Passes appetite test (consumption 30 RUTF 20 min) No medical complications (i.e.,C0008059|G0000000|C0439231|C0443334|C0205178|C0162429|C1548635|C0007637|C0557651|C0243161|G0000000|C1442061|G0000000|G0000000|C0238767|C0205323|C0013604|G0000000|C2828386|C0003618|C0022885|C0009830|C0450371|G0000000|C0450371|C0702093|G0000000|C0199168|C0009566|C0683454
"This resulted in 41 subjects (63% female; mean age 43 ± 13 yrs) entering double blind treatment (17 on EPA, and 24 on placebo).","This 41 subjects (63% female; age 43 ± 13 yrs) entering double blind treatment (17 EPA, 24 placebo).",G0000000|C0450371|C0681850|C0450371|C0015780|C0001779|C0450371|G0000000|C0450371|G0000000|C1522196|C0205173|C0150108|C0039798|C0450371|G0000000|C0450371|C0032042
"Medical records of all children with KS and HIV infection referred to the Uganda Cancer Institute in Kampala, Uganda from October 2004 to June 2007 were reviewed.","Medical records children KS HIV infection referred Uganda Cancer Institute Kampala, Uganda October 2004 June 2007 reviewed.",C0199168|C0034869|C0008059|C0022773|C0019682|C0009450|C0205543|C0041573|C0006826|C0021622|G0000000|C0041573|C3828732|G0000000|C3829443|G0000000|C0282443
"Pregnant women with pre-existing calcium or parathyroid conditions, or who required chronic diuretic or cardiac medication therapy including calcium channel blockers, or chronic hypertension were not eligible for enrollment into the study.","Pregnant women pre-existing calcium parathyroid conditions, required chronic diuretic cardiac medication therapy including calcium channel blockers, chronic hypertension eligible enrollment study.",C0549206|C0043210|C2347662|C0006675|C0030518|C0012634|C1514873|C0205191|C0012798|C0018787|C0013227|C0039798|C0332257|C0006675|C0439799|G0000000|C0205191|C0020538|C1548635|C1516879|C0557651
"The subjects were consecutive patients with non-invasive or invasive breast cancer aged over 20 years old who were treated at Okayama University Hospital, Okayama Rousai Hospital and Mizushima Kyodo Hospital in Okayama and at Kagawa Prefecture Central Hospital in Kagawa.","The subjects consecutive patients non-invasive invasive breast cancer aged 20 treated Okayama University Hospital, Okayama Rousai Hospital Mizushima Kyodo Hospital Okayama Kagawa Prefecture Central Hospital Kagawa.",G0000000|C0681850|C1707491|C0030705|C0205303|C0205281|C0006141|C0006826|C0001779|C0450371|C1522326|G0000000|C0041740|C0019994|G0000000|G0000000|C0019994|G0000000|G0000000|C0019994|G0000000|G0000000|C1709636|C0205099|C0019994|G0000000
"In the diet groups, 19 patients were sip fed as outpatients and 24 were tube fed as inpatients.","In diet groups, 19 patients sip fed outpatients 24 tube fed inpatients.",G0000000|C0012155|C0441833|C0450371|C0030705|C1823796|C0342895|C0029921|C0450371|C0175730|C0342895|C0021562
"Criteria for inclusion in the study were an age of 18 years or older, a stroke within 45 days before study entry and the ability to undergo randomization within 2 months after the stroke, residual paresis in the leg affected by stroke, the ability to walk 3 m (approximately 10 ft) with assistance from no more than one person and the ability to follow a three-step command, the treating physician’s approval of participation in the study, a self-selected speed for walking 10 m of less than 0.8 m per second, and residence in the community by the time of randomization.","Criteria inclusion study age 18 older, stroke 45 days study entry ability undergo randomization 2 months stroke, residual paresis leg stroke, ability walk 3 (approximately 10 ft) assistance person ability follow three-step command, treating physician’s approval participation study, self-selected speed walking 10 0.8 second, residence community time randomization.",C0243161|C0007637|C0557651|C0001779|C0450371|C0580836|C0038454|C0450371|C0439228|C0557651|C1705654|C0085732|G0000000|C0034656|G0000000|C0439231|C0038454|C1609982|C0030552|C0023216|C0038454|C0085732|C0080331|G0000000|C0332232|C0450371|C1881534|C0018896|C0027361|C0085732|C0332283|C0205449|G0000000|C1522326|G0000000|C0205540|C0679823|C0557651|C0036588|C0678536|C0080331|C0450371|G0000000|C0205436|C0237096|C0009462|C0040223|C0034656
"Furthermore, pregnant women who do continue to smoke may not receive support to quit [9].","Furthermore, pregnant women continue smoke receive support quit [9].",G0000000|C0549206|C0043210|C0549178|C0037366|C1514756|C0183683|C0748223|G0000000
"Of the 512 adolescents recruited into the study, 93.6% (n=479) participated in the baseline data collection, with 19 students grade-ineligible and 14 students absent from school.","Of 512 adolescents recruited study, 93.6% (n=479) participated baseline data collection, 19 students grade-ineligible 14 students absent school.",G0000000|C1442061|C0205653|G0000000|C0557651|C0450371|C0369718|G0000000|C0168634|C1511726|C1516698|C0450371|C0038492|C0441800|C0450371|C0038492|C0332197|C0036375
"Patients were recruited from outpatient palliative care and oncology clinics at MD Anderson Cancer Center or from outpatient clinics at Lyndon B. Johnson General Hospital in Houston, Texas.","Patients recruited outpatient palliative care oncology clinics MD Anderson Cancer Center outpatient clinics Lyndon B. Johnson General Hospital Houston, Texas.",C0030705|G0000000|C0029921|C0587605|C1947933|C0027651|C0442592|G0000000|G0000000|C0006826|C0205099|C0029921|C0442592|G0000000|G0000000|G0000000|C0205246|C0019994|G0000000|C0039711
"This randomized clinical trial of micronutrient supplementation was conducted for 24 months in adult men and women with HIV subtype C who were early in their HIV disease; they had a CD4 cell count greater than 350/μL (baseline median CD4 cell count of 420/μL; IQR, 336-550), were ART-naive throughout the study, and had not yet experienced any clinical AIDS symptoms.","This randomized clinical trial micronutrient supplementation conducted 24 months adult women HIV subtype C HIV disease; CD4 cell count 350/μL (baseline median CD4 cell count 420/μL; IQR, 336-550), ART-naive study, experienced clinical AIDS symptoms.",G0000000|C0034656|C0205210|C0008976|C0040577|C0242297|C0004927|C0450371|C0439231|C0001675|C0043210|C0019682|C0449560|G0000000|C0019682|C0012634|C0285590|C0007634|C0750480|G0000000|C0168634|C0549183|C0285590|C0007634|C0750480|G0000000|G0000000|C1442061|C0003826|C0557651|C0237607|C0205210|C0001175|C0683368
"Among current smokers, there were 7128 eligible (10+ CPD) smokers (69.7% of all smokers).","Among current smokers, 7128 eligible (10+ CPD) smokers (69.7% smokers).",G0000000|C0521116|C0337664|G0000000|C1548635|C0450371|C0085988|C0337664|C0450371|C0337664
We excluded potential participants who screened positive for major depression with the 9-item Patient Health Questionnaire (PHQ-9) depression scale 13 and referred them to the provincial physician wellness support program.,We excluded potential participants screened positive major depression 9-item Patient Health Questionnaire (PHQ-9) depression scale 13 referred provincial physician wellness support program.,G0000000|C1554077|C3245505|C0679646|C0220908|C0439178|C0205082|C0011570|C1551338|C0030705|C0018684|C0034394|C1879301|C0011570|C0175659|C0450371|C0205543|G0000000|C0031831|C0018684|C0183683|C1709697
"The patients were required to meet the following inclusion criteria: (a) had a stroke identifiable by computerized tomography (CT) or magnetic resonance imaging (MRI), (b) had no cognitive dysfunction that would interfere with the study purpose as indicated by a Korean Mini-Mental State Examination score [MMSE-K]>2412), (c) had no perceptual disorder or unilateral neglect that would have interfered with the study purpose as indicated by the Motor-free Visual Perception Test [MVPT]13), (d) were 3 months post stroke, and (e) had a Brunnstrom score between stagesI–IV for the UE14).","The patients required meet inclusion criteria: (a) stroke identifiable computerized tomography (CT) magnetic resonance imaging (MRI), (b) cognitive dysfunction interfere study purpose Korean Mini-Mental State Examination score [MMSE-K]>2412), (c) perceptual disorder unilateral neglect interfered study purpose Motor-free Visual Perception Test [MVPT]13), (d) 3 months post stroke, (e) Brunnstrom score stagesI–IV UE14).",G0000000|C0030705|C1514873|C1550543|C0007637|C0243161|G0000000|C0038454|C0205396|G0000000|C0040395|C0007673|C0024488|C0231881|C0011923|C0024485|G0000000|C1516691|C0031847|C0521102|C0557651|C1285529|C1556095|C0445542|C1301808|G0000000|C0449820|C0451306|G0000000|G0000000|C0012634|C0205092|C0521874|C0521102|C0557651|C1285529|C1513492|C0234621|C0030971|C0022885|C0450371|C0073187|G0000000|C0439231|C0687676|C0038454|G0000000|G0000000|C0449820|G0000000|G0000000
Approximately 54 long day care services within NSW will be randomised to the experimental or control group.,Approximately 54 day care services NSW randomised experimental control group.,C0332232|C0450371|C0332173|C1947933|C0557854|G0000000|G0000000|C1517586|C0243148|C0441833
"Good general and oral health No periodontal therapy during the past 3 months Moderate gingivitis (at least 25% of test sites showing bleeding on probing) Ability to attend the hospital at recall intervals Full complement of teeth present, except third molars.","Good oral health No periodontal therapy 3 months Moderate gingivitis (at 25% test sites bleeding probing) Ability attend hospital recall intervals Full complement teeth present, molars.",C0205170|C0442027|C0018684|G0000000|C2960678|C0039798|G0000000|C0439231|C0205081|C0017574|G0000000|C0450371|C0022885|C0205145|C0019080|C0419358|C0085732|C1999232|C0019994|C0034770|C1272706|C0443225|C0009498|C0040426|C0150312|C0026367
"The most common current chronic pain diagnosis reported by participants across both intervention conditions was lumbago (56.5%), followed by fibromyalgia (20.0%), arthritis (7.0%), cervicalgia (6.0%), or “other” pain conditions (10.5%).","The common current chronic pain diagnosis reported participants intervention conditions lumbago (56.5%), fibromyalgia (20.0%), arthritis (7.0%), cervicalgia (6.0%), “other” pain conditions (10.5%).",G0000000|C0205214|C0521116|C0205191|C0030193|C0011900|C0684224|C0679646|C0886296|C0012634|C0024031|C0450371|C0016053|C0450371|C0003864|G0000000|C0007859|G0000000|G0000000|C0030193|C0012634|C0450371
"This study was a cluster randomized, partially double-masked, placebo-controlled trial (the International Lipid-based Nutrient Supplement-Zinc Trial, iLiNS-ZINC), which took place in the Dandé Health District in southwestern Burkina Faso from April 2010 to July 2012.","This study cluster randomized, partially double-masked, placebo-controlled trial (the International Lipid-based Nutrient Supplement-Zinc Trial, iLiNS-ZINC), Dandé Health District southwestern Burkina Faso April 2010 July 2012.",G0000000|C0557651|C1555715|C0034656|G0000000|C0013072|C1706408|C0008976|G0000000|C1512888|C0023779|C0678695|C1268859|C0008976|C0043481|G0000000|C0018684|G0000000|C1710136|G0000000|G0000000|C3715024|G0000000|C3829447|G0000000
Thus to date there is no routine indication for glycine application to liver transplant recipients and no intravenous infusion containing exclusively glycine is commercially available yet.,Thus routine indication glycine application liver transplant recipients intravenous infusion exclusively glycine commercially yet.,G0000000|C0205547|C0392360|C0017890|C0185125|C0023884|C0040732|C1709854|C0348016|C0574032|G0000000|C0017890|G0000000|G0000000
"Exclusion criteria were: Sleep apnoea, CVDs requiring medical therapy, further chronic disease, like diabetes mellitus, malignant disease, kidney disease, liver disease or psychosis.","Exclusion criteria were: Sleep apnoea, CVDs requiring medical therapy, chronic disease, diabetes mellitus, malignant disease, kidney disease, liver disease psychosis.",C0680251|C0243161|G0000000|C0037313|C0003578|C0007222|G0000000|C0199168|C0039798|C0205191|C0012634|C0011847|G0000000|C0205282|C0012634|C0022646|C0012634|C0023884|C0012634|C0033975
"In conclusion, it seems that there is a subgroup of patients with severe sepsis or septic shock in which the delivery of IgM-enriched immunoglobulin preparations may have a beneficial effect.","In conclusion, subgroup patients severe sepsis septic shock delivery IgM-enriched immunoglobulin preparations beneficial effect.",G0000000|C1707478|C1079230|C0030705|C0205082|C0036690|C0333534|C0036974|C0011209|C1706005|C0021027|C1521827|G0000000|C1280500
"Exclusion criteria were: (1) diagnosis of psychotic disorders including psychotic depression and bipolar disorders; (2) current drug or alcohol abuse or dependence, or history of drug or alcohol abuse or dependence within the previous six months; (3) unstable medical or neurological conditions that were likely to interfere with the treatment of depression; (4) history of allergy to citalopram or omega-3 fatty acids, finfish or shellfish; (5) history of failure of response to adequate trial of citalopram; (6) history of seizure disorder; (7) pregnancy; (8) need for concomitant therapy with psychotropic medications including antidepressants other than citalopram or neuroleptics; (9) active suicidal ideation or other safety concerns; (10) exposure to treatment with fluoxetine or monoamine oxidase inhibitors (MAOIs) in the previous two months; (11) being on anticoagulant therapy; and, (12) a dietary intake greater than 3.0g total omega-3 per day at baseline as assessed by a three-day food diary evaluated by a certified nutritionist.","Exclusion criteria were: (1) diagnosis psychotic disorders including psychotic depression bipolar disorders; (2) current drug alcohol abuse dependence, history drug alcohol abuse dependence previous months; (3) unstable medical neurological conditions interfere treatment depression; (4) history allergy citalopram omega-3 fatty acids, finfish shellfish; (5) history failure response adequate trial citalopram; (6) history seizure disorder; (7) pregnancy; (8) concomitant therapy psychotropic medications including antidepressants citalopram neuroleptics; (9) active suicidal ideation safety concerns; (10) exposure treatment fluoxetine monoamine oxidase inhibitors (MAOIs) previous months; (11) anticoagulant therapy; and, (12) dietary intake 3.0g total omega-3 day baseline assessed three-day food diary evaluated certified nutritionist.",C0680251|C0243161|G0000000|G0000000|C0011900|C0004936|C0012634|C0332257|C0004936|C0011570|C0443156|C0012634|G0000000|C0521116|C0013227|C0001962|C0013146|C0011546|C0019664|C0013227|C0001962|C0013146|C0011546|C0205156|C0439231|G0000000|C0443343|C0199168|C0205494|C0012634|C0521102|C0039798|C0011570|G0000000|C0019664|C0002111|C0008845|C1719844|G0000000|C0001128|C0016163|C0036950|G0000000|C0019664|C0231174|C0871261|C0205410|C0008976|C0008845|G0000000|C0019664|C0036572|C0012634|G0000000|C0032961|G0000000|C0521115|C0039798|C0033978|C0013227|C0332257|C0003289|C0008845|C0040615|G0000000|C0205177|C0438696|C0392348|C0036043|C2699424|C0450371|C0274281|C0039798|C0016365|C0599682|C0242417|C0243077|C0026457|C0205156|C0439231|C0450371|C0003280|C0039798|G0000000|C0450371|C0012155|C1512806|C0017209|C0439175|C1719844|C0332173|C0168634|C1516048|C0205449|C0016452|C0376660|C0220825|C0007836|C0237083
The participants in the tai chi group performed significantly better than those in the resistance-training and stretching groups on the primary outcomes.,The participants tai chi performed resistance-training stretching primary outcomes.,G0000000|C0679646|G0000000|C1720589|C0884358|C0814409|C0600080|C0205225|C1274040
"Children between 1 and 19 years of age with primary ALL, who are treated within the DCOG ALL-11 or subsequent study, are eligible for the TropicALL.","Children 1 19 age primary ALL, treated DCOG ALL-11 subsequent study, eligible TropicALL.",C0008059|G0000000|C0450371|C0001779|C0205225|G0000000|C1522326|G0000000|C0444868|C0332282|C0557651|C1548635|G0000000
"For the intervention group, study staff reviewed clinic schedules to identify children with upcoming 12- or 24-month well-child visits.","For intervention group, study staff reviewed clinic schedules identify children upcoming 12- 24-month well-child visits.",G0000000|C0886296|C0441833|C0557651|C0851286|C0282443|C0002424|C0086960|G0000000|C0008059|G0000000|C0450371|C0450371|C0686744|C0545082
"cimetidine, trimethoprim, probenecid, sulfonamides, procaine or thiazolesulfone); treatment with fibrates in the 3 months preceding the screening visit; chronic therapy with a non-steroidal anti-inflammatory drug (with the exception of prophylactic stable low-dose aspirin) 1 month prior to screening; or changes in antihypertensive therapy in the last 3 months or in statins in the last month before screening or likely to require changes during the study.","cimetidine, trimethoprim, probenecid, sulfonamides, procaine thiazolesulfone); treatment fibrates 3 months preceding screening visit; chronic therapy non-steroidal anti-inflammatory drug (with exception prophylactic stable low-dose aspirin) 1 month prior screening; antihypertensive therapy 3 months statins month screening require study.",C0008783|C0041041|C0033209|C0038760|C0033218|G0000000|C0039798|C1449704|G0000000|C0439231|C0332152|C0220908|C0545082|C0205191|C0039798|C1518422|C0003209|C0013227|G0000000|C1554961|C0355642|C0205360|C0445550|C0004057|G0000000|C0332177|C0332152|C0220908|C0003364|C0039798|G0000000|C0439231|C0360714|C0332177|C0220908|G0000000|C0557651
The safety and efficacy of rimantadine for long-term prophylaxis of influenza A (H3N2) infection were evaluated among elderly residents in 10 nursing homes.,The safety efficacy rimantadine long-term prophylaxis influenza A (H3N2) infection evaluated elderly residents 10 nursing homes.,G0000000|C0036043|C1280519|C0035629|C0443252|C0033107|C0021400|G0000000|G0000000|C0009450|C0220825|C0001792|C1320928|C0450371|C0006147|C0442519
A detailed description of the PAL trial methods are described elsewhere.23 Survivors of breast cancer were recruited through the metropolitan Philadelphia region.24 Participants were eligible for the study if they were: 1) female survivors 1 to 15 years after diagnosis; 2) free from cancer at study entry; 3) ≥ 1 lymph node(s) removed; and 4) no medical conditions or contraindicated medications that would prohibit participation in an exercise program.,A detailed description PAL trial methods elsewhere.23 Survivors breast cancer recruited metropolitan Philadelphia region.24 Participants eligible study were: 1) female survivors 1 15 diagnosis; 2) free cancer study entry; 3) ≥ 1 lymph node(s) removed; 4) medical conditions contraindicated medications prohibit participation exercise program.,G0000000|C1522508|C0678257|G0000000|C0008976|C0025663|C0450371|C0206194|C0006141|C0006826|G0000000|C0599587|C0031525|C0017446|C0679646|C1548635|C0557651|G0000000|G0000000|C0015780|C0206194|G0000000|C0450371|C0011900|G0000000|C0332296|C0006826|C0557651|C1705654|G0000000|G0000000|G0000000|C0024202|C0746922|C0849355|G0000000|C0199168|C0012634|C1444657|C0013227|C0138547|C0679823|C0015259|C1709697
"Although CT scanning is the most common imaging procedure used to follow-up patients, FDG-PET is now sometimes used in patients with colon or rectal cancer.","Although CT scanning common imaging procedure follow-up patients, FDG-PET patients colon rectal cancer.",G0000000|C0007673|C0034606|C0205214|C0011923|C0184661|C0589120|C0030705|C0872169|C0030705|C0009368|C0205052|C0006826
"Research staff met with interested patients to explain the study, obtain consent, and administer baseline questionnaires.","Research staff met patients explain study, consent, administer baseline questionnaires.",C0035168|C0851286|C0268621|C0030705|G0000000|C0557651|C1511481|C1621583|C0168634|C0034394
Twelve patients out of 20 (60%) in C group required ETI as compared to 3 out of 20 (15%) in N group (P = 0.003).,Twelve patients 20 (60%) C required ETI compared 3 20 (15%) N (P = 0.003).,C0205458|C0030705|C0450371|C0450371|G0000000|C1514873|G0000000|C1707455|G0000000|C0450371|C0450371|C0369718|C0369773|G0000000|C1442061
Subjects of childbearing potential were to be abstinent or to have used adequate contraceptive precautions for 30 d prior to first vaccination and agreed to continue such precautions for 2 months after completion of the vaccination series.,Subjects childbearing potential abstinent adequate contraceptive precautions 30 prior vaccination agreed continue precautions 2 months completion vaccination series.,C0681850|G0000000|C3245505|C0457801|C0205410|C0009871|C1882442|C0450371|C0332152|C0042196|C3641827|C0549178|C1882442|G0000000|C0439231|C0205197|C0042196|C0205549
"Patients with severe malnutrition, pregnancy and lactation, concomitant febrile illness, which would interfere with follow-up, ingestion of antimalarial drugs in the past 14 days or known allergy and/or intolerance to drug(s) being tested were excluded from the study.","Patients severe malnutrition, pregnancy lactation, concomitant febrile illness, interfere follow-up, ingestion antimalarial drugs 14 days allergy and/or intolerance drug(s) tested excluded study.",C0030705|C0205082|C0162429|C0032961|C0006147|C0521115|C0015967|C0221423|C0521102|C0589120|C0232478|C0003374|C0013227|C0450371|C0439228|C0002111|G0000000|C0231199|C0013227|C0392366|C1554077|C0557651
"On days when multiple bowel movements were experienced, subjects recorded items from (b) through (f) for the first bowel movement only.","On days multiple bowel movements experienced, subjects recorded items (b) (f) bowel movement only.",G0000000|C0439228|C0439064|C0021853|C0026649|C0237607|C0681850|C0034869|C1551338|G0000000|C0016327|C0021853|C0026649|C0205171
Patients were defined as highly dependent using Fagerstrom's criteria modified by Heatherton and al (smoking ≥ 20 cigarettes/day and/or smoking the first cigarette within 30 minutes after waking) [8].,Patients defined highly dependent Fagerstrom's criteria modified Heatherton al (smoking ≥ 20 cigarettes/day and/or smoking cigarette 30 minutes waking) [8].,C0030705|C1704788|C0205250|C0851827|G0000000|C0243161|C0392747|G0000000|C0202311|C0037369|G0000000|C0450371|C0677453|G0000000|C0037369|C0677453|C0450371|C0439232|C0442696|G0000000
Family caregivers (FC) often experience higher distress levels than their relative with cancer.,Family caregivers (FC) experience distress levels relative cancer.,C0015576|C0085537|C2983605|C0237607|C0231303|C0441889|C0080103|C0006826
We did all analyses for all study patients and for the subgroup of patients with chronic obstructive pulmonary disease confirmed by lung function tests.,We analyses study patients subgroup patients chronic obstructive pulmonary disease confirmed lung function tests.,G0000000|C0002778|C0557651|C0030705|C1079230|C0030705|C0205191|C0549186|C0024109|C0012634|C0521093|C0024109|C0031843|C0022885
"Patients aged 2–18 years, in complete disease remission and with a proven clinical history of SD and CNI-dependent INS are eligible for inclusion in the study.","Patients aged 2–18 years, complete disease remission proven clinical history SD CNI-dependent INS eligible inclusion study.",C0030705|C0001779|G0000000|C0205197|C0012634|C0544452|C0456369|C0205210|C0019664|C2699239|C1425101|G0000000|C1548635|C0007637|C0557651
"Specifically, this study determined the extent to which the HS intervention results for (a) all enrolled smokers and (b) daily smokers were statistically mediated by SCT-based theoretical processes of smoking cessation.","Specifically, study determined extent HS intervention (a) enrolled smokers (b) daily smokers statistically mediated SCT-based theoretical processes smoking cessation.",G0000000|C0557651|G0000000|C0439792|G0000000|C0886296|G0000000|G0000000|C0337664|G0000000|C0332173|C0337664|C0038215|C0086597|C0860888|C0871935|C1184743|C0037369|C1880019
"Of the 19,114 persons who were enrolled, 9525 were assigned to receive aspirin and 9589 to receive placebo.","Of 19,114 persons enrolled, 9525 assigned receive aspirin 9589 receive placebo.",G0000000|C0450371|C0027361|G0000000|G0000000|C1516050|C1514756|C0004057|G0000000|C1514756|C0032042
"The inclusion criteria for the hemiparetic subjects were (1) stroke confirmed by computed tomography or MRI; (2) unilateral hemiparesis for no more than 3 months resulting from first stroke; (3) residual gait impairment, defined by an abnormal 10 m walk time according to age (age < 60 = 10 seconds or longer or 1 m/s; age 60 to 69: 12.5 seconds or longer or 0.8 m/s; age ≥ 70: 16.6 seconds or longer, <0.6 m/s) [24]; and adequate mental and physical capacity to attempt the tasks as instructed (Mini Mental State Examination score ≥ 27, average modified Ashworth scale score at hip, knee, and ankle ≤ 2).","The inclusion criteria hemiparetic subjects (1) stroke confirmed computed tomography MRI; (2) unilateral hemiparesis 3 months stroke; (3) residual gait impairment, defined abnormal 10 m walk time age (age < 60 = 10 1 m/s; age 60 69: 12.5 0.8 m/s; age ≥ 70: 16.6 longer, <0.6 m/s) [24]; adequate mental physical capacity attempt tasks instructed (Mini Mental State Examination score ≥ 27, average modified Ashworth scale score hip, knee, ankle ≤ 2).",G0000000|C0007637|C0243161|G0000000|C0681850|G0000000|C0038454|C0521093|C1441526|C0040395|C0024485|G0000000|C0205092|C0018989|G0000000|C0439231|C0038454|G0000000|C1609982|C0016928|C0221099|C1704788|C0205161|G0000000|C0080331|C0040223|C0001779|C0001779|G0000000|C0450371|G0000000|C0450371|G0000000|C0001779|C0450371|C0450371|C0450371|G0000000|C0001779|G0000000|C0450371|C0450371|C0205166|G0000000|C0450371|C0205410|C0229992|C0031809|C1516240|C1516084|C3540678|G0000000|C0445542|C0229992|C1301808|G0000000|C0449820|G0000000|C0450371|C1510992|C0392747|G0000000|C0175659|C0449820|C0019552|C0022742|C0003086|G0000000|G0000000
The ENID trial is a 2 × 2 × 2 factorial randomized partially blind trial of nutritional supplementation to pregnant women and their infants in the West Kiang region of The Gambia.,The ENID trial 2 × 2 × 2 factorial randomized partially blind trial nutritional supplementation pregnant women infants West Kiang region The Gambia.,G0000000|G0000000|C0008976|G0000000|C2826344|C0034656|G0000000|C0150108|C0008976|C1521739|C0242297|C0549206|C0043210|C0021270|C1705493|C0325167|C0017446|G0000000|C0016993
"The study methods have been described previously.8,10 Patients were aged 40-years-old and older, had a cigarette smoking history of 10 pack-years or greater, a forced expiratory volume (FEV1) of 50% of predicted normal value or less, and a history of one or more exacerbations in the prior year that required treatment with oral corticosteroids, antibiotics, or hospitalization.","The study methods previously.8,10 Patients aged 40-years-old older, cigarette smoking history 10 pack-years greater, forced expiratory volume (FEV1) 50% predicted normal less, history exacerbations prior required treatment oral corticosteroids, antibiotics, hospitalization.",G0000000|C0557651|C0025663|C0450371|C0030705|C0001779|C0450371|C0580836|C0677453|C0037369|C0019664|C0450371|C1277691|C1704243|C0441722|C0231800|C0449468|G0000000|C0450371|C0681842|C0205307|C0439092|C0019664|G0000000|C0332152|C1514873|C0039798|C0442027|C0001617|C0003232|C0019993
"The participants' uterine contractions started spontaneously and, at admission, the contractions occurred every 5–10 minutes and cervical dilatation was 3-4 cm.","The participants' uterine contractions started spontaneously and, admission, contractions occurred 5–10 minutes cervical dilatation 3-4 cm.",G0000000|C0679646|C0042149|C1140999|C1272689|G0000000|G0000000|C0184666|C1140999|C1709305|G0000000|C0439232|C0027530|C0012359|G0000000
"Participants will be included if they meet all of the following criteria: (1) diagnosis of PCG in either eye, (2) equal to or under 3 years of age, (3) HCD between 12 and 14 mm and (4) no previous intraocular surgery or laser treatment.","Participants included meet criteria: (1) diagnosis PCG eye, (2) equal 3 age, (3) HCD 12 14 mm (4) previous intraocular surgery laser treatment.",C0679646|C0332257|C1550543|C0243161|G0000000|C0011900|C1623167|C0015392|G0000000|C0205163|G0000000|C0001779|G0000000|C2000894|C0450371|C0450371|G0000000|G0000000|C0205156|C3282905|C0038894|C0023089|C0039798
"Of those eligible, 1346 were randomized to treatment, representing approximately 1 in 5 (19%) eligible smokers.","Of eligible, 1346 randomized treatment, representing 1 5 (19%) eligible smokers.",G0000000|C1548635|G0000000|C0034656|C0039798|C1882932|G0000000|G0000000|C0450371|C1548635|C0337664
"In the present study, patients suffering from cancer pain treated chronically with oral morphine at round clock and amitriptyline before bedtime showed a dose-dependent analgesia after a single dose of 2.5, 5 and 7.5 mg epidural methadone, which was further increased by the addition of epidural dexamethasone.","In study, patients suffering cancer pain treated chronically oral morphine round clock amitriptyline bedtime dose-dependent analgesia single dose 2.5, 5 7.5 mg epidural methadone, increased addition epidural dexamethasone.",G0000000|C0557651|C0030705|C0683278|C0006826|C0030193|C1522326|G0000000|C0442027|C0026549|C0332490|C1413503|C0002600|C0521112|C1512045|C0002766|C0037179|C0178602|G0000000|G0000000|G0000000|C0228134|C0025605|C0205217|C0332287|C0228134|C0011777
The average age of study participants was 62 years (Table 1).,The average age study participants 62 (Table 1).,G0000000|C1510992|C0001779|C0557651|C0679646|C0450371|C0039224|G0000000
"The majority of youth (n = 31, 77.5%) had comorbid psychiatric diagnoses.","The majority youth (n = 31, 77.5%) comorbid psychiatric diagnoses.",G0000000|C0680220|C0001578|C0369718|G0000000|C0450371|C0450371|C0009488|C0205487|C0011900
Eighteen subjects had previous lumbar surgery (laminectomy or discectomy).,Eighteen subjects previous lumbar surgery (laminectomy discectomy).,C3715206|C0681850|C0205156|C0024090|C0038894|C0022983|C0206078
"The exclusion criteria included uncontrolled seizures, severe health problems not typically associated with CP, contractures that limited functional arm and hand use, botulinum toxin injection in the upper limb during the last 6 months or who wished to receive it within the period of study, orthopedic surgery on their involved upper limb, visual and balance problems that would prevent them from carrying out the intervention or assessment.","The exclusion criteria included uncontrolled seizures, severe health typically CP, contractures limited functional arm hand use, botulinum toxin injection upper limb 6 months wished receive period study, orthopedic surgery involved upper limb, visual balance prevent carrying intervention assessment.",G0000000|C0680251|C0243161|C0332257|C0205318|C0036572|C0205082|C0018684|G0000000|C4050020|C0009917|C0439801|C0205245|C0446516|C0018563|C0042153|C0006055|C0040549|C0021485|C1282910|C0015385|G0000000|C0439231|C1423524|C1514756|C0439531|C0557651|C0029355|C0038894|C1314939|C1282910|C0015385|C0234621|C0014653|C0309872|C0206243|C0886296|C1261322
This survival benefit was also observed in a recent prospective study in a medical intensive care unit (ICU) population that required ICU treatment for more than three days [10].,This survival benefit observed prospective study medical intensive care unit (ICU) population required ICU treatment days [10].,G0000000|C0038952|C0814225|C1441672|C0023981|C0557651|C0199168|C0162425|C1947933|C0439148|C0021708|C0032659|C1514873|C0021708|C0039798|C0439228|C0450371
"Of a total of 115 registered patients having solitary hepatocellular carcinoma (HCC) 2 to 5 cm in diameter, 18 (15.7%) were excluded after randomization.","Of total 115 registered patients solitary hepatocellular carcinoma (HCC) 2 5 cm diameter, 18 (15.7%) excluded randomization.",G0000000|C0439175|C1442061|C1514821|C0030705|C0205171|C2697585|C0007097|C2239176|G0000000|G0000000|G0000000|C1301886|C0450371|C0450371|C1554077|C0034656
Exclusion criteria were: CDR severe dementia or severe co-morbid physical health conditions.,Exclusion criteria were: CDR severe dementia severe co-morbid physical health conditions.,C0680251|C0243161|G0000000|G0000000|C0205082|C0011265|C0205082|C0009488|C0031809|C0018684|C0012634
"Participants 1635 sedentary adults aged 70-89 years with functional limitations, defined as a short physical performance battery score ≤9, but who were able to walk 400 m. Interventions A permuted block algorithm stratified by field center and sex was used to allocate interventions.","Participants 1635 sedentary adults aged 70-89 functional limitations, defined short physical performance battery score ≤9, walk 400 m. Interventions A permuted block algorithm stratified field center sex allocate interventions.",C0679646|G0000000|C0205254|C0001675|C0001779|C0450371|C0205245|C0449295|C1704788|C1282927|C0031809|C0597198|C0337088|C0449820|G0000000|C0080331|C1442061|C0369637|C0886296|G0000000|G0000000|C0028778|C0002045|C0205363|C0440042|C0205099|C0009253|G0000000|C0886296
"The criteria of exclusion also included a kidney stone in the past 5 years, renal disease (serum creatinine > 1.2 mg/dl), liver disease, bilateral hip surgery, dietary calcium intake exceeding 1500 mg/day, therapy with testosterone, estrogen, tamoxifen, bisphosphonate, fluoride or calcitonin in the past two years.","The criteria exclusion included kidney stone 5 years, renal disease (serum creatinine > 1.2 mg/dl), liver disease, bilateral hip surgery, dietary calcium intake exceeding 1500 mg/day, therapy testosterone, estrogen, tamoxifen, bisphosphonate, fluoride calcitonin years.",G0000000|C0243161|C0680251|C0332257|C0022646|C0006736|G0000000|C0439234|C0022646|C0012634|C0229671|C0010294|G0000000|G0000000|C0439269|C0023884|C0012634|C0238767|C0019552|C0038894|C0012155|C0006675|C1512806|G0000000|G0000000|C0439422|C0039798|C0039601|C0014939|C0039286|C0012544|C0016327|C0006668|C0439234
All nurses were trained to give NHS smoking cessation support and manage NRT.,All nurses trained NHS smoking cessation support manage NRT.,G0000000|C0028661|C0336809|C0796085|C0037369|C1880019|C0183683|G0000000|C1278444
All patients having elective spinal surgery were included in our study from February 2006 to November 2006 as a consecutive series.,All patients elective spinal surgery included study February 2006 November 2006 consecutive series.,G0000000|C0030705|C0206058|C0521329|C0038894|C0332257|C0557651|C3830166|G0000000|C3828767|G0000000|C1707491|C0205549
"One year after the intervention, there was a reduction of several adverse psychosocial factors in the experimental group, whereas no such reduction was found in the control group.","One intervention, reduction adverse psychosocial factors experimental group, reduction control group.",C0205447|C0886296|C0301630|G0000000|C0542298|C1521761|C1517586|C0441833|C0301630|C0243148|C0441833
Participants are eligible for enrolment if they have a score between 7.1 and 50.0 on the EASI for disease severity.,Participants eligible enrolment score 7.1 50.0 EASI disease severity.,C0679646|C1548635|C1516879|C0449820|G0000000|C0450371|C1516931|C0012634|C0439793
The setting and environment of follow-up (primary vs secondary care) constituted our intervention.,The setting environment follow-up (primary secondary care) constituted intervention.,G0000000|C0542559|C0014406|C0589120|C0205225|C0027627|C1947933|G0000000|C0886296
HCPs will be recruited at the university medical center.,HCPs recruited university medical center.,G0000000|G0000000|C0041740|C0199168|C0205099
Exclusion criteria were: 1. a diagnosis of schizophrenia or mental retardation to avoid the complication of dual diagnoses impacting on treatment effect; 2. expected to be transferred to another residential facility within the next 3 months.,Exclusion criteria were: 1. diagnosis schizophrenia mental retardation avoid complication dual diagnoses impacting treatment effect; 2. expected transferred residential facility 3 months.,C0680251|C0243161|G0000000|G0000000|C0011900|C0036341|C0229992|C0521111|G0000000|C0009566|C1554184|C0011900|C1825598|C0039798|C1280500|G0000000|C1517001|C0348011|C0237096|C1547538|G0000000|C0439231
"All participants had primary PD diagnosed by a movement disorders specialist using the UK Brain Bank criteria,43 were in Hoehn and Yahr stages 1 through 3,44 lived in the community, and ambulated independently.","All participants primary PD diagnosed movement disorders specialist UK Brain Bank criteria,43 Hoehn Yahr stages 1 3,44 lived community, ambulated independently.",G0000000|C0679646|C0205225|G0000000|C0011900|C0026649|C0012634|C0087009|C0041700|C0006104|C0442598|C0243161|G0000000|G0000000|C1306673|G0000000|C0450371|C1548795|C0009462|C4036205|G0000000
"Percentage of clinical and radiological bone healing and secondary dislocation in each group Proportions per treatment groups are compared with χ2 statistics Skin lesion percentage in each group Proportions per treatment groups are compared with χ2 statistics The findings in this trial show that children aged 5–15 years who sustained a distal radius fracture treated with a Swim cast were significantly more satisfied than those children treated with a traditional cast, without any decrease in clinical and radiological bone healing or worsened skin condition.","Percentage clinical radiological bone healing secondary dislocation Proportions treatment compared χ2 statistics Skin lesion percentage Proportions treatment compared χ2 statistics The findings trial children aged 5–15 sustained distal radius fracture treated Swim cast satisfied children treated traditional cast, decrease clinical radiological bone healing worsened skin condition.",C0439165|C0205210|C0034599|C0262950|C0043240|C0027627|C0012691|C1709707|C0039798|C1707455|G0000000|C0038215|C0444099|C0221198|C0439165|C1709707|C0039798|C1707455|G0000000|C0038215|G0000000|C2607943|C0008976|C0008059|C0001779|G0000000|C0443318|C0205108|C0034627|C0016658|C1522326|C0039003|C0179686|C0242428|C0008059|C1522326|C0443324|C0179686|C0392756|C0205210|C0034599|C0262950|C0043240|C1457868|C0444099|C0012634
The intent-to-treat (ITT) sample included 50 youth with ASD between the ages of 7 and 14 years with a participating parent.,The intent-to-treat (ITT) sample included 50 youth ASD ages 7 14 participating parent.,G0000000|C0162425|G0000000|C0370003|C0332257|C0450371|C0001578|C0003516|C0001779|G0000000|C0450371|C0679823|C0030551
"The physical activity, behavior and mortality of each mice of each group is observed and recorded after 1/2 h, 2 h, 4 h, 8 h, 12 h, 24 h and 48 h. Subjects All the subjects were lactating mothers who were selected after general examination from the medical outdoor patients department of the Institute of Post Graduate Ayurvedic Education and Research at the S. V. S. P. Hospital, Kolkata using the following inclusion criteria: (I) age of mother between 20-40 years; (II) age of infant up to 6 months; (III) having one or more of the following symptoms: deficient lactation, infant’s crying just after feeding, painful sensation in breasts during the time of feeding, loss of appetite in mother or the manifestation of any anxiety disorder which could effect the lactation.","The physical activity, behavior mortality mice observed recorded 1/2 h, 2 h, 4 h, 8 h, 12 h, 24 48 h. Subjects All subjects lactating mothers selected examination medical outdoor patients department Institute Post Graduate Ayurvedic Education Research S. V. S. P. Hospital, Kolkata inclusion criteria: (I) age mother 20-40 years; (II) age infant 6 months; (III) symptoms: deficient lactation, infant’s crying feeding, painful sensation breasts time feeding, loss appetite mother manifestation anxiety disorder lactation.",G0000000|C0031809|C0205177|C0004927|C0026565|C0025914|C1441672|C0034869|G0000000|C0033727|G0000000|C0033727|G0000000|C0033727|G0000000|C0033727|C0450371|C0033727|C0450371|C0450371|C0033727|C0681850|G0000000|C0681850|C2828358|C0026591|C1707391|G0000000|C0199168|G0000000|C0030705|C1704729|C0021622|C0687676|C0588053|G0000000|C0013621|C0035168|C0565930|G0000000|C0565930|C0369773|C0019994|G0000000|C0007637|C0243161|C0021966|C0001779|C0026591|C0450371|C0439234|G0000000|C0001779|C0021270|G0000000|C0439231|C0439070|C0683368|C0011155|C0006147|G0000000|C0010399|C0204695|C0030193|C0036658|C0006141|C0040223|C0204695|C1517945|C0003618|C0026591|C0205319|C0003467|C0012634|C0006147
"This was a prospective, randomized controlled trial taking place over one school year, involving 4 secondary schools for adolescents 11–13 y old and 8 schools for adolescents 14–18 y old in Milan, Italy.","This prospective, randomized controlled trial school year, involving 4 secondary schools adolescents 11–13 8 schools adolescents 14–18 Milan, Italy.",G0000000|C0023981|C0034656|C2587213|C0008976|C0036375|C0439234|C1314939|G0000000|C0027627|C0036375|C0205653|G0000000|G0000000|C0036375|C0205653|G0000000|G0000000|C0022277
"Thirdly, by focusing on nations with at least 100 confirmed cases by July 6, 2009 we may have excluded nations where entry screening was more effective in delaying local transmission, or excluded some nations with fewer resources available for surveillance and confirmation of local cases.","Thirdly, focusing nations 100 confirmed July 6, 2009 excluded nations entry screening effective delaying local transmission, excluded nations fewer resources surveillance confirmation local cases.",C0205437|C0000936|C1555720|C1442061|C0521093|C3829447|G0000000|G0000000|C1554077|C1555720|C1705654|C0220908|C1280519|C0205421|C0205276|C0040722|C1554077|C1555720|C0205388|C0035201|C0220920|C0521091|C0205276|C0868928
"During the 2003 and 2004 malaria transmission seasons, 1200 Gambian children with moderate or severe anaemia (Hb concentration <7 g/dL) were randomised to receive either monthly sulfadoxine-pyrimethamine (SP) or placebo until the end of the malaria transmission season in which they were enrolled, in a double-blind trial.","During 2003 2004 malaria transmission seasons, 1200 Gambian children moderate severe anaemia (Hb concentration <7 g/dL) randomised receive monthly sulfadoxine-pyrimethamine (SP) placebo malaria transmission season enrolled, double-blind trial.",G0000000|G0000000|G0000000|C0024530|C0040722|C0036497|G0000000|C0337833|C0008059|C0205081|C0205082|C0002871|C0019046|C0004268|G0000000|C0439267|G0000000|C1514756|C0332177|C0700599|C0037747|C0032042|C0024530|C0040722|C0036497|G0000000|C0013072|C0008976
"Exclusion criteria were non-European descent, self-reported diabetes, use of neuroleptic drugs, and vegetarianism or veganism.","Exclusion criteria non-European descent, self-reported diabetes, neuroleptic drugs, vegetarianism veganism.",C0680251|C0243161|C1518422|C0205386|C0681906|C0011847|C0040615|C0013227|C0311164|C0344353
What are the most stressful aspects of managing CF?,What stressful aspects managing CF?,G0000000|C0231297|C1547011|C1273870|C0009738
"Eligible patients had pathologically confirmed cutaneous, mucosal, or unknown primary site melanoma, metastatic or unresectable disease, no evidence of CNS metastasis, and no prior treatment with either chemotherapy or MAP kinase pathway–targeted drugs.","Eligible patients pathologically confirmed cutaneous, mucosal, unknown primary site melanoma, metastatic unresectable disease, evidence CNS metastasis, prior treatment chemotherapy MAP kinase pathway–targeted drugs.",C1548635|C0030705|G0000000|C0521093|C0221912|C0026724|C0439673|C0205225|C0205145|C0025202|C0036525|C1519810|C0012634|C3887511|C3714787|C0027627|C0332152|C0039798|C0013216|C0024779|C0031727|G0000000|C0013227
Diabetes was confirmed by a second OGTT test.,Diabetes confirmed OGTT test.,C0011847|C0521093|C0029161|C0022885
The study objectives were to determine the feasibility and effects of providing therapeutic massage at home for patients with metastatic cancer.,The study objectives determine feasibility effects providing therapeutic massage patients metastatic cancer.,G0000000|C0557651|C0018017|G0000000|G0000000|C1280500|C1999230|C0087111|C0024875|C0030705|C0036525|C0006826
"A further 89 subjects were excluded because flagging was considered to be unreliable (n=8), they were no longer NHS patients at the time they joined the cohort (n=79), or they have subsequently undergone a sex change operation (n=2).","A 89 subjects excluded flagging considered unreliable (n=8), NHS patients time joined cohort (n=79), subsequently undergone sex change operation (n=2).",G0000000|C0450371|C0681850|C1554077|C1708067|C0750591|C0749770|C0369718|C0796085|C0030705|C0040223|G0000000|C0599755|C0369718|G0000000|G0000000|C0009253|C0392747|C0543467|C0369718
"This 7-day prospective, double-blind, flexible dose, randomized controlled trial study was conducted from June 2009 to April 2011 at Chiang Mai University Hospital, a tertiary care setting in northern Thailand.","This 7-day prospective, double-blind, flexible dose, randomized controlled trial study conducted June 2009 April 2011 Chiang Mai University Hospital, tertiary care setting northern Thailand.",G0000000|C0332173|C0023981|C0013072|C0443220|C0178602|C0034656|C2587213|C0008976|C0557651|C0004927|C3829443|G0000000|C3715024|G0000000|G0000000|C0026914|C0041740|C0019994|C0205372|C1947933|C0542559|C1709269|C0039725
"Eligible patients were male or female; were ≥40 years of age; had an established clinical history of COPD (in accordance with the American Thoracic Society/European Respiratory Society criteria [18]); were current or former cigarette smokers with a history of cigarette smoking of ≥10 pack-years; had pre- and post-bronchodilator forced expiratory volume in 1 s (FEV1) values of ≤70 % predicted normal; had pre- and post-bronchodilator FEV1/forced vital capacity (FVC) ratios of <0.70; had a score of ≥2 on the modified Medical Research Council Dyspnea Scale; and had a corrected QT (QTc) interval (corrected for the heart rate, according to Fridericia’s formula) of <450 or <480 ms for patients with bundle branch block.","Eligible patients male female; ≥40 age; established clinical history COPD (in American Thoracic Society/European Respiratory Society criteria [18]); current cigarette smokers history cigarette smoking ≥10 pack-years; pre- post-bronchodilator forced expiratory volume 1 (FEV1) values ≤70 % predicted normal; pre- post-bronchodilator FEV1/forced vital capacity (FVC) ratios <0.70; score ≥2 modified Medical Research Council Dyspnea Scale; corrected QT (QTc) interval (corrected heart rate, Fridericia’s formula) <450 <480 ms patients bundle branch block.",C1548635|C0030705|C0086582|C0015780|G0000000|C0001779|C0443211|C0205210|C0019664|C0024117|G0000000|C0596070|G0000000|C0037455|C0521346|C0037455|C0243161|C0450371|C0521116|C0677453|C0337664|C0019664|C0677453|C0037369|G0000000|C1277691|C0332152|C2599594|C0441722|C0231800|C0449468|G0000000|G0000000|C0042295|G0000000|G0000000|C0681842|C0205307|C0332152|C2599594|C0441722|C0442732|C1516240|C3714541|C0456603|C0450371|C0449820|G0000000|C0392747|C0199168|C0035168|C1551807|C0013404|C0175659|C0205202|C1552934|G0000000|C1272706|C0205202|C0018787|C0871208|G0000000|C0489829|C1442061|C1442061|C0039676|C0030705|G0000000|C1253959|C0028778
Other exclusion criteria that were also taken into consideration included the following: a history of severe adverse reaction or known hypersensitivity to maltose and/or silicon dioxide; patients requiring hospitalization; use of any investigational drug and/or participation in any clinical trial within 3 months before entering this study; inability to give a valid written informed consent or to properly follow the protocol.,Other exclusion criteria consideration included following: history severe adverse reaction hypersensitivity maltose and/or silicon dioxide; patients requiring hospitalization; investigational drug and/or participation clinical trial 3 months entering study; inability valid written informed consent properly follow protocol.,G0000000|C0680251|C0243161|C0518609|C0332257|C0231290|C0019664|C0205082|G0000000|C0443286|C0020517|C0024658|G0000000|C0037107|C0678717|C0030705|G0000000|C0019993|C1517586|C0013227|G0000000|C0679823|C0205210|C0008976|G0000000|C0439231|C1522196|C0557651|G0000000|C2349099|C0043266|C1522154|C1511481|G0000000|C0332283|C0442711
Twenty-eight general practices in southern England.,Twenty-eight practices southern England.,C0724000|C0237607|C1710133|C0014282
"Clinical and Molecular Characteristics Abbreviations: AO, anaplastic oligodendroglioma; AOA, anaplastic oligoastrocytoma; KPS, Karnofsky performance status; PCV, procarbazine, lomustine, and vincristine; RT, radiotherapy.","Clinical Molecular Characteristics Abbreviations: AO, anaplastic oligodendroglioma; AOA, anaplastic oligoastrocytoma; KPS, Karnofsky performance status; PCV, procarbazine, lomustine, vincristine; RT, radiotherapy.",C0205210|C1521991|C1521970|C0000723|G0000000|C0205618|C0028945|C1947970|C0205618|C0280793|C0206065|C0206065|C0597198|C0449438|C1882252|C0033223|C0023972|C0042679|C0230425|C0034619
"Prior to the trial, a double-blind acceptability trial of HO-RUTF with 148 Malawian children from 6 months to 5 years of age with SAM was conducted June-August 2013.","Prior trial, double-blind acceptability trial HO-RUTF 148 Malawian children 6 months 5 age SAM conducted June-August 2013.",C0332152|C0008976|C0013072|C0814633|C0008976|C0019905|C1442061|G0000000|C0008059|G0000000|C0439231|G0000000|C0001779|C0036002|C0004927|C3829443|G0000000
500 women with gestational age 12-16 weeks and serum 25 hydroxy vitamin D (25 (OH) D ) less than 30 ng/ml randomly categorized in two groups.,500 women gestational age 12-16 weeks serum 25 hydroxy vitamin D (25 (OH) D ) 30 ng/ml randomly categorized groups.,C1442061|C0043210|C0439671|C0001779|C0450371|C0439230|C0229671|C0450371|C0700307|C0042890|C0073187|C0450371|C0220853|C0073187|G0000000|C0450371|C0439275|G0000000|C0871968|C0441833
SETTING: One hundred and ninety-one adult patients with uncomplicated cough in 22 Scottish practices who would have received antibiotics under the GP's usual practice were randomised to receive either an immediate prescription (92 patients) or a delayed prescription (99 patients).,SETTING: One ninety-one adult patients uncomplicated cough 22 Scottish practices received antibiotics GP's usual practice randomised receive prescription (92 patients) delayed prescription (99 patients).,C0542559|C0205447|C3816959|C0001675|C0030705|C0443334|C0010200|C0450371|C0240966|C0237607|C1514756|C0003232|C3811116|C3538928|C0237607|G0000000|C1514756|C0033080|C0450371|C0030705|C0205421|C0033080|C0450371|C0030705
"Eligible patients were ≥ 18 years of age, had a Karnofsky performance score ≥ 70, and had unresectable advanced or mRCC with a component of clear cell histology and/or sarcomatoid histology not previously treated with any systemic agents for RCC.","Eligible patients ≥ 18 age, Karnofsky performance score ≥ 70, unresectable advanced mRCC component cell histology and/or sarcomatoid histology treated systemic agents RCC.",C1548635|C0030705|G0000000|C0450371|C0001779|C0206065|C0597198|C0449820|G0000000|C0450371|C1519810|C0205179|G0000000|C0449432|C0007634|C0019638|G0000000|C1261473|C0019638|C1522326|C0205373|C0450442|C0279702
"VLBW infants, less than 1,500 g, born at the Penn State Milton S. Hershey Medical Center and admitted to the Penn State Children's Hospital NICU were eligible for the study.","VLBW infants, 1,500 g, born Penn State Milton S. Hershey Medical Center admitted Penn State Children's Hospital NICU eligible study.",C0282666|C0021270|C1442061|C0439267|C0005615|G0000000|C1301808|G0000000|C0565930|G0000000|C0199168|C0205099|C0184666|G0000000|C1301808|C0008059|C0019994|C0021709|C1548635|C0557651
"Septic shock accounts for 4–8 % of pediatric intensive care unit (PICU) admissions (1–3), results in significant morbidity (4;5) and carries a 12 to 25% mortality rate (1–3;6) depending on the setting in which it occurs.","Septic shock accounts 4–8 % pediatric intensive care unit (PICU) admissions (1–3), morbidity (4;5) carries 12 25% mortality rate (1–3;6) depending setting occurs.",C0333534|C0036974|C2741673|G0000000|G0000000|C0030755|C0162425|C1947933|C0439148|C1046445|C0184666|G0000000|C0026538|G0000000|C0206243|C0450371|C0450371|C0026565|C0871208|G0000000|C0725813|C0542559|C1709305
People who were interested in the study contacted the investigator by phone or email.,People study contacted investigator phone email.,C0027361|C0557651|C0332158|C0035173|C1515258|C0013849
The primary outcome of the randomised controlled trial was the establishment of enteral feeding among VLBW infants.,The primary outcome randomised controlled trial establishment enteral feeding VLBW infants.,G0000000|C0205225|C1274040|G0000000|C2587213|C0008976|G0000000|C1304890|C0204695|C0282666|C0021270
"Subject eligibility required waist circumference ≥102 cm for men and ≥89 cm for women and at least two of the following: systolic blood pressure ≥130 or diastolic blood pressure ≥85 mmHg or taking ≥1 antihypertensive agent; fasting blood glucose (FBG) ≥6.1 mmol/L, but <7 mmol/L; fasting triglycerides (TGs) ≥1.68, but ≤8.96 mmol/L; or high-density lipoprotein cholesterol (HDL-C) ≤1 mmol/L for males and ≤1.29 mmol/L for females.","Subject eligibility required waist circumference ≥102 cm ≥89 cm women following: systolic blood pressure ≥130 diastolic blood pressure ≥85 mmHg ≥1 antihypertensive agent; fasting blood glucose (FBG) ≥6.1 mmol/L, <7 mmol/L; fasting triglycerides (TGs) ≥1.68, ≤8.96 mmol/L; high-density lipoprotein cholesterol (HDL-C) ≤1 mmol/L males ≤1.29 mmol/L females.",C0681850|C0013893|C1514873|C0230097|C0332520|G0000000|G0000000|C0043210|C0231290|C0039155|C0005767|C0033095|G0000000|C0012000|C0005767|C0033095|G0000000|G0000000|C0003364|C0450442|C0015663|C0005767|C0017725|G0000000|G0000000|G0000000|C0015663|C0041004|C1156212|G0000000|G0000000|C0205250|C0023820|C0008377|C3715113|G0000000|C0086582|G0000000|C0015780
"Eligible participants were first degree relatives of probands with Crohn’s disease who were aged more than 18 years, did not have a diagnosis of Crohn’s disease or ulcerative colitis, and smoked five or more cigarettes daily.","Eligible participants degree relatives probands Crohn’s disease aged 18 years, diagnosis Crohn’s disease ulcerative colitis, smoked cigarettes daily.",C1548635|C0679646|C0441889|C0080103|C0702111|G0000000|C0012634|C0001779|C0450371|C0439234|C0011900|G0000000|C0012634|C0041582|C0009319|C0037366|C0677453|C0332173
"1-2, modified Ashworth scale) and spasticity (i.e.","1-2, modified Ashworth scale) spasticity (i.e.",G0000000|C0392747|G0000000|C0175659|C0026838|C0683454
"Patients who were found to consume fish, flaxseed oil and foods enriched with n-3 PUFA (eggs, or milk containing n-3 PUFA supplements) during the course of the study were also excluded.","Patients consume fish, flaxseed oil foods enriched n-3 PUFA (eggs, milk n-3 PUFA supplements) study excluded.",C0030705|G0000000|C0016163|C0023753|C0028908|C0016452|C0359583|C0369718|C0032615|C0013710|C0026131|C0369718|C0032615|C0242295|C0557651|C1554077
Participants were excluded if they had experienced a lower extremity injury in the past six months and/or were currently taking chronic or daily doses of anti-inflammatory medication or nutritional supplements [2].,Participants excluded experienced lower extremity injury months and/or chronic daily doses anti-inflammatory medication nutritional supplements [2].,C0679646|C1554077|C0237607|C0441994|C0015385|C3263722|C0439231|G0000000|C0205191|C0332173|C0178602|C0003209|C0013227|C1521739|C0242295|G0000000
The purpose of this study was to pilot test an HIV risk reduction intervention for this at-risk group.,The purpose study pilot test HIV risk reduction intervention at-risk group.,G0000000|C1285529|C0557651|C0473169|C0022885|C0019682|C0035647|C0301630|C0886296|C1444641|C0441833
"Patients were excluded because of a recent (<30 days) relapse, prior immunosuppressant or monoclonal antibody therapy, pregnancy or nursing, other severe disease compromising organ function, progressive MS, history of recent drug or alcohol abuse, use of any additional food supplements, vitamins, or any form of PUFA and a history of severe allergic or anaphylactic reactions or known specific nutritional hypersensitivity.","Patients excluded (<30 days) relapse, prior immunosuppressant monoclonal antibody therapy, pregnancy nursing, severe disease compromising organ function, progressive MS, history drug alcohol abuse, additional food supplements, vitamins, form PUFA history severe allergic anaphylactic reactions specific nutritional hypersensitivity.",C0030705|C1554077|G0000000|C0035020|C0332152|C0021081|C0746619|C0003241|C0039798|C0032961|C0006147|C0205082|C0012634|C2945640|C0178784|C0031843|C0205329|C0039676|C0019664|C0013227|C0001962|C0013146|C1524062|C0016452|C0242295|C0042890|C0348078|C0032615|C0019664|C0205082|C0700624|C0002792|C0443286|C0205369|C1521739|C0020517
"Subjects were offered enrollment if they met the following inclusion and exclusion criteria: (1) age between 21 and 75 years; (2) diagnosis of epilepsy confirmed by a board-certified neurologist with subspecialty training in epilepsy; (3) occurrence of an absence, focal with impaired awareness, or generalized motor seizure within the past 12 months while taking a recommended dose of an approved antiseizure medication; (4) score of >14 on the Centers for Epidemiological Studies Depression Scale (CES-D); (5) diagnosis of current major depressive episode on the Mini International Neuropsychiatric Interview (MINI), and (6) able to read and understand study documents based on investigators’ assessment.","Subjects offered enrollment met inclusion exclusion criteria: (1) age 21 75 years; (2) diagnosis epilepsy confirmed board-certified neurologist subspecialty training epilepsy; (3) occurrence absence, focal impaired awareness, generalized motor seizure 12 months recommended dose approved antiseizure medication; (4) score >14 Centers Epidemiological Studies Depression Scale (CES-D); (5) diagnosis current major depressive episode Mini International Neuropsychiatric Interview (MINI), (6) read understand study documents based investigators’ assessment.",C0681850|C1444648|C1516879|C0268621|C0007637|C0680251|C0243161|G0000000|C0001779|C0450371|C0450371|C0439234|G0000000|C0011900|C0014544|C0521093|C0972401|C0237426|G0000000|C0040607|C0014544|G0000000|C0243132|C0332197|C0205234|C0221099|C0004448|C0205246|C1513492|C0036572|C0450371|C0439231|C0034866|C0178602|C0205540|G0000000|C0013227|G0000000|C0449820|C0450371|C0205099|C0014507|C0947630|C0011570|C0175659|C2699160|G0000000|C0011900|C0521116|C0205082|G0000000|C0332189|C0445542|C1512888|G0000000|C0021822|C0445542|G0000000|C0034754|C0162340|C0557651|C1301746|C1527178|G0000000|C1261322
"Of the women who were enrolled in the study, 560 were randomly assigned to a treatment group (285 to the NRTI group and 275 to the protease-inhibitor group), and 170 were followed observatonally (Fig.","Of women enrolled study, 560 randomly assigned treatment (285 NRTI 275 protease-inhibitor group), 170 observatonally (Fig.",G0000000|C0043210|G0000000|C0557651|C1442061|G0000000|C1516050|C0039798|C1442061|C3537103|C1442061|C0033607|C0441833|C1442061|G0000000|C0349966
"Musculoskeletal pain in pregnant women is often regarded as something that is transient, physiological, and self-limiting, but low back pain (LBP) and pelvic girdle pain (PGP) during pregnancy are associated with an increased risk of suffering these pains in future pregnancies and of the pain becoming chronic [1].","Musculoskeletal pain pregnant women regarded transient, physiological, self-limiting, low pain (LBP) pelvic girdle pain (PGP) pregnancy increased risk suffering pains future pregnancies pain chronic [1].",C0497254|C0030193|C0549206|C0043210|G0000000|C0040704|C0205463|C0036588|C0205251|C0030193|C1505993|C0030797|C0453903|C0030193|C1418520|C0032961|C0205217|C0035647|C0683278|C0030193|C0016884|C0032961|C0030193|C0205191|G0000000
There were no differences between groups in the baseline characteristics of services that did and did not consent to participate in the observations.,There differences baseline characteristics services consent participate observations.,G0000000|C1705241|C0168634|C1521970|C0557854|C1511481|G0000000|C0302523
"People with low back pain for over 3 months and a pain numeric rating scale (PNRS, 0-100) over 30, between the ages of 20 and 65 were included.5,6 Subjects were to mark the PNRS by themselves on a 10 cm ruler that ranged from 0 to 100 where 0 implies 'no pain at all,' and 100 means 'the worst pain imaginable'.5 The exclusion criteria included: acute or subacute low back pain within 3 months, recent low back pain treated within the previous 1 month, history of diabetes or thyroid disease, general disease such as rheumatic disease, pregnancy or breast-feeding, pacemaker or implanted electrical device, suspicious malignancy or thrombosis, scoliosis, vertebral fracture, myopathy, traumatic low back pain, current disc herniation, history of lumbar surgery, neurological problems of the central or peripheral nervous systems.6,7 Twenty-six patients were recruited.","People low pain 3 months pain numeric rating scale (PNRS, 0-100) 30, ages 20 65 included.5,6 Subjects mark PNRS 10 cm ruler ranged 0 100 0 implies 'no pain all,' 100 'the worst pain imaginable'.5 The exclusion criteria included: acute subacute low pain 3 months, low pain treated previous 1 month, history diabetes thyroid disease, disease rheumatic disease, pregnancy breast-feeding, pacemaker implanted electrical device, suspicious malignancy thrombosis, scoliosis, vertebral fracture, myopathy, traumatic low pain, current disc herniation, history lumbar surgery, neurological central peripheral nervous systems.6,7 Twenty-six patients recruited.",C0027361|C0205251|C0030193|G0000000|C0439231|C0030193|C0237753|C0871208|C0175659|C1417832|C1442061|C0450371|C0001779|C0450371|C0450371|C0332257|C0681850|C0522501|C1417832|C0450371|G0000000|C0522637|C1514721|G0000000|C1442061|G0000000|G0000000|G0000000|C0030193|G0000000|C1442061|G0000000|C1522166|C0030193|G0000000|G0000000|C0680251|C0243161|C0332257|C0205178|C0205365|C0205251|C0030193|G0000000|C0439231|C0205251|C0030193|C1522326|C0205156|G0000000|C0332177|C0019664|C0011847|C0040132|C0012634|C0012634|G0000000|C0012634|C0032961|C0006147|C0030163|C0021102|C0013790|C0025080|C0750493|C0006826|C0040053|C0036439|C0549207|C0016658|C0026848|C0332663|C0205251|C0030193|C0521116|C0180459|C0019270|C0019664|C0024090|C0038894|C0205494|C0205099|C0205100|C0027769|C0449913|C0724000|C0030705|G0000000
Written consent was obtained from the next of kin or legal guardians of all participants.,Written consent kin legal guardians participants.,C0043266|C1511481|C1416642|C1301860|C1274041|C0679646
A diagnosis of epilepsy with a history of at least one seizure in the 6 months preceding recruitment into the trial (not considered by those managing the epilepsy to have been a non-epileptic seizure).,A diagnosis epilepsy history seizure 6 months preceding recruitment trial (not considered managing epilepsy non-epileptic seizure).,G0000000|C0011900|C0014544|C0019664|C0036572|G0000000|C0439231|C0332152|C2949735|C0008976|C1518422|C0750591|C1273870|C0014544|C1518422|C0036572
"During the intervention period, 8 participants (21.1%) in the exercise group and 7 (20.6%) in the usual care group dropped out.","During intervention period, 8 participants (21.1%) exercise 7 (20.6%) usual care dropped out.",G0000000|C0886296|C0439531|G0000000|C0679646|C0450371|C0015259|G0000000|C0450371|C3538928|C1947933|C1705648|C0439787
"Patients were considered eligible if they were older than 18 yr, had reached end-stage renal disease and required planned hemodialysis by a catheter for at least 2 wk, had no evidence of active infection, and had discontinued any antibiotic at least 7 d before catheter implantation.","Patients considered eligible 18 yr, reached end-stage renal disease required planned hemodialysis catheter 2 wk, evidence active infection, discontinued antibiotic 7 catheter implantation.",C0030705|C0750591|C1548635|C0450371|C0439234|C2584321|C0205088|C0022646|C0012634|C1514873|C1301732|C0019004|C0085590|G0000000|C0332174|C3887511|C0205177|C0009450|C1444662|C0003232|G0000000|C0085590|C0021107
The study population consisted of 50 children (22 boys and 28 girls) aged 4–9 years each having a mandibular primary molar tooth with a lesion in the furcation area.,The study population consisted 50 children (22 boys 28 girls) aged 4–9 mandibular primary molar tooth lesion furcation area.,G0000000|C0557651|C0032659|C0332529|C0450371|C0008059|C0450371|C0870221|C0450371|C0870604|C0001779|G0000000|C0024687|C0205225|C0026367|C0040426|C0221198|C2825929|C0017446
"The study period included peak flu season, which occurs from October through December [23].","The study period included peak flu season, occurs October December [23].",G0000000|C0557651|C0439531|C0332257|C0444505|C0021400|C0036497|C1709305|C3828732|C3830550|C0450371
"Patients with SCD, genotype Hb SS, SC, or Sβ-thalassemia age 2 years or older admitted for pain who did not already have ACS were eligible for the observation arm of the trial.","Patients SCD, genotype Hb SS, SC, Sβ-thalassemia age 2 admitted pain ACS eligible observation arm trial.",C0030705|G0000000|C0017431|C0019046|C2699257|C0282380|G0000000|C0001779|G0000000|C0184666|C0030193|G0000000|C1548635|C0302523|C0446516|C0008976
"Exclusion criteria were malnutrition as judged by the ratio of weight to height, clinical signs of severe dehydration, clinical signs of coexisting acute systemic illnesses (meningitis, sepsis, pneumonia), immunodeficiency, underlying severe chronic diseases, cystic fibrosis, food allergy or other chronic gastrointestinal diseases, use of probiotics in the previous three weeks, use of antibiotics or any antidiarrhoeal medication in the previous three weeks and during the study, and poor compliance (defined by administration of less than four doses of the study medication).","Exclusion criteria malnutrition judged ratio weight height, clinical signs severe dehydration, clinical signs coexisting acute systemic illnesses (meningitis, sepsis, pneumonia), immunodeficiency, underlying severe chronic diseases, cystic fibrosis, food allergy chronic gastrointestinal diseases, probiotics previous weeks, antibiotics antidiarrhoeal medication previous weeks study, poor compliance (defined administration doses study medication).",C0680251|C0243161|C0162429|C0221191|C0456603|C0005910|C0489786|C0205210|C0220912|C0205082|C0011175|C0205210|C0220912|G0000000|C0205178|C0205373|C0221423|C0025289|C0036690|C0032285|C0021051|G0000000|C0205082|C0205191|C0012634|C0205207|C0016059|C0016452|C0002111|C0205191|C0521362|C0012634|C0525033|C0205156|C0439230|C0003232|C0003292|C0013227|C0205156|C0439230|C0557651|C0032854|C0009563|C1704788|C0001554|C0178602|C0557651|C0013227
We hypothesize that Focused Structural Massage will be more effective than Relaxation Massage.,We hypothesize Focused Structural Massage effective Relaxation Massage.,G0000000|G0000000|C0205234|C0678594|C0024875|C1280519|C0035028|C0024875
"Patients were excluded with severe airflow limitation or more (FEV1 <60%), pregnant or lactating women, any associated chronic respiratory diseases and having major psychiatric illnesses, and current smokers.","Patients excluded severe airflow limitation (FEV1 <60%), pregnant lactating women, chronic respiratory diseases major psychiatric illnesses, current smokers.",C0030705|C1554077|C0205082|C0231999|C0449295|G0000000|C0450371|C0549206|C2828358|C0043210|C0205191|C0521346|C0012634|C0205082|C0205487|C0221423|C0521116|C0337664
"After getting the approval from Institutional (King Fahad Medical City, Riyadh Saudi Arabia) and National ethical review committees (King Abdulaziz City for Science and Technology) and obtaining informed consents from patients for participation in the study in March 2007, consecutive patients with locally advanced cervical cancer, between July 2007 and April 2008, were accrued when they met the following eligibility criteria: 1) histologically proven squamous cell carcinoma, adenocarcinoma or adenosquamous carcinoma of the cervix uteri; 2) clinical and radiologic FIGO stage IIB-IVA, with no other evidence of distant metastasis outside the pelvis; 3) Eastern Cooperative Oncology Group (ECOG) performance status 0–2; 4) negative PALNs on imaging (computed tomography [CT], magnetic resonance imaging [MRI]), or flourodeoxyglucose positron emission tomography (FDG-PET); and 5) normal hematologic, hepatic, and renal functions tests (white blood cell count [WBC] ≥4,000/mm3, absolute neutrophil count [ANC] ≥1,500/mm3, platelets ≥100,000/mm3, total bilirubin ≤1.5 mg/dL, alanine transaminase ≤2 of normal and creatinine ≤1.5 mg/dL).","After approval Institutional (King Fahad Medical City, Riyadh Saudi Arabia) National ethical review committees (King Abdulaziz City Science Technology) obtaining informed consents patients participation study March 2007, consecutive patients locally advanced cervical cancer, July 2007 April 2008, accrued met eligibility criteria: 1) histologically proven squamous cell carcinoma, adenocarcinoma adenosquamous carcinoma cervix uteri; 2) clinical radiologic FIGO stage IIB-IVA, evidence distant metastasis pelvis; 3) Eastern Cooperative Oncology Group (ECOG) performance status 0–2; 4) negative PALNs imaging (computed tomography [CT], magnetic resonance imaging [MRI]), flourodeoxyglucose positron emission tomography (FDG-PET); 5) normal hematologic, hepatic, renal functions tests (white blood cell count [WBC] ≥4,000/mm3, absolute neutrophil count [ANC] ≥1,500/mm3, platelets ≥100,000/mm3, total bilirubin ≤1.5 mg/dL, alanine transaminase ≤2 normal creatinine ≤1.5 mg/dL).",G0000000|C0205540|C0018704|G0000000|G0000000|C0199168|C0008848|G0000000|G0000000|C0003671|C3245503|C0026531|C0282443|C2699414|G0000000|G0000000|C0008848|C0036397|C0039421|C1301820|C1522154|C1511481|C0030705|C0679823|C0557651|C3829202|G0000000|C1707491|C0030705|C1517927|C0205179|C0027530|C0006826|C3829447|G0000000|C3715024|G0000000|G0000000|C0268621|C0013893|C0243161|G0000000|C0205462|C0456369|C1182670|C0007634|C0007097|C0001418|G0000000|C0007097|C0007874|C0042149|G0000000|C0205210|C0034599|C2983134|C0205390|C0268575|C3887511|C0443203|C0027627|C0030797|G0000000|C1707877|C0679729|C0027651|C0441833|C0430797|C0597198|C0449438|G0000000|G0000000|C0205160|G0000000|C0011923|C1441526|C0040395|C0007673|C0024488|C0231881|C0011923|C0024485|G0000000|C0032744|C0233929|C0040395|C0872169|G0000000|C0205307|C0018943|C0205054|C0022646|C0542341|C0022885|C0007457|C0005767|C0007634|C0750480|C0023516|G0000000|C0205344|C0027950|C0750480|C0948762|G0000000|C0005821|G0000000|C0439175|C0005437|G0000000|C0439269|C0001898|C0002594|G0000000|C0205307|C0010294|G0000000|C0439269
CLV = cuff leak volume; ETT = endotracheal tube; NNT = number needed to treat; UAO = upper airway obstruction.,CLV = cuff leak volume; ETT = endotracheal tube; NNT = treat; UAO = upper airway obstruction.,G0000000|G0000000|C0441107|C0332234|C0449468|G0000000|G0000000|C0599554|C0175730|C1417750|G0000000|C0087111|G0000000|G0000000|C1282910|C0178987|C0028778
Eighty-six wards in 21 hospitals in Guangzhou and 38 wards in 5 hospitals in Hong Kong were included in the study.,Eighty-six wards 21 hospitals Guangzhou 38 wards 5 hospitals Hong Kong included study.,C3816958|C1305702|C0450371|C0019994|G0000000|C0450371|C1305702|G0000000|C0019994|G0000000|G0000000|C0332257|C0557651
Few interventions have targeted low socioeconomic status (SES) and minority smokers in primary care settings.,Few interventions targeted low socioeconomic status (SES) minority smokers primary care settings.,C0205388|C0886296|C1521840|C0205251|C0748878|C0449438|G0000000|C0026192|C0337664|C0205225|C1947933|C0542559
"In 214 patients cardiac arrest was not present at arrival of help, and in 108 patients no resuscitation was attempted.","In 214 patients cardiac arrest arrival help, 108 patients resuscitation attempted.",G0000000|C1442061|C0030705|C0018787|C0237477|C1555577|C1269765|C1442061|C0030705|C0035273|C1516084
"Patients taking stable doses of medications for Crohn’s disease were allowed to enroll with the following stipulations: 4 weeks of stable medications prior to screening for aminosalicylates and steroids (prednisone at 10 mg or less daily and budesonide at 3 mg/day), and 12 weeks for thiopurines (azathioprine or 6-mercaptopurine).","Patients stable doses medications Crohn’s disease allowed enroll stipulations: 4 weeks stable medications prior screening aminosalicylates steroids (prednisone 10 daily budesonide 3 mg/day), 12 weeks thiopurines (azathioprine 6-mercaptopurine).",C0030705|C0205360|C0178602|C0013227|G0000000|C0012634|C0683607|G0000000|G0000000|G0000000|C0439230|C0205360|C0013227|C0332152|C0220908|C0368663|C0038317|C0032952|C0450371|C0332173|C0054201|G0000000|C0439422|C0450371|C0439230|C0597573|C0004482|C0000618
This study was done on ASA physical status I-II patients between 18-80 years of age scheduled for forearm surgery at our hospital from February to May of 2010.,This study ASA physical status I-II patients 18-80 age scheduled forearm surgery hospital February May 2010.,G0000000|C0557651|C0004057|C0031809|C0449438|C0021966|C0030705|C0450371|C0001779|C0086960|C0016536|C0038894|C0019994|C3830166|G0000000|G0000000
"Trial participants (n = 324) are patients aged 18 to 70 years who have suboptimally controlled, persistent asthma, BMI between 30.0 and 44.9 kg/m2, and who do not have serious comorbidities (e.g., diabetes, heart disease, stroke).","Trial participants (n = 324) patients aged 18 70 suboptimally controlled, persistent asthma, BMI 30.0 44.9 kg/m2, comorbidities (e.g., diabetes, heart disease, stroke).",C0008976|C0679646|C0369718|G0000000|C1442061|C0030705|C0001779|C0450371|C0450371|G0000000|C2587213|C0205322|C0004096|G0000000|C0450371|C0450371|C0022718|C0009488|G0000000|C0011847|C0018787|C0012634|C0038454
"Double-blind randomized placebo controlled study conducted at Children's Medical Center in Tehran, Iran.","Double-blind randomized placebo controlled study conducted Children's Medical Center Tehran, Iran.",C0013072|C0034656|C0032042|C2587213|C0557651|C0004927|C0008059|C0199168|C0205099|G0000000|C0022065
Another study among HIV-infected women in Malawi found that 27% of women had at least 1 episode of subclinical mastitis in the first year postpartum (4).,Another study HIV-infected women Malawi 27% women 1 episode subclinical mastitis postpartum (4).,G0000000|C0557651|C0019682|C0043210|C0024548|C0450371|C0043210|G0000000|C0332189|C0205211|C0024894|C0086839|G0000000
"Patients were more than 18 years of age, with histologically confirmed, inoperable, locally advanced or recurrent, and/or metastatic adenocarcinoma of the stomach or gastroesophageal junction.","Patients 18 age, histologically confirmed, inoperable, locally advanced recurrent, and/or metastatic adenocarcinoma stomach gastroesophageal junction.",C0030705|C0450371|C0001779|C0205462|C0521093|C0205187|C1517927|C0205179|C2945760|G0000000|C0036525|C0001418|C0038351|C0744316|C0205144
"Ten men, 21 to 49 years of age, were recruited from a community-based sports and recreation wheelchair program.","Ten men, 21 49 age, recruited community-based sports recreation wheelchair program.",C0014518|C0025266|C0450371|C0450371|C0001779|G0000000|C0009462|C0038039|C0034872|C0043143|C1709697
"Patients were excluded if they had cognitive deficits as evaluated by the mini-mental state examination (<24 points), were unable to communicate (<4 points on the Utrechts Communicatie Onderzoek, UCO), or lived more than 30 km from the rehabilitation centre.","Patients excluded cognitive deficits evaluated mini-mental examination (<24 points), unable communicate (<4 Utrechts Communicatie Onderzoek, UCO), lived 30 rehabilitation centre.",C0030705|C1554077|C1516691|C2987487|C0220825|C0445542|G0000000|C0450371|C1552961|C1299582|C0566001|G0000000|G0000000|G0000000|G0000000|G0000000|C1548795|C0450371|C0034991|C0205099
Patients with warts located on the soles of the feet and near nails often had a lot of pain.,Patients warts located soles feet nails lot pain.,C0030705|C1367460|G0000000|C0230463|C0016504|C0027342|C1115660|C0030193
Definitions of PHN vary from as short as 1 month to as long as 6 months after lesion crusting [1].,Definitions PHN vary short 1 month 6 months lesion crusting [1].,C1550452|C0032768|G0000000|C1282927|G0000000|C0332177|G0000000|C0439231|C0221198|C0205204|G0000000
"Other recruitment activities included chest clinic referrals, letter mailings to university clinic patients with a COPD-related diagnosis, announcements at Better Breathers support groups and pulmonary rehabilitation programs, and newspaper advertisements.","Other recruitment activities included chest clinic referrals, letter mailings university clinic patients COPD-related diagnosis, announcements Better Breathers support pulmonary rehabilitation programs, newspaper advertisements.",G0000000|C2949735|C0441655|C0332257|C0817096|C0002424|C0034927|C1096774|C0024492|C0041740|C0002424|C0030705|C0024117|C0011900|G0000000|C0332272|G0000000|C0183683|C0024109|C0034991|C0376691|C0027989|C0949214
"Patients were eligible to participate in the current study if they: (a) had a diagnosis of MS; (b) were at least 18 years old; (c) reported chronic daily pain that was rated as being at least 4/10, on average, on a 0–10 Numerical Rating Scale of intensity; and (d) indicated on the survey that they would be willing to be contacted about possible participation in future research studies.","Patients eligible participate current study they: (a) diagnosis MS; (b) 18 old; (c) reported chronic daily pain rated 4/10, average, 0–10 Numerical Rating Scale intensity; (d) survey contacted participation future studies.",C0030705|C1548635|G0000000|C0521116|C0557651|G0000000|G0000000|C0011900|C0039676|G0000000|C0450371|C0580836|G0000000|C0684224|C0205191|C0332173|C0030193|C0871208|C0450371|C1510992|G0000000|C0237753|C0871208|C0175659|C0522510|C0073187|C0038951|C0332158|C0679823|C0016884|C0947630
"Since incisional hernias at trocar sites are known to be related to the size of the abdominal wall defect, it was concluded that the use of radially expanding needle systems should decrease the incidence of this complication.","Since incisional hernias trocar sites size abdominal wall defect, concluded radially expanding needle systems decrease incidence complication.",C1711239|C0184898|C0019270|C0041158|C0205145|C0456389|C0000726|C0677535|C1457869|C0917903|G0000000|C0205229|C0027551|C0449913|C0392756|C0021149|C0009566
"Patients with advanced prostate cancer are often seen at other departments than the Oncology Department following the diagnosis, but they are considered eligible when they are referred to systemic treatment at the Oncology Department for the first time.","Patients advanced prostate cancer departments Oncology Department diagnosis, considered eligible referred systemic treatment Oncology Department time.",C0030705|C0205179|C0033572|C0006826|C1704729|C0027651|C1704729|C0011900|C0750591|C1548635|C0205543|C0205373|C0039798|C0027651|C1704729|C0040223
"Additionally, subjects with a history of HPV vaccination, monophosphoryl lipid A (MPL) or AS04-adjuvant administration, and those with a history of chronic diseases such as autoimmune diseases or cancer were also excluded from study participation.","Additionally, subjects history HPV vaccination, monophosphoryl lipid A (MPL) AS04-adjuvant administration, history chronic diseases autoimmune diseases cancer excluded study participation.",G0000000|C0681850|C0019664|C0021344|C0042196|G0000000|C0023779|G0000000|C0066776|C0001551|C0001554|C0019664|C0205191|C0012634|C0443146|C0012634|C0006826|C1554077|C0557651|C0679823
Students in grades 1 through 8 were also recruited using passive consent procedures (no identifying information was collected).,Students grades 1 8 recruited passive consent procedures (no identifying collected).,C0038492|C0441800|G0000000|G0000000|G0000000|C3686820|C1511481|C0025664|G0000000|G0000000|C1516695
"These women were identified during baseline examination based on the following question: “are you currently being treated for heart disease, coronary disease, or joint pain that still bothers you in daily life despite the treatment.” Other exclusions included women who were expected to move away within the next six months or would have difficulty attending exercise classes regularly, as well as women who were already taking exercise classes (to determine the true effect of the intervention).","These women identified baseline examination based question: “are treated heart disease, coronary disease, joint pain bothers daily life treatment.” Other exclusions included women expected move months difficulty attending exercise classes regularly, women exercise classes (to determine true intervention).",G0000000|C0043210|C0205396|C0168634|G0000000|C1527178|C1522634|G0000000|C1522326|C0018787|C0012634|C0018787|C0012634|C0022417|C0030193|G0000000|C0332173|C0376558|G0000000|G0000000|C0680251|C0332257|C0043210|C1517001|C0560560|C0439231|C1299586|C1547429|C0015259|C0456387|G0000000|C0043210|C0015259|C0456387|G0000000|G0000000|C0205238|C0886296
"In total, 274 male and female patients, aged 18 to 65 years, were enrolled in the 2 studies; 134 patients participated in Study 1 and 140 participated in Study 2.","In total, 274 male female patients, aged 18 65 years, enrolled 2 studies; 134 patients participated Study 1 140 participated Study 2.",G0000000|C0439175|C1442061|C0086582|C0015780|C0030705|C0001779|C0450371|C0450371|C0439234|G0000000|G0000000|C0947630|C1442061|C0030705|G0000000|C0557651|G0000000|C1442061|G0000000|C0557651|G0000000
"Additional inclusion criteria were age older than 40 years, current or past cigarette smoking history of more than 10 pack-years, ability to speak English, and access to a telephone.","Additional inclusion criteria age 40 years, current cigarette smoking history 10 pack-years, ability speak English, access telephone.",C1524062|C0007637|C0243161|C0001779|C0450371|C0439234|C0521116|C0677453|C0037369|C0019664|C0450371|C1277691|C0085732|C0234856|C0376245|C0444454|C0039457
"All non-pregnant adults (ages 16 to 65 years inclusive) with a traumatic brain injury, who had a score on the Glasgow Coma Scale (GCS) of 12 or less (out of a maximum score of 15) and who had a CT scan showing an intracranial abnormality consistent with trauma, and were within eight hours of their injury, were eligible for trial entry if the responsible doctor considered there was the potential for them to benefit from the trial treatment.","All non-pregnant adults (ages 16 65 inclusive) traumatic brain injury, score Glasgow Coma Scale (GCS) 12 (out maximum score 15) CT scan intracranial abnormality consistent trauma, hours injury, eligible trial entry responsible doctor considered potential benefit trial treatment.",G0000000|C1518422|C0001675|C0001779|C0450371|C0450371|C0332257|C0332663|C0006104|C3263722|C0449820|G0000000|C0009421|C0175659|G0000000|C0450371|C0439787|C0806909|C0449820|C0450371|C0007673|C0034606|C0524466|C1704258|C0332290|C0043251|C0439227|C3263722|C1548635|C0008976|C1705654|C1273518|C0031831|C0750591|C3245505|C0814225|C0008976|C0039798
"One hundred and seven patients with the diagnosis of probable or definite ALS, of less than five years duration from symptom onset, were randomized to either treatment with daily creatine monohydrate (5 g/d) or placebo.","One patients diagnosis probable definite ALS, duration symptom onset, randomized treatment daily creatine monohydrate (5 g/d) placebo.",C0205447|C0030705|C0011900|C0033204|C0439544|G0000000|C0449238|C1457887|C0206132|C0034656|C0039798|C0332173|C0010286|C1572759|G0000000|C0439417|C0032042
"All participants were overweight (body–mass index [BMI] > 25 kg/m2) nonsmoking adults ages 25–75 with abdominal adiposity (waist circumference > 80 cm in females and >100 cm in males).28 Exclusion criteria included contraindication to abdominal computed tomography (CT) scans (weight > 375 pounds, claustrophobia, unstable vital signs, or radiation procedure in past 6 months), diagnosed diabetes, diagnosed eating disorder, uncontrolled hypertension, emphysema, intestinal or stomach disease, kidney disease (serum creatinine > 2), substance abuse, pregnancy, or intention to become pregnant during the study.","All participants overweight (body–mass [BMI] > 25 kg/m2) nonsmoking adults ages 25–75 abdominal adiposity (waist circumference > 80 cm females >100 cm males).28 Exclusion criteria included contraindication abdominal computed tomography (CT) scans (weight > 375 pounds, claustrophobia, unstable vital signs, radiation procedure 6 months), diagnosed diabetes, diagnosed eating disorder, uncontrolled hypertension, emphysema, intestinal stomach disease, kidney disease (serum creatinine > 2), substance abuse, pregnancy, intention pregnant study.",G0000000|C0679646|C0497406|G0000000|G0000000|G0000000|C0001675|C0001779|G0000000|C0000726|C0028754|C0230097|C0332520|G0000000|G0000000|C0015780|G0000000|C0086582|C0680251|C0243161|C0332257|C0522473|C0000726|C1441526|C0040395|C0007673|C0034606|C0005910|G0000000|C1442061|C0439219|C0008909|C0443343|C0442732|C0220912|C0034519|C0184661|G0000000|C0439231|C0011900|C0011847|C0011900|C0013470|C0012634|C0205318|C0020538|C0013990|C0021853|C0038351|C0012634|C0022646|C0012634|C0229671|C0010294|G0000000|G0000000|C0439861|C0013146|C0032961|C0162425|C0549206|C0557651
"Inclusion criteria were BMI ≥25, an age of 20-55 years and had no exercise (they had light physical activity: Doing household tasks, riding in a car, light activity while sitting.).","Inclusion criteria BMI ≥25, age 20-55 exercise (they light physical activity: Doing household tasks, riding car, light activity sitting.).",C0007637|C0243161|G0000000|G0000000|C0001779|C0450371|C0015259|G0000000|C0023693|C0031809|C0205177|G0000000|C0020052|C3540678|G0000000|C0004381|C0023693|C0205177|C0277814
"In this multicentre study, conducted between December 2002 and June 2004, male or female outpatients (18–65 years) who met International Headache Society (IHS) criteria for migraine with or without aura (25) were enrolled by specialist physicians of Headache Centres throughout Italy.","In multicentre study, conducted December 2002 June 2004, male female outpatients (18–65 years) met International Headache Society (IHS) criteria migraine aura (25) enrolled specialist physicians Headache Centres Italy.",G0000000|C0439743|C0557651|C0004927|C3830550|G0000000|C3829443|G0000000|C0086582|C0015780|C0029921|G0000000|C0439234|C0268621|C1512888|C0018681|C0037455|G0000000|C0243161|C0149931|C0236018|C0450371|G0000000|C0087009|C0031831|C0018681|C0205099|C0022277
"Children with severe physical disabilities, diagnosed intellectual disability (IQ < 70) and/or diagnosed autism spectrum disorder were also excluded.","Children severe physical disabilities, diagnosed intellectual disability (IQ < 70) and/or diagnosed autism spectrum disorder excluded.",C0008059|C0205082|C0031809|C0231170|C0011900|G0000000|C0231170|G0000000|G0000000|C0011900|C0004352|C1883073|C0012634|C1554077
Patients with a clinical diagnosis of SZ are referred to research staff by their therapists.,Patients clinical diagnosis SZ referred staff therapists.,C0030705|C0205210|C0011900|C0036572|C0205543|C0851286|C0871525
"Patients were eligible if they had a suspected lower respiratory tract infection with a cough lasting less than four weeks together with one focal and one systemic symptom.39 Patients provided written informed consent after the study had been explained by their general practitioner, and written information was provided.","Patients eligible suspected lower respiratory tract infection cough lasting weeks focal systemic symptom.39 Patients provided written informed consent study explained practitioner, written provided.",C0030705|C1548635|C0332147|C0441994|C0521346|C1185740|C0009450|C0010200|C1517741|C0439230|C0205234|C0205373|C1457887|C0030705|C1999230|C0043266|C1522154|C1511481|C0557651|G0000000|C1709627|C0043266|C1999230
Children 4 to 10 years of age undergoing a scheduled IV needle insertion for a diagnostic medical procedure were included in this study.,Children 4 10 age undergoing scheduled IV needle insertion diagnostic medical procedure included study.,C0008059|G0000000|C0450371|C0001779|G0000000|C0086960|C0022326|C0027551|C0021107|C0011900|C0199168|C0184661|C0332257|C0557651
"Soon after the presumptive diagnosis of sepsis, initial laboratory specimens were obtained within 2 hours, and the patients enrolled in the study were treated with standard therapy used in the treatment of sepsis and septic shock.","Soon presumptive diagnosis sepsis, initial laboratory specimens 2 hours, patients enrolled study treated standard therapy treatment sepsis septic shock.",G0000000|C3640893|C0011900|C0036690|C0205265|C0022877|C0370003|G0000000|C0439227|C0030705|G0000000|C0557651|C1522326|C1442989|C0039798|C0039798|C0036690|C0333534|C0036974
"We recruited Bangladeshi adults with diabetes, cardiovascular disease, respiratory disease or arthritis from general practices and randomised them to the CDSMP or waiting-list control.","We recruited Bangladeshi adults diabetes, cardiovascular disease, respiratory disease arthritis practices randomised CDSMP waiting-list control.",G0000000|G0000000|C0422784|C0001675|C0011847|C0007226|C0012634|C0521346|C0012634|C0003864|C0237607|G0000000|G0000000|C0043010|C0243148
"Eligible children resided in Philadelphia County, spoke either English or Spanish, had a home that was judged to be in a condition enabling remediation (in stable condition), and did not have a history of elevated BLLs.","Eligible children resided Philadelphia County, spoke English Spanish, judged condition enabling remediation (in stable condition), history elevated BLLs.",C1548635|C0008059|C2982691|C0031525|C0079170|G0000000|C0376245|C0086409|C0221191|C0012634|C1171285|G0000000|G0000000|C0205360|C0012634|C0019664|C0205250|G0000000
Approximately 85% of the patients had more than one site of metastasis and over half of the patients received previous gastrectomy.,Approximately 85% patients site metastasis half patients received previous gastrectomy.,C0332232|C0450371|C0030705|C0205145|C0027627|C2825407|C0030705|C1514756|C0205156|C0017118
Patients included in the study ranged in age between 18 and 45 years and had a history of two or more relapses during the course of their illness despite getting treatment.,Patients included study ranged age 18 45 history relapses illness treatment.,C0030705|C0332257|C0557651|C1514721|C0001779|C0450371|C0450371|C0019664|C0035020|C0221423|C0039798
Participants were 40 adult males incarcerated at a suburban jail in the mid Atlantic region of the United States.,Participants 40 adult males incarcerated suburban jail mid Atlantic region United States.,C0679646|C0450371|C0001675|C0086582|C0392751|C0178856|C0033168|C0444598|G0000000|C0017446|C0166872|C1301808
"The final sample was 49.5% male, with an average age of 10.8 years (SD, 0.6 year) at the beginning of grade 5; approximately 77% received federally subsidized school lunches, and 47% lived in 2-parent households.","The final sample 49.5% male, average age 10.8 (SD, 0.6 year) grade 5; 77% received federally subsidized school lunches, 47% lived 2-parent households.",G0000000|C0205088|C0370003|C0450371|C0086582|C1510992|C0001779|C0450371|C2699239|G0000000|C0439234|C0441800|G0000000|C0450371|C1514756|G0000000|G0000000|C0036375|C2697949|C0450371|C1548795|C0030551|C0020052
"The information collected was used to achieve balance with respect to key prognostic factors using minimisation on the basis of the following variables: sex, age (16 to ≤40; >40 to ≤50; >50 to ≤65), time since injury: (≤1 h, >1 to ≤3 h, >3 to ≤8 h); GCS: 3 to 5; 6 to 8; 9 to 12; and pupil reactivity (both, one or none).","The collected achieve balance respect key prognostic factors minimisation basis variables: sex, age (16 ≤40; >40 ≤50; >50 ≤65), time injury: (≤1 h, >1 ≤3 h, >3 ≤8 h); GCS: 3 5; 6 8; 9 12; pupil reactivity (both, none).",G0000000|C1516695|G0000000|C0014653|C0679133|G0000000|C0220901|C1521761|G0000000|C1527178|C0439828|C0009253|C0001779|C0450371|G0000000|C0450371|G0000000|C0450371|G0000000|C0040223|C3263722|G0000000|C0033727|G0000000|G0000000|C0033727|G0000000|G0000000|C0033727|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|C0450371|C0034121|C0443286|G0000000|G0000000
"Between July 2009 and February 2010 we selected hospitalized patients with influenza syndrome, acute respiratory infection, septic shock or multiple organ failure in whom influenza virus A (H1N1) 2009 infection was confirmed by real-time reverse-transcription PCR (RT-PCR) from nasopharyngeal swabs; haemagglutinin (HA) sequencing was performed.","Between July 2009 February 2010 selected hospitalized patients influenza syndrome, acute respiratory infection, septic shock multiple organ failure influenza virus A (H1N1) 2009 infection confirmed real-time reverse-transcription PCR (RT-PCR) nasopharyngeal swabs; haemagglutinin (HA) sequencing performed.",G0000000|C3829447|G0000000|C3830166|G0000000|C1707391|C0701159|C0030705|C0021400|C0039082|C0205178|C0521346|C0009450|C0333534|C0036974|C0439064|C0178784|C0231174|C0021400|C0042776|G0000000|G0000000|G0000000|C0009450|C0521093|C1550177|C0035380|C0032520|C0599161|C0027442|C0183753|C0018909|C0018510|C1294197|C0884358
"Individuals were excluded if: 1) previously received CPAP therapy; 2) suffering with chronic obstructive pulmonary disease, asthma, or neurological problems.","Individuals excluded if: 1) received CPAP therapy; 2) suffering chronic obstructive pulmonary disease, asthma, neurological problems.",C0027361|C1554077|G0000000|G0000000|C1514756|C0199451|C0039798|G0000000|C0683278|C0205191|C0549186|C0024109|C0012634|C0004096|C0205494|C1546466
Partial hepatectomy is often contraindicated because of the patient's compromised liver function and associated comorbidities.,Partial hepatectomy contraindicated patient's compromised liver function comorbidities.,C0728938|C0019144|C1444657|C0030705|C2945640|C0023884|C0031843|C0009488
The aim of this small pilot trial was to gain preliminary data to determine the effect of yoga on women with stage one breast cancer-related lymphoedema (BCRL).,The aim pilot trial gain preliminary data determine yoga women stage breast cancer-related lymphoedema (BCRL).,G0000000|C1947946|C0473169|C0008976|C1517378|C0439611|C1511726|G0000000|C0043418|C0043210|C0205390|C0006141|C2826292|C0024236|G0000000
The inclusion criteria were (a) history of CLBP of more than three months (b) pain in lumbar spine with or without radiation to legs and (c) age between 18 to 60 years.,The inclusion criteria (a) history CLBP months (b) pain lumbar spine radiation legs (c) age 18 60 years.,G0000000|C0007637|C0243161|G0000000|C0019664|G0000000|C0439231|G0000000|C0030193|C0024090|C0037949|C0034519|C1140621|G0000000|C0001779|C0450371|C0450371|C0439234
"Inclusion criteria were: a) stable COPD; b) pulmonary function results show moderate to severe disease according to GOLD criteria (forced expiratory volume in one second <70% and [FEV1]/forced vital capacity [FVC] FEV1 <80%); c) no plans to participate in a maintenance program; d) patients receiving supplemental oxygen were acceptable saturation was maintained at >88% on <6 L/min if their O2 of nasal oxygen during the six minute walk (6MW) test; e) age ≥ 40 years; f) ability to speak, read, and write English; and g) permission from health provider.","Inclusion criteria were: a) stable COPD; b) pulmonary function moderate severe disease GOLD criteria (forced expiratory volume <70% [FEV1]/forced vital capacity [FVC] FEV1 <80%); c) plans participate maintenance program; d) patients receiving supplemental oxygen acceptable saturation maintained >88% <6 L/min O2 nasal oxygen minute walk (6MW) test; e) age ≥ 40 years; f) ability speak, read, write English; g) permission health provider.",C0007637|C0243161|G0000000|G0000000|C0205360|C0024117|G0000000|C0024109|C0031843|C0205081|C0205082|C0012634|C0018026|C0243161|C0441722|C0231800|C0449468|C0450371|C0441722|C0442732|C1516240|C3714541|G0000000|C0450371|G0000000|C0270724|G0000000|C0024501|C1709697|C0073187|C0030705|C1514756|C2348609|C0030054|C1879533|C0522534|C1314677|C0450371|G0000000|C0439393|C0300971|C0028429|C0030054|C0439232|C0080331|C0026080|C0022885|G0000000|C0001779|G0000000|C0450371|C0439234|C0016327|C0085732|C0234856|C0034754|C0043266|C0376245|C0439267|C0521104|C0018684|C1138603
Participants are 80 patients 70 years or over with acute hip fracture undergoing operative repair.,Participants 80 patients 70 acute hip fracture undergoing operative repair.,C0679646|C0450371|C0030705|C0450371|C0205178|C0019552|C0016658|G0000000|C1882154|C0043240
It has been argued that some patients do not consider OSA as a serious health problem [8].,It argued patients OSA health [8].,G0000000|G0000000|C0030705|C0520679|C0018684|G0000000
"The ATTAX3 study was available for adult patients with histologically proven metastatic or locally recurrent cancer of the oesophagus, oesophagogastric junction or stomach (squamous, adenocarcinoma or undifferentiated histology), who had received no prior therapy other than neoadjuvant or adjuvant treatment completed at least 12 months earlier or palliative radiotherapy completed at least 14 days before enrolment.","The ATTAX3 study adult patients histologically proven metastatic locally recurrent cancer oesophagus, oesophagogastric junction stomach (squamous, adenocarcinoma undifferentiated histology), received prior therapy neoadjuvant adjuvant treatment completed 12 months earlier palliative radiotherapy completed 14 days enrolment.",G0000000|G0000000|C0557651|C0001675|C0030705|C0205462|C0456369|C0036525|C1517927|C2945760|C0006826|C0014876|C0475468|C0205144|C0038351|C1182670|C0001418|C0205618|C0019638|C1514756|C0332152|C0039798|C0600558|C0001551|C0039798|C0205197|C0450371|C0439231|C1279919|C0587605|C0034619|C0205197|C0450371|C0439228|C1516879
Methods: Patients with bronchiectasis and chronic P. aeruginosa infection were enrolled within 21 days of completing a course of antipseudomonal antibiotics for an exacerbation.,Methods: Patients bronchiectasis chronic P. aeruginosa infection enrolled 21 days completing antipseudomonal antibiotics exacerbation.,C0025663|C0030705|C0006267|C0205191|C0369773|G0000000|C0009450|G0000000|C0450371|C0439228|C0205197|G0000000|C0003232|G0000000
"The intervention itself was fully implemented from May 2004 until February 2005, with a pre- and post-intervention survey conducted in February to May 2004 and February to May 2005, respectively.","The intervention implemented May 2004 February 2005, pre- post-intervention survey conducted February May 2004 February May 2005, respectively.",G0000000|C0886296|G0000000|G0000000|G0000000|C3830166|G0000000|C0332152|C2347647|C0038951|C0004927|C3830166|G0000000|G0000000|C3830166|G0000000|G0000000|G0000000
Nine highly-trained male Water Polo players were recruited from the Western Australian Institute of Sport (WAIS) Water Polo squad.,Nine highly-trained male Water Polo players recruited Western Australian Institute Sport (WAIS) Water Polo squad.,C0205455|C0205250|C0086582|C0043047|G0000000|G0000000|G0000000|C1705493|C0238711|C0021622|C0038039|C0204456|C0043047|G0000000|C1530297
Vitamin C supplement is recommended to beadministered for pregnant women with the history of PPROM during pregnancy to prevent PPROM.,Vitamin C supplement recommended beadministered pregnant women history PPROM pregnancy prevent PPROM.,C0042890|G0000000|C0242295|C0034866|G0000000|C0549206|C0043210|C0019664|C0729264|C0032961|C0309872|C0729264
"Patients with an American Society of Anesthesiologists’ physical status (ASA-PS) value of 3 and above, pre-existing lung disease, tumor in the portal vein or inferior vena cava, requirement of bile duct or gastrointestinal tract repair, or requirement of additional surgical procedures other than hepatectomy were excluded.","Patients American Society Anesthesiologists’ physical status (ASA-PS) 3 above, pre-existing lung disease, tumor portal vein inferior vena cava, requirement bile duct gastrointestinal tract repair, requirement additional surgical procedures hepatectomy excluded.",C0030705|C0596070|C0037455|G0000000|C0031809|C0449438|C0647347|G0000000|C1282910|C2347662|C0024109|C0012634|C0027651|C0205054|C0042449|C0542339|C0447122|C0521083|C1514873|C0005388|C0687028|C0521362|C1185740|C0043240|C1514873|C1524062|C0543467|C0025664|C0019144|C1554077
"Overall, 44% (31 out of 70) of tumours were aneuploid.","Overall, 44% (31 70) tumours aneuploid.",C0282416|C0450371|C0450371|C0450371|C0027651|C0002938
"This trial enrolled premenopausal women age 18 to 55 years who had regular menstrual cycles of 21- to 35-days duration and pathologic stages I to II breast cancer, in whom all gross disease—including ductal carcinoma in situ—was surgically removed either in a one-stage or two-stage procedure.","This trial enrolled premenopausal women age 18 55 regular menstrual cycles 21- 35-days duration pathologic stages I II breast cancer, gross disease—including ductal carcinoma situ—was surgically removed one-stage two-stage procedure.",G0000000|C0008976|G0000000|C0279752|C0043210|C0001779|C0450371|C0450371|C0205272|C0025344|C1511572|C0450371|C0450371|C0449238|C1521733|C1306673|C0021966|G0000000|C0006141|C0006826|C0439806|G0000000|C1512083|C0007097|G0000000|C0543467|C0849355|C0205447|C0205448|C0184661
"The mean age among patients aged 65 years or older was 78.8 (SD, 8.4) years and among patients younger than 65 years was 47.9 (SD, 11.9) years.","The age patients aged 65 78.8 (SD, 8.4) patients 65 47.9 (SD, 11.9) years.",G0000000|C0001779|C0030705|C0001779|C0450371|C0450371|C2699239|G0000000|C0030705|C0450371|C0450371|C2699239|C0450371|C0439234
"To minimize disappointment (and possibly losses to follow-up), participants assigned to UC will receive $50.","To minimize disappointment (and losses follow-up), participants assigned UC receive $50.",C0040363|G0000000|C0870427|G0000000|C1517945|C0589120|C0679646|C1516050|G0000000|C1514756|C0450371
"A severe case of p(H1N1) infection was defined as a case with at least one of the following symptoms: high fever more than 3 days; purulent blood-stained sputum or chest pain; dyspnoea or cyanotic lips; alerted mental (unresponsive, lethargy, restlessness or eclampsia); severe vomiting, diarrhoea and dehydration; pneumonia by imaging examination; quick increase of cardiac enzyme, such as creatine kinase, creatine kinase isozymes; respiratory failure; infective toxic shock; multiple organ dysfunction syndrome; admission to intensive care unit.","A severe p(H1N1) infection defined symptoms: fever 3 days; purulent blood-stained sputum chest pain; dyspnoea cyanotic lips; alerted mental (unresponsive, lethargy, restlessness eclampsia); severe vomiting, diarrhoea dehydration; pneumonia imaging examination; quick increase cardiac enzyme, creatine kinase, creatine kinase isozymes; respiratory failure; infective toxic shock; multiple organ dysfunction syndrome; admission intensive care unit.",G0000000|C0205082|C0369773|C0009450|C1704788|C0683368|C0015967|G0000000|C0439665|C0005835|C0038056|C0817096|C0030193|C0013404|C0332580|C0023759|C0239110|C0229992|C0205269|C0023380|C0085631|C0013537|C0205082|C0042963|C0011991|C0011175|C0032285|C0011923|G0000000|C0456962|C0442805|C0018787|C0014442|C0010286|C0031727|C0010286|C0031727|C0022173|C0521346|C0231174|G0000000|C0600688|C0036974|C0439064|C0178784|C0031847|C0039082|C0184666|C0162425|C1947933|C0439148
"Exclusion criteria included: twin pregnancy, risk of premature birth, heart or kidney diseases affecting the mother, placenta previa, history of ante-partum haemorrhage, intrauterine growth restriction, hypertensive disease, isoimmunisation, previous uterine operations, uterine anomaly, pre-labour rupture of the membranes, multiple pregnancy, fetal congenital abnormality, contraindication to vaginal delivery and fetal death in utero.","Exclusion criteria included: twin pregnancy, risk premature birth, heart kidney diseases mother, placenta previa, history ante-partum haemorrhage, intrauterine growth restriction, hypertensive disease, isoimmunisation, previous uterine operations, uterine anomaly, pre-labour rupture membranes, multiple pregnancy, fetal congenital abnormality, contraindication vaginal delivery fetal death utero.",C0680251|C0243161|C0332257|C0041427|C0032961|C0035647|C0151526|C0005615|C0018787|C0022646|C0012634|C0026591|C0032043|G0000000|C0019664|C0456336|C0019080|C0694756|C0018270|C0443288|C0857121|C0012634|C0302020|C0205156|C0042149|C0038895|C0042149|C0332447|C0332152|C1881712|C0025255|C0439064|C0032961|C0015965|C0009678|C1704258|C0522473|C0042232|C0011209|C0015965|C0011065|C0042149
Stroke survivors demonstrate poor activity tolerance [28] and performance [29].,Stroke survivors demonstrate poor activity tolerance [28] performance [29].,C0038454|C0206194|G0000000|C0032854|C0205177|C0013220|C0450371|C0597198|C0450371
As the training is not mandatory it might be that more motivated physicians and those more interested in communication issues will participate.,As training mandatory motivated physicians communication issues participate.,G0000000|C0040607|C1514873|G0000000|C0031831|C0009452|C0033213|G0000000
"All patients had to be ineligible (unfit) for cisplatin-based chemotherapy, defined by either a WHO PS 2 and/or an impaired renal function (GFR > 30 but < 60 mL/min).","All patients ineligible (unfit) cisplatin-based chemotherapy, defined WHO PS 2 and/or impaired renal function (GFR > 30 < 60 mL/min).",G0000000|C0030705|C1512714|G0000000|C0008838|C0013216|C1704788|G0000000|C0242397|G0000000|G0000000|C0221099|C0022646|C0031843|C0017654|G0000000|C0450371|G0000000|C0450371|C0439445
"A randomized, double-blind, placebo-controlled study was conducted in 44 subjects with HIV-1 RNA > 5,000 copies/mL, CD4+ cells > 300/μL, no antiretroviral therapy for ≥12 weeks, and only R5 HIV-1 detectable.","A randomized, double-blind, placebo-controlled study conducted 44 subjects HIV-1 RNA > 5,000 copies/mL, CD4+ cells > 300/μL, antiretroviral therapy ≥12 weeks, R5 HIV-1 detectable.",G0000000|C0034656|C0013072|C1706408|C0557651|C0004927|C0450371|C0681850|C0019682|C0035668|G0000000|C1442061|C1531853|C0285590|C0007634|G0000000|G0000000|G0000000|C0039798|G0000000|C0439230|C1425688|C0019682|C3830527
"In this study we used Streitberger needles 23, a validated sham acupuncture device.","In study Streitberger needles 23, validated sham acupuncture device.",G0000000|C0557651|G0000000|C0027551|C0450371|G0000000|C0068899|C0001299|C0025080
"In second group, 3 patients (15.8%), because of refuting reference, and one case (5.3%), because of rising of serum zinc level, were excluded from the study.","In group, 3 patients (15.8%), refuting reference, (5.3%), rising serum zinc level, excluded study.",G0000000|C0441833|G0000000|C0030705|C0450371|G0000000|C1514811|G0000000|G0000000|C0229671|C0043481|C0441889|C1554077|C0557651
"All participants then completed a baseline assessment battery, which consisted of paper-and-pencil neuropsychological instruments and computerized cognitive instruments.","All participants completed baseline assessment battery, consisted paper-and-pencil neuropsychological instruments computerized cognitive instruments.",G0000000|C0679646|C0205197|C0168634|C1261322|C0337088|C0332529|C0030351|G0000000|C0348000|G0000000|C1516691|C0348000
"Two patients were ineligible because they did not have NSCLC, and five were because they did not have stage IB disease.","Two patients ineligible NSCLC, stage IB disease.",C0205448|C0030705|C1512714|C0007131|C0205390|C2744579|C0012634
"The inclusion criteria are: Adults (≥18 years); Recent (<1 month) acute ischaemic, haemorrhagic or undifferentiated stroke; Residual disability (requiring help from another person for everyday activities); Expected to survive to discharge from hospital, with a reasonable expectation of 6 month survival (i.e.","The inclusion criteria are: Adults (≥18 years); Recent (<1 month) acute ischaemic, haemorrhagic undifferentiated stroke; Residual disability (requiring person everyday activities); Expected survive discharge hospital, reasonable expectation 6 month survival (i.e.",G0000000|C0007637|C0243161|G0000000|C0001675|G0000000|C0439234|C0332185|G0000000|C0332177|C0205178|C0475224|C0333275|C0205618|C0038454|C1609982|C0231170|G0000000|C0027361|C0332173|C0441655|C1517001|C0310255|C0012621|C0019994|G0000000|C0679138|G0000000|C0332177|C0038952|C0683454
We modelled as random effects variation between practices and variation between patients (nested within practices).,We modelled random effects variation practices variation patients (nested practices).,G0000000|C3161035|C0034656|C1280500|C0205419|C0237607|C0205419|C0030705|G0000000|C0237607
Shortening of median duration of sore throat (days).,Shortening median duration sore throat (days).,C0441636|C0549183|C0449238|C0234233|C0031354|C0439228
"Patients were excluded because of a recent (<30 days) relapse, prior immunosuppressant or monoclonal antibody therapy, pregnancy or nursing, other severe disease compromising organ function, progressive MS, history of recent drug or alcohol abuse, use of any additional food supplements, vitamins or any form of polyunsaturated fatty acids, and a history of severe allergic or anaphylactic reactions or known specific nutritional hypersensitivity.","Patients excluded (<30 days) relapse, prior immunosuppressant monoclonal antibody therapy, pregnancy nursing, severe disease compromising organ function, progressive MS, history drug alcohol abuse, additional food supplements, vitamins form polyunsaturated fatty acids, history severe allergic anaphylactic reactions specific nutritional hypersensitivity.",C0030705|C1554077|G0000000|C0035020|C0332152|C0021081|C0746619|C0003241|C0039798|C0032961|C0006147|C0205082|C0012634|C2945640|C0178784|C0031843|C0205329|C0039676|C0019664|C0013227|C0001962|C0013146|C1524062|C0016452|C0242295|C0042890|C0348078|G0000000|G0000000|C0001128|C0019664|C0205082|C0700624|C0002792|C0443286|C0205369|C1521739|C0020517
"Participants were at 27–32 weeks’ gestation at the time of randomisation, could read and understand English, were not on medication for hypertension or psychological illness, and were not planning an elective caesarean section.","Participants 27–32 weeks’ gestation time randomisation, read understand English, medication hypertension psychological illness, planning elective caesarean section.",C0679646|G0000000|G0000000|C0032961|C0040223|C0034656|C0034754|C0162340|C0376245|C0013227|C0020538|C0205486|C0221423|C0032074|C0206058|C3841297|C0152060
"CA, cavernous angioma; AVM, arteriovenous malformation; f, female; m, male; nc, not classifiable.","CA, cavernous angioma; AVM, arteriovenous malformation; f, female; m, male; nc, classifiable.",C3887642|C0205201|C0018916|C0003857|C0450109|C0000768|C0016327|C0015780|C0369637|C0086582|C0027964|G0000000
"For migraines and for migraine days, the same treatment group differences were statistically significant in the two sensitivity analyses and in the intention to treat analyses at both month 10 and month 16.","For migraines migraine days, treatment differences statistically sensitivity analyses intention treat analyses month 10 month 16.",G0000000|C0149931|C0149931|C0439228|C0039798|C1705241|C0038215|C0020517|C0002778|C0162425|C0087111|C0002778|C0332177|C0450371|C0332177|C0450371
"During the course of the study, the eMM system will be accessible via any computer in the hospital allocated for inpatient clinical care, but will not be available for patients in the ICUs, theatres or outpatients.","During study, eMM system accessible computer hospital allocated inpatient clinical care, patients ICUs, theatres outpatients.",G0000000|C0557651|G0000000|C0449913|C0814423|C0009622|C0019994|G0000000|C0021562|C0205210|C1947933|C0030705|C0021708|C0475307|C0029921
"If these patients are considered smokers, the smoking prevalence of hospital admissions increases to 15.3%.","If patients considered smokers, smoking prevalence hospital admissions increases 15.3%.",G0000000|C0030705|C0750591|C0337664|C0037369|C0033105|C0019994|C0184666|C0205217|C0450371
Patients diagnosed with colorectal cancer were recruited from out-patient clinic and haematological parameters assessed.,Patients diagnosed colorectal cancer recruited out-patient clinic haematological parameters assessed.,C0030705|C0011900|C0555952|C0006826|G0000000|C0029921|C0002424|C0018943|C0449381|C1516048
Randomization was stratified by number of prior lines of therapy and International Staging System (ISS)6 disease stage.,Randomization stratified prior lines therapy International Staging System (ISS)6 disease stage.,C0034656|C0205363|C0332152|C0205132|C0039798|C1512888|C0332305|C0449913|C1845118|C0012634|C0205390
Preterm children with a gestational age less than 34 weeks meeting the inclusion criteria who cannot be breastfed will be included.,Preterm children gestational age 34 weeks meeting inclusion criteria breastfed included.,C0151526|C0008059|C0439671|C0001779|C0450371|C0439230|C0556656|C0007637|C0243161|C0006147|C0332257
Patients of age 4–12 years with displaced fracture of the distal third of the forearm reporting to the emergency or outpatient departments of our hospital from 1st June 2007 to 31st May 2008 were enrolled in the study.,Patients age 4–12 displaced fracture distal forearm reporting emergency outpatient departments hospital 1st June 2007 31st May 2008 enrolled study.,C0030705|C0001779|G0000000|C0012727|C0016658|C0205108|C0016536|C0700287|C0013956|C0029921|C1704729|C0019994|G0000000|C3829443|G0000000|G0000000|G0000000|G0000000|G0000000|C0557651
Inclusion criteria were: 1) apneas plus hypopneas >15/hour; 2) daytime sleepiness; 3) two major symptoms of the syndrome; 4) lived within 100 miles from Zhejiang.,Inclusion criteria were: 1) apneas hypopneas >15/hour; 2) daytime sleepiness; 3) major symptoms syndrome; 4) lived 100 miles Zhejiang.,C0007637|C0243161|G0000000|G0000000|C0003578|C0235546|C0450371|G0000000|C0332169|C0013144|G0000000|C0205082|C0683368|C0039082|G0000000|C1548795|C1442061|C0331865|G0000000
"The exclusion criteria are: planning pregnancy in next 6 months; current use of lipid-lowering agents (any interfering drug or diet); secondary causes of dyslipidaemia (renal or liver disease, diabetes, hypothyroidism, familial hyperlipidaemia); known nut allergy; unstable psychiatric disorder (including eating disorders); current participation in a weight loss programme or other dietary intervention; and inability to understand printed materials.","The exclusion criteria are: planning pregnancy 6 months; current lipid-lowering agents (any interfering drug diet); secondary dyslipidaemia (renal liver disease, diabetes, hypothyroidism, familial hyperlipidaemia); nut allergy; unstable psychiatric disorder (including eating disorders); current participation weight loss programme dietary intervention; inability understand printed materials.",G0000000|C0680251|C0243161|G0000000|C0032074|C0032961|G0000000|C0521116|C0023779|C0450442|G0000000|C0521102|C0013227|C0012155|C0027627|C0242339|C0022646|C0023884|C0012634|C0011847|C0020676|C0015576|C0020473|C0028723|C0002111|C0443343|C0205487|C0012634|C0332257|C0013470|C0012634|C0521116|C0679823|C0005910|C1517945|C1709697|C0012155|C0886296|G0000000|C0162340|C0033161|C0520510
"Since patients had to be willing to be looked after at home, both patients' and carers' perceptions of the benefits of HaH care were reinforced by their experience.","Since patients looked home, patients' carers' perceptions benefits HaH care reinforced experience.",C1711239|C0030705|C0233426|C0442519|C0030705|C0085537|C0030971|C0814225|G0000000|C1947933|G0000000|C0237607
"Table 1 describes the characteristics of the NO-treated and-placebo treated groups, which were balanced in terms of age, gender, genotype, hydroxyurea use, vital signs, pain scores, and laboratory values.","Table 1 describes characteristics NO-treated and-placebo treated groups, balanced terms age, gender, genotype, hydroxyurea use, vital signs, pain scores, laboratory values.",C0039224|G0000000|G0000000|C1521970|C0028128|C0032042|C1522326|C0441833|C0205415|C0233324|C0001779|C0079399|C0017431|C0020402|C0042153|C0442732|C0220912|C0030193|C0449820|C0022877|C0042295
Average (6-month to 4-year) red blood cell DHA levels were 4-fold higher in the DHA group than in the placebo group (P < .001).,Average (6-month 4-year) red blood cell DHA levels 4-fold DHA placebo (P < .001).,C1510992|C0332177|C0439234|C0332575|C0005767|C0007634|C0142831|C0441889|C0332462|C0142831|C0032042|C0369773|G0000000|C1442061
"Individuals were excluded if they had severe dysphasia, significant cognitive deficits (Mini-Mental State Examination < 20 [31]), other medical conditions (e.g.","Individuals excluded severe dysphasia, cognitive deficits (Mini-Mental State Examination < 20 [31]), medical conditions (e.g.",C0027361|C1554077|C0205082|C0973461|C1516691|C2987487|C0445542|C1301808|G0000000|C0450371|C0199168|C0012634|G0000000
"By starting the intervention within 6 weeks post-diagnosis, we made sure that all patients participated in the 18-week exercise program during (part of their) chemotherapy.","By starting intervention 6 weeks post-diagnosis, patients participated 18-week exercise program (part their) chemotherapy.",G0000000|C0439659|C0886296|G0000000|C0439230|C0687676|C0030705|G0000000|C0450371|C0015259|C1709697|C0449719|G0000000|C0013216
Exclusion criteria were: 1) seizures during the previous 36-months; 2) sensitive scalp; 3) previous brain surgery; and 4) medications that raise the seizure threshold.,Exclusion criteria were: 1) seizures previous 36-months; 2) sensitive scalp; 3) previous brain surgery; 4) medications raise seizure threshold.,C0680251|C0243161|G0000000|G0000000|C0036572|C0205156|C0450371|G0000000|C0020517|C0036270|G0000000|C0205156|C0006104|C0038894|G0000000|C0013227|G0000000|C0036572|C0449864
"Additional inclusion criteria included age between ≥ 18 and ≤ 75; Zubrod performance status < 2; adequate hematologic, liver and renal function; adequate cardiac function (defined as no clinically significant electrocardiogram abnormality, unstable atrial or ventricular arrhythmias requiring medical control, or ischemic event experienced within the prior 6 months); negative pregnancy test in females of childbearing potential within 7 days prior to first dose of study medication; use of effective contraceptive method while on the trial; and written informed consent for participation.","Additional inclusion criteria included age ≥ 18 ≤ 75; Zubrod performance status < 2; adequate hematologic, liver renal function; adequate cardiac function (defined clinically electrocardiogram abnormality, unstable atrial ventricular arrhythmias requiring medical control, ischemic event experienced prior 6 months); negative pregnancy test females childbearing potential 7 days prior dose study medication; effective contraceptive method trial; written informed consent participation.",C1524062|C0007637|C0243161|C0332257|C0001779|G0000000|C0450371|G0000000|C0450371|C3714786|C0597198|C0449438|G0000000|G0000000|C0205410|C0018943|C0023884|C0022646|C0031843|C0205410|C0018787|C0031843|C1704788|G0000000|C0013798|C1704258|C0443343|C0018792|C0018827|C0003811|G0000000|C0199168|C0243148|C0475224|C0441471|C0237607|C0332152|G0000000|C0439231|C0205160|C0032961|C0022885|C0015780|G0000000|C3245505|G0000000|C0439228|C0332152|C0178602|C0557651|C0013227|C1280519|C0009871|C0025663|C0008976|C0043266|C1522154|C1511481|C0679823
"""Best care"" in general practice (the ""comparator"" treatment) – General practice teams were trained in ""active management"" and provided patients with The Back Book.","""Best care"" practice (the ""comparator"" treatment) – General practice teams trained ""active management"" provided patients The Back Book.",C1522427|C1947933|C0237607|G0000000|C1707454|C0039798|G0000000|C0205246|C0237607|C0871489|C0336809|C0205177|C0001554|C1999230|C0030705|G0000000|C0004600|C0006002
"Inclusion criteria were as follows: 35 to 85 years old with Parkinson’s disease by research criteria; sleep maintenance insomnia (at least 3 of 7 nights of at least 2 awakenings nightly, or a total sleep time of < 6.5 hours) or sleep latency insomnia (at least 3 of 7 nights of sleep latency > 30 minutes), as well as clinically significant daytime distress or impairment (related to insomnia) during the 2 week self assessment prior to baseline.","Inclusion criteria follows: 35 85 Parkinson’s disease criteria; sleep maintenance insomnia (at 3 7 nights 2 awakenings nightly, total sleep time < 6.5 hours) sleep latency insomnia (at 3 7 nights sleep latency > 30 minutes), clinically daytime distress impairment (related insomnia) 2 week assessment prior baseline.",C0007637|C0243161|C0332283|C0450371|C0450371|G0000000|C0012634|C0243161|C0037313|C0024501|C0917801|G0000000|G0000000|G0000000|C0240526|G0000000|C1720052|G0000000|C0439175|C0037313|C0040223|G0000000|G0000000|C0439227|C0037313|C0205275|C0917801|G0000000|G0000000|G0000000|C0240526|C0037313|C0205275|G0000000|C0450371|C0439232|G0000000|C0332169|C0231303|C0221099|C0439849|C0917801|G0000000|C0332174|C1261322|C0332152|C0168634
"In one single-centered retrospective study, patients undergoing allogeneic transplantation who had reduced hemoglobin at the time of transplant received a greater number of red cell transfusions and had increased transplant-related mortality [2].","In single-centered retrospective study, patients undergoing allogeneic transplantation reduced hemoglobin time transplant received red cell transfusions increased transplant-related mortality [2].",G0000000|C0037179|C0035363|C0557651|C0030705|G0000000|C1515895|C0040732|C0392756|C0019046|C0040223|C0040732|C1514756|C0332575|C0007634|C0005841|C0205217|C0040732|C0026565|G0000000
"We excluded 23 (2.1%) children who had either congenital heart disease or Down’s syndrome, and 19 (1.7%) children who had been enrolled in a previous case-control study.","We excluded 23 (2.1%) children congenital heart disease Down’s syndrome, 19 (1.7%) children enrolled previous case-control study.",G0000000|C1554077|C0450371|G0000000|C0008059|C0009678|C0018787|C0012634|G0000000|C0039082|C0450371|G0000000|C0008059|G0000000|C0205156|C0872128|C0557651
"Our study cohort included 474 1st graders (31.5%) and 1,030 4th graders (68.5%).","Our study cohort included 474 1st graders (31.5%) 1,030 4th graders (68.5%).",G0000000|C0557651|C0599755|C0332257|C1442061|G0000000|G0000000|C0450371|C1442061|G0000000|G0000000|C0450371
Pregnant women were eligible for inclusion if they had no intention of leaving the study area for the next 2 years and provided informed written consent.,Pregnant women eligible inclusion intention leaving study 2 provided informed written consent.,C0549206|C0043210|C1548635|C0007637|C0162425|G0000000|C0557651|G0000000|C1999230|C1522154|C0043266|C1511481
"The randomized controlled trial will be conducted with 220 women who have a BMI > 18.5 (American IOM cut-off for normal weight), are 18 years of age or older, English speaking, no history of disordered eating or diabetes and are less than 18 weeks gestation at recruitment.","The randomized controlled trial conducted 220 women BMI > 18.5 (American IOM cut-off normal weight), 18 age older, English speaking, history disordered eating diabetes 18 weeks gestation recruitment.",G0000000|C0034656|C2587213|C0008976|C0004927|C1442061|C0043210|G0000000|G0000000|C0450371|C0596070|C1955637|C1442160|C0205307|C0005910|C0450371|C0001779|C0580836|C0376245|C0234856|C0019664|C0012634|C0013470|C0011847|C0450371|C0439230|C0032961|C2949735
"Most had at least a high school education (75.1%) and were single (55.8%), living with at least 1 child younger than age 18 years in the home (78.9%).","Most school education (75.1%) single (55.8%), living 1 child age 18 (78.9%).",C0205393|C0036375|C0013621|C0450371|C0037179|C0450371|C0376558|G0000000|C0008059|C0001779|C0450371|C0450371
"Eligibility criteria for girls’ (and parents’) enrollment in the project included, in addition to age, living with both biological parents, the absence of severe food allergies or chronic medical problems affecting food intake, and the absence of dietary restrictions involving animal products.","Eligibility criteria girls’ (and parents’) enrollment project included, addition age, living biological parents, absence severe food allergies chronic medical food intake, absence dietary restrictions involving animal products.",C0013893|C0243161|G0000000|G0000000|G0000000|C1516879|C1709701|C0332257|C0332287|C0001779|C0376558|C0005532|C0030551|C0332197|C0205082|C0016452|C0020517|C0205191|C0199168|C0016452|C1512806|C0332197|C0012155|C0443288|C1314939|C0003062|C1514468
"• Health centre in Santiago Metropolitan area • Situated in low-middle socio-economic status municipality • More than 400 individuals in age-group 65.0–67.9 years resident in municipality • Resident within catchment area of selected health centres • Age 65.0–67.9 at baseline • Potential national health service (FONASA) beneficiary • Inability to walk unaided • Having sought medical advice for an un-planned weight loss of 3 kg in the past 3 months • Planning to move house in the next 3 months • Being currently enrolled in PACAM or being current consumer of Años Dorados and/or Bebida Láctea • Poor cognitive health (defined low score on cognitive health screen) This pragmatic trial was designed as a public health programme effectiveness study [16] and the interventions were therefore made available through the established health system under standard operating procedures, without the use of resource-intensive extraordinary efforts to secure uptake.","• Health centre Santiago Metropolitan • Situated low-middle socio-economic status municipality • More 400 individuals age-group 65.0–67.9 resident municipality • Resident catchment selected health centres • Age 65.0–67.9 baseline • Potential national health service (FONASA) beneficiary • Inability walk unaided • Having sought medical advice un-planned weight loss 3 3 months • Planning move house 3 months • Being enrolled PACAM current consumer Años Dorados and/or Bebida Láctea • Poor cognitive health (defined low score cognitive health screen) This pragmatic trial designed public health programme effectiveness study [16] interventions established health system standard operating procedures, resource-intensive extraordinary efforts secure uptake.",G0000000|C0018684|C0205099|G0000000|C0599587|G0000000|G0000000|C0205251|C0013556|C0449438|C0600182|G0000000|C0205172|C1442061|C0027361|C0027362|G0000000|C1320928|C0600182|G0000000|C1320928|G0000000|C1707391|C0018684|C0205099|G0000000|C0001779|G0000000|C0168634|G0000000|C3245505|C3245503|C0018684|C0557854|G0000000|C1550502|G0000000|G0000000|C0080331|C0439846|G0000000|G0000000|G0000000|C0199168|C0150600|C0041701|C0005910|C1517945|G0000000|G0000000|C0439231|G0000000|C0032074|C0560560|C0442519|G0000000|C0439231|G0000000|G0000000|G0000000|G0000000|C0521116|C1707496|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|C0032854|C1516691|C0018684|C1704788|C0205251|C0449820|C1516691|C0018684|C0220908|G0000000|C0871858|C0008976|C1707689|G0000000|C0018684|C1709697|C1280519|C0557651|C0450371|C0886296|C0443211|C0018684|C0449913|C1442989|C3242339|C0025664|C0035201|G0000000|C0015264|C0659450|C0243144
A total of 479 students attending two public high schools participated.,A total 479 students attending public schools participated.,G0000000|C0439175|C1442061|C0038492|C1547429|G0000000|C0036375|G0000000
"In the general practice group there was a significantly lower frequency of regular review visits (‘regular’ = at least one review per six months) compared to the paediatrician and specialised asthma nurse group, both after one year [45.7% versus 87.9% and 94.3%, respectively, (p<0.0005)] and after two years [26.5% versus 87.9% and 75.8%, respective, (p<0.0005)].","In practice lower frequency regular review visits (‘regular’ = review months) compared paediatrician specialised asthma nurse group, [45.7% versus 87.9% 94.3%, respectively, (p<0.0005)] [26.5% versus 87.9% 75.8%, respective, (p<0.0005)].",G0000000|C0237607|C0441994|C0376249|C0205272|C0282443|C0545082|G0000000|G0000000|C0282443|C0439231|C1707455|C0237433|C0205555|C0004096|C0028661|C0441833|C0450371|G0000000|C0450371|C0450371|G0000000|C0369773|C0450371|G0000000|C0450371|C0450371|G0000000|C0369773
"Children between ages 11 and 18 years were eligible if they 1) met juvenile FMS classification criteria as determined by a pediatric rheumatologist (3), 2) were receiving stable medications for 8 weeks and were willing to continue receiving stable medications for the duration of the study, 3) reported average pain severity ≥4 on a 0–10-cm visual analog scale (VAS) based on 1 week of daily pain diaries, and 4) obtained a score >7 on the Functional Disability Inventory (FDI) (15), indicating at least mild disruption in daily activities due to juvenile FMS symptoms.","Children ages 11 18 eligible 1) met juvenile FMS classification criteria determined pediatric rheumatologist (3), 2) receiving stable medications 8 weeks continue receiving stable medications duration study, 3) reported average pain severity ≥4 0–10-cm visual analog scale (VAS) based 1 week daily pain diaries, 4) score >7 Functional Disability Inventory (FDI) (15), indicating mild disruption daily activities juvenile FMS symptoms.",C0008059|C0001779|C0450371|C0450371|C1548635|G0000000|C0268621|C3146221|G0000000|C0008902|C0243161|G0000000|C0030755|C0334889|G0000000|G0000000|C1514756|C0205360|C0013227|G0000000|C0439230|C0549178|C1514756|C0205360|C0013227|C0449238|C0557651|G0000000|C0684224|C1510992|C0030193|C0439793|G0000000|G0000000|C0234621|C0243071|C0175659|C0042815|C1527178|G0000000|C0332174|C0332173|C0030193|C0376660|G0000000|C0449820|G0000000|C0205245|C0231170|C0021941|G0000000|C0450371|G0000000|C2945599|C0332453|C0332173|C0441655|C3146221|G0000000|C0683368
Volunteer prenatal classes were randomly assigned a video or oral presentation.,Volunteer prenatal classes randomly assigned video oral presentation.,C0042960|C0678804|C0456387|G0000000|C1516050|C0042655|C0442027|C0449450
"Women were excluded if they were active smokers (more than one pack of cigarettes per day); had taken dietary supplements containing soy isoflavones, vitamin E, flaxseed, or red clover within the past 6 weeks; or were on HT or any medications for treatment of hot flashes (clonidine, selective serotonin reuptake inhibitors) within the past 6 weeks.","Women excluded active smokers (more pack cigarettes day); dietary supplements soy isoflavones, vitamin E, flaxseed, red clover 6 weeks; HT medications treatment hot flashes (clonidine, selective serotonin reuptake inhibitors) 6 weeks.",C0043210|C1554077|C0205177|C0337664|C0205172|C1968515|C0677453|C0332173|C0012155|C0242295|C0037733|C0022179|C0042890|G0000000|C0023753|C0332575|C0950074|G0000000|C0439230|C0018510|C0013227|C0039798|C0444519|C0085635|C0009014|C0036576|C0036751|C0599702|C0243077|G0000000|C0439230
"(□), Control group; (), intervention group 1, 60 g whole grain per d for 16 weeks; (■), intervention group 2, 60 g whole grain per d for 8 weeks, followed by 120 g whole grain per d for 16 weeks.","(□), Control group; (), intervention 1, 60 grain 16 weeks; (■), intervention 2, 60 grain 8 weeks, 120 grain 16 weeks.",G0000000|C0243148|C0441833|G0000000|C0886296|G0000000|C0450371|C0007757|C0450371|C0439230|G0000000|C0886296|G0000000|C0450371|C0007757|G0000000|C0439230|C1442061|C0007757|C0450371|C0439230
"Inclusion criteria included reproductive-age (between 30 and 40 years) patients with a BMI (between 30 and 40 kg/m2), defined as obesity of class I to II10 with the presence of benign pelvic mass of uterine and/or ovarian origin.","Inclusion criteria included reproductive-age (between 30 40 years) patients BMI (between 30 40 kg/m2), defined obesity class I II10 presence benign pelvic mass uterine and/or ovarian origin.",C0007637|C0243161|C0332257|C0035150|G0000000|C0450371|C0450371|C0439234|C0030705|G0000000|G0000000|C0450371|C0450371|C0022718|C1704788|C0028754|C0456387|C0021966|G0000000|C0150312|C0205183|C0030797|C0577559|C0042149|G0000000|C0205065|C0079946
"Female or male patients, 18–70 years of age, who met the 2010 American College of Rheumatology (ACR) Preliminary Diagnostic Criteria for FM were eligible for inclusion.","Female male patients, 18–70 age, met 2010 American College Rheumatology (ACR) Preliminary Diagnostic Criteria FM eligible inclusion.",C0015780|C0086582|C0030705|G0000000|C0001779|C0268621|G0000000|C0596070|C0557806|C0035452|C1412134|C0439611|C0011900|C0243161|C3540627|C1548635|C0007637
Patients aged 65 years and older who are admitted to a participating ward will be eligible for study participation.,Patients aged 65 admitted participating ward eligible study participation.,C0030705|C0001779|C0450371|C0184666|C0679823|C1305702|C1548635|C0557651|C0679823
National Institute for Neurological Disorders and Stroke.,National Institute Neurological Disorders Stroke.,C3245503|C0021622|C0205494|C0012634|C0038454
Patients aged 18 years or older with a stay longer than 48 hours and a nasogastric feeding tube were eligible for inclusion in the study.,Patients aged 18 stay 48 hours nasogastric feeding tube eligible inclusion study.,C0030705|C0001779|C0450371|G0000000|C0450371|C0439227|C0694637|C0204695|C0175730|C1548635|C0007637|C0557651
The general selection criteria of the subjects for this study were as follows: hemiplegia for over 6 months; scores of over 24 points on the Korean version of the Mini-Mental State Examination; average scores below 2.26 in the movement imagery mental test; no communication problems; hemineglect; or hearing or vision disorders.,The selection criteria subjects study follows: hemiplegia 6 months; scores 24 Korean version Mini-Mental State Examination; average scores 2.26 movement imagery mental test; communication problems; hemineglect; hearing vision disorders.,G0000000|C0036576|C0243161|C0681850|C0557651|C0332283|C0018991|G0000000|C0439231|C0449820|C0450371|C1556095|C0333052|C0445542|C1301808|G0000000|C1510992|C0449820|C0450371|C0026649|C0150627|C0229992|C0022885|C0009452|C1546466|C0150088|C0018767|C0042789|C0012634
"Inclusion criteria were: (1) age 18 yr or older; (2) CAPD patients, with a minimum of 6L of daily 2.5% Dianeal® (Baxter China Ltd., Shanghai, China) PD-2 or PD-4 dialysate with a night dwell above 8 h; and (3) a night dwell volume of 2L for a minimum of 30 d before inclusion.","Inclusion criteria were: (1) age 18 yr older; (2) CAPD patients, minimum 6L daily 2.5% Dianeal® (Baxter China Ltd., Shanghai, China) PD-2 PD-4 dialysate night dwell 8 h; (3) night dwell volume 2L minimum 30 inclusion.",C0007637|C0243161|G0000000|G0000000|C0001779|C0450371|C0439234|C0580836|G0000000|C0031140|C0030705|C1524031|C4053562|C0332173|G0000000|G0000000|G0000000|C0008115|C1136140|G0000000|C0008115|G0000000|G0000000|C0011947|C0240526|G0000000|G0000000|C0033727|G0000000|C0240526|G0000000|C0449468|C4053562|C1524031|C0450371|C0007637
Subjects were randomly assigned to one of the two sequence groups (AbMIP -placebo or placebo – AbMIP).,Subjects randomly assigned sequence (AbMIP -placebo placebo – AbMIP).,C0681850|G0000000|C1516050|C0004793|G0000000|C0032042|C0032042|G0000000|G0000000
"At week 52, point-prevalence abstinence rates were 60% in the varenicline group (24 of 40) vs 19% (9 of 47) in the placebo group (odds ratio [OR], 6.2; 95% CI, 2.2-19.2; P < .001).","At week 52, point-prevalence abstinence rates 60% varenicline (24 40) 19% (9 47) placebo (odds ratio [OR], 6.2; 95% CI, 2.2-19.2; P < .001).",G0000000|C0332174|C0450371|C1552961|C3843422|C0871208|C0450371|C1569608|C0450371|C0450371|C0450371|G0000000|C0450371|C0032042|G0000000|C0456603|G0000000|G0000000|C0450371|C0008107|C0450371|C0369773|G0000000|C1442061
"d. Patients who are currently suffering from severe nausea, anorexia or other diseases affecting health (e.g.","d. Patients suffering severe nausea, anorexia diseases health (e.g.",C0073187|C0030705|C0683278|C0205082|C0027497|C0003123|C0012634|C0018684|G0000000
"The main goal of the presented study was to elucidate the relevance of concurrent radiochemotherapy with topotecan (0.4 mg m−2 day−1 for 5 days over 4 weeks) and WBRT (2 Gy day−1, 40 Gy in total) in patients with brain metastases due to lung cancer in comparison with WBRT alone concerning overall survival.","The main goal study elucidate relevance concurrent radiochemotherapy topotecan (0.4 mg m−2 day−1 5 days 4 weeks) WBRT (2 Gy day−1, 40 Gy total) patients brain metastases lung cancer comparison WBRT survival.",G0000000|C0205225|C0018017|C0557651|G0000000|C2347946|C0205420|C0436307|C0146224|G0000000|G0000000|C0439228|G0000000|C0439230|C1520143|G0000000|G0000000|C0439175|C0030705|C0006104|C0027627|C0024109|C0006826|C1707455|C1520143|C0038952
All reported P values are based on two-sided testing.,All reported P values based two-sided testing.,G0000000|C0684224|C0369773|C0042295|C1527178|C0205448|C0039593
The burn surface area ranged from 10 to 40% TBSA.,The burn surface ranged 10 40% TBSA.,G0000000|C0006434|C0205148|C1514721|C0450371|C0450371|G0000000
• Pain score of at least 25 mm on a 100 mm visual analogue scale (VAS).,• Pain score 25 mm 100 mm visual analogue scale (VAS).,G0000000|C0030193|C0449820|C0450371|G0000000|C1442061|G0000000|C0234621|C0243071|C0175659|C0042815
"In conclusion, using a 2-week regimen, high-dose ACTH is superior to prednisone for suppression of clinical spasms and hypsarrhythmia in IS.","In conclusion, 2-week regimen, high-dose ACTH superior prednisone suppression clinical spasms hypsarrhythmia IS.",G0000000|C1707478|C0332174|C0040808|C0444956|C3539087|C1282910|C0032952|C0221103|C0205210|C0037763|C0037769|G0000000
"The present report includes persons with a baseline and at least one follow-up assessment performed between February 1, 1995, and July 1, 2004, and no prior history of esophageal cancer (n = 350).","The report includes persons baseline follow-up assessment performed February 1, 1995, July 1, 2004, prior history esophageal cancer (n = 350).",G0000000|C0684224|C0332257|C0027361|C0168634|C0589120|C1261322|C0884358|C3830166|G0000000|G0000000|C3829447|G0000000|G0000000|C0332152|C0019664|C1522619|C0006826|C0369718|G0000000|C1442061
"The inclusion criteria consisted of (1) age 18 years or older; (2) an established diagnosis of mild-to-moderate asthma for at least 6 months (meeting the American Thoracic Society[11] spirometry criteria for mild-to-moderate asthma, which requires either a forced expiratory volume in 1 second [FEV1]/forced vital capacity [FVC] below the lower limit of normal with a significant response to a bronchodilator [a ≥12% increase and a ≥200 mL absolute increase in FEV1 15 minutes after the administration of 2 puffs of a short acting β-agonist] or peak expiratory flow rate [PEFR] variability >20%); (3) taking at least one of the following: inhaled β-agonists, methylxanthines, anticholinergics, inhaled corticosteroids; and (4) stable medication dosing for the past month.","The inclusion criteria consisted (1) age 18 older; (2) established diagnosis mild-to-moderate asthma 6 months (meeting American Thoracic Society[11] spirometry criteria mild-to-moderate asthma, requires forced expiratory volume 1 [FEV1]/forced vital capacity [FVC] lower limit normal response bronchodilator [a ≥12% increase ≥200 mL absolute increase FEV1 15 minutes administration 2 puffs short acting β-agonist] peak expiratory flow rate [PEFR] variability >20%); (3) following: inhaled β-agonists, methylxanthines, anticholinergics, inhaled corticosteroids; (4) stable medication dosing month.",G0000000|C0007637|C0243161|C0332529|G0000000|C0001779|C0450371|C0580836|G0000000|C0443211|C0011900|C1299392|C0004096|G0000000|C0439231|C0556656|C0596070|G0000000|C0037455|C0037981|C0243161|C1299392|C0004096|G0000000|C0441722|C0231800|C0449468|G0000000|C0441722|C0442732|C1516240|C3714541|C0441994|C0439801|C0205307|C0871261|C0006280|G0000000|G0000000|C0442805|G0000000|C0439526|C0205344|C0442805|G0000000|C0450371|C0439232|C0001554|G0000000|C1533107|C1282927|G0000000|G0000000|C0444505|C0231800|C0806140|C0871208|C0030735|C2827666|C0450371|G0000000|C0231290|C0004048|G0000000|C0066447|C0242896|C0004048|C0001617|G0000000|C0205360|C0013227|G0000000|C0332177
These changes may contribute to the onset of AMD.,These contribute onset AMD.,G0000000|C1880177|C0206132|C3539530
Methods: Forty eight patients with congenital neuromuscular or chest wall disease aged 7–51 years and vital capacity <50% predicted underwent overnight respiratory monitoring.,Methods: Forty patients congenital neuromuscular chest wall disease aged 7–51 vital capacity <50% predicted underwent overnight respiratory monitoring.,C0025663|C3816449|C0030705|C0009678|C1979768|C0817096|C0677535|C0012634|C0001779|G0000000|C0442732|C1516240|C0450371|C0681842|G0000000|C0439583|C0521346|C0150369
"The 335 patients enrolled in this study included 104 men and 231 women, with an average age of 55.7 ± 12.4 yr (range, 23-85 yr).","The 335 patients enrolled study included 104 231 women, average age 55.7 ± 12.4 yr (range, 23-85 yr).",G0000000|C1442061|C0030705|G0000000|C0557651|C0332257|C1442061|C1442061|C0043210|C1510992|C0001779|C0450371|G0000000|C0450371|C0439234|C1514721|C0450371|C0439234
"Patients were required to meet Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for insomnia and had a WASO ≥ 45 minutes and a TST < 6.5 hours at least 3 times per week for the previous month.","Patients required meet Diagnostic Statistical Manual Mental Disorders, Fourth Edition (DSM-IV) criteria insomnia WASO ≥ 45 minutes TST < 6.5 hours 3 times week previous month.",C0030705|C1514873|C1550543|C0011900|C0038215|C0024763|C0229992|C0012634|C0205438|C0441792|C0220952|C0243161|C0917801|G0000000|G0000000|C0450371|C0439232|C1421210|G0000000|G0000000|C0439227|G0000000|C0040223|C0332174|C0205156|C0332177
"The sites are in India (Belgaum, Karnataka), Pakistan (Thatta, Sind Province), Democratic Republic of Congo (DRC, Equateur Province), and Guatemala (Chimaltenango Department), all of which have a 10-year history of working together primarily on shared common trials through the Eunice Kennedy Shriver National Institute for Child Health and Human Development (NICHD) Global Network (GN) for Women’s and Children’s Health Research (http://gn.rti.org).","The sites India (Belgaum, Karnataka), Pakistan (Thatta, Sind Province), Democratic Republic Congo (DRC, Equateur Province), Guatemala (Chimaltenango Department), 10-year history shared common trials Eunice Kennedy Shriver National Institute Child Health Human Development (NICHD) Global Network (GN) Women’s Children’s Health Research (http://gn.rti.org).",G0000000|C0205145|C0021201|G0000000|G0000000|C0030211|G0000000|G0000000|C1514578|G0000000|G0000000|C0009738|G0000000|G0000000|C1514578|C0018367|G0000000|C1704729|C0450371|C0019664|C0237876|C0205214|C0008976|C1029979|G0000000|G0000000|C3245503|C0021622|C0008059|C0018684|C0086418|C0243107|C1513896|C0205246|C0150775|C0018381|G0000000|G0000000|C0018684|C0035168|C1555015
"An additional six subjects had severe OSA (AHI = 82 ± 11; overall range 60 to 136 events/h of sleep), experienced marked oxygen desaturation (nadir SaO2 = 63 ± 3; overall range 54 to 69 %) and had high arousal thresholds (stage 2 arousal threshold = −40 ±6; overall range −25 to −63 cmH2O).","An additional subjects severe OSA (AHI = 82 ± 11; range 60 136 events/h sleep), experienced marked oxygen desaturation (nadir SaO2 = 63 ± 3; range 54 69 %) arousal thresholds (stage 2 arousal threshold = −40 ±6; range −25 −63 cmH2O).",G0000000|C1524062|C0681850|C0205082|C0520679|G0000000|G0000000|C0450371|G0000000|C0450371|C1514721|C0450371|C1442061|C0441471|C0037313|C0237607|C0522501|C0030054|C0746961|C1708760|G0000000|G0000000|C0450371|G0000000|G0000000|C1514721|C0450371|C0450371|G0000000|C0003808|C0449864|C0205390|G0000000|C0003808|C0449864|G0000000|G0000000|G0000000|C1514721|G0000000|G0000000|G0000000
"Patients who had a pain score of >50%, as assessed by visual analog scale (VAS), were enrolled in the study.","Patients pain score >50%, assessed visual analog scale (VAS), enrolled study.",C0030705|C0030193|C0449820|C0450371|C1516048|C0234621|C0243071|C0175659|C0042815|G0000000|C0557651
parent's desire for more practical strategies for preparing food and playing with children).,parent's desire practical strategies preparing food playing children).,C0030551|C0871633|G0000000|C0679199|C1521827|C0016452|C0032214|C0008059
"Age-specific SD scores were calculated to compare eGFR data with data from healthy Dutch references retrieved from the Nijmegen Biomedical study (n=3732, aged 18–85 years) (21).","Age-specific SD scores calculated compare eGFR data data healthy Dutch references retrieved Nijmegen Biomedical study (n=3732, aged 18–85 years) (21).",C0001779|C2699239|C0449820|C0444686|C1707455|C1739039|C1511726|C1511726|C3898900|C0013331|C1514811|G0000000|G0000000|C1879848|C0557651|C0369718|C0001779|G0000000|C0439234|C0450371
"Participation in the cohort depended on filling in the baseline questionnaire, and over 90% of potential participants were recruited (see figure on website).","Participation cohort depended filling baseline questionnaire, 90% potential participants recruited (see figure website).",C0679823|C0599755|C0725813|G0000000|C0168634|C0034394|C0450371|C3245505|C0679646|G0000000|C0042789|G0000000|C2349146
"Patients also had to have a PSA value of less than 50 ng per milliliter, an age of 75 years or less, negative results on a bone scan for metastatic disease, and a life expectancy of at least 10 years from the time of randomization.","Patients PSA 50 ng milliliter, age 75 less, negative bone scan metastatic disease, life expectancy 10 time randomization.",C0030705|C3810537|C0450371|C0028074|C0439242|C0001779|C0450371|C0439092|C0205160|C0262950|C0034606|C0036525|C0012634|C0376558|C0679138|C0450371|C0040223|C0034656
Inclusion criteria for both groups were: (a) first acute event of cerebrovascular stroke; (b) unilateral paresis; (c) ability to understand and follow simple instructions; (d) ability to remain in a sitting posture.,Inclusion criteria were: (a) acute event cerebrovascular stroke; (b) unilateral paresis; (c) ability understand follow simple instructions; (d) ability remain sitting posture.,C0007637|C0243161|G0000000|G0000000|C0205178|C0441471|C1880018|C0038454|G0000000|C0205092|C0030552|G0000000|C0085732|C0162340|C0332283|C0205352|C0302828|C0073187|C0085732|G0000000|C0277814|C1262869
Total intended platinum dose for stage III and IV patients was 600 mg/m2 (18 mg/kg for patients < 1 year of age) of cisplatin and 3640 mg/m2 (120 mg/kg for patients < 10 kg) of carboplatin.,Total intended platinum dose stage III IV patients 600 mg/m2 (18 mg/kg patients < 1 age) cisplatin 3640 mg/m2 (120 mg/kg patients < 10 kg) carboplatin.,C0439175|C1283828|C0032207|C0178602|C0205390|C0439070|C0022326|C0030705|C1442061|C0026410|C0450371|C0439272|C0030705|G0000000|G0000000|C0001779|C0008838|G0000000|C0026410|C1442061|C0439272|C0030705|G0000000|C0450371|C0022718|C0079083
"The inclusion criteria were as follows: (i) age of ≥20 to <75 years at the time of providing informed consent; (ii) cervical cancer with the intent for chemoradiotherapy; (iii) adequately maintained major organ function (bone marrow, liver, and kidneys) and laboratory parameters within the following ranges: white blood cell count of >3500/mm3, absolute neutrophil count of >1500/mm3, hemoglobin A1c level of ≥10.0 g/dL, platelet count of ≥100,000/mm3, total bilirubin level of ≤1.5 mg/dL, aspartate transaminase and alanine transaminase levels of <80 IU/L, serum creatinine level of <1.5 mg/dL, and creatinine clearance rate of ≥60 mL/min (Cockcroft-Gault formula or 24 h creatinine clearance); and (iv) having received an explanation of the purpose and methods of this trial and having provided written consent prior to the start of the trial.","The inclusion criteria follows: (i) age ≥20 <75 time providing informed consent; (ii) cervical cancer intent chemoradiotherapy; (iii) adequately maintained major organ function (bone marrow, liver, kidneys) laboratory parameters ranges: white blood cell count >3500/mm3, absolute neutrophil count >1500/mm3, hemoglobin A1c level ≥10.0 g/dL, platelet count ≥100,000/mm3, total bilirubin level ≤1.5 mg/dL, aspartate transaminase alanine transaminase levels <80 IU/L, serum creatinine level <1.5 mg/dL, creatinine clearance rate ≥60 mL/min (Cockcroft-Gault formula 24 h creatinine clearance); (iv) received explanation purpose methods trial provided written consent prior start trial.",G0000000|C0007637|C0243161|C0332283|C0021966|C0001779|G0000000|C0450371|C0040223|C1999230|C1522154|C1511481|G0000000|C0027530|C0006826|C0162425|C0436307|C0439070|G0000000|C1314677|C0205082|C0178784|C0031843|C0262950|C0086590|C0023884|C0022646|C0022877|C0449381|C1514721|C0007457|C0005767|C0007634|C0750480|G0000000|C0205344|C0027950|C0750480|G0000000|C0019046|G0000000|C0441889|G0000000|C0005821|C0750480|G0000000|C0439175|C0005437|C0441889|G0000000|C0085845|C0002594|C0001898|C0002594|C0441889|G0000000|C0229671|C0010294|C0441889|G0000000|C0010294|C0449297|C0871208|G0000000|G0000000|C0489829|G0000000|C0010294|C0449297|C0022326|C1514756|C0681841|C1285529|C0025663|C0008976|C1999230|C0043266|C1511481|C0332152|C0439659|C0008976
"Participant enrollment in Season 1 began 17 September 2005 and follow-up ended 31 May 2006, and enrollment in Season 2 began 16 October 2006 and follow-up ended 6 June 2007.","Participant enrollment Season 1 17 September 2005 follow-up 31 May 2006, enrollment Season 2 16 October 2006 follow-up 6 June 2007.",C0679646|C1516879|C0036497|G0000000|C0450371|C3828193|G0000000|C0589120|C0450371|G0000000|G0000000|C1516879|C0036497|G0000000|C0450371|C3828732|G0000000|C0589120|G0000000|C3829443|G0000000
"Key inclusion criteria for this study included age 18–85 years, BMI 18–42 kg/m2, HbA1c 6.5–10.0% (48–86 mmol/mol), type 2 diabetes either untreated (no glucose-lowering medication in the past 8 weeks) or treated with a stable dose of sulfonylurea, thiazolidinedione, meglitinide or insulin, as monotherapy or in combination (for at least 4 weeks), and severe RI (estimated GFR [eGFR] by the Modification of Diet in Renal Disease [MDRD] formula <30 ml min−1 [1.73 m]−2).","Key inclusion criteria study included age 18–85 years, BMI 18–42 kg/m2, HbA1c 6.5–10.0% (48–86 mmol/mol), type 2 diabetes untreated (no glucose-lowering medication 8 weeks) treated stable dose sulfonylurea, thiazolidinedione, meglitinide insulin, monotherapy combination (for 4 weeks), severe RI (estimated GFR [eGFR] Modification Diet Renal Disease [MDRD] formula <30 min−1 [1.73 m]−2).",G0000000|C0007637|C0243161|C0557651|C0332257|C0001779|G0000000|C0439234|G0000000|G0000000|C0022718|G0000000|G0000000|G0000000|C3829066|C0332307|G0000000|C0011847|C0332155|G0000000|C0017725|C0013227|G0000000|C0439230|C1522326|C0205360|C0178602|C0038766|C0289779|C0065880|C0021641|G0000000|C0205195|G0000000|G0000000|C0439230|C0205082|C0035487|C0750572|C0017654|C1739039|C0392747|C0012155|C0022646|C0012634|C3839656|C0489829|C0450371|G0000000|C0450371|G0000000
"METHODS—Eighty infants under 1 year, with persistent or recurrent wheeze and a personal or family history of atopy, were recruited to a randomised, double blind, cross over, placebo controlled trial.","METHODS—Eighty infants 1 year, persistent recurrent wheeze personal family history atopy, recruited randomised, double blind, cross over, placebo controlled trial.",G0000000|C0021270|G0000000|C0439234|C0205322|C2945760|C0043144|C1519021|C0015576|C0019664|C0392707|G0000000|G0000000|C0205173|C0150108|C2828360|C0205136|C0032042|C2587213|C0008976
Only newly diagnosed patients with histologically confirmed oesophageal cancer were finally included as case participants in the study.,Only newly diagnosed patients histologically confirmed oesophageal cancer finally included participants study.,C0205171|C0750546|C0011900|C0030705|C0205462|C0521093|C1522619|C0006826|G0000000|C0332257|C0679646|C0557651
Setting: Three general practices in Birmingham.,Setting: Three practices Birmingham.,C0542559|C0205449|C0237607|G0000000
The evaluation used a quasi-experimental design that consisted of a pre- and post-intervention telephone survey (24 months apart) of a cohort of residents (n = 909) in the intervention area (n = 520) (Fairfield and Liverpool) and a socio-demographically similar comparison area (n = 389) (Bankstown).,The evaluation quasi-experimental design consisted pre- post-intervention telephone survey (24 months apart) cohort residents (n = 909) intervention (n = 520) (Fairfield Liverpool) socio-demographically comparison (n = 389) (Bankstown).,G0000000|C0220825|C1517586|C1707689|C0332529|C0332152|C2347647|C0039457|C0038951|C0450371|C0439231|G0000000|C0599755|C1320928|C0369718|G0000000|C1442061|C0886296|C0369718|G0000000|C1442061|G0000000|G0000000|G0000000|C1707455|C0369718|G0000000|C1442061|G0000000
This is the first randomized controlled trial of self-management education for adults with poorly controlled epilepsy in the UK.,This randomized controlled trial self-management education adults controlled epilepsy UK.,G0000000|C0034656|C2587213|C0008976|C0086969|C0013621|C0001675|C2587213|C0014544|C0041700
No substantial differences in adverse effects were noted between Ca/Mg and placebo.,No substantial differences adverse effects Ca/Mg placebo.,G0000000|G0000000|C1705241|G0000000|C1280500|C3887642|C0032042
We randomised enrolled patients into an intervention group with didgeridoo training or a control group.,We randomised enrolled patients intervention didgeridoo training control group.,G0000000|G0000000|G0000000|C0030705|C0886296|G0000000|C0040607|C0243148|C0441833
"Patients who received transplants 2–3 years before, had no history of consumption of alcohol and caffeine and had no regular exercise activities were included in this study.","Patients received transplants 2–3 before, history consumption alcohol caffeine regular exercise activities included study.",C0030705|C1514756|C0332835|G0000000|C0332152|C0019664|C0009830|C0001962|C0006644|C0205272|C0015259|C0441655|C0332257|C0557651
Residents of nine community-based nursing homes in Pennsylvania were approached for the study.,Residents community-based nursing homes Pennsylvania approached study.,C1320928|C0009462|C0006147|C0442519|C0030853|C0449445|C0557651
"There were, however, only five cases of uterine cancer in the ART group, so this prompts further observation as the population of ART women ages.","There were, however, uterine cancer ART group, prompts observation population ART women ages.",G0000000|G0000000|G0000000|C0042149|C0006826|C0003826|C0441833|C0871157|C0302523|C0032659|C0003826|C0043210|C0001779
Patients who are stable for 48 hours after acute myocardial infarction with viability in the infarct-area significantly benefit from an early invasive strategy.,Patients stable 48 hours acute myocardial infarction viability infarct-area benefit invasive strategy.,C0030705|C0205360|C0450371|C0439227|C0205178|C0027061|C0021308|C0443348|C0021308|C0814225|C0205281|C0679199
"Exclusion criteria were heart failure, unstable angina, peripheral arterial occlusive disease, aphasia, dementia, untreated major depression, clinical and/or neuroimaging signs of stroke-independent neurological diseases (eg, Parkinsonian syndromes), patients already performing aerobic exercise training for >20 min/d and >1 d/wk, and other medical conditions precluding participation in exercise (for details see ACSM21).","Exclusion criteria heart failure, unstable angina, peripheral arterial occlusive disease, aphasia, dementia, untreated major depression, clinical and/or neuroimaging signs stroke-independent neurological diseases (eg, Parkinsonian syndromes), patients performing aerobic exercise training >20 min/d >1 d/wk, medical conditions precluding participation exercise (for details ACSM21).",C0680251|C0243161|C0018787|C0231174|C0443343|C0002962|C0205100|C0003842|C1947917|C0012634|C0003537|C0011265|C0332155|C0205082|C0011570|C0205210|G0000000|C0679575|C0220912|C0038454|C0205494|C0012634|C0013715|G0000000|C0039082|C0030705|C0884358|C1510824|C0015259|C0040607|C0450371|C0702093|G0000000|C0332174|C0199168|C0012634|G0000000|C0679823|C0015259|G0000000|C1522508|G0000000
Analysis included all 60 participants in each group.,Analysis included 60 participants group.,C0002778|C0332257|C0450371|C0679646|C0441833
the previous papers used data collected at 20 weeks gestation).,previous papers data collected 20 weeks gestation).,C0205156|C0030351|C1511726|C1516695|C0450371|C0439230|C0032961
"Of the 186 patients, 179 had sufficient diary data to determine the time to improvement in sore throat as defined above.","Of 186 patients, 179 sufficient diary data determine time improvement sore throat defined above.",G0000000|C1442061|C0030705|C1442061|C0205410|C0376660|C1511726|G0000000|C0040223|C2986411|C0234233|C0031354|C1704788|C1282910
"Eligible participants were females with age ranging between 65 and 95 years, who were recruited in a nursing home in Pavia, where they had been institutionalized for at least 3 months prior to enrolment.","Eligible participants females age ranging 65 95 years, recruited nursing Pavia, institutionalized 3 months prior enrolment.",C1548635|C0679646|C0015780|C0001779|C1514721|C0450371|C0450371|C0439234|G0000000|C0006147|G0000000|C0562359|G0000000|C0439231|C0332152|C1516879
"Unlike our study, fruit and vegetable intake was combined, and mean intake was 2.7 servings per day, which is lower than the 3.5 servings per day in our participants at baseline.","Unlike study, fruit vegetable intake combined, intake 2.7 servings day, lower 3.5 servings day participants baseline.",G0000000|C0557651|C0016767|C0042440|C1512806|C0205195|C1512806|G0000000|C1519269|C0332173|C0441994|G0000000|C1519269|C0332173|C0679646|C0168634
The current study assessed and intervened with students during the summer prior to their matriculation into college.,The current study assessed intervened students summer prior matriculation college.,G0000000|C0521116|C0557651|C1516048|G0000000|C0038492|C0241301|C0332152|G0000000|C0557806
Both studies recruited patients who were ≥18 years of age with a diagnosis of HIV-DSP for ≥2 months and an average baseline NPRS score [34] of 3–9.,Both studies recruited patients ≥18 age diagnosis HIV-DSP ≥2 months average baseline NPRS score [34] 3–9.,G0000000|C0947630|G0000000|C0030705|G0000000|C0001779|C0011900|C0019682|G0000000|C0439231|C1510992|C0168634|C1417814|C0449820|C0450371|G0000000
"We evaluated associations of dietary selenium, beta-carotene, calcium, vitamin D, vitamin C, vitamin E, folate, magnesium, and zinc intake with thyroid cancer risk in the National Institutes of Health – American Association of Retired Persons Diet and Health Study, a large prospective cohort of 566,398 men and women aged 50–71 years in 1995–1996.","We evaluated associations dietary selenium, beta-carotene, calcium, vitamin D, vitamin C, vitamin E, folate, magnesium, zinc intake thyroid cancer risk National Institutes Health – American Association Retired Persons Diet Health Study, prospective cohort 566,398 women aged 50–71 1995–1996.",G0000000|C0220825|C0004083|C0012155|C0036581|C0053396|C0006675|C0042890|C0073187|C0042890|G0000000|C0042890|G0000000|C0178638|C0024467|C0043481|C1512806|C0040132|C0006826|C0035647|C3245503|C0021622|C0018684|G0000000|C0596070|C0004083|C0035345|C0027361|C0012155|C0018684|C0557651|C0023981|C0599755|C1442061|C0043210|C0001779|G0000000|G0000000
As expected there was a response to TCM acupuncture and to sham treatment.,As expected response TCM acupuncture sham treatment.,G0000000|C1517001|C0871261|C1515884|C0001299|C0068899|C0039798
"Eligible participants were overweight or obese [BMI (in kg/m2): 25–42], 35–55 y of age, and were required to have a waist circumference ≥102 cm (men) or ≥88 cm (women) and at least one other criterion of MetS (18), as follows: fasting plasma glucose ≥100 mg/dL, fasting serum triglycerides ≥150 mg/dL, BP ≥130/≥85 mm Hg, and/or fasting serum HDL cholesterol <50 mg/dL (women) or <40 mg/dL (men).","Eligible participants overweight obese [BMI (in kg/m2): 25–42], 35–55 age, required waist circumference ≥102 cm (men) ≥88 cm (women) criterion MetS (18), follows: fasting plasma glucose ≥100 mg/dL, fasting serum triglycerides ≥150 mg/dL, BP ≥130/≥85 mm Hg, and/or fasting serum HDL cholesterol <50 mg/dL (women) <40 mg/dL (men).",C1548635|C0679646|C0497406|C0028754|G0000000|G0000000|C0022718|G0000000|G0000000|C0001779|C1514873|C0230097|C0332520|G0000000|G0000000|C0025266|G0000000|G0000000|C0043210|C0243161|C0812270|C0450371|C0332283|C0015663|C0032105|C0017725|G0000000|C0439269|C0015663|C0229671|C0041004|G0000000|C0439269|C0037623|G0000000|G0000000|C0025424|G0000000|C0015663|C0229671|C3715113|C0008377|C0450371|C0439269|C0043210|C0450371|C0439269|C0025266
An abbreviated list of inclusion criteria includes age older than 21 years; ischemic or hemorrhagic stroke meeting World Health Organization criteria6; upper extremity hemiparesis; voluntary finger extension; no more than 6 outpatient occupational therapy sessions; and absence of traumatic or nonvascular brain injury and subarachnoid or primary intraventricular hemorrhage.,An abbreviated list inclusion criteria includes age 21 years; ischemic hemorrhagic stroke meeting World Health Organization criteria6; upper extremity hemiparesis; voluntary finger extension; 6 outpatient occupational therapy sessions; absence traumatic nonvascular brain injury subarachnoid primary intraventricular hemorrhage.,G0000000|G0000000|C0745732|C0007637|C0243161|C0332257|C0001779|C0450371|C0439234|C0475224|C0333275|C0038454|C0556656|C2700280|C0018684|C0029237|G0000000|C1282910|C0015385|C0018989|C0439656|C0016129|C0231448|G0000000|C0029921|C0521127|C0039798|C1883016|C0332197|C0332663|G0000000|C0006104|C3263722|C1515008|C0205225|C1517569|C0019080
"Of the patients in whom resuscitation was attempted, 114 were not witnessed.","Of patients resuscitation attempted, 114 witnessed.",G0000000|C0030705|C0035273|C1516084|C1442061|C0682356
"Therefore, OS is currently the best endpoint to evaluate immunotherapeutic agents in advanced cancer.","Therefore, OS endpoint evaluate immunotherapeutic agents advanced cancer.",G0000000|C0229090|C2349179|C0220825|G0000000|C0450442|C0205179|C0006826
"Furthermore, epoetin β was well tolerated and was significantly superior to standard care in increasing Hb concentrations, irrespective of the type of tumour, or the presence and nature of chemotherapy.","Furthermore, epoetin β tolerated superior standard care increasing Hb concentrations, irrespective type tumour, presence nature chemotherapy.",G0000000|C0014822|G0000000|G0000000|C1282910|C1442989|C1947933|C0442808|C0019046|C0086045|G0000000|C0332307|C0027651|C0150312|C0349590|C0013216
"Ethnicity varied (African American, 51%; European American, 47%; other ethnicity, 2%), and 69% were boys.","Ethnicity varied (African American, 51%; European American, 47%; ethnicity, 2%), 69% boys.",C0015031|G0000000|C0027567|C0596070|C0450371|C0239307|C0596070|C0450371|C0015031|G0000000|C0450371|C0870221
Eighteen EOC patients (HLADPB1*0401 or *0402) with NY-ESO-1-expressing tumors who had completed adjuvant chemotherapy for primary or recurrent disease were entered into the trial (protocol no.,Eighteen EOC patients (HLADPB1*0401 *0402) NY-ESO-1-expressing tumors completed adjuvant chemotherapy primary recurrent disease entered trial (protocol no.,C3715206|G0000000|C0030705|G0000000|G0000000|C0027976|C0027651|C0205197|C0001551|C0013216|C0205225|C2945760|C0012634|C1521975|C0008976|C0442711|G0000000
"Among participants, 37.4% of their mothers had a high school education or less and 59.6% had some college or a college degree.","Among participants, 37.4% mothers school education 59.6% college college degree.",G0000000|C0679646|C0450371|C0026591|C0036375|C0013621|C0450371|C0557806|C0557806|C0441889
"To help increase comparability between intervention and control groups, we used restriction and propensity score matching13 based on pre-intervention characteristics to select intervention and control villages.","To increase comparability intervention control groups, restriction propensity score matching13 based pre-intervention characteristics select intervention control villages.",C0040363|C0442805|G0000000|C0886296|C0243148|C0441833|C0443288|G0000000|C0449820|G0000000|C1527178|C2347663|C1521970|C1707391|C0886296|C0243148|C0562518
"Breast cancer survivors with persistent post-treatment fatigue were recruited through multiple mechanisms, including tumor registry mailings, newspaper advertisements, and flyers distributed at cancer-related and community locations.","Breast cancer survivors persistent post-treatment fatigue recruited multiple mechanisms, including tumor registry mailings, newspaper advertisements, flyers distributed cancer-related community locations.",C0006141|C0006826|C0206194|C0205322|C2709088|C0015672|G0000000|C0439064|C0441712|C0332257|C0027651|C0034975|C0024492|C0027989|C0949214|C0683877|C1704711|C2826292|C0009462|C0450429
"Participants were described by means of morphometric and developmental parameters, such as birth weight, body weight gain, and gestational age (weeks of gestation).","Participants morphometric developmental parameters, birth weight, body weight gain, gestational age (weeks gestation).",C0679646|C0200760|C0458003|C0449381|C0005615|C0005910|C0242821|C0005910|C1517378|C0439671|C0001779|C0439230|C0032961
"There was an apparently lower IOP in the second month in the combined trabeculotomy–trabeculectomy with mitomycin C with deep sclerectomy (CTTM-DS) group than the group without deep sclerectomy, although not statistically significant (P=0.056).","There lower IOP month combined trabeculotomy–trabeculectomy mitomycin C deep sclerectomy (CTTM-DS) deep sclerectomy, statistically (P=0.056).",G0000000|C0441994|C0595921|C0332177|C0205195|G0000000|C0002475|G0000000|C0205125|C0197557|C3714751|C0205125|C0197557|C0038215|C0369773
"This study (MEM-MD-50; {""type"":""clinical-trial"",""attrs"":{""text"":""NCT00322153"",""term_id"":""NCT00322153""}}NCT00322153; http://clinicaltrials.gov/show/{""type"":""clinical-trial"",""attrs"":{""text"":""NCT00322153"",""term_id"":""NCT00322153""}}NCT00322153) was a multinational, randomized, double-blind, placebo-controlled, parallel-group clinical trial in which participants were required to complete between 4 and 14 days of single-blind placebo treatment prior to baseline.","This study (MEM-MD-50; {""type"":""clinical-trial"",""attrs"":{""text"":""NCT00322153"",""term_id"":""NCT00322153""}}NCT00322153; http://clinicaltrials.gov/show/{""type"":""clinical-trial"",""attrs"":{""text"":""NCT00322153"",""term_id"":""NCT00322153""}}NCT00322153) multinational, randomized, double-blind, placebo-controlled, parallel-group clinical trial participants required complete 4 14 days single-blind placebo treatment prior baseline.",G0000000|C0557651|C0450371|C0332307|C1555015|G0000000|C0034656|C0013072|C1706408|C2348042|C0205210|C0008976|C0679646|C1514873|C0205197|G0000000|C0450371|C0439228|C0242570|C0032042|C0039798|C0332152|C0168634
"At least 506 participants will be recruited through 15 primary and secondary care settings and will be eligible if they are over 18 years of age, have had a stroke and wish to get out of the house more often.","At 506 participants recruited 15 primary secondary care settings eligible 18 years age, stroke house often.",G0000000|C1442061|C0679646|G0000000|C0450371|C0205225|C0027627|C1947933|C0542559|C1548635|G0000000|C0001779|C0038454|C0442519|C0332183
"After exclusion of those with missing responses or with a prior history of cancer, 14 409 subjects in Cohort 1 and 20 595 in Cohort 2 remained.","After exclusion missing responses prior history cancer, 14 409 subjects Cohort 1 20 595 Cohort 2 remained.",G0000000|C0680251|C1551393|C0871261|C0332152|C0019664|C0006826|G0000000|C0681850|C0599755|G0000000|G0000000|C0599755|G0000000|G0000000
"Exclusion criteria were the presence of sleepiness which may constitute risk to self or others, unstable medical diseases, coexistence of sleep disorders other than OSA, history of previous surgery to upper airway (except those for nasal problems) and pregnant women.","Exclusion criteria presence sleepiness constitute risk others, unstable medical diseases, coexistence sleep disorders OSA, history previous surgery upper airway (except nasal problems) pregnant women.",C0680251|C0243161|C0150312|C0013144|G0000000|C0035647|C1955473|C0443343|C0199168|C0012634|G0000000|C0037313|C0012634|C0520679|C0019664|C0205156|C0038894|C1282910|C0178987|G0000000|C0028429|C1546466|C0549206|C0043210
The study included healthy children and teenagers of both genders from 6 months to 12 years of age.,The study included healthy children teenagers genders 6 months 12 age.,G0000000|C0557651|C0332257|C3898900|C0008059|C0205653|C0079399|G0000000|C0439231|C0450371|C0001779
"Eligibility criteria were one of the following: 1) clinical evidence of atherosclerotic CVD such as angina pectoris, peripheral artery disease, previous ischemic stroke, transient ischemic attack or revascularization procedure; 2) multiple risk factors (at least four CV risk factors in non-diabetic patients and one or more in diabetics) including: old age (≥ 65 years), male sex, history of arterial hypertension, history of hypercholesterolemia, smoking, obesity (BMI ≥30 kg/m2), family history of premature CVD (<55 years in father or brother; <65 years in mother or sister); 3) other conditions putting the patient at high cardiovascular risk according to the general practitioner (GP)'s judgement.","Eligibility criteria following: 1) clinical evidence atherosclerotic CVD angina pectoris, peripheral artery disease, previous ischemic stroke, transient ischemic attack revascularization procedure; 2) multiple risk factors (at CV risk factors non-diabetic patients diabetics) including: age (≥ 65 years), male sex, history arterial hypertension, history hypercholesterolemia, smoking, obesity (BMI ≥30 kg/m2), family history premature CVD (<55 father brother; <65 mother sister); 3) conditions putting patient cardiovascular risk practitioner (GP)'s judgement.",C0013893|C0243161|C0231290|G0000000|C0205210|C3887511|C0333482|C0007222|C0002962|G0000000|C0205100|C0003842|C0012634|C0205156|C0475224|C0038454|C0040704|C0475224|C0277793|C0581603|C0184661|G0000000|C0439064|C0035647|C1521761|G0000000|C3538987|C0035647|C1521761|C1518422|C0030705|C0241863|C0332257|C0001779|G0000000|C0450371|C0439234|C0086582|C0009253|C0019664|C0003842|C0020538|C0019664|C0020443|C0037369|C0028754|G0000000|G0000000|C0022718|C0015576|C0019664|C0151526|C0007222|C0450371|C0015671|C0337527|C0450371|C0026591|C0337514|G0000000|C0012634|C1882509|C0030705|C0007226|C0035647|C1709627|C3811116|C0022423
Stroke is one of the most common causes of cognitive impairment.,Stroke common cognitive impairment.,C0038454|C0205214|C1516691|C0221099
"Exclusion criteria included type 1 diabetes, pregnancy, chronic dialysis, solid-organ transplant within the past 12 months, steroid therapy >7.5 mg/day of prednisone or equivalent, known hypopituitarism or adrenal insufficiency, known hypoglycemia unawareness, length of stay <48 h, and severe liver disease.","Exclusion criteria included type 1 diabetes, pregnancy, chronic dialysis, solid-organ transplant 12 months, steroid therapy >7.5 mg/day prednisone equivalent, hypopituitarism adrenal insufficiency, hypoglycemia unawareness, length stay <48 h, severe liver disease.",C0680251|C0243161|C0332257|C0332307|G0000000|C0011847|C0032961|C0205191|C0011945|C0440790|C0040732|C0450371|C0439231|C0038317|C0039798|G0000000|C0439422|C0032952|C0205163|C0020635|G0000000|C0231179|C0020615|C0041657|C1444754|G0000000|C0450371|C0033727|C0205082|C0023884|C0012634
"Participants were healthy men and women, aged 18 to 48 years, recruited at 6 study sites (4 University sites and 2 community sites) in Michigan.","Participants healthy women, aged 18 48 years, recruited 6 study sites (4 University sites 2 community sites) Michigan.",C0679646|C3898900|C0043210|C0001779|C0450371|C0450371|C0439234|G0000000|G0000000|C0557651|C0205145|G0000000|C0041740|C0205145|G0000000|C0009462|C0205145|C0025939
The target child also had to express willingness to participate in the individual and family portions of the session.,The target child express willingness participate individual family portions session.,G0000000|C1521840|C0008059|G0000000|C0600109|G0000000|C0027361|C0015576|C0449719|C1883016
"Exclusion criteria were: (1) excessive spasticity in the affected UE, as defined as a score of ≥ 3 in the affected elbow, wrist, or fingers as determined by the Modified Ashworth Spasticity Scale;19 (2) excessive pain in the affected UE, as measured by a score ≥ 5 on a 10-point visual analog scale; (3) participating in any experimental rehabilitation or drug studies; (4) history of a parietal stroke (because some data suggest that ability to estimate manual motor performance through mental practice is disturbed after parietal lobe damage).20 The upper extremity section of the Fugl-Meyer Scale (FM)21 was our primary outcome measure.","Exclusion criteria were: (1) excessive spasticity UE, defined score ≥ 3 elbow, wrist, fingers determined Modified Ashworth Spasticity Scale;19 (2) excessive pain UE, measured score ≥ 5 10-point visual analog scale; (3) participating experimental rehabilitation drug studies; (4) history parietal stroke (because data ability estimate manual motor performance mental practice disturbed parietal lobe damage).20 The upper extremity Fugl-Meyer Scale (FM)21 primary outcome measure.",C0680251|C0243161|G0000000|G0000000|C0442802|C0026838|G0000000|C1704788|C0449820|G0000000|G0000000|C0013769|C0043262|C0016129|G0000000|C0392747|G0000000|C0026838|C0175659|G0000000|C0442802|C0030193|G0000000|C0444706|C0449820|G0000000|G0000000|C0450371|C0234621|C0243071|C0175659|G0000000|C0679823|C1517586|C0034991|C0013227|C0947630|G0000000|C0019664|C0442030|C0038454|G0000000|C1511726|C0085732|C0750572|C0024763|C1513492|C0597198|C0229992|C0237607|G0000000|C0442030|C0796494|C0010957|G0000000|C1282910|C0015385|G0000000|C0175659|C3540627|C0205225|C1274040|C0079809
"A child will be excluded if (i) he/she has a serious medical condition or (ii) his/her parents are non-Chinese speaking and cannot understand the oral health materials and counseling, which will be in Chinese.","A child excluded (i) he/she medical condition (ii) his/her parents non-Chinese speaking understand oral health materials counseling, Chinese.",G0000000|C0008059|C1554077|C0021966|G0000000|C0199168|C0012634|G0000000|G0000000|C0030551|C1518422|C0234856|C0162340|C0442027|C0018684|C0520510|C0010210|C0008120
"After, at most, two dose reductions, clinically stable patients were eligible for randomisation if they demonstrated during the 7-10 days before or at the allocation visit a forced expiratory volume in 1 second ⩾90% of the run in baseline value, less than pre-established levels of asthma symptoms and β agonist use, peak flow at least 65% of the maximum, and required a prespecified minimum dose of inhaled corticosteroids.","After, most, dose reductions, clinically stable patients eligible randomisation demonstrated 7-10 days allocation visit forced expiratory volume 1 ⩾90% baseline value, pre-established levels asthma symptoms β agonist use, peak flow 65% maximum, required prespecified minimum dose inhaled corticosteroids.",G0000000|C0205393|C0178602|C0301630|G0000000|C0205360|C0030705|C1548635|C0034656|G0000000|C0450371|C0439228|C1706778|C0545082|C0441722|C0231800|C0449468|G0000000|G0000000|C0168634|C1522609|C0332152|C0441889|C0004096|C0683368|G0000000|C2987634|C0042153|C0444505|C0806140|C0450371|C0806909|C1514873|G0000000|C1524031|C0178602|C0004048|C0001617
"A 1:2 frequency-matched case control study was performed between June 2010 and May 2011 in AnXi, in the Fujian Province of China.","A 1:2 frequency-matched control study performed June 2010 May 2011 AnXi, Fujian Province China.",G0000000|G0000000|C0376249|C0243148|C0557651|C0884358|C3829443|G0000000|G0000000|G0000000|G0000000|G0000000|C1514578|C0008115
"Inclusion criteria were: Supratentorial brain tumor-suspected to be glioblastoma on contrast-enhanced diagnostic MRI, indication for gross total resection (GTR) of the tumor, age 18 years or older, WHO Performance Scale (WPS) 2 or better, ASA class 3 or better, adequate knowledge of the Dutch or French language, and informed consent.","Inclusion criteria were: Supratentorial brain tumor-suspected glioblastoma contrast-enhanced diagnostic MRI, indication gross total resection (GTR) tumor, age 18 older, WHO Performance Scale (WPS) 2 better, ASA class 3 better, adequate knowledge Dutch French language, informed consent.",C0007637|C0243161|G0000000|C0441938|C0006104|C0027651|C0017636|C0009924|C0011900|C0024485|C0392360|C0439806|C0439175|C0015252|G0000000|C0027651|C0001779|C0450371|C0580836|G0000000|C0597198|C0175659|G0000000|G0000000|C0332272|C0004057|C0456387|G0000000|C0332272|C0205410|C0376554|C0013331|C0376246|C0023008|C1522154|C1511481
"Inclusion criteria included age between 18 to 65 years, not having cognitive and psychological disorders, understanding Persian language with at least primary education, reaching final stage of renal disease and being constantly under treatment, undergoing at least 6 months of treatment with hemodialysis, being under treatment of three times a week for three to four hours, no renal transplantation and immigration during intervention, and no formal training in relation to dialysis.","Inclusion criteria included age 18 65 years, cognitive psychological disorders, understanding Persian language primary education, reaching final stage renal disease constantly treatment, undergoing 6 months treatment hemodialysis, treatment times week hours, renal transplantation immigration intervention, formal training relation dialysis.",C0007637|C0243161|C0332257|C0001779|C0450371|C0450371|C0439234|C1516691|C0205486|C0012634|C0162340|C0699776|C0023008|C0205225|C0013621|C2584321|C0205088|C0205390|C0022646|C0012634|C1948059|C0039798|G0000000|G0000000|C0439231|C0039798|C0019004|C0039798|C0040223|C0332174|C0439227|C0022646|C0040732|C0020942|C0886296|C0348078|C0040607|C0080103|C0011945
"An aiming task, originally developed as a motor abilities screen for the SF game, was also a part of this baseline assessment battery.","An aiming task, originally developed motor abilities screen SF game, baseline assessment battery.",G0000000|C1947946|C3540678|G0000000|G0000000|C1513492|C0085732|C0220908|C0037712|C0150593|C0168634|C1261322|C0337088
Cognitive function will be assessed with the Mini Mental State Examination [21].,Cognitive function assessed Mini Mental State Examination [21].,C1516691|C0031843|C1516048|C0445542|C0229992|C1301808|G0000000|C0450371
"Gender distribution was comparable across the two arms (55% vs 50% males in the active and control arm, respectively).","Gender distribution comparable arms (55% 50% males active control arm, respectively).",C0079399|C0520511|G0000000|C0206655|C0450371|C0450371|C0086582|C0205177|C0243148|C0446516|G0000000
Acupuncture has been shown to benefit stroke rehabilitation and ameliorate the risk factors for stroke.,Acupuncture benefit stroke rehabilitation ameliorate risk factors stroke.,C0001299|C0814225|C0038454|C0034991|G0000000|C0035647|C1521761|C0038454
"Infants (<12 months) of Indigenous mothers/caregivers who receive an intensive family-centred tobacco control program about ETS, compared with 'usual care,' will have fewer health care presentations for respiratory illness.","Infants (<12 months) Indigenous mothers/caregivers receive intensive family-centred tobacco control program ETS, compared 'usual care,' fewer health care presentations respiratory illness.",C0021270|C0450371|C0439231|C1512704|C0026591|C1514756|C0162425|C0015576|C0040329|C0243148|C1709697|G0000000|C1707455|C3538928|C1947933|C0205388|C0018684|C1947933|C0449450|C0521346|C0221423
"Only patients with mild (AHI = 5-15 events/h) and moderate (AHI = 15-30 events/h) OSA were asked to participate.15 Patients were excluded from participating in the study if they (1) had other conditions that might interfere with sleep (underlying chronic respiratory disorders, uncontrolled allergies, heart failure, narcolepsy, periodic leg movements); (2) currently used ventilatory stimulants or depressants (nicotine, theophylline, acetozolamide, morphine derivatives, sedatives, β-adrenergic receptor-blocking agents, salicylates); (3) had associated obesity hypoventilation syndrome; (4) had facial abnormalities that would preclude the effective use of CPAP; (5) used CPAP within the past year; (6) were pregnant; (7) were unwilling to participate in all aspects of the study; or (8) were unable to sign informed consent.","Only patients mild (AHI = 5-15 events/h) moderate (AHI = 15-30 events/h) OSA participate.15 Patients excluded participating study (1) conditions interfere sleep (underlying chronic respiratory disorders, uncontrolled allergies, heart failure, narcolepsy, periodic leg movements); (2) ventilatory stimulants depressants (nicotine, theophylline, acetozolamide, morphine derivatives, sedatives, β-adrenergic receptor-blocking agents, salicylates); (3) obesity hypoventilation syndrome; (4) facial abnormalities preclude effective CPAP; (5) CPAP year; (6) pregnant; (7) unwilling participate aspects study; (8) unable sign informed consent.",C0205171|C0030705|C2945599|G0000000|G0000000|C0450371|C0441471|C0205081|G0000000|G0000000|C0450371|C0441471|C0520679|C0450371|C0030705|C1554077|C0679823|C0557651|G0000000|C0012634|C0521102|C0037313|G0000000|C0205191|C0521346|C0012634|C0205318|C0020517|C0018787|C0231174|C0027404|C0332182|C0023216|C0026649|G0000000|G0000000|C0002763|G0000000|C0028040|C0039771|G0000000|C0026549|C0243072|C0036557|G0000000|C0597357|C0450442|C0036077|G0000000|C0028754|C3203358|C0039082|G0000000|C0015450|C0000768|G0000000|C1280519|C0199451|G0000000|C0199451|C0439234|G0000000|C0549206|G0000000|C0558080|G0000000|C1547011|C0557651|G0000000|C1299582|C0311392|C1522154|C1511481
"Patients were excluded if they were in care, had a learning disability, were suffering from psychosis, were alcohol or substance dependent or had a coexisting medical condition that might impact their weight (such as diabetes).","Patients excluded care, learning disability, suffering psychosis, alcohol substance dependent coexisting medical condition impact weight (such diabetes).",C0030705|C1554077|C1947933|C0013621|C0231170|C0683278|C0033975|C0001962|C0439861|C0851827|G0000000|C0199168|C0012634|C1825598|C0005910|G0000000|C0011847
Patients between 18 and 45 years of age with a recent (within 1 month) ischaemic stroke are eligible for this study.,Patients 18 45 years age (within 1 month) ischaemic stroke eligible study.,C0030705|C0450371|G0000000|C0001779|G0000000|G0000000|C0475224|C0038454|C1548635|C0557651
"In Indianapolis, 520 letters of invitation were sent; 148 parents responded as interested in enrolling by telephone, return of a form to the school, or e-mail; 140 were eligible for the study; and 112 consented to participate, for an enrollment rate of 22%.","In Indianapolis, 520 letters invitation sent; 148 parents responded enrolling telephone, return form school, e-mail; 140 eligible study; 112 consented participate, enrollment rate 22%.",G0000000|G0000000|C1442061|C0282413|C2826348|C1519246|C1442061|C0030551|G0000000|G0000000|C0039457|C0332156|C0348078|C0036375|C0013849|C1442061|C1548635|C0557651|C1442061|C2711213|G0000000|C1516879|C0871208|C0450371
"Overall, 917 unvaccinated adolescents (389 males, 42.4%; mean age ± standard deviation, 14.0 ± 2.2 years) were randomized 1:1:1 into the following groups: no intervention (n = 334), website educational program only (n = 281), or website plus face to face lesson (n = 302) groups.","Overall, 917 unvaccinated adolescents (389 males, 42.4%; age ± standard deviation, 14.0 ± 2.2 years) randomized 1:1:1 groups: intervention (n = 334), website educational program (n = 281), website lesson (n = 302) groups.",C0282416|C1442061|G0000000|C0205653|C1442061|C0086582|C0450371|C0001779|G0000000|C1442989|C0012727|C0450371|G0000000|G0000000|C0439234|C0034656|G0000000|C0441833|C0886296|C0369718|G0000000|C1442061|C2349146|C0587721|C1709697|C0369718|G0000000|C1442061|C2349146|G0000000|C0369718|G0000000|C1442061|C0441833
"The male proportion was 69.5% and 69.2% for cases and controls, respectively.","The male proportion 69.5% 69.2% controls, respectively.",G0000000|C0086582|C1709707|C0450371|C0450371|C0243148|G0000000
"Patients with metastatic melanoma of cutaneous, mucosal, or unknown primary origin—but not of uveal origin—were eligible.","Patients metastatic melanoma cutaneous, mucosal, unknown primary origin—but uveal origin—were eligible.",C0030705|C0036525|C0025202|C0221912|C0026724|C0439673|C0205225|G0000000|C0042160|G0000000|C1548635
"Cohort members were followed for incidence of pancreatic cancer from enrollment to December 31, 2008; the median follow-up time was 7.1 years.","Cohort incidence pancreatic cancer enrollment December 31, 2008; median follow-up time 7.1 years.",C0599755|C0021149|C0030274|C0006826|C1516879|C3830550|C0450371|G0000000|C0549183|C0589120|C0040223|G0000000|C0439234
"Exclusion criteria included refusal to provide informed consent, any condition requiring hospitalization, a history or evidence of any disorder incompatible with subject safety, definite plans for absence from the site within 28 days, G6PD deficiency, liver transferase levels >2.5-fold above the upper limit of normal, a Fridericia-corrected QT interval of >450 ms, or anemia (hemoglobin level, <8 g/dl).","Exclusion criteria included refusal provide informed consent, condition requiring hospitalization, history evidence disorder incompatible subject safety, definite plans absence site 28 days, G6PD deficiency, liver transferase levels >2.5-fold upper limit normal, Fridericia-corrected QT interval >450 ms, anemia (hemoglobin level, <8 g/dl).",C0680251|C0243161|C0332257|G0000000|C1999230|C1522154|C1511481|C0012634|G0000000|C0019993|C0019664|C3887511|C0012634|C0679426|C0681850|C0036043|C0439544|C0270724|C0332197|C0205145|C0450371|C0439228|G0000000|C0011155|C0023884|C0040676|C0441889|C0332462|C1282910|C0439801|C0205307|C1032715|C1552934|C1272706|C1442061|C0039676|C0002871|C0019046|C0441889|G0000000|C0439267
"Our eligibility criteria included at least 7 hot flashes per day, and at least one missed menstrual cycle or spontaneous or medically-induced menopause which could allow for a heterogeneous group.","Our eligibility criteria included 7 hot flashes day, missed menstrual cycle spontaneous medically-induced menopause heterogeneous group.",G0000000|C0013893|C0243161|C0332257|G0000000|C0444519|C0085635|C0332173|C1705492|C0025344|C1511572|C0205359|C0205263|C0025320|C0019409|C0441833
The median age was 63 years (range: 34–75 years).,The median age 63 (range: 34–75 years).,G0000000|C0549183|C0001779|C0450371|C1514721|G0000000|C0439234
"The primary aim of the present study was to test, via a randomized controlled trial, a self-help intervention for preventing smoking relapse among a vulnerable population of smokers at uniquely high risk of relapse—pregnant and postpartum women.","The primary aim study test, randomized controlled trial, self-help intervention preventing smoking relapse vulnerable population smokers uniquely risk relapse—pregnant postpartum women.",G0000000|C0205225|C1947946|C0557651|C0022885|C0034656|C2587213|C0008976|C0597431|C0886296|C0309872|C0037369|C0035020|G0000000|C0032659|C0337664|G0000000|C0035647|G0000000|C0086839|C0043210
We invited people who fulfilled these criteria to attend a recruitment interview.,We invited people fulfilled criteria attend recruitment interview.,G0000000|G0000000|C0027361|C1550543|C0243161|C1999232|C2949735|C0021822
Less is known regarding the PAP adherence rates in OSA patients in Turkey.,Less PAP adherence rates OSA patients Turkey.,C0439092|C1740167|C1510802|C0871208|C0520679|C0030705|C0041400
Forty-one children with GBS requiring endotracheal mechanical ventilation (MV) within 14 days from disease onset were included.,Forty-one children GBS requiring endotracheal mechanical ventilation (MV) 14 days disease onset included.,C3816449|C0008059|C0018378|G0000000|C0599554|C0443254|C0035203|C0428679|C0450371|C0439228|C0012634|C0206132|C0332257
There is little consensus as to the preferred treatment in newborns.,There consensus preferred treatment newborns.,G0000000|C0376298|C0558295|C0039798|C0021289
These exclusion criteria were chosen to ensure a rural sample and increase the likelihood that sampled villages had a sufficient number of children 6–11 months of age.,These exclusion criteria chosen ensure rural sample increase likelihood sampled villages sufficient children 6–11 months age.,G0000000|C0680251|C0243161|C1707391|C0218063|C0240919|C0370003|C0442805|C0033204|C0441621|C0562518|C0205410|C0008059|G0000000|C0439231|C0001779
"Participants in this study were adult female residents of Dar es Salaam, Tanzania, who were pregnant, between 12 and 27 weeks of gestation, and whose consent to HIV-1 testing led to a diagnosis of HIV-1 infection.","Participants study adult female residents Dar es Salaam, Tanzania, pregnant, 12 27 weeks gestation, consent HIV-1 testing led diagnosis HIV-1 infection.",C0679646|C0557651|C0001675|C0015780|C1320928|C0022595|C0013754|G0000000|C0039298|C0549206|C0450371|C0450371|C0439230|C0032961|C1511481|C0019682|C0039593|C1708698|C0011900|C0019682|C0009450
Radiotherapy varied during the time period covered by the study.,Radiotherapy varied time period covered study.,C0034619|G0000000|C0040223|C0439531|C0439844|C0557651
We carried out a randomised double blind placebo controlled trial in children aged 12-35 months.,We carried randomised double blind placebo controlled trial children aged 12-35 months.,G0000000|C0206243|G0000000|C0205173|C0150108|C0032042|C2587213|C0008976|C0008059|C0001779|C0450371|C0439231
Patients were 18–69 years of age with a modified Fisher grade 3 or 4 SAH (short axis of cisternal blood on computed tomography [CT] ≥4 mm) who were admitted to the emergency department during the first 72 hours after the initial bleeding episode.,Patients 18–69 age modified Fisher grade 3 4 SAH (short axis cisternal blood computed tomography [CT] ≥4 mm) admitted emergency department 72 hours initial bleeding episode.,C0030705|G0000000|C0001779|C0392747|C0325045|C0441800|G0000000|G0000000|C0036001|C1282927|C0004457|C1185718|C0005767|C1441526|C0040395|C0007673|G0000000|G0000000|C0184666|C0013956|C1704729|C0450371|C0439227|C0205265|C0019080|C0332189
Most (90%) experienced penetrative vaginal or anal sexual abuse as a child or adolescent; 87% experienced sexual revictimization in adolescence and/or adulthood.,Most (90%) experienced penetrative vaginal anal sexual abuse child adolescent; 87% experienced sexual revictimization adolescence and/or adulthood.,C0205393|C0450371|C0237607|C0205321|C0042232|C0003461|C0036864|C0013146|C0008059|C0205653|C0450371|C0237607|C0036864|G0000000|C0001578|G0000000|C0700597
"For nineteen of 39 randomized participants, randomization to the other study group would not have changed the antibiotic classes of the assigned regimen.","For nineteen 39 randomized participants, randomization study changed antibiotic classes assigned regimen.",G0000000|C0450337|C0450371|C0034656|C0679646|C0034656|C0557651|C0392747|C0003232|C0456387|C1516050|C0040808
"In addition, mothers of infants requiring specialized management and with gestation less than 36 weeks were not eligible for study enrolment.","In addition, mothers infants requiring specialized management gestation 36 weeks eligible study enrolment.",G0000000|C0332287|C0026591|C0021270|G0000000|C0205555|C0001554|C0032961|C0450371|C0439230|C1548635|C0557651|C1516879
"Eligible participants were at least 18 years of age, able to read and speak English, previously aware of their diagnoses of HIV disease, and deemed physically capable (through clinical screening for Karnofsky performance scores [Karnofsky & Burchenal, 1949] of at least 60) of attending the intervention sessions and completing a 6-month follow-up requirement.","Eligible participants 18 age, read speak English, aware diagnoses HIV disease, deemed physically capable (through clinical screening Karnofsky performance scores [Karnofsky & Burchenal, 1949] 60) attending intervention sessions completing 6-month follow-up requirement.",C1548635|C0679646|C0450371|C0001779|C0034754|C0234856|C0376245|C0004448|C0011900|C0019682|C0012634|G0000000|G0000000|C2698977|G0000000|C0205210|C0220908|C0206065|C0597198|C0449820|C0206065|G0000000|G0000000|G0000000|C0450371|C1547429|C0886296|C1883016|C0205197|C0332177|C0589120|C1514873
"We evaluated a palliative care intervention for PLWH in Mombasa, Kenya.","We evaluated palliative care intervention PLWH Mombasa, Kenya.",G0000000|C0220825|C0587605|C1947933|C0886296|G0000000|G0000000|C0022558
"The study was completed on 22 patients in group 1 (19 female, 3 male; mean age ± SD 22.7 ± 5.5 years), 19 patients in group 2 (9 female, 10 male; mean age ± SD 19.9 ± 4.9 years) and 19 patients in group 3 (16 female, 3 male; mean age ± SD 19.9 ± 7.3 years).","The study completed 22 patients 1 (19 female, 3 male; age ± SD 22.7 ± 5.5 years), 19 patients 2 (9 female, 10 male; age ± SD 19.9 ± 4.9 years) 19 patients 3 (16 female, 3 male; age ± SD 19.9 ± 7.3 years).",G0000000|C0557651|C0205197|C0450371|C0030705|G0000000|C0450371|C0015780|G0000000|C0086582|C0001779|G0000000|C2699239|C0450371|G0000000|G0000000|C0439234|C0450371|C0030705|G0000000|G0000000|C0015780|C0450371|C0086582|C0001779|G0000000|C2699239|C0450371|G0000000|G0000000|C0439234|C0450371|C0030705|G0000000|C0450371|C0015780|G0000000|C0086582|C0001779|G0000000|C2699239|C0450371|G0000000|G0000000|C0439234
"The exclusion criteria were: having congestive heart failure, moderate to severe learning difficulties (as judged by hospital consultant), attended a pulmonary rehabilitation programme in the last 6 months, and severe mobility problems or terminal illness.","The exclusion criteria were: congestive heart failure, moderate severe learning difficulties (as judged hospital consultant), attended pulmonary rehabilitation programme 6 months, severe mobility terminal illness.",G0000000|C0680251|C0243161|G0000000|C0742742|C0018787|C0231174|C0205081|C0205082|C0013621|C1299586|G0000000|C0221191|C0019994|C0009817|C1456498|C0024109|C0034991|C1709697|G0000000|C0439231|C0205082|C0425245|C0205088|C0221423
"9 In the PROACTIVE Feasibility Study (ClinicalTrials.gov {""type"":""clinical-trial"",""attrs"":{""text"":""NCT00951808"",""term_id"":""NCT00951808""}}NCT00951808), 10 eligible patients with SCD hospitalized for pain were randomized to prophylactic transfusion to pre-empt nosocomial acute chest syndrome (ACS) or to standard care.","9 In PROACTIVE Feasibility Study (ClinicalTrials.gov {""type"":""clinical-trial"",""attrs"":{""text"":""NCT00951808"",""term_id"":""NCT00951808""}}NCT00951808), 10 eligible patients SCD hospitalized pain randomized prophylactic transfusion pre-empt nosocomial acute chest syndrome (ACS) standard care.",G0000000|G0000000|G0000000|G0000000|C0557651|C1419208|C0332307|C0450371|C1548635|C0030705|G0000000|C0701159|C0030193|C0034656|C0355642|C0005841|C0332152|C0019994|C0205178|C0817096|C0039082|G0000000|C1442989|C1947933
"Kaohsiung City and its suburbs including four complexes of Tsoying, Tasheh, Jenwu, and Linyuan are in southwestern Taiwan.","Kaohsiung City suburbs including complexes Tsoying, Tasheh, Jenwu, Linyuan southwestern Taiwan.",G0000000|C0008848|C0178856|C0332257|C1704241|G0000000|G0000000|G0000000|G0000000|C1710136|C0039260
"Aboriginal women were hired from the 9 communities to recruit expectant and new mothers to the trial, administer questionnaires and deliver the counseling to mothers in the test communities.","Aboriginal women hired 9 communities recruit expectant mothers trial, administer questionnaires deliver counseling mothers test communities.",C0935542|C0043210|C0031222|G0000000|C0009462|G0000000|C0679138|C0026591|C0008976|C1621583|C0034394|C0308779|C0010210|C0026591|C0022885|C0009462
"Of the 60 individuals randomized to SMART, there were four (6.7%) who attended no sessions.","Of 60 individuals randomized SMART, (6.7%) attended sessions.",G0000000|C0450371|C0027361|C0034656|G0000000|G0000000|C1456498|C1883016
"Seventy children completed the study (29 girls, 41 boys; age 6.6±3.0 years; weight 28.2±11.0 kg; 36 placebo group, 34 probiotic group).","Seventy children completed study (29 girls, 41 boys; age 6.6±3.0 years; weight 28.2±11.0 kg; 36 placebo group, 34 probiotic group).",C3816957|C0008059|C0205197|C0557651|C0450371|C0870604|C0450371|C0870221|C0001779|G0000000|C0005910|G0000000|C0450371|C0032042|C0441833|C0450371|C0525033|C0441833
The study sample will be composed of patients with histologically confirmed primary breast or colon cancer who are scheduled to undergo adjuvant chemotherapy.,The study sample composed patients histologically confirmed primary breast colon cancer scheduled undergo adjuvant chemotherapy.,G0000000|C0557651|C0370003|G0000000|C0030705|C0205462|C0521093|C0205225|C0006141|C0009368|C0006826|C0086960|G0000000|C0001551|C0013216
SUBJECTS: 2064 women aged 50-64 years who had failed to attend for breast screening.,SUBJECTS: 2064 women aged 50-64 failed attend breast screening.,C0681850|G0000000|C0043210|C0001779|C0450371|C0231175|C1999232|C0006141|C0220908
"Exclusion criteria included known major illness (malignancy, active infection and uncontrolled heart failure), pregnancy, iron deficiency anemia, poor control diabetes mellitus (hemoglobin A1c >7.5), current use of melatonin or known allergy of melatonin, acute medical or surgical condition that required hospitalization or operation throughout the study and dementia or psychotic disorder as diagnosed by researchers that interferes with patient's participation in this trial.","Exclusion criteria included major illness (malignancy, active infection uncontrolled heart failure), pregnancy, iron deficiency anemia, poor control diabetes mellitus (hemoglobin A1c >7.5), current melatonin allergy melatonin, acute medical surgical condition required hospitalization operation study dementia psychotic disorder diagnosed researchers interferes patient's participation trial.",C0680251|C0243161|C0332257|C0205082|C0221423|C0006826|C0205177|C0009450|C0205318|C0018787|C0231174|C0032961|C0302583|C0011155|C0002871|C0032854|C0243148|C0011847|G0000000|C0019046|G0000000|G0000000|C0521116|C0025219|C0002111|C0025219|C0205178|C0199168|C0543467|C0012634|C1514873|C0019993|C0543467|C0557651|C0011265|C0004936|C0012634|C0011900|C0035173|C0521102|C0030705|C0679823|C0008976
"Of the four patients who have not met the inclusion criteria, two patients had distortion of the cubital tunnel due to previous trauma to the elbow and two patients were excluded due to recurrent cubital tunnel syndrome.","Of patients met inclusion criteria, patients distortion cubital tunnel previous trauma elbow patients excluded recurrent cubital tunnel syndrome.",G0000000|C0030705|C0268621|C0007637|C0243161|C0030705|C0332482|C0013769|C0337138|C0205156|C0043251|C0013769|C0030705|C1554077|C2945760|C0013769|C0337138|C0039082
"Inclusion criteria were aged 35–50 years and best corrected visual acuity (BCVA) of 20/40 or better in both eyes and no history of diabetes mellitus, intraocular surgery, radiation therapy, corticosteroid therapy, or active use of vitamin supplements.","Inclusion criteria aged 35–50 years corrected visual acuity (BCVA) 20/40 eyes history diabetes mellitus, intraocular surgery, radiation therapy, corticosteroid therapy, active vitamin supplements.",C0007637|C0243161|C0001779|G0000000|C0205202|C0234621|C0750509|G0000000|C0450371|C0015392|C0019664|C0011847|G0000000|C3282905|C0038894|C0034519|C0039798|C0001617|C0039798|C0205177|C0042890|C0242295
"Patients who were pregnant, breast-feeding or had a history of neurologic or oncologic disease, ischemic heart disease, kidney or hepatic insufficiency were also excluded.","Patients pregnant, breast-feeding history neurologic oncologic disease, ischemic heart disease, kidney hepatic insufficiency excluded.",C0030705|C0549206|C0006147|C0019664|C0205494|C0205478|C0012634|C0475224|C0018787|C0012634|C0022646|C0205054|C0231179|C1554077
Subjects who underwent LASIK or PRK surgery within 1 year of screening visit or who were currently using a systemic medication that might affect the ocular surface also were also excluded.,Subjects underwent LASIK PRK surgery 1 screening visit systemic medication affect ocular surface excluded.,C0681850|G0000000|C0752094|C1704804|C0038894|G0000000|C0220908|C0545082|C0205373|C0013227|C0001721|C0015392|C0205148|C1554077
Mothers in the intervention group also received encouragement to have frequent and prolonged skin-to-skin contact with their babies.,Mothers intervention received encouragement frequent prolonged skin-to-skin contact babies.,C0026591|C0886296|C1514756|C0870494|C0332183|C0439590|C0444099|C0332158|C0021270
"Patients were excluded if they were pregnant, if they had end-phase chronic disease, if they had a medical staff decision of limitation of care, if they had preliminary circulatory failure, if they had shock due to a urinary infection without bacteraemia, if they had peritonitis related to peritoneal dialysis or trauma, or if they were participating in another clinical trial.","Patients excluded pregnant, end-phase chronic disease, medical staff decision limitation care, preliminary circulatory failure, shock urinary infection bacteraemia, peritonitis peritoneal dialysis trauma, participating clinical trial.",C0030705|C1554077|C0549206|C0205088|C0205191|C0012634|C0199168|C0851286|C0679006|C0449295|C1947933|C0439611|C0005775|C0231174|C0036974|C0042027|C0009450|C0004610|C0031154|C0031153|C0011945|C0043251|C0679823|C0205210|C0008976
The final convenience sample comprised forty teeth in twenty participant children (aged 5–10 years - weighted mean age of 7.1 years for males and 7.6 years for females) indicated for pulpotomy in bilateral primary molars and fulfilling the inclusion criteria was selected [Table 1].,The final convenience sample comprised forty teeth twenty participant children (aged 5–10 - weighted age 7.1 males 7.6 females) pulpotomy bilateral primary molars fulfilling inclusion criteria selected [Table 1].,G0000000|C0205088|C3831015|C0370003|C2700400|C3816449|C0040426|C0724000|C0679646|C0008059|C0001779|G0000000|G0000000|C0005910|C0001779|G0000000|C0086582|G0000000|C0015780|C0034104|C0238767|C0205225|C0026367|C1550543|C0007637|C0243161|C1707391|C0039224|G0000000
"Controls were selected to match the cases with 1:1 ratio by the following criteria: six-month age categories, sex, within two weeks from the date of the case visit, and the same ward.","Controls selected match 1:1 ratio criteria: six-month age categories, sex, weeks visit, ward.",C0243148|C1707391|C0150103|G0000000|C0456603|C0243161|C0585339|C0001779|C0683312|C0009253|C0439230|C0545082|C1305702
The increase in blood sugar was seen in three patients in rosuvastatin group and two in placebo group.,The increase blood sugar patients rosuvastatin placebo group.,G0000000|C0442805|C0005767|C0007004|C0030705|C0965129|C0032042|C0441833
"Inclusion criteria were age of 18 to 55 years, clinically definite MS (according to McDonald criteria)12 with disease duration of less than two years, RRMS disease course, and baseline Expanded Disability Status Scale score (EDSS) of less than 6.0.","Inclusion criteria age 18 55 years, clinically definite MS (according McDonald criteria)12 disease duration years, RRMS disease course, baseline Expanded Disability Status Scale score (EDSS) 6.0.",C0007637|C0243161|C0001779|C0450371|C0450371|C0439234|G0000000|C0439544|C0039676|C0680240|G0000000|C0243161|C0012634|C0449238|C0439234|C1522002|C0012634|C0750729|C0168634|C0205229|C0231170|C0449438|C0175659|C0449820|C0451246|G0000000
"At screening, patients had to demonstrate a visual analog scale (VAS) score between 40 and 70 mm during the most painful knee movement, and Lequesne's Functional Index (LFI) score greater than 7 points after 7-day withdrawal of usual medication.","At screening, patients demonstrate visual analog scale (VAS) score 40 70 mm painful knee movement, Lequesne's Functional Index (LFI) score 7 7-day withdrawal usual medication.",G0000000|C0220908|C0030705|G0000000|C0234621|C0243071|C0175659|C0042815|C0449820|C0450371|C0450371|G0000000|C0030193|C0022742|C0026649|G0000000|C0205245|C0918012|G0000000|C0449820|G0000000|C0332173|C2349954|C3538928|C0013227
"Controls were unmatched, except for the same age cut-off and recruitment period, to ensure similar level of exposure to circulating influenza.","Controls unmatched, age cut-off recruitment period, ensure level exposure circulating influenza.",C0243148|G0000000|C0001779|C1442160|C2949735|C0439531|C0218063|C0441889|C0274281|C0175630|C0021400
Participation in the study was offered to adult patients (≥ 18 yr) with pancreatic or periampulary neoplasms in whom preoperative imaging and clinical status suggested resectable disease and in whom PD was planned.,Participation study offered adult patients (≥ 18 yr) pancreatic periampulary neoplasms preoperative imaging clinical status suggested resectable disease PD planned.,C0679823|C0557651|C1444648|C0001675|C0030705|G0000000|C0450371|C0439234|C0030274|G0000000|C0027651|C0445204|C0011923|C0205210|C0449438|C1705535|C1514888|C0012634|G0000000|C1301732
16-35 y of age; parity 0-5; expectation to have first or additional pregnancy within next 2 y and without intent to utilize contraception.,16-35 age; parity 0-5; expectation additional pregnancy 2 intent utilize contraception.,C0450371|C0001779|C0030563|G0000000|C0679138|C1524062|C0032961|G0000000|C0162425|G0000000|C0700589
The microbiological ITT (MITT) population was the subset of the ITT population who had at least one Gram-negative pathogen identified on bronchoalveolar lavage (BAL) or mini-BAL at a density >104 CFU/mL with an imipenem MIC <8 μg/mL.,The microbiological ITT (MITT) population subset ITT population Gram-negative pathogen identified bronchoalveolar lavage (BAL) mini-BAL density >104 CFU/mL imipenem MIC <8 μg/mL.,G0000000|C0025953|G0000000|G0000000|C0032659|C1515021|G0000000|C0032659|C0439208|C0450254|C0205396|G0000000|C0022100|C0428249|C3161394|C0178587|C1442061|C0439361|C0020933|C0281162|G0000000|G0000000
"The treatment arms were balanced with gender, the WHO performance status, primary tumour site, Dukes' stage, and radiation therapy given (Table 1).","The treatment arms balanced gender, WHO performance status, primary tumour site, Dukes' stage, radiation therapy (Table 1).",G0000000|C0039798|C0206655|C0205415|C0079399|G0000000|C0597198|C0449438|C0205225|C0027651|C0205145|C1512090|C0205390|C0034519|C0039798|C0039224|G0000000
"Key exclusion criteria included significant risk of suicide, history of serious psychiatric disorder, substantial alcohol use or abuse, pregnancy or breastfeeding, cardiovascular disease within the past 12 months, mean systolic blood pressure >180 mmHg or diastolic blood pressure >110 mm Hg, uncontrolled narrow-angle glaucoma, active liver disease, severe renal impairment and any other medical disorder that might preclude participation as judged by the principal investigator.","Key exclusion criteria included risk suicide, history psychiatric disorder, substantial alcohol abuse, pregnancy breastfeeding, cardiovascular disease 12 months, systolic blood pressure >180 mmHg diastolic blood pressure >110 mm Hg, uncontrolled narrow-angle glaucoma, active liver disease, severe renal impairment medical disorder preclude participation judged principal investigator.",G0000000|C0680251|C0243161|C0332257|C0035647|C0038661|C0019664|C0205487|C0012634|G0000000|C0001962|C0013146|C0032961|C0006147|C0007226|C0012634|C0450371|C0439231|C0039155|C0005767|C0033095|C1442061|C0439475|C0012000|C0005767|C0033095|C1442061|G0000000|C0025424|C0205318|C0205168|C0017601|C0205177|C0023884|C0012634|C0205082|C0022646|C0221099|C0199168|C0012634|G0000000|C0679823|C0221191|C0205225|C0035173
"Eligibility criteria included: age between 6 and 18 months at the time of recruitment; axillary temperature less than or equal 37.5°C, no history of iron supplementation within 2 weeks prior to the day of recruitment, willingness to stay within the study area for at least 2 months, parental consent, ingesting a semi‐solid weaning food and Hb concentrations in the interval of 70–99 g L−1.","Eligibility criteria included: age 6 18 months time recruitment; axillary temperature equal 37.5°C, history iron supplementation 2 weeks prior day recruitment, willingness stay study 2 months, parental consent, ingesting semi‐solid weaning food Hb concentrations interval 70–99 g L−1.",C0013893|C0243161|C0332257|C0001779|G0000000|G0000000|C0040223|C2949735|C0004454|C0005903|C0205163|G0000000|C0019664|C0302583|C0242297|G0000000|C0332152|C0332173|C2949735|C0600109|G0000000|C0557651|G0000000|C0030551|C1511481|C0232478|G0000000|C0043084|C0016452|C0019046|C0086045|C1272706|G0000000
The analysis included 60 567 Chinese men aged 40–74 years at baseline.,The analysis included 60 567 Chinese aged 40–74 baseline.,G0000000|C0002778|C0332257|G0000000|C0008120|C0001779|G0000000|C0168634
"Exclusion criteria were refusal of consent (by relatives), age younger than 18 years or older than 65 years, chronic obstructive pulmonary disease, restrictive respiratory insufficiency, pneumonia, increased intracranial pressure, bronchopleural fistula, the persistence of unstable postsurgical hemodynamics despite appropriate supportive therapy, liver cell failure (Child-Pugh Class B or C), end-stage chronic renal failure on hemodialysis, acute myocardial infarction, and neuromuscular disease.","Exclusion criteria refusal consent (by relatives), age 18 65 years, chronic obstructive pulmonary disease, restrictive respiratory insufficiency, pneumonia, increased intracranial pressure, bronchopleural fistula, persistence unstable postsurgical hemodynamics supportive therapy, liver cell failure (Child-Pugh Class B C), end-stage chronic renal failure hemodialysis, acute myocardial infarction, neuromuscular disease.",C0680251|C0243161|G0000000|C1511481|G0000000|C0080103|C0001779|C0450371|C0450371|C0439234|C0205191|C0549186|C0024109|C0012634|C0443288|C0521346|C0231179|C0032285|C0205217|C0524466|C0033095|C0450194|C0016169|C0546816|C0443343|G0000000|C0019010|C1521721|C0039798|C0023884|C0007634|C0231174|C4050412|C0456387|G0000000|G0000000|C0205088|C0205191|C0022646|C0231174|C0019004|C0205178|C0027061|C0021308|C1979768|C0012634
All participants satisfied the following inclusion criteria: (1) 50 years of age or older; (2) a diagnosis of HIV infection or AIDS; (3) a BDI-II score of 10 or higher; and (4) a score of 75 or greater on the 3MS.,All participants satisfied inclusion criteria: (1) 50 age older; (2) diagnosis HIV infection AIDS; (3) BDI-II score 10 higher; (4) score 75 3MS.,G0000000|C0679646|C0242428|C0007637|C0243161|G0000000|C0450371|C0001779|C0580836|G0000000|C0011900|C0019682|C0009450|C0001175|G0000000|C0006448|C0449820|C0450371|C0205250|G0000000|C0449820|C0450371|G0000000
"Late instar anopheline larvae and all pupae were stored in 98% ethanol and taken to the laboratory for species identification by polymerase chain reaction (PCR).25 Adult vector surveys were implemented in 39 villages (10 in zone 1, 11 in zone 2, 9 in zone 3, and 9 in zone 4) at two-week intervals from July through November in 2005 and for the duration of larviciding in the intervention years.","Late instar anopheline larvae pupae stored 98% ethanol laboratory species identification polymerase chain reaction (PCR).25 Adult vector surveys implemented 39 villages (10 zone 1, 11 zone 2, 9 zone 3, 9 zone 4) two-week intervals July November 2005 duration larviciding intervention years.",C0205087|G0000000|G0000000|C0023047|C0034120|C1698986|C0450371|C0001962|C0022877|C1705920|C0020792|C1335439|C0337112|C0443286|C0032520|C0001675|C0086022|C0038951|G0000000|C0450371|C0562518|C0450371|C1710706|G0000000|C0450371|C1710706|G0000000|G0000000|C1710706|G0000000|G0000000|C1710706|G0000000|C0205448|C1272706|C3829447|C3828767|G0000000|C0449238|G0000000|C0886296|C0439234
"The study population included men and women aged ≥40 years with moderate-to-severe COPD (GOLD II or III as defined in the GOLD 2010 strategy), current or ex-smokers with a smoking history of at least 10 pack-years, post-bronchodilator forced expiratory volume in 1 s (FEV1) ≥30% and <80% of predicted value, and post-bronchodilator FEV1 to forced vital capacity (FVC) ratio <0.70 at screening.","The study population included women aged ≥40 years moderate-to-severe COPD (GOLD II III defined GOLD 2010 strategy), current ex-smokers smoking history 10 pack-years, post-bronchodilator forced expiratory volume 1 s (FEV1) ≥30% <80% predicted value, post-bronchodilator FEV1 forced vital capacity (FVC) ratio <0.70 screening.",G0000000|C0557651|C0032659|C0332257|C0043210|C0001779|G0000000|C0205081|C0024117|C0018026|G0000000|C0439070|C1704788|C0018026|G0000000|C0679199|C0521116|C0337671|C0037369|C0019664|C0450371|C1277691|C2599594|C0441722|C0231800|C0449468|G0000000|G0000000|G0000000|C0450371|C0681842|C1522609|C2599594|G0000000|C0441722|C0442732|C1516240|C3714541|C0456603|C0450371|C0220908
"Subjects had a history of a first time single left-hemispheric chronic stroke (≥6 months post-stroke-onset), had mild-to-severe non-fluent aphasia, were premorbidly right-handed (Edinburgh Handedness Inventory) (Oldfield, 1971), and had no concurrent history of neurological, psychiatric or unstable medical conditions, or any contraindication to either MRI or tDCS (Table (Table1).1).","Subjects history time single left-hemispheric chronic stroke (≥6 months post-stroke-onset), mild-to-severe non-fluent aphasia, premorbidly right-handed (Edinburgh Handedness Inventory) (Oldfield, 1971), concurrent history neurological, psychiatric unstable medical conditions, contraindication MRI tDCS (Table (Table1).1).",C0681850|C0019664|C0040223|C0037179|C0205091|C0205191|C0038454|G0000000|C0439231|C0687676|C2945599|C1518422|C0003537|G0000000|C0230370|G0000000|C0023114|C0021941|G0000000|G0000000|C0205420|C0019664|C0205494|C0205487|C0443343|C0199168|C0012634|C0522473|C0024485|C3850024|C0039224|G0000000
The median absolute neutrophil count at presentation was less than 100/μL for both groups.,The median absolute neutrophil count presentation 100/μL groups.,G0000000|C0549183|C0205344|C0027950|C0750480|C0449450|G0000000|C0441833
"Inclusion criteria were: adults with advanced (stage IV) NSCLC confirmed by histology or cytology, an Eastern Cooperative Oncology Group (ECOG) performance status of 0–2, and scheduled to receive first-line palliative chemotherapy.","Inclusion criteria were: adults advanced (stage IV) NSCLC confirmed histology cytology, Eastern Cooperative Oncology Group (ECOG) performance status 0–2, scheduled receive first-line palliative chemotherapy.",C0007637|C0243161|G0000000|C0001675|C0205179|C0205390|C0022326|C0007131|C0521093|C0019638|C0010818|C1707877|C0679729|C0027651|C0441833|C0430797|C0597198|C0449438|G0000000|C0086960|C1514756|C0205435|C0587605|C0013216
"After screening and consent, participants were randomized to one of three groups: progressive strength training (PST) combined with falls prevention education; movement strategy training (MST) combined with falls prevention education; or a control group (life skills; LS).","After screening consent, participants randomized groups: progressive strength training (PST) combined falls prevention education; movement strategy training (MST) combined falls prevention education; control (life skills; LS).",G0000000|C0220908|C1511481|C0679646|C0034656|C0441833|C0205329|C0237897|C0040607|C1152487|C0205195|C0000921|C0199176|C0013621|C0026649|C0679199|C0040607|C3891283|C0205195|C0000921|C0199176|C0013621|C0243148|C0376558|C0678856|C0023668
"Briefly, healthy girls and young women aged 9-25 y at the time of first vaccination in the study were stratified by age (9-14, 15-19, 20-25 y) and randomized (1:1:1:1) to receive 3 doses of the licensed HPV-16/18 AS04-adjuvanted vaccine formulation (containing 20 µg each of HPV-16 and −18 L1 VLPs adjuvanted with AS04) at 0, 1 and 6 months, 2 doses of the licensed vaccine formulation at 0 and 6 months, 2 doses of an alternative vaccine formulation (containing 40 µg each of HPV-16 and −18 L1 VLPs adjuvanted with AS04) at 0 and 6 months, or 2 doses of the alternative vaccine formulation at 0 and 2 months.","Briefly, healthy girls women aged 9-25 time vaccination study stratified age (9-14, 15-19, 20-25 y) randomized (1:1:1:1) receive 3 doses licensed HPV-16/18 AS04-adjuvanted vaccine formulation (containing 20 µg HPV-16 −18 L1 VLPs adjuvanted AS04) 0, 1 6 months, 2 doses licensed vaccine formulation 0 6 months, 2 doses alternative vaccine formulation (containing 40 µg HPV-16 −18 L1 VLPs adjuvanted AS04) 0 6 months, 2 doses alternative vaccine formulation 0 2 months.",G0000000|C3898900|C0870604|C0043210|C0001779|C0450371|C0040223|C0042196|C0557651|C0205363|C0001779|C0450371|C0450371|C0450371|G0000000|C0034656|G0000000|C1514756|G0000000|C0178602|C0023636|C0021344|C0001551|C0042210|C0524527|C0332256|C0450371|G0000000|C0021344|G0000000|C0441916|C0262304|C0001551|G0000000|G0000000|G0000000|G0000000|C0439231|G0000000|C0178602|C0023636|C0042210|C0524527|G0000000|G0000000|C0439231|G0000000|C0178602|C1523987|C0042210|C0524527|C0332256|C0450371|G0000000|C0021344|G0000000|C0441916|C0262304|C0001551|G0000000|G0000000|G0000000|C0439231|G0000000|C0178602|C1523987|C0042210|C0524527|G0000000|G0000000|C0439231
All patients provided written informed consent.,All patients provided written informed consent.,G0000000|C0030705|C1999230|C0043266|C1522154|C1511481
"Placebo], four armed) study in patients with therapy-resistant common warts on either hands and/or feet.","Placebo], armed) study patients therapy-resistant common warts hands and/or feet.",C0032042|C0206655|C0557651|C0030705|C0039798|C0205214|C1367460|C0018563|G0000000|C0016504
Completion of postsurgical chemotherapy (principally Dukes Stage C patients).,Completion postsurgical chemotherapy (principally Dukes Stage C patients).,C0205197|G0000000|C0013216|G0000000|C1512090|C0205390|G0000000|C0030705
"Three hundred pregnant women were recruited at the Department of Obstetrics and Gynaecology, San Camillo Forlanini Hospital, Rome, Italy, before the 8th week of pregnancy.","Three pregnant women recruited Department Obstetrics Gynaecology, San Camillo Forlanini Hospital, Rome, Italy, 8th week pregnancy.",C0205449|C0549206|C0043210|G0000000|C1704729|C0028773|C0018417|C1826357|G0000000|G0000000|C0019994|C0035831|C0022277|G0000000|C0332174|C0032961
Participant flow (combined studies).,Participant flow (combined studies).,C0679646|C0806140|C0205195|C0947630
"Overall, nivolumab alone and the combination of nivolumab and ipilimumab are promising treatment options for previously untreated advanced melanoma.","Overall, nivolumab combination nivolumab ipilimumab promising treatment options untreated advanced melanoma.",C0282416|C3657270|C0205195|C3657270|C1367202|C1555307|C0039798|C1518601|C0332155|C0205179|C0025202
Eligible patients were identified at weekly tumor boards and qualified based on (1) a late-stage cancer diagnosis within 100 days; (2) postbiopsy or surgery with additional treatment recommended; (3) at least one self-reported chronic condition; and (4) age 21 years or older.,Eligible patients identified weekly tumor boards qualified based (1) late-stage cancer diagnosis 100 days; (2) postbiopsy surgery additional treatment recommended; (3) self-reported chronic condition; (4) age 21 older.,C1548635|C0030705|C0205396|C0332174|C0027651|C0972401|G0000000|C1527178|G0000000|C1279941|C0006826|C0011900|C1442061|C0439228|G0000000|G0000000|C0038894|C1524062|C0039798|C0034866|G0000000|C0681906|C0205191|C0012634|G0000000|C0001779|C0450371|C0580836
"In Mali and Senegal, over one percent of women die giving birth in referral hospitals across the region, in places where comprehensive EmOC is available [4].","In Mali Senegal, percent women die birth referral hospitals region, comprehensive EmOC [4].",G0000000|C0024581|C0036644|C0439165|C0043210|C0011065|C0005615|C0034927|C0019994|C0017446|C1880156|G0000000|G0000000
"Firstly, we included everyone who started in the cohort, whether or not they were followed up (intention to treat analysis).","Firstly, included started cohort, (intention treat analysis).",C1279901|C0332257|C1272689|C0599755|C0162425|C0087111|C0002778
The sample consisted of 40 primary molars from 29 children aged four to seven years.,The sample consisted 40 primary molars 29 children aged years.,G0000000|C0370003|C0332529|C0450371|C0205225|C0026367|C0450371|C0008059|C0001779|C0439234
"In 23 families, both parents took part in the intervention; however only one of the parents was included in the study.","In 23 families, parents intervention; parents included study.",G0000000|C0450371|C0015576|C0030551|C0886296|C0030551|C0332257|C0557651
The curriculum focuses on a specific concern that emerged from our previous work: that economically and educationally disadvantaged mothers need help in delaying the early introduction of solids to their infants [10].,The curriculum focuses specific concern emerged previous work: economically educationally disadvantaged mothers delaying introduction solids infants [10].,G0000000|C0010478|C0205234|C0205369|C2699424|G0000000|C0205156|C0043227|C0013556|G0000000|C0012613|C0026591|C0205421|C1293116|C0205208|C0021270|C0450371
"Correlation between axial length growth-rate during the 12-months placebo controlled trial and the observation period before intervention, shown as mean values for right and left eye in each of the participants in the placebo group (p < 0.01) Tables 1 and and22 show axial growth, myopia progression, and change in corneal curvature in the two stratification layers.","Correlation axial length growth-rate 12-months placebo controlled trial observation period intervention, values left eye participants placebo (p < 0.01) Tables 1 and22 axial growth, myopia progression, change corneal curvature stratification layers.",C1707520|C0205131|C1444754|C0449249|C0450371|C0032042|C2587213|C0008976|C0302523|C0439531|C0886296|C0042295|C0205091|C0015392|C0679646|C0032042|G0000000|C0039224|G0000000|G0000000|C0205131|C0018270|C0027092|C0242656|C0392747|C0010031|G0000000|C1514983|C0934502
"According to ‘The 2012 annual screening and intervention project “Workbook of Stroke High Risk Population”’, the participants with high risk of ischemic stroke should meet two of following items (1) to (7) or item (8): (1) have a history of high blood pressure (systolic/diastolic pressure ≥ 140/90 mmHg), or be taking antihypertensive drugs; (2) have atrial fibrillation; (3) smoke (at least one cigarette each day for one year); (4) have dyslipidemia; (5) have diabetes mellitus; (6) be obviously overweight or obese (BMI ≥ 24 kg/m2); (7) have a family history of stroke (a stroke history in three generations); (8) have a history of transient ischemic attack (TIA).","According ‘The 2012 annual screening intervention project “Workbook Stroke High Risk Population”’, participants risk ischemic stroke meet items (1) (7) item (8): (1) history blood pressure (systolic/diastolic pressure ≥ 140/90 mmHg), antihypertensive drugs; (2) atrial fibrillation; (3) smoke (at cigarette day year); (4) dyslipidemia; (5) diabetes mellitus; (6) overweight obese (BMI ≥ 24 kg/m2); (7) family history stroke (a stroke history generations); (8) history transient ischemic attack (TIA).",C0680240|G0000000|G0000000|C0332181|C0220908|C0886296|C1709701|G0000000|C0038454|C0205250|C0035647|G0000000|C0679646|C0035647|C0475224|C0038454|C1550543|C1551338|G0000000|G0000000|C1551338|G0000000|G0000000|C0019664|C0005767|C0033095|C0039155|C0033095|G0000000|C1442061|C0439475|C0003364|C0013227|G0000000|C0018792|C0232197|G0000000|C0037366|G0000000|C0677453|C0332173|C0439234|G0000000|C0242339|G0000000|C0011847|G0000000|G0000000|C0497406|C0028754|G0000000|G0000000|C0450371|C0022718|G0000000|C0015576|C0019664|C0038454|G0000000|C0038454|C0019664|C0079411|G0000000|C0019664|C0040704|C0475224|C0277793|C0007787
These patients were recruited from 72 of the 97 initial centres in 17 of the 20 initial countries.,These patients recruited 72 97 initial centres 17 20 initial countries.,G0000000|C0030705|G0000000|C0450371|C0450371|C0205265|C0205099|C0450371|C0450371|C0205265|C0454664
"Data exchange in the intervention group was markedly different from the pattern in the usual care group, with participants in the intervention group sharing an average of 30 readings per month and with more than 75% ongoing participation throughout the 6-month study, whereas only 20% of the control group brought home logs to the clinic visits.","Data exchange intervention markedly pattern usual care group, participants intervention sharing average 30 readings month 75% ongoing participation 6-month study, 20% control brought logs clinic visits.",C1511726|C0678640|C0886296|C0522501|C0449774|C3538928|C1947933|C0441833|C0679646|C0886296|C0237876|C1510992|C0450371|C0034754|C0332177|C0450371|C0549178|C0679823|C0332177|C0557651|C0450371|C0243148|C0332302|C1708728|C0002424|C0545082
All parents were satisfied with the asthma care received.,All parents satisfied asthma care received.,G0000000|C0030551|C0242428|C0004096|C1947933|C1514756
"In Season 1, eligible participants were enrolled at 37 centers, and in Season 2, eligible participants were enrolled at 44 centers.","In Season 1, eligible participants enrolled 37 centers, Season 2, eligible participants enrolled 44 centers.",G0000000|C0036497|G0000000|C1548635|C0679646|G0000000|C0450371|C0205099|C0036497|G0000000|C1548635|C0679646|G0000000|C0450371|C0205099
Lavender oil also had a positive effect on BPSD in another study.,Lavender oil positive BPSD study.,C0524903|C0028908|C0439178|G0000000|C0557651
"Patients with cystic fibrosis (CF), who had documented clinical, radiologic, genotypic features and abnormal sweat test results (sweat sodium and chloride >60 mmol/L) [13], had been excluded.","Patients cystic fibrosis (CF), documented clinical, radiologic, genotypic features abnormal sweat test (sweat sodium chloride >60 mmol/L) [13], excluded.",C0030705|C0205207|C0016059|C0009738|C1301725|C0205210|C0034599|C0017431|C1521970|C0205161|C0038984|C0022885|C0038984|C0037473|C0008203|G0000000|C0450371|C1554077
"Patients with T2DM could participate if they had moderate to severe chronic renal insufficiency (eGFR <50 mL/min/1.73 m2 using the Modification of Diet in Renal Disease equation), were not on dialysis and unlikely to require dialysis for the duration of the study, had an A1C ≥7.0 and ≤9.0%, and were ≥30 years of age at the screening visit.","Patients T2DM participate moderate severe chronic renal insufficiency (eGFR <50 mL/min/1.73 m2 Modification Diet Renal Disease equation), dialysis require dialysis duration study, A1C ≥7.0 ≤9.0%, ≥30 age screening visit.",C0030705|G0000000|G0000000|C0205081|C0205082|C0205191|C0022646|C0231179|C1739039|C0450371|C0439445|C0025885|C0392747|C0012155|C0022646|C0012634|C0552449|C0011945|G0000000|C0011945|C0449238|C0557651|G0000000|G0000000|G0000000|G0000000|C0001779|C0220908|C0545082
"METHODS—A randomised, controlled, clinical trial was conducted at the neonatal intensive care unit of the Royal Women's Hospital, Melbourne, of infants with birthweights between 600 and 1250 g, ventilated via an endotracheal tube for more than 12 hours, requiring less than 50% oxygen, a ventilator rate ⩽ 20/minute, considered by the clinical management team to be ready for extubation.","METHODS—A randomised, controlled, clinical trial conducted neonatal intensive care unit Royal Women's Hospital, Melbourne, infants birthweights 600 1250 g, ventilated endotracheal tube 12 hours, requiring 50% oxygen, ventilator rate ⩽ 20/minute, considered clinical management team ready extubation.",G0000000|G0000000|C2587213|C0205210|C0008976|C0004927|C1552240|C0162425|C1947933|C0439148|G0000000|C0043210|C0019994|G0000000|C0021270|C0005612|C1442061|G0000000|C0439267|C0231923|C0599554|C0175730|C0450371|C0439227|G0000000|C0450371|C0030054|C0087153|C0871208|G0000000|C0450371|C0750591|C0205210|C0001554|C0871489|C1318963|C0553891
The presence of a developmental ID with an IQ of ≤ 70.,The presence developmental ID IQ ≤ 70.,G0000000|C0150312|C0458003|C0600091|G0000000|G0000000|C0450371
Comparison of R-appliance and Anterior Inclined Bite Plate (AIBP) group measurements Figures 3 and and44 show the same patient before treatment and after R-appliance treatment.,Comparison R-appliance Anterior Inclined Bite Plate (AIBP) measurements Figures 3 and44 patient treatment R-appliance treatment.,C1707455|C0205090|C0205094|G0000000|C0005658|C0005971|C1425525|C0242485|G0000000|G0000000|G0000000|C0030705|C0039798|C0205090|C0039798
Participants were recruited in the waiting areas of 5 health clinics in metropolitan Atlanta between 2010 and 2012.,Participants recruited waiting 5 health clinics metropolitan Atlanta 2010 2012.,C0679646|G0000000|C1610166|G0000000|C0018684|C0442592|C0599587|C2993063|G0000000|G0000000
"Subjects with MGD stage 1 or 2, as defined by the Meibomian Gland Workshop,3 were included.","Subjects MGD stage 1 2, defined Meibomian Gland Workshop,3 included.",C0681850|G0000000|C0205390|G0000000|G0000000|C1704788|G0000000|C1285092|C0242262|C0332257
A series of 97 patients diagnosed with primary GCTs of the ovary treated or referred after primary treatment to MITO centres from 1965 to 2008 were retrospectively analysed.,A series 97 patients diagnosed primary GCTs ovary treated referred primary treatment MITO centres 1965 2008 retrospectively analysed.,G0000000|C0205549|C0450371|C0030705|C0011900|C0205225|C3538813|C0029939|C1522326|C0205543|C0205225|C0039798|C0002475|C0205099|G0000000|G0000000|G0000000|G0000000
"Girls aged 9–17 years (ClinicalTrials.gov, {""type"":""clinical-trial"",""attrs"":{""text"":""NCT00996125"",""term_id"":""NCT00996125""}}NCT00996125) received vaccine (n = 374) or control (n = 376) and women aged 26–45 years ({""type"":""clinical-trial"",""attrs"":{""text"":""NCT01277042"",""term_id"":""NCT01277042""}}NCT01277042) received vaccine (n = 606) or control (n = 606) at months 0, 1, and 6.","Girls aged 9–17 (ClinicalTrials.gov, {""type"":""clinical-trial"",""attrs"":{""text"":""NCT00996125"",""term_id"":""NCT00996125""}}NCT00996125) received vaccine (n = 374) control (n = 376) women aged 26–45 ({""type"":""clinical-trial"",""attrs"":{""text"":""NCT01277042"",""term_id"":""NCT01277042""}}NCT01277042) received vaccine (n = 606) control (n = 606) months 0, 1, 6.",C0870604|C0001779|G0000000|C1419208|C0332307|C1514756|C0042210|C0369718|G0000000|C1442061|C0243148|C0369718|G0000000|C1442061|C0043210|C0001779|G0000000|C0332307|C1514756|C0042210|C0369718|G0000000|C1442061|C0243148|C0369718|G0000000|C1442061|C0439231|G0000000|G0000000|G0000000
"A shift in epilepsy surgery towards the pediatric population has, however, been set in motion over the last years and the proportion of young children who undergo epilepsy surgery is increasing [36].","A shift epilepsy surgery pediatric population has, however, set motion proportion children undergo epilepsy surgery increasing [36].",G0000000|C0333051|C0014544|C0038894|C0030755|C0032659|G0000000|G0000000|C0036849|C0026597|C1709707|C0008059|G0000000|C0014544|C0038894|C0442808|C0450371
"The inclusion criteria were as follows: aged more than 40 years old; confirmed diagnosis of COPD according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines (postbronchodilator forced expiratory volume in 1 second (FEV1)/FVC ratio ≤ 70%, and a postbronchodilator FEV1 with 30% and 80% predicted);[1] a history of COPD with more than 12 months; clinical stable COPD within 1 month before the study; no medication changes within the 3 months prior the study; and the provision of written informed consent prior to enrollment into the study.","The inclusion criteria follows: aged 40 old; confirmed diagnosis COPD Global Initiative Chronic Obstructive Lung Disease (GOLD) guidelines (postbronchodilator forced expiratory volume 1 (FEV1)/FVC ratio ≤ 70%, postbronchodilator FEV1 30% 80% predicted);[1] history COPD 12 months; clinical stable COPD 1 month study; medication 3 months prior study; provision written informed consent prior enrollment study.",G0000000|C0007637|C0243161|C0332283|C0001779|C0450371|C0580836|C0521093|C0011900|C0024117|C0205246|C0424093|C0205191|C0549186|C0024109|C0012634|C0018026|C0162791|C2599594|C0441722|C0231800|C0449468|G0000000|C3714541|C0456603|G0000000|C0450371|C2599594|G0000000|C0450371|C0450371|C0681842|C0019664|C0024117|C0450371|C0439231|C0205210|C0205360|C0024117|G0000000|C0332177|C0557651|C0013227|G0000000|C0439231|C0332152|C0557651|C1549071|C0043266|C1522154|C1511481|C0332152|C1516879|C0557651
All potential participants were referred from rheumatology clinics and met the following entry criteria: (1) American College of Rheumatology (ACR) classification criteria for FM(5); (2) weekly average pain intensity score ≥ 4 (as recorded from the wrist watch monitor); (3) on stable doses of medications for FM ≥ 4 weeks; and (4) between 18–65 years old.,All potential participants referred rheumatology clinics met entry criteria: (1) American College Rheumatology (ACR) classification criteria FM(5); (2) weekly average pain intensity score ≥ 4 (as recorded wrist watch monitor); (3) stable doses medications FM ≥ 4 weeks; (4) 18–65 old.,G0000000|C3245505|C0679646|C0205543|C0035452|C0442592|C0268621|C1705654|C0243161|G0000000|C0596070|C0557806|C0035452|C1412134|C0008902|C0243161|C3540627|G0000000|C0332174|C1510992|C0030193|C0522510|C0449820|G0000000|G0000000|G0000000|C0034869|C0043262|C0699864|C0030695|G0000000|C0205360|C0178602|C0013227|C3540627|G0000000|G0000000|C0439230|G0000000|G0000000|C0580836
"RRs were adjusted for baseline age, smoking status, education, and corresponding baseline second molar measures.","RRs adjusted baseline age, smoking status, education, baseline molar measures.",C1849334|C0456081|C0168634|C0001779|C0037369|C0449438|C0013621|C0168634|C0026367|C0079809
"Therefore, we will recruit only the high-CVD-risk patients stratified by using the Framingham general CVD risk scoring system (10-year risk).","Therefore, recruit high-CVD-risk patients stratified Framingham CVD risk scoring system (10-year risk).",G0000000|G0000000|C0332167|C0030705|C0205363|C3166866|C0007222|C0035647|C0449820|C0449913|C0450371|C0035647
Participants were from central Pennsylvania and were part of a longitudinal study of the health and development of young girls.,Participants central Pennsylvania longitudinal study health development girls.,C0679646|C0205099|C0030853|C0205127|C0557651|C0018684|C0243107|C0870604
A total of 129 patients were randomised.,A total 129 patients randomised.,G0000000|C0439175|C1442061|C0030705|G0000000
"Atopic dermatitis, a chronic recurrent disease, is frequently encountered in clinical practice.","Atopic dermatitis, chronic recurrent disease, frequently encountered clinical practice.",C0392707|C0011603|C0205191|C2945760|C0012634|C0332183|C0545082|C0205210|C0237607
"Present study was a double-blind randomized controlled trial, which was conducted, between May, 2012 and January, 2012, on 140 nulliparous pregnant women who had been referred to “Shahid Beheshti” hospital in Isfahan, Iran.","Present study double-blind randomized controlled trial, conducted, May, 2012 January, 2012, 140 nulliparous pregnant women referred “Shahid Beheshti” hospital Isfahan, Iran.",C0150312|C0557651|C0013072|C0034656|C2587213|C0008976|C0004927|G0000000|G0000000|C3829466|G0000000|C1442061|C0425979|C0549206|C0043210|C0205543|G0000000|G0000000|C0019994|G0000000|C0022065
All children 1–35 mo of age in October 2001 were eligible for enrollment.,All children 1–35 mo age October 2001 eligible enrollment.,G0000000|C0008059|G0000000|C0026544|C0001779|C3828732|G0000000|C1548635|C1516879
"Among the 144 eligible patients, 93 (65%) were enrolled and 90 (63%) were randomized and started on the standardized haloperidol regimen.","Among 144 eligible patients, 93 (65%) enrolled 90 (63%) randomized started standardized haloperidol regimen.",G0000000|C1442061|C1548635|C0030705|C0450371|C0450371|G0000000|C0450371|C0450371|C0034656|C1272689|G0000000|C0018546|C0040808
"Among the 42 cases of first episode type, 16 were males and 26 females with average age of 31.4 years.","Among 42 episode type, 16 males 26 females average age 31.4 years.",G0000000|C0450371|C0332189|C0332307|C0450371|C0086582|C0450371|C0015780|C1510992|C0001779|C0450371|C0439234
Eligible patients are those aged 18 and over presenting to their GP who are daily or weekly smokers and who are able to give informed consent.,Eligible patients aged 18 GP daily weekly smokers informed consent.,C1548635|C0030705|C0001779|C0450371|C3811116|C0332173|C0332174|C0337664|C1522154|C1511481
"Trial assessment schedules Baseline, individual‐level analysis will compare sociodemographic characteristics including age, gender, socioeconomic status, duration of epilepsy and prior seizure frequency in the two arms.","Trial assessment schedules Baseline, individual‐level analysis compare sociodemographic characteristics including age, gender, socioeconomic status, duration epilepsy prior seizure frequency arms.",C0008976|C1261322|C0086960|C0168634|G0000000|C0002778|C1707455|G0000000|C1521970|C0332257|C0001779|C0079399|C0748878|C0449438|C0449238|C0014544|C0332152|C0036572|C0376249|C0206655
"In the case of a respiratory infection or COPD exacerbation during the run-in period, the latter may be extended up to 4 weeks to allow for randomization after the respiratory infection or COPD exacerbation is resolved.","In respiratory infection COPD exacerbation run-in period, extended 4 weeks randomization respiratory infection COPD exacerbation resolved.",G0000000|C0521346|C0009450|C0024117|G0000000|C3274438|C0439531|C0231448|G0000000|C0439230|C0034656|C0521346|C0009450|C0024117|G0000000|C1514893
We performed an updated meta-analysis of randomized placebo-controlled trials testing memantine monotherapy for patients with Alzheimer’s disease (AD).,We performed updated meta-analysis randomized placebo-controlled trials testing memantine monotherapy patients Alzheimer’s disease (AD).,G0000000|C0884358|C1519814|C0282458|C0034656|C1706408|C0008976|C0039593|C0025242|G0000000|C0030705|G0000000|C0012634|G0000000
"The study medications were administered to 328 residents for up to 8 weeks, with no statistically significant differences in the frequencies of gastrointestinal or central nervous system symptoms between the groups.","The study medications administered 328 residents 8 weeks, statistically differences frequencies gastrointestinal central nervous system symptoms groups.",G0000000|C0557651|C0013227|C1521801|C1442061|C1320928|G0000000|C0439230|C0038215|C1705241|C0439603|C0521362|C0205099|C0027769|C0449913|C0683368|C0441833
Mild to moderately demented patients with a probable AD diagnosis and their caregivers were recruited and consented.,Mild moderately demented patients probable AD diagnosis caregivers recruited consented.,C2945599|C0205081|C0860630|C0030705|C0033204|G0000000|C0011900|C0085537|G0000000|C2711213
"For selecting the required sample size, a total of 1596 adolescent school girls in nine selected schools of Shimla district of Himachal Pradesh were screened for anemia.","For selecting required sample size, total 1596 adolescent school girls selected schools Shimla district Himachal Pradesh screened anemia.",G0000000|C1707391|C1514873|C0370003|C0456389|C0439175|G0000000|C0205653|C0036375|C0870604|C1707391|C0036375|G0000000|G0000000|G0000000|G0000000|C0220908|C0002871
"Exclusion criteria were treatable causes of atrial fibrillation, previous stroke, rheumatic valvular disease, myocardial infarction or cardiovascular surgery in past year, cardiomyopathy (left ventricular ejection fraction <40%), chronic heart failure, cardiac aneurysm, history of systemic embolism, retinal infarction, coumarin use in the past three months, contraindications for aspirin or coumarin (haemoglobin concentration <7.0 mmol/l, ventricular or duodenal ulcer in the past three years, gastrointestinal or urogenital bleeding in the past year, aspirin intolerance, coagulation disorder, and severe hepatic or renal disease), pacemaker, and a life expectancy less than two years.","Exclusion criteria treatable atrial fibrillation, previous stroke, rheumatic valvular disease, myocardial infarction cardiovascular surgery year, cardiomyopathy (left ventricular ejection fraction <40%), chronic heart failure, cardiac aneurysm, history systemic embolism, retinal infarction, coumarin months, contraindications aspirin coumarin (haemoglobin concentration <7.0 mmol/l, ventricular duodenal ulcer years, gastrointestinal urogenital bleeding year, aspirin intolerance, coagulation disorder, severe hepatic renal disease), pacemaker, life expectancy years.",C0680251|C0243161|G0000000|C0018792|C0232197|C0205156|C0038454|G0000000|C0184252|C0012634|C0027061|C0021308|C0007226|C0038894|C0439234|C0878544|C0205091|C0018827|C0302131|C1264633|C0450371|C0205191|C0018787|C0231174|C0018787|C0002940|C0019664|C0205373|C0013922|C0035298|C0021308|C0010206|C0439231|C0079164|C0004057|C0010206|C0019046|C0004268|G0000000|C1532563|C0018827|C0013303|C0041582|C0439234|C0521362|C0042066|C0019080|C0439234|C0004057|C0231199|C0005778|C0012634|C0205082|C0205054|C0022646|C0012634|C0030163|C0376558|C0679138|C0439234
The inclusion criteria for the current study are as follows: 1) patients who were diagnosed with hemiplegia due to stroke (onset time of less than six weeks) and have no past history of stroke; 2) patients who could perform an active extension of the affected wrist and more than two fingers at an angle of >10° and an active abduction of the affected thumb at an angle of >10°; 3) patients who can make a simple communication; 4) patients who can receive care by guardians or caregivers; and 5) patients who can maintain a sitting position for more than 30 minutes.,The inclusion criteria current study follows: 1) patients diagnosed hemiplegia stroke (onset time weeks) history stroke; 2) patients perform active extension wrist fingers angle >10° active abduction thumb angle >10°; 3) patients simple communication; 4) patients receive care guardians caregivers; 5) patients maintain sitting position 30 minutes.,G0000000|C0007637|C0243161|C0521116|C0557651|C0332283|G0000000|C0030705|C0011900|C0018991|C0038454|C0206132|C0040223|C0439230|C0019664|C0038454|G0000000|C0030705|C0884358|C0205177|C0231448|C0043262|C0016129|C0205143|G0000000|C0205177|C0086505|C0040067|C0205143|G0000000|G0000000|C0030705|C0205352|C0009452|G0000000|C0030705|C1514756|C1947933|C1274041|C0085537|G0000000|C0030705|C0024501|C0277814|C0733755|C0450371|C0439232
Reasons for exclusion were: preexisting medical condition; current vitamin D supplement use; anti-convulsant or anti-mycobacterial medications; severe anemia (hemoglobin concentration <70 g/L); hypertension at enrollment (systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg on at least two measurements); major risk factors for preterm delivery or pregnancy complications; or previous delivery of an infant with a congenital anomaly or perinatal death.,Reasons exclusion were: preexisting medical condition; current vitamin D supplement use; anti-convulsant anti-mycobacterial medications; severe anemia (hemoglobin concentration <70 g/L); hypertension enrollment (systolic blood pressure ≥140 mmHg diastolic blood pressure ≥90 mmHg measurements); major risk factors preterm delivery pregnancy complications; previous delivery infant congenital anomaly perinatal death.,C0392360|C0680251|G0000000|C2347662|C0199168|C0012634|C0521116|C0042890|C0073187|C0242295|C0042153|C0009950|C0521015|C0013227|C0205082|C0002871|C0019046|C0004268|C0450371|C0439294|C0020538|C1516879|C0039155|C0005767|C0033095|G0000000|C0439475|C0012000|C0005767|C0033095|G0000000|C0439475|C0242485|C0205082|C0035647|C1521761|C0151526|C0011209|C0032961|C0009566|C0205156|C0011209|C0021270|C0009678|C0332447|C0178795|C0011065
"The study participants had either Dukes' B or C colorectal cancer (n=126) or metastatic colorectal cancer that had been rendered free from all overt metastases by surgery (Dukes' D, n=24).","The study participants Dukes' B C colorectal cancer (n=126) metastatic colorectal cancer rendered free overt metastases surgery (Dukes' D, n=24).",G0000000|C0557651|C0679646|C1512090|G0000000|G0000000|C0555952|C0006826|C0369718|C0036525|C0555952|C0006826|G0000000|C0332296|G0000000|C0027627|C0038894|C1512090|C0073187|C0369718
"Patients were not allowed to receive any chemotherapy, androgens, estrogens, progestational drugs, or any treatment for hot flashes.","Patients allowed receive chemotherapy, androgens, estrogens, progestational drugs, treatment hot flashes.",C0030705|C0683607|C1514756|C0013216|C0002844|C0014939|G0000000|C0013227|C0039798|C0444519|C0085635
"Each child will be required to join this study together with his/her parent (mother or father) who spends the most time with him/her, so that a parent-child dyad can be recruited.","Each child required join study his/her parent (mother father) spends time him/her, parent-child dyad recruited.",G0000000|C0008059|C1514873|G0000000|C0557651|G0000000|C0030551|C0026591|C0015671|C0680968|C0040223|G0000000|C0260096|C0870454|G0000000
"The study will be conducted in the antenatal clinics of five NSW hospitals of which three are rural (Orange Base, Lismore Base and Dubbo Base) and two metropolitan (Liverpool and Blacktown).","The study conducted antenatal clinics NSW hospitals rural (Orange Base, Lismore Base Dubbo Base) metropolitan (Liverpool Blacktown).",G0000000|C0557651|C0004927|C2828394|C0442592|G0000000|C0019994|C0240919|C0440277|C0002055|G0000000|C0002055|G0000000|C0002055|C0599587|G0000000|G0000000
"Patients with any disease process suggestive of gastrointestinal obstruction or clinically significant active diverticular disease, fecal impaction, peritonitis, bowel surgery ≤10 days before dosing, or fecal ostomy, or with a body weight <38 kg were excluded.","Patients disease process suggestive gastrointestinal obstruction clinically active diverticular disease, fecal impaction, peritonitis, bowel surgery ≤10 days dosing, fecal ostomy, body weight <38 kg excluded.",C0030705|C0012634|C1184743|C0332299|C0521362|C0028778|G0000000|C0205177|C0012817|C0012634|C0015733|C0040456|C0031154|C0021853|C0038894|G0000000|C0439228|G0000000|C0015733|C0029473|C0242821|C0005910|G0000000|C1554077
"It is estimated that 20 to 100% of elderly men and women in North America and Europe are vitamin D deficient (mostly defined as a serum level of 25-(OH)D < 50 nmol/liter) [6,7].","It estimated 20 100% elderly women North America Europe vitamin D deficient (mostly defined serum level 25-(OH)D < 50 nmol/liter) [6,7].",G0000000|C0750572|C0450371|C1442061|C0001792|C0043210|C1709269|C0002454|C0015176|C0042890|C0073187|C0011155|C0205393|C1704788|C0229671|C0441889|G0000000|G0000000
"Participant inclusion criteria are women > 34 and < 39 weeks gestation, with a singleton, viable fetus, vertex presentation, who are not in active labour (active labour is defined as cervical effacement and dilatation associated with regular uterine contractions) and who are planning a vaginal birth.","Participant inclusion criteria women > 34 < 39 weeks gestation, singleton, viable fetus, vertex presentation, active labour (active labour defined cervical effacement dilatation regular uterine contractions) planning vaginal birth.",C0679646|C0007637|C0243161|C0043210|G0000000|C0450371|G0000000|C0450371|C0439230|C0032961|C0481462|C0443348|C0015965|C0230003|C0449450|C0205177|C0022864|C0205177|C0022864|C1704788|C0027530|C0552443|C0012359|C0205272|C0042149|C1140999|C0032074|C0042232|C0005615
All adults (18 years of age or older) who were admitted to a participating ICU during the trial period were enrolled at the time of ICU admission (site characteristics are described in the Supplementary Appendix).,All adults (18 age older) admitted participating ICU trial period enrolled time ICU admission (site characteristics Supplementary Appendix).,G0000000|C0001675|C0450371|C0001779|C0580836|C0184666|C0679823|C0021708|C0008976|C0439531|G0000000|C0040223|C0021708|C0184666|C0205145|C1521970|G0000000|C0003617
"Methods: Eighteen subjects with mild asthma, aged 18–65, took part in a three way randomised crossover study.","Methods: Eighteen subjects mild asthma, aged 18–65, randomised crossover study.",C0025663|C3715206|C0681850|C2945599|C0004096|C0001779|G0000000|G0000000|C0010366|C0557651
"Moreover, we also enrolled patients with brain metastases usually excluded from other trials on metastatic melanoma.","Moreover, enrolled patients brain metastases excluded trials metastatic melanoma.",G0000000|G0000000|C0030705|C0006104|C0027627|C1554077|C0008976|C0036525|C0025202
"Children had pain on average for two years and reported various chronic pain conditions including musculoskeletal pain (41%), abdominal pain (29.5%), and headache (29.5%).","Children pain average reported chronic pain conditions including musculoskeletal pain (41%), abdominal pain (29.5%), headache (29.5%).",C0008059|C0030193|C1510992|C0684224|C0205191|C0030193|C0012634|C0332257|C0497254|C0030193|C0450371|C0000726|C0030193|C0450371|C0018681|C0450371
"Enrolled criteria: Age: 18-65 years old, regardless of sex, positiveness of serum HBsAg and HBV DNA for at least 6 mo before enrolling, positiveness of serum HBeAg for at least 6 mo before enrolling, abnormal serum value of alanine transaminase (ALT) twice or more with a value 1.2 times greater than normal upper limit and a duration more than 8 wk between two tests within 6 mo before enrolling, the serum level of ALT was more than normal upper limit when screening, total serum bilirubin (TB) level less than or equal to 85.5 μmol/L, non-history of administrating antiviral and immunoregulating drugs, signing in the informed consent form, promising not to receive other drugs in clinical trial and systemic anti-viral agents, cytotoxic agents, hormone, immunoregulators, drugs capable of reducing serum enzyme activity and bilirubin level and Chinese traditional medicines, etc.","Enrolled criteria: Age: 18-65 old, sex, positiveness serum HBsAg HBV DNA 6 mo enrolling, positiveness serum HBeAg 6 mo enrolling, abnormal serum alanine transaminase (ALT) 1.2 times normal upper limit duration 8 wk tests 6 mo enrolling, serum level ALT normal upper limit screening, total serum bilirubin (TB) level equal 85.5 μmol/L, non-history administrating antiviral immunoregulating drugs, signing informed consent form, promising receive drugs clinical trial systemic anti-viral agents, cytotoxic agents, hormone, immunoregulators, drugs capable reducing serum enzyme activity bilirubin level Chinese traditional medicines, etc.",G0000000|C0243161|C0001779|C0450371|C0580836|C0009253|C0439178|C0229671|C0019168|G0000000|C0012854|G0000000|C0026544|G0000000|C0439178|C0229671|C0019167|G0000000|C0026544|G0000000|C0205161|C0229671|C0001898|C0002594|C1266129|G0000000|C0040223|C0205307|C1282910|C0439801|C0449238|G0000000|C0332174|C0022885|G0000000|C0026544|G0000000|C0229671|C0441889|C1266129|C0205307|C1282910|C0439801|C0220908|C0439175|C0229671|C0005437|G0000000|C0441889|C0205163|C0450371|G0000000|C1518422|G0000000|C0003451|G0000000|C0013227|C0311392|C1522154|C1511481|C0348078|C1555307|C1514756|C0013227|C0205210|C0008976|C0205373|C0003451|C0450442|C0677881|C0450442|C0019932|G0000000|C0013227|C2698977|C0392756|C0229671|C0014442|C0205177|C0005437|C0441889|C0008120|C0443324|C0013227|C1548556
"Adolescents seeking care for acute sexual assault or suicidal ideation, altered mental status precluding consent, or who were medically unstable (ie, abnormal vital signs) were excluded.","Adolescents seeking care acute sexual assault suicidal ideation, altered mental status precluding consent, medically unstable (ie, abnormal vital signs) excluded.",C0205653|G0000000|C1947933|C0205178|C0036864|C0004063|C0438696|C0392348|C0392747|C0229992|C0449438|G0000000|C1511481|G0000000|C0443343|G0000000|C0205161|C0442732|C0220912|C1554077
Outpatients are included in the study if they meet the following criteria: the subject 1) has a first single focal unilateral lesion with diagnosis verified by brain imaging (MRI or CT scans) that occurred at least six months prior; 2) has cognitive function sufficient to understand the experiments and follow instructions (Mini-Mental Status Score of 22 or higher or interview for aphasic subjects); 3) has a motor power (MP) score ≥1/5 and <4/5 (neither hemiplegic nor fully recovered motor function in the muscles of the shoulder and elbow and wrist); 4) is naive in that he/she has never experienced robot-assisted therapy; 5) has given informed written consent to participate in the study.,Outpatients included study meet criteria: subject 1) single focal unilateral lesion diagnosis verified brain imaging (MRI CT scans) occurred months prior; 2) cognitive function sufficient understand experiments follow instructions (Mini-Mental Status Score 22 interview aphasic subjects); 3) motor power (MP) score ≥1/5 <4/5 (neither hemiplegic recovered motor function muscles shoulder elbow wrist); 4) naive he/she experienced robot-assisted therapy; 5) informed written consent participate study.,C0029921|C0332257|C0557651|C1550543|C0243161|C0681850|G0000000|C0037179|C0205234|C0205092|C0221198|C0011900|C1711411|C0006104|C0011923|C0024485|C0007673|C0034606|C1709305|C0439231|C0332152|G0000000|C1516691|C0031843|C0205410|C0162340|C0681814|C0332283|C0302828|C0445542|C0449438|C0449820|C0450371|C0021822|C0234461|C0681850|G0000000|C1513492|C0032863|C0024944|C0449820|G0000000|G0000000|G0000000|C0259928|C0521108|C1513492|C0031843|C0026845|C0037004|C0013769|C0043262|G0000000|G0000000|G0000000|C0237607|C3844190|C0039798|G0000000|C1522154|C0043266|C1511481|G0000000|C0557651
The risk of colorectal cancer recurrence was similar in patients who were randomly assigned to 65% nitrous oxide or nitrogen during colorectal surgery.,The risk colorectal cancer recurrence patients randomly assigned 65% nitrous oxide nitrogen colorectal surgery.,G0000000|C0035647|C0555952|C0006826|C0034897|C0030705|G0000000|C1516050|C0450371|C0028158|C0030015|C0028158|C0555952|C0038894
"Eligible patients were non-smoking mild-to-moderate persistent asthmatics [1, 2] who were stable for at least 3 months prior to the study and none had received a course of oral corticosteroids or antibiotics during this period.","Eligible patients non-smoking mild-to-moderate persistent asthmatics [1, 2] stable 3 months prior study received oral corticosteroids antibiotics period.",C1548635|C0030705|C1518422|C1299392|C0205322|C0004096|G0000000|G0000000|C0205360|G0000000|C0439231|C0332152|C0557651|C1514756|C0442027|C0001617|C0003232|C0439531
"To evaluate the effect of a 3-month distribution of ready-to-use-therapeutic food on the nutritional status, mortality and morbidity of children 6 to 60 mo of age.","To evaluate 3-month distribution ready-to-use-therapeutic food nutritional status, mortality morbidity children 6 60 mo age.",C0040363|C0220825|C0332177|C0520511|C1318963|C0016452|C1521739|C0449438|C0026565|C0026538|C0008059|G0000000|C0450371|C0026544|C0001779
"After excluding patients at Hoehn and Yahr stage 3, we found that the study subjects showed a more pronounced improvement in all scores.","After excluding patients Hoehn Yahr stage 3, study subjects pronounced improvement scores.",G0000000|C0332196|C0030705|G0000000|G0000000|C0205390|G0000000|C0557651|C0681850|G0000000|C2986411|C0449820
"Regarding the safety of the two treatment arms, we hypothesized that with close follow up and CD4 monitoring, ART can be deferred until CD4 < 15% in children ages 1 to 12 years old with Center for Disease Control and Prevention (CDC) clinical class A or B and CD4 15–24% without affecting HIV disease progression.","Regarding safety treatment arms, hypothesized close follow CD4 monitoring, ART deferred CD4 < 15% children ages 1 12 Center Disease Control Prevention (CDC) clinical class A B CD4 15–24% HIV disease progression.",G0000000|C0036043|C0039798|C0206655|G0000000|C0587267|C0332283|C0285590|C0150369|C0003826|C0205421|C0285590|G0000000|C0450371|C0008059|C0001779|G0000000|C0450371|C0205099|C0012634|C0243148|C0199176|C0007670|C0205210|C0456387|G0000000|G0000000|C0285590|G0000000|C0019682|C0012634|C0242656
"We implemented the case detection program with 13,247 elementary school children and enrolled 736 children with asthma (both previously diagnosed and newly diagnosed by the case detection procedure) into the study.","We implemented detection program 13,247 elementary school children enrolled 736 children asthma (both diagnosed newly diagnosed detection procedure) study.",G0000000|G0000000|C1511790|C1709697|C0450371|C0013879|C0036375|C0008059|G0000000|C1442061|C0008059|C0004096|G0000000|C0011900|C0750546|C0011900|C1511790|C0184661|C0557651
"It is estimated that 0.7% of women 65 years or older will suffer a hip fracture during their lifetime, and demographic trends predict that the demand for care will double in the next 40 years [1-3].","It estimated 0.7% women 65 suffer hip fracture lifetime, demographic trends predict demand care double 40 [1-3].",G0000000|C0750572|G0000000|C0043210|C0450371|C0683278|C0019552|C0016658|C4071830|C0011298|C0040833|G0000000|C0441516|C1947933|C0205173|C0450371|G0000000
We noted that median PFS and OS in our ovarian cancer study population were 21 and 48 mo respectively.,We median PFS OS ovarian cancer study population 21 48 mo respectively.,G0000000|C0549183|C0242792|C0229090|C0205065|C0006826|C0557651|C0032659|C0450371|C0450371|C0026544|G0000000
"Focusing on hypertension and behavioural CVD risk factors, a programme on hypertension management has been implemented since 2006 in Phu-Cuong commune, in a typical rural area of Vietnam, 60 km to the west of Hanoi city.","Focusing hypertension behavioural CVD risk factors, programme hypertension management implemented 2006 Phu-Cuong commune, typical rural Vietnam, 60 west Hanoi city.",C0000936|C0020538|C0004927|C0007222|C0035647|C1521761|C1709697|C0020538|C0001554|G0000000|G0000000|G0000000|C0598781|C3538928|C0240919|C0042658|C0450371|C1705493|G0000000|C0008848
Patients were excluded if they were diagnosed with severe croup or impending respiratory failure by the PCP; or had prior treatment with epinephrine or oral corticosteroids for this croup episode; symptoms or signs suggesting another cause of stridor; chronic respiratory disease including asthma; or a known contraindication to systemic steroid use.,Patients excluded diagnosed severe croup impending respiratory failure PCP; prior treatment epinephrine oral corticosteroids croup episode; symptoms signs suggesting stridor; chronic respiratory disease including asthma; contraindication systemic steroid use.,C0030705|C1554077|C0011900|C0205082|C0010380|C0332190|C0521346|C0231174|C1535939|C0332152|C0039798|C0014563|C0442027|C0001617|C0010380|C0332189|C0683368|C0220912|C1705535|C0038450|C0205191|C0521346|C0012634|C0332257|C0004096|C0522473|C0205373|C0038317|C0042153
Spirometry was performed in all selected patients to confirm the diagnosis of bronchial asthma.,Spirometry performed selected patients confirm diagnosis bronchial asthma.,C0037981|C0884358|C1707391|C0030705|C0521093|C0011900|C0205039|C0004096
2) Schools are currently not using hand sanitiser products or are willing to not use hand sanitiser products for the period of the trial if they are randomised to the control group.,2) Schools hand sanitiser products hand sanitiser products period trial randomised control group.,G0000000|C0036375|C0018563|C0183086|C1514468|C0018563|C0183086|C1514468|C0439531|C0008976|G0000000|C0243148|C0441833
Participants in the study were seventh graders enrolled in 36 rural schools in 22 contiguous counties in a midwestern state.,Participants study seventh graders enrolled 36 rural schools 22 contiguous counties midwestern state.,C0679646|C0557651|C0205441|G0000000|G0000000|C0450371|C0240919|C0036375|C0450371|C0205283|C0079170|G0000000|C1301808
"Although only practices using WinMed—one of three electronic medical record systems used in Norway—were included in our study, there is no reason why these practices should differ from other practices.","Although practices WinMed—one electronic medical record systems Norway—were included study, reason practices practices.",G0000000|C0237607|G0000000|C0013850|C0199168|C0034869|C0449913|G0000000|C0332257|C0557651|C0392360|C0237607|C0237607
The study is a cluster randomized trial of a decision aid to inform and support the choice between tube feeding and assisted oral feeding in advanced dementia.,The study cluster randomized trial decision aid inform support choice tube feeding assisted oral feeding advanced dementia.,G0000000|C0557651|C1555715|C0034656|C0008976|C0679006|C0449435|C0537670|C0183683|C0008300|C0175730|C0204695|C1269765|C0442027|C0204695|C0205179|C0011265
Intraoperative biopsies of mammary gland specimens resected from below the nipple-areola complex (NAC) confirmed that both the NAC and the skin were not cancerous.,Intraoperative biopsies mammary gland specimens resected nipple-areola complex (NAC) confirmed NAC skin cancerous.,C0456904|C0005558|C0006141|C1285092|C0370003|C0015252|C0028109|C0439855|C3538756|C0521093|C3538756|C0444099|C0006826
"The main inclusion criteria were SER in each eye with cycloplegia between −1.25 and −4.50 D, astigmatism 1.50 D or less, and anisometropia equal to or less than 1.00 D. Children with previous use of bifocals, PALs, or contact lenses; strabismus; best corrected visual acuity (BCVA) worse than 20/25; and/or history of ocular disease or refractive surgery were excluded.","The main inclusion criteria SER eye cycloplegia −1.25 −4.50 D, astigmatism 1.50 D less, anisometropia equal 1.00 D. Children previous bifocals, PALs, contact lenses; strabismus; corrected visual acuity (BCVA) worse 20/25; and/or history ocular disease refractive surgery excluded.",G0000000|C0205225|C0007637|C0243161|C0523888|C0015392|C0235238|G0000000|G0000000|C0073187|C0004106|C0450371|C0073187|C0439092|C0003081|C0205163|C0450371|C0073187|C0008059|C0205156|C1275647|C0030360|C0332158|C0023317|C0038379|C0205202|C0234621|C0750509|G0000000|C0332271|C0450371|G0000000|C0019664|C0015392|C0012634|C0429585|C0038894|C1554077
The study will exclude participants: Who have had previous lower limb surgery in the past 2 years and/or botulinum toxin-A injections to the lower extremities within the past 6 months; Who cannot provide sufficient cooperation and cognitive understanding to participate in the intervention exercises; Who have undertaken lower limb resistance training within the past 6 months.,The study exclude participants: Who previous lower limb surgery 2 years and/or botulinum toxin-A injections lower extremities 6 months; Who provide sufficient cooperation cognitive understanding participate intervention exercises; Who undertaken lower limb resistance training 6 months.,G0000000|C0557651|C0332196|C0679646|G0000000|C0205156|C0441994|C0015385|C0038894|G0000000|G0000000|C0006055|C0040549|C0021485|C0441994|C0015385|G0000000|G0000000|C1999230|C0205410|C0392337|C1516691|C0162340|G0000000|C0886296|C0015259|G0000000|G0000000|C0441994|C0015385|C0237834|C0040607|G0000000
"From March 2010 through December 2014, a total of 19,114 persons (16,703 from Australia and 2411 from the United States) were enrolled in the trial, of whom 9525 were randomly assigned to receive aspirin and 9589 to receive placebo.","From March 2010 December 2014, total 19,114 persons (16,703 Australia 2411 United States) enrolled trial, 9525 randomly assigned receive aspirin 9589 receive placebo.",G0000000|C3829202|G0000000|C3830550|G0000000|C0439175|C0450371|C0027361|C0450371|C0004340|G0000000|C0166872|C1301808|G0000000|C0008976|G0000000|G0000000|C1516050|C1514756|C0004057|G0000000|C1514756|C0032042
Conclusion: Patients with neuromuscular disease with nocturnal hypoventilation are likely to deteriorate with the development of daytime hypercapnia and/or progressive symptoms within 2 years and may benefit from the introduction of nocturnal NIV before daytime hypercapnia ensues.,Conclusion: Patients neuromuscular disease nocturnal hypoventilation deteriorate development daytime hypercapnia and/or progressive symptoms 2 benefit introduction nocturnal NIV daytime hypercapnia ensues.,C1707478|C0030705|C1979768|C0012634|C0240526|C3203358|C1457868|C0243107|C0332169|C0020440|G0000000|C0205329|C0683368|G0000000|C0814225|C1293116|C0240526|C0598902|C0332169|C0020440|G0000000
The remaining 79 patients were randomly allocated to the study groups.,The remaining 79 patients randomly allocated study groups.,G0000000|C1527428|C0450371|C0030705|G0000000|G0000000|C0557651|C0441833
"Patients were eligible for inclusion if they met the following criteria: current smoker (usually smokes at least one cigarette a day, has smoked in the 7 days prior to randomization); able to read English and provide written informed consent; willing to set a quit date within 14 days after randomization; aged 18–75 years; has a mobile phone and is familiar with sending and receiving text messages; not enrolled in another formal smoking cessation study or programme; and not using smoking cessation medications at randomization date.","Patients eligible inclusion met criteria: current smoker (usually smokes cigarette day, smoked 7 days prior randomization); read English provide written informed consent; set quit 14 days randomization; aged 18–75 years; mobile phone familiar sending receiving text messages; enrolled formal smoking cessation study programme; smoking cessation medications randomization date.",C0030705|C1548635|C0007637|C0268621|C0243161|C0521116|C0337664|C3538928|C0037366|C0677453|C0332173|C0037366|G0000000|C0439228|C0332152|C0034656|C0034754|C0376245|C1999230|C0043266|C1522154|C1511481|C0036849|C0748223|C0450371|C0439228|C0034656|C0001779|G0000000|C0439234|C0231435|C1515258|C0205309|C1519246|C1514756|C1527021|C0470166|G0000000|C0348078|C0037369|C1880019|C0557651|C1709697|C0037369|C1880019|C0013227|C0034656|C0011008
Subjects were randomly assigned to one of the three groups.,Subjects randomly assigned groups.,C0681850|G0000000|C1516050|C0441833
All were required to have prebronchodilator FEV1 values of 70 to 90% of predicted and heightened airway reactivity as indicated by 12% or greater reversibility after albuterol inhalation or by PC20 (provocative concentration causing a 20% fall in FEV1) methacholine of less than 8 mg/ml.,All required prebronchodilator FEV1 values 70 90% predicted heightened airway reactivity 12% reversibility albuterol inhalation PC20 (provocative concentration causing 20% fall FEV1) methacholine 8 mg/ml.,G0000000|C1514873|C2599602|G0000000|C0042295|C0450371|C0450371|C0681842|C0442803|C0178987|C0443286|C0450371|C0449261|C0001927|C0004048|G0000000|C0449428|C0004268|C0678227|C0450371|C0085639|G0000000|C0600370|G0000000|C0439294
"Demographic characteristics measured at baseline included age, sex, ethnicity, marital status, education, job level (professional, clerical or sales, labor; coded from descriptions of job title and duties), and years working at the company.","Demographic characteristics measured baseline included age, sex, ethnicity, marital status, education, job level (professional, clerical sales, labor; coded descriptions job title duties), company.",C0011298|C1521970|C0444706|C0168634|C0332257|C0001779|C0009253|C0015031|C0024841|C0449438|C0013621|C0028811|C0441889|C0679924|C0008935|C0036070|C0022864|C0009219|C0678257|C0028811|C1519530|G0000000|C0683757
Exclusion criteria were the presence of significant medical complications or unstable vital signs that precluded participation in the study.,Exclusion criteria presence medical complications unstable vital signs precluded participation study.,C0680251|C0243161|C0150312|C0199168|C0009566|C0443343|C0442732|C0220912|G0000000|C0679823|C0557651
"Subjects were excluded for lower extremity edema, knee hyperextension during stance phase of gait, skin breakdown, or absent sensation; serious cardiac arrhythmias, pacemakers or other implanted electronic systems; pregnancy; uncontrolled seizure disorder; concomitant lower motor neuron dysfunction and non-stroke upper motor neuron dysfunction; uncompensated hemineglect; sensory or motor peripheral neuropathy; fixed ankle plantarflexor contracture; or lower extremity (LE) botulinum toxin injection within the 3-months prior to enrollment.","Subjects excluded lower extremity edema, knee hyperextension stance phase gait, skin breakdown, absent sensation; cardiac arrhythmias, pacemakers implanted electronic systems; pregnancy; uncontrolled seizure disorder; concomitant lower motor neuron dysfunction non-stroke upper motor neuron dysfunction; uncompensated hemineglect; sensory motor peripheral neuropathy; fixed ankle plantarflexor contracture; lower extremity (LE) botulinum toxin injection 3-months prior enrollment.",C0681850|C1554077|C0441994|C0015385|C0013604|C0022742|C0231451|G0000000|C0205390|C0016928|C0444099|C0443161|C0332197|C0036658|C0018787|C0003811|C0810633|C0021102|C0013850|C0449913|C0032961|C0205318|C0036572|C0012634|C0521115|C0441994|C1513492|C0027882|C0031847|C1518422|C1282910|C1513492|C0027882|C0031847|C0205433|C0150088|C0445254|C1513492|C0205100|C0442874|C0443218|C0003086|G0000000|C0009917|C0441994|C0015385|C0023190|C0006055|C0040549|C0021485|C0439231|C0332152|C1516879
"BEST is a 2×2 full factorial double-blind RCT with 7,000 adults having manifest arsenical skin lesions, and is designed to evaluate the efficacy of 6-year supplementation with vitamin E (100 mg daily) and L-selenomethionine (200 μg daily) for the prevention of NMSC.","BEST 2×2 factorial double-blind RCT 7,000 adults manifest arsenical skin lesions, designed evaluate efficacy 6-year supplementation vitamin E (100 daily) L-selenomethionine (200 μg daily) prevention NMSC.",C1522427|G0000000|C2826344|C0013072|G0000000|C1442061|C0001675|C0205319|C0003819|C0444099|C0221198|C1707689|C0220825|C1280519|C0439234|C0242297|C0042890|G0000000|C1442061|C0332173|C1517683|C1442061|G0000000|C0332173|C0199176|G0000000
Antiplatelet therapy was recommended in all subjects within 48 hours of their stroke.,Antiplatelet therapy recommended subjects 48 hours stroke.,G0000000|C0039798|C0034866|C0681850|C0450371|C0439227|C0038454
"However, patients with PS 2 and GFR less than 60 mL/min do not benefit from combination CHT.","However, patients PS 2 GFR 60 mL/min benefit combination CHT.",G0000000|C0030705|C0242397|G0000000|C0017654|C0450371|C0439445|C0814225|C0205195|C1422359
"The average score in the Ponseti group was 14.39 (SD 3.2), whereas that in the Kite group was 16.19 (SD 2.8).","The average score Ponseti 14.39 (SD 3.2), Kite 16.19 (SD 2.8).",G0000000|C1510992|C0449820|G0000000|C0450371|G0000000|G0000000|C0336865|C0450371|G0000000|G0000000
Children (≤ 18 years old) with KS and HIV infection who were referred to the Uganda Cancer Institute (UCI) from October 2004 to June 2007 were identified by review of clinical records.,Children (≤ 18 old) KS HIV infection referred Uganda Cancer Institute (UCI) October 2004 June 2007 identified review clinical records.,C0008059|G0000000|C0450371|C0580836|C0022773|C0019682|C0009450|C0205543|C0041573|C0006826|C0021622|C0560006|C3828732|G0000000|C3829443|G0000000|C0205396|C0282443|C0205210|C0034869
The most common concomitant AEDs are listed in table 1.,The common concomitant AEDs listed table 1.,G0000000|C0205214|C0521115|C0180309|C0745732|C0039224|G0000000
Patients who had a normal high-resolution anoscopy (HRA) at screening for inclusion or only had condylomas and/or low squamous intraepithelial lesion (LSIL) in anal biopsy.,Patients normal high-resolution anoscopy (HRA) screening inclusion condylomas and/or low squamous intraepithelial lesion (LSIL) anal biopsy.,C0030705|C0205307|C1719039|C0193158|C1619700|C0220908|C0007637|C0302180|G0000000|C0205251|C1182670|C1512942|C0221198|C1302773|C0003461|C0005558
"School districts with incomplete or inadequate health records, high asthma prevalence, and internal or external services available for students with asthma may benefit from a similar system.","School districts incomplete inadequate health records, asthma prevalence, internal external services students asthma benefit system.",C0036375|G0000000|C0205257|C0205412|C0018684|C0034869|C0004096|C0033105|C0205102|C0205101|C0557854|C0038492|C0004096|C0814225|C0449913
"Programme sessions are made available to both Syrian refugee and host‐community youth, separately for male and female, within urban areas, in safe and familiar community locations (Mercy Corps, 2014a).","Programme sessions Syrian refugee host‐community youth, separately male female, urban areas, safe familiar community locations (Mercy Corps, 2014a).",C1709697|C1883016|C0018561|C0034961|G0000000|C0001578|G0000000|C0086582|C0015780|C0442529|C0205146|G0000000|C0205309|C0009462|C0450429|G0000000|C0683758|G0000000
"The exclusion criteria were the adolescent’s ongoing psychotherapy, treatment for alcohol or drug use, out-of-home placement, and parents’ participation in another parent program.","The exclusion criteria adolescent’s ongoing psychotherapy, treatment alcohol drug use, out-of-home placement, parents’ participation parent program.",G0000000|C0680251|C0243161|G0000000|C0549178|C0033968|C0039798|C0001962|C0013227|C0042153|C0439787|C0441587|G0000000|C0679823|C0030551|C1709697
"Exclusion criteria included change in immunosuppressive therapy within four weeks of study entry, prior use of rituximab, diagnosis of lymphoma, severe renal insufficiency (creatinine clearance less than 30 ml/min), severe hepatic insufficiency (Childs-Pugh class B or C), co-infection with HIV or hepatitis B virus, liver transplantation, pregnancy, active systemic infection, or presence of potentially life-threatening vasculitis involving the central nervous system, heart, or gastrointestinal tract.","Exclusion criteria included change immunosuppressive therapy weeks study entry, prior rituximab, diagnosis lymphoma, severe renal insufficiency (creatinine clearance 30 ml/min), severe hepatic insufficiency (Childs-Pugh class B C), co-infection HIV hepatitis B virus, liver transplantation, pregnancy, active systemic infection, presence life-threatening vasculitis involving central nervous system, heart, gastrointestinal tract.",C0680251|C0243161|C0332257|C0392747|C0021081|C0039798|C0439230|C0557651|C1705654|C0332152|C0393022|C0011900|C0024299|C0205082|C0022646|C0231179|C0010294|C0449297|C0450371|C0439445|C0205082|C0205054|C0231179|C4050412|C0456387|G0000000|G0000000|C0275524|C0019682|C0019158|G0000000|C0042776|C0023884|C0040732|C0032961|C0205177|C0205373|C0009450|C0150312|C1517874|C0042384|C1314939|C0205099|C0027769|C0449913|C0018787|C0521362|C1185740
"Following the training of trainers, the training has been rolled out across the country, firstly at the national KMTC, then at six selected provincial training centres during the last four years.","Following training trainers, training rolled country, firstly national KMTC, selected provincial training centres years.",C0231290|C0040607|C0453962|C0040607|C3841382|C0454664|C1279901|C3245503|G0000000|C1707391|G0000000|C0040607|C0205099|C0439234
"A total of 800 traditional thatched-roofed houses constructed with mud walls, open eaves, and without ceilings or screening, with two children aged 6 months to 13 years, will be selected.","A total 800 traditional thatched-roofed houses constructed mud walls, eaves, ceilings screening, children aged 6 months 13 years, selected.",G0000000|C0439175|C1442061|C0443324|C0557685|C0442519|C2827421|C1426765|C0677535|G0000000|G0000000|C0220908|C0008059|C0001779|G0000000|C0439231|C0450371|C0439234|C1707391
"These studies show that immunogenicity and safety profiles following administration of the HPV-16/18 AS04-adjuvanted vaccine to healthy Chinese girls and women are consistent with those reported previously in females from diverse geographic settings.10-14 Importantly, we also show that HPV-16 and HPV-18 specific immune responses one month after the third vaccine dose in Chinese females aged 9–17 y and 26–45 y are non-inferior to those elicited in Chinese females aged 18–25 y enrolled in a separate trial, which has demonstrated vaccine efficacy.8 This is the first evaluation, to our knowledge, of the immunogenicity and safety of an HPV vaccine in Chinese females across a wide range of ages from 9–45 y.","These studies immunogenicity safety profiles administration HPV-16/18 AS04-adjuvanted vaccine healthy Chinese girls women consistent reported females diverse geographic settings.10-14 Importantly, HPV-16 HPV-18 specific immune responses month vaccine dose Chinese females aged 9–17 26–45 non-inferior elicited Chinese females aged 18–25 enrolled separate trial, demonstrated vaccine efficacy.8 This evaluation, knowledge, immunogenicity safety HPV vaccine Chinese females wide range ages 9–45 y.",G0000000|C0947630|C4054739|C0036043|C1979963|C0001554|C0021344|C0001551|C0042210|C3898900|C0008120|C0870604|C0043210|C0332290|C0684224|C0015780|C1880371|C1517526|C0542559|G0000000|C0021344|C0021344|C0205369|C0439662|C0871261|C0332177|C0042210|C0178602|C0008120|C0015780|C0001779|G0000000|G0000000|C1518422|C0449265|C0008120|C0015780|C0001779|G0000000|G0000000|C0443299|C0008976|G0000000|C0042210|C1280519|G0000000|C0220825|C0376554|C4054739|C0036043|C0021344|C0042210|C0008120|C0015780|C0332464|C1514721|C0001779|G0000000|G0000000
"Patients also had a score of ≥40 mm on the 100 mm pain visual analog scale (VAS) at Visit 2, and had assessed and documented their pain score on at least four of the past seven days prior to Visit 2 while recording an average pain score of ≥4 on the 11-point numeric rating scale.","Patients score ≥40 mm 100 mm pain visual analog scale (VAS) Visit 2, assessed documented pain score days prior Visit 2 recording average pain score ≥4 11-point numeric rating scale.",C0030705|C0449820|G0000000|G0000000|C1442061|G0000000|C0030193|C0234621|C0243071|C0175659|C0042815|C0545082|G0000000|C1516048|C1301725|C0030193|C0449820|C0439228|C0332152|C0545082|G0000000|G0000000|C1510992|C0030193|C0449820|G0000000|C0450371|C0237753|C0871208|C0175659
"Patients, men and women aged 20–<80 years, had to have sustained pain for ≥6 months as a result of distal symmetric polyneuropathy caused by type 1 or type 2 diabetes mellitus.","Patients, women aged 20–<80 years, sustained pain ≥6 months result distal symmetric polyneuropathy caused type 1 type 2 diabetes mellitus.",C0030705|C0043210|C0001779|G0000000|C0443318|C0030193|G0000000|C1274040|C0205108|C0332516|C0152025|C0015127|G0000000|G0000000|C0011847|G0000000
Participants progressed up to three sets per exercise over the first month.,Participants progressed sets exercise month.,C0679646|C1272688|C0036849|C0015259|C0332177
"Nonsmoking, postmenopausal women (with absence of menses of over 12 months or serum follicle-stimulating hormone >30 IU/mL) with central obesity (waist circumference; WC ≥ 80 cm), plus at least one other criterion of MetS15, who wished to lose weight, were recruited in 2014 through advertisements.","Nonsmoking, postmenopausal women (with absence menses 12 months serum follicle-stimulating hormone >30 IU/mL) central obesity (waist circumference; WC ≥ 80 cm), criterion MetS15, wished lose weight, recruited 2014 advertisements.",G0000000|C0232970|C0043210|G0000000|C0332197|C0025344|C0450371|C0439231|C0229671|C0018120|C0019932|C0450371|C0439458|C0205099|C0028754|C0230097|C0332520|G0000000|C0243161|G0000000|C1423524|G0000000|C0005910|G0000000|G0000000|C0949214
Study subjects were identified through two case series of women who attended reproductive endocrinology practices in London.,Study subjects identified series women attended reproductive endocrinology practices London.,C0557651|C0681850|C0205396|C0205549|C0043210|C1456498|C0035150|C0014137|C0237607|C0023973
Patients between 18 and 80 years of age and a Karnofsky performance status ≥ 60% were eligible.,Patients 18 80 age Karnofsky performance status ≥ 60% eligible.,C0030705|C0450371|C0450371|C0001779|C0206065|C0597198|C0449438|G0000000|C0450371|C1548635
"Patients and methods: A total of 187 patients with HCCs of 3 cm or less were randomly assigned to RFTA (n = 62), PEI (n = 62), or PAI (n = 63).","Patients methods: A total 187 patients HCCs 3 cm randomly assigned RFTA (n = 62), PEI (n = 62), PAI (n = 63).",C0030705|C0025663|G0000000|C0439175|C1442061|C0030705|C1415491|G0000000|G0000000|G0000000|C1516050|G0000000|G0000000|C0814202|G0000000|C1620101|G0000000
"The term “minimally angulated” was defined as a complete absence of any discernible clinical deformity, which on a plain X-ray would be less than 10° of angulation in any plane.","The term “minimally angulated” defined complete absence discernible clinical deformity, plain X-ray 10° angulation plane.",G0000000|C0233324|G0000000|G0000000|C1704788|C0205197|C0332197|C0205396|C0205210|C0000768|G0000000|C0034571|G0000000|C0333179|C0444660
The approach to adolescent and young adult cannabis users turned out to be well-accepted.,The approach adolescent adult cannabis users well-accepted.,G0000000|C0449445|C0205653|C0001675|C0024808|C1706077|C0205170
We randomly assigned 257 premenopausal women with operable hormone-receptor–negative breast cancer to receive standard chemotherapy with the GnRH agonist goserelin (goserelin group) or standard chemotherapy without goserelin (chemotherapy-alone group).,We randomly assigned 257 premenopausal women operable hormone-receptor–negative breast cancer receive standard chemotherapy GnRH agonist goserelin (goserelin group) standard chemotherapy goserelin (chemotherapy-alone group).,G0000000|G0000000|C1516050|C1442061|C0279752|C0043210|C0205188|G0000000|C0006141|C0006826|C1514756|C1442989|C0013216|C0023610|C2987634|C0120107|C0120107|C0441833|C1442989|C0013216|C0120107|C0013216|C0441833
No baseline differences between the donepezil and placebo groups reached significance on any of the neuropsychological test measures or questionnaires.,No baseline differences donepezil placebo reached significance neuropsychological test measures questionnaires.,G0000000|C0168634|C1705241|C0527316|C0032042|C2584321|C0237881|G0000000|C0022885|C0079809|C0034394
"Patients were eligible for the study if they were aged 18 years or younger, if a parent or guardian gave informed consent (self-consent if age 18), and if the accompanying family member answered “no” to the screening question “Is your child covered by any kind of health insurance, such as private insurance, Medicaid, special state insurance, an HMO, or any other program?” Insurance status was confirmed by each hospital’s administrative database.","Patients eligible study aged 18 younger, parent guardian informed consent (self-consent age 18), accompanying family answered “no” screening question “Is child covered health insurance, private insurance, Medicaid, special insurance, HMO, program?” Insurance status confirmed hospital’s administrative database.",C0030705|C1548635|C0557651|C0001779|C0450371|C0332239|C0030551|C0023226|C1522154|C1511481|C0036588|C0001779|C0450371|G0000000|C0015576|C1706817|G0000000|C0220908|C1522634|G0000000|C0008059|C0439844|C0018684|C0021672|C0033175|C0021672|C0025071|C0205555|C0021672|C0018720|G0000000|C0021672|C0449438|C0521093|G0000000|C1292785|C0242356
and our study indicate that the delivery mode has only a limited effect on gut microbiota composition in preterm infants [55].,study delivery mode limited gut microbiota composition preterm infants [55].,C0557651|C0011209|C1513371|C0439801|C0017189|C1000792|C0486616|C0151526|C0021270|C0450371
"Only those patients who fulfilled a diagnosis of delirium (based on the Diagnostic and Statistical Manual, 4th Revision)[18] and were aged more than 18 years were included into the study.","Only patients fulfilled diagnosis delirium (based Diagnostic Statistical Manual, 4th Revision)[18] aged 18 included study.",C0205171|C0030705|C1550543|C0011900|C0011206|C1527178|C0011900|C0038215|C0024763|G0000000|C0439617|C0001779|C0450371|C0332257|C0557651
"Vivax malaria patients (n = 98) with the inclusion criteria (acute uncomplicated vivax malaria infections, either male or female; if female, pregnancy test negative before enrolment into the study, positive only asexual forms of P. vivax in blood smears, weight ≥ 40 kg and age ≥ 15 years) were enrolled in the study, and admitted to the Bangkok Hospital for Tropical Diseases for 28 days.","Vivax malaria patients (n = 98) inclusion criteria (acute uncomplicated vivax malaria infections, male female; female, pregnancy test negative enrolment study, positive asexual forms P. vivax blood smears, weight ≥ 40 age ≥ 15 years) enrolled study, admitted Bangkok Hospital Tropical Diseases 28 days.",G0000000|C0024530|C0030705|C0369718|G0000000|C0450371|C0007637|C0243161|C0205178|C0443334|G0000000|C0024530|C3714514|C0086582|C0015780|C0015780|C0032961|C0022885|C0205160|C1516879|C0557651|C0439178|C0599655|C0348078|C0369773|G0000000|C0005767|C0444186|C0005910|G0000000|C0450371|C0001779|G0000000|C0450371|C0439234|G0000000|C0557651|C0184666|G0000000|C0019994|G0000000|C0012634|C0450371|C0439228
"We used records from the Royal New Zealand Foundation of the Blind register (in Dunedin and Auckland), the University of Auckland optometry clinic, Dunedin and Auckland hospital low vision outpatient clinics, and a private ophthalmology practice to identify potential participants aged ≥75 years with poor vision who were living in the community.","We records Royal New Zealand Foundation Blind register (in Dunedin Auckland), University Auckland optometry clinic, Dunedin Auckland hospital low vision outpatient clinics, private ophthalmology practice identify potential participants aged ≥75 poor vision living community.",G0000000|C0034869|G0000000|C0205314|G0000000|C0016617|C0150108|G0000000|G0000000|G0000000|G0000000|C0041740|G0000000|C0029147|C0002424|G0000000|G0000000|C0019994|C0205251|C0042789|C0029921|C0442592|C0033175|C0029087|C0237607|G0000000|C3245505|C0679646|C0001779|G0000000|C0032854|C0042789|C0376558|C0009462
3) PPH defined as bleeding from uterus and/or the birth canal within 24 hours postpartum.,3) PPH defined bleeding uterus and/or birth canal 24 hours postpartum.,G0000000|C1414402|C1704788|C0019080|C0042149|G0000000|C0005615|C0086881|C0450371|C0439227|C0086839
Some children become steroid-dependent (SD) and require addition of calcineurin inhibitors (CNI) to maintain remission.,Some children steroid-dependent (SD) require addition calcineurin inhibitors (CNI) maintain remission.,G0000000|C0008059|C0038317|G0000000|G0000000|C0332287|C0054450|C0243077|C1425101|C0024501|C0544452
Exclusion criteria were: (a) unclear diagnosis (no gratifying and sustained response to dopaminergic therapy); (b) MMSE < 24); (c) unable to complete Dutch questionnaires; (d) severe co-morbidity interfering with daily functioning; (e) daily institutionalized care; and (f) deep brain surgery.,Exclusion criteria were: (a) unclear diagnosis (no gratifying sustained response dopaminergic therapy); (b) MMSE < 24); (c) unable complete Dutch questionnaires; (d) severe co-morbidity interfering daily functioning; (e) daily institutionalized care; (f) deep brain surgery.,C0680251|C0243161|G0000000|G0000000|G0000000|C0011900|G0000000|G0000000|C0443318|C0871261|C0282151|C0039798|G0000000|C0451306|G0000000|C0450371|G0000000|C1299582|C0205197|C0013331|C0034394|C0073187|C0205082|C0009488|C0521102|C0332173|C0205245|G0000000|C0332173|C0562359|C1947933|C0016327|C0205125|C0006104|C0038894
"There were 2 minor imbalances noted that were not felt to affect the outcome of the study: 1) the baseline incidence of CLD was slightly lower in the M/P treatment group (13.3%) than in the P/M and motavizumab-only (control) treatment groups (16.7% and 17.2%, respectively); and 2) there were slightly more male subjects enrolled in the M/P treatment group (61% in M/P compared with 51% and 52% in the P/M and the motavizumab-only [control] groups, respectively).","There 2 minor imbalances affect outcome study: 1) baseline incidence CLD lower M/P treatment (13.3%) P/M motavizumab-only (control) treatment (16.7% 17.2%, respectively); 2) male subjects enrolled M/P treatment (61% M/P compared 51% 52% P/M motavizumab-only [control] groups, respectively).",G0000000|G0000000|C0026193|C1397014|C0001721|C1274040|C0557651|G0000000|C0168634|C0021149|G0000000|C0441994|C0369637|C0039798|C0450371|C0369773|C2713599|C0243148|C0039798|C0450371|C0450371|G0000000|G0000000|C0086582|C0681850|G0000000|C0369637|C0039798|C0450371|C0369637|C1707455|C0450371|C0450371|C0369773|C2713599|C0243148|C0441833|G0000000
"Children scoring in the highest 40% within cohort and site were solicited for the second gate of screening: parent-rated home behavior problems, using a 22-item instrument based on the Child Behavior Checklist (28).","Children scoring 40% cohort site solicited gate screening: parent-rated behavior problems, 22-item instrument based Child Behavior Checklist (28).",C0008059|C0449820|C0450371|C0599755|C0205145|G0000000|G0000000|C0220908|C0030551|C0004927|C1546466|C0450371|C0348000|C1527178|C0008059|C0004927|C1707357|C0450371
"All this considerations led us to investigate, in an open-label cohort randomized study, the preventive effects of regular vitamin C supplementation on overall hospitalization rate in the pregnant women population attending a Ugandan rural health centre for antenatal assessment.","All considerations led investigate, open-label cohort randomized study, preventive effects regular vitamin C supplementation hospitalization rate pregnant women population attending Ugandan rural health centre antenatal assessment.",G0000000|C0518609|C1708698|C1292732|C1709323|C0599755|C0034656|C0557651|C0445202|C1280500|C0205272|C0042890|G0000000|C0242297|C0019993|C0871208|C0549206|C0043210|C0032659|C1547429|C0241520|C0240919|C0018684|C0205099|C2828394|C1261322
"In patients who were alive, the minimum follow-up was 4 months, except for three patients who had 1 day, 1 month, and 2 months of follow-up.","In patients alive, minimum follow-up 4 months, patients 1 day, 1 month, 2 months follow-up.",G0000000|C0030705|C0376558|C1524031|C0589120|G0000000|C0439231|C0030705|G0000000|C0332173|G0000000|C0332177|G0000000|C0439231|C0589120
"Eligible patients were aged 18–75 years old with a diagnosis of MS fulfilling the 2010 McDonald criteria [24], uni- or bilateral optic neuropathy with VA in the worst eye of ≤ 5/10 (decimal scale; 20/40 in US customary units) confirmed at 6 months, and evidence of worsening VA during the last 3 years (defined as a change in VA of ≥ 1/10 points or more than one line).","Eligible patients aged 18–75 diagnosis MS fulfilling 2010 McDonald criteria [24], uni- bilateral optic neuropathy VA worst eye ≤ 5/10 (decimal scale; 20/40 US customary units) confirmed 6 months, evidence worsening VA 3 (defined change VA ≥ 1/10 line).",C1548635|C0030705|C0001779|G0000000|C0011900|C0039676|C1550543|G0000000|G0000000|C0243161|C0450371|C3853222|C0238767|C0015392|C0442874|C1549054|C1522166|C0015392|G0000000|C0450371|G0000000|C0175659|C0450371|G0000000|C3242380|C0439148|C0521093|G0000000|C0439231|C3887511|C0332271|C1549054|G0000000|C1704788|C0392747|C1549054|G0000000|C0450371|C0205132
The primary objective is to examine the treatment difference in Quality of Life in Epilepsy-31 (QOLIE-31) [15] scores between participants allocated to self-management education (SMILE) versus those allocated to TAU at 12 months after randomisation.,The primary objective examine treatment difference Quality Life Epilepsy-31 (QOLIE-31) [15] scores participants allocated self-management education (SMILE) versus allocated TAU 12 months randomisation.,G0000000|C0205225|C0018017|G0000000|C0039798|C1705241|C0332306|C0376558|C0014544|C0450371|C0450371|C0449820|C0679646|G0000000|C0086969|C0013621|C0037363|G0000000|G0000000|C1720655|C0450371|C0439231|C0034656
"Secondary objectives include: to determine if the intervention increases the prescribing of calcium supplements (≥500 mg/day elemental calcium); to determine if the intervention increases the prescribing of osteoporosis medications in high-risk individuals (i.e., documented osteoporosis or prior hip fracture); to understand the experience of the LTC team with the intervention and which components were perceived as feasible, acceptable, and effective; and to document falls and fractures occurring during the study period.","Secondary objectives include: determine intervention increases prescribing calcium supplements (≥500 mg/day elemental calcium); determine intervention increases prescribing osteoporosis medications high-risk individuals (i.e., documented osteoporosis prior hip fracture); understand experience LTC team intervention components perceived feasible, acceptable, effective; document falls fractures occurring study period.",C0027627|C0018017|C0332257|G0000000|C0886296|C0205217|C0278329|C0006675|C0242295|G0000000|C0013879|C0006675|G0000000|C0886296|C0205217|C0278329|C0029456|C0013227|C0332167|C0027361|C0683454|C1301725|C0029456|C0332152|C0019552|C0016658|C0162340|C0237607|G0000000|C0871489|C0886296|C0449432|C0030971|G0000000|C1879533|C1280519|C1301746|C0000921|C0016658|C1709305|C0557651|C0439531
"Therefore, 51 children exposed to LEV were included in the analysis.","Therefore, 51 children exposed LEV included analysis.",G0000000|C0450371|C0008059|C0332157|C0023556|C0332257|C0002778
"Exclusion criteria included a recent history of substance abuse or shift work, or experiencing any major illness, including unstable cardiovascular, endocrine, neoplastic, gastrointestinal, hematologic, hepatic, immunologic, metabolic, neurological, pulmonary, and/or renal disease.","Exclusion criteria included history substance abuse shift work, experiencing major illness, including unstable cardiovascular, endocrine, neoplastic, gastrointestinal, hematologic, hepatic, immunologic, metabolic, neurological, pulmonary, and/or renal disease.",C0680251|C0243161|C0332257|C0019664|C0439861|C0013146|C0333051|C0043227|C0237607|C0205082|C0221423|C0332257|C0443343|C0007226|C0014136|C1709160|C0521362|C0018943|C0205054|C0152036|C0311400|C0205494|C0024109|G0000000|C0022646|C0012634
The IMPACT Study included 50 recently diagnosed survivors aged 35–75 who had not yet begun or had only recently begun adjuvant treatment (completed fewer than 2 weeks of radiation or 2 cycles of chemotherapy).,The IMPACT Study included 50 diagnosed survivors aged 35–75 begun begun adjuvant treatment (completed fewer 2 weeks radiation 2 cycles chemotherapy).,G0000000|C1825598|C0557651|C0332257|C0450371|C0011900|C0206194|C0001779|G0000000|C0439659|C0439659|C0001551|C0039798|C0205197|C0205388|G0000000|C0439230|C0034519|G0000000|C1511572|C0013216
"To ensure that the patients would manage the planned aerobic exercise, a bicycle test at 50 watts was included in the inclusion criteria.","To ensure patients manage planned aerobic exercise, bicycle test 50 watts included inclusion criteria.",C0040363|C0218063|C0030705|G0000000|C1301732|C1510824|C0015259|C0005375|C0022885|C0450371|C0439261|C0332257|C0007637|C0243161
Treatment was started as soon as patients could take solid food by mouth after operation but not later than 10 days after surgery.,Treatment started patients solid food mouth operation 10 days surgery.,C0039798|C1272689|C0030705|C0205208|C0016452|C0226896|C0543467|C0450371|C0439228|C0038894
It could be regarded as a limitation that baseline levels of BMD in this randomized controlled trial differed significantly between the intervention and placebo group.,It regarded limitation baseline levels BMD randomized controlled trial differed intervention placebo group.,G0000000|G0000000|C0449295|C0168634|C0441889|G0000000|C0034656|C2587213|C0008976|G0000000|C0886296|C0032042|C0441833
"The design of the study was a repeated measures design with three time points (baseline, immediate post-intervention, and 3 months later).","The design study repeated measures design time (baseline, post-intervention, 3 months later).",G0000000|C1707689|C0557651|C0205341|C0079809|C1707689|C0040223|C0168634|C2347647|G0000000|C0439231|C0205087
Ischaemia also plays a pathogenic role in the carpal tunnel syndrome.,Ischaemia plays pathogenic role carpal tunnel syndrome.,C0022116|C0032214|C0450254|C0035820|C0007285|C0337138|C0039082
"The included patients had to be able to read, write, and speak Norwegian, and they were approved for participation in this study by a clinical oncologist.","The included patients read, write, speak Norwegian, approved participation study clinical oncologist.",G0000000|C0332257|C0030705|C0034754|C0043266|C0234856|C0337812|C0205540|C0679823|C0557651|C0205210|C0259990
Our inclusion criteria were a diagnosis of probable or possible Alzheimer's disease9; age > 60; clinically significant agitation for at least six weeks and scores ≥ 4 on the irritability or aberrant motor behaviour scales of the neuropsychiatric inventory; and no use of antipsychotics or cholinesterase inhibitors for four weeks before entry into the study.,Our inclusion criteria diagnosis probable Alzheimer's disease9; age > 60; clinically agitation weeks scores ≥ 4 irritability aberrant motor behaviour scales neuropsychiatric inventory; antipsychotics cholinesterase inhibitors weeks entry study.,G0000000|C0007637|C0243161|C0011900|C0033204|G0000000|G0000000|C0001779|G0000000|C0450371|G0000000|C0085631|C0439230|C0449820|G0000000|G0000000|C0022107|C0443127|C1513492|C0004927|C0175659|G0000000|C0021941|C0040615|C0008429|C0243077|C0439230|C1705654|C0557651
"One similar ward was identified as a ‘backup’, in the eventuality that one of the study wards was closed for any reason (eg, norovirus outbreak) during the recruitment period.","One ward identified ‘backup’, eventuality study wards closed reason (eg, norovirus outbreak) recruitment period.",C0205447|C1305702|C0205396|G0000000|G0000000|C0557651|C1305702|C0587267|C0392360|C0013715|C0949920|C0012652|C2949735|C0439531
Eligible patients had a baseline EDSS of 4.5–7 with evidence of disease progression during the previous 2 years (an increase of ⩾1 point if EDSS was 4.5–5.5 and ⩾0.5 point if EDSS was 6–7).,Eligible patients baseline EDSS 4.5–7 evidence disease progression previous 2 years (an increase ⩾1 EDSS 4.5–5.5 ⩾0.5 EDSS 6–7).,C1548635|C0030705|C0168634|C0451246|G0000000|C3887511|C0012634|C0242656|C0205156|G0000000|G0000000|C0442805|G0000000|C0451246|G0000000|G0000000|C0451246|G0000000
12 primary care centres in the province of Tarragona (Spain).,12 primary care centres province Tarragona (Spain).,C0450371|C0205225|C1947933|C0205099|C1514578|G0000000|C0037747
"Males between the ages of 16 and 18; individuals determined to be eligible for release within 12 months of intake; and those planning to return to the Bronx, Brooklyn, or Manhattan, the boroughs with the highest incarceration rates, were eligible for enrollment.","Males ages 16 18; individuals determined eligible release 12 months intake; planning return Bronx, Brooklyn, Manhattan, boroughs incarceration rates, eligible enrollment.",C0086582|C0001779|C0450371|C0450371|C0027361|G0000000|C1548635|C0030685|C0450371|C0439231|C1512806|C0032074|C0332156|G0000000|G0000000|G0000000|G0000000|C0205255|C0871208|C1548635|C1516879
In our article we focused on the patients’ recall of risk factors involved in elective spinal surgery.,In article focused patients’ recall risk factors involved elective spinal surgery.,G0000000|C1706852|C0205234|G0000000|C0034770|C0035647|C1521761|C1314939|C0206058|C0521329|C0038894
Inclusion criteria for enrolment were adults (≥18 years) with PAH (mean pulmonary artery pressure ≥ 25 mmHg; pulmonary capillary wedge pressure of <15 mmHg at rest) confirmed by right heart catheterization within the previous 3 years and receiving treatment with bosentan (62.5 or 125 mg twice daily) at a stable dose for ≥3 months.,Inclusion criteria enrolment adults (≥18 years) PAH (mean pulmonary artery pressure ≥ 25 mmHg; pulmonary capillary wedge pressure <15 mmHg rest) confirmed heart catheterization previous 3 receiving treatment bosentan (62.5 125 daily) stable dose ≥3 months.,C0007637|C0243161|C1516879|C0001675|G0000000|C0439234|C3203102|C0444504|C0024109|C0003842|C0033095|G0000000|C0450371|C0439475|C0024109|C0006901|C0439639|C0033095|C0450371|C0439475|C0035253|C0521093|C0018787|C0007430|C0205156|G0000000|C1514756|C0039798|C0252643|C0450371|C1442061|C0332173|C0205360|C0178602|G0000000|C0439231
PATIENTS—58 HIV seropositive patients aged 18-55 years with tuberculous pericarditis.,PATIENTS—58 HIV seropositive patients aged 18-55 tuberculous pericarditis.,G0000000|C0019682|C0521143|C0030705|C0001779|C0450371|C0041296|C0031046
"During this trial, participants received $5.00 for each breath sample with <3 ppm CO.","During trial, participants received $5.00 breath sample <3 ppm CO.",G0000000|C0008976|C0679646|C1514756|C0450371|C0225386|C0370003|G0000000|C0439187|C3245499
"Key inclusion criteria were: subjects on stable maintenance asthma medications for at least 4 weeks before entry, baseline Asthma Quality of Life Questionnaire (AQLQ) score 6.25 or lower (a higher AQLQ score represents better quality of life) (11), prebronchodilator FEV1 ≥60% of predicted, airway hyperresponsiveness (methacholine PC20 <8 mg/ml), at least 2 days of asthma symptoms during the 4-week baseline period, and being a nonsmoker for at least 1 year with less than 10 pack-years smoking history.","Key inclusion criteria were: subjects stable maintenance asthma medications 4 weeks entry, baseline Asthma Quality Life Questionnaire (AQLQ) score 6.25 lower (a AQLQ score represents quality life) (11), prebronchodilator FEV1 ≥60% predicted, airway hyperresponsiveness (methacholine PC20 <8 mg/ml), 2 days asthma symptoms 4-week baseline period, nonsmoker 1 10 pack-years smoking history.",G0000000|C0007637|C0243161|G0000000|C0681850|C0205360|C0024501|C0004096|C0013227|G0000000|C0439230|C1705654|C0168634|C0004096|C0332306|C0376558|C0034394|C4055434|C0449820|C0450371|C0441994|G0000000|C4055434|C0449820|C1882932|C0332306|C0376558|C0450371|C2599602|G0000000|G0000000|C0681842|C0178987|G0000000|C0600370|G0000000|G0000000|C0439294|G0000000|C0439228|C0004096|C0683368|C0332174|C0168634|C0439531|C0337672|G0000000|C0450371|C1277691|C0037369|C0019664
"In total, 7775 children (born between April 2002 and January 2006) entered the study (Fig.","In total, 7775 children (born April 2002 January 2006) entered study (Fig.",G0000000|C0439175|G0000000|C0008059|C0005615|C3715024|G0000000|C3829466|G0000000|C1521975|C0557651|C0349966
"The exclusion criteria for the mothers included problems such as severe bleeding, uterine inertia, gestational diabetes and hypertension, and heart disease.","The exclusion criteria mothers included severe bleeding, uterine inertia, gestational diabetes hypertension, heart disease.",G0000000|C0680251|C0243161|C0026591|C0332257|C0205082|C0019080|C0042149|C4022575|C0439671|C0011847|C0020538|C0018787|C0012634
"Four (10.3%) participants receiving placebo, 2 (5.6%) participants receiving PST, and 1 (2.9%) participant receiving escitalopram started living in a more dependent environment after their stroke.","Four (10.3%) participants receiving placebo, 2 (5.6%) participants receiving PST, 1 (2.9%) participant receiving escitalopram started living dependent environment stroke.",C0205450|C0450371|C0679646|C1514756|C0032042|G0000000|G0000000|C0679646|C1514756|C1152487|G0000000|G0000000|C0679646|C1514756|C1099456|C1272689|C0376558|C0851827|C0014406|C0038454
"The study enrolled patients with CF aged ≥6 years, with forced expiratory volume in 1s (FEV1) of 25–75% predicted,18 chronic P aeruginosa lung infection and a stable clinical condition.","The study enrolled patients CF aged ≥6 years, forced expiratory volume 1s (FEV1) 25–75% predicted,18 chronic P aeruginosa lung infection stable clinical condition.",G0000000|C0557651|G0000000|C0030705|C0009738|C0001779|G0000000|C0441722|C0231800|C0449468|C1421550|G0000000|G0000000|C0681842|C0205191|C0369773|G0000000|C0024109|C0009450|C0205360|C0205210|C0012634
"Following a seven day washout period, patients inhaled colistin twice daily for seven days through the first device.","Following day washout period, patients inhaled colistin daily days device.",C0231290|C0332173|C1710661|C0439531|C0030705|C0004048|C0009316|C0332173|C0439228|C0025080
"Table adapted from Vesikari Clinical Severity Scoring System Manual.13 Exclusions were: children who had severe vomiting (scoring 3 on the Vesikari score for maximum number of vomiting episodes per day); those with a clinical diagnosis of dysentery or a known diagnosis of liver or renal failure; children who had prescriptions of probiotics or any other antidiarrhoeal medication (loperamide, attapulgite, activated charcoal, diphenoxylate and kaolin).","Table adapted Vesikari Clinical Severity Scoring System Manual.13 Exclusions were: children severe vomiting (scoring 3 Vesikari score maximum vomiting episodes day); clinical diagnosis dysentery diagnosis liver renal failure; children prescriptions probiotics antidiarrhoeal medication (loperamide, attapulgite, activated charcoal, diphenoxylate kaolin).",C0039224|C2937289|G0000000|C0205210|C0439793|C0449820|C0449913|C0024763|C0680251|G0000000|C0008059|C0205082|C0042963|C0449820|G0000000|G0000000|C0449820|C0806909|C0042963|C0332189|C0332173|C0205210|C0011900|C0013369|C0011900|C0023884|C0022646|C0231174|C0008059|C0033080|C0525033|C0003292|C0013227|C0023992|C0052657|C1879547|C0007955|C0012525|C0022499
"They were excluded from the study if they were housebound, did not possess a telephone, or were unwilling to give informed consent.","They excluded study housebound, possess telephone, unwilling informed consent.",G0000000|C1554077|C0557651|C0242798|C0850310|C0039457|C0558080|C1522154|C1511481
"However, conclusive evidence for beneficial effects of physical activity after stroke on ADL and walking speed is still missing.","However, conclusive evidence beneficial effects physical activity stroke ADL walking speed missing.",G0000000|C2828146|C3887511|G0000000|C1280500|C0031809|C0205177|C0038454|C0001288|C0080331|C0678536|C1551393
"This was a prospective, single-center, randomized, open-label clinical study of patients with unresectable HC.","This prospective, single-center, randomized, open-label clinical study patients unresectable HC.",G0000000|C0023981|C0037179|C0034656|C1709323|C0205210|C0557651|C0030705|C1519810|C0020268
Our statistically significant findings indicate that the baseball athletes at the intervention colleges were 42% less likely to initiate ST use than the baseball athletes in the control colleges.,Our statistically findings baseball athletes intervention colleges 42% initiate ST baseball athletes control colleges.,G0000000|C0038215|C2607943|C0004795|C0238703|C0886296|C0557806|C0450371|C1548602|C0036056|C0004795|C0238703|C0243148|C0557806
The present randomized controlled trial (RCT) was conducted on 57 adult subjects with mild or moderate bronchial asthma who were allocated randomly to either the yoga (intervention) group (n = 29) or the wait-listed control group (n = 28).,The randomized controlled trial (RCT) conducted 57 adult subjects mild moderate bronchial asthma allocated randomly yoga (intervention) (n = 29) wait-listed control (n = 28).,G0000000|C0034656|C2587213|C0008976|G0000000|C0004927|C0450371|C0001675|C0681850|C2945599|C0205081|C0205039|C0004096|G0000000|G0000000|C0043418|C0886296|C0369718|G0000000|C0450371|C0043010|C0243148|C0369718|G0000000|C0450371
The participants comprised a consecutive series of patients with mild to moderate stroke or TBI.,The participants comprised consecutive series patients mild moderate stroke TBI.,G0000000|C0679646|C2700400|C1707491|C0205549|C0030705|C2945599|C0205081|C0038454|C0876926
"To ensure full exposure to a year of supplementation, per protocol, consented children who were not met despite repeated visits were excluded from the study once they had reached their 7-month birthday.","To ensure exposure supplementation, protocol, consented children met repeated visits excluded study reached 7-month birthday.",C0040363|C0218063|C0274281|C0242297|C0442711|C2711213|C0008059|C0268621|C0205341|C0545082|C1554077|C0557651|C2584321|C0332177|G0000000
"Exclusion criteria included: (i) an acute, life-threatening illness; (ii) a variable psychotropic medication regime, and (iii) a medical condition that precluded the use of topical oils.","Exclusion criteria included: (i) acute, life-threatening illness; (ii) variable psychotropic medication regime, (iii) medical condition precluded topical oils.",C0680251|C0243161|C0332257|C0021966|C0205178|C1517874|C0221423|G0000000|C0439828|C0033978|C0013227|G0000000|C0439070|C0199168|C0012634|G0000000|C0332237|C0028908
"Although not statistically different, the mortality rate was higher for patients receiving the shorter treatment courses (22% versus 14%; P = 0.38).","Although statistically different, mortality rate patients receiving shorter treatment courses (22% versus 14%; P = 0.38).",G0000000|C0038215|C1705242|C0026565|C0871208|C0030705|C1514756|C1282927|C0039798|C0750729|C0450371|G0000000|C0450371|C0369773|G0000000|C0450371
"We excluded patients who had already been critically ill for >72 hours since the opportunity to administer early cognitive and physical therapy had passed, those who had been in the ICU for more than 5 days in the previous 30 days, those were unlikely to benefit from rehabilitation targeting acute declines in cognitive or functional status due to a moribund state, severe pre-existing dementia or physical disability in activities of daily living (e.g., bathing, dressing, etc.","We excluded patients critically ill >72 hours opportunity administer cognitive physical therapy passed, ICU 5 days previous 30 days, benefit rehabilitation targeting acute declines cognitive functional status moribund state, severe pre-existing dementia physical disability activities daily living (e.g., bathing, dressing, etc.",G0000000|C1554077|C0030705|G0000000|C0231218|C0450371|C0439227|G0000000|C1621583|C1516691|C0031809|C0039798|C2828386|C0021708|G0000000|C0439228|C0205156|C0450371|C0439228|C0814225|C0034991|C1521840|C0205178|G0000000|C1516691|C0205245|C0449438|C0424547|C1301808|C0205082|C2347662|C0011265|C0031809|C0231170|C0441655|C0332173|C0376558|G0000000|C0150141|C0013119|C1548556
"Subjects were excluded if they had received treatment for low back pain in the month prior to presentation or had low back pain due to fracture, tumor, infection, spondyloarthropathy, or other nonmechanical cause; severe coexisting disease; use of pacemakers or other implantable electronic devices; coagulation disorders; use of corticosteroids or anticoagulant medications; progressive unilateral lower limb muscle weakness; or symptoms or signs of cauda equina syndrome.","Subjects excluded received treatment low pain month prior presentation low pain fracture, tumor, infection, spondyloarthropathy, nonmechanical cause; severe coexisting disease; pacemakers implantable electronic devices; coagulation disorders; corticosteroids anticoagulant medications; progressive unilateral lower limb muscle weakness; symptoms signs cauda equina syndrome.",C0681850|C1554077|C1514756|C0039798|C0205251|C0030193|C0332177|C0332152|C0449450|C0205251|C0030193|C0016658|C0027651|C0009450|C0949690|G0000000|C0015127|C0205082|G0000000|C0012634|C0810633|C0021102|C0013850|C0025080|C0005778|C0012634|C0001617|C0003280|C0013227|C0205329|C0205092|C0441994|C0015385|C0026845|C3714552|C0683368|C0220912|C0205097|C0017589|C0039082
Eligibility criteria included the following: infant age between 6 and 11 months; in good health; not severely malnourished (weight‐for‐length z‐score < −3); household not receiving other food aid; and residence within the FSM catchment area.,Eligibility criteria included following: infant age 6 11 months; health; severely malnourished (weight‐for‐length z‐score < −3); household receiving food aid; residence FSM catchment area.,C0013893|C0243161|C0332257|C0231290|C0021270|C0001779|G0000000|C0450371|C0439231|C0018684|C0205082|C0162429|G0000000|G0000000|G0000000|C0020052|C1514756|C0016452|C0449435|C0237096|C0282244|G0000000|C0017446
The end result was an intervention group of 394 students from 60 classes and a control group of 357 students from 53 classes (figure 1).,The result intervention 394 students 60 classes control 357 students 53 classes (figure 1).,G0000000|C1274040|C0886296|C1442061|C0038492|C0450371|C0456387|C0243148|C1442061|C0038492|C0450371|C0456387|G0000000|G0000000
"The projected population for 2016 was 162 188 individuals, with 31 927 (19.7%) under 5 years of age.15 Administrative map of Mopeia.","The projected population 2016 162 188 individuals, 31 927 (19.7%) 5 years age.15 Administrative map Mopeia.",G0000000|C0016538|C0032659|G0000000|G0000000|C0027361|G0000000|C0450371|G0000000|C0001779|C1292785|C0024779|G0000000
"On presentation, 45% of patients had an ulcer, 23% had a plaque, and 13% had a nodule; 29% had a WHO category I lesion, 55% a category II lesion, and 16% a category III lesion.","On presentation, 45% patients ulcer, 23% plaque, 13% nodule; 29% WHO category I lesion, 55% category II lesion, 16% category III lesion.",G0000000|C0449450|C0450371|C0030705|C0041582|C0450371|C0011389|C0450371|C0028259|C0450371|G0000000|C0683312|C0021966|C0221198|C0450371|C0683312|G0000000|C0221198|C0450371|C0683312|C0439070|C0221198
"Male and female outpatients aged ≥40 years with a clinical diagnosis of COPD (pre- and post-bronchodilator FEV1 20%–70% predicted and FEV1/slow vital capacity [SVC] ≤70%,) corresponding to mild, moderate, or severe COPD according to 1995 American Thoracic Society criteria (American Thoracic Society 1995) and a smoking history of >10 pack-years were eligible for inclusion in the study.","Male female outpatients aged ≥40 clinical diagnosis COPD (pre- post-bronchodilator FEV1 20%–70% predicted FEV1/slow vital capacity [SVC] ≤70%,) mild, moderate, severe COPD 1995 American Thoracic Society criteria (American Thoracic Society 1995) smoking history >10 pack-years eligible inclusion study.",C0086582|C0015780|C0029921|C0001779|G0000000|C0205210|C0011900|C0024117|C0332152|C2599594|G0000000|G0000000|C0681842|C0439834|C0442732|C1516240|C0231957|G0000000|C2945599|C0205081|C0205082|C0024117|G0000000|C0596070|G0000000|C0037455|C0243161|C0596070|G0000000|C0037455|G0000000|C0037369|C0019664|C0450371|C1277691|C1548635|C0007637|C0557651
Within these providers the target sample was parents who were English literate with a child eligible for the first or second dose MMR vaccination.,Within providers target sample parents English literate child eligible dose MMR vaccination.,G0000000|C1138603|C1521840|C0370003|C0030551|C0376245|C0023864|C0008059|C1548635|C0178602|C3538741|C0042196
"Patients were excluded if they had a history of renal transplant, significant cardiovascular history within 6 months, liver disease, abnormal liver function tests (alanine transaminase [ALT] >2× upper limit of normal [ULN], aspartate transaminase >2× ULN or total bilirubin >2× ULN and/or direct bilirubin >ULN) or any treatment that is contraindicated (i.e.","Patients excluded history renal transplant, cardiovascular history 6 months, liver disease, abnormal liver function tests (alanine transaminase [ALT] >2× upper limit normal [ULN], aspartate transaminase >2× ULN total bilirubin >2× ULN and/or direct bilirubin >ULN) treatment contraindicated (i.e.",C0030705|C1554077|C0019664|C0022646|C0040732|C0007226|C0019664|G0000000|C0439231|C0023884|C0012634|C0205161|C0023884|C0031843|C0022885|C0001898|C0002594|C1266129|G0000000|C1282910|C0439801|C0205307|C1519815|C0085845|C0002594|G0000000|C1519815|C0439175|C0005437|G0000000|C1519815|G0000000|C0439851|C0005437|C1519815|C0039798|C1444657|C0683454
The study was conducted in September-October 2000 among children enrolled in the first grade (Standard 1; aged 6-7 years) and in the second grade (Standard 2; aged 8-9 years) of 7 public primary schools on Pemba Island.,The study conducted September-October 2000 children enrolled grade (Standard 1; aged 6-7 years) grade (Standard 2; aged 8-9 years) 7 public primary schools Pemba Island.,G0000000|C0557651|C0004927|C3828193|G0000000|C0008059|G0000000|C0441800|C1442989|G0000000|C0001779|G0000000|C0439234|C0441800|C1442989|G0000000|C0001779|G0000000|C0439234|G0000000|G0000000|C0205225|C0036375|C0205801|C0022130
"Inclusion criteria were native Italian proficiency, pre-morbid right handedness, a single left hemispheric stroke at least 6 months prior to the investigation, and no acute or chronic neurological symptoms requiring medication.","Inclusion criteria native Italian proficiency, pre-morbid handedness, single left hemispheric stroke 6 months prior investigation, acute chronic neurological symptoms requiring medication.",C0007637|C0243161|C0302891|C0022275|G0000000|C0332152|C0023114|C0037179|C0205091|C0205139|C0038454|G0000000|C0439231|C0332152|C0220825|C0205178|C0205191|C0205494|C0683368|G0000000|C0013227
"A parallel group randomised controlled trial will be undertaken with 54 childcare services that provide food to children within New South Wales, Australia.","A parallel randomised controlled trial undertaken 54 childcare services provide food children New South Wales, Australia.",G0000000|C2348042|G0000000|C2587213|C0008976|G0000000|C0450371|C0008067|C0557854|C1999230|C0016452|C0008059|C0205314|C1710133|C0043015|C0004340
"[20] Inclusion criteria were age >18 years, ability to give informed consent, duration of HD >3 months, PSQI score ≥5 and adherence to regular and steady dialysis program or medication that interfere with melatonin secretion (such as beta adreno-receptors blocking drug).","[20] Inclusion criteria age >18 years, ability informed consent, duration HD >3 months, PSQI score ≥5 adherence regular steady dialysis program medication interfere melatonin secretion (such beta adreno-receptors blocking drug).",C0450371|C0007637|C0243161|C0001779|C0450371|C0439234|C0085732|C1522154|C1511481|C0449238|G0000000|G0000000|C0439231|C3697468|C0449820|G0000000|C1510802|C0205272|C0205361|C0011945|C1709697|C0013227|C0521102|C0025219|C0036536|G0000000|C0330390|C0597357|C0233660|C0013227
"Patients considered for this clinical trial were adult women with bothersome hot flashes, defined by occurrence at least 28 times per week and sufficient severity to make the patient desire therapeutic intervention.","Patients considered clinical trial adult women bothersome hot flashes, defined occurrence 28 times week sufficient severity patient desire therapeutic intervention.",C0030705|C0750591|C0205210|C0008976|C0001675|C0043210|G0000000|C0444519|C0085635|C1704788|C0243132|C0450371|C0040223|C0332174|C0205410|C0439793|C0030705|C0871633|C0087111|C0886296
Survey B = 6 mo after first intervention spray and 2 mo after second intervention spray.,Survey B = 6 mo intervention spray 2 mo intervention spray.,C0038951|G0000000|C0026544|C0886296|C1704413|G0000000|C0026544|C0886296|C1704413
"The mean age was 42 years, and 60.2% of the cohort was female.","The age 42 years, 60.2% cohort female.",G0000000|C0001779|C0450371|C0439234|C0450371|C0599755|C0015780
"Hence, this ‘Randomized Controlled Trial’ was undertaken in adolescent girls suffering from Iron Deficiency Anaemia visiting ‘Urban Health and Training Centre’ situated in urban slum area.","Hence, ‘Randomized Controlled Trial’ undertaken adolescent girls suffering Iron Deficiency Anaemia visiting ‘Urban Health Training Centre’ situated urban slum area.",G0000000|G0000000|C2587213|G0000000|G0000000|C0205653|C0870604|C0683278|C0302583|C0011155|C0002871|C0545082|G0000000|C0018684|C0040607|G0000000|G0000000|C0442529|C0037345|C0017446
Infants 6 weeks to 12 months old who were seen at participating pediatric EDs with a first episode of moderate to severe bronchiolitis were eligible for the study.17 Bronchiolitis was diagnosed by a history of viral upper respiratory tract infection plus wheezing and/or crackles on chest auscultation with respiratory distress.,Infants 6 weeks 12 months participating pediatric EDs episode moderate severe bronchiolitis eligible study.17 Bronchiolitis diagnosed history viral upper respiratory tract infection wheezing and/or crackles chest auscultation respiratory distress.,C0021270|G0000000|C0439230|C0450371|C0439231|C0679823|C0030755|G0000000|C0332189|C0205081|C0205082|C0006271|C1548635|C0557651|C0006271|C0011900|C0019664|C0521026|C1282910|C0521346|C1185740|C0009450|C0043144|G0000000|C0034642|C0817096|C0004339|C0521346|C0231303
Methods: A total of 350 children enrolled in Baltimore City Head Start whose caregivers reported a smoker living in the home were recruited.,Methods: A total 350 children enrolled Baltimore City Head Start caregivers reported smoker living recruited.,C0025663|G0000000|C0439175|C1442061|C0008059|G0000000|C0004716|C0008848|C0018670|C0439659|C0085537|C0684224|C0337664|C0376558|G0000000
289 patients enrolled in the RC and 365 patients enrolled in the OC.,289 patients enrolled RC 365 patients enrolled OC.,C1442061|C0030705|G0000000|C1167159|C1442061|C0030705|G0000000|C1412791
"For the purpose of this study, first year students in all state secondary schools (n = 61) in Lothian and Fife were identified (12,765 12–13-year-old children) in 2004.","For purpose study, students secondary schools (n = 61) Lothian Fife identified (12,765 12–13-year-old children) 2004.",G0000000|C1285529|C0557651|C0038492|C0027627|C0036375|C0369718|G0000000|C0450371|C0454912|C0454909|C0205396|C0450371|G0000000|C0008059|G0000000
"Inclusion criteria Participants included patients admitted with fever (> 38 °C); respiratory symptoms consistent with cough, sore throat, myalgia, or influenza-like illness; acute respiratory failure requiring ICU admission; and microbiological confirmation of viral A, B, or C infection identified by reverse transcription polymerase chain reaction (rt-PCR) at ICU admission.","Inclusion criteria Participants included patients admitted fever (> 38 °C); respiratory symptoms consistent cough, sore throat, myalgia, influenza-like illness; acute respiratory failure requiring ICU admission; microbiological confirmation viral A, B, C infection identified reverse transcription polymerase chain reaction (rt-PCR) ICU admission.",C0007637|C0243161|C0679646|C0332257|C0030705|C0184666|C0015967|G0000000|G0000000|C0521346|C0683368|C0332290|C0010200|C0234233|C0031354|C0231528|C0021400|C0221423|C0205178|C0521346|C0231174|G0000000|C0021708|C0184666|C0025953|C0521091|C0521026|G0000000|G0000000|G0000000|C0009450|C0205396|C1555029|C0040649|C1335439|C0337112|C0443286|C0599161|C0021708|C0184666
All the baris (usually composed of 5–6 adjoining households with a population of about 30–35 relatives) in the study area were listed.,All baris (usually composed 5–6 adjoining households population 30–35 relatives) study listed.,G0000000|C1890660|C3538928|G0000000|G0000000|G0000000|C0020052|C0032659|G0000000|C0080103|C0557651|C0745732
"In the main MDIG trial, a total of 1,300 pregnant women will be randomized, targeting 260 women in each group (Fig.","In main MDIG trial, total 1,300 pregnant women randomized, targeting 260 women (Fig.",G0000000|C0205225|C1426245|C0008976|C0439175|C1442061|C0549206|C0043210|C0034656|C1521840|C1442061|C0043210|C0349966
Doppler-defined pulmonary hypertension (PH) in sickle cell disease (SCD) is associated with 40% mortality at 40 months.,Doppler-defined pulmonary hypertension (PH) sickle cell disease (SCD) 40% mortality 40 months.,C0554756|C0024109|C0020538|C0450407|G0000000|C0007634|C0012634|G0000000|C0450371|C0026565|C0450371|C0439231
At least two caregivers of patients with severe cognitive compromise (patients not interviewed) were also selected.,At caregivers patients severe cognitive compromise (patients interviewed) selected.,G0000000|C0085537|C0030705|C0205082|C1516691|C2945640|C0030705|C0021822|C1707391
"Whereas, there is a clear need of Vitamin D supplementation in Kashmiri pregnant women, there is no data on safety and effectiveness of Vitamin D supplementation during pregnancy in our population.","Whereas, Vitamin D supplementation Kashmiri pregnant women, data safety effectiveness Vitamin D supplementation pregnancy population.",G0000000|C0042890|C0073187|C0242297|G0000000|C0549206|C0043210|C1511726|C0036043|C1280519|C0042890|C0073187|C0242297|C0032961|C0032659
"Twenty-one normal female volunteers were recruited by advertisement and were matched with the migraine patients by age (treatment group: 31.12±5.49 yr, monitoring group: 31.87±4.70 yr, normal control group: 29.38±4.64 yr), and mood states and mean skin temperature of the patients before the biofeedback treatment were compared with those of the normal control subjects.","Twenty-one normal female volunteers recruited advertisement matched migraine patients age (treatment group: 31.12±5.49 yr, monitoring group: 31.87±4.70 yr, normal control group: 29.38±4.64 yr), mood skin temperature patients biofeedback treatment compared normal control subjects.",C3715213|C0205307|C0015780|C0042960|G0000000|C0949214|C0150103|C0149931|C0030705|C0001779|C0039798|C0441833|G0000000|C0439234|C0150369|C0441833|G0000000|C0439234|C0205307|C0243148|C0441833|G0000000|C0439234|C0026516|C0444099|C0005903|C0030705|C0005491|C0039798|C1707455|C0205307|C0243148|C0681850
All townships in each county were included except (1) the one township per county that housed the county seat and (2) those townships that did not have any villages with at least 800 people.,All townships county included (1) township county housed county seat (2) townships villages 800 people.,G0000000|C1552925|C0079170|C0332257|G0000000|C1552925|C0079170|C0020056|C0079170|G0000000|G0000000|C1552925|C0562518|C1442061|C0027361
Sixty (51 women) nonagenarians (age range: 90–102 years) who live in a geriatric nursing home will be randomly assigned to either a usual care (control) group (n = 30) or an intervention (training) group (n = 30).,Sixty (51 women) nonagenarians (age range: 90–102 years) live geriatric nursing randomly assigned usual care (control) (n = 30) intervention (training) (n = 30).,C3816724|C0450371|C0043210|C0028296|C0001779|C1514721|G0000000|C0439234|C1548795|C1704440|C0006147|G0000000|C1516050|C3538928|C1947933|C0243148|C0369718|G0000000|C0450371|C0886296|C0040607|C0369718|G0000000|C0450371
"Age at baseline interview (years), year of baseline interview (1993–1995, 1996–1998), dialect group (Hokkien, Cantonese), level of education (none/primary, ≥secondary), body mass index (BMI) (quartiles, kg/m2), and cigarette smoking history (never, former, current) were included in multivariable regression models to adjust for possible confounding on the association between tea consumption and prostate cancer risk [25, 26].","Age baseline interview (years), baseline interview (1993–1995, 1996–1998), dialect (Hokkien, Cantonese), level education (none/primary, ≥secondary), body mass (BMI) (quartiles, kg/m2), cigarette smoking history (never, former, current) included multivariable regression models adjust confounding association tea consumption prostate cancer risk [25, 26].",C0001779|C0168634|C0021822|C0439234|C0168634|C0021822|G0000000|G0000000|C0870413|G0000000|G0000000|C0441889|C0013621|C0205225|G0000000|C0242821|C0577559|G0000000|C2828255|C0022718|C0677453|C0037369|C0019664|C2003901|C0205156|C0521116|C0332257|G0000000|C0684320|C3161035|G0000000|G0000000|C0004083|C0039400|C0009830|C0033572|C0006826|C0035647|C0450371|C0450371
"[4] Cancer has many side effects, and the most notable consequences are anxiety and depression.","[4] Cancer effects, notable consequences anxiety depression.",G0000000|C0006826|C1280500|G0000000|C0686907|C0003467|C0011570
"Briefly, eligible patients were aged 18–65 years with a history of migraine as defined in the International Classification of Headache Disorders (ICHD)-II Section 1, Migraine, with the exception of ‘complicated migraine’ 4.","Briefly, eligible patients aged 18–65 history migraine defined International Classification Headache Disorders (ICHD)-II Section 1, Migraine, exception ‘complicated migraine’ 4.",G0000000|C1548635|C0030705|C0001779|G0000000|C0019664|C0149931|C1704788|C1512888|C0008902|C0018681|C0012634|G0000000|C0152060|G0000000|C0149931|C1554961|G0000000|G0000000|G0000000
Age between 3 months and 24 months of age (not beyond second birthday at baseline) Diagnosis of epilepsy confirmed Seizure frequency greater than or equal to four seizures/week on average in the baseline period Failed response to previous trial of two antiepileptic drugs.,Age 3 months 24 months age (not birthday baseline) Diagnosis epilepsy confirmed Seizure frequency equal seizures/week average baseline period Failed response previous trial antiepileptic drugs.,C0001779|G0000000|C0439231|C0450371|C0439231|C0001779|C1518422|G0000000|C0168634|C0011900|C0014544|C0521093|C0036572|C0376249|C0205163|C0036572|C1510992|C0168634|C0439531|C0231175|C0871261|C0205156|C0008976|C0003299|C0013227
"IUI, IVF); f) Current use of illicit drugs (defined as any use in the past 6 months prior to enrollment); g) Previously enrolled in VDAART for a prior pregnancy; h) Any major fetal anomalies detected prior to delivery; i) Patient Health Questionnaire (PHQ-9)39 depression scale ≥ 15 and j) Any condition, in the opinion of the Clinical Center Principal Investigators, that would inhibit compliance with the study medications or prohibit long-term participation in the trial.","IUI, IVF); f) Current illicit drugs (defined 6 months prior enrollment); g) Previously enrolled VDAART prior pregnancy; h) Any major fetal anomalies detected prior delivery; i) Patient Health Questionnaire (PHQ-9)39 depression scale ≥ 15 j) Any condition, opinion Clinical Center Principal Investigators, inhibit compliance study medications prohibit long-term participation trial.",G0000000|C0872104|C0016327|C0521116|C0332266|C0013227|C1704788|G0000000|C0439231|C0332152|C1516879|C0439267|G0000000|G0000000|G0000000|C0332152|C0032961|C0033727|G0000000|C0205082|C0015965|C0000769|C0442726|C0332152|C0011209|C0021966|C0030705|C0018684|C0034394|C1879301|C0011570|C0175659|G0000000|C0450371|G0000000|G0000000|C0012634|C0871010|C0205210|C0205099|C0205225|C0035173|C0018790|C0009563|C0557651|C0013227|C0138547|C0443252|C0679823|C0008976
"A total of 5,551 pregnant women (households) were enrolled in the study (Figure 1).","A total 5,551 pregnant women (households) enrolled study (Figure 1).",G0000000|C0439175|C1442061|C0549206|C0043210|C0020052|G0000000|C0557651|G0000000|G0000000
"Patients were included in the study if their ages were between 16 and 60 years of age and they had suffered displaced midshaft clavicular fractures within the last 4 weeks with no cortical bone contact or shortening of over 15 mm, or if the fracture fragments were tenting or compromising the skin with an axial malalignment of over 30°.","Patients included study ages 16 60 age suffered displaced midshaft clavicular fractures 4 weeks cortical bone contact shortening 15 mm, fracture fragments tenting compromising skin axial malalignment 30°.",C0030705|C0332257|C0557651|C0001779|C0450371|C0450371|C0001779|C0683278|C0012727|G0000000|C0008913|C0016658|G0000000|C0439230|C0001613|C0262950|C0332158|C0441636|C0450371|G0000000|C0016658|C0332255|C0237322|C2945640|C0444099|C0205131|C1275957|G0000000
ITN use among children in ITN-owning households.,ITN children ITN-owning households.,G0000000|C0008059|G0000000|C0020052
Participants 742 pregnant women with one previous lower segment caesarean section and delivery expected at ≥37 weeks.,Participants 742 pregnant women previous lower segment caesarean delivery expected ≥37 weeks.,C0679646|C1442061|C0549206|C0043210|C0205156|C0441994|C0441635|C3841297|C0011209|C1517001|G0000000|C0439230
"Subjects were excluded if they had an acute upper or lower respiratory tract infection or required treatment with antibiotics or systemic corticosteroids within 28 days of study enrollment (not including normal maintenance antibiotics), had a diagnosis of sleep apnea, symptoms of allergic rhinitis, previous diagnosis of Burkholderia cepacia, smoked, or were pregnant or nursing.","Subjects excluded acute upper lower respiratory tract infection required treatment antibiotics systemic corticosteroids 28 days study enrollment (not including normal maintenance antibiotics), diagnosis sleep apnea, symptoms allergic rhinitis, previous diagnosis Burkholderia cepacia, smoked, pregnant nursing.",C0681850|C1554077|C0205178|C1282910|C0441994|C0521346|C1185740|C0009450|C1514873|C0039798|C0003232|C0205373|C0001617|C0450371|C0439228|C0557651|C1516879|C1518422|C0332257|C0205307|C0024501|C0003232|C0011900|C0037313|C0003578|C0683368|C0700624|C0035455|C0205156|C0011900|C0282676|G0000000|C0037366|C0549206|C0006147
"Exclusion criteria, determined by treating physician in most cases, included: needing significant change in the dose of insulin administered during the research, acute or chronic medical illness that makes problems in venesection or intolerance in long sessions, cinching up severe medical complications of diabetes, receiving psychiatric treatment or use of psychotropic drugs and drug abuse during the study period.","Exclusion criteria, determined treating physician cases, included: change dose insulin administered research, acute chronic medical illness venesection intolerance sessions, cinching severe medical complications diabetes, receiving psychiatric treatment psychotropic drugs drug abuse study period.",C0680251|C0243161|G0000000|C1522326|C0031831|C0868928|C0332257|C0392747|C0178602|C0021641|C1521801|C0035168|C0205178|C0205191|C0199168|C0221423|C0005857|C0231199|C1883016|C0184987|C0205082|C0199168|C0009566|C0011847|C1514756|C0205487|C0039798|C0033978|C0013227|C0013227|C0013146|C0557651|C0439531
"Exclusion criteria were fasting triglycerides>5.64 mmol/L (500 mg/dL), diabetes mellitus or fasting serum glucose>6.99 mmol/L (126 mg/dl), systolic blood pressure≥160 mmHg and/or diastolic blood pressure≥100 mmHg, untreated thyroid disease, creatinine clearance<70 ml/min, life-threatening illness with prognosis<5 years or >5 alcoholic drinks daily.","Exclusion criteria fasting triglycerides>5.64 mmol/L (500 mg/dL), diabetes mellitus fasting serum glucose>6.99 mmol/L (126 mg/dl), systolic blood pressure≥160 mmHg and/or diastolic blood pressure≥100 mmHg, untreated thyroid disease, creatinine clearance<70 ml/min, life-threatening illness prognosis<5 >5 alcoholic drinks daily.",C0680251|C0243161|C0015663|C0041004|C1532563|C1442061|C0439269|C0011847|G0000000|C0015663|C0229671|C0017725|C1532563|C1442061|C0439269|C0039155|C0005767|G0000000|C0439475|G0000000|C0012000|C0005767|G0000000|C0439475|C0332155|C0040132|C0012634|C0010294|C0449297|C0439445|C1517874|C0221423|C0033325|G0000000|C0687725|C0452428|C0332173
"Overall, 66% of the patients recruited by general practitioners allocated to training in enhanced communication skills recalled their doctors using at least three of four specific communication skills (asking opinions on antibiotics, exploring worries, eliciting expectations, and providing information on the natural course and duration of lower respiratory tract infection) compared with 19% of patients in the no training group.","Overall, 66% patients recruited practitioners allocated training enhanced communication skills recalled doctors specific communication skills (asking opinions antibiotics, exploring worries, eliciting expectations, providing natural duration lower respiratory tract infection) compared 19% patients training group.",C0282416|C0450371|C0030705|G0000000|C1709627|G0000000|C0040607|C2349975|C0009452|C0678856|C0034770|C0031831|C0205369|C0009452|C0678856|G0000000|C0871010|C0003232|G0000000|C0233481|C0449265|C0679138|C1999230|C0205296|C0449238|C0441994|C0521346|C1185740|C0009450|C1707455|C0450371|C0030705|C0040607|C0441833
"Between July 2008 and March 2009, we recruited 39 patients admitted to the Chest Department in a tertiary hospital with moderate to severe COPD according to GOLD 2007[8] criteria for diagnosis of COPD.","Between July 2008 March 2009, recruited 39 patients admitted Chest Department tertiary hospital moderate severe COPD GOLD 2007[8] criteria diagnosis COPD.",G0000000|C3829447|G0000000|C3829202|G0000000|G0000000|C0450371|C0030705|C0184666|C0817096|C1704729|C0205372|C0019994|C0205081|C0205082|C0024117|C0018026|G0000000|C0243161|C0011900|C0024117
"Participants with a history of adverse reactions to peas, beans, or peanuts were excluded because of possible cross reactions to soya protein.3 Telephone interviews were held with 202 potential participants; 133 were excluded (see fig A, a flow chart showing exclusions, on the BMJ 's website), and the remaining 69 were invited for further evaluation.","Participants history adverse reactions peas, beans, peanuts excluded cross reactions soya protein.3 Telephone interviews held 202 potential participants; 133 excluded (see fig A, flow chart exclusions, BMJ website), remaining 69 invited evaluation.",C0679646|C0019664|G0000000|C0443286|C0030738|C0004896|C0030736|C1554077|C2828360|C0443286|C0037733|C0033684|C0039457|C0021822|C0675390|C1442061|C3245505|C0679646|C1442061|C1554077|C0042789|C0349966|G0000000|C0806140|C0007963|C0680251|G0000000|C2349146|C1527428|C0450371|G0000000|C0220825
In this study pregnant women had hyperemesis but they used the finger pressure similarity of our study.,In study pregnant women hyperemesis finger pressure similarity study.,G0000000|C0557651|C0549206|C0043210|C0020450|C0016129|C0033095|C2348205|C0557651
"The three primary efficacy variables, to be measured at baseline, four, 16 and 26 weeks, are: • Pain (100 mm VAS and Western Ontario and McMaster Universities Osteoarthritis Index -WOMAC Likert format 3.1).","The primary efficacy variables, measured baseline, four, 16 26 weeks, are: • Pain (100 mm VAS Western Ontario McMaster Universities Osteoarthritis Index -WOMAC Likert format 3.1).",G0000000|C0205225|C1280519|C0439828|C0444706|C0168634|C0205450|C0450371|C0450371|C0439230|G0000000|G0000000|C0030193|C1442061|G0000000|C0042815|C1705493|C0029040|G0000000|C0041740|C0029408|C0918012|G0000000|G0000000|C1301627|G0000000
A census will be carried out prior to the start of the study.,A census carried prior start study.,G0000000|C0007663|C0206243|C0332152|C0439659|C0557651
"Thus this could be an efficient, cost effective way of providing help to those with IBS.","Thus efficient, cost effective providing IBS.",G0000000|C0442799|C0010186|C1280519|C1999230|C0022104
1).,1).,G0000000
"Improvement was defined as a decrease of ⩾0.5 point or ⩾1 point in EDSS (if baseline score was 6–7 or 4.5–5.5, respectively) or a ⩾20% decrease in timed 25-foot walk (TW25) time, compared with the best EDSS or TW25 value recorded at either the screening or the randomisation visit.","Improvement defined decrease ⩾0.5 ⩾1 EDSS (if baseline score 6–7 4.5–5.5, respectively) ⩾20% decrease timed 25-foot walk (TW25) time, compared EDSS TW25 recorded screening randomisation visit.",C2986411|C1704788|C0392756|G0000000|G0000000|C0451246|G0000000|C0168634|C0449820|G0000000|G0000000|G0000000|G0000000|C0392756|C0392761|C0450371|C0080331|G0000000|C0040223|C1707455|C0451246|G0000000|C0034869|C0220908|C0034656|C0545082
"The inclusion criteria of the study were 18–35 years of age, term pregnancy, singleton pregnancy, and healthy fetal membranes.","The inclusion criteria study 18–35 age, term pregnancy, singleton pregnancy, healthy fetal membranes.",G0000000|C0007637|C0243161|C0557651|G0000000|C0001779|C0233324|C0032961|C0481462|C0032961|C3898900|C0015965|C0025255
Criteria for probable and suspected SARS cases included travel to a SARS epidemic area in the 2 weeks before the onset of symptoms or close contact with a probable SARS patient; fever of ≥ 38°C; chest x-ray abnormalities; normal or decreased leukocycte count; and no response to treatment by antimicrobial drugs.,Criteria probable suspected SARS included travel SARS epidemic 2 weeks onset symptoms close contact probable SARS patient; fever ≥ 38°C; chest x-ray abnormalities; normal decreased leukocycte count; response treatment antimicrobial drugs.,C0243161|C0033204|C0332147|C1175175|C0332257|C0040802|C1175175|C0014499|G0000000|C0439230|C0206132|C0683368|C0587267|C0332158|C0033204|C1175175|C0030705|C0015967|G0000000|G0000000|C0817096|C0034571|C0000768|C0205307|C0205216|G0000000|C0750480|C0871261|C0039798|C1136254|C0013227
All term and preterm infants > 28+ 0 by best obstetrical estimate who require CPR at birth due to bradycardia (< 60/min) or asystole are eligible.,All term preterm infants > 28+ 0 obstetrical estimate require CPR birth bradycardia (< 60/min) asystole eligible.,G0000000|C0233324|C0151526|C0021270|G0000000|C0028773|C0750572|G0000000|C0007203|C0005615|C0428977|G0000000|C0018790|C1548635
"Eligible patients were 18 years or older and had a life expectancy of more than 12 weeks, histologically or cytologically confirmed stage IIIb or IV NSCLC, a WHO performance status of 0–2, and completed four cycles of first-line platinum-based doublet chemotherapy without disease progression and unacceptable toxicities.","Eligible patients 18 life expectancy 12 weeks, histologically cytologically confirmed stage IIIb IV NSCLC, WHO performance status 0–2, completed cycles first-line platinum-based doublet chemotherapy disease progression unacceptable toxicities.",C1548635|C0030705|C0450371|C0376558|C0679138|C0450371|C0439230|C0205462|G0000000|C0521093|C0205390|G0000000|C0022326|C0007131|G0000000|C0597198|C0449438|G0000000|C0205197|C1511572|C0205435|C0032207|G0000000|C0013216|C0012634|C0242656|C1883420|C0600688
"A pair-matched, cluster-randomized trial comparing household symptom screening and spot sputum collection (Arm 1) vs. distribution of an educational pamphlet (Arm 2) was performed in a large Brazilian favela.","A pair-matched, cluster-randomized trial comparing household symptom screening spot sputum collection (Arm 1) vs. distribution educational pamphlet (Arm 2) performed Brazilian favela.",G0000000|C1709450|C1555715|C0008976|C1707455|C0020052|C1457887|C0220908|C0329155|C0038056|C1516698|C0446516|G0000000|G0000000|C0520511|C0587721|C0030258|C0446516|G0000000|C0884358|C0238815|G0000000
"Exclusion criteria included: (1) inability to self-administer medications, (2) inability to measure own BP, (3) inability to use a mobile phone, (4) history of psychiatric illness or substance abuse, (5) pregnant, lactating or intention of becoming pregnant during the trial, (6) participant in another study, (7) inabilities to speak, hear, or understand English, and (8) poor cellular coverage in their home.","Exclusion criteria included: (1) inability self-administer medications, (2) inability measure BP, (3) inability mobile phone, (4) history psychiatric illness substance abuse, (5) pregnant, lactating intention pregnant trial, (6) participant study, (7) inabilities speak, hear, understand English, (8) poor cellular coverage home.",C0680251|C0243161|C0332257|G0000000|G0000000|C0036588|C0013227|G0000000|G0000000|C0079809|C0037623|G0000000|G0000000|C0231435|C1515258|G0000000|C0019664|C0205487|C0221423|C0439861|C0013146|G0000000|C0549206|C2828358|C0162425|C0549206|C0008976|G0000000|C0679646|C0557651|G0000000|G0000000|C0234856|C0018767|C0162340|C0376245|G0000000|C0032854|C0007634|C1551362|C0442519
All adult Chinese men aged >40 years from 2 to 3 randomly selected residential units within 45 DSPs were invited and approximately 80% of the invitees agreed to participate this study.,All adult Chinese aged >40 2 3 randomly selected residential units 45 DSPs invited 80% invitees agreed participate study.,G0000000|C0001675|C0008120|C0001779|C0450371|G0000000|G0000000|G0000000|C1707391|C0237096|C0439148|C0450371|C3279991|G0000000|C0450371|G0000000|C3641827|G0000000|C0557651
Medication use was comparable by treatment condition.,Medication comparable treatment condition.,C0013227|G0000000|C0039798|C0012634
valvular heart disease); have significant psychiatric disease; are unable to speak major language of the country of recruitment fluently or are unable to converse with the lifestyle coach in another language for which translated materials exist.,valvular heart disease); psychiatric disease; unable speak major language country recruitment fluently unable converse lifestyle coach language translated materials exist.,C0184252|C0018787|C0012634|C0205487|C0012634|C1299582|C0234856|C0205082|C0023008|C0454664|C2949735|G0000000|C1299582|G0000000|C0023676|C0557773|C0023008|C0040710|C0520510|C2987476
"The inclusion criteria were: (1) aged 20–50 years, with acute stroke diagnosed by a physician and cerebral hemorrhage or infarction observed on cranial CT or MRI; (2) stable condition, and mobile in a wheelchair or undergoing rehabilitation, for at least 6 months; (3) no indwelling urinary catheter.","The inclusion criteria were: (1) aged 20–50 years, acute stroke diagnosed physician cerebral hemorrhage infarction observed cranial CT MRI; (2) stable condition, mobile wheelchair undergoing rehabilitation, 6 months; (3) indwelling urinary catheter.",G0000000|C0007637|C0243161|G0000000|G0000000|C0001779|G0000000|C0439234|C0205178|C0038454|C0011900|C0031831|G0000000|C0019080|C0021308|C1441672|C0037303|C0007673|C0024485|G0000000|C0205360|C0012634|C0231435|C0043143|G0000000|C0034991|G0000000|C0439231|G0000000|C0439848|C0042027|C0085590
human immunodeficiency virus (HIV) and tuberculosis).,human immunodeficiency virus (HIV) tuberculosis).,C0086418|C0021051|C0042776|C0019682|C0041296
"A total of 194 patients were randomised (65.5 % male, mean age 62.8 years, mean FEV1 61.6 % predicted), with 183 (94.3 %) completing the study.","A total 194 patients randomised (65.5 % male, age 62.8 years, FEV1 61.6 % predicted), 183 (94.3 %) completing study.",G0000000|C0439175|C1442061|C0030705|G0000000|C0450371|G0000000|C0086582|C0001779|C0450371|C0439234|G0000000|C0450371|G0000000|C0681842|C1442061|C0450371|G0000000|C0205197|C0557651
Standard therapy was initiated in accordance with the South African National Tuberculosis Management Guidelines:14 weight-adjusted anti-TB drugs (Rifafourf®) and oral corticosteroids.,Standard therapy initiated South African National Tuberculosis Management Guidelines:14 weight-adjusted anti-TB drugs (Rifafourf®) oral corticosteroids.,C1442989|C0039798|C1548602|C1710133|C0027567|C3245503|C0041296|C0001554|C0162791|C0005910|G0000000|C0013227|G0000000|C0442027|C0001617
The QUARITE trial took place in referral hospitals in Mali in Senegal.,The QUARITE trial referral hospitals Mali Senegal.,G0000000|G0000000|C0008976|C0034927|C0019994|C0024581|C0036644
"A multi centre experimental hut trial was conducted in Malanville (Benin), Vallée du Kou (Burkina Faso) and Pitoa (Cameroon) to investigate the exophily, blood feeding inhibition and mortality induced by PermaNet® 3.0 (i.e.","A multi centre experimental hut trial conducted Malanville (Benin), Vallée du Kou (Burkina Faso) Pitoa (Cameroon) investigate exophily, blood feeding inhibition mortality induced PermaNet® 3.0 (i.e.",G0000000|C0439064|C0205099|C1517586|G0000000|C0008976|C0004927|G0000000|C0005005|G0000000|C0011535|C1077817|G0000000|G0000000|G0000000|C0006802|C1292732|G0000000|C0005767|C0204695|C0021467|C0026565|C0205263|G0000000|G0000000|C0683454
"Patients >1 year old and with a body weight of ≥5 kg were eligible for enrollment if they had a microscopically confirmed monoinfection of P. vivax (parasitemia, ≥5/500 white blood cells), if they were febrile (axillary temperature, ≥37.5°C) or had a history of fever, and if they or their guardians gave fully informed consent.","Patients >1 body weight ≥5 eligible enrollment microscopically confirmed monoinfection P. vivax (parasitemia, ≥5/500 white blood cells), febrile (axillary temperature, ≥37.5°C) history fever, guardians informed consent.",C0030705|G0000000|C0242821|C0005910|G0000000|C1548635|C1516879|G0000000|C0521093|G0000000|C0369773|G0000000|C0242723|G0000000|C0007457|C0005767|C0007634|C0015967|C0004454|C0005903|G0000000|C0019664|C0015967|C1274041|C1522154|C1511481
The primary outcome of the study was in-hospital mortality.,The primary outcome study in-hospital mortality.,G0000000|C0205225|C1274040|C0557651|C0019994|C0026565
"In patients receiving medical care from home health care nurses, change in perceived vulnerability to smoking-related disease is predictive of smoking cessation.","In patients receiving medical care health care nurses, change perceived vulnerability smoking-related disease predictive smoking cessation.",G0000000|C0030705|C1514756|C0199168|C1947933|C0018684|C1947933|C0028661|C0392747|C0030971|G0000000|C0037369|C0012634|C0681890|C0037369|C1880019
"In this randomized controlled trial (RCT), 540 low-income Black and White dialysis patients with household incomes at or below 250 % of the federal poverty line, some of whom receive financial assistance from the Missouri Kidney Program, will be randomly assigned to one of three education conditions: (1) standard-of-care transplant education provided by the dialysis center, (2) patient-guided ETH (ETH-PG), and (3) health educator-guided ETH (ETH-EG).","In randomized controlled trial (RCT), 540 low-income Black White dialysis patients household incomes 250 % federal poverty line, receive financial assistance Missouri Kidney Program, randomly assigned education conditions: (1) standard-of-care transplant education provided dialysis center, (2) patient-guided ETH (ETH-PG), (3) health educator-guided ETH (ETH-EG).",G0000000|C0034656|C2587213|C0008976|G0000000|C1442061|C0032854|C0005680|C0007457|C0011945|C0030705|C0020052|C0021162|C1442061|G0000000|G0000000|C0032854|C0205132|C1514756|C0376243|C0018896|C0026222|C0022646|C1709697|G0000000|C1516050|C0013621|C0012634|G0000000|C1442989|C0040732|C0013621|C1999230|C0011945|C0205099|G0000000|C0030705|C0015024|C0015024|G0000000|C0018684|C0221457|C0015024|C0015024
"Exclusion criteria were: any type of rehabilitation intervention in the month prior to recruitment, MS relapse during the three months prior to recruitment, pharmacological therapy not well defined and/or changed during the study, presence of paroxysmal vertigo, lower limb botulinum toxin injections within the previous 12 weeks.","Exclusion criteria were: type rehabilitation intervention month prior recruitment, MS relapse months prior recruitment, pharmacological therapy defined and/or changed study, presence paroxysmal vertigo, lower limb botulinum toxin injections previous 12 weeks.",C0680251|C0243161|G0000000|C0332307|C0034991|C0886296|C0332177|C0332152|C2949735|C0039676|C0035020|C0439231|C0332152|C2949735|C0031330|C0039798|C1704788|G0000000|C0392747|C0557651|C0150312|C0205311|C0042571|C0441994|C0015385|C0006055|C0040549|C0021485|C0205156|C0450371|C0439230
"In brief, 166 colorectal cancer survivors were assessed for eligibility; 138 (83.1%) were eligible, and 72 (52.2%) were randomly assigned to the exercise (n = 38) or usual care (n = 34) groups.","In brief, 166 colorectal cancer survivors assessed eligibility; 138 (83.1%) eligible, 72 (52.2%) randomly assigned exercise (n = 38) usual care (n = 34) groups.",G0000000|C1282927|C1442061|C0555952|C0006826|C0206194|C1516048|C0013893|C1442061|C0450371|C1548635|C0450371|C0450371|G0000000|C1516050|C0015259|C0369718|G0000000|C0450371|C3538928|C1947933|C0369718|G0000000|C0450371|C0441833
A retrospective multi-institutional review of patients with GCTs of the ovary treated or referred to MITO centres was conducted.,A retrospective multi-institutional review patients GCTs ovary treated referred MITO centres conducted.,G0000000|C0035363|C0439064|C0282443|C0030705|C3538813|C0029939|C1522326|C0205543|C0002475|C0205099|C0004927
"Participants were 223 smokers consuming ≥ 5 cigarettes per day, willing to quit and not using cessation aids (47.1% females, M = 37.5 years [SD = 11.8], 86.1% Swiss).","Participants 223 smokers consuming ≥ 5 cigarettes day, quit cessation aids (47.1% females, M = 37.5 [SD = 11.8], 86.1% Swiss).",C0679646|C1442061|C0337664|G0000000|C0677453|C0332173|C0748223|C1880019|C0001175|C0450371|C0015780|C0369637|G0000000|C2699239|G0000000|C0450371|C0241315
"A political crisis starting on 28 April 2006 led to civil conflict in Dili for several months, including disruption to delivery of health services and the displacement of an estimated 70% of Dili’s population to camps within the city or to the rural districts.15 The study sample consisted of patients with newly diagnosed pulmonary tuberculosis (positive and negative results on sputum smear tests).","A political crisis starting 28 April 2006 led civil conflict Dili months, including disruption delivery health services displacement estimated 70% Dili’s population camps city rural districts.15 The study sample consisted patients newly diagnosed pulmonary tuberculosis (positive negative sputum smear tests).",G0000000|G0000000|C0231224|C0439659|C0450371|C3715024|G0000000|C1708698|G0000000|C0009671|G0000000|C0439231|C0332257|C0332453|C0011209|C0018684|C0557854|C0012725|C0750572|C0450371|G0000000|C0032659|C0006811|C0008848|C0240919|C0450371|G0000000|C0557651|C0370003|C0332529|C0030705|C0750546|C0011900|C0024109|C0041296|C0439178|C0205160|C0038056|C0444186|C0022885
"Eligible participants are patients ages 70 years and older who are at risk for delirium and are admitted to the cardiology, internal medicine, geriatrics, orthopedics and surgery units of the two hospitals.","Eligible participants patients ages 70 risk delirium admitted cardiology, internal medicine, geriatrics, orthopedics surgery units hospitals.",C1548635|C0679646|C0030705|C0001779|C0450371|C0035647|C0011206|C0184666|C0007189|C0205102|C0013227|C0017469|C0029355|C0038894|C0439148|C0019994
[Subjects] Twenty-seven patients at least 6 months after stroke onset were divided randomly into an experimental group (14 patients) and a control group (13 patients).,[Subjects] Twenty-seven patients 6 months stroke onset divided randomly experimental (14 patients) control (13 patients).,C0681850|C0724000|C0030705|G0000000|C0439231|C0038454|C0206132|C0332849|G0000000|C1517586|C0450371|C0030705|C0243148|C0450371|C0030705
"Participants were recruited through flyers sent to physicians, local advertisements, and presentations at fibromyalgia support group meetings.","Participants recruited flyers physicians, local advertisements, presentations fibromyalgia support meetings.",C0679646|G0000000|C0683877|C0031831|C0205276|C0949214|C0449450|C0016053|C0183683|C0556656
"Briefly, patients enrolled in the original study were aged 18 to 80 years old.","Briefly, patients enrolled original study aged 18 80 old.",G0000000|C0030705|G0000000|C0205313|C0557651|C0001779|C0450371|C0450371|C0580836
"* This study shows that prophylactic administration of quadrivalent HPV vaccine is efficacious in preventing the development of external genital lesions associated with infection with HPV-6, 11, 16, or 18 in boys and men 16 to 26 years of age.","* This study prophylactic administration quadrivalent HPV vaccine efficacious preventing development external genital lesions infection HPV-6, 11, 16, 18 boys 16 26 age.",G0000000|G0000000|C0557651|C0355642|C0001554|G0000000|C0021344|C0042210|C1280519|C0309872|C0243107|C0205101|C0559522|C0221198|C0009450|C0021344|C0450371|C0450371|C0450371|C0870221|C0450371|C0450371|C0001779
"[12] Briefly, 1,334 participants with low back pain lasting for more than four weeks were recruited from 181 practices in the Medical Research Council General Practice Research Framework.","[12] Briefly, 1,334 participants low pain lasting weeks recruited 181 practices Medical Research Council General Practice Research Framework.",C0450371|G0000000|C1442061|C0679646|C0205251|C0030193|C1517741|C0439230|G0000000|C1442061|C0237607|C0199168|C0035168|C1551807|C0205246|C0237607|C0035168|G0000000
Women diagnosed with AJCC stage 0 to III breast cancer who had completed primary treatment but were within 5 years of diagnosis with no evidence of progressive disease or second primary tumors and who had a biological daughter who was aged ≥ 21 years were eligible.,Women diagnosed AJCC stage 0 III breast cancer completed primary treatment 5 diagnosis evidence progressive disease primary tumors biological daughter aged ≥ 21 eligible.,C0043210|C0011900|C0441915|C0205390|G0000000|C0439070|C0006141|C0006826|C0205197|C0205225|C0039798|G0000000|C0011900|C3887511|C0205329|C0012634|C0205225|C0027651|C0005532|C0011011|G0000000|C1548635
"We targeted Harlem, NY (using the South Bronx for comparison), and disseminated informational material at community forums, pharmacist training programs, and counseling or outreach programs for IDUs.","We targeted Harlem, NY (using South Bronx comparison), disseminated informational material community forums, pharmacist training programs, counseling outreach programs IDUs.",G0000000|C1521840|G0000000|C0027976|C1524063|C1710133|G0000000|C1707455|C0205221|C3242430|C0520510|C0009462|G0000000|C0031323|C0040607|C0376691|C0010210|C0683805|C0376691|C0020811
This however did not translate into differences in age at symptom onset.,This translate differences age symptom onset.,G0000000|C0040710|C1705241|C0001779|C1457887|C0206132
"For all subjects, the median age, CD4+ cell count and plasma HIV-1 RNA value at baseline were 42 years, 410 cells/μL and 25,100 copies/mL, respectively.","For subjects, median age, CD4+ cell count plasma HIV-1 RNA baseline 42 years, 410 cells/μL 25,100 copies/mL, respectively.",G0000000|C0681850|C0549183|C0001779|C0285590|C0007634|C0750480|C0032105|C0019682|C0035668|C0168634|C0450371|C0439234|C1442061|G0000000|C0450371|C1531853|G0000000
"We aim to recruit 150 patients with COPD who have been recommended to use NIV based on the GOLD criteria (from moderate to severe) [36, 37].","We aim recruit 150 patients COPD recommended NIV based GOLD criteria (from moderate severe) [36, 37].",G0000000|C1947946|G0000000|C1442061|C0030705|C0024117|C0034866|C0598902|C1527178|C0018026|C0243161|G0000000|C0205081|C0205082|C0450371|C0450371
"Most of the patients (64%) had a good ECOG performance status of 0–1, and 75% of the patients had extracerebral metastases.","Most patients (64%) ECOG performance status 0–1, 75% patients extracerebral metastases.",C0205393|C0030705|C0450371|C0430797|C0597198|C0449438|G0000000|C0450371|C0030705|G0000000|C0027627
"In this prospective randomized controlled study, patients between the age of 18 and 75 years (ASA physical status I–III), who required subclavian venous catheterization for neurosurgery at Seoul National University Bundang Hospital throughout October 2010 to November 2011 were included.","In prospective randomized controlled study, patients age 18 75 (ASA physical status I–III), required subclavian venous catheterization neurosurgery Seoul National University Bundang Hospital October 2010 November 2011 included.",G0000000|C0023981|C0034656|C2587213|C0557651|C0030705|C0001779|C0450371|C0450371|C0004057|C0031809|C0449438|G0000000|C1514873|C0589488|C0042449|C0007430|C0027926|C3850150|C3245503|C0041740|G0000000|C0019994|C3828732|G0000000|C3828767|G0000000|C0332257
Cancer down-staging will be assessed using the TNM classification.,Cancer down-staging assessed TNM classification.,C0006826|C0205104|C1516048|C0039694|C0008902
Inclusion criteria for the cross-sectional study were: i) a child 6–23.9 months (Mali) or 0–17.9 months of age (Burkina Faso); ii) child’s main caregiver living the study area since the child’s delivery; iii) child without congenital malformations that hinder the measurement of anthropometry.,Inclusion criteria cross-sectional study were: i) child 6–23.9 months (Mali) 0–17.9 months age (Burkina Faso); ii) child’s main caregiver living study child’s delivery; iii) child congenital malformations hinder measurement anthropometry.,C0007637|C0243161|C0552389|C0557651|G0000000|C0021966|C0008059|G0000000|C0439231|C0024581|G0000000|C0439231|C0001779|G0000000|G0000000|G0000000|G0000000|C0205225|C0085537|C0376558|C0557651|G0000000|C0011209|C0439070|C0008059|C0009678|C0000768|G0000000|C0242485|C0003188
Ten doses of chlorpromazine at 25 mg each were allowed as rescue medications during weeks 1 to 4.,Ten doses chlorpromazine 25 allowed rescue medications weeks 1 4.,C0014518|C0178602|C0008286|C0450371|C0683607|G0000000|C0013227|C0439230|G0000000|G0000000
Mothers of infants in Group A (41 infants) were enrolled in the last trimester of pregnancy (Figure 1).,Mothers infants Group A (41 infants) enrolled trimester pregnancy (Figure 1).,C0026591|C0021270|C0441833|G0000000|C0450371|C0021270|G0000000|C0032982|C0032961|G0000000|G0000000
The plan for study is to recruit 74 patients.,The plan study recruit 74 patients.,G0000000|C0270724|C0557651|G0000000|C0450371|C0030705
Other changes in injury risk factors could not necessarily be attributed to the program as similar changes were observed in the comparison community.,Other injury risk factors attributed program observed comparison community.,G0000000|C3263722|C0035647|C1521761|C0449234|C1709697|C1441672|C1707455|C0009462
"We conducted a two-arm cluster-randomized controlled pragmatic intervention study in a sample of 1,038 children aged 6 to 36 mo in the city of Abeche, Chad.","We conducted two-arm cluster-randomized controlled pragmatic intervention study sample 1,038 children aged 6 36 mo city Abeche, Chad.",G0000000|C0004927|C0205448|C1555715|C2587213|C0871858|C0886296|C0557651|C0370003|C1442061|C0008059|C0001779|G0000000|C0450371|C0026544|C0008848|G0000000|C0007928
Design: The study was performed on the inpatient general medicine ward of a public teaching hospital.,Design: The study performed inpatient medicine ward public teaching hospital.,C1707689|G0000000|C0557651|C0884358|C0021562|C0013227|C1305702|G0000000|C0039401|C0019994
"Inclusion criteria for the study included having at least three people living in the household, with at least one being a preschool or elementary school child; speaking English or Spanish; having a telephone; being willing to complete symptom assessments and having bimonthly home visits; and not routinely using alcohol-based hand sanitizer.","Inclusion criteria study included people living household, preschool elementary school child; speaking English Spanish; telephone; complete symptom assessments bimonthly visits; routinely alcohol-based hand sanitizer.",C0007637|C0243161|C0557651|C0332257|C0027361|C0376558|C0020052|C0424930|C0013879|C0036375|C0008059|C0234856|C0376245|C0086409|C0039457|C0205197|C1457887|C1261322|C0585337|C0545082|G0000000|C0001962|C0018563|C0183086
"Women 18 years or older, with a current pregnancy between 24 and 28 weeks, intent to breastfeed for at least 4–6 weeks, and history of breastfeeding for at least 4 weeks with a prior infant (to mitigate attrition) met inclusion criteria.","Women 18 older, current pregnancy 24 28 weeks, intent breastfeed 4–6 weeks, history breastfeeding 4 weeks prior infant (to mitigate attrition) met inclusion criteria.",C0043210|C0450371|C0580836|C0521116|C0032961|C0450371|C0450371|C0439230|C0162425|C0006147|G0000000|C0439230|C0019664|C0006147|G0000000|C0439230|C0332152|C0021270|G0000000|C1553901|C0004277|C0268621|C0007637|C0243161
"Hence, there were 78 participants in FBT and 80 in SyFT, for a total of 158 individuals included in the analysis.","Hence, 78 participants FBT 80 SyFT, total 158 individuals included analysis.",G0000000|C0450371|C0679646|G0000000|C0450371|G0000000|C0439175|C1442061|C0027361|C0332257|C0002778
Phone counseling seems to be at least as effective as group programs for promoting smoking cessation in worksites.,Phone counseling effective programs promoting smoking cessation worksites.,C1515258|C0010210|C1280519|C0376691|C0033414|C0037369|C1880019|C0162579
Patients with metastatic or irresectable cancer with a median life expectancy <12 months who meet with a medical oncologist to discuss the start or continuation of palliative systemic treatment are eligible.,Patients metastatic irresectable cancer median life expectancy <12 months meet medical oncologist start continuation palliative systemic treatment eligible.,C0030705|C0036525|G0000000|C0006826|C0549183|C0376558|C0679138|C0450371|C0439231|C1550543|C0199168|C0259990|C0439659|G0000000|C0587605|C0205373|C0039798|C1548635
"METHODS: Children from 2 mo to 12 years of age, with acute diarrhoea were selected according to inclusion criteria and randomised in S. boulardii group (treated with ORS, nutritional support and S. boulardii, 250 mg bid) and in control group (treated with ORS and nutritional support only).","METHODS: Children 2 mo 12 age, acute diarrhoea selected inclusion criteria randomised S. boulardii (treated ORS, nutritional support S. boulardii, 250 bid) control (treated ORS nutritional support only).",C0025663|C0008059|G0000000|C0026544|C0450371|C0001779|C0205178|C0011991|C1707391|C0007637|C0243161|G0000000|C0565930|G0000000|C1522326|C0069590|C1521739|C0183683|C0565930|G0000000|C1442061|G0000000|C0243148|C1522326|C0069590|C1521739|C0183683|C0205171
"The inclusion criteria were onset period of >6 months, functional ambulation category <2, independent ambulation before stroke, capability of understanding and executing RAGT, and an absence of other orthopedic or neurosurgical problems in the lower extremities.","The inclusion criteria onset period >6 months, functional ambulation category <2, independent ambulation stroke, capability understanding executing RAGT, absence orthopedic neurosurgical lower extremities.",G0000000|C0007637|C0243161|C0206132|C0439531|G0000000|C0439231|C0205245|C0080331|C0683312|G0000000|C0085862|C0080331|C0038454|C2698977|C0162340|C1552093|G0000000|C0332197|C0029355|G0000000|C0441994|C0015385
"This placebo-controlled, randomized, double-blind, single-center study was performed at the Department of Medical Intensive Care Unit and the Department of Infectious Diseases of Erciyes University Medical School during a 2-year period (from May 1997 to April 1999).","This placebo-controlled, randomized, double-blind, single-center study performed Department Medical Intensive Care Unit Department Infectious Diseases Erciyes University Medical School 2-year period (from May 1997 April 1999).",G0000000|C1706408|C0034656|C0013072|C0037179|C0557651|C0884358|C1704729|C0199168|C0162425|C1947933|C0439148|C1704729|C0009450|C0012634|G0000000|C0041740|C0199168|C0036375|C0439234|C0439531|G0000000|G0000000|G0000000|C3715024|G0000000
"Mean age of patients was 9.09 (range 3-14) years, 44 (65.7%) patients were boys (sex ratio 2:1).","Mean age patients 9.09 (range 3-14) years, 44 (65.7%) patients boys (sex ratio 2:1).",C0444504|C0001779|C0030705|C0450371|C1514721|C0450371|C0439234|C0450371|C0450371|C0030705|C0870221|C0009253|C0456603|G0000000
"In order to maximise recruitment and the representativeness of the sample, we shall attempt to recruit and obtain consent from consecutive patients who are discharged from the Edinburgh Western General Hospital stroke units and clinics and who are prescribed secondary antihypertensive medication.","In maximise recruitment representativeness sample, attempt recruit consent consecutive patients discharged Edinburgh Western General Hospital stroke units clinics prescribed secondary antihypertensive medication.",G0000000|G0000000|C2949735|C1882932|C0370003|C1516084|G0000000|C1511481|C1707491|C0030705|C0030685|G0000000|C1705493|C0205246|C0019994|C0038454|C0439148|C0442592|C0278329|C0027627|C0003364|C0013227
"All preterm babies (< 37 weeks of gestation) admitted to the NCU from KCMC labour ward, obstetrics and gynecology theater or referrals presenting with one or more signs of respiratory distress i.e tachypnea (>60breaths/min), chest retraction, nasal flaring, grunting or cyanosis were recruited.","All preterm babies (< 37 weeks gestation) admitted NCU KCMC labour ward, obstetrics gynecology theater referrals signs respiratory distress i.e tachypnea (>60breaths/min), chest retraction, nasal flaring, grunting cyanosis recruited.",G0000000|C0151526|C0021270|G0000000|C0450371|C0439230|C0032961|C0184666|G0000000|G0000000|C0022864|C1305702|C0028773|C0018417|C0475307|C0034927|C0220912|C0521346|C0231303|C0683454|C0231835|C0702093|C0817096|C0332523|C0028429|C1517205|C0234892|C0010520|G0000000
In smokers with verified abstinence at 1 week after quitting smoking (CO ≤ 10 p.p.m.,In smokers verified abstinence 1 week quitting smoking (CO ≤ 10 p.p.m.,G0000000|C0337664|C1711411|C3843422|G0000000|C0332174|C0748223|C0037369|C3245499|G0000000|C0450371|C0369773
"Major inclusion criteria were age 18 years or older; histologically proven gastric or gastroesophageal junction adenocarcinoma; measurable and/or assessable metastatic disease according to Response Evaluation Criteria In Solid Tumors (RECIST) version 1.0 [20]; KPS higher than 70; no prior palliative chemotherapy; 6 weeks or longer following radiotherapy and 3 weeks or longer following surgical intervention; and adequate hepatic, renal, and hematologic function.","Major inclusion criteria age 18 older; histologically proven gastric gastroesophageal junction adenocarcinoma; measurable and/or assessable metastatic disease Response Evaluation Criteria In Solid Tumors (RECIST) version 1.0 [20]; KPS 70; prior palliative chemotherapy; 6 weeks radiotherapy 3 weeks surgical intervention; adequate hepatic, renal, hematologic function.",C0205082|C0007637|C0243161|C0001779|C0450371|C0580836|C0205462|C0456369|C0038351|C0744316|C0205144|C0001418|C1513040|G0000000|G0000000|C0036525|C0012634|C0871261|C0220825|C0243161|G0000000|C0205208|C0027651|C1709926|C0333052|G0000000|C0450371|C0206065|C0450371|C0332152|C0587605|C0013216|G0000000|C0439230|C0034619|G0000000|C0439230|C0543467|C0886296|C0205410|C0205054|C0022646|C0018943|C0031843
"A randomised, double blind, placebo controlled trial of 50 preterm infants of gestational age ⩽32 weeks needing assisted ventilation.","A randomised, double blind, placebo controlled trial 50 preterm infants gestational age ⩽32 weeks assisted ventilation.",G0000000|G0000000|C0205173|C0150108|C0032042|C2587213|C0008976|C0450371|C0151526|C0021270|C0439671|C0001779|G0000000|C1269765|C0035203
"Eligible patients were at least 18 years of age, had a history of primary breast cancer without evidence of detectable disease, and had a self-reported history of at least 14 hot flashes per week for a period of at least 1 month before study entry.","Eligible patients 18 age, history primary breast cancer evidence detectable disease, self-reported history 14 hot flashes week period 1 month study entry.",C1548635|C0030705|C0450371|C0001779|C0019664|C0205225|C0006141|C0006826|C3887511|C3830527|C0012634|C0681906|C0019664|C0450371|C0444519|C0085635|C0332174|C0439531|G0000000|C0332177|C0557651|C1705654
"The following eligibility criteria were applied: a) Maternal personal history of or biological father history of: asthma, eczema, allergic rhinitis; b) Gestational age between 10 and 18 weeks at the time of randomization; c) Maternal age between 18 and 39 years; d) Not a current smoker (defined as not having smoked for at least 1 month prior to enrollment) and not a user of other nicotine products (e.g.","The eligibility criteria applied: a) Maternal personal history biological father history of: asthma, eczema, allergic rhinitis; b) Gestational age 10 18 weeks time randomization; c) Maternal age 18 39 years; d) Not current smoker (defined smoked 1 month prior enrollment) user nicotine products (e.g.",G0000000|C0013893|C0243161|C4048755|G0000000|C2347083|C1519021|C0019664|C0005532|C0015671|C0019664|G0000000|C0004096|C0013595|C0700624|C0035455|G0000000|C0439671|C0001779|C0450371|C0450371|C0439230|C0040223|C0034656|G0000000|C2347083|C0001779|C0450371|C0450371|C0439234|C0073187|C1518422|C0521116|C0337664|C1704788|C0037366|G0000000|C0332177|C0332152|C1516879|C1548600|C0028040|C1514468|G0000000
The back pain study includes individuals with sub-acute and chronic LBP lasting a minimum of 6 weeks in duration; the neck pain study focuses on chronic NP 12 or more weeks in duration.,The pain study includes individuals sub-acute chronic LBP lasting minimum 6 weeks duration; neck pain study focuses chronic NP 12 weeks duration.,G0000000|C0030193|C0557651|C0332257|C0027361|C0542339|C0205191|C1505993|C1517741|C1524031|G0000000|C0439230|C0449238|C0027530|C0030193|C0557651|C0205234|C0205191|C0065827|C0450371|C0439230|C0449238
Eligible subject included clinically stable preschool children with CF undergoing a simple therapy based on bronchodilator (salbutamol) and physiotherapy.,Eligible subject included clinically stable preschool children CF undergoing simple therapy based bronchodilator (salbutamol) physiotherapy.,C1548635|C0681850|C0332257|G0000000|C0205360|C0424930|C0008059|C0009738|G0000000|C0205352|C0039798|C1527178|C0006280|C0001927|C0949766
"Participants (65–85 years) met DSM-IV-TR criteria for insomnia with total sleep times (TST) ≤ 6 h, and wake time after sleep onset (WASO) ≥ 45 min.","Participants (65–85 years) met DSM-IV-TR criteria insomnia total sleep times (TST) ≤ 6 h, wake time sleep onset (WASO) ≥ 45 min.",C0679646|G0000000|C0439234|C0268621|C0220952|C0243161|C0917801|C0439175|C0037313|C0040223|C1421210|G0000000|G0000000|C0033727|C0442696|C0040223|C0037313|C0206132|G0000000|G0000000|C0450371|C0702093
The exclusion criteria included the following: Use of lipid-lowering agents within the past 6 months; TG ≥5.65 mmol/L (500 mg/dL); LDL-C ≥6.48 mmol/L (250 mg/dL); Documented history of CHD or other atherosclerotic disease; A history of known familial hypercholesterolemia; A history of serious or hypersensitivity reactions to other statins; Uncontrolled hypothyroidism; Uncontrolled hypertension; Acute liver disease or hepatic dysfunction [hepatic transaminases or bilirubin ≥1.5× the upper limit of normal (ULN)];unexplained serum creatine kinase (CK)>3× ULN; and use of prohibited concomitant medications.,The exclusion criteria included following: Use lipid-lowering agents 6 months; TG ≥5.65 mmol/L (500 mg/dL); LDL-C ≥6.48 mmol/L (250 mg/dL); Documented history CHD atherosclerotic disease; A history familial hypercholesterolemia; A history hypersensitivity reactions statins; Uncontrolled hypothyroidism; Uncontrolled hypertension; Acute liver disease hepatic dysfunction [hepatic transaminases bilirubin ≥1.5× upper limit normal (ULN)];unexplained serum creatine kinase (CK)>3× ULN; prohibited concomitant medications.,G0000000|C0680251|C0243161|C0332257|C0231290|C0042153|C0023779|C0450442|G0000000|C0439231|C0337445|G0000000|C1532563|C1442061|C0439269|G0000000|G0000000|C1532563|C1442061|C0439269|C1301725|C0019664|C0280604|C0333482|C0012634|G0000000|C0019664|C0015576|C0020443|G0000000|C0019664|C0020517|C0443286|C0360714|C0205318|C0020676|C0205318|C0020538|C0205178|C0023884|C0012634|C0205054|C0031847|C0205054|C0002594|C0005437|G0000000|C1282910|C0439801|C0205307|C1519815|C0229671|C0010286|C0031727|G0000000|C1519815|C0138547|C0521115|C0013227
Patients were also excluded if the investigators were unable to obtain informed written consent and administer the first dose of the study drug within 24 hours of intubation.,Patients excluded investigators unable informed written consent administer dose study drug 24 hours intubation.,C0030705|C1554077|C0035173|C1299582|C1522154|C0043266|C1511481|C1621583|C0178602|C0557651|C0013227|C0450371|C0439227|C0021925
"Thus, secondary prevention strategies are needed to avoid disabling stroke, the fourth leading cause of disease burden and the second leading cause of death among adults worldwide [6].","Thus, secondary prevention strategies avoid disabling stroke, fourth leading disease burden leading death adults worldwide [6].",G0000000|C0027627|C0199176|C0679199|G0000000|G0000000|C0038454|C0205438|C0332152|C0012634|C2828008|C0332152|C0011065|C0001675|G0000000|G0000000
"A total of 3,876 patients with recent ischemic stroke or TIA, no history of diabetes, fasting plasma glucose (FPG) <126 mg/dL, and insulin resistance by homeostasis model assessment of insulin resistance (HOMA-IR) score >3.0 were randomly assigned to pioglitazone or placebo.","A total 3,876 patients ischemic stroke TIA, history diabetes, fasting plasma glucose (FPG) <126 mg/dL, insulin resistance homeostasis model assessment insulin resistance (HOMA-IR) score >3.0 randomly assigned pioglitazone placebo.",G0000000|C0439175|C1442061|C0030705|C0475224|C0038454|C0007787|C0019664|C0011847|C0015663|C0032105|C0017725|G0000000|C1442061|C0439269|C0021641|C0237834|C0019868|C3161035|C1261322|C0021641|C0237834|C0022065|C0449820|G0000000|G0000000|C1516050|C0071097|C0032042
"All three measures show similar patterns, with substantially less sensory neurotoxicity in the patients who received Ca/Mg.","All measures patterns, sensory neurotoxicity patients received Ca/Mg.",G0000000|C0079809|C0449774|C0445254|C0235032|C0030705|C1514756|C3887642
"Between October 2007 and April 2009, consenting and eligible patients over age 50 with an acute fragility hip fracture (defined as femoral neck, trochanteric, subtrochanteric or subcapital) which was the result of a minimal trauma accident, defined as a fall from standing height or less, were enrolled from two large academic hospital sites in Hamilton, Ontario, Canada.","Between October 2007 April 2009, consenting eligible patients age 50 acute fragility hip fracture (defined femoral neck, trochanteric, subtrochanteric subcapital) result minimal trauma accident, defined fall standing height less, enrolled academic hospital sites Hamilton, Ontario, Canada.",G0000000|C3828732|G0000000|C3715024|G0000000|C1511481|C1548635|C0030705|C0001779|C0450371|C0205178|C0302113|C0019552|C0016658|C1704788|C0015811|C0027530|C0162370|G0000000|G0000000|C1274040|C0547040|C0043251|C0000924|C1704788|C0085639|C0231472|C0489786|C0439092|G0000000|C1510747|C0019994|C0205145|G0000000|C0029040|C0006823
"The pain intensities during the 3 standardized conditions (at rest, during movement and pressure evoked), were evaluated twice daily in the 3 days preceding patch treatment (baseline) and in the 3 days preceding the clinical visit at 1, 2 and 3 months after patch application.","The pain intensities 3 standardized conditions (at rest, movement pressure evoked), evaluated daily 3 days preceding patch treatment (baseline) 3 days preceding clinical visit 1, 2 3 months patch application.",G0000000|C0030193|C0522510|G0000000|G0000000|C0012634|G0000000|C0035253|C0026649|C0033095|C1444748|C0220825|C0332173|G0000000|C0439228|C0332152|C0332461|C0039798|C0168634|G0000000|C0439228|C0332152|C0205210|C0545082|G0000000|G0000000|G0000000|C0439231|C0332461|C0185125
"Exclusion criteria were current continuous positive airway pressure therapy, use of drugs that act on the central nervous system (such as benzodiazepines), current or planned intervention for weight reduction, consumption of ≥ 14 alcoholic drinks a week or ≥ 2 a day, and obesity (body mass index ≥ 30 kg/m2).","Exclusion criteria current continuous positive airway pressure therapy, drugs central nervous system (such benzodiazepines), current planned intervention weight reduction, consumption ≥ 14 alcoholic drinks week ≥ 2 day, obesity (body mass ≥ 30 kg/m2).",C0680251|C0243161|C0521116|C0549178|C0439178|C0178987|C0033095|C0039798|C0013227|C0205099|C0027769|C0449913|G0000000|C0005064|C0521116|C1301732|C0886296|C0005910|C0301630|C0009830|G0000000|C0450371|C0687725|C0452428|C0332174|G0000000|G0000000|C0332173|C0028754|C0242821|C0577559|G0000000|C0450371|C0022718
Children between 2 and 16 years of age who present with a first episode of INS will be screened for eligibility.,Children 2 16 age episode INS screened eligibility.,C0008059|G0000000|C0450371|C0001779|C0332189|G0000000|C0220908|C0013893
"During the intervention, each participant consumed two capsules each evening containing black cohosh, red clover, CEE/MPA, or placebo.","During intervention, participant consumed capsules evening black cohosh, red clover, CEE/MPA, placebo.",G0000000|C0886296|C0679646|G0000000|C0006935|C0587117|C0005680|G0000000|C0332575|C0950074|C0046018|C0032042
"Although the majority of women with advanced-stage ovarian cancer respond to first-line chemotherapy, most of these responses are not durable, and >70% of patients die of recurrent disease within 5 years of diagnosis.","Although majority women advanced-stage ovarian cancer respond first-line chemotherapy, responses durable, >70% patients die recurrent disease 5 diagnosis.",G0000000|C0680220|C0043210|C0205179|C0205065|C0006826|G0000000|C0205435|C0013216|C0871261|G0000000|C0450371|C0030705|C0011065|C2945760|C0012634|G0000000|C0011900
"The project did not exclude individuals with alcohol or substance use disorders, active bipolar disorder, psychotic symptoms, or individuals receiving psychotherapy because it sought to assemble a more diverse and inclusive sample representative of HIV-infected older adults likely to participate in AIDS-mental health interventions offered in community settings.","The project exclude individuals alcohol substance disorders, active bipolar disorder, psychotic symptoms, individuals receiving psychotherapy sought assemble diverse inclusive sample representative HIV-infected adults participate AIDS-mental health interventions offered community settings.",G0000000|C1709701|C0332196|C0027361|C0001962|C0439861|C0012634|C0205177|C0443156|C0012634|C0004936|C0683368|C0027361|C1514756|C0033968|G0000000|C1706853|C1880371|C0332257|C0370003|C1882932|C0019682|C0001675|G0000000|C0001175|C0018684|C0886296|C1444648|C0009462|C0542559
The study is entitled ‘The impact of yoga supplementation on cognitive function among Indian outpatients with schizophrenia’.,The study entitled ‘The impact yoga supplementation cognitive function Indian outpatients schizophrenia’.,G0000000|C0557651|G0000000|G0000000|C1825598|C0043418|C0242297|C1516691|C0031843|C1524069|C0029921|G0000000
Exclusion criteria are (1) demonstrated cognitive or psychological difficulties as defined by the treatment team’s assessment or documented within the patient’s medical history; (2) too unwell to participate in the study as determined by the patient’s treatment team; (3) past history of malignancy other than non-melanomatous skin cancer; (4) enrolment in a conflicting supportive care trial that might impact the study’s measured endpoints.,Exclusion criteria (1) demonstrated cognitive psychological difficulties defined treatment team’s assessment documented patient’s medical history; (2) unwell participate study determined patient’s treatment team; (3) history malignancy non-melanomatous skin cancer; (4) enrolment conflicting supportive care trial impact study’s measured endpoints.,C0680251|C0243161|G0000000|G0000000|C1516691|C0205486|C1299586|C1704788|C0039798|G0000000|C1261322|C1301725|G0000000|C0199168|C0019664|G0000000|C0683320|G0000000|C0557651|G0000000|G0000000|C0039798|C0871489|G0000000|C0019664|C0006826|C1518422|C0444099|C0006826|G0000000|C1516879|C0009671|C1521721|C1947933|C0008976|C1825598|G0000000|C0444706|C2349179
"Patients were excluded if they had previously been enrolled in the study, or if admitted to pediatric or trauma services or transplant services with pharmacists.","Patients excluded enrolled study, admitted pediatric trauma services transplant services pharmacists.",C0030705|C1554077|G0000000|C0557651|C0184666|C0030755|C0043251|C0557854|C0040732|C0557854|C0031323
"); Have a diagnosis of insulin dependent diabetes mellitus or those taking gliclazides; Have a HbA1c score exceeding 8 %; Have a current or prior history of cardiovascular, cerebrovascular or peripheral vascular disease; Have clinically relevant pulmonary, gastro-intestinal, renal, metabolic, hematological, neurological, psychiatric, systemic or any acute infectious disease or signs of acute illness; Are women who are pregnant; Have psychosocial or gastrointestinal (e.g.","); Have diagnosis insulin dependent diabetes mellitus gliclazides; Have HbA1c score exceeding 8 %; Have current prior history cardiovascular, cerebrovascular peripheral vascular disease; Have clinically relevant pulmonary, gastro-intestinal, renal, metabolic, hematological, neurological, psychiatric, systemic acute infectious disease signs acute illness; Are women pregnant; Have psychosocial gastrointestinal (e.g.",G0000000|G0000000|C0011900|C0021641|C0851827|C0011847|G0000000|C0017631|G0000000|G0000000|C0449820|G0000000|G0000000|G0000000|G0000000|C0521116|C0332152|C0019664|C0007226|C1880018|C0205100|C0005847|C0012634|G0000000|G0000000|C2347946|C0024109|C0521362|C0022646|C0311400|C0018943|C0205494|C0205487|C0205373|C0205178|C0009450|C0012634|C0220912|C0205178|C0221423|G0000000|C0043210|C0549206|G0000000|C0542298|C0521362|G0000000
Seventy-five patients with median age at diagnosis of 3.2 (range: 0.2-12.1) years met eligibility criteria.,Seventy-five patients median age diagnosis 3.2 (range: 0.2-12.1) met eligibility criteria.,C3816957|C0030705|C0549183|C0001779|C0011900|G0000000|C1514721|C0450371|C0268621|C0013893|C0243161
"In all, 203 consenting patients who had undergone potentially curative treatment for colon cancer were randomised to follow-up by general practitioners or surgeons.","In all, 203 consenting patients undergone curative treatment colon cancer randomised follow-up practitioners surgeons.",G0000000|G0000000|C1442061|C1511481|C0030705|G0000000|C1880198|C0039798|C0009368|C0006826|G0000000|C0589120|C1709627|C0582175
"Eligibility criteria included: (1) residence in a long-term care facility; (2) clinical evidence of AD based upon NINCDS-ADRDA criteria (McKhann et al., 1984); (3) dependence in at least one of the following: bed mobility, transfers, gait or balance; (4) ability to walk with assistance; and (5) a CSDD score of seven or above.","Eligibility criteria included: (1) residence long-term care facility; (2) clinical evidence AD based NINCDS-ADRDA criteria (McKhann al., 1984); (3) dependence following: bed mobility, transfers, gait balance; (4) ability walk assistance; (5) CSDD score above.",C0013893|C0243161|C0332257|G0000000|C0237096|C0443252|C1947933|C1547538|G0000000|C0205210|C3887511|G0000000|C1527178|G0000000|C0243161|G0000000|C0202311|G0000000|G0000000|C0011546|C0231290|C0004916|C0425245|C0728827|C0016928|C0014653|G0000000|C0085732|C0080331|C0018896|G0000000|G0000000|C0449820|C1282910
"The objective of this study was to comprehensively evaluate the association between green tea consumption and colorectal cancer risk in a population-based prospective cohort study, the Shanghai Men’s Health Study.","The objective study comprehensively evaluate association green tea consumption colorectal cancer risk population-based prospective cohort study, Shanghai Men’s Health Study.",G0000000|C0018017|C0557651|G0000000|C0220825|C0004083|C0332583|C0039400|C0009830|C0555952|C0006826|C0035647|C0032659|C0023981|C0599755|C0557651|G0000000|G0000000|C0018684|C0557651
Mean age was 14 years (SD =1.89 years).,Mean age 14 (SD =1.89 years).,C0444504|C0001779|C0450371|G0000000|C0450371|C0439234
"Participants 232 adults (mean age 38 years; 79% female) with diagnosis of migraine with or without aura according to International Headache Society classification of headache disorders criteria, who recorded at least three migraines with disability per 30 days (mean 5.5 migraines/30 days), during an optimised run-in of acute treatment.","Participants 232 adults (mean age 38 years; 79% female) diagnosis migraine aura International Headache Society classification headache disorders criteria, recorded migraines disability 30 days (mean 5.5 migraines/30 days), optimised run-in acute treatment.",C0679646|C1442061|C0001675|C0444504|C0001779|C0450371|C0439234|C0450371|C0015780|C0011900|C0149931|C0236018|C1512888|C0018681|C0037455|C0008902|C0018681|C0012634|C0243161|C0034869|C0149931|C0231170|C0450371|C0439228|C0444504|G0000000|C0149931|C0439228|G0000000|C3274438|C0205178|C0039798
"Key exclusion criteria were standard for efficacy trials of BoNT and included treatment with BoNT-A or BoNT-B within 16 weeks of enrolment, any disease of the neuromuscular junction, previous phenol injection to the neck muscles, myotomy or denervation surgery in the neck/shoulder region, cervical contracture, suspected secondary non-responsiveness or a history of poor response to BoNT-A, pure anterocollis or retrocollis, symptom remission at screening, symptoms that could interfere with TWSTRS scoring or BoNT-A neutralising antibodies.","Key exclusion criteria standard efficacy trials BoNT included treatment BoNT-A BoNT-B 16 weeks enrolment, disease neuromuscular junction, previous phenol injection neck muscles, myotomy denervation surgery neck/shoulder region, cervical contracture, suspected secondary non-responsiveness history poor response BoNT-A, pure anterocollis retrocollis, symptom remission screening, symptoms interfere TWSTRS scoring BoNT-A neutralising antibodies.",G0000000|C0680251|C0243161|C1442989|C1280519|C0008976|G0000000|C0332257|C0039798|G0000000|G0000000|G0000000|C1516879|C0012634|C1979768|C0205144|C0205156|C0031428|C0021485|C0027530|C0026845|C0185181|C0011307|C0038894|C0027530|C0017446|C0027530|C0009917|C0332147|C0027627|C1518422|C0019664|C0032854|C0871261|G0000000|C2247561|G0000000|C0040485|C1457887|C0544452|C0220908|C0683368|C0521102|G0000000|C0449820|G0000000|G0000000|C0003241
"Although the dose and frequency of bortezomib in this trial was different from ours, the patient population was relatively comparable.","Although dose frequency bortezomib trial ours, patient population comparable.",G0000000|C0178602|C0376249|C1176309|C0008976|G0000000|C0030705|C0032659|G0000000
The following were exclusion criteria: a history of wheezy bronchitis or asthma; gastro-oesophageal reflux; previous lower respiratory tract infections; risk factors for severe disease; carers lacking fluent English in the absence of translational services and patients requiring admission to high dependency or intensive care units (HDU/ICU) at presentation.,The exclusion criteria: history wheezy bronchitis asthma; gastro-oesophageal reflux; previous lower respiratory tract infections; risk factors severe disease; carers lacking fluent English absence translational services patients requiring admission dependency intensive care units (HDU/ICU) presentation.,G0000000|C0680251|C0243161|C0019664|C0043144|C0006277|C0004096|C0744316|C0017168|C0205156|C0441994|C0521346|C1185740|C3714514|C0035647|C1521761|C0205082|C0012634|C0085537|C0332268|C0870569|C0376245|C0332197|C1519614|C0557854|C0030705|G0000000|C0184666|C0011546|C0162425|C1947933|C0439148|C0021708|C0449450
The trial is reported according to the CONSORT statement.22 Further recruitment details are reported elsewhere.23 Residents in low level dependency residential care in two cities of New Zealand were eligible for this study.,The trial reported CONSORT statement.22 Further recruitment details reported elsewhere.23 Residents low level dependency residential care cities New Zealand eligible study.,G0000000|C0008976|C0684224|G0000000|C1710187|C1517331|C2949735|C1522508|C0684224|C0450371|C1320928|C0205251|C0441889|C0011546|C0237096|C1947933|C0008848|C0205314|G0000000|C1548635|C0557651
Such children were randomised as follows: 13 children (10 boys) for the MK Group and 14 children (8 boys) for the MKS Group (Fig.,Such children randomised follows: 13 children (10 boys) MK Group 14 children (8 boys) MKS Group (Fig.,G0000000|C0008059|G0000000|C0332283|C0450371|C0008059|C0450371|C0870221|C0083453|C0441833|C0450371|C0008059|G0000000|C0870221|C1417174|C0441833|C0349966
"Children were ineligible for the study if they had prior exposure to probiotics, were currently taking a course of antibiotics, or had other major medical problems.","Children ineligible study prior exposure probiotics, antibiotics, major medical problems.",C0008059|C1512714|C0557651|C0332152|C0274281|C0525033|C0003232|C0205082|C0199168|C1546466
"Clinical response was classified as ""cured"" if acute symptoms (fever, urinary syndrome and flank pain) were settled.","Clinical response classified ""cured"" acute symptoms (fever, urinary syndrome flank pain) settled.",C0205210|C0871261|C0008902|C1880198|C0205178|C0683368|C0015967|C0042027|C0039082|C0230171|C0030193|C1266099
"), and on individual patients’ predisposition or other factors.","), individual patients’ predisposition factors.",G0000000|C0027361|G0000000|C0012655|C1521761
"Participants were excluded if they planned to leave the village for three months or more during the trial period, or if they scored <24 on the Mini Mental State Examination (MMSE) in the baseline assessment indicating cognitive impairment [26].","Participants excluded planned leave village months trial period, scored <24 Mini Mental State Examination (MMSE) baseline assessment indicating cognitive impairment [26].",C0679646|C1554077|C1301732|G0000000|C0562518|C0439231|C0008976|C0439531|C0449820|C0450371|C0445542|C0229992|C1301808|G0000000|C0451306|C0168634|C1261322|G0000000|C1516691|C0221099|C0450371
Dystonic cerebral palsy is primarily caused by damage to the basal ganglia and central cortex.,Dystonic cerebral palsy caused damage basal ganglia central cortex.,G0000000|G0000000|C0522224|C0015127|C0010957|C0205112|C0017067|C0205099|C0007776
"For children with stable asthma, to test non-inferiority of care provided by a hospital-based specialised asthma nurse versus a general practitioner (GP) or paediatrician.","For children stable asthma, test non-inferiority care provided hospital-based specialised asthma nurse versus practitioner (GP) paediatrician.",G0000000|C0008059|C0205360|C0004096|C0022885|C1518422|C1947933|C1999230|C0019994|C0205555|C0004096|C0028661|G0000000|C1709627|C3811116|C0237433
COPD: chronic obstructive pulmonary disease; ICS: inhaled corticosteroids; FEV1: forced expiratory volume in 1 s; % pred: % predicted; FVC: forced vital capacity.,COPD: chronic obstructive pulmonary disease; ICS: inhaled corticosteroids; FEV1: forced expiratory volume 1 s; % pred: % predicted; FVC: forced vital capacity.,C0024117|C0205191|C0549186|C0024109|C0012634|C0022521|C0004048|C0001617|G0000000|C0441722|C0231800|C0449468|G0000000|C0565930|G0000000|C0032952|G0000000|C0681842|C3714541|C0441722|C0442732|C1516240
The inclusion criteria were: diagnosed MM; baseline without peripheral neuropathy and peripheral neuropathy appeared after chemotherapy at grade II or above (according to the NCI CTCAE version 3.0 neuropathy severity assessment) [24]; EMG examinations showing disturbances in median and peroneal nerve conduction; platelet count greater than 30 × 109/L; no history of methylcobalamin allergy; having discontinued chemotherapy within 3 months and were willing to accept new therapy and sign an informed consent form.,The inclusion criteria were: diagnosed MM; baseline peripheral neuropathy peripheral neuropathy appeared chemotherapy grade II (according NCI CTCAE version 3.0 neuropathy severity assessment) [24]; EMG examinations disturbances median peroneal nerve conduction; platelet count 30 × 109/L; history methylcobalamin allergy; discontinued chemotherapy 3 months accept therapy sign informed consent form.,G0000000|C0007637|C0243161|G0000000|C0011900|G0000000|C0168634|C0205100|C0442874|C0205100|C0442874|C0700364|C0013216|C0441800|G0000000|C0680240|C1513882|C1516728|C0333052|G0000000|C0442874|C0439793|C1261322|C0450371|G0000000|C0031809|C2699787|C0549183|C0442035|C0027740|C0232217|C0005821|C0750480|G0000000|C0019664|C0065844|C0002111|C1444662|C0013216|G0000000|C0439231|C1272684|C0039798|C0311392|C1522154|C1511481|C0348078
Data from 854 incident cases and 948 controls were analyzed in a case-control study of colorectal cancer in Western Australia during 2005–07.,Data 854 incident 948 controls analyzed case-control study colorectal cancer Western Australia 2005–07.,C1511726|C1442061|C1551358|C1442061|C0243148|C0936012|C0872128|C0557651|C0555952|C0006826|C1705493|C0004340|G0000000
"Those women with missing data regarding pregnancy history, mode of delivery in the index pregnancy, or the dates of the cervical procedure or delivery were excluded, as were any women for whom medical records were unavailable.","Those women missing data pregnancy history, mode delivery pregnancy, dates cervical procedure delivery excluded, women medical records unavailable.",G0000000|C0043210|C1551393|C1511726|C0032961|C0019664|C1513371|C0011209|C0032961|C0011008|C0027530|C0184661|C0011209|C1554077|C0043210|C0199168|C0034869|C0686905
The age of subjects at study entry was 23 ± 2.9 days.,The age subjects study entry 23 ± 2.9 days.,G0000000|C0001779|C0681850|C0557651|C1705654|C0450371|G0000000|G0000000|C0439228
"Entry criteria were normal BP of <140/90 mmHg; mean arterial pressure <107 mmHg, persistent mild to moderate proteinuria of 1.6 ± 0.5 g/day (range, 1.0–2.6), and normal or mild to moderately reduced but stable renal function (creatinine clearance; Ccr >50 mL/min/1.73m2), with a renal glomerular score between 4 and 7 according to Katafuchi's scale.","Entry criteria normal BP <140/90 mmHg; arterial pressure <107 mmHg, persistent mild moderate proteinuria 1.6 ± 0.5 g/day (range, 1.0–2.6), normal mild moderately reduced stable renal function (creatinine clearance; Ccr >50 mL/min/1.73m2), renal glomerular score 4 7 Katafuchi's scale.",C1705654|C0243161|C0205307|C0037623|C1442061|C0439475|C0003842|C0033095|C1442061|C0439475|C0205322|C2945599|C0205081|C0033687|G0000000|G0000000|G0000000|C0439417|C1514721|G0000000|C0205307|C2945599|C0205081|C0392756|C0205360|C0022646|C0031843|C0010294|C0449297|C1955905|C0450371|C0439445|C0022646|C0022663|C0449820|G0000000|G0000000|G0000000|C0175659
"In the TACE group, 8 out of 12 patients presented with diverse changes of the tumor feeding arteries.","In TACE group, 8 12 patients diverse tumor feeding arteries.",G0000000|C0723595|C0441833|G0000000|C0450371|C0030705|C1880371|C0027651|C0204695|C0003842
The remaining 24 patients were randomly divided into the Roptrotherapy group and the TENS group.,The remaining 24 patients randomly divided Roptrotherapy TENS group.,G0000000|C1527428|C0450371|C0030705|G0000000|C0332849|G0000000|C0014518|C0441833
Details about the counselling programme are published elsewhere.17  Mothers received the usual nutritional counselling of the supplemental nutrition programme and brief advice to quit smoking and not expose their children to environmental tobacco smoke.,Details counselling programme published elsewhere.17 Mothers received usual nutritional counselling supplemental nutrition programme advice quit smoking expose children environmental tobacco smoke.,C1522508|C0010210|C1709697|C0034037|C0450371|C0026591|C1514756|C3538928|C1521739|C0010210|C2348609|C0028707|C1709697|C0150600|C0748223|C0037369|G0000000|C0008059|C0014406|C0040329|C0037366
"Psychoactive medications were allowed as long as the dose had been stable at least 4 weeks prior to treatment, and had remained stable.","Psychoactive medications allowed dose stable 4 weeks prior treatment, remained stable.",G0000000|C0013227|C0683607|C0178602|C0205360|G0000000|C0439230|C0332152|C0039798|G0000000|C0205360
"In conclusion, this prospective cohort study conducted in rural Japan showed no association between consumption of green tea, coffee or black tea and the risk of prostate cancer.","In conclusion, prospective cohort study conducted rural Japan association consumption green tea, coffee black tea risk prostate cancer.",G0000000|C1707478|C0023981|C0599755|C0557651|C0004927|C0240919|C0022341|C0004083|C0009830|C0332583|C0039400|C0009237|C0005680|C0039400|C0035647|C0033572|C0006826
"Participants were study eligible if, during a telephone screen, they self-identified as a primary caregiver of a community-dwelling family member who had memory loss consistent with dementia; were older than 21; spoke English; could read the course materials; were willing to attend all group sessions; had not participated in a community caregiver support program; had not practiced meditation, yoga, or tai chi in the previous year; had to score 5 or higher on a single-item measure of self-perceived stress (scale of 1–10); had no psychiatric hospitalizations or diagnoses of mental illness in the previous 2 years; had not been taking antipsychotic or anticonvulsion medication; and had no thoughts of harming themselves in the previous 6 months.","Participants study eligible if, telephone screen, self-identified primary caregiver community-dwelling family memory loss consistent dementia; 21; spoke English; read materials; attend sessions; participated community caregiver support program; practiced meditation, yoga, tai chi previous year; score 5 single-item measure self-perceived stress (scale 1–10); psychiatric hospitalizations diagnoses mental illness previous 2 years; antipsychotic anticonvulsion medication; harming previous 6 months.",C0679646|C0557651|C1548635|G0000000|C0039457|C0220908|C0036588|C0205225|C0085537|C4045975|C0015576|C0025260|C1517945|C0332290|C0011265|C0450371|G0000000|C0376245|C0034754|C0520510|C1999232|C1883016|G0000000|C0009462|C0085537|C0183683|C1709697|C0237607|C0150277|C0043418|G0000000|C1720589|C0205156|C0439234|C0449820|G0000000|C0037179|C0079809|C0036588|C0038435|C0175659|G0000000|C0205487|C0019993|C0011900|C0229992|C0221423|C0205156|G0000000|C0439234|C0040615|G0000000|C0013227|G0000000|C0205156|G0000000|C0439231
Consecutive patients diagnosed with delirium by the consultation liaison psychiatry team were considered for this research.,Consecutive patients diagnosed delirium consultation liaison psychiatry team considered research.,C1707491|C0030705|C0011900|C0011206|C0009818|C0683597|C0033873|C0871489|C0750591|C0035168
The National Health and Nutrition Examination Survey III (NHANES) indicates that 40% of US children live in a home with at least one smoker [1].,The National Health Nutrition Examination Survey III (NHANES) 40% US children live smoker [1].,G0000000|C3245503|C0018684|C0028707|G0000000|C0038951|C0439070|C0376344|C0450371|G0000000|C0008059|C1548795|C0337664|G0000000
Most migraine patients with infrequent attacks are currently not treated with migrainespecific medication such as triptans.,Most migraine patients infrequent attacks treated migrainespecific medication triptans.,C0205393|C0149931|C0030705|C0521114|C1261512|C1522326|G0000000|C0013227|C1567966
"Eleven years after randomization, patients were reassessed.","Eleven randomization, patients reassessed.",C0205457|C0034656|C0030705|G0000000
"Exclusion criteria included terminal illness, congenital anomalies, and syndromes associated with hearing loss.","Exclusion criteria included terminal illness, congenital anomalies, syndromes hearing loss.",C0680251|C0243161|C0332257|C0205088|C0221423|C0009678|C0000769|C0039082|C0018767|C1517945
Eligible patients are those aged 18 and over presenting to their GPs who are daily or weekly smokers.,Eligible patients aged 18 GPs daily weekly smokers.,C1548635|C0030705|C0001779|C0450371|C0272302|C0332173|C0332174|C0337664
"First, adolescents' confidence in their ability to quit improved more from baseline to 3 months in intervention compared with control schools, although not at 12 months.","First, adolescents' confidence ability quit improved baseline 3 months intervention compared control schools, 12 months.",C0205435|C0205653|C0237529|C0085732|C0748223|C0184511|C0168634|G0000000|C0439231|C0886296|C1707455|C0243148|C0036375|C0450371|C0439231
The majority of the participants were diagnosed with dementia of Alzheimer's type (40%) or dementia without any further specification (38%).,The majority participants diagnosed dementia Alzheimer's type (40%) dementia specification (38%).,G0000000|C0680220|C0679646|C0011900|C0011265|G0000000|C0332307|C0450371|C0011265|C2348235|C0450371
"Overall and disease-free survivals for patients treated with percutaneous local ablative therapy (PLAT, n = 71) or surgical resection (SR, n = 90).","Overall disease-free survivals patients treated percutaneous local ablative therapy (PLAT, = 71) surgical resection (SR, = 90).",C0282416|C0012634|C0038952|C0030705|C1522326|C0522523|C0205276|G0000000|C0039798|G0000000|G0000000|C0450371|C0543467|C0015252|C3813610|G0000000|C0450371
5-FU bolus have reported disappointing results with a median survival of less than 5 months.,5-FU bolus reported disappointing median survival 5 months.,C0016360|C1511237|C0684224|G0000000|C0549183|C0038952|G0000000|C0439231
Twenty-four mild-moderate asthma patients (16–75 years) were randomized to receive either 2.0 g daily GLA (borage oil) or corn oil (placebo) for 12 months.,Twenty-four mild-moderate asthma patients (16–75 years) randomized receive 2.0 daily GLA (borage oil) corn oil (placebo) 12 months.,C3715070|C1299392|C0004096|C0030705|G0000000|C0439234|C0034656|C1514756|G0000000|C0332173|C0002986|C0522464|C0028908|C0010028|C0028908|C0032042|C0450371|C0439231
"Inclusion criteria included age ≥ 18, diagnosis of FM, Mini-Mental Status Examination (MMSE) score >25, and a Fibromyalgia Impact Questionnaire (FIQ) score >20.","Inclusion criteria included age ≥ 18, diagnosis FM, Mini-Mental Status Examination (MMSE) score >25, Fibromyalgia Impact Questionnaire (FIQ) score >20.",C0007637|C0243161|C0332257|C0001779|G0000000|C0450371|C0011900|C3540627|C0445542|C0449438|G0000000|C0451306|C0449820|C0450371|C0016053|C1825598|C0034394|G0000000|C0449820|C0450371
"Baseline characteristics of subjects in the intervention and control groups Dietary intake in the intervention and control groups As shown in Table 2, daily milk consumption increased by ≈450 g/d for the intervention group (P < 0.0001) and did not change for the control group.","Baseline characteristics subjects intervention control Dietary intake intervention control As Table 2, daily milk consumption increased ≈450 g/d intervention (P < 0.0001) change control group.",C0168634|C1521970|C0681850|C0886296|C0243148|C0012155|C1512806|C0886296|C0243148|G0000000|C0039224|G0000000|C0332173|C0026131|C0009830|C0205217|G0000000|C0439417|C0886296|C0369773|G0000000|G0000000|C0392747|C0243148|C0441833
Secondary outcome variables were quit attempts and change in motivational stage at follow-up.,Secondary outcome variables quit attempts change motivational stage follow-up.,C0027627|C1274040|C0439828|C0748223|C1516084|C0392747|C0026605|C0205390|C0589120
"Patients were excluded if they had: exposure to cancer chemotherapy or radiotherapy within the previous 28 days; previous treatment with murine monoclonal antibodies; enteral feeding at study entry or ileus within the previous 30 days and >70% tumor infiltration of the liver, or portal vein obstruction, or thrombosis.","Patients excluded had: exposure cancer chemotherapy radiotherapy previous 28 days; previous treatment murine monoclonal antibodies; enteral feeding study entry ileus previous 30 days >70% tumor infiltration liver, portal vein obstruction, thrombosis.",C0030705|C1554077|G0000000|C0274281|C0006826|C0013216|C0034619|C0205156|C0450371|C0439228|C0205156|C0039798|C0026809|C0746619|C0003241|C1304890|C0204695|C0557651|C1705654|C1258215|C0205156|C0450371|C0439228|C0450371|C0027651|C0332448|C0023884|C0205054|C0042449|C0028778|C0040053
"Two of the participating kindergartens had two departments for toddlers (aged 0–3 years), giving a total of 20 participating departments.","Two participating kindergartens departments toddlers (aged 0–3 years), total 20 participating departments.",C0205448|C0679823|C0681406|C1704729|C0682053|C0001779|G0000000|C0439234|C0439175|C0450371|C0679823|C1704729
"Criteria for inclusion: Women aged 20 to 60 years with fibromyalgia, defined by the ACR 1990 criteria [2]: a history of long-lasting generalized pain and pain in at least 11 of 18 tender points examined by manual palpation, an ablility to manage a bicycle test at 50 watts or more, and interest in exercising outdoors twice a week for 15 weeks.","Criteria inclusion: Women aged 20 60 fibromyalgia, defined ACR 1990 criteria [2]: history long-lasting generalized pain pain 11 18 tender examined manual palpation, ablility manage bicycle test 50 watts more, exercising outdoors week 15 weeks.",C0243161|C0007637|C0043210|C0001779|C0450371|C0450371|C0016053|C1704788|C1412134|G0000000|C0243161|G0000000|C0019664|C0205166|C0205246|C0030193|C0030193|C0450371|C0450371|C0234234|C0332128|C0024763|C0030247|G0000000|G0000000|C0005375|C0022885|C0450371|C0439261|C0205172|C0015259|C1709359|C0332174|C0450371|C0439230
"In these children, ofatumumab may allow maintenance of long-term remission of INS without steroids and CNI therapy.","In children, ofatumumab maintenance long-term remission INS steroids CNI therapy.",G0000000|C0008059|C1832027|C0024501|C0443252|C0544452|G0000000|C0038317|C1425101|C0039798
"Overall, the treatment groups receiving 5-Loxin® 100 mg/day, n=19, Aflapin® 100 mg/day, n=19 and placebo n=19, were similar with respect to age, Body Mass Index and pain severity (Table (Table2).2).","Overall, treatment receiving 5-Loxin® 100 mg/day, n=19, Aflapin® 100 mg/day, n=19 placebo n=19, respect age, Body Mass Index pain severity (Table (Table2).2).",C0282416|C0039798|C1514756|G0000000|C1442061|C0439422|C0369718|G0000000|C1442061|C0439422|C0369718|C0032042|C0369718|C0679133|C0001779|C0242821|C0577559|C0918012|C0030193|C0439793|C0039224|G0000000
"Inclusion criteria include: expected to be in critical care for at least 48 hours, aged 16 years or over, patients who require parenteral nutrition and are expected to have at least half their daily nutritional requirements given by that route.","Inclusion criteria include: expected critical care 48 hours, aged 16 over, patients require parenteral nutrition expected half daily nutritional requirements route.",C0007637|C0243161|C0332257|C1517001|C1511545|C1947933|C0450371|C0439227|C0001779|C0450371|C0205136|C0030705|G0000000|C0030547|C0028707|C1517001|C2825407|C0332173|C1521739|C1514873|C0013153
The study was carried out in nurse run hypertension clinics in six general practices in the Southampton area during 1999-2001.,The study carried nurse hypertension clinics practices Southampton 1999-2001.,G0000000|C0557651|C0206243|C0028661|C0020538|C0442592|C0237607|G0000000|G0000000
"An international study group has recently recommended a definition of pancreatic fistula as drain output of any measurable volume of fluid on or after postoperative day 3 with an amylase content greater than 3 times the serum amylase level, which is similar to our definition in this study.43 The group also concluded that radiologic documentation is neither mandatory nor necessary for diagnosis of pancreatic fistula.","An international study recommended definition pancreatic fistula drain output measurable volume fluid postoperative day 3 amylase content 3 times serum amylase level, definition study.43 The concluded radiologic documentation mandatory diagnosis pancreatic fistula.",G0000000|C1512888|C0557651|C0034866|C1550452|C0030274|C0016169|C0013103|C1709366|C1513040|C0449468|C0005889|C0032790|C0332173|G0000000|C0002712|C0423896|G0000000|C0040223|C0229671|C0002712|C0441889|C1550452|C0557651|G0000000|C0917903|C0034599|C0175636|C1514873|C0011900|C0030274|C0016169
"The primary exclusion criteria were a history of prostate, lung, colorectal, or ovarian cancer; ongoing treatment for any type of cancer except basal-cell or squamous-cell skin cancer; and, beginning in 1995, assessment by means of a lower endoscopic procedure (flexible sigmoidoscopy, colonoscopy, or barium enema examination) in the previous 3 years.","The primary exclusion criteria history prostate, lung, colorectal, ovarian cancer; ongoing treatment type cancer basal-cell squamous-cell skin cancer; and, 1995, assessment lower endoscopic procedure (flexible sigmoidoscopy, colonoscopy, barium enema examination) previous 3 years.",G0000000|C0205225|C0680251|C0243161|C0019664|C0033572|C0024109|C0555952|C0205065|C0006826|C0549178|C0039798|C0332307|C0006826|C0596155|C0221910|C0444099|C0006826|G0000000|G0000000|C1261322|C0441994|C0014245|C0184661|C0443220|C0037075|C0009378|C0004749|C0014268|G0000000|C0205156|G0000000|C0439234
Table 2 ▶ shows pre- and postintervention awareness and perceptions of ESAP among Harlem (intervention) and South Bronx (comparison) community residents.,Table 2 ▶ pre- postintervention awareness perceptions ESAP Harlem (intervention) South Bronx (comparison) community residents.,C0039224|G0000000|G0000000|C0332152|G0000000|C0004448|C0030971|G0000000|G0000000|C0886296|C1710133|G0000000|C1707455|C0009462|C1320928
A full description of the components of the training and demonstration of general practitioners’ sustained competence in implementing the acquired skills in daily practice after training has been reported.43 General practitioners were asked to recruit sequential eligible adults within regular consultation hours during the winters of 2005-6 and 2006-7.,A description components training demonstration practitioners’ sustained competence implementing acquired skills daily practice training reported.43 General practitioners recruit sequential eligible adults regular consultation hours winters 2005-6 2006-7.,G0000000|C0678257|C0449432|C0040607|G0000000|G0000000|C0443318|C0086035|G0000000|C0439661|C0678856|C0332173|C0237607|C0040607|C0684224|C0205246|C1709627|G0000000|C1548958|C1548635|C0001675|C0205272|C0009818|C0439227|C0241737|G0000000|G0000000
The inclusion criteria were the following items:  Primiparous pregnant women in 28-32nd pregnancy weeks who referred to private clinics and were willing to use cesarean section.,The inclusion criteria items: Primiparous pregnant women 28-32nd pregnancy weeks referred private clinics cesarean section.,G0000000|C0007637|C0243161|C1551338|C0033150|C0549206|C0043210|C0450371|C0032961|C0439230|C0205543|C0033175|C0442592|C3841297|C0152060
"Evaluations of physical activity and pain scores, serum biochemistry, haematology, urine biochemistry and proinflammatory cytokines were done at baseline (day 0) and on days 7, 30, 60 and 90 during follow up.","Evaluations physical activity pain scores, serum biochemistry, haematology, urine biochemistry proinflammatory cytokines baseline (day 0) days 7, 30, 60 90 follow up.",C0220825|C0031809|C0205177|C0030193|C0449820|C0229671|C0005477|C0018943|C0042036|C0005477|G0000000|C0079189|C0168634|C0332173|G0000000|C0439228|G0000000|C0450371|C0450371|C0450371|C0332283|G0000000
"For the animal category task, participants were asked to name as many animals as possible in 1 minute.","For animal category task, participants animals 1 minute.",G0000000|C0003062|C0683312|C3540678|C0679646|C0003062|G0000000|C0439232
"Laboratory examination showed adequate liver function (total bilirubin ≤1.5 times the upper limit, ALT/AST ≤2.5 times the upper limit) and renal function (blood creatinine ≤ 1.5 mg/dL, creatinine clearance ≥50 mL/min).","Laboratory examination adequate liver function (total bilirubin ≤1.5 times upper limit, ALT/AST ≤2.5 times upper limit) renal function (blood creatinine ≤ 1.5 mg/dL, creatinine clearance ≥50 mL/min).",C0022877|G0000000|C0205410|C0023884|C0031843|C0439175|C0005437|G0000000|C0040223|C1282910|C0439801|C3831581|G0000000|C0040223|C1282910|C0439801|C0022646|C0031843|C0005767|G0000000|C0439269|C0010294|C0449297|G0000000|C0439445
Premenopausal women 18 to 49 years of age were eligible for enrollment if they had operable stage I to IIIA estrogen-receptor (ER)–negative and progesterone-receptor (PR)–negative breast cancer for which treatment with adjuvant or neoadjuvant cyclophosphamide-containing chemotherapy was planned.,Premenopausal women 18 49 age eligible enrollment operable stage I IIIA estrogen-receptor (ER)–negative progesterone-receptor (PR)–negative breast cancer treatment adjuvant neoadjuvant cyclophosphamide-containing chemotherapy planned.,C0279752|C0043210|C0450371|C0450371|C0001779|C1548635|C1516879|C0205188|C0205390|C0021966|G0000000|C0034804|G0000000|C0034833|G0000000|C0006141|C0006826|C0039798|C0001551|C0600558|C0010583|C0013216|C1301732
"To be included in the sample, patients must have never received dental care and had to be seeking attention at the Pediatric Dentistry Clinic at the Autonomous University of San Luis Potosí for the first time and their dental treatment had to include a local anesthetic.","To included sample, patients received dental care seeking attention Pediatric Dentistry Clinic Autonomous University San Luis Potosí time dental treatment local anesthetic.",C0040363|C0332257|C0370003|C0030705|C1514756|C0011365|C1947933|G0000000|C0004268|C0030755|C0011438|C0002424|G0000000|C0041740|C1826357|C0445527|G0000000|C0040223|C0011365|C0039798|C0205276|C0002932
"Sixteen persons with hemiparesis resulting from a single cortical or subcortical stroke (confirmed by CT or MRI) greater than 6 months prior to the study, who were categorized as at least unlimited household ambulators (e.g.","Sixteen persons hemiparesis single cortical subcortical stroke (confirmed CT MRI) 6 months prior study, categorized unlimited household ambulators (e.g.",C3715157|C0027361|C0018989|C0037179|C0001613|C0815275|C0038454|C0521093|C0007673|C0024485|G0000000|C0439231|C0332152|C0557651|C0871968|C1549481|C0020052|G0000000|G0000000
"Fibromyalgia (FM), a chronic, multidimensional disorder characterized by persistent, widespread body pain and ten-derness,1 affects about 2% of the US population and occurs about 8 times more in women than in men.2 Fibromyalgia can hamper day-to-day functioning and is a major cause of disability.3 In a previous report,4 we evaluated the effects of 12 weeks of lifestyle physical activity (LPA; it involves working toward meeting the US Surgeon General’s 1996 Physical Activity Recommendations5 of accumulating at least 30 minutes, above one’s usual activity, of moderate-intensity physical activity 5–7 days a week by integrating short bouts of activity into the day, such as increasing the amount of walking, performing more yard work, or using the stairs) on pain, function, fatigue, and other outcomes in adults with FM.","Fibromyalgia (FM), chronic, multidimensional disorder characterized persistent, widespread body pain ten-derness,1 2% US population occurs 8 times women men.2 Fibromyalgia hamper day-to-day functioning major disability.3 In previous report,4 evaluated effects 12 weeks lifestyle physical activity (LPA; involves meeting US Surgeon General’s 1996 Physical Activity Recommendations5 accumulating 30 minutes, one’s usual activity, moderate-intensity physical activity 5–7 days week integrating short bouts activity day, increasing amount walking, performing yard work, stairs) pain, function, fatigue, outcomes adults FM.",C0016053|C3540627|C0205191|C2347299|C0012634|C1880022|C0205322|C0205219|C0242821|C0030193|C0014518|G0000000|G0000000|C0032659|C1709305|G0000000|C0040223|C0043210|C0025266|C0016053|C0181113|C0332173|C0205245|C0205082|C0231170|G0000000|C0205156|C0684224|C0220825|C1280500|C0450371|C0439230|C0023676|C0031809|C0205177|C1096202|G0000000|C0556656|G0000000|C0582175|G0000000|G0000000|C0031809|C0205177|G0000000|G0000000|C0450371|C0439232|G0000000|C3538928|C0205177|C0205081|C0031809|C0205177|G0000000|C0439228|C0332174|G0000000|C1282927|C0741605|C0205177|C0332173|C0442808|C1265611|C0080331|C0884358|C0439205|C0043227|C1710179|C0030193|C0031843|C0015672|C1274040|C0001675|C3540627
"hypo/hyperparathyroidism, nephrolithiasis, hypercalciuria; have hypercalciuria (>0.6 mmol/mmol creatinine in spot morning urine) or hypercalcaemia (>10.6 mg/dl | 2.65 mmol/l) detected at baseline measurement.","hypo/hyperparathyroidism, nephrolithiasis, hypercalciuria; hypercalciuria (>0.6 mmol/mmol creatinine spot morning urine) hypercalcaemia (>10.6 mg/dl | 2.65 mmol/l) detected baseline measurement.",C0020502|C0022650|C0020438|C0020438|G0000000|C1960955|C0010294|C0329155|C0332170|C0042036|C0020437|C0450371|C0439269|G0000000|C0450371|C1532563|C0442726|C0168634|C0242485
"To summarise, women between 12 to 24 weeks gestation, aged 16 years and older, able to read, write and understand English and with capacity to consent were invited to participate.","To summarise, women 12 24 weeks gestation, aged 16 older, read, write understand English capacity consent invited participate.",C0040363|G0000000|C0043210|C0450371|C0450371|C0439230|C0032961|C0001779|C0450371|C0580836|C0034754|C0043266|C0162340|C0376245|C1516240|C1511481|G0000000|G0000000
"After obtaining the approval of the Ethics Committee at the author's institution and informed parental consent, 95 children who were 3-10 yrs old, pertaining to ASA physical status 1 and undergoing surgery for strabismus or entropion were studied.","After obtaining approval Ethics Committee author's institution informed parental consent, 95 children 3-10 yrs old, pertaining ASA physical status 1 undergoing surgery strabismus entropion studied.",G0000000|C1301820|C0205540|C0015000|C2699414|C3812881|C0018704|C1522154|C0030551|C1511481|C0450371|C0008059|C0450371|G0000000|C0580836|G0000000|C0004057|C0031809|C0449438|G0000000|G0000000|C0038894|C0038379|C0014390|C0557651
The incidence of Plasmodium infections in children 6 months to 13 years of age was measured during the long and short rainy seasons each year.,The incidence Plasmodium infections children 6 months 13 age measured short rainy seasons year.,G0000000|C0021149|C0032148|C3714514|C0008059|G0000000|C0439231|C0450371|C0001779|C0444706|C1282927|C0034640|C0036497|C0439234
"chronic pulmonary (including asthma), cardiovascular, renal, hepatic, hematological, or metabolic disorders (including diabetes mellitus); immunosuppressive illness, recent/ongoing receipt of immunosuppressive therapy, or human immunodeficiency virus infection [18]; recent administration of other vaccine or immunoglobulin, contraindication to influenza vaccine, or previous influenza vaccination within 9 months.","chronic pulmonary (including asthma), cardiovascular, renal, hepatic, hematological, metabolic disorders (including diabetes mellitus); immunosuppressive illness, recent/ongoing receipt immunosuppressive therapy, human immunodeficiency virus infection [18]; administration vaccine immunoglobulin, contraindication influenza vaccine, previous influenza vaccination 9 months.",C0205191|C0024109|C0332257|C0004096|C0007226|C0022646|C0205054|C0018943|C0311400|C0012634|C0332257|C0011847|G0000000|C0021081|C0221423|C0332185|G0000000|C0021081|C0039798|C0086418|C0021051|C0042776|C0009450|C0450371|C0001554|C0042210|C0021027|C0522473|C0021400|C0042210|C0205156|C0021400|C0042196|G0000000|C0439231
"Patients aged 18 years or older with a diagnosis of moderate to severe MG, defined as Quantitative Myasthenia Gravis Score (QMGS) >10.5, and worsening weakness requiring a change in treatment modality as judged by a neuromuscular expert, were considered for the study.","Patients aged 18 diagnosis moderate severe MG, defined Quantitative Myasthenia Gravis Score (QMGS) >10.5, worsening weakness requiring change treatment modality judged neuromuscular expert, considered study.",C0030705|C0001779|C0450371|C0011900|C0205081|C0205082|C0026410|C1704788|C0392762|C0947912|C0205082|C0449820|G0000000|C0450371|C0332271|C3714552|G0000000|C0392747|C0039798|C0695347|C0221191|C1979768|G0000000|C0750591|C0557651
METHODS—Twenty four patients with CF were randomised to receive β-carotene 1 mg/kg/day (maximum 50 mg/day) for three months (high dose supplementation) and 10 mg/day for a further three months (low dose supplementation) or placebo.,METHODS—Twenty patients CF randomised receive β-carotene 1 mg/kg/day (maximum 50 mg/day) months (high dose supplementation) 10 mg/day months (low dose supplementation) placebo.,G0000000|C0030705|C0009738|G0000000|C1514756|G0000000|G0000000|C3665414|C0806909|C0450371|C0439422|C0439231|C0205250|C0178602|C0242297|C0450371|C0439422|C0439231|C0205251|C0178602|C0242297|C0032042
Infants were recruited when they were full term (>36 weeks) and SGA (birth weight <10th percentile weight-for-gestational age).,Infants recruited term (>36 weeks) SGA (birth weight <10th percentile weight-for-gestational age).,C0021270|G0000000|C0233324|C0450371|C0439230|G0000000|C0005615|C0005910|G0000000|C1264641|C0005910|C0001779
Isolated Organisms There was no suggestion that patients randomly assigned to the cooked group lived longer than those assigned to the raw group (Fig 3).,Isolated Organisms There suggestion patients randomly assigned cooked lived assigned raw (Fig 3).,C0205409|C0029235|G0000000|C0038659|C0030705|G0000000|C1516050|C0335326|C1548795|C1516050|C0001884|C0349966|G0000000
The primary molars (70) were selected from 35 children aged 4 to 6 years.,The primary molars (70) selected 35 children aged 4 6 years.,G0000000|C0205225|C0026367|C0450371|C1707391|C0450371|C0008059|C0001779|G0000000|G0000000|C0439234
"This was a prospective, randomized, double-blinded and single crossover study in which patients of 18-years or older with localized or disseminated vitiligo and with an affected body surface area of 20% or less were included.","This prospective, randomized, double-blinded single crossover study patients 18-years localized disseminated vitiligo body surface 20% included.",G0000000|C0023981|C0034656|C0205173|C0037179|C0010366|C0557651|C0030705|C0450371|C0392752|C0205221|C0042900|C0242821|C0205148|C0450371|C0332257
"The mean±SD age, weight and medical history of participants were 36.2±2.2 years, 62.9±10.6, and 10.4±1.6 years, respectively.","The mean±SD age, weight medical history participants 36.2±2.2 years, 62.9±10.6, 10.4±1.6 years, respectively.",G0000000|G0000000|C0001779|C0005910|C0199168|C0019664|C0679646|G0000000|C0439234|G0000000|G0000000|C0439234|G0000000
The examiner will be blind to the allocation of participants.,The examiner blind allocation participants.,G0000000|G0000000|C0150108|C1706778|C0679646
Randomised controlled trial of usual care compared with intervention delivered on hospital wards by cardiac rehabilitation nurses.,Randomised controlled trial usual care compared intervention delivered hospital wards cardiac rehabilitation nurses.,G0000000|C2587213|C0008976|C3538928|C1947933|C1707455|C0886296|C1705822|C0019994|C1305702|C0018787|C0034991|C0028661
We recruited women during 1993-7 from the Finnish student health service at the University of Oulu and the occupational health centre for the staff of Oulu University Hospital.,We recruited women 1993-7 Finnish student health service University Oulu occupational health centre staff Oulu University Hospital.,G0000000|G0000000|C0043210|G0000000|C1711254|C0038492|C0018684|C0557854|C0041740|G0000000|C0521127|C0018684|C0205099|C0851286|G0000000|C0041740|C0019994
The explanation as thermal effect is as well in accordance with the fact that warts are most often located on hypothermic areas like hands and feet.,The explanation thermal warts located hypothermic hands feet.,G0000000|C0681841|G0000000|C1367460|G0000000|C0020672|C0018563|C0016504
"[27] Children were excluded if they met the following criteria: a history of head injury, a diagnosis of other congenital or acquired neurological conditions, an estimated full-scale IQ <80, a diagnosis of autism spectrum disorder, psychosis, or an emergent psychiatric condition that needed immediate medication.","[27] Children excluded met criteria: history head injury, diagnosis congenital acquired neurological conditions, estimated full-scale IQ <80, diagnosis autism spectrum disorder, psychosis, emergent psychiatric condition medication.",C0450371|C0008059|C1554077|C0268621|C0243161|C0019664|C0018670|C3263722|C0011900|C0009678|C0439661|C0205494|C0012634|C0750572|C0443225|G0000000|C0450371|C0011900|C0004352|C1883073|C0012634|C0033975|C0750573|C0205487|C0012634|C0013227
"malignancies); neuropathy caused by tumor compression, nutritional disorders or infections or causes other than chemotherapy; refusal to sign the informed consent form.","malignancies); neuropathy caused tumor compression, nutritional disorders infections chemotherapy; refusal sign informed consent form.",C0006826|C0442874|C0015127|C0027651|C0332459|C1521739|C0012634|C3714514|C0013216|G0000000|C0311392|C1522154|C1511481|C0348078
The trial period was from November 2006 until 30 March 2007.,The trial period November 2006 30 March 2007.,G0000000|C0008976|C0439531|C3828767|G0000000|C0450371|C3829202|G0000000
Smokers in contemplation or pre-contemplation phase will be included in the study.,Smokers contemplation pre-contemplation phase included study.,C0337664|G0000000|C0332152|C0205390|C0332257|C0557651
Red Blood Cell (RBC) Docosahexaenoic Acid (DHA) Levels as a Function of Treatment Intervention Mean RBC DHA level as a percentage of total fatty acids vs time receiving placebo or DHA supplementation for participants in the modified intent-to-treat cohort.,Red Blood Cell (RBC) Docosahexaenoic Acid (DHA) Levels Function Treatment Intervention Mean RBC DHA level percentage total fatty acids time receiving placebo DHA supplementation participants modified intent-to-treat cohort.,C0332575|C0005767|C0007634|C0014792|G0000000|C0001128|C0142831|C0441889|C0031843|C0039798|C0886296|C0444504|C0014792|C0142831|C0441889|C0439165|C0439175|G0000000|C0001128|C0040223|C1514756|C0032042|C0142831|C0242297|C0679646|C0392747|C0162425|C0599755
Mean percent weight loss over time.,Mean percent weight loss time.,C0444504|C0439165|C0005910|C1517945|C0040223
"The sample consisted of more boys (61.4%) than girls, was dominantly of Hindu religion (81.0%), and children were between 9 and 12 years old (mean 11.03±1.05).","The sample consisted boys (61.4%) girls, dominantly Hindu religion (81.0%), children 9 12 (mean 11.03±1.05).",G0000000|C0370003|C0332529|C0870221|C0450371|C0870604|G0000000|C0019550|C0035039|C0450371|C0008059|G0000000|C0450371|C0444504|G0000000
"The inclusion criteria were an age between 5 and 10 years, the ability to follow verbal instructions, and the ability to walk independently indoors with or without walking aids (Gross Motor Function Classification; GMFCS levels I–III).","The inclusion criteria age 5 10 years, ability follow verbal instructions, ability walk independently indoors walking aids (Gross Motor Function Classification; GMFCS levels I–III).",G0000000|C0007637|C0243161|C0001779|G0000000|G0000000|C0085732|C0332283|C0439824|C0302828|C0085732|C0080331|G0000000|G0000000|C0080331|C0001175|C0439806|C1513492|C0031843|C0008902|G0000000|C0441889|G0000000
"Potential participants were excluded for illness or disorders (eg, history of cancer with a poor 7-year prognosis, major cardiovascular or cerebrovascular event within the last year, or hemachromatosis) that would make long-term follow-up or compliance with the study protocol unlikely or difficult.","Potential participants excluded illness disorders (eg, history cancer poor 7-year prognosis, major cardiovascular cerebrovascular event year, hemachromatosis) long-term follow-up compliance study protocol difficult.",C3245505|C0679646|C1554077|C0221423|C0012634|C0013715|C0019664|C0006826|C0032854|C0439234|C0033325|C0205082|C0007226|C1880018|C0441471|C0439234|C0018995|C0443252|C0589120|C0009563|C0557651|C0442711|C0332218
CRP <10 mg/l was achieved in 30% in the low LCT and 33% in the high LCT group (p=0.99).,CRP <10 mg/l achieved 30% low LCT 33% LCT (p=0.99).,C3890735|C0450371|C0439268|G0000000|C0450371|C0205251|C1416808|C0450371|C1416808|C0369773
Patients ≥6 months and ≥7 kg with uncomplicated P. vivax monoinfections were included.,Patients ≥6 months ≥7 uncomplicated P. vivax monoinfections included.,C0030705|G0000000|C0439231|G0000000|C0443334|C0369773|G0000000|G0000000|C0332257
Mean successful changes from baseline in low back pain (LBP) medication usage are depicted.,Mean successful baseline low pain (LBP) medication usage depicted.,C0444504|C0597535|C0168634|C0205251|C0030193|C1505993|C0013227|C0457083|G0000000
Both men and women presented at an advanced stage with very low median CD4 count and high plasma viral load.,Both women advanced stage low median CD4 count plasma viral load.,G0000000|C0043210|C0205179|C0205390|C0205251|C0549183|C0285590|C0750480|C0032105|C0521026|C1550025
"They are excluded if they have: (1) recurrent stroke, (2) other neurological, neuromuscular, orthopedic disease, or (3) shoulder or arm contracture/pain.","They excluded have: (1) recurrent stroke, (2) neurological, neuromuscular, orthopedic disease, (3) shoulder arm contracture/pain.",G0000000|C1554077|G0000000|G0000000|C2945760|C0038454|G0000000|C0205494|C1979768|C0029355|C0012634|G0000000|C0037004|C0446516|C0009917
"Overall, 1147 patients aged 15-60 years contacted their general practitioner because of an acute (seven days or less) sore throat.","Overall, 1147 patients aged 15-60 contacted practitioner acute (seven days less) sore throat.",C0282416|G0000000|C0030705|C0001779|C0450371|C0332158|C1709627|C0205178|C0205453|C0439228|C0439092|C0234233|C0031354
"Exclusion criteria were inability to provide informed consent; concomitant acute cardiac event; presence of musculoskeletal, neurological, or psychiatric comorbidities that would prevent the delivery of the rehabilitation intervention; and more than four emergency admissions to hospital for any cause in the previous 12 months.","Exclusion criteria inability provide informed consent; concomitant acute cardiac event; presence musculoskeletal, neurological, psychiatric comorbidities prevent delivery rehabilitation intervention; emergency admissions hospital previous 12 months.",C0680251|C0243161|G0000000|C1999230|C1522154|C1511481|C0521115|C0205178|C0018787|C0441471|C0150312|C0497254|C0205494|C0205487|C0009488|C0309872|C0011209|C0034991|C0886296|C0013956|C0184666|C0019994|C0205156|C0450371|C0439231
"We did look into operator experience as a factor, with a direct comparison between registrars (<6 years experience) and consultants (>6 years experience).","We operator experience factor, direct comparison registrars (<6 experience) consultants (>6 experience).",G0000000|C1705273|C0237607|C1521761|C0439851|C1707455|C0557514|G0000000|C0237607|C0009817|G0000000|C0237607
Baseline demographic and disease characteristics were similar in both study groups (Table 1).,Baseline demographic disease characteristics study (Table 1).,C0168634|C0011298|C0012634|C1521970|C0557651|C0039224|G0000000
"Almost all of the 820,000 people in the UK with dementia will experience Behavioural and Psychological Symptoms of Dementia (BPSD).","Almost 820,000 people UK dementia experience Behavioural Psychological Symptoms Dementia (BPSD).",C3828842|C1442061|C0027361|C0041700|C0011265|C0237607|C0004927|C0205486|C0683368|C0011265|G0000000
"Close contacts of SARS patients were defined as persons who shared meals, utensils, a residence, a hospital room, or a transportation vehicle with a suspected SARS patient or as persons who visited such a patient in a period beginning up to 14 days before the patient’s onset of symptoms.","Close contacts SARS patients defined persons shared meals, utensils, residence, hospital room, transportation vehicle suspected SARS patient persons visited patient period 14 days patient’s onset symptoms.",C0587267|C4036459|C1175175|C0030705|C1704788|C0027361|C0237876|C1998602|G0000000|C0237096|C0019994|C1547703|C0040756|C0042444|C0332147|C1175175|C0030705|C0027361|C0545082|C0030705|C0439531|C0450371|C0439228|G0000000|C0206132|C0683368
This quantitative cuff leak can be reported as either a percentage of inspired tidal volume or as an absolute cuff leak volume (CLV).,This quantitative cuff leak reported percentage inspired tidal volume absolute cuff leak volume (CLV).,G0000000|C0392762|C0441107|C0332234|C0684224|C0439165|C0004048|G0000000|C0449468|C0205344|C0441107|C0332234|C0449468|G0000000
"In the placebo group, 19 women were lost to follow-up, and 30 women discontinued treatment.8 Of those who discontinued treatment before day 14, the majority stopped their medications because their symptoms improved, and those were considered compliant.","In placebo group, 19 women lost follow-up, 30 women discontinued treatment.8 Of discontinued treatment day 14, majority stopped medications symptoms improved, considered compliant.",G0000000|C0032042|C0441833|C0450371|C0043210|C0745777|C0589120|C0450371|C0043210|C1444662|C0039798|G0000000|C1444662|C0039798|C0332173|C0450371|C0680220|C1272691|C0013227|C0683368|C0184511|C0750591|C0566588
"We excluded those with penicillin allergy, serious underlying disease, immunological deficiency, a valvular heart defect, major lesions in the mouth or nose, a grommet in the ear, or chronic otitis media.","We excluded penicillin allergy, underlying disease, immunological deficiency, valvular heart defect, major lesions mouth nose, grommet ear, chronic otitis media.",G0000000|C1554077|C0030827|C0002111|G0000000|C0012634|C0205470|C0011155|C0184252|C0018787|C1457869|C0205082|C0221198|C0226896|C0028429|C0850121|C0013443|C0205191|C0029877|C0009458
"198 Consecutive patients were enrolled and randomly assigned to receive either oral moidazolam (midazolam group, n=100) or chloral hydrate (chloral group, n=98).","198 Consecutive patients enrolled randomly assigned receive oral moidazolam (midazolam group, n=100) chloral hydrate (chloral group, n=98).",C1442061|C1707491|C0030705|G0000000|G0000000|C1516050|C1514756|C0442027|G0000000|C0026056|C0441833|C0369718|C0077034|C0720930|C0077034|C0441833|C0369718
Some patients preferred one surgical approach over the other for aesthetic reasons.,Some patients preferred surgical approach aesthetic reasons.,G0000000|C0030705|C0558295|C0543467|C0449445|C0014901|C0392360
"After providing signed consent, patient participants were asked to select a caregiver, defined as “someone who knows you well and is involved in your medical care,” to participate; however, patients were not excluded if they did not identify a caregiver.","After providing signed consent, patient participants select caregiver, defined “someone involved medical care,” participate; however, patients excluded identify caregiver.",G0000000|C1999230|C1519316|C1511481|C0030705|C0679646|C1707391|C0085537|C1704788|G0000000|C1314939|C0199168|G0000000|G0000000|G0000000|C0030705|C1554077|G0000000|C0085537
"In 2001, the Institute of Medicine documented the gap between recommended and actual practice of medicine in the United States (Institute of Medicine 2001).","In 2001, Institute Medicine documented gap recommended actual practice medicine United States (Institute Medicine 2001).",G0000000|G0000000|C0021622|C0013227|C1301725|C3887622|C0034866|C0237400|C0237607|C0013227|C0166872|C1301808|C0021622|C0013227|G0000000
"Women who had at least one pregnancy initiated by ART were classified as ART women, and women who had no registered ART pregnancies were classified as non-ART.","Women pregnancy initiated ART classified ART women, women registered ART pregnancies classified non-ART.",C0043210|C0032961|C1548602|C0003826|C0008902|C0003826|C0043210|C0043210|C1514821|C0003826|C0032961|C0008902|C1518422
"Survival in breast cancer is improving, mostly related to early diagnosis.","Survival breast cancer improving, diagnosis.",C0038952|C0006141|C0006826|C1272745|C0011900
Exclusion criteria were: pregnancy or lactation; severe clinical anaemia (<7g/dl); P. falciparum and/or P. vivax (mixed infections); intake of any antimalarial drug in the 2 weeks prior to consultation; patients unavailable for the duration of follow up (11 months); patients with concomitant infections or disease likely to mask treatment response.,Exclusion criteria were: pregnancy lactation; severe clinical anaemia (<7g/dl); P. falciparum and/or P. vivax (mixed infections); intake antimalarial drug 2 weeks prior consultation; patients unavailable duration follow (11 months); patients concomitant infections disease mask treatment response.,C0680251|C0243161|G0000000|C0032961|C0006147|C0205082|C0205210|C0002871|C0017209|C0369773|G0000000|G0000000|C0369773|G0000000|C0205430|C3714514|C1512806|C0003374|C0013227|G0000000|C0439230|C0332152|C0009818|C0030705|C0686905|C0449238|C0332283|C0450371|C0439231|C0030705|C0521115|C3714514|C0012634|C0024861|C0039798|C0871261
Mothers may incorrectly assume that they are no longer needed in the care of their hospitalized baby.,Mothers incorrectly assume care hospitalized baby.,C0026591|G0000000|G0000000|C1947933|C0701159|C0021270
Eligible patients were at least 40 years of age with a qualifying ischemic stroke or TIA within 6 months prior to randomization.,Eligible patients 40 age qualifying ischemic stroke TIA 6 months prior randomization.,C1548635|C0030705|C0450371|C0001779|C1514624|C0475224|C0038454|C0007787|G0000000|C0439231|C0332152|C0034656
Twenty facilities were involved in the trial; 10 hostels (low level facilities) and 10 nursing homes (high level facilities).,Twenty facilities involved trial; 10 hostels (low level facilities) 10 nursing homes (high level facilities).,C0724000|C1547538|C1314939|C0008976|C0450371|C0442518|C0205251|C0441889|C1547538|C0450371|C0006147|C0442519|C0205250|C0441889|C1547538
"Because we were interested in targeting women with low fish consumption for the parent RCT, whose goal was to increase intake of DHA from fish, we included only women who reported consuming fish up to 2 times per month, but who had no contraindications to fish consumption such as allergy, or self-restrictions such as vegetarian diet.","Because targeting women low fish consumption parent RCT, goal increase intake DHA fish, included women reported consuming fish 2 times month, contraindications fish consumption allergy, self-restrictions vegetarian diet.",G0000000|C1521840|C0043210|C0205251|C0016163|C0009830|C0030551|G0000000|C0018017|C0442805|C1512806|C0142831|C0016163|C0332257|C0043210|C0684224|G0000000|C0016163|G0000000|C0040223|C0332177|C0079164|C0016163|C0009830|C0002111|C0036588|C0042441|C0012155
Funded by the National Institute for Neurological Disorders and Stroke (R01NS040808).,Funded National Institute Neurological Disorders Stroke (R01NS040808).,C0016820|C3245503|C0021622|C0205494|C0012634|C0038454|G0000000
"Participants were enrolled between 2 and 24 months post surgery, chemotherapy and/or radiation therapy.","Participants enrolled 2 24 months post surgery, chemotherapy and/or radiation therapy.",C0679646|G0000000|G0000000|C0450371|C0439231|C0687676|C0038894|C0013216|G0000000|C0034519|C0039798
"Between July 2009 and March 2010, 140 adult patients with gallbladder pathologies were enrolled in this multicentre study.","Between July 2009 March 2010, 140 adult patients gallbladder pathologies enrolled multicentre study.",G0000000|C3829447|G0000000|C3829202|G0000000|C1442061|C0001675|C0030705|C0016976|C0030664|G0000000|C0439743|C0557651
"Patients were recruited from three university hospitals of TUMS in Tehran, Iran.","Patients recruited university hospitals TUMS Tehran, Iran.",C0030705|G0000000|C0041740|C0019994|C0723950|G0000000|C0022065
"In the RCT of mild to moderate cardiac iron loading, combination treatment improved RV function significantly more than deferoxamine alone.","In RCT mild moderate cardiac iron loading, combination treatment improved RV function deferoxamine alone.",G0000000|G0000000|C2945599|C0205081|C0018787|C0302583|C1708715|C0205195|C0039798|C0184511|C0035190|C0031843|C0011145|C0205171
"Viral pathogens were isolated from 6/94 (6.4%) in the surgical mask group, 8/92 (8.7%) in the P2 group, and 3/100 (3.0%) in the control group.","Viral pathogens isolated 6/94 (6.4%) surgical mask group, 8/92 (8.7%) P2 group, 3/100 (3.0%) control group.",C0521026|C0450254|C0205409|C0450371|G0000000|C0543467|C0024861|C0441833|C0450371|G0000000|C0332132|C0441833|C1442061|G0000000|C0243148|C0441833
"Thirty kidney transplant patients from a tertiary care transplant center located in the Midwestern United States meeting the following criteria were included: (i) 21 yr of age or older, (ii) prescribed at least one, twice daily prescribed, immunosuppressive medication, (iii) non-adherent with immunosuppressive medication as evidenced by a medication non-adherence score of <0.85, (iv) functioning kidney transplant, (v) transplant physician and nephrologists’ assent that recipient is able to participate in the study, (vi) ability to speak, hear, and understand English, (vii) able to open an electronic medication cap, (viii) administers immunosuppressive medications to self, (ix) has a telephone or has access to a telephone, (x) no cognitive impairment, (xi) no other diagnoses that may shorten life span, such as metastatic cancer, as determined by the transplant physician or nephrologists’ statement that life will be shortened by the diagnosis.","Thirty kidney transplant patients tertiary care transplant center located Midwestern United States meeting criteria included: (i) 21 yr age older, (ii) prescribed one, daily prescribed, immunosuppressive medication, (iii) non-adherent immunosuppressive medication evidenced medication non-adherence score <0.85, (iv) functioning kidney transplant, (v) transplant physician nephrologists’ assent recipient participate study, (vi) ability speak, hear, understand English, (vii) electronic medication cap, (viii) administers immunosuppressive medications self, (ix) telephone access telephone, (x) cognitive impairment, (xi) diagnoses shorten life span, metastatic cancer, determined transplant physician nephrologists’ statement life shortened diagnosis.",C3816446|C0022646|C0040732|C0030705|C0205372|C1947933|C0040732|C0205099|G0000000|G0000000|C0166872|C1301808|C0556656|C0243161|C0332257|C0021966|C0450371|C0439234|C0001779|C0580836|G0000000|C0278329|C0205447|C0332173|C0278329|C0021081|C0013227|C0439070|C1518422|C0021081|C0013227|C3887511|C0013227|C1518422|C0449820|C0450371|C0022326|C0205245|C0022646|C0040732|G0000000|C0040732|C0031831|G0000000|C1879749|C1709854|G0000000|C0557651|C0205999|C0085732|C0234856|C0018767|C0162340|C0376245|C0445385|C0013850|C0013227|C0179586|C0445599|C1621583|C0021081|C0013227|C0036588|C0015491|C0039457|C0444454|C0039457|G0000000|C1516691|C0221099|C1720296|C0011900|C0441636|C0376558|C1711300|C0036525|C0006826|G0000000|C0040732|C0031831|G0000000|C1710187|C0376558|C1282927|C0011900
"Patients were excluded from the study if they were pregnant, were immunosuppressed, or had known neoplasia, renal insufficiency in dialysis, HIV infection, hypogammaglobulinaemia, or anatomical or functional asplenia.","Patients excluded study pregnant, immunosuppressed, neoplasia, renal insufficiency dialysis, HIV infection, hypogammaglobulinaemia, anatomical functional asplenia.",C0030705|C1554077|C0557651|C0549206|C0085393|C0027651|C0022646|C0231179|C0011945|C0019682|C0009450|C0086438|C0220784|C0205245|C0600031
"Parents of all sixth grade students were invited to participate in the study, and 80% of all parents agreed to do so.","Parents sixth grade students invited participate study, 80% parents agreed so.",C0030551|C0205440|C0441800|C0038492|G0000000|G0000000|C0557651|C0450371|C0030551|C3641827|C0037640
"Previous adjuvant (and/or neoadjuvant) chemotherapy was allowed, provided a period of 12 months had elapsed since the end of therapy and first relapse.","Previous adjuvant (and/or neoadjuvant) chemotherapy allowed, provided period 12 months elapsed therapy relapse.",C0205156|C0001551|G0000000|C0600558|C0013216|C0683607|C1999230|C0439531|C0450371|C0439231|C1707889|C0039798|C0035020
"Gestational weeks in vaccinated and unvaccinated study groups, stratified by patient age The numbers of gravidities in the vaccinated group and the unvaccinated group were stratified by age, as shown in Table 2.","Gestational weeks vaccinated unvaccinated study groups, stratified patient age The gravidities vaccinated unvaccinated stratified age, Table 2.",C0439671|C0439230|C1116171|G0000000|C0557651|C0441833|C0205363|C0030705|C0001779|G0000000|C0600457|C1116171|G0000000|C0205363|C0001779|C0039224|G0000000
Migraine without aura patients were included in this study.,Migraine aura patients included study.,C0149931|C0236018|C0030705|C0332257|C0557651
"Exclusion criteria were: having no stable home or regular access to a telephone; history of diagnosis of schizophrenia; evidence of bipolar disorder, psychosis, or suicidal intent, or current (within the past month) alcohol or drug dependence on Mini International Neuropsychiatric Interview (MINI);45 currently receiving or planning to start evidence-based psychotherapy for depression within the 16-week study period (other forms of counseling such as rehabilitation counseling were permitted); antidepressant initiation within 6 weeks or dosage adjustment within 4 weeks prior to randomization, or planning to start an antidepressant within the 16 week intervention period; or severe cognitive impairment as defined by significant impairment on two or more of the following tests administered via telephone – Digit Span (cutoff below the lower 5th percentile),46 or the Hopkins Verbal Learning Test (HVLT),47 or Oral Trail Making Test (TMT) A and B48 (cutoff below the lower 1st percentile).","Exclusion criteria were: stable regular access telephone; history diagnosis schizophrenia; evidence bipolar disorder, psychosis, suicidal intent, current (within month) alcohol drug dependence Mini International Neuropsychiatric Interview (MINI);45 receiving planning start evidence-based psychotherapy depression 16-week study period (other forms counseling rehabilitation counseling permitted); antidepressant initiation 6 weeks dosage adjustment 4 weeks prior randomization, planning start antidepressant 16 week intervention period; severe cognitive impairment defined impairment tests administered telephone – Digit Span (cutoff lower 5th percentile),46 Hopkins Verbal Learning Test (HVLT),47 Oral Trail Making Test (TMT) A B48 (cutoff lower 1st percentile).",C0680251|C0243161|G0000000|C0205360|C0205272|C0444454|C0039457|C0019664|C0011900|C0036341|C3887511|C0443156|C0012634|C0033975|C0438696|C0162425|C0521116|G0000000|C0332177|C0001962|C0013227|C0011546|C0445542|C1512888|G0000000|C0021822|C0445542|C1514756|C0032074|C0439659|C3887511|C0033968|C0011570|C0450371|C0557651|C0439531|G0000000|C0348078|C0010210|C0034991|C0010210|C0329040|C0003289|C0589507|G0000000|C0439230|C0178602|C0376209|G0000000|C0439230|C0332152|C0034656|C0032074|C0439659|C0003289|C0450371|C0332174|C0886296|C0439531|C0205082|C1516691|C0221099|C1704788|C0221099|C0022885|C1521801|C0039457|G0000000|C0582802|C1711300|C1442160|C0441994|G0000000|C1264641|G0000000|C0439824|C0013621|C0022885|C0450371|C0442027|C1143949|C1881534|C0022885|C0040604|G0000000|G0000000|C1442160|C0441994|G0000000|C1264641
Participants recruited between November 1997 and December 2006 were included in the study.,Participants recruited November 1997 December 2006 included study.,C0679646|G0000000|C3828767|G0000000|C3830550|G0000000|C0332257|C0557651
"Objective—To evaluate the feasibility, acceptability, and effectiveness of an injury prevention program delivered by school based home visitors to the families of low income children attending preschool enrichment programs in Washington State.","Objective—To evaluate feasibility, acceptability, effectiveness injury prevention program delivered school based visitors families low income children attending preschool enrichment programs Washington State.",G0000000|C0220825|G0000000|C0814633|C1280519|C3263722|C0199176|C1709697|C1705822|C0036375|C1527178|G0000000|C0015576|C0205251|C0021162|C0008059|C1547429|C0424930|G0000000|C0376691|C0043038|C1301808
"• In septic shock, continuous hydrocortisone infusion will reduce the number of hyperglycemic episodes during intensive insulin therapy.","• In septic shock, continuous hydrocortisone infusion reduce hyperglycemic episodes intensive insulin therapy.",G0000000|G0000000|C0333534|C0036974|C0549178|C0020268|C0574032|G0000000|G0000000|C0332189|C0162425|C0021641|C0039798
"To reduce the risk of bias, patients with symptoms suggestive of an acute respiratory infection were initially recruited by a research assistant in the waiting room before consultation with a physician.","To reduce risk bias, patients symptoms suggestive acute respiratory infection initially recruited assistant waiting consultation physician.",C0040363|G0000000|C0035647|C0242568|C0030705|C0683368|C0332299|C0205178|C0521346|C0009450|C0205265|G0000000|C0011327|C1610166|C0009818|C0031831
Moreover our eligibility criteria required two or more antibiotic-treated UTIs in the previous 12 months so it was reasonable to expect that without prophylaxis most women would experience a recurrence within 6 months.,Moreover eligibility criteria required antibiotic-treated UTIs previous 12 months reasonable expect prophylaxis women experience recurrence 6 months.,G0000000|C0013893|C0243161|C1514873|C0003232|C0042029|C0205156|C0450371|C0439231|G0000000|G0000000|C0033107|C0043210|C0237607|C0034897|G0000000|C0439231
"Given the deleterious effects of acute exacerbations of COPD with respect to the risk of death, quality of life, loss of lung function, and cost of care, adding azithromycin to the treatment regimen of patients who have had an acute exacerbation of COPD within the previous year or who require supplemental oxygen is a valuable option; however, the patients should be screened for the presence of QTc prolongation and the risk of QTc prolongation and their hearing should be monitored.","Given deleterious effects acute exacerbations COPD respect risk death, quality life, loss lung function, cost care, adding azithromycin treatment regimen patients acute exacerbation COPD previous require supplemental oxygen valuable option; however, patients screened presence QTc prolongation risk QTc prolongation hearing monitored.",C1442162|G0000000|C1280500|C0205178|G0000000|C0024117|C0679133|C0035647|C0011065|C0332306|C0376558|C1517945|C0024109|C0031843|C0010186|C1947933|C1883712|C0052796|C0039798|C0040808|C0030705|C0205178|G0000000|C0024117|C0205156|G0000000|C2348609|C0030054|G0000000|C1518601|G0000000|C0030705|C0220908|C0150312|G0000000|C0439590|C0035647|G0000000|C0439590|C0018767|C0030695
The last limitation of our study concerns the inhomogeneous age of patients included in the study (7 to 18 years).,The limitation study concerns inhomogeneous age patients included study (7 18 years).,G0000000|C0449295|C0557651|C2699424|G0000000|C0001779|C0030705|C0332257|C0557651|G0000000|C0450371|C0439234
"Even in places where ocular chlamydial infection has been reduced, the risk of trichiasis and blindness persists.","Even ocular chlamydial infection reduced, risk trichiasis blindness persists.",G0000000|C0015392|C0008148|C0009450|C0392756|C0035647|C0221259|C0456909|G0000000
The overall median gestational age was 33 (range 29–36) weeks.,The median gestational age 33 (range 29–36) weeks.,G0000000|C0549183|C0439671|C0001779|C0450371|C1514721|G0000000|C0439230
Inclusion and exclusion criteria are verified and it is decided for each patient whether the study drug can be administered within 7 days after the onset of ischemic stroke.,Inclusion exclusion criteria verified decided patient study drug administered 7 days onset ischemic stroke.,C0007637|C0680251|C0243161|C1711411|G0000000|C0030705|C0557651|C0013227|C1521801|G0000000|C0206132|C0475224|C0038454
"Participants were enrolled at the Moffitt Cancer Center, James A. Haley VA Hospital, Tampa and University of Florida, Jacksonville, Florida from September 2008 to March 2013.","Participants enrolled Moffitt Cancer Center, James A. Haley VA Hospital, Tampa University Florida, Jacksonville, Florida September 2008 March 2013.",C0679646|G0000000|G0000000|C0006826|C0205099|G0000000|G0000000|G0000000|C1549054|C0019994|G0000000|C0041740|C0016253|G0000000|C0016253|C3828193|G0000000|C3829202|G0000000
"Exclusion criteria included recent changes to medications, T1D, using steroids or, taking antibiotics currently or within the previous 2 months.","Exclusion criteria included medications, T1D, steroids or, antibiotics previous 2 months.",C0680251|C0243161|C0332257|C0013227|G0000000|C0038317|G0000000|C0003232|C0205156|G0000000
"Of the 90 patients evaluated, 55 (61.1%) were male.","Of 90 patients evaluated, 55 (61.1%) male.",G0000000|C0450371|C0030705|C0220825|C0450371|C0450371|C0086582
Their mean age was 80 years.,Their age 80 years.,G0000000|C0001779|G0000000
"In 2004, a total of 1024 subjects, randomly selected from 12 villages of Linqu County (Shandong Province, China), participated in this study.","In 2004, total 1024 subjects, randomly selected 12 villages Linqu County (Shandong Province, China), participated study.",G0000000|G0000000|C0439175|G0000000|C0681850|G0000000|C1707391|C0450371|C0562518|G0000000|C0079170|G0000000|C1514578|C0008115|G0000000|C0557651
"Data displayed compare DNA methylation quantified using the Illumina Infinium 450K array, with genomic DNA templates isolated from: (a) maternal leukocytes at time of birth, (b) maternal leukocytes at 4–6 weeks postpartum, and (c) infant leukocytes at 4–6 weeks of life.","Data displayed compare DNA methylation quantified Illumina Infinium 450K array, genomic DNA templates isolated from: (a) maternal leukocytes time birth, (b) maternal leukocytes 4–6 weeks postpartum, (c) infant leukocytes 4–6 weeks life.",C1511726|C0870432|C1707455|C0012854|C0025723|C1709793|G0000000|G0000000|G0000000|C1510941|C0017428|C0012854|C0728990|C0205409|G0000000|G0000000|C2347083|C0023516|C0040223|C0005615|G0000000|C2347083|C0023516|G0000000|C0439230|C0086839|G0000000|C0021270|C0023516|G0000000|C0439230|C0376558
"Furthermore, there are few high-quality clinical studies and no internationally accepted standard treatment regimen for patients with gastric cancer in China, which accounts for the 47 % of global new gastric cancer cases [1, 2].","Furthermore, high-quality clinical studies internationally accepted standard treatment regimen patients gastric cancer China, accounts 47 % global gastric cancer [1, 2].",G0000000|C0205250|C0205210|C0947630|G0000000|C1272684|C1442989|C0039798|C0040808|C0030705|C0038351|C0006826|C0008115|C2741673|C0450371|G0000000|C0205246|C0038351|C0006826|G0000000|G0000000
"The two groups were similar in terms of age, educational level, age at marriage, marriage duration, age at first pregnancy, obstetric status, menstrual status, contraception methods, and health status.","The terms age, educational level, age marriage, marriage duration, age pregnancy, obstetric status, menstrual status, contraception methods, health status.",G0000000|C0233324|C0001779|C0587721|C0441889|C0001779|C0024841|C0024841|C0449238|C0001779|C0032961|C0205484|C0449438|C0025344|C0449438|C0700589|C0025663|C0018684|C0449438
"Thirty-six patients at the end of the double-blind phase (28 budesonide, 8 placebo) entered the follow-up phase.","Thirty-six patients double-blind phase (28 budesonide, 8 placebo) entered follow-up phase.",C3816446|C0030705|C0013072|C0205390|C0450371|C0054201|G0000000|C0032042|C1521975|C0589120|C0205390
The primary analysis is aimed at evaluation of the primary outcome of this study: the incidence of in-hospital delirium according to the DSM-IV criteria in older at-risk patients aged 70 years or over who are acutely admitted through the ED for a general medicine or surgical specialty within seven days of initiation of the study intervention.,The primary analysis aimed evaluation primary outcome study: incidence in-hospital delirium DSM-IV criteria at-risk patients aged 70 acutely admitted ED medicine surgical specialty days initiation study intervention.,G0000000|C0205225|C0002778|C1947946|C0220825|C0205225|C1274040|C0557651|C0021149|C0019994|C0011206|C0220952|C0243161|C1444641|C0030705|C0001779|C0450371|G0000000|C0184666|C3538926|C0013227|C0543467|C0037778|C0439228|C0589507|C0557651|C0886296
8352 students in year 9 (age 13-14 years) at those schools.,8352 students 9 (age 13-14 years) schools.,G0000000|C0038492|G0000000|C0001779|C0450371|C0439234|C0036375
"Inclusion criteria included age ≥18 years, enrollment in the Hopi Tribe, residence on the reservation, and being a mother or female legal guardian of a girl aged 9–12 years.","Inclusion criteria included age ≥18 years, enrollment Hopi Tribe, residence reservation, mother female legal guardian girl aged 9–12 years.",C0007637|C0243161|C0332257|C0001779|G0000000|C0439234|C1516879|C0574606|C0885860|C0237096|C1514889|C0026591|C0015780|C1301860|C0023226|C0870604|C0001779|G0000000|C0439234
Extracranial progressions were reported in 115 (64%) of 179 patients in the OBS arm and 119 (66%) of 180 in the WBRT arm.,Extracranial progressions reported 115 (64%) 179 patients OBS arm 119 (66%) 180 WBRT arm.,C0580586|C0242656|C0684224|C1442061|C0450371|C1442061|C0030705|C2986870|C0446516|C1442061|C0450371|C1442061|C1520143|C0446516
Study participants with pericardial effusions amenable to pericardiocentesis underwent aspiration until dryness.,Study participants pericardial effusions amenable pericardiocentesis underwent aspiration dryness.,C0557651|C0679646|C0031050|C0013687|C3900053|C0191234|G0000000|C0220787|C1512080
"8,000 adult smokers in China who use Nokia Life Tools and participated in Phase II (smoking education via text message) of the study.","8,000 adult smokers China Nokia Life Tools participated Phase II (smoking education text message) study.",C1442061|C0001675|C0337664|C0008115|G0000000|C0376558|C0336791|G0000000|C0205390|G0000000|C0037369|C0013621|C1527021|C0470166|C0557651
"Using this design, all participants received qigong training.","Using design, participants received qigong training.",C1524063|C1707689|C0679646|C1514756|C0282077|C0040607
"Study patients aged 1 to 45 years were diagnosed from July 2008 to February 2016 with either B-cell precursor (BCP-) or T-cell (T-) ALL and treated according to the NOPHO ALL2008 protocol in Denmark, Estonia, Finland, Iceland, Lithuania, Norway, and Sweden.","Study patients aged 1 45 diagnosed July 2008 February 2016 B-cell precursor (BCP-) T-cell (T-) ALL treated NOPHO ALL2008 protocol Denmark, Estonia, Finland, Iceland, Lithuania, Norway, Sweden.",C0557651|C0030705|C0001779|G0000000|C0450371|C0011900|C3829447|G0000000|C3830166|G0000000|C0004561|C1709634|G0000000|C0039194|C2603360|C0444868|C1522326|G0000000|G0000000|C0442711|C0011318|C0014908|C0016132|C0020750|C0023879|C0028423|C0038995
"Of the 340 subjects in the intention-to-treat population, 229 received the vaccine and 111 the placebo.","Of 340 subjects intention-to-treat population, 229 received vaccine 111 placebo.",G0000000|C1442061|C0681850|C0162425|C0032659|C1442061|C1514756|C0042210|C1442061|C0032042
"After the initial 4 weeks of nasal spray the VAS for leg pain improved by 10 mm in the calcitonin group and 0 mm in the placebo group, a difference which is not statistically significant (P = 0.51).","After initial 4 weeks nasal spray VAS leg pain improved 10 mm calcitonin 0 mm placebo group, difference statistically (P = 0.51).",G0000000|C0205265|G0000000|C0439230|C0028429|C1704413|C0042815|C0023216|C0030193|C0184511|C0450371|G0000000|C0006668|G0000000|G0000000|C0032042|C0441833|C1705241|C0038215|C0369773|G0000000|C0450371
We designed a prospective randomized controlled trial to compare above- and below-elbow casts for patients of distal forearm fracture aged 4–12 years.,We designed prospective randomized controlled trial compare above- below-elbow casts patients distal forearm fracture aged 4–12 years.,G0000000|C1707689|C0023981|C0034656|C2587213|C0008976|C1707455|C1282910|C0013769|C0179686|C0030705|C0205108|C0016536|C0016658|C0001779|G0000000|C0439234
"According to the Rome II definitions, four patients were constipation predominant, five were diarrhoea predominant, and all of the remaining patients had alternating bowel habits.","According Rome II definitions, patients constipation predominant, diarrhoea predominant, remaining patients alternating bowel habits.",C0680240|C0035831|G0000000|C1550452|C0030705|C0009806|C1542147|C0011991|C1542147|C1527428|C0030705|C0332270|C0021853|C0018464
gambiae s.s. (100% M molecular form) from Cotonou (and not from Akron) were released into the huts.,gambiae s.s. (100% M molecular form) Cotonou (and Akron) released huts.,G0000000|C0565930|C1442061|C0369637|C1521991|C0348078|G0000000|G0000000|G0000000|C0391871|G0000000
"Inclusion criteria: 18–80 years of age; either (1) ocular surface disease index (OSDI) ≥20 and tear film break‐up time (TBUT) <10 seconds, or (2) OSDI ≥20 and positive ocular (corneal and conjunctival) staining pattern by Oxford grading; body weight ≥45 kg; under stable topical and/or systemic therapy for ≥4 weeks before study procedures and ability to abstain from other therapies during study; and ability and willingness to self‐administer eye drops (Bron et al.","Inclusion criteria: 18–80 age; (1) ocular surface disease (OSDI) ≥20 tear film break‐up time (TBUT) <10 seconds, (2) OSDI ≥20 positive ocular (corneal conjunctival) staining pattern Oxford grading; body weight ≥45 kg; stable topical and/or systemic therapy ≥4 weeks study procedures ability abstain therapies study; ability willingness self‐administer eye drops (Bron al.",C0007637|C0243161|G0000000|C0001779|G0000000|C0015392|C0205148|C0012634|C3896641|G0000000|C0039409|C0086296|G0000000|C0040223|G0000000|C0450371|C0457385|G0000000|C3896641|G0000000|C0439178|C0015392|C0010031|C0009758|C0487602|C0449774|G0000000|C0441800|C0242821|C0005910|G0000000|C0022718|C0205360|C0332237|G0000000|C0205373|C0039798|G0000000|C0439230|C0557651|C0025664|C0085732|G0000000|C0087111|C0557651|C0085732|C0600109|G0000000|C0015392|C0991568|G0000000|C0202311
"We conducted a prospective, randomized, double-blinded, placebo-controlled study on new and relapsing cases of PR attending the skin outpatient department of a tertiary care hospital.","We conducted prospective, randomized, double-blinded, placebo-controlled study relapsing PR attending skin outpatient department tertiary care hospital.",G0000000|C0004927|C0023981|C0034656|C0205173|C1706408|C0557651|C0035020|C0279759|C1547429|C0444099|C0029921|C1704729|C0205372|C1947933|C0019994
Children with moderate wasting according to the WHO's current standards (WHZ < −2 but ≥ −3) and with a good appetite were eligible for the study.,Children moderate wasting WHO's current standards (WHZ < −2 ≥ −3) appetite eligible study.,C0008059|C0205081|C0006625|G0000000|C0521116|C0038137|G0000000|G0000000|G0000000|G0000000|G0000000|C0003618|C1548635|C0557651
"Inclusion criteria were: current stroke, age >55, fall risk assessed through clinical observations by an experienced PT, the ability to walk 10 m with or without a walking device, and the ability to understand and comply with instructions in Swedish.","Inclusion criteria were: current stroke, age >55, fall risk assessed clinical observations experienced PT, ability walk 10 walking device, ability understand comply instructions Swedish.",C0007637|C0243161|G0000000|C0521116|C0038454|C0001779|C0450371|C0085639|C0035647|C1516048|C0205210|C0302523|C0237607|C0699718|C0085732|C0080331|C0450371|C0080331|C0025080|C0085732|C0162340|C0725694|C0302828|C1710263
"Patients with the following criteria excluded from the study: Failure of the patient to attend follow-up sessions for any reason, and adoption of other supplementary therapies during the study.","Patients criteria excluded study: Failure patient attend follow-up sessions reason, adoption supplementary therapies study.",C0030705|C0243161|C1554077|C0557651|C0231174|C0030705|C1999232|C0589120|C1883016|C0392360|C0001593|G0000000|C0087111|C0557651
A single semi-rural practice in the southwest of England.,A single semi-rural practice southwest England.,G0000000|C0037179|C0240919|C0237607|C1710136|C0014282
Thirty practices agreed to take part and details of the recruitment of 18 of the practices have been described earlier.19 The practices were asked to carry out a search of their database for patients aged 60 years and over who had been given a repeat prescription of quinine for night cramps in the previous 3 months.,Thirty practices agreed details recruitment 18 practices earlier.19 The practices carry search database patients aged 60 repeat prescription quinine night cramps previous 3 months.,C3816446|C0237607|C3641827|C1522508|C2949735|C0450371|C0237607|C1279919|G0000000|C0237607|C0206243|C1552603|C0242356|C0030705|C0001779|C0450371|C0205341|C0033080|C0034417|C0240526|C0026821|C0205156|G0000000|C0439231
"Individuals were also excluded if they anticipated any of the following during study participation: 1) moving residence outside local area, 2) changes in usual medications, 3) elective surgery, or 4) travel outside local area during the first 4 weeks of the intervention or for > 1 week during the last 8 weeks of the intervention.","Individuals excluded anticipated study participation: 1) moving residence local area, 2) usual medications, 3) elective surgery, 4) travel local 4 weeks intervention > 1 week 8 weeks intervention.",C0027361|C1554077|C3840775|C0557651|C0679823|G0000000|C0560560|C0237096|C0205276|C0017446|G0000000|C3538928|C0013227|G0000000|C0206058|C0038894|G0000000|C0040802|C0205276|G0000000|C0439230|C0886296|G0000000|G0000000|C0332174|G0000000|C0439230|C0886296
"Those with P. falciparum (>1,000 asexual parasites/µl whole blood) or P. vivax (>250/µl) were eligible if (i) there were no features of severity [18], (ii) they had not taken a study drug in the previous 14 d, (iii) there was no history of allergy to study drugs, and (iv) there was no evidence of another infection or co-morbidity.","Those P. falciparum (>1,000 asexual parasites/µl blood) P. vivax (>250/µl) eligible (i) features severity [18], (ii) study drug previous 14 d, (iii) history allergy study drugs, (iv) evidence infection co-morbidity.",G0000000|C0369773|G0000000|C1442061|C0599655|G0000000|C0005767|C0369773|G0000000|G0000000|C1548635|C0021966|C1521970|C0439793|C0450371|G0000000|C0557651|C0013227|C0205156|C0450371|C0073187|C0439070|C0019664|C0002111|C0557651|C0013227|C0022326|C3887511|C0009450|C0009488
"For each experiment, the volunteer donned 2 pairs of gloves with the “under glove” simulating HCW hands and “top glove” simulating actual glove use in the clinical setting.","For experiment, volunteer donned 2 pairs gloves “under glove” simulating HCW hands “top glove” simulating actual glove clinical setting.",G0000000|C0681814|C0042960|C0012020|G0000000|C1709450|C0206069|G0000000|G0000000|C0284447|G0000000|C0018563|G0000000|G0000000|C0284447|C0237400|C0206069|C0205210|C0542559
Baseline characteristics were recorded at the study enrollment.,Baseline characteristics recorded study enrollment.,C0168634|C1521970|C0034869|C0557651|C1516879
"After surgery, changes were assigned to the surgical group, with follow-up measured from the date of surgery.","After surgery, assigned surgical group, follow-up measured surgery.",G0000000|C0038894|C1516050|C0543467|C0441833|C0589120|C0444706|C0038894
"Participants were excluded if they had cancer treatment (other than endocrine therapy for breast cancer) in the prior 3 months, were enrolled in hospice care, had severe hearing impairment, were experiencing severe depression (PHQ-8 ≥ 20), had previously participated in a mindfulness meditation class, or did not understand English.","Participants excluded cancer treatment (other endocrine therapy breast cancer) prior 3 months, enrolled hospice care, severe hearing impairment, experiencing severe depression (PHQ-8 ≥ 20), participated mindfulness meditation class, understand English.",C0679646|C1554077|C0006826|C0039798|G0000000|C0014136|C0039798|C0006141|C0006826|C0332152|G0000000|C0439231|G0000000|C0019947|C1947933|C0205082|C0018767|C0221099|C0237607|C0205082|C0011570|C1879301|G0000000|C0450371|G0000000|C0086045|C0150277|C0456387|C0162340|C0376245
Participants were then encouraged to continue self-practice for six months.,Participants encouraged continue self-practice months.,C0679646|G0000000|C0549178|C0036588|C0439231
"The primary cancer was colorectal (31), gynaecologic cancer (19), melanoma (16) and others (13).","The primary cancer colorectal (31), gynaecologic cancer (19), melanoma (16) (13).",G0000000|C0205225|C0006826|C0555952|C0450371|C0205480|C0006826|C0450371|C0025202|C0450371|C0450371
"The exclusion criteria were: (i) the use of any pharmacological or physical intervention that could modify temperature within the previous 6 hours or clinician intent to modify body temperature using any pharmacological or physical intervention; (ii) body temperature < 36°C or > 38.9°C; (iii) pre-specified risk factors for paracetamol toxicity (S1 Table) (iv) TBI not expected to require intensive care management for 72 hours after randomisation; (v) GCS of 3 with fixed dilated pupils, or moribund patient expected to die within 24 hours; (vi) confirmed or suspected pregnancy.","The exclusion criteria were: (i) pharmacological physical intervention modify temperature previous 6 hours clinician intent modify body temperature pharmacological physical intervention; (ii) body temperature < 36°C > 38.9°C; (iii) pre-specified risk factors paracetamol toxicity (S1 Table) (iv) TBI expected require intensive care management 72 hours randomisation; (v) GCS 3 fixed dilated pupils, moribund patient expected die 24 hours; (vi) confirmed suspected pregnancy.",G0000000|C0680251|C0243161|G0000000|C0021966|C0031330|C0031809|C0886296|C0392747|C0005903|C0205156|G0000000|C0439227|C0871685|C0162425|C0392747|C0242821|C0005903|C0031330|C0031809|C0886296|G0000000|C0242821|C0005903|G0000000|G0000000|G0000000|G0000000|C0439070|C2826245|C0035647|C1521761|C0000970|C0040539|C1519428|C0039224|C0022326|C0876926|C1517001|G0000000|C0162425|C1947933|C0001554|C0450371|C0439227|C0034656|G0000000|G0000000|G0000000|C0443218|C0700124|C0034121|C0424547|C0030705|C1517001|C0011065|C0450371|C0439227|C0205999|C0521093|C0332147|C0032961
Patients meeting eligibility criteria (Table 1) will be informed in detail and written consent of the legal representative to participate in the trial will be obtained prior to inclusion.,Patients meeting eligibility criteria (Table 1) informed detail written consent legal representative participate trial prior inclusion.,C0030705|C0556656|C0013893|C0243161|C0039224|G0000000|C1522154|C1522508|C0043266|C1511481|C1301860|C1882932|G0000000|C0008976|C0332152|C0007637
"Eligible fellows were first, second, or third-year fellows in Pediatric Cardiology, Critical Care, Hematology/Oncology, or Neonatal-Perinatal Medicine (Fig.","Eligible fellows first, second, third-year fellows Pediatric Cardiology, Critical Care, Hematology/Oncology, Neonatal-Perinatal Medicine (Fig.",C1548635|G0000000|C0205435|C0205436|C0205437|G0000000|C0030755|C0007189|C1511545|C1947933|C1441600|C1552240|C0013227|C0349966
"Earlier breast cancer diagnoses, treatment advances such as breast-conserving surgery, new chemotherapeutic agents, hormone therapies, and biologic therapy have, at least in part, altered the meaning and psychological impact of a diagnosis of breast cancer.","Earlier breast cancer diagnoses, treatment advances breast-conserving surgery, chemotherapeutic agents, hormone therapies, biologic therapy have, part, altered meaning psychological impact diagnosis breast cancer.",C1279919|C0006141|C0006826|C0011900|C0039798|C0725066|C0006141|C0038894|C0013216|C0450442|C0019932|C0087111|C0005515|C0039798|G0000000|C0449719|C0392747|C0876919|C0205486|C1825598|C0011900|C0006141|C0006826
"This was a pilot randomized, double-blind, placebo-controlled trial on 46 symmetrical vitiligo lesions of limbs in 23 patients referring to dermatology clinics, Isfahan, Iran in 2010.","This pilot randomized, double-blind, placebo-controlled trial 46 symmetrical vitiligo lesions limbs 23 patients referring dermatology clinics, Isfahan, Iran 2010.",G0000000|C0473169|C0034656|C0013072|C1706408|C0008976|C0450371|C0332516|C0042900|C0221198|C0015385|C0450371|C0030705|C0205543|C0011627|C0442592|G0000000|C0022065|G0000000
The majority of the wait-listed patients who had a decision for CABG were men (83%).,The majority wait-listed patients decision CABG (83%).,G0000000|C0680220|C0043010|C0030705|C0679006|C0010055|C0450371
Sixty‐six women carriers of the BRCA1/2 mutation who developed at least two moderate‐to‐severe menopausal symptoms after RRSO.,Sixty‐six women carriers BRCA1/2 mutation developed moderate‐to‐severe menopausal symptoms RRSO.,G0000000|C0043210|C0007294|G0000000|C0026882|G0000000|G0000000|C0025320|C0683368|G0000000
The demographic characteristics were not different (P > 0.05) between the intervention and control groups and similar to those of the parental study.,The demographic characteristics (P > 0.05) intervention control parental study.,G0000000|C0011298|C1521970|G0000000|C0886296|C0243148|C0030551|C0557651
"The between-group comparisons were performed on the intention-to-treat population with a mixed covariance pattern model for repeated measures data with unstructured covariance matrix with adjustment for sex, age and MS subtype at baseline.","The between-group comparisons performed intention-to-treat population mixed covariance pattern model repeated measures data unstructured covariance matrix adjustment sex, age MS subtype baseline.",G0000000|C0441833|C1707455|C0884358|C0162425|C0032659|C0205430|G0000000|C0449774|C3161035|C0205341|C0079809|C1511726|G0000000|G0000000|C1704640|C0376209|C0009253|C0001779|C0039676|C0449560|C0168634
"Exclusion criteria were mental or physical disability precluding compliance with the protocol for the duration of the study, and non-feasible trial follow-up.","Exclusion criteria mental physical disability precluding compliance protocol duration study, non-feasible trial follow-up.",C0680251|C0243161|C0229992|C0031809|C0231170|G0000000|C0009563|C0442711|C0449238|C0557651|C1518422|C0008976|C0589120
"Eligible families were English-speaking and had a child between birth and 17 years of age who was receiving chemotherapy and/or radiation treatment at our hospital, had no medical co-morbidities or developmental delay, and was not referred to palliative care.","Eligible families English-speaking child birth 17 age receiving chemotherapy and/or radiation treatment hospital, medical co-morbidities developmental delay, referred palliative care.",C1548635|C0015576|C0376245|C0008059|C0005615|C0450371|C0001779|C1514756|C0013216|G0000000|C0034519|C0039798|C0019994|C0199168|C0009488|C0458003|C0205421|C0205543|C0587605|C1947933
"The advantages of our study are the well-organized study design incorporating a restricted population by reproductive age (between 30 and 40 years) and BMI (between 30 and 40), the absence of previous surgery in the abdominal cavity, and size limit of benign pelvic masses to <10 cm in diameter.","The advantages study well-organized study design incorporating restricted population reproductive age (between 30 40 years) BMI (between 30 40), absence previous surgery abdominal cavity, size limit benign pelvic masses <10 cm diameter.",G0000000|G0000000|C0557651|C0205170|C0557651|C1707689|G0000000|C0443288|C0032659|C0035150|C0001779|G0000000|C0450371|C0450371|C0439234|G0000000|G0000000|C0450371|C0450371|C0332197|C0205156|C0038894|C0000726|C0011334|C0456389|C0439801|C0205183|C0030797|C0577559|C0450371|G0000000|C1301886
Treatment duration was 10 sessions with an average of two AC sessions per week.,Treatment duration 10 sessions average AC sessions week.,C0039798|C0449238|C0450371|C1883016|C1510992|C0003354|C1883016|C0332174
"According to clinical and paraclinical tests, sever and moderate patients and mild group that did not respond to conservative treatment were operated.","According clinical paraclinical tests, sever moderate patients mild respond conservative treatment operated.",C0680240|C0205210|G0000000|C0022885|C1306232|C0205081|C0030705|C2945599|G0000000|G0000000|C0039798|C3242339
"Within selected villages, women were eligible to participate if they reported that they were in their second or third trimester of pregnancy, planned to continue to live at their current residence for the next 2 years, and could speak Kiswahili, Luhya, or English.","Within selected villages, women eligible participate reported trimester pregnancy, planned continue live current residence 2 years, speak Kiswahili, Luhya, English.",G0000000|C1707391|C0562518|C0043210|C1548635|G0000000|C0684224|C0032982|C0032961|C1301732|C0549178|C1548795|C0521116|C0237096|G0000000|C0439234|C0234856|G0000000|G0000000|C0376245
"More than two-thirds (68%) of participants were female (mean age = 48, SD = 14), and the majority came from lower or middle socioeconomic strata.","More two-thirds (68%) participants female (mean age = 48, SD = 14), majority lower middle socioeconomic strata.",C0205172|C0205448|C0450371|C0679646|C0015780|C0444504|C0001779|G0000000|C0450371|C2699239|G0000000|C0450371|C0680220|C0441994|C0444598|C0748878|G0000000
The Partners Primary Care Practice–Based Research Network includes 26 primary care practices affiliated with Brigham and Women's Hospital and Massachusetts General Hospital that use the longitudinal medical record.,The Partners Primary Care Practice–Based Research Network includes 26 primary care practices affiliated Brigham Women's Hospital Massachusetts General Hospital longitudinal medical record.,G0000000|C0682323|C0205225|C1947933|G0000000|C0035168|C0150775|C0332257|C0450371|C0205225|C1947933|C0237607|C1510825|G0000000|C0043210|C0019994|C0024874|C0205246|C0019994|C0205127|C0199168|C0034869
"Pregnant women with epilepsy were recruited to the study, predominantly by community midwives.","Pregnant women epilepsy recruited study, community midwives.",C0549206|C0043210|C0014544|G0000000|C0557651|C0009462|C0026083
"To be eligible for inclusion in the study, we sought villages that had not been declared open defecation free by the Government of India, had 50–150 households, and minimum 60% latrine coverage.","To eligible inclusion study, sought villages declared defecation free Government India, 50–150 households, minimum 60% latrine coverage.",C0040363|C1548635|C0007637|C0557651|G0000000|C0562518|G0000000|C0011135|C0332296|C0018104|C0021201|G0000000|C0020052|C1524031|C0450371|C0023124|C1551362
"In addition, they had to have chronic bronchitis as defined by the American Thoracic Society [20] and at least two exacerbations requiring treatment with antibiotics and/or oral steroids in the 12 months prior to enrolment.","In addition, chronic bronchitis defined American Thoracic Society [20] exacerbations requiring treatment antibiotics and/or oral steroids 12 months prior enrolment.",G0000000|C0332287|C0205191|C0006277|C1704788|C0596070|G0000000|C0037455|C0450371|G0000000|G0000000|C0039798|C0003232|G0000000|C0442027|C0038317|C0450371|C0439231|C0332152|C1516879
"Intervention included 160 minutes/week of moderate intensity aerobic walking, twice weekly resistance training (resistance bands), and six discussion groups (to improve adherence).","Intervention included 160 minutes/week moderate intensity aerobic walking, weekly resistance training (resistance bands), discussion (to improve adherence).",C0886296|C0332257|C1442061|C0556975|C0205081|C0522510|C1510824|C0080331|C0332174|C0237834|C0040607|C0237834|C0175723|C0557061|G0000000|G0000000|C1510802
"Exclusion criteria were moderate to severe cognitive problems, inability to ambulate independently, neurological conditions that severely influenced gait and mobility, resident in a nursing home or hostel, or any unstable or terminal illness that would affect ability to do exercises.","Exclusion criteria moderate severe cognitive problems, inability ambulate independently, neurological conditions severely influenced gait mobility, resident nursing hostel, unstable terminal illness affect ability exercises.",C0680251|C0243161|C0205081|C0205082|C1516691|C1546466|G0000000|C4036205|G0000000|C0205494|C0012634|C0205082|G0000000|C0016928|C0425245|C1320928|C0006147|C0442518|C0443343|C0205088|C0221423|C0001721|C0085732|C0015259
The incidence of GDM is higher in women who are overweight or obese prior to falling pregnant [10].,The incidence GDM women overweight obese prior falling pregnant [10].,G0000000|C0021149|C0085207|C0043210|C0497406|C0028754|C0332152|C0000921|C0549206|C0450371
Fatigue-related exclusions were not fatigued (n = 30) and fatigue not related to cancer (n = 11).,Fatigue-related exclusions fatigued (n = 30) fatigue cancer (n = 11).,C0015672|C0680251|C0015672|C0369718|G0000000|C0450371|C0015672|C0006826|C0369718|G0000000|C0450371
Children in the age group of 4–8 years visiting the outpatient clinics in the Department of Pedodontics and Preventive Dentistry with a chief complaint of one or more decayed teeth were screened.,Children age 4–8 visiting outpatient clinics Department Pedodontics Preventive Dentistry chief complaint decayed teeth screened.,C0008059|C0001779|G0000000|C0545082|C0029921|C0442592|C1704729|C0030763|C0445202|C0011438|G0000000|C0277786|C1265875|C0040426|C0220908
"Men and women aged 18–75 years with a histologically and endoscopically confirmed diagnosis of established or first attack of ulcerative colitis (clinical activity index (CAI)>4 and endoscopic index (EI)⩾4 at baseline, both according to Rachmilewitz21), and having an extent of disease >15 cm from the anus were entered in the study.","Men women aged 18–75 histologically endoscopically confirmed diagnosis established attack ulcerative colitis (clinical activity (CAI)>4 endoscopic (EI)⩾4 baseline, Rachmilewitz21), extent disease >15 cm anus entered study.",C0025266|C0043210|C0001779|G0000000|C0205462|G0000000|C0521093|C0011900|C0443211|C0277793|C0041582|C0009319|C0205210|C0205177|C0064494|C0014245|G0000000|C0168634|G0000000|C0439792|C0012634|C0450371|G0000000|C0003461|C1521975|C0557651
"Thus, in total, pregabalin at a target dose of 75 to 150 mg twice daily appears to be a clinically useful means of treating hot flashes in women.","Thus, total, pregabalin target dose 75 150 daily appears clinically treating hot flashes women.",G0000000|C0439175|C0657912|C1521840|C0178602|C0450371|C1442061|C0332173|C0700364|G0000000|C1522326|C0444519|C0085635|C0043210
Patients were enrolled if the study treatment could be initiated within 4 hours after injury.,Patients enrolled study treatment initiated 4 hours injury.,C0030705|G0000000|C0557651|C0039798|C1548602|G0000000|C0439227|C3263722
"Patients with electrodiagnostically confirmed, idiopathic, bilateral carpal tunnel syndrome were included (Fig.","Patients electrodiagnostically confirmed, idiopathic, bilateral carpal tunnel syndrome included (Fig.",C0030705|G0000000|C0521093|C0332240|C0238767|C0007285|C0337138|C0039082|C0332257|C0349966
"without assistance or walking device), severe aphasia, severe vision or hearing impairment, any medical condition that a physician determined was inconsistent with study participation, and living too far away (>100 km) from the training facilities.","assistance walking device), severe aphasia, severe vision hearing impairment, medical condition physician determined inconsistent study participation, living (>100 km) training facilities.",C0018896|C0080331|C0025080|C0205082|C0003537|C0205082|C0042789|C0018767|C0221099|C0199168|C0012634|C0031831|G0000000|C0442809|C0557651|C0679823|C0376558|C1442061|G0000000|C0040607|C1547538
"Finally, 352 children aged 6–15 years, living in the 43 baris, were included in the study.","Finally, 352 children aged 6–15 years, living 43 baris, included study.",G0000000|C1442061|C0008059|C0001779|G0000000|C0439234|C0376558|C0450371|C1890660|C0332257|C0557651
"Pregnancy increases zinc requirements by 3 mg/d (1), an increment often difficult to attain in women living in resource-poor environments and having a chronic inadequate intake of zinc.","Pregnancy increases zinc requirements 3 mg/d (1), increment difficult attain women living resource-poor environments chronic inadequate intake zinc.",C0032961|C0205217|C0043481|C1514873|G0000000|C0439422|G0000000|C1705117|C0332218|G0000000|C0043210|C0376558|C0035201|C0014406|C0205191|C0205412|C1512806|C0043481
Consecutive children between 6 months and 10 years old attending with a fever of 38.0°C or more were included.,Consecutive children 6 months 10 years attending fever 38.0°C included.,C1707491|C0008059|G0000000|G0000000|C1547429|C0015967|G0000000|C0332257
"Patients were included if they were aged 15 years or older; had a single nodule or plaque less than 10 cm in maximum diameter, meeting the WHO clinical case definition for M. ulcerans disease (6); were not pregnant; were not under treatment with antibiotics; had no history of leprosy, tuberculosis, liver, kidney, or hearing problems; and gave informed written consent.","Patients included aged 15 older; single nodule plaque 10 cm maximum diameter, meeting WHO clinical definition M. ulcerans disease (6); pregnant; treatment antibiotics; history leprosy, tuberculosis, liver, kidney, hearing problems; informed written consent.",C0030705|C0332257|C0001779|C0450371|C0580836|C0037179|C0028259|C0011389|C0450371|G0000000|C0806909|C1301886|C0556656|G0000000|C0205210|C1550452|C0369637|G0000000|C0012634|G0000000|C0549206|C0039798|C0003232|C0019664|C0023343|C0041296|C0023884|C0022646|C0018767|C1546466|C1522154|C0043266|C1511481
"Patients were not eligible for the study if they: (i) were not able to comply with the requirements of the protocol and therapy program, in the opinion of the assessor; (ii) still in post-stroke intermediate care or active rehabilitation or (iii) were previously enrolled in this study.","Patients eligible study they: (i) comply requirements protocol therapy program, opinion assessor; (ii) post-stroke intermediate care active rehabilitation (iii) enrolled study.",C0030705|C1548635|C0557651|G0000000|C0021966|C0725694|C1514873|C0442711|C0039798|C1709697|C0871010|C1707957|G0000000|C0687676|C0205103|C1947933|C0205177|C0034991|C0439070|G0000000|C0557651
"The other exclusion criteria included: patients with psychosis or dementia, patients who are dying or unable to communicate, and those who have been transferred to another unit during their stay in hospital.","The exclusion criteria included: patients psychosis dementia, patients dying unable communicate, transferred unit stay hospital.",G0000000|C0680251|C0243161|C0332257|C0030705|C0033975|C0011265|C0030705|C0184532|C1299582|C0566001|C0348011|C0439148|G0000000|C0019994
A patient was assigned to the surveillance group when before CRC diagnosis at least one or more surveillance colonoscopies at regular intervals (every 1–3 years) had been performed.,A patient assigned surveillance CRC diagnosis surveillance colonoscopies regular intervals (every 1–3 years) performed.,G0000000|C0030705|C1516050|C0220920|C0009402|C0011900|C0220920|C0009378|C0205272|C1272706|G0000000|G0000000|C0439234|C0884358
"In addition, 100 females ages 9–12 y were randomized in a 4:1 ratio to receive either qHPV vaccine (n = 80) or placebo (n = 20 ).","In addition, 100 females ages 9–12 randomized 4:1 ratio receive qHPV vaccine (n = 80) placebo (n = 20 ).",G0000000|C0332287|C1442061|C0015780|C0001779|G0000000|C0034656|G0000000|C0456603|C1514756|G0000000|C0042210|C0369718|G0000000|C0450371|C0032042|C0369718|G0000000|C0450371|G0000000
"Children aged 3 months to 2 years with an established diagnosis of epilepsy, who continue to have epileptic seizures despite treatment with two AEDs, will be screened for entry into the trial.","Children aged 3 months 2 established diagnosis epilepsy, continue epileptic seizures treatment AEDs, screened entry trial.",C0008059|C0001779|G0000000|C0439231|G0000000|C0443211|C0011900|C0014544|C0549178|C0014544|C0036572|C0039798|C0180309|C0220908|C1705654|C0008976
Subjects were recruited based on the inclusion and exclusion criteria which specified low risk women with no medical or obstetric complications.,Subjects recruited based inclusion exclusion criteria low risk women medical obstetric complications.,C0681850|G0000000|C1527178|C0007637|C0680251|C0243161|C0205251|C0035647|C0043210|C0199168|C0205484|C0009566
Radiographic and clinical data from a multicenter randomized controlled trial of 51 patients with operatively treated tibial fractures formed the basis of the study data.,Radiographic clinical data multicenter randomized controlled trial 51 patients operatively treated tibial fractures formed basis study data.,C0444708|C0205210|C1511726|C0439743|C0034656|C2587213|C0008976|C0450371|C0030705|G0000000|C1522326|C0040184|C0016658|C0205431|C1527178|C0557651|C1511726
in the gut of preterm infants in response to B. lactis Bb12 supplementation.,gut preterm infants response B. lactis Bb12 supplementation.,C0017189|C0151526|C0021270|C0871261|G0000000|C3844603|G0000000|C0242297
"Patients admitted with an (sub)acute myocardial infarction, who were not treated by primary or rescue PCI, and who were stable during the first 48 hours after the acute event, were screened for the study.","Patients admitted (sub)acute myocardial infarction, treated primary rescue PCI, stable 48 hours acute event, screened study.",C0030705|C0184666|C0542339|C0027061|C0021308|C1522326|C0205225|G0000000|C4049621|C0205360|C0450371|C0439227|C0205178|C0441471|C0220908|C0557651
"In addition, pregnant women with a diagnosis of current major depressive disorder, or other psychiatric diagnoses, including current substance abuse, schizophrenia, and bipolar disorder will be excluded from study.","In addition, pregnant women diagnosis current major depressive disorder, psychiatric diagnoses, including current substance abuse, schizophrenia, bipolar disorder excluded study.",G0000000|C0332287|C0549206|C0043210|C0011900|C0521116|C0205082|G0000000|C0012634|C0205487|C0011900|C0332257|C0521116|C0439861|C0013146|C0036341|C0443156|C0012634|C1554077|C0557651
"Established cases of DVT, or patients taking antithrombotic medication, patients who sustained open fractures, and patients on pacemakers were excluded from the study.","Established DVT, patients antithrombotic medication, patients sustained fractures, patients pacemakers excluded study.",C0443211|C0149871|C0030705|G0000000|C0013227|C0030705|C0443318|C0016658|C0030705|C0810633|C1554077|C0557651
"Inclusion criteria consisted of the following: (1) fulfillment of the American College of Rheumatology (ACR) research classification criteria for FM [72], (2) 18 years of age, (3) be under the standard medical care of a physician for at least 3 months prior to enrollment so as to minimize the initiation of new pharmacological agents across subjects, and (4) possess basic computer literacy and computer access.","Inclusion criteria consisted following: (1) fulfillment American College Rheumatology (ACR) classification criteria FM [72], (2) 18 age, (3) standard medical care physician 3 months prior enrollment minimize initiation pharmacological agents subjects, (4) possess basic computer literacy computer access.",C0007637|C0243161|C0332529|C0231290|G0000000|C0242428|C0596070|C0557806|C0035452|C1412134|C0008902|C0243161|C3540627|C0450371|G0000000|C0450371|C0001779|G0000000|C1442989|C0199168|C1947933|C0031831|G0000000|C0439231|C0332152|C1516879|G0000000|C0589507|C0031330|C0450442|C0681850|G0000000|C0850310|C1527178|C0009622|C0023864|C0009622|C0444454
"The diagnosis of ASD was established using the Autism Diagnostic Observation Scale (ADOS), the Social Communication Questionnaire (SCQ) and by clinical review of the DSM-IV TR criteria by an expert clinician (RLH).","The diagnosis ASD established Autism Diagnostic Observation Scale (ADOS), Social Communication Questionnaire (SCQ) clinical review DSM-IV TR criteria expert clinician (RLH).",G0000000|C0011900|C0003516|C0443211|C0004352|C0011900|C0302523|C0175659|C0670018|C0728831|C0009452|C0034394|C0451482|C0205210|C0282443|C0220952|C3811249|C0243161|G0000000|C0871685|G0000000
The present study compares outcomes from three groups of mothers who participated in: (1) a combined educational intervention (responsive complementary feeding and mother–child interaction); (2) an education intervention on complementary food and feeding; or in (3) the standard of care – the Integrated Child Development Services (ICDS) programme.,The study compares outcomes mothers participated in: (1) combined educational intervention (responsive complementary feeding mother–child interaction); (2) education intervention complementary food feeding; (3) standard care – Integrated Child Development Services (ICDS) programme.,G0000000|C0557651|C1707455|C1274040|C0026591|G0000000|G0000000|G0000000|C0205195|C0587721|C0886296|C0205342|G0000000|C0204695|G0000000|C1704675|G0000000|C0013621|C0886296|G0000000|C0016452|C0204695|G0000000|C1442989|C1947933|G0000000|G0000000|C0008059|C0243107|C0557854|C0162589|C1709697
A total of 60 children presenting for ophthalmic surgery under sevoflurane anesthesia were randomly placed in four groups from Group I to Group IV.,A total 60 children ophthalmic surgery sevoflurane anesthesia randomly Group I Group IV.,G0000000|C0439175|C0450371|C0008059|C0015392|C0038894|C0074414|C0002903|G0000000|C0441833|C0021966|C0441833|C0022326
"Eligibility criteria included the following: (1) born to HIV-uninfected mothers, (2) residency within 30 km of the study clinic with no intention of moving outside the study area, (3) agreement to come to the study clinic for any illness and to avoid medications outside the study protocol, (4) provision of informed consent by parent/guardian, (5) no history of allergy or sensitivity to any study drugs, (6) absence of active medical problem requiring in-patient evaluation or chronic medical conditions requiring frequent attention, and (7) absence of clinically significant electrocardiogram (ECG) abnormalities, family history of long QT syndrome, and current use of drugs that prolong the QTc interval.","Eligibility criteria included following: (1) born HIV-uninfected mothers, (2) residency 30 study clinic intention moving study area, (3) agreement study clinic illness avoid medications study protocol, (4) provision informed consent parent/guardian, (5) history allergy sensitivity study drugs, (6) absence active medical requiring in-patient evaluation chronic medical conditions requiring frequent attention, (7) absence clinically electrocardiogram (ECG) abnormalities, family history QT syndrome, current drugs prolong QTc interval.",C0013893|C0243161|C0332257|C0231290|G0000000|C0005615|C0019682|C0026591|G0000000|C0035182|C0450371|C0557651|C0002424|C0162425|C0560560|C0557651|C0017446|G0000000|C0680240|C0557651|C0002424|C0221423|G0000000|C0013227|C0557651|C0442711|G0000000|C1549071|C1522154|C1511481|C0030551|G0000000|C0019664|C0002111|C0020517|C0557651|C0013227|G0000000|C0332197|C0205177|C0199168|G0000000|C0150312|C0220825|C0205191|C0199168|C0012634|G0000000|C0332183|C0004268|G0000000|C0332197|G0000000|C0013798|C1623258|C0000768|C0015576|C0019664|C1552934|C0039082|C0521116|C0013227|G0000000|G0000000|C1272706
"Patients underwent informed consent and were included if they were greater than 40 years old, had a diagnosis of moderate-to-severe COPD as defined by Global Initiative for Chronic Obstructive Lung Disease criteria (24), were current or former cigarette smokers with more than 10 pack-years of total consumption, and had chronic bronchitis defined by chronic cough and sputum production lasting at least 3 months for 2 consecutive years,.","Patients underwent informed consent included 40 old, diagnosis moderate-to-severe COPD defined Global Initiative Chronic Obstructive Lung Disease criteria (24), current cigarette smokers 10 pack-years total consumption, chronic bronchitis defined chronic cough sputum production lasting 3 months 2 consecutive years,.",C0030705|G0000000|C1522154|C1511481|C0332257|C0450371|C0580836|C0011900|C0205081|C0024117|C1704788|C0205246|C0424093|C0205191|C0549186|C0024109|C0012634|C0243161|C0450371|C0521116|C0677453|C0337664|C0450371|C1277691|C0439175|C0009830|C0205191|C0006277|C1704788|C0205191|C0010200|C0038056|C0033268|C1517741|G0000000|C0439231|G0000000|C1707491|C0439234
"Exclusion criteria are as follows: recent (past month) respiratory tract infection; intermittent asthma; current smoker; use of antioxidant supplements, or previous pregnancy complications including growth restriction, stillbirth or preterm delivery.","Exclusion criteria follows: (past month) respiratory tract infection; intermittent asthma; current smoker; antioxidant supplements, previous pregnancy complications including growth restriction, stillbirth preterm delivery.",C0680251|C0243161|C0332283|C1444637|C0332177|C0521346|C1185740|C0009450|C0205267|C0004096|C0521116|C0337664|C0003402|C0242295|C0205156|C0032961|C0009566|C0332257|C0018270|C0443288|C0595939|C0151526|C0011209
"For potential participants recruited through the voluntary sector, the presence of aphasia was confirmed using the Sheffield Screening Test for Acquired Language Disorders.15 People were excluded if they were blind or deaf, had dementia documented in their medical notes, were unable to speak English prior to stroke, or were receiving any treatment for depression at the time of their stroke.","For potential participants recruited voluntary sector, presence aphasia confirmed Sheffield Screening Test Acquired Language Disorders.15 People excluded blind deaf, dementia documented medical notes, unable speak English prior stroke, receiving treatment depression time stroke.",G0000000|C3245505|C0679646|G0000000|C0439656|C1708237|C0150312|C0003537|C0521093|G0000000|C0220908|C0022885|C0439661|C0023008|C0012634|C0027361|C1554077|C0150108|C0525064|C0011265|C1301725|C0199168|C1317574|C1299582|C0234856|C0376245|C0332152|C0038454|C1514756|C0039798|C0011570|C0040223|C0038454
Patients were recruited from the head and neck outpatient clinics at Auckland City Hospital and allocated sequentially by means of opaque sealed envelopes to immunonutrition (IMN) or standard treatment (STD) groups in a 1:1 ratio.,Patients recruited head neck outpatient clinics Auckland City Hospital allocated sequentially opaque sealed envelopes immunonutrition (IMN) standard treatment (STD) 1:1 ratio.,C0030705|G0000000|C0018670|C0027530|C0029921|C0442592|G0000000|C0008848|C0019994|G0000000|G0000000|C0029053|C0036492|C1622204|G0000000|C0022132|C1442989|C0039798|G0000000|G0000000|C0456603
Cases diagnosed with specific disorders such as infection and delivery contractions during the survey were excluded from the study.,Cases diagnosed specific disorders infection delivery contractions survey excluded study.,C0868928|C0011900|C0205369|C0012634|C0009450|C0011209|C1140999|C0038951|C1554077|C0557651
"Eligible patients were children 9 years of age and under who presented within 36 h of the onset of any influenza symptom, had an axillary temperature of 38.0°C or higher, and could inhale the test drug successfully.","Eligible patients children 9 age 36 onset influenza symptom, axillary temperature 38.0°C higher, inhale test drug successfully.",C1548635|C0030705|C0008059|G0000000|C0001779|C0450371|C0206132|C0021400|C1457887|C0004454|C0005903|G0000000|C0205250|C0004048|C0022885|C0013227|G0000000
"Inclusion criteria were having a history of primary dysmenorrhea, with regular menses in the last 3 months prior to the first visit, and no previous history of gynecologic disease and of allergy to NSAIDs, or suspected contraindication to herbal remedies, no history of pelvic major surgery, seizure, stressor factor in the last 6 months, severe gastrointestinal disorders, or any diseases that might interfere with the conduct of the study or the interpretation of the results.","Inclusion criteria history primary dysmenorrhea, regular menses 3 months prior visit, previous history gynecologic disease allergy NSAIDs, suspected contraindication herbal remedies, history pelvic major surgery, seizure, stressor factor 6 months, severe gastrointestinal disorders, diseases interfere conduct study interpretation results.",C0007637|C0243161|C0019664|C0205225|C0013390|C0205272|C0025344|G0000000|C0439231|C0332152|C0545082|C0205156|C0019664|C0205480|C0012634|C0002111|C0003211|C0332147|C0522473|C3146288|G0000000|C0019664|C0030797|C0205082|C0038894|C0036572|C0597530|C1521761|G0000000|C0439231|C0205082|C0521362|C0012634|C0012634|C0521102|C0004927|C0557651|C0459471|C1274040
"We excluded subjects with daily calcium supplementation >500mg, daily vitamin D supplementation >800 IU, any bisphosphonate use, recent steroid or chemotherapy treatments, clinically active thyroid disease, active substance or alcohol abuse, history of fragility fracture, documented osteoporosis, nephrolithiasis, or weight>300 lbs (limit of DXA scanner).","We excluded subjects daily calcium supplementation >500mg, daily vitamin D supplementation >800 IU, bisphosphonate use, steroid chemotherapy treatments, clinically active thyroid disease, active substance alcohol abuse, history fragility fracture, documented osteoporosis, nephrolithiasis, weight>300 lbs (limit DXA scanner).",G0000000|C1554077|C0681850|C0332173|C0006675|C0242297|G0000000|C0332173|C0042890|C0073187|C0242297|C1442061|C0049272|C0012544|C0042153|C0038317|C0013216|C0087111|G0000000|C0205177|C0040132|C0012634|C0205177|C0439861|C0001962|C0013146|C0019664|C0302113|C0016658|C1301725|C0029456|C0022650|C0005910|C0439219|C0439801|C1510486|C0183115
Eighty-two percent (33 of 40) of those assigned to varenicline and 60% (28 of 47) of those receiving placebo remained in the study from weeks 12 through 52.,Eighty-two percent (33 40) assigned varenicline 60% (28 47) receiving placebo remained study weeks 12 52.,C3816958|C0439165|C0450371|C0450371|C1516050|C1569608|C0450371|C0450371|C0450371|C1514756|C0032042|G0000000|C0557651|C0439230|C0450371|C0450371
"Questionnaires were completed 3-weekly for the first 12 weeks, then 6-weekly until the completion of chemotherapy, then 12-weekly until disease progression.","Questionnaires completed 3-weekly 12 weeks, 6-weekly completion chemotherapy, 12-weekly disease progression.",C0034394|C0205197|C0332174|C0450371|C0439230|C0332174|C0205197|C0013216|C0450371|C0012634|C0242656
Participants: 2678 year 8 students (74%) participated in the first wave of data collection.,Participants: 2678 8 students (74%) participated wave data collection.,C0679646|G0000000|G0000000|C0038492|C0450371|G0000000|C0678544|C1511726|C1516698
"We based the diagnosis of atopic dermatitis on the criteria of Hanifin and Rajka.13 We excluded pregnant and lactating women, and fertile women were required to use effective contraception.","We based diagnosis atopic dermatitis criteria Hanifin Rajka.13 We excluded pregnant lactating women, fertile women required effective contraception.",G0000000|C1527178|C0011900|C0392707|C0011603|C0243161|G0000000|C0450371|G0000000|C1554077|C0549206|C2828358|C0043210|C0015895|C0043210|C1514873|C1280519|C0700589
"For inclusion, eligible patients had to have had a verified stroke according to the WHO definition; be able to walk a minimum of 10 m without physical assistance (functional ambulation categories ≥3); be discharged home from a rehabilitation centre; need to continue physiotherapy during outpatient care to improve walking competency or physical condition, or both; and be able to give informed consent and be motivated to participate in a 12 week intensive programme of physiotherapy.","For inclusion, eligible patients verified stroke WHO definition; walk minimum 10 physical assistance (functional ambulation categories ≥3); discharged rehabilitation centre; continue physiotherapy outpatient care improve walking competency physical condition, both; informed consent motivated participate 12 week intensive programme physiotherapy.",G0000000|C0007637|C1548635|C0030705|C1711411|C0038454|G0000000|C1550452|C0080331|C1524031|C0450371|C0031809|C0018896|C0205245|C0080331|C0683312|G0000000|C0030685|C0034991|C0205099|C0549178|C0949766|C0029921|C1947933|G0000000|C0080331|C0086035|C0031809|C0012634|G0000000|C1522154|C1511481|G0000000|G0000000|C0450371|C0332174|C0162425|C1709697|C0949766
"Patients with advanced cancer have many visits to the hospital, especially during standard oncologic treatment.","Patients advanced cancer visits hospital, standard oncologic treatment.",C0030705|C0205179|C0006826|C0545082|C0019994|C1442989|C0205478|C0039798
"This clinical trial study was performed on 170 pregnant women with the history of PPROM, with singleton pregnancy and gestational age 14 weeks in Imam-Reza Hospital, Mashhad University of Medical Sciences during 2008 to 2010.","This clinical trial study performed 170 pregnant women history PPROM, singleton pregnancy gestational age 14 weeks Imam-Reza Hospital, Mashhad University Medical Sciences 2008 2010.",G0000000|C0205210|C0008976|C0557651|C0884358|C1442061|C0549206|C0043210|C0019664|C0729264|C0481462|C0032961|C0439671|C0001779|C0450371|C0439230|C0521321|C0019994|G0000000|C0041740|C0199168|C0036397|G0000000|G0000000
"The clusters were 16 primary schools in rural Kampong Speu province, of which four were randomly selected for each study group.","The clusters 16 primary schools rural Kampong Speu province, randomly selected study group.",G0000000|C1555715|C0450371|C0205225|C0036375|C0240919|C1036383|G0000000|C1514578|G0000000|C1707391|C0557651|C0441833
We administered third doses of MMR vaccine to eligible students aged 9–14 years in 7 schools with the highest attack rates (ARs) between 5/18/2010—5/21/2010.,We administered doses MMR vaccine eligible students aged 9–14 7 schools attack rates (ARs) 5/18/2010—5/21/2010.,G0000000|C1521801|C0178602|C3538741|C0042210|C1548635|C0038492|C0001779|G0000000|G0000000|C0036375|C0277793|C0871208|G0000000|G0000000
Older patients undergoing cardiac surgery are at particular risk to develop POD.,Older patients undergoing cardiac surgery risk develop POD.,C0580836|C0030705|G0000000|C0018787|C0038894|C0035647|G0000000|G0000000
"The subjects with respiratory disorders were classified into the following four groups: upper respiratory tract infection (n = 22), wheezing illness (n = 9), pneumonia with wheezing (n = 30), and pneumonia without wheezing (n = 28).","The subjects respiratory disorders classified groups: upper respiratory tract infection (n = 22), wheezing illness (n = 9), pneumonia wheezing (n = 30), pneumonia wheezing (n = 28).",G0000000|C0681850|C0521346|C0012634|C0008902|C0441833|C1282910|C0521346|C1185740|C0009450|G0000000|C0043144|C0221423|G0000000|C0032285|C0043144|G0000000|C0032285|C0043144|G0000000
"Unfortunately, there are few resources for those patients who have chronic pain and a history of prescription opioid misuse.","Unfortunately, resources patients chronic pain history prescription opioid misuse.",G0000000|C0035201|C0030705|C0205191|C0030193|C0019664|C0033080|C0242402|C0549649
"In all, 410 survivors suffering from moderate or greater sleep disruption between 2 and 24 months after surgery, chemotherapy, and/or radiation therapy were randomly assigned to standard care or standard care plus the 4-week yoga intervention.","In all, 410 survivors suffering moderate sleep disruption 2 24 months surgery, chemotherapy, and/or radiation therapy randomly assigned standard care standard care 4-week yoga intervention.",G0000000|G0000000|C1442061|C0206194|C0683278|C0205081|C0037313|C0332453|G0000000|C0450371|C0439231|C0038894|C0013216|G0000000|C0034519|C0039798|G0000000|C1516050|C1442989|C1947933|C1442989|C1947933|C0332174|C0043418|C0886296
Males' mean±SD age was 21.6±3.8 and for females it was 22.2±4.6 years.,Males' mean±SD age 21.6±3.8 females 22.2±4.6 years.,C0086582|G0000000|C0001779|G0000000|C0015780|G0000000|C0439234
The overall cluster populations ranged from 1158 to 3429.,The cluster populations ranged 1158 3429.,G0000000|C1555715|C0032659|C1514721|G0000000|G0000000
"In total, 431 patients with lower respiratory tract infection were recruited (factor A, 227 to the C reactive protein test group v 204 to the no test group, and factor B, 201 to the training in enhanced communication skills group v 230 to the no training group), and for all of these, data for the primary outcome measure were available.","In total, 431 patients lower respiratory tract infection recruited (factor A, 227 C reactive protein test 204 test group, factor B, 201 training enhanced communication skills 230 training group), these, data primary outcome measure available.",G0000000|C0439175|C1442061|C0030705|C0441994|C0521346|C1185740|C0009450|G0000000|C1521761|G0000000|C1442061|G0000000|C0205332|C0033684|C0022885|C1442061|C0022885|C0441833|C1521761|G0000000|C1442061|C0040607|C2349975|C0009452|C0678856|C1442061|C0040607|C0441833|G0000000|C1511726|C0205225|C1274040|C0079809|C0470187
"This study was supported by Babol University of Medical Sciences, Iran (Research Project Number: 2097).","This study supported Babol University Medical Sciences, Iran (Research Project Number: 2097).",G0000000|C0557651|C1521721|G0000000|C0041740|C0199168|C0036397|C0022065|C0035168|C1709701|C0237753|G0000000
"We excluded patients with distal tumor requiring anastomosis within 5 cm of the dentate line for technical reasons, patients with tumors larger than 6 cm or with tumor infiltration to the adjacent organs on sonography or CT, patients with previous abdominal operations near the field of the colorectal operation, patients who did not give consent to the procedure, and patients with intestinal obstruction or perforation.","We excluded patients distal tumor requiring anastomosis 5 cm dentate technical reasons, patients tumors larger 6 cm tumor infiltration adjacent organs sonography CT, patients previous abdominal operations field colorectal operation, patients consent procedure, patients intestinal obstruction perforation.",G0000000|C1554077|C0030705|C0205108|C0027651|G0000000|C0332853|G0000000|G0000000|G0000000|C0449851|C0392360|C0030705|C0027651|C0549177|G0000000|G0000000|C0027651|C0332448|C0205117|C0178784|C0041618|C0007673|C0030705|C0205156|C0000726|C0038895|C0440042|C0555952|C0543467|C0030705|C1511481|C0184661|C0030705|C0021853|C0028778|C0549099
"Exclusion criteria were asthma, a resting heart rate greater than 100 beats per minute, a prolonged corrected QT (QTc) interval (>450 msec), the use of medications that prolong the QTc interval or are associated with torsades de pointes (with the exception of amiodarone),33 and hearing impairment documented by audiometric testing.","Exclusion criteria asthma, resting heart rate 100 beats minute, prolonged corrected QT (QTc) interval (>450 msec), medications prolong QTc interval torsades de pointes (with exception amiodarone),33 hearing impairment documented audiometric testing.",C0680251|C0243161|C0004096|C0035253|C0018787|C0871208|C1442061|G0000000|C0439232|C0439590|C0205202|C1552934|G0000000|C1272706|C1442061|C0439223|C0013227|G0000000|G0000000|C1272706|G0000000|C0011198|G0000000|G0000000|C1554961|C0002598|C0018767|C0221099|C1301725|C0004286|C0039593
"Our definition of minimal angulation was a fracture with angulation of 15° or less in the sagittal plane of the radiograph.3–5 Minimal displacement was defined as translational displacement of 5 mm or less on the frontal plane.3,4 We excluded patients whose injuries were older than five days and those who had a buckle (torus), growth-plate or open fracture.","Our definition minimal angulation fracture angulation 15° sagittal plane radiograph.3–5 Minimal displacement defined translational displacement 5 mm frontal plane.3,4 We excluded patients injuries days buckle (torus), growth-plate fracture.",G0000000|C1550452|C0547040|C0333179|C0016658|C0333179|G0000000|C0205129|C0444660|G0000000|C0547040|C0012725|C1704788|C1519614|C0012725|G0000000|G0000000|C0205123|C0444660|G0000000|C1554077|C0030705|C1510467|C0439228|C0347847|C0332567|C0014570|C0016658
"(ClinicalTrials.gov number, {""type"":""clinical-trial"",""attrs"":{""text"":""NCT00221364"",""term_id"":""NCT00221364""}}NCT00221364.)","(ClinicalTrials.gov number, {""type"":""clinical-trial"",""attrs"":{""text"":""NCT00221364"",""term_id"":""NCT00221364""}}NCT00221364.)",C1419208|C0237753|C0332307
We enrolled children aged between one month and ten years who were referred for EEG recording and were uncooperative with the device setup or were referred to our center for sleep EEG recording.,We enrolled children aged month ten referred EEG recording uncooperative device setup referred center sleep EEG recording.,G0000000|G0000000|C0008059|C0001779|C0332177|C0014518|C0205543|C0013819|G0000000|C0424350|C0025080|C1521827|C0205543|C0205099|C0037313|C0013819|G0000000
"Inborn preterm neonates of ⩽32 weeks gestational age, who developed RDS within six hours of birth and needed mechanical ventilation or nasal continuous positive airway pressure, were included in the study.","Inborn preterm neonates ⩽32 weeks gestational age, developed RDS hours birth mechanical ventilation nasal continuous positive airway pressure, included study.",G0000000|C0151526|C0021289|G0000000|C0439671|C0001779|G0000000|C0035220|C0439227|C0005615|C0443254|C0035203|C0028429|C0549178|C0439178|C0178987|C0033095|C0332257|C0557651
"Exclusions included chronic transfusion therapy, serum creatinine >132μmol/l, alanine transaminase >3 × upper limit of normal, malabsorption, serum calcium <2.0 or >2.75 mmol/l, prior treatment for VDD, oral steroids, thiazide diuretics, depot medroxyprogesterone acetate, phenobarbital or phosphenytoin.","Exclusions included chronic transfusion therapy, serum creatinine >132μmol/l, alanine transaminase >3 × upper limit normal, malabsorption, serum calcium <2.0 >2.75 mmol/l, prior treatment VDD, oral steroids, thiazide diuretics, depot medroxyprogesterone acetate, phenobarbital phosphenytoin.",C0680251|C0332257|C0205191|C0005841|C0039798|C0229671|C0010294|G0000000|C0001898|C0002594|G0000000|G0000000|C1282910|C0439801|C0205307|C0024523|C0229671|C0006675|G0000000|C0450371|C1532563|C0332152|C0039798|C3810531|C0442027|C0038317|C0541746|C0012798|C3830287|C0025147|C0000975|C0031412|G0000000
Twelve patients randomized to the rituximab group and 12 patients to the control group.,Twelve patients randomized rituximab 12 patients control group.,C0205458|C0030705|C0034656|C0393022|C0450371|C0030705|C0243148|C0441833
"Therefore, the prevalence of ictal HFOs and their role in localization of epileptogenic zone on intracranial EEG are unknown.","Therefore, prevalence ictal HFOs role localization epileptogenic zone intracranial EEG unknown.",G0000000|C0033105|C0038454|G0000000|C0035820|C0475264|G0000000|C1710706|C0524466|C0013819|C0439673
Children were eligible for enrolment if they were aged between 3 months and 9 years and had a Hb concentration <7 g/dL.,Children eligible enrolment aged 3 months 9 Hb concentration <7 g/dL.,C0008059|C1548635|C1516879|C0001779|G0000000|C0439231|G0000000|C0019046|C0004268|G0000000|C0439267
"Students who had irregular menstrual cycles, endometriosis, history of medication usage, experienced acute stress, and/or had vaginal symptoms (burning, irritation, itching, or discharge) were excluded from the study.","Students irregular menstrual cycles, endometriosis, history medication usage, experienced acute stress, and/or vaginal symptoms (burning, irritation, itching, discharge) excluded study.",C0038492|C0205271|C0025344|C1511572|C0014175|C0019664|C0013227|C0457083|C0237607|C0205178|C0038435|G0000000|C0042232|C0683368|C0000912|C0441723|C0033774|C0012621|C1554077|C0557651
"However, Ouimet and colleagues [42] demonstrated that 'subsyndromal' delirium (an ICDSC score > 0) was also associated with poor outcome, and all of our patients has an ICDSC score more than 0 at some point, supporting the clinical impression that they were delirious.","However, Ouimet colleagues [42] demonstrated 'subsyndromal' delirium (an ICDSC score > 0) poor outcome, patients ICDSC score 0 point, supporting clinical impression delirious.",G0000000|G0000000|G0000000|C0450371|G0000000|G0000000|C0011206|G0000000|G0000000|C0449820|G0000000|G0000000|C0032854|C1274040|C0030705|G0000000|C0449820|G0000000|C1552961|C0183683|C0205210|C0596764|C0011206
"Inclusion criteria were pregnant women with gestational age of 26 to 29 weeks, age range 18 to <35 years, currently residing in Dhaka, plans to stay in Dhaka throughout pregnancy up to one month post-delivery, and plans to deliver at the maternity centre.","Inclusion criteria pregnant women gestational age 26 29 weeks, age range 18 <35 years, residing Dhaka, plans stay Dhaka pregnancy month post-delivery, plans deliver maternity centre.",C0007637|C0243161|C0549206|C0043210|C0439671|C0001779|C0450371|C0450371|C0439230|C0001779|C1514721|C0450371|C0450371|C0439234|C2982691|G0000000|C0270724|G0000000|G0000000|C0032961|C0332177|C0687676|C0270724|C0308779|C0681108|C0205099
Premature infants were eligible for enrollment in the randomized observational study if they were on NIMV and considered clinically stable by the medical team.,Premature infants eligible enrollment randomized observational study NIMV considered clinically stable medical team.,C0151526|C0021270|C1548635|C1516879|C0034656|C1518527|C0557651|G0000000|C0750591|G0000000|C0205360|C0199168|C0871489
"HRP-II, Standard Diagnostics, Yongin-si, Republic of Korea) and anaemia using HemoCue® Hb 301 (HemoCue, Ängelholm, Sweden) in children aged 6–59 months and women aged 15–49 years.","HRP-II, Standard Diagnostics, Yongin-si, Republic Korea) anaemia HemoCue® Hb 301 (HemoCue, Ängelholm, Sweden) children aged 6–59 months women aged 15–49 years.",C0019941|C1442989|C0011900|G0000000|G0000000|C0022771|C0002871|G0000000|C0019046|C1442061|G0000000|G0000000|C0038995|C0008059|C0001779|G0000000|C0439231|C0043210|C0001779|G0000000|C0439234
We conducted a semi-crossover randomized controlled trial between February 2008 and February 2010 in primary care in 84 non-Western immigrants visiting their general practitioner for nonspecific musculoskeletal pain.,We conducted semi-crossover randomized controlled trial February 2008 February 2010 primary care 84 non-Western immigrants visiting practitioner nonspecific musculoskeletal pain.,G0000000|C0004927|C0010366|C0034656|C2587213|C0008976|C3830166|G0000000|C3830166|G0000000|C0205225|C1947933|C0450371|C1518422|C0282163|C0545082|C1709627|C0205370|C0497254|C0030193
"Inclusion criteria include identification as an Aboriginal and/or Torres Strait Islander person and aged ≥18 years, currently receiving maintenance haemodialysis in Alice Springs or Darwin and having been receiving this treatment for more than 6 months.","Inclusion criteria identification Aboriginal and/or Torres Strait Islander person aged ≥18 years, receiving maintenance haemodialysis Alice Springs Darwin receiving treatment 6 months.",C0007637|C0243161|C0020792|C0935542|G0000000|G0000000|G0000000|G0000000|C0027361|C0001779|G0000000|C0439234|C1514756|C0024501|C0019004|C0442985|C3179043|G0000000|C1514756|C0039798|G0000000|C0439231
"Mean patient age was 61.9 ± 2.7 years (mean ± SE; range 46–73 years), two were female, all were right-handed by the Edinburgh Handedness Inventory (Oldfield, 1971), and mean time spent in full-time education was 11.6±1.5 years (range 0–16) Patient data F = female; M= male; PVWM = periventricular white matter; Patients were tested at a mean 52.4 ± 21.9 months (range 6.0 – 180.6 months) after stroke.","Mean patient age 61.9 ± 2.7 (mean ± SE; range 46–73 years), female, right-handed Edinburgh Handedness Inventory (Oldfield, 1971), time spent full-time education 11.6±1.5 (range 0–16) Patient data F = female; M= male; PVWM = periventricular white matter; Patients tested 52.4 ± 21.9 months (range 6.0 – 180.6 months) stroke.",C0444504|C0030705|C0001779|C0450371|G0000000|G0000000|C0444504|G0000000|C0036919|C1514721|G0000000|C0439234|C0015780|C0230370|G0000000|C0023114|C0021941|G0000000|G0000000|C0040223|C0680968|C0682295|C0013621|G0000000|C1514721|G0000000|C0030705|C1511726|C0016327|G0000000|C0015780|C0369637|C0086582|G0000000|G0000000|G0000000|C0007457|G0000000|C0030705|C0392366|C0450371|G0000000|C0450371|C0439231|C1514721|G0000000|G0000000|C1442061|C0439231|C0038454
Patients in the chemotherapy-alone arm received a median of 7 cycles of treatment (range 2–16) and those in the chemotherapy plus panitumumab combination arm a median of 6 cycles of treatment (range 1–12).,Patients chemotherapy-alone arm received median 7 cycles treatment (range 2–16) chemotherapy panitumumab combination arm median 6 cycles treatment (range 1–12).,C0030705|C0013216|C0446516|C1514756|C0549183|G0000000|C1511572|C0039798|C1514721|G0000000|C0013216|C0879427|C0205195|C0446516|C0549183|G0000000|C1511572|C0039798|C1514721|G0000000
"Recent studies have demonstrated that exercise can improve mobility6–8 and functional balance9,10 in older adults with chronic stroke.","Recent studies demonstrated exercise improve mobility6–8 functional balance9,10 adults chronic stroke.",C0332185|C0947630|G0000000|C0015259|G0000000|G0000000|C0205245|C0450371|C0001675|C0205191|C0038454
Stroke recurrence is a major issue.,Stroke recurrence major issue.,C0038454|C0034897|C0205082|C0033213
4) Refusal to receive blood transfusion.,4) Refusal receive blood transfusion.,G0000000|G0000000|C1514756|C0005767|C0005841
Participants Ninety-eight patients aged 34 to 81 being treated for osteoarthritis of the knee.,Participants Ninety-eight patients aged 34 81 treated osteoarthritis knee.,C0679646|C3816959|C0030705|C0001779|C0450371|C0450371|C1522326|C0029408|C0022742
"Comprehensive overview on cliniconeuropathologic correlations CA, cavernous angioma; AVM, arteriovenous malformation.","Comprehensive overview cliniconeuropathologic correlations CA, cavernous angioma; AVM, arteriovenous malformation.",C1880156|C0814812|G0000000|C1707520|C3887642|C0205201|C0018916|C0003857|C0450109|C0000768
We found that prenatally supplementing pregnant women with zinc affected anthropometric growth and body composition of their infants through 12 mo of age.,We prenatally supplementing pregnant women zinc anthropometric growth body composition infants 12 mo age.,G0000000|G0000000|C0242295|C0549206|C0043210|C0043481|C0003188|C0018270|C0242821|C0486616|C0021270|C0450371|C0026544|C0001779
"The training was piloted in three courses delivered in 2005 to 20 senior KMTC and MOH staff, and 41 selected trainers from KMTC in Nairobi, its provincial medical training colleges and MOH rural health training centres.","The training piloted courses delivered 2005 20 senior KMTC MOH staff, 41 selected trainers KMTC Nairobi, provincial medical training colleges MOH rural health training centres.",G0000000|C0040607|C0473169|C0750729|C1705822|G0000000|C0450371|C1705825|G0000000|G0000000|C0851286|C0450371|C1707391|C0453962|G0000000|G0000000|G0000000|C0199168|C0040607|C0557806|G0000000|C0240919|C0018684|C0040607|C0205099
"To be eligible for the study, men or women (not pregnant or nursing) aged 18–65 years were required to meet DSM-IV criteria for current cannabis dependence; be seeking research-based outpatient treatment for cannabis dependence that involved daily medication; and have smoked marijuana at least once in the week prior to randomization.","To eligible study, women (not pregnant nursing) aged 18–65 required meet DSM-IV criteria current cannabis dependence; seeking research-based outpatient treatment cannabis dependence involved daily medication; smoked marijuana week prior randomization.",C0040363|C1548635|C0557651|C0043210|C1518422|C0549206|C0006147|C0001779|G0000000|C1514873|C1550543|C0220952|C0243161|C0521116|C0024808|C0011546|G0000000|C2986512|C0029921|C0039798|C0024808|C0011546|C1314939|C0332173|C0013227|C0037366|C0024808|C0332174|C0332152|C0034656
"The following were reasons for exclusion from the study: use of an NSAID or aspirin for more than one week in the three months preceding the study, unwillingness to discontinue taking NSAIDs, absence of the use of effective birth control in girls and young women of childbearing age, pregnancy, a white-cell count of less than 4000 per cubic millimeter, a platelet count of less than 100,000 per cubic millimeter, a blood urea nitrogen level of more than 25 mg per deciliter (8.9 mmol per liter), a serum creatinine level of more than 1.5 mg per deciliter (132.6 μmol per liter), a history of peptic ulcer disease or gastrointestinal hemorrhage, a history of cancer, active bacterial infection, use of dimethyl sulfoxide, a history of aspirin allergy, or a body weight of less than 20 kg.","The reasons exclusion study: NSAID aspirin week months preceding study, unwillingness discontinue NSAIDs, absence effective birth control girls women childbearing age, pregnancy, white-cell count 4000 cubic millimeter, platelet count 100,000 cubic millimeter, blood urea nitrogen level 25 deciliter (8.9 mmol liter), serum creatinine level 1.5 deciliter (132.6 μmol liter), history peptic ulcer disease gastrointestinal hemorrhage, history cancer, active bacterial infection, dimethyl sulfoxide, history aspirin allergy, body weight 20 kg.",G0000000|C0392360|C0680251|C0557651|C0003211|C0004057|C0332174|C0439231|C0332152|C0557651|C0558080|C1444662|C0003211|C0332197|C1280519|C0005615|C0243148|C0870604|C0043210|G0000000|C0001779|C0032961|C0023516|C0750480|G0000000|C1880194|C0439200|C0005821|C0750480|C1442061|C1880194|C0439200|C0005767|C0041942|C0028158|C0441889|C0450371|C0439241|G0000000|C0439190|C0475211|C0229671|C0010294|C0441889|G0000000|C0439241|C1442061|G0000000|C0475211|C0019664|C0443277|C0041582|C0012634|C0521362|C0019080|C0019664|C0006826|C0205177|C0521009|C0009450|G0000000|C0038770|C0019664|C0004057|C0002111|C0242821|C0005910|C0450371|C0022718
The remaining 184 (26%) were randomised (2:1) either to home support or to a standard hospital admission.,The remaining 184 (26%) randomised (2:1) support standard hospital admission.,G0000000|C1527428|C1442061|C0450371|G0000000|G0000000|C0183683|C1442989|C0019994|C0184666
The percentage of residents (after excluding those with schizophrenia or other psychotic disorders) who were still prescribed neuroleptics at the end of 12 months was less than half that in the control homes.,The percentage residents (after excluding schizophrenia psychotic disorders) prescribed neuroleptics 12 months half control homes.,G0000000|C0439165|C1320928|G0000000|C0332196|C0036341|C0004936|C0012634|C0278329|C0040615|C0450371|C0439231|C2825407|C0243148|C0442519
"After this 2-week run-in period, patients who continued to have a VAS pain score ≥40 mm and who still expressed dissatisfaction with treatment were eligible for randomization.","After 2-week run-in period, patients continued VAS pain score ≥40 mm expressed dissatisfaction treatment eligible randomization.",G0000000|C0332174|C3274438|C0439531|C0030705|C0549178|C0042815|C0030193|C0449820|G0000000|G0000000|G0000000|C0870433|C0039798|C1548635|C0034656
"Minimum followup was 32 months (mean, 99 months; range, 32–312 months) for the patients who remained alive in the end of the study.","Minimum followup 32 months (mean, 99 months; range, 32–312 months) patients remained alive study.",C1524031|C0589120|C0450371|C0439231|C0444504|C0450371|C0439231|C1514721|G0000000|C0439231|C0030705|G0000000|C0376558|C0557651
Increased intervention intensity yields greater smoking cessation among parents of asthmatic children and better asthma outcomes.,Increased intervention intensity yields smoking cessation parents asthmatic children asthma outcomes.,C0205217|C0886296|C0522510|G0000000|C0037369|C1880019|C0030551|C0004096|C0008059|C0004096|C1274040
"We analyzed polysomnographic data of 16 SB subjects (6 males and 10 females; mean age 24.5; range 21 to 31) recorded in our laboratory between 2000 and 2004.4 Subjects were selected based on a history of tooth-grinding (> 3 nights/week) and clinical signs and symptoms of SB (tooth wear, masseter muscle hypertrophy, morning jaw muscle fatigue or tenderness).","We analyzed polysomnographic data 16 SB subjects (6 males 10 females; age 24.5; range 21 31) recorded laboratory 2000 2004.4 Subjects selected based history tooth-grinding (> 3 nights/week) clinical signs symptoms SB (tooth wear, masseter muscle hypertrophy, morning jaw muscle fatigue tenderness).",G0000000|C0936012|G0000000|C1511726|C0450371|C0038111|C0681850|G0000000|C0086582|C0450371|C0015780|C0001779|C0450371|C1514721|C0450371|C0450371|C0034869|C0022877|G0000000|G0000000|C0681850|C1707391|C1527178|C0019664|C0040426|G0000000|G0000000|C0240526|C0205210|C0220912|C0683368|C0038111|C0040426|G0000000|C0024876|C0026845|C0020564|C0332170|C0022359|C0026845|C0015672|C0234233
metformin) in the severe RI population.,metformin) severe RI population.,C0025598|C0205082|C0035487|C0032659
This may have resulted in children being less likely to perceive and/or report changes related to treatment.,This children perceive and/or report treatment.,G0000000|C0008059|G0000000|G0000000|C0684224|C0039798
"Women with childbearing potential were required to use effective contraception, and pregnant or nursing women were excluded from the study.","Women childbearing potential required effective contraception, pregnant nursing women excluded study.",C0043210|G0000000|C3245505|C1514873|C1280519|C0700589|C0549206|C0006147|C0043210|C1554077|C0557651
"Using the criteria developed, high risk infants entered the study and received erythropoietin or sham treatment until 34 weeks completed gestation.","Using criteria developed, risk infants entered study received erythropoietin sham treatment 34 weeks completed gestation.",C1524063|C0243161|G0000000|C0035647|C0021270|C1521975|C0557651|C1514756|C0014822|C0068899|C0039798|C0450371|C0439230|C0205197|C0032961
"Patients were eligible for inclusion if they fulfilled the COPE II (Study of the effects of self-treatment and an exercise program within a self-management program in outpatients with COPD) study criteria, as described previously.19 These include, eg, no exacerbation in the month prior to enrollment and three or more exacerbations or one hospitalization for respiratory problems in the 2 years preceding study entry.","Patients eligible inclusion fulfilled COPE II (Study effects self-treatment exercise program self-management program outpatients COPD) study criteria, previously.19 These include, eg, exacerbation month prior enrollment exacerbations hospitalization respiratory 2 preceding study entry.",C0030705|C1548635|C0007637|C1550543|C0009967|G0000000|C0557651|C1280500|C0679887|C0015259|C1709697|C0086969|C1709697|C0029921|C0024117|C0557651|C0243161|C0450371|G0000000|C0332257|C0013715|G0000000|C0332177|C0332152|C1516879|G0000000|C0019993|C0521346|G0000000|C0332152|C0557651|C1705654
120 eligible pregnant women since 20 weeks of pregnancy who referred to these centers were selected simply and randomized in two groups (60 in the case and 60 in the control group).,120 eligible pregnant women 20 weeks pregnancy referred centers selected simply randomized (60 60 control group).,C1442061|C1548635|C0549206|C0043210|C0450371|C0439230|C0032961|C0205543|C0205099|C1707391|G0000000|C0034656|C0450371|C0450371|C0243148|C0441833
Neutropenia was known almost 3 decades ago as a major predisposing factor for the development of infection in patients with cancer.,Neutropenia 3 decades ago major predisposing factor development infection patients cancer.,C0023530|G0000000|C2981279|G0000000|C0205082|C0231203|C1521761|C0243107|C0009450|C0030705|C0006826
"Exclusion criteria were mainly based on contra-indications for WBV: presence of infectious disease, insulin-dependent diabetes mellitus, endogenous osteosynthethical material, knee or hip prosthesis, pacemaker, epilepsy, musculo-skeletal disorders and cognitive or physical dysfunction interfering with test and training procedures.","Exclusion criteria based contra-indications WBV: presence infectious disease, insulin-dependent diabetes mellitus, endogenous osteosynthethical material, knee hip prosthesis, pacemaker, epilepsy, musculo-skeletal disorders cognitive physical dysfunction interfering test training procedures.",C0680251|C0243161|C1527178|C0392360|G0000000|C0150312|C0009450|C0012634|C0021641|C0011847|G0000000|C0205227|G0000000|C0520510|C0022742|C0019552|C0175649|C0030163|C0014544|C0026860|C0012634|C1516691|C0031809|C0031847|C0521102|C0022885|C0040607|C0025664
3 months after the intervention was complete).,3 months intervention complete).,G0000000|C0439231|C0886296|C0205197
"This Hypericum perforatum extract is therapeutically equivalent to imipramine in treating mild to moderate depression, but patients tolerate hypericum better.","This Hypericum perforatum extract therapeutically equivalent imipramine treating mild moderate depression, patients tolerate hypericum better.",G0000000|C1256259|G0000000|C2828366|G0000000|C0205163|C0020934|C1522326|C2945599|C0205081|C0011570|C0030705|G0000000|C1256259|C0332272
"Patients were randomized between the salmon calcitonin 200 U/day + physical therapy (n = 23) (Group 1) and paracetamol 1,500 mg/day + physical therapy (n = 22) (Group 2) treatment groups.","Patients randomized salmon calcitonin 200 U/day + physical therapy (n = 23) (Group 1) paracetamol 1,500 mg/day + physical therapy (n = 22) (Group 2) treatment groups.",C0030705|C0034656|C0036110|C0006668|C1442061|C0456683|G0000000|C0031809|C0039798|C0369718|G0000000|C0450371|C0441833|G0000000|C0000970|C1442061|C0439422|G0000000|C0031809|C0039798|C0369718|G0000000|C0450371|C0441833|G0000000|C0039798|C0441833
"A total population of 25,354 people centred around health facilities in the 14 clusters participated in the study and were followed up for a period of 29 months in Luangwa and 26 months in Nyimba, starting from January 2011 and April 2011, respectively.","A total population 25,354 people centred health facilities 14 clusters participated study period 29 months Luangwa 26 months Nyimba, starting January 2011 April 2011, respectively.",G0000000|C0439175|C0032659|C0450371|C0027361|C0205099|C0018684|C1547538|C0450371|C1555715|G0000000|C0557651|C0439531|C0450371|C0439231|G0000000|C0450371|C0439231|G0000000|C0439659|C3829466|G0000000|C3715024|G0000000|G0000000
They also had to have evidence of poor asthma control which was defined as: having prescriptions for at least two courses of prednisolone or 10 canisters of short-acting β2-agonist in the year prior to the study; and taking four or more rescue puffs of β2-agonist for at least 4 days a week over the previous 4 weeks.,They evidence poor asthma control defined as: prescriptions courses prednisolone 10 canisters short-acting β2-agonist prior study; rescue puffs β2-agonist 4 days week previous 4 weeks.,G0000000|C3887511|C0032854|C0004096|C0243148|C1704788|G0000000|C0033080|C0750729|C0032950|C0450371|C0336640|C1282927|G0000000|C0332152|C0557651|G0000000|C1533107|G0000000|G0000000|C0439228|C0332174|C0205156|G0000000|C0439230
"With weight reduction alone, only about 10% of the subjects achieved an AHI <5.","With weight reduction alone, 10% subjects achieved AHI <5.",G0000000|C0005910|C0301630|C0205171|C0450371|C0681850|G0000000|G0000000|G0000000
"Orthodontic treatment of a functional unilateral posterior crossbite with a bonded maxillary expansion device followed by U-bow activator therapy in the late deciduous and early mixed dentition is an effective therapeutic method, as evidenced by the results of this RCT.","Orthodontic treatment functional unilateral posterior crossbite bonded maxillary expansion device U-bow activator therapy late deciduous mixed dentition effective therapeutic method, evidenced RCT.",C0332276|C0039798|C0205245|C0205092|C0205095|C0242385|G0000000|C0024947|G0000000|C0025080|G0000000|G0000000|C0039798|C0205087|G0000000|C0205430|C0011443|C1280519|C0087111|C0025663|C3887511|G0000000
"Exclusion criteria: Aged under 20 years or over 70 years, smoking less than 10 cigarettes daily, history of major depression and other psychiatric conditions, dementias and serious or terminal illness (cancers etc.).","Exclusion criteria: Aged 20 70 years, smoking 10 cigarettes daily, history major depression psychiatric conditions, dementias terminal illness (cancers etc.).",C0680251|C0243161|C0001779|C0450371|C0450371|C0439234|C0037369|C0450371|C0677453|C0332173|C0019664|C0205082|C0011570|C0205487|C0012634|C0497327|C0205088|C0221423|C0006826|C1548556
"Exclusion criteria included: untreated, newly diagnosed metastases in the CNS; other coexisting malignancies or malignancies diagnosed within the last 5 years other than basal cell carcinoma or cervical cancer in situ; fewer than 4 weeks since completion of wide-field radiotherapy or persistence of any radiotherapy-related toxicity; unresolved chronic toxicity greater than National Cancer Institute Common Toxicity Criteria for Adverse Events grade 2 from previous anticancer therapy (except alopecia); evidence of clinically active interstitial lung disease; prior treatment with epidermal growth factor receptor inhibitors, biologic, or immunological therapy; and treatment with an investigational drug within the prior 30 days.","Exclusion criteria included: untreated, newly diagnosed metastases CNS; coexisting malignancies malignancies diagnosed 5 basal cell carcinoma cervical cancer situ; fewer 4 weeks completion wide-field radiotherapy persistence radiotherapy-related toxicity; unresolved chronic toxicity National Cancer Institute Common Toxicity Criteria Adverse Events grade 2 previous anticancer therapy (except alopecia); evidence clinically active interstitial lung disease; prior treatment epidermal growth factor receptor inhibitors, biologic, immunological therapy; treatment investigational drug prior 30 days.",C0680251|C0243161|C0332257|C0332155|C0750546|C0011900|C0027627|C3714787|G0000000|C0006826|C0006826|C0011900|G0000000|C0205112|C0007634|C0007097|C0027530|C0006826|G0000000|C0205388|G0000000|C0439230|C0205197|C0332464|C0034619|C0546816|C0034619|C0040539|C0443342|C0205191|C0040539|C3245503|C0006826|C0021622|C0205214|C0040539|C0243161|G0000000|C0441471|C0441800|G0000000|C0205156|G0000000|C0039798|G0000000|C0002170|C3887511|G0000000|C0205177|C0596790|C0024109|C0012634|C0332152|C0039798|C0014520|C0018270|C1521761|C0597357|C0243077|C0005515|C0205470|C0039798|C0039798|C1517586|C0013227|C0332152|C0450371|C0439228
Patients who are already on mannitol or HS treatment were also excluded from the study.,Patients mannitol HS treatment excluded study.,C0030705|C0024730|G0000000|C0039798|C1554077|C0557651
The subjects included pregnant women with epilepsy treated with AED monotherapy.,The subjects included pregnant women epilepsy treated AED monotherapy.,G0000000|C0681850|C0332257|C0549206|C0043210|C0014544|C1522326|C0887457|G0000000
Computer-generated random allocation was done by an independent randomisation centre (University of Ulm) and sealed envelopes are used.,Computer-generated random allocation independent randomisation centre (University Ulm) sealed envelopes used.,C0009622|C0034656|C1706778|C0085862|C0034656|C0205099|C0041740|G0000000|C0036492|C1622204|C1273517
"The exclusion criteria were: 1) patients with multifocal or bilateral independent seizure onsets; 2) recordings acquired at <1,000 Hz sampling rate; 3) non-resective surgery.","The exclusion criteria were: 1) patients multifocal bilateral independent seizure onsets; 2) recordings acquired <1,000 Hz sampling rate; 3) non-resective surgery.",G0000000|C0680251|C0243161|G0000000|G0000000|C0030705|C0205292|C0238767|C0085862|C0036572|C1299997|G0000000|G0000000|C0439661|C1442061|C0439482|C0441621|C0871208|G0000000|C1518422|C0038894
The key exclusion criteria included: current diagnosis of asthma or other respiratory disorders; hospitalisation for COPD or pneumonia within 12 weeks before the screening visit; lung volume reduction surgery 12 months before this visit; or long-term oxygen use.,The key exclusion criteria included: current diagnosis asthma respiratory disorders; hospitalisation COPD pneumonia 12 weeks screening visit; lung volume reduction surgery 12 months visit; long-term oxygen use.,G0000000|G0000000|C0680251|C0243161|C0332257|C0521116|C0011900|C0004096|C0521346|C0012634|C0019993|C0024117|C0032285|G0000000|C0220908|C0545082|C0024109|C0449468|C0301630|C0038894|G0000000|C0545082|C0443252|C0030054|C0042153
"The individuals who had following criteria were not included to the study: Having a chronic illness (e.g., cancer, renal failure, cardiovascular disease, liver, and lung failure), uncontrolled hypertension (defined as a blood pressure ≥180/100 mmHg), taking lipid-lowering medications or vitamin supplements, an inflammatory condition (e.g., lupus), diabetes or use of anti-hyperglycemic drugs, working night shifts, pregnancy or lactation, smoking, alcohol consumption or any known allergy or sensitivity to nuts.","The individuals criteria included study: Having chronic illness (e.g., cancer, renal failure, cardiovascular disease, liver, lung failure), uncontrolled hypertension (defined blood pressure ≥180/100 mmHg), lipid-lowering medications vitamin supplements, inflammatory condition (e.g., lupus), diabetes anti-hyperglycemic drugs, night shifts, pregnancy lactation, smoking, alcohol consumption allergy sensitivity nuts.",G0000000|C0027361|C0243161|C0332257|C0557651|G0000000|C0205191|C0221423|G0000000|C0006826|C0022646|C0231174|C0007226|C0012634|C0023884|C0024109|C0231174|C0205318|C0020538|C1704788|C0005767|C0033095|G0000000|C0439475|C0023779|C0013227|C0042890|C0242295|C0333348|C0012634|G0000000|C0024131|C0011847|G0000000|C0013227|C0240526|C0333051|C0032961|C0006147|C0037369|C0001962|C0009830|C0002111|C0020517|C0028723
"Exclusion criteria included: (i) a diagnosis of specific chondrosarcoma, such as clear cell, mesenchymal or extraskeletal myxoid chondrosarcoma; (ii) chondrosarcomas diagnosed as borderline Grade I/II; and (iii) cases with recurrence of chondrosarcoma or a surgical history in another hospital.","Exclusion criteria included: (i) diagnosis specific chondrosarcoma, cell, mesenchymal extraskeletal myxoid chondrosarcoma; (ii) chondrosarcomas diagnosed borderline Grade I/II; (iii) recurrence chondrosarcoma surgical history hospital.",C0680251|C0243161|C0332257|C0021966|C0011900|C0205369|C0008479|C0007634|C1513143|C1711349|C0205295|C0008479|G0000000|C0008479|C0011900|C0205189|C0441800|C0021966|C0439070|C0034897|C0008479|C0543467|C0019664|C0019994
"Remission was defined as a mean of <3 stools/day, including a mean of <1 watery stool/day.","Remission defined <3 stools/day, including <1 watery stool/day.",C0544452|C1704788|G0000000|C0015733|C0332257|G0000000|C0443350|C0015733
"PREADVISE recruited a subsample of SELECT participants age 62 and over (age 60 if black) at 130 participating clinical sites in the US, Canada, and Puerto Rico.","PREADVISE recruited subsample SELECT participants age 62 (age 60 black) 130 participating clinical sites US, Canada, Puerto Rico.",G0000000|G0000000|G0000000|C1707391|C0679646|C0001779|C0450371|C0001779|C0450371|C0005680|C1442061|C0679823|C0205210|C0205145|G0000000|C0006823|G0000000|G0000000
Pregnant women received prenatal care and each adverse pregnancy outcome was managed according to the standard guidelines.,Pregnant women received prenatal care adverse pregnancy outcome managed standard guidelines.,C0549206|C0043210|C1514756|C0678804|C1947933|G0000000|C0032961|C1274040|C1273870|C1442989|C0162791
"Inclusion criteria were diagnosis of chronic respiratory disease (chronic obstructive pulmonary disease, chronic asthma, bronchiectasis, or interstitial lung disease), self reported breathlessness on exertion when stable (Medical Research Council dyspnoea grade 3 or worse), and age 40 years or greater.","Inclusion criteria diagnosis chronic respiratory disease (chronic obstructive pulmonary disease, chronic asthma, bronchiectasis, interstitial lung disease), reported breathlessness exertion stable (Medical Research Council dyspnoea grade 3 worse), age 40 greater.",C0007637|C0243161|C0011900|C0205191|C0521346|C0012634|C0205191|C0549186|C0024109|C0012634|C0205191|C0004096|C0006267|C0596790|C0024109|C0012634|C0684224|C0013404|C0015264|C0205360|C0199168|C0035168|C1551807|C0013404|C0441800|G0000000|C0332271|C0001779|C0450371|C1704243
31 patients were excluded from this analysis—6 patients who were primarily treated with palliative intent and 25 patients with follow-up of less than 5 years after diagnosis—leaving 115 patients for this study.,31 patients excluded analysis—6 patients treated palliative intent 25 patients follow-up 5 diagnosis—leaving 115 patients study.,C0450371|C0030705|C1554077|G0000000|C0030705|C1522326|C0587605|C0162425|C0450371|C0030705|C0589120|G0000000|G0000000|C1442061|C0030705|C0557651
"In six Dutch hospitals, at-risk patients aged 70 years or older acutely admitted through the emergency department for general medicine and surgical specialties are randomised (n = 390) for treatment with prophylactic haloperidol 1 mg or placebo twice daily for a maximum of seven consecutive days.","In Dutch hospitals, at-risk patients aged 70 acutely admitted emergency department medicine surgical specialties randomised (n = 390) treatment prophylactic haloperidol 1 placebo daily maximum consecutive days.",G0000000|C0013331|C0019994|C1444641|C0030705|C0001779|C0450371|G0000000|C0184666|C0013956|C1704729|C0013227|C0543467|C0037778|G0000000|G0000000|C0039798|C0355642|C0018546|G0000000|C0032042|C0332173|C0806909|C1707491|C0439228
"We conducted a randomized, double-blind, placebo-controlled, parallel-group study of 61 subjects who had refractory eosinophilic asthma and a history of recurrent severe exacerbations.","We conducted randomized, double-blind, placebo-controlled, parallel-group study 61 subjects refractory eosinophilic asthma history recurrent severe exacerbations.",G0000000|C0004927|C0034656|C0013072|C1706408|C2348042|C0557651|C0450371|C0681850|C0205269|C0333930|C0004096|C0019664|C2945760|C0205082|G0000000
"Inclusion criteria included: BW of less than 1,500 g or 3.3 lb, born at Penn State Milton S. Hershey Medical Center.","Inclusion criteria included: BW 1,500 3.3 lb, born Penn State Milton S. Hershey Medical Center.",C0007637|C0243161|C0332257|C0005910|C1442061|G0000000|G0000000|C0005615|G0000000|C1301808|G0000000|C0565930|G0000000|C0199168|C0205099
"Exclusion criteria were any clinical or laboratory feature of severe malaria [22], haemoglobin concentration of less than 7 g/dl, concomitant disease that would mask treatment responses, known allergy to any of the study drugs, anti-malarial treatment in the previous month, mixed species Plasmodium infection, pregnancy (or unwillingness to undergo pregnancy testing), lactation, and anticipated inability or unwillingness to complete the 56 day follow-up.","Exclusion criteria clinical laboratory feature severe malaria [22], haemoglobin concentration 7 g/dl, concomitant disease mask treatment responses, allergy study drugs, anti-malarial treatment previous month, mixed species Plasmodium infection, pregnancy (or unwillingness undergo pregnancy testing), lactation, anticipated inability unwillingness complete 56 day follow-up.",C0680251|C0243161|C0205210|C0022877|C1521970|C0205082|C0024530|C0450371|C0019046|C0004268|G0000000|C0439267|C0521115|C0012634|C0024861|C0039798|C0871261|C0002111|C0557651|C0013227|C0003374|C0039798|C0205156|C0332177|C0205430|C1705920|C0032148|C0009450|C0032961|G0000000|C0558080|G0000000|C0032961|C0039593|C0006147|C3840775|G0000000|C0558080|C0205197|C0450371|C0332173|C0589120
"Households randomized to the Education (n=174), Hand Sanitizer (n=169), or Hand Sanitizer and Face Mask (n=166) group were comparable in terms of mean household size (five members, range: 3–14), gender, ages, and proportion born outside the U.S.","Households randomized Education (n=174), Hand Sanitizer (n=169), Hand Sanitizer Face Mask (n=166) comparable terms household size (five members, range: 3–14), gender, ages, proportion born U.S.",C0020052|C0034656|C0013621|C0369718|C0018563|C0183086|C0369718|C0018563|C0183086|C0015450|C0024861|C0369718|G0000000|C0233324|C0020052|C0456389|C0205451|C0680022|C1514721|G0000000|C0079399|C0001779|C1709707|C0005615|C0041703
"Children between 5 and 10 years, all Caucasians, were included, if they presented symptoms such as wheezing, prolonged cough or shortness of breath, suggesting asthma for at least 1 month before entry into the study, and significant bronchial reversibility.","Children 5 10 years, Caucasians, included, symptoms wheezing, prolonged cough shortness breath, suggesting asthma 1 month entry study, bronchial reversibility.",C0008059|G0000000|C0450371|C0439234|C0007457|C0332257|C0683368|C0043144|C0439590|C0010200|C1282927|C0225386|C1705535|C0004096|G0000000|C0332177|C1705654|C0557651|C0205039|C0449261
"Patients with chronic diarrhea of any grade, inflammatory bowel disease, uncontrolled comorbid illness, or other malignancies were excluded.","Patients chronic diarrhea grade, inflammatory bowel disease, uncontrolled comorbid illness, malignancies excluded.",C0030705|C0205191|C0011991|C0441800|C0333348|C0021853|C0012634|C0205318|C0009488|C0221423|C0006826|C1554077
"The majority of participants were freshman (61%), 19.2% were sophomores, 9.6% were juniors, and 10.2% were seniors or above; their average age was 19.3 years (SD = 1.8, range 18–29).","The majority participants freshman (61%), 19.2% sophomores, 9.6% juniors, 10.2% seniors above; average age 19.3 (SD = 1.8, range 18–29).",G0000000|C0680220|C0679646|G0000000|C0450371|C0450371|G0000000|G0000000|C1708595|C0450371|C1456594|C1282910|C1510992|C0001779|C0450371|G0000000|G0000000|G0000000|C1514721|G0000000
"CD4+ cell count below 200/mm2 and/or one opportunistic infection; CDC, 1993), and have at least a 6th grade level of education.","CD4+ cell count 200/mm2 and/or opportunistic infection; CDC, 1993), 6th grade level education.",C0285590|C0007634|C0750480|C1442061|G0000000|G0000000|C0009450|C0007670|G0000000|G0000000|C0441800|C0441889|C0013621
Patients will be recruited nationwide from 17 university hospitals or cancer centres in France.,Patients recruited nationwide 17 university hospitals cancer centres France.,C0030705|G0000000|G0000000|C0450371|C0041740|C0019994|C0006826|C0205099|C0016674
Mild to moderate cases with dementia (diagnosed using the DSM IV criteria and graded using the Clinical Dementia Rating scale) and their caregivers were included in the trial.,Mild moderate dementia (diagnosed DSM IV criteria graded Clinical Dementia Rating scale) caregivers included trial.,C2945599|C0205081|C0011265|C0011900|G0000000|C0022326|C0243161|C0441800|C0205210|C0011265|C0871208|C0175659|C0085537|C0332257|C0008976
"They needed to be: community dwelling and ambulatory with a gait speed ranging from of 0.42 to 1.3 m*s−1, able to recall all three items (or one to two items with a normal clock drawing test) on the Mini-Cog™ instrument for dementia screening [24], managing two or more co-morbid conditions- though cleared by their physician to participate in a 60 min (with rests) MCERFP.","They be: community dwelling ambulatory gait speed ranging 0.42 1.3 m*s−1, recall items (or items normal clock drawing test) Mini-Cog™ instrument dementia screening [24], managing co-morbid conditions- cleared physician participate 60 min (with rests) MCERFP.",G0000000|G0000000|C0009462|C0442519|C0439841|C0016928|C0678536|C1514721|C0450371|G0000000|G0000000|C0034770|C1551338|G0000000|C1551338|C0205307|C1413503|C0013113|C0022885|G0000000|C0348000|C0011265|C0220908|C0450371|C1273870|C0009488|C0012634|C0521097|C0031831|G0000000|C0450371|C0702093|G0000000|C0035253|G0000000
OBJECTIVE: To assess three prescribing strategies for sore throat.,OBJECTIVE: To assess prescribing strategies sore throat.,C0018017|C0040363|C1516048|C0278329|C0679199|C0234233|C0031354
"The inclusion criteria were: (1) ethnic Chinese; (2) age 18 to 65 years; (3) chief complaint of insomnia; (4) previous diagnosis of MDD based on the DSM-IV criteria, as assessed by a clinician; (5) 17 item Hamilton Rating Scale for Depression (HDRS17) score ≤ 18 at screening and baseline; and (6) taking the same antidepressants at a fixed dose for 12 weeks prior to baseline.","The inclusion criteria were: (1) ethnic Chinese; (2) age 18 65 years; (3) chief complaint insomnia; (4) previous diagnosis MDD based DSM-IV criteria, assessed clinician; (5) 17 item Hamilton Rating Scale Depression (HDRS17) score ≤ 18 screening baseline; (6) antidepressants fixed dose 12 weeks prior baseline.",G0000000|C0007637|C0243161|G0000000|G0000000|C0015031|C0008120|G0000000|C0001779|C0450371|C0450371|C0439234|G0000000|G0000000|C0277786|C0917801|G0000000|C0205156|C0011900|C1269683|C1527178|C0220952|C0243161|C1516048|C0871685|G0000000|C0450371|C1551338|G0000000|C0871208|C0175659|C0011570|G0000000|C0449820|G0000000|C0450371|C0220908|C0168634|G0000000|C0003289|C0443218|C0178602|C0450371|C0439230|C0332152|C0168634
"All girls lived in Birmingham, United Kingdom, and (a) were registered with general practitioners within the BEN and Heart of Birmingham Primary Care Trusts; (b) were eligible to be vaccinated through the participating community clinics (Sutton Cottage, Partners in Health, and Dove Medical Centre); and (c) had not been vaccinated against HPV before.","All girls lived Birmingham, United Kingdom, (a) registered practitioners BEN Heart Birmingham Primary Care Trusts; (b) eligible vaccinated participating community clinics (Sutton Cottage, Partners Health, Dove Medical Centre); (c) vaccinated HPV before.",G0000000|C0870604|C1548795|G0000000|C0166872|C1708611|G0000000|C1514821|C1709627|C0538294|C0018787|G0000000|C0205225|C1947933|C0237935|G0000000|C1548635|C1116171|C0679823|C0009462|C0442592|G0000000|C0557608|C0682323|C0018684|C0325912|C0199168|C0205099|G0000000|C1116171|C0021344|C0332152
"A total of 7,359 children were randomized (1:1 ratio) to receive either PHiD-CV (PHiD-CV group) or control vaccines (Control group) at 2, 4, 6 and 15–18 months of age, as described previously.6 In short, the PHiD-CV group received PHiD-CV (Synflorix™) and diphtheria–tetanus–acellular pertussis–hepatitis B–inactivated poliovirus–Haemophilus influenzae type b vaccine (Infanrix hexa™) at 2, 4, and 6 months of age followed by one dose of PHiD-CV at 15–18 months of age, while the control group received hepatitis B vaccine (Engerix-B™) and diphtheria–tetanus–acellular pertussis–inactivated poliovirus–Haemophilus influenzae type b vaccine (DTPa-IPV/Hib; Infanrix™-IPV/Hib) followed by one dose of hepatitis A vaccine (Havrix™).","A total 7,359 children randomized (1:1 ratio) receive PHiD-CV (PHiD-CV group) control vaccines (Control group) 2, 4, 6 15–18 months age, previously.6 In short, PHiD-CV received PHiD-CV (Synflorix™) diphtheria–tetanus–acellular pertussis–hepatitis B–inactivated poliovirus–Haemophilus influenzae type vaccine (Infanrix hexa™) 2, 4, 6 months age dose PHiD-CV 15–18 months age, control received hepatitis B vaccine (Engerix-B™) diphtheria–tetanus–acellular pertussis–inactivated poliovirus–Haemophilus influenzae type vaccine (DTPa-IPV/Hib; Infanrix™-IPV/Hib) dose hepatitis A vaccine (Havrix™).",G0000000|C0439175|C1442061|C0008059|C0034656|G0000000|C0456603|C1514756|C1864445|C1864445|C0441833|C0243148|C0042210|C0243148|C0441833|G0000000|G0000000|G0000000|G0000000|C0439231|C0001779|G0000000|G0000000|C1282927|C1864445|C1514756|C1864445|G0000000|G0000000|G0000000|G0000000|G0000000|C0021400|C0332307|C0042210|C0728745|G0000000|G0000000|G0000000|G0000000|C0439231|C0001779|C0178602|C1864445|G0000000|C0439231|C0001779|C0243148|C1514756|C0019158|G0000000|C0042210|G0000000|G0000000|G0000000|G0000000|C0021400|C0332307|C0042210|C0013254|G0000000|C0178602|C0019158|G0000000|C0042210|G0000000
"Participants were eligible for the study if HIV infection was documented, had low plasma zinc levels (<0.75 μg/ml), were ≥18 years, and did not have history of endocrine or psychiatric disorders; premenopausal women were excluded if pregnant or had intention to become pregnant.","Participants eligible study HIV infection documented, low plasma zinc levels (<0.75 μg/ml), ≥18 years, history endocrine psychiatric disorders; premenopausal women excluded pregnant intention pregnant.",C0679646|C1548635|C0557651|C0019682|C0009450|C1301725|C0205251|C0032105|C0043481|C0441889|C0450371|G0000000|G0000000|C0439234|C0019664|C0014136|C0205487|C0012634|C0279752|C0043210|C1554077|C0549206|C0162425|C0549206
"Approximately 69% of the Hmong in the intervention group resided in Fresno County and, within this group, 55% of adults lived below the federal poverty level and 50% received public assistance.14 Demographic Characteristics of Hmong Women (N = 434) Participating in a Culturally Informed Breast Cancer Screening Education Program: Central and Southern California, 1999–2001 Note.","Approximately 69% Hmong intervention resided Fresno County and, group, 55% adults lived federal poverty level 50% received public assistance.14 Demographic Characteristics Hmong Women (N = 434) Participating Culturally Informed Breast Cancer Screening Education Program: Central Southern California, 1999–2001 Note.",C0332232|C0450371|C1553324|C0886296|C2982691|C2625220|C0079170|G0000000|C0441833|C0450371|C0001675|C1548795|G0000000|C0032854|C0441889|C0450371|C1514756|G0000000|C0018896|C0011298|C1521970|C1553324|C0043210|C0369718|G0000000|C1442061|C0679823|C0010453|C1522154|C0006141|C0006826|C0220908|C0013621|C1709697|C0205099|C1710133|C0006754|G0000000|C1316572
"To be eligible, participants must have taken dopaminergic therapy (levodopa or a dopamine agonist) for at least 90 days but no more than 2 years (Supplementary Table 1).","To eligible, participants dopaminergic therapy (levodopa dopamine agonist) 90 days 2 (Supplementary Table 1).",C0040363|C1548635|C0679646|C0282151|C0039798|C0023570|C0013030|C2987634|C0450371|C0439228|G0000000|G0000000|C0039224|G0000000
VRRT is an exercise that can be safely applied to people with stroke.,VRRT exercise safely applied people stroke.,G0000000|C0015259|G0000000|C4048755|C0027361|C0038454
"The study participants will be patients who are receiving mechanical ventilation for 1 day or more, who are expected to stay in the ICU for an additional 2 days or more, and who meet no exclusion criteria.","The study participants patients receiving mechanical ventilation 1 day more, expected stay ICU additional 2 days more, meet exclusion criteria.",G0000000|C0557651|C0679646|C0030705|C1514756|C0443254|C0035203|G0000000|C0332173|C0205172|C1517001|G0000000|C0021708|C1524062|G0000000|C0439228|C0205172|C1550543|C0680251|C0243161
The analysis sample (aged 11–14 at baseline) included slightly more girls than boys (Table 1).,The analysis sample (aged 11–14 baseline) included girls boys (Table 1).,G0000000|C0002778|C0370003|C0001779|G0000000|C0168634|C0332257|C0870604|C0870221|C0039224|G0000000
"There were 153 Plasmodium falciparum (Pf), 158 Plasmodium vivax (Pv) and 90 P.falciparum/P.vivax malaria (Figure (Figure2).2).","There 153 Plasmodium falciparum (Pf), 158 Plasmodium vivax (Pv) 90 P.falciparum/P.vivax malaria (Figure (Figure2).2).",G0000000|C1442061|C0032148|G0000000|C3815179|C1442061|C0032148|G0000000|C0032463|C0450371|C0858321|C0024530|G0000000|G0000000
"Overall, 583 patients were assessed from February 1998 to August 1999, of whom 192 met the entry criteria (figure).","Overall, 583 patients assessed February 1998 August 1999, 192 met entry criteria (figure).",C0282416|C1442061|C0030705|C1516048|C3830166|G0000000|C3831448|G0000000|C1442061|C0268621|C1705654|C0243161|G0000000
Sensitivity analysis that included the dropouts and assumed a range of possibilities about their smoking status did not alter our results.,Sensitivity analysis included dropouts assumed range possibilities smoking status alter results.,C0020517|C0002778|C0332257|C0013135|C3242379|C1514721|C0332149|C0037369|C0449438|C0392747|C1274040
"There were 153 Plasmodium falciparum, 158 Plasmodium vivax and 90 P. falciparum/P.","There 153 Plasmodium falciparum, 158 Plasmodium vivax 90 P. falciparum/P.",G0000000|C1442061|C0032148|G0000000|C1442061|C0032148|G0000000|C0450371|C0369773|C0369773
"Despite random assignment of subjects to one of three groups, subjects randomized to the control condition were significantly younger (82 ± 10, post hoc Bonferroni P = .04) than subjects in the LP group (89 ± 7).","Despite random assignment subjects groups, subjects randomized control condition (82 ± 10, post hoc Bonferroni P = .04) subjects LP (89 ± 7).",G0000000|C0034656|C1516050|C0681850|C0441833|C0681850|C0034656|C0243148|C0012634|C0450371|G0000000|C0450371|C0687676|G0000000|G0000000|C0369773|G0000000|C0450371|C0681850|C0037943|C0450371|G0000000|G0000000
"Nivolumab alone or combined with ipilimumab significantly improved progression-free survival, as compared with ipilimumab, among previously untreated patients with metastatic melanoma.","Nivolumab combined ipilimumab improved progression-free survival, compared ipilimumab, untreated patients metastatic melanoma.",C3657270|C0205195|C1367202|C0184511|C0242656|C0038952|C1707455|C1367202|C0332155|C0030705|C0036525|C0025202
Setting Multicentre trial in nine outpatient rehabilitation centres in the Netherlands Participants Patients with stroke who were able to walk a minimum of 10 m without physical assistance and were discharged from inpatient rehabilitation to an outpatient rehabilitation clinic.,Setting Multicentre trial outpatient rehabilitation centres Netherlands Participants Patients stroke walk minimum 10 physical assistance discharged inpatient rehabilitation outpatient rehabilitation clinic.,C0542559|C0439743|C0008976|C0029921|C0034991|C0205099|C0027778|C0679646|C0030705|C0038454|C0080331|C1524031|C0450371|C0031809|C0018896|C0030685|C0021562|C0034991|C0029921|C0034991|C0002424
Cannabis use disorder is the most common co-occurring drug use disorder in people with schizophrenia and is associated with poor outcomes.,Cannabis disorder common co-occurring drug disorder people schizophrenia poor outcomes.,C0024808|C0012634|C0205214|C3245499|C0013227|C0012634|C0027361|C0036341|C0032854|C1274040
Children whose mothers/caregivers had diarrhea in the 2 weeks period preceding the survey were two times more likely to develop diarrhea than children whose mothers/caregivers had no diarrhea in the given period of time.,Children mothers/caregivers diarrhea 2 weeks period preceding survey times develop diarrhea children mothers/caregivers diarrhea period time.,C0008059|C0026591|C0011991|G0000000|C0439230|C0439531|C0332152|C0038951|C0040223|G0000000|C0011991|C0008059|C0026591|C0011991|C0439531|C0040223
"In addition, patients who received BoNT injection into affected muscles in at least 3 months before recruitment and those who were older than 70 years old were excluded.","In addition, patients received BoNT injection muscles 3 months recruitment 70 excluded.",G0000000|C0332287|C0030705|C1514756|G0000000|C0021485|C0026845|G0000000|C0439231|C2949735|C0450371|C1554077
"Patients were monitored by daily asthma scores, pulmonary function, and exhaled NO.","Patients monitored daily asthma scores, pulmonary function, exhaled NO.",C0030705|C0030695|C0332173|C0004096|C0449820|C0024109|C0031843|C0231800|G0000000
"Results 416 participants were randomised (136 to ibuprofen, 137 to antibiotic, and 143 to placebo) and 390 returned their symptom diaries fully completed.","Results 416 participants randomised (136 ibuprofen, 137 antibiotic, 143 placebo) 390 returned symptom diaries completed.",C1274040|C1442061|C0679646|G0000000|C1442061|C0020740|C1442061|C0003232|C1442061|C0032042|C1442061|C0332156|C1457887|C0376660|C0205197
"We randomized 112 patients to groups that were matched for age, BMI, and OSA severity.","We randomized 112 patients matched age, BMI, OSA severity.",G0000000|C0034656|C1442061|C0030705|C0150103|C0001779|G0000000|C0520679|C0439793
"To further assure blinding, each intervention arm of 4 schools was split into two groups of two schools, each given a letter code (A–H).","To assure blinding, intervention arm 4 schools split schools, letter code (A–H).",C0040363|G0000000|C0150108|C0886296|C0446516|G0000000|C0036375|C1534709|C0036375|C1096774|C0009219|G0000000
We enrolled 2549 smokers.,We enrolled 2549 smokers.,G0000000|G0000000|G0000000|C0337664
This buttresses the point that KM decreases the inability of patient with nonspecific pain at the low back better than PUS therapy.,This buttresses KM decreases inability patient nonspecific pain low PUS therapy.,G0000000|G0000000|G0000000|C0442797|G0000000|C0030705|C0205370|C0030193|C0205251|C0034161|C0039798
Communities were eligible for the study if they had a population between 250 and 600 at the most recent government census and had at least 10% prevalence of active trachoma (TF and/or TI).,Communities eligible study population 250 600 government census 10% prevalence active trachoma (TF and/or TI).,C0009462|C1548635|C0557651|C0032659|C1442061|C1442061|C0018104|C0007663|C0450371|C0033105|C0205177|C0040592|C4048299|G0000000|C0039247
The mothers were of an average age of 25.6 years while the average age of infants was 2.8 months.,The mothers average age 25.6 average age infants 2.8 months.,G0000000|C0026591|C1510992|C0001779|C0450371|C1510992|C0001779|C0021270|G0000000|C0439231
"OUTCOME MEASURES: Number and rate of patients making a first return with sore throat, pharyngitis, or tonsillitis.","OUTCOME MEASURES: Number rate patients return sore throat, pharyngitis, tonsillitis.",C1274040|C0079809|C0237753|C0871208|C0030705|C0332156|C0234233|C0031354|C0031350|C0040425
"To assess the efficacy and safety of hypericum extract (STEI 300, Steiner Arzneimittel, Berlin) compared with imipramine and placebo in patients in primary care with a current episode of moderate depression.","To assess efficacy safety hypericum extract (STEI 300, Steiner Arzneimittel, Berlin) compared imipramine placebo patients primary care current episode moderate depression.",C0040363|C1516048|C1280519|C0036043|C1256259|C2828366|G0000000|C1442061|G0000000|G0000000|C0005125|C1707455|C0020934|C0032042|C0030705|C0205225|C1947933|C0521116|C0332189|C0205081|C0011570
"Additional exclusion criteria were the inability to produce an adequate sputum sample, a FEV1<0.5 L, current smoking or having ceased smoking in the past 6 months, a known hypersensitivity to macrolides, an ECG assessment showing a prolonged QTc interval ≥440 msec or an impairment of liver function.","Additional exclusion criteria inability produce adequate sputum sample, FEV1<0.5 L, current smoking ceased smoking 6 months, hypersensitivity macrolides, ECG assessment prolonged QTc interval ≥440 msec impairment liver function.",C1524062|C0680251|C0243161|G0000000|G0000000|C0205410|C0038056|C0370003|G0000000|C0439394|C0521116|C0037369|C1272693|C0037369|G0000000|C0439231|C0020517|C0003240|C1623258|C1261322|C0439590|G0000000|C1272706|G0000000|C0439223|C0221099|C0023884|C0031843
"Of the 100 patients, 52 were female and 48 male.","Of 100 patients, 52 female 48 male.",G0000000|C1442061|C0030705|C0450371|C0015780|C0450371|C0086582
Cases with acute diarrhoea were consecutively enrolled from the OPD and inpatient paediatric ward.,Cases acute diarrhoea consecutively enrolled OPD inpatient paediatric ward.,C0868928|C0205178|C0011991|G0000000|G0000000|C3810599|C0021562|C0030755|C1305702
Patients: Women (⩾18 years of age) with IBS-C according to the Rome II criteria.,Patients: Women (⩾18 age) IBS-C Rome II criteria.,C0030705|C0043210|G0000000|C0001779|C0022104|C0035831|G0000000|C0243161
"The study population comprises mothers of infants aged 10-20 weeks, who were either exclusively or partially breastfed but had not started CF or had recently started (less than one week prior to enrollment), and lived in the study area.","The study population comprises mothers infants aged 10-20 weeks, exclusively partially breastfed started CF started (less week prior enrollment), lived study area.",G0000000|C0557651|C0032659|C2700400|C0026591|C0021270|C0001779|C0450371|C0439230|G0000000|G0000000|C0006147|C1272689|C0009738|C1272689|C0439092|C0332174|C0332152|C1516879|C1548795|C0557651|C0017446
"Potential subjects were excluded if they: 1) were receiving outpatient physical or occupational therapy; 2) had biomechanical limitations (e.g., contracture) which limited passive digit extension to 20° of finger flexion; 3) had received a botulinum toxin (e.g., Botox®) injection less than 6 months prior to enrollment, 4) had cognitive deficits limiting simple one-step commands, or 5) had significant upper extremity pain (rated as greater than 6/10).","Potential subjects excluded they: 1) receiving outpatient physical occupational therapy; 2) biomechanical limitations (e.g., contracture) limited passive digit extension 20° finger flexion; 3) received botulinum toxin (e.g., Botox®) injection 6 months prior enrollment, 4) cognitive deficits limiting simple one-step commands, 5) upper extremity pain (rated 6/10).",C3245505|C0681850|C1554077|G0000000|G0000000|C1514756|C0029921|C0031809|C0521127|C0039798|G0000000|G0000000|C0449295|G0000000|C0009917|C0439801|C3686820|C0582802|C0231448|G0000000|C0016129|C0231452|G0000000|C1514756|C0006055|C0040549|G0000000|G0000000|C0021485|G0000000|C0439231|C0332152|C1516879|G0000000|C1516691|C2987487|C0439801|C0205352|C0534010|C3639196|G0000000|C1282910|C0015385|C0030193|C0871208|C0450371
Further research on NTI in the advanced cancer setting is needed.,Further NTI advanced cancer setting needed.,C1517331|C1705048|C0205179|C0006826|C0542559|C0027552
The overall case-fatality rate was 5.8% (11/190); 38.9% (7/18) in the 500–1000g birth weight group.,The case-fatality rate 5.8% (11/190); 38.9% (7/18) 500–1000g birth weight group.,G0000000|C0868928|C0871208|G0000000|C0450371|C0450371|C0450371|G0000000|C0005615|C0005910|C0441833
Patients who had not taken SPS in the 7 days before their initial visit were eligible if their serum potassium levels measured for their regular follow-up and on the day of randomization were both from 5.0 to 5.9 mEq/L inclusively.,Patients SPS 7 days initial visit eligible serum potassium levels measured regular follow-up day randomization 5.0 5.9 mEq/L inclusively.,C0030705|C3813609|G0000000|C0439228|C0205265|C0545082|C1548635|C0229671|C0032821|C0441889|C0444706|C0205272|C0589120|C0332173|C0034656|G0000000|G0000000|C0439375|G0000000
"A random screening of 1500 school children from different schools in the city of Amritsar, aged 5–10 years was carried out from September 2013 till October 2013.","A random screening 1500 school children schools city Amritsar, aged 5–10 carried September 2013 till October 2013.",G0000000|C0034656|C0220908|G0000000|C0036375|C0008059|C0036375|C0008848|G0000000|C0001779|G0000000|C0206243|C3828193|G0000000|G0000000|C3828732|G0000000
"Participants (age = 25–75 years) were diagnosed with clinically probable or definite ALS according to the revised El Escorial criteria.13 Other inclusion criteria were as follows: (1) Amyotrophic Lateral Sclerosis Functional Rating Scale–Revised (ALSFRS‐R) score between 31 and 46, (2) stable riluzole treatment (50mg, twice daily) for at least 3 months before screening, and (3) disease duration no longer than 5 years after the onset of the first symptom.","Participants (age = 25–75 years) diagnosed clinically probable definite ALS revised El Escorial criteria.13 Other inclusion criteria follows: (1) Amyotrophic Lateral Sclerosis Functional Rating Scale–Revised (ALSFRS‐R) score 31 46, (2) stable riluzole treatment (50mg, daily) 3 months screening, (3) disease duration 5 onset symptom.",C0679646|C0001779|G0000000|G0000000|C0439234|C0011900|G0000000|C0033204|C0439544|G0000000|C1527075|C1416870|G0000000|C0243161|G0000000|C0007637|C0243161|C0332283|G0000000|C0026846|C0205093|C0036429|C0205245|C0871208|G0000000|G0000000|C0449820|C0450371|C0450371|G0000000|C0205360|C0073379|C0039798|G0000000|C0332173|G0000000|C0439231|C0220908|G0000000|C0012634|C0449238|G0000000|C0206132|C1457887
"Cluster RCT at community- and hospital-based cancer clinics in Western New York and Northern California; 38 medical oncologists (mean age 44.6 years; 11 (29%) female) and 265 community-dwelling adult patients with advanced nonhematologic cancer participated (mean age, 64.4 years, 146 [55.0%] female, 235 [89%] white; enrolled August 2012 to June 2014; followed for 3 years); 194 patients had participating caregivers.","Cluster RCT community- hospital-based cancer clinics Western New York Northern California; 38 medical oncologists (mean age 44.6 years; 11 (29%) female) 265 community-dwelling adult patients advanced nonhematologic cancer participated (mean age, 64.4 years, 146 [55.0%] female, 235 [89%] white; enrolled August 2012 June 2014; 3 years); 194 patients participating caregivers.",C1555715|G0000000|C0009462|C0019994|C0006826|C0442592|C1705493|C0205314|G0000000|C1709269|C0006754|C0450371|C0199168|C0259990|C0444504|C0001779|C0450371|C0439234|C0450371|C0450371|C0015780|C1442061|C4045975|C0001675|C0030705|C0205179|G0000000|C0006826|G0000000|C0444504|C0001779|C0450371|C0439234|C1442061|C0450371|C0015780|C1442061|C0450371|C0007457|G0000000|C3831448|G0000000|C3829443|G0000000|G0000000|C0439234|C1442061|C0030705|C0679823|C0085537
"Exclusion criteria were: a) active symptomatic illness (eg, cancer, heart failure, ischemic heart disease, neuromuscular disease, psychiatric illness); b) unable (eg, severe arthritis) or unwilling to use the study issued cell phone; and c) reside outside of the wireless coverage area.","Exclusion criteria were: a) active symptomatic illness (eg, cancer, heart failure, ischemic heart disease, neuromuscular disease, psychiatric illness); b) unable (eg, severe arthritis) unwilling study issued cell phone; c) reside wireless coverage area.",C0680251|C0243161|G0000000|G0000000|C0205177|C0231220|C0221423|C0013715|C0006826|C0018787|C0231174|C0475224|C0018787|C0012634|C1979768|C0012634|C0205487|C0221423|G0000000|C1299582|C0013715|C0205082|C0003864|C0558080|C0557651|C0033213|C0007634|C1515258|G0000000|C2982691|G0000000|C1551362|C0017446
We included 84 patients with measles in the analyses.,We included 84 patients measles analyses.,G0000000|C0332257|C0450371|C0030705|C0025007|C0002778
"This short-term study, carried out in individuals with CF admitted to hospital with an acute infective pulmonary exacerbation, showed that significantly more sputum was expectorated during a single treatment session and over a 24 h period using the patient's usual ACT than with HFCWO.","This short-term study, carried individuals CF admitted hospital acute infective pulmonary exacerbation, sputum expectorated single treatment session 24 h period patient's usual ACT HFCWO.",G0000000|C0443303|C0557651|C0206243|C0027361|C0009738|C0184666|C0019994|C0205178|G0000000|C0024109|G0000000|C0038056|C0566528|C0037179|C0039798|C1883016|G0000000|C0439531|C0030705|C3538928|C0079613|G0000000
The questionnaires – Patient Reported Costs and Patient Reported Experience - are based on the Better Access and Care for Complex Needs (BeACCoN) Measurement Framework for Evaluation of Primary and Integrated Health Care Innovation for Individuals with Complex Needs.,The questionnaires – Patient Reported Costs Patient Reported Experience - based Better Access Care Complex Needs (BeACCoN) Measurement Framework Evaluation Primary Integrated Health Care Innovation Individuals Complex Needs.,G0000000|C0034394|G0000000|C0030705|C0684224|C0010186|C0030705|C0684224|C0237607|G0000000|C1527178|C0332272|C0444454|C1947933|C0439855|C0027552|G0000000|C0242485|G0000000|C0220825|C0205225|G0000000|C0018684|C1947933|C0683243|C0027361|C0439855|C0027552
"“Join the Healthy Boat” is a multicomponent health promotion programme for kindergarten children (three to six years old) in southwest Germany, which was developed by means of Bartholomew's Intervention Mapping Approach (IMA; see Figure 1) [18].","“Join Healthy Boat” multicomponent health promotion programme kindergarten children (three old) southwest Germany, developed Bartholomew's Intervention Mapping Approach (IMA; Figure 1) [18].",G0000000|C3898900|G0000000|G0000000|C0018684|C0033414|C1709697|C0681406|C0008059|C0205449|C0580836|C1710136|C0017480|G0000000|G0000000|C0886296|C1283195|C0449445|G0000000|G0000000|G0000000|C0450371
Adult subjects with CF were enrolled if they had one second forced expiratory volumes (FEV1) of 40–110% of predicted and a BMI < 30 kg/m2.,Adult subjects CF enrolled forced expiratory volumes (FEV1) 40–110% predicted BMI < 30 kg/m2.,C0001675|C0681850|C0009738|G0000000|C0441722|C0231800|C0449468|G0000000|G0000000|C0681842|G0000000|G0000000|C0450371|C0022718
Women assigned to the observational group received nevirapine plus zidovudine–lamivudine.,Women assigned observational received nevirapine zidovudine–lamivudine.,C0043210|C1516050|C1518527|C1514756|C0132326|G0000000
"Detailed medical information from the subject's neurologist or primary physician was not always available, therefore diagnostic classification systems were only provided in 30% of the subjects.","Detailed medical subject's neurologist primary physician available, diagnostic classification systems provided 30% subjects.",C1522508|C0199168|C0681850|C0237426|C0205225|C0031831|C0470187|C0011900|C0008902|C0449913|C1999230|C0450371|C0681850
The participants will be adults (>18 years of age) receiving mechanical ventilation for 1 day and expected to require an additional 2 days or more in the ICU.,The participants adults (>18 age) receiving mechanical ventilation 1 day expected require additional 2 days ICU.,G0000000|C0679646|C0001675|C0450371|C0001779|C1514756|C0443254|C0035203|G0000000|C0332173|C1517001|G0000000|C1524062|G0000000|C0439228|C0021708
"We excluded by randomization patients with a Karnofsky performance score ≤ 70, a life expectancy ≤ 1 year, persistent vomiting or diarrhea, fistulizing disease, known Crohn’s disease or ulcerative colitis, intra-abdominal abscesses or fever (more than 37.5°C) at the time of enrolment, or clinical, microbiological, or imaging evidence of sepsis syndrome, and requirement for continuous antibiotic treatment or use of antibiotics in the last 2 wk before initiation of VSL#3 therapy.","We excluded randomization patients Karnofsky performance score ≤ 70, life expectancy ≤ 1 year, persistent vomiting diarrhea, fistulizing disease, Crohn’s disease ulcerative colitis, intra-abdominal abscesses fever (more 37.5°C) time enrolment, clinical, microbiological, imaging evidence sepsis syndrome, requirement continuous antibiotic treatment antibiotics 2 wk initiation VSL#3 therapy.",G0000000|C1554077|C0034656|C0030705|C0206065|C0597198|C0449820|G0000000|C0450371|C0376558|C0679138|G0000000|G0000000|C0439234|C0205322|C0042963|C0011991|G0000000|C0012634|G0000000|C0012634|C0041582|C0009319|C0230168|C0000833|C0015967|C0205172|G0000000|C0040223|C1516879|C0205210|C0025953|C0011923|C3887511|C0036690|C0039082|C1514873|C0549178|C0003232|C0039798|C0003232|G0000000|C0332174|C0589507|G0000000|C0039798
"Exclusion criteria were current hospitalization, altered mental status (Mini-Mental Status Examination score <23), psychosis, current substance abuse, current ongoing psychotherapy, a change in psychotropic medication in the last 6 months, or lack of English proficiency to participate in talk therapy.","Exclusion criteria current hospitalization, altered mental status (Mini-Mental Status Examination score <23), psychosis, current substance abuse, current ongoing psychotherapy, change psychotropic medication 6 months, lack English proficiency participate talk therapy.",C0680251|C0243161|C0521116|C0019993|C0392747|C0229992|C0449438|C0445542|C0449438|G0000000|C0449820|C0450371|C0033975|C0521116|C0439861|C0013146|C0521116|C0549178|C0033968|C0392747|C0033978|C0013227|G0000000|C0439231|C0332268|C0376245|G0000000|G0000000|C0037817|C0039798
"For the trial, women were asked to volunteer for HIV testing during their first antenatal visit.","For trial, women volunteer HIV testing antenatal visit.",G0000000|C0008976|C0043210|C0042960|C0019682|C0039593|C2828394|C0545082
Semi-structured interviews in both arms will explore perceptions of factors perceived to influence quality of EOL care for residents with advanced dementia.,Semi-structured interviews arms explore perceptions factors perceived influence quality EOL care residents advanced dementia.,C0678594|C0021822|C0206655|G0000000|C0030971|C1521761|C0030971|C4054723|C0332306|G0000000|C1947933|C1320928|C0205179|C0011265
"There were 4 women and 4 men, ranging in ages from 65 to 82 years (mean 75.2 ± 6.2) in case group, and 5 women and 5 men in control group.","There 4 women 4 men, ranging ages 65 82 (mean 75.2 ± 6.2) group, 5 women 5 control group.",G0000000|G0000000|C0043210|G0000000|C0025266|C1514721|C0001779|C0450371|C0450371|C0444504|C0450371|G0000000|G0000000|C0441833|G0000000|C0043210|G0000000|C0243148|C0441833
"A total of 427 patients were randomized, of whom 423 received study medication.","A total 427 patients randomized, 423 received study medication.",G0000000|C0439175|C1442061|C0030705|C0034656|C1442061|C1514756|C0557651|C0013227
QALS (the clinical trial of high dose Coenzyme Q10 in ALS) was conducted in 19 US centers.,QALS (the clinical trial dose Coenzyme Q10 ALS) conducted 19 US centers.,G0000000|G0000000|C0205210|C0008976|C0178602|C0009235|G0000000|G0000000|C0004927|C0450371|G0000000|C0205099
Interventions to help caregivers smoke away from their children may yield important health benefits.,Interventions caregivers smoke children yield health benefits.,C0886296|C0085537|C0037366|C0008059|G0000000|C0018684|C0814225
"To assess the efficacy of the intervention, baseline web-based surveys will be conducted with Grade 7 students.","To assess efficacy intervention, baseline web-based surveys conducted Grade 7 students.",C0040363|C1516048|C1280519|C0886296|C0168634|C0282111|C0038951|C0004927|C0441800|G0000000|C0038492
"Participants were recruited, enrolled and completed the protocol in one nursing home at a time.","Participants recruited, enrolled completed protocol nursing time.",C0679646|G0000000|G0000000|C0205197|C0442711|C0006147|C0040223
No cows' milk was given during the first nine months of life and no egg and fish up to 12 months of age.,No cows' milk months life egg fish 12 months age.,G0000000|C3539595|C0026131|C0439231|C0376558|C0013710|C0016163|C0450371|C0439231|C0001779
A total of 300 individuals per group will be included.,A total 300 individuals included.,G0000000|C0439175|C1442061|C0027361|C0332257
"Subjects with pregnancy, ASA class I and II, absence of hypertension, coagulation disorders, migraines and chronic headaches, no history of allergies to medicinal plants, no history of anosmia were included.","Subjects pregnancy, ASA class I II, absence hypertension, coagulation disorders, migraines chronic headaches, history allergies medicinal plants, history anosmia included.",C0681850|C0032961|C0004057|C0456387|C0021966|G0000000|C0332197|C0020538|C0005778|C0012634|C0149931|C0205191|C0018681|C0019664|C0020517|G0000000|C0032098|C0019664|C0003126|C0332257
"—From a total of 56 062 patients we identified 3860 adults on the practices' asthma registers, of whom 1813 had requested a bronchodilator in the previous six months.","—From total 56 062 patients identified 3860 adults practices' asthma registers, 1813 requested bronchodilator previous months.",G0000000|C0439175|G0000000|C0030705|C0205396|G0000000|C0001675|C0237607|C0004096|C0600375|G0000000|C1272683|C0006280|C0205156|C0439231
"METHODS: From May 1994 to July 1995, a population-based 1:2 case-control study was in Carried out in high-risk areas of gastric cancer, Changle and Fuqing cities, Fujian Province.","METHODS: From May 1994 July 1995, population-based 1:2 case-control study Carried high-risk gastric cancer, Changle Fuqing cities, Fujian Province.",C0025663|G0000000|G0000000|G0000000|C3829447|G0000000|C0032659|G0000000|C0872128|C0557651|C0206243|C0332167|C0038351|C0006826|G0000000|G0000000|C0008848|G0000000|C1514578
"Differences between control and intervention changes over time (ie, difference in differences between the baseline and intervention period cohorts of patients) in HPV vaccine series initiation (≥1 dose) and completion (≥3 doses) among patients aged 11 to 17 years seen at the practices between February 1, 2015, and January 31, 2016.","Differences control intervention time (ie, difference differences baseline intervention period cohorts patients) HPV vaccine series initiation (≥1 dose) completion (≥3 doses) patients aged 11 17 practices February 1, 2015, January 31, 2016.",C1705241|C0243148|C0886296|C0040223|G0000000|C1705241|C1705241|C0168634|C0886296|C0439531|C0599755|C0030705|C0021344|C0042210|C0205549|C0589507|G0000000|C0178602|C0205197|G0000000|C0178602|C0030705|C0001779|C0450371|C0450371|C0237607|C3830166|G0000000|G0000000|C3829466|C0450371|G0000000
"Inclusion criteria were type 2 diabetes, age 40–75 years, active diabetic nephropathy (UAE 15–300 mg/24 h or equivalent albumin-to-creatinine ratio [males 1.25–25, females 1.75–35 mg/mmol] in two of three samples within 2–6 weeks) despite ACE-Is and/or ARBs in unchanged dose for at least 3 months, glycated hemoglobin (A1C) <8.5%, and an estimated glomerular filtration rate of >30 ml/min.","Inclusion criteria type 2 diabetes, age 40–75 years, active diabetic nephropathy (UAE 15–300 mg/24 equivalent albumin-to-creatinine ratio [males 1.25–25, females 1.75–35 mg/mmol] samples 2–6 weeks) ACE-Is and/or ARBs unchanged dose 3 months, glycated hemoglobin (A1C) <8.5%, estimated glomerular filtration rate >30 ml/min.",C0007637|C0243161|C0332307|G0000000|C0011847|C0001779|G0000000|C0439234|C0205177|C0241863|C0022658|C1519789|G0000000|C0026410|C0205163|C0486293|C0456603|C0086582|G0000000|C0015780|G0000000|C0567349|C0370003|G0000000|C0439230|C1452534|G0000000|C3888198|C0442739|C0178602|G0000000|C0439231|C3666909|C0019046|G0000000|G0000000|C0750572|C0022663|C0016107|C0871208|C0450371|C0439445
"In conclusion, ginger is more effective than acupressure in alleviating mild to moderate NVP in symptomatic women before 16 weeks’ gestation of pregnancy.","In conclusion, ginger effective acupressure alleviating mild moderate NVP symptomatic women 16 weeks’ gestation pregnancy.",G0000000|C1707478|C0162751|C1280519|C0282614|G0000000|C2945599|C0205081|C0132326|C0231220|C0043210|C0450371|G0000000|C0032961|C0032961
"Characteristics of children in the sample EHFP, enhanced homestead food production; MNP, micronutrient powders; WAZ, weight‐for‐age z‐score; HAZ, length‐for‐age z‐score; WHZ, weight‐for‐length z‐score; BMI, body mass index.","Characteristics children sample EHFP, enhanced homestead food production; MNP, micronutrient powders; WAZ, weight‐for‐age z‐score; HAZ, length‐for‐age z‐score; WHZ, weight‐for‐length z‐score; BMI, body mass index.",C1521970|C0008059|C0370003|G0000000|C2349975|G0000000|C0016452|C0033268|C0282245|C0040577|C0032861|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|C0242821|C0577559|C0918012
"The employee sample was part of a larger multiple risk behavior study on smoking, diet, sun exposure and exercise.","The employee sample larger multiple risk behavior study smoking, diet, sun exposure exercise.",G0000000|C0599987|C0370003|C0549177|C0439064|C0035647|C0004927|C0557651|C0037369|C0012155|C0038817|C0274281|C0015259
"The iQuit system builds on these interventions; it is a programme designed to be used by a primary care nurse or other smoking cessation adviser (SCA), which generates a highly tailored advice report and initiates a 90-day programme of automated tailored text messages sent to the smoker's mobile phone.","The iQuit system builds interventions; programme designed primary care nurse smoking cessation adviser (SCA), generates highly tailored advice report initiates 90-day programme automated tailored text messages smoker's mobile phone.",G0000000|G0000000|C0449913|C1707059|C0886296|C1709697|C1707689|C0205225|C1947933|C0028661|C0037369|C1880019|G0000000|C0018790|G0000000|C0205250|C0402883|C0150600|C0684224|C1548602|C0450371|C1709697|C0205554|C0402883|C1527021|C0470166|C0337664|C0231435|C1515258
Participants who completed 12- and/or 18-month follow-up surveys received 10 dollar gift certificate incentives.,Participants completed 12- and/or 18-month follow-up surveys received 10 dollar gift certificate incentives.,C0679646|C0205197|C0450371|G0000000|C0450371|C0589120|C0038951|C1514756|C0450371|C0562019|C0423899|C0586303|C0021147
"For treatment areas comprising multiple clinically distinct lesions, a single diagnostic biopsy was performed and all clinically similar lesions in that area were treated as for the histological diagnosis of the index lesion.","For treatment comprising multiple clinically distinct lesions, single diagnostic biopsy performed clinically lesions treated histological diagnosis lesion.",G0000000|C0039798|C2700400|C0439064|G0000000|G0000000|C0221198|C0037179|C0011900|C0005558|C0884358|G0000000|C0221198|C1522326|C0205462|C0011900|C0221198
Eligible patients were children 9 years of age and under who had febrile influenza symptoms of no more than 36-h duration.,Eligible patients children 9 age febrile influenza symptoms 36-h duration.,C1548635|C0030705|C0008059|G0000000|C0001779|C0015967|C0021400|C0683368|C0450371|C0449238
"Of the remaining 152 303 study participants, 76 224 were in the intervention group and 76 079 were in the control group.","Of remaining 152 303 study participants, 76 224 intervention 76 079 control group.",G0000000|C1527428|C1442061|C1442061|C0557651|C0679646|C0450371|C1442061|C0886296|C0450371|C1442061|C0243148|C0441833
"Fifty-nine were female, and 41 were male.","Fifty-nine female, 41 male.",C3830128|C0015780|C0450371|C0086582
"One hundred seven children, aged 8–13 years, with a minimum myopia of −0.75 diopters (cycloplegic) in one eye were screened using two subject visits with an average interval of 6 months.","One children, aged 8–13 years, minimum myopia −0.75 diopters (cycloplegic) eye screened subject visits average interval 6 months.",C0205447|C0008059|C0001779|G0000000|C0439234|C1524031|C0027092|G0000000|C0439484|C0010586|C0015392|C0220908|C0681850|C0545082|C1510992|C1272706|G0000000|C0439231
"The region has one district general hospital, two health centres and a network of 30 nurse-run primary care clinics.","The region district hospital, health centres network 30 nurse-run primary care clinics.",G0000000|C0017446|G0000000|C0019994|C0018684|C0205099|C0150775|C0450371|C0028661|C0205225|C1947933|C0442592
Subjects responded to the email and were deemed appropriate for the inclusion criteria if each self-reported an acute episode of LPP within the previous 6 weeks and demonstrated an anterior innominate rotation as defined by a bilateral difference of 2° or greater.,Subjects responded email deemed inclusion criteria self-reported acute episode LPP previous 6 weeks demonstrated anterior innominate rotation defined bilateral difference 2° greater.,C0681850|G0000000|C0013849|G0000000|C0007637|C0243161|C0681906|C0205178|C0332189|C1416904|C0205156|G0000000|C0439230|G0000000|C0205094|G0000000|C0035868|C1704788|C0238767|C1705241|G0000000|C1704243
"Long day care services (centre-based services typically open ≥8 hours/day) located within NSW, Australia, served as the sampling frame.","Long day care services (centre-based services typically ≥8 hours/day) located NSW, Australia, served sampling frame.",C0205166|C0332173|C1947933|C0557854|C0205099|C0557854|G0000000|G0000000|C0556974|G0000000|G0000000|C0004340|G0000000|C0441621|C0080089
The ramp-up time for each stimulation was 1 second; these are the usual settings for LFS in the treatment of anal incontinence (e5).,The ramp-up time stimulation 1 second; usual settings LFS treatment anal incontinence (e5).,G0000000|C0034646|C0040223|C1292856|G0000000|C0205436|C3538928|C0542559|C0085390|C0039798|C0003461|C0021167|C1704625
Setting Three subacute wards in a metropolitan hospital specialising in rehabilitation and care of elderly patients.,Setting Three subacute wards metropolitan hospital specialising rehabilitation care elderly patients.,C0542559|C0205449|C0205365|C1305702|C0599587|C0019994|C0205555|C0034991|C1947933|C0001792|C0030705
"Exclusion criteria were female DMD carrier status, use of carnitine, other aminoacids, creatine, glutamine, coenzyme Q10, or any herbal supplements within 3 months prior to enrollment, significant concomitant illness including cardiomyopathy, positive response to purified protein derivative, and either no prior exposure to chickenpox or no varicella immunization.","Exclusion criteria female DMD carrier status, carnitine, aminoacids, creatine, glutamine, coenzyme Q10, herbal supplements 3 months prior enrollment, concomitant illness including cardiomyopathy, positive response purified protein derivative, prior exposure chickenpox varicella immunization.",C0680251|C0243161|C0015780|G0000000|C0007294|C0449438|C0007258|C0002520|C0010286|C0017797|C0009235|G0000000|C3146288|C0242295|G0000000|C0439231|C0332152|C1516879|C0521115|C0221423|C0332257|C0878544|C0439178|C0871261|C1998793|C0033684|C1527240|C0332152|C0274281|C0008049|C0008049|C0020971
Multiple Sclerosis (MS) is a demyelinating disease of the nervous system which has numerous disabling effects on patients.,Multiple Sclerosis (MS) demyelinating disease nervous system numerous disabling effects patients.,C0439064|C0036429|C0039676|G0000000|C0012634|C0027769|C0449913|C0439064|G0000000|C1280500|C0030705
"One-hundred and twenty teeth (57 primary first molars and 63 primary second molars) in 58 children were followed up clinically and radiographically after 1, 3, 6, 9, and 12 months.","One-hundred twenty teeth (57 primary molars 63 primary molars) 58 children clinically radiographically 1, 3, 6, 9, 12 months.",C0205447|C0724000|C0040426|C0450371|C0205225|C0026367|C0450371|C0205225|C0026367|C0450371|C0008059|G0000000|G0000000|G0000000|G0000000|G0000000|G0000000|C0450371|C0439231
"76 consecutive patients with severe OSA (mean ± SD AHI 60.2 ± 32.9 events/hour, ESS 13.6 ± 4.5/24, BMI 35.6 ± 7.8 kg/m2), without significant cardiac, respiratory, psychiatric, or sleep comorbidities.","76 consecutive patients severe OSA (mean ± SD AHI 60.2 ± 32.9 events/hour, ESS 13.6 ± 4.5/24, BMI 35.6 ± 7.8 kg/m2), cardiac, respiratory, psychiatric, sleep comorbidities.",C0450371|C1707491|C0030705|C0205082|C0520679|C0444504|G0000000|C2699239|G0000000|C0450371|G0000000|C0450371|C0441471|C0206630|C0450371|G0000000|C0450371|G0000000|C0450371|G0000000|G0000000|C0022718|C0018787|C0521346|C0205487|C0037313|C0009488
"A total of 32 patients (17 women) with CF, mean (± SD) age 18.5±8.6 years, completed the study.","A total 32 patients (17 women) CF, (± SD) age 18.5±8.6 years, completed study.",G0000000|C0439175|C0450371|C0030705|C0450371|C0043210|C0009738|G0000000|C2699239|C0001779|G0000000|C0439234|C0205197|C0557651
"We excluded patients known to be sensitive to cholinesterase inhibitors or antipsychotics and those with advanced, severe, progressive, or unstable disease that might interfere with efficacy or put the patient at special risk; disability that might prevent them from completing study procedures; those with severe, unstable, or poorly controlled medical conditions; bradycardia (< 50), sick sinus syndrome, or conduction defects; current diagnosis of active uncontrolled peptic ulceration within the past three months; and clinically significant urinary obstruction.","We excluded patients sensitive cholinesterase inhibitors antipsychotics advanced, severe, progressive, unstable disease interfere efficacy patient special risk; disability prevent completing study procedures; severe, unstable, controlled medical conditions; bradycardia (< 50), sick sinus syndrome, conduction defects; current diagnosis active uncontrolled peptic ulceration months; clinically urinary obstruction.",G0000000|C1554077|C0030705|C0020517|C0008429|C0243077|C0040615|C0205179|C0205082|C0205329|C0443343|C0012634|C0521102|C1280519|C0030705|C0205555|C0035647|C0231170|C0309872|C0205197|C0557651|C0025664|C0205082|C0443343|C2587213|C0199168|C0012634|C0428977|G0000000|C0450371|C0221423|C0016169|C0039082|C0232217|C0243067|C0521116|C0011900|C0205177|C0205318|C0443277|C0041582|C0439231|G0000000|C0042027|C0028778
IBS affects 10-22% of the UK population.,IBS 10-22% UK population.,C0022104|C0450371|C0041700|C0032659
"It is practically not possible for the therapist to treat single subject for 6-7 h and hence the present study aims to determine the effect of m-CIMT in improving the upper extremity function of stroke subjects in 2 h. Stroke subjects were recruited from Central Referral Hospital and STNM Hospital in Sikkim, India by simple random sampling method.","It practically therapist treat single subject 6-7 study aims determine m-CIMT improving upper extremity function stroke subjects 2 h. Stroke subjects recruited Central Referral Hospital STNM Hospital Sikkim, India simple random sampling method.",G0000000|G0000000|C0871525|C0087111|C0037179|C0681850|G0000000|C0557651|C1947946|G0000000|C0369637|C1272745|C1282910|C0015385|C0031843|C0038454|C0681850|G0000000|C0033727|C0038454|C0681850|G0000000|C0205099|C0034927|C0019994|G0000000|C0019994|C0037091|C0021201|C0205352|C0034656|C0441621|C0025663
Physicians of two German medical centers will participate in a workshop for communication skills and will be randomized to either a group with one coaching session or a group with four coaching sessions following the workshop.,Physicians German medical centers participate workshop communication skills randomized coaching session coaching sessions workshop.,C0031831|C1556085|C0199168|C0205099|G0000000|C0242262|C0009452|C0678856|C0034656|C0557773|C1883016|C0557773|C1883016|C0242262
"Additionally, patients with rifampicin-monoresistance or those with clinically presumed MDR TB, based on multiple treatment failures despite directly observed therapy (DOT), or those who were close contacts of patients with MDR TB, were also eligible for treatment.","Additionally, patients rifampicin-monoresistance clinically presumed MDR TB, based multiple treatment failures directly observed therapy (DOT), close contacts patients MDR TB, eligible treatment.",G0000000|C0030705|C0035608|G0000000|G0000000|G0000000|G0000000|C1527178|C0439064|C0039798|C0231174|C1947931|C1441672|C0039798|C0872145|C0587267|C4036459|C0030705|G0000000|G0000000|C1548635|C0039798
"The participant inclusion eligibility criteria are as follows: (1) aged 18 or above, (2) living in Australia at the time of the study, (3) easy access to the Internet and email on a regular basis, (4) doctor diagnosis of asthma, and (5) adequate English reading and written ability.","The participant inclusion eligibility criteria follows: (1) aged 18 above, (2) living Australia time study, (3) easy access Internet email regular basis, (4) doctor diagnosis asthma, (5) adequate English reading written ability.",G0000000|C0679646|C0007637|C0013893|C0243161|C0332283|G0000000|C0001779|C0450371|C1282910|G0000000|C0376558|C0004340|C0040223|C0557651|G0000000|C0332219|C0444454|C0282111|C0013849|C0205272|C1527178|G0000000|C0031831|C0011900|C0004096|G0000000|C0205410|C0376245|C0034754|C0043266|C0085732
"Eligible patients had either a documented history of ICS use for at least 4 weeks before screening, at a daily dose of not more than 500 μg fluticasone HFA pMDI (or equivalent), or were not on ICS therapy for at least 12 weeks prior to the screening visit.","Eligible patients documented history ICS 4 weeks screening, daily dose 500 μg fluticasone HFA pMDI (or equivalent), ICS therapy 12 weeks prior screening visit.",C1548635|C0030705|C1301725|C0019664|C0022521|G0000000|C0439230|C0220908|C0332173|C0178602|C1442061|G0000000|C0082607|C0015458|G0000000|G0000000|C0205163|C0022521|C0039798|C0450371|C0439230|C0332152|C0220908|C0545082
"The study is a randomized controlled trial to test an oral health promotion intervention aimed at new-born children and their parents/carers in metropolitan Perth (population 1.7 million) and the regional cities of Bunbury (population 32,000) and Busselton (population 31,000) in Western Australia.","The study randomized controlled trial test oral health promotion intervention aimed new-born children parents/carers metropolitan Perth (population 1.7 million) regional cities Bunbury (population 32,000) Busselton (population 31,000) Western Australia.",G0000000|C0557651|C0034656|C2587213|C0008976|C0022885|C0442027|C0018684|C0033414|C0886296|C1947946|C0021289|C0008059|C0030551|C0599587|G0000000|C0032659|G0000000|C1881839|C0205147|C0008848|G0000000|C0032659|C0450371|G0000000|C0032659|C0450371|C1705493|C0004340
"MORDOR was a large simple trial that randomized communities in Malawi, Niger, and Tanzania to 4 biannual mass distributions of either oral azithromycin or placebo.","MORDOR simple trial randomized communities Malawi, Niger, Tanzania 4 biannual mass distributions oral azithromycin placebo.",G0000000|C0205352|C0008976|C0034656|C0009462|C0024548|C0028074|C0039298|G0000000|G0000000|C0577559|C0037775|C0442027|C0052796|C0032042
"All residents aged 55-64 years living in the city of Oslo and Telemark County, Norway, who were registered and alive in the national population registry by November 1998 (n=55 736), were eligible for the NORCCAP trial 1.","All residents aged 55-64 living city Oslo Telemark County, Norway, registered alive national population registry November 1998 (n=55 736), eligible NORCCAP trial 1.",G0000000|C1320928|C0001779|C0450371|C0376558|C0008848|G0000000|G0000000|C0079170|C0028423|C1514821|C0376558|C3245503|C0032659|C0034975|C3828767|G0000000|G0000000|C1548635|G0000000|C0008976|G0000000
In a prospective trial involving three hospitals in the Zhejiang Province (China) 250 patients with a recent (less than 1 week previous) episode of ischemic stroke will be included.,In prospective trial involving hospitals Zhejiang Province (China) 250 patients (less 1 week previous) episode ischemic stroke included.,G0000000|C0023981|C0008976|C1314939|C0019994|G0000000|C1514578|C0008115|C1442061|C0030705|C0439092|G0000000|C0332174|C0205156|C0332189|C0475224|C0038454|C0332257
"Among the 42 chronic relapse type cases, 19 were males and 23 females with an average age of 32.6 years.","Among 42 chronic relapse type cases, 19 males 23 females average age 32.6 years.",G0000000|C0450371|C0205191|C0035020|C0332307|C0868928|C0450371|C0086582|C0450371|C0015780|C1510992|C0001779|C0450371|C0439234
The final cohort for randomization included 16 practices (4 family medicine and 12 pediatrics) that included 188 medical professionals.,The final cohort randomization included 16 practices (4 family medicine 12 pediatrics) included 188 medical professionals.,G0000000|C0205088|C0599755|C0034656|C0332257|C0450371|C0237607|G0000000|C0015576|C0013227|C0450371|C0030755|C0332257|C1442061|C0199168|C0679924
The non-IVF comparison group consisted of 6604 women whose subfertility was diagnosed in the four participating clinics that had a computerized registry of all subfertile women evaluated during 1980–1995.,The non-IVF comparison consisted 6604 women subfertility diagnosed participating clinics computerized registry subfertile women evaluated 1980–1995.,G0000000|C1518422|C1707455|C0332529|G0000000|C0043210|C0729353|C0011900|C0679823|C0442592|G0000000|C0034975|C0729353|C0043210|C0220825|G0000000
"Inclusion criteria were men and women aged 70 years or older and who had two or more falls or one injurious fall in the past 12 months, which was determined by self report.","Inclusion criteria women aged 70 falls injurious fall 12 months, determined report.",C0007637|C0243161|C0043210|C0001779|C0450371|C0000921|G0000000|C0085639|C0450371|C0439231|G0000000|C0684224
